data_6qh2_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6qh2 _Structure_validation_residue.Date_analyzed 2019-04-05 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.7 mm . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 122.185 0.993 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . 0.3 47.0 m-70 -121.75 165.12 16.3 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 112.28 -2.236 . . . . 0.0 106.542 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -149.05 162.78 39.25 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 124.501 3.319 . . . . 0.0 111.415 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.9 tt -128.27 146.23 34.11 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 1 N-CA-C 99.485 -4.265 . . . . 0.0 99.485 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HZ1' ' CG ' ' A' ' 52' ' ' ASP . 51.7 tttm -126.97 130.15 49.52 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.138 -1.601 . . . . 0.0 107.174 176.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.6 pt -139.51 170.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -161.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -81.61 140.71 47.93 Favored Pre-proline 0 C--O 1.192 -1.948 0 O-C-N 119.325 -2.109 . . . . 0.0 113.41 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -50.62 -26.64 17.45 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 123.198 2.599 . . . . 0.0 116.421 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -69.09 -25.81 64.61 Favored 'General case' 0 C--O 1.214 -0.78 0 O-C-N 119.909 -1.744 . . . . 0.0 113.636 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -82.16 -11.09 58.92 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.272 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.5 -35.5 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.566 0.698 . . . . 0.0 109.587 171.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -59.52 -36.63 76.47 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.83 -45.13 90.96 Favored 'General case' 0 C--N 1.355 0.804 0 C-N-CA 126.046 1.738 . . . . 0.0 111.904 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 t -66.07 -46.59 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 CA-C-O 115.562 -2.161 . . . . 0.0 114.579 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.6 mm -58.83 -38.36 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 123.65 2.932 . . . . 0.0 112.519 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.43 -127.06 8.16 Favored Glycine 0 CA--C 1.555 2.542 0 O-C-N 121.269 -0.895 . . . . 0.0 112.252 -172.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -104.69 95.54 5.96 Favored 'General case' 0 C--N 1.387 2.197 0 C-N-CA 128.417 2.687 . . . . 0.0 106.309 164.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.06 41.8 86.05 Favored Glycine 0 CA--C 1.479 -2.17 0 CA-C-O 114.708 -3.273 . . . . 0.0 116.152 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.53 12.2 57.32 Favored Glycine 0 N--CA 1.438 -1.224 0 O-C-N 127.648 2.617 . . . . 0.0 114.556 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.8 p -61.86 -52.25 64.88 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.86 -46.15 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 125.345 1.653 . . . . 0.0 113.111 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.3 mm -50.5 -47.06 27.45 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.385 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -56.61 -45.38 81.5 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.068 1.347 . . . . 0.0 110.816 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.72 73.34 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.069 -1.053 . . . . 0.0 113.439 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.48 -32.15 73.33 Favored 'General case' 0 C--O 1.199 -1.588 0 CA-C-O 117.457 -1.258 . . . . 0.0 112.783 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.8 m -66.3 -44.26 83.98 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 166.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -63.83 -45.61 88.79 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-O 121.611 0.72 . . . . 0.0 112.351 175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -64.55 -57.5 8.97 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.972 1.368 . . . . 0.0 110.435 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.5 p -79.53 -37.88 35.55 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.889 -167.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.9 22.48 57.69 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 123.792 1.773 . . . . 0.0 115.158 -170.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.8 p -109.58 165.36 11.72 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.472 -1.364 . . . . 0.0 110.204 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.1 m -106.11 132.52 52.09 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.56 124.03 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.859 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 -162.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -124.55 143.89 50.44 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.2 mt -118.37 143.85 28.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 125.915 2.009 . . . . 0.0 108.224 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -142.79 155.11 44.77 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.27 65.9 m-20 -48.27 167.88 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -169.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.407 ' CG ' ' HZ1' ' A' ' 19' ' ' LYS 0.291 27.2 t0 61.41 25.18 15.18 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 113.188 -1.824 . . . . 0.0 109.454 -177.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.25 23.42 58.93 Favored Glycine 0 C--N 1.375 2.718 0 C-N-CA 126.085 1.802 . . . . 0.0 117.009 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 m -84.3 131.04 34.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 126.953 2.208 . . . . 0.0 112.707 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.45 119.42 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -99.47 131.99 45.11 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.025 2.93 . . . . 0.0 104.378 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.38 115.6 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 0 CA-C-O 123.516 1.627 . . . . 0.0 106.841 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.43 130.95 49.36 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 111.226 -2.715 . . . . 0.0 108.854 -174.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.03 170.62 18.44 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.033 1.733 . . . . 0.0 106.388 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 t -109.19 -9.86 15.0 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.679 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -123.02 131.91 53.91 Favored 'General case' 0 C--O 1.199 -1.573 0 O-C-N 117.591 -3.193 . . . . 0.0 105.825 168.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.31 -44.82 10.69 Favored Glycine 0 N--CA 1.508 3.448 0 C-N-CA 128.276 2.846 . . . . 0.0 112.24 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.27 -39.64 76.08 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -65.31 -47.84 75.18 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.48 84.32 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 117.627 -1.629 . . . . 0.0 113.355 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -53.28 -47.63 68.99 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 170.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -64.75 -44.71 89.23 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 171.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.12 74.16 Favored 'General case' 0 C--O 1.255 1.385 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 172.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.4 mt -59.99 -43.64 92.9 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 CA-C-O 123.856 1.789 . . . . 0.0 111.714 173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -63.08 -43.75 97.68 Favored 'General case' 0 N--CA 1.496 1.826 1 O-C-N 116.2 -4.063 . . . . 0.0 112.508 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -66.31 -41.05 90.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 117.58 -1.2 . . . . 0.0 112.773 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.4 mt -57.2 -44.92 84.4 Favored 'Isoleucine or valine' 0 C--N 1.379 1.851 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 164.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -56.23 -40.2 73.74 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.23 1.581 . . . . 0.0 113.535 170.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -71.43 -36.98 71.48 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 121.51 0.671 . . . . 0.0 112.779 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 mt -65.54 -23.45 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 119.06 -2.275 . . . . 0.0 114.727 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.506 2.342 0 CA-C-O 124.978 2.323 . . . . 0.0 110.855 175.162 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.2 mm . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.0 154.8 44.16 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.86 147.81 8.25 Favored 'Isoleucine or valine' 0 C--N 1.386 2.168 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.09 2.57 89.0 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -93.4 136.1 34.0 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 118.248 1.024 . . . . 0.0 112.536 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.4 t -104.33 134.57 45.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -141.21 174.88 10.11 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 112.579 -2.101 . . . . 0.0 112.651 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -116.26 125.25 51.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.55 176.72 20.17 Favored Glycine 0 C--O 1.18 -3.28 0 CA-C-N 112.76 -2.018 . . . . 0.0 110.894 -168.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -148.21 125.74 11.71 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 123.764 1.745 . . . . 0.0 111.478 -167.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.11 117.11 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 113.112 -1.858 . . . . 0.0 111.226 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -103.65 -36.82 7.76 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-O 118.321 -0.847 . . . . 0.0 113.133 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.0 mtm-85 -153.98 126.26 7.95 Favored 'General case' 0 C--O 1.199 -1.592 0 CA-C-O 123.039 1.399 . . . . 0.0 110.519 -168.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.2 115.85 50.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 C-N-CA 125.404 1.482 . . . . 0.0 108.74 -170.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.05 165.71 9.9 Favored 'Isoleucine or valine' 0 C--N 1.374 1.644 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -42.59 -36.87 1.5 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.034 1.734 . . . . 0.0 115.603 175.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -114.18 13.84 18.06 Favored 'General case' 0 CA--C 1.562 1.44 0 O-C-N 120.181 -1.574 . . . . 0.0 114.181 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.05 -179.45 41.25 Favored Glycine 0 CA--C 1.483 -1.921 0 C-N-CA 117.822 -2.132 . . . . 0.0 111.803 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.67 144.51 49.22 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 119.854 -1.968 . . . . 0.0 108.533 170.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -85.47 122.95 30.34 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.827 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.9 t -125.87 120.99 58.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 O-C-N 125.854 1.971 . . . . 0.0 106.521 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.59 139.39 30.59 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 126.25 2.219 . . . . 0.0 107.58 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.274 16.8 pt -131.93 168.49 23.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 110.964 -2.834 . . . . 0.0 110.311 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.59 132.77 3.7 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 119.827 2.691 . . . . 0.0 119.827 -169.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.69 11.08 75.01 Favored Glycine 0 N--CA 1.506 3.334 0 CA-C-O 117.626 -1.652 . . . . 0.0 110.221 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.03 39.65 7.37 Favored Glycine 0 C--O 1.25 1.135 0 O-C-N 126.086 1.698 . . . . 0.0 110.181 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -98.4 99.33 10.51 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 120.996 -1.296 . . . . 0.0 113.262 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.46 88.8 7.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.021 -1.674 . . . . 0.0 111.354 -174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.26 159.11 53.53 Favored Glycine 0 N--CA 1.494 2.535 0 CA-C-N 120.135 1.334 . . . . 0.0 114.219 167.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.7 tp -105.45 111.13 23.73 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 125.928 1.605 . . . . 0.0 108.101 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.55 116.25 27.9 Favored 'Isoleucine or valine' 0 C--N 1.372 1.555 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -66.48 159.96 26.06 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.499 0.666 . . . . 0.0 112.617 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 19.5 tt -61.07 -20.08 21.38 Favored 'Isoleucine or valine' 0 C--N 1.366 1.287 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.3 p -97.64 13.02 31.62 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.072 0.463 . . . . 0.0 110.917 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -133.18 26.46 4.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.952 0.901 . . . . 0.0 109.904 -172.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.6 mm -95.59 -55.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 O-C-N 126.579 2.424 . . . . 0.0 107.336 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.72 176.6 11.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 119.344 -2.098 . . . . 0.0 113.105 -168.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -76.4 -35.38 58.63 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 122.884 1.326 . . . . 0.0 110.37 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -61.68 151.4 33.78 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 124.236 1.97 . . . . 0.0 112.22 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -64.05 142.3 58.46 Favored 'General case' 0 C--O 1.205 -1.244 0 C-N-CA 126.949 2.1 . . . . 0.0 111.11 169.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.5 t -121.84 129.01 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.074 -1.016 . . . . 0.0 109.499 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.74 -36.13 11.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 123.612 1.672 . . . . 0.0 108.843 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -150.85 144.05 24.79 Favored 'General case' 0 CA--C 1.565 1.549 0 O-C-N 117.832 -3.043 . . . . 0.0 107.216 175.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.72 -27.23 9.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.476 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.1 p -55.92 -19.91 13.97 Favored 'General case' 0 C--N 1.383 2.037 0 C-N-CA 128.649 2.78 . . . . 0.0 115.163 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -80.51 -25.42 38.74 Favored 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 128.113 2.565 . . . . 0.0 112.205 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -107.14 -26.63 11.02 Favored 'General case' 0 C--N 1.369 1.428 0 CA-C-N 114.184 -1.371 . . . . 0.0 113.243 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.1 mt -134.27 140.13 46.21 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 123.342 1.544 . . . . 0.0 113.62 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -122.35 158.93 28.54 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 102.059 -3.312 . . . . 0.0 102.059 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . 0.311 0.8 OUTLIER -70.31 145.81 50.98 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 123.462 1.601 . . . . 0.0 113.838 171.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.96 -4.04 60.8 Favored Glycine 0 C--N 1.356 1.681 0 CA-C-N 111.896 -2.411 . . . . 0.0 115.428 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -94.67 142.35 27.56 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 123.377 1.561 . . . . 0.0 112.079 -169.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -86.46 134.52 33.68 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 119.871 -1.768 . . . . 0.0 107.477 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.71 148.12 65.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.69 137.22 6.57 Favored 'Trans proline' 0 C--N 1.28 -3.062 0 C-N-CA 122.118 1.878 . . . . 0.0 110.969 172.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.18 142.89 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 118.822 -2.424 . . . . 0.0 109.167 -169.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -112.33 134.89 53.62 Favored 'General case' 0 C--O 1.18 -2.568 0 C-N-CA 123.433 0.693 . . . . 0.0 110.198 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.61 140.65 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 124.221 1.963 . . . . 0.0 114.433 172.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.34 -66.35 1.01 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 123.01 1.386 . . . . 0.0 110.097 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -128.59 147.97 50.75 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 120.341 -1.474 . . . . 0.0 109.382 -175.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.52 129.08 64.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-O 117.33 -1.319 . . . . 0.0 107.518 169.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -86.85 155.37 20.29 Favored 'General case' 0 C--N 1.371 1.512 0 O-C-N 126.068 2.105 . . . . 0.0 111.808 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -60.46 -39.98 89.52 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -57.61 -30.29 65.21 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 166.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.35 -7.11 9.86 Favored Glycine 0 N--CA 1.514 3.862 0 CA-C-N 122.376 2.353 . . . . 0.0 117.076 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -62.94 146.46 52.95 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 80.9 mt -133.2 135.98 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.28 -1.327 . . . . 0.0 114.158 -173.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.24 128.97 56.41 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 117.928 -1.509 . . . . 0.0 108.576 167.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.6 mt -114.03 168.3 9.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.194 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.8 t -137.8 127.0 24.48 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 112.312 -2.222 . . . . 0.0 113.167 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 95.6 mt -86.87 -32.97 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 CA-C-O 122.82 1.295 . . . . 0.0 109.823 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -70.54 -30.61 67.39 Favored 'General case' 0 C--O 1.252 1.206 0 C-N-CA 119.034 -1.066 . . . . 0.0 113.047 -164.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.31 -5.17 58.49 Favored 'General case' 0 C--N 1.381 1.968 0 CA-C-N 120.172 1.351 . . . . 0.0 110.222 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.2 -1.68 33.2 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.414 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.568 1.667 0 C-N-CA 124.893 1.277 . . . . 0.0 113.576 -171.552 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.1 mm . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -116.15 147.81 40.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 128.556 3.66 . . . . 0.0 114.385 164.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -128.48 130.33 47.37 Favored 'General case' 0 C--N 1.366 1.32 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.8 mm -133.66 133.02 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -166.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -98.67 137.48 37.24 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.493 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.5 pt -144.45 162.87 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 117.078 -1.439 . . . . 0.0 107.86 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -65.25 130.4 94.74 Favored Pre-proline 0 CA--C 1.597 2.766 0 O-C-N 125.281 1.613 . . . . 0.0 111.051 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -78.47 -7.83 15.96 Favored 'Trans proline' 0 N--CA 1.512 2.604 1 C-N-CA 125.885 4.39 . . . . 0.0 111.113 -172.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -83.53 5.26 24.69 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.173 -1.579 . . . . 0.0 109.021 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -131.61 5.11 4.3 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 115.487 -2.196 . . . . 0.0 111.191 -170.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.5 mt -61.79 -45.25 99.09 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 CA-C-O 117.34 -1.314 . . . . 0.0 110.126 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.03 -26.04 9.89 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.892 1.37 . . . . 0.0 114.35 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -90.12 -21.61 22.17 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -168.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.5 t -80.19 -26.61 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 125.218 1.574 . . . . 0.0 109.978 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.8 mt -81.62 -65.02 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 112.917 -3.421 . . . . 0.0 105.691 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.68 166.83 40.93 Favored Glycine 0 C--N 1.371 2.511 0 CA-C-N 123.949 3.068 . . . . 0.0 113.683 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -49.25 113.91 0.91 Allowed 'General case' 0 C--N 1.382 1.991 0 CA-C-O 122.94 1.352 . . . . 0.0 113.157 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.41 14.52 79.34 Favored Glycine 0 N--CA 1.505 3.241 0 O-C-N 118.998 -2.314 . . . . 0.0 113.624 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.8 28.54 73.73 Favored Glycine 0 C--O 1.259 1.667 0 CA-C-O 123.872 1.818 . . . . 0.0 113.698 -162.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 99.4 p -61.74 -44.42 96.94 Favored 'General case' 0 C--N 1.38 1.899 0 N-CA-C 118.305 2.706 . . . . 0.0 118.305 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.68 -39.96 85.01 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.231 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 tt -61.53 -44.63 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-N 119.844 1.202 . . . . 0.0 111.846 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -62.85 -41.71 99.47 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 171.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.37 -44.79 84.72 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 117.578 -3.201 . . . . 0.0 113.447 168.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.6 mt -63.63 -36.45 83.87 Favored 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 126.886 2.616 . . . . 0.0 112.136 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 m -58.48 -52.43 65.67 Favored 'General case' 0 CA--C 1.583 2.222 0 O-C-N 125.822 1.952 . . . . 0.0 114.024 169.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.23 -40.73 95.12 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 125.906 1.683 . . . . 0.0 108.75 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -69.7 -41.88 74.81 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.1 p -105.05 -29.91 10.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 117.714 -1.136 . . . . 0.0 114.06 -166.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.57 24.63 27.81 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 119.911 1.232 . . . . 0.0 112.802 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.5 p -121.3 167.83 12.31 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 124.52 0.776 . . . . 0.0 110.115 -168.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.5 m -125.96 119.05 26.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 119.696 -0.801 . . . . 0.0 109.681 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.4 mt -116.48 120.11 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 126.078 2.111 . . . . 0.0 107.964 -161.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -121.29 129.54 53.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.888 -1.96 . . . . 0.0 109.633 171.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 tt -124.56 150.38 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.783 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.0 157.41 41.78 Favored 'General case' 0 C--O 1.262 1.763 0 O-C-N 124.16 0.912 . . . . 0.0 109.746 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -81.92 2.34 31.01 Favored 'General case' 0 C--N 1.391 2.404 0 C-N-CA 124.748 1.219 . . . . 0.0 113.202 -157.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -94.88 6.93 47.6 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 126.32 2.962 . . . . 0.0 110.631 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.51 48.39 4.78 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 126.883 2.183 . . . . 0.0 112.493 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.2 m -128.22 134.67 49.04 Favored 'General case' 0 C--O 1.261 1.676 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.24 148.05 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 C-N-CA 116.955 -1.898 . . . . 0.0 111.595 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 128.96 56.61 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 121.155 -0.965 . . . . 0.0 109.0 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 mt -120.92 123.91 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 118.341 -2.724 . . . . 0.0 111.419 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.8 135.2 53.82 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.14 158.69 35.13 Favored 'General case' 0 CA--C 1.583 2.216 0 CA-C-N 113.403 -1.726 . . . . 0.0 109.253 -173.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.7 p -107.35 -0.9 22.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 119.593 -1.942 . . . . 0.0 114.713 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -145.19 163.64 33.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 171.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.31 -39.81 17.85 Favored Glycine 0 N--CA 1.489 2.228 0 O-C-N 118.566 -2.584 . . . . 0.0 113.486 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.304 84.2 mt-10 -61.47 -39.18 89.96 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 119.479 -2.189 . . . . 0.0 112.884 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.72 -43.02 90.02 Favored 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 119.162 0.892 . . . . 0.0 109.016 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.88 82.38 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 123.205 1.478 . . . . 0.0 114.149 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -64.41 -39.42 93.81 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 120.625 -1.297 . . . . 0.0 112.393 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -60.63 -36.18 78.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 117.457 2.392 . . . . 0.0 117.457 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.0 -48.64 70.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.801 1.64 . . . . 0.0 113.205 163.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.39 -41.17 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 CA-C-N 119.842 1.201 . . . . 0.0 113.551 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -59.99 -42.45 94.26 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.672 1.589 . . . . 0.0 112.274 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.5 mmt85 -67.11 -43.66 81.91 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 118.437 -2.665 . . . . 0.0 111.195 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.77 -49.7 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.323 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -59.98 -38.27 82.05 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 119.423 1.01 . . . . 0.0 112.433 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -61.66 -56.92 14.55 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 125.805 1.941 . . . . 0.0 114.304 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.0 mt -58.58 -45.25 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 O-C-N 123.794 0.684 . . . . 0.0 110.488 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.6 p . . . . . 0 N--CA 1.497 1.899 0 C-N-CA 117.483 -1.687 . . . . 0.0 110.548 -168.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -85.14 145.45 27.62 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-O 124.189 1.947 . . . . 0.0 115.762 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.81 132.23 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.333 1 CA-C-O 129.012 4.244 . . . . 0.0 114.493 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.48 17.08 64.95 Favored Glycine 0 C--O 1.245 0.842 0 CA-C-N 111.084 -2.78 . . . . 0.0 109.418 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -102.81 135.96 43.5 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 119.598 1.699 . . . . 0.0 109.376 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.96 115.49 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 116.627 -2.029 . . . . 0.0 107.435 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -99.34 163.99 12.3 Favored 'General case' 0 C--N 1.38 1.916 0 CA-C-N 119.668 1.122 . . . . 0.0 111.565 170.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.1 m -128.76 134.88 48.55 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.1 159.45 28.03 Favored Glycine 0 CA--C 1.486 -1.749 0 CA-C-O 116.251 -2.416 . . . . 0.0 112.722 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -71.25 132.8 45.47 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 120.753 2.277 . . . . 0.0 110.905 166.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -54.28 130.13 15.93 Favored 'Isoleucine or valine' 0 C--N 1.391 2.404 0 C-N-CA 126.801 2.041 . . . . 0.0 110.586 159.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.4 p -108.79 -38.96 5.49 Favored 'General case' 0 CA--C 1.499 -0.985 0 O-C-N 119.253 -2.154 . . . . 0.0 110.132 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mmt-85 -151.63 160.43 43.65 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 117.61 -1.636 . . . . 0.0 108.293 -169.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.8 mt -135.14 121.32 32.49 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.39 177.14 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 120.771 1.623 . . . . 0.0 108.56 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -63.46 -39.6 94.89 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.629 1.206 . . . . 0.0 110.237 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -93.2 6.43 48.06 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.39 -178.09 33.91 Favored Glycine 0 C--O 1.202 -1.894 0 CA-C-O 116.848 -2.085 . . . . 0.0 112.677 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.08 141.06 51.86 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-N 118.783 1.292 . . . . 0.0 111.001 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 108' ' ' LEU . 47.2 m-85 -87.99 130.76 34.86 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 124.594 1.184 . . . . 0.0 112.51 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.67 137.42 46.87 Favored 'Isoleucine or valine' 0 C--N 1.379 1.874 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.079 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.9 127.68 48.62 Favored 'General case' 0 C--O 1.189 -2.099 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.27 143.2 18.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.91 155.09 1.27 Allowed Glycine 0 CA--C 1.545 1.912 0 CA-C-O 124.01 1.894 . . . . 0.0 117.479 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.27 19.33 64.81 Favored Glycine 0 CA--C 1.573 3.682 0 O-C-N 119.238 -2.331 . . . . 0.0 115.223 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.6 35.56 81.22 Favored Glycine 0 N--CA 1.484 1.857 1 N-CA-C 123.204 4.042 . . . . 0.0 123.204 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -115.84 115.51 26.38 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -107.42 124.44 49.85 Favored 'General case' 0 N--CA 1.527 3.381 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.341 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.84 155.74 16.02 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 118.142 2.017 . . . . 0.0 118.142 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.415 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 30.1 tp -96.31 120.28 36.32 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 113.486 -1.357 . . . . 0.0 109.718 -173.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.27 111.81 24.87 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 CA-C-O 118.365 -0.826 . . . . 0.0 109.224 157.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -66.98 156.45 35.94 Favored 'General case' 0 C--N 1.377 1.782 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.41 -30.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.967 0.907 . . . . 0.0 112.077 -169.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 65.0 p -80.46 -12.5 59.55 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -106.91 5.5 28.39 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -173.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.09 -50.85 23.23 Favored 'Isoleucine or valine' 0 C--N 1.393 2.467 0 CA-C-N 122.173 2.26 . . . . 0.0 107.889 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -126.74 158.51 36.3 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.276 49.1 p30 -64.51 -38.47 91.15 Favored 'General case' 0 C--N 1.391 2.398 0 O-C-N 118.97 -2.331 . . . . 0.0 113.713 161.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -85.6 141.12 30.05 Favored 'General case' 0 N--CA 1.415 -2.207 0 O-C-N 119.249 -2.157 . . . . 0.0 112.501 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -41.87 130.82 3.37 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-N 112.042 -2.344 . . . . 0.0 116.346 170.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 t -113.98 111.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 120.758 1.617 . . . . 0.0 107.275 -163.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.43 -46.38 66.91 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 116.181 -1.866 . . . . 0.0 107.596 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.4 ' HZ3' ' CG ' ' A' ' 124' ' ' ASP . 17.1 pttm -149.89 133.01 16.29 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 128.755 3.785 . . . . 0.0 109.473 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.51 -20.22 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 O-C-N 119.846 -1.784 . . . . 0.0 110.872 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.8 p -56.6 -29.99 62.73 Favored 'General case' 0 C--N 1.377 1.776 0 C-N-CA 125.951 1.7 . . . . 0.0 110.286 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.4 ' CG ' ' HZ3' ' A' ' 121' ' ' LYS . 65.1 m-20 -65.11 -33.76 76.79 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 128.43 2.692 . . . . 0.0 111.76 177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -112.25 -30.77 7.08 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 72.8 mt -121.42 123.13 41.34 Favored 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -91.99 130.07 37.81 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-O 122.213 1.006 . . . . 0.0 112.003 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 21.0 mmt -61.05 111.1 1.56 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.2 16.32 64.98 Favored Glycine 0 CA--C 1.547 2.048 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.525 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -113.61 143.32 44.76 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 124.576 2.132 . . . . 0.0 112.821 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.52 146.12 49.72 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -171.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 p -144.17 142.92 20.74 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 166.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.79 136.76 68.41 Favored 'Trans proline' 0 C--N 1.284 -2.865 0 C-N-CA 121.876 1.717 . . . . 0.0 114.524 160.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.82 120.91 17.33 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.235 0 CA-C-O 124.331 2.015 . . . . 0.0 107.06 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -88.29 137.4 32.36 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 119.447 -2.033 . . . . 0.0 111.717 170.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.6 t -90.89 91.55 3.64 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.532 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.7 mt -53.75 -43.9 69.53 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 126.335 2.272 . . . . 0.0 113.601 171.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -165.1 156.26 14.53 Favored 'General case' 0 C--O 1.255 1.349 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.99 79.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 126.312 2.258 . . . . 0.0 104.993 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.532 0.5 OUTLIER -61.63 141.62 57.68 Favored 'General case' 0 CA--C 1.58 2.1 0 CA-C-N 114.161 -1.381 . . . . 0.0 110.935 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -84.96 -0.02 52.88 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-O 115.078 -2.392 . . . . 0.0 108.269 -167.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -90.68 14.27 13.84 Favored 'General case' 0 C--N 1.384 2.104 0 CA-C-N 121.123 1.783 . . . . 0.0 107.676 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.71 24.07 40.14 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 115.08 -3.066 . . . . 0.0 115.517 -173.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -120.33 114.18 21.47 Favored 'General case' 0 CA--C 1.593 2.619 0 CA-C-N 122.469 3.134 . . . . 0.0 110.659 -171.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.1 mt -102.92 125.9 57.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 CA-C-O 117.242 -1.361 . . . . 0.0 110.953 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -120.65 135.91 54.98 Favored 'General case' 0 C--N 1.368 1.409 0 O-C-N 128.583 3.677 . . . . 0.0 113.524 -171.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 51.2 mt -129.95 148.39 51.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 112.074 -2.33 . . . . 0.0 110.315 -164.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.2 t -113.82 123.79 50.66 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.4 -43.28 42.86 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 O-C-N 119.318 -2.114 . . . . 0.0 108.551 161.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -46.18 -61.36 1.8 Allowed 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 117.293 -1.336 . . . . 0.0 112.011 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -66.67 -27.56 67.76 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 122.372 2.351 . . . . 0.0 113.531 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.74 -7.11 59.56 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 118.77 -2.456 . . . . 0.0 112.802 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.495 1.819 0 O-C-N 124.913 1.383 . . . . 0.0 113.615 170.474 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.8 mm . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 122.12 0.962 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -121.84 164.41 17.55 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 116.68 -1.629 . . . . 0.0 108.415 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.5 t -153.9 159.22 41.67 Favored 'General case' 0 C--N 1.378 1.834 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 pt -161.9 155.18 3.1 Favored 'Isoleucine or valine' 0 C--N 1.369 1.421 0 C-N-CA 129.467 3.107 . . . . 0.0 103.647 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -121.57 122.25 39.26 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.454 -164.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.4 pt -127.14 142.53 43.26 Favored 'Isoleucine or valine' 0 C--N 1.387 2.215 0 C-N-CA 125.661 1.584 . . . . 0.0 111.1 -169.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -42.23 126.17 2.78 Favored Pre-proline 0 C--O 1.203 -1.389 0 C-N-CA 129.856 3.262 . . . . 0.0 114.556 175.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.57 -26.6 83.2 Favored 'Trans proline' 1 N--CA 1.54 4.214 0 N-CA-C 117.426 2.048 . . . . 0.0 117.426 -169.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.25 45.9 t0 -58.67 -38.28 77.85 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 129.71 3.204 . . . . 0.0 113.495 172.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -92.72 3.05 56.33 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.921 -1.112 . . . . 0.0 113.15 -168.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.77 -34.99 73.66 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 O-C-N 120.857 -1.152 . . . . 0.0 110.556 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -59.78 -34.81 73.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 117.336 -3.352 . . . . 0.0 114.718 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -86.5 -36.65 18.87 Favored 'General case' 0 C--N 1.38 1.933 0 O-C-N 125.76 1.913 . . . . 0.0 112.062 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.12 -37.91 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 CA-C-N 121.882 2.128 . . . . 0.0 113.512 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.0 mm -75.15 -47.37 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 C-N-CA 126.422 1.889 . . . . 0.0 112.585 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.72 -176.28 50.95 Favored Glycine 0 CA--C 1.484 -1.879 0 O-C-N 126.047 2.092 . . . . 0.0 113.566 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.297 42.2 mttp -58.11 111.71 1.28 Allowed 'General case' 0 C--N 1.36 1.057 0 CA-C-N 113.748 -1.226 . . . . 0.0 111.957 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.98 25.46 31.09 Favored Glycine 0 N--CA 1.488 2.16 0 O-C-N 127.064 2.727 . . . . 0.0 114.645 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.02 9.85 83.69 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.2 t -65.23 -39.98 93.44 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 119.069 1.435 . . . . 0.0 111.677 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.46 -45.54 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 O-C-N 126.295 2.247 . . . . 0.0 108.619 -170.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.5 tp -66.35 -28.93 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 CA-C-O 117.338 -1.315 . . . . 0.0 112.032 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -60.83 -46.82 89.04 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 120.913 1.688 . . . . 0.0 113.504 162.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.58 65.05 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 128.111 2.564 . . . . 0.0 111.045 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.18 -42.63 98.91 Favored 'General case' 0 C--N 1.374 1.644 0 O-C-N 123.752 0.658 . . . . 0.0 112.084 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 t -67.3 -43.37 81.88 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 115.817 -2.039 . . . . 0.0 114.279 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -59.61 -42.82 93.47 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 122.118 2.235 . . . . 0.0 110.913 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -73.0 -41.98 63.72 Favored 'General case' 0 C--O 1.254 1.331 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.462 HG22 ' CG ' ' A' ' 67' ' ' HIS . 44.2 p -80.53 -42.99 21.46 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 124.598 2.142 . . . . 0.0 109.711 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.76 37.27 11.97 Favored Glycine 0 C--O 1.239 0.445 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.56 145.61 35.31 Favored 'General case' 0 C--N 1.391 2.376 0 CA-C-O 116.973 -1.489 . . . . 0.0 108.864 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 m -93.52 130.28 39.44 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.35 128.14 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.23 133.25 40.64 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -116.56 127.71 74.1 Favored 'Isoleucine or valine' 0 C--N 1.378 1.847 0 CA-C-O 123.67 1.7 . . . . 0.0 111.743 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -80.03 152.97 29.13 Favored 'General case' 0 C--O 1.188 -2.147 0 CA-C-O 115.345 -2.264 . . . . 0.0 115.525 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -74.17 19.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 115.051 -2.404 . . . . 0.0 115.016 -169.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -121.2 11.35 10.84 Favored 'General case' 0 C--N 1.371 1.533 0 CA-C-O 114.82 -2.514 . . . . 0.0 110.298 165.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.39 9.08 48.45 Favored Glycine 0 C--N 1.357 1.695 0 CA-C-N 121.131 1.787 . . . . 0.0 111.465 165.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -89.66 129.21 36.13 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-O 117.189 -1.386 . . . . 0.0 108.392 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.04 128.85 70.81 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.68 0 O-C-N 126.143 2.152 . . . . 0.0 105.728 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -110.5 134.23 52.56 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 126.691 1.997 . . . . 0.0 108.908 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.05 130.63 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.25 139.06 43.48 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 117.537 -1.22 . . . . 0.0 111.033 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.49 150.85 18.19 Favored 'General case' 0 C--N 1.364 1.235 0 CA-C-O 122.917 1.342 . . . . 0.0 110.916 -165.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.284 7.1 t -114.95 -45.61 2.96 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.566 160.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -76.63 140.63 41.06 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 123.867 3.031 . . . . 0.0 114.23 171.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.93 -29.98 24.53 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 113.851 -1.522 . . . . 0.0 114.927 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -66.59 -38.52 87.19 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 119.465 -2.197 . . . . 0.0 114.581 166.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -64.35 -30.66 71.7 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 116.989 -3.57 . . . . 0.0 112.939 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.48 -46.78 81.54 Favored 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 119.367 -0.933 . . . . 0.0 113.431 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -60.82 -41.23 95.3 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.24 2.216 . . . . 0.0 111.014 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.462 ' CG ' HG22 ' A' ' 43' ' ' THR . 3.2 t-160 -54.62 -51.14 66.31 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.168 -1.582 . . . . 0.0 111.826 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.51 91.04 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.913 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 61.3 mt -66.35 -43.46 91.37 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 CA-C-N 119.521 1.055 . . . . 0.0 110.894 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -74.33 -28.16 61.03 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -71.24 -37.3 72.01 Favored 'General case' 0 C--O 1.211 -0.951 0 O-C-N 120.416 -1.427 . . . . 0.0 112.728 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 mt -62.88 -38.69 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 121.433 1.924 . . . . 0.0 111.003 165.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.69 -45.52 82.53 Favored 'General case' 0 C--N 1.373 1.597 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -174.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -51.71 -51.79 53.32 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 167.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.02 -35.48 69.19 Favored 'Isoleucine or valine' 0 C--O 1.271 2.208 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.516 2.844 0 CA-C-O 123.5 1.619 . . . . 0.0 111.25 -177.225 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.2 pt . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 125.201 2.429 . . . . 0.0 113.084 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -132.35 148.5 52.43 Favored 'General case' 0 C--N 1.366 1.301 0 O-C-N 118.447 -2.658 . . . . 0.0 110.607 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.03 144.52 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.402 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.3 13.78 58.18 Favored Glycine 0 C--N 1.381 3.045 0 N-CA-C 117.996 1.958 . . . . 0.0 117.996 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -135.27 157.89 45.77 Favored 'General case' 0 C--O 1.205 -1.289 0 O-C-N 118.462 -2.787 . . . . 0.0 108.2 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.8 t -107.93 146.48 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -136.66 167.68 20.94 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.2 m -105.85 123.38 47.86 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 120.305 1.411 . . . . 0.0 109.297 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.44 -164.18 19.98 Favored Glycine 0 C--N 1.366 2.235 0 CA-C-N 111.466 -2.606 . . . . 0.0 112.659 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -146.67 150.71 35.96 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 126.242 1.789 . . . . 0.0 107.518 164.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.3 t -77.55 112.97 16.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -86.09 -17.8 34.11 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 175.27 141.59 0.05 Allowed 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -169.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.8 mt -126.87 125.75 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.312 -169.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.14 177.69 2.21 Favored 'Isoleucine or valine' 0 C--N 1.364 1.216 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.785 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -58.06 -44.68 87.62 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.852 1.345 . . . . 0.0 112.92 -163.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -110.33 22.38 15.58 Favored 'General case' 0 CA--C 1.555 1.164 0 O-C-N 119.255 -2.153 . . . . 0.0 112.066 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.02 170.7 36.24 Favored Glycine 0 C--O 1.21 -1.377 0 C-N-CA 118.751 -1.69 . . . . 0.0 114.594 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.17 125.93 36.22 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -81.82 130.9 35.22 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.92 128.17 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -167.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 106' ' ' GLU . . . -100.84 125.57 47.37 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.545 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.8 mt -110.25 138.39 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -36.28 151.42 0.02 OUTLIER Glycine 0 C--N 1.37 2.423 0 N-CA-C 119.328 2.491 . . . . 0.0 119.328 -165.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.4 25.45 68.13 Favored Glycine 0 C--O 1.186 -2.905 0 CA-C-O 113.767 -3.796 . . . . 0.0 112.152 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.09 26.78 69.93 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 128.514 2.959 . . . . 0.0 116.955 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -92.8 93.44 8.43 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 31.6 tt0 -101.6 117.65 35.33 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -113.82 179.08 18.69 Favored Glycine 0 C--O 1.215 -1.039 0 O-C-N 126.998 2.686 . . . . 0.0 112.613 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.7 tp -120.41 125.51 48.13 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.659 -1.638 . . . . 0.0 109.891 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.3 t -95.01 111.46 25.67 Favored 'Isoleucine or valine' 0 C--N 1.371 1.523 0 O-C-N 124.857 1.348 . . . . 0.0 109.571 170.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -63.71 149.94 45.54 Favored 'General case' 0 C--O 1.208 -1.11 0 O-C-N 121.423 -0.798 . . . . 0.0 109.758 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -56.43 -8.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.425 0 C-N-CA 125.579 1.552 . . . . 0.0 115.022 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.4 p -101.92 2.92 38.55 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 125.119 1.368 . . . . 0.0 113.605 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -130.77 18.62 5.13 Favored 'General case' 0 C--O 1.257 1.472 0 CA-C-N 119.225 0.92 . . . . 0.0 111.798 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.75 -43.4 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-O 124.588 2.137 . . . . 0.0 109.976 170.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.68 163.62 33.42 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 119.931 -1.731 . . . . 0.0 109.477 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -72.17 -38.2 69.18 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 123.177 1.465 . . . . 0.0 112.756 168.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -80.48 145.55 31.82 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 125.958 1.703 . . . . 0.0 113.101 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -70.66 130.35 41.55 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.82 130.02 75.04 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -173.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -103.72 -24.58 13.33 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 120.612 -1.305 . . . . 0.0 110.931 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.39 139.48 31.7 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 125.555 1.784 . . . . 0.0 107.166 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -81.27 -22.7 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.775 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -165.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 p -63.02 -19.68 64.59 Favored 'General case' 0 C--N 1.374 1.673 0 O-C-N 119.492 -2.005 . . . . 0.0 115.462 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -59.39 -40.26 85.99 Favored 'General case' 0 C--O 1.192 -1.956 0 C-N-CA 125.25 1.42 . . . . 0.0 113.401 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.68 0.2 14.5 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 125.313 1.445 . . . . 0.0 111.143 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.4 mt -153.75 150.12 28.17 Favored 'General case' 0 C--N 1.376 1.731 0 O-C-N 119.032 -2.292 . . . . 0.0 110.05 -170.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -148.66 151.4 34.89 Favored 'General case' 0 C--N 1.38 1.895 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -63.13 142.38 58.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 125.664 2.649 . . . . 0.0 114.058 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.1 -4.24 86.18 Favored Glycine 0 CA--C 1.46 -3.354 0 C-N-CA 129.193 3.282 . . . . 0.0 116.659 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -65.6 127.77 33.25 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 127.147 3.356 . . . . 0.0 109.885 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -78.59 125.69 29.71 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 118.406 -2.684 . . . . 0.0 112.72 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.03 138.93 31.74 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.48 -168.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -72.86 124.07 9.4 Favored 'Trans proline' 0 CA--C 1.5 -1.202 0 C-N-CA 123.736 2.957 . . . . 0.0 107.119 158.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.27 131.97 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-N 113.013 -1.903 . . . . 0.0 107.206 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -90.35 134.34 34.39 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.406 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.6 t -76.47 110.8 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 118.403 -1.319 . . . . 0.0 110.556 170.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 mt -86.1 -56.01 3.66 Favored 'General case' 0 CA--C 1.468 -2.192 0 O-C-N 125.288 1.618 . . . . 0.0 114.535 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -146.21 158.21 43.87 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 125.267 1.604 . . . . 0.0 108.47 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 46.7 t -140.23 114.86 6.75 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.351 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 166.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -75.31 177.28 6.68 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 122.334 2.334 . . . . 0.0 109.828 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -67.28 -32.32 73.24 Favored 'General case' 0 C--N 1.371 1.531 0 C-N-CA 127.219 2.207 . . . . 0.0 110.913 -173.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -74.29 -30.92 62.31 Favored 'General case' 0 C--O 1.213 -0.84 0 C-N-CA 125.433 1.493 . . . . 0.0 111.426 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.3 18.98 4.8 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 115.684 -2.731 . . . . 0.0 112.404 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -80.17 127.66 32.6 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 119.45 1.625 . . . . 0.0 108.109 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 68.6 mt -104.91 118.37 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -162.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -111.59 131.03 55.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 125.136 2.398 . . . . 0.0 106.456 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.4 mt -129.96 177.15 7.49 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.416 -163.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.7 t -154.14 147.91 25.4 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.351 -1.468 . . . . 0.0 107.083 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.3 mt -102.83 -31.98 3.04 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.803 0 O-C-N 119.709 -1.87 . . . . 0.0 107.295 164.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -52.78 -53.83 42.65 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.729 1.212 . . . . 0.0 111.365 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.56 -18.29 58.76 Favored 'General case' 0 C--N 1.364 1.215 0 C-N-CA 125.087 1.355 . . . . 0.0 112.024 -172.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.95 99.68 Favored 'General case' 0 C--O 1.258 1.513 0 C-N-CA 123.756 0.822 . . . . 0.0 110.895 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 175.221 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 mm . . . . . 0 CA--C 1.502 -0.872 0 CA-C-O 123.452 1.596 . . . . 0.0 113.614 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -109.03 121.83 45.97 Favored 'General case' 0 C--N 1.366 1.318 0 O-C-N 119.699 -1.876 . . . . 0.0 110.35 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -112.89 153.12 28.43 Favored 'General case' 0 N--CA 1.397 -3.102 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -173.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.7 tt -142.49 156.29 18.7 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 166.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -118.13 113.37 21.47 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -175.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -104.58 163.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 126.883 2.614 . . . . 0.0 112.716 167.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -55.94 139.31 70.87 Favored Pre-proline 0 N--CA 1.429 -1.505 0 O-C-N 124.54 1.15 . . . . 0.0 113.088 168.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.89 -21.13 28.65 Favored 'Trans proline' 0 C--O 1.194 -1.706 0 C-N-CA 122.46 2.107 . . . . 0.0 112.2 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -90.13 1.52 56.31 Favored 'General case' 0 CA--C 1.573 1.861 0 O-C-N 119.776 -1.827 . . . . 0.0 109.243 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -118.81 7.04 11.5 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 119.468 -2.02 . . . . 0.0 112.197 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.0 mt -61.87 -46.66 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 119.999 -1.688 . . . . 0.0 111.924 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -67.17 -29.4 69.09 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 117.98 -1.488 . . . . 0.0 111.091 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.48 -32.78 72.8 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 173.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.99 -51.42 16.91 Favored 'Isoleucine or valine' 0 C--N 1.384 2.076 0 N-CA-C 115.745 1.758 . . . . 0.0 115.745 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.95 -19.24 19.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 114.324 -2.75 . . . . 0.0 114.898 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.78 -174.18 8.69 Favored Glycine 0 C--N 1.383 3.146 1 O-C-N 129.517 4.261 . . . . 0.0 108.9 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.384 22.2 pttp -72.65 129.72 38.89 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 110.061 -3.069 . . . . 0.0 114.359 -173.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.65 19.56 67.22 Favored Glycine 0 N--CA 1.483 1.807 0 O-C-N 119.665 -1.897 . . . . 0.0 114.227 -171.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.6 28.69 68.18 Favored Glycine 0 N--CA 1.5 2.928 0 CA-C-O 121.996 0.776 . . . . 0.0 112.109 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.6 p -64.65 -42.97 95.06 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.76 -41.68 91.5 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 C-N-CA 126.22 1.808 . . . . 0.0 110.286 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.69 -37.51 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 O-C-N 123.974 0.796 . . . . 0.0 110.617 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -56.05 -47.83 77.15 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.75 82.38 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 170.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.82 -51.94 67.52 Favored 'General case' 0 C--O 1.195 -1.779 0 O-C-N 125.386 1.679 . . . . 0.0 113.026 171.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.253 14.2 t -65.43 -48.51 72.5 Favored 'General case' 0 C--O 1.261 1.676 0 CA-C-O 117.742 -1.123 . . . . 0.0 110.55 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.278 27.0 tt0 -66.84 -42.75 85.27 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 118.637 -1.225 . . . . 0.0 114.075 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.31 -34.05 77.11 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.6 p -96.35 -46.14 6.52 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.721 -1.237 . . . . 0.0 111.61 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.25 -0.16 57.14 Favored Glycine 0 C--N 1.344 0.977 0 O-C-N 119.93 -1.731 . . . . 0.0 110.168 -171.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.1 p -75.18 149.41 38.97 Favored 'General case' 0 C--N 1.404 2.947 0 C-N-CA 127.718 2.407 . . . . 0.0 110.826 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.9 m -98.15 129.77 44.93 Favored 'General case' 0 C--O 1.201 -1.454 0 CA-C-O 116.004 -1.95 . . . . 0.0 110.899 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mp -117.29 126.08 74.36 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.989 0 CA-C-O 116.183 -1.865 . . . . 0.0 113.034 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -129.46 141.58 50.99 Favored 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 120.379 1.445 . . . . 0.0 109.291 173.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.88 109.84 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -156.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -76.34 156.14 33.58 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 125.09 2.376 . . . . 0.0 115.101 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -69.1 -0.26 5.6 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 120.339 -1.476 . . . . 0.0 109.438 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -103.91 -11.82 17.25 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.342 -1.474 . . . . 0.0 108.257 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.49 -1.66 53.38 Favored Glycine 0 C--N 1.364 2.104 0 CA-C-O 118.677 -1.068 . . . . 0.0 112.337 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -67.82 115.94 7.93 Favored 'General case' 0 C--O 1.204 -1.322 0 CA-C-N 120.981 2.391 . . . . 0.0 110.363 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 17' ' ' THR . 93.1 t -99.2 117.47 44.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.07 112.84 25.88 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 172.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.5 mt -100.29 106.39 19.17 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 O-C-N 126.748 2.53 . . . . 0.0 108.273 168.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.91 135.47 34.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.656 1.217 . . . . 0.0 109.392 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.62 151.78 29.22 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 102.392 -3.188 . . . . 0.0 102.392 -167.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 p -124.47 8.03 8.35 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 126.306 1.842 . . . . 0.0 108.111 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -124.65 107.84 11.41 Favored 'General case' 0 C--N 1.371 1.516 0 C-N-CA 127.23 2.212 . . . . 0.0 105.434 167.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.05 -40.34 95.43 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-O 116.679 -2.178 . . . . 0.0 115.104 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -73.15 -39.16 65.91 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.173 -172.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -58.65 -41.86 87.03 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 162.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.13 -46.13 90.37 Favored 'General case' 0 CA--C 1.586 2.355 0 CA-C-O 123.586 1.66 . . . . 0.0 113.357 168.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -58.58 -33.2 69.7 Favored 'General case' 0 N--CA 1.527 3.422 0 O-C-N 117.747 -3.096 . . . . 0.0 114.322 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -77.2 -44.46 30.01 Favored 'General case' 0 CA--C 1.563 1.462 0 O-C-N 123.504 0.502 . . . . 0.0 111.427 167.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.73 -39.44 94.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.096 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.271 9.2 tp -80.48 -26.0 11.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 O-C-N 119.995 -1.691 . . . . 0.0 109.101 -176.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -65.47 -41.54 93.23 Favored 'General case' 0 C--N 1.374 1.645 0 CA-C-N 119.992 1.269 . . . . 0.0 110.597 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -55.18 -35.23 64.58 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.0 mm -61.16 -40.48 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.708 0 CA-C-O 123.922 1.82 . . . . 0.0 113.145 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -67.75 -39.44 84.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 117.867 -3.021 . . . . 0.0 112.79 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -58.35 -48.06 81.8 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.906 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.4 mt -62.35 -45.57 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 170.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.1 m . . . . . 0 CA--C 1.575 1.933 0 O-C-N 125.031 1.457 . . . . 0.0 112.723 171.279 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 N--CA 1.441 -0.921 0 N-CA-C 103.085 -2.931 . . . . 0.0 103.085 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -88.03 134.13 33.81 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.727 -169.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.3 137.76 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.409 0 O-C-N 125.928 2.017 . . . . 0.0 112.653 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.2 -7.7 1.68 Allowed Glycine 0 C--O 1.26 1.768 0 N-CA-C 120.123 2.809 . . . . 0.0 120.123 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -79.55 146.51 32.58 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 124.747 2.213 . . . . 0.0 111.544 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.9 t -91.04 146.7 5.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 O-C-N 120.352 -1.467 . . . . 0.0 109.233 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -138.31 155.35 48.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 79.5 m -93.81 144.24 25.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -146.65 179.53 23.55 Favored Glycine 0 C--O 1.248 1.0 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 172.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -130.32 131.67 45.5 Favored 'General case' 0 C--N 1.375 1.685 0 O-C-N 120.261 -1.729 . . . . 0.0 109.73 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.35 120.28 6.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.205 0 O-C-N 120.88 -1.138 . . . . 0.0 109.22 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 p -94.12 -8.62 39.05 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-O 115.623 -2.132 . . . . 0.0 112.492 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 ptt85 165.04 148.62 0.02 OUTLIER 'General case' 0 C--N 1.369 1.435 0 O-C-N 126.624 2.452 . . . . 0.0 108.618 -170.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.4 mt -100.81 144.29 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 CA-C-N 112.855 -1.975 . . . . 0.0 108.958 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.26 35.8 m -138.58 170.43 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 O-C-N 120.784 -1.197 . . . . 0.0 109.388 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.65 -42.25 71.08 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 117.274 -3.391 . . . . 0.0 114.525 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -107.1 -0.85 22.56 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 119.131 0.878 . . . . 0.0 112.261 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.68 -154.58 11.17 Favored Glycine 0 C--O 1.212 -1.219 0 O-C-N 119.554 -1.966 . . . . 0.0 109.263 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.31 137.2 24.29 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 128.896 2.879 . . . . 0.0 104.229 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.254 92.6 m-85 -86.84 139.57 30.54 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 124.594 1.158 . . . . 0.0 109.047 173.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.82 121.43 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 112.547 -2.115 . . . . 0.0 107.841 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.33 126.04 28.84 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.621 -1.299 . . . . 0.0 110.169 165.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.8 mm -85.5 94.2 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.44 37.48 93.82 Favored Glycine 0 N--CA 1.513 3.773 0 C-N-CA 126.6 2.048 . . . . 0.0 111.295 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.53 -7.15 49.77 Favored Glycine 0 C--N 1.297 -1.633 0 O-C-N 125.87 1.571 . . . . 0.0 114.471 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.76 -169.09 5.55 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 120.024 1.912 . . . . 0.0 114.473 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -33.06 140.08 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.247 2.927 . . . . 0.0 117.388 167.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -91.79 116.26 28.75 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 112.232 -2.258 . . . . 0.0 114.914 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.28 170.7 23.69 Favored Glycine 0 C--N 1.368 2.317 0 CA-C-O 117.997 -1.446 . . . . 0.0 110.974 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.1 tp -114.62 138.17 51.0 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 128.074 2.867 . . . . 0.0 106.816 -171.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.1 p -116.97 120.53 65.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.288 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.488 157.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -74.81 153.66 38.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.414 1.578 . . . . 0.0 112.197 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.6 tt -67.82 -16.32 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -162.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.0 m -94.69 13.14 25.33 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.03 1.286 . . . . 0.0 111.845 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 -112.2 22.43 14.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.978 1.263 . . . . 0.0 111.54 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.8 mm -100.97 -48.06 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 CA-C-O 127.142 3.353 . . . . 0.0 106.464 -174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -125.42 156.01 39.51 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 112.439 -2.164 . . . . 0.0 112.261 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.262 4.8 t0 -83.2 -15.31 50.97 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 164.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -94.08 -173.55 3.14 Favored 'General case' 0 C--N 1.381 1.954 0 C-N-CA 126.547 1.939 . . . . 0.0 113.528 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.279 15.5 mmm180 -84.01 115.78 22.51 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-O 125.327 2.489 . . . . 0.0 114.546 -173.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . 0.264 21.9 t -82.67 101.34 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 112.092 -2.322 . . . . 0.0 114.675 172.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -96.54 -34.65 11.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -141.97 149.41 40.04 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 122.253 1.025 . . . . 0.0 110.09 170.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.29 -34.19 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.264 18.1 p -58.49 -20.94 49.85 Favored 'General case' 0 C--O 1.277 2.552 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 175.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.91 -43.28 83.76 Favored 'General case' 0 C--N 1.368 1.388 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -90.93 -24.68 20.1 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 116.976 -1.488 . . . . 0.0 112.627 -175.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.2 mt -137.98 151.22 47.72 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 120.479 1.49 . . . . 0.0 109.083 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -120.57 167.03 12.83 Favored 'General case' 0 C--O 1.22 -0.459 0 O-C-N 125.707 1.88 . . . . 0.0 108.075 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.6 tpt -81.36 120.71 25.3 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 111.875 -2.42 . . . . 0.0 112.066 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.82 -9.4 56.8 Favored Glycine 0 C--N 1.365 2.19 0 CA-C-N 119.832 1.197 . . . . 0.0 111.771 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -89.52 153.31 20.89 Favored 'General case' 0 CA--C 1.598 2.816 0 CA-C-N 118.316 1.058 . . . . 0.0 109.262 -164.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -88.2 151.09 22.92 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 117.733 -3.105 . . . . 0.0 108.229 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.03 136.05 9.93 Favored Pre-proline 0 N--CA 1.431 -1.399 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.39 124.69 16.69 Favored 'Trans proline' 0 N--CA 1.52 3.076 0 C-N-CA 121.299 1.333 . . . . 0.0 113.402 159.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.54 138.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.244 2.218 . . . . 0.0 107.714 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -106.57 118.36 36.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.553 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.99 119.04 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 123.829 1.776 . . . . 0.0 113.004 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.1 mt -88.64 -40.17 13.51 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 117.092 -1.432 . . . . 0.0 111.519 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -163.47 156.73 18.95 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 120.049 1.295 . . . . 0.0 107.865 -172.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.7 t -120.07 131.85 71.31 Favored 'Isoleucine or valine' 0 C--O 1.254 1.311 1 N-CA-C 98.942 -4.466 . . . . 0.0 98.942 166.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.67 178.42 6.76 Favored 'General case' 0 N--CA 1.421 -1.907 0 O-C-N 120.898 -1.126 . . . . 0.0 111.384 -168.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -78.59 -16.56 57.25 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.848 1.259 . . . . 0.0 111.483 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -112.04 2.56 16.89 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 126.089 2.118 . . . . 0.0 108.679 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.09 5.32 28.84 Favored Glycine 0 C--N 1.368 2.346 0 CA-C-O 119.692 -0.504 . . . . 0.0 114.338 162.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.85 146.89 27.08 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.1 mt -103.99 129.13 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -116.41 122.83 45.96 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 112.096 -2.32 . . . . 0.0 113.095 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.6 mt -120.55 166.12 14.07 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 125.94 1.696 . . . . 0.0 111.809 -168.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 30.0 t -129.28 130.53 46.31 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 112.036 -2.347 . . . . 0.0 108.753 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.3 mt -93.78 -39.43 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 169.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -60.84 -41.82 96.59 Favored 'General case' 0 C--N 1.379 1.867 0 O-C-N 120.239 -1.538 . . . . 0.0 113.9 -167.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -74.91 -33.93 62.08 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 126.651 2.469 . . . . 0.0 109.314 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.47 -29.56 61.49 Favored 'General case' 0 C--N 1.375 1.677 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 179.111 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 N--CA 1.432 -1.351 0 CA-C-O 123.948 1.832 . . . . 0.0 113.505 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -88.77 116.37 26.99 Favored 'General case' 0 N--CA 1.423 -1.787 0 C-N-CA 124.937 1.295 . . . . 0.0 110.958 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.6 p -93.94 138.18 32.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 124.758 2.218 . . . . 0.0 111.53 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.5 tt -135.92 123.45 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 111.545 -2.57 . . . . 0.0 109.807 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -80.4 124.71 29.13 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.274 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.96 129.69 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.925 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -66.73 143.21 97.98 Favored Pre-proline 0 N--CA 1.51 2.57 0 CA-C-O 116.289 -1.815 . . . . 0.0 112.736 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.45 -13.83 40.48 Favored 'Trans proline' 1 N--CA 1.541 4.265 0 CA-C-O 112.871 -3.054 . . . . 0.0 118.583 -165.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -86.48 -18.56 31.34 Favored 'General case' 0 C--N 1.386 2.159 0 CA-C-N 123.941 3.064 . . . . 0.0 109.251 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -84.71 -20.76 30.65 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 116.373 -1.775 . . . . 0.0 115.491 171.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.1 mt -65.22 -37.22 79.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 121.935 2.152 . . . . 0.0 112.535 166.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -61.32 -41.88 97.74 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 116.932 -1.508 . . . . 0.0 109.621 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -62.12 -41.19 97.99 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 119.863 1.211 . . . . 0.0 110.808 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 t -67.57 -36.44 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.568 1.947 . . . . 0.0 109.761 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.0 mt -67.19 -46.48 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.985 0.811 . . . . 0.0 109.224 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.49 174.07 11.21 Favored Glycine 0 CA--C 1.55 2.252 0 C-N-CA 118.818 -1.658 . . . . 0.0 114.473 -172.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -67.62 119.49 12.47 Favored 'General case' 0 C--O 1.187 -2.195 0 CA-C-N 113.937 -1.131 . . . . 0.0 110.376 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 26.36 60.78 Favored Glycine 0 N--CA 1.502 3.099 0 C-N-CA 128.497 2.951 . . . . 0.0 116.599 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.81 15.45 79.26 Favored Glycine 0 C--N 1.37 2.448 0 O-C-N 126.64 2.024 . . . . 0.0 112.682 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -62.32 -47.24 85.13 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 120.346 2.073 . . . . 0.0 115.177 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.39 -46.62 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.762 -1.212 . . . . 0.0 112.864 -173.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 tt -70.98 -32.74 49.38 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 O-C-N 127.676 3.11 . . . . 0.0 114.445 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -64.56 -49.41 71.31 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.337 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -34.47 66.83 Favored 'General case' 0 C--O 1.249 1.055 0 CA-C-N 114.162 -1.381 . . . . 0.0 113.542 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -76.76 -48.11 19.68 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 128.241 3.463 . . . . 0.0 112.638 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.312 8.5 t -62.75 -43.29 99.2 Favored 'General case' 0 C--O 1.255 1.38 0 C-N-CA 118.285 -1.366 . . . . 0.0 112.855 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -69.16 -45.36 70.23 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 116.412 -1.756 . . . . 0.0 114.419 172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -59.23 -47.64 84.59 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-O 123.498 1.618 . . . . 0.0 112.405 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.7 p -79.62 -22.34 43.77 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.972 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.81 47.85 78.55 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 125.974 1.75 . . . . 0.0 112.507 -171.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -134.67 152.75 52.0 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 126.574 1.985 . . . . 0.0 112.25 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.5 m -95.29 146.34 24.43 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 119.993 -1.692 . . . . 0.0 110.662 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.5 mt -126.22 129.26 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -171.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.94 157.66 33.8 Favored 'General case' 0 C--O 1.191 -1.987 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 154.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.3 mt -135.04 124.54 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -81.75 154.99 25.7 Favored 'General case' 0 CA--C 1.573 1.864 0 C-N-CA 127.149 2.179 . . . . 0.0 109.958 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -80.63 -13.2 59.24 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -79.16 -13.85 59.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.644 2.378 . . . . 0.0 111.477 172.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.13 -3.26 25.45 Favored Glycine 0 N--CA 1.491 2.331 0 CA-C-O 122.624 1.125 . . . . 0.0 114.436 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -83.19 108.43 16.43 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 123.838 1.78 . . . . 0.0 112.172 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.1 t -90.83 127.66 43.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-O 122.967 1.365 . . . . 0.0 111.492 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -115.67 105.56 12.89 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.206 -0.934 . . . . 0.0 108.709 -169.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.4 mm -88.09 129.13 39.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 O-C-N 120.966 -1.084 . . . . 0.0 111.706 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.96 121.77 44.93 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 118.488 -1.285 . . . . 0.0 111.315 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 65' ' ' ALA . . . -139.42 156.18 47.13 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 124.309 1.006 . . . . 0.0 111.336 -177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -72.89 -31.9 65.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 118.413 -2.679 . . . . 0.0 112.347 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -121.65 148.97 43.88 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 123.233 1.492 . . . . 0.0 109.419 -167.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.5 -48.04 81.77 Favored Glycine 0 C--O 1.197 -2.192 0 CA-C-O 116.762 -2.132 . . . . 0.0 113.002 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.8 -41.88 98.31 Favored 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 119.378 1.589 . . . . 0.0 110.956 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -60.67 -43.74 97.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 118.157 -2.84 . . . . 0.0 113.249 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.4 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . . . -67.18 -36.27 81.42 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.241 -1.537 . . . . 0.0 112.518 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -74.71 -24.13 58.7 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.593 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -72.65 -39.78 66.89 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 118.572 -2.58 . . . . 0.0 112.553 166.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.49 -38.29 90.57 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.928 -1.107 . . . . 0.0 113.298 167.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.7 mm -64.91 -50.37 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 120.684 -1.26 . . . . 0.0 112.267 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -53.85 -42.4 68.5 Favored 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 120.946 -1.096 . . . . 0.0 111.214 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -61.0 -43.49 98.81 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 mt -69.28 -39.57 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.832 0 C-N-CA 118.269 -1.373 . . . . 0.0 113.577 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.18 -39.52 75.49 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 116.692 -1.623 . . . . 0.0 114.411 164.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -61.94 -42.8 99.52 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-N 119.372 0.987 . . . . 0.0 111.211 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mt -65.06 -34.07 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.174 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.665 175.333 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mm . . . . . 0 CA--C 1.563 1.452 0 CA-C-O 123.496 1.617 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -105.28 145.29 30.9 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.698 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 t -69.72 124.97 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 O-C-N 120.645 -1.285 . . . . 0.0 110.522 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.39 19.42 74.14 Favored Glycine 0 C--O 1.211 -1.331 0 C-N-CA 118.606 -1.759 . . . . 0.0 115.883 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -101.42 148.79 24.75 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 167.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.3 t -93.12 130.8 41.65 Favored 'Isoleucine or valine' 0 C--N 1.367 1.336 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -123.91 138.19 54.51 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.3 m -88.09 105.91 17.8 Favored 'General case' 0 C--N 1.399 2.737 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.694 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.84 178.13 17.78 Favored Glycine 0 C--O 1.207 -1.587 0 C-N-CA 125.269 1.414 . . . . 0.0 112.996 -175.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -126.65 135.17 50.83 Favored 'General case' 0 CA--C 1.582 2.204 0 O-C-N 127.23 2.371 . . . . 0.0 109.427 -171.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 t -67.33 125.12 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 126.486 1.914 . . . . 0.0 112.92 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.7 p -99.53 -42.6 6.85 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 119.301 0.955 . . . . 0.0 112.536 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -165.85 152.63 9.82 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.3 mt -118.31 125.29 74.18 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.747 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.24 175.16 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 126.028 2.08 . . . . 0.0 109.627 -174.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -47.63 -42.17 23.71 Favored 'General case' 0 C--N 1.398 2.695 0 CA-C-N 119.931 1.241 . . . . 0.0 111.222 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -94.52 9.14 39.72 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.774 -1.204 . . . . 0.0 113.423 -171.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.78 -164.31 19.4 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 124.275 2.042 . . . . 0.0 116.669 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.1 125.1 53.41 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 112.539 -1.831 . . . . 0.0 110.129 -166.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -81.63 149.76 28.41 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.2 t -145.25 121.95 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 CA-C-O 121.939 0.876 . . . . 0.0 112.375 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.23 132.91 35.37 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 117.154 -3.466 . . . . 0.0 112.478 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.1 mm -112.62 158.83 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 112.327 -2.215 . . . . 0.0 106.449 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.75 158.69 51.32 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 121.185 -0.947 . . . . 0.0 111.251 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.99 23.94 77.6 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 113.722 -1.239 . . . . 0.0 113.911 -170.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.38 18.06 74.91 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 127.499 2.476 . . . . 0.0 113.609 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -88.6 163.47 15.83 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -148.31 132.44 17.32 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 124.066 1.888 . . . . 0.0 106.591 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.91 177.78 16.88 Favored Glycine 0 CA--C 1.554 2.489 0 O-C-N 119.955 -1.716 . . . . 0.0 114.65 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.91 123.43 30.73 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.704 -1.468 . . . . 0.0 109.213 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.2 116.44 38.11 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.772 0 O-C-N 119.328 -2.108 . . . . 0.0 106.08 159.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -64.84 147.16 53.79 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 126.064 2.103 . . . . 0.0 108.293 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 tp -32.66 -42.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.256 1.427 0 N-CA-C 119.576 3.176 . . . . 0.0 119.576 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.0 p -77.11 -27.14 53.93 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -97.46 7.21 46.94 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.596 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.05 -39.75 81.25 Favored 'Isoleucine or valine' 0 C--N 1.365 1.242 0 C-N-CA 124.57 1.148 . . . . 0.0 111.155 170.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.59 158.02 33.09 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 122.784 1.278 . . . . 0.0 111.502 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.02 -37.5 78.68 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 128.741 2.816 . . . . 0.0 109.089 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -112.62 117.21 31.64 Favored 'General case' 0 N--CA 1.517 2.92 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.286 167.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.11 146.29 54.83 Favored 'General case' 0 C--O 1.199 -1.601 0 C-N-CA 125.7 1.6 . . . . 0.0 114.99 -161.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.5 m -97.15 138.9 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 O-C-N 120.504 -1.372 . . . . 0.0 112.75 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -60.22 -39.51 86.87 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -139.2 147.8 42.27 Favored 'General case' 0 C--O 1.248 1.016 0 O-C-N 119.81 -1.806 . . . . 0.0 109.708 160.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.42 -37.2 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 119.191 -1.004 . . . . 0.0 112.672 169.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.2 p -67.75 -20.61 65.25 Favored 'General case' 0 CA--C 1.477 -1.841 1 CA-C-O 111.471 -4.109 . . . . 0.0 112.861 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -84.48 -13.57 51.61 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 124.053 3.115 . . . . 0.0 115.412 171.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -99.04 -23.28 15.34 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.583 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.4 mt -135.47 145.92 47.64 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -118.87 163.91 16.21 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.892 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 22.1 mmt -72.55 150.7 42.94 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 120.605 1.548 . . . . 0.0 112.915 172.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.7 -21.51 18.32 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 112.064 -2.335 . . . . 0.0 115.238 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -109.34 134.95 51.18 Favored 'General case' 0 C--N 1.361 1.075 0 O-C-N 125.625 1.427 . . . . 0.0 111.874 -161.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.14 112.93 1.51 Allowed 'General case' 0 C--N 1.388 2.24 0 O-C-N 128.985 3.928 . . . . 0.0 117.942 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 t -116.25 116.27 39.76 Favored Pre-proline 0 C--O 1.247 0.949 0 C-N-CA 127.377 2.271 . . . . 0.0 109.358 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -57.58 125.23 18.11 Favored 'Trans proline' 0 N--CA 1.515 2.743 0 C-N-CA 121.643 1.562 . . . . 0.0 115.661 157.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.93 123.48 15.41 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -96.95 146.78 24.64 Favored 'General case' 0 C--N 1.368 1.384 0 CA-C-O 123.984 1.85 . . . . 0.0 107.766 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 78.7 t -81.95 126.63 39.94 Favored 'Isoleucine or valine' 0 C--N 1.374 1.651 0 O-C-N 118.25 -2.782 . . . . 0.0 114.917 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.2 -33.93 15.2 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.847 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -174.95 140.78 0.56 Allowed 'General case' 0 N--CA 1.521 3.115 0 O-C-N 124.626 1.204 . . . . 0.0 109.88 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.19 142.64 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 O-C-N 120.429 -1.419 . . . . 0.0 109.666 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.26 66.5 t0 -142.69 138.52 30.66 Favored 'General case' 0 N--CA 1.411 -2.4 0 O-C-N 124.421 1.076 . . . . 0.0 108.715 -175.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -101.04 5.26 42.94 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-O 114.703 -2.57 . . . . 0.0 107.83 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -117.56 -57.13 2.16 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.28 164.66 33.63 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 119.814 2.686 . . . . 0.0 119.814 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -60.8 127.2 30.44 Favored 'General case' 0 C--N 1.396 2.61 0 O-C-N 117.614 -3.286 . . . . 0.0 114.401 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.7 mm -31.2 137.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 126.451 3.024 . . . . 0.0 114.77 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -94.21 132.21 39.0 Favored 'General case' 0 C--O 1.247 0.964 0 O-C-N 118.225 -2.797 . . . . 0.0 109.894 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.3 mt -136.42 146.65 46.64 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.002 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.9 t -129.9 128.25 41.81 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.154 167.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.75 -43.64 60.68 Favored 'Isoleucine or valine' 0 C--N 1.384 2.092 0 CA-C-N 111.569 -2.56 . . . . 0.0 106.933 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -73.3 -30.02 63.1 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 118.975 -2.328 . . . . 0.0 111.899 -170.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -15.02 62.91 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.092 -1.63 . . . . 0.0 113.118 174.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.314 . . -106.86 14.55 26.5 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.106 -168.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.365 0 CA-C-N 120.15 1.341 . . . . 0.0 111.087 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.2 mm . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.318 0.58 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -93.42 119.8 32.95 Favored 'General case' 0 C--O 1.191 -2.001 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.402 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.4 m -118.63 111.77 18.98 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 100.956 -3.72 . . . . 0.0 100.956 -163.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.0 mm -116.39 135.73 55.68 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 CA-C-O 116.01 -1.948 . . . . 0.0 110.514 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -95.54 123.35 39.04 Favored 'General case' 0 CA--C 1.576 1.962 0 O-C-N 124.928 1.393 . . . . 0.0 111.878 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.9 pt -131.43 161.66 40.75 Favored 'Isoleucine or valine' 0 C--O 1.259 1.589 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 -173.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -48.56 120.88 9.24 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.65 -23.93 8.83 Favored 'Trans proline' 0 N--CA 1.516 2.825 0 N-CA-C 118.131 2.32 . . . . 0.0 118.131 171.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.82 -30.04 63.72 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 116.766 -3.709 . . . . 0.0 111.692 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -91.74 -0.28 57.54 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -167.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.9 mm -62.35 -44.91 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.431 1.892 . . . . 0.0 109.539 -172.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -60.84 -38.91 87.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.674 2.39 . . . . 0.0 111.605 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -73.77 -40.69 63.28 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 119.228 -2.17 . . . . 0.0 112.794 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.39 -36.3 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.296 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.91 -43.13 89.59 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 124.335 1.054 . . . . 0.0 110.248 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.456 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 79.94 156.75 12.53 Favored Glycine 1 CA--C 1.584 4.383 0 CA-C-O 123.846 1.803 . . . . 0.0 116.535 -172.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -71.74 132.69 44.87 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-O 122.694 1.235 . . . . 0.0 108.596 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.91 20.03 24.67 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 118.804 2.282 . . . . 0.0 118.804 -168.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.99 16.38 74.98 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.229 -1.317 . . . . 0.0 111.791 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.3 t -70.62 -41.9 71.64 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 118.17 2.655 . . . . 0.0 118.17 -169.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.456 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 21.4 t -65.48 -44.3 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 CA-C-N 120.441 1.473 . . . . 0.0 114.135 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -61.83 -39.38 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.718 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -64.64 -44.46 90.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.091 -1.631 . . . . 0.0 115.283 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.97 97.57 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.44 -39.87 92.59 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 120.881 -1.137 . . . . 0.0 113.049 168.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 m -47.81 -55.55 9.44 Favored 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 125.862 1.665 . . . . 0.0 112.484 167.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.86 -33.45 72.29 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -57.84 -46.32 84.93 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 126.321 1.849 . . . . 0.0 112.101 166.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.3 p -97.51 -18.69 18.85 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 117.354 -1.738 . . . . 0.0 111.422 -165.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.77 35.77 73.85 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 124.156 0.884 . . . . 0.0 112.838 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.52 152.33 32.8 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 117.811 -1.555 . . . . 0.0 107.729 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 m -66.42 131.01 45.13 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.048 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 mt -132.11 123.0 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.923 174.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -131.37 141.52 49.9 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 tt -127.55 155.23 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -116.19 143.02 46.06 Favored 'General case' 0 C--N 1.38 1.906 0 O-C-N 117.403 -3.311 . . . . 0.0 103.389 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -62.94 -12.42 25.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -87.52 0.27 55.82 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-N 119.21 0.914 . . . . 0.0 113.441 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.67 27.15 7.26 Favored Glycine 0 CA--C 1.478 -2.245 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 168.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.2 m -107.02 110.46 22.6 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.79 142.66 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 118.853 0.751 . . . . 0.0 109.575 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -125.83 137.24 53.76 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.328 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.6 mt -121.06 119.58 59.73 Favored 'Isoleucine or valine' 0 C--N 1.366 1.307 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . 0.279 . . -87.6 118.55 27.16 Favored 'General case' 0 N--CA 1.403 -2.782 0 O-C-N 118.113 -2.867 . . . . 0.0 110.98 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.42 151.51 17.25 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -98.69 -39.94 8.42 Favored 'General case' 0 CA--C 1.484 -1.585 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.233 169.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.52 124.78 25.04 Favored 'General case' 0 N--CA 1.415 -2.211 0 O-C-N 126.02 2.075 . . . . 0.0 109.374 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.58 -25.77 64.61 Favored Glycine 0 C--N 1.356 1.652 0 O-C-N 120.452 -1.405 . . . . 0.0 116.528 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -66.4 -34.87 78.93 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 113.007 0.744 . . . . 0.0 113.007 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -63.26 -44.87 93.9 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 167.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.91 77.93 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -64.47 -50.79 66.1 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 164.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -57.73 -41.43 81.81 Favored 'General case' 0 N--CA 1.529 3.479 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.99 -44.33 87.11 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.83 -39.82 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.351 -0.94 . . . . 0.0 113.209 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -65.14 -41.84 94.38 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 121.552 1.978 . . . . 0.0 110.315 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -60.85 -38.19 84.65 Favored 'General case' 0 CA--C 1.584 2.251 1 O-C-N 116.198 -4.064 . . . . 0.0 115.593 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.79 -44.04 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 119.917 -1.739 . . . . 0.0 110.264 172.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -54.85 -41.12 70.37 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-O 115.527 -2.178 . . . . 0.0 114.776 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -63.82 -41.47 97.86 Favored 'General case' 0 C--N 1.38 1.903 0 CA-C-N 122.225 2.284 . . . . 0.0 115.287 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.7 mt -69.08 -39.8 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 122.217 2.281 . . . . 0.0 114.681 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 N--CA 1.499 2.0 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 178.849 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.8 mm . . . . . 0 N--CA 1.433 -1.281 0 CA-C-O 124.119 1.914 . . . . 0.0 113.759 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -84.01 123.8 30.38 Favored 'General case' 0 C--O 1.188 -2.15 0 CA-C-N 111.209 -2.723 . . . . 0.0 117.87 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.73 122.49 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.862 0 C-N-CA 126.311 1.844 . . . . 0.0 106.858 173.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.07 8.03 59.25 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 112.808 -1.997 . . . . 0.0 113.224 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -96.75 164.22 12.67 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 169.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.2 t -102.97 136.47 35.35 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.51 158.75 21.21 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -98.37 124.41 43.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.361 1.077 . . . . 0.0 108.447 167.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.97 -174.05 13.48 Favored Glycine 0 C--N 1.347 1.139 0 O-C-N 120.241 -1.537 . . . . 0.0 112.188 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -131.39 134.94 46.77 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.92 119.77 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 124.176 0.991 . . . . 0.0 109.072 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -84.86 -22.39 29.43 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 119.975 -1.703 . . . . 0.0 114.668 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.57 132.79 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.366 -169.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.6 mt -108.96 128.31 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -114.68 173.79 3.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -53.14 -47.88 68.36 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.395 -1.44 . . . . 0.0 113.493 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -104.08 17.89 23.17 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 120.045 -1.659 . . . . 0.0 113.618 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.78 -176.41 47.5 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 118.27 -1.919 . . . . 0.0 115.485 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.83 117.74 9.38 Favored 'General case' 0 C--N 1.373 1.618 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -75.58 137.72 40.98 Favored 'General case' 0 C--N 1.372 1.578 0 O-C-N 125.559 1.787 . . . . 0.0 111.46 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.4 t -134.25 132.57 55.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -171.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.42 136.41 37.9 Favored 'General case' 0 C--N 1.363 1.171 0 CA-C-O 122.702 1.239 . . . . 0.0 108.753 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.9 pt -139.76 160.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 CA-C-O 117.448 -1.263 . . . . 0.0 111.15 -168.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.17 138.01 0.54 Allowed Glycine 0 CA--C 1.562 2.992 0 N-CA-C 122.391 3.717 . . . . 0.0 122.391 -166.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.92 18.58 62.99 Favored Glycine 0 CA--C 1.483 -1.938 0 CA-C-O 116.189 -2.451 . . . . 0.0 116.827 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.59 33.82 41.69 Favored Glycine 0 CA--C 1.544 1.888 0 CA-C-N 120.371 2.085 . . . . 0.0 117.5 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -114.52 151.62 33.03 Favored 'General case' 0 N--CA 1.515 2.781 0 C-N-CA 124.222 1.009 . . . . 0.0 112.544 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -143.79 123.34 13.23 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 113.3 -1.773 . . . . 0.0 106.219 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -120.85 174.66 15.85 Favored Glycine 0 C--N 1.364 2.125 0 O-C-N 126.748 2.53 . . . . 0.0 113.003 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.7 tp -128.98 126.46 39.62 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 112.587 -1.807 . . . . 0.0 111.835 -166.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.3 t -95.59 116.66 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 N-CA-C 102.329 -3.212 . . . . 0.0 102.329 173.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -66.63 151.74 46.74 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 120.352 -1.467 . . . . 0.0 111.462 171.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.333 14.2 tt -39.07 -34.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.563 0 N-CA-C 120.634 3.568 . . . . 0.0 120.634 172.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.5 m -69.63 -18.87 63.62 Favored 'General case' 0 N--CA 1.534 3.725 0 O-C-N 125.758 1.911 . . . . 0.0 113.446 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -120.24 6.83 10.71 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.718 0.807 . . . . 0.0 110.817 -160.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.9 mm -74.19 -42.04 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 170.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.05 167.75 21.34 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 119.98 -1.7 . . . . 0.0 112.427 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.316 53.6 p30 -41.6 -67.0 0.29 Allowed 'General case' 0 C--N 1.363 1.161 0 O-C-N 128.584 3.678 . . . . 0.0 118.081 173.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . 0.257 66.6 mttt -99.71 164.96 11.83 Favored 'General case' 0 CA--C 1.582 2.21 0 C-N-CA 129.408 3.083 . . . . 0.0 106.091 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -59.05 140.56 55.65 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.43 HG12 HG22 ' A' ' 122' ' ' VAL . 52.1 t -102.71 136.57 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 125.057 1.473 . . . . 0.0 110.228 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -92.25 -48.62 6.59 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.697 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -143.99 127.97 17.46 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.43 HG22 HG12 ' A' ' 119' ' ' VAL . 48.1 t -72.33 -24.22 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 123.889 1.804 . . . . 0.0 113.129 -164.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 66.8 p -63.62 -26.83 68.86 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 126.691 1.996 . . . . 0.0 112.721 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -63.89 -25.59 68.22 Favored 'General case' 0 C--O 1.261 1.688 0 O-C-N 119.326 -2.109 . . . . 0.0 115.306 168.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -96.35 -46.49 6.38 Favored 'General case' 0 C--N 1.371 1.53 0 O-C-N 126.725 2.515 . . . . 0.0 114.47 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.2 mt -114.67 135.62 53.96 Favored 'General case' 0 N--CA 1.434 -1.256 0 O-C-N 125.687 1.867 . . . . 0.0 108.536 -166.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -105.94 141.62 37.04 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.8 ttp -63.95 137.19 57.9 Favored 'General case' 0 C--O 1.203 -1.362 0 O-C-N 126.328 2.267 . . . . 0.0 114.063 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.01 -24.52 7.84 Favored Glycine 0 N--CA 1.428 -1.858 0 CA-C-O 116.898 -2.057 . . . . 0.0 115.731 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -72.01 163.91 27.05 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.45 134.77 37.31 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.69 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.6 m -139.85 141.21 26.7 Favored Pre-proline 0 C--N 1.369 1.419 0 O-C-N 118.753 -2.467 . . . . 0.0 112.042 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.06 127.77 10.9 Favored 'Trans proline' 0 C--N 1.286 -2.739 0 C-N-CA 121.106 1.204 . . . . 0.0 111.707 165.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.1 m -128.33 128.43 68.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -91.61 132.68 36.16 Favored 'General case' 0 C--N 1.373 1.602 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.701 165.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -75.7 104.45 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.667 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.11 -42.65 98.92 Favored 'General case' 0 C--N 1.39 2.327 0 C-N-CA 127.048 2.139 . . . . 0.0 112.894 168.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -165.56 140.69 4.98 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 123.939 0.775 . . . . 0.0 112.298 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.9 t -106.88 116.0 49.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 156.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.251 0.3 OUTLIER -80.55 171.55 14.89 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 123.768 1.747 . . . . 0.0 113.698 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -64.34 -33.82 76.72 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 119.066 -2.271 . . . . 0.0 112.617 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -71.11 -37.74 72.36 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-O 116.757 -1.592 . . . . 0.0 110.02 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.77 9.22 1.78 Allowed Glycine 0 C--N 1.359 1.834 0 CA-C-N 122.101 2.228 . . . . 0.0 114.736 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -95.7 134.02 39.11 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -163.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.4 mt -105.54 108.88 26.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 O-C-N 121.412 -0.805 . . . . 0.0 110.333 -167.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -85.9 136.55 33.24 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 92.4 mt -127.68 163.06 25.1 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 126.077 2.111 . . . . 0.0 111.332 -170.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 42.9 t -148.9 134.55 18.73 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.27 -30.51 2.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.45 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -61.1 -40.97 95.74 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.765 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.4 -14.8 60.91 Favored 'General case' 0 CA--C 1.562 1.419 0 O-C-N 125.117 1.511 . . . . 0.0 110.232 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -96.61 -14.94 21.82 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 CA--C 1.488 -1.406 0 O-C-N 126.978 2.674 . . . . 0.0 111.703 161.348 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 122.118 0.961 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -75.96 135.79 40.04 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-O 126.027 2.823 . . . . 0.0 114.663 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.5 p -141.67 154.97 45.69 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 112.45 -2.159 . . . . 0.0 111.915 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 mt -130.3 128.4 64.04 Favored 'Isoleucine or valine' 0 C--N 1.366 1.315 0 O-C-N 126.753 2.533 . . . . 0.0 107.716 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -77.69 126.22 30.54 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 28' ' ' VAL . 36.0 mm -106.18 133.97 49.1 Favored 'Isoleucine or valine' 0 C--N 1.366 1.291 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -63.39 140.07 97.67 Favored Pre-proline 0 N--CA 1.485 1.321 0 CA-C-O 117.165 -1.397 . . . . 0.0 110.178 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -44.89 -45.71 13.59 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.622 2.881 . . . . 0.0 116.472 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -73.98 -21.29 60.06 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 128.04 3.338 . . . . 0.0 106.536 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -101.47 -4.65 26.43 Favored 'General case' 0 C--N 1.387 2.227 0 O-C-N 119.737 -1.852 . . . . 0.0 113.839 -170.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.4 mt -59.25 -42.27 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 117.23 -1.367 . . . . 0.0 114.577 168.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -58.34 -40.37 81.95 Favored 'General case' 0 C--O 1.267 1.999 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 170.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -65.88 -35.57 81.0 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 117.56 -1.209 . . . . 0.0 112.432 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG22 HD12 ' A' ' 20' ' ' ILE . 37.2 t -70.05 -44.9 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 123.867 0.73 . . . . 0.0 111.679 174.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.0 mm -85.85 -38.37 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 122.079 2.218 . . . . 0.0 112.487 -172.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.48 154.21 16.97 Favored Glycine 0 CA--C 1.474 -2.521 0 CA-C-N 120.684 1.584 . . . . 0.0 115.817 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -70.53 130.6 42.29 Favored 'General case' 0 N--CA 1.419 -1.987 0 O-C-N 119.699 -2.059 . . . . 0.0 111.026 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.74 10.07 60.29 Favored Glycine 0 N--CA 1.481 1.636 0 CA-C-O 115.373 -2.904 . . . . 0.0 113.507 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.14 22.8 67.46 Favored Glycine 0 CA--C 1.563 3.077 0 O-C-N 127.163 2.331 . . . . 0.0 112.048 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.0 p -55.29 -49.31 72.45 Favored 'General case' 0 C--O 1.261 1.681 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.5 t -71.29 -43.3 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.4 tp -68.56 -30.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.002 -1.686 . . . . 0.0 113.417 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.8 mtm-85 -63.02 -39.1 93.75 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 122.375 1.083 . . . . 0.0 110.875 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.93 98.25 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 119.874 -1.766 . . . . 0.0 114.324 166.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.3 mt -67.22 -38.82 85.91 Favored 'General case' 0 C--O 1.188 -2.134 0 O-C-N 118.338 -2.727 . . . . 0.0 109.714 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.281 15.3 t -59.46 -39.73 84.6 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 114.282 -2.77 . . . . 0.0 114.185 165.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -69.96 -38.92 76.25 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 122.827 2.558 . . . . 0.0 115.669 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -69.36 -43.13 74.24 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 126.787 2.554 . . . . 0.0 111.058 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.7 p -83.7 -25.14 30.89 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.1 30.75 54.76 Favored Glycine 0 C--N 1.318 -0.42 0 CA-C-O 117.192 -1.893 . . . . 0.0 110.201 173.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 t -152.63 162.21 41.54 Favored 'General case' 0 C--N 1.396 2.621 0 C-N-CA 128.68 2.792 . . . . 0.0 106.034 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.4 m -73.83 124.09 25.43 Favored 'General case' 0 C--N 1.371 1.539 0 C-N-CA 126.134 1.774 . . . . 0.0 113.922 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.1 mm -112.69 135.01 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 112.943 -1.935 . . . . 0.0 108.768 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -132.96 158.31 42.98 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mm -109.45 132.36 57.8 Favored 'Isoleucine or valine' 0 C--N 1.368 1.387 0 O-C-N 119.691 -1.88 . . . . 0.0 107.959 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -115.5 169.76 8.93 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.06 139.59 0.67 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 124.396 2.046 . . . . 0.0 113.731 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.317 28.2 m-20 67.51 38.34 3.16 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 113.244 -1.798 . . . . 0.0 113.0 173.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.53 41.1 77.55 Favored Glycine 0 N--CA 1.422 -2.276 0 CA-C-O 115.989 -2.561 . . . . 0.0 117.357 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.0 m -103.84 108.82 20.31 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 120.189 1.994 . . . . 0.0 111.646 -169.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -73.43 127.59 35.45 Favored 'Isoleucine or valine' 0 C--N 1.382 2.02 0 O-C-N 123.632 0.582 . . . . 0.0 111.303 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -119.41 137.16 53.93 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 124.584 2.135 . . . . 0.0 111.21 173.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.8 mt -104.33 112.48 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 113.069 -1.878 . . . . 0.0 109.425 -172.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.63 -47.48 78.42 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 116.911 -1.518 . . . . 0.0 112.969 -173.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.8 138.04 53.86 Favored 'General case' 0 C--N 1.369 1.44 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.0 p -95.54 -0.57 51.91 Favored 'General case' 0 C--N 1.369 1.426 0 O-C-N 120.185 -1.572 . . . . 0.0 114.07 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -55.47 151.94 9.56 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 126.37 2.294 . . . . 0.0 114.827 168.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.29 -48.32 5.71 Favored Glycine 0 N--CA 1.478 1.487 0 O-C-N 120.596 -1.315 . . . . 0.0 112.108 -172.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.17 -26.44 63.91 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.22 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -65.16 -41.53 94.59 Favored 'General case' 0 C--N 1.386 2.171 0 C-N-CA 123.42 0.688 . . . . 0.0 111.414 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.49 67.58 Favored 'General case' 0 C--O 1.252 1.224 0 O-C-N 124.045 0.841 . . . . 0.0 110.561 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -63.29 -40.71 98.12 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.41 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -68.25 -45.81 72.17 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 121.124 1.784 . . . . 0.0 110.564 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.91 87.32 Favored 'General case' 0 C--O 1.258 1.532 0 O-C-N 124.634 1.209 . . . . 0.0 112.302 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.256 15.0 tt -70.71 -31.56 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.372 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -61.28 -42.95 99.5 Favored 'General case' 0 CA--C 1.574 1.903 0 CA-C-N 121.043 1.747 . . . . 0.0 114.865 171.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -60.53 -47.19 87.26 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.4 mm -56.47 -38.66 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 O-C-N 120.457 -1.402 . . . . 0.0 112.722 170.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.17 -53.91 52.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.84 1.337 . . . . 0.0 113.113 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -59.58 -37.2 77.87 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.911 1.285 . . . . 0.0 114.154 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.9 mt -69.45 -36.07 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m . . . . . 0 N--CA 1.478 0.963 0 O-C-N 124.925 1.391 . . . . 0.0 109.137 179.191 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mm . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -91.64 135.19 34.06 Favored 'General case' 0 C--N 1.374 1.656 0 O-C-N 119.928 -1.733 . . . . 0.0 112.676 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.8 t -73.5 140.31 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 O-C-N 127.171 2.795 . . . . 0.0 113.589 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.05 -8.43 57.48 Favored Glycine 0 C--N 1.387 3.374 0 C-N-CA 126.276 1.894 . . . . 0.0 114.806 -171.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -89.83 149.37 22.7 Favored 'General case' 0 C--N 1.365 1.269 0 O-C-N 121.234 -1.157 . . . . 0.0 109.537 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.46 121.78 58.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.39 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -111.42 166.46 11.1 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 53.0 m -112.79 134.53 54.27 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.09 168.32 23.75 Favored Glycine 0 CA--C 1.475 -2.462 0 C-N-CA 117.547 -2.263 . . . . 0.0 108.648 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -118.41 135.37 54.38 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 113.242 -1.479 . . . . 0.0 113.631 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.3 t -69.3 135.82 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.233 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.759 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.9 p -128.4 -18.05 4.09 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.909 -1.119 . . . . 0.0 108.249 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -154.42 156.88 37.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.679 -1.888 . . . . 0.0 108.249 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 mm -123.88 135.32 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 CA-C-O 123.653 1.692 . . . . 0.0 111.136 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.9 m -126.7 168.43 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.694 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.61 -46.16 48.91 Favored 'General case' 0 C--O 1.179 -2.618 0 C-N-CA 123.899 0.88 . . . . 0.0 111.976 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -107.44 17.63 22.53 Favored 'General case' 0 N--CA 1.514 2.73 0 C-N-CA 125.898 1.679 . . . . 0.0 114.622 -169.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.93 -163.32 33.66 Favored Glycine 0 C--N 1.363 2.05 0 O-C-N 118.394 -2.691 . . . . 0.0 108.977 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.76 165.5 30.35 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 170.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -107.88 127.27 53.59 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 126.718 2.511 . . . . 0.0 111.867 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.6 t -122.45 126.22 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 CA-C-N 112.593 -2.094 . . . . 0.0 108.925 -166.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.8 109.9 21.77 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 126.157 2.161 . . . . 0.0 110.316 -171.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.7 pt -105.35 161.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.203 0 C-N-CA 126.085 1.754 . . . . 0.0 111.916 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.36 136.75 7.0 Favored Glycine 0 C--N 1.36 1.894 1 N-CA-C 124.032 4.373 . . . . 0.0 124.032 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.66 4.0 39.99 Favored Glycine 0 C--N 1.306 -1.1 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.84 23.99 56.53 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -107.28 148.54 28.85 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.981 1.391 . . . . 0.0 112.226 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -127.37 127.46 44.25 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 125.698 1.874 . . . . 0.0 110.782 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -119.38 155.93 15.93 Favored Glycine 0 CA--C 1.556 2.645 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.3 tp -90.47 118.36 29.88 Favored 'General case' 0 N--CA 1.518 2.972 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.27 107.67 20.36 Favored 'Isoleucine or valine' 0 C--N 1.396 2.62 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -68.88 162.41 26.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 118.299 -2.751 . . . . 0.0 116.872 172.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.2 tt -61.83 -37.64 78.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -59.51 -19.6 49.33 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 126.804 2.565 . . . . 0.0 116.345 167.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -106.15 9.78 32.17 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.499 -1.228 . . . . 0.0 112.588 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.9 mt -88.38 -49.42 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 119.087 0.858 . . . . 0.0 109.856 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.12 157.57 43.65 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 116.009 -1.948 . . . . 0.0 107.036 -172.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -71.46 -19.22 62.25 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -95.06 134.57 37.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.816 2.046 . . . . 0.0 105.892 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.19 116.44 1.86 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.66 120.01 35.54 Favored 'Isoleucine or valine' 0 C--O 1.262 1.724 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.34 -40.9 90.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 126.343 2.277 . . . . 0.0 111.808 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -157.52 151.69 24.67 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.2 t -63.12 -36.81 77.45 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 0 CA-C-O 116.727 -1.606 . . . . 0.0 113.15 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.59 -25.2 16.33 Favored 'General case' 0 N--CA 1.513 2.692 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -69.04 -19.85 64.11 Favored 'General case' 0 CA--C 1.575 1.918 0 C-N-CA 125.354 1.462 . . . . 0.0 113.872 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -123.48 -37.0 2.71 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.201 -1.562 . . . . 0.0 112.485 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.3 mt -130.23 150.94 51.24 Favored 'General case' 0 CA--C 1.574 1.903 0 CA-C-O 124.293 1.997 . . . . 0.0 115.328 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -159.34 155.98 27.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -172.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -43.95 125.69 4.44 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 122.705 1.241 . . . . 0.0 113.227 165.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.58 -2.72 80.85 Favored Glycine 0 N--CA 1.494 2.556 0 CA-C-N 114.264 -1.335 . . . . 0.0 116.087 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -73.65 128.48 35.61 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.471 171.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -106.52 124.92 50.33 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 124.516 1.135 . . . . 0.0 109.666 168.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.97 151.12 61.55 Favored Pre-proline 0 C--N 1.379 1.856 0 C-N-CA 127.72 2.408 . . . . 0.0 110.982 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -90.81 138.89 2.56 Favored 'Trans proline' 0 CA--C 1.493 -1.565 0 N-CA-C 104.814 -2.802 . . . . 0.0 104.814 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 6.2 m -136.41 126.77 40.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 110.946 -2.843 . . . . 0.0 109.133 -168.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.9 tttt -100.26 122.18 42.65 Favored 'General case' 0 C--N 1.368 1.397 0 O-C-N 120.222 -1.549 . . . . 0.0 111.395 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.13 118.73 5.66 Favored 'Isoleucine or valine' 0 C--O 1.264 1.856 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.488 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.5 mt -90.68 -50.26 6.01 Favored 'General case' 0 C--O 1.254 1.295 0 CA-C-N 111.888 -2.414 . . . . 0.0 113.613 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -159.78 148.58 17.6 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 116.047 -1.93 . . . . 0.0 107.371 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.0 t -133.93 120.33 35.5 Favored 'Isoleucine or valine' 0 C--N 1.388 2.271 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.92 146.78 53.28 Favored 'General case' 0 CA--C 1.556 1.205 0 O-C-N 126.028 2.08 . . . . 0.0 111.676 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -46.69 -33.76 4.55 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 167.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -92.73 29.15 1.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.11 1.364 . . . . 0.0 109.656 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.98 59.16 7.8 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 120.041 2.776 . . . . 0.0 120.041 166.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -137.19 136.82 38.52 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.3 mt -121.66 122.68 67.64 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 O-C-N 126.466 2.354 . . . . 0.0 108.892 -158.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -94.19 136.23 34.71 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.9 mt -124.73 152.35 43.9 Favored 'General case' 0 C--N 1.372 1.557 0 O-C-N 127.408 2.942 . . . . 0.0 111.524 -173.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.9 t -140.6 138.9 34.77 Favored 'General case' 0 CA--C 1.484 -1.585 0 O-C-N 120.534 -1.354 . . . . 0.0 109.974 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.65 -34.71 7.55 Favored 'Isoleucine or valine' 0 C--O 1.258 1.512 0 O-C-N 125.86 1.975 . . . . 0.0 110.432 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -77.12 -33.28 56.81 Favored 'General case' 0 C--O 1.198 -1.654 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -168.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -71.34 -30.97 66.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.43 -21.81 35.56 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 119.024 -2.297 . . . . 0.0 109.314 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.506 2.343 0 CA-C-N 121.007 1.73 . . . . 0.0 113.655 171.492 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 tp . . . . . 0 CA--C 1.579 2.093 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -116.03 113.88 23.82 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 162.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.7 m -100.62 106.13 17.59 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -109.3 158.5 9.2 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.212 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.421 -172.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -108.96 140.09 42.93 Favored 'General case' 0 C--N 1.368 1.401 0 O-C-N 119.111 -2.243 . . . . 0.0 109.021 167.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.89 162.27 36.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -64.53 132.22 95.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-O 114.254 -2.784 . . . . 0.0 112.576 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . 0.271 42.6 Cg_exo -48.79 -29.25 14.42 Favored 'Trans proline' 0 N--CA 1.515 2.742 0 N-CA-C 120.204 3.117 . . . . 0.0 120.204 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.2 -7.72 59.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.129 2.171 . . . . 0.0 111.38 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -98.98 7.88 45.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 115.59 -2.148 . . . . 0.0 114.321 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.35 -36.91 78.51 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 CA-C-N 121.25 1.841 . . . . 0.0 110.101 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.528 ' HZ1' ' CD ' ' A' ' 80' ' ' GLU . 4.9 pttp -58.09 -44.57 87.69 Favored 'General case' 0 N--CA 1.385 -3.7 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 170.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -72.46 -39.19 67.94 Favored 'General case' 0 CA--C 1.484 -1.567 0 O-C-N 126.004 2.065 . . . . 0.0 112.61 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.1 -42.34 91.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.245 0 O-C-N 125.794 1.934 . . . . 0.0 113.802 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.7 mt -72.3 -43.02 65.66 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 O-C-N 119.063 -2.273 . . . . 0.0 113.564 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.49 171.86 39.76 Favored Glycine 0 CA--C 1.56 2.897 0 CA-C-O 121.774 0.652 . . . . 0.0 113.915 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -66.87 110.61 3.38 Favored 'General case' 1 N--CA 1.539 4.004 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.65 31.37 79.78 Favored Glycine 0 CA--C 1.544 1.845 0 O-C-N 125.036 1.46 . . . . 0.0 110.902 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.13 25.54 73.42 Favored Glycine 0 N--CA 1.509 3.505 0 C-N-CA 128.035 2.731 . . . . 0.0 114.847 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 t -62.43 -47.68 83.03 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-O 116.849 -1.548 . . . . 0.0 113.662 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.45 -50.0 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 120.29 1.404 . . . . 0.0 108.836 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -55.3 -36.17 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 121.399 1.908 . . . . 0.0 112.755 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -78.84 -36.03 43.11 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 118.931 -1.108 . . . . 0.0 112.029 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.63 -40.65 84.6 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 117.361 -3.337 . . . . 0.0 108.125 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.1 tp -62.87 -40.26 96.95 Favored 'General case' 0 C--N 1.361 1.107 0 O-C-N 120.689 -1.257 . . . . 0.0 111.67 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.1 m -67.2 -48.76 66.92 Favored 'General case' 0 C--N 1.373 1.602 0 O-C-N 125.27 1.606 . . . . 0.0 112.256 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -63.97 -43.85 94.53 Favored 'General case' 0 C--N 1.381 1.97 0 O-C-N 116.502 -3.874 . . . . 0.0 115.025 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -59.23 -40.73 86.82 Favored 'General case' 0 C--N 1.385 2.121 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.8 p -108.01 -3.03 19.14 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -162.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.65 25.26 75.14 Favored Glycine 0 CA--C 1.552 2.401 0 N-CA-C 118.86 2.304 . . . . 0.0 118.86 -173.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 p -124.32 159.26 30.7 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.624 1.17 . . . . 0.0 113.578 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.0 m -110.53 131.57 54.94 Favored 'General case' 0 C--N 1.399 2.744 0 CA-C-N 119.649 1.113 . . . . 0.0 110.289 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.53 138.8 44.73 Favored 'Isoleucine or valine' 0 C--N 1.37 1.481 0 O-C-N 120.785 -1.197 . . . . 0.0 111.403 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -131.95 157.25 44.54 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.269 6.2 tt -150.67 125.02 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 O-C-N 116.716 -3.74 . . . . 0.0 109.776 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -86.53 154.05 21.38 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 119.318 -2.114 . . . . 0.0 112.53 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -53.0 -32.33 45.95 Favored 'General case' 0 C--N 1.393 2.458 0 C-N-CA 127.194 2.197 . . . . 0.0 113.095 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 p30 -86.57 12.57 10.17 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 119.804 1.183 . . . . 0.0 110.892 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.29 26.51 65.87 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-O 123.22 1.455 . . . . 0.0 114.11 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 m -92.09 108.92 20.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 167.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.27 144.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -131.61 115.05 15.58 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.39 108.68 25.95 Favored 'Isoleucine or valine' 0 C--N 1.376 1.726 0 C-N-CA 125.661 1.585 . . . . 0.0 109.896 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.14 128.93 45.35 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.38 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.88 149.05 28.53 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 104.4 -2.445 . . . . 0.0 104.4 173.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 p -78.37 -27.1 46.81 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.425 1.078 . . . . 0.0 110.388 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.54 136.22 41.74 Favored 'General case' 0 CA--C 1.58 2.1 0 C-N-CA 128.343 2.657 . . . . 0.0 112.167 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.04 -49.49 40.56 Favored Glycine 0 CA--C 1.558 2.769 0 C-N-CA 124.35 0.976 . . . . 0.0 112.576 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.27 -33.69 73.95 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 121.609 2.705 . . . . 0.0 114.201 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -68.52 -45.17 72.98 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 126.331 2.269 . . . . 0.0 110.914 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.58 83.38 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 119.326 -2.109 . . . . 0.0 113.053 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . 0.297 91.9 mttt -54.04 -41.58 68.26 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.473 1.109 . . . . 0.0 113.246 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -62.81 -38.59 91.32 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.95 -35.83 74.81 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 119.042 -2.286 . . . . 0.0 116.313 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.74 -37.24 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 O-C-N 124.676 1.235 . . . . 0.0 109.882 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -67.58 -40.34 84.86 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.46 1.482 . . . . 0.0 113.097 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -68.13 -40.64 82.41 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 120.144 -1.598 . . . . 0.0 110.814 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.04 -41.83 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.526 0 CA-C-O 116.822 -1.561 . . . . 0.0 112.049 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -48.47 -52.12 23.83 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-N 122.676 2.489 . . . . 0.0 115.956 166.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.77 -45.86 90.98 Favored 'General case' 0 CA--C 1.569 1.708 0 O-C-N 127.094 2.746 . . . . 0.0 111.141 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.5 mt -62.71 -40.3 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.941 0.896 . . . . 0.0 110.493 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 123.963 1.84 . . . . 0.0 111.517 -172.571 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.528 ' CD ' ' HZ1' ' A' ' 26' ' ' LYS . 68.2 mm-40 -73.86 148.99 41.85 Favored 'General case' 0 CA--C 1.579 2.066 0 CA-C-O 122.449 1.118 . . . . 0.0 112.575 165.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.6 137.27 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 -10.25 73.63 Favored Glycine 0 C--N 1.376 2.776 0 C-N-CA 126.989 2.233 . . . . 0.0 113.783 -174.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -97.93 163.06 12.94 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -172.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.14 139.35 30.65 Favored 'Isoleucine or valine' 0 C--N 1.386 2.196 0 CA-C-O 123.038 1.399 . . . . 0.0 110.612 -175.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -130.87 172.3 12.18 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.377 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 133' ' ' PRO . 86.9 m -133.0 123.36 25.71 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.19 -171.61 12.75 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -120.26 154.94 34.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 125.384 1.285 . . . . 0.0 114.029 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.7 t -85.31 127.75 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-O 123.331 1.538 . . . . 0.0 109.31 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.9 -36.49 6.36 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 111.609 -2.541 . . . . 0.0 112.293 -172.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.4 mtt-85 -150.11 145.89 26.6 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 122.763 1.268 . . . . 0.0 109.894 -170.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -124.26 134.97 65.21 Favored 'Isoleucine or valine' 0 C--N 1.366 1.316 0 CA-C-O 124.434 2.064 . . . . 0.0 110.453 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.69 165.66 18.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.681 0 CA-C-N 111.585 -2.552 . . . . 0.0 107.941 166.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -52.75 -35.44 56.13 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 119.347 3.092 . . . . 0.0 119.347 -163.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -118.3 19.12 13.55 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 124.733 1.213 . . . . 0.0 112.161 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.83 168.64 41.04 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.95 1.54 . . . . 0.0 116.95 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.98 167.3 18.46 Favored 'General case' 0 C--N 1.374 1.656 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -124.02 136.79 54.51 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.455 173.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.17 131.97 72.24 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.397 0 C-N-CA 123.532 0.733 . . . . 0.0 111.21 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.96 121.64 40.12 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.217 1.484 . . . . 0.0 112.511 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.6 pt -115.74 166.97 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 112.043 -2.344 . . . . 0.0 114.484 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -31.51 142.77 0.03 OUTLIER Glycine 0 CA--C 1.57 3.507 0 N-CA-C 122.132 3.613 . . . . 0.0 122.132 172.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.19 25.7 69.87 Favored Glycine 0 N--CA 1.484 1.866 0 O-C-N 120.445 -1.621 . . . . 0.0 114.811 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.91 22.74 65.46 Favored Glycine 0 C--O 1.255 1.467 0 N-CA-C 118.529 2.171 . . . . 0.0 118.529 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -94.49 152.22 18.75 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 122.137 0.97 . . . . 0.0 113.308 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -130.96 151.33 51.49 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 168.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.8 175.29 22.21 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.375 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 139.14 35.65 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.259 1.424 . . . . 0.0 112.289 -174.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.6 t -125.0 106.55 16.65 Favored 'Isoleucine or valine' 0 C--O 1.261 1.665 0 CA-C-O 124.431 2.062 . . . . 0.0 106.996 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -77.59 151.13 34.56 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.328 -1.482 . . . . 0.0 112.85 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.48 -33.11 43.46 Favored 'Isoleucine or valine' 0 C--N 1.391 2.411 0 CA-C-O 115.918 -1.991 . . . . 0.0 114.144 -164.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 95.7 p -56.57 -32.65 65.39 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 124.94 3.518 . . . . 0.0 118.342 164.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -97.91 4.18 49.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 121.063 1.756 . . . . 0.0 113.66 -161.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.2 -39.87 85.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 124.651 1.22 . . . . 0.0 107.776 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -162.97 161.58 25.66 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -69.17 -37.74 78.35 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 127.47 2.308 . . . . 0.0 109.699 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -69.79 142.8 53.12 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 113.316 -1.765 . . . . 0.0 108.194 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -82.71 115.12 21.5 Favored 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -170.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.411 HG23 ' CD1' ' A' ' 125' ' ' TYR . 58.5 t -100.28 122.85 52.71 Favored 'Isoleucine or valine' 0 C--N 1.385 2.151 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -164.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -107.45 -13.86 14.99 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.625 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.259 18.2 pttp -150.54 140.24 21.7 Favored 'General case' 0 C--O 1.21 -1.023 0 O-C-N 126.973 2.671 . . . . 0.0 106.336 159.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.54 -33.53 49.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 O-C-N 127.112 2.758 . . . . 0.0 112.915 -159.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.3 -36.54 61.32 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 109.895 -3.32 . . . . 0.0 116.713 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -57.02 -37.73 72.13 Favored 'General case' 0 N--CA 1.439 -1.025 0 O-C-N 125.221 1.576 . . . . 0.0 112.74 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.411 ' CD1' HG23 ' A' ' 119' ' ' VAL . 31.0 m-85 -93.54 -42.89 8.98 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 121.68 2.036 . . . . 0.0 114.262 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.8 mt -109.13 123.01 48.51 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.929 0.892 . . . . 0.0 109.867 -163.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -108.63 142.14 39.55 Favored 'General case' 0 C--N 1.363 1.195 0 C-N-CA 126.029 1.731 . . . . 0.0 109.129 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 33.4 mmm -66.66 144.15 56.56 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.179 -169.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 46.93 39.07 10.91 Favored Glycine 0 CA--C 1.54 1.638 0 O-C-N 127.273 2.858 . . . . 0.0 117.505 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -119.75 136.02 54.61 Favored 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 125.549 1.54 . . . . 0.0 111.713 165.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.61 128.91 39.55 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 m -122.54 131.04 24.43 Favored Pre-proline 0 C--O 1.286 3.013 0 CA-C-N 111.173 -2.739 . . . . 0.0 106.032 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 0.4 OUTLIER -63.24 148.49 92.98 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 121.05 1.167 . . . . 0.0 109.464 159.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.6 134.91 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 C-N-CA 124.873 1.269 . . . . 0.0 107.604 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -95.82 132.66 40.83 Favored 'General case' 0 N--CA 1.519 2.983 0 C-N-CA 123.154 0.582 . . . . 0.0 110.757 164.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.71 110.69 18.76 Favored 'Isoleucine or valine' 0 C--N 1.374 1.662 0 O-C-N 120.282 -1.511 . . . . 0.0 109.493 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.87 -33.43 59.99 Favored 'General case' 0 C--N 1.373 1.615 0 O-C-N 125.719 1.887 . . . . 0.0 113.381 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -178.47 144.16 0.29 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -168.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.6 t -118.41 126.25 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 O-C-N 125.071 1.482 . . . . 0.0 107.889 161.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.292 0.0 OUTLIER -85.23 173.51 10.33 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 126.118 2.866 . . . . 0.0 113.572 -170.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -38.17 59.82 Favored 'General case' 0 CA--C 1.599 2.859 0 CA-C-N 110.873 -2.876 . . . . 0.0 111.293 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -85.62 -27.47 25.42 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.566 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.38 24.72 3.7 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.681 1.134 . . . . 0.0 111.518 170.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -80.9 140.87 35.08 Favored 'General case' 0 C--N 1.373 1.591 0 C-N-CA 126.5 1.92 . . . . 0.0 110.262 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.8 mt -105.12 132.38 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -125.27 119.45 28.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -168.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.7 mt -126.18 161.94 26.54 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 124.458 1.099 . . . . 0.0 111.403 -163.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.4 t -138.88 135.49 34.54 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 54.7 mt -83.28 -38.84 14.8 Favored 'Isoleucine or valine' 0 C--N 1.362 1.112 0 CA-C-O 116.177 -1.868 . . . . 0.0 107.032 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -76.28 -19.14 58.58 Favored 'General case' 0 C--N 1.366 1.299 0 O-C-N 125.684 1.865 . . . . 0.0 108.661 -171.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -81.65 -20.88 38.7 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 119.58 -1.95 . . . . 0.0 112.16 166.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.58 -36.91 65.61 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.411 -2.056 . . . . 0.0 111.025 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.0 p . . . . . 0 N--CA 1.487 1.406 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.218 -175.286 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 mm . . . . . 0 C--O 1.263 1.795 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -119.18 131.53 55.86 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.277 -171.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -112.33 129.47 56.28 Favored 'General case' 0 C--N 1.366 1.311 0 O-C-N 124.763 1.289 . . . . 0.0 113.752 -164.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.9 pt -130.2 170.2 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 O-C-N 125.075 1.485 . . . . 0.0 109.795 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -131.84 141.9 49.56 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.606 -1.237 . . . . 0.0 111.414 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.9 133.54 54.91 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.863 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -59.38 157.98 22.36 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 124.902 1.281 . . . . 0.0 112.645 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -70.49 -37.45 7.4 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.844 2.363 . . . . 0.0 110.45 -166.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -62.13 -46.41 89.13 Favored 'General case' 0 C--N 1.37 1.482 0 C-N-CA 118.307 -1.357 . . . . 0.0 114.366 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -78.26 -20.67 51.19 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 tp -59.37 -34.3 53.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 117.717 -1.593 . . . . 0.0 114.702 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -59.95 -34.0 72.67 Favored 'General case' 0 CA--C 1.557 1.242 0 O-C-N 124.724 1.265 . . . . 0.0 113.589 170.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -68.45 -42.98 78.05 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 122.62 1.2 . . . . 0.0 114.105 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 t -64.11 -40.62 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.756 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.8 mm -98.6 28.0 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 CA-C-N 119.02 0.827 . . . . 0.0 111.498 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.89 125.44 11.93 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 118.613 2.205 . . . . 0.0 118.613 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.45 7.1 mptt 60.88 51.5 4.65 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.35 45.22 96.39 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 126.29 2.244 . . . . 0.0 114.986 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.0 0.76 67.97 Favored Glycine 0 C--N 1.358 1.774 0 CA-C-N 118.571 1.185 . . . . 0.0 111.493 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -66.47 -34.26 77.53 Favored 'General case' 0 C--O 1.202 -1.436 0 CA-C-N 119.389 1.595 . . . . 0.0 110.865 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.38 -45.59 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 CA-C-O 116.623 -1.656 . . . . 0.0 109.626 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.7 tp -80.52 -31.76 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 125.823 1.952 . . . . 0.0 111.153 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.71 -48.38 79.73 Favored 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 166.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.12 -45.17 82.06 Favored 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 124.426 1.09 . . . . 0.0 111.012 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.7 -37.92 80.16 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.263 33.3 p -64.6 -38.4 90.87 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 171.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -63.58 -47.78 80.07 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 125.008 1.443 . . . . 0.0 111.646 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -67.45 -47.14 71.03 Favored 'General case' 0 CA--C 1.457 -2.611 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.864 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -85.56 -8.41 58.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 127.583 3.052 . . . . 0.0 113.962 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.16 21.33 79.26 Favored Glycine 0 C--N 1.365 2.149 0 CA-C-O 121.819 0.677 . . . . 0.0 113.359 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -134.89 139.65 45.16 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 122.261 -0.552 . . . . 0.0 109.97 -155.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.0 m -78.23 135.27 37.55 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 119.715 1.143 . . . . 0.0 108.975 166.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.4 mt -133.01 118.2 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.244 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -84.52 131.56 34.63 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.6 mm -112.97 112.79 41.94 Favored 'Isoleucine or valine' 0 C--N 1.373 1.627 0 CA-C-N 120.342 1.428 . . . . 0.0 107.945 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -123.06 170.48 10.13 Favored 'General case' 0 C--O 1.201 -1.463 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -36.13 149.31 0.02 OUTLIER 'General case' 0 C--O 1.205 -1.277 1 C-N-CA 131.921 4.088 . . . . 0.0 118.844 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t0 62.39 35.72 14.79 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 124.418 1.087 . . . . 0.0 110.845 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 47.27 28.98 4.79 Favored Glycine 0 C--O 1.205 -1.67 0 CA-C-N 112.224 -2.262 . . . . 0.0 115.723 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.5 m -64.15 125.48 24.64 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.716 -0.873 . . . . 0.0 110.366 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -124.94 138.68 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -129.38 122.04 28.64 Favored 'General case' 0 C--N 1.366 1.314 0 O-C-N 127.596 3.06 . . . . 0.0 108.686 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.5 mm -95.52 130.15 44.64 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 O-C-N 120.22 -1.55 . . . . 0.0 107.838 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.95 117.98 33.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 117.984 -1.486 . . . . 0.0 107.355 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.3 148.67 29.13 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.671 -1.268 . . . . 0.0 110.871 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -69.0 -57.35 5.58 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.232 164.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -99.03 135.31 40.62 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 120.396 -1.44 . . . . 0.0 113.675 -163.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.12 -28.63 73.81 Favored Glycine 0 CA--C 1.506 -0.49 0 O-C-N 120.351 -1.468 . . . . 0.0 115.863 -167.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -57.87 -39.87 78.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.998 -0.707 . . . . 0.0 112.801 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -73.17 -37.9 66.39 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.96 95.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -61.82 -42.9 99.61 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.844 168.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -62.7 -39.3 93.57 Favored 'General case' 0 N--CA 1.52 3.033 0 CA-C-N 121.995 2.18 . . . . 0.0 115.093 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.49 69.03 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 120.365 1.439 . . . . 0.0 110.36 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.88 -44.48 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 122.594 1.188 . . . . 0.0 111.451 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -60.97 -42.39 98.22 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 168.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -64.63 -39.67 94.11 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.479 1.111 . . . . 0.0 112.231 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 mm -58.75 -40.7 80.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.137 168.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.65 -42.27 86.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.294 1.406 . . . . 0.0 110.917 168.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -58.16 -43.12 87.25 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.9 mm -60.14 -44.39 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 CA-C-O 123.173 1.463 . . . . 0.0 113.808 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 C--N 1.353 0.731 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -177.646 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 mm . . . . . 0 N--CA 1.498 1.963 0 CA-C-O 114.989 -2.434 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -125.09 134.85 52.33 Favored 'General case' 0 C--N 1.384 2.081 0 CA-C-N 121.288 1.858 . . . . 0.0 109.41 168.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.8 t -58.77 136.76 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.942 1.697 . . . . 0.0 111.372 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.59 -34.76 4.67 Favored Glycine 0 CA--C 1.55 2.28 0 O-C-N 120.809 -1.182 . . . . 0.0 113.789 -168.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -68.91 147.81 51.12 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-O 124.425 2.06 . . . . 0.0 113.147 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -89.1 133.3 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.694 0 CA-C-O 124.016 1.865 . . . . 0.0 111.868 169.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -133.13 169.68 16.51 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 126.874 2.07 . . . . 0.0 106.483 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.6 p -120.09 152.22 37.91 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.065 167.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.49 166.27 37.11 Favored Glycine 0 CA--C 1.465 -3.082 0 CA-C-O 123.776 1.765 . . . . 0.0 116.036 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 130' ' ' GLN . 55.6 mttm -106.31 127.76 53.49 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 110.968 -2.616 . . . . 0.0 115.334 -161.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.3 t -56.03 111.29 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.032 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -111.78 -13.44 13.71 Favored 'General case' 0 N--CA 1.525 3.309 0 CA-C-N 114.124 -1.398 . . . . 0.0 114.648 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.9 mtm-85 -155.02 153.48 31.04 Favored 'General case' 0 C--O 1.257 1.478 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 168.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.7 mt -132.21 125.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.7 m -138.3 166.83 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.585 -156.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -57.15 -35.23 69.28 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 126.87 2.606 . . . . 0.0 110.86 -165.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -111.74 10.25 20.92 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -174.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.0 -148.67 18.74 Favored Glycine 0 C--O 1.175 -3.534 0 CA-C-N 120.828 1.649 . . . . 0.0 115.83 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.91 157.13 43.9 Favored 'General case' 0 C--O 1.201 -1.457 0 O-C-N 119.489 -2.183 . . . . 0.0 108.88 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -119.76 143.98 47.52 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.54 125.59 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 CA-C-N 111.608 -2.542 . . . . 0.0 108.816 -166.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.01 123.87 31.05 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.6 mm -114.28 142.39 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.725 0 CA-C-N 112.205 -2.271 . . . . 0.0 107.405 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -34.84 138.58 0.21 Allowed Glycine 0 C--N 1.389 3.491 0 C-N-CA 128.001 2.715 . . . . 0.0 114.994 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.06 29.82 68.44 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-O 118.863 -0.965 . . . . 0.0 112.391 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.31 30.65 53.95 Favored Glycine 0 CA--C 1.477 -2.33 0 O-C-N 124.983 1.049 . . . . 0.0 115.413 167.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -106.34 162.14 13.95 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 125.862 1.566 . . . . 0.0 109.671 -170.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -149.32 122.17 8.73 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.498 1.499 . . . . 0.0 108.98 -171.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.89 162.13 15.77 Favored Glycine 0 CA--C 1.481 -2.033 0 CA-C-N 114.395 -1.275 . . . . 0.0 114.667 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.0 tp -114.56 126.24 54.7 Favored 'General case' 0 CA--C 1.491 -1.298 0 O-C-N 126.629 2.017 . . . . 0.0 111.343 -166.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.39 119.05 58.03 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 N-CA-C 100.693 -3.818 . . . . 0.0 100.693 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -82.93 169.68 15.76 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 120.725 -1.234 . . . . 0.0 109.254 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.9 tt -77.7 -25.72 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -157.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 81.7 p -92.26 7.03 44.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.416 -2.053 . . . . 0.0 111.259 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -120.33 27.36 8.65 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-O 114.779 -2.534 . . . . 0.0 109.591 -170.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.2 mt -105.03 -49.22 9.26 Favored 'Isoleucine or valine' 0 C--N 1.37 1.48 0 O-C-N 127.014 2.696 . . . . 0.0 109.117 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.22 173.73 11.24 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.333 -1.48 . . . . 0.0 109.031 -163.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -82.13 -53.39 6.12 Favored 'General case' 0 C--O 1.2 -1.509 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -65.75 138.84 58.21 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.695 0.798 . . . . 0.0 110.944 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -53.93 134.29 43.08 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.649 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -119.96 124.6 73.05 Favored 'Isoleucine or valine' 0 C--N 1.368 1.411 0 O-C-N 123.943 0.777 . . . . 0.0 111.851 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -109.18 -18.85 13.52 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 115.908 -1.996 . . . . 0.0 110.709 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -128.58 127.89 43.18 Favored 'General case' 0 C--N 1.381 1.936 0 CA-C-O 123.247 1.498 . . . . 0.0 109.024 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.21 -41.09 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 O-C-N 121.087 -1.008 . . . . 0.0 113.068 -174.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -55.88 -7.38 0.31 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 126.528 2.393 . . . . 0.0 112.481 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -69.5 -35.59 75.67 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.317 1.417 . . . . 0.0 113.871 173.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -115.23 -52.33 2.68 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 128.155 3.409 . . . . 0.0 114.251 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.1 mt -93.34 143.97 25.77 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.129 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.46 154.18 38.43 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 103.169 -2.9 . . . . 0.0 103.169 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 65.7 mmm -66.69 121.86 16.34 Favored 'General case' 0 C--O 1.192 -1.949 0 C-N-CA 127.399 2.28 . . . . 0.0 113.992 -165.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.17 -0.66 78.8 Favored Glycine 1 N--CA 1.518 4.13 0 N-CA-C 118.498 2.159 . . . . 0.0 118.498 -171.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.7 tt0 -57.75 141.09 49.89 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 167.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -87.13 121.48 29.63 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.581 170.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.2 m -113.4 129.33 24.72 Favored Pre-proline 0 C--O 1.215 -0.761 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.41 139.19 18.24 Favored 'Trans proline' 0 C--N 1.266 -3.815 0 N-CA-C 108.616 -1.34 . . . . 0.0 108.616 162.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.57 148.43 18.21 Favored 'Isoleucine or valine' 0 C--N 1.363 1.194 0 CA-C-O 123.169 1.461 . . . . 0.0 113.501 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -104.69 129.08 52.92 Favored 'General case' 0 C--O 1.19 -2.061 0 CA-C-N 111.843 -2.435 . . . . 0.0 111.819 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 81.6 t -82.4 122.27 36.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 125.575 1.797 . . . . 0.0 111.541 -170.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.5 mt -101.09 -33.13 10.26 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 117.601 -1.19 . . . . 0.0 112.227 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -145.23 146.52 31.74 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.42 119.8 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 123.157 1.456 . . . . 0.0 108.854 155.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.16 156.56 21.42 Favored 'General case' 0 C--O 1.254 1.322 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.335 169.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -51.98 -31.95 31.57 Favored 'General case' 0 C--N 1.401 2.845 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.79 13.17 33.28 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 120.427 1.467 . . . . 0.0 114.588 168.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.93 12.76 48.79 Favored Glycine 0 C--N 1.364 2.118 0 N-CA-C 118.068 1.987 . . . . 0.0 118.068 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -78.8 137.14 37.58 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-N 120.549 2.175 . . . . 0.0 109.29 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.8 mt -126.41 129.62 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 117.413 -1.28 . . . . 0.0 112.089 -159.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.09 128.67 51.73 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.622 171.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.6 mt -118.54 162.27 18.65 Favored 'General case' 0 N--CA 1.52 3.05 0 O-C-N 125.068 1.48 . . . . 0.0 114.385 -170.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.8 t -129.91 138.78 51.09 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.231 1.013 . . . . 0.0 109.414 168.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.9 mt -99.95 -28.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 167.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -57.85 -42.22 83.99 Favored 'General case' 0 C--N 1.37 1.469 0 O-C-N 119.442 -2.036 . . . . 0.0 111.6 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.33 -42.46 92.9 Favored 'General case' 0 CA--C 1.594 2.655 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.25 . . -61.6 -45.02 95.86 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 120.12 -1.613 . . . . 0.0 111.017 170.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.5 p . . . . . 0 C--O 1.2 -1.539 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.723 -175.412 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.7 mm . . . . . 0 CA--C 1.555 1.166 0 CA-C-O 122.967 1.365 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -135.79 129.36 32.38 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.78 163.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.3 m -111.62 138.4 48.23 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 122.099 0.952 . . . . 0.0 111.876 -172.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt -134.86 130.82 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 113.75 -1.568 . . . . 0.0 107.977 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -82.11 130.11 35.0 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-O 122.506 1.146 . . . . 0.0 111.607 163.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.2 mm -121.41 128.36 75.88 Favored 'Isoleucine or valine' 0 C--N 1.401 2.827 0 O-C-N 120.506 -1.371 . . . . 0.0 109.542 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -56.24 156.85 10.03 Favored Pre-proline 0 C--N 1.371 1.539 0 CA-C-N 119.555 1.07 . . . . 0.0 112.726 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -66.2 -25.47 50.26 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 N-CA-C 116.757 1.791 . . . . 0.0 116.757 -167.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.47 ' CG ' ' HZ2' ' A' ' 24' ' ' LYS . 8.4 p-10 -84.2 -27.49 27.98 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-O 117.04 -1.457 . . . . 0.0 110.777 172.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.47 ' HZ2' ' CG ' ' A' ' 23' ' ' ASP . 42.8 mmtm -86.64 -26.51 24.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 121.546 1.976 . . . . 0.0 110.109 -169.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.0 tp -74.85 -19.61 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 O-C-N 124.61 1.194 . . . . 0.0 108.277 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.269 35.5 mmtm -64.93 -39.53 93.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.057 -1.027 . . . . 0.0 113.298 168.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.11 -38.6 91.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.865 1.666 . . . . 0.0 113.574 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.03 -33.31 62.47 Favored 'Isoleucine or valine' 0 C--N 1.375 1.706 0 C-N-CA 125.483 1.513 . . . . 0.0 111.352 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.57 11.04 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-O 123.178 1.466 . . . . 0.0 111.581 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.37 167.39 13.29 Favored Glycine 0 C--N 1.296 -1.674 0 CA-C-N 111.792 -2.458 . . . . 0.0 115.944 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm 58.3 43.98 19.29 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.208 1.403 . . . . 0.0 113.327 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.3 12.72 81.83 Favored Glycine 0 CA--C 1.558 2.757 0 O-C-N 120.807 -1.183 . . . . 0.0 115.818 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.03 5.26 77.23 Favored Glycine 0 C--N 1.369 2.402 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 -171.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.7 m -63.08 -39.99 96.33 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-O 116.903 -1.522 . . . . 0.0 113.623 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 t -61.44 -47.36 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.309 6.4 tp -62.96 -39.33 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-N 119.427 1.012 . . . . 0.0 111.327 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -64.37 -51.57 62.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.351 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.05 -43.81 82.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 126.352 2.283 . . . . 0.0 115.286 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.91 -50.95 71.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.7 p -64.83 -35.2 80.33 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 120.673 -1.267 . . . . 0.0 112.564 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -72.36 -39.51 68.03 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 125.832 1.957 . . . . 0.0 110.338 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 71' ' ' ARG . 66.0 tt0 -61.76 -38.51 88.27 Favored 'General case' 0 C--O 1.259 1.555 0 CA-C-O 124.166 1.936 . . . . 0.0 113.003 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.5 p -91.24 -17.06 26.62 Favored 'General case' 0 C--N 1.367 1.335 0 O-C-N 118.663 -2.523 . . . . 0.0 116.363 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.03 28.6 73.73 Favored Glycine 0 CA--C 1.474 -2.484 1 O-C-N 129.254 4.096 . . . . 0.0 112.352 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 t -148.31 159.3 44.13 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 124.305 2.002 . . . . 0.0 107.671 -166.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -83.42 118.0 23.44 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 112.407 -2.179 . . . . 0.0 108.581 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.4 mt -124.08 121.32 61.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -113.22 147.42 37.52 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 125.573 2.606 . . . . 0.0 108.092 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.3 mm -112.09 123.4 67.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 112.014 -2.357 . . . . 0.0 109.227 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -123.88 166.83 14.98 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -165.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.281 81.9 m-20 -47.4 142.49 4.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.024 -1.672 . . . . 0.0 114.196 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.8 t0 54.27 67.3 1.03 Allowed 'General case' 0 C--N 1.35 0.598 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 171.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.53 27.47 26.39 Favored Glycine 0 C--N 1.301 -1.396 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 m -107.39 114.79 29.03 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -104.43 141.79 19.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -129.29 123.39 31.74 Favored 'General case' 0 C--N 1.363 1.19 0 CA-C-O 122.54 1.162 . . . . 0.0 109.498 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.6 mm -86.83 130.03 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.117 167.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.67 51.16 1.86 Allowed 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.87 153.38 21.37 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 119.048 -2.283 . . . . 0.0 114.729 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.7 p -100.04 21.92 12.05 Favored 'General case' 0 C--N 1.381 1.949 0 CA-C-O 115.476 -2.202 . . . . 0.0 111.301 -175.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -151.49 145.58 25.3 Favored 'General case' 0 C--N 1.372 1.585 0 O-C-N 127.244 2.84 . . . . 0.0 110.08 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.1 -33.98 61.87 Favored Glycine 0 N--CA 1.439 -1.128 0 O-C-N 125.248 1.592 . . . . 0.0 114.425 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.31 -45.43 87.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 116.703 -1.618 . . . . 0.0 108.186 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -58.74 -42.07 87.95 Favored 'General case' 0 C--N 1.375 1.681 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.86 98.13 Favored 'General case' 0 C--O 1.272 2.267 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -68.63 -37.41 79.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 125.394 1.684 . . . . 0.0 108.697 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -66.92 -42.86 84.65 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 120.074 -1.641 . . . . 0.0 114.521 170.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.15 -54.38 31.35 Favored 'General case' 0 C--O 1.191 -2.008 0 CA-C-N 121.176 1.807 . . . . 0.0 111.556 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 69' ' ' ILE . 36.1 mt -60.87 -45.14 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 124.46 1.104 . . . . 0.0 110.168 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -56.33 -44.29 79.85 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 42' ' ' GLU . 3.2 mmm180 -63.16 -41.56 99.27 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 120.597 1.544 . . . . 0.0 107.827 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.19 -42.09 85.82 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.971 0 CA-C-O 116.805 -1.569 . . . . 0.0 110.234 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.32 -42.18 90.79 Favored 'General case' 0 N--CA 1.537 3.883 0 CA-C-N 121.734 2.061 . . . . 0.0 111.281 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -69.31 -39.16 78.42 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 126.242 2.214 . . . . 0.0 114.688 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.6 mt -71.61 -32.41 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 168.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-N 120.769 1.622 . . . . 0.0 109.672 177.543 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.7 mm . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 125.039 2.352 . . . . 0.0 115.254 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.49 ' CD ' ' HE ' ' A' ' 83' ' ' ARG . 24.2 tt0 -115.59 134.55 54.94 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-N 113.028 -1.896 . . . . 0.0 106.379 173.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.17 139.03 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 O-C-N 128.134 3.396 . . . . 0.0 110.31 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.95 -10.21 48.69 Favored Glycine 0 CA--C 1.551 2.342 0 O-C-N 119.39 -2.069 . . . . 0.0 113.835 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.49 ' HE ' ' CD ' ' A' ' 80' ' ' GLU . 77.1 mtt180 -81.87 159.33 23.73 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-N 119.662 1.731 . . . . 0.0 111.176 167.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.41 140.32 31.36 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -130.83 161.65 31.32 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.9 m -117.25 125.72 51.58 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.99 -169.76 12.41 Favored Glycine 0 N--CA 1.42 -2.412 0 C-N-CA 120.295 -0.955 . . . . 0.0 114.986 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -128.56 143.22 50.92 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 122.937 1.351 . . . . 0.0 114.432 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.3 t -73.76 122.75 27.47 Favored 'Isoleucine or valine' 0 C--N 1.382 2.008 0 O-C-N 118.078 -2.889 . . . . 0.0 115.288 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.12 -25.4 7.63 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 115.929 -1.986 . . . . 0.0 113.785 -170.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 -146.22 151.47 37.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 168.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -123.65 131.44 73.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.04 174.47 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 124.047 1.88 . . . . 0.0 111.324 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -58.62 -37.4 75.8 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 117.565 -1.654 . . . . 0.0 114.518 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -98.41 18.91 15.4 Favored 'General case' 0 C--N 1.374 1.664 0 CA-C-N 120.876 1.671 . . . . 0.0 111.737 -176.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.56 -135.92 6.19 Favored Glycine 0 C--N 1.383 3.182 0 N-CA-C 115.057 0.783 . . . . 0.0 115.057 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.57 160.81 41.09 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 125.649 1.441 . . . . 0.0 114.831 167.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.29 131.48 54.17 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-O 121.884 0.849 . . . . 0.0 111.122 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 72.9 t -110.85 134.3 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.646 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -98.49 127.71 44.54 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 120.221 -1.549 . . . . 0.0 109.395 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.92 150.79 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 CA-C-N 112.883 -1.962 . . . . 0.0 112.188 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.67 154.38 0.62 Allowed Glycine 0 CA--C 1.564 3.128 0 N-CA-C 118.958 2.343 . . . . 0.0 118.958 173.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.56 8.09 24.3 Favored Glycine 0 C--N 1.366 2.214 0 C-N-CA 127.663 2.554 . . . . 0.0 117.57 -168.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.79 22.86 16.95 Favored Glycine 0 C--O 1.256 1.494 0 O-C-N 127.585 2.58 . . . . 0.0 117.219 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.96 128.14 34.19 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 117.256 0.528 . . . . 0.0 110.491 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.0 146.83 35.98 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 123.343 1.544 . . . . 0.0 108.685 169.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -145.24 163.96 28.04 Favored Glycine 0 CA--C 1.48 -2.141 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.06 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.0 tp -110.61 136.4 49.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 124.372 0.689 . . . . 0.0 110.462 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.73 113.73 45.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 CA-C-O 123.824 1.773 . . . . 0.0 108.796 160.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -62.91 150.65 41.47 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 tt -52.89 -24.83 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.3 p -90.32 6.3 43.62 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 125.825 1.65 . . . . 0.0 112.198 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -120.45 5.35 10.66 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 120.16 -1.588 . . . . 0.0 114.072 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 18.5 mm -82.84 -48.56 17.7 Favored 'Isoleucine or valine' 0 C--O 1.283 2.821 0 CA-C-O 123.734 1.73 . . . . 0.0 112.304 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.29 173.84 13.52 Favored 'General case' 0 N--CA 1.406 -2.645 0 O-C-N 116.939 -3.601 . . . . 0.0 107.224 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -66.0 -33.7 76.4 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.2 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -71.56 161.19 31.4 Favored 'General case' 0 C--N 1.365 1.264 0 C-N-CA 124.733 1.213 . . . . 0.0 114.024 -173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -70.63 122.22 19.36 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 124.679 2.181 . . . . 0.0 108.82 167.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.28 146.01 16.8 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.779 0 CA-C-N 112.38 -2.191 . . . . 0.0 110.157 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -119.84 -35.33 3.53 Favored 'General case' 0 C--N 1.369 1.445 0 CA-C-N 120.359 1.436 . . . . 0.0 113.826 160.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -123.17 129.3 51.22 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 122.7 1.238 . . . . 0.0 109.149 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.3 -20.43 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 111.814 -2.448 . . . . 0.0 106.646 -166.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.4 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.39 2.346 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -66.52 -45.33 79.85 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 125.716 1.606 . . . . 0.0 112.921 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -95.06 -17.97 21.42 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.7 mt -126.99 129.45 48.13 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -98.72 156.2 16.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.62 -1.3 . . . . 0.0 110.291 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 51.5 tpp -67.93 133.86 49.83 Favored 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 118.641 -2.537 . . . . 0.0 109.165 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.09 15.91 79.65 Favored Glycine 0 CA--C 1.548 2.132 0 O-C-N 126.061 2.1 . . . . 0.0 112.059 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -65.24 132.42 49.05 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.294 -1.709 . . . . 0.0 113.151 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -85.12 118.55 24.75 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 123.748 1.737 . . . . 0.0 112.957 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.86 125.33 20.23 Favored Pre-proline 0 CA--C 1.582 2.174 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -158.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.65 131.43 24.37 Favored 'Trans proline' 0 N--CA 1.518 2.923 0 O-C-N 117.726 -1.776 . . . . 0.0 111.786 165.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.15 136.82 57.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 CA-C-O 123.061 1.41 . . . . 0.0 110.452 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -105.01 143.42 33.22 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 120.702 -1.249 . . . . 0.0 109.764 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.9 t -86.9 137.48 20.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 122.17 0.986 . . . . 0.0 109.409 -170.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.65 -43.17 3.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 118.944 -2.348 . . . . 0.0 108.558 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -153.12 146.86 25.19 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-O 124.139 1.923 . . . . 0.0 108.205 -166.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.7 p -145.64 123.21 4.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 CA-C-O 124.119 1.914 . . . . 0.0 110.092 171.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.477 ' CG ' HH12 ' A' ' 146' ' ' ARG . 60.2 m-20 -71.74 175.34 5.79 Favored 'General case' 0 CA--C 1.592 2.593 0 O-C-N 119.826 -1.796 . . . . 0.0 115.207 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -68.51 -16.27 63.83 Favored 'General case' 0 CA--C 1.584 2.274 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.74 19.16 21.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 120.055 -1.653 . . . . 0.0 111.476 167.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.85 16.93 79.21 Favored Glycine 0 C--N 1.362 2.015 0 O-C-N 125.961 2.038 . . . . 0.0 114.468 168.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . 0.332 36.0 mtm180 -69.75 129.31 39.24 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 163.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.4 mt -108.68 141.33 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 119.545 -1.972 . . . . 0.0 110.714 -165.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.477 HH12 ' CG ' ' A' ' 140' ' ' ASP . 0.4 OUTLIER -113.1 150.09 32.6 Favored 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.606 160.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.4 mt -140.33 171.86 13.55 Favored 'General case' 0 C--O 1.258 1.508 0 CA-C-O 124.087 1.898 . . . . 0.0 111.391 -166.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.5 t -154.84 134.49 12.76 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.0 mt -87.96 -17.86 8.4 Favored 'Isoleucine or valine' 0 C--N 1.377 1.777 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -62.57 -50.18 72.34 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 172.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.56 -25.58 63.16 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 122.111 0.958 . . . . 0.0 109.714 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.08 -49.26 68.22 Favored 'General case' 0 C--O 1.257 1.478 0 O-C-N 119.797 -1.814 . . . . 0.0 115.01 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.9 p . . . . . 0 C--O 1.268 2.042 0 CA-C-N 112.138 -2.301 . . . . 0.0 111.214 -173.977 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mm . . . . . 0 CA--C 1.552 1.056 0 CA-C-O 126.28 2.943 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -116.17 138.96 50.82 Favored 'General case' 0 CA--C 1.59 2.486 0 CA-C-N 109.829 -3.35 . . . . 0.0 104.877 169.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 t -136.66 164.51 28.07 Favored 'General case' 0 N--CA 1.532 3.635 0 CA-C-O 117.627 -1.178 . . . . 0.0 112.252 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 tp -172.02 145.7 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.071 0 O-C-N 126.793 2.558 . . . . 0.0 105.228 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -128.58 130.63 47.64 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 124.8 1.24 . . . . 0.0 109.535 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.6 pt -133.33 162.99 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.834 0 O-C-N 126.513 2.383 . . . . 0.0 108.637 -166.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -43.95 141.96 2.2 Favored Pre-proline 0 N--CA 1.524 3.26 0 CA-C-N 120.024 1.284 . . . . 0.0 112.376 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -59.94 -34.33 95.25 Favored 'Trans proline' 0 CA--C 1.474 -2.475 0 C-N-CA 122.866 2.378 . . . . 0.0 112.567 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -65.2 -28.16 69.19 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-N 121.816 2.098 . . . . 0.0 113.425 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.2 -22.07 64.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.01 -43.59 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 C-N-CA 124.969 1.307 . . . . 0.0 110.649 171.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -51.87 -43.65 63.35 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 170.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -79.81 -22.13 43.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.71 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.8 t -70.61 -54.08 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-O 116.263 -1.827 . . . . 0.0 110.084 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -58.99 -42.49 86.34 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 CA-C-N 120.098 1.317 . . . . 0.0 109.022 173.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.1 175.97 49.14 Favored Glycine 0 C--N 1.374 2.69 0 O-C-N 119.425 -2.047 . . . . 0.0 113.888 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -74.78 119.2 18.64 Favored 'General case' 0 C--N 1.387 2.204 0 CA-C-N 119.704 1.752 . . . . 0.0 106.804 -171.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.49 4.48 87.36 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.43 17.64 70.73 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 118.628 -1.748 . . . . 0.0 115.962 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.1 p -69.3 -37.29 77.72 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 119.972 3.323 . . . . 0.0 119.972 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.6 t -74.28 -39.11 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 O-C-N 124.696 1.248 . . . . 0.0 112.5 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.287 17.0 tt -63.54 -41.21 91.87 Favored 'Isoleucine or valine' 0 C--O 1.262 1.738 0 O-C-N 127.16 2.787 . . . . 0.0 112.711 173.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -64.15 -37.5 87.67 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 125.666 1.854 . . . . 0.0 111.609 169.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.24 79.92 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.08 -42.32 98.29 Favored 'General case' 0 C--O 1.196 -1.744 0 O-C-N 118.328 -2.732 . . . . 0.0 108.558 170.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.1 m -59.26 -48.81 80.24 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.049 0.94 . . . . 0.0 111.024 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -73.92 -35.81 64.64 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 116.316 -2.153 . . . . 0.0 110.024 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -73.11 -41.55 63.9 Favored 'General case' 0 C--O 1.258 1.542 0 CA-C-N 122.314 2.325 . . . . 0.0 111.54 -175.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.7 p -81.85 -24.95 35.5 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 118.377 -2.702 . . . . 0.0 113.2 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.6 35.09 59.45 Favored Glycine 0 C--N 1.394 3.77 0 CA-C-N 122.061 2.209 . . . . 0.0 116.495 -169.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 p -129.55 177.37 7.26 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.127 1.771 . . . . 0.0 107.383 -165.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.2 m -121.68 114.77 21.6 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 123.121 1.439 . . . . 0.0 107.136 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mt -101.43 128.24 53.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 112.622 -2.081 . . . . 0.0 112.56 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -135.44 151.09 50.08 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-O 123.601 1.667 . . . . 0.0 109.715 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.0 mm -114.71 126.7 72.34 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.761 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.865 -171.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -118.58 147.14 44.02 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.19 162.95 0.05 OUTLIER 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 52.22 36.25 18.87 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 126.511 1.924 . . . . 0.0 115.485 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.07 8.76 66.45 Favored Glycine 0 CA--C 1.468 -2.903 0 CA-C-O 116.112 -2.493 . . . . 0.0 116.203 172.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.8 m -77.0 135.13 38.66 Favored 'General case' 0 C--O 1.256 1.432 0 O-C-N 127.248 2.381 . . . . 0.0 113.748 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -114.12 136.18 51.47 Favored 'Isoleucine or valine' 0 C--N 1.367 1.367 0 O-C-N 120.66 -1.275 . . . . 0.0 114.354 165.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -125.85 116.77 22.08 Favored 'General case' 0 C--O 1.196 -1.745 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.111 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.2 mt -114.04 119.87 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.556 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -98.02 142.11 30.14 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 126.883 2.614 . . . . 0.0 110.79 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.75 175.09 14.37 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-O 124.836 2.255 . . . . 0.0 106.131 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 t -116.95 -15.81 10.59 Favored 'General case' 0 N--CA 1.532 3.646 0 CA-C-N 112.671 -2.059 . . . . 0.0 112.296 171.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -120.42 114.51 21.92 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.18 -38.15 95.15 Favored Glycine 0 N--CA 1.505 3.268 0 N-CA-C 118.428 2.131 . . . . 0.0 118.428 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.0 -31.88 71.48 Favored 'General case' 0 C--N 1.377 1.804 0 CA-C-N 121.314 2.557 . . . . 0.0 113.772 167.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -67.69 -34.92 77.86 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 121.738 2.063 . . . . 0.0 114.385 170.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.51 -45.55 79.15 Favored 'General case' 0 C--O 1.254 1.341 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 171.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -58.39 -37.08 74.56 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 115.08 -2.391 . . . . 0.0 110.742 167.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -62.93 -36.51 83.64 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 122.756 2.525 . . . . 0.0 111.361 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.36 -38.15 74.72 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 120.31 -1.494 . . . . 0.0 112.88 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.3 mt -60.32 -43.27 93.3 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.84 168.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -60.17 -49.27 78.3 Favored 'General case' 0 C--O 1.249 1.029 0 O-C-N 120.495 -1.378 . . . . 0.0 113.787 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -67.38 -30.0 69.68 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.061 1.301 . . . . 0.0 112.757 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.9 -47.39 83.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 CA-C-O 115.492 -2.194 . . . . 0.0 110.674 166.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.67 -39.55 77.35 Favored 'General case' 0 C--O 1.206 -1.227 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -64.07 -55.18 23.94 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-O 115.927 -1.987 . . . . 0.0 114.029 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 36.6 mm -55.25 -43.49 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.368 0 CA-C-N 121.577 1.99 . . . . 0.0 109.285 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.3 p . . . . . 0 C--N 1.295 -1.79 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 174.898 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 mm . . . . . 0 C--O 1.212 -0.916 0 CA-C-O 117.551 -1.214 . . . . 0.0 114.242 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -121.0 139.82 52.77 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-O 123.613 1.673 . . . . 0.0 107.239 168.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.05 130.12 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 117.16 -3.463 . . . . 0.0 115.287 171.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.06 -8.15 41.78 Favored Glycine 0 CA--C 1.485 -1.817 0 CA-C-O 117.014 -1.992 . . . . 0.0 112.498 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -57.28 147.98 24.0 Favored 'General case' 0 C--N 1.371 1.511 0 O-C-N 124.981 1.048 . . . . 0.0 112.838 166.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.9 129.56 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 128.167 3.417 . . . . 0.0 106.905 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -135.78 168.5 19.19 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 123.444 1.592 . . . . 0.0 110.014 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 m -112.45 121.88 46.09 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 171.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.1 -172.24 13.33 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -139.76 144.33 37.38 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.33 138.2 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 170.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.4 p -115.3 -40.16 3.48 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 120.158 -1.589 . . . . 0.0 109.478 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.4 mtm-85 -146.88 141.96 27.13 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.157 0.983 . . . . 0.0 110.052 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.24 143.33 32.4 Favored 'Isoleucine or valine' 0 C--N 1.38 1.931 0 CA-C-O 122.451 1.12 . . . . 0.0 109.927 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 m -144.31 168.93 9.98 Favored 'Isoleucine or valine' 0 C--N 1.388 2.278 0 O-C-N 117.955 -2.965 . . . . 0.0 104.251 -170.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -56.66 -37.89 71.42 Favored 'General case' 0 C--O 1.269 2.094 0 CA-C-N 118.493 0.588 . . . . 0.0 111.743 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -96.06 11.33 34.52 Favored 'General case' 0 C--O 1.252 1.209 0 O-C-N 120.914 -1.117 . . . . 0.0 111.7 -168.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.72 -177.94 30.94 Favored Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.973 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.16 127.09 53.0 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.744 0.908 . . . . 0.0 110.276 174.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -76.26 131.86 39.51 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-O 123.806 1.765 . . . . 0.0 111.948 166.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.4 t -129.61 135.17 62.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 CA-C-N 112.051 -2.341 . . . . 0.0 112.024 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.96 129.97 41.62 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 112.21 -2.268 . . . . 0.0 112.632 167.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.5 mm -119.03 135.34 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.05 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.4 145.86 0.37 Allowed Glycine 0 C--N 1.378 2.909 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.54 38.84 27.28 Favored Glycine 0 N--CA 1.504 3.192 0 CA-C-N 112.78 -1.71 . . . . 0.0 111.051 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.48 6.92 84.99 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 120.507 2.963 . . . . 0.0 120.507 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -87.42 160.06 18.46 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 118.267 2.692 . . . . 0.0 118.267 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.87 131.63 20.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 109.707 172.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -122.9 163.1 16.43 Favored Glycine 0 C--N 1.349 1.25 0 C-N-CA 123.733 0.683 . . . . 0.0 112.156 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.94 124.91 44.21 Favored 'General case' 0 C--O 1.203 -1.345 0 O-C-N 126.892 2.172 . . . . 0.0 110.491 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.93 100.29 10.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 168.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -67.58 154.87 40.45 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.312 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.273 6.3 tt -52.69 -38.69 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -170.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.6 p -73.4 -0.96 16.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . 0.41 ' HB3' ' HA ' ' A' ' 148' ' ' SER . 91.1 mm-40 -119.01 5.77 11.34 Favored 'General case' 0 CA--C 1.576 1.968 0 O-C-N 123.986 0.804 . . . . 0.0 112.577 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.0 mm -77.68 -33.24 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.183 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -157.65 -176.19 5.8 Favored 'General case' 0 CA--C 1.495 -1.157 0 O-C-N 120.076 -1.64 . . . . 0.0 111.079 -170.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -105.57 -23.43 12.78 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 165.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -62.05 158.28 16.92 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 120.092 -1.63 . . . . 0.0 112.648 173.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -74.25 131.56 41.32 Favored 'General case' 0 C--O 1.205 -1.273 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.478 HG21 ' CE2' ' A' ' 125' ' ' TYR . 17.8 t -122.21 127.72 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 C-N-CA 125.793 1.637 . . . . 0.0 114.188 -173.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -110.25 -46.1 3.48 Favored 'General case' 0 C--N 1.386 2.18 0 C-N-CA 124.893 1.277 . . . . 0.0 110.202 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -120.48 150.36 40.94 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 170.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.11 -23.2 14.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-N 113.719 -1.582 . . . . 0.0 113.038 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.93 -19.39 65.09 Favored 'General case' 0 CA--C 1.581 2.141 0 O-C-N 120.115 -1.616 . . . . 0.0 114.616 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -76.59 -29.64 56.65 Favored 'General case' 0 N--CA 1.539 3.977 0 C-N-CA 126.577 1.951 . . . . 0.0 110.484 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.478 ' CE2' HG21 ' A' ' 119' ' ' VAL . 76.7 m-85 -100.79 -15.46 17.64 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 30.6 mt -151.99 162.42 41.11 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 124.22 0.95 . . . . 0.0 109.689 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -134.5 160.1 39.08 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 162.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -72.08 139.98 48.7 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 120.378 -1.451 . . . . 0.0 113.851 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 94.64 -12.35 68.84 Favored Glycine 0 N--CA 1.505 3.253 0 CA-C-O 125.39 2.661 . . . . 0.0 111.608 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -68.66 131.81 45.82 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 123.682 1.706 . . . . 0.0 111.177 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -79.65 129.6 34.62 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.931 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.57 127.16 19.48 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 120.527 -1.358 . . . . 0.0 109.062 -169.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.42 127.11 24.83 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 CA-C-O 116.769 -1.43 . . . . 0.0 113.278 160.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.0 129.43 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-N 122.669 2.486 . . . . 0.0 110.188 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -97.86 140.75 31.76 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 172.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.2 t -86.74 116.21 28.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.034 0 O-C-N 125.742 1.901 . . . . 0.0 106.789 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.0 tp -101.87 -48.01 4.41 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 116.323 -1.799 . . . . 0.0 110.658 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -136.12 150.84 49.26 Favored 'General case' 0 C--O 1.204 -1.294 0 O-C-N 125.029 1.456 . . . . 0.0 107.726 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.8 t -134.64 120.46 32.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -75.89 155.66 35.02 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.616 -1.302 . . . . 0.0 111.238 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.31 29.5 mmt180 -70.85 -27.06 63.57 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -65.74 -31.99 73.29 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 126.158 2.161 . . . . 0.0 115.833 157.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 138.02 -13.98 3.57 Favored Glycine 0 CA--C 1.549 2.206 0 C-N-CA 125.19 1.376 . . . . 0.0 111.646 162.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -54.37 137.84 41.03 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 10.6 mt -118.06 131.52 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 125.061 1.344 . . . . 0.0 113.14 -167.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -110.09 144.33 38.85 Favored 'General case' 0 N--CA 1.527 3.418 0 CA-C-O 123.283 1.516 . . . . 0.0 111.227 164.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.1 mt -129.12 151.87 49.33 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.079 -2.328 . . . . 0.0 110.29 -169.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 113' ' ' GLN . 33.8 t -125.82 115.82 20.61 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.062 1.345 . . . . 0.0 109.148 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.6 mt -74.87 -38.24 43.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 119.838 -1.789 . . . . 0.0 112.164 171.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -59.46 -47.24 86.25 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 127.015 2.697 . . . . 0.0 114.634 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -66.59 -46.34 76.27 Favored 'General case' 0 C--O 1.258 1.514 0 CA-C-N 118.345 0.52 . . . . 0.0 111.63 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.6 -18.23 64.91 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-O 116.912 -1.518 . . . . 0.0 112.569 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 117.629 -1.176 . . . . 0.0 108.234 172.085 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.0 mm . . . . . 0 C--O 1.238 0.497 0 CA-C-O 122.001 0.905 . . . . 0.0 113.395 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -123.04 138.97 54.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 124.395 2.045 . . . . 0.0 113.674 169.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 7.3 t -135.13 139.7 44.85 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 113.326 -1.761 . . . . 0.0 110.121 -173.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.3 pt -133.37 161.44 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 162.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -83.45 146.1 28.6 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 125.02 2.343 . . . . 0.0 109.447 160.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 pt -122.58 147.87 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 157.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.283 1.6 t-20 -63.35 138.53 97.38 Favored Pre-proline 0 N--CA 1.514 2.748 0 C-N-CA 128.472 2.709 . . . . 0.0 108.381 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -80.95 3.76 7.53 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 O-C-N 118.007 -1.628 . . . . 0.0 114.328 -171.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -91.43 -2.33 57.3 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 120.59 -1.319 . . . . 0.0 110.443 164.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -111.74 3.82 18.04 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.285 -0.884 . . . . 0.0 109.322 -170.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 mt -68.45 -41.31 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 119.828 -1.795 . . . . 0.0 112.366 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -52.5 -13.15 0.34 Allowed 'General case' 0 C--N 1.353 0.738 0 C-N-CA 128.34 2.656 . . . . 0.0 117.415 164.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -102.62 -32.71 9.75 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 115.734 -2.079 . . . . 0.0 113.318 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.3 t -84.15 -31.34 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 O-C-N 125.099 1.499 . . . . 0.0 109.466 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.3 mm -93.25 -55.21 6.36 Favored 'Isoleucine or valine' 0 C--N 1.361 1.08 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.62 -173.39 30.21 Favored Glycine 0 C--N 1.369 2.37 0 CA-C-O 123.506 1.614 . . . . 0.0 115.432 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -74.88 108.96 7.96 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 116.588 -1.672 . . . . 0.0 110.593 -167.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.53 9.76 59.84 Favored Glycine 0 CA--C 1.468 -2.855 0 O-C-N 127.474 2.984 . . . . 0.0 110.434 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.65 30.37 77.21 Favored Glycine 0 CA--C 1.54 1.613 0 O-C-N 125.362 1.272 . . . . 0.0 112.259 -162.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -53.05 -54.42 35.69 Favored 'General case' 0 N--CA 1.517 2.888 0 C-N-CA 126.213 1.805 . . . . 0.0 111.225 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -89.82 -35.56 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -160.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.1 tp -67.81 -38.64 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -66.12 -44.29 84.7 Favored 'General case' 0 C--N 1.399 2.731 0 C-N-CA 125.147 1.379 . . . . 0.0 110.489 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.23 47.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 127.814 3.196 . . . . 0.0 110.026 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.2 mt -51.63 -48.74 63.2 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 116.07 -1.919 . . . . 0.0 113.92 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 t -60.83 -34.42 74.54 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.6 1.545 . . . . 0.0 112.966 -175.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.25 -31.23 71.43 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -96.46 -28.12 14.57 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 126.285 1.834 . . . . 0.0 111.662 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.1 p -84.67 -19.64 32.53 Favored 'General case' 0 C--N 1.396 2.62 0 CA-C-N 120.954 1.706 . . . . 0.0 110.754 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.18 24.85 74.73 Favored Glycine 0 N--CA 1.472 1.042 0 C-N-CA 127.906 2.669 . . . . 0.0 114.12 171.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 t -141.45 161.78 37.08 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.871 0.868 . . . . 0.0 108.736 -173.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -81.68 126.09 31.37 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 125.177 1.548 . . . . 0.0 110.74 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.6 mt -114.72 121.61 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -116.83 148.79 40.92 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 124.831 2.253 . . . . 0.0 107.168 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.8 mt -128.06 123.5 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-O 123.236 1.494 . . . . 0.0 111.487 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -87.73 148.99 24.49 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-O 117.274 -1.346 . . . . 0.0 112.254 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -71.12 -3.16 18.48 Favored 'General case' 0 C--N 1.393 2.485 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -157.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -89.69 -1.85 58.12 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 125.064 1.477 . . . . 0.0 113.336 171.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.75 9.07 33.55 Favored Glycine 0 CA--C 1.48 -2.131 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -79.6 108.58 13.26 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 124.395 2.045 . . . . 0.0 111.003 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.5 t -84.63 127.72 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 166.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -116.45 123.91 48.65 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 113.347 -1.752 . . . . 0.0 107.549 -173.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.56 130.23 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.05 -8.73 19.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 118.551 2.797 . . . . 0.0 118.551 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -17.55 133.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 120.929 3.677 . . . . 0.0 120.929 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.8 m -67.6 -40.69 84.73 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 116.973 -1.489 . . . . 0.0 112.249 168.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -80.71 126.48 31.34 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.61 -40.44 95.97 Favored Glycine 0 C--N 1.361 1.954 0 O-C-N 124.493 1.121 . . . . 0.0 113.744 169.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.76 -36.25 71.86 Favored 'General case' 0 CA--C 1.586 2.363 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -66.14 -48.28 71.31 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.02 80.75 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 125.159 1.537 . . . . 0.0 113.722 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -68.68 -37.11 79.32 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 121.48 -0.762 . . . . 0.0 110.06 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -61.53 -47.21 86.61 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.111 167.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.07 95.35 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mt -59.42 -43.73 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 124.43 1.092 . . . . 0.0 113.665 172.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -65.88 -40.84 91.98 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 171.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -67.8 -38.52 83.43 Favored 'General case' 0 N--CA 1.52 3.033 0 O-C-N 119.905 -1.747 . . . . 0.0 115.045 171.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 mt -59.34 -41.53 84.54 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-N 119.457 1.026 . . . . 0.0 111.564 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -55.3 -45.44 76.25 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -62.38 -45.95 90.83 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 126.979 2.112 . . . . 0.0 112.644 171.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.258 1.1 mp -58.88 -33.23 49.07 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 168.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.498 1.935 0 O-C-N 125.601 1.813 . . . . 0.0 112.941 -178.411 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.7 pt . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -118.37 139.65 51.05 Favored 'General case' 0 C--O 1.206 -1.2 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.684 -158.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -60.75 137.77 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.28 0.32 52.24 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.179 -1.486 . . . . 0.0 115.318 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -98.17 150.39 21.53 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 120.017 -1.873 . . . . 0.0 111.679 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -105.59 143.32 16.91 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 O-C-N 125.992 2.058 . . . . 0.0 110.935 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -137.7 157.31 46.74 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 127.119 2.762 . . . . 0.0 107.396 -168.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.1 m -94.28 123.24 37.56 Favored 'General case' 0 C--N 1.372 1.55 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 164.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.52 170.5 15.24 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -126.39 135.9 52.01 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.403 ' HA ' HG21 ' A' ' 99' ' ' VAL . 13.4 t -68.39 120.52 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 122.865 1.317 . . . . 0.0 111.346 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.8 p -104.24 -31.68 9.47 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 118.839 -2.413 . . . . 0.0 111.913 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -162.92 124.02 2.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 124.327 2.013 . . . . 0.0 114.236 175.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 92' ' ' ILE . 56.6 mt -82.97 132.76 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-O 124.545 2.117 . . . . 0.0 109.937 176.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.4 m -121.39 172.11 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.606 3.128 0 C-N-CA 127.632 2.373 . . . . 0.0 108.862 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -63.69 -32.47 73.97 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 119.108 -2.245 . . . . 0.0 113.834 -166.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -118.06 23.08 11.85 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 113.297 -1.774 . . . . 0.0 111.968 -173.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 164.69 164.28 19.65 Favored Glycine 0 C--O 1.2 -2.005 0 CA-C-O 125.005 2.447 . . . . 0.0 115.186 -171.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.15 130.64 53.41 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 112.465 -1.867 . . . . 0.0 113.113 170.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -73.47 137.71 44.68 Favored 'General case' 0 C--N 1.376 1.737 0 CA-C-O 123.926 1.822 . . . . 0.0 108.821 169.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.403 HG21 ' HA ' ' A' ' 89' ' ' VAL . 50.1 t -131.18 134.78 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-O 124.252 1.977 . . . . 0.0 107.09 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.22 141.41 35.1 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 113.653 -1.612 . . . . 0.0 114.302 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.31 147.75 32.12 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.8 151.56 1.59 Allowed Glycine 0 C--N 1.362 2.013 0 N-CA-C 119.001 2.36 . . . . 0.0 119.001 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.79 17.27 58.45 Favored Glycine 0 C--N 1.368 2.353 0 CA-C-O 118.129 -1.373 . . . . 0.0 114.734 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.25 23.72 73.11 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 116.965 1.546 . . . . 0.0 116.965 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -114.37 130.88 56.71 Favored 'General case' 0 C--O 1.194 -1.841 0 CA-C-O 123.989 1.852 . . . . 0.0 108.926 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -127.13 134.43 50.21 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 120.728 -1.232 . . . . 0.0 111.453 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.48 173.26 17.49 Favored Glycine 0 C--O 1.205 -1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 112.724 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.7 tp -104.08 139.37 39.26 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 125.427 2.537 . . . . 0.0 110.294 172.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.0 t -99.13 96.47 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 CA-C-N 113.694 -1.593 . . . . 0.0 110.633 158.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -53.39 162.59 0.74 Allowed 'General case' 0 CA--C 1.576 1.967 0 CA-C-N 119.6 1.091 . . . . 0.0 113.433 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' HA ' HD13 ' A' ' 114' ' ' ILE . 3.9 tt -48.26 -33.81 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 p -90.26 7.09 40.04 Favored 'General case' 0 C--N 1.364 1.234 0 C-N-CA 126.122 1.769 . . . . 0.0 111.569 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -119.48 12.35 12.36 Favored 'General case' 0 CA--C 1.572 1.817 0 O-C-N 119.667 -1.895 . . . . 0.0 111.861 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 111' ' ' ILE . 9.8 mt -100.31 -45.85 11.75 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 O-C-N 117.451 -3.281 . . . . 0.0 109.991 -170.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.94 167.76 24.87 Favored 'General case' 0 C--N 1.402 2.872 0 CA-C-O 124.959 2.314 . . . . 0.0 114.541 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -66.13 -41.5 90.4 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 127.056 2.143 . . . . 0.0 115.547 163.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -42.5 150.96 0.13 Allowed 'General case' 0 CA--C 1.539 0.539 0 O-C-N 128.164 3.415 . . . . 0.0 115.385 169.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -65.89 97.4 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.1 t -94.64 125.35 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-N 118.77 0.714 . . . . 0.0 109.684 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -111.76 -33.41 6.33 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -145.38 148.71 33.66 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.81 -24.97 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 116.389 -1.767 . . . . 0.0 111.358 -163.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.2 p -59.3 -31.56 69.24 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 126.003 1.721 . . . . 0.0 109.014 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.58 -16.4 61.25 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -128.28 -4.47 5.51 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -173.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.2 mt -144.85 167.13 23.34 Favored 'General case' 0 C--O 1.197 -1.701 0 O-C-N 119.706 -1.871 . . . . 0.0 109.605 165.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -138.52 159.17 42.76 Favored 'General case' 0 CA--C 1.57 1.731 0 C-N-CA 124.948 1.299 . . . . 0.0 110.815 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -71.58 148.55 46.52 Favored 'General case' 0 CA--C 1.582 2.206 0 O-C-N 120.331 -1.48 . . . . 0.0 112.862 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 59.37 28.72 65.04 Favored Glycine 0 C--N 1.369 2.401 0 C-N-CA 129.957 3.646 . . . . 0.0 114.342 -170.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -95.98 145.92 25.03 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 169.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -86.04 142.55 28.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 125.115 2.388 . . . . 0.0 106.302 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.15 127.75 11.58 Favored Pre-proline 0 N--CA 1.426 -1.639 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -170.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -54.29 121.79 10.33 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 CA-C-N 121.053 1.412 . . . . 0.0 114.157 154.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . 0.351 5.4 m -123.11 131.75 72.67 Favored 'Isoleucine or valine' 0 C--N 1.383 2.064 0 CA-C-O 124.406 2.05 . . . . 0.0 114.635 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -107.66 129.71 54.98 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.57 134.28 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 1 O-C-N 114.009 -5.432 . . . . 0.0 106.004 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.7 mt -112.42 -5.27 14.1 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-N 120.514 1.507 . . . . 0.0 111.758 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -171.7 128.19 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 124.594 2.14 . . . . 0.0 110.408 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.9 t -105.24 104.59 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 155.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.64 149.06 26.1 Favored 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -76.79 -5.71 49.32 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.791 -1.193 . . . . 0.0 114.161 -171.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -90.48 -2.43 57.93 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-O 115.931 -1.985 . . . . 0.0 111.142 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.17 23.3 8.17 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-O 123.515 1.619 . . . . 0.0 111.972 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -108.7 115.84 30.85 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 -162.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 69.3 mt -114.11 117.96 57.06 Favored 'Isoleucine or valine' 0 C--N 1.398 2.703 0 CA-C-O 122.522 1.154 . . . . 0.0 108.005 -161.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -109.97 112.7 24.88 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 124.829 2.252 . . . . 0.0 111.742 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 76.1 mt -108.62 158.83 17.22 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 111.083 -2.78 . . . . 0.0 108.481 -171.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -143.38 152.65 41.84 Favored 'General case' 0 N--CA 1.516 2.832 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 57.1 mt -107.38 -45.16 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -58.08 -37.42 74.44 Favored 'General case' 0 CA--C 1.476 -1.896 0 C-N-CA 124.15 0.98 . . . . 0.0 111.824 -173.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -76.21 -24.57 54.65 Favored 'General case' 0 N--CA 1.397 -3.114 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.25 -28.95 47.88 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.002 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 65.8 p . . . . . 0 CA--C 1.579 2.074 0 O-C-N 127.312 2.882 . . . . 0.0 108.066 175.583 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -98.31 130.34 44.99 Favored 'General case' 0 C--O 1.27 2.153 0 O-C-N 118.8 -2.437 . . . . 0.0 107.056 171.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 t -148.98 165.7 30.85 Favored 'General case' 0 C--N 1.37 1.488 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.152 -164.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.6 tt -153.16 146.74 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 169.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -110.13 117.39 33.58 Favored 'General case' 0 N--CA 1.423 -1.778 0 O-C-N 116.614 -3.804 . . . . 0.0 104.277 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 pt -108.07 165.13 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.414 2.685 . . . . 0.0 109.712 -174.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -67.23 129.02 93.89 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 112.031 -2.349 . . . . 0.0 110.746 172.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 100.0 Cg_exo -57.45 -20.44 40.63 Favored 'Trans proline' 0 N--CA 1.515 2.762 0 N-CA-C 117.68 2.146 . . . . 0.0 117.68 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.14 -21.29 59.93 Favored 'General case' 0 N--CA 1.41 -2.448 0 C-N-CA 125.222 1.409 . . . . 0.0 112.524 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -97.53 -1.75 43.34 Favored 'General case' 0 CA--C 1.49 -1.352 0 C-N-CA 126.74 2.016 . . . . 0.0 109.517 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.6 mt -57.72 -46.11 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 117.035 -1.459 . . . . 0.0 112.381 164.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.48 ' HZ3' ' CD ' ' A' ' 80' ' ' GLU . 12.4 pttm -69.7 -29.46 66.88 Favored 'General case' 0 C--O 1.186 -2.277 0 CA-C-N 119.86 1.209 . . . . 0.0 111.73 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -72.73 -45.29 59.48 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.661 0.784 . . . . 0.0 111.819 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.6 t -68.5 -39.36 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 118.766 -0.635 . . . . 0.0 111.602 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.4 mt -63.86 -51.82 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 124.489 1.116 . . . . 0.0 111.902 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.38 179.99 52.48 Favored Glycine 0 C--O 1.208 -1.511 0 CA-C-N 112.759 -2.019 . . . . 0.0 113.872 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -77.74 116.32 18.18 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.404 0.708 . . . . 0.0 110.682 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.41 20.79 79.51 Favored Glycine 0 CA--C 1.551 2.307 0 CA-C-N 112.459 -2.155 . . . . 0.0 116.03 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.09 7.23 88.76 Favored Glycine 0 C--N 1.368 2.333 0 CA-C-N 120.353 2.077 . . . . 0.0 115.901 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 t -56.26 -50.67 70.67 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.246 -1.977 . . . . 0.0 113.116 -173.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.2 t -73.14 -32.24 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.144 0.884 . . . . 0.0 109.275 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -57.03 -48.82 81.12 Favored 'Isoleucine or valine' 0 C--N 1.371 1.5 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.395 172.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -62.72 -44.28 96.63 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 125.684 2.659 . . . . 0.0 112.308 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.2 73.42 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 117.309 -3.37 . . . . 0.0 116.981 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . 0.263 46.8 mt -61.05 -45.03 96.42 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 125.137 1.523 . . . . 0.0 108.816 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 m -58.61 -56.09 26.67 Favored 'General case' 0 C--N 1.389 2.288 0 O-C-N 118.579 -2.576 . . . . 0.0 115.408 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -56.44 -48.48 76.93 Favored 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 125.615 1.566 . . . . 0.0 112.844 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 67.8 tt0 -62.28 -51.02 69.36 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.405 HG21 ' HA ' ' A' ' 68' ' ' ALA . 68.5 p -79.65 -8.27 59.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 124.628 1.205 . . . . 0.0 112.344 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.93 19.88 70.14 Favored Glycine 0 C--O 1.247 0.933 0 O-C-N 125.553 1.783 . . . . 0.0 114.371 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 t -148.13 152.84 37.99 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -69.04 140.32 54.92 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 124.82 2.248 . . . . 0.0 114.352 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.15 127.63 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -135.25 151.19 50.36 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 119.411 -0.915 . . . . 0.0 112.111 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 tt -136.4 124.48 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 O-C-N 120.908 -1.12 . . . . 0.0 110.963 -170.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -86.68 168.79 13.26 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-O 123.432 1.587 . . . . 0.0 112.15 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -76.85 -15.67 59.64 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 117.376 2.361 . . . . 0.0 117.376 -169.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.96 -4.25 59.12 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 123.164 1.459 . . . . 0.0 112.37 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.45 3.35 27.37 Favored Glycine 0 CA--C 1.544 1.879 0 O-C-N 119.514 -1.992 . . . . 0.0 109.967 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.8 m -89.16 107.15 18.89 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.685 2.242 . . . . 0.0 113.943 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.96 136.82 22.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.946 -1.102 . . . . 0.0 111.291 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -115.72 120.64 39.99 Favored 'General case' 0 C--N 1.391 2.388 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.01 120.1 58.76 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 -173.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.91 90.73 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -38.04 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 1 N-CA-C 121.89 4.033 . . . . 0.0 121.89 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 m -121.16 -44.39 2.39 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.61 132.43 53.26 Favored 'General case' 0 C--N 1.389 2.32 0 CA-C-O 124.451 2.072 . . . . 0.0 107.757 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -49.87 -52.73 24.78 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 118.318 2.087 . . . . 0.0 118.318 -167.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.453 ' CD ' ' HZ1' ' A' ' 66' ' ' LYS . 70.8 mm-40 -66.05 -37.7 86.5 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.32 -42.51 88.15 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.329 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.18 80.93 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 116.31 -1.805 . . . . 0.0 110.092 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HZ1' ' CD ' ' A' ' 63' ' ' GLU . 16.9 tttt -61.13 -36.44 79.77 Favored 'General case' 0 C--N 1.366 1.289 0 C-N-CA 125.96 1.704 . . . . 0.0 113.887 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -64.51 -41.01 96.68 Favored 'General case' 0 N--CA 1.511 2.615 0 CA-C-O 124.375 2.036 . . . . 0.0 114.754 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -64.76 -38.02 89.58 Favored 'General case' 0 C--O 1.257 1.456 0 O-C-N 117.976 -2.952 . . . . 0.0 111.635 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.78 -49.89 77.99 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 O-C-N 125.542 1.776 . . . . 0.0 109.241 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -58.39 -37.72 75.85 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.424 ' HE ' ' CD ' ' A' ' 42' ' ' GLU . 11.8 mmm180 -71.38 -41.57 69.51 Favored 'General case' 0 C--N 1.366 1.31 0 O-C-N 126.751 2.532 . . . . 0.0 112.09 174.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.4 mm -56.53 -42.82 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-O 121.941 0.877 . . . . 0.0 109.599 167.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.256 12.5 mt-10 -62.56 -42.72 99.72 Favored 'General case' 0 CA--C 1.572 1.818 0 O-C-N 121.063 -1.023 . . . . 0.0 112.932 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.81 -44.18 86.17 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 117.481 -1.247 . . . . 0.0 113.406 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.3 mm -78.38 -25.46 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-N 121.481 1.946 . . . . 0.0 109.09 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 C--N 1.365 1.282 0 O-C-N 123.934 0.771 . . . . 0.0 112.322 176.904 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.1 pt . . . . . 0 C--O 1.279 2.653 0 CA-C-O 128.356 3.931 . . . . 0.0 114.98 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 26' ' ' LYS . 47.5 mt-10 -122.76 147.43 46.51 Favored 'General case' 0 C--O 1.202 -1.396 0 O-C-N 118.23 -2.794 . . . . 0.0 108.311 -172.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 m -64.79 154.94 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 123.91 1.814 . . . . 0.0 112.551 171.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.07 -9.6 45.68 Favored Glycine 0 CA--C 1.561 2.911 0 O-C-N 119.644 -1.91 . . . . 0.0 116.664 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -96.69 153.78 17.66 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 115.131 -2.366 . . . . 0.0 110.468 -172.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.31 117.03 54.32 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 O-C-N 125.067 1.48 . . . . 0.0 110.333 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.51 166.75 10.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.806 2.442 . . . . 0.0 105.82 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 83.1 m -101.53 116.87 33.74 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 171.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.67 157.62 15.65 Favored Glycine 0 CA--C 1.469 -2.829 0 O-C-N 119.654 -1.903 . . . . 0.0 109.642 -173.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -115.93 128.82 56.06 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 118.791 -1.163 . . . . 0.0 111.69 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.06 126.2 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.391 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.2 p -102.52 -35.54 8.71 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-N 120.731 1.605 . . . . 0.0 114.249 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -165.46 157.43 14.91 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 127.061 2.725 . . . . 0.0 110.892 -173.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.5 mt -140.64 142.8 30.0 Favored 'Isoleucine or valine' 0 C--N 1.383 2.06 0 O-C-N 126.294 2.246 . . . . 0.0 107.008 -167.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.19 -164.43 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -67.56 -38.99 84.93 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 128.72 2.808 . . . . 0.0 115.648 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -95.46 0.39 53.22 Favored 'General case' 0 N--CA 1.527 3.409 0 CA-C-O 114.07 -2.872 . . . . 0.0 116.044 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.64 -174.99 36.56 Favored Glycine 0 C--N 1.361 1.948 0 CA-C-N 125.245 3.657 . . . . 0.0 115.065 -170.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.61 137.25 51.59 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -91.9 144.16 25.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.6 t -143.18 136.75 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 113.554 -1.657 . . . . 0.0 108.267 -173.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 106' ' ' GLU . . . -107.76 144.67 34.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 125.008 2.337 . . . . 0.0 111.258 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.1 pt -140.25 167.73 18.17 Favored 'Isoleucine or valine' 0 C--O 1.259 1.582 0 CA-C-N 112.597 -2.092 . . . . 0.0 108.099 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -27.77 131.2 0.06 OUTLIER Glycine 0 CA--C 1.575 3.793 0 N-CA-C 122.634 3.814 . . . . 0.0 122.634 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.95 6.59 66.92 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -173.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.16 36.92 55.84 Favored Glycine 0 C--O 1.194 -2.366 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.494 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -103.17 110.45 22.4 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 119.034 1.417 . . . . 0.0 112.822 -170.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 27.1 tt0 -93.59 124.82 37.84 Favored 'General case' 0 N--CA 1.515 2.814 0 O-C-N 119.291 -2.13 . . . . 0.0 110.441 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -124.77 -175.91 14.43 Favored Glycine 0 CA--C 1.541 1.695 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.6 tp -121.43 127.66 51.36 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.843 1.306 . . . . 0.0 111.103 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.64 112.37 31.83 Favored 'Isoleucine or valine' 0 C--O 1.256 1.414 0 CA-C-N 113.932 -1.486 . . . . 0.0 107.193 166.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.44 152.88 42.86 Favored 'General case' 0 C--N 1.374 1.652 0 CA-C-O 125.217 2.436 . . . . 0.0 116.324 164.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 tt -52.98 -37.11 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 CA-C-N 111.076 -2.784 . . . . 0.0 113.569 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 76.7 p -76.75 -14.33 59.95 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 124.941 1.297 . . . . 0.0 109.488 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -101.88 7.78 41.44 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.675 1.19 . . . . 0.0 109.618 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 43.8 mm -78.1 -33.77 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.326 0 CA-C-O 123.106 1.431 . . . . 0.0 110.722 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -165.38 -178.58 5.06 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 119.067 -2.271 . . . . 0.0 112.509 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.19 -54.65 41.66 Favored 'General case' 0 CA--C 1.578 2.04 0 CA-C-N 112.729 -2.032 . . . . 0.0 111.857 165.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -93.63 160.55 14.73 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -84.25 127.38 33.92 Favored 'General case' 0 N--CA 1.512 2.643 0 O-C-N 125.698 1.874 . . . . 0.0 113.436 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.37 131.54 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 120.878 -1.139 . . . . 0.0 108.082 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -63.33 -40.04 96.21 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 118.468 -2.645 . . . . 0.0 112.987 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -129.27 118.07 21.72 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.93 1.292 . . . . 0.0 110.532 -175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.56 -30.16 49.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 C-N-CA 124.339 1.056 . . . . 0.0 109.602 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -23.31 63.15 Favored 'General case' 0 C--O 1.261 1.659 0 O-C-N 119.066 -2.271 . . . . 0.0 113.712 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -78.16 -20.92 51.06 Favored 'General case' 0 CA--C 1.49 -1.331 0 O-C-N 118.315 -2.741 . . . . 0.0 113.036 174.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -106.87 -8.79 16.56 Favored 'General case' 0 C--N 1.379 1.865 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.2 mt -146.0 159.01 43.86 Favored 'General case' 0 N--CA 1.402 -2.844 0 CA-C-O 124.018 1.866 . . . . 0.0 108.262 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -144.35 150.53 37.94 Favored 'General case' 0 C--O 1.201 -1.467 0 CA-C-N 111.334 -2.666 . . . . 0.0 106.074 -168.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -70.21 141.1 52.57 Favored 'General case' 0 CA--C 1.594 2.661 0 CA-C-O 123.607 1.67 . . . . 0.0 113.525 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.79 -11.59 68.35 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.25 140.42 40.07 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 121.016 2.408 . . . . 0.0 115.472 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -102.13 129.79 48.57 Favored 'General case' 0 C--N 1.381 1.959 0 O-C-N 124.949 1.406 . . . . 0.0 110.573 -163.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.11 143.28 46.52 Favored Pre-proline 0 CA--C 1.577 1.999 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.263 -176.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.15 136.04 70.11 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 CA-C-N 122.794 2.034 . . . . 0.0 110.447 169.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.54 148.17 27.21 Favored 'Isoleucine or valine' 0 C--O 1.255 1.371 0 O-C-N 125.732 1.895 . . . . 0.0 109.935 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -116.55 135.33 53.91 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 127.387 2.929 . . . . 0.0 104.736 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.8 t -87.05 127.89 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 126.76 2.537 . . . . 0.0 106.246 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.1 mt -101.03 -57.57 2.06 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -169.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -163.31 159.34 22.48 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 122.049 0.928 . . . . 0.0 109.407 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.68 119.86 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 102.323 -3.214 . . . . 0.0 102.323 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -71.52 162.18 29.85 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 129.003 2.921 . . . . 0.0 111.741 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -58.57 -33.53 70.05 Favored 'General case' 0 C--N 1.381 1.971 0 O-C-N 125.637 1.836 . . . . 0.0 113.111 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -90.58 11.14 22.86 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 119.296 -2.127 . . . . 0.0 109.946 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.04 16.64 69.23 Favored Glycine 0 C--O 1.251 1.193 0 CA-C-O 123.38 1.545 . . . . 0.0 113.973 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -71.12 117.28 12.43 Favored 'General case' 0 C--O 1.266 1.964 0 CA-C-N 112.384 -1.908 . . . . 0.0 114.062 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.1 mt -88.3 123.71 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.99 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -96.89 131.56 43.53 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-O 122.185 0.993 . . . . 0.0 110.573 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.5 mt -129.89 144.57 51.38 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 120.16 -1.588 . . . . 0.0 109.423 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.4 t -121.7 133.05 54.94 Favored 'General case' 0 C--N 1.375 1.708 0 CA-C-N 121.376 1.898 . . . . 0.0 110.656 163.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 76.3 mt -79.33 -45.1 23.97 Favored 'Isoleucine or valine' 0 C--N 1.377 1.801 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -55.71 -42.98 76.07 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 127.78 3.175 . . . . 0.0 112.418 -164.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -85.15 -19.9 31.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 115.042 -2.409 . . . . 0.0 109.892 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.31 -36.96 63.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 121.754 2.07 . . . . 0.0 113.773 167.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 N--CA 1.484 1.261 0 O-C-N 125.597 1.81 . . . . 0.0 111.629 174.094 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.4 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 124.251 1.977 . . . . 0.0 108.479 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -118.17 138.25 52.43 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 112.581 -2.099 . . . . 0.0 111.352 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -115.46 133.45 56.02 Favored 'General case' 0 C--N 1.38 1.918 0 O-C-N 120.271 -1.518 . . . . 0.0 110.496 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.7 mm -137.87 137.42 44.92 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -98.01 137.38 36.9 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 123.156 1.455 . . . . 0.0 112.58 167.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 pt -116.5 169.4 7.01 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 C-N-CA 125.63 1.572 . . . . 0.0 112.862 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -57.08 124.77 67.59 Favored Pre-proline 0 CA--C 1.586 2.358 0 CA-C-N 113.698 -1.592 . . . . 0.0 113.065 167.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.45 -3.21 13.31 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.67 2.246 . . . . 0.0 115.182 -176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -72.58 -19.4 61.49 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.631 1.973 . . . . 0.0 115.848 161.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -99.58 -3.98 32.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 116.604 -1.665 . . . . 0.0 111.082 -166.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.0 mt -54.96 -44.41 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 119.204 0.911 . . . . 0.0 110.937 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.31 0.1 OUTLIER -57.8 -38.0 74.75 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 125.121 1.513 . . . . 0.0 111.731 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -75.89 -35.6 59.78 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-O 114.673 -2.584 . . . . 0.0 112.925 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.76 -52.65 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 116.065 -1.922 . . . . 0.0 114.287 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.7 mt -78.22 -32.39 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 126.024 2.078 . . . . 0.0 113.247 -176.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.39 -180.0 0.18 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 120.637 3.015 . . . . 0.0 120.637 -172.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -56.4 122.05 11.0 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 113.613 -1.294 . . . . 0.0 113.397 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 49.77 22.4 4.23 Favored Glycine 0 C--N 1.36 1.882 0 N-CA-C 116.98 1.552 . . . . 0.0 116.98 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.7 77.87 Favored Glycine 1 C--N 1.402 4.221 0 CA-C-N 122.191 2.995 . . . . 0.0 113.275 -175.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.1 m -58.58 -43.46 89.45 Favored 'General case' 0 C--O 1.207 -1.172 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -172.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.0 t -72.67 -47.02 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 O-C-N 124.263 0.977 . . . . 0.0 111.53 -172.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.251 7.0 tt -62.94 -38.77 82.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 113.66 -3.067 . . . . 0.0 114.604 172.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -59.01 -49.42 77.96 Favored 'General case' 0 C--O 1.263 1.783 0 O-C-N 126.193 2.183 . . . . 0.0 111.878 167.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.16 95.89 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 175.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.77 -39.27 93.85 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.112 0.882 . . . . 0.0 111.793 172.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.8 m -52.0 -46.04 64.77 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 117.203 -1.379 . . . . 0.0 110.94 167.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -67.75 -37.08 81.66 Favored 'General case' 0 C--N 1.37 1.495 0 C-N-CA 125.602 1.561 . . . . 0.0 113.323 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.12 -37.34 64.12 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.0 p -95.09 -34.38 12.32 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.35 -1.786 . . . . 0.0 114.363 -176.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.99 37.26 22.7 Favored Glycine 0 C--N 1.386 3.317 0 CA-C-O 124.454 2.141 . . . . 0.0 108.923 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.8 p -119.64 162.05 19.64 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.982 -1.305 . . . . 0.0 109.114 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -101.62 127.49 48.33 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.443 1.116 . . . . 0.0 109.197 169.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -114.9 126.54 72.51 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 -171.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.404 ' CD ' ' HZ2' ' A' ' 56' ' ' LYS . 3.0 tm-20 -124.15 135.4 53.47 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 123.207 1.479 . . . . 0.0 107.714 173.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.54 141.18 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 119.055 -2.278 . . . . 0.0 109.726 -169.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -125.5 165.79 17.82 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-O 123.242 1.496 . . . . 0.0 107.769 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.32 43.4 p-10 -88.88 8.0 31.46 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 118.346 2.721 . . . . 0.0 118.346 -162.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -96.53 15.23 22.13 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.651 -1.613 . . . . 0.0 107.866 167.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.94 34.53 71.23 Favored Glycine 0 C--N 1.365 2.184 0 O-C-N 119.706 -1.871 . . . . 0.0 112.458 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.8 m -96.62 113.85 25.45 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-O 116.447 -1.74 . . . . 0.0 108.462 164.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -109.34 138.74 35.27 Favored 'Isoleucine or valine' 0 C--N 1.378 1.827 0 CA-C-O 122.886 1.327 . . . . 0.0 107.612 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HZ2' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -115.17 123.26 48.46 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 112.59 -2.095 . . . . 0.0 111.031 -176.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.55 119.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 119.348 -2.095 . . . . 0.0 111.733 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.89 127.18 54.56 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.155 2.582 . . . . 0.0 109.19 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.84 162.31 37.99 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 120.133 -1.604 . . . . 0.0 108.022 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.4 p -84.91 0.69 50.26 Favored 'General case' 0 N--CA 1.415 -2.22 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.196 173.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -142.82 140.66 31.4 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.584 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.68 -15.33 81.35 Favored Glycine 0 C--N 1.365 2.161 0 CA-C-O 116.363 -2.354 . . . . 0.0 113.053 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.74 -42.07 86.81 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 121.084 2.442 . . . . 0.0 109.86 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -64.13 -46.42 84.21 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.525 -2.125 . . . . 0.0 108.437 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.13 98.91 Favored 'General case' 0 C--N 1.36 1.047 0 O-C-N 120.292 -1.505 . . . . 0.0 114.422 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -65.62 -35.01 79.56 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 114.984 -2.436 . . . . 0.0 112.2 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -65.64 -38.18 88.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 125.82 1.95 . . . . 0.0 109.216 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.04 99.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.82 -1.175 . . . . 0.0 112.958 169.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.19 -45.5 84.6 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 O-C-N 120.014 -1.679 . . . . 0.0 112.925 168.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -60.69 -35.29 75.91 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 120.805 1.638 . . . . 0.0 114.052 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -74.63 -27.56 60.5 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 116.474 -1.727 . . . . 0.0 114.6 165.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . 0.349 11.3 mt -76.63 -32.22 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.46 -45.32 88.84 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.68 1.992 . . . . 0.0 115.026 169.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -64.47 -36.96 85.89 Favored 'General case' 0 C--O 1.195 -1.765 0 O-C-N 125.976 2.048 . . . . 0.0 106.743 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.2 mt -60.8 -44.53 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 125.592 3.815 . . . . 0.0 111.427 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 C--N 1.309 -1.174 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -162.489 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.0 mm . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -112.33 137.27 50.71 Favored 'General case' 0 CA--C 1.578 2.033 0 CA-C-O 124.487 2.089 . . . . 0.0 111.115 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 42.6 t -80.18 130.25 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 O-C-N 120.573 -1.329 . . . . 0.0 109.553 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.52 64.75 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 116.613 1.405 . . . . 0.0 116.613 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -119.58 135.28 54.86 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 123.882 0.873 . . . . 0.0 112.208 -174.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.0 t -72.53 130.18 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -128.7 154.53 46.23 Favored 'General case' 0 C--O 1.268 2.062 0 CA-C-N 112.452 -2.158 . . . . 0.0 107.425 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.1 m -105.88 128.24 53.64 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.61 167.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -138.53 -173.0 12.78 Favored Glycine 0 C--O 1.206 -1.606 0 O-C-N 126.791 2.557 . . . . 0.0 108.985 -167.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -144.59 150.58 37.69 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.139 -0.624 . . . . 0.0 112.365 166.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 t -59.61 132.89 25.04 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 CA-C-N 112.4 -2.182 . . . . 0.0 111.452 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -110.48 -57.08 2.26 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -134.87 150.47 50.46 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.803 1.287 . . . . 0.0 110.586 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.71 136.49 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 112.94 -1.937 . . . . 0.0 107.292 171.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.5 m -135.29 -177.15 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 111.889 -2.414 . . . . 0.0 108.576 -168.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.55 -23.81 67.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 119.162 -2.211 . . . . 0.0 115.617 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -125.66 -0.52 7.43 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.61 0.764 . . . . 0.0 111.211 -165.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.25 -169.72 41.57 Favored Glycine 0 CA--C 1.48 -2.144 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.44 146.61 46.05 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 111.663 -2.269 . . . . 0.0 108.22 167.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -100.13 137.34 38.71 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 168.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.44 129.55 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 C-N-CA 126.541 1.936 . . . . 0.0 106.246 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.66 125.26 41.0 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.8 pt -116.86 164.59 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 C-N-CA 125.874 1.67 . . . . 0.0 106.984 -175.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.03 153.58 0.54 Allowed Glycine 0 CA--C 1.543 1.821 0 N-CA-C 118.659 2.223 . . . . 0.0 118.659 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.48 23.28 65.47 Favored Glycine 0 N--CA 1.487 2.083 0 O-C-N 119.523 -2.163 . . . . 0.0 112.599 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.75 36.25 93.08 Favored Glycine 0 C--N 1.358 1.79 0 C-N-CA 126.863 2.173 . . . . 0.0 117.356 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -112.97 135.13 54.08 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 123.355 1.55 . . . . 0.0 109.842 -169.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.22 138.86 47.15 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 119.546 -1.971 . . . . 0.0 105.999 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.0 165.51 24.61 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-O 118.732 -1.038 . . . . 0.0 111.316 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.0 tp -101.5 114.18 27.97 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.055 -1.458 . . . . 0.0 109.783 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.5 98.56 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.933 0 CA-C-O 125.738 2.685 . . . . 0.0 110.317 160.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -65.43 149.64 49.67 Favored 'General case' 0 CA--C 1.558 1.284 1 O-C-N 115.878 -4.264 . . . . 0.0 113.146 172.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 tt -65.29 -16.07 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 113.411 -1.722 . . . . 0.0 114.775 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 89.6 p -90.11 -1.51 57.96 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 119.694 -1.879 . . . . 0.0 110.184 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -121.39 36.48 4.6 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.65 -44.02 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 127.144 2.178 . . . . 0.0 109.37 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -145.04 163.11 35.24 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 111.842 -2.435 . . . . 0.0 112.646 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -70.98 -45.94 63.16 Favored 'General case' 0 CA--C 1.576 1.961 0 O-C-N 119.623 -1.923 . . . . 0.0 115.924 171.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -77.63 149.83 34.7 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 120.616 -1.303 . . . . 0.0 111.336 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.259 94.8 mtt180 -47.44 132.06 13.5 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 125.11 2.386 . . . . 0.0 115.012 174.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -107.2 115.35 48.4 Favored 'Isoleucine or valine' 0 C--N 1.371 1.531 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.83 -40.13 87.9 Favored 'General case' 0 C--O 1.197 -1.708 0 C-N-CA 118.066 -1.454 . . . . 0.0 113.45 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -147.44 145.88 29.35 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.73 1.15 . . . . 0.0 108.397 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.76 -34.94 71.15 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.233 -172.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.4 p -68.32 -26.45 65.62 Favored 'General case' 0 C--N 1.365 1.275 0 CA-C-O 125.023 2.344 . . . . 0.0 113.285 -167.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -58.49 -34.77 71.28 Favored 'General case' 0 C--O 1.205 -1.258 0 O-C-N 118.5 -2.625 . . . . 0.0 113.896 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -86.96 -61.91 1.62 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 128.116 2.567 . . . . 0.0 112.586 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.2 mt -109.45 157.54 18.85 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 125.729 1.893 . . . . 0.0 111.129 -162.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -142.55 156.54 45.13 Favored 'General case' 0 C--O 1.209 -1.062 0 O-C-N 126.28 2.237 . . . . 0.0 105.835 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -66.97 141.76 57.49 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 127.252 2.221 . . . . 0.0 112.83 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.93 -6.59 74.07 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-O 115.889 -2.617 . . . . 0.0 114.006 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -77.96 125.62 29.61 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 126.715 2.068 . . . . 0.0 113.589 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.8 136.77 54.68 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-O 123.392 1.567 . . . . 0.0 112.717 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 p -152.87 142.68 15.0 Favored Pre-proline 0 C--O 1.184 -2.383 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.765 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.14 123.49 11.3 Favored 'Trans proline' 0 C--N 1.276 -3.277 0 C-N-CA 123.521 2.814 . . . . 0.0 119.026 160.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.8 m -123.4 137.8 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-O 123.356 1.55 . . . . 0.0 107.325 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -100.0 132.5 45.32 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 113.745 -1.571 . . . . 0.0 110.533 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.85 124.58 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 126.225 2.203 . . . . 0.0 109.526 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.4 mt -111.87 -28.29 8.12 Favored 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.598 -1.313 . . . . 0.0 112.786 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -160.71 144.06 13.34 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.266 1.026 . . . . 0.0 111.749 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.8 t -115.93 115.16 48.33 Favored 'Isoleucine or valine' 0 C--N 1.375 1.694 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 167.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.322 0.0 OUTLIER -82.33 161.35 22.61 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 -174.189 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -89.91 -1.05 57.9 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 119.55 -1.969 . . . . 0.0 112.768 -168.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -85.82 0.74 52.17 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 127.094 3.33 . . . . 0.0 109.635 166.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.04 4.21 61.52 Favored Glycine 0 C--O 1.217 -0.942 0 CA-C-O 115.672 -2.738 . . . . 0.0 116.323 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -76.23 105.93 7.56 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 120.578 2.189 . . . . 0.0 111.851 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.5 mt -78.51 130.86 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -123.34 131.05 53.53 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.756 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.5 mt -127.94 140.58 51.91 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 123.979 0.912 . . . . 0.0 112.734 -163.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.1 t -126.61 120.78 30.39 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.4 mt -79.04 -28.62 13.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 167.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -61.69 -51.25 69.19 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -74.79 -19.46 60.2 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 121.877 0.846 . . . . 0.0 113.078 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.89 -25.91 25.9 Favored 'General case' 0 C--N 1.369 1.415 0 O-C-N 117.088 -3.507 . . . . 0.0 111.286 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 C--O 1.251 1.142 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.259 175.177 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 pt . . . . . 0 CA--C 1.51 -0.563 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -89.2 143.09 27.1 Favored 'General case' 0 C--N 1.368 1.402 0 CA-C-N 113.651 -1.613 . . . . 0.0 106.786 168.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 t -139.89 150.19 44.3 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-O 128.497 3.999 . . . . 0.0 114.624 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -137.56 134.15 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.502 0 CA-C-N 110.517 -3.038 . . . . 0.0 106.061 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -86.2 118.56 25.73 Favored 'General case' 0 CA--C 1.473 -2.013 0 O-C-N 125.38 1.675 . . . . 0.0 111.45 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.9 pt -112.0 152.41 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.651 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -47.63 114.46 3.17 Favored Pre-proline 0 C--O 1.212 -0.904 0 CA-C-O 115.371 -2.252 . . . . 0.0 114.323 163.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.17 -0.31 10.57 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 123.655 2.341 . . . . 0.0 115.894 -167.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -65.47 -29.88 70.59 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 125.761 1.913 . . . . 0.0 115.03 165.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -90.34 8.67 32.27 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 125.276 1.61 . . . . 0.0 113.394 -173.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.9 mt -66.07 -38.2 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 120.13 1.332 . . . . 0.0 112.321 -171.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -58.93 -45.3 90.73 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 125.76 1.913 . . . . 0.0 115.601 171.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.33 -49.43 77.62 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 125.266 1.604 . . . . 0.0 112.163 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 t -55.26 -49.5 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 O-C-N 128.66 3.725 . . . . 0.0 116.017 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.1 pt -74.85 -24.35 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 114.287 -2.768 . . . . 0.0 114.484 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.19 157.49 20.89 Favored Glycine 0 C--N 1.358 1.805 0 CA-C-N 120.8 1.636 . . . . 0.0 113.404 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.61 138.3 56.31 Favored 'General case' 0 C--N 1.378 1.82 0 CA-C-O 124.827 2.251 . . . . 0.0 107.593 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 43.92 29.05 1.35 Allowed Glycine 0 CA--C 1.557 2.665 0 CA-C-N 112.633 -2.076 . . . . 0.0 116.785 -158.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.17 20.84 63.32 Favored Glycine 0 C--O 1.213 -1.2 0 CA-C-N 121.131 2.465 . . . . 0.0 116.686 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.3 p -62.91 -37.7 88.01 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 127.11 2.164 . . . . 0.0 113.781 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.252 41.3 t -75.55 -35.47 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 123.724 0.64 . . . . 0.0 111.134 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.26 19.8 tt -67.64 -37.02 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 116.417 -2.113 . . . . 0.0 112.21 173.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -60.03 -43.4 95.34 Favored 'General case' 0 CA--C 1.584 2.271 0 CA-C-N 120.85 1.659 . . . . 0.0 114.697 171.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.73 82.89 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.149 2.58 . . . . 0.0 113.242 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -60.03 -45.1 93.91 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 124.973 1.42 . . . . 0.0 108.421 170.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 31.2 m -56.3 -54.45 45.28 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 120.684 1.584 . . . . 0.0 107.563 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.42 -43.5 96.7 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 119.568 3.173 . . . . 0.0 119.568 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -83.22 -25.46 31.7 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 p -78.15 -49.18 14.34 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 119.813 -1.805 . . . . 0.0 108.842 170.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.18 34.13 6.27 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 116.49 -2.283 . . . . 0.0 109.727 -173.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.3 p -131.15 172.77 11.73 Favored 'General case' 0 C--N 1.381 1.949 0 O-C-N 126.046 1.674 . . . . 0.0 110.436 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.6 m -109.2 138.42 45.58 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 123.44 1.591 . . . . 0.0 111.587 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.6 mp -135.48 127.68 46.7 Favored 'Isoleucine or valine' 0 C--N 1.387 2.196 0 CA-C-O 123.105 1.431 . . . . 0.0 110.223 -165.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.258 29.2 tt0 -128.43 129.2 45.8 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 117.662 -3.149 . . . . 0.0 106.831 164.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.4 mt -100.71 121.31 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 125.652 1.845 . . . . 0.0 109.874 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -87.36 150.76 23.61 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.259 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -54.09 -30.63 49.14 Favored 'General case' 0 C--O 1.261 1.668 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -168.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -82.64 0.46 42.99 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 126.76 2.024 . . . . 0.0 111.765 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.56 18.23 57.16 Favored Glycine 0 N--CA 1.504 3.232 0 O-C-N 119.327 -2.108 . . . . 0.0 110.745 -175.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -84.38 101.82 12.27 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.56 133.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 125.467 1.729 . . . . 0.0 112.236 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -118.16 112.08 19.69 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.5 mm -103.88 127.89 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 126.606 1.963 . . . . 0.0 108.977 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.34 130.75 44.83 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.8 174.13 13.62 Favored 'General case' 0 C--O 1.204 -1.313 0 O-C-N 120.704 -1.247 . . . . 0.0 109.02 -159.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -132.53 14.36 4.5 Favored 'General case' 0 CA--C 1.479 -1.753 0 CA-C-O 117.366 -1.302 . . . . 0.0 109.118 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -150.51 150.22 30.99 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.61 -44.51 6.1 Favored Glycine 0 N--CA 1.507 3.405 0 C-N-CA 127.024 2.25 . . . . 0.0 113.816 -163.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -50.48 -44.12 55.69 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 163.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -62.56 -45.25 93.79 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 124.883 1.364 . . . . 0.0 110.194 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.37 85.72 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.604 1.162 . . . . 0.0 110.91 173.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -58.83 -45.28 90.39 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 169.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -58.56 -41.34 85.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 126.38 2.3 . . . . 0.0 113.718 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.77 65.13 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mm -62.97 -46.2 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.804 0 CA-C-N 111.144 -2.753 . . . . 0.0 108.323 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -64.27 -49.97 69.76 Favored 'General case' 0 C--O 1.205 -1.252 0 O-C-N 124.529 1.143 . . . . 0.0 113.746 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -57.78 -39.46 77.53 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.801 1.24 . . . . 0.0 113.398 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.62 -49.38 84.01 Favored 'Isoleucine or valine' 0 C--O 1.257 1.474 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 168.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.68 -41.72 74.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -61.97 -47.69 83.69 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 127.752 2.421 . . . . 0.0 113.374 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.1 tt -71.29 -35.47 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 C-N-CA 124.349 1.06 . . . . 0.0 111.861 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 79.0 m . . . . . 0 C--N 1.355 0.82 0 CA-C-O 116.214 -1.851 . . . . 0.0 109.911 168.444 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.4 mm . . . . . 0 CA--C 1.577 1.998 0 CA-C-O 126.141 2.877 . . . . 0.0 104.434 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -117.83 140.52 49.58 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.694 1.998 . . . . 0.0 112.105 -173.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.43 148.76 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.667 -1.213 . . . . 0.0 113.479 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.45 -19.67 22.3 Favored Glycine 0 C--O 1.208 -1.511 0 CA-C-O 113.862 -3.743 . . . . 0.0 117.016 -171.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -96.92 158.82 15.25 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.98 1.89 . . . . 0.0 111.17 -166.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.71 127.8 75.88 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -121.35 159.54 25.88 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 124.016 1.865 . . . . 0.0 109.109 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 m -98.35 118.72 35.65 Favored 'General case' 0 C--O 1.202 -1.444 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 167.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -147.03 175.43 26.41 Favored Glycine 0 CA--C 1.569 3.416 0 C-N-CA 124.41 1.005 . . . . 0.0 114.829 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -117.15 133.15 56.35 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-O 125.633 2.635 . . . . 0.0 111.45 -169.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.3 t -67.8 121.13 16.4 Favored 'Isoleucine or valine' 0 C--N 1.366 1.304 0 O-C-N 119.214 -2.179 . . . . 0.0 106.487 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.4 p -103.8 -36.87 7.68 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.037 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -146.37 154.8 42.06 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.0 mt -126.22 130.17 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 O-C-N 125.796 1.935 . . . . 0.0 110.812 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.83 173.16 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -64.07 -27.73 69.3 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 123.262 1.506 . . . . 0.0 113.436 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -113.81 21.85 14.56 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -166.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.91 -153.01 24.95 Favored Glycine 0 C--O 1.204 -1.778 0 CA-C-O 116.991 -2.005 . . . . 0.0 111.305 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -149.69 174.33 12.69 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 102.203 -3.258 . . . . 0.0 102.203 167.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -114.86 128.76 56.48 Favored 'General case' 0 C--O 1.201 -1.47 0 O-C-N 127.669 3.106 . . . . 0.0 111.527 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.86 124.66 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 O-C-N 125.363 1.665 . . . . 0.0 107.494 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.69 117.53 17.55 Favored 'General case' 0 C--O 1.215 -0.732 1 O-C-N 129.434 4.209 . . . . 0.0 114.405 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.0 pt -138.78 157.62 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 113.894 -1.503 . . . . 0.0 114.868 -167.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.25 -111.84 4.34 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 117.339 -1.812 . . . . 0.0 110.772 -176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.83 -16.03 73.78 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 120.796 2.298 . . . . 0.0 112.809 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.59 -26.16 1.5 Allowed Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 116.947 -2.549 . . . . 0.0 112.377 -171.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -49.51 132.91 20.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 120.434 3.494 . . . . 0.0 120.434 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.48 143.64 48.34 Favored 'General case' 0 C--N 1.385 2.121 0 CA-C-O 123.966 1.841 . . . . 0.0 111.259 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.11 157.93 15.97 Favored Glycine 0 CA--C 1.539 1.565 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 169.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.433 HD23 ' CE1' ' A' ' 110' ' ' HIS . 4.1 tp -112.46 116.43 30.27 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 118.843 1.322 . . . . 0.0 111.001 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.56 118.4 48.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 171.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.433 ' CE1' HD23 ' A' ' 108' ' ' LEU . 90.8 m-70 -80.0 163.45 24.23 Favored 'General case' 0 C--O 1.192 -1.966 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 111' ' ' ILE . 21.0 tt -56.29 -39.59 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 C-N-CA 126.327 1.851 . . . . 0.0 114.856 -170.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.8 p -77.87 -5.15 50.01 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 125.087 1.492 . . . . 0.0 114.971 171.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.77 3.49 42.2 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 173.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.413 HG13 HG21 ' A' ' 122' ' ' VAL . 8.6 mm -74.17 -39.76 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 124.225 1.964 . . . . 0.0 113.789 169.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.58 151.94 35.92 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.429 -170.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -92.42 -1.03 57.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.872 160.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -87.26 170.58 11.32 Favored 'General case' 0 CA--C 1.577 2.018 0 CA-C-O 124.523 2.106 . . . . 0.0 107.944 158.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.57 147.84 47.88 Favored 'General case' 0 C--O 1.2 -1.503 0 N-CA-C 118.071 2.619 . . . . 0.0 118.071 -173.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.5 t -139.31 125.09 22.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.47 -46.8 5.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 125.313 1.445 . . . . 0.0 108.527 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -140.05 146.09 38.53 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.413 HG21 HG13 ' A' ' 114' ' ' ILE . 58.2 t -92.69 -3.87 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.167 1.349 . . . . 0.0 110.982 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.0 p -68.59 -23.28 64.45 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 116.149 -1.881 . . . . 0.0 114.47 165.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.93 -8.33 56.18 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 127.391 2.932 . . . . 0.0 111.469 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -119.93 -68.93 0.88 Allowed 'General case' 0 C--N 1.356 0.884 0 O-C-N 120.315 -1.491 . . . . 0.0 111.049 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.8 mt -90.74 152.49 20.79 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.454 1.121 . . . . 0.0 108.047 -173.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -124.66 135.12 52.8 Favored 'General case' 0 C--N 1.385 2.118 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.7 mtm -65.83 142.97 57.76 Favored 'General case' 0 C--O 1.21 -0.987 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.85 1.57 82.42 Favored Glycine 0 C--O 1.197 -2.191 0 CA-C-O 114.255 -3.525 . . . . 0.0 116.16 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -97.65 143.11 28.64 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 120.931 2.366 . . . . 0.0 107.9 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -71.07 117.68 12.89 Favored 'General case' 0 C--O 1.2 -1.517 0 O-C-N 126.257 2.223 . . . . 0.0 111.092 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.97 128.15 25.89 Favored Pre-proline 0 CA--C 1.587 2.379 0 C-N-CA 123.868 0.867 . . . . 0.0 110.408 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.37 128.17 27.48 Favored 'Trans proline' 0 N--CA 1.525 3.341 0 C-N-CA 123.432 2.754 . . . . 0.0 113.588 153.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.8 m -140.99 135.42 33.01 Favored 'Isoleucine or valine' 0 C--N 1.374 1.645 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -101.89 141.44 34.73 Favored 'General case' 0 CA--C 1.566 1.585 0 O-C-N 120.335 -1.478 . . . . 0.0 108.62 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.78 126.71 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 123.428 1.585 . . . . 0.0 110.39 -176.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.5 mt -97.48 -76.41 0.52 Allowed 'General case' 0 C--N 1.365 1.282 0 CA-C-O 116.56 -1.686 . . . . 0.0 109.975 -172.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.43 148.75 36.62 Favored 'General case' 0 N--CA 1.416 -2.14 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.99 135.24 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 125.902 2.001 . . . . 0.0 110.34 160.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -84.56 168.75 15.1 Favored 'General case' 0 C--N 1.369 1.414 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -67.57 -38.45 84.1 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-O 117.592 -1.194 . . . . 0.0 112.788 -170.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -76.53 -7.66 55.61 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 131.64 1.99 4.52 Favored Glycine 0 CA--C 1.496 -1.15 0 CA-C-O 117.219 -1.878 . . . . 0.0 116.998 165.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.82 147.73 22.61 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 120.652 2.226 . . . . 0.0 113.965 -171.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 24.4 mt -100.0 141.39 17.17 Favored 'Isoleucine or valine' 0 C--N 1.376 1.719 0 C-N-CA 117.323 -1.751 . . . . 0.0 110.614 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -113.55 132.17 55.81 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.734 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.8 mt -124.55 165.39 17.91 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -165.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.0 t -136.69 135.31 38.1 Favored 'General case' 0 N--CA 1.524 3.253 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.624 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mm -88.32 -42.29 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 125.971 2.045 . . . . 0.0 109.441 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -64.65 -32.37 74.01 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 119.632 -1.917 . . . . 0.0 116.036 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -87.9 -3.48 58.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.416 -1.428 . . . . 0.0 110.79 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.266 . . -98.92 17.08 20.44 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.49 1.56 0 C-N-CA 124.775 1.23 . . . . 0.0 110.438 168.888 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.1 mt . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -113.99 131.29 56.39 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.72 1.263 . . . . 0.0 107.902 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.6 m -110.06 107.85 17.85 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.112 1.434 . . . . 0.0 110.507 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.7 126.06 74.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 113.758 -1.565 . . . . 0.0 111.224 -169.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -95.51 129.27 42.74 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 pt -127.87 162.81 33.01 Favored 'Isoleucine or valine' 0 C--N 1.381 1.966 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.995 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -45.87 116.48 3.37 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.954 1.701 . . . . 0.0 113.625 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -66.84 8.29 0.35 Allowed 'Trans proline' 0 N--CA 1.51 2.498 0 O-C-N 116.87 -2.226 . . . . 0.0 114.547 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.25 -15.39 35.97 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 120.29 1.405 . . . . 0.0 111.51 169.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -119.42 22.06 11.89 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 125.832 1.958 . . . . 0.0 114.902 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 mt -70.81 -40.11 76.29 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 C-N-CA 124.069 0.948 . . . . 0.0 109.884 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -58.2 -39.75 79.79 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 126.771 2.028 . . . . 0.0 115.976 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.76 -35.19 62.58 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.007 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.0 t -71.04 -41.08 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 123.271 1.51 . . . . 0.0 111.659 170.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.13 -55.82 19.86 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.951 0 CA-C-O 116.389 -1.767 . . . . 0.0 111.181 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.54 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 88.78 -177.9 45.16 Favored Glycine 0 C--O 1.205 -1.708 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 -172.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -77.79 122.75 25.83 Favored 'General case' 0 CA--C 1.557 1.23 0 O-C-N 119.033 -2.451 . . . . 0.0 110.293 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.94 22.41 64.6 Favored Glycine 1 N--CA 1.521 4.361 0 C-N-CA 118.159 -1.972 . . . . 0.0 112.513 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.97 5.7 70.45 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-O 116.625 -2.209 . . . . 0.0 114.308 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -55.64 -46.81 77.4 Favored 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -174.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.54 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 73.1 t -67.12 -44.22 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -69.61 -34.48 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 O-C-N 118.934 -2.354 . . . . 0.0 110.796 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -49.12 -53.87 18.78 Favored 'General case' 0 C--N 1.381 1.973 0 O-C-N 126.07 2.106 . . . . 0.0 113.755 165.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.68 -36.8 85.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.876 1.36 . . . . 0.0 114.152 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.3 tp -61.2 -47.05 87.9 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.872 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -71.19 -25.09 62.37 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.62 -46.16 55.44 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 117.933 -1.507 . . . . 0.0 113.301 166.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.58 -32.32 64.07 Favored 'General case' 0 C--O 1.255 1.354 0 O-C-N 125.145 1.528 . . . . 0.0 108.709 -167.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.2 p -82.84 -21.16 34.49 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 120.201 -1.562 . . . . 0.0 112.877 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.03 34.58 87.26 Favored Glycine 0 C--N 1.381 3.075 0 C-N-CA 129.222 3.296 . . . . 0.0 112.182 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 t -146.98 157.95 43.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 119.696 -2.061 . . . . 0.0 108.572 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.2 m -74.12 128.76 36.37 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 124.325 1.016 . . . . 0.0 112.611 -172.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.5 mt -136.13 137.69 48.16 Favored 'Isoleucine or valine' 0 C--N 1.365 1.254 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -170.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -136.89 150.01 47.99 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.987 1.715 . . . . 0.0 109.336 -169.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.2 tt -141.94 155.16 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 118.82 -1.152 . . . . 0.0 112.417 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -127.17 155.27 43.65 Favored 'General case' 0 C--N 1.362 1.137 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.636 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -86.83 20.4 2.61 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -115.57 13.86 16.44 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.32 5.99 89.11 Favored Glycine 0 C--N 1.36 1.893 0 C-N-CA 119.081 -1.533 . . . . 0.0 110.385 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.4 m -88.09 114.63 24.9 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 119.963 -1.904 . . . . 0.0 108.964 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -115.71 138.33 46.49 Favored 'Isoleucine or valine' 0 C--N 1.365 1.249 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -123.79 131.56 53.62 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 112.731 -2.032 . . . . 0.0 111.58 -169.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.39 106.96 19.7 Favored 'Isoleucine or valine' 0 C--N 1.371 1.513 0 O-C-N 125.408 1.693 . . . . 0.0 109.801 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.39 121.93 33.54 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-N 112.806 -1.997 . . . . 0.0 105.977 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.04 151.87 28.92 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -165.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -123.94 -10.12 7.71 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.075 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -120.25 123.7 43.86 Favored 'General case' 0 C--N 1.377 1.762 0 CA-C-N 119.305 0.957 . . . . 0.0 110.42 171.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.28 -36.56 53.06 Favored Glycine 0 C--N 1.361 1.92 0 CA-C-O 122.629 1.127 . . . . 0.0 114.308 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.526 ' CD ' ' HZ3' ' A' ' 66' ' ' LYS . 64.7 mm-40 -67.31 -40.73 86.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 117.243 -1.36 . . . . 0.0 112.686 177.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -68.09 -42.18 80.75 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.523 1.056 . . . . 0.0 112.115 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.61 84.94 Favored 'General case' 0 C--N 1.358 0.965 0 O-C-N 125.571 1.795 . . . . 0.0 112.869 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HZ3' ' CD ' ' A' ' 63' ' ' GLU . 8.2 mtmp? -62.76 -42.67 99.79 Favored 'General case' 0 C--O 1.261 1.678 0 O-C-N 125.179 1.55 . . . . 0.0 113.082 173.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . 0.287 12.1 t-80 -63.29 -37.64 88.05 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 126.61 2.444 . . . . 0.0 115.138 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.58 -43.39 80.68 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.865 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.318 61.4 mt -60.32 -41.74 88.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.312 0 CA-C-N 119.113 0.87 . . . . 0.0 109.683 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? -61.2 -46.02 92.17 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 117.522 -1.228 . . . . 0.0 112.825 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -59.58 -43.07 93.78 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 127.836 2.454 . . . . 0.0 110.131 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.06 -44.9 99.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -62.26 -40.05 94.92 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.06 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -54.56 -56.02 23.3 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 123.013 1.387 . . . . 0.0 113.698 173.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.257 76.9 mt -63.95 -45.16 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 112.299 -2.228 . . . . 0.0 109.776 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 N--CA 1.49 1.554 0 CA-C-N 120.619 1.554 . . . . 0.0 114.752 -176.121 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mm . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -115.03 154.86 28.06 Favored 'General case' 0 C--O 1.249 1.053 0 O-C-N 119.631 -1.918 . . . . 0.0 108.965 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.07 143.7 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.85 0 O-C-N 119.097 -2.252 . . . . 0.0 113.51 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.05 85.6 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 120.986 -1.071 . . . . 0.0 113.569 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -111.58 152.37 27.66 Favored 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 123.387 0.675 . . . . 0.0 110.804 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.58 140.09 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 126.554 2.409 . . . . 0.0 109.675 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -129.4 159.94 34.65 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 125.187 2.423 . . . . 0.0 106.657 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.5 109.86 21.98 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 118.64 -2.537 . . . . 0.0 109.319 174.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.44 166.08 18.33 Favored Glycine 0 C--N 1.368 2.348 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -169.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -120.28 149.08 42.87 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-N 112.231 -1.984 . . . . 0.0 113.544 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.18 127.71 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 124.109 1.909 . . . . 0.0 112.024 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 p -97.48 -30.2 13.03 Favored 'General case' 0 CA--C 1.48 -1.712 0 CA-C-O 116.268 -1.825 . . . . 0.0 114.218 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -171.0 151.27 3.24 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.8 mt -123.98 140.28 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 O-C-N 121.444 -0.785 . . . . 0.0 109.456 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.4 m -142.51 172.02 9.21 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.242 0 C-N-CA 126.366 1.866 . . . . 0.0 112.797 -173.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.16 -35.53 81.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 118.356 -2.715 . . . . 0.0 113.811 -165.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -109.81 18.34 20.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 125.385 1.678 . . . . 0.0 113.207 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.56 -161.81 32.47 Favored Glycine 0 CA--C 1.549 2.174 0 N-CA-C 117.711 1.845 . . . . 0.0 117.711 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.19 142.86 26.6 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 120.913 -1.345 . . . . 0.0 110.441 -173.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -99.37 134.76 41.76 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.827 1.775 . . . . 0.0 109.039 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.2 t -136.03 123.26 33.95 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.245 0 CA-C-N 112.434 -2.166 . . . . 0.0 110.497 -171.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.39 147.78 22.79 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 125.559 1.787 . . . . 0.0 113.236 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 pt -145.35 164.95 11.51 Favored 'Isoleucine or valine' 0 C--N 1.362 1.143 0 O-C-N 126.022 2.076 . . . . 0.0 110.125 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.88 141.33 1.49 Allowed Glycine 0 CA--C 1.541 1.718 0 N-CA-C 121.521 3.368 . . . . 0.0 121.521 176.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.13 24.68 51.31 Favored Glycine 0 CA--C 1.496 -1.138 0 CA-C-O 116.682 -2.177 . . . . 0.0 115.979 -174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.47 42.85 99.19 Favored Glycine 0 CA--C 1.562 2.976 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -121.76 148.93 44.01 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 120.148 -1.796 . . . . 0.0 113.325 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -130.34 119.65 23.1 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 124.103 1.906 . . . . 0.0 107.45 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.39 171.67 22.41 Favored Glycine 0 N--CA 1.408 -3.177 0 C-N-CA 125.692 1.615 . . . . 0.0 110.125 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 tp -116.08 136.56 52.91 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 115.29 -2.29 . . . . 0.0 109.709 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -101.76 115.08 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.159 2.254 . . . . 0.0 109.14 167.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -62.66 149.54 43.25 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.269 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.0 tt -56.46 -38.89 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -175.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . 0.301 71.4 m -73.81 -10.13 59.36 Favored 'General case' 0 CA--C 1.486 -1.511 0 C-N-CA 124.387 1.075 . . . . 0.0 111.208 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -117.2 18.76 14.43 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.663 1.185 . . . . 0.0 113.213 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.2 mt -81.9 -53.79 11.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 125.347 1.459 . . . . 0.0 111.521 167.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.46 166.95 27.59 Favored 'General case' 0 C--O 1.198 -1.624 0 O-C-N 123.574 0.546 . . . . 0.0 111.617 -171.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -69.53 -43.66 72.57 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.371 163.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -48.14 145.84 2.96 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 162.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -66.58 131.57 46.31 Favored 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.956 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.6 t -110.29 102.98 14.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 170.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.56 -43.08 19.21 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 124.757 1.286 . . . . 0.0 108.876 161.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -133.31 148.06 51.89 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.006 -1.684 . . . . 0.0 108.727 170.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.35 -33.06 52.55 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 126.539 1.936 . . . . 0.0 115.152 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.2 p -62.59 -9.03 7.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 116.409 -1.758 . . . . 0.0 115.69 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -69.1 -41.99 76.7 Favored 'General case' 0 C--N 1.372 1.578 0 CA-C-N 123.691 2.951 . . . . 0.0 110.648 168.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -109.97 -34.03 6.54 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -164.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.48 142.83 39.95 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -168.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -126.51 150.35 48.82 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -55.34 136.29 49.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 125.807 1.942 . . . . 0.0 114.236 168.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.49 3.44 88.79 Favored Glycine 0 C--N 1.381 3.07 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.396 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -79.99 122.96 27.37 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.46 107.2 1.3 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 128.373 3.545 . . . . 0.0 114.069 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.4 148.01 43.05 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 111.382 -2.644 . . . . 0.0 105.582 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -90.57 134.1 1.89 Allowed 'Trans proline' 1 C--N 1.255 -4.364 0 N-CA-C 104.648 -2.866 . . . . 0.0 104.648 170.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.74 137.27 39.5 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.939 0 C-N-CA 118.119 -1.432 . . . . 0.0 109.537 -172.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -113.61 135.02 54.37 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 122.863 1.316 . . . . 0.0 108.39 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.8 t -80.17 121.55 33.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 113.265 -1.789 . . . . 0.0 108.977 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 43.4 mt -104.98 -6.8 19.74 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.483 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -168.48 144.66 3.72 Favored 'General case' 0 N--CA 1.533 3.678 0 O-C-N 119.792 -1.817 . . . . 0.0 114.659 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.282 7.2 t -127.09 103.56 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 126.444 2.34 . . . . 0.0 106.041 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.46 166.05 24.16 Favored 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 -177.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -71.56 -7.61 48.75 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -107.96 14.83 24.94 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.727 1.611 . . . . 0.0 108.808 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.89 31.34 75.35 Favored Glycine 0 N--CA 1.414 -2.786 0 O-C-N 120.663 -1.273 . . . . 0.0 115.582 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . 0.252 58.3 mtm180 -80.74 117.63 21.58 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 124.027 1.87 . . . . 0.0 109.892 168.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 64.6 mt -101.94 121.2 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 O-C-N 118.582 -2.574 . . . . 0.0 107.955 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -109.76 106.14 15.65 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.832 1.777 . . . . 0.0 114.344 -175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.3 150.03 24.14 Favored 'General case' 0 C--N 1.389 2.284 0 CA-C-O 127.979 3.752 . . . . 0.0 110.861 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.3 t -119.51 129.1 54.54 Favored 'General case' 0 C--O 1.288 3.113 0 CA-C-N 110.158 -3.201 . . . . 0.0 110.734 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.41 -30.27 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 O-C-N 119.189 -2.194 . . . . 0.0 105.631 167.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -62.24 -46.92 86.71 Favored 'General case' 0 CA--C 1.553 1.075 0 O-C-N 120.537 -1.352 . . . . 0.0 114.136 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -69.63 -24.39 63.63 Favored 'General case' 0 C--O 1.264 1.837 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 171.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.11 -35.82 56.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 124.927 1.392 . . . . 0.0 111.414 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 CA--C 1.56 1.342 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 173.775 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.1 mm . . . . . 0 N--CA 1.5 2.032 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -113.87 151.48 32.1 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 102.959 -2.978 . . . . 0.0 102.959 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 p -148.29 151.81 36.04 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-O 124.819 2.247 . . . . 0.0 112.67 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.1 pt -145.87 155.58 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 O-C-N 118.669 -2.519 . . . . 0.0 105.243 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -107.21 119.75 40.25 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 121.464 -0.772 . . . . 0.0 110.217 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.05 141.66 30.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.761 0 C-N-CA 126.124 1.77 . . . . 0.0 108.815 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -73.02 146.01 86.91 Favored Pre-proline 0 C--O 1.213 -0.819 0 CA-C-O 115.33 -2.271 . . . . 0.0 113.555 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -67.2 -19.58 50.48 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 124.25 1.658 . . . . 0.0 113.251 -160.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -57.74 -44.41 86.05 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 119.871 -1.768 . . . . 0.0 111.652 166.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -92.87 -18.28 23.01 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.241 -1.537 . . . . 0.0 109.237 -167.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mm -59.74 -34.78 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.776 1.298 . . . . 0.0 108.688 165.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -61.8 -43.37 98.99 Favored 'General case' 0 CA--C 1.579 2.082 0 O-C-N 120.94 -1.1 . . . . 0.0 112.21 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -68.74 -31.0 69.74 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 114.05 -2.881 . . . . 0.0 112.262 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.28 -42.47 78.83 Favored 'Isoleucine or valine' 0 C--N 1.381 1.968 0 O-C-N 127.709 3.131 . . . . 0.0 108.843 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.8 -48.29 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 124.176 1.941 . . . . 0.0 111.296 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.99 -176.58 49.26 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 111.4 -2.636 . . . . 0.0 114.71 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -70.11 142.03 52.64 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 116.911 -1.915 . . . . 0.0 110.532 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.01 23.21 45.48 Favored Glycine 0 N--CA 1.511 3.641 0 O-C-N 120.263 -1.523 . . . . 0.0 114.702 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 52.8 43.27 60.33 Favored Glycine 0 CA--C 1.477 -2.305 0 C-N-CA 126.389 1.947 . . . . 0.0 114.689 -168.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.6 p -97.95 -33.84 11.06 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 117.446 -1.702 . . . . 0.0 114.618 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -65.66 -36.19 77.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 O-C-N 120.499 -1.376 . . . . 0.0 112.528 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.54 -42.05 94.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 O-C-N 119.487 -2.008 . . . . 0.0 114.097 167.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -62.71 -37.27 85.86 Favored 'General case' 0 CA--C 1.583 2.244 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.8 -48.15 69.88 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 117.056 -1.449 . . . . 0.0 111.186 170.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -55.62 -42.56 75.1 Favored 'General case' 0 C--N 1.37 1.458 0 C-N-CA 124.52 1.128 . . . . 0.0 108.579 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.9 m -61.86 -47.69 83.88 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 114.607 -1.178 . . . . 0.0 112.163 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -61.28 -45.81 92.95 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.772 -2.013 . . . . 0.0 112.283 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.97 -53.2 42.04 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-O 114.655 -2.593 . . . . 0.0 114.001 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.1 p -69.19 -22.93 63.86 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 125.857 1.973 . . . . 0.0 113.336 -170.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.03 13.18 53.82 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-O 114.841 -3.199 . . . . 0.0 117.548 -176.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.98 161.66 34.17 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.693 2.247 . . . . 0.0 108.714 -162.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.3 m -66.3 123.71 20.69 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 176.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.8 mm -118.15 134.65 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -140.48 167.54 21.92 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 123.344 1.545 . . . . 0.0 108.421 170.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.6 mm -113.29 130.64 66.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 104.235 -2.505 . . . . 0.0 104.235 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -118.77 163.91 16.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -45.37 160.62 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.308 79.3 m-20 69.37 32.14 3.61 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 123.515 1.626 . . . . 0.0 114.841 170.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.7 53.75 24.37 Favored Glycine 0 C--O 1.281 3.064 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.1 m -102.63 132.89 48.44 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 125.898 1.587 . . . . 0.0 110.989 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -94.94 134.44 32.3 Favored 'Isoleucine or valine' 0 C--N 1.37 1.47 0 O-C-N 119.046 -2.284 . . . . 0.0 108.305 158.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -107.78 130.36 54.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.05 124.87 69.18 Favored 'Isoleucine or valine' 0 C--N 1.372 1.555 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 167.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.55 114.93 27.83 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.88 140.91 22.94 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 123.298 1.523 . . . . 0.0 113.636 -164.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 p -110.47 4.58 20.62 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 126.61 1.964 . . . . 0.0 111.953 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -126.2 139.33 53.43 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 169.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.32 -27.73 24.48 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 125.605 1.574 . . . . 0.0 113.577 -174.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -62.02 -39.64 92.97 Favored 'General case' 0 C--O 1.248 0.976 0 O-C-N 121.316 -1.108 . . . . 0.0 113.423 168.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -65.97 -37.36 85.77 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 118.483 0.583 . . . . 0.0 112.308 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.41 89.37 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 123.469 1.604 . . . . 0.0 114.224 173.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -67.33 -42.91 82.81 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 115.179 -2.343 . . . . 0.0 113.035 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -62.61 -40.79 98.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 126.456 2.348 . . . . 0.0 111.577 169.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.64 -48.45 69.38 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.89 -37.36 71.62 Favored 'Isoleucine or valine' 0 C--N 1.368 1.397 0 O-C-N 125.399 1.687 . . . . 0.0 109.271 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.306 27.5 tpt180 -67.82 -41.86 82.42 Favored 'General case' 0 C--N 1.375 1.709 0 O-C-N 124.726 1.266 . . . . 0.0 114.413 172.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -62.41 -39.3 92.85 Favored 'General case' 0 C--O 1.253 1.274 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.132 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mm -55.43 -31.98 28.71 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 CA-C-O 117.331 -1.319 . . . . 0.0 108.668 176.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -72.82 -29.33 63.16 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 116.956 -1.898 . . . . 0.0 109.142 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.79 -40.57 79.57 Favored 'General case' 0 C--O 1.26 1.651 0 O-C-N 120.437 -1.415 . . . . 0.0 109.121 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.39 -38.33 32.05 Favored 'Isoleucine or valine' 0 C--O 1.264 1.862 0 O-C-N 127.338 2.899 . . . . 0.0 117.191 165.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.481 1.103 0 O-C-N 117.879 -3.013 . . . . 0.0 115.998 179.092 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 C--O 1.195 -1.794 0 CA-C-O 126.023 2.82 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -87.09 134.42 33.51 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.313 -167.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.46 129.07 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 CA-C-O 123.629 1.681 . . . . 0.0 112.568 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.43 16.87 79.92 Favored Glycine 0 N--CA 1.513 3.769 0 C-N-CA 126.698 2.094 . . . . 0.0 117.967 165.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -120.16 161.43 21.05 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.42 113.14 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 112.417 -2.174 . . . . 0.0 109.441 -164.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -94.7 163.01 13.54 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 113.188 -1.823 . . . . 0.0 113.662 169.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 m -104.85 127.48 52.69 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 116.944 -3.598 . . . . 0.0 104.007 163.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.66 -164.88 11.93 Favored Glycine 0 CA--C 1.493 -1.318 0 C-N-CA 126.978 2.228 . . . . 0.0 108.149 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -149.38 151.73 34.57 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-O 116.854 -1.546 . . . . 0.0 109.915 172.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.88 109.59 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 126.855 2.062 . . . . 0.0 111.864 -177.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -94.19 -55.71 3.1 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.91 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.7 mtm-85 -131.81 123.46 27.64 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -98.65 128.97 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 CA-C-O 123.481 1.61 . . . . 0.0 107.087 176.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.71 174.49 9.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 O-C-N 120.476 -1.39 . . . . 0.0 110.059 -169.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.68 -25.53 64.82 Favored 'General case' 0 C--N 1.377 1.767 0 O-C-N 117.835 -3.041 . . . . 0.0 116.054 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -125.51 14.32 8.19 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-O 117.571 -1.204 . . . . 0.0 112.637 -172.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.42 -159.14 30.72 Favored Glycine 0 C--O 1.193 -2.448 0 CA-C-N 120.647 1.567 . . . . 0.0 110.661 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.96 155.58 46.21 Favored 'General case' 0 CA--C 1.477 -1.838 0 O-C-N 124.759 0.917 . . . . 0.0 109.282 158.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -87.43 147.01 25.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.896 0.855 . . . . 0.0 109.894 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 t -136.97 130.85 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.62 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.269 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.47 139.47 38.03 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-O 125.14 2.4 . . . . 0.0 106.04 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.3 mt -119.86 137.57 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 111.539 -2.573 . . . . 0.0 111.955 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.84 129.26 1.5 Allowed Glycine 0 N--CA 1.503 3.143 0 N-CA-C 120.95 3.14 . . . . 0.0 120.95 172.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.08 18.23 29.82 Favored Glycine 0 C--N 1.364 2.112 0 C-N-CA 124.459 1.028 . . . . 0.0 114.343 -163.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.1 27.73 73.6 Favored Glycine 0 CA--C 1.54 1.64 0 O-C-N 125.871 1.571 . . . . 0.0 113.971 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -100.0 149.57 23.33 Favored 'General case' 0 C--N 1.369 1.448 0 CA-C-N 119.534 1.667 . . . . 0.0 112.178 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -146.48 141.35 26.99 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 123.119 1.438 . . . . 0.0 114.353 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.63 166.46 18.36 Favored Glycine 0 CA--C 1.495 -1.202 0 O-C-N 120.348 -1.47 . . . . 0.0 110.05 -174.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.22 130.71 50.52 Favored 'General case' 0 N--CA 1.518 2.934 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.385 173.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.58 109.61 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 163.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -70.03 150.59 46.47 Favored 'General case' 0 C--O 1.2 -1.551 0 CA-C-N 113.815 -1.539 . . . . 0.0 114.409 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.432 8.6 tt -49.47 -21.79 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 118.711 2.856 . . . . 0.0 118.711 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.7 p -106.32 14.45 27.4 Favored 'General case' 0 C--N 1.389 2.287 0 CA-C-O 117.781 -1.104 . . . . 0.0 110.855 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -124.41 22.44 8.45 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 124.867 1.354 . . . . 0.0 111.597 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.7 mt -99.08 -39.35 7.79 Favored 'Isoleucine or valine' 0 C--N 1.377 1.784 0 CA-C-N 123.075 2.67 . . . . 0.0 110.24 175.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -159.39 149.79 19.23 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 117.285 -1.766 . . . . 0.0 113.58 -170.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.29 -26.44 60.19 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 118.92 -2.363 . . . . 0.0 108.523 163.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -57.42 151.56 16.16 Favored 'General case' 0 N--CA 1.405 -2.691 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 162.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -66.65 142.2 57.53 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.653 1.216 . . . . 0.0 108.464 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.6 t -128.34 137.24 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.888 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -107.7 -75.19 0.64 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -114.39 155.37 26.42 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 173.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.25 -26.32 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 122.019 2.19 . . . . 0.0 114.257 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.3 p -65.01 -20.29 66.42 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.931 1.292 . . . . 0.0 112.979 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -102.97 31.91 3.97 Favored 'General case' 0 C--O 1.256 1.404 0 O-C-N 126.492 2.37 . . . . 0.0 107.517 -172.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -153.36 -55.98 0.12 Allowed 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.7 157.17 16.2 Favored 'General case' 0 C--N 1.375 1.706 0 C-N-CA 125.016 1.326 . . . . 0.0 111.447 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -117.39 148.18 41.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 127.137 2.773 . . . . 0.0 105.93 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -70.18 143.27 52.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 124.047 1.88 . . . . 0.0 110.084 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.6 -17.9 22.68 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 112.158 -2.292 . . . . 0.0 115.786 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -58.99 143.76 47.26 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 124.999 1.32 . . . . 0.0 111.562 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -111.24 99.4 8.23 Favored 'General case' 0 N--CA 1.513 2.679 0 CA-C-O 123.875 1.798 . . . . 0.0 113.461 -165.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.4 p -109.04 134.33 20.43 Favored Pre-proline 0 N--CA 1.399 -2.994 0 CA-C-N 113.215 -1.811 . . . . 0.0 108.369 -160.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -58.66 140.07 93.34 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.127 1.067 . . . . 0.0 112.957 160.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.6 p -149.16 130.27 4.9 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 123.668 1.699 . . . . 0.0 111.667 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -94.39 131.5 39.99 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 112.746 -2.025 . . . . 0.0 111.118 172.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.45 132.12 33.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 126.714 3.15 . . . . 0.0 111.382 170.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 mt -100.14 -51.61 3.62 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 117.728 -3.108 . . . . 0.0 114.866 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 146' ' ' ARG . 41.3 mt-10 -139.05 142.64 38.2 Favored 'General case' 0 N--CA 1.41 -2.457 0 O-C-N 125.435 1.709 . . . . 0.0 107.416 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.46 126.25 75.04 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 163.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -91.07 156.56 17.82 Favored 'General case' 0 CA--C 1.553 1.058 0 O-C-N 125.428 1.705 . . . . 0.0 108.36 167.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -70.94 -23.49 62.25 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -92.78 26.89 2.55 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-O 123.05 1.405 . . . . 0.0 111.94 168.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.73 8.43 82.79 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 122.723 3.849 . . . . 0.0 122.723 161.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -85.09 144.9 27.94 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.265 -0.468 . . . . 0.0 110.951 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.89 132.25 68.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.435 HH21 ' CD ' ' A' ' 138' ' ' GLU . 1.3 mpp_? -103.61 133.94 47.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.023 162.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.8 mt -121.96 152.33 39.81 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 112.269 -2.241 . . . . 0.0 108.607 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.8 t -125.34 123.88 40.35 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 126.044 1.738 . . . . 0.0 110.649 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 69.4 mt -86.83 -31.0 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 117.507 -1.235 . . . . 0.0 109.981 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -60.46 -49.93 75.58 Favored 'General case' 0 C--O 1.276 2.49 0 C-N-CA 129.359 3.064 . . . . 0.0 117.518 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -88.07 -7.11 57.48 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 118.749 -1.18 . . . . 0.0 112.14 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.63 -37.04 81.92 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 124.153 0.981 . . . . 0.0 112.76 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 p . . . . . 0 N--CA 1.441 -0.883 0 C-N-CA 124.245 1.018 . . . . 0.0 109.209 171.513 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -80.16 111.04 16.14 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 127.17 2.793 . . . . 0.0 114.622 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.6 p -109.92 139.98 44.4 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 127.123 2.169 . . . . 0.0 106.996 -170.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.8 tt -132.3 128.57 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -110.84 128.55 55.82 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.92 154.25 39.62 Favored 'Isoleucine or valine' 0 C--N 1.365 1.253 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.39 -162.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -58.08 148.75 59.81 Favored Pre-proline 0 C--O 1.211 -0.945 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.45 -31.25 51.89 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 N-CA-C 116.232 1.589 . . . . 0.0 116.232 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -64.83 -40.78 95.73 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 169.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -57.46 -28.28 63.21 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.6 mt -57.63 -36.89 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -65.86 -18.59 65.44 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 127.617 2.367 . . . . 0.0 115.94 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -93.02 -20.34 20.66 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.679 167.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -91.27 -22.89 6.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.231 0 O-C-N 118.243 -2.786 . . . . 0.0 114.05 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.3 mt -92.05 -55.33 6.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 119.419 -2.051 . . . . 0.0 109.642 166.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.25 173.5 48.53 Favored Glycine 0 C--N 1.375 2.703 0 O-C-N 127.551 3.032 . . . . 0.0 115.75 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -66.05 120.89 13.96 Favored 'General case' 0 CA--C 1.581 2.136 0 CA-C-O 124.239 1.971 . . . . 0.0 110.916 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.68 9.69 46.29 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 120.28 -1.512 . . . . 0.0 112.751 -172.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.43 22.57 75.39 Favored Glycine 0 C--O 1.196 -2.228 0 O-C-N 120.89 -1.359 . . . . 0.0 112.257 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 t -61.09 -41.81 97.34 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 125.042 1.337 . . . . 0.0 114.502 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.64 -44.79 59.73 Favored 'Isoleucine or valine' 0 C--O 1.258 1.541 0 CA-C-N 120.65 1.568 . . . . 0.0 113.396 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 tt -60.79 -41.14 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 119.804 -1.81 . . . . 0.0 110.437 174.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -59.9 -49.17 78.74 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 123.556 1.646 . . . . 0.0 112.843 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.56 94.15 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 124.023 1.868 . . . . 0.0 112.57 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.0 tp -56.5 -37.0 69.79 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.504 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.7 m -57.74 -60.14 4.15 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-O 115.556 -2.164 . . . . 0.0 116.239 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.63 -40.6 92.53 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 126.815 2.572 . . . . 0.0 114.336 174.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -60.65 -47.7 85.08 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 124.889 2.28 . . . . 0.0 112.223 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.3 p -88.24 -24.65 23.19 Favored 'General case' 0 C--O 1.21 -0.991 0 O-C-N 118.98 -2.325 . . . . 0.0 109.436 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.25 38.74 94.03 Favored Glycine 0 N--CA 1.484 1.855 0 C-N-CA 118.915 -1.612 . . . . 0.0 116.95 -166.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.6 p -139.85 176.89 8.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 119.94 1.87 . . . . 0.0 108.156 -172.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -118.11 121.44 40.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.811 -1.806 . . . . 0.0 107.937 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.5 126.12 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 119.782 1.174 . . . . 0.0 108.818 -170.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -123.58 147.59 47.17 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.0 mt -127.75 115.6 40.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.182 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -77.1 167.55 21.59 Favored 'General case' 0 N--CA 1.525 3.307 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -76.42 -19.38 58.15 Favored 'General case' 0 C--N 1.378 1.835 0 C-N-CA 122.749 0.42 . . . . 0.0 111.018 -170.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.31 -12.89 51.25 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.297 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.51 17.29 34.14 Favored Glycine 0 N--CA 1.475 1.257 0 CA-C-O 116.496 -2.28 . . . . 0.0 116.917 -167.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -78.82 122.22 25.78 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 120.862 2.331 . . . . 0.0 108.815 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.3 t -94.67 126.81 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 169.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -108.13 126.07 52.33 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.0 mt -115.67 113.83 44.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.933 0 CA-C-N 121.366 1.894 . . . . 0.0 113.978 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.42 137.42 32.38 Favored 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 119.661 -1.9 . . . . 0.0 108.17 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.66 141.6 45.03 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.817 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -68.39 -36.92 79.86 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.594 1.088 . . . . 0.0 108.707 170.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -119.76 129.85 54.68 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 124.401 2.048 . . . . 0.0 107.67 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.88 -29.93 71.77 Favored Glycine 0 N--CA 1.475 1.296 0 O-C-N 118.992 -2.317 . . . . 0.0 116.242 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -67.49 -28.54 67.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.358 2.079 . . . . 0.0 111.371 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.23 -37.99 84.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 124.456 1.098 . . . . 0.0 110.919 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.26 79.67 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 120.131 -1.606 . . . . 0.0 112.509 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -63.82 -45.24 90.52 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.797 174.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -63.58 -38.88 92.82 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 124.938 1.399 . . . . 0.0 112.919 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.49 82.53 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.4 mt -52.72 -43.94 45.78 Favored 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 124.234 1.014 . . . . 0.0 110.474 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -60.23 -46.29 90.29 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -61.34 -37.22 82.51 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.101 1.319 . . . . 0.0 112.111 174.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.54 -41.69 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 121.299 -0.876 . . . . 0.0 112.536 175.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -62.04 -41.97 98.68 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 164.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.13 -39.46 86.62 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.46 -46.69 82.26 Favored 'Isoleucine or valine' 0 C--N 1.371 1.541 0 C-N-CA 125.735 1.614 . . . . 0.0 110.227 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.474 0.728 0 CA-C-N 121.739 2.063 . . . . 0.0 113.073 -168.671 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.0 mm . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 119.49 -0.291 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -104.21 121.98 44.42 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.79 129.3 23.28 Favored 'Isoleucine or valine' 0 C--N 1.369 1.427 0 O-C-N 119.676 -1.89 . . . . 0.0 111.239 158.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.73 1.46 63.63 Favored Glycine 0 CA--C 1.482 -2.009 0 C-N-CA 118.676 -1.726 . . . . 0.0 111.273 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -92.54 146.89 23.32 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.449 1.119 . . . . 0.0 111.038 167.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.64 135.5 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -125.25 159.3 31.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.564 1.946 . . . . 0.0 108.491 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.64 113.68 27.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 120.738 -1.226 . . . . 0.0 108.363 169.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.75 169.09 16.74 Favored Glycine 0 CA--C 1.47 -2.727 0 C-N-CA 118.447 -1.835 . . . . 0.0 114.099 -174.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -121.1 153.05 37.96 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.932 1.866 . . . . 0.0 107.922 -175.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 81.4 t -63.68 130.79 28.92 Favored 'Isoleucine or valine' 0 C--N 1.365 1.252 0 C-N-CA 123.849 0.86 . . . . 0.0 110.572 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.4 p -100.24 -11.98 19.92 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 165.92 159.85 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 126.591 1.956 . . . . 0.0 107.176 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.417 HD12 HG22 ' A' ' 123' ' ' THR . 55.1 mt -121.55 146.66 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 O-C-N 120.64 -1.288 . . . . 0.0 109.915 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.32 178.3 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.271 0 O-C-N 117.938 -2.976 . . . . 0.0 108.612 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -65.56 -44.45 86.75 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -78.52 0.2 27.03 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 115.13 -2.367 . . . . 0.0 112.263 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.4 -155.32 26.06 Favored Glycine 0 CA--C 1.553 2.421 0 O-C-N 124.826 1.329 . . . . 0.0 115.716 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.97 155.9 47.15 Favored 'General case' 0 CA--C 1.587 2.375 0 CA-C-N 121.873 2.837 . . . . 0.0 110.549 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -86.29 129.67 34.77 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 124.159 1.933 . . . . 0.0 113.257 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.6 t -127.59 122.64 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-N 112.711 -2.041 . . . . 0.0 113.881 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.01 111.82 23.04 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.468 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.6 pt -102.91 148.5 8.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 125.903 2.763 . . . . 0.0 105.221 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -51.54 138.42 28.74 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 112.487 -2.142 . . . . 0.0 113.137 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.64 15.41 13.54 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 119.343 1.572 . . . . 0.0 110.546 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.21 21.4 65.14 Favored Glycine 0 C--N 1.303 -1.266 0 CA-C-N 120.707 2.253 . . . . 0.0 117.573 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -125.34 120.22 30.53 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -89.57 133.85 34.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 124.004 1.859 . . . . 0.0 109.09 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.54 -177.68 18.98 Favored Glycine 0 C--N 1.308 -1.009 0 O-C-N 120.88 -1.137 . . . . 0.0 110.7 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.3 tp -137.39 115.37 11.53 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 110.124 -3.038 . . . . 0.0 108.176 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.1 105.15 17.13 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 O-C-N 125.714 1.884 . . . . 0.0 108.592 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . 0.288 34.8 m80 -59.31 157.82 10.26 Favored 'General case' 0 C--O 1.191 -2.013 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 171.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.9 tp -62.23 -30.67 49.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.1 p -82.44 -18.76 40.66 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 127.831 2.452 . . . . 0.0 111.773 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -100.57 -2.62 32.42 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 124.889 1.368 . . . . 0.0 109.836 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.0 mt -73.8 -38.85 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.467 0 O-C-N 119.292 -2.13 . . . . 0.0 114.101 165.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.77 148.01 23.6 Favored 'General case' 0 N--CA 1.483 1.202 1 O-C-N 114.243 -5.285 . . . . 0.0 107.14 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -69.39 -51.83 32.84 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.442 -173.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -87.99 9.72 21.37 Favored 'General case' 0 N--CA 1.521 3.109 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.358 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.278 10.5 mpt_? 70.51 113.73 0.05 Allowed 'General case' 0 C--O 1.193 -1.885 0 C-N-CA 126.715 2.006 . . . . 0.0 112.831 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 m -72.84 155.73 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 123.697 1.713 . . . . 0.0 114.0 168.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.95 -48.6 81.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.712 1.605 . . . . 0.0 113.032 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -159.62 152.26 21.43 Favored 'General case' 0 C--N 1.361 1.1 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 168.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.9 t -58.25 -41.45 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 C-N-CA 124.946 1.298 . . . . 0.0 112.52 -171.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.417 HG22 HD12 ' A' ' 92' ' ' ILE . 43.5 p -68.51 -20.56 64.58 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.301 -2.227 . . . . 0.0 115.957 178.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -90.02 0.73 56.95 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 119.258 -2.151 . . . . 0.0 114.089 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -120.01 -21.15 7.21 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 169.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.9 mt -105.2 150.15 25.33 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 119.219 -2.176 . . . . 0.0 112.943 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -135.51 145.36 46.99 Favored 'General case' 0 C--N 1.366 1.295 0 O-C-N 125.894 1.996 . . . . 0.0 108.507 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 73.9 mmm -85.62 143.85 28.2 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 125.59 1.806 . . . . 0.0 111.916 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.54 0.64 84.7 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-N 110.346 -3.115 . . . . 0.0 113.859 -170.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -101.13 143.42 31.25 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.478 -1.601 . . . . 0.0 109.805 -174.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -80.94 123.24 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 125.88 1.988 . . . . 0.0 113.5 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.61 125.52 51.23 Favored Pre-proline 0 C--N 1.367 1.358 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 170.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -62.72 123.15 11.82 Favored 'Trans proline' 0 C--N 1.29 -2.54 0 O-C-N 117.439 -1.927 . . . . 0.0 112.063 164.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.49 130.16 46.69 Favored 'Isoleucine or valine' 0 C--N 1.373 1.614 0 O-C-N 119.294 -2.129 . . . . 0.0 109.582 -173.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -95.16 144.27 25.91 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 117.215 -1.794 . . . . 0.0 110.935 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.7 t -83.97 130.95 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.417 0 C-N-CA 117.158 -1.817 . . . . 0.0 114.894 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.0 mt -101.68 -44.33 5.59 Favored 'General case' 0 C--N 1.37 1.491 0 C-N-CA 126.033 1.733 . . . . 0.0 114.066 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -154.11 138.6 16.81 Favored 'General case' 0 C--O 1.202 -1.427 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -174.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.3 t -92.72 137.8 21.49 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 CA-C-O 122.725 1.25 . . . . 0.0 108.959 167.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -128.27 142.25 51.21 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -103.04 -5.7 23.08 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.032 -171.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -122.14 -40.26 2.52 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 124.853 1.345 . . . . 0.0 112.872 169.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.26 -174.02 34.03 Favored Glycine 0 C--N 1.37 2.42 0 C-N-CA 128.677 3.037 . . . . 0.0 109.139 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 48.1 mmt-85 -88.72 158.77 18.08 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 112.638 -1.781 . . . . 0.0 108.122 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.7 mm -66.17 138.06 23.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 O-C-N 120.856 -1.152 . . . . 0.0 111.501 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.6 mmt-85 -94.13 131.93 39.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 117.045 -1.862 . . . . 0.0 107.001 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.7 mt -139.99 152.63 46.44 Favored 'General case' 0 C--N 1.381 1.963 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 30.4 t -121.7 120.74 35.57 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.412 1.085 . . . . 0.0 108.307 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.9 mt -80.2 -34.68 15.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 O-C-N 119.639 -1.913 . . . . 0.0 107.075 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -70.78 -20.68 62.58 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -172.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -92.14 4.65 52.73 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.142 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.17 -41.03 1.01 Allowed 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 125.02 1.328 . . . . 0.0 108.376 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.491 1.575 0 O-C-N 119.713 -1.867 . . . . 0.0 108.506 -176.549 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.0 mt . . . . . 0 C--O 1.21 -1.018 0 CA-C-O 122.97 1.366 . . . . 0.0 113.868 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -102.8 149.31 24.61 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 111.217 -2.72 . . . . 0.0 107.761 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -128.65 145.38 51.17 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 tt -127.51 142.4 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -110.99 114.58 27.99 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 120.307 -1.496 . . . . 0.0 108.627 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.518 HD12 ' H ' ' A' ' 21' ' ' ASN . 4.5 tp -142.25 151.8 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 O-C-N 120.854 -1.154 . . . . 0.0 111.54 -157.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.518 ' H ' HD12 ' A' ' 20' ' ' ILE . 92.9 m-20 -83.25 148.68 56.64 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 114.657 -2.592 . . . . 0.0 108.809 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . 0.275 50.5 Cg_exo -53.44 -48.21 23.16 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 N-CA-C 118.468 2.449 . . . . 0.0 118.468 -169.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.65 -10.34 45.13 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 122.162 2.256 . . . . 0.0 115.472 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -105.79 -1.11 24.71 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mt -69.18 -43.12 81.76 Favored 'Isoleucine or valine' 0 C--O 1.263 1.812 0 C-N-CA 118.45 -1.3 . . . . 0.0 111.234 162.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -57.53 -42.02 82.07 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 115.932 -1.985 . . . . 0.0 113.809 -172.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -50.89 -32.63 21.11 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 128.809 3.818 . . . . 0.0 113.368 170.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.49 -44.31 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 123.928 0.767 . . . . 0.0 111.466 174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.57 -6.75 6.88 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.351 0 O-C-N 120.892 -1.13 . . . . 0.0 110.663 171.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -15.84 132.16 0.01 OUTLIER Glycine 0 CA--C 1.537 1.414 1 N-CA-C 127.468 5.747 . . . . 0.0 127.468 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.3 mttm 59.14 44.77 15.42 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 124.113 1.911 . . . . 0.0 113.411 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.99 30.32 65.74 Favored Glycine 0 CA--C 1.554 2.472 0 O-C-N 117.96 -2.962 . . . . 0.0 112.397 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.7 -2.15 84.26 Favored Glycine 0 C--N 1.387 3.387 0 C-N-CA 128.414 2.912 . . . . 0.0 112.941 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.3 t -58.17 -38.51 76.8 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.339 -1.094 . . . . 0.0 111.404 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 t -66.7 -47.83 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 CA-C-O 116.692 -1.623 . . . . 0.0 110.313 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 mt -55.4 -51.68 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 116.741 -1.984 . . . . 0.0 111.719 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -58.82 -43.23 90.57 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.18 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.64 88.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.037 1.29 . . . . 0.0 114.151 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.9 tp -63.46 -44.27 94.96 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 125.238 1.586 . . . . 0.0 109.082 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.1 p -62.25 -43.3 99.14 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.16 -42.13 99.37 Favored 'General case' 0 N--CA 1.514 2.743 0 CA-C-N 121.581 1.992 . . . . 0.0 113.431 166.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . 0.281 32.2 tt0 -72.19 -48.15 45.33 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.532 0.682 . . . . 0.0 111.321 -170.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.0 p -78.55 -22.05 47.8 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 114.474 -2.679 . . . . 0.0 115.531 176.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 31.54 38.24 Favored Glycine 0 C--N 1.362 1.986 0 CA-C-N 121.199 1.818 . . . . 0.0 111.466 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 p -132.57 171.04 14.33 Favored 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 126.529 1.932 . . . . 0.0 111.291 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 m -127.94 135.91 50.61 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 101.023 -3.695 . . . . 0.0 101.023 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.2 mt -118.96 135.05 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.636 0 CA-C-N 120.379 1.445 . . . . 0.0 112.938 -171.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -129.7 133.57 47.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 118.89 -2.382 . . . . 0.0 109.779 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.67 131.58 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.106 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -134.38 155.84 49.57 Favored 'General case' 0 C--N 1.363 1.177 0 O-C-N 119.416 -2.052 . . . . 0.0 110.221 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -40.14 151.77 0.04 OUTLIER 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t0 65.63 19.42 11.45 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 127.251 2.844 . . . . 0.0 117.349 -172.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.4 46.77 11.6 Favored Glycine 0 N--CA 1.444 -0.77 0 O-C-N 117.33 -3.356 . . . . 0.0 107.857 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -104.47 111.38 24.02 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.614 -1.634 . . . . 0.0 106.912 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -96.24 118.73 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -108.4 126.46 52.9 Favored 'General case' 0 C--N 1.378 1.819 0 CA-C-O 122.87 1.319 . . . . 0.0 111.643 -167.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.7 mm -107.35 104.94 17.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.208 -175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.18 135.04 38.53 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.61 158.58 44.3 Favored 'General case' 0 CA--C 1.486 -1.502 0 O-C-N 118.752 -2.468 . . . . 0.0 109.598 163.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.6 m -65.29 -37.14 86.24 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 115.218 -2.325 . . . . 0.0 114.748 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -102.52 153.95 19.58 Favored 'General case' 0 C--N 1.28 -2.451 1 O-C-N 129.922 4.514 . . . . 0.0 109.986 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.84 -48.96 61.96 Favored Glycine 0 C--N 1.374 2.676 0 C-N-CA 124.838 1.209 . . . . 0.0 112.603 171.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -61.57 -42.04 98.26 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.384 1.088 . . . . 0.0 112.078 -175.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -57.44 -44.35 84.67 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 110.783 -2.917 . . . . 0.0 115.888 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.75 95.63 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 173.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -68.66 -33.71 74.47 Favored 'General case' 0 CA--C 1.585 2.291 0 CA-C-O 123.787 1.756 . . . . 0.0 114.05 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -66.61 -44.16 82.84 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.29 2.236 . . . . 0.0 112.452 167.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.55 92.88 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.519 169.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.5 mm -50.43 -42.5 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 167.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -73.53 -40.44 64.0 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 118.278 -0.867 . . . . 0.0 112.238 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -58.38 -44.13 88.76 Favored 'General case' 0 CA--C 1.579 2.094 0 CA-C-O 123.466 1.603 . . . . 0.0 114.393 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.7 mm -60.45 -48.51 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.083 0 C-N-CA 127.066 2.147 . . . . 0.0 114.679 168.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -57.16 -44.11 83.17 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 119.636 -1.915 . . . . 0.0 107.592 170.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -64.9 -39.52 93.66 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 121.056 1.753 . . . . 0.0 112.396 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.3 mt -62.4 -52.11 64.08 Favored 'Isoleucine or valine' 0 C--N 1.373 1.615 0 CA-C-O 117.014 -1.47 . . . . 0.0 112.999 168.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.9 p . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 123.367 1.556 . . . . 0.0 113.358 -170.339 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 N--CA 1.434 -1.251 0 CA-C-O 121.398 0.618 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -107.1 146.28 31.44 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.371 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.89 150.5 4.67 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.397 0 CA-C-O 124.188 1.946 . . . . 0.0 109.811 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.61 14.81 82.05 Favored Glycine 0 C--N 1.277 -2.702 0 CA-C-N 112.57 -2.104 . . . . 0.0 116.794 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -105.88 143.27 34.26 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 119.968 -1.901 . . . . 0.0 106.247 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.8 t -90.09 144.04 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 119.081 -1.048 . . . . 0.0 110.196 171.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -132.85 166.68 21.74 Favored 'General case' 0 C--N 1.404 2.97 0 O-C-N 125.915 2.009 . . . . 0.0 109.24 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 m -116.89 132.68 56.64 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.2 177.35 20.72 Favored Glycine 0 N--CA 1.419 -2.441 0 O-C-N 124.769 1.293 . . . . 0.0 111.725 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -118.46 136.29 53.88 Favored 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 123.79 1.757 . . . . 0.0 113.314 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.93 137.21 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.8 t -131.71 -18.34 2.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.871 1.357 . . . . 0.0 110.261 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 -142.18 150.86 41.59 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 172.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 mt -137.56 136.98 46.03 Favored 'Isoleucine or valine' 0 C--N 1.395 2.573 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.18 169.29 12.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 113.631 -1.622 . . . . 0.0 106.879 -162.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -54.13 -37.17 64.06 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -100.29 13.73 33.35 Favored 'General case' 0 N--CA 1.53 3.563 0 O-C-N 118.491 -2.63 . . . . 0.0 108.418 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 151.09 -159.34 28.13 Favored Glycine 0 C--O 1.183 -3.068 0 CA-C-N 123.445 2.839 . . . . 0.0 115.6 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.36 135.93 45.04 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -90.78 131.48 36.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.659 -1.275 . . . . 0.0 110.004 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 t -112.36 137.92 43.37 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.662 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.3 147.69 24.93 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 127.214 2.821 . . . . 0.0 105.592 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.7 pt -142.63 159.13 18.98 Favored 'Isoleucine or valine' 0 C--N 1.372 1.566 0 C-N-CA 125.715 1.606 . . . . 0.0 108.228 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.06 142.07 1.93 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 120.278 2.871 . . . . 0.0 120.278 -173.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.94 13.75 45.27 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 120.095 -1.826 . . . . 0.0 114.535 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.89 21.47 78.45 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 125.205 1.383 . . . . 0.0 110.943 -175.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -89.84 136.76 32.85 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.824 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -131.07 134.86 47.02 Favored 'General case' 0 C--N 1.361 1.1 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.31 161.68 24.7 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 125.304 1.43 . . . . 0.0 114.933 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.9 tp -95.4 125.26 39.9 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.817 -0.692 . . . . 0.0 111.657 -173.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.1 111.23 25.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 CA-C-O 115.674 -2.108 . . . . 0.0 105.663 164.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -60.73 153.8 23.25 Favored 'General case' 0 C--O 1.171 -3.049 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 171.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.6 tt -52.36 -31.6 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 119.737 -1.852 . . . . 0.0 114.536 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.0 p -83.38 -15.79 48.46 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -93.51 19.03 8.93 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.8 mt -92.14 -47.2 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-O 119.491 -0.29 . . . . 0.0 111.582 -173.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.5 162.63 38.67 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.081 0.952 . . . . 0.0 112.178 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.56 -37.78 87.67 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 125.032 2.349 . . . . 0.0 110.52 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -55.99 153.02 9.38 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 112.373 -2.194 . . . . 0.0 111.536 175.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -68.58 142.07 55.29 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 119.961 -1.712 . . . . 0.0 111.108 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.23 143.25 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.435 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -112.95 -38.13 4.61 Favored 'General case' 0 C--N 1.37 1.493 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -173.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -143.44 146.71 33.67 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 169.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.14 -16.45 16.78 Favored 'Isoleucine or valine' 0 C--N 1.366 1.292 0 CA-C-O 122.856 1.312 . . . . 0.0 111.191 -164.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.3 p -85.44 -4.17 59.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -60.7 -40.61 92.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.924 1.29 . . . . 0.0 109.56 167.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -108.67 -24.87 11.14 Favored 'General case' 0 CA--C 1.557 1.22 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -118.04 126.53 52.46 Favored 'General case' 0 N--CA 1.517 2.912 0 O-C-N 117.821 -3.049 . . . . 0.0 113.696 -167.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.59 166.85 11.9 Favored 'General case' 0 C--O 1.199 -1.556 0 C-N-CA 117.042 -1.863 . . . . 0.0 109.507 166.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -62.13 145.07 54.38 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-O 126.102 2.858 . . . . 0.0 114.969 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.55 -6.04 26.27 Favored Glycine 0 C--O 1.21 -1.404 0 CA-C-O 115.758 -2.69 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -68.42 137.85 54.84 Favored 'General case' 0 C--N 1.361 1.079 0 CA-C-N 120.513 2.156 . . . . 0.0 115.747 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -88.03 104.48 16.69 Favored 'General case' 0 C--O 1.259 1.555 0 CA-C-O 123.854 1.788 . . . . 0.0 111.608 -164.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 m -108.57 117.95 53.11 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.048 -173.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -58.04 130.46 38.23 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.055 1.17 . . . . 0.0 112.285 158.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.37 145.67 34.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -111.69 138.3 48.45 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 119.564 -1.96 . . . . 0.0 109.338 171.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.34 139.77 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 117.343 -3.348 . . . . 0.0 112.504 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.8 mt -106.62 -36.69 6.67 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 115.277 -2.297 . . . . 0.0 109.803 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -157.81 164.23 37.22 Favored 'General case' 0 CA--C 1.473 -1.996 0 O-C-N 126.41 2.318 . . . . 0.0 107.116 -166.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.313 7.2 p -168.16 97.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-O 125.205 2.431 . . . . 0.0 110.154 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -71.65 165.91 22.99 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 119.882 -1.761 . . . . 0.0 112.273 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -61.03 -25.56 67.0 Favored 'General case' 0 C--N 1.37 1.466 0 O-C-N 125.331 1.644 . . . . 0.0 115.094 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -94.31 3.4 55.26 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.437 1.711 . . . . 0.0 110.723 -169.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.96 3.46 56.94 Favored Glycine 0 CA--C 1.552 2.38 0 O-C-N 119.432 -2.043 . . . . 0.0 113.9 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -84.2 118.4 24.12 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.813 1.245 . . . . 0.0 108.404 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.8 mt -125.32 131.39 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.268 -1.52 . . . . 0.0 108.965 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -109.16 146.47 34.07 Favored 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 120.635 1.561 . . . . 0.0 107.121 173.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.8 mt -129.64 157.19 42.8 Favored 'General case' 0 C--O 1.269 2.124 0 C-N-CA 126.194 1.798 . . . . 0.0 113.436 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.9 t -132.01 111.71 11.74 Favored 'General case' 0 C--N 1.387 2.232 0 O-C-N 126.99 2.681 . . . . 0.0 110.226 166.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.17 -41.63 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 158.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -66.38 -31.57 72.43 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-N 121.97 2.168 . . . . 0.0 111.831 -170.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.94 -49.0 72.08 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 124.694 1.198 . . . . 0.0 112.307 168.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.33 -42.17 81.4 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 126.148 2.155 . . . . 0.0 109.822 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.259 27.5 p . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 122.016 0.913 . . . . 0.0 113.211 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 118.783 -0.627 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 65' ' ' ALA . 26.3 m-70 -129.28 135.58 48.95 Favored 'General case' 0 CA--C 1.492 -1.275 0 O-C-N 125.134 1.521 . . . . 0.0 109.127 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 p -116.17 153.92 30.96 Favored 'General case' 0 C--N 1.377 1.78 0 C-N-CA 118.646 -1.222 . . . . 0.0 113.824 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.3 148.48 31.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 166.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -116.87 130.33 56.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -174.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.5 tp -150.04 170.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 121.762 2.074 . . . . 0.0 113.838 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -64.13 125.67 88.61 Favored Pre-proline 0 CA--C 1.561 1.4 0 O-C-N 119.156 -2.215 . . . . 0.0 110.308 -172.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.92 -20.04 22.67 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 123.465 2.777 . . . . 0.0 116.865 -165.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.9 -45.14 86.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 127.413 2.946 . . . . 0.0 111.265 167.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -79.89 -4.39 52.1 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.581 1.181 . . . . 0.0 110.553 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.2 mm -84.33 -22.37 8.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -77.94 -28.69 49.65 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 122.702 2.501 . . . . 0.0 107.99 173.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -57.85 -41.24 81.97 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.66 162.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . 0.275 47.1 t -67.71 -38.75 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.594 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.06 -45.86 53.01 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.064 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.57 174.2 24.44 Favored Glycine 0 CA--C 1.556 2.612 0 O-C-N 126.096 2.122 . . . . 0.0 110.144 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -77.79 122.5 25.5 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 118.953 -2.499 . . . . 0.0 107.68 -165.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.94 19.36 75.25 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.125 -1.609 . . . . 0.0 110.529 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.8 16.91 66.83 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 117.348 1.699 . . . . 0.0 117.348 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.9 t -60.25 -42.95 96.38 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.9 t -80.78 -32.18 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 CA-C-N 121.031 1.741 . . . . 0.0 108.998 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tt -75.86 -31.09 21.82 Favored 'Isoleucine or valine' 0 C--N 1.374 1.65 0 CA-C-N 120.713 1.597 . . . . 0.0 110.741 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -59.68 -45.89 90.71 Favored 'General case' 0 CA--C 1.562 1.414 0 O-C-N 120.191 -1.568 . . . . 0.0 114.456 164.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.72 88.34 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 170.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 tp -61.06 -34.93 75.68 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.063 -1.881 . . . . 0.0 114.559 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.6 p -66.45 -42.97 86.84 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 122.641 2.473 . . . . 0.0 114.372 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -62.26 -46.38 89.07 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 127.411 2.944 . . . . 0.0 113.903 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -53.68 -46.2 70.59 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-O 117.207 -1.378 . . . . 0.0 114.27 174.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 p -88.62 -23.39 23.09 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 125.55 1.781 . . . . 0.0 114.607 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.36 27.71 54.49 Favored Glycine 0 CA--C 1.559 2.835 0 C-N-CA 125.41 1.481 . . . . 0.0 110.258 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.5 p -134.8 166.34 23.21 Favored 'General case' 0 C--N 1.373 1.626 0 CA-C-O 124.721 2.2 . . . . 0.0 108.955 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.5 m -102.01 126.13 48.86 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 111.613 -2.54 . . . . 0.0 106.565 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.4 mt -118.15 142.72 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.121 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 -171.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -145.08 139.62 27.5 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-O 123.572 1.653 . . . . 0.0 108.193 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.0 mm -101.36 139.2 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.175 -169.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -138.36 163.02 32.93 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 119.21 -2.181 . . . . 0.0 109.499 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.307 27.1 m-20 -55.44 142.09 34.05 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 112.897 -1.956 . . . . 0.0 114.954 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.277 31.9 t0 90.56 31.75 0.02 OUTLIER 'General case' 0 C--N 1.375 1.712 0 CA-C-N 110.322 -3.126 . . . . 0.0 111.177 172.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.95 46.66 90.92 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 125.754 1.645 . . . . 0.0 111.39 -169.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.1 m -103.37 121.32 42.54 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 119.777 1.788 . . . . 0.0 110.597 -171.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.28 122.05 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 123.261 1.505 . . . . 0.0 106.998 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.31 59.7 mtpt -106.95 139.38 41.44 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.266 44.1 mm -125.52 119.94 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.709 -1.244 . . . . 0.0 108.855 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.24 136.13 42.61 Favored 'General case' 0 CA--C 1.588 2.417 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.81 157.49 16.45 Favored 'General case' 0 C--N 1.398 2.695 0 C-N-CA 125.395 1.478 . . . . 0.0 110.794 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 m -92.31 -17.9 24.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 125.626 1.829 . . . . 0.0 112.793 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -123.36 141.41 52.01 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 120.131 -1.606 . . . . 0.0 110.307 -168.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.41 -48.58 81.17 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 112.637 -2.074 . . . . 0.0 114.012 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.4 -37.23 86.78 Favored 'General case' 0 CA--C 1.589 2.445 0 O-C-N 119.901 -1.94 . . . . 0.0 115.363 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -64.52 -41.64 96.26 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 120.522 -1.361 . . . . 0.0 109.174 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.43 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . . . -64.24 -35.89 82.3 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 117.574 -1.203 . . . . 0.0 112.955 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -73.98 -33.9 64.01 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -64.95 -45.29 86.34 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 126.398 2.311 . . . . 0.0 114.101 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.61 86.22 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.629 173.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.67 -51.21 75.44 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.531 0 CA-C-O 116.648 -1.644 . . . . 0.0 112.606 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -61.76 -34.96 76.79 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 116.047 -1.93 . . . . 0.0 112.609 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -65.81 -39.44 90.88 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 124.538 1.149 . . . . 0.0 111.486 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.97 -48.52 88.18 Favored 'Isoleucine or valine' 0 C--N 1.368 1.396 0 CA-C-N 120.482 1.492 . . . . 0.0 108.616 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -45.37 -57.43 4.05 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.547 1.939 . . . . 0.0 114.07 172.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -58.94 -48.06 82.83 Favored 'General case' 0 N--CA 1.513 2.711 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 173.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.9 mt -66.42 -35.03 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.505 2.323 0 C-N-CA 124.79 1.236 . . . . 0.0 111.955 177.726 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.945 0.403 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -101.83 146.74 27.39 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-O 123.054 1.407 . . . . 0.0 112.801 171.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.05 143.24 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 113.424 -1.716 . . . . 0.0 109.829 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.93 26.01 56.74 Favored Glycine 1 N--CA 1.526 4.685 1 O-C-N 115.749 -4.344 . . . . 0.0 116.344 175.524 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -119.1 150.14 40.52 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.61 -1.295 . . . . 0.0 112.536 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.49 126.9 54.0 Favored 'Isoleucine or valine' 0 C--O 1.255 1.367 0 CA-C-O 124.911 2.291 . . . . 0.0 113.102 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -126.95 160.92 29.6 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 109.908 -3.314 . . . . 0.0 104.989 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.9 m -119.6 139.92 51.4 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.06 -173.58 16.47 Favored Glycine 0 CA--C 1.576 3.844 0 CA-C-O 123.241 1.467 . . . . 0.0 112.416 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -128.91 138.48 52.03 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 123.109 1.433 . . . . 0.0 111.332 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.28 138.11 20.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 113.284 -1.78 . . . . 0.0 106.799 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.81 -28.97 3.45 Favored 'General case' 0 CA--C 1.478 -1.824 0 CA-C-O 114.951 -2.452 . . . . 0.0 106.842 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.5 mtm-85 -143.91 146.47 33.0 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 122.42 2.373 . . . . 0.0 108.589 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.28 138.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 CA-C-O 115.579 -2.153 . . . . 0.0 113.745 168.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.78 173.6 13.43 Favored 'Isoleucine or valine' 0 C--N 1.401 2.812 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.4 -18.21 65.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.257 24.6 p90 -103.16 0.8 32.29 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.498 0.719 . . . . 0.0 111.751 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.37 -172.52 31.57 Favored Glycine 0 C--N 1.357 1.72 0 C-N-CA 117.893 -2.098 . . . . 0.0 112.752 -162.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.55 132.81 35.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.281 93.5 m-85 -79.99 133.25 36.15 Favored 'General case' 0 C--N 1.371 1.532 0 O-C-N 126.893 2.621 . . . . 0.0 109.579 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.9 130.82 72.33 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 112.577 -2.102 . . . . 0.0 105.337 -171.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . 0.261 . . -96.05 124.56 40.11 Favored 'General case' 0 CA--C 1.578 2.029 0 CA-C-N 113.54 -1.664 . . . . 0.0 107.227 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.6 mt -112.37 144.73 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 126.334 1.854 . . . . 0.0 106.484 -176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -52.66 135.11 38.48 Favored Glycine 0 C--O 1.213 -1.194 0 CA-C-O 124.623 2.235 . . . . 0.0 116.125 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.16 4.73 56.41 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.357 1.932 . . . . 0.0 113.211 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.83 31.27 5.48 Favored Glycine 0 CA--C 1.473 -2.579 0 CA-C-O 117.054 -1.97 . . . . 0.0 112.795 171.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . 0.294 51.4 mmtt -120.52 118.25 29.75 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -165.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -105.04 135.69 45.91 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 125.002 2.334 . . . . 0.0 109.754 -170.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -139.77 166.68 25.56 Favored Glycine 0 C--O 1.215 -1.086 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.699 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . 0.276 14.6 tp -113.03 135.43 53.8 Favored 'General case' 0 N--CA 1.424 -1.725 0 C-N-CA 124.374 1.07 . . . . 0.0 108.217 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.0 t -102.99 115.98 45.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 162.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -67.66 165.69 16.62 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-O 124.582 2.134 . . . . 0.0 113.984 173.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.258 11.4 tt -61.29 -32.15 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-N 111.911 -2.404 . . . . 0.0 116.703 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.3 p -84.42 -5.66 59.3 Favored 'General case' 0 C--O 1.268 2.067 0 O-C-N 124.365 1.041 . . . . 0.0 112.427 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -106.97 14.74 26.12 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 116.62 2.082 . . . . 0.0 116.62 -168.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.0 mt -85.63 -48.51 16.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-O 116.179 -1.867 . . . . 0.0 114.07 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.2 165.18 28.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 126.587 2.43 . . . . 0.0 110.053 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.15 -33.64 76.24 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.132 166.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -74.45 148.63 40.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 123.242 1.496 . . . . 0.0 113.945 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -70.42 145.2 51.19 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.773 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 37.7 t -112.62 133.86 57.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 CA-C-O 124.169 1.938 . . . . 0.0 110.884 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.72 -42.17 9.74 Favored 'General case' 0 C--N 1.38 1.906 0 O-C-N 118.574 -2.579 . . . . 0.0 108.871 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -134.77 145.87 48.82 Favored 'General case' 0 N--CA 1.526 3.342 0 O-C-N 124.473 1.108 . . . . 0.0 110.043 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.23 -29.82 47.19 Favored 'Isoleucine or valine' 0 C--O 1.254 1.292 0 CA-C-O 122.776 1.274 . . . . 0.0 113.916 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.84 20.54 2.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -86.34 -15.33 40.86 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 121.109 1.777 . . . . 0.0 111.561 161.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -125.62 -79.48 0.6 Allowed 'General case' 0 C--O 1.208 -1.088 0 C-N-CA 126.701 2.0 . . . . 0.0 110.731 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.1 mt -70.57 152.37 44.02 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 121.692 2.042 . . . . 0.0 111.752 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -132.23 152.29 51.4 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 118.777 -2.452 . . . . 0.0 106.31 165.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 40.1 mtm -63.19 131.76 49.5 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.572 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.45 0.58 50.17 Favored Glycine 0 C--N 1.363 2.06 0 O-C-N 125.011 1.444 . . . . 0.0 114.211 -171.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -84.04 149.3 26.34 Favored 'General case' 0 C--O 1.2 -1.5 0 CA-C-O 123.729 1.728 . . . . 0.0 112.765 174.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -101.14 126.07 47.81 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.646 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.2 m -137.11 121.02 12.06 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.322 -168.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.2 140.46 30.9 Favored 'Trans proline' 0 CA--C 1.492 -1.578 0 N-CA-C 107.512 -1.765 . . . . 0.0 107.512 166.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.16 126.11 29.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -163.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -91.18 135.81 33.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 102.243 -3.243 . . . . 0.0 102.243 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.2 t -79.67 136.44 23.56 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 110.947 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.8 mt -113.81 -33.81 5.67 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.604 0.716 . . . . 0.0 111.251 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.45 ' CD ' HH21 ' A' ' 146' ' ' ARG 0.297 28.5 mt-10 -145.55 154.99 42.78 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 172.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.64 118.81 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.795 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -70.02 170.18 11.88 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 125.71 2.671 . . . . 0.0 114.058 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -66.23 -30.33 70.75 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 111.93 -2.395 . . . . 0.0 110.028 169.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -93.4 14.11 19.53 Favored 'General case' 0 C--N 1.364 1.221 0 CA-C-O 117.37 -1.3 . . . . 0.0 111.504 -176.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.65 53.14 25.7 Favored Glycine 0 C--N 1.358 1.777 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -133.76 135.11 43.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 127.698 2.646 . . . . 0.0 107.838 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.4 mt -124.11 134.88 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 O-C-N 124.956 1.41 . . . . 0.0 110.379 -162.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 138' ' ' GLU . 1.8 mpp_? -102.46 134.05 46.41 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 124.967 2.318 . . . . 0.0 107.931 170.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.3 mt -134.65 156.3 48.99 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 120.518 -1.364 . . . . 0.0 110.428 -163.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 26.1 t -135.29 118.91 17.02 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 124.288 1.035 . . . . 0.0 111.581 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . 0.262 95.3 mt -81.23 -24.25 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 CA-C-O 123.791 1.758 . . . . 0.0 108.092 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -86.69 -32.59 20.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.353 -171.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -43.6 71.35 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.56 -19.41 60.9 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.551 -1.259 . . . . 0.0 112.624 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 CA--C 1.567 1.629 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.456 168.239 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 123.954 1.835 . . . . 0.0 115.515 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.7 mm -111.39 133.62 56.39 Favored 'Isoleucine or valine' 0 C--N 1.367 1.329 0 O-C-N 118.578 -2.576 . . . . 0.0 109.794 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . 0.3 47.0 m-70 -121.75 165.12 16.3 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 112.28 -2.236 . . . . 0.0 106.542 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -149.05 162.78 39.25 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 124.501 3.319 . . . . 0.0 111.415 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.9 tt -128.27 146.23 34.11 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 1 N-CA-C 99.485 -4.265 . . . . 0.0 99.485 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HZ1' ' CG ' ' A' ' 52' ' ' ASP . 51.7 tttm -126.97 130.15 49.52 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.138 -1.601 . . . . 0.0 107.174 176.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 39.6 pt -139.51 170.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -161.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -81.61 140.71 47.93 Favored Pre-proline 0 C--O 1.192 -1.948 0 O-C-N 119.325 -2.109 . . . . 0.0 113.41 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -50.62 -26.64 17.45 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 123.198 2.599 . . . . 0.0 116.421 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -69.09 -25.81 64.61 Favored 'General case' 0 C--O 1.214 -0.78 0 O-C-N 119.909 -1.744 . . . . 0.0 113.636 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -82.16 -11.09 58.92 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.272 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.5 -35.5 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.566 0.698 . . . . 0.0 109.587 171.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -59.52 -36.63 76.47 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.83 -45.13 90.96 Favored 'General case' 0 C--N 1.355 0.804 0 C-N-CA 126.046 1.738 . . . . 0.0 111.904 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 t -66.07 -46.59 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 CA-C-O 115.562 -2.161 . . . . 0.0 114.579 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.6 mm -58.83 -38.36 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 123.65 2.932 . . . . 0.0 112.519 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.43 -127.06 8.16 Favored Glycine 0 CA--C 1.555 2.542 0 O-C-N 121.269 -0.895 . . . . 0.0 112.252 -172.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -104.69 95.54 5.96 Favored 'General case' 0 C--N 1.387 2.197 0 C-N-CA 128.417 2.687 . . . . 0.0 106.309 164.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.06 41.8 86.05 Favored Glycine 0 CA--C 1.479 -2.17 0 CA-C-O 114.708 -3.273 . . . . 0.0 116.152 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.53 12.2 57.32 Favored Glycine 0 N--CA 1.438 -1.224 0 O-C-N 127.648 2.617 . . . . 0.0 114.556 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.8 p -61.86 -52.25 64.88 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.86 -46.15 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 125.345 1.653 . . . . 0.0 113.111 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.3 mm -50.5 -47.06 27.45 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.385 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -56.61 -45.38 81.5 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.068 1.347 . . . . 0.0 110.816 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.72 73.34 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.069 -1.053 . . . . 0.0 113.439 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.48 -32.15 73.33 Favored 'General case' 0 C--O 1.199 -1.588 0 CA-C-O 117.457 -1.258 . . . . 0.0 112.783 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.8 m -66.3 -44.26 83.98 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 166.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -63.83 -45.61 88.79 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-O 121.611 0.72 . . . . 0.0 112.351 175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -64.55 -57.5 8.97 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.972 1.368 . . . . 0.0 110.435 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.5 p -79.53 -37.88 35.55 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.889 -167.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.9 22.48 57.69 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 123.792 1.773 . . . . 0.0 115.158 -170.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.8 p -109.58 165.36 11.72 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.472 -1.364 . . . . 0.0 110.204 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.1 m -106.11 132.52 52.09 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.56 124.03 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.859 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 -162.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -124.55 143.89 50.44 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.2 mt -118.37 143.85 28.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 125.915 2.009 . . . . 0.0 108.224 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -142.79 155.11 44.77 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.27 65.9 m-20 -48.27 167.88 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -169.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.407 ' CG ' ' HZ1' ' A' ' 19' ' ' LYS 0.291 27.2 t0 61.41 25.18 15.18 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 113.188 -1.824 . . . . 0.0 109.454 -177.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.25 23.42 58.93 Favored Glycine 0 C--N 1.375 2.718 0 C-N-CA 126.085 1.802 . . . . 0.0 117.009 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 22.6 m -84.3 131.04 34.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 126.953 2.208 . . . . 0.0 112.707 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.45 119.42 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -99.47 131.99 45.11 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.025 2.93 . . . . 0.0 104.378 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.38 115.6 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 0 CA-C-O 123.516 1.627 . . . . 0.0 106.841 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.43 130.95 49.36 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 111.226 -2.715 . . . . 0.0 108.854 -174.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.03 170.62 18.44 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.033 1.733 . . . . 0.0 106.388 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 t -109.19 -9.86 15.0 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.679 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -123.02 131.91 53.91 Favored 'General case' 0 C--O 1.199 -1.573 0 O-C-N 117.591 -3.193 . . . . 0.0 105.825 168.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.31 -44.82 10.69 Favored Glycine 0 N--CA 1.508 3.448 0 C-N-CA 128.276 2.846 . . . . 0.0 112.24 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.27 -39.64 76.08 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -65.31 -47.84 75.18 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.48 84.32 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 117.627 -1.629 . . . . 0.0 113.355 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -53.28 -47.63 68.99 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 170.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -64.75 -44.71 89.23 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 171.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.12 74.16 Favored 'General case' 0 C--O 1.255 1.385 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 172.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.4 mt -59.99 -43.64 92.9 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 CA-C-O 123.856 1.789 . . . . 0.0 111.714 173.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -63.08 -43.75 97.68 Favored 'General case' 0 N--CA 1.496 1.826 1 O-C-N 116.2 -4.063 . . . . 0.0 112.508 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -66.31 -41.05 90.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 117.58 -1.2 . . . . 0.0 112.773 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.4 mt -57.2 -44.92 84.4 Favored 'Isoleucine or valine' 0 C--N 1.379 1.851 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 164.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -56.23 -40.2 73.74 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.23 1.581 . . . . 0.0 113.535 170.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -71.43 -36.98 71.48 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 121.51 0.671 . . . . 0.0 112.779 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 mt -65.54 -23.45 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 119.06 -2.275 . . . . 0.0 114.727 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 p -103.75 7.16 37.18 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 124.978 2.323 . . . . 0.0 110.855 175.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.92 -0.13 25.36 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 118.617 -2.552 . . . . 0.0 112.287 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -64.06 130.76 45.28 Favored 'General case' 0 C--O 1.185 -2.341 0 O-C-N 125.124 1.515 . . . . 0.0 109.661 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.2 mm -82.61 124.98 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.0 154.8 44.16 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.86 147.81 8.25 Favored 'Isoleucine or valine' 0 C--N 1.386 2.168 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.09 2.57 89.0 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -93.4 136.1 34.0 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 118.248 1.024 . . . . 0.0 112.536 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.4 t -104.33 134.57 45.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -141.21 174.88 10.11 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 112.579 -2.101 . . . . 0.0 112.651 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -116.26 125.25 51.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.55 176.72 20.17 Favored Glycine 0 C--O 1.18 -3.28 0 CA-C-N 112.76 -2.018 . . . . 0.0 110.894 -168.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 23.5 ttmt -148.21 125.74 11.71 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 123.764 1.745 . . . . 0.0 111.478 -167.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.11 117.11 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 113.112 -1.858 . . . . 0.0 111.226 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -103.65 -36.82 7.76 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-O 118.321 -0.847 . . . . 0.0 113.133 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.0 mtm-85 -153.98 126.26 7.95 Favored 'General case' 0 C--O 1.199 -1.592 0 CA-C-O 123.039 1.399 . . . . 0.0 110.519 -168.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.2 115.85 50.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 C-N-CA 125.404 1.482 . . . . 0.0 108.74 -170.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.05 165.71 9.9 Favored 'Isoleucine or valine' 0 C--N 1.374 1.644 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -42.59 -36.87 1.5 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.034 1.734 . . . . 0.0 115.603 175.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -114.18 13.84 18.06 Favored 'General case' 0 CA--C 1.562 1.44 0 O-C-N 120.181 -1.574 . . . . 0.0 114.181 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.05 -179.45 41.25 Favored Glycine 0 CA--C 1.483 -1.921 0 C-N-CA 117.822 -2.132 . . . . 0.0 111.803 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.67 144.51 49.22 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 119.854 -1.968 . . . . 0.0 108.533 170.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -85.47 122.95 30.34 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.827 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.9 t -125.87 120.99 58.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 O-C-N 125.854 1.971 . . . . 0.0 106.521 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.59 139.39 30.59 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 126.25 2.219 . . . . 0.0 107.58 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . 0.274 16.8 pt -131.93 168.49 23.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 110.964 -2.834 . . . . 0.0 110.311 170.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.59 132.77 3.7 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 119.827 2.691 . . . . 0.0 119.827 -169.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.69 11.08 75.01 Favored Glycine 0 N--CA 1.506 3.334 0 CA-C-O 117.626 -1.652 . . . . 0.0 110.221 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.03 39.65 7.37 Favored Glycine 0 C--O 1.25 1.135 0 O-C-N 126.086 1.698 . . . . 0.0 110.181 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 57.2 mttm -98.4 99.33 10.51 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 120.996 -1.296 . . . . 0.0 113.262 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.46 88.8 7.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.021 -1.674 . . . . 0.0 111.354 -174.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.26 159.11 53.53 Favored Glycine 0 N--CA 1.494 2.535 0 CA-C-N 120.135 1.334 . . . . 0.0 114.219 167.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.7 tp -105.45 111.13 23.73 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 125.928 1.605 . . . . 0.0 108.101 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.55 116.25 27.9 Favored 'Isoleucine or valine' 0 C--N 1.372 1.555 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -66.48 159.96 26.06 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.499 0.666 . . . . 0.0 112.617 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 19.5 tt -61.07 -20.08 21.38 Favored 'Isoleucine or valine' 0 C--N 1.366 1.287 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.3 p -97.64 13.02 31.62 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.072 0.463 . . . . 0.0 110.917 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -133.18 26.46 4.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.952 0.901 . . . . 0.0 109.904 -172.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.6 mm -95.59 -55.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 O-C-N 126.579 2.424 . . . . 0.0 107.336 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.72 176.6 11.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 119.344 -2.098 . . . . 0.0 113.105 -168.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -76.4 -35.38 58.63 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 122.884 1.326 . . . . 0.0 110.37 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -61.68 151.4 33.78 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 124.236 1.97 . . . . 0.0 112.22 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -64.05 142.3 58.46 Favored 'General case' 0 C--O 1.205 -1.244 0 C-N-CA 126.949 2.1 . . . . 0.0 111.11 169.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.5 t -121.84 129.01 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.074 -1.016 . . . . 0.0 109.499 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.74 -36.13 11.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 123.612 1.672 . . . . 0.0 108.843 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -150.85 144.05 24.79 Favored 'General case' 0 CA--C 1.565 1.549 0 O-C-N 117.832 -3.043 . . . . 0.0 107.216 175.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.72 -27.23 9.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.476 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.1 p -55.92 -19.91 13.97 Favored 'General case' 0 C--N 1.383 2.037 0 C-N-CA 128.649 2.78 . . . . 0.0 115.163 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -80.51 -25.42 38.74 Favored 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 128.113 2.565 . . . . 0.0 112.205 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -107.14 -26.63 11.02 Favored 'General case' 0 C--N 1.369 1.428 0 CA-C-N 114.184 -1.371 . . . . 0.0 113.243 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.1 mt -134.27 140.13 46.21 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 123.342 1.544 . . . . 0.0 113.62 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -122.35 158.93 28.54 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 102.059 -3.312 . . . . 0.0 102.059 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . 0.311 0.8 OUTLIER -70.31 145.81 50.98 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 123.462 1.601 . . . . 0.0 113.838 171.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.96 -4.04 60.8 Favored Glycine 0 C--N 1.356 1.681 0 CA-C-N 111.896 -2.411 . . . . 0.0 115.428 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -94.67 142.35 27.56 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 123.377 1.561 . . . . 0.0 112.079 -169.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -86.46 134.52 33.68 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 119.871 -1.768 . . . . 0.0 107.477 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.71 148.12 65.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.69 137.22 6.57 Favored 'Trans proline' 0 C--N 1.28 -3.062 0 C-N-CA 122.118 1.878 . . . . 0.0 110.969 172.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.18 142.89 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 118.822 -2.424 . . . . 0.0 109.167 -169.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -112.33 134.89 53.62 Favored 'General case' 0 C--O 1.18 -2.568 0 C-N-CA 123.433 0.693 . . . . 0.0 110.198 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.61 140.65 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 124.221 1.963 . . . . 0.0 114.433 172.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.4 mt -106.34 -66.35 1.01 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 123.01 1.386 . . . . 0.0 110.097 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -128.59 147.97 50.75 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 120.341 -1.474 . . . . 0.0 109.382 -175.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.52 129.08 64.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-O 117.33 -1.319 . . . . 0.0 107.518 169.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -86.85 155.37 20.29 Favored 'General case' 0 C--N 1.371 1.512 0 O-C-N 126.068 2.105 . . . . 0.0 111.808 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -60.46 -39.98 89.52 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -57.61 -30.29 65.21 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 166.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.35 -7.11 9.86 Favored Glycine 0 N--CA 1.514 3.862 0 CA-C-N 122.376 2.353 . . . . 0.0 117.076 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -62.94 146.46 52.95 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 80.9 mt -133.2 135.98 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.28 -1.327 . . . . 0.0 114.158 -173.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.24 128.97 56.41 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 117.928 -1.509 . . . . 0.0 108.576 167.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.6 mt -114.03 168.3 9.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.194 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 28.8 t -137.8 127.0 24.48 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 112.312 -2.222 . . . . 0.0 113.167 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 95.6 mt -86.87 -32.97 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 CA-C-O 122.82 1.295 . . . . 0.0 109.823 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -70.54 -30.61 67.39 Favored 'General case' 0 C--O 1.252 1.206 0 C-N-CA 119.034 -1.066 . . . . 0.0 113.047 -164.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.31 -5.17 58.49 Favored 'General case' 0 C--N 1.381 1.968 0 CA-C-N 120.172 1.351 . . . . 0.0 110.222 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.2 -1.68 33.2 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.414 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.4 m -75.48 -32.91 60.74 Favored 'General case' 0 CA--C 1.568 1.667 0 C-N-CA 124.893 1.277 . . . . 0.0 113.576 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 50.94 45.9 27.01 Favored 'General case' 0 CA--C 1.579 2.068 0 O-C-N 128.132 3.395 . . . . 0.0 114.95 170.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 . . . . . 0 C--N 1.295 -1.798 0 O-C-N 118.615 -2.553 . . . . 0.0 111.932 173.508 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.57 136.22 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.1 -1.0 . . . . 0.0 108.442 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -116.15 147.81 40.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 128.556 3.66 . . . . 0.0 114.385 164.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -128.48 130.33 47.37 Favored 'General case' 0 C--N 1.366 1.32 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.8 mm -133.66 133.02 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -166.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -98.67 137.48 37.24 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.493 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.5 pt -144.45 162.87 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 117.078 -1.439 . . . . 0.0 107.86 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -65.25 130.4 94.74 Favored Pre-proline 0 CA--C 1.597 2.766 0 O-C-N 125.281 1.613 . . . . 0.0 111.051 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -78.47 -7.83 15.96 Favored 'Trans proline' 0 N--CA 1.512 2.604 1 C-N-CA 125.885 4.39 . . . . 0.0 111.113 -172.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -83.53 5.26 24.69 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.173 -1.579 . . . . 0.0 109.021 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -131.61 5.11 4.3 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 115.487 -2.196 . . . . 0.0 111.191 -170.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.5 mt -61.79 -45.25 99.09 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 CA-C-O 117.34 -1.314 . . . . 0.0 110.126 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.03 -26.04 9.89 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.892 1.37 . . . . 0.0 114.35 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -90.12 -21.61 22.17 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -168.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.5 t -80.19 -26.61 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 125.218 1.574 . . . . 0.0 109.978 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.8 mt -81.62 -65.02 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 112.917 -3.421 . . . . 0.0 105.691 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.68 166.83 40.93 Favored Glycine 0 C--N 1.371 2.511 0 CA-C-N 123.949 3.068 . . . . 0.0 113.683 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -49.25 113.91 0.91 Allowed 'General case' 0 C--N 1.382 1.991 0 CA-C-O 122.94 1.352 . . . . 0.0 113.157 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.41 14.52 79.34 Favored Glycine 0 N--CA 1.505 3.241 0 O-C-N 118.998 -2.314 . . . . 0.0 113.624 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.8 28.54 73.73 Favored Glycine 0 C--O 1.259 1.667 0 CA-C-O 123.872 1.818 . . . . 0.0 113.698 -162.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 99.4 p -61.74 -44.42 96.94 Favored 'General case' 0 C--N 1.38 1.899 0 N-CA-C 118.305 2.706 . . . . 0.0 118.305 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.68 -39.96 85.01 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.231 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 tt -61.53 -44.63 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-N 119.844 1.202 . . . . 0.0 111.846 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -62.85 -41.71 99.47 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 171.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.37 -44.79 84.72 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 117.578 -3.201 . . . . 0.0 113.447 168.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.6 mt -63.63 -36.45 83.87 Favored 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 126.886 2.616 . . . . 0.0 112.136 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 m -58.48 -52.43 65.67 Favored 'General case' 0 CA--C 1.583 2.222 0 O-C-N 125.822 1.952 . . . . 0.0 114.024 169.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.23 -40.73 95.12 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 125.906 1.683 . . . . 0.0 108.75 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -69.7 -41.88 74.81 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.1 p -105.05 -29.91 10.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 117.714 -1.136 . . . . 0.0 114.06 -166.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.57 24.63 27.81 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 119.911 1.232 . . . . 0.0 112.802 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.5 p -121.3 167.83 12.31 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 124.52 0.776 . . . . 0.0 110.115 -168.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.5 m -125.96 119.05 26.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 119.696 -0.801 . . . . 0.0 109.681 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.4 mt -116.48 120.11 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 126.078 2.111 . . . . 0.0 107.964 -161.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -121.29 129.54 53.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.888 -1.96 . . . . 0.0 109.633 171.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 tt -124.56 150.38 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.783 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.0 157.41 41.78 Favored 'General case' 0 C--O 1.262 1.763 0 O-C-N 124.16 0.912 . . . . 0.0 109.746 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -81.92 2.34 31.01 Favored 'General case' 0 C--N 1.391 2.404 0 C-N-CA 124.748 1.219 . . . . 0.0 113.202 -157.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -94.88 6.93 47.6 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 126.32 2.962 . . . . 0.0 110.631 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.51 48.39 4.78 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 126.883 2.183 . . . . 0.0 112.493 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.2 m -128.22 134.67 49.04 Favored 'General case' 0 C--O 1.261 1.676 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.24 148.05 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 C-N-CA 116.955 -1.898 . . . . 0.0 111.595 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 128.96 56.61 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 121.155 -0.965 . . . . 0.0 109.0 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 mt -120.92 123.91 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 118.341 -2.724 . . . . 0.0 111.419 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.8 135.2 53.82 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -158.14 158.69 35.13 Favored 'General case' 0 CA--C 1.583 2.216 0 CA-C-N 113.403 -1.726 . . . . 0.0 109.253 -173.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.7 p -107.35 -0.9 22.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 119.593 -1.942 . . . . 0.0 114.713 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -145.19 163.64 33.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 171.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.31 -39.81 17.85 Favored Glycine 0 N--CA 1.489 2.228 0 O-C-N 118.566 -2.584 . . . . 0.0 113.486 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.304 84.2 mt-10 -61.47 -39.18 89.96 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 119.479 -2.189 . . . . 0.0 112.884 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.72 -43.02 90.02 Favored 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 119.162 0.892 . . . . 0.0 109.016 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.32 -36.88 82.38 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 123.205 1.478 . . . . 0.0 114.149 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -64.41 -39.42 93.81 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 120.625 -1.297 . . . . 0.0 112.393 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -60.63 -36.18 78.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 117.457 2.392 . . . . 0.0 117.457 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.0 -48.64 70.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.801 1.64 . . . . 0.0 113.205 163.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.39 -41.17 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 CA-C-N 119.842 1.201 . . . . 0.0 113.551 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -59.99 -42.45 94.26 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.672 1.589 . . . . 0.0 112.274 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.5 mmt85 -67.11 -43.66 81.91 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 118.437 -2.665 . . . . 0.0 111.195 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.77 -49.7 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.323 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -59.98 -38.27 82.05 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 119.423 1.01 . . . . 0.0 112.433 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -61.66 -56.92 14.55 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 125.805 1.941 . . . . 0.0 114.304 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.0 mt -58.58 -45.25 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 O-C-N 123.794 0.684 . . . . 0.0 110.488 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.6 p -80.09 -10.46 59.77 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 117.483 -1.687 . . . . 0.0 110.548 -168.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.62 72.79 Favored 'General case' 0 CA--C 1.589 2.449 0 O-C-N 124.41 1.069 . . . . 0.0 113.628 168.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -66.78 119.19 11.42 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.516 -168.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 mm -73.55 132.11 33.9 Favored 'Isoleucine or valine' 0 C--N 1.375 1.693 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -85.14 145.45 27.62 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-O 124.189 1.947 . . . . 0.0 115.762 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.81 132.23 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.333 1 CA-C-O 129.012 4.244 . . . . 0.0 114.493 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.48 17.08 64.95 Favored Glycine 0 C--O 1.245 0.842 0 CA-C-N 111.084 -2.78 . . . . 0.0 109.418 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -102.81 135.96 43.5 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 119.598 1.699 . . . . 0.0 109.376 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.96 115.49 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 116.627 -2.029 . . . . 0.0 107.435 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -99.34 163.99 12.3 Favored 'General case' 0 C--N 1.38 1.916 0 CA-C-N 119.668 1.122 . . . . 0.0 111.565 170.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.1 m -128.76 134.88 48.55 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.1 159.45 28.03 Favored Glycine 0 CA--C 1.486 -1.749 0 CA-C-O 116.251 -2.416 . . . . 0.0 112.722 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -71.25 132.8 45.47 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 120.753 2.277 . . . . 0.0 110.905 166.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -54.28 130.13 15.93 Favored 'Isoleucine or valine' 0 C--N 1.391 2.404 0 C-N-CA 126.801 2.041 . . . . 0.0 110.586 159.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.4 p -108.79 -38.96 5.49 Favored 'General case' 0 CA--C 1.499 -0.985 0 O-C-N 119.253 -2.154 . . . . 0.0 110.132 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mmt-85 -151.63 160.43 43.65 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 117.61 -1.636 . . . . 0.0 108.293 -169.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.8 mt -135.14 121.32 32.49 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.39 177.14 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 120.771 1.623 . . . . 0.0 108.56 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -63.46 -39.6 94.89 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.629 1.206 . . . . 0.0 110.237 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -93.2 6.43 48.06 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.39 -178.09 33.91 Favored Glycine 0 C--O 1.202 -1.894 0 CA-C-O 116.848 -2.085 . . . . 0.0 112.677 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.08 141.06 51.86 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-N 118.783 1.292 . . . . 0.0 111.001 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.415 ' CZ ' HD11 ' A' ' 108' ' ' LEU . 47.2 m-85 -87.99 130.76 34.86 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 124.594 1.184 . . . . 0.0 112.51 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.67 137.42 46.87 Favored 'Isoleucine or valine' 0 C--N 1.379 1.874 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.079 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.9 127.68 48.62 Favored 'General case' 0 C--O 1.189 -2.099 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.27 143.2 18.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.91 155.09 1.27 Allowed Glycine 0 CA--C 1.545 1.912 0 CA-C-O 124.01 1.894 . . . . 0.0 117.479 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.27 19.33 64.81 Favored Glycine 0 CA--C 1.573 3.682 0 O-C-N 119.238 -2.331 . . . . 0.0 115.223 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.6 35.56 81.22 Favored Glycine 0 N--CA 1.484 1.857 1 N-CA-C 123.204 4.042 . . . . 0.0 123.204 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -115.84 115.51 26.38 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -107.42 124.44 49.85 Favored 'General case' 0 N--CA 1.527 3.381 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.341 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.84 155.74 16.02 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 118.142 2.017 . . . . 0.0 118.142 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.415 HD11 ' CZ ' ' A' ' 98' ' ' PHE . 30.1 tp -96.31 120.28 36.32 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 113.486 -1.357 . . . . 0.0 109.718 -173.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.27 111.81 24.87 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 CA-C-O 118.365 -0.826 . . . . 0.0 109.224 157.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -66.98 156.45 35.94 Favored 'General case' 0 C--N 1.377 1.782 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.41 -30.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.967 0.907 . . . . 0.0 112.077 -169.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 65.0 p -80.46 -12.5 59.55 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -106.91 5.5 28.39 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -173.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.09 -50.85 23.23 Favored 'Isoleucine or valine' 0 C--N 1.393 2.467 0 CA-C-N 122.173 2.26 . . . . 0.0 107.889 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -126.74 158.51 36.3 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.276 49.1 p30 -64.51 -38.47 91.15 Favored 'General case' 0 C--N 1.391 2.398 0 O-C-N 118.97 -2.331 . . . . 0.0 113.713 161.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -85.6 141.12 30.05 Favored 'General case' 0 N--CA 1.415 -2.207 0 O-C-N 119.249 -2.157 . . . . 0.0 112.501 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -41.87 130.82 3.37 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-N 112.042 -2.344 . . . . 0.0 116.346 170.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 t -113.98 111.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 120.758 1.617 . . . . 0.0 107.275 -163.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.43 -46.38 66.91 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 116.181 -1.866 . . . . 0.0 107.596 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.4 ' HZ3' ' CG ' ' A' ' 124' ' ' ASP . 17.1 pttm -149.89 133.01 16.29 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 128.755 3.785 . . . . 0.0 109.473 -176.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.51 -20.22 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 O-C-N 119.846 -1.784 . . . . 0.0 110.872 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.8 p -56.6 -29.99 62.73 Favored 'General case' 0 C--N 1.377 1.776 0 C-N-CA 125.951 1.7 . . . . 0.0 110.286 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.4 ' CG ' ' HZ3' ' A' ' 121' ' ' LYS . 65.1 m-20 -65.11 -33.76 76.79 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 128.43 2.692 . . . . 0.0 111.76 177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -112.25 -30.77 7.08 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 72.8 mt -121.42 123.13 41.34 Favored 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -91.99 130.07 37.81 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-O 122.213 1.006 . . . . 0.0 112.003 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 21.0 mmt -61.05 111.1 1.56 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.2 16.32 64.98 Favored Glycine 0 CA--C 1.547 2.048 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.525 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -113.61 143.32 44.76 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 124.576 2.132 . . . . 0.0 112.821 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.52 146.12 49.72 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -171.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 p -144.17 142.92 20.74 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 166.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.79 136.76 68.41 Favored 'Trans proline' 0 C--N 1.284 -2.865 0 C-N-CA 121.876 1.717 . . . . 0.0 114.524 160.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.82 120.91 17.33 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.235 0 CA-C-O 124.331 2.015 . . . . 0.0 107.06 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -88.29 137.4 32.36 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 119.447 -2.033 . . . . 0.0 111.717 170.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.6 t -90.89 91.55 3.64 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.532 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.7 mt -53.75 -43.9 69.53 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 126.335 2.272 . . . . 0.0 113.601 171.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -165.1 156.26 14.53 Favored 'General case' 0 C--O 1.255 1.349 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.99 79.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 126.312 2.258 . . . . 0.0 104.993 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.532 0.5 OUTLIER -61.63 141.62 57.68 Favored 'General case' 0 CA--C 1.58 2.1 0 CA-C-N 114.161 -1.381 . . . . 0.0 110.935 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -84.96 -0.02 52.88 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-O 115.078 -2.392 . . . . 0.0 108.269 -167.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -90.68 14.27 13.84 Favored 'General case' 0 C--N 1.384 2.104 0 CA-C-N 121.123 1.783 . . . . 0.0 107.676 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.71 24.07 40.14 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 115.08 -3.066 . . . . 0.0 115.517 -173.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -120.33 114.18 21.47 Favored 'General case' 0 CA--C 1.593 2.619 0 CA-C-N 122.469 3.134 . . . . 0.0 110.659 -171.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.1 mt -102.92 125.9 57.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 CA-C-O 117.242 -1.361 . . . . 0.0 110.953 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -120.65 135.91 54.98 Favored 'General case' 0 C--N 1.368 1.409 0 O-C-N 128.583 3.677 . . . . 0.0 113.524 -171.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 51.2 mt -129.95 148.39 51.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 112.074 -2.33 . . . . 0.0 110.315 -164.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.2 t -113.82 123.79 50.66 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.4 -43.28 42.86 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 O-C-N 119.318 -2.114 . . . . 0.0 108.551 161.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -46.18 -61.36 1.8 Allowed 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 117.293 -1.336 . . . . 0.0 112.011 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -66.67 -27.56 67.76 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 122.372 2.351 . . . . 0.0 113.531 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.74 -7.11 59.56 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 118.77 -2.456 . . . . 0.0 112.802 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.9 p -109.79 5.04 22.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.913 1.383 . . . . 0.0 113.615 170.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.314 48.0 mt-10 71.93 36.88 1.1 Allowed 'General case' 0 C--O 1.254 1.338 0 CA-C-O 125.667 2.651 . . . . 0.0 111.428 166.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 . . . . . 0 N--CA 1.434 -1.237 0 CA-C-O 113.361 -3.209 . . . . 0.0 110.617 178.704 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.66 127.25 65.29 Favored 'Isoleucine or valine' 0 C--N 1.363 1.18 0 C-N-CA 125.571 1.548 . . . . 0.0 109.526 -176.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -121.84 164.41 17.55 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 116.68 -1.629 . . . . 0.0 108.415 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.5 t -153.9 159.22 41.67 Favored 'General case' 0 C--N 1.378 1.834 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 pt -161.9 155.18 3.1 Favored 'Isoleucine or valine' 0 C--N 1.369 1.421 0 C-N-CA 129.467 3.107 . . . . 0.0 103.647 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -121.57 122.25 39.26 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.454 -164.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.4 pt -127.14 142.53 43.26 Favored 'Isoleucine or valine' 0 C--N 1.387 2.215 0 C-N-CA 125.661 1.584 . . . . 0.0 111.1 -169.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -42.23 126.17 2.78 Favored Pre-proline 0 C--O 1.203 -1.389 0 C-N-CA 129.856 3.262 . . . . 0.0 114.556 175.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.57 -26.6 83.2 Favored 'Trans proline' 1 N--CA 1.54 4.214 0 N-CA-C 117.426 2.048 . . . . 0.0 117.426 -169.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.25 45.9 t0 -58.67 -38.28 77.85 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 129.71 3.204 . . . . 0.0 113.495 172.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -92.72 3.05 56.33 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.921 -1.112 . . . . 0.0 113.15 -168.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.77 -34.99 73.66 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 O-C-N 120.857 -1.152 . . . . 0.0 110.556 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -59.78 -34.81 73.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 117.336 -3.352 . . . . 0.0 114.718 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -86.5 -36.65 18.87 Favored 'General case' 0 C--N 1.38 1.933 0 O-C-N 125.76 1.913 . . . . 0.0 112.062 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.12 -37.91 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 CA-C-N 121.882 2.128 . . . . 0.0 113.512 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.0 mm -75.15 -47.37 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 C-N-CA 126.422 1.889 . . . . 0.0 112.585 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.72 -176.28 50.95 Favored Glycine 0 CA--C 1.484 -1.879 0 O-C-N 126.047 2.092 . . . . 0.0 113.566 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.297 42.2 mttp -58.11 111.71 1.28 Allowed 'General case' 0 C--N 1.36 1.057 0 CA-C-N 113.748 -1.226 . . . . 0.0 111.957 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.98 25.46 31.09 Favored Glycine 0 N--CA 1.488 2.16 0 O-C-N 127.064 2.727 . . . . 0.0 114.645 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.02 9.85 83.69 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.2 t -65.23 -39.98 93.44 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 119.069 1.435 . . . . 0.0 111.677 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.46 -45.54 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 O-C-N 126.295 2.247 . . . . 0.0 108.619 -170.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.5 tp -66.35 -28.93 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 CA-C-O 117.338 -1.315 . . . . 0.0 112.032 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -60.83 -46.82 89.04 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 120.913 1.688 . . . . 0.0 113.504 162.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.58 65.05 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 128.111 2.564 . . . . 0.0 111.045 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.18 -42.63 98.91 Favored 'General case' 0 C--N 1.374 1.644 0 O-C-N 123.752 0.658 . . . . 0.0 112.084 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 t -67.3 -43.37 81.88 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 115.817 -2.039 . . . . 0.0 114.279 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -59.61 -42.82 93.47 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 122.118 2.235 . . . . 0.0 110.913 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -73.0 -41.98 63.72 Favored 'General case' 0 C--O 1.254 1.331 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.462 HG22 ' CG ' ' A' ' 67' ' ' HIS . 44.2 p -80.53 -42.99 21.46 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 124.598 2.142 . . . . 0.0 109.711 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.76 37.27 11.97 Favored Glycine 0 C--O 1.239 0.445 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.56 145.61 35.31 Favored 'General case' 0 C--N 1.391 2.376 0 CA-C-O 116.973 -1.489 . . . . 0.0 108.864 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 m -93.52 130.28 39.44 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.35 128.14 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.23 133.25 40.64 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 10.7 mt -116.56 127.71 74.1 Favored 'Isoleucine or valine' 0 C--N 1.378 1.847 0 CA-C-O 123.67 1.7 . . . . 0.0 111.743 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -80.03 152.97 29.13 Favored 'General case' 0 C--O 1.188 -2.147 0 CA-C-O 115.345 -2.264 . . . . 0.0 115.525 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -74.17 19.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 115.051 -2.404 . . . . 0.0 115.016 -169.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -121.2 11.35 10.84 Favored 'General case' 0 C--N 1.371 1.533 0 CA-C-O 114.82 -2.514 . . . . 0.0 110.298 165.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.39 9.08 48.45 Favored Glycine 0 C--N 1.357 1.695 0 CA-C-N 121.131 1.787 . . . . 0.0 111.465 165.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -89.66 129.21 36.13 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-O 117.189 -1.386 . . . . 0.0 108.392 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.04 128.85 70.81 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.68 0 O-C-N 126.143 2.152 . . . . 0.0 105.728 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -110.5 134.23 52.56 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 126.691 1.997 . . . . 0.0 108.908 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.05 130.63 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.25 139.06 43.48 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 117.537 -1.22 . . . . 0.0 111.033 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.49 150.85 18.19 Favored 'General case' 0 C--N 1.364 1.235 0 CA-C-O 122.917 1.342 . . . . 0.0 110.916 -165.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.284 7.1 t -114.95 -45.61 2.96 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.566 160.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -76.63 140.63 41.06 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 123.867 3.031 . . . . 0.0 114.23 171.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.93 -29.98 24.53 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 113.851 -1.522 . . . . 0.0 114.927 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -66.59 -38.52 87.19 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 119.465 -2.197 . . . . 0.0 114.581 166.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -64.35 -30.66 71.7 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 116.989 -3.57 . . . . 0.0 112.939 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.48 -46.78 81.54 Favored 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 119.367 -0.933 . . . . 0.0 113.431 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -60.82 -41.23 95.3 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.24 2.216 . . . . 0.0 111.014 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.462 ' CG ' HG22 ' A' ' 43' ' ' THR . 3.2 t-160 -54.62 -51.14 66.31 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.168 -1.582 . . . . 0.0 111.826 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.51 91.04 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.913 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 61.3 mt -66.35 -43.46 91.37 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 CA-C-N 119.521 1.055 . . . . 0.0 110.894 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -74.33 -28.16 61.03 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -71.24 -37.3 72.01 Favored 'General case' 0 C--O 1.211 -0.951 0 O-C-N 120.416 -1.427 . . . . 0.0 112.728 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 mt -62.88 -38.69 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 121.433 1.924 . . . . 0.0 111.003 165.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.69 -45.52 82.53 Favored 'General case' 0 C--N 1.373 1.597 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -174.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -51.71 -51.79 53.32 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 167.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.02 -35.48 69.19 Favored 'Isoleucine or valine' 0 C--O 1.271 2.208 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.8 p -80.25 -16.51 54.55 Favored 'General case' 0 N--CA 1.516 2.844 0 CA-C-O 123.5 1.619 . . . . 0.0 111.25 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.64 -21.33 61.12 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -69.88 115.31 8.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.021 -1.675 . . . . 0.0 113.781 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.2 pt -72.3 149.8 8.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 CA-C-O 125.201 2.429 . . . . 0.0 113.084 -177.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -132.35 148.5 52.43 Favored 'General case' 0 C--N 1.366 1.301 0 O-C-N 118.447 -2.658 . . . . 0.0 110.607 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.03 144.52 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.402 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.3 13.78 58.18 Favored Glycine 0 C--N 1.381 3.045 0 N-CA-C 117.996 1.958 . . . . 0.0 117.996 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -135.27 157.89 45.77 Favored 'General case' 0 C--O 1.205 -1.289 0 O-C-N 118.462 -2.787 . . . . 0.0 108.2 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 24.8 t -107.93 146.48 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -136.66 167.68 20.94 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.2 m -105.85 123.38 47.86 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 120.305 1.411 . . . . 0.0 109.297 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.44 -164.18 19.98 Favored Glycine 0 C--N 1.366 2.235 0 CA-C-N 111.466 -2.606 . . . . 0.0 112.659 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -146.67 150.71 35.96 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 126.242 1.789 . . . . 0.0 107.518 164.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 78.3 t -77.55 112.97 16.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -86.09 -17.8 34.11 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 175.27 141.59 0.05 Allowed 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -169.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.8 mt -126.87 125.75 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.312 -169.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.14 177.69 2.21 Favored 'Isoleucine or valine' 0 C--N 1.364 1.216 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.785 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -58.06 -44.68 87.62 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.852 1.345 . . . . 0.0 112.92 -163.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -110.33 22.38 15.58 Favored 'General case' 0 CA--C 1.555 1.164 0 O-C-N 119.255 -2.153 . . . . 0.0 112.066 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.02 170.7 36.24 Favored Glycine 0 C--O 1.21 -1.377 0 C-N-CA 118.751 -1.69 . . . . 0.0 114.594 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.17 125.93 36.22 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -81.82 130.9 35.22 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.92 128.17 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -167.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 106' ' ' GLU . . . -100.84 125.57 47.37 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.545 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.8 mt -110.25 138.39 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -36.28 151.42 0.02 OUTLIER Glycine 0 C--N 1.37 2.423 0 N-CA-C 119.328 2.491 . . . . 0.0 119.328 -165.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.4 25.45 68.13 Favored Glycine 0 C--O 1.186 -2.905 0 CA-C-O 113.767 -3.796 . . . . 0.0 112.152 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.09 26.78 69.93 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 128.514 2.959 . . . . 0.0 116.955 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -92.8 93.44 8.43 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 31.6 tt0 -101.6 117.65 35.33 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -113.82 179.08 18.69 Favored Glycine 0 C--O 1.215 -1.039 0 O-C-N 126.998 2.686 . . . . 0.0 112.613 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.7 tp -120.41 125.51 48.13 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.659 -1.638 . . . . 0.0 109.891 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.3 t -95.01 111.46 25.67 Favored 'Isoleucine or valine' 0 C--N 1.371 1.523 0 O-C-N 124.857 1.348 . . . . 0.0 109.571 170.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -63.71 149.94 45.54 Favored 'General case' 0 C--O 1.208 -1.11 0 O-C-N 121.423 -0.798 . . . . 0.0 109.758 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -56.43 -8.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.425 0 C-N-CA 125.579 1.552 . . . . 0.0 115.022 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.4 p -101.92 2.92 38.55 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 125.119 1.368 . . . . 0.0 113.605 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -130.77 18.62 5.13 Favored 'General case' 0 C--O 1.257 1.472 0 CA-C-N 119.225 0.92 . . . . 0.0 111.798 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.75 -43.4 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-O 124.588 2.137 . . . . 0.0 109.976 170.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.68 163.62 33.42 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 119.931 -1.731 . . . . 0.0 109.477 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -72.17 -38.2 69.18 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 123.177 1.465 . . . . 0.0 112.756 168.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -80.48 145.55 31.82 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 125.958 1.703 . . . . 0.0 113.101 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -70.66 130.35 41.55 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.82 130.02 75.04 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -173.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -103.72 -24.58 13.33 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 120.612 -1.305 . . . . 0.0 110.931 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.39 139.48 31.7 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 125.555 1.784 . . . . 0.0 107.166 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -81.27 -22.7 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.775 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -165.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 p -63.02 -19.68 64.59 Favored 'General case' 0 C--N 1.374 1.673 0 O-C-N 119.492 -2.005 . . . . 0.0 115.462 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -59.39 -40.26 85.99 Favored 'General case' 0 C--O 1.192 -1.956 0 C-N-CA 125.25 1.42 . . . . 0.0 113.401 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.68 0.2 14.5 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 125.313 1.445 . . . . 0.0 111.143 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 9.4 mt -153.75 150.12 28.17 Favored 'General case' 0 C--N 1.376 1.731 0 O-C-N 119.032 -2.292 . . . . 0.0 110.05 -170.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -148.66 151.4 34.89 Favored 'General case' 0 C--N 1.38 1.895 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -63.13 142.38 58.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 125.664 2.649 . . . . 0.0 114.058 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.1 -4.24 86.18 Favored Glycine 0 CA--C 1.46 -3.354 0 C-N-CA 129.193 3.282 . . . . 0.0 116.659 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -65.6 127.77 33.25 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 127.147 3.356 . . . . 0.0 109.885 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -78.59 125.69 29.71 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 118.406 -2.684 . . . . 0.0 112.72 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.03 138.93 31.74 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.48 -168.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -72.86 124.07 9.4 Favored 'Trans proline' 0 CA--C 1.5 -1.202 0 C-N-CA 123.736 2.957 . . . . 0.0 107.119 158.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.27 131.97 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-N 113.013 -1.903 . . . . 0.0 107.206 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -90.35 134.34 34.39 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.406 -177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.6 t -76.47 110.8 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 118.403 -1.319 . . . . 0.0 110.556 170.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 mt -86.1 -56.01 3.66 Favored 'General case' 0 CA--C 1.468 -2.192 0 O-C-N 125.288 1.618 . . . . 0.0 114.535 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -146.21 158.21 43.87 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 125.267 1.604 . . . . 0.0 108.47 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 46.7 t -140.23 114.86 6.75 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.351 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 166.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -75.31 177.28 6.68 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 122.334 2.334 . . . . 0.0 109.828 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -67.28 -32.32 73.24 Favored 'General case' 0 C--N 1.371 1.531 0 C-N-CA 127.219 2.207 . . . . 0.0 110.913 -173.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -74.29 -30.92 62.31 Favored 'General case' 0 C--O 1.213 -0.84 0 C-N-CA 125.433 1.493 . . . . 0.0 111.426 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.3 18.98 4.8 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 115.684 -2.731 . . . . 0.0 112.404 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -80.17 127.66 32.6 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 119.45 1.625 . . . . 0.0 108.109 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 68.6 mt -104.91 118.37 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -162.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -111.59 131.03 55.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 125.136 2.398 . . . . 0.0 106.456 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.4 mt -129.96 177.15 7.49 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.416 -163.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 16.7 t -154.14 147.91 25.4 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.351 -1.468 . . . . 0.0 107.083 177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.3 mt -102.83 -31.98 3.04 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.803 0 O-C-N 119.709 -1.87 . . . . 0.0 107.295 164.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -52.78 -53.83 42.65 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.729 1.212 . . . . 0.0 111.365 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.56 -18.29 58.76 Favored 'General case' 0 C--N 1.364 1.215 0 C-N-CA 125.087 1.355 . . . . 0.0 112.024 -172.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.95 99.68 Favored 'General case' 0 C--O 1.258 1.513 0 C-N-CA 123.756 0.822 . . . . 0.0 110.895 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 80.6 p -96.44 2.28 52.42 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 64.02 48.52 3.02 Favored 'General case' 0 CA--C 1.615 3.47 0 CA-C-O 124.305 2.003 . . . . 0.0 112.013 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 . . . . . 0 C--O 1.253 1.28 0 O-C-N 116.803 -3.686 . . . . 0.0 108.274 168.585 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 . . . . . 0 C--O 1.225 -0.209 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 mm -105.61 120.13 55.91 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 CA-C-O 123.452 1.596 . . . . 0.0 113.614 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -109.03 121.83 45.97 Favored 'General case' 0 C--N 1.366 1.318 0 O-C-N 119.699 -1.876 . . . . 0.0 110.35 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -112.89 153.12 28.43 Favored 'General case' 0 N--CA 1.397 -3.102 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -173.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.7 tt -142.49 156.29 18.7 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 166.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -118.13 113.37 21.47 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -175.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -104.58 163.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 126.883 2.614 . . . . 0.0 112.716 167.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 -55.94 139.31 70.87 Favored Pre-proline 0 N--CA 1.429 -1.505 0 O-C-N 124.54 1.15 . . . . 0.0 113.088 168.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.89 -21.13 28.65 Favored 'Trans proline' 0 C--O 1.194 -1.706 0 C-N-CA 122.46 2.107 . . . . 0.0 112.2 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -90.13 1.52 56.31 Favored 'General case' 0 CA--C 1.573 1.861 0 O-C-N 119.776 -1.827 . . . . 0.0 109.243 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -118.81 7.04 11.5 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 119.468 -2.02 . . . . 0.0 112.197 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.0 mt -61.87 -46.66 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 119.999 -1.688 . . . . 0.0 111.924 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -67.17 -29.4 69.09 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 117.98 -1.488 . . . . 0.0 111.091 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.48 -32.78 72.8 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 173.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.99 -51.42 16.91 Favored 'Isoleucine or valine' 0 C--N 1.384 2.076 0 N-CA-C 115.745 1.758 . . . . 0.0 115.745 173.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.95 -19.24 19.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 114.324 -2.75 . . . . 0.0 114.898 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.78 -174.18 8.69 Favored Glycine 0 C--N 1.383 3.146 1 O-C-N 129.517 4.261 . . . . 0.0 108.9 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.384 22.2 pttp -72.65 129.72 38.89 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 110.061 -3.069 . . . . 0.0 114.359 -173.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.65 19.56 67.22 Favored Glycine 0 N--CA 1.483 1.807 0 O-C-N 119.665 -1.897 . . . . 0.0 114.227 -171.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.6 28.69 68.18 Favored Glycine 0 N--CA 1.5 2.928 0 CA-C-O 121.996 0.776 . . . . 0.0 112.109 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.6 p -64.65 -42.97 95.06 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.76 -41.68 91.5 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 C-N-CA 126.22 1.808 . . . . 0.0 110.286 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.69 -37.51 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 O-C-N 123.974 0.796 . . . . 0.0 110.617 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -56.05 -47.83 77.15 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.75 82.38 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 170.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.82 -51.94 67.52 Favored 'General case' 0 C--O 1.195 -1.779 0 O-C-N 125.386 1.679 . . . . 0.0 113.026 171.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.253 14.2 t -65.43 -48.51 72.5 Favored 'General case' 0 C--O 1.261 1.676 0 CA-C-O 117.742 -1.123 . . . . 0.0 110.55 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.278 27.0 tt0 -66.84 -42.75 85.27 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 118.637 -1.225 . . . . 0.0 114.075 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.31 -34.05 77.11 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.6 p -96.35 -46.14 6.52 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.721 -1.237 . . . . 0.0 111.61 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.25 -0.16 57.14 Favored Glycine 0 C--N 1.344 0.977 0 O-C-N 119.93 -1.731 . . . . 0.0 110.168 -171.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.1 p -75.18 149.41 38.97 Favored 'General case' 0 C--N 1.404 2.947 0 C-N-CA 127.718 2.407 . . . . 0.0 110.826 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.9 m -98.15 129.77 44.93 Favored 'General case' 0 C--O 1.201 -1.454 0 CA-C-O 116.004 -1.95 . . . . 0.0 110.899 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mp -117.29 126.08 74.36 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.989 0 CA-C-O 116.183 -1.865 . . . . 0.0 113.034 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -129.46 141.58 50.99 Favored 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 120.379 1.445 . . . . 0.0 109.291 173.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.88 109.84 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -156.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -76.34 156.14 33.58 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 125.09 2.376 . . . . 0.0 115.101 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -69.1 -0.26 5.6 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 120.339 -1.476 . . . . 0.0 109.438 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -103.91 -11.82 17.25 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.342 -1.474 . . . . 0.0 108.257 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.49 -1.66 53.38 Favored Glycine 0 C--N 1.364 2.104 0 CA-C-O 118.677 -1.068 . . . . 0.0 112.337 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -67.82 115.94 7.93 Favored 'General case' 0 C--O 1.204 -1.322 0 CA-C-N 120.981 2.391 . . . . 0.0 110.363 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 17' ' ' THR . 93.1 t -99.2 117.47 44.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.07 112.84 25.88 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 172.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.5 mt -100.29 106.39 19.17 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 O-C-N 126.748 2.53 . . . . 0.0 108.273 168.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.91 135.47 34.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.656 1.217 . . . . 0.0 109.392 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -154.62 151.78 29.22 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 102.392 -3.188 . . . . 0.0 102.392 -167.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 p -124.47 8.03 8.35 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 126.306 1.842 . . . . 0.0 108.111 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -124.65 107.84 11.41 Favored 'General case' 0 C--N 1.371 1.516 0 C-N-CA 127.23 2.212 . . . . 0.0 105.434 167.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.05 -40.34 95.43 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-O 116.679 -2.178 . . . . 0.0 115.104 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -73.15 -39.16 65.91 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.173 -172.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -58.65 -41.86 87.03 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 162.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.13 -46.13 90.37 Favored 'General case' 0 CA--C 1.586 2.355 0 CA-C-O 123.586 1.66 . . . . 0.0 113.357 168.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -58.58 -33.2 69.7 Favored 'General case' 0 N--CA 1.527 3.422 0 O-C-N 117.747 -3.096 . . . . 0.0 114.322 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -77.2 -44.46 30.01 Favored 'General case' 0 CA--C 1.563 1.462 0 O-C-N 123.504 0.502 . . . . 0.0 111.427 167.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.73 -39.44 94.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.096 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.271 9.2 tp -80.48 -26.0 11.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 O-C-N 119.995 -1.691 . . . . 0.0 109.101 -176.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -65.47 -41.54 93.23 Favored 'General case' 0 C--N 1.374 1.645 0 CA-C-N 119.992 1.269 . . . . 0.0 110.597 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -55.18 -35.23 64.58 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.0 mm -61.16 -40.48 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.708 0 CA-C-O 123.922 1.82 . . . . 0.0 113.145 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -67.75 -39.44 84.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 117.867 -3.021 . . . . 0.0 112.79 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -58.35 -48.06 81.8 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.906 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 74.4 mt -62.35 -45.57 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 170.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.1 m -56.56 -49.4 74.95 Favored 'General case' 0 CA--C 1.575 1.933 0 O-C-N 125.031 1.457 . . . . 0.0 112.723 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.78 -0.36 34.1 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 118.153 -2.842 . . . . 0.0 112.398 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -66.42 139.98 58.02 Favored 'General case' 0 C--N 1.376 1.743 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 169.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.19 122.91 70.71 Favored 'Isoleucine or valine' 0 C--N 1.364 1.228 0 N-CA-C 103.085 -2.931 . . . . 0.0 103.085 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -88.03 134.13 33.81 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.727 -169.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.3 137.76 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.409 0 O-C-N 125.928 2.017 . . . . 0.0 112.653 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.2 -7.7 1.68 Allowed Glycine 0 C--O 1.26 1.768 0 N-CA-C 120.123 2.809 . . . . 0.0 120.123 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -79.55 146.51 32.58 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 124.747 2.213 . . . . 0.0 111.544 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.9 t -91.04 146.7 5.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 O-C-N 120.352 -1.467 . . . . 0.0 109.233 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -138.31 155.35 48.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 79.5 m -93.81 144.24 25.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -146.65 179.53 23.55 Favored Glycine 0 C--O 1.248 1.0 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 172.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -130.32 131.67 45.5 Favored 'General case' 0 C--N 1.375 1.685 0 O-C-N 120.261 -1.729 . . . . 0.0 109.73 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.35 120.28 6.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.205 0 O-C-N 120.88 -1.138 . . . . 0.0 109.22 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.0 p -94.12 -8.62 39.05 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-O 115.623 -2.132 . . . . 0.0 112.492 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 ptt85 165.04 148.62 0.02 OUTLIER 'General case' 0 C--N 1.369 1.435 0 O-C-N 126.624 2.452 . . . . 0.0 108.618 -170.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.4 mt -100.81 144.29 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 CA-C-N 112.855 -1.975 . . . . 0.0 108.958 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.26 35.8 m -138.58 170.43 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 O-C-N 120.784 -1.197 . . . . 0.0 109.388 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.65 -42.25 71.08 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 117.274 -3.391 . . . . 0.0 114.525 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -107.1 -0.85 22.56 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 119.131 0.878 . . . . 0.0 112.261 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.68 -154.58 11.17 Favored Glycine 0 C--O 1.212 -1.219 0 O-C-N 119.554 -1.966 . . . . 0.0 109.263 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.31 137.2 24.29 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 128.896 2.879 . . . . 0.0 104.229 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.254 92.6 m-85 -86.84 139.57 30.54 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 124.594 1.158 . . . . 0.0 109.047 173.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.82 121.43 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 112.547 -2.115 . . . . 0.0 107.841 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.33 126.04 28.84 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.621 -1.299 . . . . 0.0 110.169 165.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.8 mm -85.5 94.2 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.44 37.48 93.82 Favored Glycine 0 N--CA 1.513 3.773 0 C-N-CA 126.6 2.048 . . . . 0.0 111.295 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.53 -7.15 49.77 Favored Glycine 0 C--N 1.297 -1.633 0 O-C-N 125.87 1.571 . . . . 0.0 114.471 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.76 -169.09 5.55 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 120.024 1.912 . . . . 0.0 114.473 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -33.06 140.08 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.247 2.927 . . . . 0.0 117.388 167.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -91.79 116.26 28.75 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 112.232 -2.258 . . . . 0.0 114.914 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.28 170.7 23.69 Favored Glycine 0 C--N 1.368 2.317 0 CA-C-O 117.997 -1.446 . . . . 0.0 110.974 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.1 tp -114.62 138.17 51.0 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 128.074 2.867 . . . . 0.0 106.816 -171.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.1 p -116.97 120.53 65.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.288 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.488 157.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -74.81 153.66 38.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.414 1.578 . . . . 0.0 112.197 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.6 tt -67.82 -16.32 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -162.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.0 m -94.69 13.14 25.33 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.03 1.286 . . . . 0.0 111.845 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 -112.2 22.43 14.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.978 1.263 . . . . 0.0 111.54 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.8 mm -100.97 -48.06 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 CA-C-O 127.142 3.353 . . . . 0.0 106.464 -174.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -125.42 156.01 39.51 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 112.439 -2.164 . . . . 0.0 112.261 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.262 4.8 t0 -83.2 -15.31 50.97 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 164.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -94.08 -173.55 3.14 Favored 'General case' 0 C--N 1.381 1.954 0 C-N-CA 126.547 1.939 . . . . 0.0 113.528 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.279 15.5 mmm180 -84.01 115.78 22.51 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-O 125.327 2.489 . . . . 0.0 114.546 -173.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . 0.264 21.9 t -82.67 101.34 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 112.092 -2.322 . . . . 0.0 114.675 172.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -96.54 -34.65 11.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -141.97 149.41 40.04 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 122.253 1.025 . . . . 0.0 110.09 170.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.29 -34.19 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.264 18.1 p -58.49 -20.94 49.85 Favored 'General case' 0 C--O 1.277 2.552 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 175.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.91 -43.28 83.76 Favored 'General case' 0 C--N 1.368 1.388 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -90.93 -24.68 20.1 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 116.976 -1.488 . . . . 0.0 112.627 -175.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.2 mt -137.98 151.22 47.72 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 120.479 1.49 . . . . 0.0 109.083 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -120.57 167.03 12.83 Favored 'General case' 0 C--O 1.22 -0.459 0 O-C-N 125.707 1.88 . . . . 0.0 108.075 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.6 tpt -81.36 120.71 25.3 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 111.875 -2.42 . . . . 0.0 112.066 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.82 -9.4 56.8 Favored Glycine 0 C--N 1.365 2.19 0 CA-C-N 119.832 1.197 . . . . 0.0 111.771 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -89.52 153.31 20.89 Favored 'General case' 0 CA--C 1.598 2.816 0 CA-C-N 118.316 1.058 . . . . 0.0 109.262 -164.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -88.2 151.09 22.92 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 117.733 -3.105 . . . . 0.0 108.229 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.03 136.05 9.93 Favored Pre-proline 0 N--CA 1.431 -1.399 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.39 124.69 16.69 Favored 'Trans proline' 0 N--CA 1.52 3.076 0 C-N-CA 121.299 1.333 . . . . 0.0 113.402 159.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.54 138.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.244 2.218 . . . . 0.0 107.714 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -106.57 118.36 36.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.553 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.99 119.04 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 123.829 1.776 . . . . 0.0 113.004 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.1 mt -88.64 -40.17 13.51 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 117.092 -1.432 . . . . 0.0 111.519 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -163.47 156.73 18.95 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 120.049 1.295 . . . . 0.0 107.865 -172.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.7 t -120.07 131.85 71.31 Favored 'Isoleucine or valine' 0 C--O 1.254 1.311 1 N-CA-C 98.942 -4.466 . . . . 0.0 98.942 166.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.67 178.42 6.76 Favored 'General case' 0 N--CA 1.421 -1.907 0 O-C-N 120.898 -1.126 . . . . 0.0 111.384 -168.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -78.59 -16.56 57.25 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.848 1.259 . . . . 0.0 111.483 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -112.04 2.56 16.89 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 126.089 2.118 . . . . 0.0 108.679 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.09 5.32 28.84 Favored Glycine 0 C--N 1.368 2.346 0 CA-C-O 119.692 -0.504 . . . . 0.0 114.338 162.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.85 146.89 27.08 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.1 mt -103.99 129.13 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -116.41 122.83 45.96 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 112.096 -2.32 . . . . 0.0 113.095 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 64.6 mt -120.55 166.12 14.07 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 125.94 1.696 . . . . 0.0 111.809 -168.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 30.0 t -129.28 130.53 46.31 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 112.036 -2.347 . . . . 0.0 108.753 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.3 mt -93.78 -39.43 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 169.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -60.84 -41.82 96.59 Favored 'General case' 0 C--N 1.379 1.867 0 O-C-N 120.239 -1.538 . . . . 0.0 113.9 -167.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -74.91 -33.93 62.08 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 126.651 2.469 . . . . 0.0 109.314 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.47 -29.56 61.49 Favored 'General case' 0 C--N 1.375 1.677 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.5 p -106.1 1.25 26.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 71.52 57.86 0.18 Allowed 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 . . . . . 0 C--N 1.361 1.07 0 CA-C-O 116.183 -1.865 . . . . 0.0 108.561 179.75 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 . . . . . 0 C--O 1.223 -0.325 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.1 mm -84.7 102.93 11.35 Favored 'Isoleucine or valine' 0 C--N 1.373 1.6 0 O-C-N 126.119 2.137 . . . . 0.0 113.505 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -88.77 116.37 26.99 Favored 'General case' 0 N--CA 1.423 -1.787 0 C-N-CA 124.937 1.295 . . . . 0.0 110.958 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.6 p -93.94 138.18 32.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 124.758 2.218 . . . . 0.0 111.53 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.5 tt -135.92 123.45 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 111.545 -2.57 . . . . 0.0 109.807 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -80.4 124.71 29.13 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.274 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.96 129.69 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.925 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -66.73 143.21 97.98 Favored Pre-proline 0 N--CA 1.51 2.57 0 CA-C-O 116.289 -1.815 . . . . 0.0 112.736 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.45 -13.83 40.48 Favored 'Trans proline' 1 N--CA 1.541 4.265 0 CA-C-O 112.871 -3.054 . . . . 0.0 118.583 -165.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -86.48 -18.56 31.34 Favored 'General case' 0 C--N 1.386 2.159 0 CA-C-N 123.941 3.064 . . . . 0.0 109.251 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -84.71 -20.76 30.65 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 116.373 -1.775 . . . . 0.0 115.491 171.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 54.1 mt -65.22 -37.22 79.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 121.935 2.152 . . . . 0.0 112.535 166.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -61.32 -41.88 97.74 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 116.932 -1.508 . . . . 0.0 109.621 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -62.12 -41.19 97.99 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 119.863 1.211 . . . . 0.0 110.808 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 t -67.57 -36.44 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.568 1.947 . . . . 0.0 109.761 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.0 mt -67.19 -46.48 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.985 0.811 . . . . 0.0 109.224 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.49 174.07 11.21 Favored Glycine 0 CA--C 1.55 2.252 0 C-N-CA 118.818 -1.658 . . . . 0.0 114.473 -172.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -67.62 119.49 12.47 Favored 'General case' 0 C--O 1.187 -2.195 0 CA-C-N 113.937 -1.131 . . . . 0.0 110.376 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 26.36 60.78 Favored Glycine 0 N--CA 1.502 3.099 0 C-N-CA 128.497 2.951 . . . . 0.0 116.599 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.81 15.45 79.26 Favored Glycine 0 C--N 1.37 2.448 0 O-C-N 126.64 2.024 . . . . 0.0 112.682 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -62.32 -47.24 85.13 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 120.346 2.073 . . . . 0.0 115.177 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.39 -46.62 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.762 -1.212 . . . . 0.0 112.864 -173.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 tt -70.98 -32.74 49.38 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 O-C-N 127.676 3.11 . . . . 0.0 114.445 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -64.56 -49.41 71.31 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.337 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -34.47 66.83 Favored 'General case' 0 C--O 1.249 1.055 0 CA-C-N 114.162 -1.381 . . . . 0.0 113.542 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -76.76 -48.11 19.68 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 128.241 3.463 . . . . 0.0 112.638 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.312 8.5 t -62.75 -43.29 99.2 Favored 'General case' 0 C--O 1.255 1.38 0 C-N-CA 118.285 -1.366 . . . . 0.0 112.855 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -69.16 -45.36 70.23 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 116.412 -1.756 . . . . 0.0 114.419 172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -59.23 -47.64 84.59 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-O 123.498 1.618 . . . . 0.0 112.405 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.7 p -79.62 -22.34 43.77 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.972 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.81 47.85 78.55 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 125.974 1.75 . . . . 0.0 112.507 -171.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -134.67 152.75 52.0 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 126.574 1.985 . . . . 0.0 112.25 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.5 m -95.29 146.34 24.43 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 119.993 -1.692 . . . . 0.0 110.662 -178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.5 mt -126.22 129.26 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -171.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.94 157.66 33.8 Favored 'General case' 0 C--O 1.191 -1.987 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 154.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.3 mt -135.04 124.54 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -81.75 154.99 25.7 Favored 'General case' 0 CA--C 1.573 1.864 0 C-N-CA 127.149 2.179 . . . . 0.0 109.958 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -80.63 -13.2 59.24 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -79.16 -13.85 59.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.644 2.378 . . . . 0.0 111.477 172.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.13 -3.26 25.45 Favored Glycine 0 N--CA 1.491 2.331 0 CA-C-O 122.624 1.125 . . . . 0.0 114.436 -177.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -83.19 108.43 16.43 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 123.838 1.78 . . . . 0.0 112.172 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.1 t -90.83 127.66 43.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-O 122.967 1.365 . . . . 0.0 111.492 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -115.67 105.56 12.89 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.206 -0.934 . . . . 0.0 108.709 -169.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.4 mm -88.09 129.13 39.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 O-C-N 120.966 -1.084 . . . . 0.0 111.706 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -113.96 121.77 44.93 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 118.488 -1.285 . . . . 0.0 111.315 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 65' ' ' ALA . . . -139.42 156.18 47.13 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 124.309 1.006 . . . . 0.0 111.336 -177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -72.89 -31.9 65.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 118.413 -2.679 . . . . 0.0 112.347 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -121.65 148.97 43.88 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 123.233 1.492 . . . . 0.0 109.419 -167.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.5 -48.04 81.77 Favored Glycine 0 C--O 1.197 -2.192 0 CA-C-O 116.762 -2.132 . . . . 0.0 113.002 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.8 -41.88 98.31 Favored 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 119.378 1.589 . . . . 0.0 110.956 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -60.67 -43.74 97.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 118.157 -2.84 . . . . 0.0 113.249 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.4 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . . . -67.18 -36.27 81.42 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.241 -1.537 . . . . 0.0 112.518 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -74.71 -24.13 58.7 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.593 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -72.65 -39.78 66.89 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 118.572 -2.58 . . . . 0.0 112.553 166.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.49 -38.29 90.57 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.928 -1.107 . . . . 0.0 113.298 167.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.7 mm -64.91 -50.37 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 120.684 -1.26 . . . . 0.0 112.267 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -53.85 -42.4 68.5 Favored 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 120.946 -1.096 . . . . 0.0 111.214 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -61.0 -43.49 98.81 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 mt -69.28 -39.57 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.832 0 C-N-CA 118.269 -1.373 . . . . 0.0 113.577 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.18 -39.52 75.49 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 116.692 -1.623 . . . . 0.0 114.411 164.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -61.94 -42.8 99.52 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-N 119.372 0.987 . . . . 0.0 111.211 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mt -65.06 -34.07 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.174 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 p -89.82 4.4 49.94 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.665 175.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.1 9.02 38.65 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 118.986 0.812 . . . . 0.0 109.435 162.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -76.9 132.96 39.38 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.223 1.487 . . . . 0.0 112.263 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mm -103.14 130.81 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 CA-C-O 123.496 1.617 . . . . 0.0 109.033 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -105.28 145.29 30.9 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.698 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 t -69.72 124.97 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 O-C-N 120.645 -1.285 . . . . 0.0 110.522 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.39 19.42 74.14 Favored Glycine 0 C--O 1.211 -1.331 0 C-N-CA 118.606 -1.759 . . . . 0.0 115.883 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -101.42 148.79 24.75 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 167.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.3 t -93.12 130.8 41.65 Favored 'Isoleucine or valine' 0 C--N 1.367 1.336 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -123.91 138.19 54.51 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.3 m -88.09 105.91 17.8 Favored 'General case' 0 C--N 1.399 2.737 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.694 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.84 178.13 17.78 Favored Glycine 0 C--O 1.207 -1.587 0 C-N-CA 125.269 1.414 . . . . 0.0 112.996 -175.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -126.65 135.17 50.83 Favored 'General case' 0 CA--C 1.582 2.204 0 O-C-N 127.23 2.371 . . . . 0.0 109.427 -171.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 t -67.33 125.12 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 126.486 1.914 . . . . 0.0 112.92 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.7 p -99.53 -42.6 6.85 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 119.301 0.955 . . . . 0.0 112.536 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -165.85 152.63 9.82 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.3 mt -118.31 125.29 74.18 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.747 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.24 175.16 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 126.028 2.08 . . . . 0.0 109.627 -174.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -47.63 -42.17 23.71 Favored 'General case' 0 C--N 1.398 2.695 0 CA-C-N 119.931 1.241 . . . . 0.0 111.222 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -94.52 9.14 39.72 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.774 -1.204 . . . . 0.0 113.423 -171.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.78 -164.31 19.4 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 124.275 2.042 . . . . 0.0 116.669 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.1 125.1 53.41 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 112.539 -1.831 . . . . 0.0 110.129 -166.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -81.63 149.76 28.41 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.2 t -145.25 121.95 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 CA-C-O 121.939 0.876 . . . . 0.0 112.375 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.23 132.91 35.37 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 117.154 -3.466 . . . . 0.0 112.478 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.1 mm -112.62 158.83 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 112.327 -2.215 . . . . 0.0 106.449 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.75 158.69 51.32 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 121.185 -0.947 . . . . 0.0 111.251 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.99 23.94 77.6 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 113.722 -1.239 . . . . 0.0 113.911 -170.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.38 18.06 74.91 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 127.499 2.476 . . . . 0.0 113.609 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -88.6 163.47 15.83 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -148.31 132.44 17.32 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 124.066 1.888 . . . . 0.0 106.591 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.91 177.78 16.88 Favored Glycine 0 CA--C 1.554 2.489 0 O-C-N 119.955 -1.716 . . . . 0.0 114.65 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.91 123.43 30.73 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.704 -1.468 . . . . 0.0 109.213 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t -96.2 116.44 38.11 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.772 0 O-C-N 119.328 -2.108 . . . . 0.0 106.08 159.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -64.84 147.16 53.79 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 126.064 2.103 . . . . 0.0 108.293 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 tp -32.66 -42.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.256 1.427 0 N-CA-C 119.576 3.176 . . . . 0.0 119.576 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.0 p -77.11 -27.14 53.93 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -97.46 7.21 46.94 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.596 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.05 -39.75 81.25 Favored 'Isoleucine or valine' 0 C--N 1.365 1.242 0 C-N-CA 124.57 1.148 . . . . 0.0 111.155 170.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.59 158.02 33.09 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 122.784 1.278 . . . . 0.0 111.502 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.02 -37.5 78.68 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 128.741 2.816 . . . . 0.0 109.089 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -112.62 117.21 31.64 Favored 'General case' 0 N--CA 1.517 2.92 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.286 167.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.11 146.29 54.83 Favored 'General case' 0 C--O 1.199 -1.601 0 C-N-CA 125.7 1.6 . . . . 0.0 114.99 -161.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 33.5 m -97.15 138.9 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 O-C-N 120.504 -1.372 . . . . 0.0 112.75 -172.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -60.22 -39.51 86.87 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -139.2 147.8 42.27 Favored 'General case' 0 C--O 1.248 1.016 0 O-C-N 119.81 -1.806 . . . . 0.0 109.708 160.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.42 -37.2 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 119.191 -1.004 . . . . 0.0 112.672 169.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.2 p -67.75 -20.61 65.25 Favored 'General case' 0 CA--C 1.477 -1.841 1 CA-C-O 111.471 -4.109 . . . . 0.0 112.861 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -84.48 -13.57 51.61 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 124.053 3.115 . . . . 0.0 115.412 171.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -99.04 -23.28 15.34 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.583 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.4 mt -135.47 145.92 47.64 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -118.87 163.91 16.21 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.892 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 22.1 mmt -72.55 150.7 42.94 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 120.605 1.548 . . . . 0.0 112.915 172.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.7 -21.51 18.32 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 112.064 -2.335 . . . . 0.0 115.238 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -109.34 134.95 51.18 Favored 'General case' 0 C--N 1.361 1.075 0 O-C-N 125.625 1.427 . . . . 0.0 111.874 -161.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.14 112.93 1.51 Allowed 'General case' 0 C--N 1.388 2.24 0 O-C-N 128.985 3.928 . . . . 0.0 117.942 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 t -116.25 116.27 39.76 Favored Pre-proline 0 C--O 1.247 0.949 0 C-N-CA 127.377 2.271 . . . . 0.0 109.358 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -57.58 125.23 18.11 Favored 'Trans proline' 0 N--CA 1.515 2.743 0 C-N-CA 121.643 1.562 . . . . 0.0 115.661 157.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.93 123.48 15.41 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -96.95 146.78 24.64 Favored 'General case' 0 C--N 1.368 1.384 0 CA-C-O 123.984 1.85 . . . . 0.0 107.766 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 78.7 t -81.95 126.63 39.94 Favored 'Isoleucine or valine' 0 C--N 1.374 1.651 0 O-C-N 118.25 -2.782 . . . . 0.0 114.917 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.2 -33.93 15.2 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.847 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -174.95 140.78 0.56 Allowed 'General case' 0 N--CA 1.521 3.115 0 O-C-N 124.626 1.204 . . . . 0.0 109.88 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.19 142.64 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 O-C-N 120.429 -1.419 . . . . 0.0 109.666 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.26 66.5 t0 -142.69 138.52 30.66 Favored 'General case' 0 N--CA 1.411 -2.4 0 O-C-N 124.421 1.076 . . . . 0.0 108.715 -175.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -101.04 5.26 42.94 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-O 114.703 -2.57 . . . . 0.0 107.83 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -117.56 -57.13 2.16 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.28 164.66 33.63 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 119.814 2.686 . . . . 0.0 119.814 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -60.8 127.2 30.44 Favored 'General case' 0 C--N 1.396 2.61 0 O-C-N 117.614 -3.286 . . . . 0.0 114.401 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.7 mm -31.2 137.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 126.451 3.024 . . . . 0.0 114.77 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -94.21 132.21 39.0 Favored 'General case' 0 C--O 1.247 0.964 0 O-C-N 118.225 -2.797 . . . . 0.0 109.894 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.3 mt -136.42 146.65 46.64 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.002 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.9 t -129.9 128.25 41.81 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.154 167.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 70.4 mt -72.75 -43.64 60.68 Favored 'Isoleucine or valine' 0 C--N 1.384 2.092 0 CA-C-N 111.569 -2.56 . . . . 0.0 106.933 178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -73.3 -30.02 63.1 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 118.975 -2.328 . . . . 0.0 111.899 -170.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -15.02 62.91 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.092 -1.63 . . . . 0.0 113.118 174.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.314 . . -106.86 14.55 26.5 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.106 -168.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.83 151.44 26.06 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-N 120.15 1.341 . . . . 0.0 111.087 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.292 54.1 mt-10 54.75 57.5 5.65 Favored 'General case' 0 C--N 1.374 1.664 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 171.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 172.148 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.2 mm -93.58 121.25 44.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 O-C-N 124.967 1.417 . . . . 0.0 112.18 -176.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -93.42 119.8 32.95 Favored 'General case' 0 C--O 1.191 -2.001 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.402 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.4 m -118.63 111.77 18.98 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 100.956 -3.72 . . . . 0.0 100.956 -163.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.0 mm -116.39 135.73 55.68 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 CA-C-O 116.01 -1.948 . . . . 0.0 110.514 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -95.54 123.35 39.04 Favored 'General case' 0 CA--C 1.576 1.962 0 O-C-N 124.928 1.393 . . . . 0.0 111.878 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.9 pt -131.43 161.66 40.75 Favored 'Isoleucine or valine' 0 C--O 1.259 1.589 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 -173.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -48.56 120.88 9.24 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.65 -23.93 8.83 Favored 'Trans proline' 0 N--CA 1.516 2.825 0 N-CA-C 118.131 2.32 . . . . 0.0 118.131 171.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.82 -30.04 63.72 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 116.766 -3.709 . . . . 0.0 111.692 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -91.74 -0.28 57.54 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -167.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.9 mm -62.35 -44.91 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.431 1.892 . . . . 0.0 109.539 -172.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -60.84 -38.91 87.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.674 2.39 . . . . 0.0 111.605 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -73.77 -40.69 63.28 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 119.228 -2.17 . . . . 0.0 112.794 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.39 -36.3 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.296 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.91 -43.13 89.59 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 124.335 1.054 . . . . 0.0 110.248 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.456 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 79.94 156.75 12.53 Favored Glycine 1 CA--C 1.584 4.383 0 CA-C-O 123.846 1.803 . . . . 0.0 116.535 -172.106 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -71.74 132.69 44.87 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-O 122.694 1.235 . . . . 0.0 108.596 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.91 20.03 24.67 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 118.804 2.282 . . . . 0.0 118.804 -168.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.99 16.38 74.98 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.229 -1.317 . . . . 0.0 111.791 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.3 t -70.62 -41.9 71.64 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 118.17 2.655 . . . . 0.0 118.17 -169.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.456 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 21.4 t -65.48 -44.3 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 CA-C-N 120.441 1.473 . . . . 0.0 114.135 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -61.83 -39.38 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.718 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -64.64 -44.46 90.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.091 -1.631 . . . . 0.0 115.283 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.97 97.57 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.44 -39.87 92.59 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 120.881 -1.137 . . . . 0.0 113.049 168.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 m -47.81 -55.55 9.44 Favored 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 125.862 1.665 . . . . 0.0 112.484 167.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.86 -33.45 72.29 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -57.84 -46.32 84.93 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 126.321 1.849 . . . . 0.0 112.101 166.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.3 p -97.51 -18.69 18.85 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 117.354 -1.738 . . . . 0.0 111.422 -165.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.77 35.77 73.85 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 124.156 0.884 . . . . 0.0 112.838 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.52 152.33 32.8 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 117.811 -1.555 . . . . 0.0 107.729 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 m -66.42 131.01 45.13 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.048 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 mt -132.11 123.0 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.923 174.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -131.37 141.52 49.9 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 tt -127.55 155.23 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -116.19 143.02 46.06 Favored 'General case' 0 C--N 1.38 1.906 0 O-C-N 117.403 -3.311 . . . . 0.0 103.389 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -62.94 -12.42 25.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -87.52 0.27 55.82 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-N 119.21 0.914 . . . . 0.0 113.441 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.67 27.15 7.26 Favored Glycine 0 CA--C 1.478 -2.245 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 168.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.2 m -107.02 110.46 22.6 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.79 142.66 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 118.853 0.751 . . . . 0.0 109.575 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -125.83 137.24 53.76 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.328 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.6 mt -121.06 119.58 59.73 Favored 'Isoleucine or valine' 0 C--N 1.366 1.307 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . 0.279 . . -87.6 118.55 27.16 Favored 'General case' 0 N--CA 1.403 -2.782 0 O-C-N 118.113 -2.867 . . . . 0.0 110.98 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.42 151.51 17.25 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -98.69 -39.94 8.42 Favored 'General case' 0 CA--C 1.484 -1.585 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.233 169.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.52 124.78 25.04 Favored 'General case' 0 N--CA 1.415 -2.211 0 O-C-N 126.02 2.075 . . . . 0.0 109.374 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.58 -25.77 64.61 Favored Glycine 0 C--N 1.356 1.652 0 O-C-N 120.452 -1.405 . . . . 0.0 116.528 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -66.4 -34.87 78.93 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 113.007 0.744 . . . . 0.0 113.007 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -63.26 -44.87 93.9 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 167.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.91 77.93 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -64.47 -50.79 66.1 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 164.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -57.73 -41.43 81.81 Favored 'General case' 0 N--CA 1.529 3.479 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.99 -44.33 87.11 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.83 -39.82 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.351 -0.94 . . . . 0.0 113.209 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -65.14 -41.84 94.38 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 121.552 1.978 . . . . 0.0 110.315 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -60.85 -38.19 84.65 Favored 'General case' 0 CA--C 1.584 2.251 1 O-C-N 116.198 -4.064 . . . . 0.0 115.593 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.79 -44.04 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 119.917 -1.739 . . . . 0.0 110.264 172.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -54.85 -41.12 70.37 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-O 115.527 -2.178 . . . . 0.0 114.776 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -63.82 -41.47 97.86 Favored 'General case' 0 C--N 1.38 1.903 0 CA-C-N 122.225 2.284 . . . . 0.0 115.287 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.7 mt -69.08 -39.8 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 122.217 2.281 . . . . 0.0 114.681 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.3 p -77.59 -11.5 59.87 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.69 -31.22 72.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 120.937 1.699 . . . . 0.0 114.091 160.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -69.47 160.06 32.12 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-O 125.572 2.606 . . . . 0.0 116.108 -163.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.8 mm -102.87 130.72 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 124.119 1.914 . . . . 0.0 113.759 -155.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -84.01 123.8 30.38 Favored 'General case' 0 C--O 1.188 -2.15 0 CA-C-N 111.209 -2.723 . . . . 0.0 117.87 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.73 122.49 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.862 0 C-N-CA 126.311 1.844 . . . . 0.0 106.858 173.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.07 8.03 59.25 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 112.808 -1.997 . . . . 0.0 113.224 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -96.75 164.22 12.67 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 169.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.2 t -102.97 136.47 35.35 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.51 158.75 21.21 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -98.37 124.41 43.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.361 1.077 . . . . 0.0 108.447 167.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.97 -174.05 13.48 Favored Glycine 0 C--N 1.347 1.139 0 O-C-N 120.241 -1.537 . . . . 0.0 112.188 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -131.39 134.94 46.77 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.92 119.77 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 124.176 0.991 . . . . 0.0 109.072 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -84.86 -22.39 29.43 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 119.975 -1.703 . . . . 0.0 114.668 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.57 132.79 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.366 -169.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.6 mt -108.96 128.31 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -114.68 173.79 3.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -53.14 -47.88 68.36 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.395 -1.44 . . . . 0.0 113.493 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -104.08 17.89 23.17 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 120.045 -1.659 . . . . 0.0 113.618 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.78 -176.41 47.5 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 118.27 -1.919 . . . . 0.0 115.485 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.83 117.74 9.38 Favored 'General case' 0 C--N 1.373 1.618 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -75.58 137.72 40.98 Favored 'General case' 0 C--N 1.372 1.578 0 O-C-N 125.559 1.787 . . . . 0.0 111.46 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.4 t -134.25 132.57 55.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -171.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.42 136.41 37.9 Favored 'General case' 0 C--N 1.363 1.171 0 CA-C-O 122.702 1.239 . . . . 0.0 108.753 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.9 pt -139.76 160.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 CA-C-O 117.448 -1.263 . . . . 0.0 111.15 -168.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.17 138.01 0.54 Allowed Glycine 0 CA--C 1.562 2.992 0 N-CA-C 122.391 3.717 . . . . 0.0 122.391 -166.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.92 18.58 62.99 Favored Glycine 0 CA--C 1.483 -1.938 0 CA-C-O 116.189 -2.451 . . . . 0.0 116.827 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.59 33.82 41.69 Favored Glycine 0 CA--C 1.544 1.888 0 CA-C-N 120.371 2.085 . . . . 0.0 117.5 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -114.52 151.62 33.03 Favored 'General case' 0 N--CA 1.515 2.781 0 C-N-CA 124.222 1.009 . . . . 0.0 112.544 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -143.79 123.34 13.23 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 113.3 -1.773 . . . . 0.0 106.219 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -120.85 174.66 15.85 Favored Glycine 0 C--N 1.364 2.125 0 O-C-N 126.748 2.53 . . . . 0.0 113.003 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.7 tp -128.98 126.46 39.62 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 112.587 -1.807 . . . . 0.0 111.835 -166.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.3 t -95.59 116.66 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 N-CA-C 102.329 -3.212 . . . . 0.0 102.329 173.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -66.63 151.74 46.74 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 120.352 -1.467 . . . . 0.0 111.462 171.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.333 14.2 tt -39.07 -34.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.563 0 N-CA-C 120.634 3.568 . . . . 0.0 120.634 172.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.5 m -69.63 -18.87 63.62 Favored 'General case' 0 N--CA 1.534 3.725 0 O-C-N 125.758 1.911 . . . . 0.0 113.446 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -120.24 6.83 10.71 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.718 0.807 . . . . 0.0 110.817 -160.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.9 mm -74.19 -42.04 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 170.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.05 167.75 21.34 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 119.98 -1.7 . . . . 0.0 112.427 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.316 53.6 p30 -41.6 -67.0 0.29 Allowed 'General case' 0 C--N 1.363 1.161 0 O-C-N 128.584 3.678 . . . . 0.0 118.081 173.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . 0.257 66.6 mttt -99.71 164.96 11.83 Favored 'General case' 0 CA--C 1.582 2.21 0 C-N-CA 129.408 3.083 . . . . 0.0 106.091 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -59.05 140.56 55.65 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.43 HG12 HG22 ' A' ' 122' ' ' VAL . 52.1 t -102.71 136.57 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 125.057 1.473 . . . . 0.0 110.228 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -92.25 -48.62 6.59 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.697 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -143.99 127.97 17.46 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.43 HG22 HG12 ' A' ' 119' ' ' VAL . 48.1 t -72.33 -24.22 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 123.889 1.804 . . . . 0.0 113.129 -164.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 66.8 p -63.62 -26.83 68.86 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 126.691 1.996 . . . . 0.0 112.721 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -63.89 -25.59 68.22 Favored 'General case' 0 C--O 1.261 1.688 0 O-C-N 119.326 -2.109 . . . . 0.0 115.306 168.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -96.35 -46.49 6.38 Favored 'General case' 0 C--N 1.371 1.53 0 O-C-N 126.725 2.515 . . . . 0.0 114.47 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.2 mt -114.67 135.62 53.96 Favored 'General case' 0 N--CA 1.434 -1.256 0 O-C-N 125.687 1.867 . . . . 0.0 108.536 -166.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -105.94 141.62 37.04 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.8 ttp -63.95 137.19 57.9 Favored 'General case' 0 C--O 1.203 -1.362 0 O-C-N 126.328 2.267 . . . . 0.0 114.063 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.01 -24.52 7.84 Favored Glycine 0 N--CA 1.428 -1.858 0 CA-C-O 116.898 -2.057 . . . . 0.0 115.731 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -72.01 163.91 27.05 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.45 134.77 37.31 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.69 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.6 m -139.85 141.21 26.7 Favored Pre-proline 0 C--N 1.369 1.419 0 O-C-N 118.753 -2.467 . . . . 0.0 112.042 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.06 127.77 10.9 Favored 'Trans proline' 0 C--N 1.286 -2.739 0 C-N-CA 121.106 1.204 . . . . 0.0 111.707 165.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.1 m -128.33 128.43 68.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -91.61 132.68 36.16 Favored 'General case' 0 C--N 1.373 1.602 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.701 165.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.4 t -75.7 104.45 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.667 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.11 -42.65 98.92 Favored 'General case' 0 C--N 1.39 2.327 0 C-N-CA 127.048 2.139 . . . . 0.0 112.894 168.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -165.56 140.69 4.98 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 123.939 0.775 . . . . 0.0 112.298 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.9 t -106.88 116.0 49.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 156.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.251 0.3 OUTLIER -80.55 171.55 14.89 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 123.768 1.747 . . . . 0.0 113.698 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -64.34 -33.82 76.72 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 119.066 -2.271 . . . . 0.0 112.617 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -71.11 -37.74 72.36 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-O 116.757 -1.592 . . . . 0.0 110.02 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.77 9.22 1.78 Allowed Glycine 0 C--N 1.359 1.834 0 CA-C-N 122.101 2.228 . . . . 0.0 114.736 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -95.7 134.02 39.11 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -163.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.4 mt -105.54 108.88 26.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 O-C-N 121.412 -0.805 . . . . 0.0 110.333 -167.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -85.9 136.55 33.24 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 92.4 mt -127.68 163.06 25.1 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 126.077 2.111 . . . . 0.0 111.332 -170.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 42.9 t -148.9 134.55 18.73 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.27 -30.51 2.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.45 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.426 ' HZ3' ' C ' ' A' ' 155' ' ' GLN . 24.6 tttm -61.1 -40.97 95.74 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.765 175.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.4 -14.8 60.91 Favored 'General case' 0 CA--C 1.562 1.419 0 O-C-N 125.117 1.511 . . . . 0.0 110.232 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -96.61 -14.94 21.82 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.3 p -103.19 0.93 32.41 Favored 'General case' 0 CA--C 1.488 -1.406 0 O-C-N 126.978 2.674 . . . . 0.0 111.703 161.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 65.65 38.76 5.21 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 127.107 2.754 . . . . 0.0 113.777 163.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.426 ' C ' ' HZ3' ' A' ' 150' ' ' LYS . 43.9 mm-40 . . . . . 0 N--CA 1.43 -1.434 0 CA-C-O 117.212 -1.375 . . . . 0.0 112.749 175.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 . . . . . 0 CA--C 1.552 1.021 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tp -64.74 122.76 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.737 -1.227 . . . . 0.0 111.743 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -75.96 135.79 40.04 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-O 126.027 2.823 . . . . 0.0 114.663 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.5 p -141.67 154.97 45.69 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 112.45 -2.159 . . . . 0.0 111.915 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.7 mt -130.3 128.4 64.04 Favored 'Isoleucine or valine' 0 C--N 1.366 1.315 0 O-C-N 126.753 2.533 . . . . 0.0 107.716 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -77.69 126.22 30.54 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 28' ' ' VAL . 36.0 mm -106.18 133.97 49.1 Favored 'Isoleucine or valine' 0 C--N 1.366 1.291 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -63.39 140.07 97.67 Favored Pre-proline 0 N--CA 1.485 1.321 0 CA-C-O 117.165 -1.397 . . . . 0.0 110.178 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -44.89 -45.71 13.59 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.622 2.881 . . . . 0.0 116.472 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -73.98 -21.29 60.06 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 128.04 3.338 . . . . 0.0 106.536 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -101.47 -4.65 26.43 Favored 'General case' 0 C--N 1.387 2.227 0 O-C-N 119.737 -1.852 . . . . 0.0 113.839 -170.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.4 mt -59.25 -42.27 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 117.23 -1.367 . . . . 0.0 114.577 168.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -58.34 -40.37 81.95 Favored 'General case' 0 C--O 1.267 1.999 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 170.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -65.88 -35.57 81.0 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 117.56 -1.209 . . . . 0.0 112.432 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG22 HD12 ' A' ' 20' ' ' ILE . 37.2 t -70.05 -44.9 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 123.867 0.73 . . . . 0.0 111.679 174.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.0 mm -85.85 -38.37 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 122.079 2.218 . . . . 0.0 112.487 -172.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.48 154.21 16.97 Favored Glycine 0 CA--C 1.474 -2.521 0 CA-C-N 120.684 1.584 . . . . 0.0 115.817 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -70.53 130.6 42.29 Favored 'General case' 0 N--CA 1.419 -1.987 0 O-C-N 119.699 -2.059 . . . . 0.0 111.026 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.74 10.07 60.29 Favored Glycine 0 N--CA 1.481 1.636 0 CA-C-O 115.373 -2.904 . . . . 0.0 113.507 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.14 22.8 67.46 Favored Glycine 0 CA--C 1.563 3.077 0 O-C-N 127.163 2.331 . . . . 0.0 112.048 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.0 p -55.29 -49.31 72.45 Favored 'General case' 0 C--O 1.261 1.681 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.5 t -71.29 -43.3 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.4 tp -68.56 -30.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.002 -1.686 . . . . 0.0 113.417 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.8 mtm-85 -63.02 -39.1 93.75 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 122.375 1.083 . . . . 0.0 110.875 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.93 98.25 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 119.874 -1.766 . . . . 0.0 114.324 166.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 36.3 mt -67.22 -38.82 85.91 Favored 'General case' 0 C--O 1.188 -2.134 0 O-C-N 118.338 -2.727 . . . . 0.0 109.714 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.281 15.3 t -59.46 -39.73 84.6 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 114.282 -2.77 . . . . 0.0 114.185 165.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -69.96 -38.92 76.25 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 122.827 2.558 . . . . 0.0 115.669 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -69.36 -43.13 74.24 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 126.787 2.554 . . . . 0.0 111.058 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.7 p -83.7 -25.14 30.89 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.1 30.75 54.76 Favored Glycine 0 C--N 1.318 -0.42 0 CA-C-O 117.192 -1.893 . . . . 0.0 110.201 173.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 t -152.63 162.21 41.54 Favored 'General case' 0 C--N 1.396 2.621 0 C-N-CA 128.68 2.792 . . . . 0.0 106.034 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.4 m -73.83 124.09 25.43 Favored 'General case' 0 C--N 1.371 1.539 0 C-N-CA 126.134 1.774 . . . . 0.0 113.922 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.1 mm -112.69 135.01 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 112.943 -1.935 . . . . 0.0 108.768 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -132.96 158.31 42.98 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mm -109.45 132.36 57.8 Favored 'Isoleucine or valine' 0 C--N 1.368 1.387 0 O-C-N 119.691 -1.88 . . . . 0.0 107.959 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -115.5 169.76 8.93 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.06 139.59 0.67 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 124.396 2.046 . . . . 0.0 113.731 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.317 28.2 m-20 67.51 38.34 3.16 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 113.244 -1.798 . . . . 0.0 113.0 173.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.53 41.1 77.55 Favored Glycine 0 N--CA 1.422 -2.276 0 CA-C-O 115.989 -2.561 . . . . 0.0 117.357 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.0 m -103.84 108.82 20.31 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 120.189 1.994 . . . . 0.0 111.646 -169.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -73.43 127.59 35.45 Favored 'Isoleucine or valine' 0 C--N 1.382 2.02 0 O-C-N 123.632 0.582 . . . . 0.0 111.303 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -119.41 137.16 53.93 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 124.584 2.135 . . . . 0.0 111.21 173.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 43.8 mt -104.33 112.48 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 113.069 -1.878 . . . . 0.0 109.425 -172.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.63 -47.48 78.42 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 116.911 -1.518 . . . . 0.0 112.969 -173.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.8 138.04 53.86 Favored 'General case' 0 C--N 1.369 1.44 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.0 p -95.54 -0.57 51.91 Favored 'General case' 0 C--N 1.369 1.426 0 O-C-N 120.185 -1.572 . . . . 0.0 114.07 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -55.47 151.94 9.56 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 126.37 2.294 . . . . 0.0 114.827 168.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.29 -48.32 5.71 Favored Glycine 0 N--CA 1.478 1.487 0 O-C-N 120.596 -1.315 . . . . 0.0 112.108 -172.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.17 -26.44 63.91 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.22 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -65.16 -41.53 94.59 Favored 'General case' 0 C--N 1.386 2.171 0 C-N-CA 123.42 0.688 . . . . 0.0 111.414 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.49 67.58 Favored 'General case' 0 C--O 1.252 1.224 0 O-C-N 124.045 0.841 . . . . 0.0 110.561 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -63.29 -40.71 98.12 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.41 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -68.25 -45.81 72.17 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 121.124 1.784 . . . . 0.0 110.564 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.91 87.32 Favored 'General case' 0 C--O 1.258 1.532 0 O-C-N 124.634 1.209 . . . . 0.0 112.302 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.256 15.0 tt -70.71 -31.56 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.372 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -61.28 -42.95 99.5 Favored 'General case' 0 CA--C 1.574 1.903 0 CA-C-N 121.043 1.747 . . . . 0.0 114.865 171.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -60.53 -47.19 87.26 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.4 mm -56.47 -38.66 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 O-C-N 120.457 -1.402 . . . . 0.0 112.722 170.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.17 -53.91 52.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.84 1.337 . . . . 0.0 113.113 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -59.58 -37.2 77.87 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.911 1.285 . . . . 0.0 114.154 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.9 mt -69.45 -36.07 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -64.72 -40.03 94.64 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.925 1.391 . . . . 0.0 109.137 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.58 1.73 36.69 Favored 'General case' 0 CA--C 1.589 2.469 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.77 149.66 49.8 Favored 'General case' 0 N--CA 1.516 2.864 0 O-C-N 119.603 -1.936 . . . . 0.0 110.327 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mm -61.23 131.66 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.349 -1.47 . . . . 0.0 112.698 -171.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -91.64 135.19 34.06 Favored 'General case' 0 C--N 1.374 1.656 0 O-C-N 119.928 -1.733 . . . . 0.0 112.676 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.8 t -73.5 140.31 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 O-C-N 127.171 2.795 . . . . 0.0 113.589 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.05 -8.43 57.48 Favored Glycine 0 C--N 1.387 3.374 0 C-N-CA 126.276 1.894 . . . . 0.0 114.806 -171.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -89.83 149.37 22.7 Favored 'General case' 0 C--N 1.365 1.269 0 O-C-N 121.234 -1.157 . . . . 0.0 109.537 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.46 121.78 58.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.39 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -111.42 166.46 11.1 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 53.0 m -112.79 134.53 54.27 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.09 168.32 23.75 Favored Glycine 0 CA--C 1.475 -2.462 0 C-N-CA 117.547 -2.263 . . . . 0.0 108.648 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -118.41 135.37 54.38 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 113.242 -1.479 . . . . 0.0 113.631 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.3 t -69.3 135.82 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.233 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.759 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.9 p -128.4 -18.05 4.09 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.909 -1.119 . . . . 0.0 108.249 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -154.42 156.88 37.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.679 -1.888 . . . . 0.0 108.249 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 mm -123.88 135.32 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 CA-C-O 123.653 1.692 . . . . 0.0 111.136 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.9 m -126.7 168.43 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.694 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.61 -46.16 48.91 Favored 'General case' 0 C--O 1.179 -2.618 0 C-N-CA 123.899 0.88 . . . . 0.0 111.976 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -107.44 17.63 22.53 Favored 'General case' 0 N--CA 1.514 2.73 0 C-N-CA 125.898 1.679 . . . . 0.0 114.622 -169.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.93 -163.32 33.66 Favored Glycine 0 C--N 1.363 2.05 0 O-C-N 118.394 -2.691 . . . . 0.0 108.977 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.76 165.5 30.35 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 170.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -107.88 127.27 53.59 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 126.718 2.511 . . . . 0.0 111.867 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.6 t -122.45 126.22 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 CA-C-N 112.593 -2.094 . . . . 0.0 108.925 -166.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.8 109.9 21.77 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 126.157 2.161 . . . . 0.0 110.316 -171.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.7 pt -105.35 161.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.203 0 C-N-CA 126.085 1.754 . . . . 0.0 111.916 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.36 136.75 7.0 Favored Glycine 0 C--N 1.36 1.894 1 N-CA-C 124.032 4.373 . . . . 0.0 124.032 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.66 4.0 39.99 Favored Glycine 0 C--N 1.306 -1.1 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.84 23.99 56.53 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -107.28 148.54 28.85 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.981 1.391 . . . . 0.0 112.226 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -127.37 127.46 44.25 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 125.698 1.874 . . . . 0.0 110.782 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -119.38 155.93 15.93 Favored Glycine 0 CA--C 1.556 2.645 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.3 tp -90.47 118.36 29.88 Favored 'General case' 0 N--CA 1.518 2.972 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.27 107.67 20.36 Favored 'Isoleucine or valine' 0 C--N 1.396 2.62 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -68.88 162.41 26.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 118.299 -2.751 . . . . 0.0 116.872 172.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.2 tt -61.83 -37.64 78.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -59.51 -19.6 49.33 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 126.804 2.565 . . . . 0.0 116.345 167.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -106.15 9.78 32.17 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.499 -1.228 . . . . 0.0 112.588 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.9 mt -88.38 -49.42 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 119.087 0.858 . . . . 0.0 109.856 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.12 157.57 43.65 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 116.009 -1.948 . . . . 0.0 107.036 -172.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -71.46 -19.22 62.25 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -95.06 134.57 37.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.816 2.046 . . . . 0.0 105.892 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.19 116.44 1.86 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 177.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.66 120.01 35.54 Favored 'Isoleucine or valine' 0 C--O 1.262 1.724 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.34 -40.9 90.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 126.343 2.277 . . . . 0.0 111.808 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -157.52 151.69 24.67 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.2 t -63.12 -36.81 77.45 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 0 CA-C-O 116.727 -1.606 . . . . 0.0 113.15 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.59 -25.2 16.33 Favored 'General case' 0 N--CA 1.513 2.692 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -69.04 -19.85 64.11 Favored 'General case' 0 CA--C 1.575 1.918 0 C-N-CA 125.354 1.462 . . . . 0.0 113.872 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -123.48 -37.0 2.71 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.201 -1.562 . . . . 0.0 112.485 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.3 mt -130.23 150.94 51.24 Favored 'General case' 0 CA--C 1.574 1.903 0 CA-C-O 124.293 1.997 . . . . 0.0 115.328 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -159.34 155.98 27.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -172.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -43.95 125.69 4.44 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 122.705 1.241 . . . . 0.0 113.227 165.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.58 -2.72 80.85 Favored Glycine 0 N--CA 1.494 2.556 0 CA-C-N 114.264 -1.335 . . . . 0.0 116.087 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -73.65 128.48 35.61 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.471 171.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -106.52 124.92 50.33 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 124.516 1.135 . . . . 0.0 109.666 168.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.97 151.12 61.55 Favored Pre-proline 0 C--N 1.379 1.856 0 C-N-CA 127.72 2.408 . . . . 0.0 110.982 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -90.81 138.89 2.56 Favored 'Trans proline' 0 CA--C 1.493 -1.565 0 N-CA-C 104.814 -2.802 . . . . 0.0 104.814 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 6.2 m -136.41 126.77 40.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 110.946 -2.843 . . . . 0.0 109.133 -168.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.9 tttt -100.26 122.18 42.65 Favored 'General case' 0 C--N 1.368 1.397 0 O-C-N 120.222 -1.549 . . . . 0.0 111.395 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.13 118.73 5.66 Favored 'Isoleucine or valine' 0 C--O 1.264 1.856 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.488 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.5 mt -90.68 -50.26 6.01 Favored 'General case' 0 C--O 1.254 1.295 0 CA-C-N 111.888 -2.414 . . . . 0.0 113.613 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -159.78 148.58 17.6 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 116.047 -1.93 . . . . 0.0 107.371 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.0 t -133.93 120.33 35.5 Favored 'Isoleucine or valine' 0 C--N 1.388 2.271 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.92 146.78 53.28 Favored 'General case' 0 CA--C 1.556 1.205 0 O-C-N 126.028 2.08 . . . . 0.0 111.676 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -46.69 -33.76 4.55 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 167.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -92.73 29.15 1.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.11 1.364 . . . . 0.0 109.656 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.98 59.16 7.8 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 120.041 2.776 . . . . 0.0 120.041 166.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -137.19 136.82 38.52 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.3 mt -121.66 122.68 67.64 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 O-C-N 126.466 2.354 . . . . 0.0 108.892 -158.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -94.19 136.23 34.71 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.9 mt -124.73 152.35 43.9 Favored 'General case' 0 C--N 1.372 1.557 0 O-C-N 127.408 2.942 . . . . 0.0 111.524 -173.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.9 t -140.6 138.9 34.77 Favored 'General case' 0 CA--C 1.484 -1.585 0 O-C-N 120.534 -1.354 . . . . 0.0 109.974 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.65 -34.71 7.55 Favored 'Isoleucine or valine' 0 C--O 1.258 1.512 0 O-C-N 125.86 1.975 . . . . 0.0 110.432 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -77.12 -33.28 56.81 Favored 'General case' 0 C--O 1.198 -1.654 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -168.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -71.34 -30.97 66.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.43 -21.81 35.56 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 119.024 -2.297 . . . . 0.0 109.314 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.7 p -93.09 7.27 44.86 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 121.007 1.73 . . . . 0.0 113.655 171.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.258 27.6 mt-10 74.8 51.6 0.08 Allowed 'General case' 0 C--O 1.243 0.755 0 O-C-N 118.042 -2.911 . . . . 0.0 113.295 169.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 . . . . . 0 C--N 1.375 1.709 0 CA-C-O 123.501 1.619 . . . . 0.0 111.896 163.567 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.911 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 tp -110.34 135.68 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.093 0 O-C-N 124.609 1.193 . . . . 0.0 108.328 172.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -116.03 113.88 23.82 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 162.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.7 m -100.62 106.13 17.59 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -109.3 158.5 9.2 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.212 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.421 -172.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -108.96 140.09 42.93 Favored 'General case' 0 C--N 1.368 1.401 0 O-C-N 119.111 -2.243 . . . . 0.0 109.021 167.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.89 162.27 36.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -64.53 132.22 95.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-O 114.254 -2.784 . . . . 0.0 112.576 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . 0.271 42.6 Cg_exo -48.79 -29.25 14.42 Favored 'Trans proline' 0 N--CA 1.515 2.742 0 N-CA-C 120.204 3.117 . . . . 0.0 120.204 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.2 -7.72 59.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.129 2.171 . . . . 0.0 111.38 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -98.98 7.88 45.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 115.59 -2.148 . . . . 0.0 114.321 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.35 -36.91 78.51 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 CA-C-N 121.25 1.841 . . . . 0.0 110.101 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.528 ' HZ1' ' CD ' ' A' ' 80' ' ' GLU . 4.9 pttp -58.09 -44.57 87.69 Favored 'General case' 0 N--CA 1.385 -3.7 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 170.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -72.46 -39.19 67.94 Favored 'General case' 0 CA--C 1.484 -1.567 0 O-C-N 126.004 2.065 . . . . 0.0 112.61 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.1 -42.34 91.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.245 0 O-C-N 125.794 1.934 . . . . 0.0 113.802 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.7 mt -72.3 -43.02 65.66 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 O-C-N 119.063 -2.273 . . . . 0.0 113.564 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.49 171.86 39.76 Favored Glycine 0 CA--C 1.56 2.897 0 CA-C-O 121.774 0.652 . . . . 0.0 113.915 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -66.87 110.61 3.38 Favored 'General case' 1 N--CA 1.539 4.004 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.65 31.37 79.78 Favored Glycine 0 CA--C 1.544 1.845 0 O-C-N 125.036 1.46 . . . . 0.0 110.902 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.13 25.54 73.42 Favored Glycine 0 N--CA 1.509 3.505 0 C-N-CA 128.035 2.731 . . . . 0.0 114.847 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 t -62.43 -47.68 83.03 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-O 116.849 -1.548 . . . . 0.0 113.662 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.6 t -71.45 -50.0 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 120.29 1.404 . . . . 0.0 108.836 -176.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -55.3 -36.17 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 121.399 1.908 . . . . 0.0 112.755 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -78.84 -36.03 43.11 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 118.931 -1.108 . . . . 0.0 112.029 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.63 -40.65 84.6 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 117.361 -3.337 . . . . 0.0 108.125 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.1 tp -62.87 -40.26 96.95 Favored 'General case' 0 C--N 1.361 1.107 0 O-C-N 120.689 -1.257 . . . . 0.0 111.67 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.1 m -67.2 -48.76 66.92 Favored 'General case' 0 C--N 1.373 1.602 0 O-C-N 125.27 1.606 . . . . 0.0 112.256 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -63.97 -43.85 94.53 Favored 'General case' 0 C--N 1.381 1.97 0 O-C-N 116.502 -3.874 . . . . 0.0 115.025 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -59.23 -40.73 86.82 Favored 'General case' 0 C--N 1.385 2.121 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.8 p -108.01 -3.03 19.14 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -162.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.65 25.26 75.14 Favored Glycine 0 CA--C 1.552 2.401 0 N-CA-C 118.86 2.304 . . . . 0.0 118.86 -173.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 p -124.32 159.26 30.7 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.624 1.17 . . . . 0.0 113.578 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.0 m -110.53 131.57 54.94 Favored 'General case' 0 C--N 1.399 2.744 0 CA-C-N 119.649 1.113 . . . . 0.0 110.289 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.53 138.8 44.73 Favored 'Isoleucine or valine' 0 C--N 1.37 1.481 0 O-C-N 120.785 -1.197 . . . . 0.0 111.403 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -131.95 157.25 44.54 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.269 6.2 tt -150.67 125.02 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 O-C-N 116.716 -3.74 . . . . 0.0 109.776 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -86.53 154.05 21.38 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 119.318 -2.114 . . . . 0.0 112.53 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -53.0 -32.33 45.95 Favored 'General case' 0 C--N 1.393 2.458 0 C-N-CA 127.194 2.197 . . . . 0.0 113.095 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 p30 -86.57 12.57 10.17 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 119.804 1.183 . . . . 0.0 110.892 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.29 26.51 65.87 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-O 123.22 1.455 . . . . 0.0 114.11 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 m -92.09 108.92 20.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 167.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.27 144.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -131.61 115.05 15.58 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.39 108.68 25.95 Favored 'Isoleucine or valine' 0 C--N 1.376 1.726 0 C-N-CA 125.661 1.585 . . . . 0.0 109.896 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.14 128.93 45.35 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.38 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.88 149.05 28.53 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 104.4 -2.445 . . . . 0.0 104.4 173.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 p -78.37 -27.1 46.81 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.425 1.078 . . . . 0.0 110.388 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.54 136.22 41.74 Favored 'General case' 0 CA--C 1.58 2.1 0 C-N-CA 128.343 2.657 . . . . 0.0 112.167 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.04 -49.49 40.56 Favored Glycine 0 CA--C 1.558 2.769 0 C-N-CA 124.35 0.976 . . . . 0.0 112.576 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.27 -33.69 73.95 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 121.609 2.705 . . . . 0.0 114.201 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -68.52 -45.17 72.98 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 126.331 2.269 . . . . 0.0 110.914 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.58 83.38 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 119.326 -2.109 . . . . 0.0 113.053 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . 0.297 91.9 mttt -54.04 -41.58 68.26 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.473 1.109 . . . . 0.0 113.246 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -62.81 -38.59 91.32 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.95 -35.83 74.81 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 119.042 -2.286 . . . . 0.0 116.313 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.74 -37.24 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 O-C-N 124.676 1.235 . . . . 0.0 109.882 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -67.58 -40.34 84.86 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.46 1.482 . . . . 0.0 113.097 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -68.13 -40.64 82.41 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 120.144 -1.598 . . . . 0.0 110.814 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.04 -41.83 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.526 0 CA-C-O 116.822 -1.561 . . . . 0.0 112.049 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -48.47 -52.12 23.83 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-N 122.676 2.489 . . . . 0.0 115.956 166.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.77 -45.86 90.98 Favored 'General case' 0 CA--C 1.569 1.708 0 O-C-N 127.094 2.746 . . . . 0.0 111.141 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.5 mt -62.71 -40.3 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.941 0.896 . . . . 0.0 110.493 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.7 p -85.06 -10.51 56.83 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 123.963 1.84 . . . . 0.0 111.517 -172.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.43 -37.54 71.43 Favored 'General case' 0 N--CA 1.407 -2.595 0 O-C-N 120.359 -1.463 . . . . 0.0 112.721 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.33 132.37 52.86 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.831 1.252 . . . . 0.0 110.166 -165.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.7 mm -59.95 127.18 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.528 ' CD ' ' HZ1' ' A' ' 26' ' ' LYS . 68.2 mm-40 -73.86 148.99 41.85 Favored 'General case' 0 CA--C 1.579 2.066 0 CA-C-O 122.449 1.118 . . . . 0.0 112.575 165.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.6 137.27 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 -10.25 73.63 Favored Glycine 0 C--N 1.376 2.776 0 C-N-CA 126.989 2.233 . . . . 0.0 113.783 -174.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -97.93 163.06 12.94 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -172.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.14 139.35 30.65 Favored 'Isoleucine or valine' 0 C--N 1.386 2.196 0 CA-C-O 123.038 1.399 . . . . 0.0 110.612 -175.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -130.87 172.3 12.18 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.377 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 133' ' ' PRO . 86.9 m -133.0 123.36 25.71 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.19 -171.61 12.75 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -120.26 154.94 34.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 125.384 1.285 . . . . 0.0 114.029 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.7 t -85.31 127.75 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-O 123.331 1.538 . . . . 0.0 109.31 -175.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.9 -36.49 6.36 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 111.609 -2.541 . . . . 0.0 112.293 -172.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.4 mtt-85 -150.11 145.89 26.6 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 122.763 1.268 . . . . 0.0 109.894 -170.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -124.26 134.97 65.21 Favored 'Isoleucine or valine' 0 C--N 1.366 1.316 0 CA-C-O 124.434 2.064 . . . . 0.0 110.453 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.69 165.66 18.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.681 0 CA-C-N 111.585 -2.552 . . . . 0.0 107.941 166.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -52.75 -35.44 56.13 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 119.347 3.092 . . . . 0.0 119.347 -163.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -118.3 19.12 13.55 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 124.733 1.213 . . . . 0.0 112.161 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.83 168.64 41.04 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.95 1.54 . . . . 0.0 116.95 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.98 167.3 18.46 Favored 'General case' 0 C--N 1.374 1.656 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -124.02 136.79 54.51 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.455 173.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.17 131.97 72.24 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.397 0 C-N-CA 123.532 0.733 . . . . 0.0 111.21 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.96 121.64 40.12 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.217 1.484 . . . . 0.0 112.511 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.6 pt -115.74 166.97 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 112.043 -2.344 . . . . 0.0 114.484 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -31.51 142.77 0.03 OUTLIER Glycine 0 CA--C 1.57 3.507 0 N-CA-C 122.132 3.613 . . . . 0.0 122.132 172.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.19 25.7 69.87 Favored Glycine 0 N--CA 1.484 1.866 0 O-C-N 120.445 -1.621 . . . . 0.0 114.811 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.91 22.74 65.46 Favored Glycine 0 C--O 1.255 1.467 0 N-CA-C 118.529 2.171 . . . . 0.0 118.529 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -94.49 152.22 18.75 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 122.137 0.97 . . . . 0.0 113.308 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -130.96 151.33 51.49 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 168.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.8 175.29 22.21 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.375 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 139.14 35.65 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.259 1.424 . . . . 0.0 112.289 -174.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.6 t -125.0 106.55 16.65 Favored 'Isoleucine or valine' 0 C--O 1.261 1.665 0 CA-C-O 124.431 2.062 . . . . 0.0 106.996 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -77.59 151.13 34.56 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.328 -1.482 . . . . 0.0 112.85 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.48 -33.11 43.46 Favored 'Isoleucine or valine' 0 C--N 1.391 2.411 0 CA-C-O 115.918 -1.991 . . . . 0.0 114.144 -164.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 95.7 p -56.57 -32.65 65.39 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 124.94 3.518 . . . . 0.0 118.342 164.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -97.91 4.18 49.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 121.063 1.756 . . . . 0.0 113.66 -161.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.2 -39.87 85.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 124.651 1.22 . . . . 0.0 107.776 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -162.97 161.58 25.66 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -69.17 -37.74 78.35 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 127.47 2.308 . . . . 0.0 109.699 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -69.79 142.8 53.12 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 113.316 -1.765 . . . . 0.0 108.194 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -82.71 115.12 21.5 Favored 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -170.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.411 HG23 ' CD1' ' A' ' 125' ' ' TYR . 58.5 t -100.28 122.85 52.71 Favored 'Isoleucine or valine' 0 C--N 1.385 2.151 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -164.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -107.45 -13.86 14.99 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.625 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.259 18.2 pttp -150.54 140.24 21.7 Favored 'General case' 0 C--O 1.21 -1.023 0 O-C-N 126.973 2.671 . . . . 0.0 106.336 159.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.54 -33.53 49.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 O-C-N 127.112 2.758 . . . . 0.0 112.915 -159.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.3 -36.54 61.32 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 109.895 -3.32 . . . . 0.0 116.713 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -57.02 -37.73 72.13 Favored 'General case' 0 N--CA 1.439 -1.025 0 O-C-N 125.221 1.576 . . . . 0.0 112.74 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.411 ' CD1' HG23 ' A' ' 119' ' ' VAL . 31.0 m-85 -93.54 -42.89 8.98 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 121.68 2.036 . . . . 0.0 114.262 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.8 mt -109.13 123.01 48.51 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.929 0.892 . . . . 0.0 109.867 -163.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -108.63 142.14 39.55 Favored 'General case' 0 C--N 1.363 1.195 0 C-N-CA 126.029 1.731 . . . . 0.0 109.129 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 33.4 mmm -66.66 144.15 56.56 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.179 -169.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 46.93 39.07 10.91 Favored Glycine 0 CA--C 1.54 1.638 0 O-C-N 127.273 2.858 . . . . 0.0 117.505 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -119.75 136.02 54.61 Favored 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 125.549 1.54 . . . . 0.0 111.713 165.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.61 128.91 39.55 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 m -122.54 131.04 24.43 Favored Pre-proline 0 C--O 1.286 3.013 0 CA-C-N 111.173 -2.739 . . . . 0.0 106.032 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 0.4 OUTLIER -63.24 148.49 92.98 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 121.05 1.167 . . . . 0.0 109.464 159.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.6 134.91 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 C-N-CA 124.873 1.269 . . . . 0.0 107.604 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -95.82 132.66 40.83 Favored 'General case' 0 N--CA 1.519 2.983 0 C-N-CA 123.154 0.582 . . . . 0.0 110.757 164.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.71 110.69 18.76 Favored 'Isoleucine or valine' 0 C--N 1.374 1.662 0 O-C-N 120.282 -1.511 . . . . 0.0 109.493 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.87 -33.43 59.99 Favored 'General case' 0 C--N 1.373 1.615 0 O-C-N 125.719 1.887 . . . . 0.0 113.381 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -178.47 144.16 0.29 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -168.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.6 t -118.41 126.25 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 O-C-N 125.071 1.482 . . . . 0.0 107.889 161.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.292 0.0 OUTLIER -85.23 173.51 10.33 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 126.118 2.866 . . . . 0.0 113.572 -170.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -38.17 59.82 Favored 'General case' 0 CA--C 1.599 2.859 0 CA-C-N 110.873 -2.876 . . . . 0.0 111.293 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -85.62 -27.47 25.42 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.566 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.38 24.72 3.7 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.681 1.134 . . . . 0.0 111.518 170.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -80.9 140.87 35.08 Favored 'General case' 0 C--N 1.373 1.591 0 C-N-CA 126.5 1.92 . . . . 0.0 110.262 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.8 mt -105.12 132.38 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -125.27 119.45 28.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -168.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.7 mt -126.18 161.94 26.54 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 124.458 1.099 . . . . 0.0 111.403 -163.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.4 t -138.88 135.49 34.54 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 54.7 mt -83.28 -38.84 14.8 Favored 'Isoleucine or valine' 0 C--N 1.362 1.112 0 CA-C-O 116.177 -1.868 . . . . 0.0 107.032 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -76.28 -19.14 58.58 Favored 'General case' 0 C--N 1.366 1.299 0 O-C-N 125.684 1.865 . . . . 0.0 108.661 -171.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -81.65 -20.88 38.7 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 119.58 -1.95 . . . . 0.0 112.16 166.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.58 -36.91 65.61 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.411 -2.056 . . . . 0.0 111.025 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.0 p -96.38 20.67 10.16 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.218 -175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 35.0 64.37 0.43 Allowed 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 127.027 2.131 . . . . 0.0 115.0 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 . . . . . 0 C--O 1.25 1.102 0 O-C-N 117.699 -3.125 . . . . 0.0 106.03 172.032 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 115.524 -2.179 . . . . 0.0 107.026 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 mm -119.3 125.45 74.44 Favored 'Isoleucine or valine' 0 C--O 1.263 1.795 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -170.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -119.18 131.53 55.86 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.277 -171.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -112.33 129.47 56.28 Favored 'General case' 0 C--N 1.366 1.311 0 O-C-N 124.763 1.289 . . . . 0.0 113.752 -164.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.9 pt -130.2 170.2 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 O-C-N 125.075 1.485 . . . . 0.0 109.795 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -131.84 141.9 49.56 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.606 -1.237 . . . . 0.0 111.414 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.9 133.54 54.91 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.863 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -59.38 157.98 22.36 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 124.902 1.281 . . . . 0.0 112.645 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -70.49 -37.45 7.4 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.844 2.363 . . . . 0.0 110.45 -166.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -62.13 -46.41 89.13 Favored 'General case' 0 C--N 1.37 1.482 0 C-N-CA 118.307 -1.357 . . . . 0.0 114.366 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -78.26 -20.67 51.19 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 tp -59.37 -34.3 53.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 117.717 -1.593 . . . . 0.0 114.702 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -59.95 -34.0 72.67 Favored 'General case' 0 CA--C 1.557 1.242 0 O-C-N 124.724 1.265 . . . . 0.0 113.589 170.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -68.45 -42.98 78.05 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 122.62 1.2 . . . . 0.0 114.105 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 t -64.11 -40.62 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.756 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.8 mm -98.6 28.0 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 CA-C-N 119.02 0.827 . . . . 0.0 111.498 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.89 125.44 11.93 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 118.613 2.205 . . . . 0.0 118.613 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.45 7.1 mptt 60.88 51.5 4.65 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.35 45.22 96.39 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 126.29 2.244 . . . . 0.0 114.986 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.0 0.76 67.97 Favored Glycine 0 C--N 1.358 1.774 0 CA-C-N 118.571 1.185 . . . . 0.0 111.493 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -66.47 -34.26 77.53 Favored 'General case' 0 C--O 1.202 -1.436 0 CA-C-N 119.389 1.595 . . . . 0.0 110.865 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.38 -45.59 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 CA-C-O 116.623 -1.656 . . . . 0.0 109.626 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.7 tp -80.52 -31.76 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 125.823 1.952 . . . . 0.0 111.153 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.71 -48.38 79.73 Favored 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 166.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.12 -45.17 82.06 Favored 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 124.426 1.09 . . . . 0.0 111.012 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.7 -37.92 80.16 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.263 33.3 p -64.6 -38.4 90.87 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 171.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -63.58 -47.78 80.07 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 125.008 1.443 . . . . 0.0 111.646 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -67.45 -47.14 71.03 Favored 'General case' 0 CA--C 1.457 -2.611 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.864 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -85.56 -8.41 58.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 127.583 3.052 . . . . 0.0 113.962 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.16 21.33 79.26 Favored Glycine 0 C--N 1.365 2.149 0 CA-C-O 121.819 0.677 . . . . 0.0 113.359 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -134.89 139.65 45.16 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 122.261 -0.552 . . . . 0.0 109.97 -155.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.0 m -78.23 135.27 37.55 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 119.715 1.143 . . . . 0.0 108.975 166.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.4 mt -133.01 118.2 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.244 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -84.52 131.56 34.63 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.6 mm -112.97 112.79 41.94 Favored 'Isoleucine or valine' 0 C--N 1.373 1.627 0 CA-C-N 120.342 1.428 . . . . 0.0 107.945 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -123.06 170.48 10.13 Favored 'General case' 0 C--O 1.201 -1.463 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -36.13 149.31 0.02 OUTLIER 'General case' 0 C--O 1.205 -1.277 1 C-N-CA 131.921 4.088 . . . . 0.0 118.844 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t0 62.39 35.72 14.79 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 124.418 1.087 . . . . 0.0 110.845 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 47.27 28.98 4.79 Favored Glycine 0 C--O 1.205 -1.67 0 CA-C-N 112.224 -2.262 . . . . 0.0 115.723 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.5 m -64.15 125.48 24.64 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.716 -0.873 . . . . 0.0 110.366 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -124.94 138.68 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -129.38 122.04 28.64 Favored 'General case' 0 C--N 1.366 1.314 0 O-C-N 127.596 3.06 . . . . 0.0 108.686 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.5 mm -95.52 130.15 44.64 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 O-C-N 120.22 -1.55 . . . . 0.0 107.838 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.95 117.98 33.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 117.984 -1.486 . . . . 0.0 107.355 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.3 148.67 29.13 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.671 -1.268 . . . . 0.0 110.871 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -69.0 -57.35 5.58 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.232 164.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -99.03 135.31 40.62 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 120.396 -1.44 . . . . 0.0 113.675 -163.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.12 -28.63 73.81 Favored Glycine 0 CA--C 1.506 -0.49 0 O-C-N 120.351 -1.468 . . . . 0.0 115.863 -167.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -57.87 -39.87 78.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.998 -0.707 . . . . 0.0 112.801 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -73.17 -37.9 66.39 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.96 95.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -61.82 -42.9 99.61 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.844 168.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -62.7 -39.3 93.57 Favored 'General case' 0 N--CA 1.52 3.033 0 CA-C-N 121.995 2.18 . . . . 0.0 115.093 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.49 69.03 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 120.365 1.439 . . . . 0.0 110.36 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.88 -44.48 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 122.594 1.188 . . . . 0.0 111.451 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -60.97 -42.39 98.22 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 168.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -64.63 -39.67 94.11 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.479 1.111 . . . . 0.0 112.231 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 mm -58.75 -40.7 80.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.137 168.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.65 -42.27 86.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.294 1.406 . . . . 0.0 110.917 168.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -58.16 -43.12 87.25 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.9 mm -60.14 -44.39 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 CA-C-O 123.173 1.463 . . . . 0.0 113.808 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 p -77.56 -12.0 59.92 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.92 1.74 54.93 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 167.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.3 159.21 32.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 123.153 1.454 . . . . 0.0 108.775 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 mm -88.18 118.52 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 114.989 -2.434 . . . . 0.0 111.955 -171.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -125.09 134.85 52.33 Favored 'General case' 0 C--N 1.384 2.081 0 CA-C-N 121.288 1.858 . . . . 0.0 109.41 168.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.8 t -58.77 136.76 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.942 1.697 . . . . 0.0 111.372 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.59 -34.76 4.67 Favored Glycine 0 CA--C 1.55 2.28 0 O-C-N 120.809 -1.182 . . . . 0.0 113.789 -168.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -68.91 147.81 51.12 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-O 124.425 2.06 . . . . 0.0 113.147 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -89.1 133.3 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.694 0 CA-C-O 124.016 1.865 . . . . 0.0 111.868 169.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -133.13 169.68 16.51 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 126.874 2.07 . . . . 0.0 106.483 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.6 p -120.09 152.22 37.91 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.065 167.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.49 166.27 37.11 Favored Glycine 0 CA--C 1.465 -3.082 0 CA-C-O 123.776 1.765 . . . . 0.0 116.036 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 130' ' ' GLN . 55.6 mttm -106.31 127.76 53.49 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 110.968 -2.616 . . . . 0.0 115.334 -161.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.3 t -56.03 111.29 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.032 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -111.78 -13.44 13.71 Favored 'General case' 0 N--CA 1.525 3.309 0 CA-C-N 114.124 -1.398 . . . . 0.0 114.648 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.9 mtm-85 -155.02 153.48 31.04 Favored 'General case' 0 C--O 1.257 1.478 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 168.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.7 mt -132.21 125.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.7 m -138.3 166.83 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.585 -156.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -57.15 -35.23 69.28 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 126.87 2.606 . . . . 0.0 110.86 -165.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -111.74 10.25 20.92 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -174.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.0 -148.67 18.74 Favored Glycine 0 C--O 1.175 -3.534 0 CA-C-N 120.828 1.649 . . . . 0.0 115.83 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.91 157.13 43.9 Favored 'General case' 0 C--O 1.201 -1.457 0 O-C-N 119.489 -2.183 . . . . 0.0 108.88 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -119.76 143.98 47.52 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 177.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.54 125.59 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 CA-C-N 111.608 -2.542 . . . . 0.0 108.816 -166.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.01 123.87 31.05 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.6 mm -114.28 142.39 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.725 0 CA-C-N 112.205 -2.271 . . . . 0.0 107.405 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -34.84 138.58 0.21 Allowed Glycine 0 C--N 1.389 3.491 0 C-N-CA 128.001 2.715 . . . . 0.0 114.994 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.06 29.82 68.44 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-O 118.863 -0.965 . . . . 0.0 112.391 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.31 30.65 53.95 Favored Glycine 0 CA--C 1.477 -2.33 0 O-C-N 124.983 1.049 . . . . 0.0 115.413 167.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -106.34 162.14 13.95 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 125.862 1.566 . . . . 0.0 109.671 -170.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -149.32 122.17 8.73 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.498 1.499 . . . . 0.0 108.98 -171.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.89 162.13 15.77 Favored Glycine 0 CA--C 1.481 -2.033 0 CA-C-N 114.395 -1.275 . . . . 0.0 114.667 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.0 tp -114.56 126.24 54.7 Favored 'General case' 0 CA--C 1.491 -1.298 0 O-C-N 126.629 2.017 . . . . 0.0 111.343 -166.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.39 119.05 58.03 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 N-CA-C 100.693 -3.818 . . . . 0.0 100.693 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -82.93 169.68 15.76 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 120.725 -1.234 . . . . 0.0 109.254 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.9 tt -77.7 -25.72 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -157.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 81.7 p -92.26 7.03 44.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.416 -2.053 . . . . 0.0 111.259 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -120.33 27.36 8.65 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-O 114.779 -2.534 . . . . 0.0 109.591 -170.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.2 mt -105.03 -49.22 9.26 Favored 'Isoleucine or valine' 0 C--N 1.37 1.48 0 O-C-N 127.014 2.696 . . . . 0.0 109.117 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.22 173.73 11.24 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.333 -1.48 . . . . 0.0 109.031 -163.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -82.13 -53.39 6.12 Favored 'General case' 0 C--O 1.2 -1.509 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -65.75 138.84 58.21 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.695 0.798 . . . . 0.0 110.944 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -53.93 134.29 43.08 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.649 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -119.96 124.6 73.05 Favored 'Isoleucine or valine' 0 C--N 1.368 1.411 0 O-C-N 123.943 0.777 . . . . 0.0 111.851 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -109.18 -18.85 13.52 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 115.908 -1.996 . . . . 0.0 110.709 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -128.58 127.89 43.18 Favored 'General case' 0 C--N 1.381 1.936 0 CA-C-O 123.247 1.498 . . . . 0.0 109.024 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.21 -41.09 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 O-C-N 121.087 -1.008 . . . . 0.0 113.068 -174.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -55.88 -7.38 0.31 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 126.528 2.393 . . . . 0.0 112.481 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -69.5 -35.59 75.67 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.317 1.417 . . . . 0.0 113.871 173.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -115.23 -52.33 2.68 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 128.155 3.409 . . . . 0.0 114.251 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.1 mt -93.34 143.97 25.77 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.129 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.46 154.18 38.43 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 103.169 -2.9 . . . . 0.0 103.169 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 65.7 mmm -66.69 121.86 16.34 Favored 'General case' 0 C--O 1.192 -1.949 0 C-N-CA 127.399 2.28 . . . . 0.0 113.992 -165.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.17 -0.66 78.8 Favored Glycine 1 N--CA 1.518 4.13 0 N-CA-C 118.498 2.159 . . . . 0.0 118.498 -171.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.437 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.7 tt0 -57.75 141.09 49.89 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 167.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -87.13 121.48 29.63 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.581 170.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.2 m -113.4 129.33 24.72 Favored Pre-proline 0 C--O 1.215 -0.761 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.41 139.19 18.24 Favored 'Trans proline' 0 C--N 1.266 -3.815 0 N-CA-C 108.616 -1.34 . . . . 0.0 108.616 162.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.57 148.43 18.21 Favored 'Isoleucine or valine' 0 C--N 1.363 1.194 0 CA-C-O 123.169 1.461 . . . . 0.0 113.501 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -104.69 129.08 52.92 Favored 'General case' 0 C--O 1.19 -2.061 0 CA-C-N 111.843 -2.435 . . . . 0.0 111.819 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 81.6 t -82.4 122.27 36.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 125.575 1.797 . . . . 0.0 111.541 -170.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 3.5 mt -101.09 -33.13 10.26 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 117.601 -1.19 . . . . 0.0 112.227 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -145.23 146.52 31.74 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.42 119.8 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 123.157 1.456 . . . . 0.0 108.854 155.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.16 156.56 21.42 Favored 'General case' 0 C--O 1.254 1.322 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.335 169.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -51.98 -31.95 31.57 Favored 'General case' 0 C--N 1.401 2.845 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.79 13.17 33.28 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 120.427 1.467 . . . . 0.0 114.588 168.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.93 12.76 48.79 Favored Glycine 0 C--N 1.364 2.118 0 N-CA-C 118.068 1.987 . . . . 0.0 118.068 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -78.8 137.14 37.58 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-N 120.549 2.175 . . . . 0.0 109.29 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.8 mt -126.41 129.62 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 117.413 -1.28 . . . . 0.0 112.089 -159.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.09 128.67 51.73 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.622 171.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.6 mt -118.54 162.27 18.65 Favored 'General case' 0 N--CA 1.52 3.05 0 O-C-N 125.068 1.48 . . . . 0.0 114.385 -170.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.8 t -129.91 138.78 51.09 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.231 1.013 . . . . 0.0 109.414 168.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.9 mt -99.95 -28.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 167.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -57.85 -42.22 83.99 Favored 'General case' 0 C--N 1.37 1.469 0 O-C-N 119.442 -2.036 . . . . 0.0 111.6 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.33 -42.46 92.9 Favored 'General case' 0 CA--C 1.594 2.655 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.25 . . -61.6 -45.02 95.86 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 120.12 -1.613 . . . . 0.0 111.017 170.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.5 p -89.53 11.47 19.42 Favored 'General case' 0 C--O 1.2 -1.539 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.723 -175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 49.0 54.14 11.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 129.863 3.265 . . . . 0.0 116.161 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 . . . . . 0 CA--C 1.504 -0.816 0 O-C-N 119.315 -2.116 . . . . 0.0 108.81 -169.102 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 119.562 -0.256 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.7 mm -62.48 142.57 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 C-N-CA 117.702 -1.599 . . . . 0.0 112.503 169.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -135.79 129.36 32.38 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.78 163.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.3 m -111.62 138.4 48.23 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 122.099 0.952 . . . . 0.0 111.876 -172.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt -134.86 130.82 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 113.75 -1.568 . . . . 0.0 107.977 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -82.11 130.11 35.0 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-O 122.506 1.146 . . . . 0.0 111.607 163.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.2 mm -121.41 128.36 75.88 Favored 'Isoleucine or valine' 0 C--N 1.401 2.827 0 O-C-N 120.506 -1.371 . . . . 0.0 109.542 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -56.24 156.85 10.03 Favored Pre-proline 0 C--N 1.371 1.539 0 CA-C-N 119.555 1.07 . . . . 0.0 112.726 -171.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -66.2 -25.47 50.26 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 N-CA-C 116.757 1.791 . . . . 0.0 116.757 -167.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.47 ' CG ' ' HZ2' ' A' ' 24' ' ' LYS . 8.4 p-10 -84.2 -27.49 27.98 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-O 117.04 -1.457 . . . . 0.0 110.777 172.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.47 ' HZ2' ' CG ' ' A' ' 23' ' ' ASP . 42.8 mmtm -86.64 -26.51 24.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 121.546 1.976 . . . . 0.0 110.109 -169.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.0 tp -74.85 -19.61 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 O-C-N 124.61 1.194 . . . . 0.0 108.277 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.269 35.5 mmtm -64.93 -39.53 93.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.057 -1.027 . . . . 0.0 113.298 168.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.11 -38.6 91.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.865 1.666 . . . . 0.0 113.574 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.03 -33.31 62.47 Favored 'Isoleucine or valine' 0 C--N 1.375 1.706 0 C-N-CA 125.483 1.513 . . . . 0.0 111.352 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.6 mm -97.57 11.04 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-O 123.178 1.466 . . . . 0.0 111.581 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.37 167.39 13.29 Favored Glycine 0 C--N 1.296 -1.674 0 CA-C-N 111.792 -2.458 . . . . 0.0 115.944 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm 58.3 43.98 19.29 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.208 1.403 . . . . 0.0 113.327 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.3 12.72 81.83 Favored Glycine 0 CA--C 1.558 2.757 0 O-C-N 120.807 -1.183 . . . . 0.0 115.818 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.03 5.26 77.23 Favored Glycine 0 C--N 1.369 2.402 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 -171.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.7 m -63.08 -39.99 96.33 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-O 116.903 -1.522 . . . . 0.0 113.623 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 t -61.44 -47.36 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.309 6.4 tp -62.96 -39.33 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-N 119.427 1.012 . . . . 0.0 111.327 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -64.37 -51.57 62.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.351 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.05 -43.81 82.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 126.352 2.283 . . . . 0.0 115.286 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.91 -50.95 71.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.7 p -64.83 -35.2 80.33 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 120.673 -1.267 . . . . 0.0 112.564 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -72.36 -39.51 68.03 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 125.832 1.957 . . . . 0.0 110.338 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 71' ' ' ARG . 66.0 tt0 -61.76 -38.51 88.27 Favored 'General case' 0 C--O 1.259 1.555 0 CA-C-O 124.166 1.936 . . . . 0.0 113.003 174.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.5 p -91.24 -17.06 26.62 Favored 'General case' 0 C--N 1.367 1.335 0 O-C-N 118.663 -2.523 . . . . 0.0 116.363 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.03 28.6 73.73 Favored Glycine 0 CA--C 1.474 -2.484 1 O-C-N 129.254 4.096 . . . . 0.0 112.352 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 t -148.31 159.3 44.13 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 124.305 2.002 . . . . 0.0 107.671 -166.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -83.42 118.0 23.44 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 112.407 -2.179 . . . . 0.0 108.581 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.4 mt -124.08 121.32 61.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -113.22 147.42 37.52 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 125.573 2.606 . . . . 0.0 108.092 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 16.3 mm -112.09 123.4 67.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 112.014 -2.357 . . . . 0.0 109.227 -178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -123.88 166.83 14.98 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -165.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.281 81.9 m-20 -47.4 142.49 4.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.024 -1.672 . . . . 0.0 114.196 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.8 t0 54.27 67.3 1.03 Allowed 'General case' 0 C--N 1.35 0.598 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 171.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.53 27.47 26.39 Favored Glycine 0 C--N 1.301 -1.396 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 m -107.39 114.79 29.03 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.5 t -104.43 141.79 19.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -173.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -129.29 123.39 31.74 Favored 'General case' 0 C--N 1.363 1.19 0 CA-C-O 122.54 1.162 . . . . 0.0 109.498 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.6 mm -86.83 130.03 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.117 167.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.67 51.16 1.86 Allowed 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.87 153.38 21.37 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 119.048 -2.283 . . . . 0.0 114.729 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.7 p -100.04 21.92 12.05 Favored 'General case' 0 C--N 1.381 1.949 0 CA-C-O 115.476 -2.202 . . . . 0.0 111.301 -175.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -151.49 145.58 25.3 Favored 'General case' 0 C--N 1.372 1.585 0 O-C-N 127.244 2.84 . . . . 0.0 110.08 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.1 -33.98 61.87 Favored Glycine 0 N--CA 1.439 -1.128 0 O-C-N 125.248 1.592 . . . . 0.0 114.425 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.31 -45.43 87.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 116.703 -1.618 . . . . 0.0 108.186 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -58.74 -42.07 87.95 Favored 'General case' 0 C--N 1.375 1.681 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.86 98.13 Favored 'General case' 0 C--O 1.272 2.267 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -68.63 -37.41 79.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 125.394 1.684 . . . . 0.0 108.697 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -66.92 -42.86 84.65 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 120.074 -1.641 . . . . 0.0 114.521 170.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.15 -54.38 31.35 Favored 'General case' 0 C--O 1.191 -2.008 0 CA-C-N 121.176 1.807 . . . . 0.0 111.556 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.416 HD11 HG23 ' A' ' 69' ' ' ILE . 36.1 mt -60.87 -45.14 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 124.46 1.104 . . . . 0.0 110.168 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -56.33 -44.29 79.85 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 42' ' ' GLU . 3.2 mmm180 -63.16 -41.56 99.27 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 120.597 1.544 . . . . 0.0 107.827 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.19 -42.09 85.82 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.971 0 CA-C-O 116.805 -1.569 . . . . 0.0 110.234 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.32 -42.18 90.79 Favored 'General case' 0 N--CA 1.537 3.883 0 CA-C-N 121.734 2.061 . . . . 0.0 111.281 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -69.31 -39.16 78.42 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 126.242 2.214 . . . . 0.0 114.688 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.6 mt -71.61 -32.41 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 168.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 76.1 p -99.22 24.68 7.65 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.769 1.622 . . . . 0.0 109.672 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.33 0.9 12.34 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 117.547 -1.216 . . . . 0.0 111.712 162.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.358 40.0 mt-10 -60.33 129.27 40.81 Favored 'General case' 0 N--CA 1.515 2.781 0 CA-C-O 124.295 1.998 . . . . 0.0 108.72 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.7 mm -83.76 128.67 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 125.039 2.352 . . . . 0.0 115.254 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.49 ' CD ' ' HE ' ' A' ' 83' ' ' ARG . 24.2 tt0 -115.59 134.55 54.94 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-N 113.028 -1.896 . . . . 0.0 106.379 173.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.17 139.03 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 O-C-N 128.134 3.396 . . . . 0.0 110.31 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.95 -10.21 48.69 Favored Glycine 0 CA--C 1.551 2.342 0 O-C-N 119.39 -2.069 . . . . 0.0 113.835 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.49 ' HE ' ' CD ' ' A' ' 80' ' ' GLU . 77.1 mtt180 -81.87 159.33 23.73 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-N 119.662 1.731 . . . . 0.0 111.176 167.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.41 140.32 31.36 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -130.83 161.65 31.32 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.9 m -117.25 125.72 51.58 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.99 -169.76 12.41 Favored Glycine 0 N--CA 1.42 -2.412 0 C-N-CA 120.295 -0.955 . . . . 0.0 114.986 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -128.56 143.22 50.92 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 122.937 1.351 . . . . 0.0 114.432 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.3 t -73.76 122.75 27.47 Favored 'Isoleucine or valine' 0 C--N 1.382 2.008 0 O-C-N 118.078 -2.889 . . . . 0.0 115.288 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.12 -25.4 7.63 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 115.929 -1.986 . . . . 0.0 113.785 -170.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 -146.22 151.47 37.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 168.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -123.65 131.44 73.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.04 174.47 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 124.047 1.88 . . . . 0.0 111.324 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -58.62 -37.4 75.8 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 117.565 -1.654 . . . . 0.0 114.518 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -98.41 18.91 15.4 Favored 'General case' 0 C--N 1.374 1.664 0 CA-C-N 120.876 1.671 . . . . 0.0 111.737 -176.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.56 -135.92 6.19 Favored Glycine 0 C--N 1.383 3.182 0 N-CA-C 115.057 0.783 . . . . 0.0 115.057 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.57 160.81 41.09 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 125.649 1.441 . . . . 0.0 114.831 167.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.29 131.48 54.17 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-O 121.884 0.849 . . . . 0.0 111.122 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 72.9 t -110.85 134.3 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.646 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -98.49 127.71 44.54 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 120.221 -1.549 . . . . 0.0 109.395 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.92 150.79 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 CA-C-N 112.883 -1.962 . . . . 0.0 112.188 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.67 154.38 0.62 Allowed Glycine 0 CA--C 1.564 3.128 0 N-CA-C 118.958 2.343 . . . . 0.0 118.958 173.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.56 8.09 24.3 Favored Glycine 0 C--N 1.366 2.214 0 C-N-CA 127.663 2.554 . . . . 0.0 117.57 -168.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.79 22.86 16.95 Favored Glycine 0 C--O 1.256 1.494 0 O-C-N 127.585 2.58 . . . . 0.0 117.219 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.96 128.14 34.19 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 117.256 0.528 . . . . 0.0 110.491 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.0 146.83 35.98 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 123.343 1.544 . . . . 0.0 108.685 169.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -145.24 163.96 28.04 Favored Glycine 0 CA--C 1.48 -2.141 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.06 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.0 tp -110.61 136.4 49.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 124.372 0.689 . . . . 0.0 110.462 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.73 113.73 45.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 CA-C-O 123.824 1.773 . . . . 0.0 108.796 160.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -62.91 150.65 41.47 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 tt -52.89 -24.83 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.3 p -90.32 6.3 43.62 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 125.825 1.65 . . . . 0.0 112.198 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -120.45 5.35 10.66 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 120.16 -1.588 . . . . 0.0 114.072 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 18.5 mm -82.84 -48.56 17.7 Favored 'Isoleucine or valine' 0 C--O 1.283 2.821 0 CA-C-O 123.734 1.73 . . . . 0.0 112.304 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.29 173.84 13.52 Favored 'General case' 0 N--CA 1.406 -2.645 0 O-C-N 116.939 -3.601 . . . . 0.0 107.224 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -66.0 -33.7 76.4 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.2 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -71.56 161.19 31.4 Favored 'General case' 0 C--N 1.365 1.264 0 C-N-CA 124.733 1.213 . . . . 0.0 114.024 -173.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -70.63 122.22 19.36 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 124.679 2.181 . . . . 0.0 108.82 167.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.28 146.01 16.8 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.779 0 CA-C-N 112.38 -2.191 . . . . 0.0 110.157 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -119.84 -35.33 3.53 Favored 'General case' 0 C--N 1.369 1.445 0 CA-C-N 120.359 1.436 . . . . 0.0 113.826 160.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -123.17 129.3 51.22 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 122.7 1.238 . . . . 0.0 109.149 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.3 -20.43 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 111.814 -2.448 . . . . 0.0 106.646 -166.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.4 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.39 2.346 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -66.52 -45.33 79.85 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 125.716 1.606 . . . . 0.0 112.921 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -95.06 -17.97 21.42 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.7 mt -126.99 129.45 48.13 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -98.72 156.2 16.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.62 -1.3 . . . . 0.0 110.291 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 51.5 tpp -67.93 133.86 49.83 Favored 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 118.641 -2.537 . . . . 0.0 109.165 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.09 15.91 79.65 Favored Glycine 0 CA--C 1.548 2.132 0 O-C-N 126.061 2.1 . . . . 0.0 112.059 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -65.24 132.42 49.05 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.294 -1.709 . . . . 0.0 113.151 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -85.12 118.55 24.75 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 123.748 1.737 . . . . 0.0 112.957 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.86 125.33 20.23 Favored Pre-proline 0 CA--C 1.582 2.174 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -158.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.65 131.43 24.37 Favored 'Trans proline' 0 N--CA 1.518 2.923 0 O-C-N 117.726 -1.776 . . . . 0.0 111.786 165.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.15 136.82 57.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 CA-C-O 123.061 1.41 . . . . 0.0 110.452 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -105.01 143.42 33.22 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 120.702 -1.249 . . . . 0.0 109.764 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.9 t -86.9 137.48 20.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 122.17 0.986 . . . . 0.0 109.409 -170.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.65 -43.17 3.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 118.944 -2.348 . . . . 0.0 108.558 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -153.12 146.86 25.19 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-O 124.139 1.923 . . . . 0.0 108.205 -166.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.7 p -145.64 123.21 4.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 CA-C-O 124.119 1.914 . . . . 0.0 110.092 171.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.477 ' CG ' HH12 ' A' ' 146' ' ' ARG . 60.2 m-20 -71.74 175.34 5.79 Favored 'General case' 0 CA--C 1.592 2.593 0 O-C-N 119.826 -1.796 . . . . 0.0 115.207 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -68.51 -16.27 63.83 Favored 'General case' 0 CA--C 1.584 2.274 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.74 19.16 21.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 120.055 -1.653 . . . . 0.0 111.476 167.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.85 16.93 79.21 Favored Glycine 0 C--N 1.362 2.015 0 O-C-N 125.961 2.038 . . . . 0.0 114.468 168.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . 0.332 36.0 mtm180 -69.75 129.31 39.24 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 163.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.4 mt -108.68 141.33 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 119.545 -1.972 . . . . 0.0 110.714 -165.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.477 HH12 ' CG ' ' A' ' 140' ' ' ASP . 0.4 OUTLIER -113.1 150.09 32.6 Favored 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.606 160.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.4 mt -140.33 171.86 13.55 Favored 'General case' 0 C--O 1.258 1.508 0 CA-C-O 124.087 1.898 . . . . 0.0 111.391 -166.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.5 t -154.84 134.49 12.76 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.0 mt -87.96 -17.86 8.4 Favored 'Isoleucine or valine' 0 C--N 1.377 1.777 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -62.57 -50.18 72.34 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 172.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.56 -25.58 63.16 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 122.111 0.958 . . . . 0.0 109.714 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.08 -49.26 68.22 Favored 'General case' 0 C--O 1.257 1.478 0 O-C-N 119.797 -1.814 . . . . 0.0 115.01 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.9 p -92.2 10.5 29.22 Favored 'General case' 0 C--O 1.268 2.042 0 CA-C-N 112.138 -2.301 . . . . 0.0 111.214 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.337 45.8 mt-10 71.87 53.1 0.2 Allowed 'General case' 0 C--N 1.38 1.927 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 166.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 69.7 mm-40 . . . . . 0 C--N 1.353 0.733 0 CA-C-O 116.814 -1.565 . . . . 0.0 113.717 177.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 . . . . . 0 CA--C 1.561 1.383 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mm -71.31 125.77 30.39 Favored 'Isoleucine or valine' 0 C--N 1.365 1.269 0 CA-C-O 126.28 2.943 . . . . 0.0 112.266 161.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -116.17 138.96 50.82 Favored 'General case' 0 CA--C 1.59 2.486 0 CA-C-N 109.829 -3.35 . . . . 0.0 104.877 169.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 t -136.66 164.51 28.07 Favored 'General case' 0 N--CA 1.532 3.635 0 CA-C-O 117.627 -1.178 . . . . 0.0 112.252 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 tp -172.02 145.7 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.071 0 O-C-N 126.793 2.558 . . . . 0.0 105.228 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -128.58 130.63 47.64 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 124.8 1.24 . . . . 0.0 109.535 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.6 pt -133.33 162.99 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.834 0 O-C-N 126.513 2.383 . . . . 0.0 108.637 -166.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -43.95 141.96 2.2 Favored Pre-proline 0 N--CA 1.524 3.26 0 CA-C-N 120.024 1.284 . . . . 0.0 112.376 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -59.94 -34.33 95.25 Favored 'Trans proline' 0 CA--C 1.474 -2.475 0 C-N-CA 122.866 2.378 . . . . 0.0 112.567 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -65.2 -28.16 69.19 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-N 121.816 2.098 . . . . 0.0 113.425 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.2 -22.07 64.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.01 -43.59 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 C-N-CA 124.969 1.307 . . . . 0.0 110.649 171.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -51.87 -43.65 63.35 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 170.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -79.81 -22.13 43.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.71 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.8 t -70.61 -54.08 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-O 116.263 -1.827 . . . . 0.0 110.084 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -58.99 -42.49 86.34 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 CA-C-N 120.098 1.317 . . . . 0.0 109.022 173.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.1 175.97 49.14 Favored Glycine 0 C--N 1.374 2.69 0 O-C-N 119.425 -2.047 . . . . 0.0 113.888 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -74.78 119.2 18.64 Favored 'General case' 0 C--N 1.387 2.204 0 CA-C-N 119.704 1.752 . . . . 0.0 106.804 -171.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.49 4.48 87.36 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.43 17.64 70.73 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 118.628 -1.748 . . . . 0.0 115.962 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.1 p -69.3 -37.29 77.72 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 119.972 3.323 . . . . 0.0 119.972 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.6 t -74.28 -39.11 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 O-C-N 124.696 1.248 . . . . 0.0 112.5 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.287 17.0 tt -63.54 -41.21 91.87 Favored 'Isoleucine or valine' 0 C--O 1.262 1.738 0 O-C-N 127.16 2.787 . . . . 0.0 112.711 173.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -64.15 -37.5 87.67 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 125.666 1.854 . . . . 0.0 111.609 169.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.24 79.92 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.08 -42.32 98.29 Favored 'General case' 0 C--O 1.196 -1.744 0 O-C-N 118.328 -2.732 . . . . 0.0 108.558 170.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.1 m -59.26 -48.81 80.24 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.049 0.94 . . . . 0.0 111.024 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -73.92 -35.81 64.64 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 116.316 -2.153 . . . . 0.0 110.024 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -73.11 -41.55 63.9 Favored 'General case' 0 C--O 1.258 1.542 0 CA-C-N 122.314 2.325 . . . . 0.0 111.54 -175.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.7 p -81.85 -24.95 35.5 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 118.377 -2.702 . . . . 0.0 113.2 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.6 35.09 59.45 Favored Glycine 0 C--N 1.394 3.77 0 CA-C-N 122.061 2.209 . . . . 0.0 116.495 -169.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 p -129.55 177.37 7.26 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.127 1.771 . . . . 0.0 107.383 -165.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.2 m -121.68 114.77 21.6 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 123.121 1.439 . . . . 0.0 107.136 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mt -101.43 128.24 53.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 112.622 -2.081 . . . . 0.0 112.56 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -135.44 151.09 50.08 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-O 123.601 1.667 . . . . 0.0 109.715 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.0 mm -114.71 126.7 72.34 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.761 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.865 -171.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -118.58 147.14 44.02 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.19 162.95 0.05 OUTLIER 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 52.22 36.25 18.87 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 126.511 1.924 . . . . 0.0 115.485 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.07 8.76 66.45 Favored Glycine 0 CA--C 1.468 -2.903 0 CA-C-O 116.112 -2.493 . . . . 0.0 116.203 172.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.8 m -77.0 135.13 38.66 Favored 'General case' 0 C--O 1.256 1.432 0 O-C-N 127.248 2.381 . . . . 0.0 113.748 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -114.12 136.18 51.47 Favored 'Isoleucine or valine' 0 C--N 1.367 1.367 0 O-C-N 120.66 -1.275 . . . . 0.0 114.354 165.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -125.85 116.77 22.08 Favored 'General case' 0 C--O 1.196 -1.745 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.111 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.2 mt -114.04 119.87 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.556 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -98.02 142.11 30.14 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 126.883 2.614 . . . . 0.0 110.79 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.75 175.09 14.37 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-O 124.836 2.255 . . . . 0.0 106.131 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 t -116.95 -15.81 10.59 Favored 'General case' 0 N--CA 1.532 3.646 0 CA-C-N 112.671 -2.059 . . . . 0.0 112.296 171.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -120.42 114.51 21.92 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.18 -38.15 95.15 Favored Glycine 0 N--CA 1.505 3.268 0 N-CA-C 118.428 2.131 . . . . 0.0 118.428 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.0 -31.88 71.48 Favored 'General case' 0 C--N 1.377 1.804 0 CA-C-N 121.314 2.557 . . . . 0.0 113.772 167.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -67.69 -34.92 77.86 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 121.738 2.063 . . . . 0.0 114.385 170.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.51 -45.55 79.15 Favored 'General case' 0 C--O 1.254 1.341 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 171.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 43.5 mmtt -58.39 -37.08 74.56 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 115.08 -2.391 . . . . 0.0 110.742 167.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -62.93 -36.51 83.64 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 122.756 2.525 . . . . 0.0 111.361 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.36 -38.15 74.72 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 120.31 -1.494 . . . . 0.0 112.88 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.3 mt -60.32 -43.27 93.3 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.84 168.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -60.17 -49.27 78.3 Favored 'General case' 0 C--O 1.249 1.029 0 O-C-N 120.495 -1.378 . . . . 0.0 113.787 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -67.38 -30.0 69.68 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.061 1.301 . . . . 0.0 112.757 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.9 -47.39 83.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 CA-C-O 115.492 -2.194 . . . . 0.0 110.674 166.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.67 -39.55 77.35 Favored 'General case' 0 C--O 1.206 -1.227 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -64.07 -55.18 23.94 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-O 115.927 -1.987 . . . . 0.0 114.029 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 36.6 mm -55.25 -43.49 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.368 0 CA-C-N 121.577 1.99 . . . . 0.0 109.285 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.3 p -67.44 -19.47 65.37 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.97 -19.76 36.48 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 120.977 -1.077 . . . . 0.0 113.591 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -68.01 122.85 19.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 124.701 1.251 . . . . 0.0 111.501 -164.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 mm -69.08 124.85 25.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 CA-C-O 117.551 -1.214 . . . . 0.0 114.242 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -121.0 139.82 52.77 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-O 123.613 1.673 . . . . 0.0 107.239 168.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.05 130.12 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 117.16 -3.463 . . . . 0.0 115.287 171.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.06 -8.15 41.78 Favored Glycine 0 CA--C 1.485 -1.817 0 CA-C-O 117.014 -1.992 . . . . 0.0 112.498 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -57.28 147.98 24.0 Favored 'General case' 0 C--N 1.371 1.511 0 O-C-N 124.981 1.048 . . . . 0.0 112.838 166.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.9 129.56 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 128.167 3.417 . . . . 0.0 106.905 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -135.78 168.5 19.19 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 123.444 1.592 . . . . 0.0 110.014 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 m -112.45 121.88 46.09 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 171.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.1 -172.24 13.33 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -139.76 144.33 37.38 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.33 138.2 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 170.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.4 p -115.3 -40.16 3.48 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 120.158 -1.589 . . . . 0.0 109.478 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.4 mtm-85 -146.88 141.96 27.13 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.157 0.983 . . . . 0.0 110.052 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.9 mt -120.24 143.33 32.4 Favored 'Isoleucine or valine' 0 C--N 1.38 1.931 0 CA-C-O 122.451 1.12 . . . . 0.0 109.927 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 m -144.31 168.93 9.98 Favored 'Isoleucine or valine' 0 C--N 1.388 2.278 0 O-C-N 117.955 -2.965 . . . . 0.0 104.251 -170.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -56.66 -37.89 71.42 Favored 'General case' 0 C--O 1.269 2.094 0 CA-C-N 118.493 0.588 . . . . 0.0 111.743 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -96.06 11.33 34.52 Favored 'General case' 0 C--O 1.252 1.209 0 O-C-N 120.914 -1.117 . . . . 0.0 111.7 -168.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.72 -177.94 30.94 Favored Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.973 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.16 127.09 53.0 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.744 0.908 . . . . 0.0 110.276 174.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -76.26 131.86 39.51 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-O 123.806 1.765 . . . . 0.0 111.948 166.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.4 t -129.61 135.17 62.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 CA-C-N 112.051 -2.341 . . . . 0.0 112.024 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.96 129.97 41.62 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 112.21 -2.268 . . . . 0.0 112.632 167.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.5 mm -119.03 135.34 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.05 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.4 145.86 0.37 Allowed Glycine 0 C--N 1.378 2.909 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.54 38.84 27.28 Favored Glycine 0 N--CA 1.504 3.192 0 CA-C-N 112.78 -1.71 . . . . 0.0 111.051 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.48 6.92 84.99 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 120.507 2.963 . . . . 0.0 120.507 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -87.42 160.06 18.46 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 118.267 2.692 . . . . 0.0 118.267 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.87 131.63 20.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 109.707 172.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -122.9 163.1 16.43 Favored Glycine 0 C--N 1.349 1.25 0 C-N-CA 123.733 0.683 . . . . 0.0 112.156 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.94 124.91 44.21 Favored 'General case' 0 C--O 1.203 -1.345 0 O-C-N 126.892 2.172 . . . . 0.0 110.491 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 74.1 t -96.93 100.29 10.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 168.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -67.58 154.87 40.45 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.312 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.273 6.3 tt -52.69 -38.69 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -170.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.6 p -73.4 -0.96 16.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . 0.41 ' HB3' ' HA ' ' A' ' 148' ' ' SER . 91.1 mm-40 -119.01 5.77 11.34 Favored 'General case' 0 CA--C 1.576 1.968 0 O-C-N 123.986 0.804 . . . . 0.0 112.577 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.0 mm -77.68 -33.24 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.183 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -157.65 -176.19 5.8 Favored 'General case' 0 CA--C 1.495 -1.157 0 O-C-N 120.076 -1.64 . . . . 0.0 111.079 -170.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -105.57 -23.43 12.78 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 165.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -62.05 158.28 16.92 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 120.092 -1.63 . . . . 0.0 112.648 173.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -74.25 131.56 41.32 Favored 'General case' 0 C--O 1.205 -1.273 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.478 HG21 ' CE2' ' A' ' 125' ' ' TYR . 17.8 t -122.21 127.72 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 C-N-CA 125.793 1.637 . . . . 0.0 114.188 -173.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -110.25 -46.1 3.48 Favored 'General case' 0 C--N 1.386 2.18 0 C-N-CA 124.893 1.277 . . . . 0.0 110.202 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -120.48 150.36 40.94 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 170.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.11 -23.2 14.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-N 113.719 -1.582 . . . . 0.0 113.038 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.93 -19.39 65.09 Favored 'General case' 0 CA--C 1.581 2.141 0 O-C-N 120.115 -1.616 . . . . 0.0 114.616 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -76.59 -29.64 56.65 Favored 'General case' 0 N--CA 1.539 3.977 0 C-N-CA 126.577 1.951 . . . . 0.0 110.484 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.478 ' CE2' HG21 ' A' ' 119' ' ' VAL . 76.7 m-85 -100.79 -15.46 17.64 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 30.6 mt -151.99 162.42 41.11 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 124.22 0.95 . . . . 0.0 109.689 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -134.5 160.1 39.08 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 162.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -72.08 139.98 48.7 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 120.378 -1.451 . . . . 0.0 113.851 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 94.64 -12.35 68.84 Favored Glycine 0 N--CA 1.505 3.253 0 CA-C-O 125.39 2.661 . . . . 0.0 111.608 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -68.66 131.81 45.82 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 123.682 1.706 . . . . 0.0 111.177 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -79.65 129.6 34.62 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.931 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.57 127.16 19.48 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 120.527 -1.358 . . . . 0.0 109.062 -169.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.42 127.11 24.83 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 CA-C-O 116.769 -1.43 . . . . 0.0 113.278 160.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.0 129.43 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-N 122.669 2.486 . . . . 0.0 110.188 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -97.86 140.75 31.76 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 172.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.2 t -86.74 116.21 28.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.034 0 O-C-N 125.742 1.901 . . . . 0.0 106.789 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.0 tp -101.87 -48.01 4.41 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 116.323 -1.799 . . . . 0.0 110.658 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -136.12 150.84 49.26 Favored 'General case' 0 C--O 1.204 -1.294 0 O-C-N 125.029 1.456 . . . . 0.0 107.726 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.8 t -134.64 120.46 32.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -75.89 155.66 35.02 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.616 -1.302 . . . . 0.0 111.238 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.31 29.5 mmt180 -70.85 -27.06 63.57 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -65.74 -31.99 73.29 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 126.158 2.161 . . . . 0.0 115.833 157.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 138.02 -13.98 3.57 Favored Glycine 0 CA--C 1.549 2.206 0 C-N-CA 125.19 1.376 . . . . 0.0 111.646 162.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -54.37 137.84 41.03 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 10.6 mt -118.06 131.52 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 125.061 1.344 . . . . 0.0 113.14 -167.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -110.09 144.33 38.85 Favored 'General case' 0 N--CA 1.527 3.418 0 CA-C-O 123.283 1.516 . . . . 0.0 111.227 164.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.1 mt -129.12 151.87 49.33 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.079 -2.328 . . . . 0.0 110.29 -169.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.41 ' HA ' ' HB3' ' A' ' 113' ' ' GLN . 33.8 t -125.82 115.82 20.61 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.062 1.345 . . . . 0.0 109.148 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.6 mt -74.87 -38.24 43.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 119.838 -1.789 . . . . 0.0 112.164 171.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -59.46 -47.24 86.25 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 127.015 2.697 . . . . 0.0 114.634 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -66.59 -46.34 76.27 Favored 'General case' 0 C--O 1.258 1.514 0 CA-C-N 118.345 0.52 . . . . 0.0 111.63 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.6 -18.23 64.91 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-O 116.912 -1.518 . . . . 0.0 112.569 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.1 p -98.68 3.25 47.72 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 117.629 -1.176 . . . . 0.0 108.234 172.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.471 8.7 mt-10 80.69 25.27 0.3 Allowed 'General case' 0 C--N 1.364 1.236 0 CA-C-N 120.521 1.509 . . . . 0.0 113.184 162.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 . . . . . 0 C--O 1.24 0.577 0 O-C-N 127.344 2.903 . . . . 0.0 108.273 -177.632 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.574 1.874 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.8 135.0 28.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 CA-C-O 122.001 0.905 . . . . 0.0 113.395 -171.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -123.04 138.97 54.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 124.395 2.045 . . . . 0.0 113.674 169.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 7.3 t -135.13 139.7 44.85 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 113.326 -1.761 . . . . 0.0 110.121 -173.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.3 pt -133.37 161.44 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 162.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -83.45 146.1 28.6 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 125.02 2.343 . . . . 0.0 109.447 160.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 pt -122.58 147.87 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 157.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.283 1.6 t-20 -63.35 138.53 97.38 Favored Pre-proline 0 N--CA 1.514 2.748 0 C-N-CA 128.472 2.709 . . . . 0.0 108.381 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -80.95 3.76 7.53 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 O-C-N 118.007 -1.628 . . . . 0.0 114.328 -171.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -91.43 -2.33 57.3 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 120.59 -1.319 . . . . 0.0 110.443 164.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -111.74 3.82 18.04 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.285 -0.884 . . . . 0.0 109.322 -170.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 mt -68.45 -41.31 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 119.828 -1.795 . . . . 0.0 112.366 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -52.5 -13.15 0.34 Allowed 'General case' 0 C--N 1.353 0.738 0 C-N-CA 128.34 2.656 . . . . 0.0 117.415 164.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -102.62 -32.71 9.75 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 115.734 -2.079 . . . . 0.0 113.318 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.3 t -84.15 -31.34 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 O-C-N 125.099 1.499 . . . . 0.0 109.466 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.3 mm -93.25 -55.21 6.36 Favored 'Isoleucine or valine' 0 C--N 1.361 1.08 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.62 -173.39 30.21 Favored Glycine 0 C--N 1.369 2.37 0 CA-C-O 123.506 1.614 . . . . 0.0 115.432 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -74.88 108.96 7.96 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 116.588 -1.672 . . . . 0.0 110.593 -167.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.53 9.76 59.84 Favored Glycine 0 CA--C 1.468 -2.855 0 O-C-N 127.474 2.984 . . . . 0.0 110.434 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.65 30.37 77.21 Favored Glycine 0 CA--C 1.54 1.613 0 O-C-N 125.362 1.272 . . . . 0.0 112.259 -162.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -53.05 -54.42 35.69 Favored 'General case' 0 N--CA 1.517 2.888 0 C-N-CA 126.213 1.805 . . . . 0.0 111.225 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -89.82 -35.56 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -160.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.1 tp -67.81 -38.64 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -66.12 -44.29 84.7 Favored 'General case' 0 C--N 1.399 2.731 0 C-N-CA 125.147 1.379 . . . . 0.0 110.489 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.23 47.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 127.814 3.196 . . . . 0.0 110.026 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.2 mt -51.63 -48.74 63.2 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 116.07 -1.919 . . . . 0.0 113.92 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 t -60.83 -34.42 74.54 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.6 1.545 . . . . 0.0 112.966 -175.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.25 -31.23 71.43 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -96.46 -28.12 14.57 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 126.285 1.834 . . . . 0.0 111.662 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.1 p -84.67 -19.64 32.53 Favored 'General case' 0 C--N 1.396 2.62 0 CA-C-N 120.954 1.706 . . . . 0.0 110.754 176.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.18 24.85 74.73 Favored Glycine 0 N--CA 1.472 1.042 0 C-N-CA 127.906 2.669 . . . . 0.0 114.12 171.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 t -141.45 161.78 37.08 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.871 0.868 . . . . 0.0 108.736 -173.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -81.68 126.09 31.37 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 125.177 1.548 . . . . 0.0 110.74 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.6 mt -114.72 121.61 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -116.83 148.79 40.92 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 124.831 2.253 . . . . 0.0 107.168 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.8 mt -128.06 123.5 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-O 123.236 1.494 . . . . 0.0 111.487 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -87.73 148.99 24.49 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-O 117.274 -1.346 . . . . 0.0 112.254 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -71.12 -3.16 18.48 Favored 'General case' 0 C--N 1.393 2.485 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -157.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -89.69 -1.85 58.12 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 125.064 1.477 . . . . 0.0 113.336 171.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.75 9.07 33.55 Favored Glycine 0 CA--C 1.48 -2.131 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -79.6 108.58 13.26 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 124.395 2.045 . . . . 0.0 111.003 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 17' ' ' THR . 21.5 t -84.63 127.72 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 166.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -116.45 123.91 48.65 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 113.347 -1.752 . . . . 0.0 107.549 -173.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.56 130.23 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.05 -8.73 19.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 118.551 2.797 . . . . 0.0 118.551 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -17.55 133.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 120.929 3.677 . . . . 0.0 120.929 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.8 m -67.6 -40.69 84.73 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 116.973 -1.489 . . . . 0.0 112.249 168.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -80.71 126.48 31.34 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.61 -40.44 95.97 Favored Glycine 0 C--N 1.361 1.954 0 O-C-N 124.493 1.121 . . . . 0.0 113.744 169.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.76 -36.25 71.86 Favored 'General case' 0 CA--C 1.586 2.363 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -66.14 -48.28 71.31 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.02 80.75 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 125.159 1.537 . . . . 0.0 113.722 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -68.68 -37.11 79.32 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 121.48 -0.762 . . . . 0.0 110.06 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -61.53 -47.21 86.61 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.111 167.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.59 -45.07 95.35 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mt -59.42 -43.73 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 124.43 1.092 . . . . 0.0 113.665 172.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -65.88 -40.84 91.98 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 171.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -67.8 -38.52 83.43 Favored 'General case' 0 N--CA 1.52 3.033 0 O-C-N 119.905 -1.747 . . . . 0.0 115.045 171.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 mt -59.34 -41.53 84.54 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-N 119.457 1.026 . . . . 0.0 111.564 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -55.3 -45.44 76.25 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -62.38 -45.95 90.83 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 126.979 2.112 . . . . 0.0 112.644 171.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.258 1.1 mp -58.88 -33.23 49.07 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 168.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.3 p -101.34 8.46 42.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 125.601 1.813 . . . . 0.0 112.941 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.57 23.55 0.51 Allowed 'General case' 0 CA--C 1.601 2.931 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -176.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -115.74 130.52 56.88 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 125.989 1.716 . . . . 0.0 112.774 -167.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.7 pt -100.76 144.51 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -164.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -118.37 139.65 51.05 Favored 'General case' 0 C--O 1.206 -1.2 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.684 -158.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -60.75 137.77 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.28 0.32 52.24 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.179 -1.486 . . . . 0.0 115.318 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -98.17 150.39 21.53 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 120.017 -1.873 . . . . 0.0 111.679 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -105.59 143.32 16.91 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 O-C-N 125.992 2.058 . . . . 0.0 110.935 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -137.7 157.31 46.74 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 127.119 2.762 . . . . 0.0 107.396 -168.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.1 m -94.28 123.24 37.56 Favored 'General case' 0 C--N 1.372 1.55 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 164.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.52 170.5 15.24 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -126.39 135.9 52.01 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.403 ' HA ' HG21 ' A' ' 99' ' ' VAL . 13.4 t -68.39 120.52 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 122.865 1.317 . . . . 0.0 111.346 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.8 p -104.24 -31.68 9.47 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 118.839 -2.413 . . . . 0.0 111.913 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -162.92 124.02 2.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 124.327 2.013 . . . . 0.0 114.236 175.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 92' ' ' ILE . 56.6 mt -82.97 132.76 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-O 124.545 2.117 . . . . 0.0 109.937 176.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.4 m -121.39 172.11 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.606 3.128 0 C-N-CA 127.632 2.373 . . . . 0.0 108.862 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -63.69 -32.47 73.97 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 119.108 -2.245 . . . . 0.0 113.834 -166.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -118.06 23.08 11.85 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 113.297 -1.774 . . . . 0.0 111.968 -173.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 164.69 164.28 19.65 Favored Glycine 0 C--O 1.2 -2.005 0 CA-C-O 125.005 2.447 . . . . 0.0 115.186 -171.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.15 130.64 53.41 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 112.465 -1.867 . . . . 0.0 113.113 170.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -73.47 137.71 44.68 Favored 'General case' 0 C--N 1.376 1.737 0 CA-C-O 123.926 1.822 . . . . 0.0 108.821 169.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.403 HG21 ' HA ' ' A' ' 89' ' ' VAL . 50.1 t -131.18 134.78 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-O 124.252 1.977 . . . . 0.0 107.09 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.22 141.41 35.1 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 113.653 -1.612 . . . . 0.0 114.302 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.31 147.75 32.12 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.8 151.56 1.59 Allowed Glycine 0 C--N 1.362 2.013 0 N-CA-C 119.001 2.36 . . . . 0.0 119.001 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.79 17.27 58.45 Favored Glycine 0 C--N 1.368 2.353 0 CA-C-O 118.129 -1.373 . . . . 0.0 114.734 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.25 23.72 73.11 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 116.965 1.546 . . . . 0.0 116.965 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -114.37 130.88 56.71 Favored 'General case' 0 C--O 1.194 -1.841 0 CA-C-O 123.989 1.852 . . . . 0.0 108.926 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -127.13 134.43 50.21 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 120.728 -1.232 . . . . 0.0 111.453 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.48 173.26 17.49 Favored Glycine 0 C--O 1.205 -1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 112.724 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.7 tp -104.08 139.37 39.26 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 125.427 2.537 . . . . 0.0 110.294 172.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.0 t -99.13 96.47 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 CA-C-N 113.694 -1.593 . . . . 0.0 110.633 158.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -53.39 162.59 0.74 Allowed 'General case' 0 CA--C 1.576 1.967 0 CA-C-N 119.6 1.091 . . . . 0.0 113.433 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' HA ' HD13 ' A' ' 114' ' ' ILE . 3.9 tt -48.26 -33.81 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 p -90.26 7.09 40.04 Favored 'General case' 0 C--N 1.364 1.234 0 C-N-CA 126.122 1.769 . . . . 0.0 111.569 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -119.48 12.35 12.36 Favored 'General case' 0 CA--C 1.572 1.817 0 O-C-N 119.667 -1.895 . . . . 0.0 111.861 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 111' ' ' ILE . 9.8 mt -100.31 -45.85 11.75 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 O-C-N 117.451 -3.281 . . . . 0.0 109.991 -170.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.94 167.76 24.87 Favored 'General case' 0 C--N 1.402 2.872 0 CA-C-O 124.959 2.314 . . . . 0.0 114.541 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -66.13 -41.5 90.4 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 127.056 2.143 . . . . 0.0 115.547 163.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -42.5 150.96 0.13 Allowed 'General case' 0 CA--C 1.539 0.539 0 O-C-N 128.164 3.415 . . . . 0.0 115.385 169.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -65.89 97.4 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.1 t -94.64 125.35 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-N 118.77 0.714 . . . . 0.0 109.684 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -111.76 -33.41 6.33 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -145.38 148.71 33.66 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.81 -24.97 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 116.389 -1.767 . . . . 0.0 111.358 -163.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.2 p -59.3 -31.56 69.24 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 126.003 1.721 . . . . 0.0 109.014 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.58 -16.4 61.25 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -128.28 -4.47 5.51 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -173.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.2 mt -144.85 167.13 23.34 Favored 'General case' 0 C--O 1.197 -1.701 0 O-C-N 119.706 -1.871 . . . . 0.0 109.605 165.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -138.52 159.17 42.76 Favored 'General case' 0 CA--C 1.57 1.731 0 C-N-CA 124.948 1.299 . . . . 0.0 110.815 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -71.58 148.55 46.52 Favored 'General case' 0 CA--C 1.582 2.206 0 O-C-N 120.331 -1.48 . . . . 0.0 112.862 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 59.37 28.72 65.04 Favored Glycine 0 C--N 1.369 2.401 0 C-N-CA 129.957 3.646 . . . . 0.0 114.342 -170.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -95.98 145.92 25.03 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 169.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -86.04 142.55 28.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 125.115 2.388 . . . . 0.0 106.302 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.15 127.75 11.58 Favored Pre-proline 0 N--CA 1.426 -1.639 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -170.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -54.29 121.79 10.33 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 CA-C-N 121.053 1.412 . . . . 0.0 114.157 154.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . 0.351 5.4 m -123.11 131.75 72.67 Favored 'Isoleucine or valine' 0 C--N 1.383 2.064 0 CA-C-O 124.406 2.05 . . . . 0.0 114.635 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -107.66 129.71 54.98 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.57 134.28 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 1 O-C-N 114.009 -5.432 . . . . 0.0 106.004 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.7 mt -112.42 -5.27 14.1 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-N 120.514 1.507 . . . . 0.0 111.758 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -171.7 128.19 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 124.594 2.14 . . . . 0.0 110.408 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.9 t -105.24 104.59 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 155.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.64 149.06 26.1 Favored 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -76.79 -5.71 49.32 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.791 -1.193 . . . . 0.0 114.161 -171.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -90.48 -2.43 57.93 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-O 115.931 -1.985 . . . . 0.0 111.142 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.17 23.3 8.17 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-O 123.515 1.619 . . . . 0.0 111.972 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -108.7 115.84 30.85 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 -162.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 69.3 mt -114.11 117.96 57.06 Favored 'Isoleucine or valine' 0 C--N 1.398 2.703 0 CA-C-O 122.522 1.154 . . . . 0.0 108.005 -161.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -109.97 112.7 24.88 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 124.829 2.252 . . . . 0.0 111.742 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 76.1 mt -108.62 158.83 17.22 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 111.083 -2.78 . . . . 0.0 108.481 -171.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -143.38 152.65 41.84 Favored 'General case' 0 N--CA 1.516 2.832 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 57.1 mt -107.38 -45.16 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -58.08 -37.42 74.44 Favored 'General case' 0 CA--C 1.476 -1.896 0 C-N-CA 124.15 0.98 . . . . 0.0 111.824 -173.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -76.21 -24.57 54.65 Favored 'General case' 0 N--CA 1.397 -3.114 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.25 -28.95 47.88 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.002 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 65.8 p -91.56 0.23 57.52 Favored 'General case' 0 CA--C 1.579 2.074 0 O-C-N 127.312 2.882 . . . . 0.0 108.066 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 56.94 44.79 22.42 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 130.675 3.59 . . . . 0.0 113.374 174.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 . . . . . 0 CA--C 1.502 -0.876 0 O-C-N 125.883 1.989 . . . . 0.0 115.306 179.849 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 . . . . . 0 C--O 1.215 -0.761 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.43 140.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.38 1.927 0 C-N-CA 125.303 1.441 . . . . 0.0 114.162 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -98.31 130.34 44.99 Favored 'General case' 0 C--O 1.27 2.153 0 O-C-N 118.8 -2.437 . . . . 0.0 107.056 171.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 t -148.98 165.7 30.85 Favored 'General case' 0 C--N 1.37 1.488 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.152 -164.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.6 tt -153.16 146.74 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 169.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -110.13 117.39 33.58 Favored 'General case' 0 N--CA 1.423 -1.778 0 O-C-N 116.614 -3.804 . . . . 0.0 104.277 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 pt -108.07 165.13 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.414 2.685 . . . . 0.0 109.712 -174.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -67.23 129.02 93.89 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 112.031 -2.349 . . . . 0.0 110.746 172.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 100.0 Cg_exo -57.45 -20.44 40.63 Favored 'Trans proline' 0 N--CA 1.515 2.762 0 N-CA-C 117.68 2.146 . . . . 0.0 117.68 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.14 -21.29 59.93 Favored 'General case' 0 N--CA 1.41 -2.448 0 C-N-CA 125.222 1.409 . . . . 0.0 112.524 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -97.53 -1.75 43.34 Favored 'General case' 0 CA--C 1.49 -1.352 0 C-N-CA 126.74 2.016 . . . . 0.0 109.517 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 96.6 mt -57.72 -46.11 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 117.035 -1.459 . . . . 0.0 112.381 164.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.48 ' HZ3' ' CD ' ' A' ' 80' ' ' GLU . 12.4 pttm -69.7 -29.46 66.88 Favored 'General case' 0 C--O 1.186 -2.277 0 CA-C-N 119.86 1.209 . . . . 0.0 111.73 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -72.73 -45.29 59.48 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.661 0.784 . . . . 0.0 111.819 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.6 t -68.5 -39.36 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 118.766 -0.635 . . . . 0.0 111.602 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.4 mt -63.86 -51.82 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 124.489 1.116 . . . . 0.0 111.902 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.38 179.99 52.48 Favored Glycine 0 C--O 1.208 -1.511 0 CA-C-N 112.759 -2.019 . . . . 0.0 113.872 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -77.74 116.32 18.18 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.404 0.708 . . . . 0.0 110.682 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.41 20.79 79.51 Favored Glycine 0 CA--C 1.551 2.307 0 CA-C-N 112.459 -2.155 . . . . 0.0 116.03 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.09 7.23 88.76 Favored Glycine 0 C--N 1.368 2.333 0 CA-C-N 120.353 2.077 . . . . 0.0 115.901 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 t -56.26 -50.67 70.67 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.246 -1.977 . . . . 0.0 113.116 -173.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.2 t -73.14 -32.24 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.144 0.884 . . . . 0.0 109.275 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -57.03 -48.82 81.12 Favored 'Isoleucine or valine' 0 C--N 1.371 1.5 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.395 172.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -62.72 -44.28 96.63 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 125.684 2.659 . . . . 0.0 112.308 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.2 73.42 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 117.309 -3.37 . . . . 0.0 116.981 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . 0.263 46.8 mt -61.05 -45.03 96.42 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 125.137 1.523 . . . . 0.0 108.816 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 m -58.61 -56.09 26.67 Favored 'General case' 0 C--N 1.389 2.288 0 O-C-N 118.579 -2.576 . . . . 0.0 115.408 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -56.44 -48.48 76.93 Favored 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 125.615 1.566 . . . . 0.0 112.844 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.424 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 67.8 tt0 -62.28 -51.02 69.36 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.405 HG21 ' HA ' ' A' ' 68' ' ' ALA . 68.5 p -79.65 -8.27 59.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 124.628 1.205 . . . . 0.0 112.344 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.93 19.88 70.14 Favored Glycine 0 C--O 1.247 0.933 0 O-C-N 125.553 1.783 . . . . 0.0 114.371 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 t -148.13 152.84 37.99 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -69.04 140.32 54.92 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 124.82 2.248 . . . . 0.0 114.352 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.15 127.63 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -135.25 151.19 50.36 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 119.411 -0.915 . . . . 0.0 112.111 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.3 tt -136.4 124.48 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 O-C-N 120.908 -1.12 . . . . 0.0 110.963 -170.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -86.68 168.79 13.26 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-O 123.432 1.587 . . . . 0.0 112.15 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -76.85 -15.67 59.64 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 117.376 2.361 . . . . 0.0 117.376 -169.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.96 -4.25 59.12 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 123.164 1.459 . . . . 0.0 112.37 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.45 3.35 27.37 Favored Glycine 0 CA--C 1.544 1.879 0 O-C-N 119.514 -1.992 . . . . 0.0 109.967 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.8 m -89.16 107.15 18.89 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.685 2.242 . . . . 0.0 113.943 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.96 136.82 22.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.946 -1.102 . . . . 0.0 111.291 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -115.72 120.64 39.99 Favored 'General case' 0 C--N 1.391 2.388 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.01 120.1 58.76 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 -173.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.91 90.73 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -38.04 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 1 N-CA-C 121.89 4.033 . . . . 0.0 121.89 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 m -121.16 -44.39 2.39 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.61 132.43 53.26 Favored 'General case' 0 C--N 1.389 2.32 0 CA-C-O 124.451 2.072 . . . . 0.0 107.757 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -49.87 -52.73 24.78 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 118.318 2.087 . . . . 0.0 118.318 -167.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.453 ' CD ' ' HZ1' ' A' ' 66' ' ' LYS . 70.8 mm-40 -66.05 -37.7 86.5 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.32 -42.51 88.15 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.329 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.18 80.93 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 116.31 -1.805 . . . . 0.0 110.092 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.453 ' HZ1' ' CD ' ' A' ' 63' ' ' GLU . 16.9 tttt -61.13 -36.44 79.77 Favored 'General case' 0 C--N 1.366 1.289 0 C-N-CA 125.96 1.704 . . . . 0.0 113.887 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -64.51 -41.01 96.68 Favored 'General case' 0 N--CA 1.511 2.615 0 CA-C-O 124.375 2.036 . . . . 0.0 114.754 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.405 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -64.76 -38.02 89.58 Favored 'General case' 0 C--O 1.257 1.456 0 O-C-N 117.976 -2.952 . . . . 0.0 111.635 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.78 -49.89 77.99 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 O-C-N 125.542 1.776 . . . . 0.0 109.241 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -58.39 -37.72 75.85 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.424 ' HE ' ' CD ' ' A' ' 42' ' ' GLU . 11.8 mmm180 -71.38 -41.57 69.51 Favored 'General case' 0 C--N 1.366 1.31 0 O-C-N 126.751 2.532 . . . . 0.0 112.09 174.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.4 mm -56.53 -42.82 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-O 121.941 0.877 . . . . 0.0 109.599 167.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.256 12.5 mt-10 -62.56 -42.72 99.72 Favored 'General case' 0 CA--C 1.572 1.818 0 O-C-N 121.063 -1.023 . . . . 0.0 112.932 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.81 -44.18 86.17 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 117.481 -1.247 . . . . 0.0 113.406 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.3 mm -78.38 -25.46 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-N 121.481 1.946 . . . . 0.0 109.09 -173.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 p -79.5 -17.33 54.35 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 123.934 0.771 . . . . 0.0 112.322 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.05 -19.96 58.17 Favored 'General case' 0 C--N 1.37 1.479 1 O-C-N 116.002 -4.187 . . . . 0.0 114.008 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -67.09 119.47 12.08 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -162.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.1 pt -72.39 137.85 22.7 Favored 'Isoleucine or valine' 0 C--O 1.279 2.653 0 CA-C-O 128.356 3.931 . . . . 0.0 114.98 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 26' ' ' LYS . 47.5 mt-10 -122.76 147.43 46.51 Favored 'General case' 0 C--O 1.202 -1.396 0 O-C-N 118.23 -2.794 . . . . 0.0 108.311 -172.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 m -64.79 154.94 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 123.91 1.814 . . . . 0.0 112.551 171.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.07 -9.6 45.68 Favored Glycine 0 CA--C 1.561 2.911 0 O-C-N 119.644 -1.91 . . . . 0.0 116.664 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -96.69 153.78 17.66 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 115.131 -2.366 . . . . 0.0 110.468 -172.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.31 117.03 54.32 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 O-C-N 125.067 1.48 . . . . 0.0 110.333 179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.51 166.75 10.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.806 2.442 . . . . 0.0 105.82 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 83.1 m -101.53 116.87 33.74 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 171.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.67 157.62 15.65 Favored Glycine 0 CA--C 1.469 -2.829 0 O-C-N 119.654 -1.903 . . . . 0.0 109.642 -173.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -115.93 128.82 56.06 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 118.791 -1.163 . . . . 0.0 111.69 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.06 126.2 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.391 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.2 p -102.52 -35.54 8.71 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-N 120.731 1.605 . . . . 0.0 114.249 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -165.46 157.43 14.91 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 127.061 2.725 . . . . 0.0 110.892 -173.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.5 mt -140.64 142.8 30.0 Favored 'Isoleucine or valine' 0 C--N 1.383 2.06 0 O-C-N 126.294 2.246 . . . . 0.0 107.008 -167.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.9 p -141.19 -164.43 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -67.56 -38.99 84.93 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 128.72 2.808 . . . . 0.0 115.648 176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -95.46 0.39 53.22 Favored 'General case' 0 N--CA 1.527 3.409 0 CA-C-O 114.07 -2.872 . . . . 0.0 116.044 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.64 -174.99 36.56 Favored Glycine 0 C--N 1.361 1.948 0 CA-C-N 125.245 3.657 . . . . 0.0 115.065 -170.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.61 137.25 51.59 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -91.9 144.16 25.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.6 t -143.18 136.75 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 113.554 -1.657 . . . . 0.0 108.267 -173.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 106' ' ' GLU . . . -107.76 144.67 34.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 125.008 2.337 . . . . 0.0 111.258 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.1 pt -140.25 167.73 18.17 Favored 'Isoleucine or valine' 0 C--O 1.259 1.582 0 CA-C-N 112.597 -2.092 . . . . 0.0 108.099 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -27.77 131.2 0.06 OUTLIER Glycine 0 CA--C 1.575 3.793 0 N-CA-C 122.634 3.814 . . . . 0.0 122.634 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.95 6.59 66.92 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -173.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.16 36.92 55.84 Favored Glycine 0 C--O 1.194 -2.366 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.494 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -103.17 110.45 22.4 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 119.034 1.417 . . . . 0.0 112.822 -170.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 27.1 tt0 -93.59 124.82 37.84 Favored 'General case' 0 N--CA 1.515 2.814 0 O-C-N 119.291 -2.13 . . . . 0.0 110.441 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -124.77 -175.91 14.43 Favored Glycine 0 CA--C 1.541 1.695 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.6 tp -121.43 127.66 51.36 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.843 1.306 . . . . 0.0 111.103 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.64 112.37 31.83 Favored 'Isoleucine or valine' 0 C--O 1.256 1.414 0 CA-C-N 113.932 -1.486 . . . . 0.0 107.193 166.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.44 152.88 42.86 Favored 'General case' 0 C--N 1.374 1.652 0 CA-C-O 125.217 2.436 . . . . 0.0 116.324 164.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 tt -52.98 -37.11 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 CA-C-N 111.076 -2.784 . . . . 0.0 113.569 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 76.7 p -76.75 -14.33 59.95 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 124.941 1.297 . . . . 0.0 109.488 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -101.88 7.78 41.44 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.675 1.19 . . . . 0.0 109.618 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 43.8 mm -78.1 -33.77 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.326 0 CA-C-O 123.106 1.431 . . . . 0.0 110.722 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -165.38 -178.58 5.06 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 119.067 -2.271 . . . . 0.0 112.509 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.19 -54.65 41.66 Favored 'General case' 0 CA--C 1.578 2.04 0 CA-C-N 112.729 -2.032 . . . . 0.0 111.857 165.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -93.63 160.55 14.73 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -84.25 127.38 33.92 Favored 'General case' 0 N--CA 1.512 2.643 0 O-C-N 125.698 1.874 . . . . 0.0 113.436 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.37 131.54 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 120.878 -1.139 . . . . 0.0 108.082 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -63.33 -40.04 96.21 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 118.468 -2.645 . . . . 0.0 112.987 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -129.27 118.07 21.72 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.93 1.292 . . . . 0.0 110.532 -175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.56 -30.16 49.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 C-N-CA 124.339 1.056 . . . . 0.0 109.602 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -23.31 63.15 Favored 'General case' 0 C--O 1.261 1.659 0 O-C-N 119.066 -2.271 . . . . 0.0 113.712 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -78.16 -20.92 51.06 Favored 'General case' 0 CA--C 1.49 -1.331 0 O-C-N 118.315 -2.741 . . . . 0.0 113.036 174.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -106.87 -8.79 16.56 Favored 'General case' 0 C--N 1.379 1.865 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.2 mt -146.0 159.01 43.86 Favored 'General case' 0 N--CA 1.402 -2.844 0 CA-C-O 124.018 1.866 . . . . 0.0 108.262 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -144.35 150.53 37.94 Favored 'General case' 0 C--O 1.201 -1.467 0 CA-C-N 111.334 -2.666 . . . . 0.0 106.074 -168.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -70.21 141.1 52.57 Favored 'General case' 0 CA--C 1.594 2.661 0 CA-C-O 123.607 1.67 . . . . 0.0 113.525 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.79 -11.59 68.35 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.25 140.42 40.07 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 121.016 2.408 . . . . 0.0 115.472 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -102.13 129.79 48.57 Favored 'General case' 0 C--N 1.381 1.959 0 O-C-N 124.949 1.406 . . . . 0.0 110.573 -163.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.11 143.28 46.52 Favored Pre-proline 0 CA--C 1.577 1.999 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.263 -176.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.15 136.04 70.11 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 CA-C-N 122.794 2.034 . . . . 0.0 110.447 169.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.54 148.17 27.21 Favored 'Isoleucine or valine' 0 C--O 1.255 1.371 0 O-C-N 125.732 1.895 . . . . 0.0 109.935 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -116.55 135.33 53.91 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 127.387 2.929 . . . . 0.0 104.736 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.8 t -87.05 127.89 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 126.76 2.537 . . . . 0.0 106.246 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.1 mt -101.03 -57.57 2.06 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -169.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -163.31 159.34 22.48 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 122.049 0.928 . . . . 0.0 109.407 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.68 119.86 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 102.323 -3.214 . . . . 0.0 102.323 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -71.52 162.18 29.85 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 129.003 2.921 . . . . 0.0 111.741 174.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -58.57 -33.53 70.05 Favored 'General case' 0 C--N 1.381 1.971 0 O-C-N 125.637 1.836 . . . . 0.0 113.111 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -90.58 11.14 22.86 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 119.296 -2.127 . . . . 0.0 109.946 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.04 16.64 69.23 Favored Glycine 0 C--O 1.251 1.193 0 CA-C-O 123.38 1.545 . . . . 0.0 113.973 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.2 mtm180 -71.12 117.28 12.43 Favored 'General case' 0 C--O 1.266 1.964 0 CA-C-N 112.384 -1.908 . . . . 0.0 114.062 177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.1 mt -88.3 123.71 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.99 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -96.89 131.56 43.53 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-O 122.185 0.993 . . . . 0.0 110.573 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.5 mt -129.89 144.57 51.38 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 120.16 -1.588 . . . . 0.0 109.423 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 35.4 t -121.7 133.05 54.94 Favored 'General case' 0 C--N 1.375 1.708 0 CA-C-N 121.376 1.898 . . . . 0.0 110.656 163.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 76.3 mt -79.33 -45.1 23.97 Favored 'Isoleucine or valine' 0 C--N 1.377 1.801 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -55.71 -42.98 76.07 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 127.78 3.175 . . . . 0.0 112.418 -164.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -85.15 -19.9 31.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 115.042 -2.409 . . . . 0.0 109.892 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.31 -36.96 63.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 121.754 2.07 . . . . 0.0 113.773 167.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.5 p -78.21 -10.96 59.88 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 125.597 1.81 . . . . 0.0 111.629 174.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.259 75.0 mt-10 87.7 40.05 0.01 OUTLIER 'General case' 0 CA--C 1.477 -1.861 0 CA-C-N 119.041 0.837 . . . . 0.0 112.44 157.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 . . . . . 0 N--CA 1.412 -2.361 0 CA-C-O 123.805 1.764 . . . . 0.0 113.818 -175.524 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 . . . . . 0 CA--C 1.568 1.663 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.4 mt -114.41 139.67 39.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 124.251 1.977 . . . . 0.0 108.479 -172.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -118.17 138.25 52.43 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 112.581 -2.099 . . . . 0.0 111.352 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -115.46 133.45 56.02 Favored 'General case' 0 C--N 1.38 1.918 0 O-C-N 120.271 -1.518 . . . . 0.0 110.496 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.7 mm -137.87 137.42 44.92 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -98.01 137.38 36.9 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 123.156 1.455 . . . . 0.0 112.58 167.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 pt -116.5 169.4 7.01 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 C-N-CA 125.63 1.572 . . . . 0.0 112.862 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -57.08 124.77 67.59 Favored Pre-proline 0 CA--C 1.586 2.358 0 CA-C-N 113.698 -1.592 . . . . 0.0 113.065 167.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.45 -3.21 13.31 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.67 2.246 . . . . 0.0 115.182 -176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -72.58 -19.4 61.49 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.631 1.973 . . . . 0.0 115.848 161.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -99.58 -3.98 32.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 116.604 -1.665 . . . . 0.0 111.082 -166.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.0 mt -54.96 -44.41 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 119.204 0.911 . . . . 0.0 110.937 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.31 0.1 OUTLIER -57.8 -38.0 74.75 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 125.121 1.513 . . . . 0.0 111.731 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -75.89 -35.6 59.78 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-O 114.673 -2.584 . . . . 0.0 112.925 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.76 -52.65 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 116.065 -1.922 . . . . 0.0 114.287 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.7 mt -78.22 -32.39 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 126.024 2.078 . . . . 0.0 113.247 -176.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.39 -180.0 0.18 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 120.637 3.015 . . . . 0.0 120.637 -172.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -56.4 122.05 11.0 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 113.613 -1.294 . . . . 0.0 113.397 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 49.77 22.4 4.23 Favored Glycine 0 C--N 1.36 1.882 0 N-CA-C 116.98 1.552 . . . . 0.0 116.98 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.7 77.87 Favored Glycine 1 C--N 1.402 4.221 0 CA-C-N 122.191 2.995 . . . . 0.0 113.275 -175.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.1 m -58.58 -43.46 89.45 Favored 'General case' 0 C--O 1.207 -1.172 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -172.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.0 t -72.67 -47.02 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 O-C-N 124.263 0.977 . . . . 0.0 111.53 -172.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.251 7.0 tt -62.94 -38.77 82.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 113.66 -3.067 . . . . 0.0 114.604 172.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -59.01 -49.42 77.96 Favored 'General case' 0 C--O 1.263 1.783 0 O-C-N 126.193 2.183 . . . . 0.0 111.878 167.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.16 95.89 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 175.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.77 -39.27 93.85 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.112 0.882 . . . . 0.0 111.793 172.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.8 m -52.0 -46.04 64.77 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 117.203 -1.379 . . . . 0.0 110.94 167.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -67.75 -37.08 81.66 Favored 'General case' 0 C--N 1.37 1.495 0 C-N-CA 125.602 1.561 . . . . 0.0 113.323 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.12 -37.34 64.12 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.0 p -95.09 -34.38 12.32 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.35 -1.786 . . . . 0.0 114.363 -176.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.99 37.26 22.7 Favored Glycine 0 C--N 1.386 3.317 0 CA-C-O 124.454 2.141 . . . . 0.0 108.923 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.8 p -119.64 162.05 19.64 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.982 -1.305 . . . . 0.0 109.114 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -101.62 127.49 48.33 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.443 1.116 . . . . 0.0 109.197 169.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -114.9 126.54 72.51 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 -171.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.404 ' CD ' ' HZ2' ' A' ' 56' ' ' LYS . 3.0 tm-20 -124.15 135.4 53.47 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 123.207 1.479 . . . . 0.0 107.714 173.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.54 141.18 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 119.055 -2.278 . . . . 0.0 109.726 -169.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -125.5 165.79 17.82 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-O 123.242 1.496 . . . . 0.0 107.769 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.32 43.4 p-10 -88.88 8.0 31.46 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 118.346 2.721 . . . . 0.0 118.346 -162.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -96.53 15.23 22.13 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.651 -1.613 . . . . 0.0 107.866 167.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.94 34.53 71.23 Favored Glycine 0 C--N 1.365 2.184 0 O-C-N 119.706 -1.871 . . . . 0.0 112.458 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.8 m -96.62 113.85 25.45 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-O 116.447 -1.74 . . . . 0.0 108.462 164.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -109.34 138.74 35.27 Favored 'Isoleucine or valine' 0 C--N 1.378 1.827 0 CA-C-O 122.886 1.327 . . . . 0.0 107.612 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HZ2' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -115.17 123.26 48.46 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 112.59 -2.095 . . . . 0.0 111.031 -176.683 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.55 119.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 119.348 -2.095 . . . . 0.0 111.733 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.89 127.18 54.56 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.155 2.582 . . . . 0.0 109.19 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.84 162.31 37.99 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 120.133 -1.604 . . . . 0.0 108.022 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.4 p -84.91 0.69 50.26 Favored 'General case' 0 N--CA 1.415 -2.22 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.196 173.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -142.82 140.66 31.4 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.584 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.68 -15.33 81.35 Favored Glycine 0 C--N 1.365 2.161 0 CA-C-O 116.363 -2.354 . . . . 0.0 113.053 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.74 -42.07 86.81 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 121.084 2.442 . . . . 0.0 109.86 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -64.13 -46.42 84.21 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.525 -2.125 . . . . 0.0 108.437 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.13 98.91 Favored 'General case' 0 C--N 1.36 1.047 0 O-C-N 120.292 -1.505 . . . . 0.0 114.422 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -65.62 -35.01 79.56 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 114.984 -2.436 . . . . 0.0 112.2 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -65.64 -38.18 88.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 125.82 1.95 . . . . 0.0 109.216 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.04 99.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.82 -1.175 . . . . 0.0 112.958 169.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.19 -45.5 84.6 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 O-C-N 120.014 -1.679 . . . . 0.0 112.925 168.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -60.69 -35.29 75.91 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 120.805 1.638 . . . . 0.0 114.052 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -74.63 -27.56 60.5 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 116.474 -1.727 . . . . 0.0 114.6 165.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . 0.349 11.3 mt -76.63 -32.22 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.46 -45.32 88.84 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.68 1.992 . . . . 0.0 115.026 169.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -64.47 -36.96 85.89 Favored 'General case' 0 C--O 1.195 -1.765 0 O-C-N 125.976 2.048 . . . . 0.0 106.743 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.2 mt -60.8 -44.53 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 125.592 3.815 . . . . 0.0 111.427 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.9 p -93.26 -6.56 47.3 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -162.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.11 -38.49 61.12 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -71.0 132.24 44.87 Favored 'General case' 0 CA--C 1.572 1.822 0 CA-C-O 122.386 1.089 . . . . 0.0 109.666 -169.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.0 mm -68.74 146.52 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 111.614 -2.539 . . . . 0.0 116.417 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -112.33 137.27 50.71 Favored 'General case' 0 CA--C 1.578 2.033 0 CA-C-O 124.487 2.089 . . . . 0.0 111.115 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 42.6 t -80.18 130.25 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 O-C-N 120.573 -1.329 . . . . 0.0 109.553 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.52 64.75 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 116.613 1.405 . . . . 0.0 116.613 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -119.58 135.28 54.86 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 123.882 0.873 . . . . 0.0 112.208 -174.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.0 t -72.53 130.18 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -128.7 154.53 46.23 Favored 'General case' 0 C--O 1.268 2.062 0 CA-C-N 112.452 -2.158 . . . . 0.0 107.425 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.1 m -105.88 128.24 53.64 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.61 167.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -138.53 -173.0 12.78 Favored Glycine 0 C--O 1.206 -1.606 0 O-C-N 126.791 2.557 . . . . 0.0 108.985 -167.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -144.59 150.58 37.69 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.139 -0.624 . . . . 0.0 112.365 166.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 t -59.61 132.89 25.04 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 CA-C-N 112.4 -2.182 . . . . 0.0 111.452 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -110.48 -57.08 2.26 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -134.87 150.47 50.46 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.803 1.287 . . . . 0.0 110.586 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.71 136.49 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 112.94 -1.937 . . . . 0.0 107.292 171.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.5 m -135.29 -177.15 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 111.889 -2.414 . . . . 0.0 108.576 -168.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.55 -23.81 67.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 119.162 -2.211 . . . . 0.0 115.617 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -125.66 -0.52 7.43 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.61 0.764 . . . . 0.0 111.211 -165.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.25 -169.72 41.57 Favored Glycine 0 CA--C 1.48 -2.144 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.44 146.61 46.05 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 111.663 -2.269 . . . . 0.0 108.22 167.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -100.13 137.34 38.71 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 168.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.44 129.55 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 C-N-CA 126.541 1.936 . . . . 0.0 106.246 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.66 125.26 41.0 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.8 pt -116.86 164.59 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 C-N-CA 125.874 1.67 . . . . 0.0 106.984 -175.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.03 153.58 0.54 Allowed Glycine 0 CA--C 1.543 1.821 0 N-CA-C 118.659 2.223 . . . . 0.0 118.659 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.48 23.28 65.47 Favored Glycine 0 N--CA 1.487 2.083 0 O-C-N 119.523 -2.163 . . . . 0.0 112.599 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.75 36.25 93.08 Favored Glycine 0 C--N 1.358 1.79 0 C-N-CA 126.863 2.173 . . . . 0.0 117.356 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -112.97 135.13 54.08 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 123.355 1.55 . . . . 0.0 109.842 -169.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.22 138.86 47.15 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 119.546 -1.971 . . . . 0.0 105.999 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.0 165.51 24.61 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-O 118.732 -1.038 . . . . 0.0 111.316 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.0 tp -101.5 114.18 27.97 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.055 -1.458 . . . . 0.0 109.783 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 47.9 t -77.5 98.56 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.933 0 CA-C-O 125.738 2.685 . . . . 0.0 110.317 160.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -65.43 149.64 49.67 Favored 'General case' 0 CA--C 1.558 1.284 1 O-C-N 115.878 -4.264 . . . . 0.0 113.146 172.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 tt -65.29 -16.07 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 113.411 -1.722 . . . . 0.0 114.775 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 89.6 p -90.11 -1.51 57.96 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 119.694 -1.879 . . . . 0.0 110.184 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -121.39 36.48 4.6 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.65 -44.02 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 127.144 2.178 . . . . 0.0 109.37 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -145.04 163.11 35.24 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 111.842 -2.435 . . . . 0.0 112.646 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -70.98 -45.94 63.16 Favored 'General case' 0 CA--C 1.576 1.961 0 O-C-N 119.623 -1.923 . . . . 0.0 115.924 171.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -77.63 149.83 34.7 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 120.616 -1.303 . . . . 0.0 111.336 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.259 94.8 mtt180 -47.44 132.06 13.5 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 125.11 2.386 . . . . 0.0 115.012 174.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -107.2 115.35 48.4 Favored 'Isoleucine or valine' 0 C--N 1.371 1.531 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.83 -40.13 87.9 Favored 'General case' 0 C--O 1.197 -1.708 0 C-N-CA 118.066 -1.454 . . . . 0.0 113.45 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -147.44 145.88 29.35 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.73 1.15 . . . . 0.0 108.397 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.76 -34.94 71.15 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.233 -172.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.4 p -68.32 -26.45 65.62 Favored 'General case' 0 C--N 1.365 1.275 0 CA-C-O 125.023 2.344 . . . . 0.0 113.285 -167.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -58.49 -34.77 71.28 Favored 'General case' 0 C--O 1.205 -1.258 0 O-C-N 118.5 -2.625 . . . . 0.0 113.896 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -86.96 -61.91 1.62 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 128.116 2.567 . . . . 0.0 112.586 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.2 mt -109.45 157.54 18.85 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 125.729 1.893 . . . . 0.0 111.129 -162.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -142.55 156.54 45.13 Favored 'General case' 0 C--O 1.209 -1.062 0 O-C-N 126.28 2.237 . . . . 0.0 105.835 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -66.97 141.76 57.49 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 127.252 2.221 . . . . 0.0 112.83 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.93 -6.59 74.07 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-O 115.889 -2.617 . . . . 0.0 114.006 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -77.96 125.62 29.61 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 126.715 2.068 . . . . 0.0 113.589 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -67.8 136.77 54.68 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-O 123.392 1.567 . . . . 0.0 112.717 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 p -152.87 142.68 15.0 Favored Pre-proline 0 C--O 1.184 -2.383 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.765 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.14 123.49 11.3 Favored 'Trans proline' 0 C--N 1.276 -3.277 0 C-N-CA 123.521 2.814 . . . . 0.0 119.026 160.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.8 m -123.4 137.8 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-O 123.356 1.55 . . . . 0.0 107.325 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -100.0 132.5 45.32 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 113.745 -1.571 . . . . 0.0 110.533 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.85 124.58 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 126.225 2.203 . . . . 0.0 109.526 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.4 mt -111.87 -28.29 8.12 Favored 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.598 -1.313 . . . . 0.0 112.786 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -160.71 144.06 13.34 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.266 1.026 . . . . 0.0 111.749 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.8 t -115.93 115.16 48.33 Favored 'Isoleucine or valine' 0 C--N 1.375 1.694 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 167.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.322 0.0 OUTLIER -82.33 161.35 22.61 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 -174.189 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -89.91 -1.05 57.9 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 119.55 -1.969 . . . . 0.0 112.768 -168.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -85.82 0.74 52.17 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 127.094 3.33 . . . . 0.0 109.635 166.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.04 4.21 61.52 Favored Glycine 0 C--O 1.217 -0.942 0 CA-C-O 115.672 -2.738 . . . . 0.0 116.323 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -76.23 105.93 7.56 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 120.578 2.189 . . . . 0.0 111.851 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.5 mt -78.51 130.86 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -123.34 131.05 53.53 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.756 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.5 mt -127.94 140.58 51.91 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 123.979 0.912 . . . . 0.0 112.734 -163.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.1 t -126.61 120.78 30.39 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.4 mt -79.04 -28.62 13.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 167.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -61.69 -51.25 69.19 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -74.79 -19.46 60.2 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 121.877 0.846 . . . . 0.0 113.078 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.89 -25.91 25.9 Favored 'General case' 0 C--N 1.369 1.415 0 O-C-N 117.088 -3.507 . . . . 0.0 111.286 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.8 p -86.63 -11.13 52.25 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.259 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 77.37 34.52 0.37 Allowed 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.911 -1.118 . . . . 0.0 109.527 170.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 169.743 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 . . . . . 0 CA--C 1.569 1.707 0 N-CA-C 118.01 2.596 . . . . 0.0 118.01 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 pt -73.62 134.89 28.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -89.2 143.09 27.1 Favored 'General case' 0 C--N 1.368 1.402 0 CA-C-N 113.651 -1.613 . . . . 0.0 106.786 168.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 t -139.89 150.19 44.3 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-O 128.497 3.999 . . . . 0.0 114.624 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -137.56 134.15 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.502 0 CA-C-N 110.517 -3.038 . . . . 0.0 106.061 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -86.2 118.56 25.73 Favored 'General case' 0 CA--C 1.473 -2.013 0 O-C-N 125.38 1.675 . . . . 0.0 111.45 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.9 pt -112.0 152.41 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.651 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -47.63 114.46 3.17 Favored Pre-proline 0 C--O 1.212 -0.904 0 CA-C-O 115.371 -2.252 . . . . 0.0 114.323 163.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.17 -0.31 10.57 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 123.655 2.341 . . . . 0.0 115.894 -167.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -65.47 -29.88 70.59 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 125.761 1.913 . . . . 0.0 115.03 165.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -90.34 8.67 32.27 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 125.276 1.61 . . . . 0.0 113.394 -173.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.9 mt -66.07 -38.2 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 120.13 1.332 . . . . 0.0 112.321 -171.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -58.93 -45.3 90.73 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 125.76 1.913 . . . . 0.0 115.601 171.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.33 -49.43 77.62 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 125.266 1.604 . . . . 0.0 112.163 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 t -55.26 -49.5 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 O-C-N 128.66 3.725 . . . . 0.0 116.017 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.1 pt -74.85 -24.35 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 114.287 -2.768 . . . . 0.0 114.484 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.19 157.49 20.89 Favored Glycine 0 C--N 1.358 1.805 0 CA-C-N 120.8 1.636 . . . . 0.0 113.404 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.61 138.3 56.31 Favored 'General case' 0 C--N 1.378 1.82 0 CA-C-O 124.827 2.251 . . . . 0.0 107.593 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 43.92 29.05 1.35 Allowed Glycine 0 CA--C 1.557 2.665 0 CA-C-N 112.633 -2.076 . . . . 0.0 116.785 -158.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.17 20.84 63.32 Favored Glycine 0 C--O 1.213 -1.2 0 CA-C-N 121.131 2.465 . . . . 0.0 116.686 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.3 p -62.91 -37.7 88.01 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 127.11 2.164 . . . . 0.0 113.781 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.252 41.3 t -75.55 -35.47 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 123.724 0.64 . . . . 0.0 111.134 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.26 19.8 tt -67.64 -37.02 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 116.417 -2.113 . . . . 0.0 112.21 173.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -60.03 -43.4 95.34 Favored 'General case' 0 CA--C 1.584 2.271 0 CA-C-N 120.85 1.659 . . . . 0.0 114.697 171.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.73 82.89 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.149 2.58 . . . . 0.0 113.242 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -60.03 -45.1 93.91 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 124.973 1.42 . . . . 0.0 108.421 170.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 31.2 m -56.3 -54.45 45.28 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 120.684 1.584 . . . . 0.0 107.563 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.42 -43.5 96.7 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 119.568 3.173 . . . . 0.0 119.568 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -83.22 -25.46 31.7 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 p -78.15 -49.18 14.34 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 119.813 -1.805 . . . . 0.0 108.842 170.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.18 34.13 6.27 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 116.49 -2.283 . . . . 0.0 109.727 -173.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.3 p -131.15 172.77 11.73 Favored 'General case' 0 C--N 1.381 1.949 0 O-C-N 126.046 1.674 . . . . 0.0 110.436 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.6 m -109.2 138.42 45.58 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 123.44 1.591 . . . . 0.0 111.587 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.6 mp -135.48 127.68 46.7 Favored 'Isoleucine or valine' 0 C--N 1.387 2.196 0 CA-C-O 123.105 1.431 . . . . 0.0 110.223 -165.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.258 29.2 tt0 -128.43 129.2 45.8 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 117.662 -3.149 . . . . 0.0 106.831 164.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.4 mt -100.71 121.31 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 125.652 1.845 . . . . 0.0 109.874 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -87.36 150.76 23.61 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.259 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -54.09 -30.63 49.14 Favored 'General case' 0 C--O 1.261 1.668 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -168.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -82.64 0.46 42.99 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 126.76 2.024 . . . . 0.0 111.765 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.56 18.23 57.16 Favored Glycine 0 N--CA 1.504 3.232 0 O-C-N 119.327 -2.108 . . . . 0.0 110.745 -175.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -84.38 101.82 12.27 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.56 133.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 125.467 1.729 . . . . 0.0 112.236 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -118.16 112.08 19.69 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.5 mm -103.88 127.89 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 126.606 1.963 . . . . 0.0 108.977 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.34 130.75 44.83 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.8 174.13 13.62 Favored 'General case' 0 C--O 1.204 -1.313 0 O-C-N 120.704 -1.247 . . . . 0.0 109.02 -159.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -132.53 14.36 4.5 Favored 'General case' 0 CA--C 1.479 -1.753 0 CA-C-O 117.366 -1.302 . . . . 0.0 109.118 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -150.51 150.22 30.99 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.61 -44.51 6.1 Favored Glycine 0 N--CA 1.507 3.405 0 C-N-CA 127.024 2.25 . . . . 0.0 113.816 -163.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -50.48 -44.12 55.69 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 163.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -62.56 -45.25 93.79 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 124.883 1.364 . . . . 0.0 110.194 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.37 85.72 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.604 1.162 . . . . 0.0 110.91 173.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -58.83 -45.28 90.39 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 169.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -58.56 -41.34 85.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 126.38 2.3 . . . . 0.0 113.718 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.77 65.13 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mm -62.97 -46.2 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.804 0 CA-C-N 111.144 -2.753 . . . . 0.0 108.323 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -64.27 -49.97 69.76 Favored 'General case' 0 C--O 1.205 -1.252 0 O-C-N 124.529 1.143 . . . . 0.0 113.746 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -57.78 -39.46 77.53 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.801 1.24 . . . . 0.0 113.398 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.62 -49.38 84.01 Favored 'Isoleucine or valine' 0 C--O 1.257 1.474 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 168.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.68 -41.72 74.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -61.97 -47.69 83.69 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 127.752 2.421 . . . . 0.0 113.374 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.1 tt -71.29 -35.47 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 C-N-CA 124.349 1.06 . . . . 0.0 111.861 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 79.0 m -61.18 -40.37 93.63 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 116.214 -1.851 . . . . 0.0 109.911 168.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.68 -11.8 52.86 Favored 'General case' 0 C--N 1.374 1.655 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.95 127.94 34.72 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-N 122.791 2.541 . . . . 0.0 116.465 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.4 mm -107.95 116.55 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 CA-C-O 126.141 2.877 . . . . 0.0 104.434 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -117.83 140.52 49.58 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.694 1.998 . . . . 0.0 112.105 -173.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.43 148.76 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.667 -1.213 . . . . 0.0 113.479 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.45 -19.67 22.3 Favored Glycine 0 C--O 1.208 -1.511 0 CA-C-O 113.862 -3.743 . . . . 0.0 117.016 -171.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -96.92 158.82 15.25 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.98 1.89 . . . . 0.0 111.17 -166.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.71 127.8 75.88 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -121.35 159.54 25.88 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 124.016 1.865 . . . . 0.0 109.109 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 m -98.35 118.72 35.65 Favored 'General case' 0 C--O 1.202 -1.444 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 167.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -147.03 175.43 26.41 Favored Glycine 0 CA--C 1.569 3.416 0 C-N-CA 124.41 1.005 . . . . 0.0 114.829 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -117.15 133.15 56.35 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-O 125.633 2.635 . . . . 0.0 111.45 -169.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.3 t -67.8 121.13 16.4 Favored 'Isoleucine or valine' 0 C--N 1.366 1.304 0 O-C-N 119.214 -2.179 . . . . 0.0 106.487 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.4 p -103.8 -36.87 7.68 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.037 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -146.37 154.8 42.06 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.0 mt -126.22 130.17 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 O-C-N 125.796 1.935 . . . . 0.0 110.812 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.83 173.16 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -64.07 -27.73 69.3 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 123.262 1.506 . . . . 0.0 113.436 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -113.81 21.85 14.56 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -166.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.91 -153.01 24.95 Favored Glycine 0 C--O 1.204 -1.778 0 CA-C-O 116.991 -2.005 . . . . 0.0 111.305 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -149.69 174.33 12.69 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 102.203 -3.258 . . . . 0.0 102.203 167.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -114.86 128.76 56.48 Favored 'General case' 0 C--O 1.201 -1.47 0 O-C-N 127.669 3.106 . . . . 0.0 111.527 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.86 124.66 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 O-C-N 125.363 1.665 . . . . 0.0 107.494 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.69 117.53 17.55 Favored 'General case' 0 C--O 1.215 -0.732 1 O-C-N 129.434 4.209 . . . . 0.0 114.405 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.0 pt -138.78 157.62 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 113.894 -1.503 . . . . 0.0 114.868 -167.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.25 -111.84 4.34 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 117.339 -1.812 . . . . 0.0 110.772 -176.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.83 -16.03 73.78 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 120.796 2.298 . . . . 0.0 112.809 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.59 -26.16 1.5 Allowed Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 116.947 -2.549 . . . . 0.0 112.377 -171.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -49.51 132.91 20.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 120.434 3.494 . . . . 0.0 120.434 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.48 143.64 48.34 Favored 'General case' 0 C--N 1.385 2.121 0 CA-C-O 123.966 1.841 . . . . 0.0 111.259 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.11 157.93 15.97 Favored Glycine 0 CA--C 1.539 1.565 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 169.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.433 HD23 ' CE1' ' A' ' 110' ' ' HIS . 4.1 tp -112.46 116.43 30.27 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 118.843 1.322 . . . . 0.0 111.001 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.56 118.4 48.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 171.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.433 ' CE1' HD23 ' A' ' 108' ' ' LEU . 90.8 m-70 -80.0 163.45 24.23 Favored 'General case' 0 C--O 1.192 -1.966 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 111' ' ' ILE . 21.0 tt -56.29 -39.59 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 C-N-CA 126.327 1.851 . . . . 0.0 114.856 -170.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.8 p -77.87 -5.15 50.01 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 125.087 1.492 . . . . 0.0 114.971 171.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.77 3.49 42.2 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 173.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.413 HG13 HG21 ' A' ' 122' ' ' VAL . 8.6 mm -74.17 -39.76 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 124.225 1.964 . . . . 0.0 113.789 169.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.58 151.94 35.92 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.429 -170.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -92.42 -1.03 57.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.872 160.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -87.26 170.58 11.32 Favored 'General case' 0 CA--C 1.577 2.018 0 CA-C-O 124.523 2.106 . . . . 0.0 107.944 158.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.57 147.84 47.88 Favored 'General case' 0 C--O 1.2 -1.503 0 N-CA-C 118.071 2.619 . . . . 0.0 118.071 -173.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.5 t -139.31 125.09 22.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.47 -46.8 5.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 125.313 1.445 . . . . 0.0 108.527 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -140.05 146.09 38.53 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.413 HG21 HG13 ' A' ' 114' ' ' ILE . 58.2 t -92.69 -3.87 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.167 1.349 . . . . 0.0 110.982 -178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.0 p -68.59 -23.28 64.45 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 116.149 -1.881 . . . . 0.0 114.47 165.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.93 -8.33 56.18 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 127.391 2.932 . . . . 0.0 111.469 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -119.93 -68.93 0.88 Allowed 'General case' 0 C--N 1.356 0.884 0 O-C-N 120.315 -1.491 . . . . 0.0 111.049 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.8 mt -90.74 152.49 20.79 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.454 1.121 . . . . 0.0 108.047 -173.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -124.66 135.12 52.8 Favored 'General case' 0 C--N 1.385 2.118 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.7 mtm -65.83 142.97 57.76 Favored 'General case' 0 C--O 1.21 -0.987 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.85 1.57 82.42 Favored Glycine 0 C--O 1.197 -2.191 0 CA-C-O 114.255 -3.525 . . . . 0.0 116.16 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -97.65 143.11 28.64 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 120.931 2.366 . . . . 0.0 107.9 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -71.07 117.68 12.89 Favored 'General case' 0 C--O 1.2 -1.517 0 O-C-N 126.257 2.223 . . . . 0.0 111.092 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.97 128.15 25.89 Favored Pre-proline 0 CA--C 1.587 2.379 0 C-N-CA 123.868 0.867 . . . . 0.0 110.408 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.37 128.17 27.48 Favored 'Trans proline' 0 N--CA 1.525 3.341 0 C-N-CA 123.432 2.754 . . . . 0.0 113.588 153.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.8 m -140.99 135.42 33.01 Favored 'Isoleucine or valine' 0 C--N 1.374 1.645 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -101.89 141.44 34.73 Favored 'General case' 0 CA--C 1.566 1.585 0 O-C-N 120.335 -1.478 . . . . 0.0 108.62 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.78 126.71 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 123.428 1.585 . . . . 0.0 110.39 -176.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.5 mt -97.48 -76.41 0.52 Allowed 'General case' 0 C--N 1.365 1.282 0 CA-C-O 116.56 -1.686 . . . . 0.0 109.975 -172.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.43 148.75 36.62 Favored 'General case' 0 N--CA 1.416 -2.14 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.99 135.24 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 125.902 2.001 . . . . 0.0 110.34 160.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -84.56 168.75 15.1 Favored 'General case' 0 C--N 1.369 1.414 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -67.57 -38.45 84.1 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-O 117.592 -1.194 . . . . 0.0 112.788 -170.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -76.53 -7.66 55.61 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 131.64 1.99 4.52 Favored Glycine 0 CA--C 1.496 -1.15 0 CA-C-O 117.219 -1.878 . . . . 0.0 116.998 165.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.82 147.73 22.61 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 120.652 2.226 . . . . 0.0 113.965 -171.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 24.4 mt -100.0 141.39 17.17 Favored 'Isoleucine or valine' 0 C--N 1.376 1.719 0 C-N-CA 117.323 -1.751 . . . . 0.0 110.614 176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -113.55 132.17 55.81 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.734 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.8 mt -124.55 165.39 17.91 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -165.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.0 t -136.69 135.31 38.1 Favored 'General case' 0 N--CA 1.524 3.253 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.624 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mm -88.32 -42.29 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 125.971 2.045 . . . . 0.0 109.441 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -64.65 -32.37 74.01 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 119.632 -1.917 . . . . 0.0 116.036 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -87.9 -3.48 58.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.416 -1.428 . . . . 0.0 110.79 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.266 . . -98.92 17.08 20.44 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.9 t -140.17 136.93 33.96 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.775 1.23 . . . . 0.0 110.438 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.79 163.86 4.16 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 126.683 1.993 . . . . 0.0 112.158 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 . . . . . 0 N--CA 1.477 0.91 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.047 -176.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.278 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 117.751 -1.119 . . . . 0.0 108.61 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.1 mt -105.03 135.95 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 126.394 2.309 . . . . 0.0 108.186 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -113.99 131.29 56.39 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.72 1.263 . . . . 0.0 107.902 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.6 m -110.06 107.85 17.85 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.112 1.434 . . . . 0.0 110.507 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.7 126.06 74.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 113.758 -1.565 . . . . 0.0 111.224 -169.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -95.51 129.27 42.74 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 pt -127.87 162.81 33.01 Favored 'Isoleucine or valine' 0 C--N 1.381 1.966 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.995 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -45.87 116.48 3.37 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.954 1.701 . . . . 0.0 113.625 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -66.84 8.29 0.35 Allowed 'Trans proline' 0 N--CA 1.51 2.498 0 O-C-N 116.87 -2.226 . . . . 0.0 114.547 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.25 -15.39 35.97 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 120.29 1.405 . . . . 0.0 111.51 169.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -119.42 22.06 11.89 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 125.832 1.958 . . . . 0.0 114.902 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 mt -70.81 -40.11 76.29 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 C-N-CA 124.069 0.948 . . . . 0.0 109.884 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -58.2 -39.75 79.79 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 126.771 2.028 . . . . 0.0 115.976 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.76 -35.19 62.58 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.007 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.0 t -71.04 -41.08 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 123.271 1.51 . . . . 0.0 111.659 170.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.2 mt -64.13 -55.82 19.86 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.951 0 CA-C-O 116.389 -1.767 . . . . 0.0 111.181 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.54 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 88.78 -177.9 45.16 Favored Glycine 0 C--O 1.205 -1.708 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 -172.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -77.79 122.75 25.83 Favored 'General case' 0 CA--C 1.557 1.23 0 O-C-N 119.033 -2.451 . . . . 0.0 110.293 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.94 22.41 64.6 Favored Glycine 1 N--CA 1.521 4.361 0 C-N-CA 118.159 -1.972 . . . . 0.0 112.513 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.97 5.7 70.45 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-O 116.625 -2.209 . . . . 0.0 114.308 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -55.64 -46.81 77.4 Favored 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -174.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.54 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 73.1 t -67.12 -44.22 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -69.61 -34.48 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 O-C-N 118.934 -2.354 . . . . 0.0 110.796 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -49.12 -53.87 18.78 Favored 'General case' 0 C--N 1.381 1.973 0 O-C-N 126.07 2.106 . . . . 0.0 113.755 165.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.68 -36.8 85.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.876 1.36 . . . . 0.0 114.152 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.3 tp -61.2 -47.05 87.9 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.872 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -71.19 -25.09 62.37 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.62 -46.16 55.44 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 117.933 -1.507 . . . . 0.0 113.301 166.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.58 -32.32 64.07 Favored 'General case' 0 C--O 1.255 1.354 0 O-C-N 125.145 1.528 . . . . 0.0 108.709 -167.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 75.2 p -82.84 -21.16 34.49 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 120.201 -1.562 . . . . 0.0 112.877 174.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.03 34.58 87.26 Favored Glycine 0 C--N 1.381 3.075 0 C-N-CA 129.222 3.296 . . . . 0.0 112.182 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 t -146.98 157.95 43.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 119.696 -2.061 . . . . 0.0 108.572 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.2 m -74.12 128.76 36.37 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 124.325 1.016 . . . . 0.0 112.611 -172.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.5 mt -136.13 137.69 48.16 Favored 'Isoleucine or valine' 0 C--N 1.365 1.254 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -170.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -136.89 150.01 47.99 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.987 1.715 . . . . 0.0 109.336 -169.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.2 tt -141.94 155.16 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 118.82 -1.152 . . . . 0.0 112.417 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -127.17 155.27 43.65 Favored 'General case' 0 C--N 1.362 1.137 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.636 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -86.83 20.4 2.61 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -115.57 13.86 16.44 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.32 5.99 89.11 Favored Glycine 0 C--N 1.36 1.893 0 C-N-CA 119.081 -1.533 . . . . 0.0 110.385 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.4 m -88.09 114.63 24.9 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 119.963 -1.904 . . . . 0.0 108.964 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -115.71 138.33 46.49 Favored 'Isoleucine or valine' 0 C--N 1.365 1.249 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -123.79 131.56 53.62 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 112.731 -2.032 . . . . 0.0 111.58 -169.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.39 106.96 19.7 Favored 'Isoleucine or valine' 0 C--N 1.371 1.513 0 O-C-N 125.408 1.693 . . . . 0.0 109.801 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.39 121.93 33.54 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-N 112.806 -1.997 . . . . 0.0 105.977 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.04 151.87 28.92 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -165.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -123.94 -10.12 7.71 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.075 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -120.25 123.7 43.86 Favored 'General case' 0 C--N 1.377 1.762 0 CA-C-N 119.305 0.957 . . . . 0.0 110.42 171.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.28 -36.56 53.06 Favored Glycine 0 C--N 1.361 1.92 0 CA-C-O 122.629 1.127 . . . . 0.0 114.308 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.526 ' CD ' ' HZ3' ' A' ' 66' ' ' LYS . 64.7 mm-40 -67.31 -40.73 86.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 117.243 -1.36 . . . . 0.0 112.686 177.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -68.09 -42.18 80.75 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.523 1.056 . . . . 0.0 112.115 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.61 84.94 Favored 'General case' 0 C--N 1.358 0.965 0 O-C-N 125.571 1.795 . . . . 0.0 112.869 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.526 ' HZ3' ' CD ' ' A' ' 63' ' ' GLU . 8.2 mtmp? -62.76 -42.67 99.79 Favored 'General case' 0 C--O 1.261 1.678 0 O-C-N 125.179 1.55 . . . . 0.0 113.082 173.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . 0.287 12.1 t-80 -63.29 -37.64 88.05 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 126.61 2.444 . . . . 0.0 115.138 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.58 -43.39 80.68 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.865 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.318 61.4 mt -60.32 -41.74 88.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.312 0 CA-C-N 119.113 0.87 . . . . 0.0 109.683 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? -61.2 -46.02 92.17 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 117.522 -1.228 . . . . 0.0 112.825 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -59.58 -43.07 93.78 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 127.836 2.454 . . . . 0.0 110.131 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.06 -44.9 99.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -62.26 -40.05 94.92 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.06 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -54.56 -56.02 23.3 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 123.013 1.387 . . . . 0.0 113.698 173.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.257 76.9 mt -63.95 -45.16 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 112.299 -2.228 . . . . 0.0 109.776 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.7 p -79.4 -23.32 43.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.619 1.554 . . . . 0.0 114.752 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.14 -24.66 58.0 Favored 'General case' 0 C--O 1.273 2.295 0 CA-C-N 120.573 1.533 . . . . 0.0 113.336 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -55.04 144.13 24.47 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 124.488 2.09 . . . . 0.0 114.536 -177.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mm -72.91 148.26 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 119.636 -1.915 . . . . 0.0 114.834 -157.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -115.03 154.86 28.06 Favored 'General case' 0 C--O 1.249 1.053 0 O-C-N 119.631 -1.918 . . . . 0.0 108.965 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.07 143.7 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.85 0 O-C-N 119.097 -2.252 . . . . 0.0 113.51 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.05 85.6 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 120.986 -1.071 . . . . 0.0 113.569 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -111.58 152.37 27.66 Favored 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 123.387 0.675 . . . . 0.0 110.804 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.58 140.09 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 126.554 2.409 . . . . 0.0 109.675 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -129.4 159.94 34.65 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 125.187 2.423 . . . . 0.0 106.657 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.5 109.86 21.98 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 118.64 -2.537 . . . . 0.0 109.319 174.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.44 166.08 18.33 Favored Glycine 0 C--N 1.368 2.348 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -169.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -120.28 149.08 42.87 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-N 112.231 -1.984 . . . . 0.0 113.544 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.18 127.71 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 124.109 1.909 . . . . 0.0 112.024 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 p -97.48 -30.2 13.03 Favored 'General case' 0 CA--C 1.48 -1.712 0 CA-C-O 116.268 -1.825 . . . . 0.0 114.218 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -171.0 151.27 3.24 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.8 mt -123.98 140.28 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 O-C-N 121.444 -0.785 . . . . 0.0 109.456 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.4 m -142.51 172.02 9.21 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.242 0 C-N-CA 126.366 1.866 . . . . 0.0 112.797 -173.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.16 -35.53 81.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 118.356 -2.715 . . . . 0.0 113.811 -165.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -109.81 18.34 20.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 125.385 1.678 . . . . 0.0 113.207 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.56 -161.81 32.47 Favored Glycine 0 CA--C 1.549 2.174 0 N-CA-C 117.711 1.845 . . . . 0.0 117.711 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.19 142.86 26.6 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 120.913 -1.345 . . . . 0.0 110.441 -173.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -99.37 134.76 41.76 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.827 1.775 . . . . 0.0 109.039 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.2 t -136.03 123.26 33.95 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.245 0 CA-C-N 112.434 -2.166 . . . . 0.0 110.497 -171.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.39 147.78 22.79 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 125.559 1.787 . . . . 0.0 113.236 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 pt -145.35 164.95 11.51 Favored 'Isoleucine or valine' 0 C--N 1.362 1.143 0 O-C-N 126.022 2.076 . . . . 0.0 110.125 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.88 141.33 1.49 Allowed Glycine 0 CA--C 1.541 1.718 0 N-CA-C 121.521 3.368 . . . . 0.0 121.521 176.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.13 24.68 51.31 Favored Glycine 0 CA--C 1.496 -1.138 0 CA-C-O 116.682 -2.177 . . . . 0.0 115.979 -174.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.47 42.85 99.19 Favored Glycine 0 CA--C 1.562 2.976 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -121.76 148.93 44.01 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 120.148 -1.796 . . . . 0.0 113.325 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -130.34 119.65 23.1 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 124.103 1.906 . . . . 0.0 107.45 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.39 171.67 22.41 Favored Glycine 0 N--CA 1.408 -3.177 0 C-N-CA 125.692 1.615 . . . . 0.0 110.125 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 tp -116.08 136.56 52.91 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 115.29 -2.29 . . . . 0.0 109.709 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -101.76 115.08 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.159 2.254 . . . . 0.0 109.14 167.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -62.66 149.54 43.25 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.269 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.0 tt -56.46 -38.89 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -175.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . 0.301 71.4 m -73.81 -10.13 59.36 Favored 'General case' 0 CA--C 1.486 -1.511 0 C-N-CA 124.387 1.075 . . . . 0.0 111.208 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -117.2 18.76 14.43 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.663 1.185 . . . . 0.0 113.213 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.2 mt -81.9 -53.79 11.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 125.347 1.459 . . . . 0.0 111.521 167.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.46 166.95 27.59 Favored 'General case' 0 C--O 1.198 -1.624 0 O-C-N 123.574 0.546 . . . . 0.0 111.617 -171.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -69.53 -43.66 72.57 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.371 163.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -48.14 145.84 2.96 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 162.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -66.58 131.57 46.31 Favored 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.956 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 18.6 t -110.29 102.98 14.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 170.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.56 -43.08 19.21 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 124.757 1.286 . . . . 0.0 108.876 161.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -133.31 148.06 51.89 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.006 -1.684 . . . . 0.0 108.727 170.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.35 -33.06 52.55 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 126.539 1.936 . . . . 0.0 115.152 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.2 p -62.59 -9.03 7.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 116.409 -1.758 . . . . 0.0 115.69 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -69.1 -41.99 76.7 Favored 'General case' 0 C--N 1.372 1.578 0 CA-C-N 123.691 2.951 . . . . 0.0 110.648 168.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -109.97 -34.03 6.54 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -164.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.48 142.83 39.95 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -168.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -126.51 150.35 48.82 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -55.34 136.29 49.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 125.807 1.942 . . . . 0.0 114.236 168.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.49 3.44 88.79 Favored Glycine 0 C--N 1.381 3.07 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.396 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -79.99 122.96 27.37 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.46 107.2 1.3 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 128.373 3.545 . . . . 0.0 114.069 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.4 148.01 43.05 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 111.382 -2.644 . . . . 0.0 105.582 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -90.57 134.1 1.89 Allowed 'Trans proline' 1 C--N 1.255 -4.364 0 N-CA-C 104.648 -2.866 . . . . 0.0 104.648 170.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.74 137.27 39.5 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.939 0 C-N-CA 118.119 -1.432 . . . . 0.0 109.537 -172.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -113.61 135.02 54.37 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 122.863 1.316 . . . . 0.0 108.39 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.8 t -80.17 121.55 33.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 113.265 -1.789 . . . . 0.0 108.977 173.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 43.4 mt -104.98 -6.8 19.74 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.483 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -168.48 144.66 3.72 Favored 'General case' 0 N--CA 1.533 3.678 0 O-C-N 119.792 -1.817 . . . . 0.0 114.659 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.282 7.2 t -127.09 103.56 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 126.444 2.34 . . . . 0.0 106.041 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.46 166.05 24.16 Favored 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 -177.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -71.56 -7.61 48.75 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -107.96 14.83 24.94 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.727 1.611 . . . . 0.0 108.808 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.89 31.34 75.35 Favored Glycine 0 N--CA 1.414 -2.786 0 O-C-N 120.663 -1.273 . . . . 0.0 115.582 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . 0.252 58.3 mtm180 -80.74 117.63 21.58 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 124.027 1.87 . . . . 0.0 109.892 168.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 64.6 mt -101.94 121.2 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 O-C-N 118.582 -2.574 . . . . 0.0 107.955 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -109.76 106.14 15.65 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.832 1.777 . . . . 0.0 114.344 -175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.3 150.03 24.14 Favored 'General case' 0 C--N 1.389 2.284 0 CA-C-O 127.979 3.752 . . . . 0.0 110.861 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.3 t -119.51 129.1 54.54 Favored 'General case' 0 C--O 1.288 3.113 0 CA-C-N 110.158 -3.201 . . . . 0.0 110.734 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.41 -30.27 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 O-C-N 119.189 -2.194 . . . . 0.0 105.631 167.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -62.24 -46.92 86.71 Favored 'General case' 0 CA--C 1.553 1.075 0 O-C-N 120.537 -1.352 . . . . 0.0 114.136 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -69.63 -24.39 63.63 Favored 'General case' 0 C--O 1.264 1.837 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 171.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.11 -35.82 56.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 124.927 1.392 . . . . 0.0 111.414 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.4 p -90.01 26.2 1.92 Allowed 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 173.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.261 16.2 mt-10 71.71 17.44 5.48 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-O 123.864 1.792 . . . . 0.0 113.92 166.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 C--O 1.274 2.393 0 O-C-N 118.029 -2.919 . . . . 0.0 112.725 -178.277 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 . . . . . 0 CA--C 1.567 1.597 0 N-CA-C 118.683 2.846 . . . . 0.0 118.683 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.1 mm -108.86 119.68 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -113.87 151.48 32.1 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 102.959 -2.978 . . . . 0.0 102.959 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 p -148.29 151.81 36.04 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-O 124.819 2.247 . . . . 0.0 112.67 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.1 pt -145.87 155.58 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 O-C-N 118.669 -2.519 . . . . 0.0 105.243 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -107.21 119.75 40.25 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 121.464 -0.772 . . . . 0.0 110.217 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.05 141.66 30.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.761 0 C-N-CA 126.124 1.77 . . . . 0.0 108.815 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -73.02 146.01 86.91 Favored Pre-proline 0 C--O 1.213 -0.819 0 CA-C-O 115.33 -2.271 . . . . 0.0 113.555 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -67.2 -19.58 50.48 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 124.25 1.658 . . . . 0.0 113.251 -160.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -57.74 -44.41 86.05 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 119.871 -1.768 . . . . 0.0 111.652 166.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -92.87 -18.28 23.01 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.241 -1.537 . . . . 0.0 109.237 -167.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mm -59.74 -34.78 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.776 1.298 . . . . 0.0 108.688 165.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -61.8 -43.37 98.99 Favored 'General case' 0 CA--C 1.579 2.082 0 O-C-N 120.94 -1.1 . . . . 0.0 112.21 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -68.74 -31.0 69.74 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 114.05 -2.881 . . . . 0.0 112.262 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.28 -42.47 78.83 Favored 'Isoleucine or valine' 0 C--N 1.381 1.968 0 O-C-N 127.709 3.131 . . . . 0.0 108.843 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.8 -48.29 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 124.176 1.941 . . . . 0.0 111.296 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.99 -176.58 49.26 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 111.4 -2.636 . . . . 0.0 114.71 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -70.11 142.03 52.64 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 116.911 -1.915 . . . . 0.0 110.532 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.01 23.21 45.48 Favored Glycine 0 N--CA 1.511 3.641 0 O-C-N 120.263 -1.523 . . . . 0.0 114.702 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 52.8 43.27 60.33 Favored Glycine 0 CA--C 1.477 -2.305 0 C-N-CA 126.389 1.947 . . . . 0.0 114.689 -168.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.6 p -97.95 -33.84 11.06 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 117.446 -1.702 . . . . 0.0 114.618 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -65.66 -36.19 77.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 O-C-N 120.499 -1.376 . . . . 0.0 112.528 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.54 -42.05 94.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 O-C-N 119.487 -2.008 . . . . 0.0 114.097 167.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -62.71 -37.27 85.86 Favored 'General case' 0 CA--C 1.583 2.244 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.8 -48.15 69.88 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 117.056 -1.449 . . . . 0.0 111.186 170.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -55.62 -42.56 75.1 Favored 'General case' 0 C--N 1.37 1.458 0 C-N-CA 124.52 1.128 . . . . 0.0 108.579 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.9 m -61.86 -47.69 83.88 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 114.607 -1.178 . . . . 0.0 112.163 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -61.28 -45.81 92.95 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.772 -2.013 . . . . 0.0 112.283 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.97 -53.2 42.04 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-O 114.655 -2.593 . . . . 0.0 114.001 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.1 p -69.19 -22.93 63.86 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 125.857 1.973 . . . . 0.0 113.336 -170.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.03 13.18 53.82 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-O 114.841 -3.199 . . . . 0.0 117.548 -176.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.98 161.66 34.17 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.693 2.247 . . . . 0.0 108.714 -162.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.3 m -66.3 123.71 20.69 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 176.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.8 mm -118.15 134.65 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -140.48 167.54 21.92 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 123.344 1.545 . . . . 0.0 108.421 170.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.6 mm -113.29 130.64 66.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 104.235 -2.505 . . . . 0.0 104.235 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -118.77 163.91 16.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -45.37 160.62 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.308 79.3 m-20 69.37 32.14 3.61 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 123.515 1.626 . . . . 0.0 114.841 170.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.7 53.75 24.37 Favored Glycine 0 C--O 1.281 3.064 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.1 m -102.63 132.89 48.44 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 125.898 1.587 . . . . 0.0 110.989 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -94.94 134.44 32.3 Favored 'Isoleucine or valine' 0 C--N 1.37 1.47 0 O-C-N 119.046 -2.284 . . . . 0.0 108.305 158.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -107.78 130.36 54.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.05 124.87 69.18 Favored 'Isoleucine or valine' 0 C--N 1.372 1.555 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 167.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.55 114.93 27.83 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.88 140.91 22.94 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 123.298 1.523 . . . . 0.0 113.636 -164.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 p -110.47 4.58 20.62 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 126.61 1.964 . . . . 0.0 111.953 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -126.2 139.33 53.43 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 169.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.32 -27.73 24.48 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 125.605 1.574 . . . . 0.0 113.577 -174.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -62.02 -39.64 92.97 Favored 'General case' 0 C--O 1.248 0.976 0 O-C-N 121.316 -1.108 . . . . 0.0 113.423 168.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -65.97 -37.36 85.77 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 118.483 0.583 . . . . 0.0 112.308 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.41 89.37 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 123.469 1.604 . . . . 0.0 114.224 173.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -67.33 -42.91 82.81 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 115.179 -2.343 . . . . 0.0 113.035 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -62.61 -40.79 98.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 126.456 2.348 . . . . 0.0 111.577 169.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.64 -48.45 69.38 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.89 -37.36 71.62 Favored 'Isoleucine or valine' 0 C--N 1.368 1.397 0 O-C-N 125.399 1.687 . . . . 0.0 109.271 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.306 27.5 tpt180 -67.82 -41.86 82.42 Favored 'General case' 0 C--N 1.375 1.709 0 O-C-N 124.726 1.266 . . . . 0.0 114.413 172.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -62.41 -39.3 92.85 Favored 'General case' 0 C--O 1.253 1.274 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.132 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mm -55.43 -31.98 28.71 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 CA-C-O 117.331 -1.319 . . . . 0.0 108.668 176.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -72.82 -29.33 63.16 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 116.956 -1.898 . . . . 0.0 109.142 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.79 -40.57 79.57 Favored 'General case' 0 C--O 1.26 1.651 0 O-C-N 120.437 -1.415 . . . . 0.0 109.121 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.39 -38.33 32.05 Favored 'Isoleucine or valine' 0 C--O 1.264 1.862 0 O-C-N 127.338 2.899 . . . . 0.0 117.191 165.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.0 p -88.14 -17.11 31.69 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 117.879 -3.013 . . . . 0.0 115.998 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.44 -25.36 23.81 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -71.97 148.11 46.29 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 126.482 3.039 . . . . 0.0 113.4 171.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.0 mm -79.99 135.06 26.21 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.794 0 CA-C-O 126.023 2.82 . . . . 0.0 111.827 -169.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -87.09 134.42 33.51 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.313 -167.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.46 129.07 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 CA-C-O 123.629 1.681 . . . . 0.0 112.568 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.43 16.87 79.92 Favored Glycine 0 N--CA 1.513 3.769 0 C-N-CA 126.698 2.094 . . . . 0.0 117.967 165.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -120.16 161.43 21.05 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.42 113.14 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 112.417 -2.174 . . . . 0.0 109.441 -164.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -94.7 163.01 13.54 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 113.188 -1.823 . . . . 0.0 113.662 169.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 m -104.85 127.48 52.69 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 116.944 -3.598 . . . . 0.0 104.007 163.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.66 -164.88 11.93 Favored Glycine 0 CA--C 1.493 -1.318 0 C-N-CA 126.978 2.228 . . . . 0.0 108.149 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -149.38 151.73 34.57 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-O 116.854 -1.546 . . . . 0.0 109.915 172.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.88 109.59 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 126.855 2.062 . . . . 0.0 111.864 -177.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -94.19 -55.71 3.1 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.91 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.7 mtm-85 -131.81 123.46 27.64 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -98.65 128.97 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 CA-C-O 123.481 1.61 . . . . 0.0 107.087 176.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.71 174.49 9.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 O-C-N 120.476 -1.39 . . . . 0.0 110.059 -169.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.68 -25.53 64.82 Favored 'General case' 0 C--N 1.377 1.767 0 O-C-N 117.835 -3.041 . . . . 0.0 116.054 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -125.51 14.32 8.19 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-O 117.571 -1.204 . . . . 0.0 112.637 -172.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.42 -159.14 30.72 Favored Glycine 0 C--O 1.193 -2.448 0 CA-C-N 120.647 1.567 . . . . 0.0 110.661 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.96 155.58 46.21 Favored 'General case' 0 CA--C 1.477 -1.838 0 O-C-N 124.759 0.917 . . . . 0.0 109.282 158.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -87.43 147.01 25.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.896 0.855 . . . . 0.0 109.894 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 t -136.97 130.85 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.62 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.269 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.47 139.47 38.03 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-O 125.14 2.4 . . . . 0.0 106.04 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.3 mt -119.86 137.57 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 111.539 -2.573 . . . . 0.0 111.955 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.84 129.26 1.5 Allowed Glycine 0 N--CA 1.503 3.143 0 N-CA-C 120.95 3.14 . . . . 0.0 120.95 172.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.08 18.23 29.82 Favored Glycine 0 C--N 1.364 2.112 0 C-N-CA 124.459 1.028 . . . . 0.0 114.343 -163.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.1 27.73 73.6 Favored Glycine 0 CA--C 1.54 1.64 0 O-C-N 125.871 1.571 . . . . 0.0 113.971 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -100.0 149.57 23.33 Favored 'General case' 0 C--N 1.369 1.448 0 CA-C-N 119.534 1.667 . . . . 0.0 112.178 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -146.48 141.35 26.99 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 123.119 1.438 . . . . 0.0 114.353 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.63 166.46 18.36 Favored Glycine 0 CA--C 1.495 -1.202 0 O-C-N 120.348 -1.47 . . . . 0.0 110.05 -174.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.22 130.71 50.52 Favored 'General case' 0 N--CA 1.518 2.934 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.385 173.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.58 109.61 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 163.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -70.03 150.59 46.47 Favored 'General case' 0 C--O 1.2 -1.551 0 CA-C-N 113.815 -1.539 . . . . 0.0 114.409 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.432 8.6 tt -49.47 -21.79 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 118.711 2.856 . . . . 0.0 118.711 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.7 p -106.32 14.45 27.4 Favored 'General case' 0 C--N 1.389 2.287 0 CA-C-O 117.781 -1.104 . . . . 0.0 110.855 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -124.41 22.44 8.45 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 124.867 1.354 . . . . 0.0 111.597 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.7 mt -99.08 -39.35 7.79 Favored 'Isoleucine or valine' 0 C--N 1.377 1.784 0 CA-C-N 123.075 2.67 . . . . 0.0 110.24 175.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -159.39 149.79 19.23 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 117.285 -1.766 . . . . 0.0 113.58 -170.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.29 -26.44 60.19 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 118.92 -2.363 . . . . 0.0 108.523 163.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -57.42 151.56 16.16 Favored 'General case' 0 N--CA 1.405 -2.691 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 162.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -66.65 142.2 57.53 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.653 1.216 . . . . 0.0 108.464 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.6 t -128.34 137.24 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.888 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -107.7 -75.19 0.64 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -114.39 155.37 26.42 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 173.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.25 -26.32 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 122.019 2.19 . . . . 0.0 114.257 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.3 p -65.01 -20.29 66.42 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.931 1.292 . . . . 0.0 112.979 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -102.97 31.91 3.97 Favored 'General case' 0 C--O 1.256 1.404 0 O-C-N 126.492 2.37 . . . . 0.0 107.517 -172.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -153.36 -55.98 0.12 Allowed 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.7 157.17 16.2 Favored 'General case' 0 C--N 1.375 1.706 0 C-N-CA 125.016 1.326 . . . . 0.0 111.447 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -117.39 148.18 41.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 127.137 2.773 . . . . 0.0 105.93 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -70.18 143.27 52.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 124.047 1.88 . . . . 0.0 110.084 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.6 -17.9 22.68 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 112.158 -2.292 . . . . 0.0 115.786 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -58.99 143.76 47.26 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 124.999 1.32 . . . . 0.0 111.562 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -111.24 99.4 8.23 Favored 'General case' 0 N--CA 1.513 2.679 0 CA-C-O 123.875 1.798 . . . . 0.0 113.461 -165.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.4 p -109.04 134.33 20.43 Favored Pre-proline 0 N--CA 1.399 -2.994 0 CA-C-N 113.215 -1.811 . . . . 0.0 108.369 -160.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -58.66 140.07 93.34 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.127 1.067 . . . . 0.0 112.957 160.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.6 p -149.16 130.27 4.9 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 123.668 1.699 . . . . 0.0 111.667 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -94.39 131.5 39.99 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 112.746 -2.025 . . . . 0.0 111.118 172.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.45 132.12 33.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 126.714 3.15 . . . . 0.0 111.382 170.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 mt -100.14 -51.61 3.62 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 117.728 -3.108 . . . . 0.0 114.866 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 146' ' ' ARG . 41.3 mt-10 -139.05 142.64 38.2 Favored 'General case' 0 N--CA 1.41 -2.457 0 O-C-N 125.435 1.709 . . . . 0.0 107.416 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.46 126.25 75.04 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 163.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -91.07 156.56 17.82 Favored 'General case' 0 CA--C 1.553 1.058 0 O-C-N 125.428 1.705 . . . . 0.0 108.36 167.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -70.94 -23.49 62.25 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -92.78 26.89 2.55 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-O 123.05 1.405 . . . . 0.0 111.94 168.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.73 8.43 82.79 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 122.723 3.849 . . . . 0.0 122.723 161.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -85.09 144.9 27.94 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.265 -0.468 . . . . 0.0 110.951 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.89 132.25 68.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.435 HH21 ' CD ' ' A' ' 138' ' ' GLU . 1.3 mpp_? -103.61 133.94 47.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.023 162.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.8 mt -121.96 152.33 39.81 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 112.269 -2.241 . . . . 0.0 108.607 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 9.8 t -125.34 123.88 40.35 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 126.044 1.738 . . . . 0.0 110.649 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 69.4 mt -86.83 -31.0 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 117.507 -1.235 . . . . 0.0 109.981 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -60.46 -49.93 75.58 Favored 'General case' 0 C--O 1.276 2.49 0 C-N-CA 129.359 3.064 . . . . 0.0 117.518 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -88.07 -7.11 57.48 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 118.749 -1.18 . . . . 0.0 112.14 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.63 -37.04 81.92 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 124.153 0.981 . . . . 0.0 112.76 174.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 p -104.13 9.5 36.25 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.245 1.018 . . . . 0.0 109.209 171.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 62.01 48.49 5.14 Favored 'General case' 0 C--N 1.376 1.757 0 O-C-N 119.04 -2.287 . . . . 0.0 117.116 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 . . . . . 0 CA--C 1.563 1.458 0 C-N-CA 125.243 1.417 . . . . 0.0 114.387 -178.28 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 . . . . . 0 C--O 1.216 -0.697 0 CA-C-O 124.057 1.884 . . . . 0.0 108.303 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -100.51 125.85 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 119.07 -2.269 . . . . 0.0 109.07 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 66.1 m80 -80.16 111.04 16.14 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 127.17 2.793 . . . . 0.0 114.622 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.6 p -109.92 139.98 44.4 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 127.123 2.169 . . . . 0.0 106.996 -170.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.8 tt -132.3 128.57 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -110.84 128.55 55.82 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.92 154.25 39.62 Favored 'Isoleucine or valine' 0 C--N 1.365 1.253 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.39 -162.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -58.08 148.75 59.81 Favored Pre-proline 0 C--O 1.211 -0.945 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.45 -31.25 51.89 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 N-CA-C 116.232 1.589 . . . . 0.0 116.232 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -64.83 -40.78 95.73 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 169.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -57.46 -28.28 63.21 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.6 mt -57.63 -36.89 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -65.86 -18.59 65.44 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 127.617 2.367 . . . . 0.0 115.94 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -93.02 -20.34 20.66 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.679 167.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -91.27 -22.89 6.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.231 0 O-C-N 118.243 -2.786 . . . . 0.0 114.05 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.3 mt -92.05 -55.33 6.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 119.419 -2.051 . . . . 0.0 109.642 166.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.25 173.5 48.53 Favored Glycine 0 C--N 1.375 2.703 0 O-C-N 127.551 3.032 . . . . 0.0 115.75 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -66.05 120.89 13.96 Favored 'General case' 0 CA--C 1.581 2.136 0 CA-C-O 124.239 1.971 . . . . 0.0 110.916 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.68 9.69 46.29 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 120.28 -1.512 . . . . 0.0 112.751 -172.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.43 22.57 75.39 Favored Glycine 0 C--O 1.196 -2.228 0 O-C-N 120.89 -1.359 . . . . 0.0 112.257 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 t -61.09 -41.81 97.34 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 125.042 1.337 . . . . 0.0 114.502 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.64 -44.79 59.73 Favored 'Isoleucine or valine' 0 C--O 1.258 1.541 0 CA-C-N 120.65 1.568 . . . . 0.0 113.396 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 tt -60.79 -41.14 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 119.804 -1.81 . . . . 0.0 110.437 174.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -59.9 -49.17 78.74 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 123.556 1.646 . . . . 0.0 112.843 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.56 94.15 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 124.023 1.868 . . . . 0.0 112.57 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.0 tp -56.5 -37.0 69.79 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.504 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.7 m -57.74 -60.14 4.15 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-O 115.556 -2.164 . . . . 0.0 116.239 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.63 -40.6 92.53 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 126.815 2.572 . . . . 0.0 114.336 174.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -60.65 -47.7 85.08 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 124.889 2.28 . . . . 0.0 112.223 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.3 p -88.24 -24.65 23.19 Favored 'General case' 0 C--O 1.21 -0.991 0 O-C-N 118.98 -2.325 . . . . 0.0 109.436 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.25 38.74 94.03 Favored Glycine 0 N--CA 1.484 1.855 0 C-N-CA 118.915 -1.612 . . . . 0.0 116.95 -166.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.6 p -139.85 176.89 8.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 119.94 1.87 . . . . 0.0 108.156 -172.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -118.11 121.44 40.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.811 -1.806 . . . . 0.0 107.937 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.5 126.12 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 119.782 1.174 . . . . 0.0 108.818 -170.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -123.58 147.59 47.17 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.0 mt -127.75 115.6 40.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.182 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -77.1 167.55 21.59 Favored 'General case' 0 N--CA 1.525 3.307 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -76.42 -19.38 58.15 Favored 'General case' 0 C--N 1.378 1.835 0 C-N-CA 122.749 0.42 . . . . 0.0 111.018 -170.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.31 -12.89 51.25 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.297 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.51 17.29 34.14 Favored Glycine 0 N--CA 1.475 1.257 0 CA-C-O 116.496 -2.28 . . . . 0.0 116.917 -167.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -78.82 122.22 25.78 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 120.862 2.331 . . . . 0.0 108.815 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.3 t -94.67 126.81 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 169.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -108.13 126.07 52.33 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.0 mt -115.67 113.83 44.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.933 0 CA-C-N 121.366 1.894 . . . . 0.0 113.978 178.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.42 137.42 32.38 Favored 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 119.661 -1.9 . . . . 0.0 108.17 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.66 141.6 45.03 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.817 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -68.39 -36.92 79.86 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.594 1.088 . . . . 0.0 108.707 170.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -119.76 129.85 54.68 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 124.401 2.048 . . . . 0.0 107.67 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.88 -29.93 71.77 Favored Glycine 0 N--CA 1.475 1.296 0 O-C-N 118.992 -2.317 . . . . 0.0 116.242 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -67.49 -28.54 67.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.358 2.079 . . . . 0.0 111.371 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.23 -37.99 84.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 124.456 1.098 . . . . 0.0 110.919 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.26 79.67 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 120.131 -1.606 . . . . 0.0 112.509 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -63.82 -45.24 90.52 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.797 174.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -63.58 -38.88 92.82 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 124.938 1.399 . . . . 0.0 112.919 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.49 82.53 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.4 mt -52.72 -43.94 45.78 Favored 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 124.234 1.014 . . . . 0.0 110.474 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -60.23 -46.29 90.29 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.6 mmm180 -61.34 -37.22 82.51 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.101 1.319 . . . . 0.0 112.111 174.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.1 mt -61.54 -41.69 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 121.299 -0.876 . . . . 0.0 112.536 175.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -62.04 -41.97 98.68 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 164.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.13 -39.46 86.62 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.46 -46.69 82.26 Favored 'Isoleucine or valine' 0 C--N 1.371 1.541 0 C-N-CA 125.735 1.614 . . . . 0.0 110.227 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p -90.55 -3.47 57.57 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 121.739 2.063 . . . . 0.0 113.073 -168.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.63 -39.96 14.6 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 120.721 -1.237 . . . . 0.0 112.471 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -57.64 116.74 3.59 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 125.461 2.553 . . . . 0.0 113.697 -165.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.0 mm -57.94 141.24 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 113.349 -1.751 . . . . 0.0 111.344 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -104.21 121.98 44.42 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.79 129.3 23.28 Favored 'Isoleucine or valine' 0 C--N 1.369 1.427 0 O-C-N 119.676 -1.89 . . . . 0.0 111.239 158.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.73 1.46 63.63 Favored Glycine 0 CA--C 1.482 -2.009 0 C-N-CA 118.676 -1.726 . . . . 0.0 111.273 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -92.54 146.89 23.32 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.449 1.119 . . . . 0.0 111.038 167.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 40.3 t -100.64 135.5 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -125.25 159.3 31.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.564 1.946 . . . . 0.0 108.491 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.64 113.68 27.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 120.738 -1.226 . . . . 0.0 108.363 169.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.75 169.09 16.74 Favored Glycine 0 CA--C 1.47 -2.727 0 C-N-CA 118.447 -1.835 . . . . 0.0 114.099 -174.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -121.1 153.05 37.96 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.932 1.866 . . . . 0.0 107.922 -175.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 81.4 t -63.68 130.79 28.92 Favored 'Isoleucine or valine' 0 C--N 1.365 1.252 0 C-N-CA 123.849 0.86 . . . . 0.0 110.572 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.4 p -100.24 -11.98 19.92 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 165.92 159.85 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 126.591 1.956 . . . . 0.0 107.176 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.417 HD12 HG22 ' A' ' 123' ' ' THR . 55.1 mt -121.55 146.66 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 O-C-N 120.64 -1.288 . . . . 0.0 109.915 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.32 178.3 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.271 0 O-C-N 117.938 -2.976 . . . . 0.0 108.612 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -65.56 -44.45 86.75 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -78.52 0.2 27.03 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 115.13 -2.367 . . . . 0.0 112.263 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.4 -155.32 26.06 Favored Glycine 0 CA--C 1.553 2.421 0 O-C-N 124.826 1.329 . . . . 0.0 115.716 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.97 155.9 47.15 Favored 'General case' 0 CA--C 1.587 2.375 0 CA-C-N 121.873 2.837 . . . . 0.0 110.549 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -86.29 129.67 34.77 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 124.159 1.933 . . . . 0.0 113.257 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.6 t -127.59 122.64 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-N 112.711 -2.041 . . . . 0.0 113.881 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.01 111.82 23.04 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.468 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.6 pt -102.91 148.5 8.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 125.903 2.763 . . . . 0.0 105.221 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -51.54 138.42 28.74 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 112.487 -2.142 . . . . 0.0 113.137 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.64 15.41 13.54 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 119.343 1.572 . . . . 0.0 110.546 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.21 21.4 65.14 Favored Glycine 0 C--N 1.303 -1.266 0 CA-C-N 120.707 2.253 . . . . 0.0 117.573 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -125.34 120.22 30.53 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -89.57 133.85 34.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 124.004 1.859 . . . . 0.0 109.09 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.54 -177.68 18.98 Favored Glycine 0 C--N 1.308 -1.009 0 O-C-N 120.88 -1.137 . . . . 0.0 110.7 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.3 tp -137.39 115.37 11.53 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 110.124 -3.038 . . . . 0.0 108.176 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.1 105.15 17.13 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 O-C-N 125.714 1.884 . . . . 0.0 108.592 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . 0.288 34.8 m80 -59.31 157.82 10.26 Favored 'General case' 0 C--O 1.191 -2.013 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 171.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.9 tp -62.23 -30.67 49.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.1 p -82.44 -18.76 40.66 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 127.831 2.452 . . . . 0.0 111.773 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -100.57 -2.62 32.42 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 124.889 1.368 . . . . 0.0 109.836 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.0 mt -73.8 -38.85 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.467 0 O-C-N 119.292 -2.13 . . . . 0.0 114.101 165.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.77 148.01 23.6 Favored 'General case' 0 N--CA 1.483 1.202 1 O-C-N 114.243 -5.285 . . . . 0.0 107.14 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -69.39 -51.83 32.84 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.442 -173.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -87.99 9.72 21.37 Favored 'General case' 0 N--CA 1.521 3.109 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.358 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.278 10.5 mpt_? 70.51 113.73 0.05 Allowed 'General case' 0 C--O 1.193 -1.885 0 C-N-CA 126.715 2.006 . . . . 0.0 112.831 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.8 m -72.84 155.73 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 123.697 1.713 . . . . 0.0 114.0 168.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.95 -48.6 81.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.712 1.605 . . . . 0.0 113.032 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -159.62 152.26 21.43 Favored 'General case' 0 C--N 1.361 1.1 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 168.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.9 t -58.25 -41.45 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 C-N-CA 124.946 1.298 . . . . 0.0 112.52 -171.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.417 HG22 HD12 ' A' ' 92' ' ' ILE . 43.5 p -68.51 -20.56 64.58 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.301 -2.227 . . . . 0.0 115.957 178.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -90.02 0.73 56.95 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 119.258 -2.151 . . . . 0.0 114.089 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -120.01 -21.15 7.21 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 169.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 95.9 mt -105.2 150.15 25.33 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 119.219 -2.176 . . . . 0.0 112.943 -175.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -135.51 145.36 46.99 Favored 'General case' 0 C--N 1.366 1.295 0 O-C-N 125.894 1.996 . . . . 0.0 108.507 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 73.9 mmm -85.62 143.85 28.2 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 125.59 1.806 . . . . 0.0 111.916 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.54 0.64 84.7 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-N 110.346 -3.115 . . . . 0.0 113.859 -170.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -101.13 143.42 31.25 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.478 -1.601 . . . . 0.0 109.805 -174.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -80.94 123.24 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 125.88 1.988 . . . . 0.0 113.5 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.61 125.52 51.23 Favored Pre-proline 0 C--N 1.367 1.358 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 170.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -62.72 123.15 11.82 Favored 'Trans proline' 0 C--N 1.29 -2.54 0 O-C-N 117.439 -1.927 . . . . 0.0 112.063 164.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.49 130.16 46.69 Favored 'Isoleucine or valine' 0 C--N 1.373 1.614 0 O-C-N 119.294 -2.129 . . . . 0.0 109.582 -173.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.3 ttpt -95.16 144.27 25.91 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 117.215 -1.794 . . . . 0.0 110.935 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.7 t -83.97 130.95 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.417 0 C-N-CA 117.158 -1.817 . . . . 0.0 114.894 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.0 mt -101.68 -44.33 5.59 Favored 'General case' 0 C--N 1.37 1.491 0 C-N-CA 126.033 1.733 . . . . 0.0 114.066 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -154.11 138.6 16.81 Favored 'General case' 0 C--O 1.202 -1.427 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -174.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.3 t -92.72 137.8 21.49 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 CA-C-O 122.725 1.25 . . . . 0.0 108.959 167.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -128.27 142.25 51.21 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -103.04 -5.7 23.08 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.032 -171.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -122.14 -40.26 2.52 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 124.853 1.345 . . . . 0.0 112.872 169.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.26 -174.02 34.03 Favored Glycine 0 C--N 1.37 2.42 0 C-N-CA 128.677 3.037 . . . . 0.0 109.139 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 48.1 mmt-85 -88.72 158.77 18.08 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 112.638 -1.781 . . . . 0.0 108.122 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.7 mm -66.17 138.06 23.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 O-C-N 120.856 -1.152 . . . . 0.0 111.501 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.6 mmt-85 -94.13 131.93 39.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 117.045 -1.862 . . . . 0.0 107.001 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.7 mt -139.99 152.63 46.44 Favored 'General case' 0 C--N 1.381 1.963 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 30.4 t -121.7 120.74 35.57 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.412 1.085 . . . . 0.0 108.307 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.9 mt -80.2 -34.68 15.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 O-C-N 119.639 -1.913 . . . . 0.0 107.075 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -70.78 -20.68 62.58 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -172.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -92.14 4.65 52.73 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.142 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.17 -41.03 1.01 Allowed 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 125.02 1.328 . . . . 0.0 108.376 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.2 t -71.07 136.6 48.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 119.713 -1.867 . . . . 0.0 108.506 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.284 44.3 mt-10 77.7 4.71 2.98 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 125.238 1.586 . . . . 0.0 113.246 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 . . . . . 0 C--O 1.253 1.254 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -175.581 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.0 mt -103.99 116.73 48.31 Favored 'Isoleucine or valine' 0 C--N 1.383 2.061 0 CA-C-O 122.97 1.366 . . . . 0.0 113.868 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -102.8 149.31 24.61 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 111.217 -2.72 . . . . 0.0 107.761 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -128.65 145.38 51.17 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 tt -127.51 142.4 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -110.99 114.58 27.99 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 120.307 -1.496 . . . . 0.0 108.627 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.518 HD12 ' H ' ' A' ' 21' ' ' ASN . 4.5 tp -142.25 151.8 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 O-C-N 120.854 -1.154 . . . . 0.0 111.54 -157.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.518 ' H ' HD12 ' A' ' 20' ' ' ILE . 92.9 m-20 -83.25 148.68 56.64 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 114.657 -2.592 . . . . 0.0 108.809 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . 0.275 50.5 Cg_exo -53.44 -48.21 23.16 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 N-CA-C 118.468 2.449 . . . . 0.0 118.468 -169.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.65 -10.34 45.13 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 122.162 2.256 . . . . 0.0 115.472 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -105.79 -1.11 24.71 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mt -69.18 -43.12 81.76 Favored 'Isoleucine or valine' 0 C--O 1.263 1.812 0 C-N-CA 118.45 -1.3 . . . . 0.0 111.234 162.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -57.53 -42.02 82.07 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 115.932 -1.985 . . . . 0.0 113.809 -172.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -50.89 -32.63 21.11 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 128.809 3.818 . . . . 0.0 113.368 170.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.49 -44.31 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 123.928 0.767 . . . . 0.0 111.466 174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.57 -6.75 6.88 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.351 0 O-C-N 120.892 -1.13 . . . . 0.0 110.663 171.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -15.84 132.16 0.01 OUTLIER Glycine 0 CA--C 1.537 1.414 1 N-CA-C 127.468 5.747 . . . . 0.0 127.468 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.3 mttm 59.14 44.77 15.42 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 124.113 1.911 . . . . 0.0 113.411 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.99 30.32 65.74 Favored Glycine 0 CA--C 1.554 2.472 0 O-C-N 117.96 -2.962 . . . . 0.0 112.397 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.7 -2.15 84.26 Favored Glycine 0 C--N 1.387 3.387 0 C-N-CA 128.414 2.912 . . . . 0.0 112.941 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.3 t -58.17 -38.51 76.8 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.339 -1.094 . . . . 0.0 111.404 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 t -66.7 -47.83 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 CA-C-O 116.692 -1.623 . . . . 0.0 110.313 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 mt -55.4 -51.68 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 116.741 -1.984 . . . . 0.0 111.719 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -58.82 -43.23 90.57 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.18 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.64 88.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.037 1.29 . . . . 0.0 114.151 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.9 tp -63.46 -44.27 94.96 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 125.238 1.586 . . . . 0.0 109.082 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.1 p -62.25 -43.3 99.14 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.16 -42.13 99.37 Favored 'General case' 0 N--CA 1.514 2.743 0 CA-C-N 121.581 1.992 . . . . 0.0 113.431 166.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . 0.281 32.2 tt0 -72.19 -48.15 45.33 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.532 0.682 . . . . 0.0 111.321 -170.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.0 p -78.55 -22.05 47.8 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 114.474 -2.679 . . . . 0.0 115.531 176.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 31.54 38.24 Favored Glycine 0 C--N 1.362 1.986 0 CA-C-N 121.199 1.818 . . . . 0.0 111.466 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.6 p -132.57 171.04 14.33 Favored 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 126.529 1.932 . . . . 0.0 111.291 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 m -127.94 135.91 50.61 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 101.023 -3.695 . . . . 0.0 101.023 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.2 mt -118.96 135.05 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.636 0 CA-C-N 120.379 1.445 . . . . 0.0 112.938 -171.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -129.7 133.57 47.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 118.89 -2.382 . . . . 0.0 109.779 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.67 131.58 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.106 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -134.38 155.84 49.57 Favored 'General case' 0 C--N 1.363 1.177 0 O-C-N 119.416 -2.052 . . . . 0.0 110.221 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -40.14 151.77 0.04 OUTLIER 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t0 65.63 19.42 11.45 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 127.251 2.844 . . . . 0.0 117.349 -172.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.4 46.77 11.6 Favored Glycine 0 N--CA 1.444 -0.77 0 O-C-N 117.33 -3.356 . . . . 0.0 107.857 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -104.47 111.38 24.02 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.614 -1.634 . . . . 0.0 106.912 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -96.24 118.73 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -108.4 126.46 52.9 Favored 'General case' 0 C--N 1.378 1.819 0 CA-C-O 122.87 1.319 . . . . 0.0 111.643 -167.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 32.7 mm -107.35 104.94 17.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.208 -175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.18 135.04 38.53 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.61 158.58 44.3 Favored 'General case' 0 CA--C 1.486 -1.502 0 O-C-N 118.752 -2.468 . . . . 0.0 109.598 163.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.6 m -65.29 -37.14 86.24 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 115.218 -2.325 . . . . 0.0 114.748 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -102.52 153.95 19.58 Favored 'General case' 0 C--N 1.28 -2.451 1 O-C-N 129.922 4.514 . . . . 0.0 109.986 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.84 -48.96 61.96 Favored Glycine 0 C--N 1.374 2.676 0 C-N-CA 124.838 1.209 . . . . 0.0 112.603 171.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -61.57 -42.04 98.26 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.384 1.088 . . . . 0.0 112.078 -175.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -57.44 -44.35 84.67 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 110.783 -2.917 . . . . 0.0 115.888 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.75 95.63 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 173.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -68.66 -33.71 74.47 Favored 'General case' 0 CA--C 1.585 2.291 0 CA-C-O 123.787 1.756 . . . . 0.0 114.05 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -66.61 -44.16 82.84 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.29 2.236 . . . . 0.0 112.452 167.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.55 92.88 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.519 169.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.5 mm -50.43 -42.5 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 167.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -73.53 -40.44 64.0 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 118.278 -0.867 . . . . 0.0 112.238 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -58.38 -44.13 88.76 Favored 'General case' 0 CA--C 1.579 2.094 0 CA-C-O 123.466 1.603 . . . . 0.0 114.393 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.7 mm -60.45 -48.51 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.083 0 C-N-CA 127.066 2.147 . . . . 0.0 114.679 168.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -57.16 -44.11 83.17 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 119.636 -1.915 . . . . 0.0 107.592 170.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -64.9 -39.52 93.66 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 121.056 1.753 . . . . 0.0 112.396 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.3 mt -62.4 -52.11 64.08 Favored 'Isoleucine or valine' 0 C--N 1.373 1.615 0 CA-C-O 117.014 -1.47 . . . . 0.0 112.999 168.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.9 p -66.85 -23.75 66.06 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 123.367 1.556 . . . . 0.0 113.358 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.15 -39.4 82.34 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.983 -1.917 . . . . 0.0 114.354 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -58.88 143.16 48.54 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -167.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 mm -83.91 113.97 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 109.67 -3.423 . . . . 0.0 110.412 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -107.1 146.28 31.44 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.371 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.89 150.5 4.67 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.397 0 CA-C-O 124.188 1.946 . . . . 0.0 109.811 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.61 14.81 82.05 Favored Glycine 0 C--N 1.277 -2.702 0 CA-C-N 112.57 -2.104 . . . . 0.0 116.794 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -105.88 143.27 34.26 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 119.968 -1.901 . . . . 0.0 106.247 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.8 t -90.09 144.04 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 119.081 -1.048 . . . . 0.0 110.196 171.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -132.85 166.68 21.74 Favored 'General case' 0 C--N 1.404 2.97 0 O-C-N 125.915 2.009 . . . . 0.0 109.24 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 m -116.89 132.68 56.64 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.2 177.35 20.72 Favored Glycine 0 N--CA 1.419 -2.441 0 O-C-N 124.769 1.293 . . . . 0.0 111.725 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -118.46 136.29 53.88 Favored 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 123.79 1.757 . . . . 0.0 113.314 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.93 137.21 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.8 t -131.71 -18.34 2.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.871 1.357 . . . . 0.0 110.261 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 -142.18 150.86 41.59 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 172.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 mt -137.56 136.98 46.03 Favored 'Isoleucine or valine' 0 C--N 1.395 2.573 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.18 169.29 12.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 113.631 -1.622 . . . . 0.0 106.879 -162.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -54.13 -37.17 64.06 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -100.29 13.73 33.35 Favored 'General case' 0 N--CA 1.53 3.563 0 O-C-N 118.491 -2.63 . . . . 0.0 108.418 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 151.09 -159.34 28.13 Favored Glycine 0 C--O 1.183 -3.068 0 CA-C-N 123.445 2.839 . . . . 0.0 115.6 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.36 135.93 45.04 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -90.78 131.48 36.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.659 -1.275 . . . . 0.0 110.004 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 t -112.36 137.92 43.37 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.662 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.3 147.69 24.93 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 127.214 2.821 . . . . 0.0 105.592 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.7 pt -142.63 159.13 18.98 Favored 'Isoleucine or valine' 0 C--N 1.372 1.566 0 C-N-CA 125.715 1.606 . . . . 0.0 108.228 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.06 142.07 1.93 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 120.278 2.871 . . . . 0.0 120.278 -173.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.94 13.75 45.27 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 120.095 -1.826 . . . . 0.0 114.535 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.89 21.47 78.45 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 125.205 1.383 . . . . 0.0 110.943 -175.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -89.84 136.76 32.85 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.824 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -131.07 134.86 47.02 Favored 'General case' 0 C--N 1.361 1.1 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.31 161.68 24.7 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 125.304 1.43 . . . . 0.0 114.933 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.9 tp -95.4 125.26 39.9 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.817 -0.692 . . . . 0.0 111.657 -173.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.1 111.23 25.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 CA-C-O 115.674 -2.108 . . . . 0.0 105.663 164.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -60.73 153.8 23.25 Favored 'General case' 0 C--O 1.171 -3.049 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 171.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.6 tt -52.36 -31.6 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 119.737 -1.852 . . . . 0.0 114.536 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.0 p -83.38 -15.79 48.46 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -93.51 19.03 8.93 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.8 mt -92.14 -47.2 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-O 119.491 -0.29 . . . . 0.0 111.582 -173.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.5 162.63 38.67 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.081 0.952 . . . . 0.0 112.178 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.56 -37.78 87.67 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 125.032 2.349 . . . . 0.0 110.52 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -55.99 153.02 9.38 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 112.373 -2.194 . . . . 0.0 111.536 175.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -68.58 142.07 55.29 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 119.961 -1.712 . . . . 0.0 111.108 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 42.9 t -133.23 143.25 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.435 -175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -112.95 -38.13 4.61 Favored 'General case' 0 C--N 1.37 1.493 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -173.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -143.44 146.71 33.67 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 169.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.14 -16.45 16.78 Favored 'Isoleucine or valine' 0 C--N 1.366 1.292 0 CA-C-O 122.856 1.312 . . . . 0.0 111.191 -164.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.3 p -85.44 -4.17 59.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -60.7 -40.61 92.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.924 1.29 . . . . 0.0 109.56 167.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -108.67 -24.87 11.14 Favored 'General case' 0 CA--C 1.557 1.22 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -118.04 126.53 52.46 Favored 'General case' 0 N--CA 1.517 2.912 0 O-C-N 117.821 -3.049 . . . . 0.0 113.696 -167.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.59 166.85 11.9 Favored 'General case' 0 C--O 1.199 -1.556 0 C-N-CA 117.042 -1.863 . . . . 0.0 109.507 166.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -62.13 145.07 54.38 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-O 126.102 2.858 . . . . 0.0 114.969 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.55 -6.04 26.27 Favored Glycine 0 C--O 1.21 -1.404 0 CA-C-O 115.758 -2.69 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -68.42 137.85 54.84 Favored 'General case' 0 C--N 1.361 1.079 0 CA-C-N 120.513 2.156 . . . . 0.0 115.747 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -88.03 104.48 16.69 Favored 'General case' 0 C--O 1.259 1.555 0 CA-C-O 123.854 1.788 . . . . 0.0 111.608 -164.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 m -108.57 117.95 53.11 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.048 -173.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -58.04 130.46 38.23 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.055 1.17 . . . . 0.0 112.285 158.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.37 145.67 34.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -111.69 138.3 48.45 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 119.564 -1.96 . . . . 0.0 109.338 171.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.34 139.77 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 117.343 -3.348 . . . . 0.0 112.504 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.8 mt -106.62 -36.69 6.67 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 115.277 -2.297 . . . . 0.0 109.803 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -157.81 164.23 37.22 Favored 'General case' 0 CA--C 1.473 -1.996 0 O-C-N 126.41 2.318 . . . . 0.0 107.116 -166.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.313 7.2 p -168.16 97.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-O 125.205 2.431 . . . . 0.0 110.154 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -71.65 165.91 22.99 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 119.882 -1.761 . . . . 0.0 112.273 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -61.03 -25.56 67.0 Favored 'General case' 0 C--N 1.37 1.466 0 O-C-N 125.331 1.644 . . . . 0.0 115.094 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -94.31 3.4 55.26 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.437 1.711 . . . . 0.0 110.723 -169.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.96 3.46 56.94 Favored Glycine 0 CA--C 1.552 2.38 0 O-C-N 119.432 -2.043 . . . . 0.0 113.9 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -84.2 118.4 24.12 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.813 1.245 . . . . 0.0 108.404 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.8 mt -125.32 131.39 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.268 -1.52 . . . . 0.0 108.965 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -109.16 146.47 34.07 Favored 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 120.635 1.561 . . . . 0.0 107.121 173.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.8 mt -129.64 157.19 42.8 Favored 'General case' 0 C--O 1.269 2.124 0 C-N-CA 126.194 1.798 . . . . 0.0 113.436 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.9 t -132.01 111.71 11.74 Favored 'General case' 0 C--N 1.387 2.232 0 O-C-N 126.99 2.681 . . . . 0.0 110.226 166.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.17 -41.63 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 158.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -66.38 -31.57 72.43 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-N 121.97 2.168 . . . . 0.0 111.831 -170.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.94 -49.0 72.08 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 124.694 1.198 . . . . 0.0 112.307 168.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.33 -42.17 81.4 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 126.148 2.155 . . . . 0.0 109.822 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.259 27.5 p -89.3 -1.34 58.03 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.016 0.913 . . . . 0.0 113.211 -176.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 63.12 55.93 1.84 Allowed 'General case' 0 C--O 1.256 1.437 0 C-N-CA 129.275 3.03 . . . . 0.0 113.778 168.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 . . . . . 0 C--O 1.257 1.474 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.16 -176.384 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 . . . . . 0 CA--C 1.569 1.707 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.32 127.95 73.78 Favored 'Isoleucine or valine' 0 C--N 1.376 1.759 0 CA-C-N 119.04 0.836 . . . . 0.0 109.549 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.43 ' CD2' ' HB3' ' A' ' 65' ' ' ALA . 26.3 m-70 -129.28 135.58 48.95 Favored 'General case' 0 CA--C 1.492 -1.275 0 O-C-N 125.134 1.521 . . . . 0.0 109.127 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 p -116.17 153.92 30.96 Favored 'General case' 0 C--N 1.377 1.78 0 C-N-CA 118.646 -1.222 . . . . 0.0 113.824 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.3 148.48 31.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 166.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -116.87 130.33 56.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -174.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.5 tp -150.04 170.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 121.762 2.074 . . . . 0.0 113.838 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -64.13 125.67 88.61 Favored Pre-proline 0 CA--C 1.561 1.4 0 O-C-N 119.156 -2.215 . . . . 0.0 110.308 -172.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.92 -20.04 22.67 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 123.465 2.777 . . . . 0.0 116.865 -165.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.9 -45.14 86.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 127.413 2.946 . . . . 0.0 111.265 167.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -79.89 -4.39 52.1 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.581 1.181 . . . . 0.0 110.553 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.2 mm -84.33 -22.37 8.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -77.94 -28.69 49.65 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 122.702 2.501 . . . . 0.0 107.99 173.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -57.85 -41.24 81.97 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.66 162.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . 0.275 47.1 t -67.71 -38.75 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.594 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.06 -45.86 53.01 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.064 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.57 174.2 24.44 Favored Glycine 0 CA--C 1.556 2.612 0 O-C-N 126.096 2.122 . . . . 0.0 110.144 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -77.79 122.5 25.5 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 118.953 -2.499 . . . . 0.0 107.68 -165.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.94 19.36 75.25 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.125 -1.609 . . . . 0.0 110.529 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.8 16.91 66.83 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 117.348 1.699 . . . . 0.0 117.348 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.9 t -60.25 -42.95 96.38 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.9 t -80.78 -32.18 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 CA-C-N 121.031 1.741 . . . . 0.0 108.998 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tt -75.86 -31.09 21.82 Favored 'Isoleucine or valine' 0 C--N 1.374 1.65 0 CA-C-N 120.713 1.597 . . . . 0.0 110.741 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -59.68 -45.89 90.71 Favored 'General case' 0 CA--C 1.562 1.414 0 O-C-N 120.191 -1.568 . . . . 0.0 114.456 164.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.72 88.34 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 170.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 tp -61.06 -34.93 75.68 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.063 -1.881 . . . . 0.0 114.559 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.6 p -66.45 -42.97 86.84 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 122.641 2.473 . . . . 0.0 114.372 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -62.26 -46.38 89.07 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 127.411 2.944 . . . . 0.0 113.903 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -53.68 -46.2 70.59 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-O 117.207 -1.378 . . . . 0.0 114.27 174.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 p -88.62 -23.39 23.09 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 125.55 1.781 . . . . 0.0 114.607 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.36 27.71 54.49 Favored Glycine 0 CA--C 1.559 2.835 0 C-N-CA 125.41 1.481 . . . . 0.0 110.258 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.5 p -134.8 166.34 23.21 Favored 'General case' 0 C--N 1.373 1.626 0 CA-C-O 124.721 2.2 . . . . 0.0 108.955 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.5 m -102.01 126.13 48.86 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 111.613 -2.54 . . . . 0.0 106.565 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.4 mt -118.15 142.72 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.121 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 -171.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -145.08 139.62 27.5 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-O 123.572 1.653 . . . . 0.0 108.193 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.0 mm -101.36 139.2 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.175 -169.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -138.36 163.02 32.93 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 119.21 -2.181 . . . . 0.0 109.499 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.307 27.1 m-20 -55.44 142.09 34.05 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 112.897 -1.956 . . . . 0.0 114.954 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.277 31.9 t0 90.56 31.75 0.02 OUTLIER 'General case' 0 C--N 1.375 1.712 0 CA-C-N 110.322 -3.126 . . . . 0.0 111.177 172.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.95 46.66 90.92 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 125.754 1.645 . . . . 0.0 111.39 -169.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.1 m -103.37 121.32 42.54 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 119.777 1.788 . . . . 0.0 110.597 -171.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.28 122.05 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 123.261 1.505 . . . . 0.0 106.998 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.31 59.7 mtpt -106.95 139.38 41.44 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.266 44.1 mm -125.52 119.94 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.709 -1.244 . . . . 0.0 108.855 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.24 136.13 42.61 Favored 'General case' 0 CA--C 1.588 2.417 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.81 157.49 16.45 Favored 'General case' 0 C--N 1.398 2.695 0 C-N-CA 125.395 1.478 . . . . 0.0 110.794 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 m -92.31 -17.9 24.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 125.626 1.829 . . . . 0.0 112.793 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -123.36 141.41 52.01 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 120.131 -1.606 . . . . 0.0 110.307 -168.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.41 -48.58 81.17 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 112.637 -2.074 . . . . 0.0 114.012 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.4 -37.23 86.78 Favored 'General case' 0 CA--C 1.589 2.445 0 O-C-N 119.901 -1.94 . . . . 0.0 115.363 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -64.52 -41.64 96.26 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 120.522 -1.361 . . . . 0.0 109.174 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.43 ' HB3' ' CD2' ' A' ' 16' ' ' HIS . . . -64.24 -35.89 82.3 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 117.574 -1.203 . . . . 0.0 112.955 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -73.98 -33.9 64.01 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -64.95 -45.29 86.34 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 126.398 2.311 . . . . 0.0 114.101 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.61 86.22 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.629 173.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.67 -51.21 75.44 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.531 0 CA-C-O 116.648 -1.644 . . . . 0.0 112.606 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -61.76 -34.96 76.79 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 116.047 -1.93 . . . . 0.0 112.609 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -65.81 -39.44 90.88 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 124.538 1.149 . . . . 0.0 111.486 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.97 -48.52 88.18 Favored 'Isoleucine or valine' 0 C--N 1.368 1.396 0 CA-C-N 120.482 1.492 . . . . 0.0 108.616 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -45.37 -57.43 4.05 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.547 1.939 . . . . 0.0 114.07 172.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -58.94 -48.06 82.83 Favored 'General case' 0 N--CA 1.513 2.711 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 173.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.9 mt -66.42 -35.03 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.7 p -80.89 -7.96 59.61 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 124.79 1.236 . . . . 0.0 111.955 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.6 -16.05 16.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.067 -0.395 . . . . 0.0 111.817 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -65.13 139.01 58.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.954 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.08 120.09 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.395 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -101.83 146.74 27.39 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-O 123.054 1.407 . . . . 0.0 112.801 171.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.05 143.24 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 113.424 -1.716 . . . . 0.0 109.829 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.93 26.01 56.74 Favored Glycine 1 N--CA 1.526 4.685 1 O-C-N 115.749 -4.344 . . . . 0.0 116.344 175.524 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -119.1 150.14 40.52 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.61 -1.295 . . . . 0.0 112.536 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.49 126.9 54.0 Favored 'Isoleucine or valine' 0 C--O 1.255 1.367 0 CA-C-O 124.911 2.291 . . . . 0.0 113.102 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -126.95 160.92 29.6 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 109.908 -3.314 . . . . 0.0 104.989 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.9 m -119.6 139.92 51.4 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.06 -173.58 16.47 Favored Glycine 0 CA--C 1.576 3.844 0 CA-C-O 123.241 1.467 . . . . 0.0 112.416 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -128.91 138.48 52.03 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 123.109 1.433 . . . . 0.0 111.332 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.28 138.11 20.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 113.284 -1.78 . . . . 0.0 106.799 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.81 -28.97 3.45 Favored 'General case' 0 CA--C 1.478 -1.824 0 CA-C-O 114.951 -2.452 . . . . 0.0 106.842 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.5 mtm-85 -143.91 146.47 33.0 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 122.42 2.373 . . . . 0.0 108.589 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.28 138.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 CA-C-O 115.579 -2.153 . . . . 0.0 113.745 168.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.78 173.6 13.43 Favored 'Isoleucine or valine' 0 C--N 1.401 2.812 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.4 -18.21 65.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.257 24.6 p90 -103.16 0.8 32.29 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.498 0.719 . . . . 0.0 111.751 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.37 -172.52 31.57 Favored Glycine 0 C--N 1.357 1.72 0 C-N-CA 117.893 -2.098 . . . . 0.0 112.752 -162.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.55 132.81 35.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.281 93.5 m-85 -79.99 133.25 36.15 Favored 'General case' 0 C--N 1.371 1.532 0 O-C-N 126.893 2.621 . . . . 0.0 109.579 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.9 130.82 72.33 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 112.577 -2.102 . . . . 0.0 105.337 -171.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . 0.261 . . -96.05 124.56 40.11 Favored 'General case' 0 CA--C 1.578 2.029 0 CA-C-N 113.54 -1.664 . . . . 0.0 107.227 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 77.6 mt -112.37 144.73 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 126.334 1.854 . . . . 0.0 106.484 -176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -52.66 135.11 38.48 Favored Glycine 0 C--O 1.213 -1.194 0 CA-C-O 124.623 2.235 . . . . 0.0 116.125 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.16 4.73 56.41 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.357 1.932 . . . . 0.0 113.211 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.83 31.27 5.48 Favored Glycine 0 CA--C 1.473 -2.579 0 CA-C-O 117.054 -1.97 . . . . 0.0 112.795 171.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . 0.294 51.4 mmtt -120.52 118.25 29.75 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -165.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -105.04 135.69 45.91 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 125.002 2.334 . . . . 0.0 109.754 -170.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -139.77 166.68 25.56 Favored Glycine 0 C--O 1.215 -1.086 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.699 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . 0.276 14.6 tp -113.03 135.43 53.8 Favored 'General case' 0 N--CA 1.424 -1.725 0 C-N-CA 124.374 1.07 . . . . 0.0 108.217 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.0 t -102.99 115.98 45.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 162.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -67.66 165.69 16.62 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-O 124.582 2.134 . . . . 0.0 113.984 173.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.258 11.4 tt -61.29 -32.15 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-N 111.911 -2.404 . . . . 0.0 116.703 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.3 p -84.42 -5.66 59.3 Favored 'General case' 0 C--O 1.268 2.067 0 O-C-N 124.365 1.041 . . . . 0.0 112.427 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -106.97 14.74 26.12 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 116.62 2.082 . . . . 0.0 116.62 -168.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.0 mt -85.63 -48.51 16.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-O 116.179 -1.867 . . . . 0.0 114.07 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.2 165.18 28.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 126.587 2.43 . . . . 0.0 110.053 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.15 -33.64 76.24 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.132 166.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -74.45 148.63 40.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 123.242 1.496 . . . . 0.0 113.945 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -70.42 145.2 51.19 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.773 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 37.7 t -112.62 133.86 57.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 CA-C-O 124.169 1.938 . . . . 0.0 110.884 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.72 -42.17 9.74 Favored 'General case' 0 C--N 1.38 1.906 0 O-C-N 118.574 -2.579 . . . . 0.0 108.871 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -134.77 145.87 48.82 Favored 'General case' 0 N--CA 1.526 3.342 0 O-C-N 124.473 1.108 . . . . 0.0 110.043 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.23 -29.82 47.19 Favored 'Isoleucine or valine' 0 C--O 1.254 1.292 0 CA-C-O 122.776 1.274 . . . . 0.0 113.916 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.84 20.54 2.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -86.34 -15.33 40.86 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 121.109 1.777 . . . . 0.0 111.561 161.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -125.62 -79.48 0.6 Allowed 'General case' 0 C--O 1.208 -1.088 0 C-N-CA 126.701 2.0 . . . . 0.0 110.731 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.1 mt -70.57 152.37 44.02 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 121.692 2.042 . . . . 0.0 111.752 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -132.23 152.29 51.4 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 118.777 -2.452 . . . . 0.0 106.31 165.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 40.1 mtm -63.19 131.76 49.5 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.572 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.45 0.58 50.17 Favored Glycine 0 C--N 1.363 2.06 0 O-C-N 125.011 1.444 . . . . 0.0 114.211 -171.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -84.04 149.3 26.34 Favored 'General case' 0 C--O 1.2 -1.5 0 CA-C-O 123.729 1.728 . . . . 0.0 112.765 174.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -101.14 126.07 47.81 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.646 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.2 m -137.11 121.02 12.06 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.322 -168.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.2 140.46 30.9 Favored 'Trans proline' 0 CA--C 1.492 -1.578 0 N-CA-C 107.512 -1.765 . . . . 0.0 107.512 166.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.16 126.11 29.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -163.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -91.18 135.81 33.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 102.243 -3.243 . . . . 0.0 102.243 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.2 t -79.67 136.44 23.56 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 110.947 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.8 mt -113.81 -33.81 5.67 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.604 0.716 . . . . 0.0 111.251 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.45 ' CD ' HH21 ' A' ' 146' ' ' ARG 0.297 28.5 mt-10 -145.55 154.99 42.78 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 172.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.64 118.81 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.795 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -70.02 170.18 11.88 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 125.71 2.671 . . . . 0.0 114.058 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -66.23 -30.33 70.75 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 111.93 -2.395 . . . . 0.0 110.028 169.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -93.4 14.11 19.53 Favored 'General case' 0 C--N 1.364 1.221 0 CA-C-O 117.37 -1.3 . . . . 0.0 111.504 -176.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.65 53.14 25.7 Favored Glycine 0 C--N 1.358 1.777 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -133.76 135.11 43.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 127.698 2.646 . . . . 0.0 107.838 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.4 mt -124.11 134.88 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 O-C-N 124.956 1.41 . . . . 0.0 110.379 -162.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.45 HH21 ' CD ' ' A' ' 138' ' ' GLU . 1.8 mpp_? -102.46 134.05 46.41 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 124.967 2.318 . . . . 0.0 107.931 170.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.3 mt -134.65 156.3 48.99 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 120.518 -1.364 . . . . 0.0 110.428 -163.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 26.1 t -135.29 118.91 17.02 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 124.288 1.035 . . . . 0.0 111.581 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . 0.262 95.3 mt -81.23 -24.25 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 CA-C-O 123.791 1.758 . . . . 0.0 108.092 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -86.69 -32.59 20.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.353 -171.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -43.6 71.35 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.56 -19.41 60.9 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.551 -1.259 . . . . 0.0 112.624 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.2 p -97.82 7.69 45.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.456 168.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.258 49.8 mt-10 55.31 56.75 6.07 Favored 'General case' 0 N--CA 1.528 3.441 1 N-CA-C 123.778 4.733 . . . . 0.0 123.778 173.481 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 . . . . . 0 N--CA 1.417 -2.101 0 O-C-N 117.805 -3.059 . . . . 0.0 111.593 -176.471 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.7 mm . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 122.185 0.993 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . 0.3 47.0 m-70 -121.75 165.12 16.3 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 112.28 -2.236 . . . . 0.0 106.542 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -149.05 162.78 39.25 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 124.501 3.319 . . . . 0.0 111.415 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.9 tt -128.27 146.23 34.11 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 1 N-CA-C 99.485 -4.265 . . . . 0.0 99.485 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -126.97 130.15 49.52 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.138 -1.601 . . . . 0.0 107.174 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 20' ' ' ILE . 39.6 pt -139.51 170.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -161.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -81.61 140.71 47.93 Favored Pre-proline 0 C--O 1.192 -1.948 0 O-C-N 119.325 -2.109 . . . . 0.0 113.41 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -50.62 -26.64 17.45 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 123.198 2.599 . . . . 0.0 116.421 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -69.09 -25.81 64.61 Favored 'General case' 0 C--O 1.214 -0.78 0 O-C-N 119.909 -1.744 . . . . 0.0 113.636 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -82.16 -11.09 58.92 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.272 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.5 -35.5 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.566 0.698 . . . . 0.0 109.587 171.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -59.52 -36.63 76.47 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.83 -45.13 90.96 Favored 'General case' 0 C--N 1.355 0.804 0 C-N-CA 126.046 1.738 . . . . 0.0 111.904 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 t -66.07 -46.59 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 CA-C-O 115.562 -2.161 . . . . 0.0 114.579 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.6 mm -58.83 -38.36 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 123.65 2.932 . . . . 0.0 112.519 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.43 -127.06 8.16 Favored Glycine 0 CA--C 1.555 2.542 0 O-C-N 121.269 -0.895 . . . . 0.0 112.252 -172.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -104.69 95.54 5.96 Favored 'General case' 0 C--N 1.387 2.197 0 C-N-CA 128.417 2.687 . . . . 0.0 106.309 164.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.06 41.8 86.05 Favored Glycine 0 CA--C 1.479 -2.17 0 CA-C-O 114.708 -3.273 . . . . 0.0 116.152 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.53 12.2 57.32 Favored Glycine 0 N--CA 1.438 -1.224 0 O-C-N 127.648 2.617 . . . . 0.0 114.556 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.8 p -61.86 -52.25 64.88 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.86 -46.15 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 125.345 1.653 . . . . 0.0 113.111 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.3 mm -50.5 -47.06 27.45 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.385 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -56.61 -45.38 81.5 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.068 1.347 . . . . 0.0 110.816 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.72 73.34 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.069 -1.053 . . . . 0.0 113.439 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.48 -32.15 73.33 Favored 'General case' 0 C--O 1.199 -1.588 0 CA-C-O 117.457 -1.258 . . . . 0.0 112.783 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.8 m -66.3 -44.26 83.98 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 166.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -63.83 -45.61 88.79 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-O 121.611 0.72 . . . . 0.0 112.351 175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -64.55 -57.5 8.97 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.972 1.368 . . . . 0.0 110.435 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.5 p -79.53 -37.88 35.55 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.889 -167.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.9 22.48 57.69 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 123.792 1.773 . . . . 0.0 115.158 -170.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.8 p -109.58 165.36 11.72 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.472 -1.364 . . . . 0.0 110.204 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.1 m -106.11 132.52 52.09 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.56 124.03 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.859 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 -162.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -124.55 143.89 50.44 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.2 mt -118.37 143.85 28.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 125.915 2.009 . . . . 0.0 108.224 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 54' ' ' THR . 29.1 tt0 -142.79 155.11 44.77 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.27 65.9 m-20 -48.27 167.88 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -169.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.291 27.2 t0 61.41 25.18 15.18 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 113.188 -1.824 . . . . 0.0 109.454 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.25 23.42 58.93 Favored Glycine 0 C--N 1.375 2.718 0 C-N-CA 126.085 1.802 . . . . 0.0 117.009 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 50' ' ' GLU . 22.6 m -84.3 131.04 34.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 126.953 2.208 . . . . 0.0 112.707 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.45 119.42 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -99.47 131.99 45.11 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.025 2.93 . . . . 0.0 104.378 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.38 115.6 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 0 CA-C-O 123.516 1.627 . . . . 0.0 106.841 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.43 130.95 49.36 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 111.226 -2.715 . . . . 0.0 108.854 -174.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.03 170.62 18.44 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.033 1.733 . . . . 0.0 106.388 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 t -109.19 -9.86 15.0 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.679 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -123.02 131.91 53.91 Favored 'General case' 0 C--O 1.199 -1.573 0 O-C-N 117.591 -3.193 . . . . 0.0 105.825 168.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.31 -44.82 10.69 Favored Glycine 0 N--CA 1.508 3.448 0 C-N-CA 128.276 2.846 . . . . 0.0 112.24 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.27 -39.64 76.08 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -65.31 -47.84 75.18 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.48 84.32 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 117.627 -1.629 . . . . 0.0 113.355 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -53.28 -47.63 68.99 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 170.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -64.75 -44.71 89.23 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 171.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.12 74.16 Favored 'General case' 0 C--O 1.255 1.385 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 172.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.4 mt -59.99 -43.64 92.9 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 CA-C-O 123.856 1.789 . . . . 0.0 111.714 173.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -63.08 -43.75 97.68 Favored 'General case' 0 N--CA 1.496 1.826 1 O-C-N 116.2 -4.063 . . . . 0.0 112.508 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -66.31 -41.05 90.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 117.58 -1.2 . . . . 0.0 112.773 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.4 mt -57.2 -44.92 84.4 Favored 'Isoleucine or valine' 0 C--N 1.379 1.851 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 164.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -56.23 -40.2 73.74 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.23 1.581 . . . . 0.0 113.535 170.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -71.43 -36.98 71.48 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 121.51 0.671 . . . . 0.0 112.779 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 mt -65.54 -23.45 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 119.06 -2.275 . . . . 0.0 114.727 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.506 2.342 0 CA-C-O 124.978 2.323 . . . . 0.0 110.855 175.162 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.2 mm . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.0 154.8 44.16 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.86 147.81 8.25 Favored 'Isoleucine or valine' 0 C--N 1.386 2.168 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.09 2.57 89.0 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -93.4 136.1 34.0 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 118.248 1.024 . . . . 0.0 112.536 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.4 t -104.33 134.57 45.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -141.21 174.88 10.11 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 112.579 -2.101 . . . . 0.0 112.651 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -116.26 125.25 51.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.55 176.72 20.17 Favored Glycine 0 C--O 1.18 -3.28 0 CA-C-N 112.76 -2.018 . . . . 0.0 110.894 -168.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 88' ' ' LYS . 23.5 ttmt -148.21 125.74 11.71 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 123.764 1.745 . . . . 0.0 111.478 -167.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.11 117.11 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 113.112 -1.858 . . . . 0.0 111.226 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -103.65 -36.82 7.76 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-O 118.321 -0.847 . . . . 0.0 113.133 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.0 mtm-85 -153.98 126.26 7.95 Favored 'General case' 0 C--O 1.199 -1.592 0 CA-C-O 123.039 1.399 . . . . 0.0 110.519 -168.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.2 115.85 50.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 C-N-CA 125.404 1.482 . . . . 0.0 108.74 -170.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.05 165.71 9.9 Favored 'Isoleucine or valine' 0 C--N 1.374 1.644 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -42.59 -36.87 1.5 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.034 1.734 . . . . 0.0 115.603 175.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -114.18 13.84 18.06 Favored 'General case' 0 CA--C 1.562 1.44 0 O-C-N 120.181 -1.574 . . . . 0.0 114.181 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.05 -179.45 41.25 Favored Glycine 0 CA--C 1.483 -1.921 0 C-N-CA 117.822 -2.132 . . . . 0.0 111.803 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.67 144.51 49.22 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 119.854 -1.968 . . . . 0.0 108.533 170.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -85.47 122.95 30.34 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.827 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.9 t -125.87 120.99 58.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 O-C-N 125.854 1.971 . . . . 0.0 106.521 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.59 139.39 30.59 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 126.25 2.219 . . . . 0.0 107.58 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 105' ' ' LYS 0.274 16.8 pt -131.93 168.49 23.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 110.964 -2.834 . . . . 0.0 110.311 170.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.59 132.77 3.7 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 119.827 2.691 . . . . 0.0 119.827 -169.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.69 11.08 75.01 Favored Glycine 0 N--CA 1.506 3.334 0 CA-C-O 117.626 -1.652 . . . . 0.0 110.221 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.03 39.65 7.37 Favored Glycine 0 C--O 1.25 1.135 0 O-C-N 126.086 1.698 . . . . 0.0 110.181 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.408 ' HB2' HG13 ' A' ' 101' ' ' ILE . 57.2 mttm -98.4 99.33 10.51 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 120.996 -1.296 . . . . 0.0 113.262 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.46 88.8 7.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.021 -1.674 . . . . 0.0 111.354 -174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.26 159.11 53.53 Favored Glycine 0 N--CA 1.494 2.535 0 CA-C-N 120.135 1.334 . . . . 0.0 114.219 167.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.7 tp -105.45 111.13 23.73 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 125.928 1.605 . . . . 0.0 108.101 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.55 116.25 27.9 Favored 'Isoleucine or valine' 0 C--N 1.372 1.555 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -66.48 159.96 26.06 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.499 0.666 . . . . 0.0 112.617 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 19.5 tt -61.07 -20.08 21.38 Favored 'Isoleucine or valine' 0 C--N 1.366 1.287 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.3 p -97.64 13.02 31.62 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.072 0.463 . . . . 0.0 110.917 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -133.18 26.46 4.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.952 0.901 . . . . 0.0 109.904 -172.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.6 mm -95.59 -55.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 O-C-N 126.579 2.424 . . . . 0.0 107.336 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.72 176.6 11.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 119.344 -2.098 . . . . 0.0 113.105 -168.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -76.4 -35.38 58.63 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 122.884 1.326 . . . . 0.0 110.37 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -61.68 151.4 33.78 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 124.236 1.97 . . . . 0.0 112.22 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -64.05 142.3 58.46 Favored 'General case' 0 C--O 1.205 -1.244 0 C-N-CA 126.949 2.1 . . . . 0.0 111.11 169.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.5 t -121.84 129.01 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.074 -1.016 . . . . 0.0 109.499 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.74 -36.13 11.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 123.612 1.672 . . . . 0.0 108.843 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -150.85 144.05 24.79 Favored 'General case' 0 CA--C 1.565 1.549 0 O-C-N 117.832 -3.043 . . . . 0.0 107.216 175.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.72 -27.23 9.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.476 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.1 p -55.92 -19.91 13.97 Favored 'General case' 0 C--N 1.383 2.037 0 C-N-CA 128.649 2.78 . . . . 0.0 115.163 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -80.51 -25.42 38.74 Favored 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 128.113 2.565 . . . . 0.0 112.205 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -107.14 -26.63 11.02 Favored 'General case' 0 C--N 1.369 1.428 0 CA-C-N 114.184 -1.371 . . . . 0.0 113.243 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.1 mt -134.27 140.13 46.21 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 123.342 1.544 . . . . 0.0 113.62 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -122.35 158.93 28.54 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 102.059 -3.312 . . . . 0.0 102.059 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . 0.311 0.8 OUTLIER -70.31 145.81 50.98 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 123.462 1.601 . . . . 0.0 113.838 171.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.96 -4.04 60.8 Favored Glycine 0 C--N 1.356 1.681 0 CA-C-N 111.896 -2.411 . . . . 0.0 115.428 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -94.67 142.35 27.56 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 123.377 1.561 . . . . 0.0 112.079 -169.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -86.46 134.52 33.68 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 119.871 -1.768 . . . . 0.0 107.477 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.71 148.12 65.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.69 137.22 6.57 Favored 'Trans proline' 0 C--N 1.28 -3.062 0 C-N-CA 122.118 1.878 . . . . 0.0 110.969 172.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.18 142.89 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 118.822 -2.424 . . . . 0.0 109.167 -169.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -112.33 134.89 53.62 Favored 'General case' 0 C--O 1.18 -2.568 0 C-N-CA 123.433 0.693 . . . . 0.0 110.198 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.61 140.65 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 124.221 1.963 . . . . 0.0 114.433 172.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 148' ' ' SER . 20.4 mt -106.34 -66.35 1.01 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 123.01 1.386 . . . . 0.0 110.097 170.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -128.59 147.97 50.75 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 120.341 -1.474 . . . . 0.0 109.382 -175.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.52 129.08 64.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-O 117.33 -1.319 . . . . 0.0 107.518 169.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -86.85 155.37 20.29 Favored 'General case' 0 C--N 1.371 1.512 0 O-C-N 126.068 2.105 . . . . 0.0 111.808 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -60.46 -39.98 89.52 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -57.61 -30.29 65.21 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 166.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.35 -7.11 9.86 Favored Glycine 0 N--CA 1.514 3.862 0 CA-C-N 122.376 2.353 . . . . 0.0 117.076 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -62.94 146.46 52.95 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 80.9 mt -133.2 135.98 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.28 -1.327 . . . . 0.0 114.158 -173.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.24 128.97 56.41 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 117.928 -1.509 . . . . 0.0 108.576 167.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.6 mt -114.03 168.3 9.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.194 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.463 ' HB2' HD11 ' A' ' 137' ' ' LEU . 28.8 t -137.8 127.0 24.48 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 112.312 -2.222 . . . . 0.0 113.167 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 95.6 mt -86.87 -32.97 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 CA-C-O 122.82 1.295 . . . . 0.0 109.823 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -70.54 -30.61 67.39 Favored 'General case' 0 C--O 1.252 1.206 0 C-N-CA 119.034 -1.066 . . . . 0.0 113.047 -164.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.31 -5.17 58.49 Favored 'General case' 0 C--N 1.381 1.968 0 CA-C-N 120.172 1.351 . . . . 0.0 110.222 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.2 -1.68 33.2 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.414 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.568 1.667 0 C-N-CA 124.893 1.277 . . . . 0.0 113.576 -171.552 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.1 mm . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -116.15 147.81 40.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 128.556 3.66 . . . . 0.0 114.385 164.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -128.48 130.33 47.37 Favored 'General case' 0 C--N 1.366 1.32 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.8 mm -133.66 133.02 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -166.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -98.67 137.48 37.24 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.493 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.5 pt -144.45 162.87 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 117.078 -1.439 . . . . 0.0 107.86 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -65.25 130.4 94.74 Favored Pre-proline 0 CA--C 1.597 2.766 0 O-C-N 125.281 1.613 . . . . 0.0 111.051 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -78.47 -7.83 15.96 Favored 'Trans proline' 0 N--CA 1.512 2.604 1 C-N-CA 125.885 4.39 . . . . 0.0 111.113 -172.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -83.53 5.26 24.69 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.173 -1.579 . . . . 0.0 109.021 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -131.61 5.11 4.3 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 115.487 -2.196 . . . . 0.0 111.191 -170.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.5 mt -61.79 -45.25 99.09 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 CA-C-O 117.34 -1.314 . . . . 0.0 110.126 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.03 -26.04 9.89 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.892 1.37 . . . . 0.0 114.35 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -90.12 -21.61 22.17 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -168.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.5 t -80.19 -26.61 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 125.218 1.574 . . . . 0.0 109.978 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.8 mt -81.62 -65.02 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 112.917 -3.421 . . . . 0.0 105.691 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.68 166.83 40.93 Favored Glycine 0 C--N 1.371 2.511 0 CA-C-N 123.949 3.068 . . . . 0.0 113.683 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -49.25 113.91 0.91 Allowed 'General case' 0 C--N 1.382 1.991 0 CA-C-O 122.94 1.352 . . . . 0.0 113.157 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.41 14.52 79.34 Favored Glycine 0 N--CA 1.505 3.241 0 O-C-N 118.998 -2.314 . . . . 0.0 113.624 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.8 28.54 73.73 Favored Glycine 0 C--O 1.259 1.667 0 CA-C-O 123.872 1.818 . . . . 0.0 113.698 -162.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 99.4 p -61.74 -44.42 96.94 Favored 'General case' 0 C--N 1.38 1.899 0 N-CA-C 118.305 2.706 . . . . 0.0 118.305 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.68 -39.96 85.01 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.231 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 tt -61.53 -44.63 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-N 119.844 1.202 . . . . 0.0 111.846 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -62.85 -41.71 99.47 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 171.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.37 -44.79 84.72 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 117.578 -3.201 . . . . 0.0 113.447 168.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.6 mt -63.63 -36.45 83.87 Favored 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 126.886 2.616 . . . . 0.0 112.136 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 m -58.48 -52.43 65.67 Favored 'General case' 0 CA--C 1.583 2.222 0 O-C-N 125.822 1.952 . . . . 0.0 114.024 169.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.23 -40.73 95.12 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 125.906 1.683 . . . . 0.0 108.75 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -69.7 -41.88 74.81 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.1 p -105.05 -29.91 10.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 117.714 -1.136 . . . . 0.0 114.06 -166.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.57 24.63 27.81 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 119.911 1.232 . . . . 0.0 112.802 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.5 p -121.3 167.83 12.31 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 124.52 0.776 . . . . 0.0 110.115 -168.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.5 m -125.96 119.05 26.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 119.696 -0.801 . . . . 0.0 109.681 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.4 mt -116.48 120.11 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 126.078 2.111 . . . . 0.0 107.964 -161.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -121.29 129.54 53.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.888 -1.96 . . . . 0.0 109.633 171.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 tt -124.56 150.38 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.783 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.0 157.41 41.78 Favored 'General case' 0 C--O 1.262 1.763 0 O-C-N 124.16 0.912 . . . . 0.0 109.746 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -81.92 2.34 31.01 Favored 'General case' 0 C--N 1.391 2.404 0 C-N-CA 124.748 1.219 . . . . 0.0 113.202 -157.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -94.88 6.93 47.6 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 126.32 2.962 . . . . 0.0 110.631 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.51 48.39 4.78 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 126.883 2.183 . . . . 0.0 112.493 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.2 m -128.22 134.67 49.04 Favored 'General case' 0 C--O 1.261 1.676 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.24 148.05 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 C-N-CA 116.955 -1.898 . . . . 0.0 111.595 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 128.96 56.61 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 121.155 -0.965 . . . . 0.0 109.0 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 mt -120.92 123.91 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 118.341 -2.724 . . . . 0.0 111.419 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.8 135.2 53.82 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . . . -158.14 158.69 35.13 Favored 'General case' 0 CA--C 1.583 2.216 0 CA-C-N 113.403 -1.726 . . . . 0.0 109.253 -173.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.7 p -107.35 -0.9 22.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 119.593 -1.942 . . . . 0.0 114.713 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -145.19 163.64 33.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 171.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.31 -39.81 17.85 Favored Glycine 0 N--CA 1.489 2.228 0 O-C-N 118.566 -2.584 . . . . 0.0 113.486 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.304 84.2 mt-10 -61.47 -39.18 89.96 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 119.479 -2.189 . . . . 0.0 112.884 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.72 -43.02 90.02 Favored 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 119.162 0.892 . . . . 0.0 109.016 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . . . -67.32 -36.88 82.38 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 123.205 1.478 . . . . 0.0 114.149 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -64.41 -39.42 93.81 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 120.625 -1.297 . . . . 0.0 112.393 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -60.63 -36.18 78.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 117.457 2.392 . . . . 0.0 117.457 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.0 -48.64 70.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.801 1.64 . . . . 0.0 113.205 163.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.39 -41.17 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 CA-C-N 119.842 1.201 . . . . 0.0 113.551 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -59.99 -42.45 94.26 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.672 1.589 . . . . 0.0 112.274 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.5 mmt85 -67.11 -43.66 81.91 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 118.437 -2.665 . . . . 0.0 111.195 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.77 -49.7 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.323 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -59.98 -38.27 82.05 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 119.423 1.01 . . . . 0.0 112.433 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -61.66 -56.92 14.55 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 125.805 1.941 . . . . 0.0 114.304 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.0 mt -58.58 -45.25 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 O-C-N 123.794 0.684 . . . . 0.0 110.488 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.6 p . . . . . 0 N--CA 1.497 1.899 0 C-N-CA 117.483 -1.687 . . . . 0.0 110.548 -168.988 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -85.14 145.45 27.62 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-O 124.189 1.947 . . . . 0.0 115.762 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.81 132.23 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.333 1 CA-C-O 129.012 4.244 . . . . 0.0 114.493 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.48 17.08 64.95 Favored Glycine 0 C--O 1.245 0.842 0 CA-C-N 111.084 -2.78 . . . . 0.0 109.418 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -102.81 135.96 43.5 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 119.598 1.699 . . . . 0.0 109.376 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.96 115.49 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 116.627 -2.029 . . . . 0.0 107.435 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -99.34 163.99 12.3 Favored 'General case' 0 C--N 1.38 1.916 0 CA-C-N 119.668 1.122 . . . . 0.0 111.565 170.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.1 m -128.76 134.88 48.55 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.1 159.45 28.03 Favored Glycine 0 CA--C 1.486 -1.749 0 CA-C-O 116.251 -2.416 . . . . 0.0 112.722 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -71.25 132.8 45.47 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 120.753 2.277 . . . . 0.0 110.905 166.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -54.28 130.13 15.93 Favored 'Isoleucine or valine' 0 C--N 1.391 2.404 0 C-N-CA 126.801 2.041 . . . . 0.0 110.586 159.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.4 p -108.79 -38.96 5.49 Favored 'General case' 0 CA--C 1.499 -0.985 0 O-C-N 119.253 -2.154 . . . . 0.0 110.132 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mmt-85 -151.63 160.43 43.65 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 117.61 -1.636 . . . . 0.0 108.293 -169.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.8 mt -135.14 121.32 32.49 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.39 177.14 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 120.771 1.623 . . . . 0.0 108.56 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -63.46 -39.6 94.89 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.629 1.206 . . . . 0.0 110.237 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -93.2 6.43 48.06 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.39 -178.09 33.91 Favored Glycine 0 C--O 1.202 -1.894 0 CA-C-O 116.848 -2.085 . . . . 0.0 112.677 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.08 141.06 51.86 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-N 118.783 1.292 . . . . 0.0 111.001 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 47.2 m-85 -87.99 130.76 34.86 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 124.594 1.184 . . . . 0.0 112.51 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.67 137.42 46.87 Favored 'Isoleucine or valine' 0 C--N 1.379 1.874 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.079 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.9 127.68 48.62 Favored 'General case' 0 C--O 1.189 -2.099 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.27 143.2 18.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.91 155.09 1.27 Allowed Glycine 0 CA--C 1.545 1.912 0 CA-C-O 124.01 1.894 . . . . 0.0 117.479 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.27 19.33 64.81 Favored Glycine 0 CA--C 1.573 3.682 0 O-C-N 119.238 -2.331 . . . . 0.0 115.223 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.6 35.56 81.22 Favored Glycine 0 N--CA 1.484 1.857 1 N-CA-C 123.204 4.042 . . . . 0.0 123.204 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -115.84 115.51 26.38 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -107.42 124.44 49.85 Favored 'General case' 0 N--CA 1.527 3.381 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.341 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.84 155.74 16.02 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 118.142 2.017 . . . . 0.0 118.142 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.458 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 30.1 tp -96.31 120.28 36.32 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 113.486 -1.357 . . . . 0.0 109.718 -173.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.27 111.81 24.87 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 CA-C-O 118.365 -0.826 . . . . 0.0 109.224 157.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -66.98 156.45 35.94 Favored 'General case' 0 C--N 1.377 1.782 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.41 -30.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.967 0.907 . . . . 0.0 112.077 -169.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 65.0 p -80.46 -12.5 59.55 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -106.91 5.5 28.39 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -173.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.09 -50.85 23.23 Favored 'Isoleucine or valine' 0 C--N 1.393 2.467 0 CA-C-N 122.173 2.26 . . . . 0.0 107.889 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -126.74 158.51 36.3 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.276 49.1 p30 -64.51 -38.47 91.15 Favored 'General case' 0 C--N 1.391 2.398 0 O-C-N 118.97 -2.331 . . . . 0.0 113.713 161.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -85.6 141.12 30.05 Favored 'General case' 0 N--CA 1.415 -2.207 0 O-C-N 119.249 -2.157 . . . . 0.0 112.501 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -41.87 130.82 3.37 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-N 112.042 -2.344 . . . . 0.0 116.346 170.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 t -113.98 111.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 120.758 1.617 . . . . 0.0 107.275 -163.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.43 -46.38 66.91 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 116.181 -1.866 . . . . 0.0 107.596 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -149.89 133.01 16.29 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 128.755 3.785 . . . . 0.0 109.473 -176.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.51 -20.22 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 O-C-N 119.846 -1.784 . . . . 0.0 110.872 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.8 p -56.6 -29.99 62.73 Favored 'General case' 0 C--N 1.377 1.776 0 C-N-CA 125.951 1.7 . . . . 0.0 110.286 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -65.11 -33.76 76.79 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 128.43 2.692 . . . . 0.0 111.76 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -112.25 -30.77 7.08 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 72.8 mt -121.42 123.13 41.34 Favored 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -91.99 130.07 37.81 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-O 122.213 1.006 . . . . 0.0 112.003 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 21.0 mmt -61.05 111.1 1.56 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.2 16.32 64.98 Favored Glycine 0 CA--C 1.547 2.048 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.525 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -113.61 143.32 44.76 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 124.576 2.132 . . . . 0.0 112.821 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.52 146.12 49.72 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -171.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 p -144.17 142.92 20.74 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 166.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.79 136.76 68.41 Favored 'Trans proline' 0 C--N 1.284 -2.865 0 C-N-CA 121.876 1.717 . . . . 0.0 114.524 160.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.82 120.91 17.33 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.235 0 CA-C-O 124.331 2.015 . . . . 0.0 107.06 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.458 ' N ' ' HB2' ' A' ' 152' ' ' ALA . 65.1 tttt -88.29 137.4 32.36 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 119.447 -2.033 . . . . 0.0 111.717 170.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.6 t -90.89 91.55 3.64 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.532 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.7 mt -53.75 -43.9 69.53 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 126.335 2.272 . . . . 0.0 113.601 171.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -165.1 156.26 14.53 Favored 'General case' 0 C--O 1.255 1.349 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.99 79.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 126.312 2.258 . . . . 0.0 104.993 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.532 0.5 OUTLIER -61.63 141.62 57.68 Favored 'General case' 0 CA--C 1.58 2.1 0 CA-C-N 114.161 -1.381 . . . . 0.0 110.935 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -84.96 -0.02 52.88 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-O 115.078 -2.392 . . . . 0.0 108.269 -167.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -90.68 14.27 13.84 Favored 'General case' 0 C--N 1.384 2.104 0 CA-C-N 121.123 1.783 . . . . 0.0 107.676 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.71 24.07 40.14 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 115.08 -3.066 . . . . 0.0 115.517 -173.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -120.33 114.18 21.47 Favored 'General case' 0 CA--C 1.593 2.619 0 CA-C-N 122.469 3.134 . . . . 0.0 110.659 -171.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.1 mt -102.92 125.9 57.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 CA-C-O 117.242 -1.361 . . . . 0.0 110.953 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -120.65 135.91 54.98 Favored 'General case' 0 C--N 1.368 1.409 0 O-C-N 128.583 3.677 . . . . 0.0 113.524 -171.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 51.2 mt -129.95 148.39 51.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 112.074 -2.33 . . . . 0.0 110.315 -164.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.2 t -113.82 123.79 50.66 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.4 -43.28 42.86 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 O-C-N 119.318 -2.114 . . . . 0.0 108.551 161.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -46.18 -61.36 1.8 Allowed 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 117.293 -1.336 . . . . 0.0 112.011 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -66.67 -27.56 67.76 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 122.372 2.351 . . . . 0.0 113.531 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.458 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -81.74 -7.11 59.56 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 118.77 -2.456 . . . . 0.0 112.802 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.495 1.819 0 O-C-N 124.913 1.383 . . . . 0.0 113.615 170.474 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.8 mm . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 122.12 0.962 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -121.84 164.41 17.55 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 116.68 -1.629 . . . . 0.0 108.415 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.5 t -153.9 159.22 41.67 Favored 'General case' 0 C--N 1.378 1.834 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 pt -161.9 155.18 3.1 Favored 'Isoleucine or valine' 0 C--N 1.369 1.421 0 C-N-CA 129.467 3.107 . . . . 0.0 103.647 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -121.57 122.25 39.26 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.454 -164.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.4 pt -127.14 142.53 43.26 Favored 'Isoleucine or valine' 0 C--N 1.387 2.215 0 C-N-CA 125.661 1.584 . . . . 0.0 111.1 -169.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -42.23 126.17 2.78 Favored Pre-proline 0 C--O 1.203 -1.389 0 C-N-CA 129.856 3.262 . . . . 0.0 114.556 175.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.57 -26.6 83.2 Favored 'Trans proline' 1 N--CA 1.54 4.214 0 N-CA-C 117.426 2.048 . . . . 0.0 117.426 -169.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.25 45.9 t0 -58.67 -38.28 77.85 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 129.71 3.204 . . . . 0.0 113.495 172.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -92.72 3.05 56.33 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.921 -1.112 . . . . 0.0 113.15 -168.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.77 -34.99 73.66 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 O-C-N 120.857 -1.152 . . . . 0.0 110.556 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -59.78 -34.81 73.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 117.336 -3.352 . . . . 0.0 114.718 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -86.5 -36.65 18.87 Favored 'General case' 0 C--N 1.38 1.933 0 O-C-N 125.76 1.913 . . . . 0.0 112.062 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.12 -37.91 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 CA-C-N 121.882 2.128 . . . . 0.0 113.512 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.0 mm -75.15 -47.37 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 C-N-CA 126.422 1.889 . . . . 0.0 112.585 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.72 -176.28 50.95 Favored Glycine 0 CA--C 1.484 -1.879 0 O-C-N 126.047 2.092 . . . . 0.0 113.566 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.297 42.2 mttp -58.11 111.71 1.28 Allowed 'General case' 0 C--N 1.36 1.057 0 CA-C-N 113.748 -1.226 . . . . 0.0 111.957 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.98 25.46 31.09 Favored Glycine 0 N--CA 1.488 2.16 0 O-C-N 127.064 2.727 . . . . 0.0 114.645 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.02 9.85 83.69 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.2 t -65.23 -39.98 93.44 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 119.069 1.435 . . . . 0.0 111.677 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.46 -45.54 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 O-C-N 126.295 2.247 . . . . 0.0 108.619 -170.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.5 tp -66.35 -28.93 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 CA-C-O 117.338 -1.315 . . . . 0.0 112.032 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -60.83 -46.82 89.04 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 120.913 1.688 . . . . 0.0 113.504 162.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.58 65.05 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 128.111 2.564 . . . . 0.0 111.045 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.18 -42.63 98.91 Favored 'General case' 0 C--N 1.374 1.644 0 O-C-N 123.752 0.658 . . . . 0.0 112.084 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 t -67.3 -43.37 81.88 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 115.817 -2.039 . . . . 0.0 114.279 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -59.61 -42.82 93.47 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 122.118 2.235 . . . . 0.0 110.913 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -73.0 -41.98 63.72 Favored 'General case' 0 C--O 1.254 1.331 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.2 p -80.53 -42.99 21.46 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 124.598 2.142 . . . . 0.0 109.711 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.76 37.27 11.97 Favored Glycine 0 C--O 1.239 0.445 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.56 145.61 35.31 Favored 'General case' 0 C--N 1.391 2.376 0 CA-C-O 116.973 -1.489 . . . . 0.0 108.864 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 m -93.52 130.28 39.44 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.35 128.14 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.23 133.25 40.64 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.443 HG12 HG22 ' A' ' 55' ' ' VAL . 10.7 mt -116.56 127.71 74.1 Favored 'Isoleucine or valine' 0 C--N 1.378 1.847 0 CA-C-O 123.67 1.7 . . . . 0.0 111.743 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -80.03 152.97 29.13 Favored 'General case' 0 C--O 1.188 -2.147 0 CA-C-O 115.345 -2.264 . . . . 0.0 115.525 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -74.17 19.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 115.051 -2.404 . . . . 0.0 115.016 -169.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -121.2 11.35 10.84 Favored 'General case' 0 C--N 1.371 1.533 0 CA-C-O 114.82 -2.514 . . . . 0.0 110.298 165.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.39 9.08 48.45 Favored Glycine 0 C--N 1.357 1.695 0 CA-C-N 121.131 1.787 . . . . 0.0 111.465 165.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -89.66 129.21 36.13 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-O 117.189 -1.386 . . . . 0.0 108.392 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.443 HG22 HG12 ' A' ' 49' ' ' ILE . 48.5 t -114.04 128.85 70.81 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.68 0 O-C-N 126.143 2.152 . . . . 0.0 105.728 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -110.5 134.23 52.56 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 126.691 1.997 . . . . 0.0 108.908 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.05 130.63 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.25 139.06 43.48 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 117.537 -1.22 . . . . 0.0 111.033 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.49 150.85 18.19 Favored 'General case' 0 C--N 1.364 1.235 0 CA-C-O 122.917 1.342 . . . . 0.0 110.916 -165.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.284 7.1 t -114.95 -45.61 2.96 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.566 160.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -76.63 140.63 41.06 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 123.867 3.031 . . . . 0.0 114.23 171.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.93 -29.98 24.53 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 113.851 -1.522 . . . . 0.0 114.927 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -66.59 -38.52 87.19 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 119.465 -2.197 . . . . 0.0 114.581 166.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -64.35 -30.66 71.7 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 116.989 -3.57 . . . . 0.0 112.939 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.48 -46.78 81.54 Favored 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 119.367 -0.933 . . . . 0.0 113.431 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -60.82 -41.23 95.3 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.24 2.216 . . . . 0.0 111.014 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -54.62 -51.14 66.31 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.168 -1.582 . . . . 0.0 111.826 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.51 91.04 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.913 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 61.3 mt -66.35 -43.46 91.37 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 CA-C-N 119.521 1.055 . . . . 0.0 110.894 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -74.33 -28.16 61.03 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -71.24 -37.3 72.01 Favored 'General case' 0 C--O 1.211 -0.951 0 O-C-N 120.416 -1.427 . . . . 0.0 112.728 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 mt -62.88 -38.69 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 121.433 1.924 . . . . 0.0 111.003 165.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.69 -45.52 82.53 Favored 'General case' 0 C--N 1.373 1.597 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -174.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -51.71 -51.79 53.32 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 167.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.02 -35.48 69.19 Favored 'Isoleucine or valine' 0 C--O 1.271 2.208 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.516 2.844 0 CA-C-O 123.5 1.619 . . . . 0.0 111.25 -177.225 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.2 pt . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 125.201 2.429 . . . . 0.0 113.084 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -132.35 148.5 52.43 Favored 'General case' 0 C--N 1.366 1.301 0 O-C-N 118.447 -2.658 . . . . 0.0 110.607 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.03 144.52 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.402 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.3 13.78 58.18 Favored Glycine 0 C--N 1.381 3.045 0 N-CA-C 117.996 1.958 . . . . 0.0 117.996 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -135.27 157.89 45.77 Favored 'General case' 0 C--O 1.205 -1.289 0 O-C-N 118.462 -2.787 . . . . 0.0 108.2 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 135' ' ' LYS . 24.8 t -107.93 146.48 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -136.66 167.68 20.94 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.2 m -105.85 123.38 47.86 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 120.305 1.411 . . . . 0.0 109.297 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.44 -164.18 19.98 Favored Glycine 0 C--N 1.366 2.235 0 CA-C-N 111.466 -2.606 . . . . 0.0 112.659 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -146.67 150.71 35.96 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 126.242 1.789 . . . . 0.0 107.518 164.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.458 HG21 HD22 ' A' ' 126' ' ' LEU . 78.3 t -77.55 112.97 16.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -86.09 -17.8 34.11 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 175.27 141.59 0.05 Allowed 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -169.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.8 mt -126.87 125.75 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.312 -169.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.14 177.69 2.21 Favored 'Isoleucine or valine' 0 C--N 1.364 1.216 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.785 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -58.06 -44.68 87.62 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.852 1.345 . . . . 0.0 112.92 -163.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -110.33 22.38 15.58 Favored 'General case' 0 CA--C 1.555 1.164 0 O-C-N 119.255 -2.153 . . . . 0.0 112.066 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.02 170.7 36.24 Favored Glycine 0 C--O 1.21 -1.377 0 C-N-CA 118.751 -1.69 . . . . 0.0 114.594 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.17 125.93 36.22 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -81.82 130.9 35.22 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.92 128.17 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -167.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 106' ' ' GLU . . . -100.84 125.57 47.37 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.545 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.8 mt -110.25 138.39 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -36.28 151.42 0.02 OUTLIER Glycine 0 C--N 1.37 2.423 0 N-CA-C 119.328 2.491 . . . . 0.0 119.328 -165.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.4 25.45 68.13 Favored Glycine 0 C--O 1.186 -2.905 0 CA-C-O 113.767 -3.796 . . . . 0.0 112.152 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.09 26.78 69.93 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 128.514 2.959 . . . . 0.0 116.955 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -92.8 93.44 8.43 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 31.6 tt0 -101.6 117.65 35.33 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -113.82 179.08 18.69 Favored Glycine 0 C--O 1.215 -1.039 0 O-C-N 126.998 2.686 . . . . 0.0 112.613 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.7 tp -120.41 125.51 48.13 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.659 -1.638 . . . . 0.0 109.891 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 148' ' ' SER . 20.3 t -95.01 111.46 25.67 Favored 'Isoleucine or valine' 0 C--N 1.371 1.523 0 O-C-N 124.857 1.348 . . . . 0.0 109.571 170.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -63.71 149.94 45.54 Favored 'General case' 0 C--O 1.208 -1.11 0 O-C-N 121.423 -0.798 . . . . 0.0 109.758 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -56.43 -8.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.425 0 C-N-CA 125.579 1.552 . . . . 0.0 115.022 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.4 p -101.92 2.92 38.55 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 125.119 1.368 . . . . 0.0 113.605 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -130.77 18.62 5.13 Favored 'General case' 0 C--O 1.257 1.472 0 CA-C-N 119.225 0.92 . . . . 0.0 111.798 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.75 -43.4 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-O 124.588 2.137 . . . . 0.0 109.976 170.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.68 163.62 33.42 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 119.931 -1.731 . . . . 0.0 109.477 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -72.17 -38.2 69.18 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 123.177 1.465 . . . . 0.0 112.756 168.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -80.48 145.55 31.82 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 125.958 1.703 . . . . 0.0 113.101 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -70.66 130.35 41.55 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.82 130.02 75.04 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -173.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -103.72 -24.58 13.33 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 120.612 -1.305 . . . . 0.0 110.931 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.39 139.48 31.7 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 125.555 1.784 . . . . 0.0 107.166 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -81.27 -22.7 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.775 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -165.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 p -63.02 -19.68 64.59 Favored 'General case' 0 C--N 1.374 1.673 0 O-C-N 119.492 -2.005 . . . . 0.0 115.462 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -59.39 -40.26 85.99 Favored 'General case' 0 C--O 1.192 -1.956 0 C-N-CA 125.25 1.42 . . . . 0.0 113.401 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.68 0.2 14.5 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 125.313 1.445 . . . . 0.0 111.143 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.458 HD22 HG21 ' A' ' 89' ' ' VAL . 9.4 mt -153.75 150.12 28.17 Favored 'General case' 0 C--N 1.376 1.731 0 O-C-N 119.032 -2.292 . . . . 0.0 110.05 -170.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -148.66 151.4 34.89 Favored 'General case' 0 C--N 1.38 1.895 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -63.13 142.38 58.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 125.664 2.649 . . . . 0.0 114.058 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.1 -4.24 86.18 Favored Glycine 0 CA--C 1.46 -3.354 0 C-N-CA 129.193 3.282 . . . . 0.0 116.659 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -65.6 127.77 33.25 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 127.147 3.356 . . . . 0.0 109.885 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -78.59 125.69 29.71 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 118.406 -2.684 . . . . 0.0 112.72 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.03 138.93 31.74 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.48 -168.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -72.86 124.07 9.4 Favored 'Trans proline' 0 CA--C 1.5 -1.202 0 C-N-CA 123.736 2.957 . . . . 0.0 107.119 158.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.27 131.97 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-N 113.013 -1.903 . . . . 0.0 107.206 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 88.9 tttt -90.35 134.34 34.39 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.406 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.6 t -76.47 110.8 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 118.403 -1.319 . . . . 0.0 110.556 170.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 mt -86.1 -56.01 3.66 Favored 'General case' 0 CA--C 1.468 -2.192 0 O-C-N 125.288 1.618 . . . . 0.0 114.535 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -146.21 158.21 43.87 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 125.267 1.604 . . . . 0.0 108.47 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.425 HG13 HG12 ' A' ' 145' ' ' ILE . 46.7 t -140.23 114.86 6.75 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.351 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 166.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -75.31 177.28 6.68 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 122.334 2.334 . . . . 0.0 109.828 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -67.28 -32.32 73.24 Favored 'General case' 0 C--N 1.371 1.531 0 C-N-CA 127.219 2.207 . . . . 0.0 110.913 -173.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -74.29 -30.92 62.31 Favored 'General case' 0 C--O 1.213 -0.84 0 C-N-CA 125.433 1.493 . . . . 0.0 111.426 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.3 18.98 4.8 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 115.684 -2.731 . . . . 0.0 112.404 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -80.17 127.66 32.6 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 119.45 1.625 . . . . 0.0 108.109 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.425 HG12 HG13 ' A' ' 139' ' ' VAL . 68.6 mt -104.91 118.37 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -162.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -111.59 131.03 55.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 125.136 2.398 . . . . 0.0 106.456 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.4 mt -129.96 177.15 7.49 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.416 -163.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.405 ' HA ' HG13 ' A' ' 109' ' ' VAL . 16.7 t -154.14 147.91 25.4 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.351 -1.468 . . . . 0.0 107.083 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.3 mt -102.83 -31.98 3.04 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.803 0 O-C-N 119.709 -1.87 . . . . 0.0 107.295 164.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -52.78 -53.83 42.65 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.729 1.212 . . . . 0.0 111.365 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.56 -18.29 58.76 Favored 'General case' 0 C--N 1.364 1.215 0 C-N-CA 125.087 1.355 . . . . 0.0 112.024 -172.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.95 99.68 Favored 'General case' 0 C--O 1.258 1.513 0 C-N-CA 123.756 0.822 . . . . 0.0 110.895 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 175.221 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 mm . . . . . 0 CA--C 1.502 -0.872 0 CA-C-O 123.452 1.596 . . . . 0.0 113.614 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -109.03 121.83 45.97 Favored 'General case' 0 C--N 1.366 1.318 0 O-C-N 119.699 -1.876 . . . . 0.0 110.35 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -112.89 153.12 28.43 Favored 'General case' 0 N--CA 1.397 -3.102 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -173.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.7 tt -142.49 156.29 18.7 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 166.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -118.13 113.37 21.47 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -175.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -104.58 163.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 126.883 2.614 . . . . 0.0 112.716 167.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 55.7 t-20 -55.94 139.31 70.87 Favored Pre-proline 0 N--CA 1.429 -1.505 0 O-C-N 124.54 1.15 . . . . 0.0 113.088 168.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 21' ' ' ASN . 17.8 Cg_endo -70.89 -21.13 28.65 Favored 'Trans proline' 0 C--O 1.194 -1.706 0 C-N-CA 122.46 2.107 . . . . 0.0 112.2 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -90.13 1.52 56.31 Favored 'General case' 0 CA--C 1.573 1.861 0 O-C-N 119.776 -1.827 . . . . 0.0 109.243 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -118.81 7.04 11.5 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 119.468 -2.02 . . . . 0.0 112.197 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.0 mt -61.87 -46.66 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 119.999 -1.688 . . . . 0.0 111.924 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -67.17 -29.4 69.09 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 117.98 -1.488 . . . . 0.0 111.091 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.48 -32.78 72.8 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 173.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.462 ' HA ' ' CG2' ' A' ' 75' ' ' ILE . 41.6 t -78.99 -51.42 16.91 Favored 'Isoleucine or valine' 0 C--N 1.384 2.076 0 N-CA-C 115.745 1.758 . . . . 0.0 115.745 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.95 -19.24 19.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 114.324 -2.75 . . . . 0.0 114.898 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.78 -174.18 8.69 Favored Glycine 0 C--N 1.383 3.146 1 O-C-N 129.517 4.261 . . . . 0.0 108.9 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.384 22.2 pttp -72.65 129.72 38.89 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 110.061 -3.069 . . . . 0.0 114.359 -173.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.65 19.56 67.22 Favored Glycine 0 N--CA 1.483 1.807 0 O-C-N 119.665 -1.897 . . . . 0.0 114.227 -171.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.6 28.69 68.18 Favored Glycine 0 N--CA 1.5 2.928 0 CA-C-O 121.996 0.776 . . . . 0.0 112.109 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.6 p -64.65 -42.97 95.06 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.76 -41.68 91.5 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 C-N-CA 126.22 1.808 . . . . 0.0 110.286 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.69 -37.51 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 O-C-N 123.974 0.796 . . . . 0.0 110.617 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -56.05 -47.83 77.15 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.75 82.38 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 170.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.82 -51.94 67.52 Favored 'General case' 0 C--O 1.195 -1.779 0 O-C-N 125.386 1.679 . . . . 0.0 113.026 171.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.253 14.2 t -65.43 -48.51 72.5 Favored 'General case' 0 C--O 1.261 1.676 0 CA-C-O 117.742 -1.123 . . . . 0.0 110.55 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.278 27.0 tt0 -66.84 -42.75 85.27 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 118.637 -1.225 . . . . 0.0 114.075 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.31 -34.05 77.11 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.6 p -96.35 -46.14 6.52 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.721 -1.237 . . . . 0.0 111.61 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.25 -0.16 57.14 Favored Glycine 0 C--N 1.344 0.977 0 O-C-N 119.93 -1.731 . . . . 0.0 110.168 -171.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.1 p -75.18 149.41 38.97 Favored 'General case' 0 C--N 1.404 2.947 0 C-N-CA 127.718 2.407 . . . . 0.0 110.826 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.9 m -98.15 129.77 44.93 Favored 'General case' 0 C--O 1.201 -1.454 0 CA-C-O 116.004 -1.95 . . . . 0.0 110.899 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mp -117.29 126.08 74.36 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.989 0 CA-C-O 116.183 -1.865 . . . . 0.0 113.034 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -129.46 141.58 50.99 Favored 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 120.379 1.445 . . . . 0.0 109.291 173.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.88 109.84 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -156.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -76.34 156.14 33.58 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 125.09 2.376 . . . . 0.0 115.101 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -69.1 -0.26 5.6 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 120.339 -1.476 . . . . 0.0 109.438 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -103.91 -11.82 17.25 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.342 -1.474 . . . . 0.0 108.257 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.49 -1.66 53.38 Favored Glycine 0 C--N 1.364 2.104 0 CA-C-O 118.677 -1.068 . . . . 0.0 112.337 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -67.82 115.94 7.93 Favored 'General case' 0 C--O 1.204 -1.322 0 CA-C-N 120.981 2.391 . . . . 0.0 110.363 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 17' ' ' THR . 93.1 t -99.2 117.47 44.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.07 112.84 25.88 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 172.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.5 mt -100.29 106.39 19.17 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 O-C-N 126.748 2.53 . . . . 0.0 108.273 168.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.91 135.47 34.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.656 1.217 . . . . 0.0 109.392 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 65' ' ' ALA . . . -154.62 151.78 29.22 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 102.392 -3.188 . . . . 0.0 102.392 -167.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 p -124.47 8.03 8.35 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 126.306 1.842 . . . . 0.0 108.111 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -124.65 107.84 11.41 Favored 'General case' 0 C--N 1.371 1.516 0 C-N-CA 127.23 2.212 . . . . 0.0 105.434 167.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.05 -40.34 95.43 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-O 116.679 -2.178 . . . . 0.0 115.104 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -73.15 -39.16 65.91 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.173 -172.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -58.65 -41.86 87.03 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 162.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.547 ' HB2' ' CB ' ' A' ' 59' ' ' ALA . . . -62.13 -46.13 90.37 Favored 'General case' 0 CA--C 1.586 2.355 0 CA-C-O 123.586 1.66 . . . . 0.0 113.357 168.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -58.58 -33.2 69.7 Favored 'General case' 0 N--CA 1.527 3.422 0 O-C-N 117.747 -3.096 . . . . 0.0 114.322 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -77.2 -44.46 30.01 Favored 'General case' 0 CA--C 1.563 1.462 0 O-C-N 123.504 0.502 . . . . 0.0 111.427 167.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.73 -39.44 94.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.096 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.271 9.2 tp -80.48 -26.0 11.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 O-C-N 119.995 -1.691 . . . . 0.0 109.101 -176.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -65.47 -41.54 93.23 Favored 'General case' 0 C--N 1.374 1.645 0 CA-C-N 119.992 1.269 . . . . 0.0 110.597 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -55.18 -35.23 64.58 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.0 mm -61.16 -40.48 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.708 0 CA-C-O 123.922 1.82 . . . . 0.0 113.145 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -67.75 -39.44 84.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 117.867 -3.021 . . . . 0.0 112.79 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -58.35 -48.06 81.8 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.906 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 28' ' ' VAL . 74.4 mt -62.35 -45.57 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 170.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.1 m . . . . . 0 CA--C 1.575 1.933 0 O-C-N 125.031 1.457 . . . . 0.0 112.723 171.279 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 N--CA 1.441 -0.921 0 N-CA-C 103.085 -2.931 . . . . 0.0 103.085 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -88.03 134.13 33.81 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.727 -169.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.3 137.76 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.409 0 O-C-N 125.928 2.017 . . . . 0.0 112.653 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.2 -7.7 1.68 Allowed Glycine 0 C--O 1.26 1.768 0 N-CA-C 120.123 2.809 . . . . 0.0 120.123 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -79.55 146.51 32.58 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 124.747 2.213 . . . . 0.0 111.544 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.9 t -91.04 146.7 5.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 O-C-N 120.352 -1.467 . . . . 0.0 109.233 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -138.31 155.35 48.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 79.5 m -93.81 144.24 25.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -146.65 179.53 23.55 Favored Glycine 0 C--O 1.248 1.0 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 172.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -130.32 131.67 45.5 Favored 'General case' 0 C--N 1.375 1.685 0 O-C-N 120.261 -1.729 . . . . 0.0 109.73 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.35 120.28 6.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.205 0 O-C-N 120.88 -1.138 . . . . 0.0 109.22 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.43 HG21 ' HB2' ' A' ' 100' ' ' ALA . 12.0 p -94.12 -8.62 39.05 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-O 115.623 -2.132 . . . . 0.0 112.492 -176.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 ptt85 165.04 148.62 0.02 OUTLIER 'General case' 0 C--N 1.369 1.435 0 O-C-N 126.624 2.452 . . . . 0.0 108.618 -170.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.4 mt -100.81 144.29 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 CA-C-N 112.855 -1.975 . . . . 0.0 108.958 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.26 35.8 m -138.58 170.43 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 O-C-N 120.784 -1.197 . . . . 0.0 109.388 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.65 -42.25 71.08 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 117.274 -3.391 . . . . 0.0 114.525 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -107.1 -0.85 22.56 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 119.131 0.878 . . . . 0.0 112.261 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.68 -154.58 11.17 Favored Glycine 0 C--O 1.212 -1.219 0 O-C-N 119.554 -1.966 . . . . 0.0 109.263 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.31 137.2 24.29 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 128.896 2.879 . . . . 0.0 104.229 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.254 92.6 m-85 -86.84 139.57 30.54 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 124.594 1.158 . . . . 0.0 109.047 173.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.82 121.43 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 112.547 -2.115 . . . . 0.0 107.841 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 90' ' ' THR . . . -72.33 126.04 28.84 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.621 -1.299 . . . . 0.0 110.169 165.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 147' ' ' LEU . 27.8 mm -85.5 94.2 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.44 37.48 93.82 Favored Glycine 0 N--CA 1.513 3.773 0 C-N-CA 126.6 2.048 . . . . 0.0 111.295 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.53 -7.15 49.77 Favored Glycine 0 C--N 1.297 -1.633 0 O-C-N 125.87 1.571 . . . . 0.0 114.471 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.76 -169.09 5.55 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 120.024 1.912 . . . . 0.0 114.473 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -33.06 140.08 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.247 2.927 . . . . 0.0 117.388 167.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -91.79 116.26 28.75 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 112.232 -2.258 . . . . 0.0 114.914 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.28 170.7 23.69 Favored Glycine 0 C--N 1.368 2.317 0 CA-C-O 117.997 -1.446 . . . . 0.0 110.974 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.1 tp -114.62 138.17 51.0 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 128.074 2.867 . . . . 0.0 106.816 -171.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.1 p -116.97 120.53 65.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.288 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.488 157.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -74.81 153.66 38.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.414 1.578 . . . . 0.0 112.197 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.6 tt -67.82 -16.32 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -162.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.0 m -94.69 13.14 25.33 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.03 1.286 . . . . 0.0 111.845 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 -112.2 22.43 14.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.978 1.263 . . . . 0.0 111.54 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.8 mm -100.97 -48.06 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 CA-C-O 127.142 3.353 . . . . 0.0 106.464 -174.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -125.42 156.01 39.51 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 112.439 -2.164 . . . . 0.0 112.261 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.262 4.8 t0 -83.2 -15.31 50.97 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 164.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -94.08 -173.55 3.14 Favored 'General case' 0 C--N 1.381 1.954 0 C-N-CA 126.547 1.939 . . . . 0.0 113.528 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.279 15.5 mmm180 -84.01 115.78 22.51 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-O 125.327 2.489 . . . . 0.0 114.546 -173.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.4 HG22 ' CE2' ' A' ' 125' ' ' TYR 0.264 21.9 t -82.67 101.34 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 112.092 -2.322 . . . . 0.0 114.675 172.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -96.54 -34.65 11.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -141.97 149.41 40.04 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 122.253 1.025 . . . . 0.0 110.09 170.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.29 -34.19 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.264 18.1 p -58.49 -20.94 49.85 Favored 'General case' 0 C--O 1.277 2.552 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 175.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.91 -43.28 83.76 Favored 'General case' 0 C--N 1.368 1.388 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.4 ' CE2' HG22 ' A' ' 119' ' ' VAL . 98.0 m-85 -90.93 -24.68 20.1 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 116.976 -1.488 . . . . 0.0 112.627 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.2 mt -137.98 151.22 47.72 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 120.479 1.49 . . . . 0.0 109.083 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -120.57 167.03 12.83 Favored 'General case' 0 C--O 1.22 -0.459 0 O-C-N 125.707 1.88 . . . . 0.0 108.075 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.6 tpt -81.36 120.71 25.3 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 111.875 -2.42 . . . . 0.0 112.066 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.82 -9.4 56.8 Favored Glycine 0 C--N 1.365 2.19 0 CA-C-N 119.832 1.197 . . . . 0.0 111.771 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -89.52 153.31 20.89 Favored 'General case' 0 CA--C 1.598 2.816 0 CA-C-N 118.316 1.058 . . . . 0.0 109.262 -164.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -88.2 151.09 22.92 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 117.733 -3.105 . . . . 0.0 108.229 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.03 136.05 9.93 Favored Pre-proline 0 N--CA 1.431 -1.399 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.39 124.69 16.69 Favored 'Trans proline' 0 N--CA 1.52 3.076 0 C-N-CA 121.299 1.333 . . . . 0.0 113.402 159.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.54 138.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.244 2.218 . . . . 0.0 107.714 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -106.57 118.36 36.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.553 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.99 119.04 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 123.829 1.776 . . . . 0.0 113.004 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.1 mt -88.64 -40.17 13.51 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 117.092 -1.432 . . . . 0.0 111.519 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -163.47 156.73 18.95 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 120.049 1.295 . . . . 0.0 107.865 -172.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.7 t -120.07 131.85 71.31 Favored 'Isoleucine or valine' 0 C--O 1.254 1.311 1 N-CA-C 98.942 -4.466 . . . . 0.0 98.942 166.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.67 178.42 6.76 Favored 'General case' 0 N--CA 1.421 -1.907 0 O-C-N 120.898 -1.126 . . . . 0.0 111.384 -168.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -78.59 -16.56 57.25 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.848 1.259 . . . . 0.0 111.483 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -112.04 2.56 16.89 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 126.089 2.118 . . . . 0.0 108.679 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.09 5.32 28.84 Favored Glycine 0 C--N 1.368 2.346 0 CA-C-O 119.692 -0.504 . . . . 0.0 114.338 162.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.85 146.89 27.08 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.1 mt -103.99 129.13 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -116.41 122.83 45.96 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 112.096 -2.32 . . . . 0.0 113.095 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.415 HD11 HD11 ' A' ' 101' ' ' ILE . 64.6 mt -120.55 166.12 14.07 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 125.94 1.696 . . . . 0.0 111.809 -168.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 30.0 t -129.28 130.53 46.31 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 112.036 -2.347 . . . . 0.0 108.753 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.3 mt -93.78 -39.43 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 169.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -60.84 -41.82 96.59 Favored 'General case' 0 C--N 1.379 1.867 0 O-C-N 120.239 -1.538 . . . . 0.0 113.9 -167.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -74.91 -33.93 62.08 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 126.651 2.469 . . . . 0.0 109.314 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.47 -29.56 61.49 Favored 'General case' 0 C--N 1.375 1.677 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 179.111 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 N--CA 1.432 -1.351 0 CA-C-O 123.948 1.832 . . . . 0.0 113.505 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -88.77 116.37 26.99 Favored 'General case' 0 N--CA 1.423 -1.787 0 C-N-CA 124.937 1.295 . . . . 0.0 110.958 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.6 p -93.94 138.18 32.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 124.758 2.218 . . . . 0.0 111.53 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.5 tt -135.92 123.45 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 111.545 -2.57 . . . . 0.0 109.807 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -80.4 124.71 29.13 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.274 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.96 129.69 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.925 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -66.73 143.21 97.98 Favored Pre-proline 0 N--CA 1.51 2.57 0 CA-C-O 116.289 -1.815 . . . . 0.0 112.736 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.45 -13.83 40.48 Favored 'Trans proline' 1 N--CA 1.541 4.265 0 CA-C-O 112.871 -3.054 . . . . 0.0 118.583 -165.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -86.48 -18.56 31.34 Favored 'General case' 0 C--N 1.386 2.159 0 CA-C-N 123.941 3.064 . . . . 0.0 109.251 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -84.71 -20.76 30.65 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 116.373 -1.775 . . . . 0.0 115.491 171.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.435 HD11 ' HA2' ' A' ' 53' ' ' GLY . 54.1 mt -65.22 -37.22 79.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 121.935 2.152 . . . . 0.0 112.535 166.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -61.32 -41.88 97.74 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 116.932 -1.508 . . . . 0.0 109.621 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -62.12 -41.19 97.99 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 119.863 1.211 . . . . 0.0 110.808 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 t -67.57 -36.44 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.568 1.947 . . . . 0.0 109.761 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.0 mt -67.19 -46.48 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.985 0.811 . . . . 0.0 109.224 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.49 174.07 11.21 Favored Glycine 0 CA--C 1.55 2.252 0 C-N-CA 118.818 -1.658 . . . . 0.0 114.473 -172.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -67.62 119.49 12.47 Favored 'General case' 0 C--O 1.187 -2.195 0 CA-C-N 113.937 -1.131 . . . . 0.0 110.376 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 26.36 60.78 Favored Glycine 0 N--CA 1.502 3.099 0 C-N-CA 128.497 2.951 . . . . 0.0 116.599 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.81 15.45 79.26 Favored Glycine 0 C--N 1.37 2.448 0 O-C-N 126.64 2.024 . . . . 0.0 112.682 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -62.32 -47.24 85.13 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 120.346 2.073 . . . . 0.0 115.177 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.39 -46.62 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.762 -1.212 . . . . 0.0 112.864 -173.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 47' ' ' ILE . 2.6 tt -70.98 -32.74 49.38 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 O-C-N 127.676 3.11 . . . . 0.0 114.445 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -64.56 -49.41 71.31 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.337 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -34.47 66.83 Favored 'General case' 0 C--O 1.249 1.055 0 CA-C-N 114.162 -1.381 . . . . 0.0 113.542 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -76.76 -48.11 19.68 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 128.241 3.463 . . . . 0.0 112.638 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.312 8.5 t -62.75 -43.29 99.2 Favored 'General case' 0 C--O 1.255 1.38 0 C-N-CA 118.285 -1.366 . . . . 0.0 112.855 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -69.16 -45.36 70.23 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 116.412 -1.756 . . . . 0.0 114.419 172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -59.23 -47.64 84.59 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-O 123.498 1.618 . . . . 0.0 112.405 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.7 p -79.62 -22.34 43.77 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.972 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.81 47.85 78.55 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 125.974 1.75 . . . . 0.0 112.507 -171.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -134.67 152.75 52.0 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 126.574 1.985 . . . . 0.0 112.25 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 89.5 m -95.29 146.34 24.43 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 119.993 -1.692 . . . . 0.0 110.662 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 36' ' ' ILE . 35.5 mt -126.22 129.26 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -171.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.94 157.66 33.8 Favored 'General case' 0 C--O 1.191 -1.987 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 154.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.3 mt -135.04 124.54 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -81.75 154.99 25.7 Favored 'General case' 0 CA--C 1.573 1.864 0 C-N-CA 127.149 2.179 . . . . 0.0 109.958 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -80.63 -13.2 59.24 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -79.16 -13.85 59.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.644 2.378 . . . . 0.0 111.477 172.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 25' ' ' ILE . . . 113.13 -3.26 25.45 Favored Glycine 0 N--CA 1.491 2.331 0 CA-C-O 122.624 1.125 . . . . 0.0 114.436 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -83.19 108.43 16.43 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 123.838 1.78 . . . . 0.0 112.172 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.1 t -90.83 127.66 43.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-O 122.967 1.365 . . . . 0.0 111.492 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -115.67 105.56 12.89 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.206 -0.934 . . . . 0.0 108.709 -169.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.4 mm -88.09 129.13 39.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 O-C-N 120.966 -1.084 . . . . 0.0 111.706 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 46' ' ' THR . . . -113.96 121.77 44.93 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 118.488 -1.285 . . . . 0.0 111.315 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . . . -139.42 156.18 47.13 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 124.309 1.006 . . . . 0.0 111.336 -177.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -72.89 -31.9 65.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 118.413 -2.679 . . . . 0.0 112.347 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -121.65 148.97 43.88 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 123.233 1.492 . . . . 0.0 109.419 -167.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.5 -48.04 81.77 Favored Glycine 0 C--O 1.197 -2.192 0 CA-C-O 116.762 -2.132 . . . . 0.0 113.002 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.8 -41.88 98.31 Favored 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 119.378 1.589 . . . . 0.0 110.956 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -60.67 -43.74 97.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 118.157 -2.84 . . . . 0.0 113.249 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . . . -67.18 -36.27 81.42 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.241 -1.537 . . . . 0.0 112.518 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -74.71 -24.13 58.7 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.593 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -72.65 -39.78 66.89 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 118.572 -2.58 . . . . 0.0 112.553 166.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.49 -38.29 90.57 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.928 -1.107 . . . . 0.0 113.298 167.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.7 mm -64.91 -50.37 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 120.684 -1.26 . . . . 0.0 112.267 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -53.85 -42.4 68.5 Favored 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 120.946 -1.096 . . . . 0.0 111.214 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -61.0 -43.49 98.81 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 mt -69.28 -39.57 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.832 0 C-N-CA 118.269 -1.373 . . . . 0.0 113.577 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.18 -39.52 75.49 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 116.692 -1.623 . . . . 0.0 114.411 164.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -61.94 -42.8 99.52 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-N 119.372 0.987 . . . . 0.0 111.211 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mt -65.06 -34.07 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.174 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.665 175.333 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mm . . . . . 0 CA--C 1.563 1.452 0 CA-C-O 123.496 1.617 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -105.28 145.29 30.9 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.698 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 t -69.72 124.97 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 O-C-N 120.645 -1.285 . . . . 0.0 110.522 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.39 19.42 74.14 Favored Glycine 0 C--O 1.211 -1.331 0 C-N-CA 118.606 -1.759 . . . . 0.0 115.883 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -101.42 148.79 24.75 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 167.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 135' ' ' LYS . 8.3 t -93.12 130.8 41.65 Favored 'Isoleucine or valine' 0 C--N 1.367 1.336 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -123.91 138.19 54.51 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.3 m -88.09 105.91 17.8 Favored 'General case' 0 C--N 1.399 2.737 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.694 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.84 178.13 17.78 Favored Glycine 0 C--O 1.207 -1.587 0 C-N-CA 125.269 1.414 . . . . 0.0 112.996 -175.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -126.65 135.17 50.83 Favored 'General case' 0 CA--C 1.582 2.204 0 O-C-N 127.23 2.371 . . . . 0.0 109.427 -171.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 t -67.33 125.12 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 126.486 1.914 . . . . 0.0 112.92 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.7 p -99.53 -42.6 6.85 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 119.301 0.955 . . . . 0.0 112.536 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -165.85 152.63 9.82 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.3 mt -118.31 125.29 74.18 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.747 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.24 175.16 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 126.028 2.08 . . . . 0.0 109.627 -174.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -47.63 -42.17 23.71 Favored 'General case' 0 C--N 1.398 2.695 0 CA-C-N 119.931 1.241 . . . . 0.0 111.222 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -94.52 9.14 39.72 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.774 -1.204 . . . . 0.0 113.423 -171.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.78 -164.31 19.4 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 124.275 2.042 . . . . 0.0 116.669 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.1 125.1 53.41 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 112.539 -1.831 . . . . 0.0 110.129 -166.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -81.63 149.76 28.41 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.2 t -145.25 121.95 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 CA-C-O 121.939 0.876 . . . . 0.0 112.375 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.23 132.91 35.37 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 117.154 -3.466 . . . . 0.0 112.478 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.1 mm -112.62 158.83 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 112.327 -2.215 . . . . 0.0 106.449 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.75 158.69 51.32 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 121.185 -0.947 . . . . 0.0 111.251 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.99 23.94 77.6 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 113.722 -1.239 . . . . 0.0 113.911 -170.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.38 18.06 74.91 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 127.499 2.476 . . . . 0.0 113.609 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -88.6 163.47 15.83 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -148.31 132.44 17.32 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 124.066 1.888 . . . . 0.0 106.591 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.91 177.78 16.88 Favored Glycine 0 CA--C 1.554 2.489 0 O-C-N 119.955 -1.716 . . . . 0.0 114.65 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.91 123.43 30.73 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.704 -1.468 . . . . 0.0 109.213 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.483 HG21 HG13 ' A' ' 149' ' ' ILE . 21.5 t -96.2 116.44 38.11 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.772 0 O-C-N 119.328 -2.108 . . . . 0.0 106.08 159.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -64.84 147.16 53.79 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 126.064 2.103 . . . . 0.0 108.293 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 tp -32.66 -42.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.256 1.427 0 N-CA-C 119.576 3.176 . . . . 0.0 119.576 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.0 p -77.11 -27.14 53.93 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -97.46 7.21 46.94 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.596 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.05 -39.75 81.25 Favored 'Isoleucine or valine' 0 C--N 1.365 1.242 0 C-N-CA 124.57 1.148 . . . . 0.0 111.155 170.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.59 158.02 33.09 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 122.784 1.278 . . . . 0.0 111.502 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.02 -37.5 78.68 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 128.741 2.816 . . . . 0.0 109.089 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -112.62 117.21 31.64 Favored 'General case' 0 N--CA 1.517 2.92 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.286 167.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.11 146.29 54.83 Favored 'General case' 0 C--O 1.199 -1.601 0 C-N-CA 125.7 1.6 . . . . 0.0 114.99 -161.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.438 HG11 ' CG ' ' A' ' 125' ' ' TYR . 33.5 m -97.15 138.9 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 O-C-N 120.504 -1.372 . . . . 0.0 112.75 -172.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -60.22 -39.51 86.87 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -139.2 147.8 42.27 Favored 'General case' 0 C--O 1.248 1.016 0 O-C-N 119.81 -1.806 . . . . 0.0 109.708 160.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.42 -37.2 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 119.191 -1.004 . . . . 0.0 112.672 169.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.2 p -67.75 -20.61 65.25 Favored 'General case' 0 CA--C 1.477 -1.841 1 CA-C-O 111.471 -4.109 . . . . 0.0 112.861 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -84.48 -13.57 51.61 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 124.053 3.115 . . . . 0.0 115.412 171.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.438 ' CG ' HG11 ' A' ' 119' ' ' VAL . 79.7 t80 -99.04 -23.28 15.34 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.583 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.4 mt -135.47 145.92 47.64 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -118.87 163.91 16.21 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.892 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 22.1 mmt -72.55 150.7 42.94 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 120.605 1.548 . . . . 0.0 112.915 172.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.7 -21.51 18.32 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 112.064 -2.335 . . . . 0.0 115.238 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -109.34 134.95 51.18 Favored 'General case' 0 C--N 1.361 1.075 0 O-C-N 125.625 1.427 . . . . 0.0 111.874 -161.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.14 112.93 1.51 Allowed 'General case' 0 C--N 1.388 2.24 0 O-C-N 128.985 3.928 . . . . 0.0 117.942 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 t -116.25 116.27 39.76 Favored Pre-proline 0 C--O 1.247 0.949 0 C-N-CA 127.377 2.271 . . . . 0.0 109.358 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -57.58 125.23 18.11 Favored 'Trans proline' 0 N--CA 1.515 2.743 0 C-N-CA 121.643 1.562 . . . . 0.0 115.661 157.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.93 123.48 15.41 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 78.5 tttt -96.95 146.78 24.64 Favored 'General case' 0 C--N 1.368 1.384 0 CA-C-O 123.984 1.85 . . . . 0.0 107.766 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 78.7 t -81.95 126.63 39.94 Favored 'Isoleucine or valine' 0 C--N 1.374 1.651 0 O-C-N 118.25 -2.782 . . . . 0.0 114.917 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.2 -33.93 15.2 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.847 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -174.95 140.78 0.56 Allowed 'General case' 0 N--CA 1.521 3.115 0 O-C-N 124.626 1.204 . . . . 0.0 109.88 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.19 142.64 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 O-C-N 120.429 -1.419 . . . . 0.0 109.666 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.26 66.5 t0 -142.69 138.52 30.66 Favored 'General case' 0 N--CA 1.411 -2.4 0 O-C-N 124.421 1.076 . . . . 0.0 108.715 -175.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -101.04 5.26 42.94 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-O 114.703 -2.57 . . . . 0.0 107.83 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -117.56 -57.13 2.16 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.28 164.66 33.63 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 119.814 2.686 . . . . 0.0 119.814 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -60.8 127.2 30.44 Favored 'General case' 0 C--N 1.396 2.61 0 O-C-N 117.614 -3.286 . . . . 0.0 114.401 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.7 mm -31.2 137.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 126.451 3.024 . . . . 0.0 114.77 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -94.21 132.21 39.0 Favored 'General case' 0 C--O 1.247 0.964 0 O-C-N 118.225 -2.797 . . . . 0.0 109.894 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.3 mt -136.42 146.65 46.64 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.002 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.9 t -129.9 128.25 41.81 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.154 167.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.483 HG13 HG21 ' A' ' 109' ' ' VAL . 70.4 mt -72.75 -43.64 60.68 Favored 'Isoleucine or valine' 0 C--N 1.384 2.092 0 CA-C-N 111.569 -2.56 . . . . 0.0 106.933 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -73.3 -30.02 63.1 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 118.975 -2.328 . . . . 0.0 111.899 -170.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -15.02 62.91 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.092 -1.63 . . . . 0.0 113.118 174.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.314 . . -106.86 14.55 26.5 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.106 -168.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.365 0 CA-C-N 120.15 1.341 . . . . 0.0 111.087 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.2 mm . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.318 0.58 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -93.42 119.8 32.95 Favored 'General case' 0 C--O 1.191 -2.001 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.402 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.4 m -118.63 111.77 18.98 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 100.956 -3.72 . . . . 0.0 100.956 -163.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.0 mm -116.39 135.73 55.68 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 CA-C-O 116.01 -1.948 . . . . 0.0 110.514 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -95.54 123.35 39.04 Favored 'General case' 0 CA--C 1.576 1.962 0 O-C-N 124.928 1.393 . . . . 0.0 111.878 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.9 pt -131.43 161.66 40.75 Favored 'Isoleucine or valine' 0 C--O 1.259 1.589 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 -173.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -48.56 120.88 9.24 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.65 -23.93 8.83 Favored 'Trans proline' 0 N--CA 1.516 2.825 0 N-CA-C 118.131 2.32 . . . . 0.0 118.131 171.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.82 -30.04 63.72 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 116.766 -3.709 . . . . 0.0 111.692 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -91.74 -0.28 57.54 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -167.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.9 mm -62.35 -44.91 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.431 1.892 . . . . 0.0 109.539 -172.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -60.84 -38.91 87.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.674 2.39 . . . . 0.0 111.605 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -73.77 -40.69 63.28 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 119.228 -2.17 . . . . 0.0 112.794 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.39 -36.3 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.296 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.91 -43.13 89.59 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 124.335 1.054 . . . . 0.0 110.248 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 79.94 156.75 12.53 Favored Glycine 1 CA--C 1.584 4.383 0 CA-C-O 123.846 1.803 . . . . 0.0 116.535 -172.106 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -71.74 132.69 44.87 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-O 122.694 1.235 . . . . 0.0 108.596 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.91 20.03 24.67 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 118.804 2.282 . . . . 0.0 118.804 -168.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.99 16.38 74.98 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.229 -1.317 . . . . 0.0 111.791 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.3 t -70.62 -41.9 71.64 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 118.17 2.655 . . . . 0.0 118.17 -169.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.533 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 21.4 t -65.48 -44.3 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 CA-C-N 120.441 1.473 . . . . 0.0 114.135 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -61.83 -39.38 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.718 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -64.64 -44.46 90.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.091 -1.631 . . . . 0.0 115.283 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.97 97.57 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.44 -39.87 92.59 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 120.881 -1.137 . . . . 0.0 113.049 168.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 m -47.81 -55.55 9.44 Favored 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 125.862 1.665 . . . . 0.0 112.484 167.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.86 -33.45 72.29 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -57.84 -46.32 84.93 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 126.321 1.849 . . . . 0.0 112.101 166.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.3 p -97.51 -18.69 18.85 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 117.354 -1.738 . . . . 0.0 111.422 -165.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.77 35.77 73.85 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 124.156 0.884 . . . . 0.0 112.838 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.52 152.33 32.8 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 117.811 -1.555 . . . . 0.0 107.729 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 m -66.42 131.01 45.13 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.048 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 mt -132.11 123.0 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.923 174.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -131.37 141.52 49.9 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 tt -127.55 155.23 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -116.19 143.02 46.06 Favored 'General case' 0 C--N 1.38 1.906 0 O-C-N 117.403 -3.311 . . . . 0.0 103.389 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -62.94 -12.42 25.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -87.52 0.27 55.82 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-N 119.21 0.914 . . . . 0.0 113.441 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.67 27.15 7.26 Favored Glycine 0 CA--C 1.478 -2.245 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 168.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.2 m -107.02 110.46 22.6 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.79 142.66 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 118.853 0.751 . . . . 0.0 109.575 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -125.83 137.24 53.76 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.328 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.6 mt -121.06 119.58 59.73 Favored 'Isoleucine or valine' 0 C--N 1.366 1.307 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . 0.279 . . -87.6 118.55 27.16 Favored 'General case' 0 N--CA 1.403 -2.782 0 O-C-N 118.113 -2.867 . . . . 0.0 110.98 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.42 151.51 17.25 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -98.69 -39.94 8.42 Favored 'General case' 0 CA--C 1.484 -1.585 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.233 169.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.52 124.78 25.04 Favored 'General case' 0 N--CA 1.415 -2.211 0 O-C-N 126.02 2.075 . . . . 0.0 109.374 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.58 -25.77 64.61 Favored Glycine 0 C--N 1.356 1.652 0 O-C-N 120.452 -1.405 . . . . 0.0 116.528 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -66.4 -34.87 78.93 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 113.007 0.744 . . . . 0.0 113.007 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -63.26 -44.87 93.9 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 167.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.91 77.93 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -64.47 -50.79 66.1 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 164.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -57.73 -41.43 81.81 Favored 'General case' 0 N--CA 1.529 3.479 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.99 -44.33 87.11 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.83 -39.82 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.351 -0.94 . . . . 0.0 113.209 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -65.14 -41.84 94.38 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 121.552 1.978 . . . . 0.0 110.315 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -60.85 -38.19 84.65 Favored 'General case' 0 CA--C 1.584 2.251 1 O-C-N 116.198 -4.064 . . . . 0.0 115.593 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.79 -44.04 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 119.917 -1.739 . . . . 0.0 110.264 172.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -54.85 -41.12 70.37 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-O 115.527 -2.178 . . . . 0.0 114.776 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -63.82 -41.47 97.86 Favored 'General case' 0 C--N 1.38 1.903 0 CA-C-N 122.225 2.284 . . . . 0.0 115.287 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.7 mt -69.08 -39.8 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 122.217 2.281 . . . . 0.0 114.681 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 N--CA 1.499 2.0 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 178.849 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.8 mm . . . . . 0 N--CA 1.433 -1.281 0 CA-C-O 124.119 1.914 . . . . 0.0 113.759 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -84.01 123.8 30.38 Favored 'General case' 0 C--O 1.188 -2.15 0 CA-C-N 111.209 -2.723 . . . . 0.0 117.87 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.73 122.49 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.862 0 C-N-CA 126.311 1.844 . . . . 0.0 106.858 173.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.07 8.03 59.25 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 112.808 -1.997 . . . . 0.0 113.224 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -96.75 164.22 12.67 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 169.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.2 t -102.97 136.47 35.35 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.51 158.75 21.21 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -98.37 124.41 43.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.361 1.077 . . . . 0.0 108.447 167.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.97 -174.05 13.48 Favored Glycine 0 C--N 1.347 1.139 0 O-C-N 120.241 -1.537 . . . . 0.0 112.188 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -131.39 134.94 46.77 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.92 119.77 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 124.176 0.991 . . . . 0.0 109.072 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -84.86 -22.39 29.43 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 119.975 -1.703 . . . . 0.0 114.668 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.57 132.79 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.366 -169.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.6 mt -108.96 128.31 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -114.68 173.79 3.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -53.14 -47.88 68.36 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.395 -1.44 . . . . 0.0 113.493 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -104.08 17.89 23.17 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 120.045 -1.659 . . . . 0.0 113.618 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.78 -176.41 47.5 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 118.27 -1.919 . . . . 0.0 115.485 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.83 117.74 9.38 Favored 'General case' 0 C--N 1.373 1.618 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -75.58 137.72 40.98 Favored 'General case' 0 C--N 1.372 1.578 0 O-C-N 125.559 1.787 . . . . 0.0 111.46 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.4 t -134.25 132.57 55.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -171.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.42 136.41 37.9 Favored 'General case' 0 C--N 1.363 1.171 0 CA-C-O 122.702 1.239 . . . . 0.0 108.753 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.9 pt -139.76 160.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 CA-C-O 117.448 -1.263 . . . . 0.0 111.15 -168.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.17 138.01 0.54 Allowed Glycine 0 CA--C 1.562 2.992 0 N-CA-C 122.391 3.717 . . . . 0.0 122.391 -166.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.92 18.58 62.99 Favored Glycine 0 CA--C 1.483 -1.938 0 CA-C-O 116.189 -2.451 . . . . 0.0 116.827 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.59 33.82 41.69 Favored Glycine 0 CA--C 1.544 1.888 0 CA-C-N 120.371 2.085 . . . . 0.0 117.5 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -114.52 151.62 33.03 Favored 'General case' 0 N--CA 1.515 2.781 0 C-N-CA 124.222 1.009 . . . . 0.0 112.544 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -143.79 123.34 13.23 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 113.3 -1.773 . . . . 0.0 106.219 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -120.85 174.66 15.85 Favored Glycine 0 C--N 1.364 2.125 0 O-C-N 126.748 2.53 . . . . 0.0 113.003 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.7 tp -128.98 126.46 39.62 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 112.587 -1.807 . . . . 0.0 111.835 -166.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.3 t -95.59 116.66 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 N-CA-C 102.329 -3.212 . . . . 0.0 102.329 173.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -66.63 151.74 46.74 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 120.352 -1.467 . . . . 0.0 111.462 171.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.333 14.2 tt -39.07 -34.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.563 0 N-CA-C 120.634 3.568 . . . . 0.0 120.634 172.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.5 m -69.63 -18.87 63.62 Favored 'General case' 0 N--CA 1.534 3.725 0 O-C-N 125.758 1.911 . . . . 0.0 113.446 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -120.24 6.83 10.71 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.718 0.807 . . . . 0.0 110.817 -160.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.9 mm -74.19 -42.04 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 170.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.05 167.75 21.34 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 119.98 -1.7 . . . . 0.0 112.427 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.316 53.6 p30 -41.6 -67.0 0.29 Allowed 'General case' 0 C--N 1.363 1.161 0 O-C-N 128.584 3.678 . . . . 0.0 118.081 173.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . 0.257 66.6 mttt -99.71 164.96 11.83 Favored 'General case' 0 CA--C 1.582 2.21 0 C-N-CA 129.408 3.083 . . . . 0.0 106.091 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -59.05 140.56 55.65 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.1 t -102.71 136.57 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 125.057 1.473 . . . . 0.0 110.228 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -92.25 -48.62 6.59 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.697 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -143.99 127.97 17.46 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.1 t -72.33 -24.22 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 123.889 1.804 . . . . 0.0 113.129 -164.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 66.8 p -63.62 -26.83 68.86 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 126.691 1.996 . . . . 0.0 112.721 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -63.89 -25.59 68.22 Favored 'General case' 0 C--O 1.261 1.688 0 O-C-N 119.326 -2.109 . . . . 0.0 115.306 168.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -96.35 -46.49 6.38 Favored 'General case' 0 C--N 1.371 1.53 0 O-C-N 126.725 2.515 . . . . 0.0 114.47 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.2 mt -114.67 135.62 53.96 Favored 'General case' 0 N--CA 1.434 -1.256 0 O-C-N 125.687 1.867 . . . . 0.0 108.536 -166.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -105.94 141.62 37.04 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.8 ttp -63.95 137.19 57.9 Favored 'General case' 0 C--O 1.203 -1.362 0 O-C-N 126.328 2.267 . . . . 0.0 114.063 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.01 -24.52 7.84 Favored Glycine 0 N--CA 1.428 -1.858 0 CA-C-O 116.898 -2.057 . . . . 0.0 115.731 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -72.01 163.91 27.05 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.45 134.77 37.31 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.69 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.6 m -139.85 141.21 26.7 Favored Pre-proline 0 C--N 1.369 1.419 0 O-C-N 118.753 -2.467 . . . . 0.0 112.042 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.06 127.77 10.9 Favored 'Trans proline' 0 C--N 1.286 -2.739 0 C-N-CA 121.106 1.204 . . . . 0.0 111.707 165.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.1 m -128.33 128.43 68.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -91.61 132.68 36.16 Favored 'General case' 0 C--N 1.373 1.602 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.701 165.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.488 ' HA ' HD23 ' A' ' 147' ' ' LEU . 46.4 t -75.7 104.45 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.667 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.11 -42.65 98.92 Favored 'General case' 0 C--N 1.39 2.327 0 C-N-CA 127.048 2.139 . . . . 0.0 112.894 168.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -165.56 140.69 4.98 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 123.939 0.775 . . . . 0.0 112.298 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.9 t -106.88 116.0 49.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 156.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.251 0.3 OUTLIER -80.55 171.55 14.89 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 123.768 1.747 . . . . 0.0 113.698 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -64.34 -33.82 76.72 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 119.066 -2.271 . . . . 0.0 112.617 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -71.11 -37.74 72.36 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-O 116.757 -1.592 . . . . 0.0 110.02 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.77 9.22 1.78 Allowed Glycine 0 C--N 1.359 1.834 0 CA-C-N 122.101 2.228 . . . . 0.0 114.736 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -95.7 134.02 39.11 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -163.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.4 mt -105.54 108.88 26.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 O-C-N 121.412 -0.805 . . . . 0.0 110.333 -167.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -85.9 136.55 33.24 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 136' ' ' VAL . 92.4 mt -127.68 163.06 25.1 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 126.077 2.111 . . . . 0.0 111.332 -170.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 42.9 t -148.9 134.55 18.73 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.27 -30.51 2.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.45 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -61.1 -40.97 95.74 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.765 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.4 -14.8 60.91 Favored 'General case' 0 CA--C 1.562 1.419 0 O-C-N 125.117 1.511 . . . . 0.0 110.232 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -96.61 -14.94 21.82 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 CA--C 1.488 -1.406 0 O-C-N 126.978 2.674 . . . . 0.0 111.703 161.348 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 122.118 0.961 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -75.96 135.79 40.04 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-O 126.027 2.823 . . . . 0.0 114.663 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.466 HG22 ' HG2' ' A' ' 56' ' ' LYS . 43.5 p -141.67 154.97 45.69 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 112.45 -2.159 . . . . 0.0 111.915 -176.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 57' ' ' ILE . 6.7 mt -130.3 128.4 64.04 Favored 'Isoleucine or valine' 0 C--N 1.366 1.315 0 O-C-N 126.753 2.533 . . . . 0.0 107.716 172.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -77.69 126.22 30.54 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.0 mm -106.18 133.97 49.1 Favored 'Isoleucine or valine' 0 C--N 1.366 1.291 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -63.39 140.07 97.67 Favored Pre-proline 0 N--CA 1.485 1.321 0 CA-C-O 117.165 -1.397 . . . . 0.0 110.178 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -44.89 -45.71 13.59 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.622 2.881 . . . . 0.0 116.472 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -73.98 -21.29 60.06 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 128.04 3.338 . . . . 0.0 106.536 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -101.47 -4.65 26.43 Favored 'General case' 0 C--N 1.387 2.227 0 O-C-N 119.737 -1.852 . . . . 0.0 113.839 -170.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.4 mt -59.25 -42.27 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 117.23 -1.367 . . . . 0.0 114.577 168.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -58.34 -40.37 81.95 Favored 'General case' 0 C--O 1.267 1.999 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 170.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -65.88 -35.57 81.0 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 117.56 -1.209 . . . . 0.0 112.432 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.2 t -70.05 -44.9 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 123.867 0.73 . . . . 0.0 111.679 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.0 mm -85.85 -38.37 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 122.079 2.218 . . . . 0.0 112.487 -172.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.48 154.21 16.97 Favored Glycine 0 CA--C 1.474 -2.521 0 CA-C-N 120.684 1.584 . . . . 0.0 115.817 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -70.53 130.6 42.29 Favored 'General case' 0 N--CA 1.419 -1.987 0 O-C-N 119.699 -2.059 . . . . 0.0 111.026 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.74 10.07 60.29 Favored Glycine 0 N--CA 1.481 1.636 0 CA-C-O 115.373 -2.904 . . . . 0.0 113.507 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.14 22.8 67.46 Favored Glycine 0 CA--C 1.563 3.077 0 O-C-N 127.163 2.331 . . . . 0.0 112.048 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.0 p -55.29 -49.31 72.45 Favored 'General case' 0 C--O 1.261 1.681 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.5 t -71.29 -43.3 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.441 HD12 ' HB2' ' A' ' 39' ' ' LEU . 10.4 tp -68.56 -30.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.002 -1.686 . . . . 0.0 113.417 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.8 mtm-85 -63.02 -39.1 93.75 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 122.375 1.083 . . . . 0.0 110.875 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.93 98.25 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 119.874 -1.766 . . . . 0.0 114.324 166.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' HB2' HD12 ' A' ' 36' ' ' ILE . 36.3 mt -67.22 -38.82 85.91 Favored 'General case' 0 C--O 1.188 -2.134 0 O-C-N 118.338 -2.727 . . . . 0.0 109.714 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.281 15.3 t -59.46 -39.73 84.6 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 114.282 -2.77 . . . . 0.0 114.185 165.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -69.96 -38.92 76.25 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 122.827 2.558 . . . . 0.0 115.669 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -69.36 -43.13 74.24 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 126.787 2.554 . . . . 0.0 111.058 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.7 p -83.7 -25.14 30.89 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.1 30.75 54.76 Favored Glycine 0 C--N 1.318 -0.42 0 CA-C-O 117.192 -1.893 . . . . 0.0 110.201 173.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 t -152.63 162.21 41.54 Favored 'General case' 0 C--N 1.396 2.621 0 C-N-CA 128.68 2.792 . . . . 0.0 106.034 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.4 m -73.83 124.09 25.43 Favored 'General case' 0 C--N 1.371 1.539 0 C-N-CA 126.134 1.774 . . . . 0.0 113.922 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.1 mm -112.69 135.01 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 112.943 -1.935 . . . . 0.0 108.768 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -132.96 158.31 42.98 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mm -109.45 132.36 57.8 Favored 'Isoleucine or valine' 0 C--N 1.368 1.387 0 O-C-N 119.691 -1.88 . . . . 0.0 107.959 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -115.5 169.76 8.93 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.06 139.59 0.67 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 124.396 2.046 . . . . 0.0 113.731 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.317 28.2 m-20 67.51 38.34 3.16 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 113.244 -1.798 . . . . 0.0 113.0 173.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.53 41.1 77.55 Favored Glycine 0 N--CA 1.422 -2.276 0 CA-C-O 115.989 -2.561 . . . . 0.0 117.357 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.0 m -103.84 108.82 20.31 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 120.189 1.994 . . . . 0.0 111.646 -169.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -73.43 127.59 35.45 Favored 'Isoleucine or valine' 0 C--N 1.382 2.02 0 O-C-N 123.632 0.582 . . . . 0.0 111.303 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HG2' HG22 ' A' ' 17' ' ' THR . 38.5 mtmt -119.41 137.16 53.93 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 124.584 2.135 . . . . 0.0 111.21 173.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 18' ' ' ILE . 43.8 mt -104.33 112.48 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 113.069 -1.878 . . . . 0.0 109.425 -172.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.63 -47.48 78.42 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 116.911 -1.518 . . . . 0.0 112.969 -173.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.8 138.04 53.86 Favored 'General case' 0 C--N 1.369 1.44 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.0 p -95.54 -0.57 51.91 Favored 'General case' 0 C--N 1.369 1.426 0 O-C-N 120.185 -1.572 . . . . 0.0 114.07 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -55.47 151.94 9.56 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 126.37 2.294 . . . . 0.0 114.827 168.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.29 -48.32 5.71 Favored Glycine 0 N--CA 1.478 1.487 0 O-C-N 120.596 -1.315 . . . . 0.0 112.108 -172.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.17 -26.44 63.91 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.22 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -65.16 -41.53 94.59 Favored 'General case' 0 C--N 1.386 2.171 0 C-N-CA 123.42 0.688 . . . . 0.0 111.414 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.49 67.58 Favored 'General case' 0 C--O 1.252 1.224 0 O-C-N 124.045 0.841 . . . . 0.0 110.561 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -63.29 -40.71 98.12 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.41 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -68.25 -45.81 72.17 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 121.124 1.784 . . . . 0.0 110.564 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.91 87.32 Favored 'General case' 0 C--O 1.258 1.532 0 O-C-N 124.634 1.209 . . . . 0.0 112.302 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.256 15.0 tt -70.71 -31.56 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.372 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -61.28 -42.95 99.5 Favored 'General case' 0 CA--C 1.574 1.903 0 CA-C-N 121.043 1.747 . . . . 0.0 114.865 171.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -60.53 -47.19 87.26 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.4 mm -56.47 -38.66 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 O-C-N 120.457 -1.402 . . . . 0.0 112.722 170.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.17 -53.91 52.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.84 1.337 . . . . 0.0 113.113 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -59.58 -37.2 77.87 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.911 1.285 . . . . 0.0 114.154 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.9 mt -69.45 -36.07 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m . . . . . 0 N--CA 1.478 0.963 0 O-C-N 124.925 1.391 . . . . 0.0 109.137 179.191 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mm . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -91.64 135.19 34.06 Favored 'General case' 0 C--N 1.374 1.656 0 O-C-N 119.928 -1.733 . . . . 0.0 112.676 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.8 t -73.5 140.31 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 O-C-N 127.171 2.795 . . . . 0.0 113.589 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.05 -8.43 57.48 Favored Glycine 0 C--N 1.387 3.374 0 C-N-CA 126.276 1.894 . . . . 0.0 114.806 -171.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -89.83 149.37 22.7 Favored 'General case' 0 C--N 1.365 1.269 0 O-C-N 121.234 -1.157 . . . . 0.0 109.537 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.46 121.78 58.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.39 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -111.42 166.46 11.1 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 53.0 m -112.79 134.53 54.27 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.09 168.32 23.75 Favored Glycine 0 CA--C 1.475 -2.462 0 C-N-CA 117.547 -2.263 . . . . 0.0 108.648 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -118.41 135.37 54.38 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 113.242 -1.479 . . . . 0.0 113.631 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.3 t -69.3 135.82 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.233 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.759 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.9 p -128.4 -18.05 4.09 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.909 -1.119 . . . . 0.0 108.249 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -154.42 156.88 37.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.679 -1.888 . . . . 0.0 108.249 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 mm -123.88 135.32 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 CA-C-O 123.653 1.692 . . . . 0.0 111.136 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.9 m -126.7 168.43 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.694 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.61 -46.16 48.91 Favored 'General case' 0 C--O 1.179 -2.618 0 C-N-CA 123.899 0.88 . . . . 0.0 111.976 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -107.44 17.63 22.53 Favored 'General case' 0 N--CA 1.514 2.73 0 C-N-CA 125.898 1.679 . . . . 0.0 114.622 -169.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.93 -163.32 33.66 Favored Glycine 0 C--N 1.363 2.05 0 O-C-N 118.394 -2.691 . . . . 0.0 108.977 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.76 165.5 30.35 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 170.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -107.88 127.27 53.59 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 126.718 2.511 . . . . 0.0 111.867 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.6 t -122.45 126.22 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 CA-C-N 112.593 -2.094 . . . . 0.0 108.925 -166.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.8 109.9 21.77 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 126.157 2.161 . . . . 0.0 110.316 -171.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.7 pt -105.35 161.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.203 0 C-N-CA 126.085 1.754 . . . . 0.0 111.916 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.36 136.75 7.0 Favored Glycine 0 C--N 1.36 1.894 1 N-CA-C 124.032 4.373 . . . . 0.0 124.032 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.66 4.0 39.99 Favored Glycine 0 C--N 1.306 -1.1 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.84 23.99 56.53 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -107.28 148.54 28.85 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.981 1.391 . . . . 0.0 112.226 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -127.37 127.46 44.25 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 125.698 1.874 . . . . 0.0 110.782 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -119.38 155.93 15.93 Favored Glycine 0 CA--C 1.556 2.645 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.3 tp -90.47 118.36 29.88 Favored 'General case' 0 N--CA 1.518 2.972 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.27 107.67 20.36 Favored 'Isoleucine or valine' 0 C--N 1.396 2.62 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -68.88 162.41 26.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 118.299 -2.751 . . . . 0.0 116.872 172.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.2 tt -61.83 -37.64 78.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -59.51 -19.6 49.33 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 126.804 2.565 . . . . 0.0 116.345 167.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -106.15 9.78 32.17 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.499 -1.228 . . . . 0.0 112.588 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.9 mt -88.38 -49.42 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 119.087 0.858 . . . . 0.0 109.856 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.12 157.57 43.65 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 116.009 -1.948 . . . . 0.0 107.036 -172.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -71.46 -19.22 62.25 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -95.06 134.57 37.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.816 2.046 . . . . 0.0 105.892 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.19 116.44 1.86 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.66 120.01 35.54 Favored 'Isoleucine or valine' 0 C--O 1.262 1.724 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.34 -40.9 90.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 126.343 2.277 . . . . 0.0 111.808 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -157.52 151.69 24.67 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.2 t -63.12 -36.81 77.45 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 0 CA-C-O 116.727 -1.606 . . . . 0.0 113.15 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.59 -25.2 16.33 Favored 'General case' 0 N--CA 1.513 2.692 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -69.04 -19.85 64.11 Favored 'General case' 0 CA--C 1.575 1.918 0 C-N-CA 125.354 1.462 . . . . 0.0 113.872 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -123.48 -37.0 2.71 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.201 -1.562 . . . . 0.0 112.485 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.3 mt -130.23 150.94 51.24 Favored 'General case' 0 CA--C 1.574 1.903 0 CA-C-O 124.293 1.997 . . . . 0.0 115.328 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -159.34 155.98 27.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -172.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -43.95 125.69 4.44 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 122.705 1.241 . . . . 0.0 113.227 165.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.58 -2.72 80.85 Favored Glycine 0 N--CA 1.494 2.556 0 CA-C-N 114.264 -1.335 . . . . 0.0 116.087 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -73.65 128.48 35.61 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.471 171.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -106.52 124.92 50.33 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 124.516 1.135 . . . . 0.0 109.666 168.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.97 151.12 61.55 Favored Pre-proline 0 C--N 1.379 1.856 0 C-N-CA 127.72 2.408 . . . . 0.0 110.982 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -90.81 138.89 2.56 Favored 'Trans proline' 0 CA--C 1.493 -1.565 0 N-CA-C 104.814 -2.802 . . . . 0.0 104.814 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.464 HG21 HD13 ' A' ' 147' ' ' LEU . 6.2 m -136.41 126.77 40.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 110.946 -2.843 . . . . 0.0 109.133 -168.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.9 tttt -100.26 122.18 42.65 Favored 'General case' 0 C--N 1.368 1.397 0 O-C-N 120.222 -1.549 . . . . 0.0 111.395 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.13 118.73 5.66 Favored 'Isoleucine or valine' 0 C--O 1.264 1.856 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.488 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 148' ' ' SER . 63.5 mt -90.68 -50.26 6.01 Favored 'General case' 0 C--O 1.254 1.295 0 CA-C-N 111.888 -2.414 . . . . 0.0 113.613 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -159.78 148.58 17.6 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 116.047 -1.93 . . . . 0.0 107.371 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 145' ' ' ILE . 18.0 t -133.93 120.33 35.5 Favored 'Isoleucine or valine' 0 C--N 1.388 2.271 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.92 146.78 53.28 Favored 'General case' 0 CA--C 1.556 1.205 0 O-C-N 126.028 2.08 . . . . 0.0 111.676 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -46.69 -33.76 4.55 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 167.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -92.73 29.15 1.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.11 1.364 . . . . 0.0 109.656 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.98 59.16 7.8 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 120.041 2.776 . . . . 0.0 120.041 166.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -137.19 136.82 38.52 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.405 HG23 HG22 ' A' ' 139' ' ' VAL . 3.3 mt -121.66 122.68 67.64 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 O-C-N 126.466 2.354 . . . . 0.0 108.892 -158.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -94.19 136.23 34.71 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 134' ' ' VAL . 18.9 mt -124.73 152.35 43.9 Favored 'General case' 0 C--N 1.372 1.557 0 O-C-N 127.408 2.942 . . . . 0.0 111.524 -173.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.54 ' HB2' HD11 ' A' ' 137' ' ' LEU . 38.9 t -140.6 138.9 34.77 Favored 'General case' 0 CA--C 1.484 -1.585 0 O-C-N 120.534 -1.354 . . . . 0.0 109.974 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.65 -34.71 7.55 Favored 'Isoleucine or valine' 0 C--O 1.258 1.512 0 O-C-N 125.86 1.975 . . . . 0.0 110.432 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -77.12 -33.28 56.81 Favored 'General case' 0 C--O 1.198 -1.654 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -168.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -71.34 -30.97 66.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.43 -21.81 35.56 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 119.024 -2.297 . . . . 0.0 109.314 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.506 2.343 0 CA-C-N 121.007 1.73 . . . . 0.0 113.655 171.492 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 tp . . . . . 0 CA--C 1.579 2.093 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -116.03 113.88 23.82 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 162.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.7 m -100.62 106.13 17.59 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -109.3 158.5 9.2 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.212 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.421 -172.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -108.96 140.09 42.93 Favored 'General case' 0 C--N 1.368 1.401 0 O-C-N 119.111 -2.243 . . . . 0.0 109.021 167.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.89 162.27 36.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -64.53 132.22 95.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-O 114.254 -2.784 . . . . 0.0 112.576 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . 0.271 42.6 Cg_exo -48.79 -29.25 14.42 Favored 'Trans proline' 0 N--CA 1.515 2.742 0 N-CA-C 120.204 3.117 . . . . 0.0 120.204 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.2 -7.72 59.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.129 2.171 . . . . 0.0 111.38 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -98.98 7.88 45.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 115.59 -2.148 . . . . 0.0 114.321 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.35 -36.91 78.51 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 CA-C-N 121.25 1.841 . . . . 0.0 110.101 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -58.09 -44.57 87.69 Favored 'General case' 0 N--CA 1.385 -3.7 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 170.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -72.46 -39.19 67.94 Favored 'General case' 0 CA--C 1.484 -1.567 0 O-C-N 126.004 2.065 . . . . 0.0 112.61 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.1 -42.34 91.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.245 0 O-C-N 125.794 1.934 . . . . 0.0 113.802 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.7 mt -72.3 -43.02 65.66 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 O-C-N 119.063 -2.273 . . . . 0.0 113.564 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.416 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 78.49 171.86 39.76 Favored Glycine 0 CA--C 1.56 2.897 0 CA-C-O 121.774 0.652 . . . . 0.0 113.915 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 5.6 mmmm -66.87 110.61 3.38 Favored 'General case' 1 N--CA 1.539 4.004 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 177.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.65 31.37 79.78 Favored Glycine 0 CA--C 1.544 1.845 0 O-C-N 125.036 1.46 . . . . 0.0 110.902 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.13 25.54 73.42 Favored Glycine 0 N--CA 1.509 3.505 0 C-N-CA 128.035 2.731 . . . . 0.0 114.847 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 t -62.43 -47.68 83.03 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-O 116.849 -1.548 . . . . 0.0 113.662 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 76.6 t -71.45 -50.0 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 120.29 1.404 . . . . 0.0 108.836 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -55.3 -36.17 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 121.399 1.908 . . . . 0.0 112.755 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -78.84 -36.03 43.11 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 118.931 -1.108 . . . . 0.0 112.029 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.63 -40.65 84.6 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 117.361 -3.337 . . . . 0.0 108.125 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.1 tp -62.87 -40.26 96.95 Favored 'General case' 0 C--N 1.361 1.107 0 O-C-N 120.689 -1.257 . . . . 0.0 111.67 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.1 m -67.2 -48.76 66.92 Favored 'General case' 0 C--N 1.373 1.602 0 O-C-N 125.27 1.606 . . . . 0.0 112.256 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -63.97 -43.85 94.53 Favored 'General case' 0 C--N 1.381 1.97 0 O-C-N 116.502 -3.874 . . . . 0.0 115.025 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -59.23 -40.73 86.82 Favored 'General case' 0 C--N 1.385 2.121 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.8 p -108.01 -3.03 19.14 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -162.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.65 25.26 75.14 Favored Glycine 0 CA--C 1.552 2.401 0 N-CA-C 118.86 2.304 . . . . 0.0 118.86 -173.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 p -124.32 159.26 30.7 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.624 1.17 . . . . 0.0 113.578 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.0 m -110.53 131.57 54.94 Favored 'General case' 0 C--N 1.399 2.744 0 CA-C-N 119.649 1.113 . . . . 0.0 110.289 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.53 138.8 44.73 Favored 'Isoleucine or valine' 0 C--N 1.37 1.481 0 O-C-N 120.785 -1.197 . . . . 0.0 111.403 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -131.95 157.25 44.54 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.269 6.2 tt -150.67 125.02 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 O-C-N 116.716 -3.74 . . . . 0.0 109.776 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -86.53 154.05 21.38 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 119.318 -2.114 . . . . 0.0 112.53 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -53.0 -32.33 45.95 Favored 'General case' 0 C--N 1.393 2.458 0 C-N-CA 127.194 2.197 . . . . 0.0 113.095 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 p30 -86.57 12.57 10.17 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 119.804 1.183 . . . . 0.0 110.892 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.29 26.51 65.87 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-O 123.22 1.455 . . . . 0.0 114.11 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 m -92.09 108.92 20.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 167.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.27 144.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -131.61 115.05 15.58 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.39 108.68 25.95 Favored 'Isoleucine or valine' 0 C--N 1.376 1.726 0 C-N-CA 125.661 1.585 . . . . 0.0 109.896 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.14 128.93 45.35 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.38 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.88 149.05 28.53 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 104.4 -2.445 . . . . 0.0 104.4 173.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 p -78.37 -27.1 46.81 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.425 1.078 . . . . 0.0 110.388 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.54 136.22 41.74 Favored 'General case' 0 CA--C 1.58 2.1 0 C-N-CA 128.343 2.657 . . . . 0.0 112.167 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.04 -49.49 40.56 Favored Glycine 0 CA--C 1.558 2.769 0 C-N-CA 124.35 0.976 . . . . 0.0 112.576 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.27 -33.69 73.95 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 121.609 2.705 . . . . 0.0 114.201 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -68.52 -45.17 72.98 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 126.331 2.269 . . . . 0.0 110.914 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.58 83.38 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 119.326 -2.109 . . . . 0.0 113.053 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . 0.297 91.9 mttt -54.04 -41.58 68.26 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.473 1.109 . . . . 0.0 113.246 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -62.81 -38.59 91.32 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.95 -35.83 74.81 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 119.042 -2.286 . . . . 0.0 116.313 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.74 -37.24 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 O-C-N 124.676 1.235 . . . . 0.0 109.882 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -67.58 -40.34 84.86 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.46 1.482 . . . . 0.0 113.097 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -68.13 -40.64 82.41 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 120.144 -1.598 . . . . 0.0 110.814 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.04 -41.83 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.526 0 CA-C-O 116.822 -1.561 . . . . 0.0 112.049 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -48.47 -52.12 23.83 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-N 122.676 2.489 . . . . 0.0 115.956 166.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.77 -45.86 90.98 Favored 'General case' 0 CA--C 1.569 1.708 0 O-C-N 127.094 2.746 . . . . 0.0 111.141 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.5 mt -62.71 -40.3 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.941 0.896 . . . . 0.0 110.493 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 123.963 1.84 . . . . 0.0 111.517 -172.571 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -73.86 148.99 41.85 Favored 'General case' 0 CA--C 1.579 2.066 0 CA-C-O 122.449 1.118 . . . . 0.0 112.575 165.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.6 137.27 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 -10.25 73.63 Favored Glycine 0 C--N 1.376 2.776 0 C-N-CA 126.989 2.233 . . . . 0.0 113.783 -174.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -97.93 163.06 12.94 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -172.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.14 139.35 30.65 Favored 'Isoleucine or valine' 0 C--N 1.386 2.196 0 CA-C-O 123.038 1.399 . . . . 0.0 110.612 -175.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -130.87 172.3 12.18 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.377 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 133' ' ' PRO . 86.9 m -133.0 123.36 25.71 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.19 -171.61 12.75 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -120.26 154.94 34.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 125.384 1.285 . . . . 0.0 114.029 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.446 HG21 HD22 ' A' ' 126' ' ' LEU . 45.7 t -85.31 127.75 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-O 123.331 1.538 . . . . 0.0 109.31 -175.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.9 -36.49 6.36 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 111.609 -2.541 . . . . 0.0 112.293 -172.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.4 mtt-85 -150.11 145.89 26.6 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 122.763 1.268 . . . . 0.0 109.894 -170.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -124.26 134.97 65.21 Favored 'Isoleucine or valine' 0 C--N 1.366 1.316 0 CA-C-O 124.434 2.064 . . . . 0.0 110.453 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.69 165.66 18.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.681 0 CA-C-N 111.585 -2.552 . . . . 0.0 107.941 166.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -52.75 -35.44 56.13 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 119.347 3.092 . . . . 0.0 119.347 -163.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -118.3 19.12 13.55 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 124.733 1.213 . . . . 0.0 112.161 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.83 168.64 41.04 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.95 1.54 . . . . 0.0 116.95 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.98 167.3 18.46 Favored 'General case' 0 C--N 1.374 1.656 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -124.02 136.79 54.51 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.455 173.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.17 131.97 72.24 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.397 0 C-N-CA 123.532 0.733 . . . . 0.0 111.21 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.96 121.64 40.12 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.217 1.484 . . . . 0.0 112.511 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.6 pt -115.74 166.97 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 112.043 -2.344 . . . . 0.0 114.484 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -31.51 142.77 0.03 OUTLIER Glycine 0 CA--C 1.57 3.507 0 N-CA-C 122.132 3.613 . . . . 0.0 122.132 172.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.19 25.7 69.87 Favored Glycine 0 N--CA 1.484 1.866 0 O-C-N 120.445 -1.621 . . . . 0.0 114.811 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.91 22.74 65.46 Favored Glycine 0 C--O 1.255 1.467 0 N-CA-C 118.529 2.171 . . . . 0.0 118.529 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -94.49 152.22 18.75 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 122.137 0.97 . . . . 0.0 113.308 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -130.96 151.33 51.49 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 168.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.8 175.29 22.21 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.375 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 139.14 35.65 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.259 1.424 . . . . 0.0 112.289 -174.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.6 t -125.0 106.55 16.65 Favored 'Isoleucine or valine' 0 C--O 1.261 1.665 0 CA-C-O 124.431 2.062 . . . . 0.0 106.996 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -77.59 151.13 34.56 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.328 -1.482 . . . . 0.0 112.85 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.48 -33.11 43.46 Favored 'Isoleucine or valine' 0 C--N 1.391 2.411 0 CA-C-O 115.918 -1.991 . . . . 0.0 114.144 -164.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 95.7 p -56.57 -32.65 65.39 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 124.94 3.518 . . . . 0.0 118.342 164.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -97.91 4.18 49.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 121.063 1.756 . . . . 0.0 113.66 -161.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.2 -39.87 85.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 124.651 1.22 . . . . 0.0 107.776 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -162.97 161.58 25.66 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -69.17 -37.74 78.35 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 127.47 2.308 . . . . 0.0 109.699 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -69.79 142.8 53.12 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 113.316 -1.765 . . . . 0.0 108.194 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -82.71 115.12 21.5 Favored 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -170.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.5 t -100.28 122.85 52.71 Favored 'Isoleucine or valine' 0 C--N 1.385 2.151 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -164.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -107.45 -13.86 14.99 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.625 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.259 18.2 pttp -150.54 140.24 21.7 Favored 'General case' 0 C--O 1.21 -1.023 0 O-C-N 126.973 2.671 . . . . 0.0 106.336 159.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.54 -33.53 49.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 O-C-N 127.112 2.758 . . . . 0.0 112.915 -159.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.3 -36.54 61.32 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 109.895 -3.32 . . . . 0.0 116.713 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -57.02 -37.73 72.13 Favored 'General case' 0 N--CA 1.439 -1.025 0 O-C-N 125.221 1.576 . . . . 0.0 112.74 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -93.54 -42.89 8.98 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 121.68 2.036 . . . . 0.0 114.262 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.446 HD22 HG21 ' A' ' 89' ' ' VAL . 80.8 mt -109.13 123.01 48.51 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.929 0.892 . . . . 0.0 109.867 -163.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -108.63 142.14 39.55 Favored 'General case' 0 C--N 1.363 1.195 0 C-N-CA 126.029 1.731 . . . . 0.0 109.129 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 33.4 mmm -66.66 144.15 56.56 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.179 -169.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 46.93 39.07 10.91 Favored Glycine 0 CA--C 1.54 1.638 0 O-C-N 127.273 2.858 . . . . 0.0 117.505 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -119.75 136.02 54.61 Favored 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 125.549 1.54 . . . . 0.0 111.713 165.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.61 128.91 39.55 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 m -122.54 131.04 24.43 Favored Pre-proline 0 C--O 1.286 3.013 0 CA-C-N 111.173 -2.739 . . . . 0.0 106.032 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 0.4 OUTLIER -63.24 148.49 92.98 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 121.05 1.167 . . . . 0.0 109.464 159.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.6 134.91 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 C-N-CA 124.873 1.269 . . . . 0.0 107.604 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 152' ' ' ALA . 13.7 tppt? -95.82 132.66 40.83 Favored 'General case' 0 N--CA 1.519 2.983 0 C-N-CA 123.154 0.582 . . . . 0.0 110.757 164.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.71 110.69 18.76 Favored 'Isoleucine or valine' 0 C--N 1.374 1.662 0 O-C-N 120.282 -1.511 . . . . 0.0 109.493 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.87 -33.43 59.99 Favored 'General case' 0 C--N 1.373 1.615 0 O-C-N 125.719 1.887 . . . . 0.0 113.381 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -178.47 144.16 0.29 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -168.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.6 t -118.41 126.25 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 O-C-N 125.071 1.482 . . . . 0.0 107.889 161.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.292 0.0 OUTLIER -85.23 173.51 10.33 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 126.118 2.866 . . . . 0.0 113.572 -170.349 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -38.17 59.82 Favored 'General case' 0 CA--C 1.599 2.859 0 CA-C-N 110.873 -2.876 . . . . 0.0 111.293 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -85.62 -27.47 25.42 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.566 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.38 24.72 3.7 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.681 1.134 . . . . 0.0 111.518 170.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -80.9 140.87 35.08 Favored 'General case' 0 C--N 1.373 1.591 0 C-N-CA 126.5 1.92 . . . . 0.0 110.262 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.8 mt -105.12 132.38 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -125.27 119.45 28.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -168.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.7 mt -126.18 161.94 26.54 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 124.458 1.099 . . . . 0.0 111.403 -163.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.4 t -138.88 135.49 34.54 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 54.7 mt -83.28 -38.84 14.8 Favored 'Isoleucine or valine' 0 C--N 1.362 1.112 0 CA-C-O 116.177 -1.868 . . . . 0.0 107.032 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -76.28 -19.14 58.58 Favored 'General case' 0 C--N 1.366 1.299 0 O-C-N 125.684 1.865 . . . . 0.0 108.661 -171.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -81.65 -20.88 38.7 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 119.58 -1.95 . . . . 0.0 112.16 166.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.407 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -73.58 -36.91 65.61 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.411 -2.056 . . . . 0.0 111.025 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.0 p . . . . . 0 N--CA 1.487 1.406 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.218 -175.286 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 mm . . . . . 0 C--O 1.263 1.795 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -119.18 131.53 55.86 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.277 -171.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -112.33 129.47 56.28 Favored 'General case' 0 C--N 1.366 1.311 0 O-C-N 124.763 1.289 . . . . 0.0 113.752 -164.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.9 pt -130.2 170.2 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 O-C-N 125.075 1.485 . . . . 0.0 109.795 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -131.84 141.9 49.56 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.606 -1.237 . . . . 0.0 111.414 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.9 133.54 54.91 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.863 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -59.38 157.98 22.36 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 124.902 1.281 . . . . 0.0 112.645 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -70.49 -37.45 7.4 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.844 2.363 . . . . 0.0 110.45 -166.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -62.13 -46.41 89.13 Favored 'General case' 0 C--N 1.37 1.482 0 C-N-CA 118.307 -1.357 . . . . 0.0 114.366 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -78.26 -20.67 51.19 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 tp -59.37 -34.3 53.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 117.717 -1.593 . . . . 0.0 114.702 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -59.95 -34.0 72.67 Favored 'General case' 0 CA--C 1.557 1.242 0 O-C-N 124.724 1.265 . . . . 0.0 113.589 170.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -68.45 -42.98 78.05 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 122.62 1.2 . . . . 0.0 114.105 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 t -64.11 -40.62 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.756 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 29' ' ' ILE . 24.8 mm -98.6 28.0 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 CA-C-N 119.02 0.827 . . . . 0.0 111.498 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.89 125.44 11.93 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 118.613 2.205 . . . . 0.0 118.613 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.45 7.1 mptt 60.88 51.5 4.65 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.35 45.22 96.39 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 126.29 2.244 . . . . 0.0 114.986 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.0 0.76 67.97 Favored Glycine 0 C--N 1.358 1.774 0 CA-C-N 118.571 1.185 . . . . 0.0 111.493 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -66.47 -34.26 77.53 Favored 'General case' 0 C--O 1.202 -1.436 0 CA-C-N 119.389 1.595 . . . . 0.0 110.865 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.38 -45.59 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 CA-C-O 116.623 -1.656 . . . . 0.0 109.626 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.7 tp -80.52 -31.76 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 125.823 1.952 . . . . 0.0 111.153 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.71 -48.38 79.73 Favored 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 166.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.12 -45.17 82.06 Favored 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 124.426 1.09 . . . . 0.0 111.012 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.7 -37.92 80.16 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.263 33.3 p -64.6 -38.4 90.87 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 171.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -63.58 -47.78 80.07 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 125.008 1.443 . . . . 0.0 111.646 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -67.45 -47.14 71.03 Favored 'General case' 0 CA--C 1.457 -2.611 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.864 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -85.56 -8.41 58.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 127.583 3.052 . . . . 0.0 113.962 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.16 21.33 79.26 Favored Glycine 0 C--N 1.365 2.149 0 CA-C-O 121.819 0.677 . . . . 0.0 113.359 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -134.89 139.65 45.16 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 122.261 -0.552 . . . . 0.0 109.97 -155.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.0 m -78.23 135.27 37.55 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 119.715 1.143 . . . . 0.0 108.975 166.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.4 mt -133.01 118.2 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.244 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -84.52 131.56 34.63 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.6 mm -112.97 112.79 41.94 Favored 'Isoleucine or valine' 0 C--N 1.373 1.627 0 CA-C-N 120.342 1.428 . . . . 0.0 107.945 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -123.06 170.48 10.13 Favored 'General case' 0 C--O 1.201 -1.463 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -36.13 149.31 0.02 OUTLIER 'General case' 0 C--O 1.205 -1.277 1 C-N-CA 131.921 4.088 . . . . 0.0 118.844 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t0 62.39 35.72 14.79 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 124.418 1.087 . . . . 0.0 110.845 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 47.27 28.98 4.79 Favored Glycine 0 C--O 1.205 -1.67 0 CA-C-N 112.224 -2.262 . . . . 0.0 115.723 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.5 m -64.15 125.48 24.64 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.716 -0.873 . . . . 0.0 110.366 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -124.94 138.68 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -129.38 122.04 28.64 Favored 'General case' 0 C--N 1.366 1.314 0 O-C-N 127.596 3.06 . . . . 0.0 108.686 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.5 mm -95.52 130.15 44.64 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 O-C-N 120.22 -1.55 . . . . 0.0 107.838 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.95 117.98 33.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 117.984 -1.486 . . . . 0.0 107.355 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.3 148.67 29.13 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.671 -1.268 . . . . 0.0 110.871 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -69.0 -57.35 5.58 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.232 164.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -99.03 135.31 40.62 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 120.396 -1.44 . . . . 0.0 113.675 -163.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.12 -28.63 73.81 Favored Glycine 0 CA--C 1.506 -0.49 0 O-C-N 120.351 -1.468 . . . . 0.0 115.863 -167.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -57.87 -39.87 78.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.998 -0.707 . . . . 0.0 112.801 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -73.17 -37.9 66.39 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.96 95.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -61.82 -42.9 99.61 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.844 168.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -62.7 -39.3 93.57 Favored 'General case' 0 N--CA 1.52 3.033 0 CA-C-N 121.995 2.18 . . . . 0.0 115.093 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.49 69.03 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 120.365 1.439 . . . . 0.0 110.36 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.88 -44.48 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 122.594 1.188 . . . . 0.0 111.451 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -60.97 -42.39 98.22 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 168.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 21.8 mmm180 -64.63 -39.67 94.11 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.479 1.111 . . . . 0.0 112.231 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 mm -58.75 -40.7 80.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.137 168.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.65 -42.27 86.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.294 1.406 . . . . 0.0 110.917 168.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 71' ' ' ARG . 68.9 mt-10 -58.16 -43.12 87.25 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.9 mm -60.14 -44.39 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 CA-C-O 123.173 1.463 . . . . 0.0 113.808 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 C--N 1.353 0.731 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -177.646 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 mm . . . . . 0 N--CA 1.498 1.963 0 CA-C-O 114.989 -2.434 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -125.09 134.85 52.33 Favored 'General case' 0 C--N 1.384 2.081 0 CA-C-N 121.288 1.858 . . . . 0.0 109.41 168.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.8 t -58.77 136.76 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.942 1.697 . . . . 0.0 111.372 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.59 -34.76 4.67 Favored Glycine 0 CA--C 1.55 2.28 0 O-C-N 120.809 -1.182 . . . . 0.0 113.789 -168.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -68.91 147.81 51.12 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-O 124.425 2.06 . . . . 0.0 113.147 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -89.1 133.3 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.694 0 CA-C-O 124.016 1.865 . . . . 0.0 111.868 169.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -133.13 169.68 16.51 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 126.874 2.07 . . . . 0.0 106.483 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.6 p -120.09 152.22 37.91 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.065 167.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.49 166.27 37.11 Favored Glycine 0 CA--C 1.465 -3.082 0 CA-C-O 123.776 1.765 . . . . 0.0 116.036 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 130' ' ' GLN . 55.6 mttm -106.31 127.76 53.49 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 110.968 -2.616 . . . . 0.0 115.334 -161.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.3 t -56.03 111.29 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.032 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -111.78 -13.44 13.71 Favored 'General case' 0 N--CA 1.525 3.309 0 CA-C-N 114.124 -1.398 . . . . 0.0 114.648 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.46 HH12 ' CD ' ' A' ' 106' ' ' GLU . 78.9 mtm-85 -155.02 153.48 31.04 Favored 'General case' 0 C--O 1.257 1.478 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 168.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.7 mt -132.21 125.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.7 m -138.3 166.83 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.585 -156.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -57.15 -35.23 69.28 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 126.87 2.606 . . . . 0.0 110.86 -165.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -111.74 10.25 20.92 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -174.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.0 -148.67 18.74 Favored Glycine 0 C--O 1.175 -3.534 0 CA-C-N 120.828 1.649 . . . . 0.0 115.83 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.91 157.13 43.9 Favored 'General case' 0 C--O 1.201 -1.457 0 O-C-N 119.489 -2.183 . . . . 0.0 108.88 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.433 ' CE2' HD13 ' A' ' 108' ' ' LEU . 85.3 m-85 -119.76 143.98 47.52 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.54 125.59 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 CA-C-N 111.608 -2.542 . . . . 0.0 108.816 -166.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.01 123.87 31.05 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.6 mm -114.28 142.39 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.725 0 CA-C-N 112.205 -2.271 . . . . 0.0 107.405 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -34.84 138.58 0.21 Allowed Glycine 0 C--N 1.389 3.491 0 C-N-CA 128.001 2.715 . . . . 0.0 114.994 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.06 29.82 68.44 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-O 118.863 -0.965 . . . . 0.0 112.391 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.31 30.65 53.95 Favored Glycine 0 CA--C 1.477 -2.33 0 O-C-N 124.983 1.049 . . . . 0.0 115.413 167.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -106.34 162.14 13.95 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 125.862 1.566 . . . . 0.0 109.671 -170.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.46 ' CD ' HH12 ' A' ' 91' ' ' ARG . 32.7 tt0 -149.32 122.17 8.73 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.498 1.499 . . . . 0.0 108.98 -171.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.89 162.13 15.77 Favored Glycine 0 CA--C 1.481 -2.033 0 CA-C-N 114.395 -1.275 . . . . 0.0 114.667 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.433 HD13 ' CE2' ' A' ' 98' ' ' PHE . 36.0 tp -114.56 126.24 54.7 Favored 'General case' 0 CA--C 1.491 -1.298 0 O-C-N 126.629 2.017 . . . . 0.0 111.343 -166.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.39 119.05 58.03 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 N-CA-C 100.693 -3.818 . . . . 0.0 100.693 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -82.93 169.68 15.76 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 120.725 -1.234 . . . . 0.0 109.254 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.9 tt -77.7 -25.72 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -157.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 81.7 p -92.26 7.03 44.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.416 -2.053 . . . . 0.0 111.259 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -120.33 27.36 8.65 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-O 114.779 -2.534 . . . . 0.0 109.591 -170.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.2 mt -105.03 -49.22 9.26 Favored 'Isoleucine or valine' 0 C--N 1.37 1.48 0 O-C-N 127.014 2.696 . . . . 0.0 109.117 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.22 173.73 11.24 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.333 -1.48 . . . . 0.0 109.031 -163.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -82.13 -53.39 6.12 Favored 'General case' 0 C--O 1.2 -1.509 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -65.75 138.84 58.21 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.695 0.798 . . . . 0.0 110.944 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -53.93 134.29 43.08 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.649 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -119.96 124.6 73.05 Favored 'Isoleucine or valine' 0 C--N 1.368 1.411 0 O-C-N 123.943 0.777 . . . . 0.0 111.851 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -109.18 -18.85 13.52 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 115.908 -1.996 . . . . 0.0 110.709 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -128.58 127.89 43.18 Favored 'General case' 0 C--N 1.381 1.936 0 CA-C-O 123.247 1.498 . . . . 0.0 109.024 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.21 -41.09 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 O-C-N 121.087 -1.008 . . . . 0.0 113.068 -174.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -55.88 -7.38 0.31 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 126.528 2.393 . . . . 0.0 112.481 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -69.5 -35.59 75.67 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.317 1.417 . . . . 0.0 113.871 173.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -115.23 -52.33 2.68 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 128.155 3.409 . . . . 0.0 114.251 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.1 mt -93.34 143.97 25.77 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.129 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.46 154.18 38.43 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 103.169 -2.9 . . . . 0.0 103.169 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 65.7 mmm -66.69 121.86 16.34 Favored 'General case' 0 C--O 1.192 -1.949 0 C-N-CA 127.399 2.28 . . . . 0.0 113.992 -165.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.17 -0.66 78.8 Favored Glycine 1 N--CA 1.518 4.13 0 N-CA-C 118.498 2.159 . . . . 0.0 118.498 -171.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.7 tt0 -57.75 141.09 49.89 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 167.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -87.13 121.48 29.63 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.581 170.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.2 m -113.4 129.33 24.72 Favored Pre-proline 0 C--O 1.215 -0.761 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.41 139.19 18.24 Favored 'Trans proline' 0 C--N 1.266 -3.815 0 N-CA-C 108.616 -1.34 . . . . 0.0 108.616 162.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.57 148.43 18.21 Favored 'Isoleucine or valine' 0 C--N 1.363 1.194 0 CA-C-O 123.169 1.461 . . . . 0.0 113.501 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -104.69 129.08 52.92 Favored 'General case' 0 C--O 1.19 -2.061 0 CA-C-N 111.843 -2.435 . . . . 0.0 111.819 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 81.6 t -82.4 122.27 36.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 125.575 1.797 . . . . 0.0 111.541 -170.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 148' ' ' SER . 3.5 mt -101.09 -33.13 10.26 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 117.601 -1.19 . . . . 0.0 112.227 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -145.23 146.52 31.74 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.42 119.8 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 123.157 1.456 . . . . 0.0 108.854 155.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.16 156.56 21.42 Favored 'General case' 0 C--O 1.254 1.322 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.335 169.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -51.98 -31.95 31.57 Favored 'General case' 0 C--N 1.401 2.845 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.79 13.17 33.28 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 120.427 1.467 . . . . 0.0 114.588 168.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.93 12.76 48.79 Favored Glycine 0 C--N 1.364 2.118 0 N-CA-C 118.068 1.987 . . . . 0.0 118.068 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -78.8 137.14 37.58 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-N 120.549 2.175 . . . . 0.0 109.29 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.8 mt -126.41 129.62 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 117.413 -1.28 . . . . 0.0 112.089 -159.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.09 128.67 51.73 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.622 171.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.6 mt -118.54 162.27 18.65 Favored 'General case' 0 N--CA 1.52 3.05 0 O-C-N 125.068 1.48 . . . . 0.0 114.385 -170.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.407 ' HB2' HD21 ' A' ' 137' ' ' LEU . 35.8 t -129.91 138.78 51.09 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.231 1.013 . . . . 0.0 109.414 168.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.9 mt -99.95 -28.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 167.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -57.85 -42.22 83.99 Favored 'General case' 0 C--N 1.37 1.469 0 O-C-N 119.442 -2.036 . . . . 0.0 111.6 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.33 -42.46 92.9 Favored 'General case' 0 CA--C 1.594 2.655 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.25 . . -61.6 -45.02 95.86 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 120.12 -1.613 . . . . 0.0 111.017 170.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.5 p . . . . . 0 C--O 1.2 -1.539 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.723 -175.412 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.7 mm . . . . . 0 CA--C 1.555 1.166 0 CA-C-O 122.967 1.365 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -135.79 129.36 32.38 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.78 163.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.3 m -111.62 138.4 48.23 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 122.099 0.952 . . . . 0.0 111.876 -172.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt -134.86 130.82 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 113.75 -1.568 . . . . 0.0 107.977 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -82.11 130.11 35.0 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-O 122.506 1.146 . . . . 0.0 111.607 163.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.2 mm -121.41 128.36 75.88 Favored 'Isoleucine or valine' 0 C--N 1.401 2.827 0 O-C-N 120.506 -1.371 . . . . 0.0 109.542 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 5.7 m-20 -56.24 156.85 10.03 Favored Pre-proline 0 C--N 1.371 1.539 0 CA-C-N 119.555 1.07 . . . . 0.0 112.726 -171.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 21' ' ' ASN . 54.5 Cg_exo -66.2 -25.47 50.26 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 N-CA-C 116.757 1.791 . . . . 0.0 116.757 -167.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -84.2 -27.49 27.98 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-O 117.04 -1.457 . . . . 0.0 110.777 172.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -86.64 -26.51 24.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 121.546 1.976 . . . . 0.0 110.109 -169.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 49' ' ' ILE . 10.0 tp -74.85 -19.61 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 O-C-N 124.61 1.194 . . . . 0.0 108.277 173.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.269 35.5 mmtm -64.93 -39.53 93.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.057 -1.027 . . . . 0.0 113.298 168.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.11 -38.6 91.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.865 1.666 . . . . 0.0 113.574 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.03 -33.31 62.47 Favored 'Isoleucine or valine' 0 C--N 1.375 1.706 0 C-N-CA 125.483 1.513 . . . . 0.0 111.352 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.497 ' O ' HG22 ' A' ' 29' ' ' ILE . 47.6 mm -97.57 11.04 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-O 123.178 1.466 . . . . 0.0 111.581 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.37 167.39 13.29 Favored Glycine 0 C--N 1.296 -1.674 0 CA-C-N 111.792 -2.458 . . . . 0.0 115.944 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm 58.3 43.98 19.29 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.208 1.403 . . . . 0.0 113.327 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.3 12.72 81.83 Favored Glycine 0 CA--C 1.558 2.757 0 O-C-N 120.807 -1.183 . . . . 0.0 115.818 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.03 5.26 77.23 Favored Glycine 0 C--N 1.369 2.402 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 -171.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.7 m -63.08 -39.99 96.33 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-O 116.903 -1.522 . . . . 0.0 113.623 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 t -61.44 -47.36 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.309 6.4 tp -62.96 -39.33 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-N 119.427 1.012 . . . . 0.0 111.327 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -64.37 -51.57 62.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.351 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.05 -43.81 82.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 126.352 2.283 . . . . 0.0 115.286 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.91 -50.95 71.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.7 p -64.83 -35.2 80.33 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 120.673 -1.267 . . . . 0.0 112.564 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -72.36 -39.51 68.03 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 125.832 1.957 . . . . 0.0 110.338 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -61.76 -38.51 88.27 Favored 'General case' 0 C--O 1.259 1.555 0 CA-C-O 124.166 1.936 . . . . 0.0 113.003 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.5 p -91.24 -17.06 26.62 Favored 'General case' 0 C--N 1.367 1.335 0 O-C-N 118.663 -2.523 . . . . 0.0 116.363 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.03 28.6 73.73 Favored Glycine 0 CA--C 1.474 -2.484 1 O-C-N 129.254 4.096 . . . . 0.0 112.352 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 t -148.31 159.3 44.13 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 124.305 2.002 . . . . 0.0 107.671 -166.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -83.42 118.0 23.44 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 112.407 -2.179 . . . . 0.0 108.581 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.632 HG23 HD13 ' A' ' 57' ' ' ILE . 16.4 mt -124.08 121.32 61.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -113.22 147.42 37.52 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 125.573 2.606 . . . . 0.0 108.092 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.533 HD12 HD11 ' A' ' 25' ' ' ILE . 16.3 mm -112.09 123.4 67.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 112.014 -2.357 . . . . 0.0 109.227 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -123.88 166.83 14.98 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -165.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.281 81.9 m-20 -47.4 142.49 4.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.024 -1.672 . . . . 0.0 114.196 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.8 t0 54.27 67.3 1.03 Allowed 'General case' 0 C--N 1.35 0.598 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 171.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.53 27.47 26.39 Favored Glycine 0 C--N 1.301 -1.396 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 m -107.39 114.79 29.03 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 49' ' ' ILE . 24.5 t -104.43 141.79 19.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -173.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -129.29 123.39 31.74 Favored 'General case' 0 C--N 1.363 1.19 0 CA-C-O 122.54 1.162 . . . . 0.0 109.498 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.632 HD13 HG23 ' A' ' 47' ' ' ILE . 12.6 mm -86.83 130.03 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.117 167.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.67 51.16 1.86 Allowed 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.87 153.38 21.37 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 119.048 -2.283 . . . . 0.0 114.729 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.7 p -100.04 21.92 12.05 Favored 'General case' 0 C--N 1.381 1.949 0 CA-C-O 115.476 -2.202 . . . . 0.0 111.301 -175.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -151.49 145.58 25.3 Favored 'General case' 0 C--N 1.372 1.585 0 O-C-N 127.244 2.84 . . . . 0.0 110.08 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.1 -33.98 61.87 Favored Glycine 0 N--CA 1.439 -1.128 0 O-C-N 125.248 1.592 . . . . 0.0 114.425 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.31 -45.43 87.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 116.703 -1.618 . . . . 0.0 108.186 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -58.74 -42.07 87.95 Favored 'General case' 0 C--N 1.375 1.681 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.86 98.13 Favored 'General case' 0 C--O 1.272 2.267 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -68.63 -37.41 79.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 125.394 1.684 . . . . 0.0 108.697 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -66.92 -42.86 84.65 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 120.074 -1.641 . . . . 0.0 114.521 170.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.15 -54.38 31.35 Favored 'General case' 0 C--O 1.191 -2.008 0 CA-C-N 121.176 1.807 . . . . 0.0 111.556 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 mt -60.87 -45.14 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 124.46 1.104 . . . . 0.0 110.168 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -56.33 -44.29 79.85 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -63.16 -41.56 99.27 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 120.597 1.544 . . . . 0.0 107.827 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.19 -42.09 85.82 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.971 0 CA-C-O 116.805 -1.569 . . . . 0.0 110.234 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.32 -42.18 90.79 Favored 'General case' 0 N--CA 1.537 3.883 0 CA-C-N 121.734 2.061 . . . . 0.0 111.281 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -69.31 -39.16 78.42 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 126.242 2.214 . . . . 0.0 114.688 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.6 mt -71.61 -32.41 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 168.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-N 120.769 1.622 . . . . 0.0 109.672 177.543 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.7 mm . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 125.039 2.352 . . . . 0.0 115.254 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -115.59 134.55 54.94 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-N 113.028 -1.896 . . . . 0.0 106.379 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.17 139.03 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 O-C-N 128.134 3.396 . . . . 0.0 110.31 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.95 -10.21 48.69 Favored Glycine 0 CA--C 1.551 2.342 0 O-C-N 119.39 -2.069 . . . . 0.0 113.835 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -81.87 159.33 23.73 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-N 119.662 1.731 . . . . 0.0 111.176 167.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.41 140.32 31.36 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -130.83 161.65 31.32 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.9 m -117.25 125.72 51.58 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.99 -169.76 12.41 Favored Glycine 0 N--CA 1.42 -2.412 0 C-N-CA 120.295 -0.955 . . . . 0.0 114.986 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -128.56 143.22 50.92 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 122.937 1.351 . . . . 0.0 114.432 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.3 t -73.76 122.75 27.47 Favored 'Isoleucine or valine' 0 C--N 1.382 2.008 0 O-C-N 118.078 -2.889 . . . . 0.0 115.288 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.12 -25.4 7.63 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 115.929 -1.986 . . . . 0.0 113.785 -170.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 -146.22 151.47 37.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 168.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -123.65 131.44 73.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.04 174.47 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 124.047 1.88 . . . . 0.0 111.324 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -58.62 -37.4 75.8 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 117.565 -1.654 . . . . 0.0 114.518 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -98.41 18.91 15.4 Favored 'General case' 0 C--N 1.374 1.664 0 CA-C-N 120.876 1.671 . . . . 0.0 111.737 -176.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.56 -135.92 6.19 Favored Glycine 0 C--N 1.383 3.182 0 N-CA-C 115.057 0.783 . . . . 0.0 115.057 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.57 160.81 41.09 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 125.649 1.441 . . . . 0.0 114.831 167.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.29 131.48 54.17 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-O 121.884 0.849 . . . . 0.0 111.122 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 72.9 t -110.85 134.3 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.646 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -98.49 127.71 44.54 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 120.221 -1.549 . . . . 0.0 109.395 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.92 150.79 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 CA-C-N 112.883 -1.962 . . . . 0.0 112.188 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.67 154.38 0.62 Allowed Glycine 0 CA--C 1.564 3.128 0 N-CA-C 118.958 2.343 . . . . 0.0 118.958 173.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.56 8.09 24.3 Favored Glycine 0 C--N 1.366 2.214 0 C-N-CA 127.663 2.554 . . . . 0.0 117.57 -168.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.79 22.86 16.95 Favored Glycine 0 C--O 1.256 1.494 0 O-C-N 127.585 2.58 . . . . 0.0 117.219 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.96 128.14 34.19 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 117.256 0.528 . . . . 0.0 110.491 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.0 146.83 35.98 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 123.343 1.544 . . . . 0.0 108.685 169.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -145.24 163.96 28.04 Favored Glycine 0 CA--C 1.48 -2.141 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.06 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.0 tp -110.61 136.4 49.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 124.372 0.689 . . . . 0.0 110.462 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.73 113.73 45.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 CA-C-O 123.824 1.773 . . . . 0.0 108.796 160.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -62.91 150.65 41.47 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 tt -52.89 -24.83 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.3 p -90.32 6.3 43.62 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 125.825 1.65 . . . . 0.0 112.198 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -120.45 5.35 10.66 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 120.16 -1.588 . . . . 0.0 114.072 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 18.5 mm -82.84 -48.56 17.7 Favored 'Isoleucine or valine' 0 C--O 1.283 2.821 0 CA-C-O 123.734 1.73 . . . . 0.0 112.304 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.29 173.84 13.52 Favored 'General case' 0 N--CA 1.406 -2.645 0 O-C-N 116.939 -3.601 . . . . 0.0 107.224 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -66.0 -33.7 76.4 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.2 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -71.56 161.19 31.4 Favored 'General case' 0 C--N 1.365 1.264 0 C-N-CA 124.733 1.213 . . . . 0.0 114.024 -173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -70.63 122.22 19.36 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 124.679 2.181 . . . . 0.0 108.82 167.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.28 146.01 16.8 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.779 0 CA-C-N 112.38 -2.191 . . . . 0.0 110.157 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -119.84 -35.33 3.53 Favored 'General case' 0 C--N 1.369 1.445 0 CA-C-N 120.359 1.436 . . . . 0.0 113.826 160.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -123.17 129.3 51.22 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 122.7 1.238 . . . . 0.0 109.149 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.3 -20.43 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 111.814 -2.448 . . . . 0.0 106.646 -166.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.4 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.39 2.346 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -66.52 -45.33 79.85 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 125.716 1.606 . . . . 0.0 112.921 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -95.06 -17.97 21.42 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.7 mt -126.99 129.45 48.13 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -98.72 156.2 16.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.62 -1.3 . . . . 0.0 110.291 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 51.5 tpp -67.93 133.86 49.83 Favored 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 118.641 -2.537 . . . . 0.0 109.165 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.09 15.91 79.65 Favored Glycine 0 CA--C 1.548 2.132 0 O-C-N 126.061 2.1 . . . . 0.0 112.059 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -65.24 132.42 49.05 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.294 -1.709 . . . . 0.0 113.151 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -85.12 118.55 24.75 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 123.748 1.737 . . . . 0.0 112.957 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.86 125.33 20.23 Favored Pre-proline 0 CA--C 1.582 2.174 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -158.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.65 131.43 24.37 Favored 'Trans proline' 0 N--CA 1.518 2.923 0 O-C-N 117.726 -1.776 . . . . 0.0 111.786 165.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.15 136.82 57.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 CA-C-O 123.061 1.41 . . . . 0.0 110.452 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -105.01 143.42 33.22 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 120.702 -1.249 . . . . 0.0 109.764 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.9 t -86.9 137.48 20.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 122.17 0.986 . . . . 0.0 109.409 -170.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.65 -43.17 3.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 118.944 -2.348 . . . . 0.0 108.558 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -153.12 146.86 25.19 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-O 124.139 1.923 . . . . 0.0 108.205 -166.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.7 p -145.64 123.21 4.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 CA-C-O 124.119 1.914 . . . . 0.0 110.092 171.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' A' ' 146' ' ' ARG . 60.2 m-20 -71.74 175.34 5.79 Favored 'General case' 0 CA--C 1.592 2.593 0 O-C-N 119.826 -1.796 . . . . 0.0 115.207 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -68.51 -16.27 63.83 Favored 'General case' 0 CA--C 1.584 2.274 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.74 19.16 21.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 120.055 -1.653 . . . . 0.0 111.476 167.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.85 16.93 79.21 Favored Glycine 0 C--N 1.362 2.015 0 O-C-N 125.961 2.038 . . . . 0.0 114.468 168.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . 0.332 36.0 mtm180 -69.75 129.31 39.24 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 163.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.4 mt -108.68 141.33 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 119.545 -1.972 . . . . 0.0 110.714 -165.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.458 HH12 ' CG ' ' A' ' 140' ' ' ASP . 0.4 OUTLIER -113.1 150.09 32.6 Favored 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.606 160.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.4 mt -140.33 171.86 13.55 Favored 'General case' 0 C--O 1.258 1.508 0 CA-C-O 124.087 1.898 . . . . 0.0 111.391 -166.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.5 t -154.84 134.49 12.76 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.0 mt -87.96 -17.86 8.4 Favored 'Isoleucine or valine' 0 C--N 1.377 1.777 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -62.57 -50.18 72.34 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 172.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.56 -25.58 63.16 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 122.111 0.958 . . . . 0.0 109.714 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.08 -49.26 68.22 Favored 'General case' 0 C--O 1.257 1.478 0 O-C-N 119.797 -1.814 . . . . 0.0 115.01 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.9 p . . . . . 0 C--O 1.268 2.042 0 CA-C-N 112.138 -2.301 . . . . 0.0 111.214 -173.977 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mm . . . . . 0 CA--C 1.552 1.056 0 CA-C-O 126.28 2.943 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -116.17 138.96 50.82 Favored 'General case' 0 CA--C 1.59 2.486 0 CA-C-N 109.829 -3.35 . . . . 0.0 104.877 169.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 t -136.66 164.51 28.07 Favored 'General case' 0 N--CA 1.532 3.635 0 CA-C-O 117.627 -1.178 . . . . 0.0 112.252 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 tp -172.02 145.7 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.071 0 O-C-N 126.793 2.558 . . . . 0.0 105.228 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -128.58 130.63 47.64 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 124.8 1.24 . . . . 0.0 109.535 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.6 pt -133.33 162.99 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.834 0 O-C-N 126.513 2.383 . . . . 0.0 108.637 -166.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -43.95 141.96 2.2 Favored Pre-proline 0 N--CA 1.524 3.26 0 CA-C-N 120.024 1.284 . . . . 0.0 112.376 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -59.94 -34.33 95.25 Favored 'Trans proline' 0 CA--C 1.474 -2.475 0 C-N-CA 122.866 2.378 . . . . 0.0 112.567 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -65.2 -28.16 69.19 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-N 121.816 2.098 . . . . 0.0 113.425 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.2 -22.07 64.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.01 -43.59 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 C-N-CA 124.969 1.307 . . . . 0.0 110.649 171.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -51.87 -43.65 63.35 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 170.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -79.81 -22.13 43.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.71 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.8 t -70.61 -54.08 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-O 116.263 -1.827 . . . . 0.0 110.084 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -58.99 -42.49 86.34 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 CA-C-N 120.098 1.317 . . . . 0.0 109.022 173.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.1 175.97 49.14 Favored Glycine 0 C--N 1.374 2.69 0 O-C-N 119.425 -2.047 . . . . 0.0 113.888 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -74.78 119.2 18.64 Favored 'General case' 0 C--N 1.387 2.204 0 CA-C-N 119.704 1.752 . . . . 0.0 106.804 -171.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.49 4.48 87.36 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.43 17.64 70.73 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 118.628 -1.748 . . . . 0.0 115.962 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.1 p -69.3 -37.29 77.72 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 119.972 3.323 . . . . 0.0 119.972 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.6 t -74.28 -39.11 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 O-C-N 124.696 1.248 . . . . 0.0 112.5 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.287 17.0 tt -63.54 -41.21 91.87 Favored 'Isoleucine or valine' 0 C--O 1.262 1.738 0 O-C-N 127.16 2.787 . . . . 0.0 112.711 173.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -64.15 -37.5 87.67 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 125.666 1.854 . . . . 0.0 111.609 169.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.24 79.92 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.08 -42.32 98.29 Favored 'General case' 0 C--O 1.196 -1.744 0 O-C-N 118.328 -2.732 . . . . 0.0 108.558 170.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.1 m -59.26 -48.81 80.24 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.049 0.94 . . . . 0.0 111.024 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -73.92 -35.81 64.64 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 116.316 -2.153 . . . . 0.0 110.024 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -73.11 -41.55 63.9 Favored 'General case' 0 C--O 1.258 1.542 0 CA-C-N 122.314 2.325 . . . . 0.0 111.54 -175.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.7 p -81.85 -24.95 35.5 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 118.377 -2.702 . . . . 0.0 113.2 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.6 35.09 59.45 Favored Glycine 0 C--N 1.394 3.77 0 CA-C-N 122.061 2.209 . . . . 0.0 116.495 -169.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 p -129.55 177.37 7.26 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.127 1.771 . . . . 0.0 107.383 -165.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.2 m -121.68 114.77 21.6 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 123.121 1.439 . . . . 0.0 107.136 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mt -101.43 128.24 53.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 112.622 -2.081 . . . . 0.0 112.56 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -135.44 151.09 50.08 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-O 123.601 1.667 . . . . 0.0 109.715 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.0 mm -114.71 126.7 72.34 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.761 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.865 -171.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -118.58 147.14 44.02 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.19 162.95 0.05 OUTLIER 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 52.22 36.25 18.87 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 126.511 1.924 . . . . 0.0 115.485 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.07 8.76 66.45 Favored Glycine 0 CA--C 1.468 -2.903 0 CA-C-O 116.112 -2.493 . . . . 0.0 116.203 172.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.8 m -77.0 135.13 38.66 Favored 'General case' 0 C--O 1.256 1.432 0 O-C-N 127.248 2.381 . . . . 0.0 113.748 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -114.12 136.18 51.47 Favored 'Isoleucine or valine' 0 C--N 1.367 1.367 0 O-C-N 120.66 -1.275 . . . . 0.0 114.354 165.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -125.85 116.77 22.08 Favored 'General case' 0 C--O 1.196 -1.745 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.111 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.2 mt -114.04 119.87 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.556 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -98.02 142.11 30.14 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 126.883 2.614 . . . . 0.0 110.79 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.75 175.09 14.37 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-O 124.836 2.255 . . . . 0.0 106.131 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 t -116.95 -15.81 10.59 Favored 'General case' 0 N--CA 1.532 3.646 0 CA-C-N 112.671 -2.059 . . . . 0.0 112.296 171.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -120.42 114.51 21.92 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.18 -38.15 95.15 Favored Glycine 0 N--CA 1.505 3.268 0 N-CA-C 118.428 2.131 . . . . 0.0 118.428 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.0 -31.88 71.48 Favored 'General case' 0 C--N 1.377 1.804 0 CA-C-N 121.314 2.557 . . . . 0.0 113.772 167.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -67.69 -34.92 77.86 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 121.738 2.063 . . . . 0.0 114.385 170.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.51 -45.55 79.15 Favored 'General case' 0 C--O 1.254 1.341 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 171.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HA ' HD12 ' A' ' 69' ' ' ILE . 43.5 mmtt -58.39 -37.08 74.56 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 115.08 -2.391 . . . . 0.0 110.742 167.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -62.93 -36.51 83.64 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 122.756 2.525 . . . . 0.0 111.361 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.36 -38.15 74.72 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 120.31 -1.494 . . . . 0.0 112.88 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 66' ' ' LYS . 19.3 mt -60.32 -43.27 93.3 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.84 168.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -60.17 -49.27 78.3 Favored 'General case' 0 C--O 1.249 1.029 0 O-C-N 120.495 -1.378 . . . . 0.0 113.787 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -67.38 -30.0 69.68 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.061 1.301 . . . . 0.0 112.757 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.9 -47.39 83.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 CA-C-O 115.492 -2.194 . . . . 0.0 110.674 166.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.67 -39.55 77.35 Favored 'General case' 0 C--O 1.206 -1.227 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -64.07 -55.18 23.94 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-O 115.927 -1.987 . . . . 0.0 114.029 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 36.6 mm -55.25 -43.49 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.368 0 CA-C-N 121.577 1.99 . . . . 0.0 109.285 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.3 p . . . . . 0 C--N 1.295 -1.79 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 174.898 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 mm . . . . . 0 C--O 1.212 -0.916 0 CA-C-O 117.551 -1.214 . . . . 0.0 114.242 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -121.0 139.82 52.77 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-O 123.613 1.673 . . . . 0.0 107.239 168.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.05 130.12 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 117.16 -3.463 . . . . 0.0 115.287 171.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.06 -8.15 41.78 Favored Glycine 0 CA--C 1.485 -1.817 0 CA-C-O 117.014 -1.992 . . . . 0.0 112.498 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -57.28 147.98 24.0 Favored 'General case' 0 C--N 1.371 1.511 0 O-C-N 124.981 1.048 . . . . 0.0 112.838 166.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.9 129.56 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 128.167 3.417 . . . . 0.0 106.905 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -135.78 168.5 19.19 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 123.444 1.592 . . . . 0.0 110.014 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 m -112.45 121.88 46.09 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 171.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.1 -172.24 13.33 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -139.76 144.33 37.38 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.33 138.2 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 170.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.4 p -115.3 -40.16 3.48 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 120.158 -1.589 . . . . 0.0 109.478 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.4 mtm-85 -146.88 141.96 27.13 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.157 0.983 . . . . 0.0 110.052 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 92' ' ' ILE . 96.9 mt -120.24 143.33 32.4 Favored 'Isoleucine or valine' 0 C--N 1.38 1.931 0 CA-C-O 122.451 1.12 . . . . 0.0 109.927 176.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 m -144.31 168.93 9.98 Favored 'Isoleucine or valine' 0 C--N 1.388 2.278 0 O-C-N 117.955 -2.965 . . . . 0.0 104.251 -170.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -56.66 -37.89 71.42 Favored 'General case' 0 C--O 1.269 2.094 0 CA-C-N 118.493 0.588 . . . . 0.0 111.743 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -96.06 11.33 34.52 Favored 'General case' 0 C--O 1.252 1.209 0 O-C-N 120.914 -1.117 . . . . 0.0 111.7 -168.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.72 -177.94 30.94 Favored Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.973 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.16 127.09 53.0 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.744 0.908 . . . . 0.0 110.276 174.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -76.26 131.86 39.51 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-O 123.806 1.765 . . . . 0.0 111.948 166.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.4 t -129.61 135.17 62.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 CA-C-N 112.051 -2.341 . . . . 0.0 112.024 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.96 129.97 41.62 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 112.21 -2.268 . . . . 0.0 112.632 167.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.5 mm -119.03 135.34 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.05 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.4 145.86 0.37 Allowed Glycine 0 C--N 1.378 2.909 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.54 38.84 27.28 Favored Glycine 0 N--CA 1.504 3.192 0 CA-C-N 112.78 -1.71 . . . . 0.0 111.051 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.48 6.92 84.99 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 120.507 2.963 . . . . 0.0 120.507 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -87.42 160.06 18.46 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 118.267 2.692 . . . . 0.0 118.267 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.87 131.63 20.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 109.707 172.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -122.9 163.1 16.43 Favored Glycine 0 C--N 1.349 1.25 0 C-N-CA 123.733 0.683 . . . . 0.0 112.156 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.94 124.91 44.21 Favored 'General case' 0 C--O 1.203 -1.345 0 O-C-N 126.892 2.172 . . . . 0.0 110.491 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 147' ' ' LEU . 74.1 t -96.93 100.29 10.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 168.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -67.58 154.87 40.45 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.312 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.273 6.3 tt -52.69 -38.69 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -170.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.6 p -73.4 -0.96 16.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 148' ' ' SER . 91.1 mm-40 -119.01 5.77 11.34 Favored 'General case' 0 CA--C 1.576 1.968 0 O-C-N 123.986 0.804 . . . . 0.0 112.577 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.0 mm -77.68 -33.24 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.183 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -157.65 -176.19 5.8 Favored 'General case' 0 CA--C 1.495 -1.157 0 O-C-N 120.076 -1.64 . . . . 0.0 111.079 -170.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -105.57 -23.43 12.78 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 165.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -62.05 158.28 16.92 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 120.092 -1.63 . . . . 0.0 112.648 173.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -74.25 131.56 41.32 Favored 'General case' 0 C--O 1.205 -1.273 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.49 HG22 ' CE2' ' A' ' 125' ' ' TYR . 17.8 t -122.21 127.72 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 C-N-CA 125.793 1.637 . . . . 0.0 114.188 -173.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -110.25 -46.1 3.48 Favored 'General case' 0 C--N 1.386 2.18 0 C-N-CA 124.893 1.277 . . . . 0.0 110.202 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -120.48 150.36 40.94 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 170.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.11 -23.2 14.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-N 113.719 -1.582 . . . . 0.0 113.038 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.93 -19.39 65.09 Favored 'General case' 0 CA--C 1.581 2.141 0 O-C-N 120.115 -1.616 . . . . 0.0 114.616 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -76.59 -29.64 56.65 Favored 'General case' 0 N--CA 1.539 3.977 0 C-N-CA 126.577 1.951 . . . . 0.0 110.484 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.49 ' CE2' HG22 ' A' ' 119' ' ' VAL . 76.7 m-85 -100.79 -15.46 17.64 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 126' ' ' LEU . 30.6 mt -151.99 162.42 41.11 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 124.22 0.95 . . . . 0.0 109.689 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -134.5 160.1 39.08 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 162.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -72.08 139.98 48.7 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 120.378 -1.451 . . . . 0.0 113.851 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 94.64 -12.35 68.84 Favored Glycine 0 N--CA 1.505 3.253 0 CA-C-O 125.39 2.661 . . . . 0.0 111.608 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -68.66 131.81 45.82 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 123.682 1.706 . . . . 0.0 111.177 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -79.65 129.6 34.62 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.931 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.57 127.16 19.48 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 120.527 -1.358 . . . . 0.0 109.062 -169.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.42 127.11 24.83 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 CA-C-O 116.769 -1.43 . . . . 0.0 113.278 160.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.0 129.43 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-N 122.669 2.486 . . . . 0.0 110.188 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -97.86 140.75 31.76 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 172.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.2 t -86.74 116.21 28.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.034 0 O-C-N 125.742 1.901 . . . . 0.0 106.789 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.0 tp -101.87 -48.01 4.41 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 116.323 -1.799 . . . . 0.0 110.658 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -136.12 150.84 49.26 Favored 'General case' 0 C--O 1.204 -1.294 0 O-C-N 125.029 1.456 . . . . 0.0 107.726 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.8 t -134.64 120.46 32.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -75.89 155.66 35.02 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.616 -1.302 . . . . 0.0 111.238 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.31 29.5 mmt180 -70.85 -27.06 63.57 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -65.74 -31.99 73.29 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 126.158 2.161 . . . . 0.0 115.833 157.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 138.02 -13.98 3.57 Favored Glycine 0 CA--C 1.549 2.206 0 C-N-CA 125.19 1.376 . . . . 0.0 111.646 162.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -54.37 137.84 41.03 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 10.6 mt -118.06 131.52 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 125.061 1.344 . . . . 0.0 113.14 -167.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -110.09 144.33 38.85 Favored 'General case' 0 N--CA 1.527 3.418 0 CA-C-O 123.283 1.516 . . . . 0.0 111.227 164.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.444 ' HB2' HG22 ' A' ' 109' ' ' VAL . 67.1 mt -129.12 151.87 49.33 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.079 -2.328 . . . . 0.0 110.29 -169.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 113' ' ' GLN . 33.8 t -125.82 115.82 20.61 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.062 1.345 . . . . 0.0 109.148 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.6 mt -74.87 -38.24 43.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 119.838 -1.789 . . . . 0.0 112.164 171.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -59.46 -47.24 86.25 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 127.015 2.697 . . . . 0.0 114.634 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -66.59 -46.34 76.27 Favored 'General case' 0 C--O 1.258 1.514 0 CA-C-N 118.345 0.52 . . . . 0.0 111.63 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.6 -18.23 64.91 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-O 116.912 -1.518 . . . . 0.0 112.569 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 117.629 -1.176 . . . . 0.0 108.234 172.085 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.0 mm . . . . . 0 C--O 1.238 0.497 0 CA-C-O 122.001 0.905 . . . . 0.0 113.395 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -123.04 138.97 54.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 124.395 2.045 . . . . 0.0 113.674 169.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -135.13 139.7 44.85 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 113.326 -1.761 . . . . 0.0 110.121 -173.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.3 pt -133.37 161.44 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 162.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -83.45 146.1 28.6 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 125.02 2.343 . . . . 0.0 109.447 160.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 pt -122.58 147.87 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 157.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.283 1.6 t-20 -63.35 138.53 97.38 Favored Pre-proline 0 N--CA 1.514 2.748 0 C-N-CA 128.472 2.709 . . . . 0.0 108.381 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -80.95 3.76 7.53 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 O-C-N 118.007 -1.628 . . . . 0.0 114.328 -171.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -91.43 -2.33 57.3 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 120.59 -1.319 . . . . 0.0 110.443 164.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -111.74 3.82 18.04 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.285 -0.884 . . . . 0.0 109.322 -170.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 mt -68.45 -41.31 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 119.828 -1.795 . . . . 0.0 112.366 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -52.5 -13.15 0.34 Allowed 'General case' 0 C--N 1.353 0.738 0 C-N-CA 128.34 2.656 . . . . 0.0 117.415 164.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -102.62 -32.71 9.75 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 115.734 -2.079 . . . . 0.0 113.318 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.3 t -84.15 -31.34 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 O-C-N 125.099 1.499 . . . . 0.0 109.466 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.3 mm -93.25 -55.21 6.36 Favored 'Isoleucine or valine' 0 C--N 1.361 1.08 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.62 -173.39 30.21 Favored Glycine 0 C--N 1.369 2.37 0 CA-C-O 123.506 1.614 . . . . 0.0 115.432 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -74.88 108.96 7.96 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 116.588 -1.672 . . . . 0.0 110.593 -167.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.53 9.76 59.84 Favored Glycine 0 CA--C 1.468 -2.855 0 O-C-N 127.474 2.984 . . . . 0.0 110.434 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.65 30.37 77.21 Favored Glycine 0 CA--C 1.54 1.613 0 O-C-N 125.362 1.272 . . . . 0.0 112.259 -162.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -53.05 -54.42 35.69 Favored 'General case' 0 N--CA 1.517 2.888 0 C-N-CA 126.213 1.805 . . . . 0.0 111.225 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -89.82 -35.56 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -160.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.1 tp -67.81 -38.64 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -66.12 -44.29 84.7 Favored 'General case' 0 C--N 1.399 2.731 0 C-N-CA 125.147 1.379 . . . . 0.0 110.489 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.23 47.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 127.814 3.196 . . . . 0.0 110.026 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.2 mt -51.63 -48.74 63.2 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 116.07 -1.919 . . . . 0.0 113.92 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 t -60.83 -34.42 74.54 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.6 1.545 . . . . 0.0 112.966 -175.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.25 -31.23 71.43 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -96.46 -28.12 14.57 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 126.285 1.834 . . . . 0.0 111.662 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.468 HG21 ' HA ' ' A' ' 68' ' ' ALA . 11.1 p -84.67 -19.64 32.53 Favored 'General case' 0 C--N 1.396 2.62 0 CA-C-N 120.954 1.706 . . . . 0.0 110.754 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.18 24.85 74.73 Favored Glycine 0 N--CA 1.472 1.042 0 C-N-CA 127.906 2.669 . . . . 0.0 114.12 171.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 t -141.45 161.78 37.08 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.871 0.868 . . . . 0.0 108.736 -173.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -81.68 126.09 31.37 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 125.177 1.548 . . . . 0.0 110.74 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.6 mt -114.72 121.61 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -116.83 148.79 40.92 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 124.831 2.253 . . . . 0.0 107.168 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.8 mt -128.06 123.5 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-O 123.236 1.494 . . . . 0.0 111.487 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -87.73 148.99 24.49 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-O 117.274 -1.346 . . . . 0.0 112.254 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -71.12 -3.16 18.48 Favored 'General case' 0 C--N 1.393 2.485 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -157.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -89.69 -1.85 58.12 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 125.064 1.477 . . . . 0.0 113.336 171.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.75 9.07 33.55 Favored Glycine 0 CA--C 1.48 -2.131 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -79.6 108.58 13.26 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 124.395 2.045 . . . . 0.0 111.003 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.63 127.72 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 166.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -116.45 123.91 48.65 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 113.347 -1.752 . . . . 0.0 107.549 -173.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.56 130.23 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.05 -8.73 19.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 118.551 2.797 . . . . 0.0 118.551 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -17.55 133.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 120.929 3.677 . . . . 0.0 120.929 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.8 m -67.6 -40.69 84.73 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 116.973 -1.489 . . . . 0.0 112.249 168.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -80.71 126.48 31.34 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.61 -40.44 95.97 Favored Glycine 0 C--N 1.361 1.954 0 O-C-N 124.493 1.121 . . . . 0.0 113.744 169.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.76 -36.25 71.86 Favored 'General case' 0 CA--C 1.586 2.363 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -66.14 -48.28 71.31 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.02 80.75 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 125.159 1.537 . . . . 0.0 113.722 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -68.68 -37.11 79.32 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 121.48 -0.762 . . . . 0.0 110.06 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -61.53 -47.21 86.61 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.111 167.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -60.59 -45.07 95.35 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mt -59.42 -43.73 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 124.43 1.092 . . . . 0.0 113.665 172.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -65.88 -40.84 91.98 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 171.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -67.8 -38.52 83.43 Favored 'General case' 0 N--CA 1.52 3.033 0 O-C-N 119.905 -1.747 . . . . 0.0 115.045 171.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 mt -59.34 -41.53 84.54 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-N 119.457 1.026 . . . . 0.0 111.564 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -55.3 -45.44 76.25 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -62.38 -45.95 90.83 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 126.979 2.112 . . . . 0.0 112.644 171.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.258 1.1 mp -58.88 -33.23 49.07 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 168.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.498 1.935 0 O-C-N 125.601 1.813 . . . . 0.0 112.941 -178.411 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.7 pt . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -118.37 139.65 51.05 Favored 'General case' 0 C--O 1.206 -1.2 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.684 -158.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -60.75 137.77 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.28 0.32 52.24 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.179 -1.486 . . . . 0.0 115.318 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -98.17 150.39 21.53 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 120.017 -1.873 . . . . 0.0 111.679 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -105.59 143.32 16.91 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 O-C-N 125.992 2.058 . . . . 0.0 110.935 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -137.7 157.31 46.74 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 127.119 2.762 . . . . 0.0 107.396 -168.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.1 m -94.28 123.24 37.56 Favored 'General case' 0 C--N 1.372 1.55 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 164.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.52 170.5 15.24 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -126.39 135.9 52.01 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.4 t -68.39 120.52 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 122.865 1.317 . . . . 0.0 111.346 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.8 p -104.24 -31.68 9.47 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 118.839 -2.413 . . . . 0.0 111.913 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -162.92 124.02 2.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 124.327 2.013 . . . . 0.0 114.236 175.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.6 mt -82.97 132.76 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-O 124.545 2.117 . . . . 0.0 109.937 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.4 m -121.39 172.11 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.606 3.128 0 C-N-CA 127.632 2.373 . . . . 0.0 108.862 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -63.69 -32.47 73.97 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 119.108 -2.245 . . . . 0.0 113.834 -166.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -118.06 23.08 11.85 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 113.297 -1.774 . . . . 0.0 111.968 -173.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 164.69 164.28 19.65 Favored Glycine 0 C--O 1.2 -2.005 0 CA-C-O 125.005 2.447 . . . . 0.0 115.186 -171.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.15 130.64 53.41 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 112.465 -1.867 . . . . 0.0 113.113 170.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -73.47 137.71 44.68 Favored 'General case' 0 C--N 1.376 1.737 0 CA-C-O 123.926 1.822 . . . . 0.0 108.821 169.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.1 t -131.18 134.78 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-O 124.252 1.977 . . . . 0.0 107.09 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.22 141.41 35.1 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 113.653 -1.612 . . . . 0.0 114.302 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.31 147.75 32.12 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.8 151.56 1.59 Allowed Glycine 0 C--N 1.362 2.013 0 N-CA-C 119.001 2.36 . . . . 0.0 119.001 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.79 17.27 58.45 Favored Glycine 0 C--N 1.368 2.353 0 CA-C-O 118.129 -1.373 . . . . 0.0 114.734 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.25 23.72 73.11 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 116.965 1.546 . . . . 0.0 116.965 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -114.37 130.88 56.71 Favored 'General case' 0 C--O 1.194 -1.841 0 CA-C-O 123.989 1.852 . . . . 0.0 108.926 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -127.13 134.43 50.21 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 120.728 -1.232 . . . . 0.0 111.453 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.48 173.26 17.49 Favored Glycine 0 C--O 1.205 -1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 112.724 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.7 tp -104.08 139.37 39.26 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 125.427 2.537 . . . . 0.0 110.294 172.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.0 t -99.13 96.47 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 CA-C-N 113.694 -1.593 . . . . 0.0 110.633 158.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -53.39 162.59 0.74 Allowed 'General case' 0 CA--C 1.576 1.967 0 CA-C-N 119.6 1.091 . . . . 0.0 113.433 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.48 ' HA ' HD12 ' A' ' 114' ' ' ILE . 3.9 tt -48.26 -33.81 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 p -90.26 7.09 40.04 Favored 'General case' 0 C--N 1.364 1.234 0 C-N-CA 126.122 1.769 . . . . 0.0 111.569 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -119.48 12.35 12.36 Favored 'General case' 0 CA--C 1.572 1.817 0 O-C-N 119.667 -1.895 . . . . 0.0 111.861 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 111' ' ' ILE . 9.8 mt -100.31 -45.85 11.75 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 O-C-N 117.451 -3.281 . . . . 0.0 109.991 -170.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.94 167.76 24.87 Favored 'General case' 0 C--N 1.402 2.872 0 CA-C-O 124.959 2.314 . . . . 0.0 114.541 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -66.13 -41.5 90.4 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 127.056 2.143 . . . . 0.0 115.547 163.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -42.5 150.96 0.13 Allowed 'General case' 0 CA--C 1.539 0.539 0 O-C-N 128.164 3.415 . . . . 0.0 115.385 169.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -65.89 97.4 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.1 t -94.64 125.35 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-N 118.77 0.714 . . . . 0.0 109.684 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -111.76 -33.41 6.33 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -145.38 148.71 33.66 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.81 -24.97 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 116.389 -1.767 . . . . 0.0 111.358 -163.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.2 p -59.3 -31.56 69.24 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 126.003 1.721 . . . . 0.0 109.014 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.58 -16.4 61.25 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -128.28 -4.47 5.51 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -173.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.2 mt -144.85 167.13 23.34 Favored 'General case' 0 C--O 1.197 -1.701 0 O-C-N 119.706 -1.871 . . . . 0.0 109.605 165.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -138.52 159.17 42.76 Favored 'General case' 0 CA--C 1.57 1.731 0 C-N-CA 124.948 1.299 . . . . 0.0 110.815 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -71.58 148.55 46.52 Favored 'General case' 0 CA--C 1.582 2.206 0 O-C-N 120.331 -1.48 . . . . 0.0 112.862 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 59.37 28.72 65.04 Favored Glycine 0 C--N 1.369 2.401 0 C-N-CA 129.957 3.646 . . . . 0.0 114.342 -170.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -95.98 145.92 25.03 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 169.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -86.04 142.55 28.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 125.115 2.388 . . . . 0.0 106.302 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.15 127.75 11.58 Favored Pre-proline 0 N--CA 1.426 -1.639 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -170.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -54.29 121.79 10.33 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 CA-C-N 121.053 1.412 . . . . 0.0 114.157 154.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . 0.351 5.4 m -123.11 131.75 72.67 Favored 'Isoleucine or valine' 0 C--N 1.383 2.064 0 CA-C-O 124.406 2.05 . . . . 0.0 114.635 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -107.66 129.71 54.98 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.57 134.28 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 1 O-C-N 114.009 -5.432 . . . . 0.0 106.004 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.7 mt -112.42 -5.27 14.1 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-N 120.514 1.507 . . . . 0.0 111.758 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -171.7 128.19 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 124.594 2.14 . . . . 0.0 110.408 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.9 t -105.24 104.59 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 155.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.64 149.06 26.1 Favored 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -76.79 -5.71 49.32 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.791 -1.193 . . . . 0.0 114.161 -171.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -90.48 -2.43 57.93 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-O 115.931 -1.985 . . . . 0.0 111.142 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.17 23.3 8.17 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-O 123.515 1.619 . . . . 0.0 111.972 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -108.7 115.84 30.85 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 -162.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 69.3 mt -114.11 117.96 57.06 Favored 'Isoleucine or valine' 0 C--N 1.398 2.703 0 CA-C-O 122.522 1.154 . . . . 0.0 108.005 -161.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -109.97 112.7 24.88 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 124.829 2.252 . . . . 0.0 111.742 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 76.1 mt -108.62 158.83 17.22 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 111.083 -2.78 . . . . 0.0 108.481 -171.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -143.38 152.65 41.84 Favored 'General case' 0 N--CA 1.516 2.832 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 57.1 mt -107.38 -45.16 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -58.08 -37.42 74.44 Favored 'General case' 0 CA--C 1.476 -1.896 0 C-N-CA 124.15 0.98 . . . . 0.0 111.824 -173.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -76.21 -24.57 54.65 Favored 'General case' 0 N--CA 1.397 -3.114 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.25 -28.95 47.88 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.002 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 65.8 p . . . . . 0 CA--C 1.579 2.074 0 O-C-N 127.312 2.882 . . . . 0.0 108.066 175.583 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -98.31 130.34 44.99 Favored 'General case' 0 C--O 1.27 2.153 0 O-C-N 118.8 -2.437 . . . . 0.0 107.056 171.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 t -148.98 165.7 30.85 Favored 'General case' 0 C--N 1.37 1.488 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.152 -164.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.6 tt -153.16 146.74 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 169.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -110.13 117.39 33.58 Favored 'General case' 0 N--CA 1.423 -1.778 0 O-C-N 116.614 -3.804 . . . . 0.0 104.277 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 pt -108.07 165.13 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.414 2.685 . . . . 0.0 109.712 -174.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -67.23 129.02 93.89 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 112.031 -2.349 . . . . 0.0 110.746 172.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HA ' HG13 ' A' ' 25' ' ' ILE . 100.0 Cg_exo -57.45 -20.44 40.63 Favored 'Trans proline' 0 N--CA 1.515 2.762 0 N-CA-C 117.68 2.146 . . . . 0.0 117.68 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.14 -21.29 59.93 Favored 'General case' 0 N--CA 1.41 -2.448 0 C-N-CA 125.222 1.409 . . . . 0.0 112.524 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -97.53 -1.75 43.34 Favored 'General case' 0 CA--C 1.49 -1.352 0 C-N-CA 126.74 2.016 . . . . 0.0 109.517 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 22' ' ' PRO . 96.6 mt -57.72 -46.11 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 117.035 -1.459 . . . . 0.0 112.381 164.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 pttm -69.7 -29.46 66.88 Favored 'General case' 0 C--O 1.186 -2.277 0 CA-C-N 119.86 1.209 . . . . 0.0 111.73 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -72.73 -45.29 59.48 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.661 0.784 . . . . 0.0 111.819 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.443 ' HA ' HG21 ' A' ' 75' ' ' ILE . 38.6 t -68.5 -39.36 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 118.766 -0.635 . . . . 0.0 111.602 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.4 mt -63.86 -51.82 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 124.489 1.116 . . . . 0.0 111.902 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.38 179.99 52.48 Favored Glycine 0 C--O 1.208 -1.511 0 CA-C-N 112.759 -2.019 . . . . 0.0 113.872 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -77.74 116.32 18.18 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.404 0.708 . . . . 0.0 110.682 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.41 20.79 79.51 Favored Glycine 0 CA--C 1.551 2.307 0 CA-C-N 112.459 -2.155 . . . . 0.0 116.03 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.09 7.23 88.76 Favored Glycine 0 C--N 1.368 2.333 0 CA-C-N 120.353 2.077 . . . . 0.0 115.901 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 t -56.26 -50.67 70.67 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.246 -1.977 . . . . 0.0 113.116 -173.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.2 t -73.14 -32.24 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.144 0.884 . . . . 0.0 109.275 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.769 HD11 HG22 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -57.03 -48.82 81.12 Favored 'Isoleucine or valine' 0 C--N 1.371 1.5 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.395 172.451 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -62.72 -44.28 96.63 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 125.684 2.659 . . . . 0.0 112.308 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.2 73.42 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 117.309 -3.37 . . . . 0.0 116.981 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . 0.263 46.8 mt -61.05 -45.03 96.42 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 125.137 1.523 . . . . 0.0 108.816 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 m -58.61 -56.09 26.67 Favored 'General case' 0 C--N 1.389 2.288 0 O-C-N 118.579 -2.576 . . . . 0.0 115.408 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -56.44 -48.48 76.93 Favored 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 125.615 1.566 . . . . 0.0 112.844 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 67.8 tt0 -62.28 -51.02 69.36 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 68' ' ' ALA . 68.5 p -79.65 -8.27 59.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 124.628 1.205 . . . . 0.0 112.344 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.93 19.88 70.14 Favored Glycine 0 C--O 1.247 0.933 0 O-C-N 125.553 1.783 . . . . 0.0 114.371 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 t -148.13 152.84 37.99 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -69.04 140.32 54.92 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 124.82 2.248 . . . . 0.0 114.352 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.15 127.63 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -135.25 151.19 50.36 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 119.411 -0.915 . . . . 0.0 112.111 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.769 HG22 HD11 ' A' ' 36' ' ' ILE . 8.3 tt -136.4 124.48 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 O-C-N 120.908 -1.12 . . . . 0.0 110.963 -170.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -86.68 168.79 13.26 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-O 123.432 1.587 . . . . 0.0 112.15 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -76.85 -15.67 59.64 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 117.376 2.361 . . . . 0.0 117.376 -169.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.96 -4.25 59.12 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 123.164 1.459 . . . . 0.0 112.37 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.45 3.35 27.37 Favored Glycine 0 CA--C 1.544 1.879 0 O-C-N 119.514 -1.992 . . . . 0.0 109.967 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.8 m -89.16 107.15 18.89 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.685 2.242 . . . . 0.0 113.943 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.96 136.82 22.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.946 -1.102 . . . . 0.0 111.291 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -115.72 120.64 39.99 Favored 'General case' 0 C--N 1.391 2.388 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.01 120.1 58.76 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 -173.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.91 90.73 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -38.04 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 1 N-CA-C 121.89 4.033 . . . . 0.0 121.89 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 m -121.16 -44.39 2.39 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.61 132.43 53.26 Favored 'General case' 0 C--N 1.389 2.32 0 CA-C-O 124.451 2.072 . . . . 0.0 107.757 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -49.87 -52.73 24.78 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 118.318 2.087 . . . . 0.0 118.318 -167.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . 70.8 mm-40 -66.05 -37.7 86.5 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.32 -42.51 88.15 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.329 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.18 80.93 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 116.31 -1.805 . . . . 0.0 110.092 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 63' ' ' GLU . 16.9 tttt -61.13 -36.44 79.77 Favored 'General case' 0 C--N 1.366 1.289 0 C-N-CA 125.96 1.704 . . . . 0.0 113.887 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -64.51 -41.01 96.68 Favored 'General case' 0 N--CA 1.511 2.615 0 CA-C-O 124.375 2.036 . . . . 0.0 114.754 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.496 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -64.76 -38.02 89.58 Favored 'General case' 0 C--O 1.257 1.456 0 O-C-N 117.976 -2.952 . . . . 0.0 111.635 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.78 -49.89 77.99 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 O-C-N 125.542 1.776 . . . . 0.0 109.241 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -58.39 -37.72 75.85 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HE ' ' CD ' ' A' ' 42' ' ' GLU . 11.8 mmm180 -71.38 -41.57 69.51 Favored 'General case' 0 C--N 1.366 1.31 0 O-C-N 126.751 2.532 . . . . 0.0 112.09 174.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.4 mm -56.53 -42.82 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-O 121.941 0.877 . . . . 0.0 109.599 167.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.256 12.5 mt-10 -62.56 -42.72 99.72 Favored 'General case' 0 CA--C 1.572 1.818 0 O-C-N 121.063 -1.023 . . . . 0.0 112.932 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.81 -44.18 86.17 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 117.481 -1.247 . . . . 0.0 113.406 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 28' ' ' VAL . 19.3 mm -78.38 -25.46 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-N 121.481 1.946 . . . . 0.0 109.09 -173.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 C--N 1.365 1.282 0 O-C-N 123.934 0.771 . . . . 0.0 112.322 176.904 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.1 pt . . . . . 0 C--O 1.279 2.653 0 CA-C-O 128.356 3.931 . . . . 0.0 114.98 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -122.76 147.43 46.51 Favored 'General case' 0 C--O 1.202 -1.396 0 O-C-N 118.23 -2.794 . . . . 0.0 108.311 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 m -64.79 154.94 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 123.91 1.814 . . . . 0.0 112.551 171.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.07 -9.6 45.68 Favored Glycine 0 CA--C 1.561 2.911 0 O-C-N 119.644 -1.91 . . . . 0.0 116.664 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -96.69 153.78 17.66 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 115.131 -2.366 . . . . 0.0 110.468 -172.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 152' ' ' ALA . 62.4 t -115.31 117.03 54.32 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 O-C-N 125.067 1.48 . . . . 0.0 110.333 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.51 166.75 10.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.806 2.442 . . . . 0.0 105.82 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 83.1 m -101.53 116.87 33.74 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 171.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.67 157.62 15.65 Favored Glycine 0 CA--C 1.469 -2.829 0 O-C-N 119.654 -1.903 . . . . 0.0 109.642 -173.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -115.93 128.82 56.06 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 118.791 -1.163 . . . . 0.0 111.69 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.06 126.2 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.391 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.2 p -102.52 -35.54 8.71 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-N 120.731 1.605 . . . . 0.0 114.249 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -165.46 157.43 14.91 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 127.061 2.725 . . . . 0.0 110.892 -173.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.5 mt -140.64 142.8 30.0 Favored 'Isoleucine or valine' 0 C--N 1.383 2.06 0 O-C-N 126.294 2.246 . . . . 0.0 107.008 -167.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.479 HG11 ' CZ ' ' A' ' 95' ' ' PHE . 2.9 p -141.19 -164.43 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.455 ' H ' HG22 ' A' ' 93' ' ' VAL . 37.3 m-20 -67.56 -38.99 84.93 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 128.72 2.808 . . . . 0.0 115.648 176.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CZ ' HG11 ' A' ' 93' ' ' VAL . 21.0 p90 -95.46 0.39 53.22 Favored 'General case' 0 N--CA 1.527 3.409 0 CA-C-O 114.07 -2.872 . . . . 0.0 116.044 174.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.64 -174.99 36.56 Favored Glycine 0 C--N 1.361 1.948 0 CA-C-N 125.245 3.657 . . . . 0.0 115.065 -170.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.61 137.25 51.59 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -91.9 144.16 25.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.6 t -143.18 136.75 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 113.554 -1.657 . . . . 0.0 108.267 -173.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' GLU . . . -107.76 144.67 34.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 125.008 2.337 . . . . 0.0 111.258 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.1 pt -140.25 167.73 18.17 Favored 'Isoleucine or valine' 0 C--O 1.259 1.582 0 CA-C-N 112.597 -2.092 . . . . 0.0 108.099 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -27.77 131.2 0.06 OUTLIER Glycine 0 CA--C 1.575 3.793 0 N-CA-C 122.634 3.814 . . . . 0.0 122.634 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.95 6.59 66.92 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -173.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.16 36.92 55.84 Favored Glycine 0 C--O 1.194 -2.366 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.494 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -103.17 110.45 22.4 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 119.034 1.417 . . . . 0.0 112.822 -170.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 27.1 tt0 -93.59 124.82 37.84 Favored 'General case' 0 N--CA 1.515 2.814 0 O-C-N 119.291 -2.13 . . . . 0.0 110.441 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -124.77 -175.91 14.43 Favored Glycine 0 CA--C 1.541 1.695 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.6 tp -121.43 127.66 51.36 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.843 1.306 . . . . 0.0 111.103 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.64 112.37 31.83 Favored 'Isoleucine or valine' 0 C--O 1.256 1.414 0 CA-C-N 113.932 -1.486 . . . . 0.0 107.193 166.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.44 152.88 42.86 Favored 'General case' 0 C--N 1.374 1.652 0 CA-C-O 125.217 2.436 . . . . 0.0 116.324 164.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 tt -52.98 -37.11 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 CA-C-N 111.076 -2.784 . . . . 0.0 113.569 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 76.7 p -76.75 -14.33 59.95 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 124.941 1.297 . . . . 0.0 109.488 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -101.88 7.78 41.44 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.675 1.19 . . . . 0.0 109.618 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 43.8 mm -78.1 -33.77 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.326 0 CA-C-O 123.106 1.431 . . . . 0.0 110.722 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -165.38 -178.58 5.06 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 119.067 -2.271 . . . . 0.0 112.509 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.19 -54.65 41.66 Favored 'General case' 0 CA--C 1.578 2.04 0 CA-C-N 112.729 -2.032 . . . . 0.0 111.857 165.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -93.63 160.55 14.73 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -84.25 127.38 33.92 Favored 'General case' 0 N--CA 1.512 2.643 0 O-C-N 125.698 1.874 . . . . 0.0 113.436 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.37 131.54 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 120.878 -1.139 . . . . 0.0 108.082 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -63.33 -40.04 96.21 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 118.468 -2.645 . . . . 0.0 112.987 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -129.27 118.07 21.72 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.93 1.292 . . . . 0.0 110.532 -175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.56 -30.16 49.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 C-N-CA 124.339 1.056 . . . . 0.0 109.602 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -23.31 63.15 Favored 'General case' 0 C--O 1.261 1.659 0 O-C-N 119.066 -2.271 . . . . 0.0 113.712 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -78.16 -20.92 51.06 Favored 'General case' 0 CA--C 1.49 -1.331 0 O-C-N 118.315 -2.741 . . . . 0.0 113.036 174.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -106.87 -8.79 16.56 Favored 'General case' 0 C--N 1.379 1.865 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.2 mt -146.0 159.01 43.86 Favored 'General case' 0 N--CA 1.402 -2.844 0 CA-C-O 124.018 1.866 . . . . 0.0 108.262 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -144.35 150.53 37.94 Favored 'General case' 0 C--O 1.201 -1.467 0 CA-C-N 111.334 -2.666 . . . . 0.0 106.074 -168.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -70.21 141.1 52.57 Favored 'General case' 0 CA--C 1.594 2.661 0 CA-C-O 123.607 1.67 . . . . 0.0 113.525 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.79 -11.59 68.35 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.25 140.42 40.07 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 121.016 2.408 . . . . 0.0 115.472 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -102.13 129.79 48.57 Favored 'General case' 0 C--N 1.381 1.959 0 O-C-N 124.949 1.406 . . . . 0.0 110.573 -163.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.11 143.28 46.52 Favored Pre-proline 0 CA--C 1.577 1.999 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.263 -176.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.15 136.04 70.11 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 CA-C-N 122.794 2.034 . . . . 0.0 110.447 169.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.54 148.17 27.21 Favored 'Isoleucine or valine' 0 C--O 1.255 1.371 0 O-C-N 125.732 1.895 . . . . 0.0 109.935 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -116.55 135.33 53.91 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 127.387 2.929 . . . . 0.0 104.736 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.8 t -87.05 127.89 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 126.76 2.537 . . . . 0.0 106.246 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 148' ' ' SER . 28.1 mt -101.03 -57.57 2.06 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -169.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -163.31 159.34 22.48 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 122.049 0.928 . . . . 0.0 109.407 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.68 119.86 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 102.323 -3.214 . . . . 0.0 102.323 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.421 ' CG ' ' HE ' ' A' ' 144' ' ' ARG . 3.5 t70 -71.52 162.18 29.85 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 129.003 2.921 . . . . 0.0 111.741 174.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -58.57 -33.53 70.05 Favored 'General case' 0 C--N 1.381 1.971 0 O-C-N 125.637 1.836 . . . . 0.0 113.111 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -90.58 11.14 22.86 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 119.296 -2.127 . . . . 0.0 109.946 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.04 16.64 69.23 Favored Glycine 0 C--O 1.251 1.193 0 CA-C-O 123.38 1.545 . . . . 0.0 113.973 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.421 ' HE ' ' CG ' ' A' ' 140' ' ' ASP . 9.2 mtm180 -71.12 117.28 12.43 Favored 'General case' 0 C--O 1.266 1.964 0 CA-C-N 112.384 -1.908 . . . . 0.0 114.062 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.1 mt -88.3 123.71 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.99 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -96.89 131.56 43.53 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-O 122.185 0.993 . . . . 0.0 110.573 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.5 mt -129.89 144.57 51.38 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 120.16 -1.588 . . . . 0.0 109.423 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.432 ' HB2' HD11 ' A' ' 137' ' ' LEU . 35.4 t -121.7 133.05 54.94 Favored 'General case' 0 C--N 1.375 1.708 0 CA-C-N 121.376 1.898 . . . . 0.0 110.656 163.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 76.3 mt -79.33 -45.1 23.97 Favored 'Isoleucine or valine' 0 C--N 1.377 1.801 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -55.71 -42.98 76.07 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 127.78 3.175 . . . . 0.0 112.418 -164.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -85.15 -19.9 31.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 115.042 -2.409 . . . . 0.0 109.892 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' A' ' 84' ' ' VAL . . . -74.31 -36.96 63.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 121.754 2.07 . . . . 0.0 113.773 167.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 N--CA 1.484 1.261 0 O-C-N 125.597 1.81 . . . . 0.0 111.629 174.094 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.4 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 124.251 1.977 . . . . 0.0 108.479 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -118.17 138.25 52.43 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 112.581 -2.099 . . . . 0.0 111.352 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -115.46 133.45 56.02 Favored 'General case' 0 C--N 1.38 1.918 0 O-C-N 120.271 -1.518 . . . . 0.0 110.496 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.7 mm -137.87 137.42 44.92 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -98.01 137.38 36.9 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 123.156 1.455 . . . . 0.0 112.58 167.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 pt -116.5 169.4 7.01 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 C-N-CA 125.63 1.572 . . . . 0.0 112.862 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -57.08 124.77 67.59 Favored Pre-proline 0 CA--C 1.586 2.358 0 CA-C-N 113.698 -1.592 . . . . 0.0 113.065 167.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.45 -3.21 13.31 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.67 2.246 . . . . 0.0 115.182 -176.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -72.58 -19.4 61.49 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.631 1.973 . . . . 0.0 115.848 161.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -99.58 -3.98 32.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 116.604 -1.665 . . . . 0.0 111.082 -166.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.0 mt -54.96 -44.41 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 119.204 0.911 . . . . 0.0 110.937 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.31 0.1 OUTLIER -57.8 -38.0 74.75 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 125.121 1.513 . . . . 0.0 111.731 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -75.89 -35.6 59.78 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-O 114.673 -2.584 . . . . 0.0 112.925 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.76 -52.65 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 116.065 -1.922 . . . . 0.0 114.287 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.7 mt -78.22 -32.39 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 126.024 2.078 . . . . 0.0 113.247 -176.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.39 -180.0 0.18 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 120.637 3.015 . . . . 0.0 120.637 -172.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -56.4 122.05 11.0 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 113.613 -1.294 . . . . 0.0 113.397 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 49.77 22.4 4.23 Favored Glycine 0 C--N 1.36 1.882 0 N-CA-C 116.98 1.552 . . . . 0.0 116.98 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.7 77.87 Favored Glycine 1 C--N 1.402 4.221 0 CA-C-N 122.191 2.995 . . . . 0.0 113.275 -175.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.1 m -58.58 -43.46 89.45 Favored 'General case' 0 C--O 1.207 -1.172 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -172.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.0 t -72.67 -47.02 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 O-C-N 124.263 0.977 . . . . 0.0 111.53 -172.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.251 7.0 tt -62.94 -38.77 82.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 113.66 -3.067 . . . . 0.0 114.604 172.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -59.01 -49.42 77.96 Favored 'General case' 0 C--O 1.263 1.783 0 O-C-N 126.193 2.183 . . . . 0.0 111.878 167.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.16 95.89 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 175.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.77 -39.27 93.85 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.112 0.882 . . . . 0.0 111.793 172.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.8 m -52.0 -46.04 64.77 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 117.203 -1.379 . . . . 0.0 110.94 167.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -67.75 -37.08 81.66 Favored 'General case' 0 C--N 1.37 1.495 0 C-N-CA 125.602 1.561 . . . . 0.0 113.323 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.12 -37.34 64.12 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.0 p -95.09 -34.38 12.32 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.35 -1.786 . . . . 0.0 114.363 -176.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.99 37.26 22.7 Favored Glycine 0 C--N 1.386 3.317 0 CA-C-O 124.454 2.141 . . . . 0.0 108.923 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.8 p -119.64 162.05 19.64 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.982 -1.305 . . . . 0.0 109.114 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -101.62 127.49 48.33 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.443 1.116 . . . . 0.0 109.197 169.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -114.9 126.54 72.51 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 -171.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -124.15 135.4 53.47 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 123.207 1.479 . . . . 0.0 107.714 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.54 141.18 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 119.055 -2.278 . . . . 0.0 109.726 -169.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -125.5 165.79 17.82 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-O 123.242 1.496 . . . . 0.0 107.769 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.32 43.4 p-10 -88.88 8.0 31.46 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 118.346 2.721 . . . . 0.0 118.346 -162.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -96.53 15.23 22.13 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.651 -1.613 . . . . 0.0 107.866 167.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.94 34.53 71.23 Favored Glycine 0 C--N 1.365 2.184 0 O-C-N 119.706 -1.871 . . . . 0.0 112.458 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.8 m -96.62 113.85 25.45 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-O 116.447 -1.74 . . . . 0.0 108.462 164.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -109.34 138.74 35.27 Favored 'Isoleucine or valine' 0 C--N 1.378 1.827 0 CA-C-O 122.886 1.327 . . . . 0.0 107.612 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.17 123.26 48.46 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 112.59 -2.095 . . . . 0.0 111.031 -176.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.55 119.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 119.348 -2.095 . . . . 0.0 111.733 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.89 127.18 54.56 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.155 2.582 . . . . 0.0 109.19 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.84 162.31 37.99 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 120.133 -1.604 . . . . 0.0 108.022 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.4 p -84.91 0.69 50.26 Favored 'General case' 0 N--CA 1.415 -2.22 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.196 173.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -142.82 140.66 31.4 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.584 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.68 -15.33 81.35 Favored Glycine 0 C--N 1.365 2.161 0 CA-C-O 116.363 -2.354 . . . . 0.0 113.053 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.74 -42.07 86.81 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 121.084 2.442 . . . . 0.0 109.86 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -64.13 -46.42 84.21 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.525 -2.125 . . . . 0.0 108.437 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.13 98.91 Favored 'General case' 0 C--N 1.36 1.047 0 O-C-N 120.292 -1.505 . . . . 0.0 114.422 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -65.62 -35.01 79.56 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 114.984 -2.436 . . . . 0.0 112.2 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -65.64 -38.18 88.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 125.82 1.95 . . . . 0.0 109.216 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.04 99.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.82 -1.175 . . . . 0.0 112.958 169.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.19 -45.5 84.6 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 O-C-N 120.014 -1.679 . . . . 0.0 112.925 168.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -60.69 -35.29 75.91 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 120.805 1.638 . . . . 0.0 114.052 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -74.63 -27.56 60.5 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 116.474 -1.727 . . . . 0.0 114.6 165.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . 0.349 11.3 mt -76.63 -32.22 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.46 -45.32 88.84 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.68 1.992 . . . . 0.0 115.026 169.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -64.47 -36.96 85.89 Favored 'General case' 0 C--O 1.195 -1.765 0 O-C-N 125.976 2.048 . . . . 0.0 106.743 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.2 mt -60.8 -44.53 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 125.592 3.815 . . . . 0.0 111.427 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 C--N 1.309 -1.174 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -162.489 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.0 mm . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -112.33 137.27 50.71 Favored 'General case' 0 CA--C 1.578 2.033 0 CA-C-O 124.487 2.089 . . . . 0.0 111.115 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 42.6 t -80.18 130.25 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 O-C-N 120.573 -1.329 . . . . 0.0 109.553 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.52 64.75 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 116.613 1.405 . . . . 0.0 116.613 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -119.58 135.28 54.86 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 123.882 0.873 . . . . 0.0 112.208 -174.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.0 t -72.53 130.18 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -128.7 154.53 46.23 Favored 'General case' 0 C--O 1.268 2.062 0 CA-C-N 112.452 -2.158 . . . . 0.0 107.425 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.1 m -105.88 128.24 53.64 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.61 167.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 131' ' ' GLU . . . -138.53 -173.0 12.78 Favored Glycine 0 C--O 1.206 -1.606 0 O-C-N 126.791 2.557 . . . . 0.0 108.985 -167.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -144.59 150.58 37.69 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.139 -0.624 . . . . 0.0 112.365 166.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 t -59.61 132.89 25.04 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 CA-C-N 112.4 -2.182 . . . . 0.0 111.452 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -110.48 -57.08 2.26 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -134.87 150.47 50.46 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.803 1.287 . . . . 0.0 110.586 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.71 136.49 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 112.94 -1.937 . . . . 0.0 107.292 171.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.5 m -135.29 -177.15 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 111.889 -2.414 . . . . 0.0 108.576 -168.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.55 -23.81 67.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 119.162 -2.211 . . . . 0.0 115.617 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -125.66 -0.52 7.43 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.61 0.764 . . . . 0.0 111.211 -165.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.25 -169.72 41.57 Favored Glycine 0 CA--C 1.48 -2.144 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' VAL . . . -120.44 146.61 46.05 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 111.663 -2.269 . . . . 0.0 108.22 167.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -100.13 137.34 38.71 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 168.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.44 129.55 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 C-N-CA 126.541 1.936 . . . . 0.0 106.246 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.66 125.26 41.0 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 101' ' ' ILE . 1.8 pt -116.86 164.59 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 C-N-CA 125.874 1.67 . . . . 0.0 106.984 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.03 153.58 0.54 Allowed Glycine 0 CA--C 1.543 1.821 0 N-CA-C 118.659 2.223 . . . . 0.0 118.659 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.48 23.28 65.47 Favored Glycine 0 N--CA 1.487 2.083 0 O-C-N 119.523 -2.163 . . . . 0.0 112.599 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.75 36.25 93.08 Favored Glycine 0 C--N 1.358 1.79 0 C-N-CA 126.863 2.173 . . . . 0.0 117.356 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -112.97 135.13 54.08 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 123.355 1.55 . . . . 0.0 109.842 -169.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.22 138.86 47.15 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 119.546 -1.971 . . . . 0.0 105.999 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.0 165.51 24.61 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-O 118.732 -1.038 . . . . 0.0 111.316 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.0 tp -101.5 114.18 27.97 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.055 -1.458 . . . . 0.0 109.783 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 97' ' ' ALA . 47.9 t -77.5 98.56 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.933 0 CA-C-O 125.738 2.685 . . . . 0.0 110.317 160.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -65.43 149.64 49.67 Favored 'General case' 0 CA--C 1.558 1.284 1 O-C-N 115.878 -4.264 . . . . 0.0 113.146 172.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 tt -65.29 -16.07 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 113.411 -1.722 . . . . 0.0 114.775 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 89.6 p -90.11 -1.51 57.96 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 119.694 -1.879 . . . . 0.0 110.184 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -121.39 36.48 4.6 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.65 -44.02 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 127.144 2.178 . . . . 0.0 109.37 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -145.04 163.11 35.24 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 111.842 -2.435 . . . . 0.0 112.646 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -70.98 -45.94 63.16 Favored 'General case' 0 CA--C 1.576 1.961 0 O-C-N 119.623 -1.923 . . . . 0.0 115.924 171.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -77.63 149.83 34.7 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 120.616 -1.303 . . . . 0.0 111.336 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.259 94.8 mtt180 -47.44 132.06 13.5 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 125.11 2.386 . . . . 0.0 115.012 174.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -107.2 115.35 48.4 Favored 'Isoleucine or valine' 0 C--N 1.371 1.531 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.83 -40.13 87.9 Favored 'General case' 0 C--O 1.197 -1.708 0 C-N-CA 118.066 -1.454 . . . . 0.0 113.45 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -147.44 145.88 29.35 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.73 1.15 . . . . 0.0 108.397 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.76 -34.94 71.15 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.233 -172.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.4 p -68.32 -26.45 65.62 Favored 'General case' 0 C--N 1.365 1.275 0 CA-C-O 125.023 2.344 . . . . 0.0 113.285 -167.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -58.49 -34.77 71.28 Favored 'General case' 0 C--O 1.205 -1.258 0 O-C-N 118.5 -2.625 . . . . 0.0 113.896 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -86.96 -61.91 1.62 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 128.116 2.567 . . . . 0.0 112.586 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.2 mt -109.45 157.54 18.85 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 125.729 1.893 . . . . 0.0 111.129 -162.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -142.55 156.54 45.13 Favored 'General case' 0 C--O 1.209 -1.062 0 O-C-N 126.28 2.237 . . . . 0.0 105.835 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -66.97 141.76 57.49 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 127.252 2.221 . . . . 0.0 112.83 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.93 -6.59 74.07 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-O 115.889 -2.617 . . . . 0.0 114.006 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -77.96 125.62 29.61 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 126.715 2.068 . . . . 0.0 113.589 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 35.3 mt-10 -67.8 136.77 54.68 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-O 123.392 1.567 . . . . 0.0 112.717 166.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 p -152.87 142.68 15.0 Favored Pre-proline 0 C--O 1.184 -2.383 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.765 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.14 123.49 11.3 Favored 'Trans proline' 0 C--N 1.276 -3.277 0 C-N-CA 123.521 2.814 . . . . 0.0 119.026 160.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.8 m -123.4 137.8 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-O 123.356 1.55 . . . . 0.0 107.325 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -100.0 132.5 45.32 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 113.745 -1.571 . . . . 0.0 110.533 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.85 124.58 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 126.225 2.203 . . . . 0.0 109.526 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.4 mt -111.87 -28.29 8.12 Favored 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.598 -1.313 . . . . 0.0 112.786 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -160.71 144.06 13.34 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.266 1.026 . . . . 0.0 111.749 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.8 t -115.93 115.16 48.33 Favored 'Isoleucine or valine' 0 C--N 1.375 1.694 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 167.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.322 0.0 OUTLIER -82.33 161.35 22.61 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 -174.189 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -89.91 -1.05 57.9 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 119.55 -1.969 . . . . 0.0 112.768 -168.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -85.82 0.74 52.17 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 127.094 3.33 . . . . 0.0 109.635 166.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.04 4.21 61.52 Favored Glycine 0 C--O 1.217 -0.942 0 CA-C-O 115.672 -2.738 . . . . 0.0 116.323 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -76.23 105.93 7.56 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 120.578 2.189 . . . . 0.0 111.851 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.5 mt -78.51 130.86 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -123.34 131.05 53.53 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.756 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.5 mt -127.94 140.58 51.91 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 123.979 0.912 . . . . 0.0 112.734 -163.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.1 t -126.61 120.78 30.39 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.4 mt -79.04 -28.62 13.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 167.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -61.69 -51.25 69.19 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -74.79 -19.46 60.2 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 121.877 0.846 . . . . 0.0 113.078 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.89 -25.91 25.9 Favored 'General case' 0 C--N 1.369 1.415 0 O-C-N 117.088 -3.507 . . . . 0.0 111.286 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 C--O 1.251 1.142 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.259 175.177 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 pt . . . . . 0 CA--C 1.51 -0.563 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -89.2 143.09 27.1 Favored 'General case' 0 C--N 1.368 1.402 0 CA-C-N 113.651 -1.613 . . . . 0.0 106.786 168.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 t -139.89 150.19 44.3 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-O 128.497 3.999 . . . . 0.0 114.624 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -137.56 134.15 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.502 0 CA-C-N 110.517 -3.038 . . . . 0.0 106.061 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -86.2 118.56 25.73 Favored 'General case' 0 CA--C 1.473 -2.013 0 O-C-N 125.38 1.675 . . . . 0.0 111.45 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.9 pt -112.0 152.41 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.651 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -47.63 114.46 3.17 Favored Pre-proline 0 C--O 1.212 -0.904 0 CA-C-O 115.371 -2.252 . . . . 0.0 114.323 163.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.17 -0.31 10.57 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 123.655 2.341 . . . . 0.0 115.894 -167.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -65.47 -29.88 70.59 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 125.761 1.913 . . . . 0.0 115.03 165.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -90.34 8.67 32.27 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 125.276 1.61 . . . . 0.0 113.394 -173.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.9 mt -66.07 -38.2 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 120.13 1.332 . . . . 0.0 112.321 -171.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -58.93 -45.3 90.73 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 125.76 1.913 . . . . 0.0 115.601 171.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.33 -49.43 77.62 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 125.266 1.604 . . . . 0.0 112.163 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 t -55.26 -49.5 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 O-C-N 128.66 3.725 . . . . 0.0 116.017 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.1 pt -74.85 -24.35 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 114.287 -2.768 . . . . 0.0 114.484 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.19 157.49 20.89 Favored Glycine 0 C--N 1.358 1.805 0 CA-C-N 120.8 1.636 . . . . 0.0 113.404 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.61 138.3 56.31 Favored 'General case' 0 C--N 1.378 1.82 0 CA-C-O 124.827 2.251 . . . . 0.0 107.593 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 43.92 29.05 1.35 Allowed Glycine 0 CA--C 1.557 2.665 0 CA-C-N 112.633 -2.076 . . . . 0.0 116.785 -158.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.17 20.84 63.32 Favored Glycine 0 C--O 1.213 -1.2 0 CA-C-N 121.131 2.465 . . . . 0.0 116.686 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.3 p -62.91 -37.7 88.01 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 127.11 2.164 . . . . 0.0 113.781 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.252 41.3 t -75.55 -35.47 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 123.724 0.64 . . . . 0.0 111.134 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.26 19.8 tt -67.64 -37.02 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 116.417 -2.113 . . . . 0.0 112.21 173.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -60.03 -43.4 95.34 Favored 'General case' 0 CA--C 1.584 2.271 0 CA-C-N 120.85 1.659 . . . . 0.0 114.697 171.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.73 82.89 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.149 2.58 . . . . 0.0 113.242 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -60.03 -45.1 93.91 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 124.973 1.42 . . . . 0.0 108.421 170.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 31.2 m -56.3 -54.45 45.28 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 120.684 1.584 . . . . 0.0 107.563 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.42 -43.5 96.7 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 119.568 3.173 . . . . 0.0 119.568 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -83.22 -25.46 31.7 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 p -78.15 -49.18 14.34 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 119.813 -1.805 . . . . 0.0 108.842 170.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.18 34.13 6.27 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 116.49 -2.283 . . . . 0.0 109.727 -173.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.3 p -131.15 172.77 11.73 Favored 'General case' 0 C--N 1.381 1.949 0 O-C-N 126.046 1.674 . . . . 0.0 110.436 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.6 m -109.2 138.42 45.58 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 123.44 1.591 . . . . 0.0 111.587 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.6 mp -135.48 127.68 46.7 Favored 'Isoleucine or valine' 0 C--N 1.387 2.196 0 CA-C-O 123.105 1.431 . . . . 0.0 110.223 -165.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.258 29.2 tt0 -128.43 129.2 45.8 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 117.662 -3.149 . . . . 0.0 106.831 164.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.4 mt -100.71 121.31 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 125.652 1.845 . . . . 0.0 109.874 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -87.36 150.76 23.61 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.259 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -54.09 -30.63 49.14 Favored 'General case' 0 C--O 1.261 1.668 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -168.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -82.64 0.46 42.99 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 126.76 2.024 . . . . 0.0 111.765 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.56 18.23 57.16 Favored Glycine 0 N--CA 1.504 3.232 0 O-C-N 119.327 -2.108 . . . . 0.0 110.745 -175.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -84.38 101.82 12.27 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.56 133.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 125.467 1.729 . . . . 0.0 112.236 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -118.16 112.08 19.69 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.5 mm -103.88 127.89 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 126.606 1.963 . . . . 0.0 108.977 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.34 130.75 44.83 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.8 174.13 13.62 Favored 'General case' 0 C--O 1.204 -1.313 0 O-C-N 120.704 -1.247 . . . . 0.0 109.02 -159.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -132.53 14.36 4.5 Favored 'General case' 0 CA--C 1.479 -1.753 0 CA-C-O 117.366 -1.302 . . . . 0.0 109.118 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -150.51 150.22 30.99 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.61 -44.51 6.1 Favored Glycine 0 N--CA 1.507 3.405 0 C-N-CA 127.024 2.25 . . . . 0.0 113.816 -163.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -50.48 -44.12 55.69 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 163.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -62.56 -45.25 93.79 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 124.883 1.364 . . . . 0.0 110.194 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.37 85.72 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.604 1.162 . . . . 0.0 110.91 173.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -58.83 -45.28 90.39 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 169.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -58.56 -41.34 85.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 126.38 2.3 . . . . 0.0 113.718 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.77 65.13 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mm -62.97 -46.2 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.804 0 CA-C-N 111.144 -2.753 . . . . 0.0 108.323 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -64.27 -49.97 69.76 Favored 'General case' 0 C--O 1.205 -1.252 0 O-C-N 124.529 1.143 . . . . 0.0 113.746 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -57.78 -39.46 77.53 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.801 1.24 . . . . 0.0 113.398 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.62 -49.38 84.01 Favored 'Isoleucine or valine' 0 C--O 1.257 1.474 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 168.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.68 -41.72 74.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -61.97 -47.69 83.69 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 127.752 2.421 . . . . 0.0 113.374 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.1 tt -71.29 -35.47 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 C-N-CA 124.349 1.06 . . . . 0.0 111.861 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 79.0 m . . . . . 0 C--N 1.355 0.82 0 CA-C-O 116.214 -1.851 . . . . 0.0 109.911 168.444 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.498 HG21 HD13 ' A' ' 145' ' ' ILE . 6.4 mm . . . . . 0 CA--C 1.577 1.998 0 CA-C-O 126.141 2.877 . . . . 0.0 104.434 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -117.83 140.52 49.58 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.694 1.998 . . . . 0.0 112.105 -173.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.43 148.76 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.667 -1.213 . . . . 0.0 113.479 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.45 -19.67 22.3 Favored Glycine 0 C--O 1.208 -1.511 0 CA-C-O 113.862 -3.743 . . . . 0.0 117.016 -171.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -96.92 158.82 15.25 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.98 1.89 . . . . 0.0 111.17 -166.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.71 127.8 75.88 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -121.35 159.54 25.88 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 124.016 1.865 . . . . 0.0 109.109 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 m -98.35 118.72 35.65 Favored 'General case' 0 C--O 1.202 -1.444 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 167.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -147.03 175.43 26.41 Favored Glycine 0 CA--C 1.569 3.416 0 C-N-CA 124.41 1.005 . . . . 0.0 114.829 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -117.15 133.15 56.35 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-O 125.633 2.635 . . . . 0.0 111.45 -169.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.3 t -67.8 121.13 16.4 Favored 'Isoleucine or valine' 0 C--N 1.366 1.304 0 O-C-N 119.214 -2.179 . . . . 0.0 106.487 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.4 p -103.8 -36.87 7.68 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.037 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -146.37 154.8 42.06 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.0 mt -126.22 130.17 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 O-C-N 125.796 1.935 . . . . 0.0 110.812 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.83 173.16 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -64.07 -27.73 69.3 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 123.262 1.506 . . . . 0.0 113.436 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -113.81 21.85 14.56 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -166.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.91 -153.01 24.95 Favored Glycine 0 C--O 1.204 -1.778 0 CA-C-O 116.991 -2.005 . . . . 0.0 111.305 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -149.69 174.33 12.69 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 102.203 -3.258 . . . . 0.0 102.203 167.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -114.86 128.76 56.48 Favored 'General case' 0 C--O 1.201 -1.47 0 O-C-N 127.669 3.106 . . . . 0.0 111.527 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.86 124.66 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 O-C-N 125.363 1.665 . . . . 0.0 107.494 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.69 117.53 17.55 Favored 'General case' 0 C--O 1.215 -0.732 1 O-C-N 129.434 4.209 . . . . 0.0 114.405 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 101' ' ' ILE . 46.0 pt -138.78 157.62 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 113.894 -1.503 . . . . 0.0 114.868 -167.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.25 -111.84 4.34 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 117.339 -1.812 . . . . 0.0 110.772 -176.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.83 -16.03 73.78 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 120.796 2.298 . . . . 0.0 112.809 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.59 -26.16 1.5 Allowed Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 116.947 -2.549 . . . . 0.0 112.377 -171.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -49.51 132.91 20.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 120.434 3.494 . . . . 0.0 120.434 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.48 143.64 48.34 Favored 'General case' 0 C--N 1.385 2.121 0 CA-C-O 123.966 1.841 . . . . 0.0 111.259 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.11 157.93 15.97 Favored Glycine 0 CA--C 1.539 1.565 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 169.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.423 HD21 ' CE1' ' A' ' 110' ' ' HIS . 4.1 tp -112.46 116.43 30.27 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 118.843 1.322 . . . . 0.0 111.001 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.56 118.4 48.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 171.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.423 ' CE1' HD21 ' A' ' 108' ' ' LEU . 90.8 m-70 -80.0 163.45 24.23 Favored 'General case' 0 C--O 1.192 -1.966 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.0 tt -56.29 -39.59 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 C-N-CA 126.327 1.851 . . . . 0.0 114.856 -170.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.8 p -77.87 -5.15 50.01 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 125.087 1.492 . . . . 0.0 114.971 171.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.77 3.49 42.2 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 173.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.6 mm -74.17 -39.76 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 124.225 1.964 . . . . 0.0 113.789 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.58 151.94 35.92 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.429 -170.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -92.42 -1.03 57.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.872 160.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -87.26 170.58 11.32 Favored 'General case' 0 CA--C 1.577 2.018 0 CA-C-O 124.523 2.106 . . . . 0.0 107.944 158.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.57 147.84 47.88 Favored 'General case' 0 C--O 1.2 -1.503 0 N-CA-C 118.071 2.619 . . . . 0.0 118.071 -173.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.5 t -139.31 125.09 22.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.47 -46.8 5.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 125.313 1.445 . . . . 0.0 108.527 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -140.05 146.09 38.53 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.69 -3.87 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.167 1.349 . . . . 0.0 110.982 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.0 p -68.59 -23.28 64.45 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 116.149 -1.881 . . . . 0.0 114.47 165.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.93 -8.33 56.18 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 127.391 2.932 . . . . 0.0 111.469 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -119.93 -68.93 0.88 Allowed 'General case' 0 C--N 1.356 0.884 0 O-C-N 120.315 -1.491 . . . . 0.0 111.049 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.8 mt -90.74 152.49 20.79 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.454 1.121 . . . . 0.0 108.047 -173.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -124.66 135.12 52.8 Favored 'General case' 0 C--N 1.385 2.118 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.7 mtm -65.83 142.97 57.76 Favored 'General case' 0 C--O 1.21 -0.987 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.85 1.57 82.42 Favored Glycine 0 C--O 1.197 -2.191 0 CA-C-O 114.255 -3.525 . . . . 0.0 116.16 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -97.65 143.11 28.64 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 120.931 2.366 . . . . 0.0 107.9 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -71.07 117.68 12.89 Favored 'General case' 0 C--O 1.2 -1.517 0 O-C-N 126.257 2.223 . . . . 0.0 111.092 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.97 128.15 25.89 Favored Pre-proline 0 CA--C 1.587 2.379 0 C-N-CA 123.868 0.867 . . . . 0.0 110.408 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.37 128.17 27.48 Favored 'Trans proline' 0 N--CA 1.525 3.341 0 C-N-CA 123.432 2.754 . . . . 0.0 113.588 153.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.8 m -140.99 135.42 33.01 Favored 'Isoleucine or valine' 0 C--N 1.374 1.645 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -101.89 141.44 34.73 Favored 'General case' 0 CA--C 1.566 1.585 0 O-C-N 120.335 -1.478 . . . . 0.0 108.62 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.78 126.71 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 123.428 1.585 . . . . 0.0 110.39 -176.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.5 mt -97.48 -76.41 0.52 Allowed 'General case' 0 C--N 1.365 1.282 0 CA-C-O 116.56 -1.686 . . . . 0.0 109.975 -172.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.43 148.75 36.62 Favored 'General case' 0 N--CA 1.416 -2.14 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.99 135.24 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 125.902 2.001 . . . . 0.0 110.34 160.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -84.56 168.75 15.1 Favored 'General case' 0 C--N 1.369 1.414 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -67.57 -38.45 84.1 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-O 117.592 -1.194 . . . . 0.0 112.788 -170.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -76.53 -7.66 55.61 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 131.64 1.99 4.52 Favored Glycine 0 CA--C 1.496 -1.15 0 CA-C-O 117.219 -1.878 . . . . 0.0 116.998 165.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.82 147.73 22.61 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 120.652 2.226 . . . . 0.0 113.965 -171.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.498 HD13 HG21 ' A' ' 79' ' ' ILE . 24.4 mt -100.0 141.39 17.17 Favored 'Isoleucine or valine' 0 C--N 1.376 1.719 0 C-N-CA 117.323 -1.751 . . . . 0.0 110.614 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -113.55 132.17 55.81 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.734 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.8 mt -124.55 165.39 17.91 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -165.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.0 t -136.69 135.31 38.1 Favored 'General case' 0 N--CA 1.524 3.253 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.624 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mm -88.32 -42.29 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 125.971 2.045 . . . . 0.0 109.441 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -64.65 -32.37 74.01 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 119.632 -1.917 . . . . 0.0 116.036 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -87.9 -3.48 58.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.416 -1.428 . . . . 0.0 110.79 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.266 . . -98.92 17.08 20.44 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.49 1.56 0 C-N-CA 124.775 1.23 . . . . 0.0 110.438 168.888 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.1 mt . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -113.99 131.29 56.39 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.72 1.263 . . . . 0.0 107.902 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.6 m -110.06 107.85 17.85 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.112 1.434 . . . . 0.0 110.507 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.7 126.06 74.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 113.758 -1.565 . . . . 0.0 111.224 -169.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -95.51 129.27 42.74 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 pt -127.87 162.81 33.01 Favored 'Isoleucine or valine' 0 C--N 1.381 1.966 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.995 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -45.87 116.48 3.37 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.954 1.701 . . . . 0.0 113.625 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -66.84 8.29 0.35 Allowed 'Trans proline' 0 N--CA 1.51 2.498 0 O-C-N 116.87 -2.226 . . . . 0.0 114.547 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.25 -15.39 35.97 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 120.29 1.405 . . . . 0.0 111.51 169.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -119.42 22.06 11.89 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 125.832 1.958 . . . . 0.0 114.902 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 mt -70.81 -40.11 76.29 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 C-N-CA 124.069 0.948 . . . . 0.0 109.884 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -58.2 -39.75 79.79 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 126.771 2.028 . . . . 0.0 115.976 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.76 -35.19 62.58 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.007 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.0 t -71.04 -41.08 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 123.271 1.51 . . . . 0.0 111.659 170.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.435 HG23 ' HA2' ' A' ' 33' ' ' GLY . 94.2 mt -64.13 -55.82 19.86 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.951 0 CA-C-O 116.389 -1.767 . . . . 0.0 111.181 173.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.721 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 88.78 -177.9 45.16 Favored Glycine 0 C--O 1.205 -1.708 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 -172.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -77.79 122.75 25.83 Favored 'General case' 0 CA--C 1.557 1.23 0 O-C-N 119.033 -2.451 . . . . 0.0 110.293 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.94 22.41 64.6 Favored Glycine 1 N--CA 1.521 4.361 0 C-N-CA 118.159 -1.972 . . . . 0.0 112.513 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.435 ' HA2' HG23 ' A' ' 29' ' ' ILE . . . 89.97 5.7 70.45 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-O 116.625 -2.209 . . . . 0.0 114.308 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -55.64 -46.81 77.4 Favored 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -174.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.721 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 73.1 t -67.12 -44.22 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -69.61 -34.48 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 O-C-N 118.934 -2.354 . . . . 0.0 110.796 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -49.12 -53.87 18.78 Favored 'General case' 0 C--N 1.381 1.973 0 O-C-N 126.07 2.106 . . . . 0.0 113.755 165.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.68 -36.8 85.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.876 1.36 . . . . 0.0 114.152 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.3 tp -61.2 -47.05 87.9 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.872 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -71.19 -25.09 62.37 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.62 -46.16 55.44 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 117.933 -1.507 . . . . 0.0 113.301 166.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.58 -32.32 64.07 Favored 'General case' 0 C--O 1.255 1.354 0 O-C-N 125.145 1.528 . . . . 0.0 108.709 -167.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.64 HG21 ' HA ' ' A' ' 68' ' ' ALA . 75.2 p -82.84 -21.16 34.49 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 120.201 -1.562 . . . . 0.0 112.877 174.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.03 34.58 87.26 Favored Glycine 0 C--N 1.381 3.075 0 C-N-CA 129.222 3.296 . . . . 0.0 112.182 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 t -146.98 157.95 43.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 119.696 -2.061 . . . . 0.0 108.572 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.2 m -74.12 128.76 36.37 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 124.325 1.016 . . . . 0.0 112.611 -172.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.5 mt -136.13 137.69 48.16 Favored 'Isoleucine or valine' 0 C--N 1.365 1.254 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -170.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -136.89 150.01 47.99 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.987 1.715 . . . . 0.0 109.336 -169.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.2 tt -141.94 155.16 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 118.82 -1.152 . . . . 0.0 112.417 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -127.17 155.27 43.65 Favored 'General case' 0 C--N 1.362 1.137 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.636 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -86.83 20.4 2.61 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -115.57 13.86 16.44 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.32 5.99 89.11 Favored Glycine 0 C--N 1.36 1.893 0 C-N-CA 119.081 -1.533 . . . . 0.0 110.385 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.4 m -88.09 114.63 24.9 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 119.963 -1.904 . . . . 0.0 108.964 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -115.71 138.33 46.49 Favored 'Isoleucine or valine' 0 C--N 1.365 1.249 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -123.79 131.56 53.62 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 112.731 -2.032 . . . . 0.0 111.58 -169.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.39 106.96 19.7 Favored 'Isoleucine or valine' 0 C--N 1.371 1.513 0 O-C-N 125.408 1.693 . . . . 0.0 109.801 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.39 121.93 33.54 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-N 112.806 -1.997 . . . . 0.0 105.977 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.04 151.87 28.92 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -165.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -123.94 -10.12 7.71 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.075 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -120.25 123.7 43.86 Favored 'General case' 0 C--N 1.377 1.762 0 CA-C-N 119.305 0.957 . . . . 0.0 110.42 171.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.28 -36.56 53.06 Favored Glycine 0 C--N 1.361 1.92 0 CA-C-O 122.629 1.127 . . . . 0.0 114.308 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -67.31 -40.73 86.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 117.243 -1.36 . . . . 0.0 112.686 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -68.09 -42.18 80.75 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.523 1.056 . . . . 0.0 112.115 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.61 84.94 Favored 'General case' 0 C--N 1.358 0.965 0 O-C-N 125.571 1.795 . . . . 0.0 112.869 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -62.76 -42.67 99.79 Favored 'General case' 0 C--O 1.261 1.678 0 O-C-N 125.179 1.55 . . . . 0.0 113.082 173.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . 0.287 3.2 t60 -63.29 -37.64 88.05 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 126.61 2.444 . . . . 0.0 115.138 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.64 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -67.58 -43.39 80.68 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.865 170.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.318 61.4 mt -60.32 -41.74 88.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.312 0 CA-C-N 119.113 0.87 . . . . 0.0 109.683 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? -61.2 -46.02 92.17 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 117.522 -1.228 . . . . 0.0 112.825 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -59.58 -43.07 93.78 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 127.836 2.454 . . . . 0.0 110.131 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.06 -44.9 99.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -62.26 -40.05 94.92 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.06 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -54.56 -56.02 23.3 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 123.013 1.387 . . . . 0.0 113.698 173.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.257 76.9 mt -63.95 -45.16 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 112.299 -2.228 . . . . 0.0 109.776 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 N--CA 1.49 1.554 0 CA-C-N 120.619 1.554 . . . . 0.0 114.752 -176.121 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mm . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -115.03 154.86 28.06 Favored 'General case' 0 C--O 1.249 1.053 0 O-C-N 119.631 -1.918 . . . . 0.0 108.965 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.07 143.7 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.85 0 O-C-N 119.097 -2.252 . . . . 0.0 113.51 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.05 85.6 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 120.986 -1.071 . . . . 0.0 113.569 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -111.58 152.37 27.66 Favored 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 123.387 0.675 . . . . 0.0 110.804 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.58 140.09 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 126.554 2.409 . . . . 0.0 109.675 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -129.4 159.94 34.65 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 125.187 2.423 . . . . 0.0 106.657 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.5 109.86 21.98 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 118.64 -2.537 . . . . 0.0 109.319 174.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.44 166.08 18.33 Favored Glycine 0 C--N 1.368 2.348 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -169.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -120.28 149.08 42.87 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-N 112.231 -1.984 . . . . 0.0 113.544 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.18 127.71 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 124.109 1.909 . . . . 0.0 112.024 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 p -97.48 -30.2 13.03 Favored 'General case' 0 CA--C 1.48 -1.712 0 CA-C-O 116.268 -1.825 . . . . 0.0 114.218 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -171.0 151.27 3.24 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.8 mt -123.98 140.28 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 O-C-N 121.444 -0.785 . . . . 0.0 109.456 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.4 m -142.51 172.02 9.21 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.242 0 C-N-CA 126.366 1.866 . . . . 0.0 112.797 -173.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.16 -35.53 81.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 118.356 -2.715 . . . . 0.0 113.811 -165.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -109.81 18.34 20.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 125.385 1.678 . . . . 0.0 113.207 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.56 -161.81 32.47 Favored Glycine 0 CA--C 1.549 2.174 0 N-CA-C 117.711 1.845 . . . . 0.0 117.711 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.19 142.86 26.6 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 120.913 -1.345 . . . . 0.0 110.441 -173.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -99.37 134.76 41.76 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.827 1.775 . . . . 0.0 109.039 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.2 t -136.03 123.26 33.95 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.245 0 CA-C-N 112.434 -2.166 . . . . 0.0 110.497 -171.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.39 147.78 22.79 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 125.559 1.787 . . . . 0.0 113.236 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 pt -145.35 164.95 11.51 Favored 'Isoleucine or valine' 0 C--N 1.362 1.143 0 O-C-N 126.022 2.076 . . . . 0.0 110.125 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.88 141.33 1.49 Allowed Glycine 0 CA--C 1.541 1.718 0 N-CA-C 121.521 3.368 . . . . 0.0 121.521 176.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.13 24.68 51.31 Favored Glycine 0 CA--C 1.496 -1.138 0 CA-C-O 116.682 -2.177 . . . . 0.0 115.979 -174.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.47 42.85 99.19 Favored Glycine 0 CA--C 1.562 2.976 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -121.76 148.93 44.01 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 120.148 -1.796 . . . . 0.0 113.325 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -130.34 119.65 23.1 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 124.103 1.906 . . . . 0.0 107.45 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.39 171.67 22.41 Favored Glycine 0 N--CA 1.408 -3.177 0 C-N-CA 125.692 1.615 . . . . 0.0 110.125 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 tp -116.08 136.56 52.91 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 115.29 -2.29 . . . . 0.0 109.709 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -101.76 115.08 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.159 2.254 . . . . 0.0 109.14 167.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -62.66 149.54 43.25 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.269 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.0 tt -56.46 -38.89 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -175.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . 0.301 71.4 m -73.81 -10.13 59.36 Favored 'General case' 0 CA--C 1.486 -1.511 0 C-N-CA 124.387 1.075 . . . . 0.0 111.208 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -117.2 18.76 14.43 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.663 1.185 . . . . 0.0 113.213 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.407 ' HB ' HG21 ' A' ' 119' ' ' VAL . 37.2 mt -81.9 -53.79 11.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 125.347 1.459 . . . . 0.0 111.521 167.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.46 166.95 27.59 Favored 'General case' 0 C--O 1.198 -1.624 0 O-C-N 123.574 0.546 . . . . 0.0 111.617 -171.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -69.53 -43.66 72.57 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.371 163.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -48.14 145.84 2.96 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 162.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -66.58 131.57 46.31 Favored 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.956 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.407 HG21 ' HB ' ' A' ' 114' ' ' ILE . 18.6 t -110.29 102.98 14.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 170.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.56 -43.08 19.21 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 124.757 1.286 . . . . 0.0 108.876 161.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -133.31 148.06 51.89 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.006 -1.684 . . . . 0.0 108.727 170.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.35 -33.06 52.55 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 126.539 1.936 . . . . 0.0 115.152 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.2 p -62.59 -9.03 7.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 116.409 -1.758 . . . . 0.0 115.69 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -69.1 -41.99 76.7 Favored 'General case' 0 C--N 1.372 1.578 0 CA-C-N 123.691 2.951 . . . . 0.0 110.648 168.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -109.97 -34.03 6.54 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -164.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.48 142.83 39.95 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -168.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -126.51 150.35 48.82 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -55.34 136.29 49.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 125.807 1.942 . . . . 0.0 114.236 168.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.49 3.44 88.79 Favored Glycine 0 C--N 1.381 3.07 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.396 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -79.99 122.96 27.37 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.46 107.2 1.3 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 128.373 3.545 . . . . 0.0 114.069 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.4 148.01 43.05 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 111.382 -2.644 . . . . 0.0 105.582 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -90.57 134.1 1.89 Allowed 'Trans proline' 1 C--N 1.255 -4.364 0 N-CA-C 104.648 -2.866 . . . . 0.0 104.648 170.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.74 137.27 39.5 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.939 0 C-N-CA 118.119 -1.432 . . . . 0.0 109.537 -172.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -113.61 135.02 54.37 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 122.863 1.316 . . . . 0.0 108.39 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.572 HG22 HD23 ' A' ' 147' ' ' LEU . 65.8 t -80.17 121.55 33.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 113.265 -1.789 . . . . 0.0 108.977 173.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 43.4 mt -104.98 -6.8 19.74 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.483 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -168.48 144.66 3.72 Favored 'General case' 0 N--CA 1.533 3.678 0 O-C-N 119.792 -1.817 . . . . 0.0 114.659 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.282 7.2 t -127.09 103.56 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 126.444 2.34 . . . . 0.0 106.041 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.46 166.05 24.16 Favored 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 -177.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -71.56 -7.61 48.75 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -107.96 14.83 24.94 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.727 1.611 . . . . 0.0 108.808 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.89 31.34 75.35 Favored Glycine 0 N--CA 1.414 -2.786 0 O-C-N 120.663 -1.273 . . . . 0.0 115.582 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . 0.252 58.3 mtm180 -80.74 117.63 21.58 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 124.027 1.87 . . . . 0.0 109.892 168.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 64.6 mt -101.94 121.2 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 O-C-N 118.582 -2.574 . . . . 0.0 107.955 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -109.76 106.14 15.65 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.832 1.777 . . . . 0.0 114.344 -175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.572 HD23 HG22 ' A' ' 136' ' ' VAL . 20.0 mt -87.3 150.03 24.14 Favored 'General case' 0 C--N 1.389 2.284 0 CA-C-O 127.979 3.752 . . . . 0.0 110.861 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.3 t -119.51 129.1 54.54 Favored 'General case' 0 C--O 1.288 3.113 0 CA-C-N 110.158 -3.201 . . . . 0.0 110.734 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.41 -30.27 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 O-C-N 119.189 -2.194 . . . . 0.0 105.631 167.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -62.24 -46.92 86.71 Favored 'General case' 0 CA--C 1.553 1.075 0 O-C-N 120.537 -1.352 . . . . 0.0 114.136 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -69.63 -24.39 63.63 Favored 'General case' 0 C--O 1.264 1.837 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 171.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.11 -35.82 56.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 124.927 1.392 . . . . 0.0 111.414 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 CA--C 1.56 1.342 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 173.775 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.1 mm . . . . . 0 N--CA 1.5 2.032 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -113.87 151.48 32.1 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 102.959 -2.978 . . . . 0.0 102.959 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 p -148.29 151.81 36.04 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-O 124.819 2.247 . . . . 0.0 112.67 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.1 pt -145.87 155.58 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 O-C-N 118.669 -2.519 . . . . 0.0 105.243 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -107.21 119.75 40.25 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 121.464 -0.772 . . . . 0.0 110.217 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.05 141.66 30.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.761 0 C-N-CA 126.124 1.77 . . . . 0.0 108.815 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -73.02 146.01 86.91 Favored Pre-proline 0 C--O 1.213 -0.819 0 CA-C-O 115.33 -2.271 . . . . 0.0 113.555 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -67.2 -19.58 50.48 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 124.25 1.658 . . . . 0.0 113.251 -160.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -57.74 -44.41 86.05 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 119.871 -1.768 . . . . 0.0 111.652 166.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -92.87 -18.28 23.01 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.241 -1.537 . . . . 0.0 109.237 -167.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mm -59.74 -34.78 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.776 1.298 . . . . 0.0 108.688 165.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -61.8 -43.37 98.99 Favored 'General case' 0 CA--C 1.579 2.082 0 O-C-N 120.94 -1.1 . . . . 0.0 112.21 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -68.74 -31.0 69.74 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 114.05 -2.881 . . . . 0.0 112.262 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.28 -42.47 78.83 Favored 'Isoleucine or valine' 0 C--N 1.381 1.968 0 O-C-N 127.709 3.131 . . . . 0.0 108.843 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.8 -48.29 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 124.176 1.941 . . . . 0.0 111.296 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.99 -176.58 49.26 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 111.4 -2.636 . . . . 0.0 114.71 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -70.11 142.03 52.64 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 116.911 -1.915 . . . . 0.0 110.532 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.01 23.21 45.48 Favored Glycine 0 N--CA 1.511 3.641 0 O-C-N 120.263 -1.523 . . . . 0.0 114.702 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 52.8 43.27 60.33 Favored Glycine 0 CA--C 1.477 -2.305 0 C-N-CA 126.389 1.947 . . . . 0.0 114.689 -168.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.6 p -97.95 -33.84 11.06 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 117.446 -1.702 . . . . 0.0 114.618 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -65.66 -36.19 77.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 O-C-N 120.499 -1.376 . . . . 0.0 112.528 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.54 -42.05 94.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 O-C-N 119.487 -2.008 . . . . 0.0 114.097 167.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -62.71 -37.27 85.86 Favored 'General case' 0 CA--C 1.583 2.244 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.8 -48.15 69.88 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 117.056 -1.449 . . . . 0.0 111.186 170.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -55.62 -42.56 75.1 Favored 'General case' 0 C--N 1.37 1.458 0 C-N-CA 124.52 1.128 . . . . 0.0 108.579 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.9 m -61.86 -47.69 83.88 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 114.607 -1.178 . . . . 0.0 112.163 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -61.28 -45.81 92.95 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.772 -2.013 . . . . 0.0 112.283 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.97 -53.2 42.04 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-O 114.655 -2.593 . . . . 0.0 114.001 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.1 p -69.19 -22.93 63.86 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 125.857 1.973 . . . . 0.0 113.336 -170.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.03 13.18 53.82 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-O 114.841 -3.199 . . . . 0.0 117.548 -176.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.98 161.66 34.17 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.693 2.247 . . . . 0.0 108.714 -162.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.3 m -66.3 123.71 20.69 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 176.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.8 mm -118.15 134.65 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -140.48 167.54 21.92 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 123.344 1.545 . . . . 0.0 108.421 170.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.6 mm -113.29 130.64 66.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 104.235 -2.505 . . . . 0.0 104.235 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -118.77 163.91 16.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -45.37 160.62 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.308 79.3 m-20 69.37 32.14 3.61 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 123.515 1.626 . . . . 0.0 114.841 170.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.7 53.75 24.37 Favored Glycine 0 C--O 1.281 3.064 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.1 m -102.63 132.89 48.44 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 125.898 1.587 . . . . 0.0 110.989 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -94.94 134.44 32.3 Favored 'Isoleucine or valine' 0 C--N 1.37 1.47 0 O-C-N 119.046 -2.284 . . . . 0.0 108.305 158.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -107.78 130.36 54.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.05 124.87 69.18 Favored 'Isoleucine or valine' 0 C--N 1.372 1.555 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 167.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.55 114.93 27.83 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.88 140.91 22.94 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 123.298 1.523 . . . . 0.0 113.636 -164.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 p -110.47 4.58 20.62 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 126.61 1.964 . . . . 0.0 111.953 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -126.2 139.33 53.43 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 169.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.32 -27.73 24.48 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 125.605 1.574 . . . . 0.0 113.577 -174.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -62.02 -39.64 92.97 Favored 'General case' 0 C--O 1.248 0.976 0 O-C-N 121.316 -1.108 . . . . 0.0 113.423 168.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -65.97 -37.36 85.77 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 118.483 0.583 . . . . 0.0 112.308 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.41 89.37 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 123.469 1.604 . . . . 0.0 114.224 173.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -67.33 -42.91 82.81 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 115.179 -2.343 . . . . 0.0 113.035 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -62.61 -40.79 98.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 126.456 2.348 . . . . 0.0 111.577 169.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.64 -48.45 69.38 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.89 -37.36 71.62 Favored 'Isoleucine or valine' 0 C--N 1.368 1.397 0 O-C-N 125.399 1.687 . . . . 0.0 109.271 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.306 27.5 tpt180 -67.82 -41.86 82.42 Favored 'General case' 0 C--N 1.375 1.709 0 O-C-N 124.726 1.266 . . . . 0.0 114.413 172.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -62.41 -39.3 92.85 Favored 'General case' 0 C--O 1.253 1.274 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.132 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mm -55.43 -31.98 28.71 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 CA-C-O 117.331 -1.319 . . . . 0.0 108.668 176.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -72.82 -29.33 63.16 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 116.956 -1.898 . . . . 0.0 109.142 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.79 -40.57 79.57 Favored 'General case' 0 C--O 1.26 1.651 0 O-C-N 120.437 -1.415 . . . . 0.0 109.121 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.39 -38.33 32.05 Favored 'Isoleucine or valine' 0 C--O 1.264 1.862 0 O-C-N 127.338 2.899 . . . . 0.0 117.191 165.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.481 1.103 0 O-C-N 117.879 -3.013 . . . . 0.0 115.998 179.092 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 C--O 1.195 -1.794 0 CA-C-O 126.023 2.82 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -87.09 134.42 33.51 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.313 -167.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.46 129.07 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 CA-C-O 123.629 1.681 . . . . 0.0 112.568 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.43 16.87 79.92 Favored Glycine 0 N--CA 1.513 3.769 0 C-N-CA 126.698 2.094 . . . . 0.0 117.967 165.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -120.16 161.43 21.05 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.42 113.14 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 112.417 -2.174 . . . . 0.0 109.441 -164.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -94.7 163.01 13.54 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 113.188 -1.823 . . . . 0.0 113.662 169.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 m -104.85 127.48 52.69 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 116.944 -3.598 . . . . 0.0 104.007 163.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.66 -164.88 11.93 Favored Glycine 0 CA--C 1.493 -1.318 0 C-N-CA 126.978 2.228 . . . . 0.0 108.149 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -149.38 151.73 34.57 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-O 116.854 -1.546 . . . . 0.0 109.915 172.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.88 109.59 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 126.855 2.062 . . . . 0.0 111.864 -177.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -94.19 -55.71 3.1 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.91 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.7 mtm-85 -131.81 123.46 27.64 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -98.65 128.97 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 CA-C-O 123.481 1.61 . . . . 0.0 107.087 176.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.71 174.49 9.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 O-C-N 120.476 -1.39 . . . . 0.0 110.059 -169.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.68 -25.53 64.82 Favored 'General case' 0 C--N 1.377 1.767 0 O-C-N 117.835 -3.041 . . . . 0.0 116.054 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -125.51 14.32 8.19 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-O 117.571 -1.204 . . . . 0.0 112.637 -172.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.42 -159.14 30.72 Favored Glycine 0 C--O 1.193 -2.448 0 CA-C-N 120.647 1.567 . . . . 0.0 110.661 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.96 155.58 46.21 Favored 'General case' 0 CA--C 1.477 -1.838 0 O-C-N 124.759 0.917 . . . . 0.0 109.282 158.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -87.43 147.01 25.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.896 0.855 . . . . 0.0 109.894 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 t -136.97 130.85 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.62 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.269 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.47 139.47 38.03 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-O 125.14 2.4 . . . . 0.0 106.04 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.3 mt -119.86 137.57 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 111.539 -2.573 . . . . 0.0 111.955 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.84 129.26 1.5 Allowed Glycine 0 N--CA 1.503 3.143 0 N-CA-C 120.95 3.14 . . . . 0.0 120.95 172.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.08 18.23 29.82 Favored Glycine 0 C--N 1.364 2.112 0 C-N-CA 124.459 1.028 . . . . 0.0 114.343 -163.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.1 27.73 73.6 Favored Glycine 0 CA--C 1.54 1.64 0 O-C-N 125.871 1.571 . . . . 0.0 113.971 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -100.0 149.57 23.33 Favored 'General case' 0 C--N 1.369 1.448 0 CA-C-N 119.534 1.667 . . . . 0.0 112.178 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -146.48 141.35 26.99 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 123.119 1.438 . . . . 0.0 114.353 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.63 166.46 18.36 Favored Glycine 0 CA--C 1.495 -1.202 0 O-C-N 120.348 -1.47 . . . . 0.0 110.05 -174.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.22 130.71 50.52 Favored 'General case' 0 N--CA 1.518 2.934 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.385 173.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.58 109.61 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 163.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -70.03 150.59 46.47 Favored 'General case' 0 C--O 1.2 -1.551 0 CA-C-N 113.815 -1.539 . . . . 0.0 114.409 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.432 8.6 tt -49.47 -21.79 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 118.711 2.856 . . . . 0.0 118.711 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.7 p -106.32 14.45 27.4 Favored 'General case' 0 C--N 1.389 2.287 0 CA-C-O 117.781 -1.104 . . . . 0.0 110.855 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -124.41 22.44 8.45 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 124.867 1.354 . . . . 0.0 111.597 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.7 mt -99.08 -39.35 7.79 Favored 'Isoleucine or valine' 0 C--N 1.377 1.784 0 CA-C-N 123.075 2.67 . . . . 0.0 110.24 175.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -159.39 149.79 19.23 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 117.285 -1.766 . . . . 0.0 113.58 -170.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.29 -26.44 60.19 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 118.92 -2.363 . . . . 0.0 108.523 163.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -57.42 151.56 16.16 Favored 'General case' 0 N--CA 1.405 -2.691 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 162.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -66.65 142.2 57.53 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.653 1.216 . . . . 0.0 108.464 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.6 t -128.34 137.24 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.888 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -107.7 -75.19 0.64 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -114.39 155.37 26.42 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 173.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.25 -26.32 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 122.019 2.19 . . . . 0.0 114.257 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.3 p -65.01 -20.29 66.42 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.931 1.292 . . . . 0.0 112.979 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -102.97 31.91 3.97 Favored 'General case' 0 C--O 1.256 1.404 0 O-C-N 126.492 2.37 . . . . 0.0 107.517 -172.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -153.36 -55.98 0.12 Allowed 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.7 157.17 16.2 Favored 'General case' 0 C--N 1.375 1.706 0 C-N-CA 125.016 1.326 . . . . 0.0 111.447 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -117.39 148.18 41.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 127.137 2.773 . . . . 0.0 105.93 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -70.18 143.27 52.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 124.047 1.88 . . . . 0.0 110.084 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.6 -17.9 22.68 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 112.158 -2.292 . . . . 0.0 115.786 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -58.99 143.76 47.26 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 124.999 1.32 . . . . 0.0 111.562 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -111.24 99.4 8.23 Favored 'General case' 0 N--CA 1.513 2.679 0 CA-C-O 123.875 1.798 . . . . 0.0 113.461 -165.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.4 p -109.04 134.33 20.43 Favored Pre-proline 0 N--CA 1.399 -2.994 0 CA-C-N 113.215 -1.811 . . . . 0.0 108.369 -160.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -58.66 140.07 93.34 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.127 1.067 . . . . 0.0 112.957 160.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.6 p -149.16 130.27 4.9 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 123.668 1.699 . . . . 0.0 111.667 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 152' ' ' ALA . 83.8 tttt -94.39 131.5 39.99 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 112.746 -2.025 . . . . 0.0 111.118 172.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.45 132.12 33.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 126.714 3.15 . . . . 0.0 111.382 170.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 148' ' ' SER . 58.8 mt -100.14 -51.61 3.62 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 117.728 -3.108 . . . . 0.0 114.866 173.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 146' ' ' ARG . 41.3 mt-10 -139.05 142.64 38.2 Favored 'General case' 0 N--CA 1.41 -2.457 0 O-C-N 125.435 1.709 . . . . 0.0 107.416 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.46 126.25 75.04 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 163.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -91.07 156.56 17.82 Favored 'General case' 0 CA--C 1.553 1.058 0 O-C-N 125.428 1.705 . . . . 0.0 108.36 167.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -70.94 -23.49 62.25 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -92.78 26.89 2.55 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-O 123.05 1.405 . . . . 0.0 111.94 168.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.73 8.43 82.79 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 122.723 3.849 . . . . 0.0 122.723 161.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -85.09 144.9 27.94 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.265 -0.468 . . . . 0.0 110.951 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.89 132.25 68.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 138' ' ' GLU . 1.3 mpp_? -103.61 133.94 47.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.023 162.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.8 mt -121.96 152.33 39.81 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 112.269 -2.241 . . . . 0.0 108.607 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' SER . . . . . 0.412 ' HB2' HD11 ' A' ' 137' ' ' LEU . 9.8 t -125.34 123.88 40.35 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 126.044 1.738 . . . . 0.0 110.649 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 69.4 mt -86.83 -31.0 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 117.507 -1.235 . . . . 0.0 109.981 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -60.46 -49.93 75.58 Favored 'General case' 0 C--O 1.276 2.49 0 C-N-CA 129.359 3.064 . . . . 0.0 117.518 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -88.07 -7.11 57.48 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 118.749 -1.18 . . . . 0.0 112.14 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.459 ' HB2' ' H ' ' A' ' 135' ' ' LYS . . . -67.63 -37.04 81.92 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 124.153 0.981 . . . . 0.0 112.76 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 p . . . . . 0 N--CA 1.441 -0.883 0 C-N-CA 124.245 1.018 . . . . 0.0 109.209 171.513 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.445 ' HB3' HD11 ' A' ' 69' ' ' ILE . 66.1 m80 -80.16 111.04 16.14 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 127.17 2.793 . . . . 0.0 114.622 165.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.6 p -109.92 139.98 44.4 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 127.123 2.169 . . . . 0.0 106.996 -170.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.8 tt -132.3 128.57 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -110.84 128.55 55.82 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.92 154.25 39.62 Favored 'Isoleucine or valine' 0 C--N 1.365 1.253 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.39 -162.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -58.08 148.75 59.81 Favored Pre-proline 0 C--O 1.211 -0.945 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.45 -31.25 51.89 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 N-CA-C 116.232 1.589 . . . . 0.0 116.232 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -64.83 -40.78 95.73 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 169.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -57.46 -28.28 63.21 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.6 mt -57.63 -36.89 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -65.86 -18.59 65.44 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 127.617 2.367 . . . . 0.0 115.94 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -93.02 -20.34 20.66 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.679 167.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -91.27 -22.89 6.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.231 0 O-C-N 118.243 -2.786 . . . . 0.0 114.05 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.3 mt -92.05 -55.33 6.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 119.419 -2.051 . . . . 0.0 109.642 166.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.25 173.5 48.53 Favored Glycine 0 C--N 1.375 2.703 0 O-C-N 127.551 3.032 . . . . 0.0 115.75 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -66.05 120.89 13.96 Favored 'General case' 0 CA--C 1.581 2.136 0 CA-C-O 124.239 1.971 . . . . 0.0 110.916 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.68 9.69 46.29 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 120.28 -1.512 . . . . 0.0 112.751 -172.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.43 22.57 75.39 Favored Glycine 0 C--O 1.196 -2.228 0 O-C-N 120.89 -1.359 . . . . 0.0 112.257 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 t -61.09 -41.81 97.34 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 125.042 1.337 . . . . 0.0 114.502 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.64 -44.79 59.73 Favored 'Isoleucine or valine' 0 C--O 1.258 1.541 0 CA-C-N 120.65 1.568 . . . . 0.0 113.396 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 tt -60.79 -41.14 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 119.804 -1.81 . . . . 0.0 110.437 174.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -59.9 -49.17 78.74 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 123.556 1.646 . . . . 0.0 112.843 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.56 94.15 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 124.023 1.868 . . . . 0.0 112.57 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.0 tp -56.5 -37.0 69.79 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.504 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.7 m -57.74 -60.14 4.15 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-O 115.556 -2.164 . . . . 0.0 116.239 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.63 -40.6 92.53 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 126.815 2.572 . . . . 0.0 114.336 174.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.512 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 28.1 tt0 -60.65 -47.7 85.08 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 124.889 2.28 . . . . 0.0 112.223 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.3 p -88.24 -24.65 23.19 Favored 'General case' 0 C--O 1.21 -0.991 0 O-C-N 118.98 -2.325 . . . . 0.0 109.436 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.25 38.74 94.03 Favored Glycine 0 N--CA 1.484 1.855 0 C-N-CA 118.915 -1.612 . . . . 0.0 116.95 -166.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.6 p -139.85 176.89 8.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 119.94 1.87 . . . . 0.0 108.156 -172.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -118.11 121.44 40.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.811 -1.806 . . . . 0.0 107.937 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.5 126.12 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 119.782 1.174 . . . . 0.0 108.818 -170.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -123.58 147.59 47.17 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.0 mt -127.75 115.6 40.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.182 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -77.1 167.55 21.59 Favored 'General case' 0 N--CA 1.525 3.307 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -76.42 -19.38 58.15 Favored 'General case' 0 C--N 1.378 1.835 0 C-N-CA 122.749 0.42 . . . . 0.0 111.018 -170.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.31 -12.89 51.25 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.297 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.51 17.29 34.14 Favored Glycine 0 N--CA 1.475 1.257 0 CA-C-O 116.496 -2.28 . . . . 0.0 116.917 -167.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -78.82 122.22 25.78 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 120.862 2.331 . . . . 0.0 108.815 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.3 t -94.67 126.81 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 169.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -108.13 126.07 52.33 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.449 HD11 HD12 ' A' ' 72' ' ' ILE . 5.0 mt -115.67 113.83 44.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.933 0 CA-C-N 121.366 1.894 . . . . 0.0 113.978 178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.42 137.42 32.38 Favored 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 119.661 -1.9 . . . . 0.0 108.17 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.66 141.6 45.03 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.817 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -68.39 -36.92 79.86 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.594 1.088 . . . . 0.0 108.707 170.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -119.76 129.85 54.68 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 124.401 2.048 . . . . 0.0 107.67 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.88 -29.93 71.77 Favored Glycine 0 N--CA 1.475 1.296 0 O-C-N 118.992 -2.317 . . . . 0.0 116.242 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -67.49 -28.54 67.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.358 2.079 . . . . 0.0 111.371 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.23 -37.99 84.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 124.456 1.098 . . . . 0.0 110.919 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.26 79.67 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 120.131 -1.606 . . . . 0.0 112.509 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -63.82 -45.24 90.52 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.797 174.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -63.58 -38.88 92.82 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 124.938 1.399 . . . . 0.0 112.919 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.49 82.53 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 16' ' ' HIS . 46.4 mt -52.72 -43.94 45.78 Favored 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 124.234 1.014 . . . . 0.0 110.474 170.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -60.23 -46.29 90.29 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.512 ' HE ' ' CD ' ' A' ' 42' ' ' GLU . 4.6 mmm180 -61.34 -37.22 82.51 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.101 1.319 . . . . 0.0 112.111 174.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.449 HD12 HD11 ' A' ' 57' ' ' ILE . 63.1 mt -61.54 -41.69 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 121.299 -0.876 . . . . 0.0 112.536 175.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -62.04 -41.97 98.68 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 164.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.13 -39.46 86.62 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.46 -46.69 82.26 Favored 'Isoleucine or valine' 0 C--N 1.371 1.541 0 C-N-CA 125.735 1.614 . . . . 0.0 110.227 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.474 0.728 0 CA-C-N 121.739 2.063 . . . . 0.0 113.073 -168.671 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.0 mm . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 119.49 -0.291 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -104.21 121.98 44.42 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.79 129.3 23.28 Favored 'Isoleucine or valine' 0 C--N 1.369 1.427 0 O-C-N 119.676 -1.89 . . . . 0.0 111.239 158.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.73 1.46 63.63 Favored Glycine 0 CA--C 1.482 -2.009 0 C-N-CA 118.676 -1.726 . . . . 0.0 111.273 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HB3' ' HE1' ' A' ' 85' ' ' TYR . 21.6 ttm180 -92.54 146.89 23.32 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.449 1.119 . . . . 0.0 111.038 167.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 135' ' ' LYS . 40.3 t -100.64 135.5 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.426 ' HE1' ' HB3' ' A' ' 83' ' ' ARG . 27.9 m-85 -125.25 159.3 31.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.564 1.946 . . . . 0.0 108.491 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.64 113.68 27.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 120.738 -1.226 . . . . 0.0 108.363 169.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.75 169.09 16.74 Favored Glycine 0 CA--C 1.47 -2.727 0 C-N-CA 118.447 -1.835 . . . . 0.0 114.099 -174.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -121.1 153.05 37.96 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.932 1.866 . . . . 0.0 107.922 -175.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 81.4 t -63.68 130.79 28.92 Favored 'Isoleucine or valine' 0 C--N 1.365 1.252 0 C-N-CA 123.849 0.86 . . . . 0.0 110.572 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.4 p -100.24 -11.98 19.92 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 165.92 159.85 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 126.591 1.956 . . . . 0.0 107.176 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.467 HD12 HG22 ' A' ' 123' ' ' THR . 55.1 mt -121.55 146.66 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 O-C-N 120.64 -1.288 . . . . 0.0 109.915 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.32 178.3 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.271 0 O-C-N 117.938 -2.976 . . . . 0.0 108.612 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -65.56 -44.45 86.75 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -78.52 0.2 27.03 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 115.13 -2.367 . . . . 0.0 112.263 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.4 -155.32 26.06 Favored Glycine 0 CA--C 1.553 2.421 0 O-C-N 124.826 1.329 . . . . 0.0 115.716 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.97 155.9 47.15 Favored 'General case' 0 CA--C 1.587 2.375 0 CA-C-N 121.873 2.837 . . . . 0.0 110.549 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -86.29 129.67 34.77 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 124.159 1.933 . . . . 0.0 113.257 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.6 t -127.59 122.64 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-N 112.711 -2.041 . . . . 0.0 113.881 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.01 111.82 23.04 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.468 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.6 pt -102.91 148.5 8.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 125.903 2.763 . . . . 0.0 105.221 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -51.54 138.42 28.74 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 112.487 -2.142 . . . . 0.0 113.137 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.64 15.41 13.54 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 119.343 1.572 . . . . 0.0 110.546 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.21 21.4 65.14 Favored Glycine 0 C--N 1.303 -1.266 0 CA-C-N 120.707 2.253 . . . . 0.0 117.573 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -125.34 120.22 30.53 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -89.57 133.85 34.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 124.004 1.859 . . . . 0.0 109.09 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.54 -177.68 18.98 Favored Glycine 0 C--N 1.308 -1.009 0 O-C-N 120.88 -1.137 . . . . 0.0 110.7 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.3 tp -137.39 115.37 11.53 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 110.124 -3.038 . . . . 0.0 108.176 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.1 105.15 17.13 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 O-C-N 125.714 1.884 . . . . 0.0 108.592 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . 0.288 34.8 m80 -59.31 157.82 10.26 Favored 'General case' 0 C--O 1.191 -2.013 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 171.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.9 tp -62.23 -30.67 49.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.1 p -82.44 -18.76 40.66 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 127.831 2.452 . . . . 0.0 111.773 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -100.57 -2.62 32.42 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 124.889 1.368 . . . . 0.0 109.836 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.0 mt -73.8 -38.85 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.467 0 O-C-N 119.292 -2.13 . . . . 0.0 114.101 165.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.77 148.01 23.6 Favored 'General case' 0 N--CA 1.483 1.202 1 O-C-N 114.243 -5.285 . . . . 0.0 107.14 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -69.39 -51.83 32.84 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.442 -173.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -87.99 9.72 21.37 Favored 'General case' 0 N--CA 1.521 3.109 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.358 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.278 10.5 mpt_? 70.51 113.73 0.05 Allowed 'General case' 0 C--O 1.193 -1.885 0 C-N-CA 126.715 2.006 . . . . 0.0 112.831 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 119' ' ' VAL . 14.8 m -72.84 155.73 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 123.697 1.713 . . . . 0.0 114.0 168.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.95 -48.6 81.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.712 1.605 . . . . 0.0 113.032 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -159.62 152.26 21.43 Favored 'General case' 0 C--N 1.361 1.1 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 168.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.62 HG12 HD12 ' A' ' 126' ' ' LEU . 20.9 t -58.25 -41.45 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 C-N-CA 124.946 1.298 . . . . 0.0 112.52 -171.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.467 HG22 HD12 ' A' ' 92' ' ' ILE . 43.5 p -68.51 -20.56 64.58 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.301 -2.227 . . . . 0.0 115.957 178.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -90.02 0.73 56.95 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 119.258 -2.151 . . . . 0.0 114.089 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -120.01 -21.15 7.21 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 169.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.62 HD12 HG12 ' A' ' 122' ' ' VAL . 95.9 mt -105.2 150.15 25.33 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 119.219 -2.176 . . . . 0.0 112.943 -175.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -135.51 145.36 46.99 Favored 'General case' 0 C--N 1.366 1.295 0 O-C-N 125.894 1.996 . . . . 0.0 108.507 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 73.9 mmm -85.62 143.85 28.2 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 125.59 1.806 . . . . 0.0 111.916 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.54 0.64 84.7 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-N 110.346 -3.115 . . . . 0.0 113.859 -170.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -101.13 143.42 31.25 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.478 -1.601 . . . . 0.0 109.805 -174.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -80.94 123.24 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 125.88 1.988 . . . . 0.0 113.5 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.61 125.52 51.23 Favored Pre-proline 0 C--N 1.367 1.358 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 170.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -62.72 123.15 11.82 Favored 'Trans proline' 0 C--N 1.29 -2.54 0 O-C-N 117.439 -1.927 . . . . 0.0 112.063 164.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.49 130.16 46.69 Favored 'Isoleucine or valine' 0 C--N 1.373 1.614 0 O-C-N 119.294 -2.129 . . . . 0.0 109.582 -173.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.443 ' HB2' HG22 ' A' ' 84' ' ' VAL . 33.3 ttpt -95.16 144.27 25.91 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 117.215 -1.794 . . . . 0.0 110.935 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.7 t -83.97 130.95 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.417 0 C-N-CA 117.158 -1.817 . . . . 0.0 114.894 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.0 mt -101.68 -44.33 5.59 Favored 'General case' 0 C--N 1.37 1.491 0 C-N-CA 126.033 1.733 . . . . 0.0 114.066 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -154.11 138.6 16.81 Favored 'General case' 0 C--O 1.202 -1.427 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -174.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.3 t -92.72 137.8 21.49 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 CA-C-O 122.725 1.25 . . . . 0.0 108.959 167.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -128.27 142.25 51.21 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -103.04 -5.7 23.08 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.032 -171.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -122.14 -40.26 2.52 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 124.853 1.345 . . . . 0.0 112.872 169.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.26 -174.02 34.03 Favored Glycine 0 C--N 1.37 2.42 0 C-N-CA 128.677 3.037 . . . . 0.0 109.139 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 48.1 mmt-85 -88.72 158.77 18.08 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 112.638 -1.781 . . . . 0.0 108.122 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.7 mm -66.17 138.06 23.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 O-C-N 120.856 -1.152 . . . . 0.0 111.501 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.6 mmt-85 -94.13 131.93 39.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 117.045 -1.862 . . . . 0.0 107.001 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.7 mt -139.99 152.63 46.44 Favored 'General case' 0 C--N 1.381 1.963 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 30.4 t -121.7 120.74 35.57 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.412 1.085 . . . . 0.0 108.307 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.9 mt -80.2 -34.68 15.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 O-C-N 119.639 -1.913 . . . . 0.0 107.075 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -70.78 -20.68 62.58 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -172.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -92.14 4.65 52.73 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.142 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.17 -41.03 1.01 Allowed 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 125.02 1.328 . . . . 0.0 108.376 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.491 1.575 0 O-C-N 119.713 -1.867 . . . . 0.0 108.506 -176.549 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.0 mt . . . . . 0 C--O 1.21 -1.018 0 CA-C-O 122.97 1.366 . . . . 0.0 113.868 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -102.8 149.31 24.61 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 111.217 -2.72 . . . . 0.0 107.761 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -128.65 145.38 51.17 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 tt -127.51 142.4 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -110.99 114.58 27.99 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 120.307 -1.496 . . . . 0.0 108.627 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 21' ' ' ASN . 4.5 tp -142.25 151.8 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 O-C-N 120.854 -1.154 . . . . 0.0 111.54 -157.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.56 ' H ' HD12 ' A' ' 20' ' ' ILE . 92.9 m-20 -83.25 148.68 56.64 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 114.657 -2.592 . . . . 0.0 108.809 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . 0.275 50.5 Cg_exo -53.44 -48.21 23.16 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 N-CA-C 118.468 2.449 . . . . 0.0 118.468 -169.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.65 -10.34 45.13 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 122.162 2.256 . . . . 0.0 115.472 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -105.79 -1.11 24.71 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.439 HG12 HG23 ' A' ' 20' ' ' ILE . 37.8 mt -69.18 -43.12 81.76 Favored 'Isoleucine or valine' 0 C--O 1.263 1.812 0 C-N-CA 118.45 -1.3 . . . . 0.0 111.234 162.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -57.53 -42.02 82.07 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 115.932 -1.985 . . . . 0.0 113.809 -172.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -50.89 -32.63 21.11 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 128.809 3.818 . . . . 0.0 113.368 170.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.49 -44.31 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 123.928 0.767 . . . . 0.0 111.466 174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.57 -6.75 6.88 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.351 0 O-C-N 120.892 -1.13 . . . . 0.0 110.663 171.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -15.84 132.16 0.01 OUTLIER Glycine 0 CA--C 1.537 1.414 1 N-CA-C 127.468 5.747 . . . . 0.0 127.468 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.3 mttm 59.14 44.77 15.42 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 124.113 1.911 . . . . 0.0 113.411 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.99 30.32 65.74 Favored Glycine 0 CA--C 1.554 2.472 0 O-C-N 117.96 -2.962 . . . . 0.0 112.397 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.7 -2.15 84.26 Favored Glycine 0 C--N 1.387 3.387 0 C-N-CA 128.414 2.912 . . . . 0.0 112.941 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.3 t -58.17 -38.51 76.8 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.339 -1.094 . . . . 0.0 111.404 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 t -66.7 -47.83 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 CA-C-O 116.692 -1.623 . . . . 0.0 110.313 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 mt -55.4 -51.68 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 116.741 -1.984 . . . . 0.0 111.719 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -58.82 -43.23 90.57 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.18 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.64 88.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.037 1.29 . . . . 0.0 114.151 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.9 tp -63.46 -44.27 94.96 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 125.238 1.586 . . . . 0.0 109.082 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.1 p -62.25 -43.3 99.14 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.16 -42.13 99.37 Favored 'General case' 0 N--CA 1.514 2.743 0 CA-C-N 121.581 1.992 . . . . 0.0 113.431 166.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . 0.281 32.2 tt0 -72.19 -48.15 45.33 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.532 0.682 . . . . 0.0 111.321 -170.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.0 p -78.55 -22.05 47.8 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 114.474 -2.679 . . . . 0.0 115.531 176.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 31.54 38.24 Favored Glycine 0 C--N 1.362 1.986 0 CA-C-N 121.199 1.818 . . . . 0.0 111.466 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.526 HG21 ' HB2' ' A' ' 68' ' ' ALA . 17.6 p -132.57 171.04 14.33 Favored 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 126.529 1.932 . . . . 0.0 111.291 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 m -127.94 135.91 50.61 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 101.023 -3.695 . . . . 0.0 101.023 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.2 mt -118.96 135.05 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.636 0 CA-C-N 120.379 1.445 . . . . 0.0 112.938 -171.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -129.7 133.57 47.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 118.89 -2.382 . . . . 0.0 109.779 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.67 131.58 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.106 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -134.38 155.84 49.57 Favored 'General case' 0 C--N 1.363 1.177 0 O-C-N 119.416 -2.052 . . . . 0.0 110.221 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -40.14 151.77 0.04 OUTLIER 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t0 65.63 19.42 11.45 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 127.251 2.844 . . . . 0.0 117.349 -172.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.4 46.77 11.6 Favored Glycine 0 N--CA 1.444 -0.77 0 O-C-N 117.33 -3.356 . . . . 0.0 107.857 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -104.47 111.38 24.02 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.614 -1.634 . . . . 0.0 106.912 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -96.24 118.73 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -108.4 126.46 52.9 Favored 'General case' 0 C--N 1.378 1.819 0 CA-C-O 122.87 1.319 . . . . 0.0 111.643 -167.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 68' ' ' ALA . 32.7 mm -107.35 104.94 17.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.208 -175.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.18 135.04 38.53 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' A' ' 45' ' ' THR . . . -149.61 158.58 44.3 Favored 'General case' 0 CA--C 1.486 -1.502 0 O-C-N 118.752 -2.468 . . . . 0.0 109.598 163.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.6 m -65.29 -37.14 86.24 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 115.218 -2.325 . . . . 0.0 114.748 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -102.52 153.95 19.58 Favored 'General case' 0 C--N 1.28 -2.451 1 O-C-N 129.922 4.514 . . . . 0.0 109.986 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.84 -48.96 61.96 Favored Glycine 0 C--N 1.374 2.676 0 C-N-CA 124.838 1.209 . . . . 0.0 112.603 171.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -61.57 -42.04 98.26 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.384 1.088 . . . . 0.0 112.078 -175.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -57.44 -44.35 84.67 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 110.783 -2.917 . . . . 0.0 115.888 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.75 95.63 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 173.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -68.66 -33.71 74.47 Favored 'General case' 0 CA--C 1.585 2.291 0 CA-C-O 123.787 1.756 . . . . 0.0 114.05 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -66.61 -44.16 82.84 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.29 2.236 . . . . 0.0 112.452 167.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 45' ' ' THR . . . -62.18 -45.55 92.88 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.519 169.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.5 mm -50.43 -42.5 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 167.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -73.53 -40.44 64.0 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 118.278 -0.867 . . . . 0.0 112.238 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -58.38 -44.13 88.76 Favored 'General case' 0 CA--C 1.579 2.094 0 CA-C-O 123.466 1.603 . . . . 0.0 114.393 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.7 mm -60.45 -48.51 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.083 0 C-N-CA 127.066 2.147 . . . . 0.0 114.679 168.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -57.16 -44.11 83.17 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 119.636 -1.915 . . . . 0.0 107.592 170.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -64.9 -39.52 93.66 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 121.056 1.753 . . . . 0.0 112.396 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.3 mt -62.4 -52.11 64.08 Favored 'Isoleucine or valine' 0 C--N 1.373 1.615 0 CA-C-O 117.014 -1.47 . . . . 0.0 112.999 168.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.9 p . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 123.367 1.556 . . . . 0.0 113.358 -170.339 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 N--CA 1.434 -1.251 0 CA-C-O 121.398 0.618 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -107.1 146.28 31.44 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.371 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.89 150.5 4.67 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.397 0 CA-C-O 124.188 1.946 . . . . 0.0 109.811 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.61 14.81 82.05 Favored Glycine 0 C--N 1.277 -2.702 0 CA-C-N 112.57 -2.104 . . . . 0.0 116.794 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -105.88 143.27 34.26 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 119.968 -1.901 . . . . 0.0 106.247 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.8 t -90.09 144.04 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 119.081 -1.048 . . . . 0.0 110.196 171.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -132.85 166.68 21.74 Favored 'General case' 0 C--N 1.404 2.97 0 O-C-N 125.915 2.009 . . . . 0.0 109.24 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 m -116.89 132.68 56.64 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.2 177.35 20.72 Favored Glycine 0 N--CA 1.419 -2.441 0 O-C-N 124.769 1.293 . . . . 0.0 111.725 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -118.46 136.29 53.88 Favored 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 123.79 1.757 . . . . 0.0 113.314 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.93 137.21 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.8 t -131.71 -18.34 2.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.871 1.357 . . . . 0.0 110.261 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 -142.18 150.86 41.59 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 172.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 mt -137.56 136.98 46.03 Favored 'Isoleucine or valine' 0 C--N 1.395 2.573 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.18 169.29 12.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 113.631 -1.622 . . . . 0.0 106.879 -162.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -54.13 -37.17 64.06 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -100.29 13.73 33.35 Favored 'General case' 0 N--CA 1.53 3.563 0 O-C-N 118.491 -2.63 . . . . 0.0 108.418 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 151.09 -159.34 28.13 Favored Glycine 0 C--O 1.183 -3.068 0 CA-C-N 123.445 2.839 . . . . 0.0 115.6 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.36 135.93 45.04 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -90.78 131.48 36.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.659 -1.275 . . . . 0.0 110.004 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 t -112.36 137.92 43.37 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.662 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.3 147.69 24.93 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 127.214 2.821 . . . . 0.0 105.592 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.7 pt -142.63 159.13 18.98 Favored 'Isoleucine or valine' 0 C--N 1.372 1.566 0 C-N-CA 125.715 1.606 . . . . 0.0 108.228 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.06 142.07 1.93 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 120.278 2.871 . . . . 0.0 120.278 -173.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.94 13.75 45.27 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 120.095 -1.826 . . . . 0.0 114.535 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.89 21.47 78.45 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 125.205 1.383 . . . . 0.0 110.943 -175.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -89.84 136.76 32.85 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.824 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -131.07 134.86 47.02 Favored 'General case' 0 C--N 1.361 1.1 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.31 161.68 24.7 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 125.304 1.43 . . . . 0.0 114.933 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.9 tp -95.4 125.26 39.9 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.817 -0.692 . . . . 0.0 111.657 -173.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.1 111.23 25.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 CA-C-O 115.674 -2.108 . . . . 0.0 105.663 164.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -60.73 153.8 23.25 Favored 'General case' 0 C--O 1.171 -3.049 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 171.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.479 HG13 HG22 ' A' ' 122' ' ' VAL . 20.6 tt -52.36 -31.6 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 119.737 -1.852 . . . . 0.0 114.536 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.0 p -83.38 -15.79 48.46 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -93.51 19.03 8.93 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.582 HD11 HG13 ' A' ' 122' ' ' VAL . 17.8 mt -92.14 -47.2 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-O 119.491 -0.29 . . . . 0.0 111.582 -173.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.5 162.63 38.67 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.081 0.952 . . . . 0.0 112.178 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.56 -37.78 87.67 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 125.032 2.349 . . . . 0.0 110.52 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -55.99 153.02 9.38 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 112.373 -2.194 . . . . 0.0 111.536 175.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -68.58 142.07 55.29 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 119.961 -1.712 . . . . 0.0 111.108 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.449 HG11 HD12 ' A' ' 114' ' ' ILE . 42.9 t -133.23 143.25 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.435 -175.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -112.95 -38.13 4.61 Favored 'General case' 0 C--N 1.37 1.493 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -173.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -143.44 146.71 33.67 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 169.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.582 HG13 HD11 ' A' ' 114' ' ' ILE . 24.7 t -74.14 -16.45 16.78 Favored 'Isoleucine or valine' 0 C--N 1.366 1.292 0 CA-C-O 122.856 1.312 . . . . 0.0 111.191 -164.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.3 p -85.44 -4.17 59.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -60.7 -40.61 92.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.924 1.29 . . . . 0.0 109.56 167.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -108.67 -24.87 11.14 Favored 'General case' 0 CA--C 1.557 1.22 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -118.04 126.53 52.46 Favored 'General case' 0 N--CA 1.517 2.912 0 O-C-N 117.821 -3.049 . . . . 0.0 113.696 -167.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -117.59 166.85 11.9 Favored 'General case' 0 C--O 1.199 -1.556 0 C-N-CA 117.042 -1.863 . . . . 0.0 109.507 166.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -62.13 145.07 54.38 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-O 126.102 2.858 . . . . 0.0 114.969 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.55 -6.04 26.27 Favored Glycine 0 C--O 1.21 -1.404 0 CA-C-O 115.758 -2.69 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -68.42 137.85 54.84 Favored 'General case' 0 C--N 1.361 1.079 0 CA-C-N 120.513 2.156 . . . . 0.0 115.747 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -88.03 104.48 16.69 Favored 'General case' 0 C--O 1.259 1.555 0 CA-C-O 123.854 1.788 . . . . 0.0 111.608 -164.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 m -108.57 117.95 53.11 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.048 -173.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -58.04 130.46 38.23 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.055 1.17 . . . . 0.0 112.285 158.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.37 145.67 34.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -111.69 138.3 48.45 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 119.564 -1.96 . . . . 0.0 109.338 171.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.34 139.77 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 117.343 -3.348 . . . . 0.0 112.504 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.8 mt -106.62 -36.69 6.67 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 115.277 -2.297 . . . . 0.0 109.803 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -157.81 164.23 37.22 Favored 'General case' 0 CA--C 1.473 -1.996 0 O-C-N 126.41 2.318 . . . . 0.0 107.116 -166.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.313 7.2 p -168.16 97.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-O 125.205 2.431 . . . . 0.0 110.154 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -71.65 165.91 22.99 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 119.882 -1.761 . . . . 0.0 112.273 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -61.03 -25.56 67.0 Favored 'General case' 0 C--N 1.37 1.466 0 O-C-N 125.331 1.644 . . . . 0.0 115.094 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -94.31 3.4 55.26 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.437 1.711 . . . . 0.0 110.723 -169.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.96 3.46 56.94 Favored Glycine 0 CA--C 1.552 2.38 0 O-C-N 119.432 -2.043 . . . . 0.0 113.9 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -84.2 118.4 24.12 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.813 1.245 . . . . 0.0 108.404 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.8 mt -125.32 131.39 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.268 -1.52 . . . . 0.0 108.965 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -109.16 146.47 34.07 Favored 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 120.635 1.561 . . . . 0.0 107.121 173.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.8 mt -129.64 157.19 42.8 Favored 'General case' 0 C--O 1.269 2.124 0 C-N-CA 126.194 1.798 . . . . 0.0 113.436 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.9 t -132.01 111.71 11.74 Favored 'General case' 0 C--N 1.387 2.232 0 O-C-N 126.99 2.681 . . . . 0.0 110.226 166.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.17 -41.63 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 158.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -66.38 -31.57 72.43 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-N 121.97 2.168 . . . . 0.0 111.831 -170.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.94 -49.0 72.08 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 124.694 1.198 . . . . 0.0 112.307 168.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.33 -42.17 81.4 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 126.148 2.155 . . . . 0.0 109.822 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.259 27.5 p . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 122.016 0.913 . . . . 0.0 113.211 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 118.783 -0.627 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -129.28 135.58 48.95 Favored 'General case' 0 CA--C 1.492 -1.275 0 O-C-N 125.134 1.521 . . . . 0.0 109.127 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 p -116.17 153.92 30.96 Favored 'General case' 0 C--N 1.377 1.78 0 C-N-CA 118.646 -1.222 . . . . 0.0 113.824 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.3 148.48 31.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 166.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -116.87 130.33 56.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -174.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.5 tp -150.04 170.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 121.762 2.074 . . . . 0.0 113.838 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -64.13 125.67 88.61 Favored Pre-proline 0 CA--C 1.561 1.4 0 O-C-N 119.156 -2.215 . . . . 0.0 110.308 -172.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.92 -20.04 22.67 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 123.465 2.777 . . . . 0.0 116.865 -165.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.9 -45.14 86.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 127.413 2.946 . . . . 0.0 111.265 167.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -79.89 -4.39 52.1 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.581 1.181 . . . . 0.0 110.553 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.413 ' HA ' ' HB ' ' A' ' 28' ' ' VAL . 17.2 mm -84.33 -22.37 8.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -77.94 -28.69 49.65 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 122.702 2.501 . . . . 0.0 107.99 173.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -57.85 -41.24 81.97 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.66 162.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 25' ' ' ILE 0.275 47.1 t -67.71 -38.75 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.594 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.326 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.06 -45.86 53.01 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.064 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.57 174.2 24.44 Favored Glycine 0 CA--C 1.556 2.612 0 O-C-N 126.096 2.122 . . . . 0.0 110.144 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -77.79 122.5 25.5 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 118.953 -2.499 . . . . 0.0 107.68 -165.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.94 19.36 75.25 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.125 -1.609 . . . . 0.0 110.529 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.8 16.91 66.83 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 117.348 1.699 . . . . 0.0 117.348 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.9 t -60.25 -42.95 96.38 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.9 t -80.78 -32.18 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 CA-C-N 121.031 1.741 . . . . 0.0 108.998 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tt -75.86 -31.09 21.82 Favored 'Isoleucine or valine' 0 C--N 1.374 1.65 0 CA-C-N 120.713 1.597 . . . . 0.0 110.741 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -59.68 -45.89 90.71 Favored 'General case' 0 CA--C 1.562 1.414 0 O-C-N 120.191 -1.568 . . . . 0.0 114.456 164.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.72 88.34 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 170.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 tp -61.06 -34.93 75.68 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.063 -1.881 . . . . 0.0 114.559 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.6 p -66.45 -42.97 86.84 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 122.641 2.473 . . . . 0.0 114.372 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -62.26 -46.38 89.07 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 127.411 2.944 . . . . 0.0 113.903 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -53.68 -46.2 70.59 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-O 117.207 -1.378 . . . . 0.0 114.27 174.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 p -88.62 -23.39 23.09 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 125.55 1.781 . . . . 0.0 114.607 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.36 27.71 54.49 Favored Glycine 0 CA--C 1.559 2.835 0 C-N-CA 125.41 1.481 . . . . 0.0 110.258 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.5 p -134.8 166.34 23.21 Favored 'General case' 0 C--N 1.373 1.626 0 CA-C-O 124.721 2.2 . . . . 0.0 108.955 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.5 m -102.01 126.13 48.86 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 111.613 -2.54 . . . . 0.0 106.565 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.4 mt -118.15 142.72 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.121 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 -171.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -145.08 139.62 27.5 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-O 123.572 1.653 . . . . 0.0 108.193 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.0 mm -101.36 139.2 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.175 -169.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -138.36 163.02 32.93 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 119.21 -2.181 . . . . 0.0 109.499 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.307 27.1 m-20 -55.44 142.09 34.05 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 112.897 -1.956 . . . . 0.0 114.954 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.277 31.9 t0 90.56 31.75 0.02 OUTLIER 'General case' 0 C--N 1.375 1.712 0 CA-C-N 110.322 -3.126 . . . . 0.0 111.177 172.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.95 46.66 90.92 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 125.754 1.645 . . . . 0.0 111.39 -169.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.1 m -103.37 121.32 42.54 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 119.777 1.788 . . . . 0.0 110.597 -171.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.28 122.05 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 123.261 1.505 . . . . 0.0 106.998 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.31 59.7 mtpt -106.95 139.38 41.44 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.266 44.1 mm -125.52 119.94 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.709 -1.244 . . . . 0.0 108.855 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.24 136.13 42.61 Favored 'General case' 0 CA--C 1.588 2.417 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.81 157.49 16.45 Favored 'General case' 0 C--N 1.398 2.695 0 C-N-CA 125.395 1.478 . . . . 0.0 110.794 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 m -92.31 -17.9 24.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 125.626 1.829 . . . . 0.0 112.793 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -123.36 141.41 52.01 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 120.131 -1.606 . . . . 0.0 110.307 -168.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.41 -48.58 81.17 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 112.637 -2.074 . . . . 0.0 114.012 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.4 -37.23 86.78 Favored 'General case' 0 CA--C 1.589 2.445 0 O-C-N 119.901 -1.94 . . . . 0.0 115.363 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -64.52 -41.64 96.26 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 120.522 -1.361 . . . . 0.0 109.174 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.24 -35.89 82.3 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 117.574 -1.203 . . . . 0.0 112.955 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -73.98 -33.9 64.01 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -64.95 -45.29 86.34 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 126.398 2.311 . . . . 0.0 114.101 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.61 86.22 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.629 173.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.67 -51.21 75.44 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.531 0 CA-C-O 116.648 -1.644 . . . . 0.0 112.606 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -61.76 -34.96 76.79 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 116.047 -1.93 . . . . 0.0 112.609 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -65.81 -39.44 90.88 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 124.538 1.149 . . . . 0.0 111.486 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.97 -48.52 88.18 Favored 'Isoleucine or valine' 0 C--N 1.368 1.396 0 CA-C-N 120.482 1.492 . . . . 0.0 108.616 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -45.37 -57.43 4.05 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.547 1.939 . . . . 0.0 114.07 172.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -58.94 -48.06 82.83 Favored 'General case' 0 N--CA 1.513 2.711 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 173.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.9 mt -66.42 -35.03 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.505 2.323 0 C-N-CA 124.79 1.236 . . . . 0.0 111.955 177.726 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.945 0.403 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -101.83 146.74 27.39 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-O 123.054 1.407 . . . . 0.0 112.801 171.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.05 143.24 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 113.424 -1.716 . . . . 0.0 109.829 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.93 26.01 56.74 Favored Glycine 1 N--CA 1.526 4.685 1 O-C-N 115.749 -4.344 . . . . 0.0 116.344 175.524 . . . . . . . . 3 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -119.1 150.14 40.52 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.61 -1.295 . . . . 0.0 112.536 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.49 126.9 54.0 Favored 'Isoleucine or valine' 0 C--O 1.255 1.367 0 CA-C-O 124.911 2.291 . . . . 0.0 113.102 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -126.95 160.92 29.6 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 109.908 -3.314 . . . . 0.0 104.989 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.9 m -119.6 139.92 51.4 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.06 -173.58 16.47 Favored Glycine 0 CA--C 1.576 3.844 0 CA-C-O 123.241 1.467 . . . . 0.0 112.416 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -128.91 138.48 52.03 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 123.109 1.433 . . . . 0.0 111.332 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.28 138.11 20.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 113.284 -1.78 . . . . 0.0 106.799 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.81 -28.97 3.45 Favored 'General case' 0 CA--C 1.478 -1.824 0 CA-C-O 114.951 -2.452 . . . . 0.0 106.842 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.5 mtm-85 -143.91 146.47 33.0 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 122.42 2.373 . . . . 0.0 108.589 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.28 138.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 CA-C-O 115.579 -2.153 . . . . 0.0 113.745 168.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.78 173.6 13.43 Favored 'Isoleucine or valine' 0 C--N 1.401 2.812 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.4 -18.21 65.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.257 24.6 p90 -103.16 0.8 32.29 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.498 0.719 . . . . 0.0 111.751 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.37 -172.52 31.57 Favored Glycine 0 C--N 1.357 1.72 0 C-N-CA 117.893 -2.098 . . . . 0.0 112.752 -162.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.55 132.81 35.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.281 93.5 m-85 -79.99 133.25 36.15 Favored 'General case' 0 C--N 1.371 1.532 0 O-C-N 126.893 2.621 . . . . 0.0 109.579 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.453 HG12 HG13 ' A' ' 101' ' ' ILE . 41.8 t -125.9 130.82 72.33 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 112.577 -2.102 . . . . 0.0 105.337 -171.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . 0.261 . . -96.05 124.56 40.11 Favored 'General case' 0 CA--C 1.578 2.029 0 CA-C-N 113.54 -1.664 . . . . 0.0 107.227 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.453 HG13 HG12 ' A' ' 99' ' ' VAL . 77.6 mt -112.37 144.73 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 126.334 1.854 . . . . 0.0 106.484 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -52.66 135.11 38.48 Favored Glycine 0 C--O 1.213 -1.194 0 CA-C-O 124.623 2.235 . . . . 0.0 116.125 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.16 4.73 56.41 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.357 1.932 . . . . 0.0 113.211 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.83 31.27 5.48 Favored Glycine 0 CA--C 1.473 -2.579 0 CA-C-O 117.054 -1.97 . . . . 0.0 112.795 171.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . 0.294 51.4 mmtt -120.52 118.25 29.75 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -165.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -105.04 135.69 45.91 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 125.002 2.334 . . . . 0.0 109.754 -170.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -139.77 166.68 25.56 Favored Glycine 0 C--O 1.215 -1.086 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.699 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . 0.276 14.6 tp -113.03 135.43 53.8 Favored 'General case' 0 N--CA 1.424 -1.725 0 C-N-CA 124.374 1.07 . . . . 0.0 108.217 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.0 t -102.99 115.98 45.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 162.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -67.66 165.69 16.62 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-O 124.582 2.134 . . . . 0.0 113.984 173.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.258 11.4 tt -61.29 -32.15 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-N 111.911 -2.404 . . . . 0.0 116.703 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.3 p -84.42 -5.66 59.3 Favored 'General case' 0 C--O 1.268 2.067 0 O-C-N 124.365 1.041 . . . . 0.0 112.427 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -106.97 14.74 26.12 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 116.62 2.082 . . . . 0.0 116.62 -168.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.0 mt -85.63 -48.51 16.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-O 116.179 -1.867 . . . . 0.0 114.07 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.2 165.18 28.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 126.587 2.43 . . . . 0.0 110.053 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.15 -33.64 76.24 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.132 166.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -74.45 148.63 40.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 123.242 1.496 . . . . 0.0 113.945 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -70.42 145.2 51.19 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.773 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 37.7 t -112.62 133.86 57.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 CA-C-O 124.169 1.938 . . . . 0.0 110.884 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.72 -42.17 9.74 Favored 'General case' 0 C--N 1.38 1.906 0 O-C-N 118.574 -2.579 . . . . 0.0 108.871 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -134.77 145.87 48.82 Favored 'General case' 0 N--CA 1.526 3.342 0 O-C-N 124.473 1.108 . . . . 0.0 110.043 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.23 -29.82 47.19 Favored 'Isoleucine or valine' 0 C--O 1.254 1.292 0 CA-C-O 122.776 1.274 . . . . 0.0 113.916 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.84 20.54 2.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -86.34 -15.33 40.86 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 121.109 1.777 . . . . 0.0 111.561 161.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -125.62 -79.48 0.6 Allowed 'General case' 0 C--O 1.208 -1.088 0 C-N-CA 126.701 2.0 . . . . 0.0 110.731 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.1 mt -70.57 152.37 44.02 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 121.692 2.042 . . . . 0.0 111.752 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -132.23 152.29 51.4 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 118.777 -2.452 . . . . 0.0 106.31 165.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 40.1 mtm -63.19 131.76 49.5 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.572 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.45 0.58 50.17 Favored Glycine 0 C--N 1.363 2.06 0 O-C-N 125.011 1.444 . . . . 0.0 114.211 -171.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -84.04 149.3 26.34 Favored 'General case' 0 C--O 1.2 -1.5 0 CA-C-O 123.729 1.728 . . . . 0.0 112.765 174.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -101.14 126.07 47.81 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.646 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 132' ' ' VAL . 14.2 m -137.11 121.02 12.06 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.322 -168.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.2 140.46 30.9 Favored 'Trans proline' 0 CA--C 1.492 -1.578 0 N-CA-C 107.512 -1.765 . . . . 0.0 107.512 166.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.16 126.11 29.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -163.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -91.18 135.81 33.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 102.243 -3.243 . . . . 0.0 102.243 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.2 t -79.67 136.44 23.56 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 110.947 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.8 mt -113.81 -33.81 5.67 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.604 0.716 . . . . 0.0 111.251 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 146' ' ' ARG 0.297 28.5 mt-10 -145.55 154.99 42.78 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 172.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.64 118.81 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.795 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -70.02 170.18 11.88 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 125.71 2.671 . . . . 0.0 114.058 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -66.23 -30.33 70.75 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 111.93 -2.395 . . . . 0.0 110.028 169.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -93.4 14.11 19.53 Favored 'General case' 0 C--N 1.364 1.221 0 CA-C-O 117.37 -1.3 . . . . 0.0 111.504 -176.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.65 53.14 25.7 Favored Glycine 0 C--N 1.358 1.777 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -133.76 135.11 43.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 127.698 2.646 . . . . 0.0 107.838 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.4 mt -124.11 134.88 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 O-C-N 124.956 1.41 . . . . 0.0 110.379 -162.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.435 HH21 ' CD ' ' A' ' 138' ' ' GLU . 1.8 mpp_? -102.46 134.05 46.41 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 124.967 2.318 . . . . 0.0 107.931 170.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.3 mt -134.65 156.3 48.99 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 120.518 -1.364 . . . . 0.0 110.428 -163.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 26.1 t -135.29 118.91 17.02 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 124.288 1.035 . . . . 0.0 111.581 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . 0.262 95.3 mt -81.23 -24.25 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 CA-C-O 123.791 1.758 . . . . 0.0 108.092 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.425 ' HZ2' ' CD ' ' A' ' 151' ' ' GLU . 14.6 pttp -86.69 -32.59 20.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.353 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLU . . . . . 0.425 ' CD ' ' HZ2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -69.92 -43.6 71.35 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.267 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.56 -19.41 60.9 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.551 -1.259 . . . . 0.0 112.624 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 CA--C 1.567 1.629 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.456 168.239 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 123.954 1.835 . . . . 0.0 115.515 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.7 mm -111.39 133.62 56.39 Favored 'Isoleucine or valine' 0 C--N 1.367 1.329 0 O-C-N 118.578 -2.576 . . . . 0.0 109.794 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . 0.3 47.0 m-70 -121.75 165.12 16.3 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 112.28 -2.236 . . . . 0.0 106.542 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -149.05 162.78 39.25 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 124.501 3.319 . . . . 0.0 111.415 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.9 tt -128.27 146.23 34.11 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 1 N-CA-C 99.485 -4.265 . . . . 0.0 99.485 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -126.97 130.15 49.52 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.138 -1.601 . . . . 0.0 107.174 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 20' ' ' ILE . 39.6 pt -139.51 170.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -161.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -81.61 140.71 47.93 Favored Pre-proline 0 C--O 1.192 -1.948 0 O-C-N 119.325 -2.109 . . . . 0.0 113.41 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -50.62 -26.64 17.45 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 123.198 2.599 . . . . 0.0 116.421 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -69.09 -25.81 64.61 Favored 'General case' 0 C--O 1.214 -0.78 0 O-C-N 119.909 -1.744 . . . . 0.0 113.636 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -82.16 -11.09 58.92 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.272 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.5 -35.5 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.566 0.698 . . . . 0.0 109.587 171.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -59.52 -36.63 76.47 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.83 -45.13 90.96 Favored 'General case' 0 C--N 1.355 0.804 0 C-N-CA 126.046 1.738 . . . . 0.0 111.904 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 t -66.07 -46.59 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 CA-C-O 115.562 -2.161 . . . . 0.0 114.579 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.6 mm -58.83 -38.36 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 123.65 2.932 . . . . 0.0 112.519 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.43 -127.06 8.16 Favored Glycine 0 CA--C 1.555 2.542 0 O-C-N 121.269 -0.895 . . . . 0.0 112.252 -172.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -104.69 95.54 5.96 Favored 'General case' 0 C--N 1.387 2.197 0 C-N-CA 128.417 2.687 . . . . 0.0 106.309 164.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.06 41.8 86.05 Favored Glycine 0 CA--C 1.479 -2.17 0 CA-C-O 114.708 -3.273 . . . . 0.0 116.152 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.53 12.2 57.32 Favored Glycine 0 N--CA 1.438 -1.224 0 O-C-N 127.648 2.617 . . . . 0.0 114.556 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.8 p -61.86 -52.25 64.88 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.86 -46.15 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 125.345 1.653 . . . . 0.0 113.111 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.3 mm -50.5 -47.06 27.45 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.385 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -56.61 -45.38 81.5 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.068 1.347 . . . . 0.0 110.816 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.72 73.34 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.069 -1.053 . . . . 0.0 113.439 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.48 -32.15 73.33 Favored 'General case' 0 C--O 1.199 -1.588 0 CA-C-O 117.457 -1.258 . . . . 0.0 112.783 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.8 m -66.3 -44.26 83.98 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 166.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -63.83 -45.61 88.79 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-O 121.611 0.72 . . . . 0.0 112.351 175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -64.55 -57.5 8.97 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.972 1.368 . . . . 0.0 110.435 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.5 p -79.53 -37.88 35.55 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.889 -167.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.9 22.48 57.69 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 123.792 1.773 . . . . 0.0 115.158 -170.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.8 p -109.58 165.36 11.72 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.472 -1.364 . . . . 0.0 110.204 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.1 m -106.11 132.52 52.09 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.56 124.03 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.859 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 -162.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -124.55 143.89 50.44 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.2 mt -118.37 143.85 28.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 125.915 2.009 . . . . 0.0 108.224 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 54' ' ' THR . 29.1 tt0 -142.79 155.11 44.77 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.27 65.9 m-20 -48.27 167.88 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -169.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.291 27.2 t0 61.41 25.18 15.18 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 113.188 -1.824 . . . . 0.0 109.454 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.25 23.42 58.93 Favored Glycine 0 C--N 1.375 2.718 0 C-N-CA 126.085 1.802 . . . . 0.0 117.009 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 50' ' ' GLU . 22.6 m -84.3 131.04 34.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 126.953 2.208 . . . . 0.0 112.707 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.45 119.42 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -99.47 131.99 45.11 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.025 2.93 . . . . 0.0 104.378 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.38 115.6 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 0 CA-C-O 123.516 1.627 . . . . 0.0 106.841 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.43 130.95 49.36 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 111.226 -2.715 . . . . 0.0 108.854 -174.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.03 170.62 18.44 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.033 1.733 . . . . 0.0 106.388 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 t -109.19 -9.86 15.0 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.679 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -123.02 131.91 53.91 Favored 'General case' 0 C--O 1.199 -1.573 0 O-C-N 117.591 -3.193 . . . . 0.0 105.825 168.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.31 -44.82 10.69 Favored Glycine 0 N--CA 1.508 3.448 0 C-N-CA 128.276 2.846 . . . . 0.0 112.24 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.27 -39.64 76.08 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -65.31 -47.84 75.18 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.48 84.32 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 117.627 -1.629 . . . . 0.0 113.355 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -53.28 -47.63 68.99 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 170.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -64.75 -44.71 89.23 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 171.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.12 74.16 Favored 'General case' 0 C--O 1.255 1.385 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 172.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.4 mt -59.99 -43.64 92.9 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 CA-C-O 123.856 1.789 . . . . 0.0 111.714 173.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -63.08 -43.75 97.68 Favored 'General case' 0 N--CA 1.496 1.826 1 O-C-N 116.2 -4.063 . . . . 0.0 112.508 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -66.31 -41.05 90.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 117.58 -1.2 . . . . 0.0 112.773 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.4 mt -57.2 -44.92 84.4 Favored 'Isoleucine or valine' 0 C--N 1.379 1.851 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 164.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -56.23 -40.2 73.74 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.23 1.581 . . . . 0.0 113.535 170.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -71.43 -36.98 71.48 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 121.51 0.671 . . . . 0.0 112.779 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 mt -65.54 -23.45 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 119.06 -2.275 . . . . 0.0 114.727 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 p -103.75 7.16 37.18 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 124.978 2.323 . . . . 0.0 110.855 175.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.92 -0.13 25.36 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 118.617 -2.552 . . . . 0.0 112.287 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -64.06 130.76 45.28 Favored 'General case' 0 C--O 1.185 -2.341 0 O-C-N 125.124 1.515 . . . . 0.0 109.661 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.2 mm -82.61 124.98 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.0 154.8 44.16 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.86 147.81 8.25 Favored 'Isoleucine or valine' 0 C--N 1.386 2.168 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.09 2.57 89.0 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -93.4 136.1 34.0 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 118.248 1.024 . . . . 0.0 112.536 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.4 t -104.33 134.57 45.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -141.21 174.88 10.11 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 112.579 -2.101 . . . . 0.0 112.651 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -116.26 125.25 51.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.55 176.72 20.17 Favored Glycine 0 C--O 1.18 -3.28 0 CA-C-N 112.76 -2.018 . . . . 0.0 110.894 -168.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 88' ' ' LYS . 23.5 ttmt -148.21 125.74 11.71 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 123.764 1.745 . . . . 0.0 111.478 -167.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.11 117.11 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 113.112 -1.858 . . . . 0.0 111.226 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -103.65 -36.82 7.76 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-O 118.321 -0.847 . . . . 0.0 113.133 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.0 mtm-85 -153.98 126.26 7.95 Favored 'General case' 0 C--O 1.199 -1.592 0 CA-C-O 123.039 1.399 . . . . 0.0 110.519 -168.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.2 115.85 50.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 C-N-CA 125.404 1.482 . . . . 0.0 108.74 -170.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.05 165.71 9.9 Favored 'Isoleucine or valine' 0 C--N 1.374 1.644 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -42.59 -36.87 1.5 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.034 1.734 . . . . 0.0 115.603 175.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -114.18 13.84 18.06 Favored 'General case' 0 CA--C 1.562 1.44 0 O-C-N 120.181 -1.574 . . . . 0.0 114.181 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.05 -179.45 41.25 Favored Glycine 0 CA--C 1.483 -1.921 0 C-N-CA 117.822 -2.132 . . . . 0.0 111.803 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.67 144.51 49.22 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 119.854 -1.968 . . . . 0.0 108.533 170.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -85.47 122.95 30.34 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.827 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.9 t -125.87 120.99 58.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 O-C-N 125.854 1.971 . . . . 0.0 106.521 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.59 139.39 30.59 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 126.25 2.219 . . . . 0.0 107.58 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 105' ' ' LYS 0.274 16.8 pt -131.93 168.49 23.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 110.964 -2.834 . . . . 0.0 110.311 170.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.59 132.77 3.7 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 119.827 2.691 . . . . 0.0 119.827 -169.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.69 11.08 75.01 Favored Glycine 0 N--CA 1.506 3.334 0 CA-C-O 117.626 -1.652 . . . . 0.0 110.221 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.03 39.65 7.37 Favored Glycine 0 C--O 1.25 1.135 0 O-C-N 126.086 1.698 . . . . 0.0 110.181 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.408 ' HB2' HG13 ' A' ' 101' ' ' ILE . 57.2 mttm -98.4 99.33 10.51 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 120.996 -1.296 . . . . 0.0 113.262 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.46 88.8 7.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.021 -1.674 . . . . 0.0 111.354 -174.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.26 159.11 53.53 Favored Glycine 0 N--CA 1.494 2.535 0 CA-C-N 120.135 1.334 . . . . 0.0 114.219 167.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.7 tp -105.45 111.13 23.73 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 125.928 1.605 . . . . 0.0 108.101 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.55 116.25 27.9 Favored 'Isoleucine or valine' 0 C--N 1.372 1.555 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -66.48 159.96 26.06 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.499 0.666 . . . . 0.0 112.617 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 19.5 tt -61.07 -20.08 21.38 Favored 'Isoleucine or valine' 0 C--N 1.366 1.287 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.3 p -97.64 13.02 31.62 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.072 0.463 . . . . 0.0 110.917 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -133.18 26.46 4.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.952 0.901 . . . . 0.0 109.904 -172.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.6 mm -95.59 -55.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 O-C-N 126.579 2.424 . . . . 0.0 107.336 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.72 176.6 11.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 119.344 -2.098 . . . . 0.0 113.105 -168.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -76.4 -35.38 58.63 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 122.884 1.326 . . . . 0.0 110.37 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -61.68 151.4 33.78 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 124.236 1.97 . . . . 0.0 112.22 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -64.05 142.3 58.46 Favored 'General case' 0 C--O 1.205 -1.244 0 C-N-CA 126.949 2.1 . . . . 0.0 111.11 169.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.5 t -121.84 129.01 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.074 -1.016 . . . . 0.0 109.499 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.74 -36.13 11.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 123.612 1.672 . . . . 0.0 108.843 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -150.85 144.05 24.79 Favored 'General case' 0 CA--C 1.565 1.549 0 O-C-N 117.832 -3.043 . . . . 0.0 107.216 175.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.72 -27.23 9.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.476 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.1 p -55.92 -19.91 13.97 Favored 'General case' 0 C--N 1.383 2.037 0 C-N-CA 128.649 2.78 . . . . 0.0 115.163 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -80.51 -25.42 38.74 Favored 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 128.113 2.565 . . . . 0.0 112.205 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -107.14 -26.63 11.02 Favored 'General case' 0 C--N 1.369 1.428 0 CA-C-N 114.184 -1.371 . . . . 0.0 113.243 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.1 mt -134.27 140.13 46.21 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 123.342 1.544 . . . . 0.0 113.62 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -122.35 158.93 28.54 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 102.059 -3.312 . . . . 0.0 102.059 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . 0.311 0.8 OUTLIER -70.31 145.81 50.98 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 123.462 1.601 . . . . 0.0 113.838 171.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.96 -4.04 60.8 Favored Glycine 0 C--N 1.356 1.681 0 CA-C-N 111.896 -2.411 . . . . 0.0 115.428 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -94.67 142.35 27.56 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 123.377 1.561 . . . . 0.0 112.079 -169.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -86.46 134.52 33.68 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 119.871 -1.768 . . . . 0.0 107.477 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.71 148.12 65.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.69 137.22 6.57 Favored 'Trans proline' 0 C--N 1.28 -3.062 0 C-N-CA 122.118 1.878 . . . . 0.0 110.969 172.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.18 142.89 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 118.822 -2.424 . . . . 0.0 109.167 -169.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -112.33 134.89 53.62 Favored 'General case' 0 C--O 1.18 -2.568 0 C-N-CA 123.433 0.693 . . . . 0.0 110.198 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.61 140.65 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 124.221 1.963 . . . . 0.0 114.433 172.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 148' ' ' SER . 20.4 mt -106.34 -66.35 1.01 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 123.01 1.386 . . . . 0.0 110.097 170.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -128.59 147.97 50.75 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 120.341 -1.474 . . . . 0.0 109.382 -175.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.52 129.08 64.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-O 117.33 -1.319 . . . . 0.0 107.518 169.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -86.85 155.37 20.29 Favored 'General case' 0 C--N 1.371 1.512 0 O-C-N 126.068 2.105 . . . . 0.0 111.808 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -60.46 -39.98 89.52 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -57.61 -30.29 65.21 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 166.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.35 -7.11 9.86 Favored Glycine 0 N--CA 1.514 3.862 0 CA-C-N 122.376 2.353 . . . . 0.0 117.076 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -62.94 146.46 52.95 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 80.9 mt -133.2 135.98 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.28 -1.327 . . . . 0.0 114.158 -173.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.24 128.97 56.41 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 117.928 -1.509 . . . . 0.0 108.576 167.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.6 mt -114.03 168.3 9.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.194 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.463 ' HB2' HD11 ' A' ' 137' ' ' LEU . 28.8 t -137.8 127.0 24.48 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 112.312 -2.222 . . . . 0.0 113.167 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 95.6 mt -86.87 -32.97 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 CA-C-O 122.82 1.295 . . . . 0.0 109.823 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -70.54 -30.61 67.39 Favored 'General case' 0 C--O 1.252 1.206 0 C-N-CA 119.034 -1.066 . . . . 0.0 113.047 -164.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.31 -5.17 58.49 Favored 'General case' 0 C--N 1.381 1.968 0 CA-C-N 120.172 1.351 . . . . 0.0 110.222 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.2 -1.68 33.2 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.414 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.4 m -75.48 -32.91 60.74 Favored 'General case' 0 CA--C 1.568 1.667 0 C-N-CA 124.893 1.277 . . . . 0.0 113.576 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 50.94 45.9 27.01 Favored 'General case' 0 CA--C 1.579 2.068 0 O-C-N 128.132 3.395 . . . . 0.0 114.95 170.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 . . . . . 0 C--N 1.295 -1.798 0 O-C-N 118.615 -2.553 . . . . 0.0 111.932 173.508 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.57 136.22 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.1 -1.0 . . . . 0.0 108.442 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -116.15 147.81 40.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 128.556 3.66 . . . . 0.0 114.385 164.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -128.48 130.33 47.37 Favored 'General case' 0 C--N 1.366 1.32 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.8 mm -133.66 133.02 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -166.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -98.67 137.48 37.24 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.493 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.5 pt -144.45 162.87 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 117.078 -1.439 . . . . 0.0 107.86 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -65.25 130.4 94.74 Favored Pre-proline 0 CA--C 1.597 2.766 0 O-C-N 125.281 1.613 . . . . 0.0 111.051 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -78.47 -7.83 15.96 Favored 'Trans proline' 0 N--CA 1.512 2.604 1 C-N-CA 125.885 4.39 . . . . 0.0 111.113 -172.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -83.53 5.26 24.69 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.173 -1.579 . . . . 0.0 109.021 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -131.61 5.11 4.3 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 115.487 -2.196 . . . . 0.0 111.191 -170.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.5 mt -61.79 -45.25 99.09 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 CA-C-O 117.34 -1.314 . . . . 0.0 110.126 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.03 -26.04 9.89 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.892 1.37 . . . . 0.0 114.35 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -90.12 -21.61 22.17 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -168.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.5 t -80.19 -26.61 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 125.218 1.574 . . . . 0.0 109.978 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.8 mt -81.62 -65.02 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 112.917 -3.421 . . . . 0.0 105.691 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.68 166.83 40.93 Favored Glycine 0 C--N 1.371 2.511 0 CA-C-N 123.949 3.068 . . . . 0.0 113.683 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -49.25 113.91 0.91 Allowed 'General case' 0 C--N 1.382 1.991 0 CA-C-O 122.94 1.352 . . . . 0.0 113.157 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.41 14.52 79.34 Favored Glycine 0 N--CA 1.505 3.241 0 O-C-N 118.998 -2.314 . . . . 0.0 113.624 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.8 28.54 73.73 Favored Glycine 0 C--O 1.259 1.667 0 CA-C-O 123.872 1.818 . . . . 0.0 113.698 -162.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 99.4 p -61.74 -44.42 96.94 Favored 'General case' 0 C--N 1.38 1.899 0 N-CA-C 118.305 2.706 . . . . 0.0 118.305 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.68 -39.96 85.01 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.231 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 tt -61.53 -44.63 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-N 119.844 1.202 . . . . 0.0 111.846 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -62.85 -41.71 99.47 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 171.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.37 -44.79 84.72 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 117.578 -3.201 . . . . 0.0 113.447 168.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.6 mt -63.63 -36.45 83.87 Favored 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 126.886 2.616 . . . . 0.0 112.136 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 m -58.48 -52.43 65.67 Favored 'General case' 0 CA--C 1.583 2.222 0 O-C-N 125.822 1.952 . . . . 0.0 114.024 169.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.23 -40.73 95.12 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 125.906 1.683 . . . . 0.0 108.75 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -69.7 -41.88 74.81 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.1 p -105.05 -29.91 10.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 117.714 -1.136 . . . . 0.0 114.06 -166.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.57 24.63 27.81 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 119.911 1.232 . . . . 0.0 112.802 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.5 p -121.3 167.83 12.31 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 124.52 0.776 . . . . 0.0 110.115 -168.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.5 m -125.96 119.05 26.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 119.696 -0.801 . . . . 0.0 109.681 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.4 mt -116.48 120.11 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 126.078 2.111 . . . . 0.0 107.964 -161.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -121.29 129.54 53.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.888 -1.96 . . . . 0.0 109.633 171.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 tt -124.56 150.38 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.783 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.0 157.41 41.78 Favored 'General case' 0 C--O 1.262 1.763 0 O-C-N 124.16 0.912 . . . . 0.0 109.746 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -81.92 2.34 31.01 Favored 'General case' 0 C--N 1.391 2.404 0 C-N-CA 124.748 1.219 . . . . 0.0 113.202 -157.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -94.88 6.93 47.6 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 126.32 2.962 . . . . 0.0 110.631 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.51 48.39 4.78 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 126.883 2.183 . . . . 0.0 112.493 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.2 m -128.22 134.67 49.04 Favored 'General case' 0 C--O 1.261 1.676 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.24 148.05 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 C-N-CA 116.955 -1.898 . . . . 0.0 111.595 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 128.96 56.61 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 121.155 -0.965 . . . . 0.0 109.0 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 mt -120.92 123.91 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 118.341 -2.724 . . . . 0.0 111.419 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.8 135.2 53.82 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . . . -158.14 158.69 35.13 Favored 'General case' 0 CA--C 1.583 2.216 0 CA-C-N 113.403 -1.726 . . . . 0.0 109.253 -173.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.7 p -107.35 -0.9 22.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 119.593 -1.942 . . . . 0.0 114.713 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -145.19 163.64 33.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 171.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.31 -39.81 17.85 Favored Glycine 0 N--CA 1.489 2.228 0 O-C-N 118.566 -2.584 . . . . 0.0 113.486 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.304 84.2 mt-10 -61.47 -39.18 89.96 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 119.479 -2.189 . . . . 0.0 112.884 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.72 -43.02 90.02 Favored 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 119.162 0.892 . . . . 0.0 109.016 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . . . -67.32 -36.88 82.38 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 123.205 1.478 . . . . 0.0 114.149 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -64.41 -39.42 93.81 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 120.625 -1.297 . . . . 0.0 112.393 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -60.63 -36.18 78.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 117.457 2.392 . . . . 0.0 117.457 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.0 -48.64 70.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.801 1.64 . . . . 0.0 113.205 163.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.39 -41.17 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 CA-C-N 119.842 1.201 . . . . 0.0 113.551 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -59.99 -42.45 94.26 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.672 1.589 . . . . 0.0 112.274 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.5 mmt85 -67.11 -43.66 81.91 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 118.437 -2.665 . . . . 0.0 111.195 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.77 -49.7 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.323 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -59.98 -38.27 82.05 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 119.423 1.01 . . . . 0.0 112.433 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -61.66 -56.92 14.55 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 125.805 1.941 . . . . 0.0 114.304 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.0 mt -58.58 -45.25 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 O-C-N 123.794 0.684 . . . . 0.0 110.488 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.6 p -80.09 -10.46 59.77 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 117.483 -1.687 . . . . 0.0 110.548 -168.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.62 72.79 Favored 'General case' 0 CA--C 1.589 2.449 0 O-C-N 124.41 1.069 . . . . 0.0 113.628 168.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -66.78 119.19 11.42 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.516 -168.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 mm -73.55 132.11 33.9 Favored 'Isoleucine or valine' 0 C--N 1.375 1.693 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -85.14 145.45 27.62 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-O 124.189 1.947 . . . . 0.0 115.762 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.81 132.23 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.333 1 CA-C-O 129.012 4.244 . . . . 0.0 114.493 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.48 17.08 64.95 Favored Glycine 0 C--O 1.245 0.842 0 CA-C-N 111.084 -2.78 . . . . 0.0 109.418 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -102.81 135.96 43.5 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 119.598 1.699 . . . . 0.0 109.376 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.96 115.49 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 116.627 -2.029 . . . . 0.0 107.435 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -99.34 163.99 12.3 Favored 'General case' 0 C--N 1.38 1.916 0 CA-C-N 119.668 1.122 . . . . 0.0 111.565 170.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.1 m -128.76 134.88 48.55 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.1 159.45 28.03 Favored Glycine 0 CA--C 1.486 -1.749 0 CA-C-O 116.251 -2.416 . . . . 0.0 112.722 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -71.25 132.8 45.47 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 120.753 2.277 . . . . 0.0 110.905 166.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -54.28 130.13 15.93 Favored 'Isoleucine or valine' 0 C--N 1.391 2.404 0 C-N-CA 126.801 2.041 . . . . 0.0 110.586 159.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.4 p -108.79 -38.96 5.49 Favored 'General case' 0 CA--C 1.499 -0.985 0 O-C-N 119.253 -2.154 . . . . 0.0 110.132 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mmt-85 -151.63 160.43 43.65 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 117.61 -1.636 . . . . 0.0 108.293 -169.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.8 mt -135.14 121.32 32.49 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.39 177.14 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 120.771 1.623 . . . . 0.0 108.56 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -63.46 -39.6 94.89 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.629 1.206 . . . . 0.0 110.237 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -93.2 6.43 48.06 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.39 -178.09 33.91 Favored Glycine 0 C--O 1.202 -1.894 0 CA-C-O 116.848 -2.085 . . . . 0.0 112.677 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.08 141.06 51.86 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-N 118.783 1.292 . . . . 0.0 111.001 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 47.2 m-85 -87.99 130.76 34.86 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 124.594 1.184 . . . . 0.0 112.51 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.67 137.42 46.87 Favored 'Isoleucine or valine' 0 C--N 1.379 1.874 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.079 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.9 127.68 48.62 Favored 'General case' 0 C--O 1.189 -2.099 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.27 143.2 18.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.91 155.09 1.27 Allowed Glycine 0 CA--C 1.545 1.912 0 CA-C-O 124.01 1.894 . . . . 0.0 117.479 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.27 19.33 64.81 Favored Glycine 0 CA--C 1.573 3.682 0 O-C-N 119.238 -2.331 . . . . 0.0 115.223 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.6 35.56 81.22 Favored Glycine 0 N--CA 1.484 1.857 1 N-CA-C 123.204 4.042 . . . . 0.0 123.204 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -115.84 115.51 26.38 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -107.42 124.44 49.85 Favored 'General case' 0 N--CA 1.527 3.381 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.341 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.84 155.74 16.02 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 118.142 2.017 . . . . 0.0 118.142 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.458 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 30.1 tp -96.31 120.28 36.32 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 113.486 -1.357 . . . . 0.0 109.718 -173.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.27 111.81 24.87 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 CA-C-O 118.365 -0.826 . . . . 0.0 109.224 157.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -66.98 156.45 35.94 Favored 'General case' 0 C--N 1.377 1.782 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.41 -30.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.967 0.907 . . . . 0.0 112.077 -169.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 65.0 p -80.46 -12.5 59.55 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -106.91 5.5 28.39 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -173.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.09 -50.85 23.23 Favored 'Isoleucine or valine' 0 C--N 1.393 2.467 0 CA-C-N 122.173 2.26 . . . . 0.0 107.889 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -126.74 158.51 36.3 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.276 49.1 p30 -64.51 -38.47 91.15 Favored 'General case' 0 C--N 1.391 2.398 0 O-C-N 118.97 -2.331 . . . . 0.0 113.713 161.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -85.6 141.12 30.05 Favored 'General case' 0 N--CA 1.415 -2.207 0 O-C-N 119.249 -2.157 . . . . 0.0 112.501 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -41.87 130.82 3.37 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-N 112.042 -2.344 . . . . 0.0 116.346 170.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 t -113.98 111.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 120.758 1.617 . . . . 0.0 107.275 -163.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.43 -46.38 66.91 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 116.181 -1.866 . . . . 0.0 107.596 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -149.89 133.01 16.29 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 128.755 3.785 . . . . 0.0 109.473 -176.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.51 -20.22 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 O-C-N 119.846 -1.784 . . . . 0.0 110.872 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.8 p -56.6 -29.99 62.73 Favored 'General case' 0 C--N 1.377 1.776 0 C-N-CA 125.951 1.7 . . . . 0.0 110.286 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -65.11 -33.76 76.79 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 128.43 2.692 . . . . 0.0 111.76 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -112.25 -30.77 7.08 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 72.8 mt -121.42 123.13 41.34 Favored 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -91.99 130.07 37.81 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-O 122.213 1.006 . . . . 0.0 112.003 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 21.0 mmt -61.05 111.1 1.56 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.2 16.32 64.98 Favored Glycine 0 CA--C 1.547 2.048 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.525 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -113.61 143.32 44.76 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 124.576 2.132 . . . . 0.0 112.821 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.52 146.12 49.72 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -171.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 p -144.17 142.92 20.74 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 166.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.79 136.76 68.41 Favored 'Trans proline' 0 C--N 1.284 -2.865 0 C-N-CA 121.876 1.717 . . . . 0.0 114.524 160.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.82 120.91 17.33 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.235 0 CA-C-O 124.331 2.015 . . . . 0.0 107.06 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.458 ' N ' ' HB2' ' A' ' 152' ' ' ALA . 65.1 tttt -88.29 137.4 32.36 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 119.447 -2.033 . . . . 0.0 111.717 170.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.6 t -90.89 91.55 3.64 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.532 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.7 mt -53.75 -43.9 69.53 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 126.335 2.272 . . . . 0.0 113.601 171.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -165.1 156.26 14.53 Favored 'General case' 0 C--O 1.255 1.349 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.99 79.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 126.312 2.258 . . . . 0.0 104.993 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.532 0.5 OUTLIER -61.63 141.62 57.68 Favored 'General case' 0 CA--C 1.58 2.1 0 CA-C-N 114.161 -1.381 . . . . 0.0 110.935 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -84.96 -0.02 52.88 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-O 115.078 -2.392 . . . . 0.0 108.269 -167.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -90.68 14.27 13.84 Favored 'General case' 0 C--N 1.384 2.104 0 CA-C-N 121.123 1.783 . . . . 0.0 107.676 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.71 24.07 40.14 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 115.08 -3.066 . . . . 0.0 115.517 -173.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -120.33 114.18 21.47 Favored 'General case' 0 CA--C 1.593 2.619 0 CA-C-N 122.469 3.134 . . . . 0.0 110.659 -171.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.1 mt -102.92 125.9 57.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 CA-C-O 117.242 -1.361 . . . . 0.0 110.953 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -120.65 135.91 54.98 Favored 'General case' 0 C--N 1.368 1.409 0 O-C-N 128.583 3.677 . . . . 0.0 113.524 -171.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 51.2 mt -129.95 148.39 51.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 112.074 -2.33 . . . . 0.0 110.315 -164.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.2 t -113.82 123.79 50.66 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.4 -43.28 42.86 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 O-C-N 119.318 -2.114 . . . . 0.0 108.551 161.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -46.18 -61.36 1.8 Allowed 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 117.293 -1.336 . . . . 0.0 112.011 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -66.67 -27.56 67.76 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 122.372 2.351 . . . . 0.0 113.531 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.458 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -81.74 -7.11 59.56 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 118.77 -2.456 . . . . 0.0 112.802 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.9 p -109.79 5.04 22.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.913 1.383 . . . . 0.0 113.615 170.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.314 48.0 mt-10 71.93 36.88 1.1 Allowed 'General case' 0 C--O 1.254 1.338 0 CA-C-O 125.667 2.651 . . . . 0.0 111.428 166.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 . . . . . 0 N--CA 1.434 -1.237 0 CA-C-O 113.361 -3.209 . . . . 0.0 110.617 178.704 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.66 127.25 65.29 Favored 'Isoleucine or valine' 0 C--N 1.363 1.18 0 C-N-CA 125.571 1.548 . . . . 0.0 109.526 -176.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -121.84 164.41 17.55 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 116.68 -1.629 . . . . 0.0 108.415 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.5 t -153.9 159.22 41.67 Favored 'General case' 0 C--N 1.378 1.834 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 pt -161.9 155.18 3.1 Favored 'Isoleucine or valine' 0 C--N 1.369 1.421 0 C-N-CA 129.467 3.107 . . . . 0.0 103.647 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -121.57 122.25 39.26 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.454 -164.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.4 pt -127.14 142.53 43.26 Favored 'Isoleucine or valine' 0 C--N 1.387 2.215 0 C-N-CA 125.661 1.584 . . . . 0.0 111.1 -169.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -42.23 126.17 2.78 Favored Pre-proline 0 C--O 1.203 -1.389 0 C-N-CA 129.856 3.262 . . . . 0.0 114.556 175.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.57 -26.6 83.2 Favored 'Trans proline' 1 N--CA 1.54 4.214 0 N-CA-C 117.426 2.048 . . . . 0.0 117.426 -169.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.25 45.9 t0 -58.67 -38.28 77.85 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 129.71 3.204 . . . . 0.0 113.495 172.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -92.72 3.05 56.33 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.921 -1.112 . . . . 0.0 113.15 -168.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.77 -34.99 73.66 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 O-C-N 120.857 -1.152 . . . . 0.0 110.556 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -59.78 -34.81 73.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 117.336 -3.352 . . . . 0.0 114.718 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -86.5 -36.65 18.87 Favored 'General case' 0 C--N 1.38 1.933 0 O-C-N 125.76 1.913 . . . . 0.0 112.062 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.12 -37.91 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 CA-C-N 121.882 2.128 . . . . 0.0 113.512 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.0 mm -75.15 -47.37 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 C-N-CA 126.422 1.889 . . . . 0.0 112.585 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.72 -176.28 50.95 Favored Glycine 0 CA--C 1.484 -1.879 0 O-C-N 126.047 2.092 . . . . 0.0 113.566 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.297 42.2 mttp -58.11 111.71 1.28 Allowed 'General case' 0 C--N 1.36 1.057 0 CA-C-N 113.748 -1.226 . . . . 0.0 111.957 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.98 25.46 31.09 Favored Glycine 0 N--CA 1.488 2.16 0 O-C-N 127.064 2.727 . . . . 0.0 114.645 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.02 9.85 83.69 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.2 t -65.23 -39.98 93.44 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 119.069 1.435 . . . . 0.0 111.677 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.46 -45.54 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 O-C-N 126.295 2.247 . . . . 0.0 108.619 -170.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.5 tp -66.35 -28.93 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 CA-C-O 117.338 -1.315 . . . . 0.0 112.032 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -60.83 -46.82 89.04 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 120.913 1.688 . . . . 0.0 113.504 162.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.58 65.05 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 128.111 2.564 . . . . 0.0 111.045 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.18 -42.63 98.91 Favored 'General case' 0 C--N 1.374 1.644 0 O-C-N 123.752 0.658 . . . . 0.0 112.084 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 t -67.3 -43.37 81.88 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 115.817 -2.039 . . . . 0.0 114.279 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -59.61 -42.82 93.47 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 122.118 2.235 . . . . 0.0 110.913 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -73.0 -41.98 63.72 Favored 'General case' 0 C--O 1.254 1.331 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.2 p -80.53 -42.99 21.46 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 124.598 2.142 . . . . 0.0 109.711 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.76 37.27 11.97 Favored Glycine 0 C--O 1.239 0.445 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.56 145.61 35.31 Favored 'General case' 0 C--N 1.391 2.376 0 CA-C-O 116.973 -1.489 . . . . 0.0 108.864 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 m -93.52 130.28 39.44 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.35 128.14 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.23 133.25 40.64 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.443 HG12 HG22 ' A' ' 55' ' ' VAL . 10.7 mt -116.56 127.71 74.1 Favored 'Isoleucine or valine' 0 C--N 1.378 1.847 0 CA-C-O 123.67 1.7 . . . . 0.0 111.743 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -80.03 152.97 29.13 Favored 'General case' 0 C--O 1.188 -2.147 0 CA-C-O 115.345 -2.264 . . . . 0.0 115.525 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -74.17 19.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 115.051 -2.404 . . . . 0.0 115.016 -169.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -121.2 11.35 10.84 Favored 'General case' 0 C--N 1.371 1.533 0 CA-C-O 114.82 -2.514 . . . . 0.0 110.298 165.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.39 9.08 48.45 Favored Glycine 0 C--N 1.357 1.695 0 CA-C-N 121.131 1.787 . . . . 0.0 111.465 165.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -89.66 129.21 36.13 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-O 117.189 -1.386 . . . . 0.0 108.392 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.443 HG22 HG12 ' A' ' 49' ' ' ILE . 48.5 t -114.04 128.85 70.81 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.68 0 O-C-N 126.143 2.152 . . . . 0.0 105.728 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -110.5 134.23 52.56 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 126.691 1.997 . . . . 0.0 108.908 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.05 130.63 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.25 139.06 43.48 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 117.537 -1.22 . . . . 0.0 111.033 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.49 150.85 18.19 Favored 'General case' 0 C--N 1.364 1.235 0 CA-C-O 122.917 1.342 . . . . 0.0 110.916 -165.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.284 7.1 t -114.95 -45.61 2.96 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.566 160.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -76.63 140.63 41.06 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 123.867 3.031 . . . . 0.0 114.23 171.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.93 -29.98 24.53 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 113.851 -1.522 . . . . 0.0 114.927 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -66.59 -38.52 87.19 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 119.465 -2.197 . . . . 0.0 114.581 166.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -64.35 -30.66 71.7 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 116.989 -3.57 . . . . 0.0 112.939 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.48 -46.78 81.54 Favored 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 119.367 -0.933 . . . . 0.0 113.431 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -60.82 -41.23 95.3 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.24 2.216 . . . . 0.0 111.014 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -54.62 -51.14 66.31 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.168 -1.582 . . . . 0.0 111.826 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.51 91.04 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.913 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 61.3 mt -66.35 -43.46 91.37 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 CA-C-N 119.521 1.055 . . . . 0.0 110.894 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -74.33 -28.16 61.03 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -71.24 -37.3 72.01 Favored 'General case' 0 C--O 1.211 -0.951 0 O-C-N 120.416 -1.427 . . . . 0.0 112.728 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 mt -62.88 -38.69 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 121.433 1.924 . . . . 0.0 111.003 165.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.69 -45.52 82.53 Favored 'General case' 0 C--N 1.373 1.597 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -174.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -51.71 -51.79 53.32 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 167.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.02 -35.48 69.19 Favored 'Isoleucine or valine' 0 C--O 1.271 2.208 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.8 p -80.25 -16.51 54.55 Favored 'General case' 0 N--CA 1.516 2.844 0 CA-C-O 123.5 1.619 . . . . 0.0 111.25 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.64 -21.33 61.12 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -69.88 115.31 8.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.021 -1.675 . . . . 0.0 113.781 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.2 pt -72.3 149.8 8.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 CA-C-O 125.201 2.429 . . . . 0.0 113.084 -177.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -132.35 148.5 52.43 Favored 'General case' 0 C--N 1.366 1.301 0 O-C-N 118.447 -2.658 . . . . 0.0 110.607 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.03 144.52 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.402 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.3 13.78 58.18 Favored Glycine 0 C--N 1.381 3.045 0 N-CA-C 117.996 1.958 . . . . 0.0 117.996 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -135.27 157.89 45.77 Favored 'General case' 0 C--O 1.205 -1.289 0 O-C-N 118.462 -2.787 . . . . 0.0 108.2 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 135' ' ' LYS . 24.8 t -107.93 146.48 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -136.66 167.68 20.94 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.2 m -105.85 123.38 47.86 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 120.305 1.411 . . . . 0.0 109.297 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.44 -164.18 19.98 Favored Glycine 0 C--N 1.366 2.235 0 CA-C-N 111.466 -2.606 . . . . 0.0 112.659 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -146.67 150.71 35.96 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 126.242 1.789 . . . . 0.0 107.518 164.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.458 HG21 HD22 ' A' ' 126' ' ' LEU . 78.3 t -77.55 112.97 16.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -86.09 -17.8 34.11 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 175.27 141.59 0.05 Allowed 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -169.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.8 mt -126.87 125.75 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.312 -169.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.14 177.69 2.21 Favored 'Isoleucine or valine' 0 C--N 1.364 1.216 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.785 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -58.06 -44.68 87.62 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.852 1.345 . . . . 0.0 112.92 -163.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -110.33 22.38 15.58 Favored 'General case' 0 CA--C 1.555 1.164 0 O-C-N 119.255 -2.153 . . . . 0.0 112.066 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.02 170.7 36.24 Favored Glycine 0 C--O 1.21 -1.377 0 C-N-CA 118.751 -1.69 . . . . 0.0 114.594 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.17 125.93 36.22 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -81.82 130.9 35.22 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.92 128.17 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -167.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 106' ' ' GLU . . . -100.84 125.57 47.37 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.545 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.8 mt -110.25 138.39 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -36.28 151.42 0.02 OUTLIER Glycine 0 C--N 1.37 2.423 0 N-CA-C 119.328 2.491 . . . . 0.0 119.328 -165.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.4 25.45 68.13 Favored Glycine 0 C--O 1.186 -2.905 0 CA-C-O 113.767 -3.796 . . . . 0.0 112.152 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.09 26.78 69.93 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 128.514 2.959 . . . . 0.0 116.955 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -92.8 93.44 8.43 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 31.6 tt0 -101.6 117.65 35.33 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -113.82 179.08 18.69 Favored Glycine 0 C--O 1.215 -1.039 0 O-C-N 126.998 2.686 . . . . 0.0 112.613 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.7 tp -120.41 125.51 48.13 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.659 -1.638 . . . . 0.0 109.891 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 148' ' ' SER . 20.3 t -95.01 111.46 25.67 Favored 'Isoleucine or valine' 0 C--N 1.371 1.523 0 O-C-N 124.857 1.348 . . . . 0.0 109.571 170.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -63.71 149.94 45.54 Favored 'General case' 0 C--O 1.208 -1.11 0 O-C-N 121.423 -0.798 . . . . 0.0 109.758 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -56.43 -8.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.425 0 C-N-CA 125.579 1.552 . . . . 0.0 115.022 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.4 p -101.92 2.92 38.55 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 125.119 1.368 . . . . 0.0 113.605 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -130.77 18.62 5.13 Favored 'General case' 0 C--O 1.257 1.472 0 CA-C-N 119.225 0.92 . . . . 0.0 111.798 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.75 -43.4 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-O 124.588 2.137 . . . . 0.0 109.976 170.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.68 163.62 33.42 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 119.931 -1.731 . . . . 0.0 109.477 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -72.17 -38.2 69.18 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 123.177 1.465 . . . . 0.0 112.756 168.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -80.48 145.55 31.82 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 125.958 1.703 . . . . 0.0 113.101 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -70.66 130.35 41.55 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.82 130.02 75.04 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -173.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -103.72 -24.58 13.33 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 120.612 -1.305 . . . . 0.0 110.931 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.39 139.48 31.7 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 125.555 1.784 . . . . 0.0 107.166 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -81.27 -22.7 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.775 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -165.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 p -63.02 -19.68 64.59 Favored 'General case' 0 C--N 1.374 1.673 0 O-C-N 119.492 -2.005 . . . . 0.0 115.462 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -59.39 -40.26 85.99 Favored 'General case' 0 C--O 1.192 -1.956 0 C-N-CA 125.25 1.42 . . . . 0.0 113.401 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.68 0.2 14.5 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 125.313 1.445 . . . . 0.0 111.143 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.458 HD22 HG21 ' A' ' 89' ' ' VAL . 9.4 mt -153.75 150.12 28.17 Favored 'General case' 0 C--N 1.376 1.731 0 O-C-N 119.032 -2.292 . . . . 0.0 110.05 -170.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -148.66 151.4 34.89 Favored 'General case' 0 C--N 1.38 1.895 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -63.13 142.38 58.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 125.664 2.649 . . . . 0.0 114.058 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.1 -4.24 86.18 Favored Glycine 0 CA--C 1.46 -3.354 0 C-N-CA 129.193 3.282 . . . . 0.0 116.659 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -65.6 127.77 33.25 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 127.147 3.356 . . . . 0.0 109.885 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -78.59 125.69 29.71 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 118.406 -2.684 . . . . 0.0 112.72 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.03 138.93 31.74 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.48 -168.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -72.86 124.07 9.4 Favored 'Trans proline' 0 CA--C 1.5 -1.202 0 C-N-CA 123.736 2.957 . . . . 0.0 107.119 158.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.27 131.97 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-N 113.013 -1.903 . . . . 0.0 107.206 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 88.9 tttt -90.35 134.34 34.39 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.406 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.6 t -76.47 110.8 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 118.403 -1.319 . . . . 0.0 110.556 170.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 mt -86.1 -56.01 3.66 Favored 'General case' 0 CA--C 1.468 -2.192 0 O-C-N 125.288 1.618 . . . . 0.0 114.535 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -146.21 158.21 43.87 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 125.267 1.604 . . . . 0.0 108.47 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.425 HG13 HG12 ' A' ' 145' ' ' ILE . 46.7 t -140.23 114.86 6.75 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.351 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 166.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -75.31 177.28 6.68 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 122.334 2.334 . . . . 0.0 109.828 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -67.28 -32.32 73.24 Favored 'General case' 0 C--N 1.371 1.531 0 C-N-CA 127.219 2.207 . . . . 0.0 110.913 -173.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -74.29 -30.92 62.31 Favored 'General case' 0 C--O 1.213 -0.84 0 C-N-CA 125.433 1.493 . . . . 0.0 111.426 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.3 18.98 4.8 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 115.684 -2.731 . . . . 0.0 112.404 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -80.17 127.66 32.6 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 119.45 1.625 . . . . 0.0 108.109 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.425 HG12 HG13 ' A' ' 139' ' ' VAL . 68.6 mt -104.91 118.37 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -162.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -111.59 131.03 55.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 125.136 2.398 . . . . 0.0 106.456 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.4 mt -129.96 177.15 7.49 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.416 -163.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.405 ' HA ' HG13 ' A' ' 109' ' ' VAL . 16.7 t -154.14 147.91 25.4 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.351 -1.468 . . . . 0.0 107.083 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.3 mt -102.83 -31.98 3.04 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.803 0 O-C-N 119.709 -1.87 . . . . 0.0 107.295 164.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -52.78 -53.83 42.65 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.729 1.212 . . . . 0.0 111.365 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.56 -18.29 58.76 Favored 'General case' 0 C--N 1.364 1.215 0 C-N-CA 125.087 1.355 . . . . 0.0 112.024 -172.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.95 99.68 Favored 'General case' 0 C--O 1.258 1.513 0 C-N-CA 123.756 0.822 . . . . 0.0 110.895 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 80.6 p -96.44 2.28 52.42 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 64.02 48.52 3.02 Favored 'General case' 0 CA--C 1.615 3.47 0 CA-C-O 124.305 2.003 . . . . 0.0 112.013 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 . . . . . 0 C--O 1.253 1.28 0 O-C-N 116.803 -3.686 . . . . 0.0 108.274 168.585 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 . . . . . 0 C--O 1.225 -0.209 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 mm -105.61 120.13 55.91 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 CA-C-O 123.452 1.596 . . . . 0.0 113.614 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.41 ' CD2' ' HB1' ' A' ' 65' ' ' ALA . 74.6 m-70 -109.03 121.83 45.97 Favored 'General case' 0 C--N 1.366 1.318 0 O-C-N 119.699 -1.876 . . . . 0.0 110.35 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -112.89 153.12 28.43 Favored 'General case' 0 N--CA 1.397 -3.102 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -173.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.7 tt -142.49 156.29 18.7 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 166.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -118.13 113.37 21.47 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -175.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -104.58 163.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 126.883 2.614 . . . . 0.0 112.716 167.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 55.7 t-20 -55.94 139.31 70.87 Favored Pre-proline 0 N--CA 1.429 -1.505 0 O-C-N 124.54 1.15 . . . . 0.0 113.088 168.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 21' ' ' ASN . 17.8 Cg_endo -70.89 -21.13 28.65 Favored 'Trans proline' 0 C--O 1.194 -1.706 0 C-N-CA 122.46 2.107 . . . . 0.0 112.2 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -90.13 1.52 56.31 Favored 'General case' 0 CA--C 1.573 1.861 0 O-C-N 119.776 -1.827 . . . . 0.0 109.243 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -118.81 7.04 11.5 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 119.468 -2.02 . . . . 0.0 112.197 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.0 mt -61.87 -46.66 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 119.999 -1.688 . . . . 0.0 111.924 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -67.17 -29.4 69.09 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 117.98 -1.488 . . . . 0.0 111.091 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.48 -32.78 72.8 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 173.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.462 ' HA ' ' CG2' ' A' ' 75' ' ' ILE . 41.6 t -78.99 -51.42 16.91 Favored 'Isoleucine or valine' 0 C--N 1.384 2.076 0 N-CA-C 115.745 1.758 . . . . 0.0 115.745 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.95 -19.24 19.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 114.324 -2.75 . . . . 0.0 114.898 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.78 -174.18 8.69 Favored Glycine 0 C--N 1.383 3.146 1 O-C-N 129.517 4.261 . . . . 0.0 108.9 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.384 22.2 pttp -72.65 129.72 38.89 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 110.061 -3.069 . . . . 0.0 114.359 -173.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.65 19.56 67.22 Favored Glycine 0 N--CA 1.483 1.807 0 O-C-N 119.665 -1.897 . . . . 0.0 114.227 -171.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.6 28.69 68.18 Favored Glycine 0 N--CA 1.5 2.928 0 CA-C-O 121.996 0.776 . . . . 0.0 112.109 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.6 p -64.65 -42.97 95.06 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.76 -41.68 91.5 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 C-N-CA 126.22 1.808 . . . . 0.0 110.286 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.69 -37.51 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 O-C-N 123.974 0.796 . . . . 0.0 110.617 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -56.05 -47.83 77.15 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.75 82.38 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 170.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.82 -51.94 67.52 Favored 'General case' 0 C--O 1.195 -1.779 0 O-C-N 125.386 1.679 . . . . 0.0 113.026 171.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.253 14.2 t -65.43 -48.51 72.5 Favored 'General case' 0 C--O 1.261 1.676 0 CA-C-O 117.742 -1.123 . . . . 0.0 110.55 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.278 27.0 tt0 -66.84 -42.75 85.27 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 118.637 -1.225 . . . . 0.0 114.075 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.31 -34.05 77.11 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.6 p -96.35 -46.14 6.52 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.721 -1.237 . . . . 0.0 111.61 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.25 -0.16 57.14 Favored Glycine 0 C--N 1.344 0.977 0 O-C-N 119.93 -1.731 . . . . 0.0 110.168 -171.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.1 p -75.18 149.41 38.97 Favored 'General case' 0 C--N 1.404 2.947 0 C-N-CA 127.718 2.407 . . . . 0.0 110.826 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.9 m -98.15 129.77 44.93 Favored 'General case' 0 C--O 1.201 -1.454 0 CA-C-O 116.004 -1.95 . . . . 0.0 110.899 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mp -117.29 126.08 74.36 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.989 0 CA-C-O 116.183 -1.865 . . . . 0.0 113.034 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -129.46 141.58 50.99 Favored 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 120.379 1.445 . . . . 0.0 109.291 173.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.88 109.84 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -156.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -76.34 156.14 33.58 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 125.09 2.376 . . . . 0.0 115.101 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -69.1 -0.26 5.6 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 120.339 -1.476 . . . . 0.0 109.438 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -103.91 -11.82 17.25 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.342 -1.474 . . . . 0.0 108.257 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.49 -1.66 53.38 Favored Glycine 0 C--N 1.364 2.104 0 CA-C-O 118.677 -1.068 . . . . 0.0 112.337 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -67.82 115.94 7.93 Favored 'General case' 0 C--O 1.204 -1.322 0 CA-C-N 120.981 2.391 . . . . 0.0 110.363 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 17' ' ' THR . 93.1 t -99.2 117.47 44.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.07 112.84 25.88 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 172.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.5 mt -100.29 106.39 19.17 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 O-C-N 126.748 2.53 . . . . 0.0 108.273 168.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.91 135.47 34.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.656 1.217 . . . . 0.0 109.392 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 65' ' ' ALA . . . -154.62 151.78 29.22 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 102.392 -3.188 . . . . 0.0 102.392 -167.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 p -124.47 8.03 8.35 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 126.306 1.842 . . . . 0.0 108.111 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -124.65 107.84 11.41 Favored 'General case' 0 C--N 1.371 1.516 0 C-N-CA 127.23 2.212 . . . . 0.0 105.434 167.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.05 -40.34 95.43 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-O 116.679 -2.178 . . . . 0.0 115.104 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -73.15 -39.16 65.91 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.173 -172.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -58.65 -41.86 87.03 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 162.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.547 ' HB2' ' CB ' ' A' ' 59' ' ' ALA . . . -62.13 -46.13 90.37 Favored 'General case' 0 CA--C 1.586 2.355 0 CA-C-O 123.586 1.66 . . . . 0.0 113.357 168.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -58.58 -33.2 69.7 Favored 'General case' 0 N--CA 1.527 3.422 0 O-C-N 117.747 -3.096 . . . . 0.0 114.322 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -77.2 -44.46 30.01 Favored 'General case' 0 CA--C 1.563 1.462 0 O-C-N 123.504 0.502 . . . . 0.0 111.427 167.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.73 -39.44 94.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.096 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.271 9.2 tp -80.48 -26.0 11.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 O-C-N 119.995 -1.691 . . . . 0.0 109.101 -176.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -65.47 -41.54 93.23 Favored 'General case' 0 C--N 1.374 1.645 0 CA-C-N 119.992 1.269 . . . . 0.0 110.597 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -55.18 -35.23 64.58 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.0 mm -61.16 -40.48 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.708 0 CA-C-O 123.922 1.82 . . . . 0.0 113.145 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -67.75 -39.44 84.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 117.867 -3.021 . . . . 0.0 112.79 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -58.35 -48.06 81.8 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.906 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 28' ' ' VAL . 74.4 mt -62.35 -45.57 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 170.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.1 m -56.56 -49.4 74.95 Favored 'General case' 0 CA--C 1.575 1.933 0 O-C-N 125.031 1.457 . . . . 0.0 112.723 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.78 -0.36 34.1 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 118.153 -2.842 . . . . 0.0 112.398 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -66.42 139.98 58.02 Favored 'General case' 0 C--N 1.376 1.743 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 169.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.19 122.91 70.71 Favored 'Isoleucine or valine' 0 C--N 1.364 1.228 0 N-CA-C 103.085 -2.931 . . . . 0.0 103.085 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -88.03 134.13 33.81 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.727 -169.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.3 137.76 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.409 0 O-C-N 125.928 2.017 . . . . 0.0 112.653 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.2 -7.7 1.68 Allowed Glycine 0 C--O 1.26 1.768 0 N-CA-C 120.123 2.809 . . . . 0.0 120.123 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -79.55 146.51 32.58 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 124.747 2.213 . . . . 0.0 111.544 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.9 t -91.04 146.7 5.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 O-C-N 120.352 -1.467 . . . . 0.0 109.233 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -138.31 155.35 48.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 79.5 m -93.81 144.24 25.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -146.65 179.53 23.55 Favored Glycine 0 C--O 1.248 1.0 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 172.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -130.32 131.67 45.5 Favored 'General case' 0 C--N 1.375 1.685 0 O-C-N 120.261 -1.729 . . . . 0.0 109.73 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.35 120.28 6.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.205 0 O-C-N 120.88 -1.138 . . . . 0.0 109.22 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.43 HG21 ' HB2' ' A' ' 100' ' ' ALA . 12.0 p -94.12 -8.62 39.05 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-O 115.623 -2.132 . . . . 0.0 112.492 -176.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 ptt85 165.04 148.62 0.02 OUTLIER 'General case' 0 C--N 1.369 1.435 0 O-C-N 126.624 2.452 . . . . 0.0 108.618 -170.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.4 mt -100.81 144.29 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 CA-C-N 112.855 -1.975 . . . . 0.0 108.958 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.26 35.8 m -138.58 170.43 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 O-C-N 120.784 -1.197 . . . . 0.0 109.388 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.65 -42.25 71.08 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 117.274 -3.391 . . . . 0.0 114.525 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -107.1 -0.85 22.56 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 119.131 0.878 . . . . 0.0 112.261 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.68 -154.58 11.17 Favored Glycine 0 C--O 1.212 -1.219 0 O-C-N 119.554 -1.966 . . . . 0.0 109.263 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.31 137.2 24.29 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 128.896 2.879 . . . . 0.0 104.229 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.254 92.6 m-85 -86.84 139.57 30.54 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 124.594 1.158 . . . . 0.0 109.047 173.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.82 121.43 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 112.547 -2.115 . . . . 0.0 107.841 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 90' ' ' THR . . . -72.33 126.04 28.84 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.621 -1.299 . . . . 0.0 110.169 165.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 147' ' ' LEU . 27.8 mm -85.5 94.2 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.44 37.48 93.82 Favored Glycine 0 N--CA 1.513 3.773 0 C-N-CA 126.6 2.048 . . . . 0.0 111.295 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.53 -7.15 49.77 Favored Glycine 0 C--N 1.297 -1.633 0 O-C-N 125.87 1.571 . . . . 0.0 114.471 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.76 -169.09 5.55 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 120.024 1.912 . . . . 0.0 114.473 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -33.06 140.08 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.247 2.927 . . . . 0.0 117.388 167.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -91.79 116.26 28.75 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 112.232 -2.258 . . . . 0.0 114.914 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.28 170.7 23.69 Favored Glycine 0 C--N 1.368 2.317 0 CA-C-O 117.997 -1.446 . . . . 0.0 110.974 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.1 tp -114.62 138.17 51.0 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 128.074 2.867 . . . . 0.0 106.816 -171.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.1 p -116.97 120.53 65.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.288 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.488 157.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -74.81 153.66 38.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.414 1.578 . . . . 0.0 112.197 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.6 tt -67.82 -16.32 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -162.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.0 m -94.69 13.14 25.33 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.03 1.286 . . . . 0.0 111.845 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 -112.2 22.43 14.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.978 1.263 . . . . 0.0 111.54 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.8 mm -100.97 -48.06 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 CA-C-O 127.142 3.353 . . . . 0.0 106.464 -174.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -125.42 156.01 39.51 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 112.439 -2.164 . . . . 0.0 112.261 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.262 4.8 t0 -83.2 -15.31 50.97 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 164.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -94.08 -173.55 3.14 Favored 'General case' 0 C--N 1.381 1.954 0 C-N-CA 126.547 1.939 . . . . 0.0 113.528 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.279 15.5 mmm180 -84.01 115.78 22.51 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-O 125.327 2.489 . . . . 0.0 114.546 -173.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.4 HG22 ' CE2' ' A' ' 125' ' ' TYR 0.264 21.9 t -82.67 101.34 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 112.092 -2.322 . . . . 0.0 114.675 172.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -96.54 -34.65 11.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -141.97 149.41 40.04 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 122.253 1.025 . . . . 0.0 110.09 170.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.29 -34.19 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.264 18.1 p -58.49 -20.94 49.85 Favored 'General case' 0 C--O 1.277 2.552 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 175.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.91 -43.28 83.76 Favored 'General case' 0 C--N 1.368 1.388 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.4 ' CE2' HG22 ' A' ' 119' ' ' VAL . 98.0 m-85 -90.93 -24.68 20.1 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 116.976 -1.488 . . . . 0.0 112.627 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.2 mt -137.98 151.22 47.72 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 120.479 1.49 . . . . 0.0 109.083 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -120.57 167.03 12.83 Favored 'General case' 0 C--O 1.22 -0.459 0 O-C-N 125.707 1.88 . . . . 0.0 108.075 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.6 tpt -81.36 120.71 25.3 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 111.875 -2.42 . . . . 0.0 112.066 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.82 -9.4 56.8 Favored Glycine 0 C--N 1.365 2.19 0 CA-C-N 119.832 1.197 . . . . 0.0 111.771 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -89.52 153.31 20.89 Favored 'General case' 0 CA--C 1.598 2.816 0 CA-C-N 118.316 1.058 . . . . 0.0 109.262 -164.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -88.2 151.09 22.92 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 117.733 -3.105 . . . . 0.0 108.229 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.03 136.05 9.93 Favored Pre-proline 0 N--CA 1.431 -1.399 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.39 124.69 16.69 Favored 'Trans proline' 0 N--CA 1.52 3.076 0 C-N-CA 121.299 1.333 . . . . 0.0 113.402 159.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.54 138.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.244 2.218 . . . . 0.0 107.714 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -106.57 118.36 36.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.553 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.99 119.04 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 123.829 1.776 . . . . 0.0 113.004 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.1 mt -88.64 -40.17 13.51 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 117.092 -1.432 . . . . 0.0 111.519 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -163.47 156.73 18.95 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 120.049 1.295 . . . . 0.0 107.865 -172.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.7 t -120.07 131.85 71.31 Favored 'Isoleucine or valine' 0 C--O 1.254 1.311 1 N-CA-C 98.942 -4.466 . . . . 0.0 98.942 166.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.67 178.42 6.76 Favored 'General case' 0 N--CA 1.421 -1.907 0 O-C-N 120.898 -1.126 . . . . 0.0 111.384 -168.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -78.59 -16.56 57.25 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.848 1.259 . . . . 0.0 111.483 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -112.04 2.56 16.89 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 126.089 2.118 . . . . 0.0 108.679 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.09 5.32 28.84 Favored Glycine 0 C--N 1.368 2.346 0 CA-C-O 119.692 -0.504 . . . . 0.0 114.338 162.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.85 146.89 27.08 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.1 mt -103.99 129.13 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -116.41 122.83 45.96 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 112.096 -2.32 . . . . 0.0 113.095 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.415 HD11 HD11 ' A' ' 101' ' ' ILE . 64.6 mt -120.55 166.12 14.07 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 125.94 1.696 . . . . 0.0 111.809 -168.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 30.0 t -129.28 130.53 46.31 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 112.036 -2.347 . . . . 0.0 108.753 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.3 mt -93.78 -39.43 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 169.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -60.84 -41.82 96.59 Favored 'General case' 0 C--N 1.379 1.867 0 O-C-N 120.239 -1.538 . . . . 0.0 113.9 -167.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -74.91 -33.93 62.08 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 126.651 2.469 . . . . 0.0 109.314 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.47 -29.56 61.49 Favored 'General case' 0 C--N 1.375 1.677 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.5 p -106.1 1.25 26.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 71.52 57.86 0.18 Allowed 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 . . . . . 0 C--N 1.361 1.07 0 CA-C-O 116.183 -1.865 . . . . 0.0 108.561 179.75 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 . . . . . 0 C--O 1.223 -0.325 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.1 mm -84.7 102.93 11.35 Favored 'Isoleucine or valine' 0 C--N 1.373 1.6 0 O-C-N 126.119 2.137 . . . . 0.0 113.505 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -88.77 116.37 26.99 Favored 'General case' 0 N--CA 1.423 -1.787 0 C-N-CA 124.937 1.295 . . . . 0.0 110.958 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.6 p -93.94 138.18 32.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 124.758 2.218 . . . . 0.0 111.53 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.5 tt -135.92 123.45 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 111.545 -2.57 . . . . 0.0 109.807 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -80.4 124.71 29.13 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.274 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.96 129.69 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.925 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -66.73 143.21 97.98 Favored Pre-proline 0 N--CA 1.51 2.57 0 CA-C-O 116.289 -1.815 . . . . 0.0 112.736 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.45 -13.83 40.48 Favored 'Trans proline' 1 N--CA 1.541 4.265 0 CA-C-O 112.871 -3.054 . . . . 0.0 118.583 -165.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -86.48 -18.56 31.34 Favored 'General case' 0 C--N 1.386 2.159 0 CA-C-N 123.941 3.064 . . . . 0.0 109.251 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -84.71 -20.76 30.65 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 116.373 -1.775 . . . . 0.0 115.491 171.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.435 HD11 ' HA2' ' A' ' 53' ' ' GLY . 54.1 mt -65.22 -37.22 79.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 121.935 2.152 . . . . 0.0 112.535 166.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -61.32 -41.88 97.74 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 116.932 -1.508 . . . . 0.0 109.621 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -62.12 -41.19 97.99 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 119.863 1.211 . . . . 0.0 110.808 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 t -67.57 -36.44 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.568 1.947 . . . . 0.0 109.761 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.0 mt -67.19 -46.48 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.985 0.811 . . . . 0.0 109.224 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.49 174.07 11.21 Favored Glycine 0 CA--C 1.55 2.252 0 C-N-CA 118.818 -1.658 . . . . 0.0 114.473 -172.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -67.62 119.49 12.47 Favored 'General case' 0 C--O 1.187 -2.195 0 CA-C-N 113.937 -1.131 . . . . 0.0 110.376 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 26.36 60.78 Favored Glycine 0 N--CA 1.502 3.099 0 C-N-CA 128.497 2.951 . . . . 0.0 116.599 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.81 15.45 79.26 Favored Glycine 0 C--N 1.37 2.448 0 O-C-N 126.64 2.024 . . . . 0.0 112.682 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -62.32 -47.24 85.13 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 120.346 2.073 . . . . 0.0 115.177 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.39 -46.62 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.762 -1.212 . . . . 0.0 112.864 -173.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 47' ' ' ILE . 2.6 tt -70.98 -32.74 49.38 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 O-C-N 127.676 3.11 . . . . 0.0 114.445 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -64.56 -49.41 71.31 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.337 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -34.47 66.83 Favored 'General case' 0 C--O 1.249 1.055 0 CA-C-N 114.162 -1.381 . . . . 0.0 113.542 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -76.76 -48.11 19.68 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 128.241 3.463 . . . . 0.0 112.638 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.312 8.5 t -62.75 -43.29 99.2 Favored 'General case' 0 C--O 1.255 1.38 0 C-N-CA 118.285 -1.366 . . . . 0.0 112.855 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -69.16 -45.36 70.23 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 116.412 -1.756 . . . . 0.0 114.419 172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -59.23 -47.64 84.59 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-O 123.498 1.618 . . . . 0.0 112.405 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.7 p -79.62 -22.34 43.77 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.972 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.81 47.85 78.55 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 125.974 1.75 . . . . 0.0 112.507 -171.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -134.67 152.75 52.0 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 126.574 1.985 . . . . 0.0 112.25 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 89.5 m -95.29 146.34 24.43 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 119.993 -1.692 . . . . 0.0 110.662 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 36' ' ' ILE . 35.5 mt -126.22 129.26 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -171.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.94 157.66 33.8 Favored 'General case' 0 C--O 1.191 -1.987 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 154.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.3 mt -135.04 124.54 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -81.75 154.99 25.7 Favored 'General case' 0 CA--C 1.573 1.864 0 C-N-CA 127.149 2.179 . . . . 0.0 109.958 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -80.63 -13.2 59.24 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -79.16 -13.85 59.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.644 2.378 . . . . 0.0 111.477 172.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 25' ' ' ILE . . . 113.13 -3.26 25.45 Favored Glycine 0 N--CA 1.491 2.331 0 CA-C-O 122.624 1.125 . . . . 0.0 114.436 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -83.19 108.43 16.43 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 123.838 1.78 . . . . 0.0 112.172 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.1 t -90.83 127.66 43.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-O 122.967 1.365 . . . . 0.0 111.492 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -115.67 105.56 12.89 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.206 -0.934 . . . . 0.0 108.709 -169.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.4 mm -88.09 129.13 39.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 O-C-N 120.966 -1.084 . . . . 0.0 111.706 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 46' ' ' THR . . . -113.96 121.77 44.93 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 118.488 -1.285 . . . . 0.0 111.315 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . . . -139.42 156.18 47.13 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 124.309 1.006 . . . . 0.0 111.336 -177.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -72.89 -31.9 65.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 118.413 -2.679 . . . . 0.0 112.347 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -121.65 148.97 43.88 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 123.233 1.492 . . . . 0.0 109.419 -167.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.5 -48.04 81.77 Favored Glycine 0 C--O 1.197 -2.192 0 CA-C-O 116.762 -2.132 . . . . 0.0 113.002 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.8 -41.88 98.31 Favored 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 119.378 1.589 . . . . 0.0 110.956 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -60.67 -43.74 97.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 118.157 -2.84 . . . . 0.0 113.249 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . . . -67.18 -36.27 81.42 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.241 -1.537 . . . . 0.0 112.518 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -74.71 -24.13 58.7 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.593 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -72.65 -39.78 66.89 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 118.572 -2.58 . . . . 0.0 112.553 166.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.49 -38.29 90.57 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.928 -1.107 . . . . 0.0 113.298 167.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.7 mm -64.91 -50.37 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 120.684 -1.26 . . . . 0.0 112.267 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -53.85 -42.4 68.5 Favored 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 120.946 -1.096 . . . . 0.0 111.214 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -61.0 -43.49 98.81 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 mt -69.28 -39.57 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.832 0 C-N-CA 118.269 -1.373 . . . . 0.0 113.577 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.18 -39.52 75.49 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 116.692 -1.623 . . . . 0.0 114.411 164.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -61.94 -42.8 99.52 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-N 119.372 0.987 . . . . 0.0 111.211 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mt -65.06 -34.07 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.174 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 p -89.82 4.4 49.94 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.665 175.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.1 9.02 38.65 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 118.986 0.812 . . . . 0.0 109.435 162.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -76.9 132.96 39.38 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.223 1.487 . . . . 0.0 112.263 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mm -103.14 130.81 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 CA-C-O 123.496 1.617 . . . . 0.0 109.033 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -105.28 145.29 30.9 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.698 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 t -69.72 124.97 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 O-C-N 120.645 -1.285 . . . . 0.0 110.522 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.39 19.42 74.14 Favored Glycine 0 C--O 1.211 -1.331 0 C-N-CA 118.606 -1.759 . . . . 0.0 115.883 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -101.42 148.79 24.75 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 167.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 135' ' ' LYS . 8.3 t -93.12 130.8 41.65 Favored 'Isoleucine or valine' 0 C--N 1.367 1.336 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -123.91 138.19 54.51 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.3 m -88.09 105.91 17.8 Favored 'General case' 0 C--N 1.399 2.737 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.694 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.84 178.13 17.78 Favored Glycine 0 C--O 1.207 -1.587 0 C-N-CA 125.269 1.414 . . . . 0.0 112.996 -175.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -126.65 135.17 50.83 Favored 'General case' 0 CA--C 1.582 2.204 0 O-C-N 127.23 2.371 . . . . 0.0 109.427 -171.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 t -67.33 125.12 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 126.486 1.914 . . . . 0.0 112.92 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.7 p -99.53 -42.6 6.85 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 119.301 0.955 . . . . 0.0 112.536 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -165.85 152.63 9.82 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.3 mt -118.31 125.29 74.18 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.747 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.24 175.16 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 126.028 2.08 . . . . 0.0 109.627 -174.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -47.63 -42.17 23.71 Favored 'General case' 0 C--N 1.398 2.695 0 CA-C-N 119.931 1.241 . . . . 0.0 111.222 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -94.52 9.14 39.72 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.774 -1.204 . . . . 0.0 113.423 -171.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.78 -164.31 19.4 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 124.275 2.042 . . . . 0.0 116.669 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.1 125.1 53.41 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 112.539 -1.831 . . . . 0.0 110.129 -166.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -81.63 149.76 28.41 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.2 t -145.25 121.95 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 CA-C-O 121.939 0.876 . . . . 0.0 112.375 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.23 132.91 35.37 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 117.154 -3.466 . . . . 0.0 112.478 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.1 mm -112.62 158.83 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 112.327 -2.215 . . . . 0.0 106.449 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.75 158.69 51.32 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 121.185 -0.947 . . . . 0.0 111.251 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.99 23.94 77.6 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 113.722 -1.239 . . . . 0.0 113.911 -170.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.38 18.06 74.91 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 127.499 2.476 . . . . 0.0 113.609 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -88.6 163.47 15.83 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -148.31 132.44 17.32 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 124.066 1.888 . . . . 0.0 106.591 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.91 177.78 16.88 Favored Glycine 0 CA--C 1.554 2.489 0 O-C-N 119.955 -1.716 . . . . 0.0 114.65 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.91 123.43 30.73 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.704 -1.468 . . . . 0.0 109.213 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.483 HG21 HG13 ' A' ' 149' ' ' ILE . 21.5 t -96.2 116.44 38.11 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.772 0 O-C-N 119.328 -2.108 . . . . 0.0 106.08 159.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -64.84 147.16 53.79 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 126.064 2.103 . . . . 0.0 108.293 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 tp -32.66 -42.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.256 1.427 0 N-CA-C 119.576 3.176 . . . . 0.0 119.576 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.0 p -77.11 -27.14 53.93 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -97.46 7.21 46.94 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.596 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.05 -39.75 81.25 Favored 'Isoleucine or valine' 0 C--N 1.365 1.242 0 C-N-CA 124.57 1.148 . . . . 0.0 111.155 170.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.59 158.02 33.09 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 122.784 1.278 . . . . 0.0 111.502 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.02 -37.5 78.68 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 128.741 2.816 . . . . 0.0 109.089 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -112.62 117.21 31.64 Favored 'General case' 0 N--CA 1.517 2.92 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.286 167.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.11 146.29 54.83 Favored 'General case' 0 C--O 1.199 -1.601 0 C-N-CA 125.7 1.6 . . . . 0.0 114.99 -161.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.438 HG11 ' CG ' ' A' ' 125' ' ' TYR . 33.5 m -97.15 138.9 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 O-C-N 120.504 -1.372 . . . . 0.0 112.75 -172.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -60.22 -39.51 86.87 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -139.2 147.8 42.27 Favored 'General case' 0 C--O 1.248 1.016 0 O-C-N 119.81 -1.806 . . . . 0.0 109.708 160.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.42 -37.2 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 119.191 -1.004 . . . . 0.0 112.672 169.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.2 p -67.75 -20.61 65.25 Favored 'General case' 0 CA--C 1.477 -1.841 1 CA-C-O 111.471 -4.109 . . . . 0.0 112.861 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -84.48 -13.57 51.61 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 124.053 3.115 . . . . 0.0 115.412 171.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.438 ' CG ' HG11 ' A' ' 119' ' ' VAL . 79.7 t80 -99.04 -23.28 15.34 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.583 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.4 mt -135.47 145.92 47.64 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -118.87 163.91 16.21 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.892 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 22.1 mmt -72.55 150.7 42.94 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 120.605 1.548 . . . . 0.0 112.915 172.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.7 -21.51 18.32 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 112.064 -2.335 . . . . 0.0 115.238 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -109.34 134.95 51.18 Favored 'General case' 0 C--N 1.361 1.075 0 O-C-N 125.625 1.427 . . . . 0.0 111.874 -161.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.14 112.93 1.51 Allowed 'General case' 0 C--N 1.388 2.24 0 O-C-N 128.985 3.928 . . . . 0.0 117.942 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 t -116.25 116.27 39.76 Favored Pre-proline 0 C--O 1.247 0.949 0 C-N-CA 127.377 2.271 . . . . 0.0 109.358 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -57.58 125.23 18.11 Favored 'Trans proline' 0 N--CA 1.515 2.743 0 C-N-CA 121.643 1.562 . . . . 0.0 115.661 157.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.93 123.48 15.41 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 78.5 tttt -96.95 146.78 24.64 Favored 'General case' 0 C--N 1.368 1.384 0 CA-C-O 123.984 1.85 . . . . 0.0 107.766 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 78.7 t -81.95 126.63 39.94 Favored 'Isoleucine or valine' 0 C--N 1.374 1.651 0 O-C-N 118.25 -2.782 . . . . 0.0 114.917 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.2 -33.93 15.2 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.847 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -174.95 140.78 0.56 Allowed 'General case' 0 N--CA 1.521 3.115 0 O-C-N 124.626 1.204 . . . . 0.0 109.88 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.19 142.64 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 O-C-N 120.429 -1.419 . . . . 0.0 109.666 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.26 66.5 t0 -142.69 138.52 30.66 Favored 'General case' 0 N--CA 1.411 -2.4 0 O-C-N 124.421 1.076 . . . . 0.0 108.715 -175.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -101.04 5.26 42.94 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-O 114.703 -2.57 . . . . 0.0 107.83 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -117.56 -57.13 2.16 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.28 164.66 33.63 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 119.814 2.686 . . . . 0.0 119.814 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -60.8 127.2 30.44 Favored 'General case' 0 C--N 1.396 2.61 0 O-C-N 117.614 -3.286 . . . . 0.0 114.401 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.7 mm -31.2 137.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 126.451 3.024 . . . . 0.0 114.77 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -94.21 132.21 39.0 Favored 'General case' 0 C--O 1.247 0.964 0 O-C-N 118.225 -2.797 . . . . 0.0 109.894 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.3 mt -136.42 146.65 46.64 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.002 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.9 t -129.9 128.25 41.81 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.154 167.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.483 HG13 HG21 ' A' ' 109' ' ' VAL . 70.4 mt -72.75 -43.64 60.68 Favored 'Isoleucine or valine' 0 C--N 1.384 2.092 0 CA-C-N 111.569 -2.56 . . . . 0.0 106.933 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -73.3 -30.02 63.1 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 118.975 -2.328 . . . . 0.0 111.899 -170.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -15.02 62.91 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.092 -1.63 . . . . 0.0 113.118 174.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.314 . . -106.86 14.55 26.5 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.106 -168.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.83 151.44 26.06 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-N 120.15 1.341 . . . . 0.0 111.087 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.292 54.1 mt-10 54.75 57.5 5.65 Favored 'General case' 0 C--N 1.374 1.664 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 171.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 172.148 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.2 mm -93.58 121.25 44.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 O-C-N 124.967 1.417 . . . . 0.0 112.18 -176.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -93.42 119.8 32.95 Favored 'General case' 0 C--O 1.191 -2.001 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.402 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.4 m -118.63 111.77 18.98 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 100.956 -3.72 . . . . 0.0 100.956 -163.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.0 mm -116.39 135.73 55.68 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 CA-C-O 116.01 -1.948 . . . . 0.0 110.514 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -95.54 123.35 39.04 Favored 'General case' 0 CA--C 1.576 1.962 0 O-C-N 124.928 1.393 . . . . 0.0 111.878 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.9 pt -131.43 161.66 40.75 Favored 'Isoleucine or valine' 0 C--O 1.259 1.589 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 -173.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -48.56 120.88 9.24 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.65 -23.93 8.83 Favored 'Trans proline' 0 N--CA 1.516 2.825 0 N-CA-C 118.131 2.32 . . . . 0.0 118.131 171.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.82 -30.04 63.72 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 116.766 -3.709 . . . . 0.0 111.692 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -91.74 -0.28 57.54 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -167.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.9 mm -62.35 -44.91 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.431 1.892 . . . . 0.0 109.539 -172.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -60.84 -38.91 87.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.674 2.39 . . . . 0.0 111.605 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -73.77 -40.69 63.28 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 119.228 -2.17 . . . . 0.0 112.794 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.39 -36.3 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.296 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.91 -43.13 89.59 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 124.335 1.054 . . . . 0.0 110.248 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 79.94 156.75 12.53 Favored Glycine 1 CA--C 1.584 4.383 0 CA-C-O 123.846 1.803 . . . . 0.0 116.535 -172.106 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -71.74 132.69 44.87 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-O 122.694 1.235 . . . . 0.0 108.596 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.91 20.03 24.67 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 118.804 2.282 . . . . 0.0 118.804 -168.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.99 16.38 74.98 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.229 -1.317 . . . . 0.0 111.791 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.3 t -70.62 -41.9 71.64 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 118.17 2.655 . . . . 0.0 118.17 -169.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.533 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 21.4 t -65.48 -44.3 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 CA-C-N 120.441 1.473 . . . . 0.0 114.135 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -61.83 -39.38 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.718 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -64.64 -44.46 90.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.091 -1.631 . . . . 0.0 115.283 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.97 97.57 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.44 -39.87 92.59 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 120.881 -1.137 . . . . 0.0 113.049 168.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 m -47.81 -55.55 9.44 Favored 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 125.862 1.665 . . . . 0.0 112.484 167.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.86 -33.45 72.29 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -57.84 -46.32 84.93 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 126.321 1.849 . . . . 0.0 112.101 166.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.3 p -97.51 -18.69 18.85 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 117.354 -1.738 . . . . 0.0 111.422 -165.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.77 35.77 73.85 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 124.156 0.884 . . . . 0.0 112.838 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.52 152.33 32.8 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 117.811 -1.555 . . . . 0.0 107.729 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 m -66.42 131.01 45.13 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.048 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 mt -132.11 123.0 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.923 174.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -131.37 141.52 49.9 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 tt -127.55 155.23 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -116.19 143.02 46.06 Favored 'General case' 0 C--N 1.38 1.906 0 O-C-N 117.403 -3.311 . . . . 0.0 103.389 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -62.94 -12.42 25.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -87.52 0.27 55.82 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-N 119.21 0.914 . . . . 0.0 113.441 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.67 27.15 7.26 Favored Glycine 0 CA--C 1.478 -2.245 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 168.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.2 m -107.02 110.46 22.6 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.79 142.66 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 118.853 0.751 . . . . 0.0 109.575 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -125.83 137.24 53.76 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.328 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.6 mt -121.06 119.58 59.73 Favored 'Isoleucine or valine' 0 C--N 1.366 1.307 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . 0.279 . . -87.6 118.55 27.16 Favored 'General case' 0 N--CA 1.403 -2.782 0 O-C-N 118.113 -2.867 . . . . 0.0 110.98 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.42 151.51 17.25 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -98.69 -39.94 8.42 Favored 'General case' 0 CA--C 1.484 -1.585 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.233 169.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.52 124.78 25.04 Favored 'General case' 0 N--CA 1.415 -2.211 0 O-C-N 126.02 2.075 . . . . 0.0 109.374 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.58 -25.77 64.61 Favored Glycine 0 C--N 1.356 1.652 0 O-C-N 120.452 -1.405 . . . . 0.0 116.528 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -66.4 -34.87 78.93 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 113.007 0.744 . . . . 0.0 113.007 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -63.26 -44.87 93.9 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 167.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.91 77.93 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -64.47 -50.79 66.1 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 164.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -57.73 -41.43 81.81 Favored 'General case' 0 N--CA 1.529 3.479 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.99 -44.33 87.11 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.83 -39.82 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.351 -0.94 . . . . 0.0 113.209 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -65.14 -41.84 94.38 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 121.552 1.978 . . . . 0.0 110.315 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -60.85 -38.19 84.65 Favored 'General case' 0 CA--C 1.584 2.251 1 O-C-N 116.198 -4.064 . . . . 0.0 115.593 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.79 -44.04 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 119.917 -1.739 . . . . 0.0 110.264 172.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -54.85 -41.12 70.37 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-O 115.527 -2.178 . . . . 0.0 114.776 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -63.82 -41.47 97.86 Favored 'General case' 0 C--N 1.38 1.903 0 CA-C-N 122.225 2.284 . . . . 0.0 115.287 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.7 mt -69.08 -39.8 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 122.217 2.281 . . . . 0.0 114.681 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.3 p -77.59 -11.5 59.87 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.69 -31.22 72.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 120.937 1.699 . . . . 0.0 114.091 160.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -69.47 160.06 32.12 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-O 125.572 2.606 . . . . 0.0 116.108 -163.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.8 mm -102.87 130.72 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 124.119 1.914 . . . . 0.0 113.759 -155.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -84.01 123.8 30.38 Favored 'General case' 0 C--O 1.188 -2.15 0 CA-C-N 111.209 -2.723 . . . . 0.0 117.87 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.73 122.49 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.862 0 C-N-CA 126.311 1.844 . . . . 0.0 106.858 173.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.07 8.03 59.25 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 112.808 -1.997 . . . . 0.0 113.224 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -96.75 164.22 12.67 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 169.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.2 t -102.97 136.47 35.35 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.51 158.75 21.21 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -98.37 124.41 43.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.361 1.077 . . . . 0.0 108.447 167.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.97 -174.05 13.48 Favored Glycine 0 C--N 1.347 1.139 0 O-C-N 120.241 -1.537 . . . . 0.0 112.188 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -131.39 134.94 46.77 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.92 119.77 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 124.176 0.991 . . . . 0.0 109.072 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -84.86 -22.39 29.43 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 119.975 -1.703 . . . . 0.0 114.668 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.57 132.79 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.366 -169.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.6 mt -108.96 128.31 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -114.68 173.79 3.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -53.14 -47.88 68.36 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.395 -1.44 . . . . 0.0 113.493 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -104.08 17.89 23.17 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 120.045 -1.659 . . . . 0.0 113.618 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.78 -176.41 47.5 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 118.27 -1.919 . . . . 0.0 115.485 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.83 117.74 9.38 Favored 'General case' 0 C--N 1.373 1.618 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -75.58 137.72 40.98 Favored 'General case' 0 C--N 1.372 1.578 0 O-C-N 125.559 1.787 . . . . 0.0 111.46 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.4 t -134.25 132.57 55.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -171.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.42 136.41 37.9 Favored 'General case' 0 C--N 1.363 1.171 0 CA-C-O 122.702 1.239 . . . . 0.0 108.753 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.9 pt -139.76 160.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 CA-C-O 117.448 -1.263 . . . . 0.0 111.15 -168.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.17 138.01 0.54 Allowed Glycine 0 CA--C 1.562 2.992 0 N-CA-C 122.391 3.717 . . . . 0.0 122.391 -166.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.92 18.58 62.99 Favored Glycine 0 CA--C 1.483 -1.938 0 CA-C-O 116.189 -2.451 . . . . 0.0 116.827 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.59 33.82 41.69 Favored Glycine 0 CA--C 1.544 1.888 0 CA-C-N 120.371 2.085 . . . . 0.0 117.5 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -114.52 151.62 33.03 Favored 'General case' 0 N--CA 1.515 2.781 0 C-N-CA 124.222 1.009 . . . . 0.0 112.544 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -143.79 123.34 13.23 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 113.3 -1.773 . . . . 0.0 106.219 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -120.85 174.66 15.85 Favored Glycine 0 C--N 1.364 2.125 0 O-C-N 126.748 2.53 . . . . 0.0 113.003 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.7 tp -128.98 126.46 39.62 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 112.587 -1.807 . . . . 0.0 111.835 -166.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.3 t -95.59 116.66 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 N-CA-C 102.329 -3.212 . . . . 0.0 102.329 173.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -66.63 151.74 46.74 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 120.352 -1.467 . . . . 0.0 111.462 171.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.333 14.2 tt -39.07 -34.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.563 0 N-CA-C 120.634 3.568 . . . . 0.0 120.634 172.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 66.5 m -69.63 -18.87 63.62 Favored 'General case' 0 N--CA 1.534 3.725 0 O-C-N 125.758 1.911 . . . . 0.0 113.446 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -120.24 6.83 10.71 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.718 0.807 . . . . 0.0 110.817 -160.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.9 mm -74.19 -42.04 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 170.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.05 167.75 21.34 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 119.98 -1.7 . . . . 0.0 112.427 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.316 53.6 p30 -41.6 -67.0 0.29 Allowed 'General case' 0 C--N 1.363 1.161 0 O-C-N 128.584 3.678 . . . . 0.0 118.081 173.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . 0.257 66.6 mttt -99.71 164.96 11.83 Favored 'General case' 0 CA--C 1.582 2.21 0 C-N-CA 129.408 3.083 . . . . 0.0 106.091 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -59.05 140.56 55.65 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.1 t -102.71 136.57 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 125.057 1.473 . . . . 0.0 110.228 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -92.25 -48.62 6.59 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.697 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -143.99 127.97 17.46 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.1 t -72.33 -24.22 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 123.889 1.804 . . . . 0.0 113.129 -164.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 66.8 p -63.62 -26.83 68.86 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 126.691 1.996 . . . . 0.0 112.721 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -63.89 -25.59 68.22 Favored 'General case' 0 C--O 1.261 1.688 0 O-C-N 119.326 -2.109 . . . . 0.0 115.306 168.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -96.35 -46.49 6.38 Favored 'General case' 0 C--N 1.371 1.53 0 O-C-N 126.725 2.515 . . . . 0.0 114.47 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.2 mt -114.67 135.62 53.96 Favored 'General case' 0 N--CA 1.434 -1.256 0 O-C-N 125.687 1.867 . . . . 0.0 108.536 -166.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -105.94 141.62 37.04 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.8 ttp -63.95 137.19 57.9 Favored 'General case' 0 C--O 1.203 -1.362 0 O-C-N 126.328 2.267 . . . . 0.0 114.063 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.01 -24.52 7.84 Favored Glycine 0 N--CA 1.428 -1.858 0 CA-C-O 116.898 -2.057 . . . . 0.0 115.731 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -72.01 163.91 27.05 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.45 134.77 37.31 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.69 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.6 m -139.85 141.21 26.7 Favored Pre-proline 0 C--N 1.369 1.419 0 O-C-N 118.753 -2.467 . . . . 0.0 112.042 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.06 127.77 10.9 Favored 'Trans proline' 0 C--N 1.286 -2.739 0 C-N-CA 121.106 1.204 . . . . 0.0 111.707 165.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.1 m -128.33 128.43 68.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -91.61 132.68 36.16 Favored 'General case' 0 C--N 1.373 1.602 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.701 165.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.488 ' HA ' HD23 ' A' ' 147' ' ' LEU . 46.4 t -75.7 104.45 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.667 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.11 -42.65 98.92 Favored 'General case' 0 C--N 1.39 2.327 0 C-N-CA 127.048 2.139 . . . . 0.0 112.894 168.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -165.56 140.69 4.98 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 123.939 0.775 . . . . 0.0 112.298 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.9 t -106.88 116.0 49.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 156.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.251 0.3 OUTLIER -80.55 171.55 14.89 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 123.768 1.747 . . . . 0.0 113.698 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -64.34 -33.82 76.72 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 119.066 -2.271 . . . . 0.0 112.617 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -71.11 -37.74 72.36 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-O 116.757 -1.592 . . . . 0.0 110.02 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.77 9.22 1.78 Allowed Glycine 0 C--N 1.359 1.834 0 CA-C-N 122.101 2.228 . . . . 0.0 114.736 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -95.7 134.02 39.11 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -163.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.4 mt -105.54 108.88 26.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 O-C-N 121.412 -0.805 . . . . 0.0 110.333 -167.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -85.9 136.55 33.24 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 136' ' ' VAL . 92.4 mt -127.68 163.06 25.1 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 126.077 2.111 . . . . 0.0 111.332 -170.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 42.9 t -148.9 134.55 18.73 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.27 -30.51 2.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.45 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -61.1 -40.97 95.74 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.765 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.4 -14.8 60.91 Favored 'General case' 0 CA--C 1.562 1.419 0 O-C-N 125.117 1.511 . . . . 0.0 110.232 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -96.61 -14.94 21.82 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.3 p -103.19 0.93 32.41 Favored 'General case' 0 CA--C 1.488 -1.406 0 O-C-N 126.978 2.674 . . . . 0.0 111.703 161.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 65.65 38.76 5.21 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 127.107 2.754 . . . . 0.0 113.777 163.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 . . . . . 0 N--CA 1.43 -1.434 0 CA-C-O 117.212 -1.375 . . . . 0.0 112.749 175.576 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 . . . . . 0 CA--C 1.552 1.021 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tp -64.74 122.76 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.737 -1.227 . . . . 0.0 111.743 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -75.96 135.79 40.04 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-O 126.027 2.823 . . . . 0.0 114.663 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.466 HG22 ' HG2' ' A' ' 56' ' ' LYS . 43.5 p -141.67 154.97 45.69 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 112.45 -2.159 . . . . 0.0 111.915 -176.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 57' ' ' ILE . 6.7 mt -130.3 128.4 64.04 Favored 'Isoleucine or valine' 0 C--N 1.366 1.315 0 O-C-N 126.753 2.533 . . . . 0.0 107.716 172.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -77.69 126.22 30.54 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.0 mm -106.18 133.97 49.1 Favored 'Isoleucine or valine' 0 C--N 1.366 1.291 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -63.39 140.07 97.67 Favored Pre-proline 0 N--CA 1.485 1.321 0 CA-C-O 117.165 -1.397 . . . . 0.0 110.178 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -44.89 -45.71 13.59 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.622 2.881 . . . . 0.0 116.472 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -73.98 -21.29 60.06 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 128.04 3.338 . . . . 0.0 106.536 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -101.47 -4.65 26.43 Favored 'General case' 0 C--N 1.387 2.227 0 O-C-N 119.737 -1.852 . . . . 0.0 113.839 -170.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.4 mt -59.25 -42.27 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 117.23 -1.367 . . . . 0.0 114.577 168.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -58.34 -40.37 81.95 Favored 'General case' 0 C--O 1.267 1.999 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 170.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -65.88 -35.57 81.0 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 117.56 -1.209 . . . . 0.0 112.432 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.2 t -70.05 -44.9 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 123.867 0.73 . . . . 0.0 111.679 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.0 mm -85.85 -38.37 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 122.079 2.218 . . . . 0.0 112.487 -172.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.48 154.21 16.97 Favored Glycine 0 CA--C 1.474 -2.521 0 CA-C-N 120.684 1.584 . . . . 0.0 115.817 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -70.53 130.6 42.29 Favored 'General case' 0 N--CA 1.419 -1.987 0 O-C-N 119.699 -2.059 . . . . 0.0 111.026 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.74 10.07 60.29 Favored Glycine 0 N--CA 1.481 1.636 0 CA-C-O 115.373 -2.904 . . . . 0.0 113.507 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.14 22.8 67.46 Favored Glycine 0 CA--C 1.563 3.077 0 O-C-N 127.163 2.331 . . . . 0.0 112.048 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.0 p -55.29 -49.31 72.45 Favored 'General case' 0 C--O 1.261 1.681 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.5 t -71.29 -43.3 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.441 HD12 ' HB2' ' A' ' 39' ' ' LEU . 10.4 tp -68.56 -30.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.002 -1.686 . . . . 0.0 113.417 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.8 mtm-85 -63.02 -39.1 93.75 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 122.375 1.083 . . . . 0.0 110.875 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.93 98.25 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 119.874 -1.766 . . . . 0.0 114.324 166.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' HB2' HD12 ' A' ' 36' ' ' ILE . 36.3 mt -67.22 -38.82 85.91 Favored 'General case' 0 C--O 1.188 -2.134 0 O-C-N 118.338 -2.727 . . . . 0.0 109.714 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.281 15.3 t -59.46 -39.73 84.6 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 114.282 -2.77 . . . . 0.0 114.185 165.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -69.96 -38.92 76.25 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 122.827 2.558 . . . . 0.0 115.669 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -69.36 -43.13 74.24 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 126.787 2.554 . . . . 0.0 111.058 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.7 p -83.7 -25.14 30.89 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.1 30.75 54.76 Favored Glycine 0 C--N 1.318 -0.42 0 CA-C-O 117.192 -1.893 . . . . 0.0 110.201 173.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 t -152.63 162.21 41.54 Favored 'General case' 0 C--N 1.396 2.621 0 C-N-CA 128.68 2.792 . . . . 0.0 106.034 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.4 m -73.83 124.09 25.43 Favored 'General case' 0 C--N 1.371 1.539 0 C-N-CA 126.134 1.774 . . . . 0.0 113.922 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.1 mm -112.69 135.01 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 112.943 -1.935 . . . . 0.0 108.768 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -132.96 158.31 42.98 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mm -109.45 132.36 57.8 Favored 'Isoleucine or valine' 0 C--N 1.368 1.387 0 O-C-N 119.691 -1.88 . . . . 0.0 107.959 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -115.5 169.76 8.93 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.06 139.59 0.67 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 124.396 2.046 . . . . 0.0 113.731 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.317 28.2 m-20 67.51 38.34 3.16 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 113.244 -1.798 . . . . 0.0 113.0 173.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.53 41.1 77.55 Favored Glycine 0 N--CA 1.422 -2.276 0 CA-C-O 115.989 -2.561 . . . . 0.0 117.357 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.0 m -103.84 108.82 20.31 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 120.189 1.994 . . . . 0.0 111.646 -169.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -73.43 127.59 35.45 Favored 'Isoleucine or valine' 0 C--N 1.382 2.02 0 O-C-N 123.632 0.582 . . . . 0.0 111.303 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HG2' HG22 ' A' ' 17' ' ' THR . 38.5 mtmt -119.41 137.16 53.93 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 124.584 2.135 . . . . 0.0 111.21 173.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 18' ' ' ILE . 43.8 mt -104.33 112.48 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 113.069 -1.878 . . . . 0.0 109.425 -172.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.63 -47.48 78.42 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 116.911 -1.518 . . . . 0.0 112.969 -173.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.8 138.04 53.86 Favored 'General case' 0 C--N 1.369 1.44 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.0 p -95.54 -0.57 51.91 Favored 'General case' 0 C--N 1.369 1.426 0 O-C-N 120.185 -1.572 . . . . 0.0 114.07 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -55.47 151.94 9.56 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 126.37 2.294 . . . . 0.0 114.827 168.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.29 -48.32 5.71 Favored Glycine 0 N--CA 1.478 1.487 0 O-C-N 120.596 -1.315 . . . . 0.0 112.108 -172.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.17 -26.44 63.91 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.22 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -65.16 -41.53 94.59 Favored 'General case' 0 C--N 1.386 2.171 0 C-N-CA 123.42 0.688 . . . . 0.0 111.414 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.49 67.58 Favored 'General case' 0 C--O 1.252 1.224 0 O-C-N 124.045 0.841 . . . . 0.0 110.561 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -63.29 -40.71 98.12 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.41 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -68.25 -45.81 72.17 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 121.124 1.784 . . . . 0.0 110.564 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.91 87.32 Favored 'General case' 0 C--O 1.258 1.532 0 O-C-N 124.634 1.209 . . . . 0.0 112.302 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.256 15.0 tt -70.71 -31.56 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.372 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -61.28 -42.95 99.5 Favored 'General case' 0 CA--C 1.574 1.903 0 CA-C-N 121.043 1.747 . . . . 0.0 114.865 171.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -60.53 -47.19 87.26 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.4 mm -56.47 -38.66 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 O-C-N 120.457 -1.402 . . . . 0.0 112.722 170.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.17 -53.91 52.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.84 1.337 . . . . 0.0 113.113 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -59.58 -37.2 77.87 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.911 1.285 . . . . 0.0 114.154 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.9 mt -69.45 -36.07 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -64.72 -40.03 94.64 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.925 1.391 . . . . 0.0 109.137 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.58 1.73 36.69 Favored 'General case' 0 CA--C 1.589 2.469 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.77 149.66 49.8 Favored 'General case' 0 N--CA 1.516 2.864 0 O-C-N 119.603 -1.936 . . . . 0.0 110.327 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mm -61.23 131.66 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.349 -1.47 . . . . 0.0 112.698 -171.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -91.64 135.19 34.06 Favored 'General case' 0 C--N 1.374 1.656 0 O-C-N 119.928 -1.733 . . . . 0.0 112.676 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.8 t -73.5 140.31 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 O-C-N 127.171 2.795 . . . . 0.0 113.589 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.05 -8.43 57.48 Favored Glycine 0 C--N 1.387 3.374 0 C-N-CA 126.276 1.894 . . . . 0.0 114.806 -171.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -89.83 149.37 22.7 Favored 'General case' 0 C--N 1.365 1.269 0 O-C-N 121.234 -1.157 . . . . 0.0 109.537 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.46 121.78 58.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.39 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -111.42 166.46 11.1 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 53.0 m -112.79 134.53 54.27 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.09 168.32 23.75 Favored Glycine 0 CA--C 1.475 -2.462 0 C-N-CA 117.547 -2.263 . . . . 0.0 108.648 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -118.41 135.37 54.38 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 113.242 -1.479 . . . . 0.0 113.631 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.3 t -69.3 135.82 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.233 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.759 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.9 p -128.4 -18.05 4.09 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.909 -1.119 . . . . 0.0 108.249 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -154.42 156.88 37.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.679 -1.888 . . . . 0.0 108.249 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 mm -123.88 135.32 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 CA-C-O 123.653 1.692 . . . . 0.0 111.136 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.9 m -126.7 168.43 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.694 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.61 -46.16 48.91 Favored 'General case' 0 C--O 1.179 -2.618 0 C-N-CA 123.899 0.88 . . . . 0.0 111.976 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -107.44 17.63 22.53 Favored 'General case' 0 N--CA 1.514 2.73 0 C-N-CA 125.898 1.679 . . . . 0.0 114.622 -169.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.93 -163.32 33.66 Favored Glycine 0 C--N 1.363 2.05 0 O-C-N 118.394 -2.691 . . . . 0.0 108.977 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.76 165.5 30.35 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 170.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -107.88 127.27 53.59 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 126.718 2.511 . . . . 0.0 111.867 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.6 t -122.45 126.22 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 CA-C-N 112.593 -2.094 . . . . 0.0 108.925 -166.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.8 109.9 21.77 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 126.157 2.161 . . . . 0.0 110.316 -171.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.7 pt -105.35 161.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.203 0 C-N-CA 126.085 1.754 . . . . 0.0 111.916 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.36 136.75 7.0 Favored Glycine 0 C--N 1.36 1.894 1 N-CA-C 124.032 4.373 . . . . 0.0 124.032 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.66 4.0 39.99 Favored Glycine 0 C--N 1.306 -1.1 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.84 23.99 56.53 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -107.28 148.54 28.85 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.981 1.391 . . . . 0.0 112.226 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -127.37 127.46 44.25 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 125.698 1.874 . . . . 0.0 110.782 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -119.38 155.93 15.93 Favored Glycine 0 CA--C 1.556 2.645 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.3 tp -90.47 118.36 29.88 Favored 'General case' 0 N--CA 1.518 2.972 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.27 107.67 20.36 Favored 'Isoleucine or valine' 0 C--N 1.396 2.62 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -68.88 162.41 26.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 118.299 -2.751 . . . . 0.0 116.872 172.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.2 tt -61.83 -37.64 78.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -59.51 -19.6 49.33 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 126.804 2.565 . . . . 0.0 116.345 167.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -106.15 9.78 32.17 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.499 -1.228 . . . . 0.0 112.588 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.9 mt -88.38 -49.42 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 119.087 0.858 . . . . 0.0 109.856 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.12 157.57 43.65 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 116.009 -1.948 . . . . 0.0 107.036 -172.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -71.46 -19.22 62.25 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -95.06 134.57 37.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.816 2.046 . . . . 0.0 105.892 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.19 116.44 1.86 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.66 120.01 35.54 Favored 'Isoleucine or valine' 0 C--O 1.262 1.724 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.34 -40.9 90.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 126.343 2.277 . . . . 0.0 111.808 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -157.52 151.69 24.67 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.2 t -63.12 -36.81 77.45 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 0 CA-C-O 116.727 -1.606 . . . . 0.0 113.15 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.59 -25.2 16.33 Favored 'General case' 0 N--CA 1.513 2.692 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -69.04 -19.85 64.11 Favored 'General case' 0 CA--C 1.575 1.918 0 C-N-CA 125.354 1.462 . . . . 0.0 113.872 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -123.48 -37.0 2.71 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.201 -1.562 . . . . 0.0 112.485 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.3 mt -130.23 150.94 51.24 Favored 'General case' 0 CA--C 1.574 1.903 0 CA-C-O 124.293 1.997 . . . . 0.0 115.328 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -159.34 155.98 27.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -172.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -43.95 125.69 4.44 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 122.705 1.241 . . . . 0.0 113.227 165.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.58 -2.72 80.85 Favored Glycine 0 N--CA 1.494 2.556 0 CA-C-N 114.264 -1.335 . . . . 0.0 116.087 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -73.65 128.48 35.61 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.471 171.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -106.52 124.92 50.33 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 124.516 1.135 . . . . 0.0 109.666 168.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.97 151.12 61.55 Favored Pre-proline 0 C--N 1.379 1.856 0 C-N-CA 127.72 2.408 . . . . 0.0 110.982 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -90.81 138.89 2.56 Favored 'Trans proline' 0 CA--C 1.493 -1.565 0 N-CA-C 104.814 -2.802 . . . . 0.0 104.814 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.464 HG21 HD13 ' A' ' 147' ' ' LEU . 6.2 m -136.41 126.77 40.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 110.946 -2.843 . . . . 0.0 109.133 -168.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.9 tttt -100.26 122.18 42.65 Favored 'General case' 0 C--N 1.368 1.397 0 O-C-N 120.222 -1.549 . . . . 0.0 111.395 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.13 118.73 5.66 Favored 'Isoleucine or valine' 0 C--O 1.264 1.856 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.488 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 148' ' ' SER . 63.5 mt -90.68 -50.26 6.01 Favored 'General case' 0 C--O 1.254 1.295 0 CA-C-N 111.888 -2.414 . . . . 0.0 113.613 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -159.78 148.58 17.6 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 116.047 -1.93 . . . . 0.0 107.371 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 145' ' ' ILE . 18.0 t -133.93 120.33 35.5 Favored 'Isoleucine or valine' 0 C--N 1.388 2.271 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.92 146.78 53.28 Favored 'General case' 0 CA--C 1.556 1.205 0 O-C-N 126.028 2.08 . . . . 0.0 111.676 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -46.69 -33.76 4.55 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 167.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -92.73 29.15 1.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.11 1.364 . . . . 0.0 109.656 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.98 59.16 7.8 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 120.041 2.776 . . . . 0.0 120.041 166.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -137.19 136.82 38.52 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.405 HG23 HG22 ' A' ' 139' ' ' VAL . 3.3 mt -121.66 122.68 67.64 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 O-C-N 126.466 2.354 . . . . 0.0 108.892 -158.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -94.19 136.23 34.71 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 134' ' ' VAL . 18.9 mt -124.73 152.35 43.9 Favored 'General case' 0 C--N 1.372 1.557 0 O-C-N 127.408 2.942 . . . . 0.0 111.524 -173.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.54 ' HB2' HD11 ' A' ' 137' ' ' LEU . 38.9 t -140.6 138.9 34.77 Favored 'General case' 0 CA--C 1.484 -1.585 0 O-C-N 120.534 -1.354 . . . . 0.0 109.974 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.65 -34.71 7.55 Favored 'Isoleucine or valine' 0 C--O 1.258 1.512 0 O-C-N 125.86 1.975 . . . . 0.0 110.432 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -77.12 -33.28 56.81 Favored 'General case' 0 C--O 1.198 -1.654 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -168.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -71.34 -30.97 66.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.43 -21.81 35.56 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 119.024 -2.297 . . . . 0.0 109.314 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.7 p -93.09 7.27 44.86 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 121.007 1.73 . . . . 0.0 113.655 171.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.258 27.6 mt-10 74.8 51.6 0.08 Allowed 'General case' 0 C--O 1.243 0.755 0 O-C-N 118.042 -2.911 . . . . 0.0 113.295 169.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 . . . . . 0 C--N 1.375 1.709 0 CA-C-O 123.501 1.619 . . . . 0.0 111.896 163.567 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.911 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 tp -110.34 135.68 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.093 0 O-C-N 124.609 1.193 . . . . 0.0 108.328 172.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -116.03 113.88 23.82 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 162.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.7 m -100.62 106.13 17.59 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -109.3 158.5 9.2 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.212 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.421 -172.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -108.96 140.09 42.93 Favored 'General case' 0 C--N 1.368 1.401 0 O-C-N 119.111 -2.243 . . . . 0.0 109.021 167.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.89 162.27 36.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -64.53 132.22 95.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-O 114.254 -2.784 . . . . 0.0 112.576 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . 0.271 42.6 Cg_exo -48.79 -29.25 14.42 Favored 'Trans proline' 0 N--CA 1.515 2.742 0 N-CA-C 120.204 3.117 . . . . 0.0 120.204 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.2 -7.72 59.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.129 2.171 . . . . 0.0 111.38 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -98.98 7.88 45.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 115.59 -2.148 . . . . 0.0 114.321 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.35 -36.91 78.51 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 CA-C-N 121.25 1.841 . . . . 0.0 110.101 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -58.09 -44.57 87.69 Favored 'General case' 0 N--CA 1.385 -3.7 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 170.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -72.46 -39.19 67.94 Favored 'General case' 0 CA--C 1.484 -1.567 0 O-C-N 126.004 2.065 . . . . 0.0 112.61 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.1 -42.34 91.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.245 0 O-C-N 125.794 1.934 . . . . 0.0 113.802 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.7 mt -72.3 -43.02 65.66 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 O-C-N 119.063 -2.273 . . . . 0.0 113.564 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.416 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 78.49 171.86 39.76 Favored Glycine 0 CA--C 1.56 2.897 0 CA-C-O 121.774 0.652 . . . . 0.0 113.915 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 5.6 mmmm -66.87 110.61 3.38 Favored 'General case' 1 N--CA 1.539 4.004 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 177.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.65 31.37 79.78 Favored Glycine 0 CA--C 1.544 1.845 0 O-C-N 125.036 1.46 . . . . 0.0 110.902 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.13 25.54 73.42 Favored Glycine 0 N--CA 1.509 3.505 0 C-N-CA 128.035 2.731 . . . . 0.0 114.847 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 t -62.43 -47.68 83.03 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-O 116.849 -1.548 . . . . 0.0 113.662 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 76.6 t -71.45 -50.0 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 120.29 1.404 . . . . 0.0 108.836 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -55.3 -36.17 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 121.399 1.908 . . . . 0.0 112.755 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -78.84 -36.03 43.11 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 118.931 -1.108 . . . . 0.0 112.029 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.63 -40.65 84.6 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 117.361 -3.337 . . . . 0.0 108.125 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.1 tp -62.87 -40.26 96.95 Favored 'General case' 0 C--N 1.361 1.107 0 O-C-N 120.689 -1.257 . . . . 0.0 111.67 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.1 m -67.2 -48.76 66.92 Favored 'General case' 0 C--N 1.373 1.602 0 O-C-N 125.27 1.606 . . . . 0.0 112.256 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -63.97 -43.85 94.53 Favored 'General case' 0 C--N 1.381 1.97 0 O-C-N 116.502 -3.874 . . . . 0.0 115.025 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -59.23 -40.73 86.82 Favored 'General case' 0 C--N 1.385 2.121 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.8 p -108.01 -3.03 19.14 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -162.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.65 25.26 75.14 Favored Glycine 0 CA--C 1.552 2.401 0 N-CA-C 118.86 2.304 . . . . 0.0 118.86 -173.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 p -124.32 159.26 30.7 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.624 1.17 . . . . 0.0 113.578 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.0 m -110.53 131.57 54.94 Favored 'General case' 0 C--N 1.399 2.744 0 CA-C-N 119.649 1.113 . . . . 0.0 110.289 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.53 138.8 44.73 Favored 'Isoleucine or valine' 0 C--N 1.37 1.481 0 O-C-N 120.785 -1.197 . . . . 0.0 111.403 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -131.95 157.25 44.54 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.269 6.2 tt -150.67 125.02 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 O-C-N 116.716 -3.74 . . . . 0.0 109.776 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -86.53 154.05 21.38 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 119.318 -2.114 . . . . 0.0 112.53 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -53.0 -32.33 45.95 Favored 'General case' 0 C--N 1.393 2.458 0 C-N-CA 127.194 2.197 . . . . 0.0 113.095 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 p30 -86.57 12.57 10.17 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 119.804 1.183 . . . . 0.0 110.892 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.29 26.51 65.87 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-O 123.22 1.455 . . . . 0.0 114.11 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 m -92.09 108.92 20.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 167.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.27 144.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -131.61 115.05 15.58 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.39 108.68 25.95 Favored 'Isoleucine or valine' 0 C--N 1.376 1.726 0 C-N-CA 125.661 1.585 . . . . 0.0 109.896 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.14 128.93 45.35 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.38 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.88 149.05 28.53 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 104.4 -2.445 . . . . 0.0 104.4 173.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 p -78.37 -27.1 46.81 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.425 1.078 . . . . 0.0 110.388 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.54 136.22 41.74 Favored 'General case' 0 CA--C 1.58 2.1 0 C-N-CA 128.343 2.657 . . . . 0.0 112.167 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.04 -49.49 40.56 Favored Glycine 0 CA--C 1.558 2.769 0 C-N-CA 124.35 0.976 . . . . 0.0 112.576 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.27 -33.69 73.95 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 121.609 2.705 . . . . 0.0 114.201 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -68.52 -45.17 72.98 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 126.331 2.269 . . . . 0.0 110.914 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.58 83.38 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 119.326 -2.109 . . . . 0.0 113.053 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . 0.297 91.9 mttt -54.04 -41.58 68.26 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.473 1.109 . . . . 0.0 113.246 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -62.81 -38.59 91.32 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.95 -35.83 74.81 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 119.042 -2.286 . . . . 0.0 116.313 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.74 -37.24 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 O-C-N 124.676 1.235 . . . . 0.0 109.882 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -67.58 -40.34 84.86 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.46 1.482 . . . . 0.0 113.097 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -68.13 -40.64 82.41 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 120.144 -1.598 . . . . 0.0 110.814 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.04 -41.83 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.526 0 CA-C-O 116.822 -1.561 . . . . 0.0 112.049 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -48.47 -52.12 23.83 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-N 122.676 2.489 . . . . 0.0 115.956 166.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.77 -45.86 90.98 Favored 'General case' 0 CA--C 1.569 1.708 0 O-C-N 127.094 2.746 . . . . 0.0 111.141 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.5 mt -62.71 -40.3 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.941 0.896 . . . . 0.0 110.493 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.7 p -85.06 -10.51 56.83 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 123.963 1.84 . . . . 0.0 111.517 -172.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.43 -37.54 71.43 Favored 'General case' 0 N--CA 1.407 -2.595 0 O-C-N 120.359 -1.463 . . . . 0.0 112.721 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.33 132.37 52.86 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.831 1.252 . . . . 0.0 110.166 -165.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.7 mm -59.95 127.18 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -73.86 148.99 41.85 Favored 'General case' 0 CA--C 1.579 2.066 0 CA-C-O 122.449 1.118 . . . . 0.0 112.575 165.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.6 137.27 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 -10.25 73.63 Favored Glycine 0 C--N 1.376 2.776 0 C-N-CA 126.989 2.233 . . . . 0.0 113.783 -174.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -97.93 163.06 12.94 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -172.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.14 139.35 30.65 Favored 'Isoleucine or valine' 0 C--N 1.386 2.196 0 CA-C-O 123.038 1.399 . . . . 0.0 110.612 -175.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -130.87 172.3 12.18 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.377 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 133' ' ' PRO . 86.9 m -133.0 123.36 25.71 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.19 -171.61 12.75 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -120.26 154.94 34.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 125.384 1.285 . . . . 0.0 114.029 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.446 HG21 HD22 ' A' ' 126' ' ' LEU . 45.7 t -85.31 127.75 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-O 123.331 1.538 . . . . 0.0 109.31 -175.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.9 -36.49 6.36 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 111.609 -2.541 . . . . 0.0 112.293 -172.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.4 mtt-85 -150.11 145.89 26.6 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 122.763 1.268 . . . . 0.0 109.894 -170.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -124.26 134.97 65.21 Favored 'Isoleucine or valine' 0 C--N 1.366 1.316 0 CA-C-O 124.434 2.064 . . . . 0.0 110.453 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.69 165.66 18.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.681 0 CA-C-N 111.585 -2.552 . . . . 0.0 107.941 166.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -52.75 -35.44 56.13 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 119.347 3.092 . . . . 0.0 119.347 -163.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -118.3 19.12 13.55 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 124.733 1.213 . . . . 0.0 112.161 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.83 168.64 41.04 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.95 1.54 . . . . 0.0 116.95 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.98 167.3 18.46 Favored 'General case' 0 C--N 1.374 1.656 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -124.02 136.79 54.51 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.455 173.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.17 131.97 72.24 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.397 0 C-N-CA 123.532 0.733 . . . . 0.0 111.21 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.96 121.64 40.12 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.217 1.484 . . . . 0.0 112.511 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.6 pt -115.74 166.97 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 112.043 -2.344 . . . . 0.0 114.484 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -31.51 142.77 0.03 OUTLIER Glycine 0 CA--C 1.57 3.507 0 N-CA-C 122.132 3.613 . . . . 0.0 122.132 172.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.19 25.7 69.87 Favored Glycine 0 N--CA 1.484 1.866 0 O-C-N 120.445 -1.621 . . . . 0.0 114.811 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.91 22.74 65.46 Favored Glycine 0 C--O 1.255 1.467 0 N-CA-C 118.529 2.171 . . . . 0.0 118.529 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -94.49 152.22 18.75 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 122.137 0.97 . . . . 0.0 113.308 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -130.96 151.33 51.49 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 168.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.8 175.29 22.21 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.375 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 139.14 35.65 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.259 1.424 . . . . 0.0 112.289 -174.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.6 t -125.0 106.55 16.65 Favored 'Isoleucine or valine' 0 C--O 1.261 1.665 0 CA-C-O 124.431 2.062 . . . . 0.0 106.996 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -77.59 151.13 34.56 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.328 -1.482 . . . . 0.0 112.85 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.48 -33.11 43.46 Favored 'Isoleucine or valine' 0 C--N 1.391 2.411 0 CA-C-O 115.918 -1.991 . . . . 0.0 114.144 -164.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 95.7 p -56.57 -32.65 65.39 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 124.94 3.518 . . . . 0.0 118.342 164.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -97.91 4.18 49.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 121.063 1.756 . . . . 0.0 113.66 -161.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.2 -39.87 85.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 124.651 1.22 . . . . 0.0 107.776 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -162.97 161.58 25.66 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -69.17 -37.74 78.35 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 127.47 2.308 . . . . 0.0 109.699 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -69.79 142.8 53.12 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 113.316 -1.765 . . . . 0.0 108.194 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -82.71 115.12 21.5 Favored 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -170.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.5 t -100.28 122.85 52.71 Favored 'Isoleucine or valine' 0 C--N 1.385 2.151 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -164.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -107.45 -13.86 14.99 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.625 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.259 18.2 pttp -150.54 140.24 21.7 Favored 'General case' 0 C--O 1.21 -1.023 0 O-C-N 126.973 2.671 . . . . 0.0 106.336 159.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.54 -33.53 49.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 O-C-N 127.112 2.758 . . . . 0.0 112.915 -159.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.3 -36.54 61.32 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 109.895 -3.32 . . . . 0.0 116.713 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -57.02 -37.73 72.13 Favored 'General case' 0 N--CA 1.439 -1.025 0 O-C-N 125.221 1.576 . . . . 0.0 112.74 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -93.54 -42.89 8.98 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 121.68 2.036 . . . . 0.0 114.262 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.446 HD22 HG21 ' A' ' 89' ' ' VAL . 80.8 mt -109.13 123.01 48.51 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.929 0.892 . . . . 0.0 109.867 -163.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -108.63 142.14 39.55 Favored 'General case' 0 C--N 1.363 1.195 0 C-N-CA 126.029 1.731 . . . . 0.0 109.129 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 33.4 mmm -66.66 144.15 56.56 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.179 -169.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 46.93 39.07 10.91 Favored Glycine 0 CA--C 1.54 1.638 0 O-C-N 127.273 2.858 . . . . 0.0 117.505 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -119.75 136.02 54.61 Favored 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 125.549 1.54 . . . . 0.0 111.713 165.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.61 128.91 39.55 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 m -122.54 131.04 24.43 Favored Pre-proline 0 C--O 1.286 3.013 0 CA-C-N 111.173 -2.739 . . . . 0.0 106.032 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 0.4 OUTLIER -63.24 148.49 92.98 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 121.05 1.167 . . . . 0.0 109.464 159.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.6 134.91 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 C-N-CA 124.873 1.269 . . . . 0.0 107.604 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 152' ' ' ALA . 13.7 tppt? -95.82 132.66 40.83 Favored 'General case' 0 N--CA 1.519 2.983 0 C-N-CA 123.154 0.582 . . . . 0.0 110.757 164.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.71 110.69 18.76 Favored 'Isoleucine or valine' 0 C--N 1.374 1.662 0 O-C-N 120.282 -1.511 . . . . 0.0 109.493 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.87 -33.43 59.99 Favored 'General case' 0 C--N 1.373 1.615 0 O-C-N 125.719 1.887 . . . . 0.0 113.381 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -178.47 144.16 0.29 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -168.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.6 t -118.41 126.25 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 O-C-N 125.071 1.482 . . . . 0.0 107.889 161.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.292 0.0 OUTLIER -85.23 173.51 10.33 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 126.118 2.866 . . . . 0.0 113.572 -170.349 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -38.17 59.82 Favored 'General case' 0 CA--C 1.599 2.859 0 CA-C-N 110.873 -2.876 . . . . 0.0 111.293 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -85.62 -27.47 25.42 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.566 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.38 24.72 3.7 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.681 1.134 . . . . 0.0 111.518 170.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -80.9 140.87 35.08 Favored 'General case' 0 C--N 1.373 1.591 0 C-N-CA 126.5 1.92 . . . . 0.0 110.262 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.8 mt -105.12 132.38 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -125.27 119.45 28.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -168.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.7 mt -126.18 161.94 26.54 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 124.458 1.099 . . . . 0.0 111.403 -163.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.4 t -138.88 135.49 34.54 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 54.7 mt -83.28 -38.84 14.8 Favored 'Isoleucine or valine' 0 C--N 1.362 1.112 0 CA-C-O 116.177 -1.868 . . . . 0.0 107.032 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -76.28 -19.14 58.58 Favored 'General case' 0 C--N 1.366 1.299 0 O-C-N 125.684 1.865 . . . . 0.0 108.661 -171.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -81.65 -20.88 38.7 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 119.58 -1.95 . . . . 0.0 112.16 166.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.407 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -73.58 -36.91 65.61 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.411 -2.056 . . . . 0.0 111.025 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.0 p -96.38 20.67 10.16 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.218 -175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 35.0 64.37 0.43 Allowed 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 127.027 2.131 . . . . 0.0 115.0 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 . . . . . 0 C--O 1.25 1.102 0 O-C-N 117.699 -3.125 . . . . 0.0 106.03 172.032 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 115.524 -2.179 . . . . 0.0 107.026 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 mm -119.3 125.45 74.44 Favored 'Isoleucine or valine' 0 C--O 1.263 1.795 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -170.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -119.18 131.53 55.86 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.277 -171.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -112.33 129.47 56.28 Favored 'General case' 0 C--N 1.366 1.311 0 O-C-N 124.763 1.289 . . . . 0.0 113.752 -164.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.9 pt -130.2 170.2 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 O-C-N 125.075 1.485 . . . . 0.0 109.795 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -131.84 141.9 49.56 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.606 -1.237 . . . . 0.0 111.414 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.9 133.54 54.91 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.863 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -59.38 157.98 22.36 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 124.902 1.281 . . . . 0.0 112.645 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -70.49 -37.45 7.4 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.844 2.363 . . . . 0.0 110.45 -166.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -62.13 -46.41 89.13 Favored 'General case' 0 C--N 1.37 1.482 0 C-N-CA 118.307 -1.357 . . . . 0.0 114.366 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -78.26 -20.67 51.19 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 tp -59.37 -34.3 53.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 117.717 -1.593 . . . . 0.0 114.702 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -59.95 -34.0 72.67 Favored 'General case' 0 CA--C 1.557 1.242 0 O-C-N 124.724 1.265 . . . . 0.0 113.589 170.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -68.45 -42.98 78.05 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 122.62 1.2 . . . . 0.0 114.105 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 t -64.11 -40.62 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.756 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.5 ' O ' HG22 ' A' ' 29' ' ' ILE . 24.8 mm -98.6 28.0 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 CA-C-N 119.02 0.827 . . . . 0.0 111.498 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.89 125.44 11.93 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 118.613 2.205 . . . . 0.0 118.613 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.45 7.1 mptt 60.88 51.5 4.65 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.35 45.22 96.39 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 126.29 2.244 . . . . 0.0 114.986 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.0 0.76 67.97 Favored Glycine 0 C--N 1.358 1.774 0 CA-C-N 118.571 1.185 . . . . 0.0 111.493 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -66.47 -34.26 77.53 Favored 'General case' 0 C--O 1.202 -1.436 0 CA-C-N 119.389 1.595 . . . . 0.0 110.865 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.38 -45.59 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 CA-C-O 116.623 -1.656 . . . . 0.0 109.626 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.7 tp -80.52 -31.76 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 125.823 1.952 . . . . 0.0 111.153 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.71 -48.38 79.73 Favored 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 166.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.12 -45.17 82.06 Favored 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 124.426 1.09 . . . . 0.0 111.012 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.7 -37.92 80.16 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.263 33.3 p -64.6 -38.4 90.87 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 171.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -63.58 -47.78 80.07 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 125.008 1.443 . . . . 0.0 111.646 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -67.45 -47.14 71.03 Favored 'General case' 0 CA--C 1.457 -2.611 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.864 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -85.56 -8.41 58.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 127.583 3.052 . . . . 0.0 113.962 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.16 21.33 79.26 Favored Glycine 0 C--N 1.365 2.149 0 CA-C-O 121.819 0.677 . . . . 0.0 113.359 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -134.89 139.65 45.16 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 122.261 -0.552 . . . . 0.0 109.97 -155.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.0 m -78.23 135.27 37.55 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 119.715 1.143 . . . . 0.0 108.975 166.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.4 mt -133.01 118.2 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.244 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -84.52 131.56 34.63 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.6 mm -112.97 112.79 41.94 Favored 'Isoleucine or valine' 0 C--N 1.373 1.627 0 CA-C-N 120.342 1.428 . . . . 0.0 107.945 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -123.06 170.48 10.13 Favored 'General case' 0 C--O 1.201 -1.463 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -36.13 149.31 0.02 OUTLIER 'General case' 0 C--O 1.205 -1.277 1 C-N-CA 131.921 4.088 . . . . 0.0 118.844 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t0 62.39 35.72 14.79 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 124.418 1.087 . . . . 0.0 110.845 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 47.27 28.98 4.79 Favored Glycine 0 C--O 1.205 -1.67 0 CA-C-N 112.224 -2.262 . . . . 0.0 115.723 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.5 m -64.15 125.48 24.64 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.716 -0.873 . . . . 0.0 110.366 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -124.94 138.68 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -129.38 122.04 28.64 Favored 'General case' 0 C--N 1.366 1.314 0 O-C-N 127.596 3.06 . . . . 0.0 108.686 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.5 mm -95.52 130.15 44.64 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 O-C-N 120.22 -1.55 . . . . 0.0 107.838 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.95 117.98 33.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 117.984 -1.486 . . . . 0.0 107.355 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.3 148.67 29.13 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.671 -1.268 . . . . 0.0 110.871 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -69.0 -57.35 5.58 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.232 164.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -99.03 135.31 40.62 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 120.396 -1.44 . . . . 0.0 113.675 -163.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.12 -28.63 73.81 Favored Glycine 0 CA--C 1.506 -0.49 0 O-C-N 120.351 -1.468 . . . . 0.0 115.863 -167.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -57.87 -39.87 78.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.998 -0.707 . . . . 0.0 112.801 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -73.17 -37.9 66.39 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.96 95.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -61.82 -42.9 99.61 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.844 168.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -62.7 -39.3 93.57 Favored 'General case' 0 N--CA 1.52 3.033 0 CA-C-N 121.995 2.18 . . . . 0.0 115.093 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.49 69.03 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 120.365 1.439 . . . . 0.0 110.36 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.88 -44.48 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 122.594 1.188 . . . . 0.0 111.451 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -60.97 -42.39 98.22 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 168.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 21.8 mmm180 -64.63 -39.67 94.11 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.479 1.111 . . . . 0.0 112.231 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 mm -58.75 -40.7 80.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.137 168.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.65 -42.27 86.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.294 1.406 . . . . 0.0 110.917 168.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 71' ' ' ARG . 68.9 mt-10 -58.16 -43.12 87.25 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.9 mm -60.14 -44.39 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 CA-C-O 123.173 1.463 . . . . 0.0 113.808 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 p -77.56 -12.0 59.92 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.92 1.74 54.93 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 167.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.3 159.21 32.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 123.153 1.454 . . . . 0.0 108.775 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 mm -88.18 118.52 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 114.989 -2.434 . . . . 0.0 111.955 -171.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -125.09 134.85 52.33 Favored 'General case' 0 C--N 1.384 2.081 0 CA-C-N 121.288 1.858 . . . . 0.0 109.41 168.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.8 t -58.77 136.76 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.942 1.697 . . . . 0.0 111.372 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.59 -34.76 4.67 Favored Glycine 0 CA--C 1.55 2.28 0 O-C-N 120.809 -1.182 . . . . 0.0 113.789 -168.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -68.91 147.81 51.12 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-O 124.425 2.06 . . . . 0.0 113.147 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -89.1 133.3 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.694 0 CA-C-O 124.016 1.865 . . . . 0.0 111.868 169.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -133.13 169.68 16.51 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 126.874 2.07 . . . . 0.0 106.483 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.6 p -120.09 152.22 37.91 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.065 167.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.49 166.27 37.11 Favored Glycine 0 CA--C 1.465 -3.082 0 CA-C-O 123.776 1.765 . . . . 0.0 116.036 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 130' ' ' GLN . 55.6 mttm -106.31 127.76 53.49 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 110.968 -2.616 . . . . 0.0 115.334 -161.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.3 t -56.03 111.29 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.032 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -111.78 -13.44 13.71 Favored 'General case' 0 N--CA 1.525 3.309 0 CA-C-N 114.124 -1.398 . . . . 0.0 114.648 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.46 HH12 ' CD ' ' A' ' 106' ' ' GLU . 78.9 mtm-85 -155.02 153.48 31.04 Favored 'General case' 0 C--O 1.257 1.478 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 168.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.7 mt -132.21 125.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.7 m -138.3 166.83 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.585 -156.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -57.15 -35.23 69.28 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 126.87 2.606 . . . . 0.0 110.86 -165.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -111.74 10.25 20.92 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -174.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.0 -148.67 18.74 Favored Glycine 0 C--O 1.175 -3.534 0 CA-C-N 120.828 1.649 . . . . 0.0 115.83 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.91 157.13 43.9 Favored 'General case' 0 C--O 1.201 -1.457 0 O-C-N 119.489 -2.183 . . . . 0.0 108.88 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.433 ' CE2' HD13 ' A' ' 108' ' ' LEU . 85.3 m-85 -119.76 143.98 47.52 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.54 125.59 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 CA-C-N 111.608 -2.542 . . . . 0.0 108.816 -166.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.01 123.87 31.05 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.6 mm -114.28 142.39 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.725 0 CA-C-N 112.205 -2.271 . . . . 0.0 107.405 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -34.84 138.58 0.21 Allowed Glycine 0 C--N 1.389 3.491 0 C-N-CA 128.001 2.715 . . . . 0.0 114.994 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.06 29.82 68.44 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-O 118.863 -0.965 . . . . 0.0 112.391 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.31 30.65 53.95 Favored Glycine 0 CA--C 1.477 -2.33 0 O-C-N 124.983 1.049 . . . . 0.0 115.413 167.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -106.34 162.14 13.95 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 125.862 1.566 . . . . 0.0 109.671 -170.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.46 ' CD ' HH12 ' A' ' 91' ' ' ARG . 32.7 tt0 -149.32 122.17 8.73 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.498 1.499 . . . . 0.0 108.98 -171.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.89 162.13 15.77 Favored Glycine 0 CA--C 1.481 -2.033 0 CA-C-N 114.395 -1.275 . . . . 0.0 114.667 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.433 HD13 ' CE2' ' A' ' 98' ' ' PHE . 36.0 tp -114.56 126.24 54.7 Favored 'General case' 0 CA--C 1.491 -1.298 0 O-C-N 126.629 2.017 . . . . 0.0 111.343 -166.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.39 119.05 58.03 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 N-CA-C 100.693 -3.818 . . . . 0.0 100.693 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -82.93 169.68 15.76 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 120.725 -1.234 . . . . 0.0 109.254 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.9 tt -77.7 -25.72 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -157.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 81.7 p -92.26 7.03 44.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.416 -2.053 . . . . 0.0 111.259 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -120.33 27.36 8.65 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-O 114.779 -2.534 . . . . 0.0 109.591 -170.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.2 mt -105.03 -49.22 9.26 Favored 'Isoleucine or valine' 0 C--N 1.37 1.48 0 O-C-N 127.014 2.696 . . . . 0.0 109.117 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.22 173.73 11.24 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.333 -1.48 . . . . 0.0 109.031 -163.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -82.13 -53.39 6.12 Favored 'General case' 0 C--O 1.2 -1.509 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -65.75 138.84 58.21 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.695 0.798 . . . . 0.0 110.944 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -53.93 134.29 43.08 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.649 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -119.96 124.6 73.05 Favored 'Isoleucine or valine' 0 C--N 1.368 1.411 0 O-C-N 123.943 0.777 . . . . 0.0 111.851 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -109.18 -18.85 13.52 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 115.908 -1.996 . . . . 0.0 110.709 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -128.58 127.89 43.18 Favored 'General case' 0 C--N 1.381 1.936 0 CA-C-O 123.247 1.498 . . . . 0.0 109.024 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.21 -41.09 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 O-C-N 121.087 -1.008 . . . . 0.0 113.068 -174.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -55.88 -7.38 0.31 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 126.528 2.393 . . . . 0.0 112.481 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -69.5 -35.59 75.67 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.317 1.417 . . . . 0.0 113.871 173.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -115.23 -52.33 2.68 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 128.155 3.409 . . . . 0.0 114.251 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.1 mt -93.34 143.97 25.77 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.129 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.46 154.18 38.43 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 103.169 -2.9 . . . . 0.0 103.169 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 65.7 mmm -66.69 121.86 16.34 Favored 'General case' 0 C--O 1.192 -1.949 0 C-N-CA 127.399 2.28 . . . . 0.0 113.992 -165.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.17 -0.66 78.8 Favored Glycine 1 N--CA 1.518 4.13 0 N-CA-C 118.498 2.159 . . . . 0.0 118.498 -171.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.7 tt0 -57.75 141.09 49.89 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 167.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -87.13 121.48 29.63 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.581 170.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.2 m -113.4 129.33 24.72 Favored Pre-proline 0 C--O 1.215 -0.761 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.41 139.19 18.24 Favored 'Trans proline' 0 C--N 1.266 -3.815 0 N-CA-C 108.616 -1.34 . . . . 0.0 108.616 162.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.57 148.43 18.21 Favored 'Isoleucine or valine' 0 C--N 1.363 1.194 0 CA-C-O 123.169 1.461 . . . . 0.0 113.501 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -104.69 129.08 52.92 Favored 'General case' 0 C--O 1.19 -2.061 0 CA-C-N 111.843 -2.435 . . . . 0.0 111.819 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 81.6 t -82.4 122.27 36.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 125.575 1.797 . . . . 0.0 111.541 -170.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 148' ' ' SER . 3.5 mt -101.09 -33.13 10.26 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 117.601 -1.19 . . . . 0.0 112.227 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -145.23 146.52 31.74 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.42 119.8 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 123.157 1.456 . . . . 0.0 108.854 155.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.16 156.56 21.42 Favored 'General case' 0 C--O 1.254 1.322 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.335 169.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -51.98 -31.95 31.57 Favored 'General case' 0 C--N 1.401 2.845 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.79 13.17 33.28 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 120.427 1.467 . . . . 0.0 114.588 168.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.93 12.76 48.79 Favored Glycine 0 C--N 1.364 2.118 0 N-CA-C 118.068 1.987 . . . . 0.0 118.068 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -78.8 137.14 37.58 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-N 120.549 2.175 . . . . 0.0 109.29 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.8 mt -126.41 129.62 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 117.413 -1.28 . . . . 0.0 112.089 -159.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.09 128.67 51.73 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.622 171.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.6 mt -118.54 162.27 18.65 Favored 'General case' 0 N--CA 1.52 3.05 0 O-C-N 125.068 1.48 . . . . 0.0 114.385 -170.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.407 ' HB2' HD21 ' A' ' 137' ' ' LEU . 35.8 t -129.91 138.78 51.09 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.231 1.013 . . . . 0.0 109.414 168.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.9 mt -99.95 -28.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 167.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -57.85 -42.22 83.99 Favored 'General case' 0 C--N 1.37 1.469 0 O-C-N 119.442 -2.036 . . . . 0.0 111.6 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.33 -42.46 92.9 Favored 'General case' 0 CA--C 1.594 2.655 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.25 . . -61.6 -45.02 95.86 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 120.12 -1.613 . . . . 0.0 111.017 170.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.5 p -89.53 11.47 19.42 Favored 'General case' 0 C--O 1.2 -1.539 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.723 -175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 49.0 54.14 11.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 129.863 3.265 . . . . 0.0 116.161 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 . . . . . 0 CA--C 1.504 -0.816 0 O-C-N 119.315 -2.116 . . . . 0.0 108.81 -169.102 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 119.562 -0.256 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.7 mm -62.48 142.57 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 C-N-CA 117.702 -1.599 . . . . 0.0 112.503 169.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -135.79 129.36 32.38 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.78 163.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.3 m -111.62 138.4 48.23 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 122.099 0.952 . . . . 0.0 111.876 -172.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt -134.86 130.82 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 113.75 -1.568 . . . . 0.0 107.977 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -82.11 130.11 35.0 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-O 122.506 1.146 . . . . 0.0 111.607 163.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.2 mm -121.41 128.36 75.88 Favored 'Isoleucine or valine' 0 C--N 1.401 2.827 0 O-C-N 120.506 -1.371 . . . . 0.0 109.542 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 5.7 m-20 -56.24 156.85 10.03 Favored Pre-proline 0 C--N 1.371 1.539 0 CA-C-N 119.555 1.07 . . . . 0.0 112.726 -171.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 21' ' ' ASN . 54.5 Cg_exo -66.2 -25.47 50.26 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 N-CA-C 116.757 1.791 . . . . 0.0 116.757 -167.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -84.2 -27.49 27.98 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-O 117.04 -1.457 . . . . 0.0 110.777 172.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -86.64 -26.51 24.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 121.546 1.976 . . . . 0.0 110.109 -169.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 49' ' ' ILE . 10.0 tp -74.85 -19.61 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 O-C-N 124.61 1.194 . . . . 0.0 108.277 173.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.269 35.5 mmtm -64.93 -39.53 93.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.057 -1.027 . . . . 0.0 113.298 168.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.11 -38.6 91.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.865 1.666 . . . . 0.0 113.574 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.03 -33.31 62.47 Favored 'Isoleucine or valine' 0 C--N 1.375 1.706 0 C-N-CA 125.483 1.513 . . . . 0.0 111.352 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.497 ' O ' HG22 ' A' ' 29' ' ' ILE . 47.6 mm -97.57 11.04 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-O 123.178 1.466 . . . . 0.0 111.581 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.37 167.39 13.29 Favored Glycine 0 C--N 1.296 -1.674 0 CA-C-N 111.792 -2.458 . . . . 0.0 115.944 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm 58.3 43.98 19.29 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.208 1.403 . . . . 0.0 113.327 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.3 12.72 81.83 Favored Glycine 0 CA--C 1.558 2.757 0 O-C-N 120.807 -1.183 . . . . 0.0 115.818 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.03 5.26 77.23 Favored Glycine 0 C--N 1.369 2.402 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 -171.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.7 m -63.08 -39.99 96.33 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-O 116.903 -1.522 . . . . 0.0 113.623 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 t -61.44 -47.36 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.309 6.4 tp -62.96 -39.33 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-N 119.427 1.012 . . . . 0.0 111.327 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -64.37 -51.57 62.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.351 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.05 -43.81 82.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 126.352 2.283 . . . . 0.0 115.286 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.91 -50.95 71.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.7 p -64.83 -35.2 80.33 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 120.673 -1.267 . . . . 0.0 112.564 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -72.36 -39.51 68.03 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 125.832 1.957 . . . . 0.0 110.338 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -61.76 -38.51 88.27 Favored 'General case' 0 C--O 1.259 1.555 0 CA-C-O 124.166 1.936 . . . . 0.0 113.003 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.5 p -91.24 -17.06 26.62 Favored 'General case' 0 C--N 1.367 1.335 0 O-C-N 118.663 -2.523 . . . . 0.0 116.363 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.03 28.6 73.73 Favored Glycine 0 CA--C 1.474 -2.484 1 O-C-N 129.254 4.096 . . . . 0.0 112.352 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 t -148.31 159.3 44.13 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 124.305 2.002 . . . . 0.0 107.671 -166.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -83.42 118.0 23.44 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 112.407 -2.179 . . . . 0.0 108.581 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.632 HG23 HD13 ' A' ' 57' ' ' ILE . 16.4 mt -124.08 121.32 61.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -113.22 147.42 37.52 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 125.573 2.606 . . . . 0.0 108.092 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.533 HD12 HD11 ' A' ' 25' ' ' ILE . 16.3 mm -112.09 123.4 67.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 112.014 -2.357 . . . . 0.0 109.227 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -123.88 166.83 14.98 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -165.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.281 81.9 m-20 -47.4 142.49 4.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.024 -1.672 . . . . 0.0 114.196 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.8 t0 54.27 67.3 1.03 Allowed 'General case' 0 C--N 1.35 0.598 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 171.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.53 27.47 26.39 Favored Glycine 0 C--N 1.301 -1.396 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 m -107.39 114.79 29.03 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 49' ' ' ILE . 24.5 t -104.43 141.79 19.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -173.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -129.29 123.39 31.74 Favored 'General case' 0 C--N 1.363 1.19 0 CA-C-O 122.54 1.162 . . . . 0.0 109.498 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.632 HD13 HG23 ' A' ' 47' ' ' ILE . 12.6 mm -86.83 130.03 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.117 167.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.67 51.16 1.86 Allowed 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.87 153.38 21.37 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 119.048 -2.283 . . . . 0.0 114.729 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.7 p -100.04 21.92 12.05 Favored 'General case' 0 C--N 1.381 1.949 0 CA-C-O 115.476 -2.202 . . . . 0.0 111.301 -175.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -151.49 145.58 25.3 Favored 'General case' 0 C--N 1.372 1.585 0 O-C-N 127.244 2.84 . . . . 0.0 110.08 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.1 -33.98 61.87 Favored Glycine 0 N--CA 1.439 -1.128 0 O-C-N 125.248 1.592 . . . . 0.0 114.425 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.31 -45.43 87.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 116.703 -1.618 . . . . 0.0 108.186 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -58.74 -42.07 87.95 Favored 'General case' 0 C--N 1.375 1.681 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.86 98.13 Favored 'General case' 0 C--O 1.272 2.267 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -68.63 -37.41 79.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 125.394 1.684 . . . . 0.0 108.697 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -66.92 -42.86 84.65 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 120.074 -1.641 . . . . 0.0 114.521 170.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.15 -54.38 31.35 Favored 'General case' 0 C--O 1.191 -2.008 0 CA-C-N 121.176 1.807 . . . . 0.0 111.556 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 mt -60.87 -45.14 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 124.46 1.104 . . . . 0.0 110.168 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -56.33 -44.29 79.85 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -63.16 -41.56 99.27 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 120.597 1.544 . . . . 0.0 107.827 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.19 -42.09 85.82 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.971 0 CA-C-O 116.805 -1.569 . . . . 0.0 110.234 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.32 -42.18 90.79 Favored 'General case' 0 N--CA 1.537 3.883 0 CA-C-N 121.734 2.061 . . . . 0.0 111.281 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -69.31 -39.16 78.42 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 126.242 2.214 . . . . 0.0 114.688 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.6 mt -71.61 -32.41 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 168.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 76.1 p -99.22 24.68 7.65 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.769 1.622 . . . . 0.0 109.672 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.33 0.9 12.34 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 117.547 -1.216 . . . . 0.0 111.712 162.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.358 40.0 mt-10 -60.33 129.27 40.81 Favored 'General case' 0 N--CA 1.515 2.781 0 CA-C-O 124.295 1.998 . . . . 0.0 108.72 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.7 mm -83.76 128.67 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 125.039 2.352 . . . . 0.0 115.254 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -115.59 134.55 54.94 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-N 113.028 -1.896 . . . . 0.0 106.379 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.17 139.03 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 O-C-N 128.134 3.396 . . . . 0.0 110.31 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.95 -10.21 48.69 Favored Glycine 0 CA--C 1.551 2.342 0 O-C-N 119.39 -2.069 . . . . 0.0 113.835 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -81.87 159.33 23.73 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-N 119.662 1.731 . . . . 0.0 111.176 167.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.41 140.32 31.36 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -130.83 161.65 31.32 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.9 m -117.25 125.72 51.58 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.99 -169.76 12.41 Favored Glycine 0 N--CA 1.42 -2.412 0 C-N-CA 120.295 -0.955 . . . . 0.0 114.986 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -128.56 143.22 50.92 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 122.937 1.351 . . . . 0.0 114.432 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.3 t -73.76 122.75 27.47 Favored 'Isoleucine or valine' 0 C--N 1.382 2.008 0 O-C-N 118.078 -2.889 . . . . 0.0 115.288 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.12 -25.4 7.63 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 115.929 -1.986 . . . . 0.0 113.785 -170.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 -146.22 151.47 37.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 168.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -123.65 131.44 73.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.04 174.47 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 124.047 1.88 . . . . 0.0 111.324 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -58.62 -37.4 75.8 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 117.565 -1.654 . . . . 0.0 114.518 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -98.41 18.91 15.4 Favored 'General case' 0 C--N 1.374 1.664 0 CA-C-N 120.876 1.671 . . . . 0.0 111.737 -176.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.56 -135.92 6.19 Favored Glycine 0 C--N 1.383 3.182 0 N-CA-C 115.057 0.783 . . . . 0.0 115.057 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.57 160.81 41.09 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 125.649 1.441 . . . . 0.0 114.831 167.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.29 131.48 54.17 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-O 121.884 0.849 . . . . 0.0 111.122 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 72.9 t -110.85 134.3 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.646 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -98.49 127.71 44.54 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 120.221 -1.549 . . . . 0.0 109.395 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.92 150.79 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 CA-C-N 112.883 -1.962 . . . . 0.0 112.188 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.67 154.38 0.62 Allowed Glycine 0 CA--C 1.564 3.128 0 N-CA-C 118.958 2.343 . . . . 0.0 118.958 173.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.56 8.09 24.3 Favored Glycine 0 C--N 1.366 2.214 0 C-N-CA 127.663 2.554 . . . . 0.0 117.57 -168.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.79 22.86 16.95 Favored Glycine 0 C--O 1.256 1.494 0 O-C-N 127.585 2.58 . . . . 0.0 117.219 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.96 128.14 34.19 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 117.256 0.528 . . . . 0.0 110.491 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.0 146.83 35.98 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 123.343 1.544 . . . . 0.0 108.685 169.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -145.24 163.96 28.04 Favored Glycine 0 CA--C 1.48 -2.141 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.06 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.0 tp -110.61 136.4 49.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 124.372 0.689 . . . . 0.0 110.462 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.73 113.73 45.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 CA-C-O 123.824 1.773 . . . . 0.0 108.796 160.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -62.91 150.65 41.47 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 tt -52.89 -24.83 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.3 p -90.32 6.3 43.62 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 125.825 1.65 . . . . 0.0 112.198 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -120.45 5.35 10.66 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 120.16 -1.588 . . . . 0.0 114.072 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 18.5 mm -82.84 -48.56 17.7 Favored 'Isoleucine or valine' 0 C--O 1.283 2.821 0 CA-C-O 123.734 1.73 . . . . 0.0 112.304 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.29 173.84 13.52 Favored 'General case' 0 N--CA 1.406 -2.645 0 O-C-N 116.939 -3.601 . . . . 0.0 107.224 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -66.0 -33.7 76.4 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.2 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -71.56 161.19 31.4 Favored 'General case' 0 C--N 1.365 1.264 0 C-N-CA 124.733 1.213 . . . . 0.0 114.024 -173.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -70.63 122.22 19.36 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 124.679 2.181 . . . . 0.0 108.82 167.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.28 146.01 16.8 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.779 0 CA-C-N 112.38 -2.191 . . . . 0.0 110.157 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -119.84 -35.33 3.53 Favored 'General case' 0 C--N 1.369 1.445 0 CA-C-N 120.359 1.436 . . . . 0.0 113.826 160.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -123.17 129.3 51.22 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 122.7 1.238 . . . . 0.0 109.149 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.3 -20.43 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 111.814 -2.448 . . . . 0.0 106.646 -166.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.4 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.39 2.346 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -66.52 -45.33 79.85 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 125.716 1.606 . . . . 0.0 112.921 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -95.06 -17.97 21.42 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.7 mt -126.99 129.45 48.13 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -98.72 156.2 16.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.62 -1.3 . . . . 0.0 110.291 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 51.5 tpp -67.93 133.86 49.83 Favored 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 118.641 -2.537 . . . . 0.0 109.165 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.09 15.91 79.65 Favored Glycine 0 CA--C 1.548 2.132 0 O-C-N 126.061 2.1 . . . . 0.0 112.059 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -65.24 132.42 49.05 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.294 -1.709 . . . . 0.0 113.151 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -85.12 118.55 24.75 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 123.748 1.737 . . . . 0.0 112.957 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.86 125.33 20.23 Favored Pre-proline 0 CA--C 1.582 2.174 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -158.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.65 131.43 24.37 Favored 'Trans proline' 0 N--CA 1.518 2.923 0 O-C-N 117.726 -1.776 . . . . 0.0 111.786 165.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.15 136.82 57.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 CA-C-O 123.061 1.41 . . . . 0.0 110.452 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -105.01 143.42 33.22 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 120.702 -1.249 . . . . 0.0 109.764 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.9 t -86.9 137.48 20.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 122.17 0.986 . . . . 0.0 109.409 -170.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.65 -43.17 3.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 118.944 -2.348 . . . . 0.0 108.558 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -153.12 146.86 25.19 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-O 124.139 1.923 . . . . 0.0 108.205 -166.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.7 p -145.64 123.21 4.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 CA-C-O 124.119 1.914 . . . . 0.0 110.092 171.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' A' ' 146' ' ' ARG . 60.2 m-20 -71.74 175.34 5.79 Favored 'General case' 0 CA--C 1.592 2.593 0 O-C-N 119.826 -1.796 . . . . 0.0 115.207 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -68.51 -16.27 63.83 Favored 'General case' 0 CA--C 1.584 2.274 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.74 19.16 21.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 120.055 -1.653 . . . . 0.0 111.476 167.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.85 16.93 79.21 Favored Glycine 0 C--N 1.362 2.015 0 O-C-N 125.961 2.038 . . . . 0.0 114.468 168.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . 0.332 36.0 mtm180 -69.75 129.31 39.24 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 163.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.4 mt -108.68 141.33 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 119.545 -1.972 . . . . 0.0 110.714 -165.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.458 HH12 ' CG ' ' A' ' 140' ' ' ASP . 0.4 OUTLIER -113.1 150.09 32.6 Favored 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.606 160.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.4 mt -140.33 171.86 13.55 Favored 'General case' 0 C--O 1.258 1.508 0 CA-C-O 124.087 1.898 . . . . 0.0 111.391 -166.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.5 t -154.84 134.49 12.76 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.0 mt -87.96 -17.86 8.4 Favored 'Isoleucine or valine' 0 C--N 1.377 1.777 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -62.57 -50.18 72.34 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 172.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.56 -25.58 63.16 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 122.111 0.958 . . . . 0.0 109.714 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.08 -49.26 68.22 Favored 'General case' 0 C--O 1.257 1.478 0 O-C-N 119.797 -1.814 . . . . 0.0 115.01 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.9 p -92.2 10.5 29.22 Favored 'General case' 0 C--O 1.268 2.042 0 CA-C-N 112.138 -2.301 . . . . 0.0 111.214 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.337 45.8 mt-10 71.87 53.1 0.2 Allowed 'General case' 0 C--N 1.38 1.927 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 166.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 69.7 mm-40 . . . . . 0 C--N 1.353 0.733 0 CA-C-O 116.814 -1.565 . . . . 0.0 113.717 177.989 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 . . . . . 0 CA--C 1.561 1.383 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mm -71.31 125.77 30.39 Favored 'Isoleucine or valine' 0 C--N 1.365 1.269 0 CA-C-O 126.28 2.943 . . . . 0.0 112.266 161.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -116.17 138.96 50.82 Favored 'General case' 0 CA--C 1.59 2.486 0 CA-C-N 109.829 -3.35 . . . . 0.0 104.877 169.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 t -136.66 164.51 28.07 Favored 'General case' 0 N--CA 1.532 3.635 0 CA-C-O 117.627 -1.178 . . . . 0.0 112.252 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 tp -172.02 145.7 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.071 0 O-C-N 126.793 2.558 . . . . 0.0 105.228 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -128.58 130.63 47.64 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 124.8 1.24 . . . . 0.0 109.535 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.6 pt -133.33 162.99 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.834 0 O-C-N 126.513 2.383 . . . . 0.0 108.637 -166.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -43.95 141.96 2.2 Favored Pre-proline 0 N--CA 1.524 3.26 0 CA-C-N 120.024 1.284 . . . . 0.0 112.376 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -59.94 -34.33 95.25 Favored 'Trans proline' 0 CA--C 1.474 -2.475 0 C-N-CA 122.866 2.378 . . . . 0.0 112.567 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -65.2 -28.16 69.19 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-N 121.816 2.098 . . . . 0.0 113.425 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.2 -22.07 64.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.01 -43.59 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 C-N-CA 124.969 1.307 . . . . 0.0 110.649 171.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -51.87 -43.65 63.35 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 170.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -79.81 -22.13 43.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.71 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.8 t -70.61 -54.08 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-O 116.263 -1.827 . . . . 0.0 110.084 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -58.99 -42.49 86.34 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 CA-C-N 120.098 1.317 . . . . 0.0 109.022 173.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.1 175.97 49.14 Favored Glycine 0 C--N 1.374 2.69 0 O-C-N 119.425 -2.047 . . . . 0.0 113.888 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -74.78 119.2 18.64 Favored 'General case' 0 C--N 1.387 2.204 0 CA-C-N 119.704 1.752 . . . . 0.0 106.804 -171.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.49 4.48 87.36 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.43 17.64 70.73 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 118.628 -1.748 . . . . 0.0 115.962 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.1 p -69.3 -37.29 77.72 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 119.972 3.323 . . . . 0.0 119.972 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.6 t -74.28 -39.11 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 O-C-N 124.696 1.248 . . . . 0.0 112.5 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.287 17.0 tt -63.54 -41.21 91.87 Favored 'Isoleucine or valine' 0 C--O 1.262 1.738 0 O-C-N 127.16 2.787 . . . . 0.0 112.711 173.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -64.15 -37.5 87.67 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 125.666 1.854 . . . . 0.0 111.609 169.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.24 79.92 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.08 -42.32 98.29 Favored 'General case' 0 C--O 1.196 -1.744 0 O-C-N 118.328 -2.732 . . . . 0.0 108.558 170.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.1 m -59.26 -48.81 80.24 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.049 0.94 . . . . 0.0 111.024 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -73.92 -35.81 64.64 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 116.316 -2.153 . . . . 0.0 110.024 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -73.11 -41.55 63.9 Favored 'General case' 0 C--O 1.258 1.542 0 CA-C-N 122.314 2.325 . . . . 0.0 111.54 -175.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.7 p -81.85 -24.95 35.5 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 118.377 -2.702 . . . . 0.0 113.2 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.6 35.09 59.45 Favored Glycine 0 C--N 1.394 3.77 0 CA-C-N 122.061 2.209 . . . . 0.0 116.495 -169.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 p -129.55 177.37 7.26 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.127 1.771 . . . . 0.0 107.383 -165.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.2 m -121.68 114.77 21.6 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 123.121 1.439 . . . . 0.0 107.136 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mt -101.43 128.24 53.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 112.622 -2.081 . . . . 0.0 112.56 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -135.44 151.09 50.08 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-O 123.601 1.667 . . . . 0.0 109.715 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.0 mm -114.71 126.7 72.34 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.761 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.865 -171.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -118.58 147.14 44.02 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.19 162.95 0.05 OUTLIER 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 52.22 36.25 18.87 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 126.511 1.924 . . . . 0.0 115.485 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.07 8.76 66.45 Favored Glycine 0 CA--C 1.468 -2.903 0 CA-C-O 116.112 -2.493 . . . . 0.0 116.203 172.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.8 m -77.0 135.13 38.66 Favored 'General case' 0 C--O 1.256 1.432 0 O-C-N 127.248 2.381 . . . . 0.0 113.748 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -114.12 136.18 51.47 Favored 'Isoleucine or valine' 0 C--N 1.367 1.367 0 O-C-N 120.66 -1.275 . . . . 0.0 114.354 165.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -125.85 116.77 22.08 Favored 'General case' 0 C--O 1.196 -1.745 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.111 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.2 mt -114.04 119.87 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.556 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -98.02 142.11 30.14 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 126.883 2.614 . . . . 0.0 110.79 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.75 175.09 14.37 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-O 124.836 2.255 . . . . 0.0 106.131 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 t -116.95 -15.81 10.59 Favored 'General case' 0 N--CA 1.532 3.646 0 CA-C-N 112.671 -2.059 . . . . 0.0 112.296 171.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -120.42 114.51 21.92 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.18 -38.15 95.15 Favored Glycine 0 N--CA 1.505 3.268 0 N-CA-C 118.428 2.131 . . . . 0.0 118.428 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.0 -31.88 71.48 Favored 'General case' 0 C--N 1.377 1.804 0 CA-C-N 121.314 2.557 . . . . 0.0 113.772 167.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -67.69 -34.92 77.86 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 121.738 2.063 . . . . 0.0 114.385 170.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.51 -45.55 79.15 Favored 'General case' 0 C--O 1.254 1.341 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 171.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HA ' HD12 ' A' ' 69' ' ' ILE . 43.5 mmtt -58.39 -37.08 74.56 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 115.08 -2.391 . . . . 0.0 110.742 167.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -62.93 -36.51 83.64 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 122.756 2.525 . . . . 0.0 111.361 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.36 -38.15 74.72 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 120.31 -1.494 . . . . 0.0 112.88 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 66' ' ' LYS . 19.3 mt -60.32 -43.27 93.3 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.84 168.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -60.17 -49.27 78.3 Favored 'General case' 0 C--O 1.249 1.029 0 O-C-N 120.495 -1.378 . . . . 0.0 113.787 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -67.38 -30.0 69.68 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.061 1.301 . . . . 0.0 112.757 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.9 -47.39 83.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 CA-C-O 115.492 -2.194 . . . . 0.0 110.674 166.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.67 -39.55 77.35 Favored 'General case' 0 C--O 1.206 -1.227 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -64.07 -55.18 23.94 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-O 115.927 -1.987 . . . . 0.0 114.029 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 36.6 mm -55.25 -43.49 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.368 0 CA-C-N 121.577 1.99 . . . . 0.0 109.285 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.3 p -67.44 -19.47 65.37 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.97 -19.76 36.48 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 120.977 -1.077 . . . . 0.0 113.591 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -68.01 122.85 19.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 124.701 1.251 . . . . 0.0 111.501 -164.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 mm -69.08 124.85 25.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 CA-C-O 117.551 -1.214 . . . . 0.0 114.242 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -121.0 139.82 52.77 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-O 123.613 1.673 . . . . 0.0 107.239 168.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.05 130.12 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 117.16 -3.463 . . . . 0.0 115.287 171.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.06 -8.15 41.78 Favored Glycine 0 CA--C 1.485 -1.817 0 CA-C-O 117.014 -1.992 . . . . 0.0 112.498 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -57.28 147.98 24.0 Favored 'General case' 0 C--N 1.371 1.511 0 O-C-N 124.981 1.048 . . . . 0.0 112.838 166.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.9 129.56 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 128.167 3.417 . . . . 0.0 106.905 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -135.78 168.5 19.19 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 123.444 1.592 . . . . 0.0 110.014 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 m -112.45 121.88 46.09 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 171.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.1 -172.24 13.33 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -139.76 144.33 37.38 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.33 138.2 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 170.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.4 p -115.3 -40.16 3.48 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 120.158 -1.589 . . . . 0.0 109.478 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.4 mtm-85 -146.88 141.96 27.13 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.157 0.983 . . . . 0.0 110.052 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 92' ' ' ILE . 96.9 mt -120.24 143.33 32.4 Favored 'Isoleucine or valine' 0 C--N 1.38 1.931 0 CA-C-O 122.451 1.12 . . . . 0.0 109.927 176.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 m -144.31 168.93 9.98 Favored 'Isoleucine or valine' 0 C--N 1.388 2.278 0 O-C-N 117.955 -2.965 . . . . 0.0 104.251 -170.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -56.66 -37.89 71.42 Favored 'General case' 0 C--O 1.269 2.094 0 CA-C-N 118.493 0.588 . . . . 0.0 111.743 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -96.06 11.33 34.52 Favored 'General case' 0 C--O 1.252 1.209 0 O-C-N 120.914 -1.117 . . . . 0.0 111.7 -168.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.72 -177.94 30.94 Favored Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.973 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.16 127.09 53.0 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.744 0.908 . . . . 0.0 110.276 174.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -76.26 131.86 39.51 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-O 123.806 1.765 . . . . 0.0 111.948 166.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.4 t -129.61 135.17 62.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 CA-C-N 112.051 -2.341 . . . . 0.0 112.024 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.96 129.97 41.62 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 112.21 -2.268 . . . . 0.0 112.632 167.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.5 mm -119.03 135.34 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.05 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.4 145.86 0.37 Allowed Glycine 0 C--N 1.378 2.909 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.54 38.84 27.28 Favored Glycine 0 N--CA 1.504 3.192 0 CA-C-N 112.78 -1.71 . . . . 0.0 111.051 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.48 6.92 84.99 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 120.507 2.963 . . . . 0.0 120.507 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -87.42 160.06 18.46 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 118.267 2.692 . . . . 0.0 118.267 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.87 131.63 20.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 109.707 172.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -122.9 163.1 16.43 Favored Glycine 0 C--N 1.349 1.25 0 C-N-CA 123.733 0.683 . . . . 0.0 112.156 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.94 124.91 44.21 Favored 'General case' 0 C--O 1.203 -1.345 0 O-C-N 126.892 2.172 . . . . 0.0 110.491 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 147' ' ' LEU . 74.1 t -96.93 100.29 10.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 168.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -67.58 154.87 40.45 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.312 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.273 6.3 tt -52.69 -38.69 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -170.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.6 p -73.4 -0.96 16.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 148' ' ' SER . 91.1 mm-40 -119.01 5.77 11.34 Favored 'General case' 0 CA--C 1.576 1.968 0 O-C-N 123.986 0.804 . . . . 0.0 112.577 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.0 mm -77.68 -33.24 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.183 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -157.65 -176.19 5.8 Favored 'General case' 0 CA--C 1.495 -1.157 0 O-C-N 120.076 -1.64 . . . . 0.0 111.079 -170.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -105.57 -23.43 12.78 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 165.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -62.05 158.28 16.92 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 120.092 -1.63 . . . . 0.0 112.648 173.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -74.25 131.56 41.32 Favored 'General case' 0 C--O 1.205 -1.273 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.49 HG22 ' CE2' ' A' ' 125' ' ' TYR . 17.8 t -122.21 127.72 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 C-N-CA 125.793 1.637 . . . . 0.0 114.188 -173.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -110.25 -46.1 3.48 Favored 'General case' 0 C--N 1.386 2.18 0 C-N-CA 124.893 1.277 . . . . 0.0 110.202 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -120.48 150.36 40.94 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 170.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.11 -23.2 14.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-N 113.719 -1.582 . . . . 0.0 113.038 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.93 -19.39 65.09 Favored 'General case' 0 CA--C 1.581 2.141 0 O-C-N 120.115 -1.616 . . . . 0.0 114.616 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -76.59 -29.64 56.65 Favored 'General case' 0 N--CA 1.539 3.977 0 C-N-CA 126.577 1.951 . . . . 0.0 110.484 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.49 ' CE2' HG22 ' A' ' 119' ' ' VAL . 76.7 m-85 -100.79 -15.46 17.64 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 126' ' ' LEU . 30.6 mt -151.99 162.42 41.11 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 124.22 0.95 . . . . 0.0 109.689 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -134.5 160.1 39.08 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 162.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -72.08 139.98 48.7 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 120.378 -1.451 . . . . 0.0 113.851 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 94.64 -12.35 68.84 Favored Glycine 0 N--CA 1.505 3.253 0 CA-C-O 125.39 2.661 . . . . 0.0 111.608 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -68.66 131.81 45.82 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 123.682 1.706 . . . . 0.0 111.177 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -79.65 129.6 34.62 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.931 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.57 127.16 19.48 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 120.527 -1.358 . . . . 0.0 109.062 -169.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.42 127.11 24.83 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 CA-C-O 116.769 -1.43 . . . . 0.0 113.278 160.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.0 129.43 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-N 122.669 2.486 . . . . 0.0 110.188 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -97.86 140.75 31.76 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 172.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.2 t -86.74 116.21 28.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.034 0 O-C-N 125.742 1.901 . . . . 0.0 106.789 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.0 tp -101.87 -48.01 4.41 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 116.323 -1.799 . . . . 0.0 110.658 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -136.12 150.84 49.26 Favored 'General case' 0 C--O 1.204 -1.294 0 O-C-N 125.029 1.456 . . . . 0.0 107.726 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.8 t -134.64 120.46 32.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -75.89 155.66 35.02 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.616 -1.302 . . . . 0.0 111.238 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.31 29.5 mmt180 -70.85 -27.06 63.57 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -65.74 -31.99 73.29 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 126.158 2.161 . . . . 0.0 115.833 157.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 138.02 -13.98 3.57 Favored Glycine 0 CA--C 1.549 2.206 0 C-N-CA 125.19 1.376 . . . . 0.0 111.646 162.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -54.37 137.84 41.03 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 10.6 mt -118.06 131.52 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 125.061 1.344 . . . . 0.0 113.14 -167.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -110.09 144.33 38.85 Favored 'General case' 0 N--CA 1.527 3.418 0 CA-C-O 123.283 1.516 . . . . 0.0 111.227 164.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.444 ' HB2' HG22 ' A' ' 109' ' ' VAL . 67.1 mt -129.12 151.87 49.33 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.079 -2.328 . . . . 0.0 110.29 -169.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 113' ' ' GLN . 33.8 t -125.82 115.82 20.61 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.062 1.345 . . . . 0.0 109.148 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.6 mt -74.87 -38.24 43.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 119.838 -1.789 . . . . 0.0 112.164 171.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -59.46 -47.24 86.25 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 127.015 2.697 . . . . 0.0 114.634 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -66.59 -46.34 76.27 Favored 'General case' 0 C--O 1.258 1.514 0 CA-C-N 118.345 0.52 . . . . 0.0 111.63 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.6 -18.23 64.91 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-O 116.912 -1.518 . . . . 0.0 112.569 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.1 p -98.68 3.25 47.72 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 117.629 -1.176 . . . . 0.0 108.234 172.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.471 8.7 mt-10 80.69 25.27 0.3 Allowed 'General case' 0 C--N 1.364 1.236 0 CA-C-N 120.521 1.509 . . . . 0.0 113.184 162.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 . . . . . 0 C--O 1.24 0.577 0 O-C-N 127.344 2.903 . . . . 0.0 108.273 -177.632 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.574 1.874 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.8 135.0 28.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 CA-C-O 122.001 0.905 . . . . 0.0 113.395 -171.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -123.04 138.97 54.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 124.395 2.045 . . . . 0.0 113.674 169.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -135.13 139.7 44.85 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 113.326 -1.761 . . . . 0.0 110.121 -173.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.3 pt -133.37 161.44 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 162.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -83.45 146.1 28.6 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 125.02 2.343 . . . . 0.0 109.447 160.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 pt -122.58 147.87 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 157.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.283 1.6 t-20 -63.35 138.53 97.38 Favored Pre-proline 0 N--CA 1.514 2.748 0 C-N-CA 128.472 2.709 . . . . 0.0 108.381 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -80.95 3.76 7.53 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 O-C-N 118.007 -1.628 . . . . 0.0 114.328 -171.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -91.43 -2.33 57.3 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 120.59 -1.319 . . . . 0.0 110.443 164.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -111.74 3.82 18.04 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.285 -0.884 . . . . 0.0 109.322 -170.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 mt -68.45 -41.31 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 119.828 -1.795 . . . . 0.0 112.366 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -52.5 -13.15 0.34 Allowed 'General case' 0 C--N 1.353 0.738 0 C-N-CA 128.34 2.656 . . . . 0.0 117.415 164.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -102.62 -32.71 9.75 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 115.734 -2.079 . . . . 0.0 113.318 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.3 t -84.15 -31.34 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 O-C-N 125.099 1.499 . . . . 0.0 109.466 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.3 mm -93.25 -55.21 6.36 Favored 'Isoleucine or valine' 0 C--N 1.361 1.08 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.62 -173.39 30.21 Favored Glycine 0 C--N 1.369 2.37 0 CA-C-O 123.506 1.614 . . . . 0.0 115.432 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -74.88 108.96 7.96 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 116.588 -1.672 . . . . 0.0 110.593 -167.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.53 9.76 59.84 Favored Glycine 0 CA--C 1.468 -2.855 0 O-C-N 127.474 2.984 . . . . 0.0 110.434 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.65 30.37 77.21 Favored Glycine 0 CA--C 1.54 1.613 0 O-C-N 125.362 1.272 . . . . 0.0 112.259 -162.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -53.05 -54.42 35.69 Favored 'General case' 0 N--CA 1.517 2.888 0 C-N-CA 126.213 1.805 . . . . 0.0 111.225 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -89.82 -35.56 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -160.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.1 tp -67.81 -38.64 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -66.12 -44.29 84.7 Favored 'General case' 0 C--N 1.399 2.731 0 C-N-CA 125.147 1.379 . . . . 0.0 110.489 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.23 47.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 127.814 3.196 . . . . 0.0 110.026 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.2 mt -51.63 -48.74 63.2 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 116.07 -1.919 . . . . 0.0 113.92 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 t -60.83 -34.42 74.54 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.6 1.545 . . . . 0.0 112.966 -175.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.25 -31.23 71.43 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -96.46 -28.12 14.57 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 126.285 1.834 . . . . 0.0 111.662 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.468 HG21 ' HA ' ' A' ' 68' ' ' ALA . 11.1 p -84.67 -19.64 32.53 Favored 'General case' 0 C--N 1.396 2.62 0 CA-C-N 120.954 1.706 . . . . 0.0 110.754 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.18 24.85 74.73 Favored Glycine 0 N--CA 1.472 1.042 0 C-N-CA 127.906 2.669 . . . . 0.0 114.12 171.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 t -141.45 161.78 37.08 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.871 0.868 . . . . 0.0 108.736 -173.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -81.68 126.09 31.37 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 125.177 1.548 . . . . 0.0 110.74 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.6 mt -114.72 121.61 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -116.83 148.79 40.92 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 124.831 2.253 . . . . 0.0 107.168 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.8 mt -128.06 123.5 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-O 123.236 1.494 . . . . 0.0 111.487 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -87.73 148.99 24.49 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-O 117.274 -1.346 . . . . 0.0 112.254 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -71.12 -3.16 18.48 Favored 'General case' 0 C--N 1.393 2.485 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -157.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -89.69 -1.85 58.12 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 125.064 1.477 . . . . 0.0 113.336 171.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.75 9.07 33.55 Favored Glycine 0 CA--C 1.48 -2.131 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -79.6 108.58 13.26 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 124.395 2.045 . . . . 0.0 111.003 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.63 127.72 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 166.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -116.45 123.91 48.65 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 113.347 -1.752 . . . . 0.0 107.549 -173.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.56 130.23 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.05 -8.73 19.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 118.551 2.797 . . . . 0.0 118.551 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -17.55 133.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 120.929 3.677 . . . . 0.0 120.929 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.8 m -67.6 -40.69 84.73 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 116.973 -1.489 . . . . 0.0 112.249 168.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -80.71 126.48 31.34 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.61 -40.44 95.97 Favored Glycine 0 C--N 1.361 1.954 0 O-C-N 124.493 1.121 . . . . 0.0 113.744 169.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.76 -36.25 71.86 Favored 'General case' 0 CA--C 1.586 2.363 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -66.14 -48.28 71.31 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.02 80.75 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 125.159 1.537 . . . . 0.0 113.722 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -68.68 -37.11 79.32 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 121.48 -0.762 . . . . 0.0 110.06 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -61.53 -47.21 86.61 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.111 167.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -60.59 -45.07 95.35 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mt -59.42 -43.73 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 124.43 1.092 . . . . 0.0 113.665 172.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -65.88 -40.84 91.98 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 171.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -67.8 -38.52 83.43 Favored 'General case' 0 N--CA 1.52 3.033 0 O-C-N 119.905 -1.747 . . . . 0.0 115.045 171.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 mt -59.34 -41.53 84.54 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-N 119.457 1.026 . . . . 0.0 111.564 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -55.3 -45.44 76.25 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -62.38 -45.95 90.83 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 126.979 2.112 . . . . 0.0 112.644 171.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.258 1.1 mp -58.88 -33.23 49.07 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 168.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.3 p -101.34 8.46 42.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 125.601 1.813 . . . . 0.0 112.941 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.57 23.55 0.51 Allowed 'General case' 0 CA--C 1.601 2.931 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -176.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -115.74 130.52 56.88 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 125.989 1.716 . . . . 0.0 112.774 -167.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.7 pt -100.76 144.51 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -164.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -118.37 139.65 51.05 Favored 'General case' 0 C--O 1.206 -1.2 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.684 -158.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -60.75 137.77 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.28 0.32 52.24 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.179 -1.486 . . . . 0.0 115.318 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -98.17 150.39 21.53 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 120.017 -1.873 . . . . 0.0 111.679 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -105.59 143.32 16.91 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 O-C-N 125.992 2.058 . . . . 0.0 110.935 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -137.7 157.31 46.74 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 127.119 2.762 . . . . 0.0 107.396 -168.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.1 m -94.28 123.24 37.56 Favored 'General case' 0 C--N 1.372 1.55 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 164.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.52 170.5 15.24 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -126.39 135.9 52.01 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.4 t -68.39 120.52 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 122.865 1.317 . . . . 0.0 111.346 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.8 p -104.24 -31.68 9.47 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 118.839 -2.413 . . . . 0.0 111.913 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -162.92 124.02 2.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 124.327 2.013 . . . . 0.0 114.236 175.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.6 mt -82.97 132.76 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-O 124.545 2.117 . . . . 0.0 109.937 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.4 m -121.39 172.11 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.606 3.128 0 C-N-CA 127.632 2.373 . . . . 0.0 108.862 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -63.69 -32.47 73.97 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 119.108 -2.245 . . . . 0.0 113.834 -166.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -118.06 23.08 11.85 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 113.297 -1.774 . . . . 0.0 111.968 -173.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 164.69 164.28 19.65 Favored Glycine 0 C--O 1.2 -2.005 0 CA-C-O 125.005 2.447 . . . . 0.0 115.186 -171.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.15 130.64 53.41 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 112.465 -1.867 . . . . 0.0 113.113 170.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -73.47 137.71 44.68 Favored 'General case' 0 C--N 1.376 1.737 0 CA-C-O 123.926 1.822 . . . . 0.0 108.821 169.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.1 t -131.18 134.78 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-O 124.252 1.977 . . . . 0.0 107.09 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.22 141.41 35.1 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 113.653 -1.612 . . . . 0.0 114.302 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.31 147.75 32.12 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.8 151.56 1.59 Allowed Glycine 0 C--N 1.362 2.013 0 N-CA-C 119.001 2.36 . . . . 0.0 119.001 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.79 17.27 58.45 Favored Glycine 0 C--N 1.368 2.353 0 CA-C-O 118.129 -1.373 . . . . 0.0 114.734 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.25 23.72 73.11 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 116.965 1.546 . . . . 0.0 116.965 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -114.37 130.88 56.71 Favored 'General case' 0 C--O 1.194 -1.841 0 CA-C-O 123.989 1.852 . . . . 0.0 108.926 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -127.13 134.43 50.21 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 120.728 -1.232 . . . . 0.0 111.453 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.48 173.26 17.49 Favored Glycine 0 C--O 1.205 -1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 112.724 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.7 tp -104.08 139.37 39.26 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 125.427 2.537 . . . . 0.0 110.294 172.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.0 t -99.13 96.47 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 CA-C-N 113.694 -1.593 . . . . 0.0 110.633 158.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -53.39 162.59 0.74 Allowed 'General case' 0 CA--C 1.576 1.967 0 CA-C-N 119.6 1.091 . . . . 0.0 113.433 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.48 ' HA ' HD12 ' A' ' 114' ' ' ILE . 3.9 tt -48.26 -33.81 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 p -90.26 7.09 40.04 Favored 'General case' 0 C--N 1.364 1.234 0 C-N-CA 126.122 1.769 . . . . 0.0 111.569 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -119.48 12.35 12.36 Favored 'General case' 0 CA--C 1.572 1.817 0 O-C-N 119.667 -1.895 . . . . 0.0 111.861 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 111' ' ' ILE . 9.8 mt -100.31 -45.85 11.75 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 O-C-N 117.451 -3.281 . . . . 0.0 109.991 -170.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.94 167.76 24.87 Favored 'General case' 0 C--N 1.402 2.872 0 CA-C-O 124.959 2.314 . . . . 0.0 114.541 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -66.13 -41.5 90.4 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 127.056 2.143 . . . . 0.0 115.547 163.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -42.5 150.96 0.13 Allowed 'General case' 0 CA--C 1.539 0.539 0 O-C-N 128.164 3.415 . . . . 0.0 115.385 169.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -65.89 97.4 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.1 t -94.64 125.35 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-N 118.77 0.714 . . . . 0.0 109.684 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -111.76 -33.41 6.33 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -145.38 148.71 33.66 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.81 -24.97 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 116.389 -1.767 . . . . 0.0 111.358 -163.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.2 p -59.3 -31.56 69.24 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 126.003 1.721 . . . . 0.0 109.014 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.58 -16.4 61.25 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -128.28 -4.47 5.51 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -173.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.2 mt -144.85 167.13 23.34 Favored 'General case' 0 C--O 1.197 -1.701 0 O-C-N 119.706 -1.871 . . . . 0.0 109.605 165.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -138.52 159.17 42.76 Favored 'General case' 0 CA--C 1.57 1.731 0 C-N-CA 124.948 1.299 . . . . 0.0 110.815 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -71.58 148.55 46.52 Favored 'General case' 0 CA--C 1.582 2.206 0 O-C-N 120.331 -1.48 . . . . 0.0 112.862 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 59.37 28.72 65.04 Favored Glycine 0 C--N 1.369 2.401 0 C-N-CA 129.957 3.646 . . . . 0.0 114.342 -170.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -95.98 145.92 25.03 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 169.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -86.04 142.55 28.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 125.115 2.388 . . . . 0.0 106.302 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.15 127.75 11.58 Favored Pre-proline 0 N--CA 1.426 -1.639 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -170.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -54.29 121.79 10.33 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 CA-C-N 121.053 1.412 . . . . 0.0 114.157 154.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . 0.351 5.4 m -123.11 131.75 72.67 Favored 'Isoleucine or valine' 0 C--N 1.383 2.064 0 CA-C-O 124.406 2.05 . . . . 0.0 114.635 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -107.66 129.71 54.98 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.57 134.28 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 1 O-C-N 114.009 -5.432 . . . . 0.0 106.004 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.7 mt -112.42 -5.27 14.1 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-N 120.514 1.507 . . . . 0.0 111.758 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -171.7 128.19 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 124.594 2.14 . . . . 0.0 110.408 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.9 t -105.24 104.59 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 155.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.64 149.06 26.1 Favored 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -76.79 -5.71 49.32 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.791 -1.193 . . . . 0.0 114.161 -171.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -90.48 -2.43 57.93 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-O 115.931 -1.985 . . . . 0.0 111.142 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.17 23.3 8.17 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-O 123.515 1.619 . . . . 0.0 111.972 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -108.7 115.84 30.85 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 -162.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 69.3 mt -114.11 117.96 57.06 Favored 'Isoleucine or valine' 0 C--N 1.398 2.703 0 CA-C-O 122.522 1.154 . . . . 0.0 108.005 -161.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -109.97 112.7 24.88 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 124.829 2.252 . . . . 0.0 111.742 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 76.1 mt -108.62 158.83 17.22 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 111.083 -2.78 . . . . 0.0 108.481 -171.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -143.38 152.65 41.84 Favored 'General case' 0 N--CA 1.516 2.832 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 57.1 mt -107.38 -45.16 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -58.08 -37.42 74.44 Favored 'General case' 0 CA--C 1.476 -1.896 0 C-N-CA 124.15 0.98 . . . . 0.0 111.824 -173.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -76.21 -24.57 54.65 Favored 'General case' 0 N--CA 1.397 -3.114 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.25 -28.95 47.88 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.002 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 65.8 p -91.56 0.23 57.52 Favored 'General case' 0 CA--C 1.579 2.074 0 O-C-N 127.312 2.882 . . . . 0.0 108.066 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 56.94 44.79 22.42 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 130.675 3.59 . . . . 0.0 113.374 174.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 . . . . . 0 CA--C 1.502 -0.876 0 O-C-N 125.883 1.989 . . . . 0.0 115.306 179.849 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 . . . . . 0 C--O 1.215 -0.761 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.43 140.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.38 1.927 0 C-N-CA 125.303 1.441 . . . . 0.0 114.162 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -98.31 130.34 44.99 Favored 'General case' 0 C--O 1.27 2.153 0 O-C-N 118.8 -2.437 . . . . 0.0 107.056 171.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 t -148.98 165.7 30.85 Favored 'General case' 0 C--N 1.37 1.488 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.152 -164.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.6 tt -153.16 146.74 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 169.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -110.13 117.39 33.58 Favored 'General case' 0 N--CA 1.423 -1.778 0 O-C-N 116.614 -3.804 . . . . 0.0 104.277 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 pt -108.07 165.13 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.414 2.685 . . . . 0.0 109.712 -174.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -67.23 129.02 93.89 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 112.031 -2.349 . . . . 0.0 110.746 172.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HA ' HG13 ' A' ' 25' ' ' ILE . 100.0 Cg_exo -57.45 -20.44 40.63 Favored 'Trans proline' 0 N--CA 1.515 2.762 0 N-CA-C 117.68 2.146 . . . . 0.0 117.68 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.14 -21.29 59.93 Favored 'General case' 0 N--CA 1.41 -2.448 0 C-N-CA 125.222 1.409 . . . . 0.0 112.524 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -97.53 -1.75 43.34 Favored 'General case' 0 CA--C 1.49 -1.352 0 C-N-CA 126.74 2.016 . . . . 0.0 109.517 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 22' ' ' PRO . 96.6 mt -57.72 -46.11 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 117.035 -1.459 . . . . 0.0 112.381 164.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 pttm -69.7 -29.46 66.88 Favored 'General case' 0 C--O 1.186 -2.277 0 CA-C-N 119.86 1.209 . . . . 0.0 111.73 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -72.73 -45.29 59.48 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.661 0.784 . . . . 0.0 111.819 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.443 ' HA ' HG21 ' A' ' 75' ' ' ILE . 38.6 t -68.5 -39.36 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 118.766 -0.635 . . . . 0.0 111.602 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.4 mt -63.86 -51.82 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 124.489 1.116 . . . . 0.0 111.902 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.38 179.99 52.48 Favored Glycine 0 C--O 1.208 -1.511 0 CA-C-N 112.759 -2.019 . . . . 0.0 113.872 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -77.74 116.32 18.18 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.404 0.708 . . . . 0.0 110.682 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.41 20.79 79.51 Favored Glycine 0 CA--C 1.551 2.307 0 CA-C-N 112.459 -2.155 . . . . 0.0 116.03 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.09 7.23 88.76 Favored Glycine 0 C--N 1.368 2.333 0 CA-C-N 120.353 2.077 . . . . 0.0 115.901 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 t -56.26 -50.67 70.67 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.246 -1.977 . . . . 0.0 113.116 -173.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.2 t -73.14 -32.24 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.144 0.884 . . . . 0.0 109.275 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.769 HD11 HG22 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -57.03 -48.82 81.12 Favored 'Isoleucine or valine' 0 C--N 1.371 1.5 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.395 172.451 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -62.72 -44.28 96.63 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 125.684 2.659 . . . . 0.0 112.308 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.2 73.42 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 117.309 -3.37 . . . . 0.0 116.981 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . 0.263 46.8 mt -61.05 -45.03 96.42 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 125.137 1.523 . . . . 0.0 108.816 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 m -58.61 -56.09 26.67 Favored 'General case' 0 C--N 1.389 2.288 0 O-C-N 118.579 -2.576 . . . . 0.0 115.408 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -56.44 -48.48 76.93 Favored 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 125.615 1.566 . . . . 0.0 112.844 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 67.8 tt0 -62.28 -51.02 69.36 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 68' ' ' ALA . 68.5 p -79.65 -8.27 59.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 124.628 1.205 . . . . 0.0 112.344 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.93 19.88 70.14 Favored Glycine 0 C--O 1.247 0.933 0 O-C-N 125.553 1.783 . . . . 0.0 114.371 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 t -148.13 152.84 37.99 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -69.04 140.32 54.92 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 124.82 2.248 . . . . 0.0 114.352 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.15 127.63 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -135.25 151.19 50.36 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 119.411 -0.915 . . . . 0.0 112.111 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.769 HG22 HD11 ' A' ' 36' ' ' ILE . 8.3 tt -136.4 124.48 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 O-C-N 120.908 -1.12 . . . . 0.0 110.963 -170.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -86.68 168.79 13.26 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-O 123.432 1.587 . . . . 0.0 112.15 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -76.85 -15.67 59.64 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 117.376 2.361 . . . . 0.0 117.376 -169.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.96 -4.25 59.12 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 123.164 1.459 . . . . 0.0 112.37 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.45 3.35 27.37 Favored Glycine 0 CA--C 1.544 1.879 0 O-C-N 119.514 -1.992 . . . . 0.0 109.967 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.8 m -89.16 107.15 18.89 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.685 2.242 . . . . 0.0 113.943 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.96 136.82 22.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.946 -1.102 . . . . 0.0 111.291 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -115.72 120.64 39.99 Favored 'General case' 0 C--N 1.391 2.388 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.01 120.1 58.76 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 -173.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.91 90.73 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -38.04 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 1 N-CA-C 121.89 4.033 . . . . 0.0 121.89 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 m -121.16 -44.39 2.39 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.61 132.43 53.26 Favored 'General case' 0 C--N 1.389 2.32 0 CA-C-O 124.451 2.072 . . . . 0.0 107.757 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -49.87 -52.73 24.78 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 118.318 2.087 . . . . 0.0 118.318 -167.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . 70.8 mm-40 -66.05 -37.7 86.5 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.32 -42.51 88.15 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.329 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.18 80.93 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 116.31 -1.805 . . . . 0.0 110.092 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 63' ' ' GLU . 16.9 tttt -61.13 -36.44 79.77 Favored 'General case' 0 C--N 1.366 1.289 0 C-N-CA 125.96 1.704 . . . . 0.0 113.887 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -64.51 -41.01 96.68 Favored 'General case' 0 N--CA 1.511 2.615 0 CA-C-O 124.375 2.036 . . . . 0.0 114.754 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.496 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -64.76 -38.02 89.58 Favored 'General case' 0 C--O 1.257 1.456 0 O-C-N 117.976 -2.952 . . . . 0.0 111.635 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.78 -49.89 77.99 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 O-C-N 125.542 1.776 . . . . 0.0 109.241 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -58.39 -37.72 75.85 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HE ' ' CD ' ' A' ' 42' ' ' GLU . 11.8 mmm180 -71.38 -41.57 69.51 Favored 'General case' 0 C--N 1.366 1.31 0 O-C-N 126.751 2.532 . . . . 0.0 112.09 174.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.4 mm -56.53 -42.82 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-O 121.941 0.877 . . . . 0.0 109.599 167.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.256 12.5 mt-10 -62.56 -42.72 99.72 Favored 'General case' 0 CA--C 1.572 1.818 0 O-C-N 121.063 -1.023 . . . . 0.0 112.932 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.81 -44.18 86.17 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 117.481 -1.247 . . . . 0.0 113.406 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 28' ' ' VAL . 19.3 mm -78.38 -25.46 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-N 121.481 1.946 . . . . 0.0 109.09 -173.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 p -79.5 -17.33 54.35 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 123.934 0.771 . . . . 0.0 112.322 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.05 -19.96 58.17 Favored 'General case' 0 C--N 1.37 1.479 1 O-C-N 116.002 -4.187 . . . . 0.0 114.008 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -67.09 119.47 12.08 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -162.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.1 pt -72.39 137.85 22.7 Favored 'Isoleucine or valine' 0 C--O 1.279 2.653 0 CA-C-O 128.356 3.931 . . . . 0.0 114.98 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -122.76 147.43 46.51 Favored 'General case' 0 C--O 1.202 -1.396 0 O-C-N 118.23 -2.794 . . . . 0.0 108.311 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 m -64.79 154.94 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 123.91 1.814 . . . . 0.0 112.551 171.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.07 -9.6 45.68 Favored Glycine 0 CA--C 1.561 2.911 0 O-C-N 119.644 -1.91 . . . . 0.0 116.664 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -96.69 153.78 17.66 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 115.131 -2.366 . . . . 0.0 110.468 -172.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 152' ' ' ALA . 62.4 t -115.31 117.03 54.32 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 O-C-N 125.067 1.48 . . . . 0.0 110.333 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.51 166.75 10.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.806 2.442 . . . . 0.0 105.82 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 83.1 m -101.53 116.87 33.74 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 171.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.67 157.62 15.65 Favored Glycine 0 CA--C 1.469 -2.829 0 O-C-N 119.654 -1.903 . . . . 0.0 109.642 -173.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -115.93 128.82 56.06 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 118.791 -1.163 . . . . 0.0 111.69 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.06 126.2 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.391 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.2 p -102.52 -35.54 8.71 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-N 120.731 1.605 . . . . 0.0 114.249 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -165.46 157.43 14.91 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 127.061 2.725 . . . . 0.0 110.892 -173.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.5 mt -140.64 142.8 30.0 Favored 'Isoleucine or valine' 0 C--N 1.383 2.06 0 O-C-N 126.294 2.246 . . . . 0.0 107.008 -167.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.479 HG11 ' CZ ' ' A' ' 95' ' ' PHE . 2.9 p -141.19 -164.43 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.455 ' H ' HG22 ' A' ' 93' ' ' VAL . 37.3 m-20 -67.56 -38.99 84.93 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 128.72 2.808 . . . . 0.0 115.648 176.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CZ ' HG11 ' A' ' 93' ' ' VAL . 21.0 p90 -95.46 0.39 53.22 Favored 'General case' 0 N--CA 1.527 3.409 0 CA-C-O 114.07 -2.872 . . . . 0.0 116.044 174.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.64 -174.99 36.56 Favored Glycine 0 C--N 1.361 1.948 0 CA-C-N 125.245 3.657 . . . . 0.0 115.065 -170.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.61 137.25 51.59 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -91.9 144.16 25.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.6 t -143.18 136.75 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 113.554 -1.657 . . . . 0.0 108.267 -173.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' GLU . . . -107.76 144.67 34.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 125.008 2.337 . . . . 0.0 111.258 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.1 pt -140.25 167.73 18.17 Favored 'Isoleucine or valine' 0 C--O 1.259 1.582 0 CA-C-N 112.597 -2.092 . . . . 0.0 108.099 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -27.77 131.2 0.06 OUTLIER Glycine 0 CA--C 1.575 3.793 0 N-CA-C 122.634 3.814 . . . . 0.0 122.634 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.95 6.59 66.92 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -173.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.16 36.92 55.84 Favored Glycine 0 C--O 1.194 -2.366 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.494 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -103.17 110.45 22.4 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 119.034 1.417 . . . . 0.0 112.822 -170.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 27.1 tt0 -93.59 124.82 37.84 Favored 'General case' 0 N--CA 1.515 2.814 0 O-C-N 119.291 -2.13 . . . . 0.0 110.441 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -124.77 -175.91 14.43 Favored Glycine 0 CA--C 1.541 1.695 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.6 tp -121.43 127.66 51.36 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.843 1.306 . . . . 0.0 111.103 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.64 112.37 31.83 Favored 'Isoleucine or valine' 0 C--O 1.256 1.414 0 CA-C-N 113.932 -1.486 . . . . 0.0 107.193 166.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.44 152.88 42.86 Favored 'General case' 0 C--N 1.374 1.652 0 CA-C-O 125.217 2.436 . . . . 0.0 116.324 164.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 tt -52.98 -37.11 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 CA-C-N 111.076 -2.784 . . . . 0.0 113.569 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 76.7 p -76.75 -14.33 59.95 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 124.941 1.297 . . . . 0.0 109.488 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -101.88 7.78 41.44 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.675 1.19 . . . . 0.0 109.618 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 43.8 mm -78.1 -33.77 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.326 0 CA-C-O 123.106 1.431 . . . . 0.0 110.722 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -165.38 -178.58 5.06 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 119.067 -2.271 . . . . 0.0 112.509 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.19 -54.65 41.66 Favored 'General case' 0 CA--C 1.578 2.04 0 CA-C-N 112.729 -2.032 . . . . 0.0 111.857 165.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -93.63 160.55 14.73 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -84.25 127.38 33.92 Favored 'General case' 0 N--CA 1.512 2.643 0 O-C-N 125.698 1.874 . . . . 0.0 113.436 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.37 131.54 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 120.878 -1.139 . . . . 0.0 108.082 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -63.33 -40.04 96.21 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 118.468 -2.645 . . . . 0.0 112.987 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -129.27 118.07 21.72 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.93 1.292 . . . . 0.0 110.532 -175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.56 -30.16 49.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 C-N-CA 124.339 1.056 . . . . 0.0 109.602 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -23.31 63.15 Favored 'General case' 0 C--O 1.261 1.659 0 O-C-N 119.066 -2.271 . . . . 0.0 113.712 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -78.16 -20.92 51.06 Favored 'General case' 0 CA--C 1.49 -1.331 0 O-C-N 118.315 -2.741 . . . . 0.0 113.036 174.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -106.87 -8.79 16.56 Favored 'General case' 0 C--N 1.379 1.865 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.2 mt -146.0 159.01 43.86 Favored 'General case' 0 N--CA 1.402 -2.844 0 CA-C-O 124.018 1.866 . . . . 0.0 108.262 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -144.35 150.53 37.94 Favored 'General case' 0 C--O 1.201 -1.467 0 CA-C-N 111.334 -2.666 . . . . 0.0 106.074 -168.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -70.21 141.1 52.57 Favored 'General case' 0 CA--C 1.594 2.661 0 CA-C-O 123.607 1.67 . . . . 0.0 113.525 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.79 -11.59 68.35 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.25 140.42 40.07 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 121.016 2.408 . . . . 0.0 115.472 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -102.13 129.79 48.57 Favored 'General case' 0 C--N 1.381 1.959 0 O-C-N 124.949 1.406 . . . . 0.0 110.573 -163.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.11 143.28 46.52 Favored Pre-proline 0 CA--C 1.577 1.999 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.263 -176.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.15 136.04 70.11 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 CA-C-N 122.794 2.034 . . . . 0.0 110.447 169.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.54 148.17 27.21 Favored 'Isoleucine or valine' 0 C--O 1.255 1.371 0 O-C-N 125.732 1.895 . . . . 0.0 109.935 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -116.55 135.33 53.91 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 127.387 2.929 . . . . 0.0 104.736 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.8 t -87.05 127.89 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 126.76 2.537 . . . . 0.0 106.246 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 148' ' ' SER . 28.1 mt -101.03 -57.57 2.06 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -169.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -163.31 159.34 22.48 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 122.049 0.928 . . . . 0.0 109.407 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.68 119.86 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 102.323 -3.214 . . . . 0.0 102.323 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.421 ' CG ' ' HE ' ' A' ' 144' ' ' ARG . 3.5 t70 -71.52 162.18 29.85 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 129.003 2.921 . . . . 0.0 111.741 174.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -58.57 -33.53 70.05 Favored 'General case' 0 C--N 1.381 1.971 0 O-C-N 125.637 1.836 . . . . 0.0 113.111 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -90.58 11.14 22.86 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 119.296 -2.127 . . . . 0.0 109.946 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.04 16.64 69.23 Favored Glycine 0 C--O 1.251 1.193 0 CA-C-O 123.38 1.545 . . . . 0.0 113.973 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.421 ' HE ' ' CG ' ' A' ' 140' ' ' ASP . 9.2 mtm180 -71.12 117.28 12.43 Favored 'General case' 0 C--O 1.266 1.964 0 CA-C-N 112.384 -1.908 . . . . 0.0 114.062 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.1 mt -88.3 123.71 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.99 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -96.89 131.56 43.53 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-O 122.185 0.993 . . . . 0.0 110.573 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.5 mt -129.89 144.57 51.38 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 120.16 -1.588 . . . . 0.0 109.423 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.432 ' HB2' HD11 ' A' ' 137' ' ' LEU . 35.4 t -121.7 133.05 54.94 Favored 'General case' 0 C--N 1.375 1.708 0 CA-C-N 121.376 1.898 . . . . 0.0 110.656 163.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 76.3 mt -79.33 -45.1 23.97 Favored 'Isoleucine or valine' 0 C--N 1.377 1.801 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -55.71 -42.98 76.07 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 127.78 3.175 . . . . 0.0 112.418 -164.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -85.15 -19.9 31.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 115.042 -2.409 . . . . 0.0 109.892 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' A' ' 84' ' ' VAL . . . -74.31 -36.96 63.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 121.754 2.07 . . . . 0.0 113.773 167.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.5 p -78.21 -10.96 59.88 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 125.597 1.81 . . . . 0.0 111.629 174.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.259 75.0 mt-10 87.7 40.05 0.01 OUTLIER 'General case' 0 CA--C 1.477 -1.861 0 CA-C-N 119.041 0.837 . . . . 0.0 112.44 157.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 . . . . . 0 N--CA 1.412 -2.361 0 CA-C-O 123.805 1.764 . . . . 0.0 113.818 -175.524 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 . . . . . 0 CA--C 1.568 1.663 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.4 mt -114.41 139.67 39.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 124.251 1.977 . . . . 0.0 108.479 -172.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -118.17 138.25 52.43 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 112.581 -2.099 . . . . 0.0 111.352 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -115.46 133.45 56.02 Favored 'General case' 0 C--N 1.38 1.918 0 O-C-N 120.271 -1.518 . . . . 0.0 110.496 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.7 mm -137.87 137.42 44.92 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -98.01 137.38 36.9 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 123.156 1.455 . . . . 0.0 112.58 167.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 pt -116.5 169.4 7.01 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 C-N-CA 125.63 1.572 . . . . 0.0 112.862 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -57.08 124.77 67.59 Favored Pre-proline 0 CA--C 1.586 2.358 0 CA-C-N 113.698 -1.592 . . . . 0.0 113.065 167.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.45 -3.21 13.31 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.67 2.246 . . . . 0.0 115.182 -176.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -72.58 -19.4 61.49 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.631 1.973 . . . . 0.0 115.848 161.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -99.58 -3.98 32.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 116.604 -1.665 . . . . 0.0 111.082 -166.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.0 mt -54.96 -44.41 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 119.204 0.911 . . . . 0.0 110.937 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.31 0.1 OUTLIER -57.8 -38.0 74.75 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 125.121 1.513 . . . . 0.0 111.731 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -75.89 -35.6 59.78 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-O 114.673 -2.584 . . . . 0.0 112.925 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.76 -52.65 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 116.065 -1.922 . . . . 0.0 114.287 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.7 mt -78.22 -32.39 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 126.024 2.078 . . . . 0.0 113.247 -176.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.39 -180.0 0.18 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 120.637 3.015 . . . . 0.0 120.637 -172.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -56.4 122.05 11.0 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 113.613 -1.294 . . . . 0.0 113.397 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 49.77 22.4 4.23 Favored Glycine 0 C--N 1.36 1.882 0 N-CA-C 116.98 1.552 . . . . 0.0 116.98 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.7 77.87 Favored Glycine 1 C--N 1.402 4.221 0 CA-C-N 122.191 2.995 . . . . 0.0 113.275 -175.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.1 m -58.58 -43.46 89.45 Favored 'General case' 0 C--O 1.207 -1.172 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -172.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.0 t -72.67 -47.02 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 O-C-N 124.263 0.977 . . . . 0.0 111.53 -172.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.251 7.0 tt -62.94 -38.77 82.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 113.66 -3.067 . . . . 0.0 114.604 172.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -59.01 -49.42 77.96 Favored 'General case' 0 C--O 1.263 1.783 0 O-C-N 126.193 2.183 . . . . 0.0 111.878 167.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.16 95.89 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 175.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.77 -39.27 93.85 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.112 0.882 . . . . 0.0 111.793 172.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.8 m -52.0 -46.04 64.77 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 117.203 -1.379 . . . . 0.0 110.94 167.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -67.75 -37.08 81.66 Favored 'General case' 0 C--N 1.37 1.495 0 C-N-CA 125.602 1.561 . . . . 0.0 113.323 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.12 -37.34 64.12 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.0 p -95.09 -34.38 12.32 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.35 -1.786 . . . . 0.0 114.363 -176.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.99 37.26 22.7 Favored Glycine 0 C--N 1.386 3.317 0 CA-C-O 124.454 2.141 . . . . 0.0 108.923 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.8 p -119.64 162.05 19.64 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.982 -1.305 . . . . 0.0 109.114 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -101.62 127.49 48.33 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.443 1.116 . . . . 0.0 109.197 169.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -114.9 126.54 72.51 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 -171.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -124.15 135.4 53.47 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 123.207 1.479 . . . . 0.0 107.714 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.54 141.18 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 119.055 -2.278 . . . . 0.0 109.726 -169.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -125.5 165.79 17.82 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-O 123.242 1.496 . . . . 0.0 107.769 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.32 43.4 p-10 -88.88 8.0 31.46 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 118.346 2.721 . . . . 0.0 118.346 -162.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -96.53 15.23 22.13 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.651 -1.613 . . . . 0.0 107.866 167.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.94 34.53 71.23 Favored Glycine 0 C--N 1.365 2.184 0 O-C-N 119.706 -1.871 . . . . 0.0 112.458 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.8 m -96.62 113.85 25.45 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-O 116.447 -1.74 . . . . 0.0 108.462 164.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -109.34 138.74 35.27 Favored 'Isoleucine or valine' 0 C--N 1.378 1.827 0 CA-C-O 122.886 1.327 . . . . 0.0 107.612 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.17 123.26 48.46 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 112.59 -2.095 . . . . 0.0 111.031 -176.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.55 119.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 119.348 -2.095 . . . . 0.0 111.733 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.89 127.18 54.56 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.155 2.582 . . . . 0.0 109.19 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.84 162.31 37.99 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 120.133 -1.604 . . . . 0.0 108.022 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.4 p -84.91 0.69 50.26 Favored 'General case' 0 N--CA 1.415 -2.22 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.196 173.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -142.82 140.66 31.4 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.584 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.68 -15.33 81.35 Favored Glycine 0 C--N 1.365 2.161 0 CA-C-O 116.363 -2.354 . . . . 0.0 113.053 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.74 -42.07 86.81 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 121.084 2.442 . . . . 0.0 109.86 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -64.13 -46.42 84.21 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.525 -2.125 . . . . 0.0 108.437 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.13 98.91 Favored 'General case' 0 C--N 1.36 1.047 0 O-C-N 120.292 -1.505 . . . . 0.0 114.422 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -65.62 -35.01 79.56 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 114.984 -2.436 . . . . 0.0 112.2 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -65.64 -38.18 88.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 125.82 1.95 . . . . 0.0 109.216 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.04 99.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.82 -1.175 . . . . 0.0 112.958 169.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.19 -45.5 84.6 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 O-C-N 120.014 -1.679 . . . . 0.0 112.925 168.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -60.69 -35.29 75.91 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 120.805 1.638 . . . . 0.0 114.052 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -74.63 -27.56 60.5 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 116.474 -1.727 . . . . 0.0 114.6 165.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . 0.349 11.3 mt -76.63 -32.22 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.46 -45.32 88.84 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.68 1.992 . . . . 0.0 115.026 169.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -64.47 -36.96 85.89 Favored 'General case' 0 C--O 1.195 -1.765 0 O-C-N 125.976 2.048 . . . . 0.0 106.743 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.2 mt -60.8 -44.53 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 125.592 3.815 . . . . 0.0 111.427 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.9 p -93.26 -6.56 47.3 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -162.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.11 -38.49 61.12 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -71.0 132.24 44.87 Favored 'General case' 0 CA--C 1.572 1.822 0 CA-C-O 122.386 1.089 . . . . 0.0 109.666 -169.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.0 mm -68.74 146.52 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 111.614 -2.539 . . . . 0.0 116.417 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -112.33 137.27 50.71 Favored 'General case' 0 CA--C 1.578 2.033 0 CA-C-O 124.487 2.089 . . . . 0.0 111.115 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 42.6 t -80.18 130.25 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 O-C-N 120.573 -1.329 . . . . 0.0 109.553 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.52 64.75 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 116.613 1.405 . . . . 0.0 116.613 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -119.58 135.28 54.86 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 123.882 0.873 . . . . 0.0 112.208 -174.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.0 t -72.53 130.18 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -128.7 154.53 46.23 Favored 'General case' 0 C--O 1.268 2.062 0 CA-C-N 112.452 -2.158 . . . . 0.0 107.425 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.1 m -105.88 128.24 53.64 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.61 167.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 131' ' ' GLU . . . -138.53 -173.0 12.78 Favored Glycine 0 C--O 1.206 -1.606 0 O-C-N 126.791 2.557 . . . . 0.0 108.985 -167.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -144.59 150.58 37.69 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.139 -0.624 . . . . 0.0 112.365 166.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 t -59.61 132.89 25.04 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 CA-C-N 112.4 -2.182 . . . . 0.0 111.452 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -110.48 -57.08 2.26 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -134.87 150.47 50.46 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.803 1.287 . . . . 0.0 110.586 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.71 136.49 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 112.94 -1.937 . . . . 0.0 107.292 171.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.5 m -135.29 -177.15 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 111.889 -2.414 . . . . 0.0 108.576 -168.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.55 -23.81 67.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 119.162 -2.211 . . . . 0.0 115.617 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -125.66 -0.52 7.43 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.61 0.764 . . . . 0.0 111.211 -165.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.25 -169.72 41.57 Favored Glycine 0 CA--C 1.48 -2.144 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' VAL . . . -120.44 146.61 46.05 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 111.663 -2.269 . . . . 0.0 108.22 167.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -100.13 137.34 38.71 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 168.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.44 129.55 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 C-N-CA 126.541 1.936 . . . . 0.0 106.246 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.66 125.26 41.0 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 101' ' ' ILE . 1.8 pt -116.86 164.59 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 C-N-CA 125.874 1.67 . . . . 0.0 106.984 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.03 153.58 0.54 Allowed Glycine 0 CA--C 1.543 1.821 0 N-CA-C 118.659 2.223 . . . . 0.0 118.659 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.48 23.28 65.47 Favored Glycine 0 N--CA 1.487 2.083 0 O-C-N 119.523 -2.163 . . . . 0.0 112.599 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.75 36.25 93.08 Favored Glycine 0 C--N 1.358 1.79 0 C-N-CA 126.863 2.173 . . . . 0.0 117.356 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -112.97 135.13 54.08 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 123.355 1.55 . . . . 0.0 109.842 -169.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.22 138.86 47.15 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 119.546 -1.971 . . . . 0.0 105.999 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.0 165.51 24.61 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-O 118.732 -1.038 . . . . 0.0 111.316 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.0 tp -101.5 114.18 27.97 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.055 -1.458 . . . . 0.0 109.783 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 97' ' ' ALA . 47.9 t -77.5 98.56 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.933 0 CA-C-O 125.738 2.685 . . . . 0.0 110.317 160.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -65.43 149.64 49.67 Favored 'General case' 0 CA--C 1.558 1.284 1 O-C-N 115.878 -4.264 . . . . 0.0 113.146 172.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 tt -65.29 -16.07 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 113.411 -1.722 . . . . 0.0 114.775 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 89.6 p -90.11 -1.51 57.96 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 119.694 -1.879 . . . . 0.0 110.184 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -121.39 36.48 4.6 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.65 -44.02 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 127.144 2.178 . . . . 0.0 109.37 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -145.04 163.11 35.24 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 111.842 -2.435 . . . . 0.0 112.646 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -70.98 -45.94 63.16 Favored 'General case' 0 CA--C 1.576 1.961 0 O-C-N 119.623 -1.923 . . . . 0.0 115.924 171.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -77.63 149.83 34.7 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 120.616 -1.303 . . . . 0.0 111.336 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.259 94.8 mtt180 -47.44 132.06 13.5 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 125.11 2.386 . . . . 0.0 115.012 174.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -107.2 115.35 48.4 Favored 'Isoleucine or valine' 0 C--N 1.371 1.531 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.83 -40.13 87.9 Favored 'General case' 0 C--O 1.197 -1.708 0 C-N-CA 118.066 -1.454 . . . . 0.0 113.45 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -147.44 145.88 29.35 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.73 1.15 . . . . 0.0 108.397 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.76 -34.94 71.15 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.233 -172.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.4 p -68.32 -26.45 65.62 Favored 'General case' 0 C--N 1.365 1.275 0 CA-C-O 125.023 2.344 . . . . 0.0 113.285 -167.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -58.49 -34.77 71.28 Favored 'General case' 0 C--O 1.205 -1.258 0 O-C-N 118.5 -2.625 . . . . 0.0 113.896 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -86.96 -61.91 1.62 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 128.116 2.567 . . . . 0.0 112.586 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.2 mt -109.45 157.54 18.85 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 125.729 1.893 . . . . 0.0 111.129 -162.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -142.55 156.54 45.13 Favored 'General case' 0 C--O 1.209 -1.062 0 O-C-N 126.28 2.237 . . . . 0.0 105.835 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -66.97 141.76 57.49 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 127.252 2.221 . . . . 0.0 112.83 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.93 -6.59 74.07 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-O 115.889 -2.617 . . . . 0.0 114.006 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -77.96 125.62 29.61 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 126.715 2.068 . . . . 0.0 113.589 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 35.3 mt-10 -67.8 136.77 54.68 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-O 123.392 1.567 . . . . 0.0 112.717 166.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 p -152.87 142.68 15.0 Favored Pre-proline 0 C--O 1.184 -2.383 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.765 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.14 123.49 11.3 Favored 'Trans proline' 0 C--N 1.276 -3.277 0 C-N-CA 123.521 2.814 . . . . 0.0 119.026 160.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.8 m -123.4 137.8 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-O 123.356 1.55 . . . . 0.0 107.325 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -100.0 132.5 45.32 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 113.745 -1.571 . . . . 0.0 110.533 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.85 124.58 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 126.225 2.203 . . . . 0.0 109.526 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.4 mt -111.87 -28.29 8.12 Favored 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.598 -1.313 . . . . 0.0 112.786 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -160.71 144.06 13.34 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.266 1.026 . . . . 0.0 111.749 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.8 t -115.93 115.16 48.33 Favored 'Isoleucine or valine' 0 C--N 1.375 1.694 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 167.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.322 0.0 OUTLIER -82.33 161.35 22.61 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 -174.189 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -89.91 -1.05 57.9 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 119.55 -1.969 . . . . 0.0 112.768 -168.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -85.82 0.74 52.17 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 127.094 3.33 . . . . 0.0 109.635 166.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.04 4.21 61.52 Favored Glycine 0 C--O 1.217 -0.942 0 CA-C-O 115.672 -2.738 . . . . 0.0 116.323 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -76.23 105.93 7.56 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 120.578 2.189 . . . . 0.0 111.851 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.5 mt -78.51 130.86 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -123.34 131.05 53.53 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.756 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.5 mt -127.94 140.58 51.91 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 123.979 0.912 . . . . 0.0 112.734 -163.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.1 t -126.61 120.78 30.39 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.4 mt -79.04 -28.62 13.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 167.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -61.69 -51.25 69.19 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -74.79 -19.46 60.2 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 121.877 0.846 . . . . 0.0 113.078 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.89 -25.91 25.9 Favored 'General case' 0 C--N 1.369 1.415 0 O-C-N 117.088 -3.507 . . . . 0.0 111.286 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.8 p -86.63 -11.13 52.25 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.259 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 77.37 34.52 0.37 Allowed 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.911 -1.118 . . . . 0.0 109.527 170.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 169.743 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 . . . . . 0 CA--C 1.569 1.707 0 N-CA-C 118.01 2.596 . . . . 0.0 118.01 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 pt -73.62 134.89 28.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -89.2 143.09 27.1 Favored 'General case' 0 C--N 1.368 1.402 0 CA-C-N 113.651 -1.613 . . . . 0.0 106.786 168.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 t -139.89 150.19 44.3 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-O 128.497 3.999 . . . . 0.0 114.624 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -137.56 134.15 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.502 0 CA-C-N 110.517 -3.038 . . . . 0.0 106.061 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -86.2 118.56 25.73 Favored 'General case' 0 CA--C 1.473 -2.013 0 O-C-N 125.38 1.675 . . . . 0.0 111.45 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.9 pt -112.0 152.41 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.651 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -47.63 114.46 3.17 Favored Pre-proline 0 C--O 1.212 -0.904 0 CA-C-O 115.371 -2.252 . . . . 0.0 114.323 163.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.17 -0.31 10.57 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 123.655 2.341 . . . . 0.0 115.894 -167.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -65.47 -29.88 70.59 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 125.761 1.913 . . . . 0.0 115.03 165.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -90.34 8.67 32.27 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 125.276 1.61 . . . . 0.0 113.394 -173.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.9 mt -66.07 -38.2 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 120.13 1.332 . . . . 0.0 112.321 -171.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -58.93 -45.3 90.73 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 125.76 1.913 . . . . 0.0 115.601 171.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.33 -49.43 77.62 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 125.266 1.604 . . . . 0.0 112.163 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 t -55.26 -49.5 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 O-C-N 128.66 3.725 . . . . 0.0 116.017 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.1 pt -74.85 -24.35 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 114.287 -2.768 . . . . 0.0 114.484 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.19 157.49 20.89 Favored Glycine 0 C--N 1.358 1.805 0 CA-C-N 120.8 1.636 . . . . 0.0 113.404 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.61 138.3 56.31 Favored 'General case' 0 C--N 1.378 1.82 0 CA-C-O 124.827 2.251 . . . . 0.0 107.593 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 43.92 29.05 1.35 Allowed Glycine 0 CA--C 1.557 2.665 0 CA-C-N 112.633 -2.076 . . . . 0.0 116.785 -158.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.17 20.84 63.32 Favored Glycine 0 C--O 1.213 -1.2 0 CA-C-N 121.131 2.465 . . . . 0.0 116.686 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.3 p -62.91 -37.7 88.01 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 127.11 2.164 . . . . 0.0 113.781 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.252 41.3 t -75.55 -35.47 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 123.724 0.64 . . . . 0.0 111.134 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.26 19.8 tt -67.64 -37.02 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 116.417 -2.113 . . . . 0.0 112.21 173.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -60.03 -43.4 95.34 Favored 'General case' 0 CA--C 1.584 2.271 0 CA-C-N 120.85 1.659 . . . . 0.0 114.697 171.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.73 82.89 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.149 2.58 . . . . 0.0 113.242 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -60.03 -45.1 93.91 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 124.973 1.42 . . . . 0.0 108.421 170.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 31.2 m -56.3 -54.45 45.28 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 120.684 1.584 . . . . 0.0 107.563 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.42 -43.5 96.7 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 119.568 3.173 . . . . 0.0 119.568 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -83.22 -25.46 31.7 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 p -78.15 -49.18 14.34 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 119.813 -1.805 . . . . 0.0 108.842 170.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.18 34.13 6.27 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 116.49 -2.283 . . . . 0.0 109.727 -173.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.3 p -131.15 172.77 11.73 Favored 'General case' 0 C--N 1.381 1.949 0 O-C-N 126.046 1.674 . . . . 0.0 110.436 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.6 m -109.2 138.42 45.58 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 123.44 1.591 . . . . 0.0 111.587 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.6 mp -135.48 127.68 46.7 Favored 'Isoleucine or valine' 0 C--N 1.387 2.196 0 CA-C-O 123.105 1.431 . . . . 0.0 110.223 -165.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.258 29.2 tt0 -128.43 129.2 45.8 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 117.662 -3.149 . . . . 0.0 106.831 164.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.4 mt -100.71 121.31 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 125.652 1.845 . . . . 0.0 109.874 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -87.36 150.76 23.61 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.259 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -54.09 -30.63 49.14 Favored 'General case' 0 C--O 1.261 1.668 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -168.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -82.64 0.46 42.99 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 126.76 2.024 . . . . 0.0 111.765 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.56 18.23 57.16 Favored Glycine 0 N--CA 1.504 3.232 0 O-C-N 119.327 -2.108 . . . . 0.0 110.745 -175.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -84.38 101.82 12.27 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.56 133.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 125.467 1.729 . . . . 0.0 112.236 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -118.16 112.08 19.69 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.5 mm -103.88 127.89 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 126.606 1.963 . . . . 0.0 108.977 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.34 130.75 44.83 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.8 174.13 13.62 Favored 'General case' 0 C--O 1.204 -1.313 0 O-C-N 120.704 -1.247 . . . . 0.0 109.02 -159.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -132.53 14.36 4.5 Favored 'General case' 0 CA--C 1.479 -1.753 0 CA-C-O 117.366 -1.302 . . . . 0.0 109.118 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -150.51 150.22 30.99 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.61 -44.51 6.1 Favored Glycine 0 N--CA 1.507 3.405 0 C-N-CA 127.024 2.25 . . . . 0.0 113.816 -163.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -50.48 -44.12 55.69 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 163.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -62.56 -45.25 93.79 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 124.883 1.364 . . . . 0.0 110.194 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.37 85.72 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.604 1.162 . . . . 0.0 110.91 173.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -58.83 -45.28 90.39 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 169.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -58.56 -41.34 85.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 126.38 2.3 . . . . 0.0 113.718 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.77 65.13 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mm -62.97 -46.2 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.804 0 CA-C-N 111.144 -2.753 . . . . 0.0 108.323 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -64.27 -49.97 69.76 Favored 'General case' 0 C--O 1.205 -1.252 0 O-C-N 124.529 1.143 . . . . 0.0 113.746 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -57.78 -39.46 77.53 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.801 1.24 . . . . 0.0 113.398 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.62 -49.38 84.01 Favored 'Isoleucine or valine' 0 C--O 1.257 1.474 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 168.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.68 -41.72 74.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -61.97 -47.69 83.69 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 127.752 2.421 . . . . 0.0 113.374 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.1 tt -71.29 -35.47 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 C-N-CA 124.349 1.06 . . . . 0.0 111.861 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 79.0 m -61.18 -40.37 93.63 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 116.214 -1.851 . . . . 0.0 109.911 168.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.68 -11.8 52.86 Favored 'General case' 0 C--N 1.374 1.655 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.95 127.94 34.72 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-N 122.791 2.541 . . . . 0.0 116.465 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.498 HG21 HD13 ' A' ' 145' ' ' ILE . 6.4 mm -107.95 116.55 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 CA-C-O 126.141 2.877 . . . . 0.0 104.434 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -117.83 140.52 49.58 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.694 1.998 . . . . 0.0 112.105 -173.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.43 148.76 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.667 -1.213 . . . . 0.0 113.479 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.45 -19.67 22.3 Favored Glycine 0 C--O 1.208 -1.511 0 CA-C-O 113.862 -3.743 . . . . 0.0 117.016 -171.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -96.92 158.82 15.25 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.98 1.89 . . . . 0.0 111.17 -166.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.71 127.8 75.88 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -121.35 159.54 25.88 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 124.016 1.865 . . . . 0.0 109.109 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 m -98.35 118.72 35.65 Favored 'General case' 0 C--O 1.202 -1.444 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 167.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -147.03 175.43 26.41 Favored Glycine 0 CA--C 1.569 3.416 0 C-N-CA 124.41 1.005 . . . . 0.0 114.829 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -117.15 133.15 56.35 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-O 125.633 2.635 . . . . 0.0 111.45 -169.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.3 t -67.8 121.13 16.4 Favored 'Isoleucine or valine' 0 C--N 1.366 1.304 0 O-C-N 119.214 -2.179 . . . . 0.0 106.487 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.4 p -103.8 -36.87 7.68 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.037 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -146.37 154.8 42.06 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.0 mt -126.22 130.17 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 O-C-N 125.796 1.935 . . . . 0.0 110.812 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.83 173.16 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -64.07 -27.73 69.3 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 123.262 1.506 . . . . 0.0 113.436 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -113.81 21.85 14.56 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -166.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.91 -153.01 24.95 Favored Glycine 0 C--O 1.204 -1.778 0 CA-C-O 116.991 -2.005 . . . . 0.0 111.305 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -149.69 174.33 12.69 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 102.203 -3.258 . . . . 0.0 102.203 167.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -114.86 128.76 56.48 Favored 'General case' 0 C--O 1.201 -1.47 0 O-C-N 127.669 3.106 . . . . 0.0 111.527 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.86 124.66 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 O-C-N 125.363 1.665 . . . . 0.0 107.494 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.69 117.53 17.55 Favored 'General case' 0 C--O 1.215 -0.732 1 O-C-N 129.434 4.209 . . . . 0.0 114.405 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 101' ' ' ILE . 46.0 pt -138.78 157.62 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 113.894 -1.503 . . . . 0.0 114.868 -167.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.25 -111.84 4.34 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 117.339 -1.812 . . . . 0.0 110.772 -176.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.83 -16.03 73.78 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 120.796 2.298 . . . . 0.0 112.809 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.59 -26.16 1.5 Allowed Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 116.947 -2.549 . . . . 0.0 112.377 -171.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -49.51 132.91 20.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 120.434 3.494 . . . . 0.0 120.434 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.48 143.64 48.34 Favored 'General case' 0 C--N 1.385 2.121 0 CA-C-O 123.966 1.841 . . . . 0.0 111.259 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.11 157.93 15.97 Favored Glycine 0 CA--C 1.539 1.565 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 169.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.423 HD21 ' CE1' ' A' ' 110' ' ' HIS . 4.1 tp -112.46 116.43 30.27 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 118.843 1.322 . . . . 0.0 111.001 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.56 118.4 48.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 171.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.423 ' CE1' HD21 ' A' ' 108' ' ' LEU . 90.8 m-70 -80.0 163.45 24.23 Favored 'General case' 0 C--O 1.192 -1.966 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.0 tt -56.29 -39.59 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 C-N-CA 126.327 1.851 . . . . 0.0 114.856 -170.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.8 p -77.87 -5.15 50.01 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 125.087 1.492 . . . . 0.0 114.971 171.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.77 3.49 42.2 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 173.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.6 mm -74.17 -39.76 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 124.225 1.964 . . . . 0.0 113.789 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.58 151.94 35.92 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.429 -170.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -92.42 -1.03 57.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.872 160.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -87.26 170.58 11.32 Favored 'General case' 0 CA--C 1.577 2.018 0 CA-C-O 124.523 2.106 . . . . 0.0 107.944 158.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.57 147.84 47.88 Favored 'General case' 0 C--O 1.2 -1.503 0 N-CA-C 118.071 2.619 . . . . 0.0 118.071 -173.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.5 t -139.31 125.09 22.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.47 -46.8 5.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 125.313 1.445 . . . . 0.0 108.527 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -140.05 146.09 38.53 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.69 -3.87 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.167 1.349 . . . . 0.0 110.982 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.0 p -68.59 -23.28 64.45 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 116.149 -1.881 . . . . 0.0 114.47 165.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.93 -8.33 56.18 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 127.391 2.932 . . . . 0.0 111.469 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -119.93 -68.93 0.88 Allowed 'General case' 0 C--N 1.356 0.884 0 O-C-N 120.315 -1.491 . . . . 0.0 111.049 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.8 mt -90.74 152.49 20.79 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.454 1.121 . . . . 0.0 108.047 -173.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -124.66 135.12 52.8 Favored 'General case' 0 C--N 1.385 2.118 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.7 mtm -65.83 142.97 57.76 Favored 'General case' 0 C--O 1.21 -0.987 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.85 1.57 82.42 Favored Glycine 0 C--O 1.197 -2.191 0 CA-C-O 114.255 -3.525 . . . . 0.0 116.16 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -97.65 143.11 28.64 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 120.931 2.366 . . . . 0.0 107.9 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -71.07 117.68 12.89 Favored 'General case' 0 C--O 1.2 -1.517 0 O-C-N 126.257 2.223 . . . . 0.0 111.092 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.97 128.15 25.89 Favored Pre-proline 0 CA--C 1.587 2.379 0 C-N-CA 123.868 0.867 . . . . 0.0 110.408 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.37 128.17 27.48 Favored 'Trans proline' 0 N--CA 1.525 3.341 0 C-N-CA 123.432 2.754 . . . . 0.0 113.588 153.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.8 m -140.99 135.42 33.01 Favored 'Isoleucine or valine' 0 C--N 1.374 1.645 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -101.89 141.44 34.73 Favored 'General case' 0 CA--C 1.566 1.585 0 O-C-N 120.335 -1.478 . . . . 0.0 108.62 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.78 126.71 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 123.428 1.585 . . . . 0.0 110.39 -176.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.5 mt -97.48 -76.41 0.52 Allowed 'General case' 0 C--N 1.365 1.282 0 CA-C-O 116.56 -1.686 . . . . 0.0 109.975 -172.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.43 148.75 36.62 Favored 'General case' 0 N--CA 1.416 -2.14 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.99 135.24 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 125.902 2.001 . . . . 0.0 110.34 160.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -84.56 168.75 15.1 Favored 'General case' 0 C--N 1.369 1.414 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -67.57 -38.45 84.1 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-O 117.592 -1.194 . . . . 0.0 112.788 -170.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -76.53 -7.66 55.61 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 131.64 1.99 4.52 Favored Glycine 0 CA--C 1.496 -1.15 0 CA-C-O 117.219 -1.878 . . . . 0.0 116.998 165.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.82 147.73 22.61 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 120.652 2.226 . . . . 0.0 113.965 -171.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.498 HD13 HG21 ' A' ' 79' ' ' ILE . 24.4 mt -100.0 141.39 17.17 Favored 'Isoleucine or valine' 0 C--N 1.376 1.719 0 C-N-CA 117.323 -1.751 . . . . 0.0 110.614 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -113.55 132.17 55.81 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.734 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.8 mt -124.55 165.39 17.91 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -165.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.0 t -136.69 135.31 38.1 Favored 'General case' 0 N--CA 1.524 3.253 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.624 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mm -88.32 -42.29 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 125.971 2.045 . . . . 0.0 109.441 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -64.65 -32.37 74.01 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 119.632 -1.917 . . . . 0.0 116.036 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -87.9 -3.48 58.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.416 -1.428 . . . . 0.0 110.79 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.266 . . -98.92 17.08 20.44 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.9 t -140.17 136.93 33.96 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.775 1.23 . . . . 0.0 110.438 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.79 163.86 4.16 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 126.683 1.993 . . . . 0.0 112.158 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 . . . . . 0 N--CA 1.477 0.91 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.047 -176.954 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.278 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 117.751 -1.119 . . . . 0.0 108.61 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.1 mt -105.03 135.95 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 126.394 2.309 . . . . 0.0 108.186 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -113.99 131.29 56.39 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.72 1.263 . . . . 0.0 107.902 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.6 m -110.06 107.85 17.85 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.112 1.434 . . . . 0.0 110.507 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.7 126.06 74.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 113.758 -1.565 . . . . 0.0 111.224 -169.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -95.51 129.27 42.74 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 pt -127.87 162.81 33.01 Favored 'Isoleucine or valine' 0 C--N 1.381 1.966 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.995 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -45.87 116.48 3.37 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.954 1.701 . . . . 0.0 113.625 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -66.84 8.29 0.35 Allowed 'Trans proline' 0 N--CA 1.51 2.498 0 O-C-N 116.87 -2.226 . . . . 0.0 114.547 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.25 -15.39 35.97 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 120.29 1.405 . . . . 0.0 111.51 169.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -119.42 22.06 11.89 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 125.832 1.958 . . . . 0.0 114.902 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 mt -70.81 -40.11 76.29 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 C-N-CA 124.069 0.948 . . . . 0.0 109.884 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -58.2 -39.75 79.79 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 126.771 2.028 . . . . 0.0 115.976 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.76 -35.19 62.58 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.007 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.0 t -71.04 -41.08 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 123.271 1.51 . . . . 0.0 111.659 170.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.435 HG23 ' HA2' ' A' ' 33' ' ' GLY . 94.2 mt -64.13 -55.82 19.86 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.951 0 CA-C-O 116.389 -1.767 . . . . 0.0 111.181 173.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.721 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 88.78 -177.9 45.16 Favored Glycine 0 C--O 1.205 -1.708 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 -172.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -77.79 122.75 25.83 Favored 'General case' 0 CA--C 1.557 1.23 0 O-C-N 119.033 -2.451 . . . . 0.0 110.293 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.94 22.41 64.6 Favored Glycine 1 N--CA 1.521 4.361 0 C-N-CA 118.159 -1.972 . . . . 0.0 112.513 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.435 ' HA2' HG23 ' A' ' 29' ' ' ILE . . . 89.97 5.7 70.45 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-O 116.625 -2.209 . . . . 0.0 114.308 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -55.64 -46.81 77.4 Favored 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -174.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.721 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 73.1 t -67.12 -44.22 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -69.61 -34.48 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 O-C-N 118.934 -2.354 . . . . 0.0 110.796 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -49.12 -53.87 18.78 Favored 'General case' 0 C--N 1.381 1.973 0 O-C-N 126.07 2.106 . . . . 0.0 113.755 165.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.68 -36.8 85.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.876 1.36 . . . . 0.0 114.152 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.3 tp -61.2 -47.05 87.9 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.872 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -71.19 -25.09 62.37 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.62 -46.16 55.44 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 117.933 -1.507 . . . . 0.0 113.301 166.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.58 -32.32 64.07 Favored 'General case' 0 C--O 1.255 1.354 0 O-C-N 125.145 1.528 . . . . 0.0 108.709 -167.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.64 HG21 ' HA ' ' A' ' 68' ' ' ALA . 75.2 p -82.84 -21.16 34.49 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 120.201 -1.562 . . . . 0.0 112.877 174.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.03 34.58 87.26 Favored Glycine 0 C--N 1.381 3.075 0 C-N-CA 129.222 3.296 . . . . 0.0 112.182 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 t -146.98 157.95 43.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 119.696 -2.061 . . . . 0.0 108.572 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.2 m -74.12 128.76 36.37 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 124.325 1.016 . . . . 0.0 112.611 -172.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.5 mt -136.13 137.69 48.16 Favored 'Isoleucine or valine' 0 C--N 1.365 1.254 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -170.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -136.89 150.01 47.99 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.987 1.715 . . . . 0.0 109.336 -169.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.2 tt -141.94 155.16 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 118.82 -1.152 . . . . 0.0 112.417 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -127.17 155.27 43.65 Favored 'General case' 0 C--N 1.362 1.137 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.636 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -86.83 20.4 2.61 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -115.57 13.86 16.44 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.32 5.99 89.11 Favored Glycine 0 C--N 1.36 1.893 0 C-N-CA 119.081 -1.533 . . . . 0.0 110.385 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.4 m -88.09 114.63 24.9 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 119.963 -1.904 . . . . 0.0 108.964 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -115.71 138.33 46.49 Favored 'Isoleucine or valine' 0 C--N 1.365 1.249 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -123.79 131.56 53.62 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 112.731 -2.032 . . . . 0.0 111.58 -169.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.39 106.96 19.7 Favored 'Isoleucine or valine' 0 C--N 1.371 1.513 0 O-C-N 125.408 1.693 . . . . 0.0 109.801 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.39 121.93 33.54 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-N 112.806 -1.997 . . . . 0.0 105.977 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.04 151.87 28.92 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -165.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -123.94 -10.12 7.71 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.075 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -120.25 123.7 43.86 Favored 'General case' 0 C--N 1.377 1.762 0 CA-C-N 119.305 0.957 . . . . 0.0 110.42 171.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.28 -36.56 53.06 Favored Glycine 0 C--N 1.361 1.92 0 CA-C-O 122.629 1.127 . . . . 0.0 114.308 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -67.31 -40.73 86.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 117.243 -1.36 . . . . 0.0 112.686 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -68.09 -42.18 80.75 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.523 1.056 . . . . 0.0 112.115 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.61 84.94 Favored 'General case' 0 C--N 1.358 0.965 0 O-C-N 125.571 1.795 . . . . 0.0 112.869 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -62.76 -42.67 99.79 Favored 'General case' 0 C--O 1.261 1.678 0 O-C-N 125.179 1.55 . . . . 0.0 113.082 173.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . 0.287 3.2 t60 -63.29 -37.64 88.05 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 126.61 2.444 . . . . 0.0 115.138 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.64 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -67.58 -43.39 80.68 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.865 170.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.318 61.4 mt -60.32 -41.74 88.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.312 0 CA-C-N 119.113 0.87 . . . . 0.0 109.683 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? -61.2 -46.02 92.17 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 117.522 -1.228 . . . . 0.0 112.825 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -59.58 -43.07 93.78 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 127.836 2.454 . . . . 0.0 110.131 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.06 -44.9 99.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -62.26 -40.05 94.92 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.06 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -54.56 -56.02 23.3 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 123.013 1.387 . . . . 0.0 113.698 173.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.257 76.9 mt -63.95 -45.16 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 112.299 -2.228 . . . . 0.0 109.776 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.7 p -79.4 -23.32 43.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.619 1.554 . . . . 0.0 114.752 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.14 -24.66 58.0 Favored 'General case' 0 C--O 1.273 2.295 0 CA-C-N 120.573 1.533 . . . . 0.0 113.336 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -55.04 144.13 24.47 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 124.488 2.09 . . . . 0.0 114.536 -177.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mm -72.91 148.26 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 119.636 -1.915 . . . . 0.0 114.834 -157.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -115.03 154.86 28.06 Favored 'General case' 0 C--O 1.249 1.053 0 O-C-N 119.631 -1.918 . . . . 0.0 108.965 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.07 143.7 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.85 0 O-C-N 119.097 -2.252 . . . . 0.0 113.51 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.05 85.6 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 120.986 -1.071 . . . . 0.0 113.569 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -111.58 152.37 27.66 Favored 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 123.387 0.675 . . . . 0.0 110.804 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.58 140.09 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 126.554 2.409 . . . . 0.0 109.675 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -129.4 159.94 34.65 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 125.187 2.423 . . . . 0.0 106.657 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.5 109.86 21.98 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 118.64 -2.537 . . . . 0.0 109.319 174.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.44 166.08 18.33 Favored Glycine 0 C--N 1.368 2.348 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -169.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -120.28 149.08 42.87 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-N 112.231 -1.984 . . . . 0.0 113.544 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.18 127.71 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 124.109 1.909 . . . . 0.0 112.024 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 p -97.48 -30.2 13.03 Favored 'General case' 0 CA--C 1.48 -1.712 0 CA-C-O 116.268 -1.825 . . . . 0.0 114.218 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -171.0 151.27 3.24 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.8 mt -123.98 140.28 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 O-C-N 121.444 -0.785 . . . . 0.0 109.456 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.4 m -142.51 172.02 9.21 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.242 0 C-N-CA 126.366 1.866 . . . . 0.0 112.797 -173.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.16 -35.53 81.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 118.356 -2.715 . . . . 0.0 113.811 -165.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -109.81 18.34 20.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 125.385 1.678 . . . . 0.0 113.207 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.56 -161.81 32.47 Favored Glycine 0 CA--C 1.549 2.174 0 N-CA-C 117.711 1.845 . . . . 0.0 117.711 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.19 142.86 26.6 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 120.913 -1.345 . . . . 0.0 110.441 -173.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -99.37 134.76 41.76 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.827 1.775 . . . . 0.0 109.039 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.2 t -136.03 123.26 33.95 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.245 0 CA-C-N 112.434 -2.166 . . . . 0.0 110.497 -171.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.39 147.78 22.79 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 125.559 1.787 . . . . 0.0 113.236 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 pt -145.35 164.95 11.51 Favored 'Isoleucine or valine' 0 C--N 1.362 1.143 0 O-C-N 126.022 2.076 . . . . 0.0 110.125 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.88 141.33 1.49 Allowed Glycine 0 CA--C 1.541 1.718 0 N-CA-C 121.521 3.368 . . . . 0.0 121.521 176.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.13 24.68 51.31 Favored Glycine 0 CA--C 1.496 -1.138 0 CA-C-O 116.682 -2.177 . . . . 0.0 115.979 -174.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.47 42.85 99.19 Favored Glycine 0 CA--C 1.562 2.976 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -121.76 148.93 44.01 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 120.148 -1.796 . . . . 0.0 113.325 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -130.34 119.65 23.1 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 124.103 1.906 . . . . 0.0 107.45 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.39 171.67 22.41 Favored Glycine 0 N--CA 1.408 -3.177 0 C-N-CA 125.692 1.615 . . . . 0.0 110.125 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 tp -116.08 136.56 52.91 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 115.29 -2.29 . . . . 0.0 109.709 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -101.76 115.08 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.159 2.254 . . . . 0.0 109.14 167.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -62.66 149.54 43.25 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.269 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.0 tt -56.46 -38.89 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -175.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . 0.301 71.4 m -73.81 -10.13 59.36 Favored 'General case' 0 CA--C 1.486 -1.511 0 C-N-CA 124.387 1.075 . . . . 0.0 111.208 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -117.2 18.76 14.43 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.663 1.185 . . . . 0.0 113.213 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.407 ' HB ' HG21 ' A' ' 119' ' ' VAL . 37.2 mt -81.9 -53.79 11.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 125.347 1.459 . . . . 0.0 111.521 167.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.46 166.95 27.59 Favored 'General case' 0 C--O 1.198 -1.624 0 O-C-N 123.574 0.546 . . . . 0.0 111.617 -171.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -69.53 -43.66 72.57 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.371 163.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -48.14 145.84 2.96 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 162.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -66.58 131.57 46.31 Favored 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.956 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.407 HG21 ' HB ' ' A' ' 114' ' ' ILE . 18.6 t -110.29 102.98 14.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 170.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.56 -43.08 19.21 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 124.757 1.286 . . . . 0.0 108.876 161.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -133.31 148.06 51.89 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.006 -1.684 . . . . 0.0 108.727 170.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.35 -33.06 52.55 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 126.539 1.936 . . . . 0.0 115.152 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.2 p -62.59 -9.03 7.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 116.409 -1.758 . . . . 0.0 115.69 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -69.1 -41.99 76.7 Favored 'General case' 0 C--N 1.372 1.578 0 CA-C-N 123.691 2.951 . . . . 0.0 110.648 168.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -109.97 -34.03 6.54 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -164.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.48 142.83 39.95 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -168.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -126.51 150.35 48.82 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -55.34 136.29 49.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 125.807 1.942 . . . . 0.0 114.236 168.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.49 3.44 88.79 Favored Glycine 0 C--N 1.381 3.07 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.396 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -79.99 122.96 27.37 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.46 107.2 1.3 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 128.373 3.545 . . . . 0.0 114.069 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.4 148.01 43.05 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 111.382 -2.644 . . . . 0.0 105.582 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -90.57 134.1 1.89 Allowed 'Trans proline' 1 C--N 1.255 -4.364 0 N-CA-C 104.648 -2.866 . . . . 0.0 104.648 170.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.74 137.27 39.5 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.939 0 C-N-CA 118.119 -1.432 . . . . 0.0 109.537 -172.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -113.61 135.02 54.37 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 122.863 1.316 . . . . 0.0 108.39 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.572 HG22 HD23 ' A' ' 147' ' ' LEU . 65.8 t -80.17 121.55 33.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 113.265 -1.789 . . . . 0.0 108.977 173.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 43.4 mt -104.98 -6.8 19.74 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.483 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -168.48 144.66 3.72 Favored 'General case' 0 N--CA 1.533 3.678 0 O-C-N 119.792 -1.817 . . . . 0.0 114.659 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.282 7.2 t -127.09 103.56 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 126.444 2.34 . . . . 0.0 106.041 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.46 166.05 24.16 Favored 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 -177.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -71.56 -7.61 48.75 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -107.96 14.83 24.94 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.727 1.611 . . . . 0.0 108.808 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.89 31.34 75.35 Favored Glycine 0 N--CA 1.414 -2.786 0 O-C-N 120.663 -1.273 . . . . 0.0 115.582 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . 0.252 58.3 mtm180 -80.74 117.63 21.58 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 124.027 1.87 . . . . 0.0 109.892 168.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 64.6 mt -101.94 121.2 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 O-C-N 118.582 -2.574 . . . . 0.0 107.955 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -109.76 106.14 15.65 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.832 1.777 . . . . 0.0 114.344 -175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.572 HD23 HG22 ' A' ' 136' ' ' VAL . 20.0 mt -87.3 150.03 24.14 Favored 'General case' 0 C--N 1.389 2.284 0 CA-C-O 127.979 3.752 . . . . 0.0 110.861 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.3 t -119.51 129.1 54.54 Favored 'General case' 0 C--O 1.288 3.113 0 CA-C-N 110.158 -3.201 . . . . 0.0 110.734 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.41 -30.27 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 O-C-N 119.189 -2.194 . . . . 0.0 105.631 167.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -62.24 -46.92 86.71 Favored 'General case' 0 CA--C 1.553 1.075 0 O-C-N 120.537 -1.352 . . . . 0.0 114.136 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -69.63 -24.39 63.63 Favored 'General case' 0 C--O 1.264 1.837 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 171.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.11 -35.82 56.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 124.927 1.392 . . . . 0.0 111.414 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.4 p -90.01 26.2 1.92 Allowed 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 173.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.261 16.2 mt-10 71.71 17.44 5.48 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-O 123.864 1.792 . . . . 0.0 113.92 166.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 C--O 1.274 2.393 0 O-C-N 118.029 -2.919 . . . . 0.0 112.725 -178.277 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 . . . . . 0 CA--C 1.567 1.597 0 N-CA-C 118.683 2.846 . . . . 0.0 118.683 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.1 mm -108.86 119.68 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -113.87 151.48 32.1 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 102.959 -2.978 . . . . 0.0 102.959 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 p -148.29 151.81 36.04 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-O 124.819 2.247 . . . . 0.0 112.67 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.1 pt -145.87 155.58 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 O-C-N 118.669 -2.519 . . . . 0.0 105.243 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -107.21 119.75 40.25 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 121.464 -0.772 . . . . 0.0 110.217 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.05 141.66 30.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.761 0 C-N-CA 126.124 1.77 . . . . 0.0 108.815 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -73.02 146.01 86.91 Favored Pre-proline 0 C--O 1.213 -0.819 0 CA-C-O 115.33 -2.271 . . . . 0.0 113.555 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -67.2 -19.58 50.48 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 124.25 1.658 . . . . 0.0 113.251 -160.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -57.74 -44.41 86.05 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 119.871 -1.768 . . . . 0.0 111.652 166.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -92.87 -18.28 23.01 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.241 -1.537 . . . . 0.0 109.237 -167.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mm -59.74 -34.78 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.776 1.298 . . . . 0.0 108.688 165.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -61.8 -43.37 98.99 Favored 'General case' 0 CA--C 1.579 2.082 0 O-C-N 120.94 -1.1 . . . . 0.0 112.21 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -68.74 -31.0 69.74 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 114.05 -2.881 . . . . 0.0 112.262 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.28 -42.47 78.83 Favored 'Isoleucine or valine' 0 C--N 1.381 1.968 0 O-C-N 127.709 3.131 . . . . 0.0 108.843 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.8 -48.29 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 124.176 1.941 . . . . 0.0 111.296 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.99 -176.58 49.26 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 111.4 -2.636 . . . . 0.0 114.71 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -70.11 142.03 52.64 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 116.911 -1.915 . . . . 0.0 110.532 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.01 23.21 45.48 Favored Glycine 0 N--CA 1.511 3.641 0 O-C-N 120.263 -1.523 . . . . 0.0 114.702 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 52.8 43.27 60.33 Favored Glycine 0 CA--C 1.477 -2.305 0 C-N-CA 126.389 1.947 . . . . 0.0 114.689 -168.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.6 p -97.95 -33.84 11.06 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 117.446 -1.702 . . . . 0.0 114.618 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -65.66 -36.19 77.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 O-C-N 120.499 -1.376 . . . . 0.0 112.528 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.54 -42.05 94.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 O-C-N 119.487 -2.008 . . . . 0.0 114.097 167.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -62.71 -37.27 85.86 Favored 'General case' 0 CA--C 1.583 2.244 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.8 -48.15 69.88 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 117.056 -1.449 . . . . 0.0 111.186 170.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -55.62 -42.56 75.1 Favored 'General case' 0 C--N 1.37 1.458 0 C-N-CA 124.52 1.128 . . . . 0.0 108.579 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.9 m -61.86 -47.69 83.88 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 114.607 -1.178 . . . . 0.0 112.163 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -61.28 -45.81 92.95 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.772 -2.013 . . . . 0.0 112.283 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.97 -53.2 42.04 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-O 114.655 -2.593 . . . . 0.0 114.001 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.1 p -69.19 -22.93 63.86 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 125.857 1.973 . . . . 0.0 113.336 -170.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.03 13.18 53.82 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-O 114.841 -3.199 . . . . 0.0 117.548 -176.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.98 161.66 34.17 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.693 2.247 . . . . 0.0 108.714 -162.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.3 m -66.3 123.71 20.69 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 176.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.8 mm -118.15 134.65 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -140.48 167.54 21.92 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 123.344 1.545 . . . . 0.0 108.421 170.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.6 mm -113.29 130.64 66.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 104.235 -2.505 . . . . 0.0 104.235 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -118.77 163.91 16.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -45.37 160.62 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.308 79.3 m-20 69.37 32.14 3.61 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 123.515 1.626 . . . . 0.0 114.841 170.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.7 53.75 24.37 Favored Glycine 0 C--O 1.281 3.064 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.1 m -102.63 132.89 48.44 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 125.898 1.587 . . . . 0.0 110.989 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -94.94 134.44 32.3 Favored 'Isoleucine or valine' 0 C--N 1.37 1.47 0 O-C-N 119.046 -2.284 . . . . 0.0 108.305 158.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -107.78 130.36 54.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.05 124.87 69.18 Favored 'Isoleucine or valine' 0 C--N 1.372 1.555 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 167.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.55 114.93 27.83 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.88 140.91 22.94 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 123.298 1.523 . . . . 0.0 113.636 -164.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 p -110.47 4.58 20.62 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 126.61 1.964 . . . . 0.0 111.953 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -126.2 139.33 53.43 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 169.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.32 -27.73 24.48 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 125.605 1.574 . . . . 0.0 113.577 -174.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -62.02 -39.64 92.97 Favored 'General case' 0 C--O 1.248 0.976 0 O-C-N 121.316 -1.108 . . . . 0.0 113.423 168.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -65.97 -37.36 85.77 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 118.483 0.583 . . . . 0.0 112.308 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.41 89.37 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 123.469 1.604 . . . . 0.0 114.224 173.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -67.33 -42.91 82.81 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 115.179 -2.343 . . . . 0.0 113.035 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -62.61 -40.79 98.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 126.456 2.348 . . . . 0.0 111.577 169.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.64 -48.45 69.38 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.89 -37.36 71.62 Favored 'Isoleucine or valine' 0 C--N 1.368 1.397 0 O-C-N 125.399 1.687 . . . . 0.0 109.271 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.306 27.5 tpt180 -67.82 -41.86 82.42 Favored 'General case' 0 C--N 1.375 1.709 0 O-C-N 124.726 1.266 . . . . 0.0 114.413 172.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -62.41 -39.3 92.85 Favored 'General case' 0 C--O 1.253 1.274 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.132 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mm -55.43 -31.98 28.71 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 CA-C-O 117.331 -1.319 . . . . 0.0 108.668 176.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -72.82 -29.33 63.16 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 116.956 -1.898 . . . . 0.0 109.142 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.79 -40.57 79.57 Favored 'General case' 0 C--O 1.26 1.651 0 O-C-N 120.437 -1.415 . . . . 0.0 109.121 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.39 -38.33 32.05 Favored 'Isoleucine or valine' 0 C--O 1.264 1.862 0 O-C-N 127.338 2.899 . . . . 0.0 117.191 165.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.0 p -88.14 -17.11 31.69 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 117.879 -3.013 . . . . 0.0 115.998 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.44 -25.36 23.81 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -71.97 148.11 46.29 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 126.482 3.039 . . . . 0.0 113.4 171.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.0 mm -79.99 135.06 26.21 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.794 0 CA-C-O 126.023 2.82 . . . . 0.0 111.827 -169.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -87.09 134.42 33.51 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.313 -167.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.46 129.07 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 CA-C-O 123.629 1.681 . . . . 0.0 112.568 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.43 16.87 79.92 Favored Glycine 0 N--CA 1.513 3.769 0 C-N-CA 126.698 2.094 . . . . 0.0 117.967 165.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -120.16 161.43 21.05 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.42 113.14 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 112.417 -2.174 . . . . 0.0 109.441 -164.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -94.7 163.01 13.54 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 113.188 -1.823 . . . . 0.0 113.662 169.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 m -104.85 127.48 52.69 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 116.944 -3.598 . . . . 0.0 104.007 163.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.66 -164.88 11.93 Favored Glycine 0 CA--C 1.493 -1.318 0 C-N-CA 126.978 2.228 . . . . 0.0 108.149 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -149.38 151.73 34.57 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-O 116.854 -1.546 . . . . 0.0 109.915 172.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.88 109.59 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 126.855 2.062 . . . . 0.0 111.864 -177.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -94.19 -55.71 3.1 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.91 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.7 mtm-85 -131.81 123.46 27.64 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -98.65 128.97 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 CA-C-O 123.481 1.61 . . . . 0.0 107.087 176.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.71 174.49 9.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 O-C-N 120.476 -1.39 . . . . 0.0 110.059 -169.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.68 -25.53 64.82 Favored 'General case' 0 C--N 1.377 1.767 0 O-C-N 117.835 -3.041 . . . . 0.0 116.054 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -125.51 14.32 8.19 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-O 117.571 -1.204 . . . . 0.0 112.637 -172.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.42 -159.14 30.72 Favored Glycine 0 C--O 1.193 -2.448 0 CA-C-N 120.647 1.567 . . . . 0.0 110.661 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.96 155.58 46.21 Favored 'General case' 0 CA--C 1.477 -1.838 0 O-C-N 124.759 0.917 . . . . 0.0 109.282 158.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -87.43 147.01 25.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.896 0.855 . . . . 0.0 109.894 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 t -136.97 130.85 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.62 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.269 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.47 139.47 38.03 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-O 125.14 2.4 . . . . 0.0 106.04 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.3 mt -119.86 137.57 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 111.539 -2.573 . . . . 0.0 111.955 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.84 129.26 1.5 Allowed Glycine 0 N--CA 1.503 3.143 0 N-CA-C 120.95 3.14 . . . . 0.0 120.95 172.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.08 18.23 29.82 Favored Glycine 0 C--N 1.364 2.112 0 C-N-CA 124.459 1.028 . . . . 0.0 114.343 -163.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.1 27.73 73.6 Favored Glycine 0 CA--C 1.54 1.64 0 O-C-N 125.871 1.571 . . . . 0.0 113.971 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -100.0 149.57 23.33 Favored 'General case' 0 C--N 1.369 1.448 0 CA-C-N 119.534 1.667 . . . . 0.0 112.178 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -146.48 141.35 26.99 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 123.119 1.438 . . . . 0.0 114.353 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.63 166.46 18.36 Favored Glycine 0 CA--C 1.495 -1.202 0 O-C-N 120.348 -1.47 . . . . 0.0 110.05 -174.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.22 130.71 50.52 Favored 'General case' 0 N--CA 1.518 2.934 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.385 173.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.58 109.61 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 163.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -70.03 150.59 46.47 Favored 'General case' 0 C--O 1.2 -1.551 0 CA-C-N 113.815 -1.539 . . . . 0.0 114.409 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.432 8.6 tt -49.47 -21.79 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 118.711 2.856 . . . . 0.0 118.711 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.7 p -106.32 14.45 27.4 Favored 'General case' 0 C--N 1.389 2.287 0 CA-C-O 117.781 -1.104 . . . . 0.0 110.855 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -124.41 22.44 8.45 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 124.867 1.354 . . . . 0.0 111.597 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.7 mt -99.08 -39.35 7.79 Favored 'Isoleucine or valine' 0 C--N 1.377 1.784 0 CA-C-N 123.075 2.67 . . . . 0.0 110.24 175.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -159.39 149.79 19.23 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 117.285 -1.766 . . . . 0.0 113.58 -170.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.29 -26.44 60.19 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 118.92 -2.363 . . . . 0.0 108.523 163.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -57.42 151.56 16.16 Favored 'General case' 0 N--CA 1.405 -2.691 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 162.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -66.65 142.2 57.53 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.653 1.216 . . . . 0.0 108.464 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.6 t -128.34 137.24 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.888 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -107.7 -75.19 0.64 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -114.39 155.37 26.42 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 173.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.25 -26.32 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 122.019 2.19 . . . . 0.0 114.257 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.3 p -65.01 -20.29 66.42 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.931 1.292 . . . . 0.0 112.979 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -102.97 31.91 3.97 Favored 'General case' 0 C--O 1.256 1.404 0 O-C-N 126.492 2.37 . . . . 0.0 107.517 -172.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -153.36 -55.98 0.12 Allowed 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.7 157.17 16.2 Favored 'General case' 0 C--N 1.375 1.706 0 C-N-CA 125.016 1.326 . . . . 0.0 111.447 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -117.39 148.18 41.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 127.137 2.773 . . . . 0.0 105.93 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -70.18 143.27 52.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 124.047 1.88 . . . . 0.0 110.084 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.6 -17.9 22.68 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 112.158 -2.292 . . . . 0.0 115.786 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -58.99 143.76 47.26 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 124.999 1.32 . . . . 0.0 111.562 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -111.24 99.4 8.23 Favored 'General case' 0 N--CA 1.513 2.679 0 CA-C-O 123.875 1.798 . . . . 0.0 113.461 -165.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.4 p -109.04 134.33 20.43 Favored Pre-proline 0 N--CA 1.399 -2.994 0 CA-C-N 113.215 -1.811 . . . . 0.0 108.369 -160.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -58.66 140.07 93.34 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.127 1.067 . . . . 0.0 112.957 160.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.6 p -149.16 130.27 4.9 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 123.668 1.699 . . . . 0.0 111.667 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 152' ' ' ALA . 83.8 tttt -94.39 131.5 39.99 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 112.746 -2.025 . . . . 0.0 111.118 172.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.45 132.12 33.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 126.714 3.15 . . . . 0.0 111.382 170.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 148' ' ' SER . 58.8 mt -100.14 -51.61 3.62 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 117.728 -3.108 . . . . 0.0 114.866 173.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 146' ' ' ARG . 41.3 mt-10 -139.05 142.64 38.2 Favored 'General case' 0 N--CA 1.41 -2.457 0 O-C-N 125.435 1.709 . . . . 0.0 107.416 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.46 126.25 75.04 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 163.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -91.07 156.56 17.82 Favored 'General case' 0 CA--C 1.553 1.058 0 O-C-N 125.428 1.705 . . . . 0.0 108.36 167.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -70.94 -23.49 62.25 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -92.78 26.89 2.55 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-O 123.05 1.405 . . . . 0.0 111.94 168.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.73 8.43 82.79 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 122.723 3.849 . . . . 0.0 122.723 161.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -85.09 144.9 27.94 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.265 -0.468 . . . . 0.0 110.951 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.89 132.25 68.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 138' ' ' GLU . 1.3 mpp_? -103.61 133.94 47.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.023 162.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.8 mt -121.96 152.33 39.81 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 112.269 -2.241 . . . . 0.0 108.607 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.412 ' HB2' HD11 ' A' ' 137' ' ' LEU . 9.8 t -125.34 123.88 40.35 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 126.044 1.738 . . . . 0.0 110.649 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 69.4 mt -86.83 -31.0 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 117.507 -1.235 . . . . 0.0 109.981 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -60.46 -49.93 75.58 Favored 'General case' 0 C--O 1.276 2.49 0 C-N-CA 129.359 3.064 . . . . 0.0 117.518 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -88.07 -7.11 57.48 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 118.749 -1.18 . . . . 0.0 112.14 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.459 ' HB2' ' H ' ' A' ' 135' ' ' LYS . . . -67.63 -37.04 81.92 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 124.153 0.981 . . . . 0.0 112.76 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 p -104.13 9.5 36.25 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.245 1.018 . . . . 0.0 109.209 171.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 62.01 48.49 5.14 Favored 'General case' 0 C--N 1.376 1.757 0 O-C-N 119.04 -2.287 . . . . 0.0 117.116 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 . . . . . 0 CA--C 1.563 1.458 0 C-N-CA 125.243 1.417 . . . . 0.0 114.387 -178.28 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 . . . . . 0 C--O 1.216 -0.697 0 CA-C-O 124.057 1.884 . . . . 0.0 108.303 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -100.51 125.85 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 119.07 -2.269 . . . . 0.0 109.07 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.445 ' HB3' HD11 ' A' ' 69' ' ' ILE . 66.1 m80 -80.16 111.04 16.14 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 127.17 2.793 . . . . 0.0 114.622 165.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.6 p -109.92 139.98 44.4 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 127.123 2.169 . . . . 0.0 106.996 -170.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.8 tt -132.3 128.57 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -110.84 128.55 55.82 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.92 154.25 39.62 Favored 'Isoleucine or valine' 0 C--N 1.365 1.253 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.39 -162.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -58.08 148.75 59.81 Favored Pre-proline 0 C--O 1.211 -0.945 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.45 -31.25 51.89 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 N-CA-C 116.232 1.589 . . . . 0.0 116.232 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -64.83 -40.78 95.73 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 169.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -57.46 -28.28 63.21 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.6 mt -57.63 -36.89 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -65.86 -18.59 65.44 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 127.617 2.367 . . . . 0.0 115.94 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -93.02 -20.34 20.66 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.679 167.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -91.27 -22.89 6.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.231 0 O-C-N 118.243 -2.786 . . . . 0.0 114.05 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.3 mt -92.05 -55.33 6.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 119.419 -2.051 . . . . 0.0 109.642 166.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.25 173.5 48.53 Favored Glycine 0 C--N 1.375 2.703 0 O-C-N 127.551 3.032 . . . . 0.0 115.75 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -66.05 120.89 13.96 Favored 'General case' 0 CA--C 1.581 2.136 0 CA-C-O 124.239 1.971 . . . . 0.0 110.916 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.68 9.69 46.29 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 120.28 -1.512 . . . . 0.0 112.751 -172.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.43 22.57 75.39 Favored Glycine 0 C--O 1.196 -2.228 0 O-C-N 120.89 -1.359 . . . . 0.0 112.257 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 t -61.09 -41.81 97.34 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 125.042 1.337 . . . . 0.0 114.502 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.64 -44.79 59.73 Favored 'Isoleucine or valine' 0 C--O 1.258 1.541 0 CA-C-N 120.65 1.568 . . . . 0.0 113.396 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 tt -60.79 -41.14 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 119.804 -1.81 . . . . 0.0 110.437 174.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -59.9 -49.17 78.74 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 123.556 1.646 . . . . 0.0 112.843 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.56 94.15 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 124.023 1.868 . . . . 0.0 112.57 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.0 tp -56.5 -37.0 69.79 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.504 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.7 m -57.74 -60.14 4.15 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-O 115.556 -2.164 . . . . 0.0 116.239 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.63 -40.6 92.53 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 126.815 2.572 . . . . 0.0 114.336 174.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.512 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 28.1 tt0 -60.65 -47.7 85.08 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 124.889 2.28 . . . . 0.0 112.223 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.3 p -88.24 -24.65 23.19 Favored 'General case' 0 C--O 1.21 -0.991 0 O-C-N 118.98 -2.325 . . . . 0.0 109.436 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.25 38.74 94.03 Favored Glycine 0 N--CA 1.484 1.855 0 C-N-CA 118.915 -1.612 . . . . 0.0 116.95 -166.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.6 p -139.85 176.89 8.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 119.94 1.87 . . . . 0.0 108.156 -172.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -118.11 121.44 40.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.811 -1.806 . . . . 0.0 107.937 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.5 126.12 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 119.782 1.174 . . . . 0.0 108.818 -170.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -123.58 147.59 47.17 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.0 mt -127.75 115.6 40.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.182 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -77.1 167.55 21.59 Favored 'General case' 0 N--CA 1.525 3.307 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -76.42 -19.38 58.15 Favored 'General case' 0 C--N 1.378 1.835 0 C-N-CA 122.749 0.42 . . . . 0.0 111.018 -170.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.31 -12.89 51.25 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.297 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.51 17.29 34.14 Favored Glycine 0 N--CA 1.475 1.257 0 CA-C-O 116.496 -2.28 . . . . 0.0 116.917 -167.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -78.82 122.22 25.78 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 120.862 2.331 . . . . 0.0 108.815 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.3 t -94.67 126.81 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 169.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -108.13 126.07 52.33 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.449 HD11 HD12 ' A' ' 72' ' ' ILE . 5.0 mt -115.67 113.83 44.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.933 0 CA-C-N 121.366 1.894 . . . . 0.0 113.978 178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.42 137.42 32.38 Favored 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 119.661 -1.9 . . . . 0.0 108.17 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.66 141.6 45.03 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.817 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -68.39 -36.92 79.86 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.594 1.088 . . . . 0.0 108.707 170.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -119.76 129.85 54.68 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 124.401 2.048 . . . . 0.0 107.67 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.88 -29.93 71.77 Favored Glycine 0 N--CA 1.475 1.296 0 O-C-N 118.992 -2.317 . . . . 0.0 116.242 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -67.49 -28.54 67.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.358 2.079 . . . . 0.0 111.371 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.23 -37.99 84.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 124.456 1.098 . . . . 0.0 110.919 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.26 79.67 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 120.131 -1.606 . . . . 0.0 112.509 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -63.82 -45.24 90.52 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.797 174.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -63.58 -38.88 92.82 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 124.938 1.399 . . . . 0.0 112.919 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.49 82.53 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 16' ' ' HIS . 46.4 mt -52.72 -43.94 45.78 Favored 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 124.234 1.014 . . . . 0.0 110.474 170.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -60.23 -46.29 90.29 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.512 ' HE ' ' CD ' ' A' ' 42' ' ' GLU . 4.6 mmm180 -61.34 -37.22 82.51 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.101 1.319 . . . . 0.0 112.111 174.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.449 HD12 HD11 ' A' ' 57' ' ' ILE . 63.1 mt -61.54 -41.69 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 121.299 -0.876 . . . . 0.0 112.536 175.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -62.04 -41.97 98.68 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 164.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.13 -39.46 86.62 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.46 -46.69 82.26 Favored 'Isoleucine or valine' 0 C--N 1.371 1.541 0 C-N-CA 125.735 1.614 . . . . 0.0 110.227 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p -90.55 -3.47 57.57 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 121.739 2.063 . . . . 0.0 113.073 -168.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.63 -39.96 14.6 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 120.721 -1.237 . . . . 0.0 112.471 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -57.64 116.74 3.59 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 125.461 2.553 . . . . 0.0 113.697 -165.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.0 mm -57.94 141.24 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 113.349 -1.751 . . . . 0.0 111.344 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -104.21 121.98 44.42 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.79 129.3 23.28 Favored 'Isoleucine or valine' 0 C--N 1.369 1.427 0 O-C-N 119.676 -1.89 . . . . 0.0 111.239 158.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.73 1.46 63.63 Favored Glycine 0 CA--C 1.482 -2.009 0 C-N-CA 118.676 -1.726 . . . . 0.0 111.273 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HB3' ' HE1' ' A' ' 85' ' ' TYR . 21.6 ttm180 -92.54 146.89 23.32 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.449 1.119 . . . . 0.0 111.038 167.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 135' ' ' LYS . 40.3 t -100.64 135.5 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.426 ' HE1' ' HB3' ' A' ' 83' ' ' ARG . 27.9 m-85 -125.25 159.3 31.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.564 1.946 . . . . 0.0 108.491 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.64 113.68 27.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 120.738 -1.226 . . . . 0.0 108.363 169.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.75 169.09 16.74 Favored Glycine 0 CA--C 1.47 -2.727 0 C-N-CA 118.447 -1.835 . . . . 0.0 114.099 -174.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -121.1 153.05 37.96 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.932 1.866 . . . . 0.0 107.922 -175.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 81.4 t -63.68 130.79 28.92 Favored 'Isoleucine or valine' 0 C--N 1.365 1.252 0 C-N-CA 123.849 0.86 . . . . 0.0 110.572 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.4 p -100.24 -11.98 19.92 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 165.92 159.85 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 126.591 1.956 . . . . 0.0 107.176 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.467 HD12 HG22 ' A' ' 123' ' ' THR . 55.1 mt -121.55 146.66 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 O-C-N 120.64 -1.288 . . . . 0.0 109.915 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.32 178.3 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.271 0 O-C-N 117.938 -2.976 . . . . 0.0 108.612 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -65.56 -44.45 86.75 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -78.52 0.2 27.03 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 115.13 -2.367 . . . . 0.0 112.263 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.4 -155.32 26.06 Favored Glycine 0 CA--C 1.553 2.421 0 O-C-N 124.826 1.329 . . . . 0.0 115.716 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.97 155.9 47.15 Favored 'General case' 0 CA--C 1.587 2.375 0 CA-C-N 121.873 2.837 . . . . 0.0 110.549 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -86.29 129.67 34.77 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 124.159 1.933 . . . . 0.0 113.257 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.6 t -127.59 122.64 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-N 112.711 -2.041 . . . . 0.0 113.881 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.01 111.82 23.04 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.468 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.6 pt -102.91 148.5 8.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 125.903 2.763 . . . . 0.0 105.221 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -51.54 138.42 28.74 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 112.487 -2.142 . . . . 0.0 113.137 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.64 15.41 13.54 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 119.343 1.572 . . . . 0.0 110.546 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.21 21.4 65.14 Favored Glycine 0 C--N 1.303 -1.266 0 CA-C-N 120.707 2.253 . . . . 0.0 117.573 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -125.34 120.22 30.53 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -89.57 133.85 34.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 124.004 1.859 . . . . 0.0 109.09 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.54 -177.68 18.98 Favored Glycine 0 C--N 1.308 -1.009 0 O-C-N 120.88 -1.137 . . . . 0.0 110.7 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.3 tp -137.39 115.37 11.53 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 110.124 -3.038 . . . . 0.0 108.176 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.1 105.15 17.13 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 O-C-N 125.714 1.884 . . . . 0.0 108.592 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . 0.288 34.8 m80 -59.31 157.82 10.26 Favored 'General case' 0 C--O 1.191 -2.013 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 171.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.9 tp -62.23 -30.67 49.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.1 p -82.44 -18.76 40.66 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 127.831 2.452 . . . . 0.0 111.773 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -100.57 -2.62 32.42 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 124.889 1.368 . . . . 0.0 109.836 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.0 mt -73.8 -38.85 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.467 0 O-C-N 119.292 -2.13 . . . . 0.0 114.101 165.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.77 148.01 23.6 Favored 'General case' 0 N--CA 1.483 1.202 1 O-C-N 114.243 -5.285 . . . . 0.0 107.14 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -69.39 -51.83 32.84 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.442 -173.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -87.99 9.72 21.37 Favored 'General case' 0 N--CA 1.521 3.109 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.358 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.278 10.5 mpt_? 70.51 113.73 0.05 Allowed 'General case' 0 C--O 1.193 -1.885 0 C-N-CA 126.715 2.006 . . . . 0.0 112.831 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 119' ' ' VAL . 14.8 m -72.84 155.73 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 123.697 1.713 . . . . 0.0 114.0 168.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.95 -48.6 81.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.712 1.605 . . . . 0.0 113.032 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -159.62 152.26 21.43 Favored 'General case' 0 C--N 1.361 1.1 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 168.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.62 HG12 HD12 ' A' ' 126' ' ' LEU . 20.9 t -58.25 -41.45 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 C-N-CA 124.946 1.298 . . . . 0.0 112.52 -171.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.467 HG22 HD12 ' A' ' 92' ' ' ILE . 43.5 p -68.51 -20.56 64.58 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.301 -2.227 . . . . 0.0 115.957 178.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -90.02 0.73 56.95 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 119.258 -2.151 . . . . 0.0 114.089 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -120.01 -21.15 7.21 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 169.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.62 HD12 HG12 ' A' ' 122' ' ' VAL . 95.9 mt -105.2 150.15 25.33 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 119.219 -2.176 . . . . 0.0 112.943 -175.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -135.51 145.36 46.99 Favored 'General case' 0 C--N 1.366 1.295 0 O-C-N 125.894 1.996 . . . . 0.0 108.507 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 73.9 mmm -85.62 143.85 28.2 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 125.59 1.806 . . . . 0.0 111.916 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.54 0.64 84.7 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-N 110.346 -3.115 . . . . 0.0 113.859 -170.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -101.13 143.42 31.25 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.478 -1.601 . . . . 0.0 109.805 -174.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -80.94 123.24 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 125.88 1.988 . . . . 0.0 113.5 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.61 125.52 51.23 Favored Pre-proline 0 C--N 1.367 1.358 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 170.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -62.72 123.15 11.82 Favored 'Trans proline' 0 C--N 1.29 -2.54 0 O-C-N 117.439 -1.927 . . . . 0.0 112.063 164.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.49 130.16 46.69 Favored 'Isoleucine or valine' 0 C--N 1.373 1.614 0 O-C-N 119.294 -2.129 . . . . 0.0 109.582 -173.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.443 ' HB2' HG22 ' A' ' 84' ' ' VAL . 33.3 ttpt -95.16 144.27 25.91 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 117.215 -1.794 . . . . 0.0 110.935 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.7 t -83.97 130.95 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.417 0 C-N-CA 117.158 -1.817 . . . . 0.0 114.894 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.0 mt -101.68 -44.33 5.59 Favored 'General case' 0 C--N 1.37 1.491 0 C-N-CA 126.033 1.733 . . . . 0.0 114.066 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -154.11 138.6 16.81 Favored 'General case' 0 C--O 1.202 -1.427 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -174.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.3 t -92.72 137.8 21.49 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 CA-C-O 122.725 1.25 . . . . 0.0 108.959 167.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -128.27 142.25 51.21 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -103.04 -5.7 23.08 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.032 -171.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -122.14 -40.26 2.52 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 124.853 1.345 . . . . 0.0 112.872 169.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.26 -174.02 34.03 Favored Glycine 0 C--N 1.37 2.42 0 C-N-CA 128.677 3.037 . . . . 0.0 109.139 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 48.1 mmt-85 -88.72 158.77 18.08 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 112.638 -1.781 . . . . 0.0 108.122 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.7 mm -66.17 138.06 23.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 O-C-N 120.856 -1.152 . . . . 0.0 111.501 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.6 mmt-85 -94.13 131.93 39.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 117.045 -1.862 . . . . 0.0 107.001 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.7 mt -139.99 152.63 46.44 Favored 'General case' 0 C--N 1.381 1.963 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 30.4 t -121.7 120.74 35.57 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.412 1.085 . . . . 0.0 108.307 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.9 mt -80.2 -34.68 15.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 O-C-N 119.639 -1.913 . . . . 0.0 107.075 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -70.78 -20.68 62.58 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -172.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -92.14 4.65 52.73 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.142 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.17 -41.03 1.01 Allowed 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 125.02 1.328 . . . . 0.0 108.376 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.2 t -71.07 136.6 48.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 119.713 -1.867 . . . . 0.0 108.506 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.284 44.3 mt-10 77.7 4.71 2.98 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 125.238 1.586 . . . . 0.0 113.246 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 . . . . . 0 C--O 1.253 1.254 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -175.581 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.0 mt -103.99 116.73 48.31 Favored 'Isoleucine or valine' 0 C--N 1.383 2.061 0 CA-C-O 122.97 1.366 . . . . 0.0 113.868 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -102.8 149.31 24.61 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 111.217 -2.72 . . . . 0.0 107.761 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -128.65 145.38 51.17 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 tt -127.51 142.4 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -110.99 114.58 27.99 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 120.307 -1.496 . . . . 0.0 108.627 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 21' ' ' ASN . 4.5 tp -142.25 151.8 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 O-C-N 120.854 -1.154 . . . . 0.0 111.54 -157.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.56 ' H ' HD12 ' A' ' 20' ' ' ILE . 92.9 m-20 -83.25 148.68 56.64 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 114.657 -2.592 . . . . 0.0 108.809 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . 0.275 50.5 Cg_exo -53.44 -48.21 23.16 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 N-CA-C 118.468 2.449 . . . . 0.0 118.468 -169.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.65 -10.34 45.13 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 122.162 2.256 . . . . 0.0 115.472 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -105.79 -1.11 24.71 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.439 HG12 HG23 ' A' ' 20' ' ' ILE . 37.8 mt -69.18 -43.12 81.76 Favored 'Isoleucine or valine' 0 C--O 1.263 1.812 0 C-N-CA 118.45 -1.3 . . . . 0.0 111.234 162.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -57.53 -42.02 82.07 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 115.932 -1.985 . . . . 0.0 113.809 -172.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -50.89 -32.63 21.11 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 128.809 3.818 . . . . 0.0 113.368 170.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.49 -44.31 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 123.928 0.767 . . . . 0.0 111.466 174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.57 -6.75 6.88 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.351 0 O-C-N 120.892 -1.13 . . . . 0.0 110.663 171.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -15.84 132.16 0.01 OUTLIER Glycine 0 CA--C 1.537 1.414 1 N-CA-C 127.468 5.747 . . . . 0.0 127.468 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.3 mttm 59.14 44.77 15.42 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 124.113 1.911 . . . . 0.0 113.411 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.99 30.32 65.74 Favored Glycine 0 CA--C 1.554 2.472 0 O-C-N 117.96 -2.962 . . . . 0.0 112.397 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.7 -2.15 84.26 Favored Glycine 0 C--N 1.387 3.387 0 C-N-CA 128.414 2.912 . . . . 0.0 112.941 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.3 t -58.17 -38.51 76.8 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.339 -1.094 . . . . 0.0 111.404 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 t -66.7 -47.83 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 CA-C-O 116.692 -1.623 . . . . 0.0 110.313 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 mt -55.4 -51.68 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 116.741 -1.984 . . . . 0.0 111.719 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -58.82 -43.23 90.57 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.18 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.64 88.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.037 1.29 . . . . 0.0 114.151 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.9 tp -63.46 -44.27 94.96 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 125.238 1.586 . . . . 0.0 109.082 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.1 p -62.25 -43.3 99.14 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.16 -42.13 99.37 Favored 'General case' 0 N--CA 1.514 2.743 0 CA-C-N 121.581 1.992 . . . . 0.0 113.431 166.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . 0.281 32.2 tt0 -72.19 -48.15 45.33 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.532 0.682 . . . . 0.0 111.321 -170.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.0 p -78.55 -22.05 47.8 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 114.474 -2.679 . . . . 0.0 115.531 176.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 31.54 38.24 Favored Glycine 0 C--N 1.362 1.986 0 CA-C-N 121.199 1.818 . . . . 0.0 111.466 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.526 HG21 ' HB2' ' A' ' 68' ' ' ALA . 17.6 p -132.57 171.04 14.33 Favored 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 126.529 1.932 . . . . 0.0 111.291 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 m -127.94 135.91 50.61 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 101.023 -3.695 . . . . 0.0 101.023 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.2 mt -118.96 135.05 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.636 0 CA-C-N 120.379 1.445 . . . . 0.0 112.938 -171.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -129.7 133.57 47.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 118.89 -2.382 . . . . 0.0 109.779 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.67 131.58 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.106 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -134.38 155.84 49.57 Favored 'General case' 0 C--N 1.363 1.177 0 O-C-N 119.416 -2.052 . . . . 0.0 110.221 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -40.14 151.77 0.04 OUTLIER 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t0 65.63 19.42 11.45 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 127.251 2.844 . . . . 0.0 117.349 -172.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.4 46.77 11.6 Favored Glycine 0 N--CA 1.444 -0.77 0 O-C-N 117.33 -3.356 . . . . 0.0 107.857 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -104.47 111.38 24.02 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.614 -1.634 . . . . 0.0 106.912 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -96.24 118.73 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -108.4 126.46 52.9 Favored 'General case' 0 C--N 1.378 1.819 0 CA-C-O 122.87 1.319 . . . . 0.0 111.643 -167.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 68' ' ' ALA . 32.7 mm -107.35 104.94 17.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.208 -175.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.18 135.04 38.53 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' A' ' 45' ' ' THR . . . -149.61 158.58 44.3 Favored 'General case' 0 CA--C 1.486 -1.502 0 O-C-N 118.752 -2.468 . . . . 0.0 109.598 163.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.6 m -65.29 -37.14 86.24 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 115.218 -2.325 . . . . 0.0 114.748 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -102.52 153.95 19.58 Favored 'General case' 0 C--N 1.28 -2.451 1 O-C-N 129.922 4.514 . . . . 0.0 109.986 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.84 -48.96 61.96 Favored Glycine 0 C--N 1.374 2.676 0 C-N-CA 124.838 1.209 . . . . 0.0 112.603 171.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -61.57 -42.04 98.26 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.384 1.088 . . . . 0.0 112.078 -175.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -57.44 -44.35 84.67 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 110.783 -2.917 . . . . 0.0 115.888 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.75 95.63 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 173.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -68.66 -33.71 74.47 Favored 'General case' 0 CA--C 1.585 2.291 0 CA-C-O 123.787 1.756 . . . . 0.0 114.05 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -66.61 -44.16 82.84 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.29 2.236 . . . . 0.0 112.452 167.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 45' ' ' THR . . . -62.18 -45.55 92.88 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.519 169.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.5 mm -50.43 -42.5 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 167.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -73.53 -40.44 64.0 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 118.278 -0.867 . . . . 0.0 112.238 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -58.38 -44.13 88.76 Favored 'General case' 0 CA--C 1.579 2.094 0 CA-C-O 123.466 1.603 . . . . 0.0 114.393 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.7 mm -60.45 -48.51 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.083 0 C-N-CA 127.066 2.147 . . . . 0.0 114.679 168.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -57.16 -44.11 83.17 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 119.636 -1.915 . . . . 0.0 107.592 170.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -64.9 -39.52 93.66 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 121.056 1.753 . . . . 0.0 112.396 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.3 mt -62.4 -52.11 64.08 Favored 'Isoleucine or valine' 0 C--N 1.373 1.615 0 CA-C-O 117.014 -1.47 . . . . 0.0 112.999 168.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.9 p -66.85 -23.75 66.06 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 123.367 1.556 . . . . 0.0 113.358 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.15 -39.4 82.34 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.983 -1.917 . . . . 0.0 114.354 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -58.88 143.16 48.54 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -167.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 mm -83.91 113.97 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 109.67 -3.423 . . . . 0.0 110.412 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -107.1 146.28 31.44 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.371 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.89 150.5 4.67 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.397 0 CA-C-O 124.188 1.946 . . . . 0.0 109.811 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.61 14.81 82.05 Favored Glycine 0 C--N 1.277 -2.702 0 CA-C-N 112.57 -2.104 . . . . 0.0 116.794 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -105.88 143.27 34.26 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 119.968 -1.901 . . . . 0.0 106.247 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.8 t -90.09 144.04 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 119.081 -1.048 . . . . 0.0 110.196 171.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -132.85 166.68 21.74 Favored 'General case' 0 C--N 1.404 2.97 0 O-C-N 125.915 2.009 . . . . 0.0 109.24 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 m -116.89 132.68 56.64 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.2 177.35 20.72 Favored Glycine 0 N--CA 1.419 -2.441 0 O-C-N 124.769 1.293 . . . . 0.0 111.725 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -118.46 136.29 53.88 Favored 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 123.79 1.757 . . . . 0.0 113.314 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.93 137.21 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.8 t -131.71 -18.34 2.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.871 1.357 . . . . 0.0 110.261 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 -142.18 150.86 41.59 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 172.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 mt -137.56 136.98 46.03 Favored 'Isoleucine or valine' 0 C--N 1.395 2.573 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.18 169.29 12.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 113.631 -1.622 . . . . 0.0 106.879 -162.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -54.13 -37.17 64.06 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -100.29 13.73 33.35 Favored 'General case' 0 N--CA 1.53 3.563 0 O-C-N 118.491 -2.63 . . . . 0.0 108.418 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 151.09 -159.34 28.13 Favored Glycine 0 C--O 1.183 -3.068 0 CA-C-N 123.445 2.839 . . . . 0.0 115.6 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.36 135.93 45.04 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -90.78 131.48 36.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.659 -1.275 . . . . 0.0 110.004 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 t -112.36 137.92 43.37 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.662 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.3 147.69 24.93 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 127.214 2.821 . . . . 0.0 105.592 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.7 pt -142.63 159.13 18.98 Favored 'Isoleucine or valine' 0 C--N 1.372 1.566 0 C-N-CA 125.715 1.606 . . . . 0.0 108.228 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.06 142.07 1.93 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 120.278 2.871 . . . . 0.0 120.278 -173.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.94 13.75 45.27 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 120.095 -1.826 . . . . 0.0 114.535 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.89 21.47 78.45 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 125.205 1.383 . . . . 0.0 110.943 -175.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -89.84 136.76 32.85 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.824 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -131.07 134.86 47.02 Favored 'General case' 0 C--N 1.361 1.1 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.31 161.68 24.7 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 125.304 1.43 . . . . 0.0 114.933 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.9 tp -95.4 125.26 39.9 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.817 -0.692 . . . . 0.0 111.657 -173.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.1 111.23 25.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 CA-C-O 115.674 -2.108 . . . . 0.0 105.663 164.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -60.73 153.8 23.25 Favored 'General case' 0 C--O 1.171 -3.049 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 171.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.479 HG13 HG22 ' A' ' 122' ' ' VAL . 20.6 tt -52.36 -31.6 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 119.737 -1.852 . . . . 0.0 114.536 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.0 p -83.38 -15.79 48.46 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -93.51 19.03 8.93 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.582 HD11 HG13 ' A' ' 122' ' ' VAL . 17.8 mt -92.14 -47.2 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-O 119.491 -0.29 . . . . 0.0 111.582 -173.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.5 162.63 38.67 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.081 0.952 . . . . 0.0 112.178 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.56 -37.78 87.67 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 125.032 2.349 . . . . 0.0 110.52 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -55.99 153.02 9.38 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 112.373 -2.194 . . . . 0.0 111.536 175.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -68.58 142.07 55.29 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 119.961 -1.712 . . . . 0.0 111.108 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.449 HG11 HD12 ' A' ' 114' ' ' ILE . 42.9 t -133.23 143.25 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.435 -175.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -112.95 -38.13 4.61 Favored 'General case' 0 C--N 1.37 1.493 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -173.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -143.44 146.71 33.67 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 169.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.582 HG13 HD11 ' A' ' 114' ' ' ILE . 24.7 t -74.14 -16.45 16.78 Favored 'Isoleucine or valine' 0 C--N 1.366 1.292 0 CA-C-O 122.856 1.312 . . . . 0.0 111.191 -164.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.3 p -85.44 -4.17 59.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -60.7 -40.61 92.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.924 1.29 . . . . 0.0 109.56 167.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -108.67 -24.87 11.14 Favored 'General case' 0 CA--C 1.557 1.22 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -118.04 126.53 52.46 Favored 'General case' 0 N--CA 1.517 2.912 0 O-C-N 117.821 -3.049 . . . . 0.0 113.696 -167.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 10.9 mm-40 -117.59 166.85 11.9 Favored 'General case' 0 C--O 1.199 -1.556 0 C-N-CA 117.042 -1.863 . . . . 0.0 109.507 166.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -62.13 145.07 54.38 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-O 126.102 2.858 . . . . 0.0 114.969 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.55 -6.04 26.27 Favored Glycine 0 C--O 1.21 -1.404 0 CA-C-O 115.758 -2.69 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -68.42 137.85 54.84 Favored 'General case' 0 C--N 1.361 1.079 0 CA-C-N 120.513 2.156 . . . . 0.0 115.747 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -88.03 104.48 16.69 Favored 'General case' 0 C--O 1.259 1.555 0 CA-C-O 123.854 1.788 . . . . 0.0 111.608 -164.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 m -108.57 117.95 53.11 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.048 -173.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -58.04 130.46 38.23 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.055 1.17 . . . . 0.0 112.285 158.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.37 145.67 34.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -111.69 138.3 48.45 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 119.564 -1.96 . . . . 0.0 109.338 171.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.34 139.77 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 117.343 -3.348 . . . . 0.0 112.504 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.8 mt -106.62 -36.69 6.67 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 115.277 -2.297 . . . . 0.0 109.803 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -157.81 164.23 37.22 Favored 'General case' 0 CA--C 1.473 -1.996 0 O-C-N 126.41 2.318 . . . . 0.0 107.116 -166.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.313 7.2 p -168.16 97.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-O 125.205 2.431 . . . . 0.0 110.154 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -71.65 165.91 22.99 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 119.882 -1.761 . . . . 0.0 112.273 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -61.03 -25.56 67.0 Favored 'General case' 0 C--N 1.37 1.466 0 O-C-N 125.331 1.644 . . . . 0.0 115.094 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -94.31 3.4 55.26 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.437 1.711 . . . . 0.0 110.723 -169.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.96 3.46 56.94 Favored Glycine 0 CA--C 1.552 2.38 0 O-C-N 119.432 -2.043 . . . . 0.0 113.9 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -84.2 118.4 24.12 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.813 1.245 . . . . 0.0 108.404 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.8 mt -125.32 131.39 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.268 -1.52 . . . . 0.0 108.965 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -109.16 146.47 34.07 Favored 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 120.635 1.561 . . . . 0.0 107.121 173.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.8 mt -129.64 157.19 42.8 Favored 'General case' 0 C--O 1.269 2.124 0 C-N-CA 126.194 1.798 . . . . 0.0 113.436 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.9 t -132.01 111.71 11.74 Favored 'General case' 0 C--N 1.387 2.232 0 O-C-N 126.99 2.681 . . . . 0.0 110.226 166.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.17 -41.63 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 158.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -66.38 -31.57 72.43 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-N 121.97 2.168 . . . . 0.0 111.831 -170.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.94 -49.0 72.08 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 124.694 1.198 . . . . 0.0 112.307 168.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.33 -42.17 81.4 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 126.148 2.155 . . . . 0.0 109.822 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.259 27.5 p -89.3 -1.34 58.03 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.016 0.913 . . . . 0.0 113.211 -176.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 63.12 55.93 1.84 Allowed 'General case' 0 C--O 1.256 1.437 0 C-N-CA 129.275 3.03 . . . . 0.0 113.778 168.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 . . . . . 0 C--O 1.257 1.474 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.16 -176.384 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 . . . . . 0 CA--C 1.569 1.707 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.32 127.95 73.78 Favored 'Isoleucine or valine' 0 C--N 1.376 1.759 0 CA-C-N 119.04 0.836 . . . . 0.0 109.549 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -129.28 135.58 48.95 Favored 'General case' 0 CA--C 1.492 -1.275 0 O-C-N 125.134 1.521 . . . . 0.0 109.127 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 p -116.17 153.92 30.96 Favored 'General case' 0 C--N 1.377 1.78 0 C-N-CA 118.646 -1.222 . . . . 0.0 113.824 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.3 148.48 31.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 166.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -116.87 130.33 56.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -174.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.5 tp -150.04 170.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 121.762 2.074 . . . . 0.0 113.838 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -64.13 125.67 88.61 Favored Pre-proline 0 CA--C 1.561 1.4 0 O-C-N 119.156 -2.215 . . . . 0.0 110.308 -172.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.92 -20.04 22.67 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 123.465 2.777 . . . . 0.0 116.865 -165.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.9 -45.14 86.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 127.413 2.946 . . . . 0.0 111.265 167.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -79.89 -4.39 52.1 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.581 1.181 . . . . 0.0 110.553 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.413 ' HA ' ' HB ' ' A' ' 28' ' ' VAL . 17.2 mm -84.33 -22.37 8.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -77.94 -28.69 49.65 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 122.702 2.501 . . . . 0.0 107.99 173.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -57.85 -41.24 81.97 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.66 162.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 25' ' ' ILE 0.275 47.1 t -67.71 -38.75 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.594 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.326 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.06 -45.86 53.01 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.064 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.57 174.2 24.44 Favored Glycine 0 CA--C 1.556 2.612 0 O-C-N 126.096 2.122 . . . . 0.0 110.144 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -77.79 122.5 25.5 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 118.953 -2.499 . . . . 0.0 107.68 -165.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.94 19.36 75.25 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.125 -1.609 . . . . 0.0 110.529 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.8 16.91 66.83 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 117.348 1.699 . . . . 0.0 117.348 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.9 t -60.25 -42.95 96.38 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.9 t -80.78 -32.18 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 CA-C-N 121.031 1.741 . . . . 0.0 108.998 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tt -75.86 -31.09 21.82 Favored 'Isoleucine or valine' 0 C--N 1.374 1.65 0 CA-C-N 120.713 1.597 . . . . 0.0 110.741 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -59.68 -45.89 90.71 Favored 'General case' 0 CA--C 1.562 1.414 0 O-C-N 120.191 -1.568 . . . . 0.0 114.456 164.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.72 88.34 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 170.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 tp -61.06 -34.93 75.68 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.063 -1.881 . . . . 0.0 114.559 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.6 p -66.45 -42.97 86.84 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 122.641 2.473 . . . . 0.0 114.372 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -62.26 -46.38 89.07 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 127.411 2.944 . . . . 0.0 113.903 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -53.68 -46.2 70.59 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-O 117.207 -1.378 . . . . 0.0 114.27 174.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 p -88.62 -23.39 23.09 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 125.55 1.781 . . . . 0.0 114.607 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.36 27.71 54.49 Favored Glycine 0 CA--C 1.559 2.835 0 C-N-CA 125.41 1.481 . . . . 0.0 110.258 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.5 p -134.8 166.34 23.21 Favored 'General case' 0 C--N 1.373 1.626 0 CA-C-O 124.721 2.2 . . . . 0.0 108.955 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.5 m -102.01 126.13 48.86 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 111.613 -2.54 . . . . 0.0 106.565 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.4 mt -118.15 142.72 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.121 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 -171.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -145.08 139.62 27.5 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-O 123.572 1.653 . . . . 0.0 108.193 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.0 mm -101.36 139.2 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.175 -169.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -138.36 163.02 32.93 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 119.21 -2.181 . . . . 0.0 109.499 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.307 27.1 m-20 -55.44 142.09 34.05 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 112.897 -1.956 . . . . 0.0 114.954 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.277 31.9 t0 90.56 31.75 0.02 OUTLIER 'General case' 0 C--N 1.375 1.712 0 CA-C-N 110.322 -3.126 . . . . 0.0 111.177 172.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.95 46.66 90.92 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 125.754 1.645 . . . . 0.0 111.39 -169.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.1 m -103.37 121.32 42.54 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 119.777 1.788 . . . . 0.0 110.597 -171.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.28 122.05 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 123.261 1.505 . . . . 0.0 106.998 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.31 59.7 mtpt -106.95 139.38 41.44 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.266 44.1 mm -125.52 119.94 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.709 -1.244 . . . . 0.0 108.855 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.24 136.13 42.61 Favored 'General case' 0 CA--C 1.588 2.417 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.81 157.49 16.45 Favored 'General case' 0 C--N 1.398 2.695 0 C-N-CA 125.395 1.478 . . . . 0.0 110.794 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 m -92.31 -17.9 24.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 125.626 1.829 . . . . 0.0 112.793 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -123.36 141.41 52.01 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 120.131 -1.606 . . . . 0.0 110.307 -168.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.41 -48.58 81.17 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 112.637 -2.074 . . . . 0.0 114.012 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.4 -37.23 86.78 Favored 'General case' 0 CA--C 1.589 2.445 0 O-C-N 119.901 -1.94 . . . . 0.0 115.363 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -64.52 -41.64 96.26 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 120.522 -1.361 . . . . 0.0 109.174 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.24 -35.89 82.3 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 117.574 -1.203 . . . . 0.0 112.955 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -73.98 -33.9 64.01 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -64.95 -45.29 86.34 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 126.398 2.311 . . . . 0.0 114.101 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.61 86.22 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.629 173.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.67 -51.21 75.44 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.531 0 CA-C-O 116.648 -1.644 . . . . 0.0 112.606 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -61.76 -34.96 76.79 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 116.047 -1.93 . . . . 0.0 112.609 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -65.81 -39.44 90.88 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 124.538 1.149 . . . . 0.0 111.486 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.97 -48.52 88.18 Favored 'Isoleucine or valine' 0 C--N 1.368 1.396 0 CA-C-N 120.482 1.492 . . . . 0.0 108.616 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -45.37 -57.43 4.05 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.547 1.939 . . . . 0.0 114.07 172.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -58.94 -48.06 82.83 Favored 'General case' 0 N--CA 1.513 2.711 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 173.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.9 mt -66.42 -35.03 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.7 p -80.89 -7.96 59.61 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 124.79 1.236 . . . . 0.0 111.955 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.6 -16.05 16.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.067 -0.395 . . . . 0.0 111.817 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -65.13 139.01 58.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.954 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.08 120.09 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.395 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -101.83 146.74 27.39 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-O 123.054 1.407 . . . . 0.0 112.801 171.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.05 143.24 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 113.424 -1.716 . . . . 0.0 109.829 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.93 26.01 56.74 Favored Glycine 1 N--CA 1.526 4.685 1 O-C-N 115.749 -4.344 . . . . 0.0 116.344 175.524 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -119.1 150.14 40.52 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.61 -1.295 . . . . 0.0 112.536 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.49 126.9 54.0 Favored 'Isoleucine or valine' 0 C--O 1.255 1.367 0 CA-C-O 124.911 2.291 . . . . 0.0 113.102 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -126.95 160.92 29.6 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 109.908 -3.314 . . . . 0.0 104.989 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.9 m -119.6 139.92 51.4 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.06 -173.58 16.47 Favored Glycine 0 CA--C 1.576 3.844 0 CA-C-O 123.241 1.467 . . . . 0.0 112.416 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -128.91 138.48 52.03 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 123.109 1.433 . . . . 0.0 111.332 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.28 138.11 20.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 113.284 -1.78 . . . . 0.0 106.799 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.81 -28.97 3.45 Favored 'General case' 0 CA--C 1.478 -1.824 0 CA-C-O 114.951 -2.452 . . . . 0.0 106.842 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.5 mtm-85 -143.91 146.47 33.0 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 122.42 2.373 . . . . 0.0 108.589 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.28 138.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 CA-C-O 115.579 -2.153 . . . . 0.0 113.745 168.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.78 173.6 13.43 Favored 'Isoleucine or valine' 0 C--N 1.401 2.812 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.4 -18.21 65.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.257 24.6 p90 -103.16 0.8 32.29 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.498 0.719 . . . . 0.0 111.751 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.37 -172.52 31.57 Favored Glycine 0 C--N 1.357 1.72 0 C-N-CA 117.893 -2.098 . . . . 0.0 112.752 -162.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.55 132.81 35.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.281 93.5 m-85 -79.99 133.25 36.15 Favored 'General case' 0 C--N 1.371 1.532 0 O-C-N 126.893 2.621 . . . . 0.0 109.579 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.453 HG12 HG13 ' A' ' 101' ' ' ILE . 41.8 t -125.9 130.82 72.33 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 112.577 -2.102 . . . . 0.0 105.337 -171.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . 0.261 . . -96.05 124.56 40.11 Favored 'General case' 0 CA--C 1.578 2.029 0 CA-C-N 113.54 -1.664 . . . . 0.0 107.227 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.453 HG13 HG12 ' A' ' 99' ' ' VAL . 77.6 mt -112.37 144.73 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 126.334 1.854 . . . . 0.0 106.484 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -52.66 135.11 38.48 Favored Glycine 0 C--O 1.213 -1.194 0 CA-C-O 124.623 2.235 . . . . 0.0 116.125 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.16 4.73 56.41 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.357 1.932 . . . . 0.0 113.211 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.83 31.27 5.48 Favored Glycine 0 CA--C 1.473 -2.579 0 CA-C-O 117.054 -1.97 . . . . 0.0 112.795 171.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . 0.294 51.4 mmtt -120.52 118.25 29.75 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -165.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -105.04 135.69 45.91 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 125.002 2.334 . . . . 0.0 109.754 -170.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -139.77 166.68 25.56 Favored Glycine 0 C--O 1.215 -1.086 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.699 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . 0.276 14.6 tp -113.03 135.43 53.8 Favored 'General case' 0 N--CA 1.424 -1.725 0 C-N-CA 124.374 1.07 . . . . 0.0 108.217 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.0 t -102.99 115.98 45.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 162.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -67.66 165.69 16.62 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-O 124.582 2.134 . . . . 0.0 113.984 173.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.258 11.4 tt -61.29 -32.15 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-N 111.911 -2.404 . . . . 0.0 116.703 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.3 p -84.42 -5.66 59.3 Favored 'General case' 0 C--O 1.268 2.067 0 O-C-N 124.365 1.041 . . . . 0.0 112.427 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -106.97 14.74 26.12 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 116.62 2.082 . . . . 0.0 116.62 -168.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.0 mt -85.63 -48.51 16.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-O 116.179 -1.867 . . . . 0.0 114.07 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.2 165.18 28.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 126.587 2.43 . . . . 0.0 110.053 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.15 -33.64 76.24 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.132 166.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -74.45 148.63 40.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 123.242 1.496 . . . . 0.0 113.945 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -70.42 145.2 51.19 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.773 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 37.7 t -112.62 133.86 57.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 CA-C-O 124.169 1.938 . . . . 0.0 110.884 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.72 -42.17 9.74 Favored 'General case' 0 C--N 1.38 1.906 0 O-C-N 118.574 -2.579 . . . . 0.0 108.871 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -134.77 145.87 48.82 Favored 'General case' 0 N--CA 1.526 3.342 0 O-C-N 124.473 1.108 . . . . 0.0 110.043 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.23 -29.82 47.19 Favored 'Isoleucine or valine' 0 C--O 1.254 1.292 0 CA-C-O 122.776 1.274 . . . . 0.0 113.916 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.84 20.54 2.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -86.34 -15.33 40.86 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 121.109 1.777 . . . . 0.0 111.561 161.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -125.62 -79.48 0.6 Allowed 'General case' 0 C--O 1.208 -1.088 0 C-N-CA 126.701 2.0 . . . . 0.0 110.731 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.1 mt -70.57 152.37 44.02 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 121.692 2.042 . . . . 0.0 111.752 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -132.23 152.29 51.4 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 118.777 -2.452 . . . . 0.0 106.31 165.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 40.1 mtm -63.19 131.76 49.5 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.572 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.45 0.58 50.17 Favored Glycine 0 C--N 1.363 2.06 0 O-C-N 125.011 1.444 . . . . 0.0 114.211 -171.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -84.04 149.3 26.34 Favored 'General case' 0 C--O 1.2 -1.5 0 CA-C-O 123.729 1.728 . . . . 0.0 112.765 174.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -101.14 126.07 47.81 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.646 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 132' ' ' VAL . 14.2 m -137.11 121.02 12.06 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.322 -168.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.2 140.46 30.9 Favored 'Trans proline' 0 CA--C 1.492 -1.578 0 N-CA-C 107.512 -1.765 . . . . 0.0 107.512 166.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.16 126.11 29.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -163.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -91.18 135.81 33.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 102.243 -3.243 . . . . 0.0 102.243 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.2 t -79.67 136.44 23.56 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 110.947 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.8 mt -113.81 -33.81 5.67 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.604 0.716 . . . . 0.0 111.251 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 146' ' ' ARG 0.297 28.5 mt-10 -145.55 154.99 42.78 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 172.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.64 118.81 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.795 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -70.02 170.18 11.88 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 125.71 2.671 . . . . 0.0 114.058 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -66.23 -30.33 70.75 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 111.93 -2.395 . . . . 0.0 110.028 169.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -93.4 14.11 19.53 Favored 'General case' 0 C--N 1.364 1.221 0 CA-C-O 117.37 -1.3 . . . . 0.0 111.504 -176.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.65 53.14 25.7 Favored Glycine 0 C--N 1.358 1.777 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -133.76 135.11 43.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 127.698 2.646 . . . . 0.0 107.838 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.4 mt -124.11 134.88 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 O-C-N 124.956 1.41 . . . . 0.0 110.379 -162.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.435 HH21 ' CD ' ' A' ' 138' ' ' GLU . 1.8 mpp_? -102.46 134.05 46.41 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 124.967 2.318 . . . . 0.0 107.931 170.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.3 mt -134.65 156.3 48.99 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 120.518 -1.364 . . . . 0.0 110.428 -163.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 26.1 t -135.29 118.91 17.02 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 124.288 1.035 . . . . 0.0 111.581 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . 0.262 95.3 mt -81.23 -24.25 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 CA-C-O 123.791 1.758 . . . . 0.0 108.092 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.425 ' HZ2' ' CD ' ' A' ' 151' ' ' GLU . 14.6 pttp -86.69 -32.59 20.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.353 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.425 ' CD ' ' HZ2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -69.92 -43.6 71.35 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.267 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.56 -19.41 60.9 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.551 -1.259 . . . . 0.0 112.624 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.2 p -97.82 7.69 45.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.456 168.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.258 49.8 mt-10 55.31 56.75 6.07 Favored 'General case' 0 N--CA 1.528 3.441 1 N-CA-C 123.778 4.733 . . . . 0.0 123.778 173.481 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 . . . . . 0 N--CA 1.417 -2.101 0 O-C-N 117.805 -3.059 . . . . 0.0 111.593 -176.471 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.7 mm . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 122.185 0.993 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . 0.3 47.0 m-70 -121.75 165.12 16.3 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 112.28 -2.236 . . . . 0.0 106.542 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -149.05 162.78 39.25 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 124.501 3.319 . . . . 0.0 111.415 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.9 tt -128.27 146.23 34.11 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 1 N-CA-C 99.485 -4.265 . . . . 0.0 99.485 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -126.97 130.15 49.52 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.138 -1.601 . . . . 0.0 107.174 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 20' ' ' ILE . 39.6 pt -139.51 170.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -161.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -81.61 140.71 47.93 Favored Pre-proline 0 C--O 1.192 -1.948 0 O-C-N 119.325 -2.109 . . . . 0.0 113.41 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -50.62 -26.64 17.45 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 123.198 2.599 . . . . 0.0 116.421 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -69.09 -25.81 64.61 Favored 'General case' 0 C--O 1.214 -0.78 0 O-C-N 119.909 -1.744 . . . . 0.0 113.636 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -82.16 -11.09 58.92 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.272 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.5 -35.5 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.566 0.698 . . . . 0.0 109.587 171.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -59.52 -36.63 76.47 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.83 -45.13 90.96 Favored 'General case' 0 C--N 1.355 0.804 0 C-N-CA 126.046 1.738 . . . . 0.0 111.904 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 t -66.07 -46.59 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 CA-C-O 115.562 -2.161 . . . . 0.0 114.579 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.6 mm -58.83 -38.36 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 123.65 2.932 . . . . 0.0 112.519 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.43 -127.06 8.16 Favored Glycine 0 CA--C 1.555 2.542 0 O-C-N 121.269 -0.895 . . . . 0.0 112.252 -172.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -104.69 95.54 5.96 Favored 'General case' 0 C--N 1.387 2.197 0 C-N-CA 128.417 2.687 . . . . 0.0 106.309 164.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.06 41.8 86.05 Favored Glycine 0 CA--C 1.479 -2.17 0 CA-C-O 114.708 -3.273 . . . . 0.0 116.152 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.53 12.2 57.32 Favored Glycine 0 N--CA 1.438 -1.224 0 O-C-N 127.648 2.617 . . . . 0.0 114.556 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.8 p -61.86 -52.25 64.88 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.86 -46.15 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 125.345 1.653 . . . . 0.0 113.111 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.3 mm -50.5 -47.06 27.45 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.385 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -56.61 -45.38 81.5 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.068 1.347 . . . . 0.0 110.816 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.72 73.34 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.069 -1.053 . . . . 0.0 113.439 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.48 -32.15 73.33 Favored 'General case' 0 C--O 1.199 -1.588 0 CA-C-O 117.457 -1.258 . . . . 0.0 112.783 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.8 m -66.3 -44.26 83.98 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 166.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -63.83 -45.61 88.79 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-O 121.611 0.72 . . . . 0.0 112.351 175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -64.55 -57.5 8.97 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.972 1.368 . . . . 0.0 110.435 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.5 p -79.53 -37.88 35.55 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.889 -167.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.9 22.48 57.69 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 123.792 1.773 . . . . 0.0 115.158 -170.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.8 p -109.58 165.36 11.72 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.472 -1.364 . . . . 0.0 110.204 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.1 m -106.11 132.52 52.09 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.56 124.03 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.859 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 -162.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -124.55 143.89 50.44 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.2 mt -118.37 143.85 28.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 125.915 2.009 . . . . 0.0 108.224 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 54' ' ' THR . 29.1 tt0 -142.79 155.11 44.77 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.27 65.9 m-20 -48.27 167.88 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -169.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.291 27.2 t0 61.41 25.18 15.18 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 113.188 -1.824 . . . . 0.0 109.454 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.25 23.42 58.93 Favored Glycine 0 C--N 1.375 2.718 0 C-N-CA 126.085 1.802 . . . . 0.0 117.009 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 50' ' ' GLU . 22.6 m -84.3 131.04 34.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 126.953 2.208 . . . . 0.0 112.707 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.45 119.42 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -99.47 131.99 45.11 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.025 2.93 . . . . 0.0 104.378 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.38 115.6 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 0 CA-C-O 123.516 1.627 . . . . 0.0 106.841 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.43 130.95 49.36 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 111.226 -2.715 . . . . 0.0 108.854 -174.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.03 170.62 18.44 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.033 1.733 . . . . 0.0 106.388 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 t -109.19 -9.86 15.0 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.679 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -123.02 131.91 53.91 Favored 'General case' 0 C--O 1.199 -1.573 0 O-C-N 117.591 -3.193 . . . . 0.0 105.825 168.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.31 -44.82 10.69 Favored Glycine 0 N--CA 1.508 3.448 0 C-N-CA 128.276 2.846 . . . . 0.0 112.24 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.27 -39.64 76.08 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -65.31 -47.84 75.18 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.48 84.32 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 117.627 -1.629 . . . . 0.0 113.355 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -53.28 -47.63 68.99 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 170.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -64.75 -44.71 89.23 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 171.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.12 74.16 Favored 'General case' 0 C--O 1.255 1.385 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 172.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.4 mt -59.99 -43.64 92.9 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 CA-C-O 123.856 1.789 . . . . 0.0 111.714 173.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -63.08 -43.75 97.68 Favored 'General case' 0 N--CA 1.496 1.826 1 O-C-N 116.2 -4.063 . . . . 0.0 112.508 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -66.31 -41.05 90.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 117.58 -1.2 . . . . 0.0 112.773 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.4 mt -57.2 -44.92 84.4 Favored 'Isoleucine or valine' 0 C--N 1.379 1.851 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 164.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -56.23 -40.2 73.74 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.23 1.581 . . . . 0.0 113.535 170.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -71.43 -36.98 71.48 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 121.51 0.671 . . . . 0.0 112.779 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 mt -65.54 -23.45 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 119.06 -2.275 . . . . 0.0 114.727 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 p . . . . . 0 N--CA 1.506 2.342 0 CA-C-O 124.978 2.323 . . . . 0.0 110.855 175.162 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.2 mm . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.0 154.8 44.16 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.86 147.81 8.25 Favored 'Isoleucine or valine' 0 C--N 1.386 2.168 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.09 2.57 89.0 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -93.4 136.1 34.0 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 118.248 1.024 . . . . 0.0 112.536 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.4 t -104.33 134.57 45.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -141.21 174.88 10.11 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 112.579 -2.101 . . . . 0.0 112.651 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -116.26 125.25 51.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.55 176.72 20.17 Favored Glycine 0 C--O 1.18 -3.28 0 CA-C-N 112.76 -2.018 . . . . 0.0 110.894 -168.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 88' ' ' LYS . 23.5 ttmt -148.21 125.74 11.71 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 123.764 1.745 . . . . 0.0 111.478 -167.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.11 117.11 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 113.112 -1.858 . . . . 0.0 111.226 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -103.65 -36.82 7.76 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-O 118.321 -0.847 . . . . 0.0 113.133 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.0 mtm-85 -153.98 126.26 7.95 Favored 'General case' 0 C--O 1.199 -1.592 0 CA-C-O 123.039 1.399 . . . . 0.0 110.519 -168.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.2 115.85 50.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 C-N-CA 125.404 1.482 . . . . 0.0 108.74 -170.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.05 165.71 9.9 Favored 'Isoleucine or valine' 0 C--N 1.374 1.644 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -42.59 -36.87 1.5 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.034 1.734 . . . . 0.0 115.603 175.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -114.18 13.84 18.06 Favored 'General case' 0 CA--C 1.562 1.44 0 O-C-N 120.181 -1.574 . . . . 0.0 114.181 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.05 -179.45 41.25 Favored Glycine 0 CA--C 1.483 -1.921 0 C-N-CA 117.822 -2.132 . . . . 0.0 111.803 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.67 144.51 49.22 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 119.854 -1.968 . . . . 0.0 108.533 170.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -85.47 122.95 30.34 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.827 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.9 t -125.87 120.99 58.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 O-C-N 125.854 1.971 . . . . 0.0 106.521 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.59 139.39 30.59 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 126.25 2.219 . . . . 0.0 107.58 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 105' ' ' LYS 0.274 16.8 pt -131.93 168.49 23.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 110.964 -2.834 . . . . 0.0 110.311 170.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.59 132.77 3.7 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 119.827 2.691 . . . . 0.0 119.827 -169.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.69 11.08 75.01 Favored Glycine 0 N--CA 1.506 3.334 0 CA-C-O 117.626 -1.652 . . . . 0.0 110.221 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.03 39.65 7.37 Favored Glycine 0 C--O 1.25 1.135 0 O-C-N 126.086 1.698 . . . . 0.0 110.181 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.408 ' HB2' HG13 ' A' ' 101' ' ' ILE . 57.2 mttm -98.4 99.33 10.51 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 120.996 -1.296 . . . . 0.0 113.262 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.46 88.8 7.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.021 -1.674 . . . . 0.0 111.354 -174.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.26 159.11 53.53 Favored Glycine 0 N--CA 1.494 2.535 0 CA-C-N 120.135 1.334 . . . . 0.0 114.219 167.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.7 tp -105.45 111.13 23.73 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 125.928 1.605 . . . . 0.0 108.101 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.55 116.25 27.9 Favored 'Isoleucine or valine' 0 C--N 1.372 1.555 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -66.48 159.96 26.06 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.499 0.666 . . . . 0.0 112.617 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 19.5 tt -61.07 -20.08 21.38 Favored 'Isoleucine or valine' 0 C--N 1.366 1.287 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.3 p -97.64 13.02 31.62 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.072 0.463 . . . . 0.0 110.917 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -133.18 26.46 4.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.952 0.901 . . . . 0.0 109.904 -172.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.6 mm -95.59 -55.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 O-C-N 126.579 2.424 . . . . 0.0 107.336 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.72 176.6 11.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 119.344 -2.098 . . . . 0.0 113.105 -168.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -76.4 -35.38 58.63 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 122.884 1.326 . . . . 0.0 110.37 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -61.68 151.4 33.78 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 124.236 1.97 . . . . 0.0 112.22 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -64.05 142.3 58.46 Favored 'General case' 0 C--O 1.205 -1.244 0 C-N-CA 126.949 2.1 . . . . 0.0 111.11 169.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.5 t -121.84 129.01 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.074 -1.016 . . . . 0.0 109.499 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.74 -36.13 11.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 123.612 1.672 . . . . 0.0 108.843 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -150.85 144.05 24.79 Favored 'General case' 0 CA--C 1.565 1.549 0 O-C-N 117.832 -3.043 . . . . 0.0 107.216 175.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.72 -27.23 9.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.476 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.1 p -55.92 -19.91 13.97 Favored 'General case' 0 C--N 1.383 2.037 0 C-N-CA 128.649 2.78 . . . . 0.0 115.163 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -80.51 -25.42 38.74 Favored 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 128.113 2.565 . . . . 0.0 112.205 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -107.14 -26.63 11.02 Favored 'General case' 0 C--N 1.369 1.428 0 CA-C-N 114.184 -1.371 . . . . 0.0 113.243 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.1 mt -134.27 140.13 46.21 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 123.342 1.544 . . . . 0.0 113.62 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -122.35 158.93 28.54 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 102.059 -3.312 . . . . 0.0 102.059 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . 0.311 0.8 OUTLIER -70.31 145.81 50.98 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 123.462 1.601 . . . . 0.0 113.838 171.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.96 -4.04 60.8 Favored Glycine 0 C--N 1.356 1.681 0 CA-C-N 111.896 -2.411 . . . . 0.0 115.428 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -94.67 142.35 27.56 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 123.377 1.561 . . . . 0.0 112.079 -169.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -86.46 134.52 33.68 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 119.871 -1.768 . . . . 0.0 107.477 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.71 148.12 65.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.69 137.22 6.57 Favored 'Trans proline' 0 C--N 1.28 -3.062 0 C-N-CA 122.118 1.878 . . . . 0.0 110.969 172.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.18 142.89 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 118.822 -2.424 . . . . 0.0 109.167 -169.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -112.33 134.89 53.62 Favored 'General case' 0 C--O 1.18 -2.568 0 C-N-CA 123.433 0.693 . . . . 0.0 110.198 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.61 140.65 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 124.221 1.963 . . . . 0.0 114.433 172.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 148' ' ' SER . 20.4 mt -106.34 -66.35 1.01 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 123.01 1.386 . . . . 0.0 110.097 170.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -128.59 147.97 50.75 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 120.341 -1.474 . . . . 0.0 109.382 -175.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.52 129.08 64.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-O 117.33 -1.319 . . . . 0.0 107.518 169.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -86.85 155.37 20.29 Favored 'General case' 0 C--N 1.371 1.512 0 O-C-N 126.068 2.105 . . . . 0.0 111.808 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -60.46 -39.98 89.52 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -57.61 -30.29 65.21 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 166.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.35 -7.11 9.86 Favored Glycine 0 N--CA 1.514 3.862 0 CA-C-N 122.376 2.353 . . . . 0.0 117.076 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -62.94 146.46 52.95 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 80.9 mt -133.2 135.98 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.28 -1.327 . . . . 0.0 114.158 -173.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.24 128.97 56.41 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 117.928 -1.509 . . . . 0.0 108.576 167.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.6 mt -114.03 168.3 9.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.194 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.463 ' HB2' HD11 ' A' ' 137' ' ' LEU . 28.8 t -137.8 127.0 24.48 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 112.312 -2.222 . . . . 0.0 113.167 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 95.6 mt -86.87 -32.97 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 CA-C-O 122.82 1.295 . . . . 0.0 109.823 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -70.54 -30.61 67.39 Favored 'General case' 0 C--O 1.252 1.206 0 C-N-CA 119.034 -1.066 . . . . 0.0 113.047 -164.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.31 -5.17 58.49 Favored 'General case' 0 C--N 1.381 1.968 0 CA-C-N 120.172 1.351 . . . . 0.0 110.222 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.2 -1.68 33.2 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.414 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.568 1.667 0 C-N-CA 124.893 1.277 . . . . 0.0 113.576 -171.552 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.1 mm . . . . . 0 N--CA 1.486 1.332 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -116.15 147.81 40.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 128.556 3.66 . . . . 0.0 114.385 164.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -128.48 130.33 47.37 Favored 'General case' 0 C--N 1.366 1.32 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.8 mm -133.66 133.02 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -166.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -98.67 137.48 37.24 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.493 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.5 pt -144.45 162.87 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 117.078 -1.439 . . . . 0.0 107.86 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -65.25 130.4 94.74 Favored Pre-proline 0 CA--C 1.597 2.766 0 O-C-N 125.281 1.613 . . . . 0.0 111.051 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -78.47 -7.83 15.96 Favored 'Trans proline' 0 N--CA 1.512 2.604 1 C-N-CA 125.885 4.39 . . . . 0.0 111.113 -172.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -83.53 5.26 24.69 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.173 -1.579 . . . . 0.0 109.021 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -131.61 5.11 4.3 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 115.487 -2.196 . . . . 0.0 111.191 -170.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.5 mt -61.79 -45.25 99.09 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 CA-C-O 117.34 -1.314 . . . . 0.0 110.126 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.03 -26.04 9.89 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.892 1.37 . . . . 0.0 114.35 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -90.12 -21.61 22.17 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -168.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.5 t -80.19 -26.61 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 125.218 1.574 . . . . 0.0 109.978 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.8 mt -81.62 -65.02 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 112.917 -3.421 . . . . 0.0 105.691 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.68 166.83 40.93 Favored Glycine 0 C--N 1.371 2.511 0 CA-C-N 123.949 3.068 . . . . 0.0 113.683 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -49.25 113.91 0.91 Allowed 'General case' 0 C--N 1.382 1.991 0 CA-C-O 122.94 1.352 . . . . 0.0 113.157 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.41 14.52 79.34 Favored Glycine 0 N--CA 1.505 3.241 0 O-C-N 118.998 -2.314 . . . . 0.0 113.624 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.8 28.54 73.73 Favored Glycine 0 C--O 1.259 1.667 0 CA-C-O 123.872 1.818 . . . . 0.0 113.698 -162.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 99.4 p -61.74 -44.42 96.94 Favored 'General case' 0 C--N 1.38 1.899 0 N-CA-C 118.305 2.706 . . . . 0.0 118.305 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.68 -39.96 85.01 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.231 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 tt -61.53 -44.63 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-N 119.844 1.202 . . . . 0.0 111.846 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -62.85 -41.71 99.47 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 171.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.37 -44.79 84.72 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 117.578 -3.201 . . . . 0.0 113.447 168.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.6 mt -63.63 -36.45 83.87 Favored 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 126.886 2.616 . . . . 0.0 112.136 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 m -58.48 -52.43 65.67 Favored 'General case' 0 CA--C 1.583 2.222 0 O-C-N 125.822 1.952 . . . . 0.0 114.024 169.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.23 -40.73 95.12 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 125.906 1.683 . . . . 0.0 108.75 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -69.7 -41.88 74.81 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.1 p -105.05 -29.91 10.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 117.714 -1.136 . . . . 0.0 114.06 -166.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.57 24.63 27.81 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 119.911 1.232 . . . . 0.0 112.802 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.5 p -121.3 167.83 12.31 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 124.52 0.776 . . . . 0.0 110.115 -168.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.5 m -125.96 119.05 26.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 119.696 -0.801 . . . . 0.0 109.681 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.4 mt -116.48 120.11 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 126.078 2.111 . . . . 0.0 107.964 -161.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -121.29 129.54 53.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.888 -1.96 . . . . 0.0 109.633 171.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 tt -124.56 150.38 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.783 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.0 157.41 41.78 Favored 'General case' 0 C--O 1.262 1.763 0 O-C-N 124.16 0.912 . . . . 0.0 109.746 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -81.92 2.34 31.01 Favored 'General case' 0 C--N 1.391 2.404 0 C-N-CA 124.748 1.219 . . . . 0.0 113.202 -157.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -94.88 6.93 47.6 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 126.32 2.962 . . . . 0.0 110.631 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.51 48.39 4.78 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 126.883 2.183 . . . . 0.0 112.493 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.2 m -128.22 134.67 49.04 Favored 'General case' 0 C--O 1.261 1.676 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.24 148.05 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 C-N-CA 116.955 -1.898 . . . . 0.0 111.595 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 128.96 56.61 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 121.155 -0.965 . . . . 0.0 109.0 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 mt -120.92 123.91 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 118.341 -2.724 . . . . 0.0 111.419 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.8 135.2 53.82 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . . . -158.14 158.69 35.13 Favored 'General case' 0 CA--C 1.583 2.216 0 CA-C-N 113.403 -1.726 . . . . 0.0 109.253 -173.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.7 p -107.35 -0.9 22.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 119.593 -1.942 . . . . 0.0 114.713 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -145.19 163.64 33.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 171.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.31 -39.81 17.85 Favored Glycine 0 N--CA 1.489 2.228 0 O-C-N 118.566 -2.584 . . . . 0.0 113.486 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.304 84.2 mt-10 -61.47 -39.18 89.96 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 119.479 -2.189 . . . . 0.0 112.884 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.72 -43.02 90.02 Favored 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 119.162 0.892 . . . . 0.0 109.016 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . . . -67.32 -36.88 82.38 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 123.205 1.478 . . . . 0.0 114.149 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -64.41 -39.42 93.81 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 120.625 -1.297 . . . . 0.0 112.393 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -60.63 -36.18 78.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 117.457 2.392 . . . . 0.0 117.457 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.0 -48.64 70.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.801 1.64 . . . . 0.0 113.205 163.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.39 -41.17 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 CA-C-N 119.842 1.201 . . . . 0.0 113.551 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -59.99 -42.45 94.26 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.672 1.589 . . . . 0.0 112.274 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.5 mmt85 -67.11 -43.66 81.91 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 118.437 -2.665 . . . . 0.0 111.195 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.77 -49.7 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.323 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -59.98 -38.27 82.05 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 119.423 1.01 . . . . 0.0 112.433 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -61.66 -56.92 14.55 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 125.805 1.941 . . . . 0.0 114.304 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.0 mt -58.58 -45.25 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 O-C-N 123.794 0.684 . . . . 0.0 110.488 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.6 p . . . . . 0 N--CA 1.497 1.899 0 C-N-CA 117.483 -1.687 . . . . 0.0 110.548 -168.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 mm . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -85.14 145.45 27.62 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-O 124.189 1.947 . . . . 0.0 115.762 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.81 132.23 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.333 1 CA-C-O 129.012 4.244 . . . . 0.0 114.493 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.48 17.08 64.95 Favored Glycine 0 C--O 1.245 0.842 0 CA-C-N 111.084 -2.78 . . . . 0.0 109.418 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -102.81 135.96 43.5 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 119.598 1.699 . . . . 0.0 109.376 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.96 115.49 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 116.627 -2.029 . . . . 0.0 107.435 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -99.34 163.99 12.3 Favored 'General case' 0 C--N 1.38 1.916 0 CA-C-N 119.668 1.122 . . . . 0.0 111.565 170.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.1 m -128.76 134.88 48.55 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.1 159.45 28.03 Favored Glycine 0 CA--C 1.486 -1.749 0 CA-C-O 116.251 -2.416 . . . . 0.0 112.722 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -71.25 132.8 45.47 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 120.753 2.277 . . . . 0.0 110.905 166.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -54.28 130.13 15.93 Favored 'Isoleucine or valine' 0 C--N 1.391 2.404 0 C-N-CA 126.801 2.041 . . . . 0.0 110.586 159.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.4 p -108.79 -38.96 5.49 Favored 'General case' 0 CA--C 1.499 -0.985 0 O-C-N 119.253 -2.154 . . . . 0.0 110.132 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mmt-85 -151.63 160.43 43.65 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 117.61 -1.636 . . . . 0.0 108.293 -169.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.8 mt -135.14 121.32 32.49 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.39 177.14 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 120.771 1.623 . . . . 0.0 108.56 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -63.46 -39.6 94.89 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.629 1.206 . . . . 0.0 110.237 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -93.2 6.43 48.06 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.39 -178.09 33.91 Favored Glycine 0 C--O 1.202 -1.894 0 CA-C-O 116.848 -2.085 . . . . 0.0 112.677 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.08 141.06 51.86 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-N 118.783 1.292 . . . . 0.0 111.001 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 47.2 m-85 -87.99 130.76 34.86 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 124.594 1.184 . . . . 0.0 112.51 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.67 137.42 46.87 Favored 'Isoleucine or valine' 0 C--N 1.379 1.874 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.079 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.9 127.68 48.62 Favored 'General case' 0 C--O 1.189 -2.099 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.27 143.2 18.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.91 155.09 1.27 Allowed Glycine 0 CA--C 1.545 1.912 0 CA-C-O 124.01 1.894 . . . . 0.0 117.479 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.27 19.33 64.81 Favored Glycine 0 CA--C 1.573 3.682 0 O-C-N 119.238 -2.331 . . . . 0.0 115.223 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.6 35.56 81.22 Favored Glycine 0 N--CA 1.484 1.857 1 N-CA-C 123.204 4.042 . . . . 0.0 123.204 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -115.84 115.51 26.38 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -107.42 124.44 49.85 Favored 'General case' 0 N--CA 1.527 3.381 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.341 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.84 155.74 16.02 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 118.142 2.017 . . . . 0.0 118.142 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.458 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 30.1 tp -96.31 120.28 36.32 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 113.486 -1.357 . . . . 0.0 109.718 -173.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.27 111.81 24.87 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 CA-C-O 118.365 -0.826 . . . . 0.0 109.224 157.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -66.98 156.45 35.94 Favored 'General case' 0 C--N 1.377 1.782 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.41 -30.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.967 0.907 . . . . 0.0 112.077 -169.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 65.0 p -80.46 -12.5 59.55 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -106.91 5.5 28.39 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -173.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.09 -50.85 23.23 Favored 'Isoleucine or valine' 0 C--N 1.393 2.467 0 CA-C-N 122.173 2.26 . . . . 0.0 107.889 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -126.74 158.51 36.3 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.276 49.1 p30 -64.51 -38.47 91.15 Favored 'General case' 0 C--N 1.391 2.398 0 O-C-N 118.97 -2.331 . . . . 0.0 113.713 161.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -85.6 141.12 30.05 Favored 'General case' 0 N--CA 1.415 -2.207 0 O-C-N 119.249 -2.157 . . . . 0.0 112.501 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -41.87 130.82 3.37 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-N 112.042 -2.344 . . . . 0.0 116.346 170.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 t -113.98 111.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 120.758 1.617 . . . . 0.0 107.275 -163.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.43 -46.38 66.91 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 116.181 -1.866 . . . . 0.0 107.596 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -149.89 133.01 16.29 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 128.755 3.785 . . . . 0.0 109.473 -176.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.51 -20.22 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 O-C-N 119.846 -1.784 . . . . 0.0 110.872 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.8 p -56.6 -29.99 62.73 Favored 'General case' 0 C--N 1.377 1.776 0 C-N-CA 125.951 1.7 . . . . 0.0 110.286 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -65.11 -33.76 76.79 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 128.43 2.692 . . . . 0.0 111.76 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -112.25 -30.77 7.08 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 72.8 mt -121.42 123.13 41.34 Favored 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -91.99 130.07 37.81 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-O 122.213 1.006 . . . . 0.0 112.003 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 21.0 mmt -61.05 111.1 1.56 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.2 16.32 64.98 Favored Glycine 0 CA--C 1.547 2.048 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.525 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -113.61 143.32 44.76 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 124.576 2.132 . . . . 0.0 112.821 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.52 146.12 49.72 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -171.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 p -144.17 142.92 20.74 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 166.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.79 136.76 68.41 Favored 'Trans proline' 0 C--N 1.284 -2.865 0 C-N-CA 121.876 1.717 . . . . 0.0 114.524 160.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.82 120.91 17.33 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.235 0 CA-C-O 124.331 2.015 . . . . 0.0 107.06 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.458 ' N ' ' HB2' ' A' ' 152' ' ' ALA . 65.1 tttt -88.29 137.4 32.36 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 119.447 -2.033 . . . . 0.0 111.717 170.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.6 t -90.89 91.55 3.64 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.532 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.7 mt -53.75 -43.9 69.53 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 126.335 2.272 . . . . 0.0 113.601 171.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -165.1 156.26 14.53 Favored 'General case' 0 C--O 1.255 1.349 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.99 79.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 126.312 2.258 . . . . 0.0 104.993 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.532 0.5 OUTLIER -61.63 141.62 57.68 Favored 'General case' 0 CA--C 1.58 2.1 0 CA-C-N 114.161 -1.381 . . . . 0.0 110.935 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -84.96 -0.02 52.88 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-O 115.078 -2.392 . . . . 0.0 108.269 -167.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -90.68 14.27 13.84 Favored 'General case' 0 C--N 1.384 2.104 0 CA-C-N 121.123 1.783 . . . . 0.0 107.676 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.71 24.07 40.14 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 115.08 -3.066 . . . . 0.0 115.517 -173.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -120.33 114.18 21.47 Favored 'General case' 0 CA--C 1.593 2.619 0 CA-C-N 122.469 3.134 . . . . 0.0 110.659 -171.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.1 mt -102.92 125.9 57.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 CA-C-O 117.242 -1.361 . . . . 0.0 110.953 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -120.65 135.91 54.98 Favored 'General case' 0 C--N 1.368 1.409 0 O-C-N 128.583 3.677 . . . . 0.0 113.524 -171.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 51.2 mt -129.95 148.39 51.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 112.074 -2.33 . . . . 0.0 110.315 -164.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.2 t -113.82 123.79 50.66 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.4 -43.28 42.86 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 O-C-N 119.318 -2.114 . . . . 0.0 108.551 161.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -46.18 -61.36 1.8 Allowed 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 117.293 -1.336 . . . . 0.0 112.011 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -66.67 -27.56 67.76 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 122.372 2.351 . . . . 0.0 113.531 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.458 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -81.74 -7.11 59.56 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 118.77 -2.456 . . . . 0.0 112.802 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.495 1.819 0 O-C-N 124.913 1.383 . . . . 0.0 113.615 170.474 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.8 mm . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 122.12 0.962 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -121.84 164.41 17.55 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 116.68 -1.629 . . . . 0.0 108.415 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.5 t -153.9 159.22 41.67 Favored 'General case' 0 C--N 1.378 1.834 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 pt -161.9 155.18 3.1 Favored 'Isoleucine or valine' 0 C--N 1.369 1.421 0 C-N-CA 129.467 3.107 . . . . 0.0 103.647 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -121.57 122.25 39.26 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.454 -164.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.4 pt -127.14 142.53 43.26 Favored 'Isoleucine or valine' 0 C--N 1.387 2.215 0 C-N-CA 125.661 1.584 . . . . 0.0 111.1 -169.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -42.23 126.17 2.78 Favored Pre-proline 0 C--O 1.203 -1.389 0 C-N-CA 129.856 3.262 . . . . 0.0 114.556 175.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.57 -26.6 83.2 Favored 'Trans proline' 1 N--CA 1.54 4.214 0 N-CA-C 117.426 2.048 . . . . 0.0 117.426 -169.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.25 45.9 t0 -58.67 -38.28 77.85 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 129.71 3.204 . . . . 0.0 113.495 172.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -92.72 3.05 56.33 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.921 -1.112 . . . . 0.0 113.15 -168.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.77 -34.99 73.66 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 O-C-N 120.857 -1.152 . . . . 0.0 110.556 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -59.78 -34.81 73.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 117.336 -3.352 . . . . 0.0 114.718 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -86.5 -36.65 18.87 Favored 'General case' 0 C--N 1.38 1.933 0 O-C-N 125.76 1.913 . . . . 0.0 112.062 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.12 -37.91 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 CA-C-N 121.882 2.128 . . . . 0.0 113.512 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.0 mm -75.15 -47.37 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 C-N-CA 126.422 1.889 . . . . 0.0 112.585 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.72 -176.28 50.95 Favored Glycine 0 CA--C 1.484 -1.879 0 O-C-N 126.047 2.092 . . . . 0.0 113.566 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.297 42.2 mttp -58.11 111.71 1.28 Allowed 'General case' 0 C--N 1.36 1.057 0 CA-C-N 113.748 -1.226 . . . . 0.0 111.957 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.98 25.46 31.09 Favored Glycine 0 N--CA 1.488 2.16 0 O-C-N 127.064 2.727 . . . . 0.0 114.645 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.02 9.85 83.69 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.2 t -65.23 -39.98 93.44 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 119.069 1.435 . . . . 0.0 111.677 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.46 -45.54 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 O-C-N 126.295 2.247 . . . . 0.0 108.619 -170.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.5 tp -66.35 -28.93 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 CA-C-O 117.338 -1.315 . . . . 0.0 112.032 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -60.83 -46.82 89.04 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 120.913 1.688 . . . . 0.0 113.504 162.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.58 65.05 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 128.111 2.564 . . . . 0.0 111.045 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.18 -42.63 98.91 Favored 'General case' 0 C--N 1.374 1.644 0 O-C-N 123.752 0.658 . . . . 0.0 112.084 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 t -67.3 -43.37 81.88 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 115.817 -2.039 . . . . 0.0 114.279 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -59.61 -42.82 93.47 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 122.118 2.235 . . . . 0.0 110.913 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -73.0 -41.98 63.72 Favored 'General case' 0 C--O 1.254 1.331 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.2 p -80.53 -42.99 21.46 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 124.598 2.142 . . . . 0.0 109.711 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.76 37.27 11.97 Favored Glycine 0 C--O 1.239 0.445 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.56 145.61 35.31 Favored 'General case' 0 C--N 1.391 2.376 0 CA-C-O 116.973 -1.489 . . . . 0.0 108.864 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 m -93.52 130.28 39.44 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.35 128.14 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.23 133.25 40.64 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.443 HG12 HG22 ' A' ' 55' ' ' VAL . 10.7 mt -116.56 127.71 74.1 Favored 'Isoleucine or valine' 0 C--N 1.378 1.847 0 CA-C-O 123.67 1.7 . . . . 0.0 111.743 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -80.03 152.97 29.13 Favored 'General case' 0 C--O 1.188 -2.147 0 CA-C-O 115.345 -2.264 . . . . 0.0 115.525 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -74.17 19.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 115.051 -2.404 . . . . 0.0 115.016 -169.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -121.2 11.35 10.84 Favored 'General case' 0 C--N 1.371 1.533 0 CA-C-O 114.82 -2.514 . . . . 0.0 110.298 165.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.39 9.08 48.45 Favored Glycine 0 C--N 1.357 1.695 0 CA-C-N 121.131 1.787 . . . . 0.0 111.465 165.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -89.66 129.21 36.13 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-O 117.189 -1.386 . . . . 0.0 108.392 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.443 HG22 HG12 ' A' ' 49' ' ' ILE . 48.5 t -114.04 128.85 70.81 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.68 0 O-C-N 126.143 2.152 . . . . 0.0 105.728 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -110.5 134.23 52.56 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 126.691 1.997 . . . . 0.0 108.908 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.05 130.63 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.25 139.06 43.48 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 117.537 -1.22 . . . . 0.0 111.033 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.49 150.85 18.19 Favored 'General case' 0 C--N 1.364 1.235 0 CA-C-O 122.917 1.342 . . . . 0.0 110.916 -165.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.284 7.1 t -114.95 -45.61 2.96 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.566 160.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -76.63 140.63 41.06 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 123.867 3.031 . . . . 0.0 114.23 171.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.93 -29.98 24.53 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 113.851 -1.522 . . . . 0.0 114.927 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -66.59 -38.52 87.19 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 119.465 -2.197 . . . . 0.0 114.581 166.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -64.35 -30.66 71.7 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 116.989 -3.57 . . . . 0.0 112.939 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.48 -46.78 81.54 Favored 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 119.367 -0.933 . . . . 0.0 113.431 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -60.82 -41.23 95.3 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.24 2.216 . . . . 0.0 111.014 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -54.62 -51.14 66.31 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.168 -1.582 . . . . 0.0 111.826 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.51 91.04 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.913 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 61.3 mt -66.35 -43.46 91.37 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 CA-C-N 119.521 1.055 . . . . 0.0 110.894 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -74.33 -28.16 61.03 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -71.24 -37.3 72.01 Favored 'General case' 0 C--O 1.211 -0.951 0 O-C-N 120.416 -1.427 . . . . 0.0 112.728 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 mt -62.88 -38.69 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 121.433 1.924 . . . . 0.0 111.003 165.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.69 -45.52 82.53 Favored 'General case' 0 C--N 1.373 1.597 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -174.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -51.71 -51.79 53.32 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 167.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.02 -35.48 69.19 Favored 'Isoleucine or valine' 0 C--O 1.271 2.208 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.516 2.844 0 CA-C-O 123.5 1.619 . . . . 0.0 111.25 -177.225 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.2 pt . . . . . 0 N--CA 1.469 0.487 0 CA-C-O 125.201 2.429 . . . . 0.0 113.084 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -132.35 148.5 52.43 Favored 'General case' 0 C--N 1.366 1.301 0 O-C-N 118.447 -2.658 . . . . 0.0 110.607 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.03 144.52 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.402 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.3 13.78 58.18 Favored Glycine 0 C--N 1.381 3.045 0 N-CA-C 117.996 1.958 . . . . 0.0 117.996 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -135.27 157.89 45.77 Favored 'General case' 0 C--O 1.205 -1.289 0 O-C-N 118.462 -2.787 . . . . 0.0 108.2 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 135' ' ' LYS . 24.8 t -107.93 146.48 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -136.66 167.68 20.94 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.2 m -105.85 123.38 47.86 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 120.305 1.411 . . . . 0.0 109.297 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.44 -164.18 19.98 Favored Glycine 0 C--N 1.366 2.235 0 CA-C-N 111.466 -2.606 . . . . 0.0 112.659 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -146.67 150.71 35.96 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 126.242 1.789 . . . . 0.0 107.518 164.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.458 HG21 HD22 ' A' ' 126' ' ' LEU . 78.3 t -77.55 112.97 16.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -86.09 -17.8 34.11 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 175.27 141.59 0.05 Allowed 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -169.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.8 mt -126.87 125.75 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.312 -169.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.14 177.69 2.21 Favored 'Isoleucine or valine' 0 C--N 1.364 1.216 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.785 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -58.06 -44.68 87.62 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.852 1.345 . . . . 0.0 112.92 -163.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -110.33 22.38 15.58 Favored 'General case' 0 CA--C 1.555 1.164 0 O-C-N 119.255 -2.153 . . . . 0.0 112.066 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.02 170.7 36.24 Favored Glycine 0 C--O 1.21 -1.377 0 C-N-CA 118.751 -1.69 . . . . 0.0 114.594 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.17 125.93 36.22 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -81.82 130.9 35.22 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.92 128.17 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -167.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 106' ' ' GLU . . . -100.84 125.57 47.37 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.545 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.8 mt -110.25 138.39 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -36.28 151.42 0.02 OUTLIER Glycine 0 C--N 1.37 2.423 0 N-CA-C 119.328 2.491 . . . . 0.0 119.328 -165.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.4 25.45 68.13 Favored Glycine 0 C--O 1.186 -2.905 0 CA-C-O 113.767 -3.796 . . . . 0.0 112.152 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.09 26.78 69.93 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 128.514 2.959 . . . . 0.0 116.955 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -92.8 93.44 8.43 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 31.6 tt0 -101.6 117.65 35.33 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -113.82 179.08 18.69 Favored Glycine 0 C--O 1.215 -1.039 0 O-C-N 126.998 2.686 . . . . 0.0 112.613 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.7 tp -120.41 125.51 48.13 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.659 -1.638 . . . . 0.0 109.891 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 148' ' ' SER . 20.3 t -95.01 111.46 25.67 Favored 'Isoleucine or valine' 0 C--N 1.371 1.523 0 O-C-N 124.857 1.348 . . . . 0.0 109.571 170.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -63.71 149.94 45.54 Favored 'General case' 0 C--O 1.208 -1.11 0 O-C-N 121.423 -0.798 . . . . 0.0 109.758 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -56.43 -8.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.425 0 C-N-CA 125.579 1.552 . . . . 0.0 115.022 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.4 p -101.92 2.92 38.55 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 125.119 1.368 . . . . 0.0 113.605 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -130.77 18.62 5.13 Favored 'General case' 0 C--O 1.257 1.472 0 CA-C-N 119.225 0.92 . . . . 0.0 111.798 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.75 -43.4 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-O 124.588 2.137 . . . . 0.0 109.976 170.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.68 163.62 33.42 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 119.931 -1.731 . . . . 0.0 109.477 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -72.17 -38.2 69.18 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 123.177 1.465 . . . . 0.0 112.756 168.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -80.48 145.55 31.82 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 125.958 1.703 . . . . 0.0 113.101 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -70.66 130.35 41.55 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.82 130.02 75.04 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -173.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -103.72 -24.58 13.33 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 120.612 -1.305 . . . . 0.0 110.931 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.39 139.48 31.7 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 125.555 1.784 . . . . 0.0 107.166 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -81.27 -22.7 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.775 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -165.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 p -63.02 -19.68 64.59 Favored 'General case' 0 C--N 1.374 1.673 0 O-C-N 119.492 -2.005 . . . . 0.0 115.462 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -59.39 -40.26 85.99 Favored 'General case' 0 C--O 1.192 -1.956 0 C-N-CA 125.25 1.42 . . . . 0.0 113.401 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.68 0.2 14.5 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 125.313 1.445 . . . . 0.0 111.143 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.458 HD22 HG21 ' A' ' 89' ' ' VAL . 9.4 mt -153.75 150.12 28.17 Favored 'General case' 0 C--N 1.376 1.731 0 O-C-N 119.032 -2.292 . . . . 0.0 110.05 -170.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -148.66 151.4 34.89 Favored 'General case' 0 C--N 1.38 1.895 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -63.13 142.38 58.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 125.664 2.649 . . . . 0.0 114.058 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.1 -4.24 86.18 Favored Glycine 0 CA--C 1.46 -3.354 0 C-N-CA 129.193 3.282 . . . . 0.0 116.659 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -65.6 127.77 33.25 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 127.147 3.356 . . . . 0.0 109.885 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -78.59 125.69 29.71 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 118.406 -2.684 . . . . 0.0 112.72 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.03 138.93 31.74 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.48 -168.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -72.86 124.07 9.4 Favored 'Trans proline' 0 CA--C 1.5 -1.202 0 C-N-CA 123.736 2.957 . . . . 0.0 107.119 158.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.27 131.97 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-N 113.013 -1.903 . . . . 0.0 107.206 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 88.9 tttt -90.35 134.34 34.39 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.406 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.6 t -76.47 110.8 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 118.403 -1.319 . . . . 0.0 110.556 170.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 mt -86.1 -56.01 3.66 Favored 'General case' 0 CA--C 1.468 -2.192 0 O-C-N 125.288 1.618 . . . . 0.0 114.535 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -146.21 158.21 43.87 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 125.267 1.604 . . . . 0.0 108.47 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.425 HG13 HG12 ' A' ' 145' ' ' ILE . 46.7 t -140.23 114.86 6.75 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.351 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 166.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -75.31 177.28 6.68 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 122.334 2.334 . . . . 0.0 109.828 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -67.28 -32.32 73.24 Favored 'General case' 0 C--N 1.371 1.531 0 C-N-CA 127.219 2.207 . . . . 0.0 110.913 -173.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -74.29 -30.92 62.31 Favored 'General case' 0 C--O 1.213 -0.84 0 C-N-CA 125.433 1.493 . . . . 0.0 111.426 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.3 18.98 4.8 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 115.684 -2.731 . . . . 0.0 112.404 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -80.17 127.66 32.6 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 119.45 1.625 . . . . 0.0 108.109 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.425 HG12 HG13 ' A' ' 139' ' ' VAL . 68.6 mt -104.91 118.37 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -162.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -111.59 131.03 55.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 125.136 2.398 . . . . 0.0 106.456 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.4 mt -129.96 177.15 7.49 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.416 -163.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.405 ' HA ' HG13 ' A' ' 109' ' ' VAL . 16.7 t -154.14 147.91 25.4 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.351 -1.468 . . . . 0.0 107.083 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.3 mt -102.83 -31.98 3.04 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.803 0 O-C-N 119.709 -1.87 . . . . 0.0 107.295 164.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -52.78 -53.83 42.65 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.729 1.212 . . . . 0.0 111.365 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.56 -18.29 58.76 Favored 'General case' 0 C--N 1.364 1.215 0 C-N-CA 125.087 1.355 . . . . 0.0 112.024 -172.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.95 99.68 Favored 'General case' 0 C--O 1.258 1.513 0 C-N-CA 123.756 0.822 . . . . 0.0 110.895 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.483 1.212 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 175.221 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 mm . . . . . 0 CA--C 1.502 -0.872 0 CA-C-O 123.452 1.596 . . . . 0.0 113.614 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.41 ' CD2' ' HB1' ' A' ' 65' ' ' ALA . 74.6 m-70 -109.03 121.83 45.97 Favored 'General case' 0 C--N 1.366 1.318 0 O-C-N 119.699 -1.876 . . . . 0.0 110.35 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -112.89 153.12 28.43 Favored 'General case' 0 N--CA 1.397 -3.102 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -173.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.7 tt -142.49 156.29 18.7 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 166.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -118.13 113.37 21.47 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -175.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -104.58 163.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 126.883 2.614 . . . . 0.0 112.716 167.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 55.7 t-20 -55.94 139.31 70.87 Favored Pre-proline 0 N--CA 1.429 -1.505 0 O-C-N 124.54 1.15 . . . . 0.0 113.088 168.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 21' ' ' ASN . 17.8 Cg_endo -70.89 -21.13 28.65 Favored 'Trans proline' 0 C--O 1.194 -1.706 0 C-N-CA 122.46 2.107 . . . . 0.0 112.2 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -90.13 1.52 56.31 Favored 'General case' 0 CA--C 1.573 1.861 0 O-C-N 119.776 -1.827 . . . . 0.0 109.243 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -118.81 7.04 11.5 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 119.468 -2.02 . . . . 0.0 112.197 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.0 mt -61.87 -46.66 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 119.999 -1.688 . . . . 0.0 111.924 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -67.17 -29.4 69.09 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 117.98 -1.488 . . . . 0.0 111.091 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.48 -32.78 72.8 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 173.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.462 ' HA ' ' CG2' ' A' ' 75' ' ' ILE . 41.6 t -78.99 -51.42 16.91 Favored 'Isoleucine or valine' 0 C--N 1.384 2.076 0 N-CA-C 115.745 1.758 . . . . 0.0 115.745 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.95 -19.24 19.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 114.324 -2.75 . . . . 0.0 114.898 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.78 -174.18 8.69 Favored Glycine 0 C--N 1.383 3.146 1 O-C-N 129.517 4.261 . . . . 0.0 108.9 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.384 22.2 pttp -72.65 129.72 38.89 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 110.061 -3.069 . . . . 0.0 114.359 -173.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.65 19.56 67.22 Favored Glycine 0 N--CA 1.483 1.807 0 O-C-N 119.665 -1.897 . . . . 0.0 114.227 -171.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.6 28.69 68.18 Favored Glycine 0 N--CA 1.5 2.928 0 CA-C-O 121.996 0.776 . . . . 0.0 112.109 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.6 p -64.65 -42.97 95.06 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.76 -41.68 91.5 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 C-N-CA 126.22 1.808 . . . . 0.0 110.286 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.69 -37.51 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 O-C-N 123.974 0.796 . . . . 0.0 110.617 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -56.05 -47.83 77.15 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.75 82.38 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 170.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.82 -51.94 67.52 Favored 'General case' 0 C--O 1.195 -1.779 0 O-C-N 125.386 1.679 . . . . 0.0 113.026 171.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.253 14.2 t -65.43 -48.51 72.5 Favored 'General case' 0 C--O 1.261 1.676 0 CA-C-O 117.742 -1.123 . . . . 0.0 110.55 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.278 27.0 tt0 -66.84 -42.75 85.27 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 118.637 -1.225 . . . . 0.0 114.075 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.31 -34.05 77.11 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.6 p -96.35 -46.14 6.52 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.721 -1.237 . . . . 0.0 111.61 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.25 -0.16 57.14 Favored Glycine 0 C--N 1.344 0.977 0 O-C-N 119.93 -1.731 . . . . 0.0 110.168 -171.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.1 p -75.18 149.41 38.97 Favored 'General case' 0 C--N 1.404 2.947 0 C-N-CA 127.718 2.407 . . . . 0.0 110.826 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.9 m -98.15 129.77 44.93 Favored 'General case' 0 C--O 1.201 -1.454 0 CA-C-O 116.004 -1.95 . . . . 0.0 110.899 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mp -117.29 126.08 74.36 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.989 0 CA-C-O 116.183 -1.865 . . . . 0.0 113.034 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -129.46 141.58 50.99 Favored 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 120.379 1.445 . . . . 0.0 109.291 173.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.88 109.84 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -156.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -76.34 156.14 33.58 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 125.09 2.376 . . . . 0.0 115.101 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -69.1 -0.26 5.6 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 120.339 -1.476 . . . . 0.0 109.438 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -103.91 -11.82 17.25 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.342 -1.474 . . . . 0.0 108.257 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.49 -1.66 53.38 Favored Glycine 0 C--N 1.364 2.104 0 CA-C-O 118.677 -1.068 . . . . 0.0 112.337 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -67.82 115.94 7.93 Favored 'General case' 0 C--O 1.204 -1.322 0 CA-C-N 120.981 2.391 . . . . 0.0 110.363 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 17' ' ' THR . 93.1 t -99.2 117.47 44.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.07 112.84 25.88 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 172.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.5 mt -100.29 106.39 19.17 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 O-C-N 126.748 2.53 . . . . 0.0 108.273 168.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.91 135.47 34.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.656 1.217 . . . . 0.0 109.392 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 65' ' ' ALA . . . -154.62 151.78 29.22 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 102.392 -3.188 . . . . 0.0 102.392 -167.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 p -124.47 8.03 8.35 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 126.306 1.842 . . . . 0.0 108.111 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -124.65 107.84 11.41 Favored 'General case' 0 C--N 1.371 1.516 0 C-N-CA 127.23 2.212 . . . . 0.0 105.434 167.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.05 -40.34 95.43 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-O 116.679 -2.178 . . . . 0.0 115.104 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -73.15 -39.16 65.91 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.173 -172.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -58.65 -41.86 87.03 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 162.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.547 ' HB2' ' CB ' ' A' ' 59' ' ' ALA . . . -62.13 -46.13 90.37 Favored 'General case' 0 CA--C 1.586 2.355 0 CA-C-O 123.586 1.66 . . . . 0.0 113.357 168.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -58.58 -33.2 69.7 Favored 'General case' 0 N--CA 1.527 3.422 0 O-C-N 117.747 -3.096 . . . . 0.0 114.322 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -77.2 -44.46 30.01 Favored 'General case' 0 CA--C 1.563 1.462 0 O-C-N 123.504 0.502 . . . . 0.0 111.427 167.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.73 -39.44 94.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.096 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.271 9.2 tp -80.48 -26.0 11.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 O-C-N 119.995 -1.691 . . . . 0.0 109.101 -176.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -65.47 -41.54 93.23 Favored 'General case' 0 C--N 1.374 1.645 0 CA-C-N 119.992 1.269 . . . . 0.0 110.597 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -55.18 -35.23 64.58 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.0 mm -61.16 -40.48 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.708 0 CA-C-O 123.922 1.82 . . . . 0.0 113.145 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -67.75 -39.44 84.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 117.867 -3.021 . . . . 0.0 112.79 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -58.35 -48.06 81.8 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.906 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 28' ' ' VAL . 74.4 mt -62.35 -45.57 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 170.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.1 m . . . . . 0 CA--C 1.575 1.933 0 O-C-N 125.031 1.457 . . . . 0.0 112.723 171.279 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.1 mm . . . . . 0 N--CA 1.441 -0.921 0 N-CA-C 103.085 -2.931 . . . . 0.0 103.085 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -88.03 134.13 33.81 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.727 -169.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.3 137.76 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.409 0 O-C-N 125.928 2.017 . . . . 0.0 112.653 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.2 -7.7 1.68 Allowed Glycine 0 C--O 1.26 1.768 0 N-CA-C 120.123 2.809 . . . . 0.0 120.123 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -79.55 146.51 32.58 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 124.747 2.213 . . . . 0.0 111.544 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.9 t -91.04 146.7 5.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 O-C-N 120.352 -1.467 . . . . 0.0 109.233 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -138.31 155.35 48.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 79.5 m -93.81 144.24 25.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -146.65 179.53 23.55 Favored Glycine 0 C--O 1.248 1.0 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 172.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -130.32 131.67 45.5 Favored 'General case' 0 C--N 1.375 1.685 0 O-C-N 120.261 -1.729 . . . . 0.0 109.73 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.35 120.28 6.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.205 0 O-C-N 120.88 -1.138 . . . . 0.0 109.22 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.43 HG21 ' HB2' ' A' ' 100' ' ' ALA . 12.0 p -94.12 -8.62 39.05 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-O 115.623 -2.132 . . . . 0.0 112.492 -176.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 ptt85 165.04 148.62 0.02 OUTLIER 'General case' 0 C--N 1.369 1.435 0 O-C-N 126.624 2.452 . . . . 0.0 108.618 -170.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.4 mt -100.81 144.29 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 CA-C-N 112.855 -1.975 . . . . 0.0 108.958 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.26 35.8 m -138.58 170.43 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 O-C-N 120.784 -1.197 . . . . 0.0 109.388 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.65 -42.25 71.08 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 117.274 -3.391 . . . . 0.0 114.525 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -107.1 -0.85 22.56 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 119.131 0.878 . . . . 0.0 112.261 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.68 -154.58 11.17 Favored Glycine 0 C--O 1.212 -1.219 0 O-C-N 119.554 -1.966 . . . . 0.0 109.263 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.31 137.2 24.29 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 128.896 2.879 . . . . 0.0 104.229 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.254 92.6 m-85 -86.84 139.57 30.54 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 124.594 1.158 . . . . 0.0 109.047 173.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.82 121.43 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 112.547 -2.115 . . . . 0.0 107.841 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 90' ' ' THR . . . -72.33 126.04 28.84 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.621 -1.299 . . . . 0.0 110.169 165.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 147' ' ' LEU . 27.8 mm -85.5 94.2 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.44 37.48 93.82 Favored Glycine 0 N--CA 1.513 3.773 0 C-N-CA 126.6 2.048 . . . . 0.0 111.295 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.53 -7.15 49.77 Favored Glycine 0 C--N 1.297 -1.633 0 O-C-N 125.87 1.571 . . . . 0.0 114.471 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.76 -169.09 5.55 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 120.024 1.912 . . . . 0.0 114.473 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -33.06 140.08 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.247 2.927 . . . . 0.0 117.388 167.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -91.79 116.26 28.75 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 112.232 -2.258 . . . . 0.0 114.914 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.28 170.7 23.69 Favored Glycine 0 C--N 1.368 2.317 0 CA-C-O 117.997 -1.446 . . . . 0.0 110.974 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.1 tp -114.62 138.17 51.0 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 128.074 2.867 . . . . 0.0 106.816 -171.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.1 p -116.97 120.53 65.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.288 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.488 157.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -74.81 153.66 38.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.414 1.578 . . . . 0.0 112.197 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.6 tt -67.82 -16.32 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -162.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.0 m -94.69 13.14 25.33 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.03 1.286 . . . . 0.0 111.845 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 -112.2 22.43 14.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.978 1.263 . . . . 0.0 111.54 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.8 mm -100.97 -48.06 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 CA-C-O 127.142 3.353 . . . . 0.0 106.464 -174.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -125.42 156.01 39.51 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 112.439 -2.164 . . . . 0.0 112.261 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.262 4.8 t0 -83.2 -15.31 50.97 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 164.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -94.08 -173.55 3.14 Favored 'General case' 0 C--N 1.381 1.954 0 C-N-CA 126.547 1.939 . . . . 0.0 113.528 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.279 15.5 mmm180 -84.01 115.78 22.51 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-O 125.327 2.489 . . . . 0.0 114.546 -173.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.4 HG22 ' CE2' ' A' ' 125' ' ' TYR 0.264 21.9 t -82.67 101.34 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 112.092 -2.322 . . . . 0.0 114.675 172.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -96.54 -34.65 11.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -141.97 149.41 40.04 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 122.253 1.025 . . . . 0.0 110.09 170.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.29 -34.19 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.264 18.1 p -58.49 -20.94 49.85 Favored 'General case' 0 C--O 1.277 2.552 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 175.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.91 -43.28 83.76 Favored 'General case' 0 C--N 1.368 1.388 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.4 ' CE2' HG22 ' A' ' 119' ' ' VAL . 98.0 m-85 -90.93 -24.68 20.1 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 116.976 -1.488 . . . . 0.0 112.627 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.2 mt -137.98 151.22 47.72 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 120.479 1.49 . . . . 0.0 109.083 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -120.57 167.03 12.83 Favored 'General case' 0 C--O 1.22 -0.459 0 O-C-N 125.707 1.88 . . . . 0.0 108.075 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.6 tpt -81.36 120.71 25.3 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 111.875 -2.42 . . . . 0.0 112.066 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.82 -9.4 56.8 Favored Glycine 0 C--N 1.365 2.19 0 CA-C-N 119.832 1.197 . . . . 0.0 111.771 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -89.52 153.31 20.89 Favored 'General case' 0 CA--C 1.598 2.816 0 CA-C-N 118.316 1.058 . . . . 0.0 109.262 -164.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -88.2 151.09 22.92 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 117.733 -3.105 . . . . 0.0 108.229 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.03 136.05 9.93 Favored Pre-proline 0 N--CA 1.431 -1.399 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.39 124.69 16.69 Favored 'Trans proline' 0 N--CA 1.52 3.076 0 C-N-CA 121.299 1.333 . . . . 0.0 113.402 159.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.54 138.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.244 2.218 . . . . 0.0 107.714 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -106.57 118.36 36.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.553 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.99 119.04 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 123.829 1.776 . . . . 0.0 113.004 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.1 mt -88.64 -40.17 13.51 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 117.092 -1.432 . . . . 0.0 111.519 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -163.47 156.73 18.95 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 120.049 1.295 . . . . 0.0 107.865 -172.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.7 t -120.07 131.85 71.31 Favored 'Isoleucine or valine' 0 C--O 1.254 1.311 1 N-CA-C 98.942 -4.466 . . . . 0.0 98.942 166.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.67 178.42 6.76 Favored 'General case' 0 N--CA 1.421 -1.907 0 O-C-N 120.898 -1.126 . . . . 0.0 111.384 -168.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -78.59 -16.56 57.25 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.848 1.259 . . . . 0.0 111.483 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -112.04 2.56 16.89 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 126.089 2.118 . . . . 0.0 108.679 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.09 5.32 28.84 Favored Glycine 0 C--N 1.368 2.346 0 CA-C-O 119.692 -0.504 . . . . 0.0 114.338 162.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.85 146.89 27.08 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.1 mt -103.99 129.13 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -116.41 122.83 45.96 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 112.096 -2.32 . . . . 0.0 113.095 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.415 HD11 HD11 ' A' ' 101' ' ' ILE . 64.6 mt -120.55 166.12 14.07 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 125.94 1.696 . . . . 0.0 111.809 -168.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 30.0 t -129.28 130.53 46.31 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 112.036 -2.347 . . . . 0.0 108.753 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.3 mt -93.78 -39.43 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 169.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -60.84 -41.82 96.59 Favored 'General case' 0 C--N 1.379 1.867 0 O-C-N 120.239 -1.538 . . . . 0.0 113.9 -167.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -74.91 -33.93 62.08 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 126.651 2.469 . . . . 0.0 109.314 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.47 -29.56 61.49 Favored 'General case' 0 C--N 1.375 1.677 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 179.111 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 N--CA 1.432 -1.351 0 CA-C-O 123.948 1.832 . . . . 0.0 113.505 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -88.77 116.37 26.99 Favored 'General case' 0 N--CA 1.423 -1.787 0 C-N-CA 124.937 1.295 . . . . 0.0 110.958 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.6 p -93.94 138.18 32.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 124.758 2.218 . . . . 0.0 111.53 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.5 tt -135.92 123.45 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 111.545 -2.57 . . . . 0.0 109.807 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -80.4 124.71 29.13 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.274 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.96 129.69 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.925 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -66.73 143.21 97.98 Favored Pre-proline 0 N--CA 1.51 2.57 0 CA-C-O 116.289 -1.815 . . . . 0.0 112.736 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.45 -13.83 40.48 Favored 'Trans proline' 1 N--CA 1.541 4.265 0 CA-C-O 112.871 -3.054 . . . . 0.0 118.583 -165.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -86.48 -18.56 31.34 Favored 'General case' 0 C--N 1.386 2.159 0 CA-C-N 123.941 3.064 . . . . 0.0 109.251 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -84.71 -20.76 30.65 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 116.373 -1.775 . . . . 0.0 115.491 171.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.435 HD11 ' HA2' ' A' ' 53' ' ' GLY . 54.1 mt -65.22 -37.22 79.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 121.935 2.152 . . . . 0.0 112.535 166.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -61.32 -41.88 97.74 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 116.932 -1.508 . . . . 0.0 109.621 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -62.12 -41.19 97.99 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 119.863 1.211 . . . . 0.0 110.808 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 t -67.57 -36.44 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.568 1.947 . . . . 0.0 109.761 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.0 mt -67.19 -46.48 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.985 0.811 . . . . 0.0 109.224 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.49 174.07 11.21 Favored Glycine 0 CA--C 1.55 2.252 0 C-N-CA 118.818 -1.658 . . . . 0.0 114.473 -172.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -67.62 119.49 12.47 Favored 'General case' 0 C--O 1.187 -2.195 0 CA-C-N 113.937 -1.131 . . . . 0.0 110.376 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 26.36 60.78 Favored Glycine 0 N--CA 1.502 3.099 0 C-N-CA 128.497 2.951 . . . . 0.0 116.599 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.81 15.45 79.26 Favored Glycine 0 C--N 1.37 2.448 0 O-C-N 126.64 2.024 . . . . 0.0 112.682 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -62.32 -47.24 85.13 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 120.346 2.073 . . . . 0.0 115.177 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.39 -46.62 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.762 -1.212 . . . . 0.0 112.864 -173.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 47' ' ' ILE . 2.6 tt -70.98 -32.74 49.38 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 O-C-N 127.676 3.11 . . . . 0.0 114.445 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -64.56 -49.41 71.31 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.337 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -34.47 66.83 Favored 'General case' 0 C--O 1.249 1.055 0 CA-C-N 114.162 -1.381 . . . . 0.0 113.542 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -76.76 -48.11 19.68 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 128.241 3.463 . . . . 0.0 112.638 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.312 8.5 t -62.75 -43.29 99.2 Favored 'General case' 0 C--O 1.255 1.38 0 C-N-CA 118.285 -1.366 . . . . 0.0 112.855 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -69.16 -45.36 70.23 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 116.412 -1.756 . . . . 0.0 114.419 172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -59.23 -47.64 84.59 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-O 123.498 1.618 . . . . 0.0 112.405 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.7 p -79.62 -22.34 43.77 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.972 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.81 47.85 78.55 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 125.974 1.75 . . . . 0.0 112.507 -171.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -134.67 152.75 52.0 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 126.574 1.985 . . . . 0.0 112.25 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 89.5 m -95.29 146.34 24.43 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 119.993 -1.692 . . . . 0.0 110.662 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 36' ' ' ILE . 35.5 mt -126.22 129.26 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -171.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.94 157.66 33.8 Favored 'General case' 0 C--O 1.191 -1.987 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 154.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.3 mt -135.04 124.54 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -81.75 154.99 25.7 Favored 'General case' 0 CA--C 1.573 1.864 0 C-N-CA 127.149 2.179 . . . . 0.0 109.958 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -80.63 -13.2 59.24 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -79.16 -13.85 59.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.644 2.378 . . . . 0.0 111.477 172.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 25' ' ' ILE . . . 113.13 -3.26 25.45 Favored Glycine 0 N--CA 1.491 2.331 0 CA-C-O 122.624 1.125 . . . . 0.0 114.436 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -83.19 108.43 16.43 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 123.838 1.78 . . . . 0.0 112.172 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.1 t -90.83 127.66 43.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-O 122.967 1.365 . . . . 0.0 111.492 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -115.67 105.56 12.89 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.206 -0.934 . . . . 0.0 108.709 -169.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.4 mm -88.09 129.13 39.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 O-C-N 120.966 -1.084 . . . . 0.0 111.706 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 46' ' ' THR . . . -113.96 121.77 44.93 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 118.488 -1.285 . . . . 0.0 111.315 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . . . -139.42 156.18 47.13 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 124.309 1.006 . . . . 0.0 111.336 -177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -72.89 -31.9 65.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 118.413 -2.679 . . . . 0.0 112.347 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -121.65 148.97 43.88 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 123.233 1.492 . . . . 0.0 109.419 -167.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.5 -48.04 81.77 Favored Glycine 0 C--O 1.197 -2.192 0 CA-C-O 116.762 -2.132 . . . . 0.0 113.002 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.8 -41.88 98.31 Favored 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 119.378 1.589 . . . . 0.0 110.956 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -60.67 -43.74 97.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 118.157 -2.84 . . . . 0.0 113.249 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . . . -67.18 -36.27 81.42 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.241 -1.537 . . . . 0.0 112.518 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -74.71 -24.13 58.7 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.593 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -72.65 -39.78 66.89 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 118.572 -2.58 . . . . 0.0 112.553 166.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.49 -38.29 90.57 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.928 -1.107 . . . . 0.0 113.298 167.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.7 mm -64.91 -50.37 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 120.684 -1.26 . . . . 0.0 112.267 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -53.85 -42.4 68.5 Favored 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 120.946 -1.096 . . . . 0.0 111.214 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -61.0 -43.49 98.81 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 mt -69.28 -39.57 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.832 0 C-N-CA 118.269 -1.373 . . . . 0.0 113.577 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.18 -39.52 75.49 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 116.692 -1.623 . . . . 0.0 114.411 164.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -61.94 -42.8 99.52 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-N 119.372 0.987 . . . . 0.0 111.211 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mt -65.06 -34.07 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.174 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.665 175.333 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mm . . . . . 0 CA--C 1.563 1.452 0 CA-C-O 123.496 1.617 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -105.28 145.29 30.9 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.698 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 t -69.72 124.97 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 O-C-N 120.645 -1.285 . . . . 0.0 110.522 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.39 19.42 74.14 Favored Glycine 0 C--O 1.211 -1.331 0 C-N-CA 118.606 -1.759 . . . . 0.0 115.883 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -101.42 148.79 24.75 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 167.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 135' ' ' LYS . 8.3 t -93.12 130.8 41.65 Favored 'Isoleucine or valine' 0 C--N 1.367 1.336 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -123.91 138.19 54.51 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.3 m -88.09 105.91 17.8 Favored 'General case' 0 C--N 1.399 2.737 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.694 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.84 178.13 17.78 Favored Glycine 0 C--O 1.207 -1.587 0 C-N-CA 125.269 1.414 . . . . 0.0 112.996 -175.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -126.65 135.17 50.83 Favored 'General case' 0 CA--C 1.582 2.204 0 O-C-N 127.23 2.371 . . . . 0.0 109.427 -171.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 t -67.33 125.12 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 126.486 1.914 . . . . 0.0 112.92 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.7 p -99.53 -42.6 6.85 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 119.301 0.955 . . . . 0.0 112.536 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -165.85 152.63 9.82 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.3 mt -118.31 125.29 74.18 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.747 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.24 175.16 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 126.028 2.08 . . . . 0.0 109.627 -174.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -47.63 -42.17 23.71 Favored 'General case' 0 C--N 1.398 2.695 0 CA-C-N 119.931 1.241 . . . . 0.0 111.222 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -94.52 9.14 39.72 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.774 -1.204 . . . . 0.0 113.423 -171.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.78 -164.31 19.4 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 124.275 2.042 . . . . 0.0 116.669 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.1 125.1 53.41 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 112.539 -1.831 . . . . 0.0 110.129 -166.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -81.63 149.76 28.41 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.2 t -145.25 121.95 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 CA-C-O 121.939 0.876 . . . . 0.0 112.375 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.23 132.91 35.37 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 117.154 -3.466 . . . . 0.0 112.478 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.1 mm -112.62 158.83 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 112.327 -2.215 . . . . 0.0 106.449 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.75 158.69 51.32 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 121.185 -0.947 . . . . 0.0 111.251 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.99 23.94 77.6 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 113.722 -1.239 . . . . 0.0 113.911 -170.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.38 18.06 74.91 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 127.499 2.476 . . . . 0.0 113.609 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -88.6 163.47 15.83 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -148.31 132.44 17.32 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 124.066 1.888 . . . . 0.0 106.591 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.91 177.78 16.88 Favored Glycine 0 CA--C 1.554 2.489 0 O-C-N 119.955 -1.716 . . . . 0.0 114.65 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.91 123.43 30.73 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.704 -1.468 . . . . 0.0 109.213 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.483 HG21 HG13 ' A' ' 149' ' ' ILE . 21.5 t -96.2 116.44 38.11 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.772 0 O-C-N 119.328 -2.108 . . . . 0.0 106.08 159.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -64.84 147.16 53.79 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 126.064 2.103 . . . . 0.0 108.293 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 tp -32.66 -42.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.256 1.427 0 N-CA-C 119.576 3.176 . . . . 0.0 119.576 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.0 p -77.11 -27.14 53.93 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -97.46 7.21 46.94 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.596 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.05 -39.75 81.25 Favored 'Isoleucine or valine' 0 C--N 1.365 1.242 0 C-N-CA 124.57 1.148 . . . . 0.0 111.155 170.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.59 158.02 33.09 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 122.784 1.278 . . . . 0.0 111.502 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.02 -37.5 78.68 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 128.741 2.816 . . . . 0.0 109.089 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -112.62 117.21 31.64 Favored 'General case' 0 N--CA 1.517 2.92 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.286 167.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.11 146.29 54.83 Favored 'General case' 0 C--O 1.199 -1.601 0 C-N-CA 125.7 1.6 . . . . 0.0 114.99 -161.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.438 HG11 ' CG ' ' A' ' 125' ' ' TYR . 33.5 m -97.15 138.9 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 O-C-N 120.504 -1.372 . . . . 0.0 112.75 -172.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -60.22 -39.51 86.87 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -139.2 147.8 42.27 Favored 'General case' 0 C--O 1.248 1.016 0 O-C-N 119.81 -1.806 . . . . 0.0 109.708 160.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.42 -37.2 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 119.191 -1.004 . . . . 0.0 112.672 169.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.2 p -67.75 -20.61 65.25 Favored 'General case' 0 CA--C 1.477 -1.841 1 CA-C-O 111.471 -4.109 . . . . 0.0 112.861 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -84.48 -13.57 51.61 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 124.053 3.115 . . . . 0.0 115.412 171.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.438 ' CG ' HG11 ' A' ' 119' ' ' VAL . 79.7 t80 -99.04 -23.28 15.34 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.583 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.4 mt -135.47 145.92 47.64 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -118.87 163.91 16.21 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.892 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 22.1 mmt -72.55 150.7 42.94 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 120.605 1.548 . . . . 0.0 112.915 172.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.7 -21.51 18.32 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 112.064 -2.335 . . . . 0.0 115.238 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -109.34 134.95 51.18 Favored 'General case' 0 C--N 1.361 1.075 0 O-C-N 125.625 1.427 . . . . 0.0 111.874 -161.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.14 112.93 1.51 Allowed 'General case' 0 C--N 1.388 2.24 0 O-C-N 128.985 3.928 . . . . 0.0 117.942 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 t -116.25 116.27 39.76 Favored Pre-proline 0 C--O 1.247 0.949 0 C-N-CA 127.377 2.271 . . . . 0.0 109.358 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -57.58 125.23 18.11 Favored 'Trans proline' 0 N--CA 1.515 2.743 0 C-N-CA 121.643 1.562 . . . . 0.0 115.661 157.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.93 123.48 15.41 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 78.5 tttt -96.95 146.78 24.64 Favored 'General case' 0 C--N 1.368 1.384 0 CA-C-O 123.984 1.85 . . . . 0.0 107.766 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 78.7 t -81.95 126.63 39.94 Favored 'Isoleucine or valine' 0 C--N 1.374 1.651 0 O-C-N 118.25 -2.782 . . . . 0.0 114.917 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.2 -33.93 15.2 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.847 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -174.95 140.78 0.56 Allowed 'General case' 0 N--CA 1.521 3.115 0 O-C-N 124.626 1.204 . . . . 0.0 109.88 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.19 142.64 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 O-C-N 120.429 -1.419 . . . . 0.0 109.666 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.26 66.5 t0 -142.69 138.52 30.66 Favored 'General case' 0 N--CA 1.411 -2.4 0 O-C-N 124.421 1.076 . . . . 0.0 108.715 -175.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -101.04 5.26 42.94 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-O 114.703 -2.57 . . . . 0.0 107.83 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -117.56 -57.13 2.16 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.28 164.66 33.63 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 119.814 2.686 . . . . 0.0 119.814 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -60.8 127.2 30.44 Favored 'General case' 0 C--N 1.396 2.61 0 O-C-N 117.614 -3.286 . . . . 0.0 114.401 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.7 mm -31.2 137.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 126.451 3.024 . . . . 0.0 114.77 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -94.21 132.21 39.0 Favored 'General case' 0 C--O 1.247 0.964 0 O-C-N 118.225 -2.797 . . . . 0.0 109.894 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.3 mt -136.42 146.65 46.64 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.002 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.9 t -129.9 128.25 41.81 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.154 167.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.483 HG13 HG21 ' A' ' 109' ' ' VAL . 70.4 mt -72.75 -43.64 60.68 Favored 'Isoleucine or valine' 0 C--N 1.384 2.092 0 CA-C-N 111.569 -2.56 . . . . 0.0 106.933 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -73.3 -30.02 63.1 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 118.975 -2.328 . . . . 0.0 111.899 -170.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -15.02 62.91 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.092 -1.63 . . . . 0.0 113.118 174.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.314 . . -106.86 14.55 26.5 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.106 -168.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.255 1.365 0 CA-C-N 120.15 1.341 . . . . 0.0 111.087 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.2 mm . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.318 0.58 . . . . 0.0 112.18 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -93.42 119.8 32.95 Favored 'General case' 0 C--O 1.191 -2.001 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.402 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.4 m -118.63 111.77 18.98 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 100.956 -3.72 . . . . 0.0 100.956 -163.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.0 mm -116.39 135.73 55.68 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 CA-C-O 116.01 -1.948 . . . . 0.0 110.514 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -95.54 123.35 39.04 Favored 'General case' 0 CA--C 1.576 1.962 0 O-C-N 124.928 1.393 . . . . 0.0 111.878 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.9 pt -131.43 161.66 40.75 Favored 'Isoleucine or valine' 0 C--O 1.259 1.589 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 -173.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -48.56 120.88 9.24 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.65 -23.93 8.83 Favored 'Trans proline' 0 N--CA 1.516 2.825 0 N-CA-C 118.131 2.32 . . . . 0.0 118.131 171.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.82 -30.04 63.72 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 116.766 -3.709 . . . . 0.0 111.692 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -91.74 -0.28 57.54 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -167.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.9 mm -62.35 -44.91 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.431 1.892 . . . . 0.0 109.539 -172.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -60.84 -38.91 87.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.674 2.39 . . . . 0.0 111.605 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -73.77 -40.69 63.28 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 119.228 -2.17 . . . . 0.0 112.794 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.39 -36.3 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.296 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.91 -43.13 89.59 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 124.335 1.054 . . . . 0.0 110.248 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 79.94 156.75 12.53 Favored Glycine 1 CA--C 1.584 4.383 0 CA-C-O 123.846 1.803 . . . . 0.0 116.535 -172.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -71.74 132.69 44.87 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-O 122.694 1.235 . . . . 0.0 108.596 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.91 20.03 24.67 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 118.804 2.282 . . . . 0.0 118.804 -168.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.99 16.38 74.98 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.229 -1.317 . . . . 0.0 111.791 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.3 t -70.62 -41.9 71.64 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 118.17 2.655 . . . . 0.0 118.17 -169.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.533 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 21.4 t -65.48 -44.3 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 CA-C-N 120.441 1.473 . . . . 0.0 114.135 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -61.83 -39.38 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.718 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -64.64 -44.46 90.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.091 -1.631 . . . . 0.0 115.283 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.97 97.57 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.44 -39.87 92.59 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 120.881 -1.137 . . . . 0.0 113.049 168.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 m -47.81 -55.55 9.44 Favored 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 125.862 1.665 . . . . 0.0 112.484 167.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.86 -33.45 72.29 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -57.84 -46.32 84.93 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 126.321 1.849 . . . . 0.0 112.101 166.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.3 p -97.51 -18.69 18.85 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 117.354 -1.738 . . . . 0.0 111.422 -165.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.77 35.77 73.85 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 124.156 0.884 . . . . 0.0 112.838 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.52 152.33 32.8 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 117.811 -1.555 . . . . 0.0 107.729 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 m -66.42 131.01 45.13 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.048 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 mt -132.11 123.0 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.923 174.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -131.37 141.52 49.9 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 tt -127.55 155.23 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -116.19 143.02 46.06 Favored 'General case' 0 C--N 1.38 1.906 0 O-C-N 117.403 -3.311 . . . . 0.0 103.389 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -62.94 -12.42 25.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -87.52 0.27 55.82 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-N 119.21 0.914 . . . . 0.0 113.441 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.67 27.15 7.26 Favored Glycine 0 CA--C 1.478 -2.245 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 168.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.2 m -107.02 110.46 22.6 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.79 142.66 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 118.853 0.751 . . . . 0.0 109.575 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -125.83 137.24 53.76 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.328 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.6 mt -121.06 119.58 59.73 Favored 'Isoleucine or valine' 0 C--N 1.366 1.307 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . 0.279 . . -87.6 118.55 27.16 Favored 'General case' 0 N--CA 1.403 -2.782 0 O-C-N 118.113 -2.867 . . . . 0.0 110.98 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.42 151.51 17.25 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -98.69 -39.94 8.42 Favored 'General case' 0 CA--C 1.484 -1.585 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.233 169.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.52 124.78 25.04 Favored 'General case' 0 N--CA 1.415 -2.211 0 O-C-N 126.02 2.075 . . . . 0.0 109.374 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.58 -25.77 64.61 Favored Glycine 0 C--N 1.356 1.652 0 O-C-N 120.452 -1.405 . . . . 0.0 116.528 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -66.4 -34.87 78.93 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 113.007 0.744 . . . . 0.0 113.007 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -63.26 -44.87 93.9 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 167.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.91 77.93 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -64.47 -50.79 66.1 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 164.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -57.73 -41.43 81.81 Favored 'General case' 0 N--CA 1.529 3.479 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.99 -44.33 87.11 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.83 -39.82 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.351 -0.94 . . . . 0.0 113.209 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -65.14 -41.84 94.38 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 121.552 1.978 . . . . 0.0 110.315 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -60.85 -38.19 84.65 Favored 'General case' 0 CA--C 1.584 2.251 1 O-C-N 116.198 -4.064 . . . . 0.0 115.593 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.79 -44.04 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 119.917 -1.739 . . . . 0.0 110.264 172.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -54.85 -41.12 70.37 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-O 115.527 -2.178 . . . . 0.0 114.776 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -63.82 -41.47 97.86 Favored 'General case' 0 C--N 1.38 1.903 0 CA-C-N 122.225 2.284 . . . . 0.0 115.287 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.7 mt -69.08 -39.8 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 122.217 2.281 . . . . 0.0 114.681 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 N--CA 1.499 2.0 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 178.849 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.8 mm . . . . . 0 N--CA 1.433 -1.281 0 CA-C-O 124.119 1.914 . . . . 0.0 113.759 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -84.01 123.8 30.38 Favored 'General case' 0 C--O 1.188 -2.15 0 CA-C-N 111.209 -2.723 . . . . 0.0 117.87 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.73 122.49 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.862 0 C-N-CA 126.311 1.844 . . . . 0.0 106.858 173.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.07 8.03 59.25 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 112.808 -1.997 . . . . 0.0 113.224 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -96.75 164.22 12.67 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 169.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.2 t -102.97 136.47 35.35 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.51 158.75 21.21 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -98.37 124.41 43.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.361 1.077 . . . . 0.0 108.447 167.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.97 -174.05 13.48 Favored Glycine 0 C--N 1.347 1.139 0 O-C-N 120.241 -1.537 . . . . 0.0 112.188 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -131.39 134.94 46.77 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.92 119.77 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 124.176 0.991 . . . . 0.0 109.072 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -84.86 -22.39 29.43 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 119.975 -1.703 . . . . 0.0 114.668 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.57 132.79 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.366 -169.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.6 mt -108.96 128.31 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -114.68 173.79 3.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -53.14 -47.88 68.36 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.395 -1.44 . . . . 0.0 113.493 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -104.08 17.89 23.17 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 120.045 -1.659 . . . . 0.0 113.618 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.78 -176.41 47.5 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 118.27 -1.919 . . . . 0.0 115.485 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.83 117.74 9.38 Favored 'General case' 0 C--N 1.373 1.618 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -75.58 137.72 40.98 Favored 'General case' 0 C--N 1.372 1.578 0 O-C-N 125.559 1.787 . . . . 0.0 111.46 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.4 t -134.25 132.57 55.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -171.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.42 136.41 37.9 Favored 'General case' 0 C--N 1.363 1.171 0 CA-C-O 122.702 1.239 . . . . 0.0 108.753 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.9 pt -139.76 160.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 CA-C-O 117.448 -1.263 . . . . 0.0 111.15 -168.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.17 138.01 0.54 Allowed Glycine 0 CA--C 1.562 2.992 0 N-CA-C 122.391 3.717 . . . . 0.0 122.391 -166.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.92 18.58 62.99 Favored Glycine 0 CA--C 1.483 -1.938 0 CA-C-O 116.189 -2.451 . . . . 0.0 116.827 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.59 33.82 41.69 Favored Glycine 0 CA--C 1.544 1.888 0 CA-C-N 120.371 2.085 . . . . 0.0 117.5 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -114.52 151.62 33.03 Favored 'General case' 0 N--CA 1.515 2.781 0 C-N-CA 124.222 1.009 . . . . 0.0 112.544 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -143.79 123.34 13.23 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 113.3 -1.773 . . . . 0.0 106.219 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -120.85 174.66 15.85 Favored Glycine 0 C--N 1.364 2.125 0 O-C-N 126.748 2.53 . . . . 0.0 113.003 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.7 tp -128.98 126.46 39.62 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 112.587 -1.807 . . . . 0.0 111.835 -166.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.3 t -95.59 116.66 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 N-CA-C 102.329 -3.212 . . . . 0.0 102.329 173.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.472 ' CD2' ' H ' ' A' ' 112' ' ' SER . 58.5 t60 -66.63 151.74 46.74 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 120.352 -1.467 . . . . 0.0 111.462 171.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.333 14.2 tt -39.07 -34.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.563 0 N-CA-C 120.634 3.568 . . . . 0.0 120.634 172.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.472 ' H ' ' CD2' ' A' ' 110' ' ' HIS . 66.5 m -69.63 -18.87 63.62 Favored 'General case' 0 N--CA 1.534 3.725 0 O-C-N 125.758 1.911 . . . . 0.0 113.446 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -120.24 6.83 10.71 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.718 0.807 . . . . 0.0 110.817 -160.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.9 mm -74.19 -42.04 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 170.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.05 167.75 21.34 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 119.98 -1.7 . . . . 0.0 112.427 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.316 53.6 p30 -41.6 -67.0 0.29 Allowed 'General case' 0 C--N 1.363 1.161 0 O-C-N 128.584 3.678 . . . . 0.0 118.081 173.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . 0.257 66.6 mttt -99.71 164.96 11.83 Favored 'General case' 0 CA--C 1.582 2.21 0 C-N-CA 129.408 3.083 . . . . 0.0 106.091 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -59.05 140.56 55.65 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.1 t -102.71 136.57 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 125.057 1.473 . . . . 0.0 110.228 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -92.25 -48.62 6.59 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.697 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -143.99 127.97 17.46 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.1 t -72.33 -24.22 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 123.889 1.804 . . . . 0.0 113.129 -164.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 66.8 p -63.62 -26.83 68.86 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 126.691 1.996 . . . . 0.0 112.721 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -63.89 -25.59 68.22 Favored 'General case' 0 C--O 1.261 1.688 0 O-C-N 119.326 -2.109 . . . . 0.0 115.306 168.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -96.35 -46.49 6.38 Favored 'General case' 0 C--N 1.371 1.53 0 O-C-N 126.725 2.515 . . . . 0.0 114.47 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.2 mt -114.67 135.62 53.96 Favored 'General case' 0 N--CA 1.434 -1.256 0 O-C-N 125.687 1.867 . . . . 0.0 108.536 -166.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -105.94 141.62 37.04 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.8 ttp -63.95 137.19 57.9 Favored 'General case' 0 C--O 1.203 -1.362 0 O-C-N 126.328 2.267 . . . . 0.0 114.063 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.01 -24.52 7.84 Favored Glycine 0 N--CA 1.428 -1.858 0 CA-C-O 116.898 -2.057 . . . . 0.0 115.731 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -72.01 163.91 27.05 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.45 134.77 37.31 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.69 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.6 m -139.85 141.21 26.7 Favored Pre-proline 0 C--N 1.369 1.419 0 O-C-N 118.753 -2.467 . . . . 0.0 112.042 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.06 127.77 10.9 Favored 'Trans proline' 0 C--N 1.286 -2.739 0 C-N-CA 121.106 1.204 . . . . 0.0 111.707 165.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.1 m -128.33 128.43 68.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -91.61 132.68 36.16 Favored 'General case' 0 C--N 1.373 1.602 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.701 165.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.488 ' HA ' HD23 ' A' ' 147' ' ' LEU . 46.4 t -75.7 104.45 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.667 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.11 -42.65 98.92 Favored 'General case' 0 C--N 1.39 2.327 0 C-N-CA 127.048 2.139 . . . . 0.0 112.894 168.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -165.56 140.69 4.98 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 123.939 0.775 . . . . 0.0 112.298 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.9 t -106.88 116.0 49.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 156.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.251 0.3 OUTLIER -80.55 171.55 14.89 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 123.768 1.747 . . . . 0.0 113.698 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -64.34 -33.82 76.72 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 119.066 -2.271 . . . . 0.0 112.617 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -71.11 -37.74 72.36 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-O 116.757 -1.592 . . . . 0.0 110.02 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.77 9.22 1.78 Allowed Glycine 0 C--N 1.359 1.834 0 CA-C-N 122.101 2.228 . . . . 0.0 114.736 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -95.7 134.02 39.11 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -163.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.4 mt -105.54 108.88 26.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 O-C-N 121.412 -0.805 . . . . 0.0 110.333 -167.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -85.9 136.55 33.24 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 136' ' ' VAL . 92.4 mt -127.68 163.06 25.1 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 126.077 2.111 . . . . 0.0 111.332 -170.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 42.9 t -148.9 134.55 18.73 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.27 -30.51 2.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.45 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -61.1 -40.97 95.74 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.765 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.4 -14.8 60.91 Favored 'General case' 0 CA--C 1.562 1.419 0 O-C-N 125.117 1.511 . . . . 0.0 110.232 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -96.61 -14.94 21.82 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.3 p . . . . . 0 CA--C 1.488 -1.406 0 O-C-N 126.978 2.674 . . . . 0.0 111.703 161.348 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 122.118 0.961 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -75.96 135.79 40.04 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-O 126.027 2.823 . . . . 0.0 114.663 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.466 HG22 ' HG2' ' A' ' 56' ' ' LYS . 43.5 p -141.67 154.97 45.69 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 112.45 -2.159 . . . . 0.0 111.915 -176.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 57' ' ' ILE . 6.7 mt -130.3 128.4 64.04 Favored 'Isoleucine or valine' 0 C--N 1.366 1.315 0 O-C-N 126.753 2.533 . . . . 0.0 107.716 172.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -77.69 126.22 30.54 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.0 mm -106.18 133.97 49.1 Favored 'Isoleucine or valine' 0 C--N 1.366 1.291 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -63.39 140.07 97.67 Favored Pre-proline 0 N--CA 1.485 1.321 0 CA-C-O 117.165 -1.397 . . . . 0.0 110.178 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -44.89 -45.71 13.59 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.622 2.881 . . . . 0.0 116.472 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -73.98 -21.29 60.06 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 128.04 3.338 . . . . 0.0 106.536 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -101.47 -4.65 26.43 Favored 'General case' 0 C--N 1.387 2.227 0 O-C-N 119.737 -1.852 . . . . 0.0 113.839 -170.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.4 mt -59.25 -42.27 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 117.23 -1.367 . . . . 0.0 114.577 168.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -58.34 -40.37 81.95 Favored 'General case' 0 C--O 1.267 1.999 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 170.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -65.88 -35.57 81.0 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 117.56 -1.209 . . . . 0.0 112.432 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.2 t -70.05 -44.9 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 123.867 0.73 . . . . 0.0 111.679 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.0 mm -85.85 -38.37 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 122.079 2.218 . . . . 0.0 112.487 -172.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.48 154.21 16.97 Favored Glycine 0 CA--C 1.474 -2.521 0 CA-C-N 120.684 1.584 . . . . 0.0 115.817 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -70.53 130.6 42.29 Favored 'General case' 0 N--CA 1.419 -1.987 0 O-C-N 119.699 -2.059 . . . . 0.0 111.026 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.74 10.07 60.29 Favored Glycine 0 N--CA 1.481 1.636 0 CA-C-O 115.373 -2.904 . . . . 0.0 113.507 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.14 22.8 67.46 Favored Glycine 0 CA--C 1.563 3.077 0 O-C-N 127.163 2.331 . . . . 0.0 112.048 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.0 p -55.29 -49.31 72.45 Favored 'General case' 0 C--O 1.261 1.681 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.5 t -71.29 -43.3 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.441 HD12 ' HB2' ' A' ' 39' ' ' LEU . 10.4 tp -68.56 -30.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.002 -1.686 . . . . 0.0 113.417 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.8 mtm-85 -63.02 -39.1 93.75 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 122.375 1.083 . . . . 0.0 110.875 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.93 98.25 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 119.874 -1.766 . . . . 0.0 114.324 166.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.441 ' HB2' HD12 ' A' ' 36' ' ' ILE . 36.3 mt -67.22 -38.82 85.91 Favored 'General case' 0 C--O 1.188 -2.134 0 O-C-N 118.338 -2.727 . . . . 0.0 109.714 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.281 15.3 t -59.46 -39.73 84.6 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 114.282 -2.77 . . . . 0.0 114.185 165.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -69.96 -38.92 76.25 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 122.827 2.558 . . . . 0.0 115.669 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -69.36 -43.13 74.24 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 126.787 2.554 . . . . 0.0 111.058 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.7 p -83.7 -25.14 30.89 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.1 30.75 54.76 Favored Glycine 0 C--N 1.318 -0.42 0 CA-C-O 117.192 -1.893 . . . . 0.0 110.201 173.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 t -152.63 162.21 41.54 Favored 'General case' 0 C--N 1.396 2.621 0 C-N-CA 128.68 2.792 . . . . 0.0 106.034 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.4 m -73.83 124.09 25.43 Favored 'General case' 0 C--N 1.371 1.539 0 C-N-CA 126.134 1.774 . . . . 0.0 113.922 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.1 mm -112.69 135.01 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 112.943 -1.935 . . . . 0.0 108.768 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -132.96 158.31 42.98 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mm -109.45 132.36 57.8 Favored 'Isoleucine or valine' 0 C--N 1.368 1.387 0 O-C-N 119.691 -1.88 . . . . 0.0 107.959 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -115.5 169.76 8.93 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.06 139.59 0.67 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 124.396 2.046 . . . . 0.0 113.731 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.317 28.2 m-20 67.51 38.34 3.16 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 113.244 -1.798 . . . . 0.0 113.0 173.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.53 41.1 77.55 Favored Glycine 0 N--CA 1.422 -2.276 0 CA-C-O 115.989 -2.561 . . . . 0.0 117.357 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.0 m -103.84 108.82 20.31 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 120.189 1.994 . . . . 0.0 111.646 -169.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -73.43 127.59 35.45 Favored 'Isoleucine or valine' 0 C--N 1.382 2.02 0 O-C-N 123.632 0.582 . . . . 0.0 111.303 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HG2' HG22 ' A' ' 17' ' ' THR . 38.5 mtmt -119.41 137.16 53.93 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 124.584 2.135 . . . . 0.0 111.21 173.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 18' ' ' ILE . 43.8 mt -104.33 112.48 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 113.069 -1.878 . . . . 0.0 109.425 -172.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.63 -47.48 78.42 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 116.911 -1.518 . . . . 0.0 112.969 -173.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.8 138.04 53.86 Favored 'General case' 0 C--N 1.369 1.44 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.0 p -95.54 -0.57 51.91 Favored 'General case' 0 C--N 1.369 1.426 0 O-C-N 120.185 -1.572 . . . . 0.0 114.07 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -55.47 151.94 9.56 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 126.37 2.294 . . . . 0.0 114.827 168.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.29 -48.32 5.71 Favored Glycine 0 N--CA 1.478 1.487 0 O-C-N 120.596 -1.315 . . . . 0.0 112.108 -172.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.17 -26.44 63.91 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.22 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -65.16 -41.53 94.59 Favored 'General case' 0 C--N 1.386 2.171 0 C-N-CA 123.42 0.688 . . . . 0.0 111.414 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.49 67.58 Favored 'General case' 0 C--O 1.252 1.224 0 O-C-N 124.045 0.841 . . . . 0.0 110.561 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -63.29 -40.71 98.12 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.41 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -68.25 -45.81 72.17 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 121.124 1.784 . . . . 0.0 110.564 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.91 87.32 Favored 'General case' 0 C--O 1.258 1.532 0 O-C-N 124.634 1.209 . . . . 0.0 112.302 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.256 15.0 tt -70.71 -31.56 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.372 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -61.28 -42.95 99.5 Favored 'General case' 0 CA--C 1.574 1.903 0 CA-C-N 121.043 1.747 . . . . 0.0 114.865 171.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -60.53 -47.19 87.26 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.4 mm -56.47 -38.66 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 O-C-N 120.457 -1.402 . . . . 0.0 112.722 170.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.17 -53.91 52.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.84 1.337 . . . . 0.0 113.113 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -59.58 -37.2 77.87 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.911 1.285 . . . . 0.0 114.154 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.9 mt -69.45 -36.07 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m . . . . . 0 N--CA 1.478 0.963 0 O-C-N 124.925 1.391 . . . . 0.0 109.137 179.191 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mm . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -91.64 135.19 34.06 Favored 'General case' 0 C--N 1.374 1.656 0 O-C-N 119.928 -1.733 . . . . 0.0 112.676 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.8 t -73.5 140.31 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 O-C-N 127.171 2.795 . . . . 0.0 113.589 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.05 -8.43 57.48 Favored Glycine 0 C--N 1.387 3.374 0 C-N-CA 126.276 1.894 . . . . 0.0 114.806 -171.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -89.83 149.37 22.7 Favored 'General case' 0 C--N 1.365 1.269 0 O-C-N 121.234 -1.157 . . . . 0.0 109.537 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.46 121.78 58.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.39 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -111.42 166.46 11.1 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 53.0 m -112.79 134.53 54.27 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.09 168.32 23.75 Favored Glycine 0 CA--C 1.475 -2.462 0 C-N-CA 117.547 -2.263 . . . . 0.0 108.648 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -118.41 135.37 54.38 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 113.242 -1.479 . . . . 0.0 113.631 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.3 t -69.3 135.82 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.233 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.759 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.9 p -128.4 -18.05 4.09 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.909 -1.119 . . . . 0.0 108.249 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -154.42 156.88 37.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.679 -1.888 . . . . 0.0 108.249 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 mm -123.88 135.32 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 CA-C-O 123.653 1.692 . . . . 0.0 111.136 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.9 m -126.7 168.43 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.694 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.61 -46.16 48.91 Favored 'General case' 0 C--O 1.179 -2.618 0 C-N-CA 123.899 0.88 . . . . 0.0 111.976 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -107.44 17.63 22.53 Favored 'General case' 0 N--CA 1.514 2.73 0 C-N-CA 125.898 1.679 . . . . 0.0 114.622 -169.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.93 -163.32 33.66 Favored Glycine 0 C--N 1.363 2.05 0 O-C-N 118.394 -2.691 . . . . 0.0 108.977 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.76 165.5 30.35 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 170.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -107.88 127.27 53.59 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 126.718 2.511 . . . . 0.0 111.867 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.6 t -122.45 126.22 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 CA-C-N 112.593 -2.094 . . . . 0.0 108.925 -166.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.8 109.9 21.77 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 126.157 2.161 . . . . 0.0 110.316 -171.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.7 pt -105.35 161.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.203 0 C-N-CA 126.085 1.754 . . . . 0.0 111.916 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.36 136.75 7.0 Favored Glycine 0 C--N 1.36 1.894 1 N-CA-C 124.032 4.373 . . . . 0.0 124.032 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.66 4.0 39.99 Favored Glycine 0 C--N 1.306 -1.1 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.84 23.99 56.53 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -107.28 148.54 28.85 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.981 1.391 . . . . 0.0 112.226 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -127.37 127.46 44.25 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 125.698 1.874 . . . . 0.0 110.782 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -119.38 155.93 15.93 Favored Glycine 0 CA--C 1.556 2.645 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.3 tp -90.47 118.36 29.88 Favored 'General case' 0 N--CA 1.518 2.972 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.27 107.67 20.36 Favored 'Isoleucine or valine' 0 C--N 1.396 2.62 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -68.88 162.41 26.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 118.299 -2.751 . . . . 0.0 116.872 172.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.2 tt -61.83 -37.64 78.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -59.51 -19.6 49.33 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 126.804 2.565 . . . . 0.0 116.345 167.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -106.15 9.78 32.17 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.499 -1.228 . . . . 0.0 112.588 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.9 mt -88.38 -49.42 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 119.087 0.858 . . . . 0.0 109.856 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.12 157.57 43.65 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 116.009 -1.948 . . . . 0.0 107.036 -172.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -71.46 -19.22 62.25 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -95.06 134.57 37.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.816 2.046 . . . . 0.0 105.892 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.19 116.44 1.86 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.66 120.01 35.54 Favored 'Isoleucine or valine' 0 C--O 1.262 1.724 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.34 -40.9 90.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 126.343 2.277 . . . . 0.0 111.808 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -157.52 151.69 24.67 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.2 t -63.12 -36.81 77.45 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 0 CA-C-O 116.727 -1.606 . . . . 0.0 113.15 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.59 -25.2 16.33 Favored 'General case' 0 N--CA 1.513 2.692 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -69.04 -19.85 64.11 Favored 'General case' 0 CA--C 1.575 1.918 0 C-N-CA 125.354 1.462 . . . . 0.0 113.872 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -123.48 -37.0 2.71 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.201 -1.562 . . . . 0.0 112.485 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.3 mt -130.23 150.94 51.24 Favored 'General case' 0 CA--C 1.574 1.903 0 CA-C-O 124.293 1.997 . . . . 0.0 115.328 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -159.34 155.98 27.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -172.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -43.95 125.69 4.44 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 122.705 1.241 . . . . 0.0 113.227 165.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.58 -2.72 80.85 Favored Glycine 0 N--CA 1.494 2.556 0 CA-C-N 114.264 -1.335 . . . . 0.0 116.087 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -73.65 128.48 35.61 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.471 171.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -106.52 124.92 50.33 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 124.516 1.135 . . . . 0.0 109.666 168.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.97 151.12 61.55 Favored Pre-proline 0 C--N 1.379 1.856 0 C-N-CA 127.72 2.408 . . . . 0.0 110.982 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -90.81 138.89 2.56 Favored 'Trans proline' 0 CA--C 1.493 -1.565 0 N-CA-C 104.814 -2.802 . . . . 0.0 104.814 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.464 HG21 HD13 ' A' ' 147' ' ' LEU . 6.2 m -136.41 126.77 40.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 110.946 -2.843 . . . . 0.0 109.133 -168.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.9 tttt -100.26 122.18 42.65 Favored 'General case' 0 C--N 1.368 1.397 0 O-C-N 120.222 -1.549 . . . . 0.0 111.395 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.13 118.73 5.66 Favored 'Isoleucine or valine' 0 C--O 1.264 1.856 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.488 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 148' ' ' SER . 63.5 mt -90.68 -50.26 6.01 Favored 'General case' 0 C--O 1.254 1.295 0 CA-C-N 111.888 -2.414 . . . . 0.0 113.613 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -159.78 148.58 17.6 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 116.047 -1.93 . . . . 0.0 107.371 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 145' ' ' ILE . 18.0 t -133.93 120.33 35.5 Favored 'Isoleucine or valine' 0 C--N 1.388 2.271 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.92 146.78 53.28 Favored 'General case' 0 CA--C 1.556 1.205 0 O-C-N 126.028 2.08 . . . . 0.0 111.676 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -46.69 -33.76 4.55 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 167.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -92.73 29.15 1.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.11 1.364 . . . . 0.0 109.656 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.98 59.16 7.8 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 120.041 2.776 . . . . 0.0 120.041 166.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -137.19 136.82 38.52 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.405 HG23 HG22 ' A' ' 139' ' ' VAL . 3.3 mt -121.66 122.68 67.64 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 O-C-N 126.466 2.354 . . . . 0.0 108.892 -158.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -94.19 136.23 34.71 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 134' ' ' VAL . 18.9 mt -124.73 152.35 43.9 Favored 'General case' 0 C--N 1.372 1.557 0 O-C-N 127.408 2.942 . . . . 0.0 111.524 -173.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.54 ' HB2' HD11 ' A' ' 137' ' ' LEU . 38.9 t -140.6 138.9 34.77 Favored 'General case' 0 CA--C 1.484 -1.585 0 O-C-N 120.534 -1.354 . . . . 0.0 109.974 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.65 -34.71 7.55 Favored 'Isoleucine or valine' 0 C--O 1.258 1.512 0 O-C-N 125.86 1.975 . . . . 0.0 110.432 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -77.12 -33.28 56.81 Favored 'General case' 0 C--O 1.198 -1.654 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -168.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -71.34 -30.97 66.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.43 -21.81 35.56 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 119.024 -2.297 . . . . 0.0 109.314 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.506 2.343 0 CA-C-N 121.007 1.73 . . . . 0.0 113.655 171.492 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 tp . . . . . 0 CA--C 1.579 2.093 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -116.03 113.88 23.82 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 162.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.7 m -100.62 106.13 17.59 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -109.3 158.5 9.2 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.212 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.421 -172.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -108.96 140.09 42.93 Favored 'General case' 0 C--N 1.368 1.401 0 O-C-N 119.111 -2.243 . . . . 0.0 109.021 167.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.89 162.27 36.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -64.53 132.22 95.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-O 114.254 -2.784 . . . . 0.0 112.576 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . 0.271 42.6 Cg_exo -48.79 -29.25 14.42 Favored 'Trans proline' 0 N--CA 1.515 2.742 0 N-CA-C 120.204 3.117 . . . . 0.0 120.204 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.2 -7.72 59.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.129 2.171 . . . . 0.0 111.38 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -98.98 7.88 45.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 115.59 -2.148 . . . . 0.0 114.321 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.35 -36.91 78.51 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 CA-C-N 121.25 1.841 . . . . 0.0 110.101 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -58.09 -44.57 87.69 Favored 'General case' 0 N--CA 1.385 -3.7 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 170.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -72.46 -39.19 67.94 Favored 'General case' 0 CA--C 1.484 -1.567 0 O-C-N 126.004 2.065 . . . . 0.0 112.61 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.1 -42.34 91.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.245 0 O-C-N 125.794 1.934 . . . . 0.0 113.802 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.7 mt -72.3 -43.02 65.66 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 O-C-N 119.063 -2.273 . . . . 0.0 113.564 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.416 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 78.49 171.86 39.76 Favored Glycine 0 CA--C 1.56 2.897 0 CA-C-O 121.774 0.652 . . . . 0.0 113.915 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 5.6 mmmm -66.87 110.61 3.38 Favored 'General case' 1 N--CA 1.539 4.004 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 177.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.65 31.37 79.78 Favored Glycine 0 CA--C 1.544 1.845 0 O-C-N 125.036 1.46 . . . . 0.0 110.902 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.13 25.54 73.42 Favored Glycine 0 N--CA 1.509 3.505 0 C-N-CA 128.035 2.731 . . . . 0.0 114.847 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 t -62.43 -47.68 83.03 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-O 116.849 -1.548 . . . . 0.0 113.662 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 76.6 t -71.45 -50.0 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 120.29 1.404 . . . . 0.0 108.836 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -55.3 -36.17 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 121.399 1.908 . . . . 0.0 112.755 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -78.84 -36.03 43.11 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 118.931 -1.108 . . . . 0.0 112.029 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.63 -40.65 84.6 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 117.361 -3.337 . . . . 0.0 108.125 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.1 tp -62.87 -40.26 96.95 Favored 'General case' 0 C--N 1.361 1.107 0 O-C-N 120.689 -1.257 . . . . 0.0 111.67 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.1 m -67.2 -48.76 66.92 Favored 'General case' 0 C--N 1.373 1.602 0 O-C-N 125.27 1.606 . . . . 0.0 112.256 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -63.97 -43.85 94.53 Favored 'General case' 0 C--N 1.381 1.97 0 O-C-N 116.502 -3.874 . . . . 0.0 115.025 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -59.23 -40.73 86.82 Favored 'General case' 0 C--N 1.385 2.121 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.8 p -108.01 -3.03 19.14 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -162.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.65 25.26 75.14 Favored Glycine 0 CA--C 1.552 2.401 0 N-CA-C 118.86 2.304 . . . . 0.0 118.86 -173.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 p -124.32 159.26 30.7 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.624 1.17 . . . . 0.0 113.578 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.0 m -110.53 131.57 54.94 Favored 'General case' 0 C--N 1.399 2.744 0 CA-C-N 119.649 1.113 . . . . 0.0 110.289 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.53 138.8 44.73 Favored 'Isoleucine or valine' 0 C--N 1.37 1.481 0 O-C-N 120.785 -1.197 . . . . 0.0 111.403 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -131.95 157.25 44.54 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.269 6.2 tt -150.67 125.02 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 O-C-N 116.716 -3.74 . . . . 0.0 109.776 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -86.53 154.05 21.38 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 119.318 -2.114 . . . . 0.0 112.53 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -53.0 -32.33 45.95 Favored 'General case' 0 C--N 1.393 2.458 0 C-N-CA 127.194 2.197 . . . . 0.0 113.095 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 p30 -86.57 12.57 10.17 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 119.804 1.183 . . . . 0.0 110.892 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.29 26.51 65.87 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-O 123.22 1.455 . . . . 0.0 114.11 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 m -92.09 108.92 20.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 167.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.27 144.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -131.61 115.05 15.58 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.39 108.68 25.95 Favored 'Isoleucine or valine' 0 C--N 1.376 1.726 0 C-N-CA 125.661 1.585 . . . . 0.0 109.896 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.14 128.93 45.35 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.38 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.88 149.05 28.53 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 104.4 -2.445 . . . . 0.0 104.4 173.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 p -78.37 -27.1 46.81 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.425 1.078 . . . . 0.0 110.388 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.54 136.22 41.74 Favored 'General case' 0 CA--C 1.58 2.1 0 C-N-CA 128.343 2.657 . . . . 0.0 112.167 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.04 -49.49 40.56 Favored Glycine 0 CA--C 1.558 2.769 0 C-N-CA 124.35 0.976 . . . . 0.0 112.576 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.27 -33.69 73.95 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 121.609 2.705 . . . . 0.0 114.201 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -68.52 -45.17 72.98 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 126.331 2.269 . . . . 0.0 110.914 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.58 83.38 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 119.326 -2.109 . . . . 0.0 113.053 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . 0.297 91.9 mttt -54.04 -41.58 68.26 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.473 1.109 . . . . 0.0 113.246 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -62.81 -38.59 91.32 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.95 -35.83 74.81 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 119.042 -2.286 . . . . 0.0 116.313 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.74 -37.24 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 O-C-N 124.676 1.235 . . . . 0.0 109.882 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -67.58 -40.34 84.86 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.46 1.482 . . . . 0.0 113.097 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -68.13 -40.64 82.41 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 120.144 -1.598 . . . . 0.0 110.814 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.04 -41.83 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.526 0 CA-C-O 116.822 -1.561 . . . . 0.0 112.049 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -48.47 -52.12 23.83 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-N 122.676 2.489 . . . . 0.0 115.956 166.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.77 -45.86 90.98 Favored 'General case' 0 CA--C 1.569 1.708 0 O-C-N 127.094 2.746 . . . . 0.0 111.141 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.5 mt -62.71 -40.3 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.941 0.896 . . . . 0.0 110.493 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 N--CA 1.474 0.768 0 CA-C-O 123.963 1.84 . . . . 0.0 111.517 -172.571 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -73.86 148.99 41.85 Favored 'General case' 0 CA--C 1.579 2.066 0 CA-C-O 122.449 1.118 . . . . 0.0 112.575 165.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.6 137.27 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 -10.25 73.63 Favored Glycine 0 C--N 1.376 2.776 0 C-N-CA 126.989 2.233 . . . . 0.0 113.783 -174.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -97.93 163.06 12.94 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -172.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.14 139.35 30.65 Favored 'Isoleucine or valine' 0 C--N 1.386 2.196 0 CA-C-O 123.038 1.399 . . . . 0.0 110.612 -175.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -130.87 172.3 12.18 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.377 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 133' ' ' PRO . 86.9 m -133.0 123.36 25.71 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.19 -171.61 12.75 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -120.26 154.94 34.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 125.384 1.285 . . . . 0.0 114.029 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.446 HG21 HD22 ' A' ' 126' ' ' LEU . 45.7 t -85.31 127.75 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-O 123.331 1.538 . . . . 0.0 109.31 -175.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.9 -36.49 6.36 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 111.609 -2.541 . . . . 0.0 112.293 -172.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.4 mtt-85 -150.11 145.89 26.6 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 122.763 1.268 . . . . 0.0 109.894 -170.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -124.26 134.97 65.21 Favored 'Isoleucine or valine' 0 C--N 1.366 1.316 0 CA-C-O 124.434 2.064 . . . . 0.0 110.453 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.69 165.66 18.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.681 0 CA-C-N 111.585 -2.552 . . . . 0.0 107.941 166.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -52.75 -35.44 56.13 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 119.347 3.092 . . . . 0.0 119.347 -163.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -118.3 19.12 13.55 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 124.733 1.213 . . . . 0.0 112.161 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.83 168.64 41.04 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.95 1.54 . . . . 0.0 116.95 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.98 167.3 18.46 Favored 'General case' 0 C--N 1.374 1.656 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -124.02 136.79 54.51 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.455 173.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.17 131.97 72.24 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.397 0 C-N-CA 123.532 0.733 . . . . 0.0 111.21 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.96 121.64 40.12 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.217 1.484 . . . . 0.0 112.511 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.6 pt -115.74 166.97 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 112.043 -2.344 . . . . 0.0 114.484 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -31.51 142.77 0.03 OUTLIER Glycine 0 CA--C 1.57 3.507 0 N-CA-C 122.132 3.613 . . . . 0.0 122.132 172.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.19 25.7 69.87 Favored Glycine 0 N--CA 1.484 1.866 0 O-C-N 120.445 -1.621 . . . . 0.0 114.811 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.91 22.74 65.46 Favored Glycine 0 C--O 1.255 1.467 0 N-CA-C 118.529 2.171 . . . . 0.0 118.529 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -94.49 152.22 18.75 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 122.137 0.97 . . . . 0.0 113.308 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -130.96 151.33 51.49 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 168.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.8 175.29 22.21 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.375 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 139.14 35.65 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.259 1.424 . . . . 0.0 112.289 -174.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.6 t -125.0 106.55 16.65 Favored 'Isoleucine or valine' 0 C--O 1.261 1.665 0 CA-C-O 124.431 2.062 . . . . 0.0 106.996 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -77.59 151.13 34.56 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.328 -1.482 . . . . 0.0 112.85 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.48 -33.11 43.46 Favored 'Isoleucine or valine' 0 C--N 1.391 2.411 0 CA-C-O 115.918 -1.991 . . . . 0.0 114.144 -164.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 95.7 p -56.57 -32.65 65.39 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 124.94 3.518 . . . . 0.0 118.342 164.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -97.91 4.18 49.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 121.063 1.756 . . . . 0.0 113.66 -161.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.2 -39.87 85.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 124.651 1.22 . . . . 0.0 107.776 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -162.97 161.58 25.66 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -69.17 -37.74 78.35 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 127.47 2.308 . . . . 0.0 109.699 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -69.79 142.8 53.12 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 113.316 -1.765 . . . . 0.0 108.194 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -82.71 115.12 21.5 Favored 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -170.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.5 t -100.28 122.85 52.71 Favored 'Isoleucine or valine' 0 C--N 1.385 2.151 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -164.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -107.45 -13.86 14.99 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.625 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.259 18.2 pttp -150.54 140.24 21.7 Favored 'General case' 0 C--O 1.21 -1.023 0 O-C-N 126.973 2.671 . . . . 0.0 106.336 159.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.54 -33.53 49.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 O-C-N 127.112 2.758 . . . . 0.0 112.915 -159.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.3 -36.54 61.32 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 109.895 -3.32 . . . . 0.0 116.713 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -57.02 -37.73 72.13 Favored 'General case' 0 N--CA 1.439 -1.025 0 O-C-N 125.221 1.576 . . . . 0.0 112.74 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -93.54 -42.89 8.98 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 121.68 2.036 . . . . 0.0 114.262 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.446 HD22 HG21 ' A' ' 89' ' ' VAL . 80.8 mt -109.13 123.01 48.51 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.929 0.892 . . . . 0.0 109.867 -163.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -108.63 142.14 39.55 Favored 'General case' 0 C--N 1.363 1.195 0 C-N-CA 126.029 1.731 . . . . 0.0 109.129 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 33.4 mmm -66.66 144.15 56.56 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.179 -169.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 46.93 39.07 10.91 Favored Glycine 0 CA--C 1.54 1.638 0 O-C-N 127.273 2.858 . . . . 0.0 117.505 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -119.75 136.02 54.61 Favored 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 125.549 1.54 . . . . 0.0 111.713 165.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.61 128.91 39.55 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 m -122.54 131.04 24.43 Favored Pre-proline 0 C--O 1.286 3.013 0 CA-C-N 111.173 -2.739 . . . . 0.0 106.032 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 0.4 OUTLIER -63.24 148.49 92.98 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 121.05 1.167 . . . . 0.0 109.464 159.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.6 134.91 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 C-N-CA 124.873 1.269 . . . . 0.0 107.604 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 152' ' ' ALA . 13.7 tppt? -95.82 132.66 40.83 Favored 'General case' 0 N--CA 1.519 2.983 0 C-N-CA 123.154 0.582 . . . . 0.0 110.757 164.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.71 110.69 18.76 Favored 'Isoleucine or valine' 0 C--N 1.374 1.662 0 O-C-N 120.282 -1.511 . . . . 0.0 109.493 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.87 -33.43 59.99 Favored 'General case' 0 C--N 1.373 1.615 0 O-C-N 125.719 1.887 . . . . 0.0 113.381 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -178.47 144.16 0.29 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -168.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.6 t -118.41 126.25 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 O-C-N 125.071 1.482 . . . . 0.0 107.889 161.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.292 0.0 OUTLIER -85.23 173.51 10.33 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 126.118 2.866 . . . . 0.0 113.572 -170.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -38.17 59.82 Favored 'General case' 0 CA--C 1.599 2.859 0 CA-C-N 110.873 -2.876 . . . . 0.0 111.293 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -85.62 -27.47 25.42 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.566 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.38 24.72 3.7 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.681 1.134 . . . . 0.0 111.518 170.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -80.9 140.87 35.08 Favored 'General case' 0 C--N 1.373 1.591 0 C-N-CA 126.5 1.92 . . . . 0.0 110.262 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.8 mt -105.12 132.38 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -125.27 119.45 28.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -168.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.7 mt -126.18 161.94 26.54 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 124.458 1.099 . . . . 0.0 111.403 -163.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.4 t -138.88 135.49 34.54 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 54.7 mt -83.28 -38.84 14.8 Favored 'Isoleucine or valine' 0 C--N 1.362 1.112 0 CA-C-O 116.177 -1.868 . . . . 0.0 107.032 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -76.28 -19.14 58.58 Favored 'General case' 0 C--N 1.366 1.299 0 O-C-N 125.684 1.865 . . . . 0.0 108.661 -171.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -81.65 -20.88 38.7 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 119.58 -1.95 . . . . 0.0 112.16 166.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.407 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -73.58 -36.91 65.61 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.411 -2.056 . . . . 0.0 111.025 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.0 p . . . . . 0 N--CA 1.487 1.406 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.218 -175.286 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 mm . . . . . 0 C--O 1.263 1.795 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -119.18 131.53 55.86 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.277 -171.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -112.33 129.47 56.28 Favored 'General case' 0 C--N 1.366 1.311 0 O-C-N 124.763 1.289 . . . . 0.0 113.752 -164.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.9 pt -130.2 170.2 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 O-C-N 125.075 1.485 . . . . 0.0 109.795 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -131.84 141.9 49.56 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.606 -1.237 . . . . 0.0 111.414 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.9 133.54 54.91 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.863 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -59.38 157.98 22.36 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 124.902 1.281 . . . . 0.0 112.645 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -70.49 -37.45 7.4 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.844 2.363 . . . . 0.0 110.45 -166.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -62.13 -46.41 89.13 Favored 'General case' 0 C--N 1.37 1.482 0 C-N-CA 118.307 -1.357 . . . . 0.0 114.366 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -78.26 -20.67 51.19 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 tp -59.37 -34.3 53.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 117.717 -1.593 . . . . 0.0 114.702 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -59.95 -34.0 72.67 Favored 'General case' 0 CA--C 1.557 1.242 0 O-C-N 124.724 1.265 . . . . 0.0 113.589 170.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -68.45 -42.98 78.05 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 122.62 1.2 . . . . 0.0 114.105 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 t -64.11 -40.62 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.756 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 29' ' ' ILE . 24.8 mm -98.6 28.0 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 CA-C-N 119.02 0.827 . . . . 0.0 111.498 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.89 125.44 11.93 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 118.613 2.205 . . . . 0.0 118.613 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.45 7.1 mptt 60.88 51.5 4.65 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.35 45.22 96.39 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 126.29 2.244 . . . . 0.0 114.986 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.0 0.76 67.97 Favored Glycine 0 C--N 1.358 1.774 0 CA-C-N 118.571 1.185 . . . . 0.0 111.493 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -66.47 -34.26 77.53 Favored 'General case' 0 C--O 1.202 -1.436 0 CA-C-N 119.389 1.595 . . . . 0.0 110.865 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.38 -45.59 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 CA-C-O 116.623 -1.656 . . . . 0.0 109.626 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.7 tp -80.52 -31.76 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 125.823 1.952 . . . . 0.0 111.153 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.71 -48.38 79.73 Favored 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 166.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.12 -45.17 82.06 Favored 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 124.426 1.09 . . . . 0.0 111.012 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.7 -37.92 80.16 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.263 33.3 p -64.6 -38.4 90.87 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 171.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -63.58 -47.78 80.07 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 125.008 1.443 . . . . 0.0 111.646 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -67.45 -47.14 71.03 Favored 'General case' 0 CA--C 1.457 -2.611 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.864 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -85.56 -8.41 58.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 127.583 3.052 . . . . 0.0 113.962 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.16 21.33 79.26 Favored Glycine 0 C--N 1.365 2.149 0 CA-C-O 121.819 0.677 . . . . 0.0 113.359 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -134.89 139.65 45.16 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 122.261 -0.552 . . . . 0.0 109.97 -155.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.0 m -78.23 135.27 37.55 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 119.715 1.143 . . . . 0.0 108.975 166.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.4 mt -133.01 118.2 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.244 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -84.52 131.56 34.63 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.6 mm -112.97 112.79 41.94 Favored 'Isoleucine or valine' 0 C--N 1.373 1.627 0 CA-C-N 120.342 1.428 . . . . 0.0 107.945 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -123.06 170.48 10.13 Favored 'General case' 0 C--O 1.201 -1.463 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -36.13 149.31 0.02 OUTLIER 'General case' 0 C--O 1.205 -1.277 1 C-N-CA 131.921 4.088 . . . . 0.0 118.844 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t0 62.39 35.72 14.79 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 124.418 1.087 . . . . 0.0 110.845 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 47.27 28.98 4.79 Favored Glycine 0 C--O 1.205 -1.67 0 CA-C-N 112.224 -2.262 . . . . 0.0 115.723 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.5 m -64.15 125.48 24.64 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.716 -0.873 . . . . 0.0 110.366 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -124.94 138.68 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -129.38 122.04 28.64 Favored 'General case' 0 C--N 1.366 1.314 0 O-C-N 127.596 3.06 . . . . 0.0 108.686 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.5 mm -95.52 130.15 44.64 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 O-C-N 120.22 -1.55 . . . . 0.0 107.838 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.95 117.98 33.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 117.984 -1.486 . . . . 0.0 107.355 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.3 148.67 29.13 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.671 -1.268 . . . . 0.0 110.871 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -69.0 -57.35 5.58 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.232 164.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -99.03 135.31 40.62 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 120.396 -1.44 . . . . 0.0 113.675 -163.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.12 -28.63 73.81 Favored Glycine 0 CA--C 1.506 -0.49 0 O-C-N 120.351 -1.468 . . . . 0.0 115.863 -167.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -57.87 -39.87 78.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.998 -0.707 . . . . 0.0 112.801 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -73.17 -37.9 66.39 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.96 95.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -61.82 -42.9 99.61 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.844 168.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -62.7 -39.3 93.57 Favored 'General case' 0 N--CA 1.52 3.033 0 CA-C-N 121.995 2.18 . . . . 0.0 115.093 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.49 69.03 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 120.365 1.439 . . . . 0.0 110.36 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.88 -44.48 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 122.594 1.188 . . . . 0.0 111.451 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -60.97 -42.39 98.22 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 168.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 21.8 mmm180 -64.63 -39.67 94.11 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.479 1.111 . . . . 0.0 112.231 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 mm -58.75 -40.7 80.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.137 168.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.65 -42.27 86.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.294 1.406 . . . . 0.0 110.917 168.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 71' ' ' ARG . 68.9 mt-10 -58.16 -43.12 87.25 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.9 mm -60.14 -44.39 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 CA-C-O 123.173 1.463 . . . . 0.0 113.808 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 C--N 1.353 0.731 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -177.646 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 mm . . . . . 0 N--CA 1.498 1.963 0 CA-C-O 114.989 -2.434 . . . . 0.0 111.955 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -125.09 134.85 52.33 Favored 'General case' 0 C--N 1.384 2.081 0 CA-C-N 121.288 1.858 . . . . 0.0 109.41 168.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.8 t -58.77 136.76 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.942 1.697 . . . . 0.0 111.372 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.59 -34.76 4.67 Favored Glycine 0 CA--C 1.55 2.28 0 O-C-N 120.809 -1.182 . . . . 0.0 113.789 -168.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -68.91 147.81 51.12 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-O 124.425 2.06 . . . . 0.0 113.147 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -89.1 133.3 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.694 0 CA-C-O 124.016 1.865 . . . . 0.0 111.868 169.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -133.13 169.68 16.51 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 126.874 2.07 . . . . 0.0 106.483 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.6 p -120.09 152.22 37.91 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.065 167.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.49 166.27 37.11 Favored Glycine 0 CA--C 1.465 -3.082 0 CA-C-O 123.776 1.765 . . . . 0.0 116.036 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 130' ' ' GLN . 55.6 mttm -106.31 127.76 53.49 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 110.968 -2.616 . . . . 0.0 115.334 -161.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.3 t -56.03 111.29 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.032 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -111.78 -13.44 13.71 Favored 'General case' 0 N--CA 1.525 3.309 0 CA-C-N 114.124 -1.398 . . . . 0.0 114.648 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.46 HH12 ' CD ' ' A' ' 106' ' ' GLU . 78.9 mtm-85 -155.02 153.48 31.04 Favored 'General case' 0 C--O 1.257 1.478 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 168.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.7 mt -132.21 125.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.7 m -138.3 166.83 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.585 -156.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -57.15 -35.23 69.28 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 126.87 2.606 . . . . 0.0 110.86 -165.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -111.74 10.25 20.92 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -174.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.0 -148.67 18.74 Favored Glycine 0 C--O 1.175 -3.534 0 CA-C-N 120.828 1.649 . . . . 0.0 115.83 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.91 157.13 43.9 Favored 'General case' 0 C--O 1.201 -1.457 0 O-C-N 119.489 -2.183 . . . . 0.0 108.88 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.433 ' CE2' HD13 ' A' ' 108' ' ' LEU . 85.3 m-85 -119.76 143.98 47.52 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.54 125.59 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 CA-C-N 111.608 -2.542 . . . . 0.0 108.816 -166.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.01 123.87 31.05 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.6 mm -114.28 142.39 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.725 0 CA-C-N 112.205 -2.271 . . . . 0.0 107.405 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -34.84 138.58 0.21 Allowed Glycine 0 C--N 1.389 3.491 0 C-N-CA 128.001 2.715 . . . . 0.0 114.994 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.06 29.82 68.44 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-O 118.863 -0.965 . . . . 0.0 112.391 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.31 30.65 53.95 Favored Glycine 0 CA--C 1.477 -2.33 0 O-C-N 124.983 1.049 . . . . 0.0 115.413 167.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -106.34 162.14 13.95 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 125.862 1.566 . . . . 0.0 109.671 -170.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.46 ' CD ' HH12 ' A' ' 91' ' ' ARG . 32.7 tt0 -149.32 122.17 8.73 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.498 1.499 . . . . 0.0 108.98 -171.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.89 162.13 15.77 Favored Glycine 0 CA--C 1.481 -2.033 0 CA-C-N 114.395 -1.275 . . . . 0.0 114.667 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.433 HD13 ' CE2' ' A' ' 98' ' ' PHE . 36.0 tp -114.56 126.24 54.7 Favored 'General case' 0 CA--C 1.491 -1.298 0 O-C-N 126.629 2.017 . . . . 0.0 111.343 -166.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.39 119.05 58.03 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 N-CA-C 100.693 -3.818 . . . . 0.0 100.693 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -82.93 169.68 15.76 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 120.725 -1.234 . . . . 0.0 109.254 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.9 tt -77.7 -25.72 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -157.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 81.7 p -92.26 7.03 44.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.416 -2.053 . . . . 0.0 111.259 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -120.33 27.36 8.65 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-O 114.779 -2.534 . . . . 0.0 109.591 -170.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.2 mt -105.03 -49.22 9.26 Favored 'Isoleucine or valine' 0 C--N 1.37 1.48 0 O-C-N 127.014 2.696 . . . . 0.0 109.117 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.22 173.73 11.24 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.333 -1.48 . . . . 0.0 109.031 -163.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -82.13 -53.39 6.12 Favored 'General case' 0 C--O 1.2 -1.509 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -65.75 138.84 58.21 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.695 0.798 . . . . 0.0 110.944 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -53.93 134.29 43.08 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.649 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -119.96 124.6 73.05 Favored 'Isoleucine or valine' 0 C--N 1.368 1.411 0 O-C-N 123.943 0.777 . . . . 0.0 111.851 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -109.18 -18.85 13.52 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 115.908 -1.996 . . . . 0.0 110.709 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -128.58 127.89 43.18 Favored 'General case' 0 C--N 1.381 1.936 0 CA-C-O 123.247 1.498 . . . . 0.0 109.024 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.21 -41.09 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 O-C-N 121.087 -1.008 . . . . 0.0 113.068 -174.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -55.88 -7.38 0.31 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 126.528 2.393 . . . . 0.0 112.481 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -69.5 -35.59 75.67 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.317 1.417 . . . . 0.0 113.871 173.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -115.23 -52.33 2.68 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 128.155 3.409 . . . . 0.0 114.251 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.1 mt -93.34 143.97 25.77 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.129 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.46 154.18 38.43 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 103.169 -2.9 . . . . 0.0 103.169 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 65.7 mmm -66.69 121.86 16.34 Favored 'General case' 0 C--O 1.192 -1.949 0 C-N-CA 127.399 2.28 . . . . 0.0 113.992 -165.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.17 -0.66 78.8 Favored Glycine 1 N--CA 1.518 4.13 0 N-CA-C 118.498 2.159 . . . . 0.0 118.498 -171.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.7 tt0 -57.75 141.09 49.89 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 167.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -87.13 121.48 29.63 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.581 170.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.2 m -113.4 129.33 24.72 Favored Pre-proline 0 C--O 1.215 -0.761 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.41 139.19 18.24 Favored 'Trans proline' 0 C--N 1.266 -3.815 0 N-CA-C 108.616 -1.34 . . . . 0.0 108.616 162.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.57 148.43 18.21 Favored 'Isoleucine or valine' 0 C--N 1.363 1.194 0 CA-C-O 123.169 1.461 . . . . 0.0 113.501 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -104.69 129.08 52.92 Favored 'General case' 0 C--O 1.19 -2.061 0 CA-C-N 111.843 -2.435 . . . . 0.0 111.819 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 81.6 t -82.4 122.27 36.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 125.575 1.797 . . . . 0.0 111.541 -170.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 148' ' ' SER . 3.5 mt -101.09 -33.13 10.26 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 117.601 -1.19 . . . . 0.0 112.227 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -145.23 146.52 31.74 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.42 119.8 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 123.157 1.456 . . . . 0.0 108.854 155.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.16 156.56 21.42 Favored 'General case' 0 C--O 1.254 1.322 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.335 169.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -51.98 -31.95 31.57 Favored 'General case' 0 C--N 1.401 2.845 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.79 13.17 33.28 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 120.427 1.467 . . . . 0.0 114.588 168.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.93 12.76 48.79 Favored Glycine 0 C--N 1.364 2.118 0 N-CA-C 118.068 1.987 . . . . 0.0 118.068 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -78.8 137.14 37.58 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-N 120.549 2.175 . . . . 0.0 109.29 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.8 mt -126.41 129.62 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 117.413 -1.28 . . . . 0.0 112.089 -159.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.09 128.67 51.73 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.622 171.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.6 mt -118.54 162.27 18.65 Favored 'General case' 0 N--CA 1.52 3.05 0 O-C-N 125.068 1.48 . . . . 0.0 114.385 -170.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.407 ' HB2' HD21 ' A' ' 137' ' ' LEU . 35.8 t -129.91 138.78 51.09 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.231 1.013 . . . . 0.0 109.414 168.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.9 mt -99.95 -28.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 167.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -57.85 -42.22 83.99 Favored 'General case' 0 C--N 1.37 1.469 0 O-C-N 119.442 -2.036 . . . . 0.0 111.6 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.33 -42.46 92.9 Favored 'General case' 0 CA--C 1.594 2.655 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.25 . . -61.6 -45.02 95.86 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 120.12 -1.613 . . . . 0.0 111.017 170.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.5 p . . . . . 0 C--O 1.2 -1.539 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.723 -175.412 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.7 mm . . . . . 0 CA--C 1.555 1.166 0 CA-C-O 122.967 1.365 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -135.79 129.36 32.38 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.78 163.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.3 m -111.62 138.4 48.23 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 122.099 0.952 . . . . 0.0 111.876 -172.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt -134.86 130.82 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 113.75 -1.568 . . . . 0.0 107.977 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -82.11 130.11 35.0 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-O 122.506 1.146 . . . . 0.0 111.607 163.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.2 mm -121.41 128.36 75.88 Favored 'Isoleucine or valine' 0 C--N 1.401 2.827 0 O-C-N 120.506 -1.371 . . . . 0.0 109.542 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 5.7 m-20 -56.24 156.85 10.03 Favored Pre-proline 0 C--N 1.371 1.539 0 CA-C-N 119.555 1.07 . . . . 0.0 112.726 -171.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 21' ' ' ASN . 54.5 Cg_exo -66.2 -25.47 50.26 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 N-CA-C 116.757 1.791 . . . . 0.0 116.757 -167.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -84.2 -27.49 27.98 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-O 117.04 -1.457 . . . . 0.0 110.777 172.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -86.64 -26.51 24.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 121.546 1.976 . . . . 0.0 110.109 -169.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 49' ' ' ILE . 10.0 tp -74.85 -19.61 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 O-C-N 124.61 1.194 . . . . 0.0 108.277 173.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.269 35.5 mmtm -64.93 -39.53 93.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.057 -1.027 . . . . 0.0 113.298 168.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.11 -38.6 91.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.865 1.666 . . . . 0.0 113.574 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.03 -33.31 62.47 Favored 'Isoleucine or valine' 0 C--N 1.375 1.706 0 C-N-CA 125.483 1.513 . . . . 0.0 111.352 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 29' ' ' ILE . 47.6 mm -97.57 11.04 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-O 123.178 1.466 . . . . 0.0 111.581 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.37 167.39 13.29 Favored Glycine 0 C--N 1.296 -1.674 0 CA-C-N 111.792 -2.458 . . . . 0.0 115.944 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm 58.3 43.98 19.29 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.208 1.403 . . . . 0.0 113.327 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.3 12.72 81.83 Favored Glycine 0 CA--C 1.558 2.757 0 O-C-N 120.807 -1.183 . . . . 0.0 115.818 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.03 5.26 77.23 Favored Glycine 0 C--N 1.369 2.402 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 -171.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.7 m -63.08 -39.99 96.33 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-O 116.903 -1.522 . . . . 0.0 113.623 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 t -61.44 -47.36 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.309 6.4 tp -62.96 -39.33 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-N 119.427 1.012 . . . . 0.0 111.327 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -64.37 -51.57 62.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.351 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.05 -43.81 82.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 126.352 2.283 . . . . 0.0 115.286 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.91 -50.95 71.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.7 p -64.83 -35.2 80.33 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 120.673 -1.267 . . . . 0.0 112.564 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -72.36 -39.51 68.03 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 125.832 1.957 . . . . 0.0 110.338 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -61.76 -38.51 88.27 Favored 'General case' 0 C--O 1.259 1.555 0 CA-C-O 124.166 1.936 . . . . 0.0 113.003 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.5 p -91.24 -17.06 26.62 Favored 'General case' 0 C--N 1.367 1.335 0 O-C-N 118.663 -2.523 . . . . 0.0 116.363 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.03 28.6 73.73 Favored Glycine 0 CA--C 1.474 -2.484 1 O-C-N 129.254 4.096 . . . . 0.0 112.352 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 t -148.31 159.3 44.13 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 124.305 2.002 . . . . 0.0 107.671 -166.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -83.42 118.0 23.44 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 112.407 -2.179 . . . . 0.0 108.581 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.632 HG23 HD13 ' A' ' 57' ' ' ILE . 16.4 mt -124.08 121.32 61.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -113.22 147.42 37.52 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 125.573 2.606 . . . . 0.0 108.092 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.533 HD12 HD11 ' A' ' 25' ' ' ILE . 16.3 mm -112.09 123.4 67.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 112.014 -2.357 . . . . 0.0 109.227 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -123.88 166.83 14.98 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -165.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.281 81.9 m-20 -47.4 142.49 4.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.024 -1.672 . . . . 0.0 114.196 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.8 t0 54.27 67.3 1.03 Allowed 'General case' 0 C--N 1.35 0.598 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 171.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.53 27.47 26.39 Favored Glycine 0 C--N 1.301 -1.396 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 m -107.39 114.79 29.03 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 49' ' ' ILE . 24.5 t -104.43 141.79 19.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -173.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -129.29 123.39 31.74 Favored 'General case' 0 C--N 1.363 1.19 0 CA-C-O 122.54 1.162 . . . . 0.0 109.498 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.632 HD13 HG23 ' A' ' 47' ' ' ILE . 12.6 mm -86.83 130.03 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.117 167.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.67 51.16 1.86 Allowed 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.87 153.38 21.37 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 119.048 -2.283 . . . . 0.0 114.729 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.7 p -100.04 21.92 12.05 Favored 'General case' 0 C--N 1.381 1.949 0 CA-C-O 115.476 -2.202 . . . . 0.0 111.301 -175.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -151.49 145.58 25.3 Favored 'General case' 0 C--N 1.372 1.585 0 O-C-N 127.244 2.84 . . . . 0.0 110.08 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.1 -33.98 61.87 Favored Glycine 0 N--CA 1.439 -1.128 0 O-C-N 125.248 1.592 . . . . 0.0 114.425 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.31 -45.43 87.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 116.703 -1.618 . . . . 0.0 108.186 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -58.74 -42.07 87.95 Favored 'General case' 0 C--N 1.375 1.681 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.86 98.13 Favored 'General case' 0 C--O 1.272 2.267 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -68.63 -37.41 79.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 125.394 1.684 . . . . 0.0 108.697 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -66.92 -42.86 84.65 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 120.074 -1.641 . . . . 0.0 114.521 170.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.15 -54.38 31.35 Favored 'General case' 0 C--O 1.191 -2.008 0 CA-C-N 121.176 1.807 . . . . 0.0 111.556 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 mt -60.87 -45.14 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 124.46 1.104 . . . . 0.0 110.168 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -56.33 -44.29 79.85 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -63.16 -41.56 99.27 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 120.597 1.544 . . . . 0.0 107.827 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.19 -42.09 85.82 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.971 0 CA-C-O 116.805 -1.569 . . . . 0.0 110.234 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.32 -42.18 90.79 Favored 'General case' 0 N--CA 1.537 3.883 0 CA-C-N 121.734 2.061 . . . . 0.0 111.281 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -69.31 -39.16 78.42 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 126.242 2.214 . . . . 0.0 114.688 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.6 mt -71.61 -32.41 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 168.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.491 1.603 0 CA-C-N 120.769 1.622 . . . . 0.0 109.672 177.543 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.7 mm . . . . . 0 N--CA 1.429 -1.482 0 CA-C-O 125.039 2.352 . . . . 0.0 115.254 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -115.59 134.55 54.94 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-N 113.028 -1.896 . . . . 0.0 106.379 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.17 139.03 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 O-C-N 128.134 3.396 . . . . 0.0 110.31 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.95 -10.21 48.69 Favored Glycine 0 CA--C 1.551 2.342 0 O-C-N 119.39 -2.069 . . . . 0.0 113.835 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -81.87 159.33 23.73 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-N 119.662 1.731 . . . . 0.0 111.176 167.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.41 140.32 31.36 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -130.83 161.65 31.32 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.9 m -117.25 125.72 51.58 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.99 -169.76 12.41 Favored Glycine 0 N--CA 1.42 -2.412 0 C-N-CA 120.295 -0.955 . . . . 0.0 114.986 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -128.56 143.22 50.92 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 122.937 1.351 . . . . 0.0 114.432 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.3 t -73.76 122.75 27.47 Favored 'Isoleucine or valine' 0 C--N 1.382 2.008 0 O-C-N 118.078 -2.889 . . . . 0.0 115.288 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.12 -25.4 7.63 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 115.929 -1.986 . . . . 0.0 113.785 -170.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 -146.22 151.47 37.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 168.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -123.65 131.44 73.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.04 174.47 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 124.047 1.88 . . . . 0.0 111.324 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -58.62 -37.4 75.8 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 117.565 -1.654 . . . . 0.0 114.518 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -98.41 18.91 15.4 Favored 'General case' 0 C--N 1.374 1.664 0 CA-C-N 120.876 1.671 . . . . 0.0 111.737 -176.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.56 -135.92 6.19 Favored Glycine 0 C--N 1.383 3.182 0 N-CA-C 115.057 0.783 . . . . 0.0 115.057 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.57 160.81 41.09 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 125.649 1.441 . . . . 0.0 114.831 167.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.29 131.48 54.17 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-O 121.884 0.849 . . . . 0.0 111.122 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 72.9 t -110.85 134.3 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.646 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -98.49 127.71 44.54 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 120.221 -1.549 . . . . 0.0 109.395 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.92 150.79 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 CA-C-N 112.883 -1.962 . . . . 0.0 112.188 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.67 154.38 0.62 Allowed Glycine 0 CA--C 1.564 3.128 0 N-CA-C 118.958 2.343 . . . . 0.0 118.958 173.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.56 8.09 24.3 Favored Glycine 0 C--N 1.366 2.214 0 C-N-CA 127.663 2.554 . . . . 0.0 117.57 -168.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.79 22.86 16.95 Favored Glycine 0 C--O 1.256 1.494 0 O-C-N 127.585 2.58 . . . . 0.0 117.219 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.96 128.14 34.19 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 117.256 0.528 . . . . 0.0 110.491 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.0 146.83 35.98 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 123.343 1.544 . . . . 0.0 108.685 169.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -145.24 163.96 28.04 Favored Glycine 0 CA--C 1.48 -2.141 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.06 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.0 tp -110.61 136.4 49.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 124.372 0.689 . . . . 0.0 110.462 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.73 113.73 45.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 CA-C-O 123.824 1.773 . . . . 0.0 108.796 160.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -62.91 150.65 41.47 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 tt -52.89 -24.83 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.3 p -90.32 6.3 43.62 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 125.825 1.65 . . . . 0.0 112.198 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -120.45 5.35 10.66 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 120.16 -1.588 . . . . 0.0 114.072 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 18.5 mm -82.84 -48.56 17.7 Favored 'Isoleucine or valine' 0 C--O 1.283 2.821 0 CA-C-O 123.734 1.73 . . . . 0.0 112.304 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.29 173.84 13.52 Favored 'General case' 0 N--CA 1.406 -2.645 0 O-C-N 116.939 -3.601 . . . . 0.0 107.224 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -66.0 -33.7 76.4 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.2 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -71.56 161.19 31.4 Favored 'General case' 0 C--N 1.365 1.264 0 C-N-CA 124.733 1.213 . . . . 0.0 114.024 -173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -70.63 122.22 19.36 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 124.679 2.181 . . . . 0.0 108.82 167.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.28 146.01 16.8 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.779 0 CA-C-N 112.38 -2.191 . . . . 0.0 110.157 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -119.84 -35.33 3.53 Favored 'General case' 0 C--N 1.369 1.445 0 CA-C-N 120.359 1.436 . . . . 0.0 113.826 160.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -123.17 129.3 51.22 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 122.7 1.238 . . . . 0.0 109.149 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.3 -20.43 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 111.814 -2.448 . . . . 0.0 106.646 -166.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.4 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.39 2.346 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -66.52 -45.33 79.85 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 125.716 1.606 . . . . 0.0 112.921 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -95.06 -17.97 21.42 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.7 mt -126.99 129.45 48.13 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -98.72 156.2 16.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.62 -1.3 . . . . 0.0 110.291 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 51.5 tpp -67.93 133.86 49.83 Favored 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 118.641 -2.537 . . . . 0.0 109.165 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.09 15.91 79.65 Favored Glycine 0 CA--C 1.548 2.132 0 O-C-N 126.061 2.1 . . . . 0.0 112.059 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -65.24 132.42 49.05 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.294 -1.709 . . . . 0.0 113.151 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -85.12 118.55 24.75 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 123.748 1.737 . . . . 0.0 112.957 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.86 125.33 20.23 Favored Pre-proline 0 CA--C 1.582 2.174 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -158.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.65 131.43 24.37 Favored 'Trans proline' 0 N--CA 1.518 2.923 0 O-C-N 117.726 -1.776 . . . . 0.0 111.786 165.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.15 136.82 57.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 CA-C-O 123.061 1.41 . . . . 0.0 110.452 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -105.01 143.42 33.22 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 120.702 -1.249 . . . . 0.0 109.764 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.9 t -86.9 137.48 20.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 122.17 0.986 . . . . 0.0 109.409 -170.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.65 -43.17 3.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 118.944 -2.348 . . . . 0.0 108.558 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -153.12 146.86 25.19 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-O 124.139 1.923 . . . . 0.0 108.205 -166.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.7 p -145.64 123.21 4.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 CA-C-O 124.119 1.914 . . . . 0.0 110.092 171.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' A' ' 146' ' ' ARG . 60.2 m-20 -71.74 175.34 5.79 Favored 'General case' 0 CA--C 1.592 2.593 0 O-C-N 119.826 -1.796 . . . . 0.0 115.207 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -68.51 -16.27 63.83 Favored 'General case' 0 CA--C 1.584 2.274 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.74 19.16 21.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 120.055 -1.653 . . . . 0.0 111.476 167.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.85 16.93 79.21 Favored Glycine 0 C--N 1.362 2.015 0 O-C-N 125.961 2.038 . . . . 0.0 114.468 168.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . 0.332 36.0 mtm180 -69.75 129.31 39.24 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 163.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.4 mt -108.68 141.33 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 119.545 -1.972 . . . . 0.0 110.714 -165.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.458 HH12 ' CG ' ' A' ' 140' ' ' ASP . 0.4 OUTLIER -113.1 150.09 32.6 Favored 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.606 160.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.4 mt -140.33 171.86 13.55 Favored 'General case' 0 C--O 1.258 1.508 0 CA-C-O 124.087 1.898 . . . . 0.0 111.391 -166.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.5 t -154.84 134.49 12.76 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.0 mt -87.96 -17.86 8.4 Favored 'Isoleucine or valine' 0 C--N 1.377 1.777 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -62.57 -50.18 72.34 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 172.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.56 -25.58 63.16 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 122.111 0.958 . . . . 0.0 109.714 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.08 -49.26 68.22 Favored 'General case' 0 C--O 1.257 1.478 0 O-C-N 119.797 -1.814 . . . . 0.0 115.01 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.9 p . . . . . 0 C--O 1.268 2.042 0 CA-C-N 112.138 -2.301 . . . . 0.0 111.214 -173.977 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mm . . . . . 0 CA--C 1.552 1.056 0 CA-C-O 126.28 2.943 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -116.17 138.96 50.82 Favored 'General case' 0 CA--C 1.59 2.486 0 CA-C-N 109.829 -3.35 . . . . 0.0 104.877 169.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 t -136.66 164.51 28.07 Favored 'General case' 0 N--CA 1.532 3.635 0 CA-C-O 117.627 -1.178 . . . . 0.0 112.252 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 tp -172.02 145.7 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.071 0 O-C-N 126.793 2.558 . . . . 0.0 105.228 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -128.58 130.63 47.64 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 124.8 1.24 . . . . 0.0 109.535 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.6 pt -133.33 162.99 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.834 0 O-C-N 126.513 2.383 . . . . 0.0 108.637 -166.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -43.95 141.96 2.2 Favored Pre-proline 0 N--CA 1.524 3.26 0 CA-C-N 120.024 1.284 . . . . 0.0 112.376 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -59.94 -34.33 95.25 Favored 'Trans proline' 0 CA--C 1.474 -2.475 0 C-N-CA 122.866 2.378 . . . . 0.0 112.567 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -65.2 -28.16 69.19 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-N 121.816 2.098 . . . . 0.0 113.425 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.2 -22.07 64.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.01 -43.59 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 C-N-CA 124.969 1.307 . . . . 0.0 110.649 171.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -51.87 -43.65 63.35 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 170.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -79.81 -22.13 43.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.71 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.8 t -70.61 -54.08 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-O 116.263 -1.827 . . . . 0.0 110.084 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -58.99 -42.49 86.34 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 CA-C-N 120.098 1.317 . . . . 0.0 109.022 173.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.1 175.97 49.14 Favored Glycine 0 C--N 1.374 2.69 0 O-C-N 119.425 -2.047 . . . . 0.0 113.888 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -74.78 119.2 18.64 Favored 'General case' 0 C--N 1.387 2.204 0 CA-C-N 119.704 1.752 . . . . 0.0 106.804 -171.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.49 4.48 87.36 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.43 17.64 70.73 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 118.628 -1.748 . . . . 0.0 115.962 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.1 p -69.3 -37.29 77.72 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 119.972 3.323 . . . . 0.0 119.972 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.6 t -74.28 -39.11 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 O-C-N 124.696 1.248 . . . . 0.0 112.5 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.287 17.0 tt -63.54 -41.21 91.87 Favored 'Isoleucine or valine' 0 C--O 1.262 1.738 0 O-C-N 127.16 2.787 . . . . 0.0 112.711 173.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -64.15 -37.5 87.67 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 125.666 1.854 . . . . 0.0 111.609 169.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.24 79.92 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.08 -42.32 98.29 Favored 'General case' 0 C--O 1.196 -1.744 0 O-C-N 118.328 -2.732 . . . . 0.0 108.558 170.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.1 m -59.26 -48.81 80.24 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.049 0.94 . . . . 0.0 111.024 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -73.92 -35.81 64.64 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 116.316 -2.153 . . . . 0.0 110.024 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -73.11 -41.55 63.9 Favored 'General case' 0 C--O 1.258 1.542 0 CA-C-N 122.314 2.325 . . . . 0.0 111.54 -175.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.7 p -81.85 -24.95 35.5 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 118.377 -2.702 . . . . 0.0 113.2 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.6 35.09 59.45 Favored Glycine 0 C--N 1.394 3.77 0 CA-C-N 122.061 2.209 . . . . 0.0 116.495 -169.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 p -129.55 177.37 7.26 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.127 1.771 . . . . 0.0 107.383 -165.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.2 m -121.68 114.77 21.6 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 123.121 1.439 . . . . 0.0 107.136 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mt -101.43 128.24 53.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 112.622 -2.081 . . . . 0.0 112.56 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -135.44 151.09 50.08 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-O 123.601 1.667 . . . . 0.0 109.715 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.0 mm -114.71 126.7 72.34 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.761 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.865 -171.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -118.58 147.14 44.02 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.19 162.95 0.05 OUTLIER 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 52.22 36.25 18.87 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 126.511 1.924 . . . . 0.0 115.485 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.07 8.76 66.45 Favored Glycine 0 CA--C 1.468 -2.903 0 CA-C-O 116.112 -2.493 . . . . 0.0 116.203 172.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.8 m -77.0 135.13 38.66 Favored 'General case' 0 C--O 1.256 1.432 0 O-C-N 127.248 2.381 . . . . 0.0 113.748 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -114.12 136.18 51.47 Favored 'Isoleucine or valine' 0 C--N 1.367 1.367 0 O-C-N 120.66 -1.275 . . . . 0.0 114.354 165.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -125.85 116.77 22.08 Favored 'General case' 0 C--O 1.196 -1.745 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.111 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.2 mt -114.04 119.87 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.556 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -98.02 142.11 30.14 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 126.883 2.614 . . . . 0.0 110.79 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.75 175.09 14.37 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-O 124.836 2.255 . . . . 0.0 106.131 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 t -116.95 -15.81 10.59 Favored 'General case' 0 N--CA 1.532 3.646 0 CA-C-N 112.671 -2.059 . . . . 0.0 112.296 171.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -120.42 114.51 21.92 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.18 -38.15 95.15 Favored Glycine 0 N--CA 1.505 3.268 0 N-CA-C 118.428 2.131 . . . . 0.0 118.428 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.0 -31.88 71.48 Favored 'General case' 0 C--N 1.377 1.804 0 CA-C-N 121.314 2.557 . . . . 0.0 113.772 167.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -67.69 -34.92 77.86 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 121.738 2.063 . . . . 0.0 114.385 170.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.51 -45.55 79.15 Favored 'General case' 0 C--O 1.254 1.341 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 171.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HA ' HD12 ' A' ' 69' ' ' ILE . 43.5 mmtt -58.39 -37.08 74.56 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 115.08 -2.391 . . . . 0.0 110.742 167.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -62.93 -36.51 83.64 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 122.756 2.525 . . . . 0.0 111.361 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.36 -38.15 74.72 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 120.31 -1.494 . . . . 0.0 112.88 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 66' ' ' LYS . 19.3 mt -60.32 -43.27 93.3 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.84 168.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -60.17 -49.27 78.3 Favored 'General case' 0 C--O 1.249 1.029 0 O-C-N 120.495 -1.378 . . . . 0.0 113.787 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -67.38 -30.0 69.68 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.061 1.301 . . . . 0.0 112.757 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.9 -47.39 83.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 CA-C-O 115.492 -2.194 . . . . 0.0 110.674 166.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.67 -39.55 77.35 Favored 'General case' 0 C--O 1.206 -1.227 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -64.07 -55.18 23.94 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-O 115.927 -1.987 . . . . 0.0 114.029 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 36.6 mm -55.25 -43.49 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.368 0 CA-C-N 121.577 1.99 . . . . 0.0 109.285 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.3 p . . . . . 0 C--N 1.295 -1.79 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 174.898 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 mm . . . . . 0 C--O 1.212 -0.916 0 CA-C-O 117.551 -1.214 . . . . 0.0 114.242 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -121.0 139.82 52.77 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-O 123.613 1.673 . . . . 0.0 107.239 168.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.05 130.12 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 117.16 -3.463 . . . . 0.0 115.287 171.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.06 -8.15 41.78 Favored Glycine 0 CA--C 1.485 -1.817 0 CA-C-O 117.014 -1.992 . . . . 0.0 112.498 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -57.28 147.98 24.0 Favored 'General case' 0 C--N 1.371 1.511 0 O-C-N 124.981 1.048 . . . . 0.0 112.838 166.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.9 129.56 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 128.167 3.417 . . . . 0.0 106.905 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -135.78 168.5 19.19 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 123.444 1.592 . . . . 0.0 110.014 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 m -112.45 121.88 46.09 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 171.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.1 -172.24 13.33 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -139.76 144.33 37.38 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.33 138.2 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 170.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.4 p -115.3 -40.16 3.48 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 120.158 -1.589 . . . . 0.0 109.478 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.4 mtm-85 -146.88 141.96 27.13 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.157 0.983 . . . . 0.0 110.052 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 92' ' ' ILE . 96.9 mt -120.24 143.33 32.4 Favored 'Isoleucine or valine' 0 C--N 1.38 1.931 0 CA-C-O 122.451 1.12 . . . . 0.0 109.927 176.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 m -144.31 168.93 9.98 Favored 'Isoleucine or valine' 0 C--N 1.388 2.278 0 O-C-N 117.955 -2.965 . . . . 0.0 104.251 -170.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -56.66 -37.89 71.42 Favored 'General case' 0 C--O 1.269 2.094 0 CA-C-N 118.493 0.588 . . . . 0.0 111.743 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -96.06 11.33 34.52 Favored 'General case' 0 C--O 1.252 1.209 0 O-C-N 120.914 -1.117 . . . . 0.0 111.7 -168.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.72 -177.94 30.94 Favored Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.973 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.16 127.09 53.0 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.744 0.908 . . . . 0.0 110.276 174.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -76.26 131.86 39.51 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-O 123.806 1.765 . . . . 0.0 111.948 166.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.4 t -129.61 135.17 62.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 CA-C-N 112.051 -2.341 . . . . 0.0 112.024 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.96 129.97 41.62 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 112.21 -2.268 . . . . 0.0 112.632 167.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.5 mm -119.03 135.34 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.05 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.4 145.86 0.37 Allowed Glycine 0 C--N 1.378 2.909 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.54 38.84 27.28 Favored Glycine 0 N--CA 1.504 3.192 0 CA-C-N 112.78 -1.71 . . . . 0.0 111.051 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.48 6.92 84.99 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 120.507 2.963 . . . . 0.0 120.507 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -87.42 160.06 18.46 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 118.267 2.692 . . . . 0.0 118.267 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.87 131.63 20.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 109.707 172.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -122.9 163.1 16.43 Favored Glycine 0 C--N 1.349 1.25 0 C-N-CA 123.733 0.683 . . . . 0.0 112.156 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.94 124.91 44.21 Favored 'General case' 0 C--O 1.203 -1.345 0 O-C-N 126.892 2.172 . . . . 0.0 110.491 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 147' ' ' LEU . 74.1 t -96.93 100.29 10.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 168.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -67.58 154.87 40.45 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.312 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.273 6.3 tt -52.69 -38.69 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -170.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.6 p -73.4 -0.96 16.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 148' ' ' SER . 91.1 mm-40 -119.01 5.77 11.34 Favored 'General case' 0 CA--C 1.576 1.968 0 O-C-N 123.986 0.804 . . . . 0.0 112.577 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.0 mm -77.68 -33.24 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.183 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -157.65 -176.19 5.8 Favored 'General case' 0 CA--C 1.495 -1.157 0 O-C-N 120.076 -1.64 . . . . 0.0 111.079 -170.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -105.57 -23.43 12.78 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 165.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -62.05 158.28 16.92 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 120.092 -1.63 . . . . 0.0 112.648 173.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -74.25 131.56 41.32 Favored 'General case' 0 C--O 1.205 -1.273 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.49 HG22 ' CE2' ' A' ' 125' ' ' TYR . 17.8 t -122.21 127.72 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 C-N-CA 125.793 1.637 . . . . 0.0 114.188 -173.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -110.25 -46.1 3.48 Favored 'General case' 0 C--N 1.386 2.18 0 C-N-CA 124.893 1.277 . . . . 0.0 110.202 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -120.48 150.36 40.94 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 170.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.11 -23.2 14.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-N 113.719 -1.582 . . . . 0.0 113.038 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.93 -19.39 65.09 Favored 'General case' 0 CA--C 1.581 2.141 0 O-C-N 120.115 -1.616 . . . . 0.0 114.616 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -76.59 -29.64 56.65 Favored 'General case' 0 N--CA 1.539 3.977 0 C-N-CA 126.577 1.951 . . . . 0.0 110.484 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.49 ' CE2' HG22 ' A' ' 119' ' ' VAL . 76.7 m-85 -100.79 -15.46 17.64 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 126' ' ' LEU . 30.6 mt -151.99 162.42 41.11 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 124.22 0.95 . . . . 0.0 109.689 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -134.5 160.1 39.08 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 162.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -72.08 139.98 48.7 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 120.378 -1.451 . . . . 0.0 113.851 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 94.64 -12.35 68.84 Favored Glycine 0 N--CA 1.505 3.253 0 CA-C-O 125.39 2.661 . . . . 0.0 111.608 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -68.66 131.81 45.82 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 123.682 1.706 . . . . 0.0 111.177 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -79.65 129.6 34.62 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.931 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.57 127.16 19.48 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 120.527 -1.358 . . . . 0.0 109.062 -169.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.42 127.11 24.83 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 CA-C-O 116.769 -1.43 . . . . 0.0 113.278 160.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.0 129.43 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-N 122.669 2.486 . . . . 0.0 110.188 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -97.86 140.75 31.76 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 172.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.2 t -86.74 116.21 28.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.034 0 O-C-N 125.742 1.901 . . . . 0.0 106.789 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.0 tp -101.87 -48.01 4.41 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 116.323 -1.799 . . . . 0.0 110.658 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -136.12 150.84 49.26 Favored 'General case' 0 C--O 1.204 -1.294 0 O-C-N 125.029 1.456 . . . . 0.0 107.726 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.8 t -134.64 120.46 32.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -75.89 155.66 35.02 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.616 -1.302 . . . . 0.0 111.238 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.31 29.5 mmt180 -70.85 -27.06 63.57 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -65.74 -31.99 73.29 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 126.158 2.161 . . . . 0.0 115.833 157.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 138.02 -13.98 3.57 Favored Glycine 0 CA--C 1.549 2.206 0 C-N-CA 125.19 1.376 . . . . 0.0 111.646 162.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -54.37 137.84 41.03 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 10.6 mt -118.06 131.52 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 125.061 1.344 . . . . 0.0 113.14 -167.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -110.09 144.33 38.85 Favored 'General case' 0 N--CA 1.527 3.418 0 CA-C-O 123.283 1.516 . . . . 0.0 111.227 164.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.444 ' HB2' HG22 ' A' ' 109' ' ' VAL . 67.1 mt -129.12 151.87 49.33 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.079 -2.328 . . . . 0.0 110.29 -169.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 113' ' ' GLN . 33.8 t -125.82 115.82 20.61 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.062 1.345 . . . . 0.0 109.148 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.6 mt -74.87 -38.24 43.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 119.838 -1.789 . . . . 0.0 112.164 171.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -59.46 -47.24 86.25 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 127.015 2.697 . . . . 0.0 114.634 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -66.59 -46.34 76.27 Favored 'General case' 0 C--O 1.258 1.514 0 CA-C-N 118.345 0.52 . . . . 0.0 111.63 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.6 -18.23 64.91 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-O 116.912 -1.518 . . . . 0.0 112.569 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 117.629 -1.176 . . . . 0.0 108.234 172.085 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.0 mm . . . . . 0 C--O 1.238 0.497 0 CA-C-O 122.001 0.905 . . . . 0.0 113.395 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -123.04 138.97 54.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 124.395 2.045 . . . . 0.0 113.674 169.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -135.13 139.7 44.85 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 113.326 -1.761 . . . . 0.0 110.121 -173.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.3 pt -133.37 161.44 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 162.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -83.45 146.1 28.6 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 125.02 2.343 . . . . 0.0 109.447 160.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 pt -122.58 147.87 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 157.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.283 1.6 t-20 -63.35 138.53 97.38 Favored Pre-proline 0 N--CA 1.514 2.748 0 C-N-CA 128.472 2.709 . . . . 0.0 108.381 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -80.95 3.76 7.53 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 O-C-N 118.007 -1.628 . . . . 0.0 114.328 -171.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -91.43 -2.33 57.3 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 120.59 -1.319 . . . . 0.0 110.443 164.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -111.74 3.82 18.04 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.285 -0.884 . . . . 0.0 109.322 -170.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 mt -68.45 -41.31 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 119.828 -1.795 . . . . 0.0 112.366 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -52.5 -13.15 0.34 Allowed 'General case' 0 C--N 1.353 0.738 0 C-N-CA 128.34 2.656 . . . . 0.0 117.415 164.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -102.62 -32.71 9.75 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 115.734 -2.079 . . . . 0.0 113.318 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.3 t -84.15 -31.34 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 O-C-N 125.099 1.499 . . . . 0.0 109.466 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.3 mm -93.25 -55.21 6.36 Favored 'Isoleucine or valine' 0 C--N 1.361 1.08 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.62 -173.39 30.21 Favored Glycine 0 C--N 1.369 2.37 0 CA-C-O 123.506 1.614 . . . . 0.0 115.432 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -74.88 108.96 7.96 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 116.588 -1.672 . . . . 0.0 110.593 -167.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.53 9.76 59.84 Favored Glycine 0 CA--C 1.468 -2.855 0 O-C-N 127.474 2.984 . . . . 0.0 110.434 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.65 30.37 77.21 Favored Glycine 0 CA--C 1.54 1.613 0 O-C-N 125.362 1.272 . . . . 0.0 112.259 -162.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -53.05 -54.42 35.69 Favored 'General case' 0 N--CA 1.517 2.888 0 C-N-CA 126.213 1.805 . . . . 0.0 111.225 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -89.82 -35.56 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -160.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.1 tp -67.81 -38.64 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -66.12 -44.29 84.7 Favored 'General case' 0 C--N 1.399 2.731 0 C-N-CA 125.147 1.379 . . . . 0.0 110.489 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.23 47.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 127.814 3.196 . . . . 0.0 110.026 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.2 mt -51.63 -48.74 63.2 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 116.07 -1.919 . . . . 0.0 113.92 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 t -60.83 -34.42 74.54 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.6 1.545 . . . . 0.0 112.966 -175.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.25 -31.23 71.43 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -96.46 -28.12 14.57 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 126.285 1.834 . . . . 0.0 111.662 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.468 HG21 ' HA ' ' A' ' 68' ' ' ALA . 11.1 p -84.67 -19.64 32.53 Favored 'General case' 0 C--N 1.396 2.62 0 CA-C-N 120.954 1.706 . . . . 0.0 110.754 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.18 24.85 74.73 Favored Glycine 0 N--CA 1.472 1.042 0 C-N-CA 127.906 2.669 . . . . 0.0 114.12 171.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 t -141.45 161.78 37.08 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.871 0.868 . . . . 0.0 108.736 -173.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -81.68 126.09 31.37 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 125.177 1.548 . . . . 0.0 110.74 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.6 mt -114.72 121.61 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -116.83 148.79 40.92 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 124.831 2.253 . . . . 0.0 107.168 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.8 mt -128.06 123.5 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-O 123.236 1.494 . . . . 0.0 111.487 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -87.73 148.99 24.49 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-O 117.274 -1.346 . . . . 0.0 112.254 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -71.12 -3.16 18.48 Favored 'General case' 0 C--N 1.393 2.485 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -157.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -89.69 -1.85 58.12 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 125.064 1.477 . . . . 0.0 113.336 171.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.75 9.07 33.55 Favored Glycine 0 CA--C 1.48 -2.131 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -79.6 108.58 13.26 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 124.395 2.045 . . . . 0.0 111.003 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.63 127.72 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 166.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -116.45 123.91 48.65 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 113.347 -1.752 . . . . 0.0 107.549 -173.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.56 130.23 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.05 -8.73 19.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 118.551 2.797 . . . . 0.0 118.551 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -17.55 133.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 120.929 3.677 . . . . 0.0 120.929 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.8 m -67.6 -40.69 84.73 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 116.973 -1.489 . . . . 0.0 112.249 168.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -80.71 126.48 31.34 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.61 -40.44 95.97 Favored Glycine 0 C--N 1.361 1.954 0 O-C-N 124.493 1.121 . . . . 0.0 113.744 169.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.76 -36.25 71.86 Favored 'General case' 0 CA--C 1.586 2.363 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -66.14 -48.28 71.31 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.02 80.75 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 125.159 1.537 . . . . 0.0 113.722 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -68.68 -37.11 79.32 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 121.48 -0.762 . . . . 0.0 110.06 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -61.53 -47.21 86.61 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.111 167.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -60.59 -45.07 95.35 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mt -59.42 -43.73 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 124.43 1.092 . . . . 0.0 113.665 172.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -65.88 -40.84 91.98 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 171.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -67.8 -38.52 83.43 Favored 'General case' 0 N--CA 1.52 3.033 0 O-C-N 119.905 -1.747 . . . . 0.0 115.045 171.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 mt -59.34 -41.53 84.54 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-N 119.457 1.026 . . . . 0.0 111.564 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -55.3 -45.44 76.25 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -62.38 -45.95 90.83 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 126.979 2.112 . . . . 0.0 112.644 171.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.258 1.1 mp -58.88 -33.23 49.07 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 168.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.498 1.935 0 O-C-N 125.601 1.813 . . . . 0.0 112.941 -178.411 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.7 pt . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -118.37 139.65 51.05 Favored 'General case' 0 C--O 1.206 -1.2 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.684 -158.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -60.75 137.77 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.28 0.32 52.24 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.179 -1.486 . . . . 0.0 115.318 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -98.17 150.39 21.53 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 120.017 -1.873 . . . . 0.0 111.679 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -105.59 143.32 16.91 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 O-C-N 125.992 2.058 . . . . 0.0 110.935 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -137.7 157.31 46.74 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 127.119 2.762 . . . . 0.0 107.396 -168.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.1 m -94.28 123.24 37.56 Favored 'General case' 0 C--N 1.372 1.55 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 164.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.52 170.5 15.24 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -126.39 135.9 52.01 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.4 t -68.39 120.52 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 122.865 1.317 . . . . 0.0 111.346 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.8 p -104.24 -31.68 9.47 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 118.839 -2.413 . . . . 0.0 111.913 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -162.92 124.02 2.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 124.327 2.013 . . . . 0.0 114.236 175.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.6 mt -82.97 132.76 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-O 124.545 2.117 . . . . 0.0 109.937 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.4 m -121.39 172.11 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.606 3.128 0 C-N-CA 127.632 2.373 . . . . 0.0 108.862 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -63.69 -32.47 73.97 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 119.108 -2.245 . . . . 0.0 113.834 -166.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -118.06 23.08 11.85 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 113.297 -1.774 . . . . 0.0 111.968 -173.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 164.69 164.28 19.65 Favored Glycine 0 C--O 1.2 -2.005 0 CA-C-O 125.005 2.447 . . . . 0.0 115.186 -171.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.15 130.64 53.41 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 112.465 -1.867 . . . . 0.0 113.113 170.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -73.47 137.71 44.68 Favored 'General case' 0 C--N 1.376 1.737 0 CA-C-O 123.926 1.822 . . . . 0.0 108.821 169.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.1 t -131.18 134.78 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-O 124.252 1.977 . . . . 0.0 107.09 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.22 141.41 35.1 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 113.653 -1.612 . . . . 0.0 114.302 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.31 147.75 32.12 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.8 151.56 1.59 Allowed Glycine 0 C--N 1.362 2.013 0 N-CA-C 119.001 2.36 . . . . 0.0 119.001 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.79 17.27 58.45 Favored Glycine 0 C--N 1.368 2.353 0 CA-C-O 118.129 -1.373 . . . . 0.0 114.734 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.25 23.72 73.11 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 116.965 1.546 . . . . 0.0 116.965 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -114.37 130.88 56.71 Favored 'General case' 0 C--O 1.194 -1.841 0 CA-C-O 123.989 1.852 . . . . 0.0 108.926 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -127.13 134.43 50.21 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 120.728 -1.232 . . . . 0.0 111.453 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.48 173.26 17.49 Favored Glycine 0 C--O 1.205 -1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 112.724 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.7 tp -104.08 139.37 39.26 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 125.427 2.537 . . . . 0.0 110.294 172.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.0 t -99.13 96.47 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 CA-C-N 113.694 -1.593 . . . . 0.0 110.633 158.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -53.39 162.59 0.74 Allowed 'General case' 0 CA--C 1.576 1.967 0 CA-C-N 119.6 1.091 . . . . 0.0 113.433 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.48 ' HA ' HD12 ' A' ' 114' ' ' ILE . 3.9 tt -48.26 -33.81 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 p -90.26 7.09 40.04 Favored 'General case' 0 C--N 1.364 1.234 0 C-N-CA 126.122 1.769 . . . . 0.0 111.569 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -119.48 12.35 12.36 Favored 'General case' 0 CA--C 1.572 1.817 0 O-C-N 119.667 -1.895 . . . . 0.0 111.861 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 111' ' ' ILE . 9.8 mt -100.31 -45.85 11.75 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 O-C-N 117.451 -3.281 . . . . 0.0 109.991 -170.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.94 167.76 24.87 Favored 'General case' 0 C--N 1.402 2.872 0 CA-C-O 124.959 2.314 . . . . 0.0 114.541 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -66.13 -41.5 90.4 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 127.056 2.143 . . . . 0.0 115.547 163.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -42.5 150.96 0.13 Allowed 'General case' 0 CA--C 1.539 0.539 0 O-C-N 128.164 3.415 . . . . 0.0 115.385 169.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -65.89 97.4 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.1 t -94.64 125.35 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-N 118.77 0.714 . . . . 0.0 109.684 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -111.76 -33.41 6.33 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -145.38 148.71 33.66 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.81 -24.97 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 116.389 -1.767 . . . . 0.0 111.358 -163.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.2 p -59.3 -31.56 69.24 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 126.003 1.721 . . . . 0.0 109.014 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.58 -16.4 61.25 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -128.28 -4.47 5.51 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -173.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.2 mt -144.85 167.13 23.34 Favored 'General case' 0 C--O 1.197 -1.701 0 O-C-N 119.706 -1.871 . . . . 0.0 109.605 165.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -138.52 159.17 42.76 Favored 'General case' 0 CA--C 1.57 1.731 0 C-N-CA 124.948 1.299 . . . . 0.0 110.815 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -71.58 148.55 46.52 Favored 'General case' 0 CA--C 1.582 2.206 0 O-C-N 120.331 -1.48 . . . . 0.0 112.862 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 59.37 28.72 65.04 Favored Glycine 0 C--N 1.369 2.401 0 C-N-CA 129.957 3.646 . . . . 0.0 114.342 -170.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -95.98 145.92 25.03 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 169.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -86.04 142.55 28.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 125.115 2.388 . . . . 0.0 106.302 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.15 127.75 11.58 Favored Pre-proline 0 N--CA 1.426 -1.639 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -170.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -54.29 121.79 10.33 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 CA-C-N 121.053 1.412 . . . . 0.0 114.157 154.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . 0.351 5.4 m -123.11 131.75 72.67 Favored 'Isoleucine or valine' 0 C--N 1.383 2.064 0 CA-C-O 124.406 2.05 . . . . 0.0 114.635 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -107.66 129.71 54.98 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.57 134.28 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 1 O-C-N 114.009 -5.432 . . . . 0.0 106.004 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.7 mt -112.42 -5.27 14.1 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-N 120.514 1.507 . . . . 0.0 111.758 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -171.7 128.19 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 124.594 2.14 . . . . 0.0 110.408 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.9 t -105.24 104.59 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 155.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.64 149.06 26.1 Favored 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -76.79 -5.71 49.32 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.791 -1.193 . . . . 0.0 114.161 -171.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -90.48 -2.43 57.93 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-O 115.931 -1.985 . . . . 0.0 111.142 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.17 23.3 8.17 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-O 123.515 1.619 . . . . 0.0 111.972 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -108.7 115.84 30.85 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 -162.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 69.3 mt -114.11 117.96 57.06 Favored 'Isoleucine or valine' 0 C--N 1.398 2.703 0 CA-C-O 122.522 1.154 . . . . 0.0 108.005 -161.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -109.97 112.7 24.88 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 124.829 2.252 . . . . 0.0 111.742 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 76.1 mt -108.62 158.83 17.22 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 111.083 -2.78 . . . . 0.0 108.481 -171.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -143.38 152.65 41.84 Favored 'General case' 0 N--CA 1.516 2.832 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 57.1 mt -107.38 -45.16 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -58.08 -37.42 74.44 Favored 'General case' 0 CA--C 1.476 -1.896 0 C-N-CA 124.15 0.98 . . . . 0.0 111.824 -173.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -76.21 -24.57 54.65 Favored 'General case' 0 N--CA 1.397 -3.114 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.25 -28.95 47.88 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.002 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 65.8 p . . . . . 0 CA--C 1.579 2.074 0 O-C-N 127.312 2.882 . . . . 0.0 108.066 175.583 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -98.31 130.34 44.99 Favored 'General case' 0 C--O 1.27 2.153 0 O-C-N 118.8 -2.437 . . . . 0.0 107.056 171.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 t -148.98 165.7 30.85 Favored 'General case' 0 C--N 1.37 1.488 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.152 -164.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.6 tt -153.16 146.74 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 169.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -110.13 117.39 33.58 Favored 'General case' 0 N--CA 1.423 -1.778 0 O-C-N 116.614 -3.804 . . . . 0.0 104.277 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 pt -108.07 165.13 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.414 2.685 . . . . 0.0 109.712 -174.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -67.23 129.02 93.89 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 112.031 -2.349 . . . . 0.0 110.746 172.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HA ' HG13 ' A' ' 25' ' ' ILE . 100.0 Cg_exo -57.45 -20.44 40.63 Favored 'Trans proline' 0 N--CA 1.515 2.762 0 N-CA-C 117.68 2.146 . . . . 0.0 117.68 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.14 -21.29 59.93 Favored 'General case' 0 N--CA 1.41 -2.448 0 C-N-CA 125.222 1.409 . . . . 0.0 112.524 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -97.53 -1.75 43.34 Favored 'General case' 0 CA--C 1.49 -1.352 0 C-N-CA 126.74 2.016 . . . . 0.0 109.517 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 22' ' ' PRO . 96.6 mt -57.72 -46.11 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 117.035 -1.459 . . . . 0.0 112.381 164.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 pttm -69.7 -29.46 66.88 Favored 'General case' 0 C--O 1.186 -2.277 0 CA-C-N 119.86 1.209 . . . . 0.0 111.73 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -72.73 -45.29 59.48 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.661 0.784 . . . . 0.0 111.819 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.443 ' HA ' HG21 ' A' ' 75' ' ' ILE . 38.6 t -68.5 -39.36 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 118.766 -0.635 . . . . 0.0 111.602 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.4 mt -63.86 -51.82 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 124.489 1.116 . . . . 0.0 111.902 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.38 179.99 52.48 Favored Glycine 0 C--O 1.208 -1.511 0 CA-C-N 112.759 -2.019 . . . . 0.0 113.872 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -77.74 116.32 18.18 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.404 0.708 . . . . 0.0 110.682 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.41 20.79 79.51 Favored Glycine 0 CA--C 1.551 2.307 0 CA-C-N 112.459 -2.155 . . . . 0.0 116.03 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.09 7.23 88.76 Favored Glycine 0 C--N 1.368 2.333 0 CA-C-N 120.353 2.077 . . . . 0.0 115.901 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 t -56.26 -50.67 70.67 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.246 -1.977 . . . . 0.0 113.116 -173.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.2 t -73.14 -32.24 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.144 0.884 . . . . 0.0 109.275 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.769 HD11 HG22 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -57.03 -48.82 81.12 Favored 'Isoleucine or valine' 0 C--N 1.371 1.5 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.395 172.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -62.72 -44.28 96.63 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 125.684 2.659 . . . . 0.0 112.308 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.2 73.42 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 117.309 -3.37 . . . . 0.0 116.981 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . 0.263 46.8 mt -61.05 -45.03 96.42 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 125.137 1.523 . . . . 0.0 108.816 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 m -58.61 -56.09 26.67 Favored 'General case' 0 C--N 1.389 2.288 0 O-C-N 118.579 -2.576 . . . . 0.0 115.408 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -56.44 -48.48 76.93 Favored 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 125.615 1.566 . . . . 0.0 112.844 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 67.8 tt0 -62.28 -51.02 69.36 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 68' ' ' ALA . 68.5 p -79.65 -8.27 59.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 124.628 1.205 . . . . 0.0 112.344 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.93 19.88 70.14 Favored Glycine 0 C--O 1.247 0.933 0 O-C-N 125.553 1.783 . . . . 0.0 114.371 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 t -148.13 152.84 37.99 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -69.04 140.32 54.92 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 124.82 2.248 . . . . 0.0 114.352 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.15 127.63 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -135.25 151.19 50.36 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 119.411 -0.915 . . . . 0.0 112.111 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.769 HG22 HD11 ' A' ' 36' ' ' ILE . 8.3 tt -136.4 124.48 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 O-C-N 120.908 -1.12 . . . . 0.0 110.963 -170.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -86.68 168.79 13.26 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-O 123.432 1.587 . . . . 0.0 112.15 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -76.85 -15.67 59.64 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 117.376 2.361 . . . . 0.0 117.376 -169.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.96 -4.25 59.12 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 123.164 1.459 . . . . 0.0 112.37 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.45 3.35 27.37 Favored Glycine 0 CA--C 1.544 1.879 0 O-C-N 119.514 -1.992 . . . . 0.0 109.967 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.8 m -89.16 107.15 18.89 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.685 2.242 . . . . 0.0 113.943 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.96 136.82 22.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.946 -1.102 . . . . 0.0 111.291 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -115.72 120.64 39.99 Favored 'General case' 0 C--N 1.391 2.388 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.01 120.1 58.76 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 -173.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.91 90.73 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -38.04 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 1 N-CA-C 121.89 4.033 . . . . 0.0 121.89 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 m -121.16 -44.39 2.39 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.61 132.43 53.26 Favored 'General case' 0 C--N 1.389 2.32 0 CA-C-O 124.451 2.072 . . . . 0.0 107.757 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -49.87 -52.73 24.78 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 118.318 2.087 . . . . 0.0 118.318 -167.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . 70.8 mm-40 -66.05 -37.7 86.5 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.32 -42.51 88.15 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.329 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.18 80.93 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 116.31 -1.805 . . . . 0.0 110.092 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 63' ' ' GLU . 16.9 tttt -61.13 -36.44 79.77 Favored 'General case' 0 C--N 1.366 1.289 0 C-N-CA 125.96 1.704 . . . . 0.0 113.887 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -64.51 -41.01 96.68 Favored 'General case' 0 N--CA 1.511 2.615 0 CA-C-O 124.375 2.036 . . . . 0.0 114.754 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.496 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -64.76 -38.02 89.58 Favored 'General case' 0 C--O 1.257 1.456 0 O-C-N 117.976 -2.952 . . . . 0.0 111.635 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.78 -49.89 77.99 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 O-C-N 125.542 1.776 . . . . 0.0 109.241 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -58.39 -37.72 75.85 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HE ' ' CD ' ' A' ' 42' ' ' GLU . 11.8 mmm180 -71.38 -41.57 69.51 Favored 'General case' 0 C--N 1.366 1.31 0 O-C-N 126.751 2.532 . . . . 0.0 112.09 174.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.4 mm -56.53 -42.82 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-O 121.941 0.877 . . . . 0.0 109.599 167.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.256 12.5 mt-10 -62.56 -42.72 99.72 Favored 'General case' 0 CA--C 1.572 1.818 0 O-C-N 121.063 -1.023 . . . . 0.0 112.932 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.81 -44.18 86.17 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 117.481 -1.247 . . . . 0.0 113.406 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 28' ' ' VAL . 19.3 mm -78.38 -25.46 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-N 121.481 1.946 . . . . 0.0 109.09 -173.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 p . . . . . 0 C--N 1.365 1.282 0 O-C-N 123.934 0.771 . . . . 0.0 112.322 176.904 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.1 pt . . . . . 0 C--O 1.279 2.653 0 CA-C-O 128.356 3.931 . . . . 0.0 114.98 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -122.76 147.43 46.51 Favored 'General case' 0 C--O 1.202 -1.396 0 O-C-N 118.23 -2.794 . . . . 0.0 108.311 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 m -64.79 154.94 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 123.91 1.814 . . . . 0.0 112.551 171.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.07 -9.6 45.68 Favored Glycine 0 CA--C 1.561 2.911 0 O-C-N 119.644 -1.91 . . . . 0.0 116.664 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -96.69 153.78 17.66 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 115.131 -2.366 . . . . 0.0 110.468 -172.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 152' ' ' ALA . 62.4 t -115.31 117.03 54.32 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 O-C-N 125.067 1.48 . . . . 0.0 110.333 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.51 166.75 10.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.806 2.442 . . . . 0.0 105.82 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 83.1 m -101.53 116.87 33.74 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 171.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.67 157.62 15.65 Favored Glycine 0 CA--C 1.469 -2.829 0 O-C-N 119.654 -1.903 . . . . 0.0 109.642 -173.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -115.93 128.82 56.06 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 118.791 -1.163 . . . . 0.0 111.69 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.06 126.2 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.391 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.2 p -102.52 -35.54 8.71 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-N 120.731 1.605 . . . . 0.0 114.249 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -165.46 157.43 14.91 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 127.061 2.725 . . . . 0.0 110.892 -173.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.5 mt -140.64 142.8 30.0 Favored 'Isoleucine or valine' 0 C--N 1.383 2.06 0 O-C-N 126.294 2.246 . . . . 0.0 107.008 -167.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.479 HG11 ' CZ ' ' A' ' 95' ' ' PHE . 2.9 p -141.19 -164.43 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.455 ' H ' HG22 ' A' ' 93' ' ' VAL . 37.3 m-20 -67.56 -38.99 84.93 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 128.72 2.808 . . . . 0.0 115.648 176.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CZ ' HG11 ' A' ' 93' ' ' VAL . 21.0 p90 -95.46 0.39 53.22 Favored 'General case' 0 N--CA 1.527 3.409 0 CA-C-O 114.07 -2.872 . . . . 0.0 116.044 174.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.64 -174.99 36.56 Favored Glycine 0 C--N 1.361 1.948 0 CA-C-N 125.245 3.657 . . . . 0.0 115.065 -170.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.61 137.25 51.59 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -91.9 144.16 25.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.6 t -143.18 136.75 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 113.554 -1.657 . . . . 0.0 108.267 -173.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' GLU . . . -107.76 144.67 34.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 125.008 2.337 . . . . 0.0 111.258 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.1 pt -140.25 167.73 18.17 Favored 'Isoleucine or valine' 0 C--O 1.259 1.582 0 CA-C-N 112.597 -2.092 . . . . 0.0 108.099 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -27.77 131.2 0.06 OUTLIER Glycine 0 CA--C 1.575 3.793 0 N-CA-C 122.634 3.814 . . . . 0.0 122.634 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.95 6.59 66.92 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -173.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.16 36.92 55.84 Favored Glycine 0 C--O 1.194 -2.366 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.494 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -103.17 110.45 22.4 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 119.034 1.417 . . . . 0.0 112.822 -170.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 27.1 tt0 -93.59 124.82 37.84 Favored 'General case' 0 N--CA 1.515 2.814 0 O-C-N 119.291 -2.13 . . . . 0.0 110.441 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -124.77 -175.91 14.43 Favored Glycine 0 CA--C 1.541 1.695 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.6 tp -121.43 127.66 51.36 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.843 1.306 . . . . 0.0 111.103 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.64 112.37 31.83 Favored 'Isoleucine or valine' 0 C--O 1.256 1.414 0 CA-C-N 113.932 -1.486 . . . . 0.0 107.193 166.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.44 152.88 42.86 Favored 'General case' 0 C--N 1.374 1.652 0 CA-C-O 125.217 2.436 . . . . 0.0 116.324 164.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 tt -52.98 -37.11 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 CA-C-N 111.076 -2.784 . . . . 0.0 113.569 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 76.7 p -76.75 -14.33 59.95 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 124.941 1.297 . . . . 0.0 109.488 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -101.88 7.78 41.44 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.675 1.19 . . . . 0.0 109.618 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 43.8 mm -78.1 -33.77 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.326 0 CA-C-O 123.106 1.431 . . . . 0.0 110.722 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -165.38 -178.58 5.06 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 119.067 -2.271 . . . . 0.0 112.509 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.19 -54.65 41.66 Favored 'General case' 0 CA--C 1.578 2.04 0 CA-C-N 112.729 -2.032 . . . . 0.0 111.857 165.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -93.63 160.55 14.73 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -84.25 127.38 33.92 Favored 'General case' 0 N--CA 1.512 2.643 0 O-C-N 125.698 1.874 . . . . 0.0 113.436 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.37 131.54 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 120.878 -1.139 . . . . 0.0 108.082 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -63.33 -40.04 96.21 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 118.468 -2.645 . . . . 0.0 112.987 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -129.27 118.07 21.72 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.93 1.292 . . . . 0.0 110.532 -175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.56 -30.16 49.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 C-N-CA 124.339 1.056 . . . . 0.0 109.602 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -23.31 63.15 Favored 'General case' 0 C--O 1.261 1.659 0 O-C-N 119.066 -2.271 . . . . 0.0 113.712 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -78.16 -20.92 51.06 Favored 'General case' 0 CA--C 1.49 -1.331 0 O-C-N 118.315 -2.741 . . . . 0.0 113.036 174.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -106.87 -8.79 16.56 Favored 'General case' 0 C--N 1.379 1.865 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.2 mt -146.0 159.01 43.86 Favored 'General case' 0 N--CA 1.402 -2.844 0 CA-C-O 124.018 1.866 . . . . 0.0 108.262 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -144.35 150.53 37.94 Favored 'General case' 0 C--O 1.201 -1.467 0 CA-C-N 111.334 -2.666 . . . . 0.0 106.074 -168.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -70.21 141.1 52.57 Favored 'General case' 0 CA--C 1.594 2.661 0 CA-C-O 123.607 1.67 . . . . 0.0 113.525 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.79 -11.59 68.35 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.25 140.42 40.07 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 121.016 2.408 . . . . 0.0 115.472 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -102.13 129.79 48.57 Favored 'General case' 0 C--N 1.381 1.959 0 O-C-N 124.949 1.406 . . . . 0.0 110.573 -163.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.11 143.28 46.52 Favored Pre-proline 0 CA--C 1.577 1.999 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.263 -176.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.15 136.04 70.11 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 CA-C-N 122.794 2.034 . . . . 0.0 110.447 169.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.54 148.17 27.21 Favored 'Isoleucine or valine' 0 C--O 1.255 1.371 0 O-C-N 125.732 1.895 . . . . 0.0 109.935 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -116.55 135.33 53.91 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 127.387 2.929 . . . . 0.0 104.736 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.8 t -87.05 127.89 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 126.76 2.537 . . . . 0.0 106.246 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 148' ' ' SER . 28.1 mt -101.03 -57.57 2.06 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -169.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -163.31 159.34 22.48 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 122.049 0.928 . . . . 0.0 109.407 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.68 119.86 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 102.323 -3.214 . . . . 0.0 102.323 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.421 ' CG ' ' HE ' ' A' ' 144' ' ' ARG . 3.5 t70 -71.52 162.18 29.85 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 129.003 2.921 . . . . 0.0 111.741 174.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -58.57 -33.53 70.05 Favored 'General case' 0 C--N 1.381 1.971 0 O-C-N 125.637 1.836 . . . . 0.0 113.111 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -90.58 11.14 22.86 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 119.296 -2.127 . . . . 0.0 109.946 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.04 16.64 69.23 Favored Glycine 0 C--O 1.251 1.193 0 CA-C-O 123.38 1.545 . . . . 0.0 113.973 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.421 ' HE ' ' CG ' ' A' ' 140' ' ' ASP . 9.2 mtm180 -71.12 117.28 12.43 Favored 'General case' 0 C--O 1.266 1.964 0 CA-C-N 112.384 -1.908 . . . . 0.0 114.062 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.1 mt -88.3 123.71 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.99 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -96.89 131.56 43.53 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-O 122.185 0.993 . . . . 0.0 110.573 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.5 mt -129.89 144.57 51.38 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 120.16 -1.588 . . . . 0.0 109.423 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.432 ' HB2' HD11 ' A' ' 137' ' ' LEU . 35.4 t -121.7 133.05 54.94 Favored 'General case' 0 C--N 1.375 1.708 0 CA-C-N 121.376 1.898 . . . . 0.0 110.656 163.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 76.3 mt -79.33 -45.1 23.97 Favored 'Isoleucine or valine' 0 C--N 1.377 1.801 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -55.71 -42.98 76.07 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 127.78 3.175 . . . . 0.0 112.418 -164.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -85.15 -19.9 31.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 115.042 -2.409 . . . . 0.0 109.892 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' A' ' 84' ' ' VAL . . . -74.31 -36.96 63.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 121.754 2.07 . . . . 0.0 113.773 167.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.5 p . . . . . 0 N--CA 1.484 1.261 0 O-C-N 125.597 1.81 . . . . 0.0 111.629 174.094 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.4 mt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 124.251 1.977 . . . . 0.0 108.479 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -118.17 138.25 52.43 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 112.581 -2.099 . . . . 0.0 111.352 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -115.46 133.45 56.02 Favored 'General case' 0 C--N 1.38 1.918 0 O-C-N 120.271 -1.518 . . . . 0.0 110.496 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.7 mm -137.87 137.42 44.92 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -98.01 137.38 36.9 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 123.156 1.455 . . . . 0.0 112.58 167.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 pt -116.5 169.4 7.01 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 C-N-CA 125.63 1.572 . . . . 0.0 112.862 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -57.08 124.77 67.59 Favored Pre-proline 0 CA--C 1.586 2.358 0 CA-C-N 113.698 -1.592 . . . . 0.0 113.065 167.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.45 -3.21 13.31 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.67 2.246 . . . . 0.0 115.182 -176.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -72.58 -19.4 61.49 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.631 1.973 . . . . 0.0 115.848 161.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -99.58 -3.98 32.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 116.604 -1.665 . . . . 0.0 111.082 -166.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.0 mt -54.96 -44.41 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 119.204 0.911 . . . . 0.0 110.937 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.31 0.1 OUTLIER -57.8 -38.0 74.75 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 125.121 1.513 . . . . 0.0 111.731 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -75.89 -35.6 59.78 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-O 114.673 -2.584 . . . . 0.0 112.925 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.76 -52.65 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 116.065 -1.922 . . . . 0.0 114.287 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.7 mt -78.22 -32.39 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 126.024 2.078 . . . . 0.0 113.247 -176.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.39 -180.0 0.18 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 120.637 3.015 . . . . 0.0 120.637 -172.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -56.4 122.05 11.0 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 113.613 -1.294 . . . . 0.0 113.397 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 49.77 22.4 4.23 Favored Glycine 0 C--N 1.36 1.882 0 N-CA-C 116.98 1.552 . . . . 0.0 116.98 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.7 77.87 Favored Glycine 1 C--N 1.402 4.221 0 CA-C-N 122.191 2.995 . . . . 0.0 113.275 -175.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.1 m -58.58 -43.46 89.45 Favored 'General case' 0 C--O 1.207 -1.172 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -172.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.0 t -72.67 -47.02 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 O-C-N 124.263 0.977 . . . . 0.0 111.53 -172.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.251 7.0 tt -62.94 -38.77 82.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 113.66 -3.067 . . . . 0.0 114.604 172.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -59.01 -49.42 77.96 Favored 'General case' 0 C--O 1.263 1.783 0 O-C-N 126.193 2.183 . . . . 0.0 111.878 167.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.16 95.89 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 175.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.77 -39.27 93.85 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.112 0.882 . . . . 0.0 111.793 172.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.8 m -52.0 -46.04 64.77 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 117.203 -1.379 . . . . 0.0 110.94 167.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -67.75 -37.08 81.66 Favored 'General case' 0 C--N 1.37 1.495 0 C-N-CA 125.602 1.561 . . . . 0.0 113.323 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.12 -37.34 64.12 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.0 p -95.09 -34.38 12.32 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.35 -1.786 . . . . 0.0 114.363 -176.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.99 37.26 22.7 Favored Glycine 0 C--N 1.386 3.317 0 CA-C-O 124.454 2.141 . . . . 0.0 108.923 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.8 p -119.64 162.05 19.64 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.982 -1.305 . . . . 0.0 109.114 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -101.62 127.49 48.33 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.443 1.116 . . . . 0.0 109.197 169.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -114.9 126.54 72.51 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 -171.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -124.15 135.4 53.47 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 123.207 1.479 . . . . 0.0 107.714 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.54 141.18 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 119.055 -2.278 . . . . 0.0 109.726 -169.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -125.5 165.79 17.82 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-O 123.242 1.496 . . . . 0.0 107.769 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.32 43.4 p-10 -88.88 8.0 31.46 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 118.346 2.721 . . . . 0.0 118.346 -162.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -96.53 15.23 22.13 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.651 -1.613 . . . . 0.0 107.866 167.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.94 34.53 71.23 Favored Glycine 0 C--N 1.365 2.184 0 O-C-N 119.706 -1.871 . . . . 0.0 112.458 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.8 m -96.62 113.85 25.45 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-O 116.447 -1.74 . . . . 0.0 108.462 164.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -109.34 138.74 35.27 Favored 'Isoleucine or valine' 0 C--N 1.378 1.827 0 CA-C-O 122.886 1.327 . . . . 0.0 107.612 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.17 123.26 48.46 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 112.59 -2.095 . . . . 0.0 111.031 -176.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.55 119.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 119.348 -2.095 . . . . 0.0 111.733 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.89 127.18 54.56 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.155 2.582 . . . . 0.0 109.19 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.84 162.31 37.99 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 120.133 -1.604 . . . . 0.0 108.022 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.4 p -84.91 0.69 50.26 Favored 'General case' 0 N--CA 1.415 -2.22 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.196 173.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -142.82 140.66 31.4 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.584 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.68 -15.33 81.35 Favored Glycine 0 C--N 1.365 2.161 0 CA-C-O 116.363 -2.354 . . . . 0.0 113.053 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.74 -42.07 86.81 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 121.084 2.442 . . . . 0.0 109.86 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -64.13 -46.42 84.21 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.525 -2.125 . . . . 0.0 108.437 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.13 98.91 Favored 'General case' 0 C--N 1.36 1.047 0 O-C-N 120.292 -1.505 . . . . 0.0 114.422 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -65.62 -35.01 79.56 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 114.984 -2.436 . . . . 0.0 112.2 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -65.64 -38.18 88.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 125.82 1.95 . . . . 0.0 109.216 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.04 99.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.82 -1.175 . . . . 0.0 112.958 169.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.19 -45.5 84.6 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 O-C-N 120.014 -1.679 . . . . 0.0 112.925 168.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -60.69 -35.29 75.91 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 120.805 1.638 . . . . 0.0 114.052 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -74.63 -27.56 60.5 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 116.474 -1.727 . . . . 0.0 114.6 165.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . 0.349 11.3 mt -76.63 -32.22 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.46 -45.32 88.84 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.68 1.992 . . . . 0.0 115.026 169.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -64.47 -36.96 85.89 Favored 'General case' 0 C--O 1.195 -1.765 0 O-C-N 125.976 2.048 . . . . 0.0 106.743 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.2 mt -60.8 -44.53 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 125.592 3.815 . . . . 0.0 111.427 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 C--N 1.309 -1.174 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -162.489 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.0 mm . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -112.33 137.27 50.71 Favored 'General case' 0 CA--C 1.578 2.033 0 CA-C-O 124.487 2.089 . . . . 0.0 111.115 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 42.6 t -80.18 130.25 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 O-C-N 120.573 -1.329 . . . . 0.0 109.553 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.52 64.75 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 116.613 1.405 . . . . 0.0 116.613 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -119.58 135.28 54.86 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 123.882 0.873 . . . . 0.0 112.208 -174.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.0 t -72.53 130.18 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -128.7 154.53 46.23 Favored 'General case' 0 C--O 1.268 2.062 0 CA-C-N 112.452 -2.158 . . . . 0.0 107.425 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.1 m -105.88 128.24 53.64 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.61 167.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 131' ' ' GLU . . . -138.53 -173.0 12.78 Favored Glycine 0 C--O 1.206 -1.606 0 O-C-N 126.791 2.557 . . . . 0.0 108.985 -167.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -144.59 150.58 37.69 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.139 -0.624 . . . . 0.0 112.365 166.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 t -59.61 132.89 25.04 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 CA-C-N 112.4 -2.182 . . . . 0.0 111.452 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -110.48 -57.08 2.26 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -134.87 150.47 50.46 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.803 1.287 . . . . 0.0 110.586 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.71 136.49 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 112.94 -1.937 . . . . 0.0 107.292 171.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.5 m -135.29 -177.15 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 111.889 -2.414 . . . . 0.0 108.576 -168.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.55 -23.81 67.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 119.162 -2.211 . . . . 0.0 115.617 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -125.66 -0.52 7.43 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.61 0.764 . . . . 0.0 111.211 -165.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.25 -169.72 41.57 Favored Glycine 0 CA--C 1.48 -2.144 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' VAL . . . -120.44 146.61 46.05 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 111.663 -2.269 . . . . 0.0 108.22 167.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -100.13 137.34 38.71 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 168.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.44 129.55 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 C-N-CA 126.541 1.936 . . . . 0.0 106.246 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.66 125.26 41.0 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 101' ' ' ILE . 1.8 pt -116.86 164.59 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 C-N-CA 125.874 1.67 . . . . 0.0 106.984 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.03 153.58 0.54 Allowed Glycine 0 CA--C 1.543 1.821 0 N-CA-C 118.659 2.223 . . . . 0.0 118.659 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.48 23.28 65.47 Favored Glycine 0 N--CA 1.487 2.083 0 O-C-N 119.523 -2.163 . . . . 0.0 112.599 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.75 36.25 93.08 Favored Glycine 0 C--N 1.358 1.79 0 C-N-CA 126.863 2.173 . . . . 0.0 117.356 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -112.97 135.13 54.08 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 123.355 1.55 . . . . 0.0 109.842 -169.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.22 138.86 47.15 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 119.546 -1.971 . . . . 0.0 105.999 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.0 165.51 24.61 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-O 118.732 -1.038 . . . . 0.0 111.316 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.0 tp -101.5 114.18 27.97 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.055 -1.458 . . . . 0.0 109.783 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 97' ' ' ALA . 47.9 t -77.5 98.56 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.933 0 CA-C-O 125.738 2.685 . . . . 0.0 110.317 160.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -65.43 149.64 49.67 Favored 'General case' 0 CA--C 1.558 1.284 1 O-C-N 115.878 -4.264 . . . . 0.0 113.146 172.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 tt -65.29 -16.07 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 113.411 -1.722 . . . . 0.0 114.775 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 89.6 p -90.11 -1.51 57.96 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 119.694 -1.879 . . . . 0.0 110.184 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -121.39 36.48 4.6 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.65 -44.02 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 127.144 2.178 . . . . 0.0 109.37 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -145.04 163.11 35.24 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 111.842 -2.435 . . . . 0.0 112.646 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -70.98 -45.94 63.16 Favored 'General case' 0 CA--C 1.576 1.961 0 O-C-N 119.623 -1.923 . . . . 0.0 115.924 171.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -77.63 149.83 34.7 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 120.616 -1.303 . . . . 0.0 111.336 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.259 94.8 mtt180 -47.44 132.06 13.5 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 125.11 2.386 . . . . 0.0 115.012 174.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -107.2 115.35 48.4 Favored 'Isoleucine or valine' 0 C--N 1.371 1.531 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.83 -40.13 87.9 Favored 'General case' 0 C--O 1.197 -1.708 0 C-N-CA 118.066 -1.454 . . . . 0.0 113.45 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -147.44 145.88 29.35 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.73 1.15 . . . . 0.0 108.397 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.76 -34.94 71.15 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.233 -172.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.4 p -68.32 -26.45 65.62 Favored 'General case' 0 C--N 1.365 1.275 0 CA-C-O 125.023 2.344 . . . . 0.0 113.285 -167.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -58.49 -34.77 71.28 Favored 'General case' 0 C--O 1.205 -1.258 0 O-C-N 118.5 -2.625 . . . . 0.0 113.896 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -86.96 -61.91 1.62 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 128.116 2.567 . . . . 0.0 112.586 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.2 mt -109.45 157.54 18.85 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 125.729 1.893 . . . . 0.0 111.129 -162.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -142.55 156.54 45.13 Favored 'General case' 0 C--O 1.209 -1.062 0 O-C-N 126.28 2.237 . . . . 0.0 105.835 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -66.97 141.76 57.49 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 127.252 2.221 . . . . 0.0 112.83 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.93 -6.59 74.07 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-O 115.889 -2.617 . . . . 0.0 114.006 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -77.96 125.62 29.61 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 126.715 2.068 . . . . 0.0 113.589 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 35.3 mt-10 -67.8 136.77 54.68 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-O 123.392 1.567 . . . . 0.0 112.717 166.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 p -152.87 142.68 15.0 Favored Pre-proline 0 C--O 1.184 -2.383 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.765 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.14 123.49 11.3 Favored 'Trans proline' 0 C--N 1.276 -3.277 0 C-N-CA 123.521 2.814 . . . . 0.0 119.026 160.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.8 m -123.4 137.8 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-O 123.356 1.55 . . . . 0.0 107.325 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -100.0 132.5 45.32 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 113.745 -1.571 . . . . 0.0 110.533 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.85 124.58 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 126.225 2.203 . . . . 0.0 109.526 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.4 mt -111.87 -28.29 8.12 Favored 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.598 -1.313 . . . . 0.0 112.786 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -160.71 144.06 13.34 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.266 1.026 . . . . 0.0 111.749 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.8 t -115.93 115.16 48.33 Favored 'Isoleucine or valine' 0 C--N 1.375 1.694 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 167.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.322 0.0 OUTLIER -82.33 161.35 22.61 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 -174.189 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -89.91 -1.05 57.9 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 119.55 -1.969 . . . . 0.0 112.768 -168.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -85.82 0.74 52.17 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 127.094 3.33 . . . . 0.0 109.635 166.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.04 4.21 61.52 Favored Glycine 0 C--O 1.217 -0.942 0 CA-C-O 115.672 -2.738 . . . . 0.0 116.323 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -76.23 105.93 7.56 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 120.578 2.189 . . . . 0.0 111.851 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.5 mt -78.51 130.86 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -123.34 131.05 53.53 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.756 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.5 mt -127.94 140.58 51.91 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 123.979 0.912 . . . . 0.0 112.734 -163.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.1 t -126.61 120.78 30.39 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.4 mt -79.04 -28.62 13.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 167.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -61.69 -51.25 69.19 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -74.79 -19.46 60.2 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 121.877 0.846 . . . . 0.0 113.078 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.89 -25.91 25.9 Favored 'General case' 0 C--N 1.369 1.415 0 O-C-N 117.088 -3.507 . . . . 0.0 111.286 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.8 p . . . . . 0 C--O 1.251 1.142 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.259 175.177 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 pt . . . . . 0 CA--C 1.51 -0.563 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -89.2 143.09 27.1 Favored 'General case' 0 C--N 1.368 1.402 0 CA-C-N 113.651 -1.613 . . . . 0.0 106.786 168.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 t -139.89 150.19 44.3 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-O 128.497 3.999 . . . . 0.0 114.624 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -137.56 134.15 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.502 0 CA-C-N 110.517 -3.038 . . . . 0.0 106.061 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -86.2 118.56 25.73 Favored 'General case' 0 CA--C 1.473 -2.013 0 O-C-N 125.38 1.675 . . . . 0.0 111.45 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.9 pt -112.0 152.41 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.651 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -47.63 114.46 3.17 Favored Pre-proline 0 C--O 1.212 -0.904 0 CA-C-O 115.371 -2.252 . . . . 0.0 114.323 163.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.17 -0.31 10.57 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 123.655 2.341 . . . . 0.0 115.894 -167.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -65.47 -29.88 70.59 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 125.761 1.913 . . . . 0.0 115.03 165.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -90.34 8.67 32.27 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 125.276 1.61 . . . . 0.0 113.394 -173.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.9 mt -66.07 -38.2 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 120.13 1.332 . . . . 0.0 112.321 -171.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -58.93 -45.3 90.73 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 125.76 1.913 . . . . 0.0 115.601 171.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.33 -49.43 77.62 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 125.266 1.604 . . . . 0.0 112.163 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 t -55.26 -49.5 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 O-C-N 128.66 3.725 . . . . 0.0 116.017 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.1 pt -74.85 -24.35 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 114.287 -2.768 . . . . 0.0 114.484 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.19 157.49 20.89 Favored Glycine 0 C--N 1.358 1.805 0 CA-C-N 120.8 1.636 . . . . 0.0 113.404 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.61 138.3 56.31 Favored 'General case' 0 C--N 1.378 1.82 0 CA-C-O 124.827 2.251 . . . . 0.0 107.593 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 43.92 29.05 1.35 Allowed Glycine 0 CA--C 1.557 2.665 0 CA-C-N 112.633 -2.076 . . . . 0.0 116.785 -158.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.17 20.84 63.32 Favored Glycine 0 C--O 1.213 -1.2 0 CA-C-N 121.131 2.465 . . . . 0.0 116.686 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.3 p -62.91 -37.7 88.01 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 127.11 2.164 . . . . 0.0 113.781 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.252 41.3 t -75.55 -35.47 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 123.724 0.64 . . . . 0.0 111.134 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.26 19.8 tt -67.64 -37.02 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 116.417 -2.113 . . . . 0.0 112.21 173.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -60.03 -43.4 95.34 Favored 'General case' 0 CA--C 1.584 2.271 0 CA-C-N 120.85 1.659 . . . . 0.0 114.697 171.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.73 82.89 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.149 2.58 . . . . 0.0 113.242 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -60.03 -45.1 93.91 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 124.973 1.42 . . . . 0.0 108.421 170.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 31.2 m -56.3 -54.45 45.28 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 120.684 1.584 . . . . 0.0 107.563 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.42 -43.5 96.7 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 119.568 3.173 . . . . 0.0 119.568 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -83.22 -25.46 31.7 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 p -78.15 -49.18 14.34 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 119.813 -1.805 . . . . 0.0 108.842 170.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.18 34.13 6.27 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 116.49 -2.283 . . . . 0.0 109.727 -173.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.3 p -131.15 172.77 11.73 Favored 'General case' 0 C--N 1.381 1.949 0 O-C-N 126.046 1.674 . . . . 0.0 110.436 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.6 m -109.2 138.42 45.58 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 123.44 1.591 . . . . 0.0 111.587 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.6 mp -135.48 127.68 46.7 Favored 'Isoleucine or valine' 0 C--N 1.387 2.196 0 CA-C-O 123.105 1.431 . . . . 0.0 110.223 -165.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.258 29.2 tt0 -128.43 129.2 45.8 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 117.662 -3.149 . . . . 0.0 106.831 164.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.4 mt -100.71 121.31 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 125.652 1.845 . . . . 0.0 109.874 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -87.36 150.76 23.61 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.259 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -54.09 -30.63 49.14 Favored 'General case' 0 C--O 1.261 1.668 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -168.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -82.64 0.46 42.99 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 126.76 2.024 . . . . 0.0 111.765 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.56 18.23 57.16 Favored Glycine 0 N--CA 1.504 3.232 0 O-C-N 119.327 -2.108 . . . . 0.0 110.745 -175.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -84.38 101.82 12.27 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.56 133.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 125.467 1.729 . . . . 0.0 112.236 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -118.16 112.08 19.69 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.5 mm -103.88 127.89 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 126.606 1.963 . . . . 0.0 108.977 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.34 130.75 44.83 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.8 174.13 13.62 Favored 'General case' 0 C--O 1.204 -1.313 0 O-C-N 120.704 -1.247 . . . . 0.0 109.02 -159.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -132.53 14.36 4.5 Favored 'General case' 0 CA--C 1.479 -1.753 0 CA-C-O 117.366 -1.302 . . . . 0.0 109.118 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -150.51 150.22 30.99 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.61 -44.51 6.1 Favored Glycine 0 N--CA 1.507 3.405 0 C-N-CA 127.024 2.25 . . . . 0.0 113.816 -163.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -50.48 -44.12 55.69 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 163.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -62.56 -45.25 93.79 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 124.883 1.364 . . . . 0.0 110.194 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.37 85.72 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.604 1.162 . . . . 0.0 110.91 173.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -58.83 -45.28 90.39 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 169.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -58.56 -41.34 85.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 126.38 2.3 . . . . 0.0 113.718 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.77 65.13 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mm -62.97 -46.2 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.804 0 CA-C-N 111.144 -2.753 . . . . 0.0 108.323 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -64.27 -49.97 69.76 Favored 'General case' 0 C--O 1.205 -1.252 0 O-C-N 124.529 1.143 . . . . 0.0 113.746 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -57.78 -39.46 77.53 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.801 1.24 . . . . 0.0 113.398 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.62 -49.38 84.01 Favored 'Isoleucine or valine' 0 C--O 1.257 1.474 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 168.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.68 -41.72 74.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -61.97 -47.69 83.69 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 127.752 2.421 . . . . 0.0 113.374 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.1 tt -71.29 -35.47 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 C-N-CA 124.349 1.06 . . . . 0.0 111.861 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 79.0 m . . . . . 0 C--N 1.355 0.82 0 CA-C-O 116.214 -1.851 . . . . 0.0 109.911 168.444 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.498 HG21 HD13 ' A' ' 145' ' ' ILE . 6.4 mm . . . . . 0 CA--C 1.577 1.998 0 CA-C-O 126.141 2.877 . . . . 0.0 104.434 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -117.83 140.52 49.58 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.694 1.998 . . . . 0.0 112.105 -173.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.43 148.76 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.667 -1.213 . . . . 0.0 113.479 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.45 -19.67 22.3 Favored Glycine 0 C--O 1.208 -1.511 0 CA-C-O 113.862 -3.743 . . . . 0.0 117.016 -171.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -96.92 158.82 15.25 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.98 1.89 . . . . 0.0 111.17 -166.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.71 127.8 75.88 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -121.35 159.54 25.88 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 124.016 1.865 . . . . 0.0 109.109 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 m -98.35 118.72 35.65 Favored 'General case' 0 C--O 1.202 -1.444 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 167.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -147.03 175.43 26.41 Favored Glycine 0 CA--C 1.569 3.416 0 C-N-CA 124.41 1.005 . . . . 0.0 114.829 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -117.15 133.15 56.35 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-O 125.633 2.635 . . . . 0.0 111.45 -169.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.3 t -67.8 121.13 16.4 Favored 'Isoleucine or valine' 0 C--N 1.366 1.304 0 O-C-N 119.214 -2.179 . . . . 0.0 106.487 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.4 p -103.8 -36.87 7.68 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.037 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -146.37 154.8 42.06 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.0 mt -126.22 130.17 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 O-C-N 125.796 1.935 . . . . 0.0 110.812 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.83 173.16 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -64.07 -27.73 69.3 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 123.262 1.506 . . . . 0.0 113.436 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -113.81 21.85 14.56 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -166.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.91 -153.01 24.95 Favored Glycine 0 C--O 1.204 -1.778 0 CA-C-O 116.991 -2.005 . . . . 0.0 111.305 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -149.69 174.33 12.69 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 102.203 -3.258 . . . . 0.0 102.203 167.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -114.86 128.76 56.48 Favored 'General case' 0 C--O 1.201 -1.47 0 O-C-N 127.669 3.106 . . . . 0.0 111.527 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.86 124.66 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 O-C-N 125.363 1.665 . . . . 0.0 107.494 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.69 117.53 17.55 Favored 'General case' 0 C--O 1.215 -0.732 1 O-C-N 129.434 4.209 . . . . 0.0 114.405 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 101' ' ' ILE . 46.0 pt -138.78 157.62 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 113.894 -1.503 . . . . 0.0 114.868 -167.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.25 -111.84 4.34 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 117.339 -1.812 . . . . 0.0 110.772 -176.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.83 -16.03 73.78 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 120.796 2.298 . . . . 0.0 112.809 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.59 -26.16 1.5 Allowed Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 116.947 -2.549 . . . . 0.0 112.377 -171.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -49.51 132.91 20.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 120.434 3.494 . . . . 0.0 120.434 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.48 143.64 48.34 Favored 'General case' 0 C--N 1.385 2.121 0 CA-C-O 123.966 1.841 . . . . 0.0 111.259 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.11 157.93 15.97 Favored Glycine 0 CA--C 1.539 1.565 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 169.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.423 HD21 ' CE1' ' A' ' 110' ' ' HIS . 4.1 tp -112.46 116.43 30.27 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 118.843 1.322 . . . . 0.0 111.001 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.56 118.4 48.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 171.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.423 ' CE1' HD21 ' A' ' 108' ' ' LEU . 90.8 m-70 -80.0 163.45 24.23 Favored 'General case' 0 C--O 1.192 -1.966 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.0 tt -56.29 -39.59 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 C-N-CA 126.327 1.851 . . . . 0.0 114.856 -170.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.8 p -77.87 -5.15 50.01 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 125.087 1.492 . . . . 0.0 114.971 171.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.77 3.49 42.2 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 173.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.6 mm -74.17 -39.76 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 124.225 1.964 . . . . 0.0 113.789 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.58 151.94 35.92 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.429 -170.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -92.42 -1.03 57.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.872 160.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -87.26 170.58 11.32 Favored 'General case' 0 CA--C 1.577 2.018 0 CA-C-O 124.523 2.106 . . . . 0.0 107.944 158.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.57 147.84 47.88 Favored 'General case' 0 C--O 1.2 -1.503 0 N-CA-C 118.071 2.619 . . . . 0.0 118.071 -173.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.5 t -139.31 125.09 22.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.47 -46.8 5.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 125.313 1.445 . . . . 0.0 108.527 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -140.05 146.09 38.53 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.69 -3.87 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.167 1.349 . . . . 0.0 110.982 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.0 p -68.59 -23.28 64.45 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 116.149 -1.881 . . . . 0.0 114.47 165.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.93 -8.33 56.18 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 127.391 2.932 . . . . 0.0 111.469 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -119.93 -68.93 0.88 Allowed 'General case' 0 C--N 1.356 0.884 0 O-C-N 120.315 -1.491 . . . . 0.0 111.049 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.8 mt -90.74 152.49 20.79 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.454 1.121 . . . . 0.0 108.047 -173.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -124.66 135.12 52.8 Favored 'General case' 0 C--N 1.385 2.118 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.7 mtm -65.83 142.97 57.76 Favored 'General case' 0 C--O 1.21 -0.987 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.85 1.57 82.42 Favored Glycine 0 C--O 1.197 -2.191 0 CA-C-O 114.255 -3.525 . . . . 0.0 116.16 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -97.65 143.11 28.64 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 120.931 2.366 . . . . 0.0 107.9 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -71.07 117.68 12.89 Favored 'General case' 0 C--O 1.2 -1.517 0 O-C-N 126.257 2.223 . . . . 0.0 111.092 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.97 128.15 25.89 Favored Pre-proline 0 CA--C 1.587 2.379 0 C-N-CA 123.868 0.867 . . . . 0.0 110.408 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.37 128.17 27.48 Favored 'Trans proline' 0 N--CA 1.525 3.341 0 C-N-CA 123.432 2.754 . . . . 0.0 113.588 153.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.8 m -140.99 135.42 33.01 Favored 'Isoleucine or valine' 0 C--N 1.374 1.645 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -101.89 141.44 34.73 Favored 'General case' 0 CA--C 1.566 1.585 0 O-C-N 120.335 -1.478 . . . . 0.0 108.62 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.78 126.71 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 123.428 1.585 . . . . 0.0 110.39 -176.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.5 mt -97.48 -76.41 0.52 Allowed 'General case' 0 C--N 1.365 1.282 0 CA-C-O 116.56 -1.686 . . . . 0.0 109.975 -172.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.43 148.75 36.62 Favored 'General case' 0 N--CA 1.416 -2.14 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.99 135.24 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 125.902 2.001 . . . . 0.0 110.34 160.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -84.56 168.75 15.1 Favored 'General case' 0 C--N 1.369 1.414 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -67.57 -38.45 84.1 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-O 117.592 -1.194 . . . . 0.0 112.788 -170.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -76.53 -7.66 55.61 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 131.64 1.99 4.52 Favored Glycine 0 CA--C 1.496 -1.15 0 CA-C-O 117.219 -1.878 . . . . 0.0 116.998 165.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.82 147.73 22.61 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 120.652 2.226 . . . . 0.0 113.965 -171.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.498 HD13 HG21 ' A' ' 79' ' ' ILE . 24.4 mt -100.0 141.39 17.17 Favored 'Isoleucine or valine' 0 C--N 1.376 1.719 0 C-N-CA 117.323 -1.751 . . . . 0.0 110.614 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -113.55 132.17 55.81 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.734 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.8 mt -124.55 165.39 17.91 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -165.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.0 t -136.69 135.31 38.1 Favored 'General case' 0 N--CA 1.524 3.253 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.624 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mm -88.32 -42.29 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 125.971 2.045 . . . . 0.0 109.441 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -64.65 -32.37 74.01 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 119.632 -1.917 . . . . 0.0 116.036 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -87.9 -3.48 58.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.416 -1.428 . . . . 0.0 110.79 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.266 . . -98.92 17.08 20.44 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.49 1.56 0 C-N-CA 124.775 1.23 . . . . 0.0 110.438 168.888 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.1 mt . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -113.99 131.29 56.39 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.72 1.263 . . . . 0.0 107.902 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.6 m -110.06 107.85 17.85 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.112 1.434 . . . . 0.0 110.507 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.7 126.06 74.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 113.758 -1.565 . . . . 0.0 111.224 -169.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -95.51 129.27 42.74 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 pt -127.87 162.81 33.01 Favored 'Isoleucine or valine' 0 C--N 1.381 1.966 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.995 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -45.87 116.48 3.37 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.954 1.701 . . . . 0.0 113.625 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -66.84 8.29 0.35 Allowed 'Trans proline' 0 N--CA 1.51 2.498 0 O-C-N 116.87 -2.226 . . . . 0.0 114.547 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.25 -15.39 35.97 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 120.29 1.405 . . . . 0.0 111.51 169.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -119.42 22.06 11.89 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 125.832 1.958 . . . . 0.0 114.902 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 mt -70.81 -40.11 76.29 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 C-N-CA 124.069 0.948 . . . . 0.0 109.884 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -58.2 -39.75 79.79 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 126.771 2.028 . . . . 0.0 115.976 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.76 -35.19 62.58 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.007 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.0 t -71.04 -41.08 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 123.271 1.51 . . . . 0.0 111.659 170.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.435 HG23 ' HA2' ' A' ' 33' ' ' GLY . 94.2 mt -64.13 -55.82 19.86 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.951 0 CA-C-O 116.389 -1.767 . . . . 0.0 111.181 173.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.721 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 88.78 -177.9 45.16 Favored Glycine 0 C--O 1.205 -1.708 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 -172.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -77.79 122.75 25.83 Favored 'General case' 0 CA--C 1.557 1.23 0 O-C-N 119.033 -2.451 . . . . 0.0 110.293 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.94 22.41 64.6 Favored Glycine 1 N--CA 1.521 4.361 0 C-N-CA 118.159 -1.972 . . . . 0.0 112.513 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.435 ' HA2' HG23 ' A' ' 29' ' ' ILE . . . 89.97 5.7 70.45 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-O 116.625 -2.209 . . . . 0.0 114.308 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -55.64 -46.81 77.4 Favored 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -174.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.721 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 73.1 t -67.12 -44.22 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -69.61 -34.48 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 O-C-N 118.934 -2.354 . . . . 0.0 110.796 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -49.12 -53.87 18.78 Favored 'General case' 0 C--N 1.381 1.973 0 O-C-N 126.07 2.106 . . . . 0.0 113.755 165.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.68 -36.8 85.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.876 1.36 . . . . 0.0 114.152 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.3 tp -61.2 -47.05 87.9 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.872 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -71.19 -25.09 62.37 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.62 -46.16 55.44 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 117.933 -1.507 . . . . 0.0 113.301 166.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.58 -32.32 64.07 Favored 'General case' 0 C--O 1.255 1.354 0 O-C-N 125.145 1.528 . . . . 0.0 108.709 -167.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.64 HG21 ' HA ' ' A' ' 68' ' ' ALA . 75.2 p -82.84 -21.16 34.49 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 120.201 -1.562 . . . . 0.0 112.877 174.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.03 34.58 87.26 Favored Glycine 0 C--N 1.381 3.075 0 C-N-CA 129.222 3.296 . . . . 0.0 112.182 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 t -146.98 157.95 43.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 119.696 -2.061 . . . . 0.0 108.572 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.2 m -74.12 128.76 36.37 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 124.325 1.016 . . . . 0.0 112.611 -172.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.5 mt -136.13 137.69 48.16 Favored 'Isoleucine or valine' 0 C--N 1.365 1.254 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -170.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -136.89 150.01 47.99 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.987 1.715 . . . . 0.0 109.336 -169.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.2 tt -141.94 155.16 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 118.82 -1.152 . . . . 0.0 112.417 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -127.17 155.27 43.65 Favored 'General case' 0 C--N 1.362 1.137 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.636 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -86.83 20.4 2.61 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -115.57 13.86 16.44 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.32 5.99 89.11 Favored Glycine 0 C--N 1.36 1.893 0 C-N-CA 119.081 -1.533 . . . . 0.0 110.385 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.4 m -88.09 114.63 24.9 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 119.963 -1.904 . . . . 0.0 108.964 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -115.71 138.33 46.49 Favored 'Isoleucine or valine' 0 C--N 1.365 1.249 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -123.79 131.56 53.62 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 112.731 -2.032 . . . . 0.0 111.58 -169.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.39 106.96 19.7 Favored 'Isoleucine or valine' 0 C--N 1.371 1.513 0 O-C-N 125.408 1.693 . . . . 0.0 109.801 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.39 121.93 33.54 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-N 112.806 -1.997 . . . . 0.0 105.977 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.04 151.87 28.92 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -165.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -123.94 -10.12 7.71 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.075 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -120.25 123.7 43.86 Favored 'General case' 0 C--N 1.377 1.762 0 CA-C-N 119.305 0.957 . . . . 0.0 110.42 171.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.28 -36.56 53.06 Favored Glycine 0 C--N 1.361 1.92 0 CA-C-O 122.629 1.127 . . . . 0.0 114.308 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -67.31 -40.73 86.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 117.243 -1.36 . . . . 0.0 112.686 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -68.09 -42.18 80.75 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.523 1.056 . . . . 0.0 112.115 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.61 84.94 Favored 'General case' 0 C--N 1.358 0.965 0 O-C-N 125.571 1.795 . . . . 0.0 112.869 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -62.76 -42.67 99.79 Favored 'General case' 0 C--O 1.261 1.678 0 O-C-N 125.179 1.55 . . . . 0.0 113.082 173.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . 0.287 12.1 t-80 -63.29 -37.64 88.05 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 126.61 2.444 . . . . 0.0 115.138 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.64 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -67.58 -43.39 80.68 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.865 170.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.318 61.4 mt -60.32 -41.74 88.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.312 0 CA-C-N 119.113 0.87 . . . . 0.0 109.683 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? -61.2 -46.02 92.17 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 117.522 -1.228 . . . . 0.0 112.825 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -59.58 -43.07 93.78 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 127.836 2.454 . . . . 0.0 110.131 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.06 -44.9 99.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -62.26 -40.05 94.92 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.06 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -54.56 -56.02 23.3 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 123.013 1.387 . . . . 0.0 113.698 173.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.257 76.9 mt -63.95 -45.16 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 112.299 -2.228 . . . . 0.0 109.776 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 N--CA 1.49 1.554 0 CA-C-N 120.619 1.554 . . . . 0.0 114.752 -176.121 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mm . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -115.03 154.86 28.06 Favored 'General case' 0 C--O 1.249 1.053 0 O-C-N 119.631 -1.918 . . . . 0.0 108.965 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.07 143.7 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.85 0 O-C-N 119.097 -2.252 . . . . 0.0 113.51 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.05 85.6 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 120.986 -1.071 . . . . 0.0 113.569 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -111.58 152.37 27.66 Favored 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 123.387 0.675 . . . . 0.0 110.804 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.58 140.09 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 126.554 2.409 . . . . 0.0 109.675 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -129.4 159.94 34.65 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 125.187 2.423 . . . . 0.0 106.657 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.5 109.86 21.98 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 118.64 -2.537 . . . . 0.0 109.319 174.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.44 166.08 18.33 Favored Glycine 0 C--N 1.368 2.348 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -169.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -120.28 149.08 42.87 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-N 112.231 -1.984 . . . . 0.0 113.544 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.18 127.71 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 124.109 1.909 . . . . 0.0 112.024 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 p -97.48 -30.2 13.03 Favored 'General case' 0 CA--C 1.48 -1.712 0 CA-C-O 116.268 -1.825 . . . . 0.0 114.218 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -171.0 151.27 3.24 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.8 mt -123.98 140.28 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 O-C-N 121.444 -0.785 . . . . 0.0 109.456 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.4 m -142.51 172.02 9.21 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.242 0 C-N-CA 126.366 1.866 . . . . 0.0 112.797 -173.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.16 -35.53 81.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 118.356 -2.715 . . . . 0.0 113.811 -165.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -109.81 18.34 20.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 125.385 1.678 . . . . 0.0 113.207 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.56 -161.81 32.47 Favored Glycine 0 CA--C 1.549 2.174 0 N-CA-C 117.711 1.845 . . . . 0.0 117.711 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.19 142.86 26.6 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 120.913 -1.345 . . . . 0.0 110.441 -173.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -99.37 134.76 41.76 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.827 1.775 . . . . 0.0 109.039 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.2 t -136.03 123.26 33.95 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.245 0 CA-C-N 112.434 -2.166 . . . . 0.0 110.497 -171.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.39 147.78 22.79 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 125.559 1.787 . . . . 0.0 113.236 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 pt -145.35 164.95 11.51 Favored 'Isoleucine or valine' 0 C--N 1.362 1.143 0 O-C-N 126.022 2.076 . . . . 0.0 110.125 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.88 141.33 1.49 Allowed Glycine 0 CA--C 1.541 1.718 0 N-CA-C 121.521 3.368 . . . . 0.0 121.521 176.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.13 24.68 51.31 Favored Glycine 0 CA--C 1.496 -1.138 0 CA-C-O 116.682 -2.177 . . . . 0.0 115.979 -174.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.47 42.85 99.19 Favored Glycine 0 CA--C 1.562 2.976 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -121.76 148.93 44.01 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 120.148 -1.796 . . . . 0.0 113.325 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -130.34 119.65 23.1 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 124.103 1.906 . . . . 0.0 107.45 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.39 171.67 22.41 Favored Glycine 0 N--CA 1.408 -3.177 0 C-N-CA 125.692 1.615 . . . . 0.0 110.125 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 tp -116.08 136.56 52.91 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 115.29 -2.29 . . . . 0.0 109.709 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -101.76 115.08 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.159 2.254 . . . . 0.0 109.14 167.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -62.66 149.54 43.25 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.269 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.0 tt -56.46 -38.89 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -175.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . 0.301 71.4 m -73.81 -10.13 59.36 Favored 'General case' 0 CA--C 1.486 -1.511 0 C-N-CA 124.387 1.075 . . . . 0.0 111.208 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -117.2 18.76 14.43 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.663 1.185 . . . . 0.0 113.213 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.407 ' HB ' HG21 ' A' ' 119' ' ' VAL . 37.2 mt -81.9 -53.79 11.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 125.347 1.459 . . . . 0.0 111.521 167.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.46 166.95 27.59 Favored 'General case' 0 C--O 1.198 -1.624 0 O-C-N 123.574 0.546 . . . . 0.0 111.617 -171.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -69.53 -43.66 72.57 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.371 163.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -48.14 145.84 2.96 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 162.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -66.58 131.57 46.31 Favored 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.956 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.407 HG21 ' HB ' ' A' ' 114' ' ' ILE . 18.6 t -110.29 102.98 14.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 170.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.56 -43.08 19.21 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 124.757 1.286 . . . . 0.0 108.876 161.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -133.31 148.06 51.89 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.006 -1.684 . . . . 0.0 108.727 170.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.35 -33.06 52.55 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 126.539 1.936 . . . . 0.0 115.152 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.2 p -62.59 -9.03 7.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 116.409 -1.758 . . . . 0.0 115.69 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -69.1 -41.99 76.7 Favored 'General case' 0 C--N 1.372 1.578 0 CA-C-N 123.691 2.951 . . . . 0.0 110.648 168.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -109.97 -34.03 6.54 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -164.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.48 142.83 39.95 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -168.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -126.51 150.35 48.82 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -55.34 136.29 49.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 125.807 1.942 . . . . 0.0 114.236 168.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.49 3.44 88.79 Favored Glycine 0 C--N 1.381 3.07 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.396 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -79.99 122.96 27.37 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.46 107.2 1.3 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 128.373 3.545 . . . . 0.0 114.069 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.4 148.01 43.05 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 111.382 -2.644 . . . . 0.0 105.582 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -90.57 134.1 1.89 Allowed 'Trans proline' 1 C--N 1.255 -4.364 0 N-CA-C 104.648 -2.866 . . . . 0.0 104.648 170.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.74 137.27 39.5 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.939 0 C-N-CA 118.119 -1.432 . . . . 0.0 109.537 -172.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -113.61 135.02 54.37 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 122.863 1.316 . . . . 0.0 108.39 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.572 HG22 HD23 ' A' ' 147' ' ' LEU . 65.8 t -80.17 121.55 33.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 113.265 -1.789 . . . . 0.0 108.977 173.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 43.4 mt -104.98 -6.8 19.74 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.483 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -168.48 144.66 3.72 Favored 'General case' 0 N--CA 1.533 3.678 0 O-C-N 119.792 -1.817 . . . . 0.0 114.659 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.282 7.2 t -127.09 103.56 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 126.444 2.34 . . . . 0.0 106.041 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.46 166.05 24.16 Favored 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 -177.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -71.56 -7.61 48.75 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -107.96 14.83 24.94 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.727 1.611 . . . . 0.0 108.808 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.89 31.34 75.35 Favored Glycine 0 N--CA 1.414 -2.786 0 O-C-N 120.663 -1.273 . . . . 0.0 115.582 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . 0.252 58.3 mtm180 -80.74 117.63 21.58 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 124.027 1.87 . . . . 0.0 109.892 168.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 64.6 mt -101.94 121.2 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 O-C-N 118.582 -2.574 . . . . 0.0 107.955 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -109.76 106.14 15.65 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.832 1.777 . . . . 0.0 114.344 -175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.572 HD23 HG22 ' A' ' 136' ' ' VAL . 20.0 mt -87.3 150.03 24.14 Favored 'General case' 0 C--N 1.389 2.284 0 CA-C-O 127.979 3.752 . . . . 0.0 110.861 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.3 t -119.51 129.1 54.54 Favored 'General case' 0 C--O 1.288 3.113 0 CA-C-N 110.158 -3.201 . . . . 0.0 110.734 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.41 -30.27 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 O-C-N 119.189 -2.194 . . . . 0.0 105.631 167.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -62.24 -46.92 86.71 Favored 'General case' 0 CA--C 1.553 1.075 0 O-C-N 120.537 -1.352 . . . . 0.0 114.136 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -69.63 -24.39 63.63 Favored 'General case' 0 C--O 1.264 1.837 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 171.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.11 -35.82 56.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 124.927 1.392 . . . . 0.0 111.414 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.4 p . . . . . 0 CA--C 1.56 1.342 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 173.775 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.1 mm . . . . . 0 N--CA 1.5 2.032 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -113.87 151.48 32.1 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 102.959 -2.978 . . . . 0.0 102.959 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 p -148.29 151.81 36.04 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-O 124.819 2.247 . . . . 0.0 112.67 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.1 pt -145.87 155.58 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 O-C-N 118.669 -2.519 . . . . 0.0 105.243 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -107.21 119.75 40.25 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 121.464 -0.772 . . . . 0.0 110.217 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.05 141.66 30.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.761 0 C-N-CA 126.124 1.77 . . . . 0.0 108.815 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -73.02 146.01 86.91 Favored Pre-proline 0 C--O 1.213 -0.819 0 CA-C-O 115.33 -2.271 . . . . 0.0 113.555 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -67.2 -19.58 50.48 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 124.25 1.658 . . . . 0.0 113.251 -160.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -57.74 -44.41 86.05 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 119.871 -1.768 . . . . 0.0 111.652 166.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -92.87 -18.28 23.01 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.241 -1.537 . . . . 0.0 109.237 -167.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mm -59.74 -34.78 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.776 1.298 . . . . 0.0 108.688 165.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -61.8 -43.37 98.99 Favored 'General case' 0 CA--C 1.579 2.082 0 O-C-N 120.94 -1.1 . . . . 0.0 112.21 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -68.74 -31.0 69.74 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 114.05 -2.881 . . . . 0.0 112.262 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.28 -42.47 78.83 Favored 'Isoleucine or valine' 0 C--N 1.381 1.968 0 O-C-N 127.709 3.131 . . . . 0.0 108.843 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.8 -48.29 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 124.176 1.941 . . . . 0.0 111.296 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.99 -176.58 49.26 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 111.4 -2.636 . . . . 0.0 114.71 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -70.11 142.03 52.64 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 116.911 -1.915 . . . . 0.0 110.532 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.01 23.21 45.48 Favored Glycine 0 N--CA 1.511 3.641 0 O-C-N 120.263 -1.523 . . . . 0.0 114.702 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 52.8 43.27 60.33 Favored Glycine 0 CA--C 1.477 -2.305 0 C-N-CA 126.389 1.947 . . . . 0.0 114.689 -168.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.6 p -97.95 -33.84 11.06 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 117.446 -1.702 . . . . 0.0 114.618 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -65.66 -36.19 77.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 O-C-N 120.499 -1.376 . . . . 0.0 112.528 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.54 -42.05 94.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 O-C-N 119.487 -2.008 . . . . 0.0 114.097 167.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -62.71 -37.27 85.86 Favored 'General case' 0 CA--C 1.583 2.244 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.8 -48.15 69.88 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 117.056 -1.449 . . . . 0.0 111.186 170.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -55.62 -42.56 75.1 Favored 'General case' 0 C--N 1.37 1.458 0 C-N-CA 124.52 1.128 . . . . 0.0 108.579 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.9 m -61.86 -47.69 83.88 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 114.607 -1.178 . . . . 0.0 112.163 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -61.28 -45.81 92.95 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.772 -2.013 . . . . 0.0 112.283 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.97 -53.2 42.04 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-O 114.655 -2.593 . . . . 0.0 114.001 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.1 p -69.19 -22.93 63.86 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 125.857 1.973 . . . . 0.0 113.336 -170.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.03 13.18 53.82 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-O 114.841 -3.199 . . . . 0.0 117.548 -176.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.98 161.66 34.17 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.693 2.247 . . . . 0.0 108.714 -162.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.3 m -66.3 123.71 20.69 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 176.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.8 mm -118.15 134.65 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -140.48 167.54 21.92 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 123.344 1.545 . . . . 0.0 108.421 170.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.6 mm -113.29 130.64 66.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 104.235 -2.505 . . . . 0.0 104.235 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -118.77 163.91 16.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -45.37 160.62 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.308 79.3 m-20 69.37 32.14 3.61 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 123.515 1.626 . . . . 0.0 114.841 170.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.7 53.75 24.37 Favored Glycine 0 C--O 1.281 3.064 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.1 m -102.63 132.89 48.44 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 125.898 1.587 . . . . 0.0 110.989 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -94.94 134.44 32.3 Favored 'Isoleucine or valine' 0 C--N 1.37 1.47 0 O-C-N 119.046 -2.284 . . . . 0.0 108.305 158.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -107.78 130.36 54.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.05 124.87 69.18 Favored 'Isoleucine or valine' 0 C--N 1.372 1.555 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 167.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.55 114.93 27.83 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.88 140.91 22.94 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 123.298 1.523 . . . . 0.0 113.636 -164.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 p -110.47 4.58 20.62 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 126.61 1.964 . . . . 0.0 111.953 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -126.2 139.33 53.43 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 169.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.32 -27.73 24.48 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 125.605 1.574 . . . . 0.0 113.577 -174.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -62.02 -39.64 92.97 Favored 'General case' 0 C--O 1.248 0.976 0 O-C-N 121.316 -1.108 . . . . 0.0 113.423 168.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -65.97 -37.36 85.77 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 118.483 0.583 . . . . 0.0 112.308 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.41 89.37 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 123.469 1.604 . . . . 0.0 114.224 173.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -67.33 -42.91 82.81 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 115.179 -2.343 . . . . 0.0 113.035 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -62.61 -40.79 98.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 126.456 2.348 . . . . 0.0 111.577 169.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.64 -48.45 69.38 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.89 -37.36 71.62 Favored 'Isoleucine or valine' 0 C--N 1.368 1.397 0 O-C-N 125.399 1.687 . . . . 0.0 109.271 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.306 27.5 tpt180 -67.82 -41.86 82.42 Favored 'General case' 0 C--N 1.375 1.709 0 O-C-N 124.726 1.266 . . . . 0.0 114.413 172.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -62.41 -39.3 92.85 Favored 'General case' 0 C--O 1.253 1.274 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.132 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mm -55.43 -31.98 28.71 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 CA-C-O 117.331 -1.319 . . . . 0.0 108.668 176.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -72.82 -29.33 63.16 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 116.956 -1.898 . . . . 0.0 109.142 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.79 -40.57 79.57 Favored 'General case' 0 C--O 1.26 1.651 0 O-C-N 120.437 -1.415 . . . . 0.0 109.121 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.39 -38.33 32.05 Favored 'Isoleucine or valine' 0 C--O 1.264 1.862 0 O-C-N 127.338 2.899 . . . . 0.0 117.191 165.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.481 1.103 0 O-C-N 117.879 -3.013 . . . . 0.0 115.998 179.092 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 C--O 1.195 -1.794 0 CA-C-O 126.023 2.82 . . . . 0.0 111.827 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -87.09 134.42 33.51 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.313 -167.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.46 129.07 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 CA-C-O 123.629 1.681 . . . . 0.0 112.568 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.43 16.87 79.92 Favored Glycine 0 N--CA 1.513 3.769 0 C-N-CA 126.698 2.094 . . . . 0.0 117.967 165.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -120.16 161.43 21.05 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.42 113.14 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 112.417 -2.174 . . . . 0.0 109.441 -164.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -94.7 163.01 13.54 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 113.188 -1.823 . . . . 0.0 113.662 169.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 m -104.85 127.48 52.69 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 116.944 -3.598 . . . . 0.0 104.007 163.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.66 -164.88 11.93 Favored Glycine 0 CA--C 1.493 -1.318 0 C-N-CA 126.978 2.228 . . . . 0.0 108.149 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -149.38 151.73 34.57 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-O 116.854 -1.546 . . . . 0.0 109.915 172.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.88 109.59 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 126.855 2.062 . . . . 0.0 111.864 -177.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -94.19 -55.71 3.1 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.91 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.7 mtm-85 -131.81 123.46 27.64 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -98.65 128.97 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 CA-C-O 123.481 1.61 . . . . 0.0 107.087 176.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.71 174.49 9.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 O-C-N 120.476 -1.39 . . . . 0.0 110.059 -169.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.68 -25.53 64.82 Favored 'General case' 0 C--N 1.377 1.767 0 O-C-N 117.835 -3.041 . . . . 0.0 116.054 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -125.51 14.32 8.19 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-O 117.571 -1.204 . . . . 0.0 112.637 -172.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.42 -159.14 30.72 Favored Glycine 0 C--O 1.193 -2.448 0 CA-C-N 120.647 1.567 . . . . 0.0 110.661 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.96 155.58 46.21 Favored 'General case' 0 CA--C 1.477 -1.838 0 O-C-N 124.759 0.917 . . . . 0.0 109.282 158.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -87.43 147.01 25.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.896 0.855 . . . . 0.0 109.894 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 t -136.97 130.85 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.62 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.269 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.47 139.47 38.03 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-O 125.14 2.4 . . . . 0.0 106.04 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.3 mt -119.86 137.57 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 111.539 -2.573 . . . . 0.0 111.955 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.84 129.26 1.5 Allowed Glycine 0 N--CA 1.503 3.143 0 N-CA-C 120.95 3.14 . . . . 0.0 120.95 172.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.08 18.23 29.82 Favored Glycine 0 C--N 1.364 2.112 0 C-N-CA 124.459 1.028 . . . . 0.0 114.343 -163.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.1 27.73 73.6 Favored Glycine 0 CA--C 1.54 1.64 0 O-C-N 125.871 1.571 . . . . 0.0 113.971 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -100.0 149.57 23.33 Favored 'General case' 0 C--N 1.369 1.448 0 CA-C-N 119.534 1.667 . . . . 0.0 112.178 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -146.48 141.35 26.99 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 123.119 1.438 . . . . 0.0 114.353 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.63 166.46 18.36 Favored Glycine 0 CA--C 1.495 -1.202 0 O-C-N 120.348 -1.47 . . . . 0.0 110.05 -174.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.22 130.71 50.52 Favored 'General case' 0 N--CA 1.518 2.934 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.385 173.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.58 109.61 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 163.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -70.03 150.59 46.47 Favored 'General case' 0 C--O 1.2 -1.551 0 CA-C-N 113.815 -1.539 . . . . 0.0 114.409 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.432 8.6 tt -49.47 -21.79 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 118.711 2.856 . . . . 0.0 118.711 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.7 p -106.32 14.45 27.4 Favored 'General case' 0 C--N 1.389 2.287 0 CA-C-O 117.781 -1.104 . . . . 0.0 110.855 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -124.41 22.44 8.45 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 124.867 1.354 . . . . 0.0 111.597 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.7 mt -99.08 -39.35 7.79 Favored 'Isoleucine or valine' 0 C--N 1.377 1.784 0 CA-C-N 123.075 2.67 . . . . 0.0 110.24 175.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -159.39 149.79 19.23 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 117.285 -1.766 . . . . 0.0 113.58 -170.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.29 -26.44 60.19 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 118.92 -2.363 . . . . 0.0 108.523 163.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -57.42 151.56 16.16 Favored 'General case' 0 N--CA 1.405 -2.691 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 162.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -66.65 142.2 57.53 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.653 1.216 . . . . 0.0 108.464 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.6 t -128.34 137.24 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.888 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -107.7 -75.19 0.64 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -114.39 155.37 26.42 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 173.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.25 -26.32 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 122.019 2.19 . . . . 0.0 114.257 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.3 p -65.01 -20.29 66.42 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.931 1.292 . . . . 0.0 112.979 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -102.97 31.91 3.97 Favored 'General case' 0 C--O 1.256 1.404 0 O-C-N 126.492 2.37 . . . . 0.0 107.517 -172.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -153.36 -55.98 0.12 Allowed 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.7 157.17 16.2 Favored 'General case' 0 C--N 1.375 1.706 0 C-N-CA 125.016 1.326 . . . . 0.0 111.447 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -117.39 148.18 41.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 127.137 2.773 . . . . 0.0 105.93 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -70.18 143.27 52.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 124.047 1.88 . . . . 0.0 110.084 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.6 -17.9 22.68 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 112.158 -2.292 . . . . 0.0 115.786 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -58.99 143.76 47.26 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 124.999 1.32 . . . . 0.0 111.562 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -111.24 99.4 8.23 Favored 'General case' 0 N--CA 1.513 2.679 0 CA-C-O 123.875 1.798 . . . . 0.0 113.461 -165.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.4 p -109.04 134.33 20.43 Favored Pre-proline 0 N--CA 1.399 -2.994 0 CA-C-N 113.215 -1.811 . . . . 0.0 108.369 -160.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -58.66 140.07 93.34 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.127 1.067 . . . . 0.0 112.957 160.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.6 p -149.16 130.27 4.9 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 123.668 1.699 . . . . 0.0 111.667 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 152' ' ' ALA . 83.8 tttt -94.39 131.5 39.99 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 112.746 -2.025 . . . . 0.0 111.118 172.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.45 132.12 33.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 126.714 3.15 . . . . 0.0 111.382 170.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 148' ' ' SER . 58.8 mt -100.14 -51.61 3.62 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 117.728 -3.108 . . . . 0.0 114.866 173.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 146' ' ' ARG . 41.3 mt-10 -139.05 142.64 38.2 Favored 'General case' 0 N--CA 1.41 -2.457 0 O-C-N 125.435 1.709 . . . . 0.0 107.416 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.46 126.25 75.04 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 163.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -91.07 156.56 17.82 Favored 'General case' 0 CA--C 1.553 1.058 0 O-C-N 125.428 1.705 . . . . 0.0 108.36 167.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -70.94 -23.49 62.25 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -92.78 26.89 2.55 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-O 123.05 1.405 . . . . 0.0 111.94 168.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.73 8.43 82.79 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 122.723 3.849 . . . . 0.0 122.723 161.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -85.09 144.9 27.94 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.265 -0.468 . . . . 0.0 110.951 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.89 132.25 68.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 138' ' ' GLU . 1.3 mpp_? -103.61 133.94 47.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.023 162.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.8 mt -121.96 152.33 39.81 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 112.269 -2.241 . . . . 0.0 108.607 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . 0.412 ' HB2' HD11 ' A' ' 137' ' ' LEU . 9.8 t -125.34 123.88 40.35 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 126.044 1.738 . . . . 0.0 110.649 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 69.4 mt -86.83 -31.0 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 117.507 -1.235 . . . . 0.0 109.981 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -60.46 -49.93 75.58 Favored 'General case' 0 C--O 1.276 2.49 0 C-N-CA 129.359 3.064 . . . . 0.0 117.518 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -88.07 -7.11 57.48 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 118.749 -1.18 . . . . 0.0 112.14 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.459 ' HB2' ' H ' ' A' ' 135' ' ' LYS . . . -67.63 -37.04 81.92 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 124.153 0.981 . . . . 0.0 112.76 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 p . . . . . 0 N--CA 1.441 -0.883 0 C-N-CA 124.245 1.018 . . . . 0.0 109.209 171.513 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.445 ' HB3' HD11 ' A' ' 69' ' ' ILE . 66.1 m80 -80.16 111.04 16.14 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 127.17 2.793 . . . . 0.0 114.622 165.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.6 p -109.92 139.98 44.4 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 127.123 2.169 . . . . 0.0 106.996 -170.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.8 tt -132.3 128.57 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -110.84 128.55 55.82 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.92 154.25 39.62 Favored 'Isoleucine or valine' 0 C--N 1.365 1.253 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.39 -162.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -58.08 148.75 59.81 Favored Pre-proline 0 C--O 1.211 -0.945 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.45 -31.25 51.89 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 N-CA-C 116.232 1.589 . . . . 0.0 116.232 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -64.83 -40.78 95.73 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 169.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -57.46 -28.28 63.21 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.6 mt -57.63 -36.89 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -65.86 -18.59 65.44 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 127.617 2.367 . . . . 0.0 115.94 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -93.02 -20.34 20.66 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.679 167.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -91.27 -22.89 6.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.231 0 O-C-N 118.243 -2.786 . . . . 0.0 114.05 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.3 mt -92.05 -55.33 6.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 119.419 -2.051 . . . . 0.0 109.642 166.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.25 173.5 48.53 Favored Glycine 0 C--N 1.375 2.703 0 O-C-N 127.551 3.032 . . . . 0.0 115.75 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -66.05 120.89 13.96 Favored 'General case' 0 CA--C 1.581 2.136 0 CA-C-O 124.239 1.971 . . . . 0.0 110.916 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.68 9.69 46.29 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 120.28 -1.512 . . . . 0.0 112.751 -172.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.43 22.57 75.39 Favored Glycine 0 C--O 1.196 -2.228 0 O-C-N 120.89 -1.359 . . . . 0.0 112.257 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 t -61.09 -41.81 97.34 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 125.042 1.337 . . . . 0.0 114.502 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.64 -44.79 59.73 Favored 'Isoleucine or valine' 0 C--O 1.258 1.541 0 CA-C-N 120.65 1.568 . . . . 0.0 113.396 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 tt -60.79 -41.14 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 119.804 -1.81 . . . . 0.0 110.437 174.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -59.9 -49.17 78.74 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 123.556 1.646 . . . . 0.0 112.843 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.56 94.15 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 124.023 1.868 . . . . 0.0 112.57 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.0 tp -56.5 -37.0 69.79 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.504 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.7 m -57.74 -60.14 4.15 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-O 115.556 -2.164 . . . . 0.0 116.239 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.63 -40.6 92.53 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 126.815 2.572 . . . . 0.0 114.336 174.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.512 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 28.1 tt0 -60.65 -47.7 85.08 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 124.889 2.28 . . . . 0.0 112.223 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.3 p -88.24 -24.65 23.19 Favored 'General case' 0 C--O 1.21 -0.991 0 O-C-N 118.98 -2.325 . . . . 0.0 109.436 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.25 38.74 94.03 Favored Glycine 0 N--CA 1.484 1.855 0 C-N-CA 118.915 -1.612 . . . . 0.0 116.95 -166.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.6 p -139.85 176.89 8.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 119.94 1.87 . . . . 0.0 108.156 -172.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -118.11 121.44 40.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.811 -1.806 . . . . 0.0 107.937 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.5 126.12 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 119.782 1.174 . . . . 0.0 108.818 -170.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -123.58 147.59 47.17 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.0 mt -127.75 115.6 40.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.182 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -77.1 167.55 21.59 Favored 'General case' 0 N--CA 1.525 3.307 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -76.42 -19.38 58.15 Favored 'General case' 0 C--N 1.378 1.835 0 C-N-CA 122.749 0.42 . . . . 0.0 111.018 -170.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.31 -12.89 51.25 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.297 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.51 17.29 34.14 Favored Glycine 0 N--CA 1.475 1.257 0 CA-C-O 116.496 -2.28 . . . . 0.0 116.917 -167.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -78.82 122.22 25.78 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 120.862 2.331 . . . . 0.0 108.815 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.3 t -94.67 126.81 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 169.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -108.13 126.07 52.33 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.449 HD11 HD12 ' A' ' 72' ' ' ILE . 5.0 mt -115.67 113.83 44.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.933 0 CA-C-N 121.366 1.894 . . . . 0.0 113.978 178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.42 137.42 32.38 Favored 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 119.661 -1.9 . . . . 0.0 108.17 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.66 141.6 45.03 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.817 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -68.39 -36.92 79.86 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.594 1.088 . . . . 0.0 108.707 170.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -119.76 129.85 54.68 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 124.401 2.048 . . . . 0.0 107.67 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.88 -29.93 71.77 Favored Glycine 0 N--CA 1.475 1.296 0 O-C-N 118.992 -2.317 . . . . 0.0 116.242 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -67.49 -28.54 67.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.358 2.079 . . . . 0.0 111.371 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.23 -37.99 84.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 124.456 1.098 . . . . 0.0 110.919 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.26 79.67 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 120.131 -1.606 . . . . 0.0 112.509 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -63.82 -45.24 90.52 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.797 174.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -63.58 -38.88 92.82 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 124.938 1.399 . . . . 0.0 112.919 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.49 82.53 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 16' ' ' HIS . 46.4 mt -52.72 -43.94 45.78 Favored 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 124.234 1.014 . . . . 0.0 110.474 170.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -60.23 -46.29 90.29 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.512 ' HE ' ' CD ' ' A' ' 42' ' ' GLU . 4.6 mmm180 -61.34 -37.22 82.51 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.101 1.319 . . . . 0.0 112.111 174.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.449 HD12 HD11 ' A' ' 57' ' ' ILE . 63.1 mt -61.54 -41.69 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 121.299 -0.876 . . . . 0.0 112.536 175.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -62.04 -41.97 98.68 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 164.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.13 -39.46 86.62 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.46 -46.69 82.26 Favored 'Isoleucine or valine' 0 C--N 1.371 1.541 0 C-N-CA 125.735 1.614 . . . . 0.0 110.227 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.474 0.728 0 CA-C-N 121.739 2.063 . . . . 0.0 113.073 -168.671 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.0 mm . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 119.49 -0.291 . . . . 0.0 111.344 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -104.21 121.98 44.42 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.79 129.3 23.28 Favored 'Isoleucine or valine' 0 C--N 1.369 1.427 0 O-C-N 119.676 -1.89 . . . . 0.0 111.239 158.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.73 1.46 63.63 Favored Glycine 0 CA--C 1.482 -2.009 0 C-N-CA 118.676 -1.726 . . . . 0.0 111.273 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HB3' ' HE1' ' A' ' 85' ' ' TYR . 21.6 ttm180 -92.54 146.89 23.32 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.449 1.119 . . . . 0.0 111.038 167.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 135' ' ' LYS . 40.3 t -100.64 135.5 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.426 ' HE1' ' HB3' ' A' ' 83' ' ' ARG . 27.9 m-85 -125.25 159.3 31.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.564 1.946 . . . . 0.0 108.491 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.64 113.68 27.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 120.738 -1.226 . . . . 0.0 108.363 169.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.75 169.09 16.74 Favored Glycine 0 CA--C 1.47 -2.727 0 C-N-CA 118.447 -1.835 . . . . 0.0 114.099 -174.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -121.1 153.05 37.96 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.932 1.866 . . . . 0.0 107.922 -175.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 81.4 t -63.68 130.79 28.92 Favored 'Isoleucine or valine' 0 C--N 1.365 1.252 0 C-N-CA 123.849 0.86 . . . . 0.0 110.572 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.4 p -100.24 -11.98 19.92 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 165.92 159.85 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 126.591 1.956 . . . . 0.0 107.176 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.467 HD12 HG22 ' A' ' 123' ' ' THR . 55.1 mt -121.55 146.66 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 O-C-N 120.64 -1.288 . . . . 0.0 109.915 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.32 178.3 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.271 0 O-C-N 117.938 -2.976 . . . . 0.0 108.612 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -65.56 -44.45 86.75 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -78.52 0.2 27.03 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 115.13 -2.367 . . . . 0.0 112.263 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.4 -155.32 26.06 Favored Glycine 0 CA--C 1.553 2.421 0 O-C-N 124.826 1.329 . . . . 0.0 115.716 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.97 155.9 47.15 Favored 'General case' 0 CA--C 1.587 2.375 0 CA-C-N 121.873 2.837 . . . . 0.0 110.549 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -86.29 129.67 34.77 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 124.159 1.933 . . . . 0.0 113.257 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.6 t -127.59 122.64 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-N 112.711 -2.041 . . . . 0.0 113.881 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.01 111.82 23.04 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.468 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.6 pt -102.91 148.5 8.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 125.903 2.763 . . . . 0.0 105.221 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -51.54 138.42 28.74 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 112.487 -2.142 . . . . 0.0 113.137 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.64 15.41 13.54 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 119.343 1.572 . . . . 0.0 110.546 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.21 21.4 65.14 Favored Glycine 0 C--N 1.303 -1.266 0 CA-C-N 120.707 2.253 . . . . 0.0 117.573 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -125.34 120.22 30.53 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -89.57 133.85 34.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 124.004 1.859 . . . . 0.0 109.09 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.54 -177.68 18.98 Favored Glycine 0 C--N 1.308 -1.009 0 O-C-N 120.88 -1.137 . . . . 0.0 110.7 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.3 tp -137.39 115.37 11.53 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 110.124 -3.038 . . . . 0.0 108.176 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.1 105.15 17.13 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 O-C-N 125.714 1.884 . . . . 0.0 108.592 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . 0.288 34.8 m80 -59.31 157.82 10.26 Favored 'General case' 0 C--O 1.191 -2.013 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 171.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.9 tp -62.23 -30.67 49.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.1 p -82.44 -18.76 40.66 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 127.831 2.452 . . . . 0.0 111.773 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -100.57 -2.62 32.42 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 124.889 1.368 . . . . 0.0 109.836 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.0 mt -73.8 -38.85 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.467 0 O-C-N 119.292 -2.13 . . . . 0.0 114.101 165.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.77 148.01 23.6 Favored 'General case' 0 N--CA 1.483 1.202 1 O-C-N 114.243 -5.285 . . . . 0.0 107.14 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -69.39 -51.83 32.84 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.442 -173.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -87.99 9.72 21.37 Favored 'General case' 0 N--CA 1.521 3.109 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.358 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.278 10.5 mpt_? 70.51 113.73 0.05 Allowed 'General case' 0 C--O 1.193 -1.885 0 C-N-CA 126.715 2.006 . . . . 0.0 112.831 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 119' ' ' VAL . 14.8 m -72.84 155.73 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 123.697 1.713 . . . . 0.0 114.0 168.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.95 -48.6 81.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.712 1.605 . . . . 0.0 113.032 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -159.62 152.26 21.43 Favored 'General case' 0 C--N 1.361 1.1 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 168.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.62 HG12 HD12 ' A' ' 126' ' ' LEU . 20.9 t -58.25 -41.45 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 C-N-CA 124.946 1.298 . . . . 0.0 112.52 -171.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.467 HG22 HD12 ' A' ' 92' ' ' ILE . 43.5 p -68.51 -20.56 64.58 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.301 -2.227 . . . . 0.0 115.957 178.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -90.02 0.73 56.95 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 119.258 -2.151 . . . . 0.0 114.089 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -120.01 -21.15 7.21 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 169.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.62 HD12 HG12 ' A' ' 122' ' ' VAL . 95.9 mt -105.2 150.15 25.33 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 119.219 -2.176 . . . . 0.0 112.943 -175.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -135.51 145.36 46.99 Favored 'General case' 0 C--N 1.366 1.295 0 O-C-N 125.894 1.996 . . . . 0.0 108.507 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 73.9 mmm -85.62 143.85 28.2 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 125.59 1.806 . . . . 0.0 111.916 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.54 0.64 84.7 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-N 110.346 -3.115 . . . . 0.0 113.859 -170.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -101.13 143.42 31.25 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.478 -1.601 . . . . 0.0 109.805 -174.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -80.94 123.24 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 125.88 1.988 . . . . 0.0 113.5 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.61 125.52 51.23 Favored Pre-proline 0 C--N 1.367 1.358 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 170.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -62.72 123.15 11.82 Favored 'Trans proline' 0 C--N 1.29 -2.54 0 O-C-N 117.439 -1.927 . . . . 0.0 112.063 164.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.49 130.16 46.69 Favored 'Isoleucine or valine' 0 C--N 1.373 1.614 0 O-C-N 119.294 -2.129 . . . . 0.0 109.582 -173.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.443 ' HB2' HG22 ' A' ' 84' ' ' VAL . 33.3 ttpt -95.16 144.27 25.91 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 117.215 -1.794 . . . . 0.0 110.935 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.7 t -83.97 130.95 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.417 0 C-N-CA 117.158 -1.817 . . . . 0.0 114.894 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.0 mt -101.68 -44.33 5.59 Favored 'General case' 0 C--N 1.37 1.491 0 C-N-CA 126.033 1.733 . . . . 0.0 114.066 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -154.11 138.6 16.81 Favored 'General case' 0 C--O 1.202 -1.427 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -174.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.3 t -92.72 137.8 21.49 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 CA-C-O 122.725 1.25 . . . . 0.0 108.959 167.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -128.27 142.25 51.21 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -103.04 -5.7 23.08 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.032 -171.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -122.14 -40.26 2.52 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 124.853 1.345 . . . . 0.0 112.872 169.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.26 -174.02 34.03 Favored Glycine 0 C--N 1.37 2.42 0 C-N-CA 128.677 3.037 . . . . 0.0 109.139 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 48.1 mmt-85 -88.72 158.77 18.08 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 112.638 -1.781 . . . . 0.0 108.122 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.7 mm -66.17 138.06 23.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 O-C-N 120.856 -1.152 . . . . 0.0 111.501 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.6 mmt-85 -94.13 131.93 39.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 117.045 -1.862 . . . . 0.0 107.001 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.7 mt -139.99 152.63 46.44 Favored 'General case' 0 C--N 1.381 1.963 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 30.4 t -121.7 120.74 35.57 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.412 1.085 . . . . 0.0 108.307 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.9 mt -80.2 -34.68 15.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 O-C-N 119.639 -1.913 . . . . 0.0 107.075 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -70.78 -20.68 62.58 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -172.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -92.14 4.65 52.73 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.142 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.17 -41.03 1.01 Allowed 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 125.02 1.328 . . . . 0.0 108.376 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.491 1.575 0 O-C-N 119.713 -1.867 . . . . 0.0 108.506 -176.549 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.0 mt . . . . . 0 C--O 1.21 -1.018 0 CA-C-O 122.97 1.366 . . . . 0.0 113.868 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -102.8 149.31 24.61 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 111.217 -2.72 . . . . 0.0 107.761 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -128.65 145.38 51.17 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 tt -127.51 142.4 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -110.99 114.58 27.99 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 120.307 -1.496 . . . . 0.0 108.627 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 21' ' ' ASN . 4.5 tp -142.25 151.8 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 O-C-N 120.854 -1.154 . . . . 0.0 111.54 -157.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.56 ' H ' HD12 ' A' ' 20' ' ' ILE . 92.9 m-20 -83.25 148.68 56.64 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 114.657 -2.592 . . . . 0.0 108.809 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . 0.275 50.5 Cg_exo -53.44 -48.21 23.16 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 N-CA-C 118.468 2.449 . . . . 0.0 118.468 -169.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.65 -10.34 45.13 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 122.162 2.256 . . . . 0.0 115.472 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -105.79 -1.11 24.71 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.439 HG12 HG23 ' A' ' 20' ' ' ILE . 37.8 mt -69.18 -43.12 81.76 Favored 'Isoleucine or valine' 0 C--O 1.263 1.812 0 C-N-CA 118.45 -1.3 . . . . 0.0 111.234 162.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -57.53 -42.02 82.07 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 115.932 -1.985 . . . . 0.0 113.809 -172.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -50.89 -32.63 21.11 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 128.809 3.818 . . . . 0.0 113.368 170.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.49 -44.31 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 123.928 0.767 . . . . 0.0 111.466 174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.57 -6.75 6.88 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.351 0 O-C-N 120.892 -1.13 . . . . 0.0 110.663 171.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -15.84 132.16 0.01 OUTLIER Glycine 0 CA--C 1.537 1.414 1 N-CA-C 127.468 5.747 . . . . 0.0 127.468 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.3 mttm 59.14 44.77 15.42 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 124.113 1.911 . . . . 0.0 113.411 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.99 30.32 65.74 Favored Glycine 0 CA--C 1.554 2.472 0 O-C-N 117.96 -2.962 . . . . 0.0 112.397 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.7 -2.15 84.26 Favored Glycine 0 C--N 1.387 3.387 0 C-N-CA 128.414 2.912 . . . . 0.0 112.941 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.3 t -58.17 -38.51 76.8 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.339 -1.094 . . . . 0.0 111.404 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 t -66.7 -47.83 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 CA-C-O 116.692 -1.623 . . . . 0.0 110.313 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 mt -55.4 -51.68 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 116.741 -1.984 . . . . 0.0 111.719 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -58.82 -43.23 90.57 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.18 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.64 88.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.037 1.29 . . . . 0.0 114.151 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.9 tp -63.46 -44.27 94.96 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 125.238 1.586 . . . . 0.0 109.082 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.1 p -62.25 -43.3 99.14 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.16 -42.13 99.37 Favored 'General case' 0 N--CA 1.514 2.743 0 CA-C-N 121.581 1.992 . . . . 0.0 113.431 166.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . 0.281 32.2 tt0 -72.19 -48.15 45.33 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.532 0.682 . . . . 0.0 111.321 -170.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.0 p -78.55 -22.05 47.8 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 114.474 -2.679 . . . . 0.0 115.531 176.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 31.54 38.24 Favored Glycine 0 C--N 1.362 1.986 0 CA-C-N 121.199 1.818 . . . . 0.0 111.466 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.526 HG21 ' HB2' ' A' ' 68' ' ' ALA . 17.6 p -132.57 171.04 14.33 Favored 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 126.529 1.932 . . . . 0.0 111.291 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 m -127.94 135.91 50.61 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 101.023 -3.695 . . . . 0.0 101.023 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.2 mt -118.96 135.05 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.636 0 CA-C-N 120.379 1.445 . . . . 0.0 112.938 -171.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -129.7 133.57 47.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 118.89 -2.382 . . . . 0.0 109.779 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.67 131.58 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.106 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -134.38 155.84 49.57 Favored 'General case' 0 C--N 1.363 1.177 0 O-C-N 119.416 -2.052 . . . . 0.0 110.221 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -40.14 151.77 0.04 OUTLIER 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t0 65.63 19.42 11.45 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 127.251 2.844 . . . . 0.0 117.349 -172.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.4 46.77 11.6 Favored Glycine 0 N--CA 1.444 -0.77 0 O-C-N 117.33 -3.356 . . . . 0.0 107.857 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -104.47 111.38 24.02 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.614 -1.634 . . . . 0.0 106.912 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -96.24 118.73 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -108.4 126.46 52.9 Favored 'General case' 0 C--N 1.378 1.819 0 CA-C-O 122.87 1.319 . . . . 0.0 111.643 -167.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 68' ' ' ALA . 32.7 mm -107.35 104.94 17.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.208 -175.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.18 135.04 38.53 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' A' ' 45' ' ' THR . . . -149.61 158.58 44.3 Favored 'General case' 0 CA--C 1.486 -1.502 0 O-C-N 118.752 -2.468 . . . . 0.0 109.598 163.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.6 m -65.29 -37.14 86.24 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 115.218 -2.325 . . . . 0.0 114.748 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -102.52 153.95 19.58 Favored 'General case' 0 C--N 1.28 -2.451 1 O-C-N 129.922 4.514 . . . . 0.0 109.986 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.84 -48.96 61.96 Favored Glycine 0 C--N 1.374 2.676 0 C-N-CA 124.838 1.209 . . . . 0.0 112.603 171.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -61.57 -42.04 98.26 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.384 1.088 . . . . 0.0 112.078 -175.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -57.44 -44.35 84.67 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 110.783 -2.917 . . . . 0.0 115.888 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.75 95.63 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 173.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -68.66 -33.71 74.47 Favored 'General case' 0 CA--C 1.585 2.291 0 CA-C-O 123.787 1.756 . . . . 0.0 114.05 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -66.61 -44.16 82.84 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.29 2.236 . . . . 0.0 112.452 167.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 45' ' ' THR . . . -62.18 -45.55 92.88 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.519 169.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.5 mm -50.43 -42.5 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 167.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -73.53 -40.44 64.0 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 118.278 -0.867 . . . . 0.0 112.238 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -58.38 -44.13 88.76 Favored 'General case' 0 CA--C 1.579 2.094 0 CA-C-O 123.466 1.603 . . . . 0.0 114.393 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.7 mm -60.45 -48.51 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.083 0 C-N-CA 127.066 2.147 . . . . 0.0 114.679 168.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -57.16 -44.11 83.17 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 119.636 -1.915 . . . . 0.0 107.592 170.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -64.9 -39.52 93.66 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 121.056 1.753 . . . . 0.0 112.396 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.3 mt -62.4 -52.11 64.08 Favored 'Isoleucine or valine' 0 C--N 1.373 1.615 0 CA-C-O 117.014 -1.47 . . . . 0.0 112.999 168.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.9 p . . . . . 0 N--CA 1.498 1.929 0 CA-C-O 123.367 1.556 . . . . 0.0 113.358 -170.339 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 N--CA 1.434 -1.251 0 CA-C-O 121.398 0.618 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -107.1 146.28 31.44 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.371 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.89 150.5 4.67 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.397 0 CA-C-O 124.188 1.946 . . . . 0.0 109.811 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.61 14.81 82.05 Favored Glycine 0 C--N 1.277 -2.702 0 CA-C-N 112.57 -2.104 . . . . 0.0 116.794 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -105.88 143.27 34.26 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 119.968 -1.901 . . . . 0.0 106.247 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.8 t -90.09 144.04 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 119.081 -1.048 . . . . 0.0 110.196 171.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -132.85 166.68 21.74 Favored 'General case' 0 C--N 1.404 2.97 0 O-C-N 125.915 2.009 . . . . 0.0 109.24 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 m -116.89 132.68 56.64 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.2 177.35 20.72 Favored Glycine 0 N--CA 1.419 -2.441 0 O-C-N 124.769 1.293 . . . . 0.0 111.725 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -118.46 136.29 53.88 Favored 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 123.79 1.757 . . . . 0.0 113.314 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.93 137.21 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.8 t -131.71 -18.34 2.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.871 1.357 . . . . 0.0 110.261 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 -142.18 150.86 41.59 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 172.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 mt -137.56 136.98 46.03 Favored 'Isoleucine or valine' 0 C--N 1.395 2.573 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.18 169.29 12.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 113.631 -1.622 . . . . 0.0 106.879 -162.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -54.13 -37.17 64.06 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -100.29 13.73 33.35 Favored 'General case' 0 N--CA 1.53 3.563 0 O-C-N 118.491 -2.63 . . . . 0.0 108.418 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 151.09 -159.34 28.13 Favored Glycine 0 C--O 1.183 -3.068 0 CA-C-N 123.445 2.839 . . . . 0.0 115.6 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.36 135.93 45.04 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -90.78 131.48 36.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.659 -1.275 . . . . 0.0 110.004 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 t -112.36 137.92 43.37 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.662 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.3 147.69 24.93 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 127.214 2.821 . . . . 0.0 105.592 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.7 pt -142.63 159.13 18.98 Favored 'Isoleucine or valine' 0 C--N 1.372 1.566 0 C-N-CA 125.715 1.606 . . . . 0.0 108.228 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.06 142.07 1.93 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 120.278 2.871 . . . . 0.0 120.278 -173.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.94 13.75 45.27 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 120.095 -1.826 . . . . 0.0 114.535 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.89 21.47 78.45 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 125.205 1.383 . . . . 0.0 110.943 -175.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -89.84 136.76 32.85 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.824 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -131.07 134.86 47.02 Favored 'General case' 0 C--N 1.361 1.1 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.31 161.68 24.7 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 125.304 1.43 . . . . 0.0 114.933 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.9 tp -95.4 125.26 39.9 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.817 -0.692 . . . . 0.0 111.657 -173.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.1 111.23 25.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 CA-C-O 115.674 -2.108 . . . . 0.0 105.663 164.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -60.73 153.8 23.25 Favored 'General case' 0 C--O 1.171 -3.049 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 171.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.479 HG13 HG22 ' A' ' 122' ' ' VAL . 20.6 tt -52.36 -31.6 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 119.737 -1.852 . . . . 0.0 114.536 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.0 p -83.38 -15.79 48.46 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -93.51 19.03 8.93 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.582 HD11 HG13 ' A' ' 122' ' ' VAL . 17.8 mt -92.14 -47.2 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-O 119.491 -0.29 . . . . 0.0 111.582 -173.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.5 162.63 38.67 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.081 0.952 . . . . 0.0 112.178 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.56 -37.78 87.67 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 125.032 2.349 . . . . 0.0 110.52 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -55.99 153.02 9.38 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 112.373 -2.194 . . . . 0.0 111.536 175.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -68.58 142.07 55.29 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 119.961 -1.712 . . . . 0.0 111.108 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.449 HG11 HD12 ' A' ' 114' ' ' ILE . 42.9 t -133.23 143.25 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.435 -175.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -112.95 -38.13 4.61 Favored 'General case' 0 C--N 1.37 1.493 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -173.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -143.44 146.71 33.67 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 169.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.582 HG13 HD11 ' A' ' 114' ' ' ILE . 24.7 t -74.14 -16.45 16.78 Favored 'Isoleucine or valine' 0 C--N 1.366 1.292 0 CA-C-O 122.856 1.312 . . . . 0.0 111.191 -164.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.3 p -85.44 -4.17 59.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -60.7 -40.61 92.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.924 1.29 . . . . 0.0 109.56 167.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -108.67 -24.87 11.14 Favored 'General case' 0 CA--C 1.557 1.22 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -118.04 126.53 52.46 Favored 'General case' 0 N--CA 1.517 2.912 0 O-C-N 117.821 -3.049 . . . . 0.0 113.696 -167.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . 0.43 ' HA ' HE21 ' A' ' 127' ' ' GLN . 0.3 OUTLIER -117.59 166.85 11.9 Favored 'General case' 0 C--O 1.199 -1.556 0 C-N-CA 117.042 -1.863 . . . . 0.0 109.507 166.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -62.13 145.07 54.38 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-O 126.102 2.858 . . . . 0.0 114.969 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.55 -6.04 26.27 Favored Glycine 0 C--O 1.21 -1.404 0 CA-C-O 115.758 -2.69 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -68.42 137.85 54.84 Favored 'General case' 0 C--N 1.361 1.079 0 CA-C-N 120.513 2.156 . . . . 0.0 115.747 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -88.03 104.48 16.69 Favored 'General case' 0 C--O 1.259 1.555 0 CA-C-O 123.854 1.788 . . . . 0.0 111.608 -164.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 m -108.57 117.95 53.11 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.048 -173.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -58.04 130.46 38.23 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.055 1.17 . . . . 0.0 112.285 158.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.37 145.67 34.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -111.69 138.3 48.45 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 119.564 -1.96 . . . . 0.0 109.338 171.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.34 139.77 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 117.343 -3.348 . . . . 0.0 112.504 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.8 mt -106.62 -36.69 6.67 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 115.277 -2.297 . . . . 0.0 109.803 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -157.81 164.23 37.22 Favored 'General case' 0 CA--C 1.473 -1.996 0 O-C-N 126.41 2.318 . . . . 0.0 107.116 -166.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.313 7.2 p -168.16 97.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-O 125.205 2.431 . . . . 0.0 110.154 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -71.65 165.91 22.99 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 119.882 -1.761 . . . . 0.0 112.273 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -61.03 -25.56 67.0 Favored 'General case' 0 C--N 1.37 1.466 0 O-C-N 125.331 1.644 . . . . 0.0 115.094 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -94.31 3.4 55.26 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.437 1.711 . . . . 0.0 110.723 -169.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.96 3.46 56.94 Favored Glycine 0 CA--C 1.552 2.38 0 O-C-N 119.432 -2.043 . . . . 0.0 113.9 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -84.2 118.4 24.12 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.813 1.245 . . . . 0.0 108.404 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.8 mt -125.32 131.39 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.268 -1.52 . . . . 0.0 108.965 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -109.16 146.47 34.07 Favored 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 120.635 1.561 . . . . 0.0 107.121 173.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.8 mt -129.64 157.19 42.8 Favored 'General case' 0 C--O 1.269 2.124 0 C-N-CA 126.194 1.798 . . . . 0.0 113.436 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.9 t -132.01 111.71 11.74 Favored 'General case' 0 C--N 1.387 2.232 0 O-C-N 126.99 2.681 . . . . 0.0 110.226 166.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.17 -41.63 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 158.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -66.38 -31.57 72.43 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-N 121.97 2.168 . . . . 0.0 111.831 -170.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.94 -49.0 72.08 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 124.694 1.198 . . . . 0.0 112.307 168.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.33 -42.17 81.4 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 126.148 2.155 . . . . 0.0 109.822 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.259 27.5 p . . . . . 0 N--CA 1.483 1.213 0 CA-C-O 122.016 0.913 . . . . 0.0 113.211 -176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 118.783 -0.627 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.445 ' CD2' ' HB1' ' A' ' 65' ' ' ALA . 26.3 m-70 -129.28 135.58 48.95 Favored 'General case' 0 CA--C 1.492 -1.275 0 O-C-N 125.134 1.521 . . . . 0.0 109.127 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 p -116.17 153.92 30.96 Favored 'General case' 0 C--N 1.377 1.78 0 C-N-CA 118.646 -1.222 . . . . 0.0 113.824 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.3 148.48 31.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 166.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -116.87 130.33 56.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -174.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.5 tp -150.04 170.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 121.762 2.074 . . . . 0.0 113.838 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -64.13 125.67 88.61 Favored Pre-proline 0 CA--C 1.561 1.4 0 O-C-N 119.156 -2.215 . . . . 0.0 110.308 -172.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.92 -20.04 22.67 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 123.465 2.777 . . . . 0.0 116.865 -165.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.9 -45.14 86.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 127.413 2.946 . . . . 0.0 111.265 167.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -79.89 -4.39 52.1 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.581 1.181 . . . . 0.0 110.553 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.413 ' HA ' ' HB ' ' A' ' 28' ' ' VAL . 17.2 mm -84.33 -22.37 8.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -77.94 -28.69 49.65 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 122.702 2.501 . . . . 0.0 107.99 173.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -57.85 -41.24 81.97 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.66 162.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 25' ' ' ILE 0.275 47.1 t -67.71 -38.75 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.594 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.06 -45.86 53.01 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.064 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.57 174.2 24.44 Favored Glycine 0 CA--C 1.556 2.612 0 O-C-N 126.096 2.122 . . . . 0.0 110.144 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -77.79 122.5 25.5 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 118.953 -2.499 . . . . 0.0 107.68 -165.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.94 19.36 75.25 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.125 -1.609 . . . . 0.0 110.529 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.8 16.91 66.83 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 117.348 1.699 . . . . 0.0 117.348 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.9 t -60.25 -42.95 96.38 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.9 t -80.78 -32.18 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 CA-C-N 121.031 1.741 . . . . 0.0 108.998 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tt -75.86 -31.09 21.82 Favored 'Isoleucine or valine' 0 C--N 1.374 1.65 0 CA-C-N 120.713 1.597 . . . . 0.0 110.741 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -59.68 -45.89 90.71 Favored 'General case' 0 CA--C 1.562 1.414 0 O-C-N 120.191 -1.568 . . . . 0.0 114.456 164.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.72 88.34 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 170.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 tp -61.06 -34.93 75.68 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.063 -1.881 . . . . 0.0 114.559 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.6 p -66.45 -42.97 86.84 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 122.641 2.473 . . . . 0.0 114.372 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -62.26 -46.38 89.07 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 127.411 2.944 . . . . 0.0 113.903 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -53.68 -46.2 70.59 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-O 117.207 -1.378 . . . . 0.0 114.27 174.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 p -88.62 -23.39 23.09 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 125.55 1.781 . . . . 0.0 114.607 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.36 27.71 54.49 Favored Glycine 0 CA--C 1.559 2.835 0 C-N-CA 125.41 1.481 . . . . 0.0 110.258 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.5 p -134.8 166.34 23.21 Favored 'General case' 0 C--N 1.373 1.626 0 CA-C-O 124.721 2.2 . . . . 0.0 108.955 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.5 m -102.01 126.13 48.86 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 111.613 -2.54 . . . . 0.0 106.565 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.4 mt -118.15 142.72 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.121 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 -171.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -145.08 139.62 27.5 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-O 123.572 1.653 . . . . 0.0 108.193 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.0 mm -101.36 139.2 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.175 -169.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -138.36 163.02 32.93 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 119.21 -2.181 . . . . 0.0 109.499 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.307 27.1 m-20 -55.44 142.09 34.05 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 112.897 -1.956 . . . . 0.0 114.954 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.277 31.9 t0 90.56 31.75 0.02 OUTLIER 'General case' 0 C--N 1.375 1.712 0 CA-C-N 110.322 -3.126 . . . . 0.0 111.177 172.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.95 46.66 90.92 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 125.754 1.645 . . . . 0.0 111.39 -169.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.1 m -103.37 121.32 42.54 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 119.777 1.788 . . . . 0.0 110.597 -171.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.28 122.05 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 123.261 1.505 . . . . 0.0 106.998 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.31 59.7 mtpt -106.95 139.38 41.44 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.266 44.1 mm -125.52 119.94 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.709 -1.244 . . . . 0.0 108.855 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.24 136.13 42.61 Favored 'General case' 0 CA--C 1.588 2.417 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.81 157.49 16.45 Favored 'General case' 0 C--N 1.398 2.695 0 C-N-CA 125.395 1.478 . . . . 0.0 110.794 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 m -92.31 -17.9 24.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 125.626 1.829 . . . . 0.0 112.793 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -123.36 141.41 52.01 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 120.131 -1.606 . . . . 0.0 110.307 -168.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.41 -48.58 81.17 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 112.637 -2.074 . . . . 0.0 114.012 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.4 -37.23 86.78 Favored 'General case' 0 CA--C 1.589 2.445 0 O-C-N 119.901 -1.94 . . . . 0.0 115.363 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -64.52 -41.64 96.26 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 120.522 -1.361 . . . . 0.0 109.174 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB1' ' CD2' ' A' ' 16' ' ' HIS . . . -64.24 -35.89 82.3 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 117.574 -1.203 . . . . 0.0 112.955 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -73.98 -33.9 64.01 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -64.95 -45.29 86.34 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 126.398 2.311 . . . . 0.0 114.101 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.61 86.22 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.629 173.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.67 -51.21 75.44 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.531 0 CA-C-O 116.648 -1.644 . . . . 0.0 112.606 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -61.76 -34.96 76.79 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 116.047 -1.93 . . . . 0.0 112.609 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -65.81 -39.44 90.88 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 124.538 1.149 . . . . 0.0 111.486 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.97 -48.52 88.18 Favored 'Isoleucine or valine' 0 C--N 1.368 1.396 0 CA-C-N 120.482 1.492 . . . . 0.0 108.616 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -45.37 -57.43 4.05 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.547 1.939 . . . . 0.0 114.07 172.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -58.94 -48.06 82.83 Favored 'General case' 0 N--CA 1.513 2.711 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 173.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.9 mt -66.42 -35.03 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.505 2.323 0 C-N-CA 124.79 1.236 . . . . 0.0 111.955 177.726 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.945 0.403 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -101.83 146.74 27.39 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-O 123.054 1.407 . . . . 0.0 112.801 171.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.05 143.24 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 113.424 -1.716 . . . . 0.0 109.829 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.93 26.01 56.74 Favored Glycine 1 N--CA 1.526 4.685 1 O-C-N 115.749 -4.344 . . . . 0.0 116.344 175.524 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -119.1 150.14 40.52 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.61 -1.295 . . . . 0.0 112.536 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.49 126.9 54.0 Favored 'Isoleucine or valine' 0 C--O 1.255 1.367 0 CA-C-O 124.911 2.291 . . . . 0.0 113.102 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -126.95 160.92 29.6 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 109.908 -3.314 . . . . 0.0 104.989 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.9 m -119.6 139.92 51.4 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.06 -173.58 16.47 Favored Glycine 0 CA--C 1.576 3.844 0 CA-C-O 123.241 1.467 . . . . 0.0 112.416 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -128.91 138.48 52.03 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 123.109 1.433 . . . . 0.0 111.332 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.28 138.11 20.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 113.284 -1.78 . . . . 0.0 106.799 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.81 -28.97 3.45 Favored 'General case' 0 CA--C 1.478 -1.824 0 CA-C-O 114.951 -2.452 . . . . 0.0 106.842 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.5 mtm-85 -143.91 146.47 33.0 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 122.42 2.373 . . . . 0.0 108.589 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.28 138.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 CA-C-O 115.579 -2.153 . . . . 0.0 113.745 168.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.78 173.6 13.43 Favored 'Isoleucine or valine' 0 C--N 1.401 2.812 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.4 -18.21 65.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.257 24.6 p90 -103.16 0.8 32.29 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.498 0.719 . . . . 0.0 111.751 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.37 -172.52 31.57 Favored Glycine 0 C--N 1.357 1.72 0 C-N-CA 117.893 -2.098 . . . . 0.0 112.752 -162.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.55 132.81 35.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.281 93.5 m-85 -79.99 133.25 36.15 Favored 'General case' 0 C--N 1.371 1.532 0 O-C-N 126.893 2.621 . . . . 0.0 109.579 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.453 HG12 HG13 ' A' ' 101' ' ' ILE . 41.8 t -125.9 130.82 72.33 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 112.577 -2.102 . . . . 0.0 105.337 -171.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . 0.261 . . -96.05 124.56 40.11 Favored 'General case' 0 CA--C 1.578 2.029 0 CA-C-N 113.54 -1.664 . . . . 0.0 107.227 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.453 HG13 HG12 ' A' ' 99' ' ' VAL . 77.6 mt -112.37 144.73 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 126.334 1.854 . . . . 0.0 106.484 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -52.66 135.11 38.48 Favored Glycine 0 C--O 1.213 -1.194 0 CA-C-O 124.623 2.235 . . . . 0.0 116.125 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.16 4.73 56.41 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.357 1.932 . . . . 0.0 113.211 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.83 31.27 5.48 Favored Glycine 0 CA--C 1.473 -2.579 0 CA-C-O 117.054 -1.97 . . . . 0.0 112.795 171.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . 0.294 51.4 mmtt -120.52 118.25 29.75 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -165.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -105.04 135.69 45.91 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 125.002 2.334 . . . . 0.0 109.754 -170.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -139.77 166.68 25.56 Favored Glycine 0 C--O 1.215 -1.086 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.699 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . 0.276 14.6 tp -113.03 135.43 53.8 Favored 'General case' 0 N--CA 1.424 -1.725 0 C-N-CA 124.374 1.07 . . . . 0.0 108.217 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.0 t -102.99 115.98 45.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 162.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -67.66 165.69 16.62 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-O 124.582 2.134 . . . . 0.0 113.984 173.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.258 11.4 tt -61.29 -32.15 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-N 111.911 -2.404 . . . . 0.0 116.703 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.3 p -84.42 -5.66 59.3 Favored 'General case' 0 C--O 1.268 2.067 0 O-C-N 124.365 1.041 . . . . 0.0 112.427 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -106.97 14.74 26.12 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 116.62 2.082 . . . . 0.0 116.62 -168.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.0 mt -85.63 -48.51 16.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-O 116.179 -1.867 . . . . 0.0 114.07 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.2 165.18 28.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 126.587 2.43 . . . . 0.0 110.053 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.15 -33.64 76.24 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.132 166.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -74.45 148.63 40.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 123.242 1.496 . . . . 0.0 113.945 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -70.42 145.2 51.19 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.773 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 37.7 t -112.62 133.86 57.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 CA-C-O 124.169 1.938 . . . . 0.0 110.884 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.72 -42.17 9.74 Favored 'General case' 0 C--N 1.38 1.906 0 O-C-N 118.574 -2.579 . . . . 0.0 108.871 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -134.77 145.87 48.82 Favored 'General case' 0 N--CA 1.526 3.342 0 O-C-N 124.473 1.108 . . . . 0.0 110.043 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.23 -29.82 47.19 Favored 'Isoleucine or valine' 0 C--O 1.254 1.292 0 CA-C-O 122.776 1.274 . . . . 0.0 113.916 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.84 20.54 2.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -86.34 -15.33 40.86 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 121.109 1.777 . . . . 0.0 111.561 161.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -125.62 -79.48 0.6 Allowed 'General case' 0 C--O 1.208 -1.088 0 C-N-CA 126.701 2.0 . . . . 0.0 110.731 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.1 mt -70.57 152.37 44.02 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 121.692 2.042 . . . . 0.0 111.752 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -132.23 152.29 51.4 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 118.777 -2.452 . . . . 0.0 106.31 165.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 40.1 mtm -63.19 131.76 49.5 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.572 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.45 0.58 50.17 Favored Glycine 0 C--N 1.363 2.06 0 O-C-N 125.011 1.444 . . . . 0.0 114.211 -171.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -84.04 149.3 26.34 Favored 'General case' 0 C--O 1.2 -1.5 0 CA-C-O 123.729 1.728 . . . . 0.0 112.765 174.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -101.14 126.07 47.81 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.646 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 132' ' ' VAL . 14.2 m -137.11 121.02 12.06 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.322 -168.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.2 140.46 30.9 Favored 'Trans proline' 0 CA--C 1.492 -1.578 0 N-CA-C 107.512 -1.765 . . . . 0.0 107.512 166.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.16 126.11 29.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -163.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -91.18 135.81 33.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 102.243 -3.243 . . . . 0.0 102.243 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.2 t -79.67 136.44 23.56 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 110.947 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.8 mt -113.81 -33.81 5.67 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.604 0.716 . . . . 0.0 111.251 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 146' ' ' ARG 0.297 28.5 mt-10 -145.55 154.99 42.78 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 172.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.64 118.81 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.795 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -70.02 170.18 11.88 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 125.71 2.671 . . . . 0.0 114.058 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -66.23 -30.33 70.75 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 111.93 -2.395 . . . . 0.0 110.028 169.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -93.4 14.11 19.53 Favored 'General case' 0 C--N 1.364 1.221 0 CA-C-O 117.37 -1.3 . . . . 0.0 111.504 -176.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.65 53.14 25.7 Favored Glycine 0 C--N 1.358 1.777 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -133.76 135.11 43.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 127.698 2.646 . . . . 0.0 107.838 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.4 mt -124.11 134.88 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 O-C-N 124.956 1.41 . . . . 0.0 110.379 -162.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.435 HH21 ' CD ' ' A' ' 138' ' ' GLU . 1.8 mpp_? -102.46 134.05 46.41 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 124.967 2.318 . . . . 0.0 107.931 170.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.3 mt -134.65 156.3 48.99 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 120.518 -1.364 . . . . 0.0 110.428 -163.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 26.1 t -135.29 118.91 17.02 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 124.288 1.035 . . . . 0.0 111.581 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . 0.262 95.3 mt -81.23 -24.25 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 CA-C-O 123.791 1.758 . . . . 0.0 108.092 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.425 ' HZ2' ' CD ' ' A' ' 151' ' ' GLU . 14.6 pttp -86.69 -32.59 20.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.353 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLU . . . . . 0.425 ' CD ' ' HZ2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -69.92 -43.6 71.35 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.267 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.56 -19.41 60.9 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.551 -1.259 . . . . 0.0 112.624 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 CA--C 1.567 1.629 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.456 168.239 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 123.954 1.835 . . . . 0.0 115.515 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 33.7 mm -111.39 133.62 56.39 Favored 'Isoleucine or valine' 0 C--N 1.367 1.329 0 O-C-N 118.578 -2.576 . . . . 0.0 109.794 174.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . 0.3 47.0 m-70 -121.75 165.12 16.3 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 112.28 -2.236 . . . . 0.0 106.542 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.2 t -149.05 162.78 39.25 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 124.501 3.319 . . . . 0.0 111.415 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.9 tt -128.27 146.23 34.11 Favored 'Isoleucine or valine' 0 C--O 1.255 1.363 1 N-CA-C 99.485 -4.265 . . . . 0.0 99.485 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -126.97 130.15 49.52 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.138 -1.601 . . . . 0.0 107.174 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 20' ' ' ILE . 39.6 pt -139.51 170.73 15.2 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -161.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -81.61 140.71 47.93 Favored Pre-proline 0 C--O 1.192 -1.948 0 O-C-N 119.325 -2.109 . . . . 0.0 113.41 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -50.62 -26.64 17.45 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 123.198 2.599 . . . . 0.0 116.421 -171.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -69.09 -25.81 64.61 Favored 'General case' 0 C--O 1.214 -0.78 0 O-C-N 119.909 -1.744 . . . . 0.0 113.636 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -82.16 -11.09 58.92 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.272 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.5 -35.5 72.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.566 0.698 . . . . 0.0 109.587 171.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -59.52 -36.63 76.47 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 116.688 2.107 . . . . 0.0 116.688 174.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -63.83 -45.13 90.96 Favored 'General case' 0 C--N 1.355 0.804 0 C-N-CA 126.046 1.738 . . . . 0.0 111.904 169.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.5 t -66.07 -46.59 87.53 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 CA-C-O 115.562 -2.161 . . . . 0.0 114.579 171.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.6 mm -58.83 -38.36 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-N 123.65 2.932 . . . . 0.0 112.519 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.43 -127.06 8.16 Favored Glycine 0 CA--C 1.555 2.542 0 O-C-N 121.269 -0.895 . . . . 0.0 112.252 -172.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -104.69 95.54 5.96 Favored 'General case' 0 C--N 1.387 2.197 0 C-N-CA 128.417 2.687 . . . . 0.0 106.309 164.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.06 41.8 86.05 Favored Glycine 0 CA--C 1.479 -2.17 0 CA-C-O 114.708 -3.273 . . . . 0.0 116.152 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.53 12.2 57.32 Favored Glycine 0 N--CA 1.438 -1.224 0 O-C-N 127.648 2.617 . . . . 0.0 114.556 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.8 p -61.86 -52.25 64.88 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.86 -46.15 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.512 0 O-C-N 125.345 1.653 . . . . 0.0 113.111 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.3 mm -50.5 -47.06 27.45 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 CA-C-O 118.466 -0.778 . . . . 0.0 112.385 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -56.61 -45.38 81.5 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.068 1.347 . . . . 0.0 110.816 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.72 73.34 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.069 -1.053 . . . . 0.0 113.439 -177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.48 -32.15 73.33 Favored 'General case' 0 C--O 1.199 -1.588 0 CA-C-O 117.457 -1.258 . . . . 0.0 112.783 174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.8 m -66.3 -44.26 83.98 Favored 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 166.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -63.83 -45.61 88.79 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-O 121.611 0.72 . . . . 0.0 112.351 175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -64.55 -57.5 8.97 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.972 1.368 . . . . 0.0 110.435 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 60.5 p -79.53 -37.88 35.55 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.889 -167.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.9 22.48 57.69 Favored Glycine 0 C--N 1.35 1.317 0 CA-C-O 123.792 1.773 . . . . 0.0 115.158 -170.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.8 p -109.58 165.36 11.72 Favored 'General case' 0 C--N 1.27 -2.872 0 CA-C-N 113.472 -1.364 . . . . 0.0 110.204 -177.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.1 m -106.11 132.52 52.09 Favored 'General case' 0 C--O 1.209 -1.051 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.9 mm -117.56 124.03 72.52 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.859 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 -162.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -124.55 143.89 50.44 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 102.004 -3.332 . . . . 0.0 102.004 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.2 mt -118.37 143.85 28.11 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.28 0 O-C-N 125.915 2.009 . . . . 0.0 108.224 -177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 54' ' ' THR . 29.1 tt0 -142.79 155.11 44.77 Favored 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.27 65.9 m-20 -48.27 167.88 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 117.096 2.258 . . . . 0.0 117.096 -169.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.291 27.2 t0 61.41 25.18 15.18 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 113.188 -1.824 . . . . 0.0 109.454 -177.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.25 23.42 58.93 Favored Glycine 0 C--N 1.375 2.718 0 C-N-CA 126.085 1.802 . . . . 0.0 117.009 172.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 50' ' ' GLU . 22.6 m -84.3 131.04 34.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 126.953 2.208 . . . . 0.0 112.707 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.8 t -121.45 119.42 58.96 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -99.47 131.99 45.11 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.025 2.93 . . . . 0.0 104.378 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 69.6 mt -127.38 115.6 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.843 0 CA-C-O 123.516 1.627 . . . . 0.0 106.841 -170.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.43 130.95 49.36 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 111.226 -2.715 . . . . 0.0 108.854 -174.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.03 170.62 18.44 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.033 1.733 . . . . 0.0 106.388 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 t -109.19 -9.86 15.0 Favored 'General case' 0 CA--C 1.564 1.509 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.679 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -123.02 131.91 53.91 Favored 'General case' 0 C--O 1.199 -1.573 0 O-C-N 117.591 -3.193 . . . . 0.0 105.825 168.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -45.31 -44.82 10.69 Favored Glycine 0 N--CA 1.508 3.448 0 C-N-CA 128.276 2.846 . . . . 0.0 112.24 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.27 -39.64 76.08 Favored 'General case' 0 CA--C 1.569 1.706 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -65.31 -47.84 75.18 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 173.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.45 -36.48 84.32 Favored 'General case' 0 N--CA 1.436 -1.151 0 C-N-CA 117.627 -1.629 . . . . 0.0 113.355 173.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -53.28 -47.63 68.99 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 170.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -64.75 -44.71 89.23 Favored 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 171.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.12 74.16 Favored 'General case' 0 C--O 1.255 1.385 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 172.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 21.4 mt -59.99 -43.64 92.9 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 CA-C-O 123.856 1.789 . . . . 0.0 111.714 173.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -63.08 -43.75 97.68 Favored 'General case' 0 N--CA 1.496 1.826 1 O-C-N 116.2 -4.063 . . . . 0.0 112.508 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -66.31 -41.05 90.26 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 117.58 -1.2 . . . . 0.0 112.773 -176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 92.4 mt -57.2 -44.92 84.4 Favored 'Isoleucine or valine' 0 C--N 1.379 1.851 0 N-CA-C 116.828 2.159 . . . . 0.0 116.828 164.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -56.23 -40.2 73.74 Favored 'General case' 0 N--CA 1.518 2.935 0 O-C-N 125.23 1.581 . . . . 0.0 113.535 170.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -71.43 -36.98 71.48 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 121.51 0.671 . . . . 0.0 112.779 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.8 mt -65.54 -23.45 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 O-C-N 119.06 -2.275 . . . . 0.0 114.727 178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 p -103.75 7.16 37.18 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 124.978 2.323 . . . . 0.0 110.855 175.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -105.92 -0.13 25.36 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 118.617 -2.552 . . . . 0.0 112.287 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -64.06 130.76 45.28 Favored 'General case' 0 C--O 1.185 -2.341 0 O-C-N 125.124 1.515 . . . . 0.0 109.661 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.2 mm -82.61 124.98 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 171.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -127.0 154.8 44.16 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 m -74.86 147.81 8.25 Favored 'Isoleucine or valine' 0 C--N 1.386 2.168 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.09 2.57 89.0 Favored Glycine 0 C--O 1.221 -0.67 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 -177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.9 mmt85 -93.4 136.1 34.0 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 118.248 1.024 . . . . 0.0 112.536 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.4 t -104.33 134.57 45.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -141.21 174.88 10.11 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 112.579 -2.101 . . . . 0.0 112.651 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 19.0 m -116.26 125.25 51.94 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -136.55 176.72 20.17 Favored Glycine 0 C--O 1.18 -3.28 0 CA-C-N 112.76 -2.018 . . . . 0.0 110.894 -168.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 88' ' ' LYS . 23.5 ttmt -148.21 125.74 11.71 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 123.764 1.745 . . . . 0.0 111.478 -167.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 77.0 t -71.11 117.11 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 CA-C-N 113.112 -1.858 . . . . 0.0 111.226 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.1 p -103.65 -36.82 7.76 Favored 'General case' 0 C--N 1.364 1.223 0 CA-C-O 118.321 -0.847 . . . . 0.0 113.133 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 82.0 mtm-85 -153.98 126.26 7.95 Favored 'General case' 0 C--O 1.199 -1.592 0 CA-C-O 123.039 1.399 . . . . 0.0 110.519 -168.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.3 mp -116.2 115.85 50.44 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 C-N-CA 125.404 1.482 . . . . 0.0 108.74 -170.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.05 165.71 9.9 Favored 'Isoleucine or valine' 0 C--N 1.374 1.644 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -42.59 -36.87 1.5 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.034 1.734 . . . . 0.0 115.603 175.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -114.18 13.84 18.06 Favored 'General case' 0 CA--C 1.562 1.44 0 O-C-N 120.181 -1.574 . . . . 0.0 114.181 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 168.05 -179.45 41.25 Favored Glycine 0 CA--C 1.483 -1.921 0 C-N-CA 117.822 -2.132 . . . . 0.0 111.803 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.67 144.51 49.22 Favored 'General case' 0 N--CA 1.44 -0.933 0 O-C-N 119.854 -1.968 . . . . 0.0 108.533 170.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -85.47 122.95 30.34 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.827 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.9 t -125.87 120.99 58.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.959 0 O-C-N 125.854 1.971 . . . . 0.0 106.521 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -89.59 139.39 30.59 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 126.25 2.219 . . . . 0.0 107.58 -176.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 105' ' ' LYS 0.274 16.8 pt -131.93 168.49 23.89 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 110.964 -2.834 . . . . 0.0 110.311 170.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.59 132.77 3.7 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 119.827 2.691 . . . . 0.0 119.827 -169.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.69 11.08 75.01 Favored Glycine 0 N--CA 1.506 3.334 0 CA-C-O 117.626 -1.652 . . . . 0.0 110.221 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.03 39.65 7.37 Favored Glycine 0 C--O 1.25 1.135 0 O-C-N 126.086 1.698 . . . . 0.0 110.181 173.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.408 ' HB2' HG13 ' A' ' 101' ' ' ILE . 57.2 mttm -98.4 99.33 10.51 Favored 'General case' 0 C--N 1.375 1.711 0 O-C-N 120.996 -1.296 . . . . 0.0 113.262 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.46 88.8 7.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.021 -1.674 . . . . 0.0 111.354 -174.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -70.26 159.11 53.53 Favored Glycine 0 N--CA 1.494 2.535 0 CA-C-N 120.135 1.334 . . . . 0.0 114.219 167.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.7 tp -105.45 111.13 23.73 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 125.928 1.605 . . . . 0.0 108.101 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.5 t -84.55 116.25 27.9 Favored 'Isoleucine or valine' 0 C--N 1.372 1.555 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 169.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -66.48 159.96 26.06 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.499 0.666 . . . . 0.0 112.617 177.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 19.5 tt -61.07 -20.08 21.38 Favored 'Isoleucine or valine' 0 C--N 1.366 1.287 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.3 p -97.64 13.02 31.62 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.072 0.463 . . . . 0.0 110.917 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -133.18 26.46 4.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.952 0.901 . . . . 0.0 109.904 -172.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.6 mm -95.59 -55.98 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.249 0 O-C-N 126.579 2.424 . . . . 0.0 107.336 173.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -151.72 176.6 11.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 119.344 -2.098 . . . . 0.0 113.105 -168.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -76.4 -35.38 58.63 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 122.884 1.326 . . . . 0.0 110.37 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.1 mmtm -61.68 151.4 33.78 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 124.236 1.97 . . . . 0.0 112.22 169.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -64.05 142.3 58.46 Favored 'General case' 0 C--O 1.205 -1.244 0 C-N-CA 126.949 2.1 . . . . 0.0 111.11 169.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.5 t -121.84 129.01 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 121.074 -1.016 . . . . 0.0 109.499 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -94.74 -36.13 11.84 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 123.612 1.672 . . . . 0.0 108.843 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -150.85 144.05 24.79 Favored 'General case' 0 CA--C 1.565 1.549 0 O-C-N 117.832 -3.043 . . . . 0.0 107.216 175.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.72 -27.23 9.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.476 -175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 70.1 p -55.92 -19.91 13.97 Favored 'General case' 0 C--N 1.383 2.037 0 C-N-CA 128.649 2.78 . . . . 0.0 115.163 175.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -80.51 -25.42 38.74 Favored 'General case' 0 N--CA 1.508 2.438 0 C-N-CA 128.113 2.565 . . . . 0.0 112.205 173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -107.14 -26.63 11.02 Favored 'General case' 0 C--N 1.369 1.428 0 CA-C-N 114.184 -1.371 . . . . 0.0 113.243 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.1 mt -134.27 140.13 46.21 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 123.342 1.544 . . . . 0.0 113.62 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -122.35 158.93 28.54 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 102.059 -3.312 . . . . 0.0 102.059 175.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . 0.311 0.8 OUTLIER -70.31 145.81 50.98 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 123.462 1.601 . . . . 0.0 113.838 171.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.96 -4.04 60.8 Favored Glycine 0 C--N 1.356 1.681 0 CA-C-N 111.896 -2.411 . . . . 0.0 115.428 176.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -94.67 142.35 27.56 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-O 123.377 1.561 . . . . 0.0 112.079 -169.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -86.46 134.52 33.68 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 119.871 -1.768 . . . . 0.0 107.477 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.71 148.12 65.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.69 137.22 6.57 Favored 'Trans proline' 0 C--N 1.28 -3.062 0 C-N-CA 122.118 1.878 . . . . 0.0 110.969 172.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.18 142.89 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 118.822 -2.424 . . . . 0.0 109.167 -169.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -112.33 134.89 53.62 Favored 'General case' 0 C--O 1.18 -2.568 0 C-N-CA 123.433 0.693 . . . . 0.0 110.198 173.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.61 140.65 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 124.221 1.963 . . . . 0.0 114.433 172.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 148' ' ' SER . 20.4 mt -106.34 -66.35 1.01 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 123.01 1.386 . . . . 0.0 110.097 170.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -128.59 147.97 50.75 Favored 'General case' 0 C--N 1.319 -0.734 0 O-C-N 120.341 -1.474 . . . . 0.0 109.382 -175.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 76.9 t -130.52 129.08 64.3 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 CA-C-O 117.33 -1.319 . . . . 0.0 107.518 169.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -86.85 155.37 20.29 Favored 'General case' 0 C--N 1.371 1.512 0 O-C-N 126.068 2.105 . . . . 0.0 111.808 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -60.46 -39.98 89.52 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -57.61 -30.29 65.21 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 116.234 1.939 . . . . 0.0 116.234 166.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 122.35 -7.11 9.86 Favored Glycine 0 N--CA 1.514 3.862 0 CA-C-N 122.376 2.353 . . . . 0.0 117.076 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.8 mtt180 -62.94 146.46 52.95 Favored 'General case' 0 C--O 1.208 -1.103 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 80.9 mt -133.2 135.98 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 CA-C-N 114.28 -1.327 . . . . 0.0 114.158 -173.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.24 128.97 56.41 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 117.928 -1.509 . . . . 0.0 108.576 167.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.6 mt -114.03 168.3 9.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 113.264 -1.789 . . . . 0.0 110.194 -175.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.463 ' HB2' HD11 ' A' ' 137' ' ' LEU . 28.8 t -137.8 127.0 24.48 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 112.312 -2.222 . . . . 0.0 113.167 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 95.6 mt -86.87 -32.97 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.598 0 CA-C-O 122.82 1.295 . . . . 0.0 109.823 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -70.54 -30.61 67.39 Favored 'General case' 0 C--O 1.252 1.206 0 C-N-CA 119.034 -1.066 . . . . 0.0 113.047 -164.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -88.31 -5.17 58.49 Favored 'General case' 0 C--N 1.381 1.968 0 CA-C-N 120.172 1.351 . . . . 0.0 110.222 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -101.2 -1.68 33.2 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-O 118.35 -0.833 . . . . 0.0 112.414 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.4 m -75.48 -32.91 60.74 Favored 'General case' 0 CA--C 1.568 1.667 0 C-N-CA 124.893 1.277 . . . . 0.0 113.576 -171.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 50.94 45.9 27.01 Favored 'General case' 0 CA--C 1.579 2.068 0 O-C-N 128.132 3.395 . . . . 0.0 114.95 170.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 . . . . . 0 C--N 1.295 -1.798 0 O-C-N 118.615 -2.553 . . . . 0.0 111.932 173.508 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.57 136.22 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.1 -1.0 . . . . 0.0 108.442 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -116.15 147.81 40.99 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 128.556 3.66 . . . . 0.0 114.385 164.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 55.1 m -128.48 130.33 47.37 Favored 'General case' 0 C--N 1.366 1.32 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.8 mm -133.66 133.02 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.608 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -166.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -98.67 137.48 37.24 Favored 'General case' 0 C--O 1.207 -1.147 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.493 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.5 pt -144.45 162.87 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 117.078 -1.439 . . . . 0.0 107.86 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -65.25 130.4 94.74 Favored Pre-proline 0 CA--C 1.597 2.766 0 O-C-N 125.281 1.613 . . . . 0.0 111.051 -176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -78.47 -7.83 15.96 Favored 'Trans proline' 0 N--CA 1.512 2.604 1 C-N-CA 125.885 4.39 . . . . 0.0 111.113 -172.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -83.53 5.26 24.69 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.173 -1.579 . . . . 0.0 109.021 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.4 mmmt -131.61 5.11 4.3 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 115.487 -2.196 . . . . 0.0 111.191 -170.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.5 mt -61.79 -45.25 99.09 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 CA-C-O 117.34 -1.314 . . . . 0.0 110.126 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -52.03 -26.04 9.89 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 124.892 1.37 . . . . 0.0 114.35 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -90.12 -21.61 22.17 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 116.175 1.917 . . . . 0.0 116.175 -168.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.5 t -80.19 -26.61 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 125.218 1.574 . . . . 0.0 109.978 172.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.8 mt -81.62 -65.02 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-O 112.917 -3.421 . . . . 0.0 105.691 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.68 166.83 40.93 Favored Glycine 0 C--N 1.371 2.511 0 CA-C-N 123.949 3.068 . . . . 0.0 113.683 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -49.25 113.91 0.91 Allowed 'General case' 0 C--N 1.382 1.991 0 CA-C-O 122.94 1.352 . . . . 0.0 113.157 -174.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.41 14.52 79.34 Favored Glycine 0 N--CA 1.505 3.241 0 O-C-N 118.998 -2.314 . . . . 0.0 113.624 176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.8 28.54 73.73 Favored Glycine 0 C--O 1.259 1.667 0 CA-C-O 123.872 1.818 . . . . 0.0 113.698 -162.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 99.4 p -61.74 -44.42 96.94 Favored 'General case' 0 C--N 1.38 1.899 0 N-CA-C 118.305 2.706 . . . . 0.0 118.305 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.68 -39.96 85.01 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.231 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 174.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 tt -61.53 -44.63 98.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-N 119.844 1.202 . . . . 0.0 111.846 175.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -62.85 -41.71 99.47 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 171.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.37 -44.79 84.72 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 117.578 -3.201 . . . . 0.0 113.447 168.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 76.6 mt -63.63 -36.45 83.87 Favored 'General case' 0 CA--C 1.498 -1.054 0 O-C-N 126.886 2.616 . . . . 0.0 112.136 -179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 43.5 m -58.48 -52.43 65.67 Favored 'General case' 0 CA--C 1.583 2.222 0 O-C-N 125.822 1.952 . . . . 0.0 114.024 169.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -61.23 -40.73 95.12 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 125.906 1.683 . . . . 0.0 108.75 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -69.7 -41.88 74.81 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.1 p -105.05 -29.91 10.11 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 117.714 -1.136 . . . . 0.0 114.06 -166.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.57 24.63 27.81 Favored Glycine 0 C--N 1.341 0.856 0 CA-C-N 119.911 1.232 . . . . 0.0 112.802 179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 52.5 p -121.3 167.83 12.31 Favored 'General case' 0 CA--C 1.507 -0.691 0 O-C-N 124.52 0.776 . . . . 0.0 110.115 -168.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.5 m -125.96 119.05 26.71 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 119.696 -0.801 . . . . 0.0 109.681 -174.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 76.4 mt -116.48 120.11 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 126.078 2.111 . . . . 0.0 107.964 -161.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -121.29 129.54 53.18 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.888 -1.96 . . . . 0.0 109.633 171.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 9.0 tt -124.56 150.38 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 116.986 -1.483 . . . . 0.0 109.783 -173.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.0 157.41 41.78 Favored 'General case' 0 C--O 1.262 1.763 0 O-C-N 124.16 0.912 . . . . 0.0 109.746 173.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -81.92 2.34 31.01 Favored 'General case' 0 C--N 1.391 2.404 0 C-N-CA 124.748 1.219 . . . . 0.0 113.202 -157.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -94.88 6.93 47.6 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-O 126.32 2.962 . . . . 0.0 110.631 175.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 85.51 48.39 4.78 Favored Glycine 0 N--CA 1.421 -2.324 0 C-N-CA 126.883 2.183 . . . . 0.0 112.493 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 58.2 m -128.22 134.67 49.04 Favored 'General case' 0 C--O 1.261 1.676 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.0 p -122.24 148.05 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.544 0 C-N-CA 116.955 -1.898 . . . . 0.0 111.595 173.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.4 128.96 56.61 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 121.155 -0.965 . . . . 0.0 109.0 175.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 mt -120.92 123.91 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 118.341 -2.724 . . . . 0.0 111.419 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.8 135.2 53.82 Favored 'General case' 0 N--CA 1.422 -1.844 0 N-CA-C 102.697 -3.075 . . . . 0.0 102.697 -174.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . . . -158.14 158.69 35.13 Favored 'General case' 0 CA--C 1.583 2.216 0 CA-C-N 113.403 -1.726 . . . . 0.0 109.253 -173.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 65.7 p -107.35 -0.9 22.1 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 119.593 -1.942 . . . . 0.0 114.713 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -145.19 163.64 33.78 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 104.605 -2.368 . . . . 0.0 104.605 171.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.31 -39.81 17.85 Favored Glycine 0 N--CA 1.489 2.228 0 O-C-N 118.566 -2.584 . . . . 0.0 113.486 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . 0.304 84.2 mt-10 -61.47 -39.18 89.96 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 119.479 -2.189 . . . . 0.0 112.884 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -58.72 -43.02 90.02 Favored 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 119.162 0.892 . . . . 0.0 109.016 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . . . -67.32 -36.88 82.38 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 123.205 1.478 . . . . 0.0 114.149 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 mmmt -64.41 -39.42 93.81 Favored 'General case' 0 CA--C 1.509 -0.617 0 O-C-N 120.625 -1.297 . . . . 0.0 112.393 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -60.63 -36.18 78.0 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 117.457 2.392 . . . . 0.0 117.457 173.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.0 -48.64 70.52 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 125.801 1.64 . . . . 0.0 113.205 163.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 64.3 mt -56.39 -41.17 70.93 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 CA-C-N 119.842 1.201 . . . . 0.0 113.551 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -59.99 -42.45 94.26 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 125.672 1.589 . . . . 0.0 112.274 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.5 mmt85 -67.11 -43.66 81.91 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 118.437 -2.665 . . . . 0.0 111.195 171.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.1 mp -63.77 -49.7 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 CA-C-O 118.096 -0.954 . . . . 0.0 109.323 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -59.98 -38.27 82.05 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 119.423 1.01 . . . . 0.0 112.433 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -61.66 -56.92 14.55 Favored 'General case' 0 CA--C 1.501 -0.91 0 O-C-N 125.805 1.941 . . . . 0.0 114.304 176.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.0 mt -58.58 -45.25 90.53 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.016 0 O-C-N 123.794 0.684 . . . . 0.0 110.488 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.6 p -80.09 -10.46 59.77 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 117.483 -1.687 . . . . 0.0 110.548 -168.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.62 72.79 Favored 'General case' 0 CA--C 1.589 2.449 0 O-C-N 124.41 1.069 . . . . 0.0 113.628 168.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -66.78 119.19 11.42 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.648 -1.16 . . . . 0.0 108.516 -168.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.8 mm -73.55 132.11 33.9 Favored 'Isoleucine or valine' 0 C--N 1.375 1.693 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -85.14 145.45 27.62 Favored 'General case' 0 C--N 1.377 1.793 0 CA-C-O 124.189 1.947 . . . . 0.0 115.762 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 42.8 t -90.81 132.23 35.92 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.333 1 CA-C-O 129.012 4.244 . . . . 0.0 114.493 175.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.48 17.08 64.95 Favored Glycine 0 C--O 1.245 0.842 0 CA-C-N 111.084 -2.78 . . . . 0.0 109.418 -176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -102.81 135.96 43.5 Favored 'General case' 0 C--N 1.38 1.897 0 CA-C-N 119.598 1.699 . . . . 0.0 109.376 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.96 115.49 20.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 116.627 -2.029 . . . . 0.0 107.435 177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -99.34 163.99 12.3 Favored 'General case' 0 C--N 1.38 1.916 0 CA-C-N 119.668 1.122 . . . . 0.0 111.565 170.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 62.1 m -128.76 134.88 48.55 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 172.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -148.1 159.45 28.03 Favored Glycine 0 CA--C 1.486 -1.749 0 CA-C-O 116.251 -2.416 . . . . 0.0 112.722 -177.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -71.25 132.8 45.47 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-N 120.753 2.277 . . . . 0.0 110.905 166.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -54.28 130.13 15.93 Favored 'Isoleucine or valine' 0 C--N 1.391 2.404 0 C-N-CA 126.801 2.041 . . . . 0.0 110.586 159.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 28.4 p -108.79 -38.96 5.49 Favored 'General case' 0 CA--C 1.499 -0.985 0 O-C-N 119.253 -2.154 . . . . 0.0 110.132 -177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.3 mmt-85 -151.63 160.43 43.65 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 117.61 -1.636 . . . . 0.0 108.293 -169.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.8 mt -135.14 121.32 32.49 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.744 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.7 m -123.39 177.14 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 CA-C-N 120.771 1.623 . . . . 0.0 108.56 -176.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -63.46 -39.6 94.89 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.629 1.206 . . . . 0.0 110.237 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -93.2 6.43 48.06 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.39 -178.09 33.91 Favored Glycine 0 C--O 1.202 -1.894 0 CA-C-O 116.848 -2.085 . . . . 0.0 112.677 -177.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.08 141.06 51.86 Favored 'General case' 0 C--N 1.361 1.107 0 CA-C-N 118.783 1.292 . . . . 0.0 111.001 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.458 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 47.2 m-85 -87.99 130.76 34.86 Favored 'General case' 0 CA--C 1.489 -1.388 0 O-C-N 124.594 1.184 . . . . 0.0 112.51 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.67 137.42 46.87 Favored 'Isoleucine or valine' 0 C--N 1.379 1.874 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.079 172.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.9 127.68 48.62 Favored 'General case' 0 C--O 1.189 -2.099 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.8 mp -107.27 143.2 18.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -47.91 155.09 1.27 Allowed Glycine 0 CA--C 1.545 1.912 0 CA-C-O 124.01 1.894 . . . . 0.0 117.479 171.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 82.27 19.33 64.81 Favored Glycine 0 CA--C 1.573 3.682 0 O-C-N 119.238 -2.331 . . . . 0.0 115.223 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.6 35.56 81.22 Favored Glycine 0 N--CA 1.484 1.857 1 N-CA-C 123.204 4.042 . . . . 0.0 123.204 -174.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -115.84 115.51 26.38 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -107.42 124.44 49.85 Favored 'General case' 0 N--CA 1.527 3.381 0 CA-C-O 118.211 -0.899 . . . . 0.0 111.341 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.84 155.74 16.02 Favored Glycine 0 N--CA 1.506 3.306 0 N-CA-C 118.142 2.017 . . . . 0.0 118.142 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.458 HD13 ' CZ ' ' A' ' 98' ' ' PHE . 30.1 tp -96.31 120.28 36.32 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 113.486 -1.357 . . . . 0.0 109.718 -173.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.0 t -92.27 111.81 24.87 Favored 'Isoleucine or valine' 0 C--N 1.376 1.738 0 CA-C-O 118.365 -0.826 . . . . 0.0 109.224 157.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 41.1 t-80 -66.98 156.45 35.94 Favored 'General case' 0 C--N 1.377 1.782 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.4 tp -56.41 -30.87 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 123.967 0.907 . . . . 0.0 112.077 -169.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 65.0 p -80.46 -12.5 59.55 Favored 'General case' 0 C--N 1.35 0.604 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -106.91 5.5 28.39 Favored 'General case' 0 CA--C 1.564 1.504 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -173.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.2 mt -75.09 -50.85 23.23 Favored 'Isoleucine or valine' 0 C--N 1.393 2.467 0 CA-C-N 122.173 2.26 . . . . 0.0 107.889 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -126.74 158.51 36.3 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.276 49.1 p30 -64.51 -38.47 91.15 Favored 'General case' 0 C--N 1.391 2.398 0 O-C-N 118.97 -2.331 . . . . 0.0 113.713 161.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 26.8 mmtp -85.6 141.12 30.05 Favored 'General case' 0 N--CA 1.415 -2.207 0 O-C-N 119.249 -2.157 . . . . 0.0 112.501 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -41.87 130.82 3.37 Favored 'General case' 0 N--CA 1.517 2.882 0 CA-C-N 112.042 -2.344 . . . . 0.0 116.346 170.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 t -113.98 111.87 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 120.758 1.617 . . . . 0.0 107.275 -163.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -69.43 -46.38 66.91 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-O 116.181 -1.866 . . . . 0.0 107.596 174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -149.89 133.01 16.29 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 128.755 3.785 . . . . 0.0 109.473 -176.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.51 -20.22 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 O-C-N 119.846 -1.784 . . . . 0.0 110.872 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 68.8 p -56.6 -29.99 62.73 Favored 'General case' 0 C--N 1.377 1.776 0 C-N-CA 125.951 1.7 . . . . 0.0 110.286 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -65.11 -33.76 76.79 Favored 'General case' 0 CA--C 1.485 -1.525 0 C-N-CA 128.43 2.692 . . . . 0.0 111.76 177.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -112.25 -30.77 7.08 Favored 'General case' 0 CA--C 1.488 -1.405 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -168.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 72.8 mt -121.42 123.13 41.34 Favored 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 116.296 1.961 . . . . 0.0 116.296 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 43.5 mm-40 -91.99 130.07 37.81 Favored 'General case' 0 CA--C 1.56 1.356 0 CA-C-O 122.213 1.006 . . . . 0.0 112.003 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 21.0 mmt -61.05 111.1 1.56 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 117.032 2.234 . . . . 0.0 117.032 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.2 16.32 64.98 Favored Glycine 0 CA--C 1.547 2.048 0 CA-C-N 113.144 -1.844 . . . . 0.0 115.525 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -113.61 143.32 44.76 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 124.576 2.132 . . . . 0.0 112.821 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.52 146.12 49.72 Favored 'General case' 0 CA--C 1.556 1.202 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 -171.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 p -144.17 142.92 20.74 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 166.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.79 136.76 68.41 Favored 'Trans proline' 0 C--N 1.284 -2.865 0 C-N-CA 121.876 1.717 . . . . 0.0 114.524 160.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.82 120.91 17.33 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.235 0 CA-C-O 124.331 2.015 . . . . 0.0 107.06 175.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.458 ' N ' ' HB2' ' A' ' 152' ' ' ALA . 65.1 tttt -88.29 137.4 32.36 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 119.447 -2.033 . . . . 0.0 111.717 170.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 42.6 t -90.89 91.55 3.64 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.186 0 CA-C-N 112.322 -2.217 . . . . 0.0 112.532 -175.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 53.7 mt -53.75 -43.9 69.53 Favored 'General case' 0 N--CA 1.437 -1.089 0 O-C-N 126.335 2.272 . . . . 0.0 113.601 171.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -165.1 156.26 14.53 Favored 'General case' 0 C--O 1.255 1.349 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -172.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 55.2 t -126.99 79.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 126.312 2.258 . . . . 0.0 104.993 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.532 0.5 OUTLIER -61.63 141.62 57.68 Favored 'General case' 0 CA--C 1.58 2.1 0 CA-C-N 114.161 -1.381 . . . . 0.0 110.935 -178.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -84.96 -0.02 52.88 Favored 'General case' 0 CA--C 1.558 1.282 0 CA-C-O 115.078 -2.392 . . . . 0.0 108.269 -167.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -90.68 14.27 13.84 Favored 'General case' 0 C--N 1.384 2.104 0 CA-C-N 121.123 1.783 . . . . 0.0 107.676 174.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.71 24.07 40.14 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 115.08 -3.066 . . . . 0.0 115.517 -173.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -120.33 114.18 21.47 Favored 'General case' 0 CA--C 1.593 2.619 0 CA-C-N 122.469 3.134 . . . . 0.0 110.659 -171.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 33.1 mt -102.92 125.9 57.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 CA-C-O 117.242 -1.361 . . . . 0.0 110.953 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -120.65 135.91 54.98 Favored 'General case' 0 C--N 1.368 1.409 0 O-C-N 128.583 3.677 . . . . 0.0 113.524 -171.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 51.2 mt -129.95 148.39 51.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 112.074 -2.33 . . . . 0.0 110.315 -164.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 17.2 t -113.82 123.79 50.66 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 166.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.4 -43.28 42.86 Favored 'Isoleucine or valine' 0 C--N 1.359 0.995 0 O-C-N 119.318 -2.114 . . . . 0.0 108.551 161.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -46.18 -61.36 1.8 Allowed 'General case' 0 N--CA 1.504 2.267 0 CA-C-O 117.293 -1.336 . . . . 0.0 112.011 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -66.67 -27.56 67.76 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 122.372 2.351 . . . . 0.0 113.531 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.458 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -81.74 -7.11 59.56 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 118.77 -2.456 . . . . 0.0 112.802 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.9 p -109.79 5.04 22.33 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.913 1.383 . . . . 0.0 113.615 170.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.314 48.0 mt-10 71.93 36.88 1.1 Allowed 'General case' 0 C--O 1.254 1.338 0 CA-C-O 125.667 2.651 . . . . 0.0 111.428 166.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 . . . . . 0 N--CA 1.434 -1.237 0 CA-C-O 113.361 -3.209 . . . . 0.0 110.617 178.704 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 43.8 mm -108.66 127.25 65.29 Favored 'Isoleucine or valine' 0 C--N 1.363 1.18 0 C-N-CA 125.571 1.548 . . . . 0.0 109.526 -176.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -121.84 164.41 17.55 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 116.68 -1.629 . . . . 0.0 108.415 177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.5 t -153.9 159.22 41.67 Favored 'General case' 0 C--N 1.378 1.834 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.9 pt -161.9 155.18 3.1 Favored 'Isoleucine or valine' 0 C--N 1.369 1.421 0 C-N-CA 129.467 3.107 . . . . 0.0 103.647 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -121.57 122.25 39.26 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.454 -164.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.4 pt -127.14 142.53 43.26 Favored 'Isoleucine or valine' 0 C--N 1.387 2.215 0 C-N-CA 125.661 1.584 . . . . 0.0 111.1 -169.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -42.23 126.17 2.78 Favored Pre-proline 0 C--O 1.203 -1.389 0 C-N-CA 129.856 3.262 . . . . 0.0 114.556 175.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -60.57 -26.6 83.2 Favored 'Trans proline' 1 N--CA 1.54 4.214 0 N-CA-C 117.426 2.048 . . . . 0.0 117.426 -169.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . 0.25 45.9 t0 -58.67 -38.28 77.85 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 129.71 3.204 . . . . 0.0 113.495 172.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -92.72 3.05 56.33 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.921 -1.112 . . . . 0.0 113.15 -168.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.0 mt -66.77 -34.99 73.66 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.449 0 O-C-N 120.857 -1.152 . . . . 0.0 110.556 173.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -59.78 -34.81 73.5 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 117.336 -3.352 . . . . 0.0 114.718 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -86.5 -36.65 18.87 Favored 'General case' 0 C--N 1.38 1.933 0 O-C-N 125.76 1.913 . . . . 0.0 112.062 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.1 t -60.12 -37.91 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 CA-C-N 121.882 2.128 . . . . 0.0 113.512 170.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.0 mm -75.15 -47.37 36.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 C-N-CA 126.422 1.889 . . . . 0.0 112.585 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.72 -176.28 50.95 Favored Glycine 0 CA--C 1.484 -1.879 0 O-C-N 126.047 2.092 . . . . 0.0 113.566 169.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.297 42.2 mttp -58.11 111.71 1.28 Allowed 'General case' 0 C--N 1.36 1.057 0 CA-C-N 113.748 -1.226 . . . . 0.0 111.957 -175.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.98 25.46 31.09 Favored Glycine 0 N--CA 1.488 2.16 0 O-C-N 127.064 2.727 . . . . 0.0 114.645 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.02 9.85 83.69 Favored Glycine 0 N--CA 1.431 -1.641 0 N-CA-C 116.193 1.237 . . . . 0.0 116.193 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.2 t -65.23 -39.98 93.44 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 119.069 1.435 . . . . 0.0 111.677 -172.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.1 t -67.46 -45.54 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 O-C-N 126.295 2.247 . . . . 0.0 108.619 -170.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.5 tp -66.35 -28.93 45.0 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.316 0 CA-C-O 117.338 -1.315 . . . . 0.0 112.032 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -60.83 -46.82 89.04 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 120.913 1.688 . . . . 0.0 113.504 162.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.23 -52.58 65.05 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 128.111 2.564 . . . . 0.0 111.045 -173.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.18 -42.63 98.91 Favored 'General case' 0 C--N 1.374 1.644 0 O-C-N 123.752 0.658 . . . . 0.0 112.084 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.7 t -67.3 -43.37 81.88 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 115.817 -2.039 . . . . 0.0 114.279 172.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -59.61 -42.82 93.47 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 122.118 2.235 . . . . 0.0 110.913 176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 72.4 tt0 -73.0 -41.98 63.72 Favored 'General case' 0 C--O 1.254 1.331 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.2 p -80.53 -42.99 21.46 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 124.598 2.142 . . . . 0.0 109.711 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.76 37.27 11.97 Favored Glycine 0 C--O 1.239 0.445 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 -175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.56 145.61 35.31 Favored 'General case' 0 C--N 1.391 2.376 0 CA-C-O 116.973 -1.489 . . . . 0.0 108.864 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.3 m -93.52 130.28 39.44 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 6.0 mt -123.35 128.14 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.909 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 -172.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -134.23 133.25 40.64 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.443 HG12 HG22 ' A' ' 55' ' ' VAL . 10.7 mt -116.56 127.71 74.1 Favored 'Isoleucine or valine' 0 C--N 1.378 1.847 0 CA-C-O 123.67 1.7 . . . . 0.0 111.743 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -80.03 152.97 29.13 Favored 'General case' 0 C--O 1.188 -2.147 0 CA-C-O 115.345 -2.264 . . . . 0.0 115.525 168.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.4 p-10 -74.17 19.81 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 115.051 -2.404 . . . . 0.0 115.016 -169.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.1 p30 -121.2 11.35 10.84 Favored 'General case' 0 C--N 1.371 1.533 0 CA-C-O 114.82 -2.514 . . . . 0.0 110.298 165.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.39 9.08 48.45 Favored Glycine 0 C--N 1.357 1.695 0 CA-C-N 121.131 1.787 . . . . 0.0 111.465 165.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 m -89.66 129.21 36.13 Favored 'General case' 0 C--O 1.21 -0.991 0 CA-C-O 117.189 -1.386 . . . . 0.0 108.392 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.443 HG22 HG12 ' A' ' 49' ' ' ILE . 48.5 t -114.04 128.85 70.81 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.68 0 O-C-N 126.143 2.152 . . . . 0.0 105.728 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -110.5 134.23 52.56 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 126.691 1.997 . . . . 0.0 108.908 170.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 mp -124.05 130.63 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -108.25 139.06 43.48 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 117.537 -1.22 . . . . 0.0 111.033 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -160.49 150.85 18.19 Favored 'General case' 0 C--N 1.364 1.235 0 CA-C-O 122.917 1.342 . . . . 0.0 110.916 -165.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.284 7.1 t -114.95 -45.61 2.96 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.566 160.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -76.63 140.63 41.06 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 123.867 3.031 . . . . 0.0 114.23 171.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.93 -29.98 24.53 Favored Glycine 0 N--CA 1.437 -1.261 0 CA-C-N 113.851 -1.522 . . . . 0.0 114.927 -178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -66.59 -38.52 87.19 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 119.465 -2.197 . . . . 0.0 114.581 166.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -64.35 -30.66 71.7 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 116.989 -3.57 . . . . 0.0 112.939 170.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.48 -46.78 81.54 Favored 'General case' 0 CA--C 1.571 1.756 0 C-N-CA 119.367 -0.933 . . . . 0.0 113.431 174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mmtm -60.82 -41.23 95.3 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 127.24 2.216 . . . . 0.0 111.014 170.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -54.62 -51.14 66.31 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.168 -1.582 . . . . 0.0 111.826 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.98 -41.51 91.04 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.913 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 61.3 mt -66.35 -43.46 91.37 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 CA-C-N 119.521 1.055 . . . . 0.0 110.894 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.3 mmp_? -74.33 -28.16 61.03 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -71.24 -37.3 72.01 Favored 'General case' 0 C--O 1.211 -0.951 0 O-C-N 120.416 -1.427 . . . . 0.0 112.728 172.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 12.4 mt -62.88 -38.69 82.53 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-N 121.433 1.924 . . . . 0.0 111.003 165.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.69 -45.52 82.53 Favored 'General case' 0 C--N 1.373 1.597 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -174.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -51.71 -51.79 53.32 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 167.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 68.3 mt -69.02 -35.48 69.19 Favored 'Isoleucine or valine' 0 C--O 1.271 2.208 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.8 p -80.25 -16.51 54.55 Favored 'General case' 0 N--CA 1.516 2.844 0 CA-C-O 123.5 1.619 . . . . 0.0 111.25 -177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.64 -21.33 61.12 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 170.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -69.88 115.31 8.95 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.021 -1.675 . . . . 0.0 113.781 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.2 pt -72.3 149.8 8.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 CA-C-O 125.201 2.429 . . . . 0.0 113.084 -177.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -132.35 148.5 52.43 Favored 'General case' 0 C--N 1.366 1.301 0 O-C-N 118.447 -2.658 . . . . 0.0 110.607 175.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.8 t -62.03 144.52 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.335 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.402 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 91.3 13.78 58.18 Favored Glycine 0 C--N 1.381 3.045 0 N-CA-C 117.996 1.958 . . . . 0.0 117.996 177.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -135.27 157.89 45.77 Favored 'General case' 0 C--O 1.205 -1.289 0 O-C-N 118.462 -2.787 . . . . 0.0 108.2 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 135' ' ' LYS . 24.8 t -107.93 146.48 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.375 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -136.66 167.68 20.94 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 26.2 m -105.85 123.38 47.86 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 120.305 1.411 . . . . 0.0 109.297 173.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -109.44 -164.18 19.98 Favored Glycine 0 C--N 1.366 2.235 0 CA-C-N 111.466 -2.606 . . . . 0.0 112.659 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.4 ptmt -146.67 150.71 35.96 Favored 'General case' 0 C--O 1.214 -0.803 0 O-C-N 126.242 1.789 . . . . 0.0 107.518 164.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.458 HG21 HD22 ' A' ' 126' ' ' LEU . 78.3 t -77.55 112.97 16.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.948 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -86.09 -17.8 34.11 Favored 'General case' 0 C--O 1.2 -1.547 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 175.27 141.59 0.05 Allowed 'General case' 0 CA--C 1.566 1.594 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -169.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 82.8 mt -126.87 125.75 67.28 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.312 -169.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.14 177.69 2.21 Favored 'Isoleucine or valine' 0 C--N 1.364 1.216 0 CA-C-N 114.306 -1.315 . . . . 0.0 110.785 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -58.06 -44.68 87.62 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.852 1.345 . . . . 0.0 112.92 -163.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -110.33 22.38 15.58 Favored 'General case' 0 CA--C 1.555 1.164 0 O-C-N 119.255 -2.153 . . . . 0.0 112.066 -177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 172.02 170.7 36.24 Favored Glycine 0 C--O 1.21 -1.377 0 C-N-CA 118.751 -1.69 . . . . 0.0 114.594 -176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.17 125.93 36.22 Favored 'General case' 0 C--O 1.181 -2.545 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -81.82 130.9 35.22 Favored 'General case' 0 CA--C 1.568 1.641 0 N-CA-C 115.729 1.752 . . . . 0.0 115.729 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.92 128.17 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -167.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 106' ' ' GLU . . . -100.84 125.57 47.37 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.545 -174.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.8 mt -110.25 138.39 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -36.28 151.42 0.02 OUTLIER Glycine 0 C--N 1.37 2.423 0 N-CA-C 119.328 2.491 . . . . 0.0 119.328 -165.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 75.4 25.45 68.13 Favored Glycine 0 C--O 1.186 -2.905 0 CA-C-O 113.767 -3.796 . . . . 0.0 112.152 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.09 26.78 69.93 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 128.514 2.959 . . . . 0.0 116.955 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -92.8 93.44 8.43 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 31.6 tt0 -101.6 117.65 35.33 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -113.82 179.08 18.69 Favored Glycine 0 C--O 1.215 -1.039 0 O-C-N 126.998 2.686 . . . . 0.0 112.613 176.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.7 tp -120.41 125.51 48.13 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.659 -1.638 . . . . 0.0 109.891 -169.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 148' ' ' SER . 20.3 t -95.01 111.46 25.67 Favored 'Isoleucine or valine' 0 C--N 1.371 1.523 0 O-C-N 124.857 1.348 . . . . 0.0 109.571 170.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -63.71 149.94 45.54 Favored 'General case' 0 C--O 1.208 -1.11 0 O-C-N 121.423 -0.798 . . . . 0.0 109.758 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.7 tt -56.43 -8.78 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.425 0 C-N-CA 125.579 1.552 . . . . 0.0 115.022 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 10.4 p -101.92 2.92 38.55 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 125.119 1.368 . . . . 0.0 113.605 177.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -130.77 18.62 5.13 Favored 'General case' 0 C--O 1.257 1.472 0 CA-C-N 119.225 0.92 . . . . 0.0 111.798 -175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 71.2 mt -90.75 -43.4 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-O 124.588 2.137 . . . . 0.0 109.976 170.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -144.68 163.62 33.42 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 119.931 -1.731 . . . . 0.0 109.477 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -72.17 -38.2 69.18 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-O 123.177 1.465 . . . . 0.0 112.756 168.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -80.48 145.55 31.82 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 125.958 1.703 . . . . 0.0 113.101 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -70.66 130.35 41.55 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.1 t -120.82 130.02 75.04 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 N-CA-C 103.432 -2.803 . . . . 0.0 103.432 -173.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -103.72 -24.58 13.33 Favored 'General case' 0 N--CA 1.518 2.948 0 O-C-N 120.612 -1.305 . . . . 0.0 110.931 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.39 139.48 31.7 Favored 'General case' 0 C--O 1.25 1.13 0 O-C-N 125.555 1.784 . . . . 0.0 107.166 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.9 t -81.27 -22.7 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.384 -3.775 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -165.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.8 p -63.02 -19.68 64.59 Favored 'General case' 0 C--N 1.374 1.673 0 O-C-N 119.492 -2.005 . . . . 0.0 115.462 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -59.39 -40.26 85.99 Favored 'General case' 0 C--O 1.192 -1.956 0 C-N-CA 125.25 1.42 . . . . 0.0 113.401 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.68 0.2 14.5 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 125.313 1.445 . . . . 0.0 111.143 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.458 HD22 HG21 ' A' ' 89' ' ' VAL . 9.4 mt -153.75 150.12 28.17 Favored 'General case' 0 C--N 1.376 1.731 0 O-C-N 119.032 -2.292 . . . . 0.0 110.05 -170.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -148.66 151.4 34.89 Favored 'General case' 0 C--N 1.38 1.895 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -63.13 142.38 58.41 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 125.664 2.649 . . . . 0.0 114.058 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.1 -4.24 86.18 Favored Glycine 0 CA--C 1.46 -3.354 0 C-N-CA 129.193 3.282 . . . . 0.0 116.659 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 30.0 mm100 -65.6 127.77 33.25 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 127.147 3.356 . . . . 0.0 109.885 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -78.59 125.69 29.71 Favored 'General case' 0 N--CA 1.509 2.496 0 O-C-N 118.406 -2.684 . . . . 0.0 112.72 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.03 138.93 31.74 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.48 -168.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -72.86 124.07 9.4 Favored 'Trans proline' 0 CA--C 1.5 -1.202 0 C-N-CA 123.736 2.957 . . . . 0.0 107.119 158.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.27 131.97 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.986 0 CA-C-N 113.013 -1.903 . . . . 0.0 107.206 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 88.9 tttt -90.35 134.34 34.39 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.406 -177.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.6 t -76.47 110.8 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 118.403 -1.319 . . . . 0.0 110.556 170.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 10.2 mt -86.1 -56.01 3.66 Favored 'General case' 0 CA--C 1.468 -2.192 0 O-C-N 125.288 1.618 . . . . 0.0 114.535 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -146.21 158.21 43.87 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 125.267 1.604 . . . . 0.0 108.47 -178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.425 HG13 HG12 ' A' ' 145' ' ' ILE . 46.7 t -140.23 114.86 6.75 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.351 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 166.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -75.31 177.28 6.68 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 122.334 2.334 . . . . 0.0 109.828 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -67.28 -32.32 73.24 Favored 'General case' 0 C--N 1.371 1.531 0 C-N-CA 127.219 2.207 . . . . 0.0 110.913 -173.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -74.29 -30.92 62.31 Favored 'General case' 0 C--O 1.213 -0.84 0 C-N-CA 125.433 1.493 . . . . 0.0 111.426 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 118.3 18.98 4.8 Favored Glycine 0 CA--C 1.529 0.928 0 CA-C-O 115.684 -2.731 . . . . 0.0 112.404 171.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -80.17 127.66 32.6 Favored 'General case' 0 CA--C 1.556 1.189 0 CA-C-N 119.45 1.625 . . . . 0.0 108.109 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.425 HG12 HG13 ' A' ' 139' ' ' VAL . 68.6 mt -104.91 118.37 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 -162.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -111.59 131.03 55.55 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-O 125.136 2.398 . . . . 0.0 106.456 -172.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 73.4 mt -129.96 177.15 7.49 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 113.186 -1.825 . . . . 0.0 111.416 -163.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.405 ' HA ' HG13 ' A' ' 109' ' ' VAL . 16.7 t -154.14 147.91 25.4 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 120.351 -1.468 . . . . 0.0 107.083 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 17.3 mt -102.83 -31.98 3.04 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.803 0 O-C-N 119.709 -1.87 . . . . 0.0 107.295 164.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -52.78 -53.83 42.65 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.729 1.212 . . . . 0.0 111.365 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -76.56 -18.29 58.76 Favored 'General case' 0 C--N 1.364 1.215 0 C-N-CA 125.087 1.355 . . . . 0.0 112.024 -172.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.95 99.68 Favored 'General case' 0 C--O 1.258 1.513 0 C-N-CA 123.756 0.822 . . . . 0.0 110.895 -177.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 80.6 p -96.44 2.28 52.42 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 175.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 64.02 48.52 3.02 Favored 'General case' 0 CA--C 1.615 3.47 0 CA-C-O 124.305 2.003 . . . . 0.0 112.013 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 . . . . . 0 C--O 1.253 1.28 0 O-C-N 116.803 -3.686 . . . . 0.0 108.274 168.585 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 . . . . . 0 C--O 1.225 -0.209 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 8.4 mm -105.61 120.13 55.91 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 CA-C-O 123.452 1.596 . . . . 0.0 113.614 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.41 ' CD2' ' HB1' ' A' ' 65' ' ' ALA . 74.6 m-70 -109.03 121.83 45.97 Favored 'General case' 0 C--N 1.366 1.318 0 O-C-N 119.699 -1.876 . . . . 0.0 110.35 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -112.89 153.12 28.43 Favored 'General case' 0 N--CA 1.397 -3.102 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -173.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.7 tt -142.49 156.29 18.7 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 166.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -118.13 113.37 21.47 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -175.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.4 pt -104.58 163.05 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 O-C-N 126.883 2.614 . . . . 0.0 112.716 167.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 22' ' ' PRO . 55.7 t-20 -55.94 139.31 70.87 Favored Pre-proline 0 N--CA 1.429 -1.505 0 O-C-N 124.54 1.15 . . . . 0.0 113.088 168.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 21' ' ' ASN . 17.8 Cg_endo -70.89 -21.13 28.65 Favored 'Trans proline' 0 C--O 1.194 -1.706 0 C-N-CA 122.46 2.107 . . . . 0.0 112.2 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -90.13 1.52 56.31 Favored 'General case' 0 CA--C 1.573 1.861 0 O-C-N 119.776 -1.827 . . . . 0.0 109.243 176.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -118.81 7.04 11.5 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 119.468 -2.02 . . . . 0.0 112.197 176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 56.0 mt -61.87 -46.66 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 119.999 -1.688 . . . . 0.0 111.924 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -67.17 -29.4 69.09 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 117.98 -1.488 . . . . 0.0 111.091 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -61.48 -32.78 72.8 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 173.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.462 ' HA ' ' CG2' ' A' ' 75' ' ' ILE . 41.6 t -78.99 -51.42 16.91 Favored 'Isoleucine or valine' 0 C--N 1.384 2.076 0 N-CA-C 115.745 1.758 . . . . 0.0 115.745 173.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 pt -71.95 -19.24 19.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 114.324 -2.75 . . . . 0.0 114.898 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.78 -174.18 8.69 Favored Glycine 0 C--N 1.383 3.146 1 O-C-N 129.517 4.261 . . . . 0.0 108.9 -175.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.384 22.2 pttp -72.65 129.72 38.89 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-N 110.061 -3.069 . . . . 0.0 114.359 -173.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.65 19.56 67.22 Favored Glycine 0 N--CA 1.483 1.807 0 O-C-N 119.665 -1.897 . . . . 0.0 114.227 -171.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 60.6 28.69 68.18 Favored Glycine 0 N--CA 1.5 2.928 0 CA-C-O 121.996 0.776 . . . . 0.0 112.109 -175.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.6 p -64.65 -42.97 95.06 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -169.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.5 t -61.76 -41.68 91.5 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.23 0 C-N-CA 126.22 1.808 . . . . 0.0 110.286 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.8 mm -59.69 -37.51 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 O-C-N 123.974 0.796 . . . . 0.0 110.617 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 mtt85 -56.05 -47.83 77.15 Favored 'General case' 0 CA--C 1.559 1.294 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.75 82.38 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 117.022 2.23 . . . . 0.0 117.022 170.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.82 -51.94 67.52 Favored 'General case' 0 C--O 1.195 -1.779 0 O-C-N 125.386 1.679 . . . . 0.0 113.026 171.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.253 14.2 t -65.43 -48.51 72.5 Favored 'General case' 0 C--O 1.261 1.676 0 CA-C-O 117.742 -1.123 . . . . 0.0 110.55 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . 0.278 27.0 tt0 -66.84 -42.75 85.27 Favored 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 118.637 -1.225 . . . . 0.0 114.075 -172.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.31 -34.05 77.11 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.6 p -96.35 -46.14 6.52 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.721 -1.237 . . . . 0.0 111.61 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.25 -0.16 57.14 Favored Glycine 0 C--N 1.344 0.977 0 O-C-N 119.93 -1.731 . . . . 0.0 110.168 -171.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.1 p -75.18 149.41 38.97 Favored 'General case' 0 C--N 1.404 2.947 0 C-N-CA 127.718 2.407 . . . . 0.0 110.826 173.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 83.9 m -98.15 129.77 44.93 Favored 'General case' 0 C--O 1.201 -1.454 0 CA-C-O 116.004 -1.95 . . . . 0.0 110.899 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mp -117.29 126.08 74.36 Favored 'Isoleucine or valine' 0 C--O 1.191 -1.989 0 CA-C-O 116.183 -1.865 . . . . 0.0 113.034 175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -129.46 141.58 50.99 Favored 'General case' 0 CA--C 1.571 1.752 0 CA-C-N 120.379 1.445 . . . . 0.0 109.291 173.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.88 109.84 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -156.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -76.34 156.14 33.58 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 125.09 2.376 . . . . 0.0 115.101 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -69.1 -0.26 5.6 Favored 'General case' 0 N--CA 1.514 2.738 0 O-C-N 120.339 -1.476 . . . . 0.0 109.438 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -103.91 -11.82 17.25 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 120.342 -1.474 . . . . 0.0 108.257 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.49 -1.66 53.38 Favored Glycine 0 C--N 1.364 2.104 0 CA-C-O 118.677 -1.068 . . . . 0.0 112.337 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -67.82 115.94 7.93 Favored 'General case' 0 C--O 1.204 -1.322 0 CA-C-N 120.981 2.391 . . . . 0.0 110.363 171.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 17' ' ' THR . 93.1 t -99.2 117.47 44.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.07 112.84 25.88 Favored 'General case' 0 CA--C 1.5 -0.952 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 172.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.5 mt -100.29 106.39 19.17 Favored 'Isoleucine or valine' 0 C--N 1.348 0.53 0 O-C-N 126.748 2.53 . . . . 0.0 108.273 168.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.91 135.47 34.11 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 122.656 1.217 . . . . 0.0 109.392 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.547 ' CB ' ' HB2' ' A' ' 65' ' ' ALA . . . -154.62 151.78 29.22 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 102.392 -3.188 . . . . 0.0 102.392 -167.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 p -124.47 8.03 8.35 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 126.306 1.842 . . . . 0.0 108.111 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -124.65 107.84 11.41 Favored 'General case' 0 C--N 1.371 1.516 0 C-N-CA 127.23 2.212 . . . . 0.0 105.434 167.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.05 -40.34 95.43 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-O 116.679 -2.178 . . . . 0.0 115.104 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -73.15 -39.16 65.91 Favored 'General case' 0 C--O 1.249 1.064 0 C-N-CA 118.502 -1.279 . . . . 0.0 112.173 -172.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -58.65 -41.86 87.03 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 162.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.547 ' HB2' ' CB ' ' A' ' 59' ' ' ALA . . . -62.13 -46.13 90.37 Favored 'General case' 0 CA--C 1.586 2.355 0 CA-C-O 123.586 1.66 . . . . 0.0 113.357 168.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.8 mtmt -58.58 -33.2 69.7 Favored 'General case' 0 N--CA 1.527 3.422 0 O-C-N 117.747 -3.096 . . . . 0.0 114.322 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -77.2 -44.46 30.01 Favored 'General case' 0 CA--C 1.563 1.462 0 O-C-N 123.504 0.502 . . . . 0.0 111.427 167.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.73 -39.44 94.1 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 119.395 -0.922 . . . . 0.0 112.096 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.271 9.2 tp -80.48 -26.0 11.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 O-C-N 119.995 -1.691 . . . . 0.0 109.101 -176.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -65.47 -41.54 93.23 Favored 'General case' 0 C--N 1.374 1.645 0 CA-C-N 119.992 1.269 . . . . 0.0 110.597 166.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 34.4 ttt180 -55.18 -35.23 64.58 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.0 mm -61.16 -40.48 85.99 Favored 'Isoleucine or valine' 0 CA--C 1.595 2.708 0 CA-C-O 123.922 1.82 . . . . 0.0 113.145 170.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -67.75 -39.44 84.18 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 117.867 -3.021 . . . . 0.0 112.79 175.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -58.35 -48.06 81.8 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.145 -1.843 . . . . 0.0 114.906 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 28' ' ' VAL . 74.4 mt -62.35 -45.57 98.47 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 170.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 94.1 m -56.56 -49.4 74.95 Favored 'General case' 0 CA--C 1.575 1.933 0 O-C-N 125.031 1.457 . . . . 0.0 112.723 171.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.78 -0.36 34.1 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 118.153 -2.842 . . . . 0.0 112.398 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -66.42 139.98 58.02 Favored 'General case' 0 C--N 1.376 1.743 0 N-CA-C 117.967 2.58 . . . . 0.0 117.967 169.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.19 122.91 70.71 Favored 'Isoleucine or valine' 0 C--N 1.364 1.228 0 N-CA-C 103.085 -2.931 . . . . 0.0 103.085 171.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -88.03 134.13 33.81 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.442 -1.254 . . . . 0.0 111.727 -169.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.3 137.76 24.27 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.409 0 O-C-N 125.928 2.017 . . . . 0.0 112.653 173.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 67.2 -7.7 1.68 Allowed Glycine 0 C--O 1.26 1.768 0 N-CA-C 120.123 2.809 . . . . 0.0 120.123 -174.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -79.55 146.51 32.58 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 124.747 2.213 . . . . 0.0 111.544 169.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.9 t -91.04 146.7 5.89 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.978 0 O-C-N 120.352 -1.467 . . . . 0.0 109.233 178.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -138.31 155.35 48.67 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 79.5 m -93.81 144.24 25.61 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -146.65 179.53 23.55 Favored Glycine 0 C--O 1.248 1.0 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 172.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -130.32 131.67 45.5 Favored 'General case' 0 C--N 1.375 1.685 0 O-C-N 120.261 -1.729 . . . . 0.0 109.73 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.0 t -61.35 120.28 6.96 Favored 'Isoleucine or valine' 0 C--N 1.364 1.205 0 O-C-N 120.88 -1.138 . . . . 0.0 109.22 -177.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.43 HG21 ' HB2' ' A' ' 100' ' ' ALA . 12.0 p -94.12 -8.62 39.05 Favored 'General case' 0 C--O 1.252 1.207 0 CA-C-O 115.623 -2.132 . . . . 0.0 112.492 -176.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 ptt85 165.04 148.62 0.02 OUTLIER 'General case' 0 C--N 1.369 1.435 0 O-C-N 126.624 2.452 . . . . 0.0 108.618 -170.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.4 mt -100.81 144.29 12.96 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.454 0 CA-C-N 112.855 -1.975 . . . . 0.0 108.958 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . 0.26 35.8 m -138.58 170.43 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 O-C-N 120.784 -1.197 . . . . 0.0 109.388 -176.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.65 -42.25 71.08 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 117.274 -3.391 . . . . 0.0 114.525 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -107.1 -0.85 22.56 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 119.131 0.878 . . . . 0.0 112.261 -172.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.68 -154.58 11.17 Favored Glycine 0 C--O 1.212 -1.219 0 O-C-N 119.554 -1.966 . . . . 0.0 109.263 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -146.31 137.2 24.29 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 128.896 2.879 . . . . 0.0 104.229 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.254 92.6 m-85 -86.84 139.57 30.54 Favored 'General case' 0 N--CA 1.509 2.483 0 C-N-CA 124.594 1.158 . . . . 0.0 109.047 173.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.2 t -116.82 121.43 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 112.547 -2.115 . . . . 0.0 107.841 177.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 90' ' ' THR . . . -72.33 126.04 28.84 Favored 'General case' 0 N--CA 1.51 2.553 0 O-C-N 120.621 -1.299 . . . . 0.0 110.169 165.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.415 HD11 HD11 ' A' ' 147' ' ' LEU . 27.8 mm -85.5 94.2 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.44 37.48 93.82 Favored Glycine 0 N--CA 1.513 3.773 0 C-N-CA 126.6 2.048 . . . . 0.0 111.295 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.53 -7.15 49.77 Favored Glycine 0 C--N 1.297 -1.633 0 O-C-N 125.87 1.571 . . . . 0.0 114.471 -172.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -68.76 -169.09 5.55 Favored Glycine 0 C--N 1.355 1.604 0 CA-C-N 120.024 1.912 . . . . 0.0 114.473 167.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -33.06 140.08 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.247 2.927 . . . . 0.0 117.388 167.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -91.79 116.26 28.75 Favored 'General case' 0 C--O 1.215 -0.719 0 CA-C-N 112.232 -2.258 . . . . 0.0 114.914 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -99.28 170.7 23.69 Favored Glycine 0 C--N 1.368 2.317 0 CA-C-O 117.997 -1.446 . . . . 0.0 110.974 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.1 tp -114.62 138.17 51.0 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 128.074 2.867 . . . . 0.0 106.816 -171.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.1 p -116.97 120.53 65.34 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.288 0 CA-C-N 114.165 -1.38 . . . . 0.0 109.488 157.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -74.81 153.66 38.64 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 123.414 1.578 . . . . 0.0 112.197 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.6 tt -67.82 -16.32 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 N-CA-C 116.486 2.032 . . . . 0.0 116.486 -162.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.0 m -94.69 13.14 25.33 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 120.03 1.286 . . . . 0.0 111.845 169.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 62.9 mm-40 -112.2 22.43 14.77 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.978 1.263 . . . . 0.0 111.54 172.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.8 mm -100.97 -48.06 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.451 0 CA-C-O 127.142 3.353 . . . . 0.0 106.464 -174.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -125.42 156.01 39.51 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 112.439 -2.164 . . . . 0.0 112.261 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.262 4.8 t0 -83.2 -15.31 50.97 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 164.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -94.08 -173.55 3.14 Favored 'General case' 0 C--N 1.381 1.954 0 C-N-CA 126.547 1.939 . . . . 0.0 113.528 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.279 15.5 mmm180 -84.01 115.78 22.51 Favored 'General case' 0 C--N 1.375 1.706 0 CA-C-O 125.327 2.489 . . . . 0.0 114.546 -173.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.4 HG22 ' CE2' ' A' ' 125' ' ' TYR 0.264 21.9 t -82.67 101.34 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 112.092 -2.322 . . . . 0.0 114.675 172.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -96.54 -34.65 11.38 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -141.97 149.41 40.04 Favored 'General case' 0 C--O 1.248 0.984 0 CA-C-O 122.253 1.025 . . . . 0.0 110.09 170.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 56.0 t -72.29 -34.19 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . 0.264 18.1 p -58.49 -20.94 49.85 Favored 'General case' 0 C--O 1.277 2.552 0 N-CA-C 116.197 1.925 . . . . 0.0 116.197 175.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.91 -43.28 83.76 Favored 'General case' 0 C--N 1.368 1.388 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 167.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.4 ' CE2' HG22 ' A' ' 119' ' ' VAL . 98.0 m-85 -90.93 -24.68 20.1 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 116.976 -1.488 . . . . 0.0 112.627 -175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 97.2 mt -137.98 151.22 47.72 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-N 120.479 1.49 . . . . 0.0 109.083 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -120.57 167.03 12.83 Favored 'General case' 0 C--O 1.22 -0.459 0 O-C-N 125.707 1.88 . . . . 0.0 108.075 175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.6 tpt -81.36 120.71 25.3 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 111.875 -2.42 . . . . 0.0 112.066 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 101.82 -9.4 56.8 Favored Glycine 0 C--N 1.365 2.19 0 CA-C-N 119.832 1.197 . . . . 0.0 111.771 169.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -89.52 153.31 20.89 Favored 'General case' 0 CA--C 1.598 2.816 0 CA-C-N 118.316 1.058 . . . . 0.0 109.262 -164.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -88.2 151.09 22.92 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 117.733 -3.105 . . . . 0.0 108.229 -175.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.1 p -152.03 136.05 9.93 Favored Pre-proline 0 N--CA 1.431 -1.399 0 N-CA-C 104.365 -2.457 . . . . 0.0 104.365 169.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -54.39 124.69 16.69 Favored 'Trans proline' 0 N--CA 1.52 3.076 0 C-N-CA 121.299 1.333 . . . . 0.0 113.402 159.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.5 m -119.54 138.94 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 127.244 2.218 . . . . 0.0 107.714 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 69.0 tttt -106.57 118.36 36.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.553 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 64.4 t -63.99 119.04 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 CA-C-O 123.829 1.776 . . . . 0.0 113.004 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.1 mt -88.64 -40.17 13.51 Favored 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 117.092 -1.432 . . . . 0.0 111.519 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -163.47 156.73 18.95 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 120.049 1.295 . . . . 0.0 107.865 -172.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.7 t -120.07 131.85 71.31 Favored 'Isoleucine or valine' 0 C--O 1.254 1.311 1 N-CA-C 98.942 -4.466 . . . . 0.0 98.942 166.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.67 178.42 6.76 Favored 'General case' 0 N--CA 1.421 -1.907 0 O-C-N 120.898 -1.126 . . . . 0.0 111.384 -168.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -78.59 -16.56 57.25 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.848 1.259 . . . . 0.0 111.483 -168.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -112.04 2.56 16.89 Favored 'General case' 0 C--N 1.358 0.943 0 O-C-N 126.089 2.118 . . . . 0.0 108.679 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 110.09 5.32 28.84 Favored Glycine 0 C--N 1.368 2.346 0 CA-C-O 119.692 -0.504 . . . . 0.0 114.338 162.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -84.85 146.89 27.08 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.1 mt -103.99 129.13 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.951 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -116.41 122.83 45.96 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 112.096 -2.32 . . . . 0.0 113.095 177.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.415 HD11 HD11 ' A' ' 101' ' ' ILE . 64.6 mt -120.55 166.12 14.07 Favored 'General case' 0 CA--C 1.563 1.478 0 C-N-CA 125.94 1.696 . . . . 0.0 111.809 -168.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 30.0 t -129.28 130.53 46.31 Favored 'General case' 0 N--CA 1.505 2.282 0 CA-C-N 112.036 -2.347 . . . . 0.0 108.753 173.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.3 mt -93.78 -39.43 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 169.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -60.84 -41.82 96.59 Favored 'General case' 0 C--N 1.379 1.867 0 O-C-N 120.239 -1.538 . . . . 0.0 113.9 -167.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -74.91 -33.93 62.08 Favored 'General case' 0 C--N 1.318 -0.794 0 O-C-N 126.651 2.469 . . . . 0.0 109.314 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.47 -29.56 61.49 Favored 'General case' 0 C--N 1.375 1.677 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -173.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 18.5 p -106.1 1.25 26.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 71.52 57.86 0.18 Allowed 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 . . . . . 0 C--N 1.361 1.07 0 CA-C-O 116.183 -1.865 . . . . 0.0 108.561 179.75 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 . . . . . 0 C--O 1.223 -0.325 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 25.1 mm -84.7 102.93 11.35 Favored 'Isoleucine or valine' 0 C--N 1.373 1.6 0 O-C-N 126.119 2.137 . . . . 0.0 113.505 175.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -88.77 116.37 26.99 Favored 'General case' 0 N--CA 1.423 -1.787 0 C-N-CA 124.937 1.295 . . . . 0.0 110.958 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.6 p -93.94 138.18 32.35 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 124.758 2.218 . . . . 0.0 111.53 176.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.5 tt -135.92 123.45 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-N 111.545 -2.57 . . . . 0.0 109.807 172.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -80.4 124.71 29.13 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 114.736 -1.12 . . . . 0.0 111.274 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.96 129.69 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.925 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -66.73 143.21 97.98 Favored Pre-proline 0 N--CA 1.51 2.57 0 CA-C-O 116.289 -1.815 . . . . 0.0 112.736 -174.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -67.45 -13.83 40.48 Favored 'Trans proline' 1 N--CA 1.541 4.265 0 CA-C-O 112.871 -3.054 . . . . 0.0 118.583 -165.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -86.48 -18.56 31.34 Favored 'General case' 0 C--N 1.386 2.159 0 CA-C-N 123.941 3.064 . . . . 0.0 109.251 169.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -84.71 -20.76 30.65 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 116.373 -1.775 . . . . 0.0 115.491 171.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.435 HD11 ' HA2' ' A' ' 53' ' ' GLY . 54.1 mt -65.22 -37.22 79.62 Favored 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 121.935 2.152 . . . . 0.0 112.535 166.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -61.32 -41.88 97.74 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 116.932 -1.508 . . . . 0.0 109.621 172.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -62.12 -41.19 97.99 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-N 119.863 1.211 . . . . 0.0 110.808 175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 t -67.57 -36.44 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 126.568 1.947 . . . . 0.0 109.761 174.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.0 mt -67.19 -46.48 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.985 0.811 . . . . 0.0 109.224 174.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.49 174.07 11.21 Favored Glycine 0 CA--C 1.55 2.252 0 C-N-CA 118.818 -1.658 . . . . 0.0 114.473 -172.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -67.62 119.49 12.47 Favored 'General case' 0 C--O 1.187 -2.195 0 CA-C-N 113.937 -1.131 . . . . 0.0 110.376 -179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 26.36 60.78 Favored Glycine 0 N--CA 1.502 3.099 0 C-N-CA 128.497 2.951 . . . . 0.0 116.599 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.81 15.45 79.26 Favored Glycine 0 C--N 1.37 2.448 0 O-C-N 126.64 2.024 . . . . 0.0 112.682 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -62.32 -47.24 85.13 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 120.346 2.073 . . . . 0.0 115.177 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 69.8 t -62.39 -46.62 96.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.762 -1.212 . . . . 0.0 112.864 -173.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.439 HD11 HG21 ' A' ' 47' ' ' ILE . 2.6 tt -70.98 -32.74 49.38 Favored 'Isoleucine or valine' 0 C--O 1.256 1.44 0 O-C-N 127.676 3.11 . . . . 0.0 114.445 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -64.56 -49.41 71.31 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.337 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -34.47 66.83 Favored 'General case' 0 C--O 1.249 1.055 0 CA-C-N 114.162 -1.381 . . . . 0.0 113.542 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.8 tp -76.76 -48.11 19.68 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 128.241 3.463 . . . . 0.0 112.638 -178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.312 8.5 t -62.75 -43.29 99.2 Favored 'General case' 0 C--O 1.255 1.38 0 C-N-CA 118.285 -1.366 . . . . 0.0 112.855 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -69.16 -45.36 70.23 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-O 116.412 -1.756 . . . . 0.0 114.419 172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -59.23 -47.64 84.59 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-O 123.498 1.618 . . . . 0.0 112.405 -175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 65.7 p -79.62 -22.34 43.77 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.972 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.81 47.85 78.55 Favored Glycine 0 CA--C 1.543 1.83 0 C-N-CA 125.974 1.75 . . . . 0.0 112.507 -171.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -134.67 152.75 52.0 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 126.574 1.985 . . . . 0.0 112.25 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 58' ' ' ALA . 89.5 m -95.29 146.34 24.43 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 119.993 -1.692 . . . . 0.0 110.662 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.439 HG21 HD11 ' A' ' 36' ' ' ILE . 35.5 mt -126.22 129.26 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -171.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -123.94 157.66 33.8 Favored 'General case' 0 C--O 1.191 -1.987 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 154.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.3 mt -135.04 124.54 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -81.75 154.99 25.7 Favored 'General case' 0 CA--C 1.573 1.864 0 C-N-CA 127.149 2.179 . . . . 0.0 109.958 177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -80.63 -13.2 59.24 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -79.16 -13.85 59.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.644 2.378 . . . . 0.0 111.477 172.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.435 ' HA2' HD11 ' A' ' 25' ' ' ILE . . . 113.13 -3.26 25.45 Favored Glycine 0 N--CA 1.491 2.331 0 CA-C-O 122.624 1.125 . . . . 0.0 114.436 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -83.19 108.43 16.43 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-O 123.838 1.78 . . . . 0.0 112.172 -174.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.1 t -90.83 127.66 43.14 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.954 0 CA-C-O 122.967 1.365 . . . . 0.0 111.492 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -115.67 105.56 12.89 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.206 -0.934 . . . . 0.0 108.709 -169.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.4 mm -88.09 129.13 39.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 O-C-N 120.966 -1.084 . . . . 0.0 111.706 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.47 ' HB3' ' HB ' ' A' ' 46' ' ' THR . . . -113.96 121.77 44.93 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 118.488 -1.285 . . . . 0.0 111.315 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.491 ' HB3' ' HB2' ' A' ' 65' ' ' ALA . . . -139.42 156.18 47.13 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 124.309 1.006 . . . . 0.0 111.336 -177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.8 m -72.89 -31.9 65.0 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 118.413 -2.679 . . . . 0.0 112.347 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -121.65 148.97 43.88 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 123.233 1.492 . . . . 0.0 109.419 -167.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.5 -48.04 81.77 Favored Glycine 0 C--O 1.197 -2.192 0 CA-C-O 116.762 -2.132 . . . . 0.0 113.002 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -61.8 -41.88 98.31 Favored 'General case' 0 CA--C 1.578 2.038 0 CA-C-N 119.378 1.589 . . . . 0.0 110.956 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -60.67 -43.74 97.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 118.157 -2.84 . . . . 0.0 113.249 173.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . . . -67.18 -36.27 81.42 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.241 -1.537 . . . . 0.0 112.518 176.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.5 mmmt -74.71 -24.13 58.7 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.593 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -72.65 -39.78 66.89 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 118.572 -2.58 . . . . 0.0 112.553 166.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.49 -38.29 90.57 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.928 -1.107 . . . . 0.0 113.298 167.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 22.7 mm -64.91 -50.37 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 120.684 -1.26 . . . . 0.0 112.267 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -53.85 -42.4 68.5 Favored 'General case' 0 N--CA 1.425 -1.677 0 O-C-N 120.946 -1.096 . . . . 0.0 111.214 175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -61.0 -43.49 98.81 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 174.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.9 mt -69.28 -39.57 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.832 0 C-N-CA 118.269 -1.373 . . . . 0.0 113.577 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.18 -39.52 75.49 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 116.692 -1.623 . . . . 0.0 114.411 164.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -61.94 -42.8 99.52 Favored 'General case' 0 C--N 1.366 1.304 0 CA-C-N 119.372 0.987 . . . . 0.0 111.211 169.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 42.3 mt -65.06 -34.07 68.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.09 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.174 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 p -89.82 4.4 49.94 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.665 175.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -103.1 9.02 38.65 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 118.986 0.812 . . . . 0.0 109.435 162.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -76.9 132.96 39.38 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 123.223 1.487 . . . . 0.0 112.263 -175.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mm -103.14 130.81 52.74 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 CA-C-O 123.496 1.617 . . . . 0.0 109.033 -176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -105.28 145.29 30.9 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 114.207 -1.361 . . . . 0.0 107.698 -176.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.7 t -69.72 124.97 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 O-C-N 120.645 -1.285 . . . . 0.0 110.522 174.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 78.39 19.42 74.14 Favored Glycine 0 C--O 1.211 -1.331 0 C-N-CA 118.606 -1.759 . . . . 0.0 115.883 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -101.42 148.79 24.75 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 167.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 135' ' ' LYS . 8.3 t -93.12 130.8 41.65 Favored 'Isoleucine or valine' 0 C--N 1.367 1.336 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -123.91 138.19 54.51 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 56.3 m -88.09 105.91 17.8 Favored 'General case' 0 C--N 1.399 2.737 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.694 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -114.84 178.13 17.78 Favored Glycine 0 C--O 1.207 -1.587 0 C-N-CA 125.269 1.414 . . . . 0.0 112.996 -175.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -126.65 135.17 50.83 Favored 'General case' 0 CA--C 1.582 2.204 0 O-C-N 127.23 2.371 . . . . 0.0 109.427 -171.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 t -67.33 125.12 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 126.486 1.914 . . . . 0.0 112.92 -176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.7 p -99.53 -42.6 6.85 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 119.301 0.955 . . . . 0.0 112.536 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -165.85 152.63 9.82 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 81.3 mt -118.31 125.29 74.18 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.747 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -174.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 35.5 m -124.24 175.16 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 126.028 2.08 . . . . 0.0 109.627 -174.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -47.63 -42.17 23.71 Favored 'General case' 0 C--N 1.398 2.695 0 CA-C-N 119.931 1.241 . . . . 0.0 111.222 175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -94.52 9.14 39.72 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.774 -1.204 . . . . 0.0 113.423 -171.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.78 -164.31 19.4 Favored Glycine 0 CA--C 1.539 1.592 0 CA-C-O 124.275 2.042 . . . . 0.0 116.669 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -111.1 125.1 53.41 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 112.539 -1.831 . . . . 0.0 110.129 -166.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -81.63 149.76 28.41 Favored 'General case' 0 CA--C 1.568 1.655 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 174.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 84.2 t -145.25 121.95 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 0 CA-C-O 121.939 0.876 . . . . 0.0 112.375 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.23 132.91 35.37 Favored 'General case' 0 N--CA 1.482 1.134 0 O-C-N 117.154 -3.466 . . . . 0.0 112.478 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 36.1 mm -112.62 158.83 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 112.327 -2.215 . . . . 0.0 106.449 -173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -67.75 158.69 51.32 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 121.185 -0.947 . . . . 0.0 111.251 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 70.99 23.94 77.6 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 113.722 -1.239 . . . . 0.0 113.911 -170.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.38 18.06 74.91 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 127.499 2.476 . . . . 0.0 113.609 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -88.6 163.47 15.83 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 101.91 -3.367 . . . . 0.0 101.91 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -148.31 132.44 17.32 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 124.066 1.888 . . . . 0.0 106.591 -177.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -116.91 177.78 16.88 Favored Glycine 0 CA--C 1.554 2.489 0 O-C-N 119.955 -1.716 . . . . 0.0 114.65 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.91 123.43 30.73 Favored 'General case' 0 CA--C 1.563 1.473 0 O-C-N 120.704 -1.468 . . . . 0.0 109.213 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.483 HG21 HG13 ' A' ' 149' ' ' ILE . 21.5 t -96.2 116.44 38.11 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.772 0 O-C-N 119.328 -2.108 . . . . 0.0 106.08 159.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -64.84 147.16 53.79 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 126.064 2.103 . . . . 0.0 108.293 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 tp -32.66 -42.66 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.256 1.427 0 N-CA-C 119.576 3.176 . . . . 0.0 119.576 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 74.0 p -77.11 -27.14 53.93 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -97.46 7.21 46.94 Favored 'General case' 0 CA--C 1.565 1.548 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.596 -175.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 45.4 mm -60.05 -39.75 81.25 Favored 'Isoleucine or valine' 0 C--N 1.365 1.242 0 C-N-CA 124.57 1.148 . . . . 0.0 111.155 170.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -158.59 158.02 33.09 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 122.784 1.278 . . . . 0.0 111.502 171.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -69.02 -37.5 78.68 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 128.741 2.816 . . . . 0.0 109.089 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -112.62 117.21 31.64 Favored 'General case' 0 N--CA 1.517 2.92 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.286 167.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -66.11 146.29 54.83 Favored 'General case' 0 C--O 1.199 -1.601 0 C-N-CA 125.7 1.6 . . . . 0.0 114.99 -161.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.438 HG11 ' CG ' ' A' ' 125' ' ' TYR . 33.5 m -97.15 138.9 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 O-C-N 120.504 -1.372 . . . . 0.0 112.75 -172.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -60.22 -39.51 86.87 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 33.6 mtmt -139.2 147.8 42.27 Favored 'General case' 0 C--O 1.248 1.016 0 O-C-N 119.81 -1.806 . . . . 0.0 109.708 160.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.42 -37.2 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 C-N-CA 119.191 -1.004 . . . . 0.0 112.672 169.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.2 p -67.75 -20.61 65.25 Favored 'General case' 0 CA--C 1.477 -1.841 1 CA-C-O 111.471 -4.109 . . . . 0.0 112.861 178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -84.48 -13.57 51.61 Favored 'General case' 0 CA--C 1.56 1.35 0 CA-C-N 124.053 3.115 . . . . 0.0 115.412 171.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.438 ' CG ' HG11 ' A' ' 119' ' ' VAL . 79.7 t80 -99.04 -23.28 15.34 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.583 -172.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.4 mt -135.47 145.92 47.64 Favored 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -118.87 163.91 16.21 Favored 'General case' 0 N--CA 1.504 2.246 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.892 175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 22.1 mmt -72.55 150.7 42.94 Favored 'General case' 0 C--N 1.362 1.129 0 CA-C-N 120.605 1.548 . . . . 0.0 112.915 172.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.7 -21.51 18.32 Favored Glycine 0 N--CA 1.473 1.161 0 CA-C-N 112.064 -2.335 . . . . 0.0 115.238 173.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -109.34 134.95 51.18 Favored 'General case' 0 C--N 1.361 1.075 0 O-C-N 125.625 1.427 . . . . 0.0 111.874 -161.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -57.14 112.93 1.51 Allowed 'General case' 0 C--N 1.388 2.24 0 O-C-N 128.985 3.928 . . . . 0.0 117.942 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.8 t -116.25 116.27 39.76 Favored Pre-proline 0 C--O 1.247 0.949 0 C-N-CA 127.377 2.271 . . . . 0.0 109.358 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -57.58 125.23 18.11 Favored 'Trans proline' 0 N--CA 1.515 2.743 0 C-N-CA 121.643 1.562 . . . . 0.0 115.661 157.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.2 m -140.93 123.48 15.41 Favored 'Isoleucine or valine' 0 C--O 1.25 1.114 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 -169.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 84' ' ' VAL . 78.5 tttt -96.95 146.78 24.64 Favored 'General case' 0 C--N 1.368 1.384 0 CA-C-O 123.984 1.85 . . . . 0.0 107.766 -175.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 78.7 t -81.95 126.63 39.94 Favored 'Isoleucine or valine' 0 C--N 1.374 1.651 0 O-C-N 118.25 -2.782 . . . . 0.0 114.917 -175.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.2 -33.93 15.2 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.847 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -174.95 140.78 0.56 Allowed 'General case' 0 N--CA 1.521 3.115 0 O-C-N 124.626 1.204 . . . . 0.0 109.88 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -106.19 142.64 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.301 0 O-C-N 120.429 -1.419 . . . . 0.0 109.666 -170.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.26 66.5 t0 -142.69 138.52 30.66 Favored 'General case' 0 N--CA 1.411 -2.4 0 O-C-N 124.421 1.076 . . . . 0.0 108.715 -175.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -101.04 5.26 42.94 Favored 'General case' 0 C--N 1.367 1.345 0 CA-C-O 114.703 -2.57 . . . . 0.0 107.83 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -117.56 -57.13 2.16 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.28 164.66 33.63 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 119.814 2.686 . . . . 0.0 119.814 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.7 mmt-85 -60.8 127.2 30.44 Favored 'General case' 0 C--N 1.396 2.61 0 O-C-N 117.614 -3.286 . . . . 0.0 114.401 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.7 mm -31.2 137.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 CA-C-O 126.451 3.024 . . . . 0.0 114.77 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -94.21 132.21 39.0 Favored 'General case' 0 C--O 1.247 0.964 0 O-C-N 118.225 -2.797 . . . . 0.0 109.894 172.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 68.3 mt -136.42 146.65 46.64 Favored 'General case' 0 C--N 1.359 1.018 0 CA-C-N 112.69 -2.05 . . . . 0.0 113.002 -169.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 27.9 t -129.9 128.25 41.81 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.154 167.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.483 HG13 HG21 ' A' ' 109' ' ' VAL . 70.4 mt -72.75 -43.64 60.68 Favored 'Isoleucine or valine' 0 C--N 1.384 2.092 0 CA-C-N 111.569 -2.56 . . . . 0.0 106.933 178.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -73.3 -30.02 63.1 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 118.975 -2.328 . . . . 0.0 111.899 -170.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.13 -15.02 62.91 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 120.092 -1.63 . . . . 0.0 113.118 174.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.314 . . -106.86 14.55 26.5 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.106 -168.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -82.83 151.44 26.06 Favored 'General case' 0 C--O 1.255 1.365 0 CA-C-N 120.15 1.341 . . . . 0.0 111.087 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.292 54.1 mt-10 54.75 57.5 5.65 Favored 'General case' 0 C--N 1.374 1.664 0 N-CA-C 117.906 2.558 . . . . 0.0 117.906 171.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 103.751 -2.685 . . . . 0.0 103.751 172.148 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 32.2 mm -93.58 121.25 44.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 O-C-N 124.967 1.417 . . . . 0.0 112.18 -176.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -93.42 119.8 32.95 Favored 'General case' 0 C--O 1.191 -2.001 0 CA-C-N 114.262 -1.335 . . . . 0.0 107.402 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.4 m -118.63 111.77 18.98 Favored 'General case' 0 CA--C 1.481 -1.687 0 N-CA-C 100.956 -3.72 . . . . 0.0 100.956 -163.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 26.0 mm -116.39 135.73 55.68 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 CA-C-O 116.01 -1.948 . . . . 0.0 110.514 -175.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -95.54 123.35 39.04 Favored 'General case' 0 CA--C 1.576 1.962 0 O-C-N 124.928 1.393 . . . . 0.0 111.878 176.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.9 pt -131.43 161.66 40.75 Favored 'Isoleucine or valine' 0 C--O 1.259 1.589 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 -173.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -48.56 120.88 9.24 Favored Pre-proline 0 N--CA 1.45 -0.473 0 N-CA-C 117.418 2.377 . . . . 0.0 117.418 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.65 -23.93 8.83 Favored 'Trans proline' 0 N--CA 1.516 2.825 0 N-CA-C 118.131 2.32 . . . . 0.0 118.131 171.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -72.82 -30.04 63.72 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 116.766 -3.709 . . . . 0.0 111.692 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -91.74 -0.28 57.54 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 -167.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.9 mm -62.35 -44.91 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.431 1.892 . . . . 0.0 109.539 -172.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -60.84 -38.91 87.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 127.674 2.39 . . . . 0.0 111.605 174.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -73.77 -40.69 63.28 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 119.228 -2.17 . . . . 0.0 112.794 -175.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.39 -36.3 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.296 169.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.5 mt -66.91 -43.13 89.59 Favored 'Isoleucine or valine' 0 C--N 1.349 0.554 0 C-N-CA 124.335 1.054 . . . . 0.0 110.248 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.533 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 79.94 156.75 12.53 Favored Glycine 1 CA--C 1.584 4.383 0 CA-C-O 123.846 1.803 . . . . 0.0 116.535 -172.106 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -71.74 132.69 44.87 Favored 'General case' 0 C--O 1.198 -1.611 0 CA-C-O 122.694 1.235 . . . . 0.0 108.596 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.91 20.03 24.67 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 118.804 2.282 . . . . 0.0 118.804 -168.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.99 16.38 74.98 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.229 -1.317 . . . . 0.0 111.791 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.3 t -70.62 -41.9 71.64 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 118.17 2.655 . . . . 0.0 118.17 -169.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.533 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 21.4 t -65.48 -44.3 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 CA-C-N 120.441 1.473 . . . . 0.0 114.135 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -61.83 -39.38 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.718 -178.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -64.64 -44.46 90.4 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.091 -1.631 . . . . 0.0 115.283 175.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.04 -40.97 97.57 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 118.055 2.613 . . . . 0.0 118.055 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.8 tp -65.44 -39.87 92.59 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 120.881 -1.137 . . . . 0.0 113.049 168.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 52.6 m -47.81 -55.55 9.44 Favored 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 125.862 1.665 . . . . 0.0 112.484 167.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -69.86 -33.45 72.29 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -57.84 -46.32 84.93 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 126.321 1.849 . . . . 0.0 112.101 166.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.3 p -97.51 -18.69 18.85 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 117.354 -1.738 . . . . 0.0 111.422 -165.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.77 35.77 73.85 Favored Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 124.156 0.884 . . . . 0.0 112.838 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -151.52 152.33 32.8 Favored 'General case' 0 C--N 1.286 -2.188 0 C-N-CA 117.811 -1.555 . . . . 0.0 107.729 -178.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 m -66.42 131.01 45.13 Favored 'General case' 0 C--O 1.208 -1.117 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.048 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.0 mt -132.11 123.0 49.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.581 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.923 174.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -131.37 141.52 49.9 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 104.158 -2.534 . . . . 0.0 104.158 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.1 tt -127.55 155.23 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 71.2 mt-10 -116.19 143.02 46.06 Favored 'General case' 0 C--N 1.38 1.906 0 O-C-N 117.403 -3.311 . . . . 0.0 103.389 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -62.94 -12.42 25.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -174.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.6 p30 -87.52 0.27 55.82 Favored 'General case' 0 C--N 1.364 1.22 0 CA-C-N 119.21 0.914 . . . . 0.0 113.441 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.67 27.15 7.26 Favored Glycine 0 CA--C 1.478 -2.245 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 168.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.2 m -107.02 110.46 22.6 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 p -92.79 142.66 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.342 0 CA-C-N 118.853 0.751 . . . . 0.0 109.575 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -125.83 137.24 53.76 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.509 -1.276 . . . . 0.0 113.328 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.6 mt -121.06 119.58 59.73 Favored 'Isoleucine or valine' 0 C--N 1.366 1.307 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . 0.279 . . -87.6 118.55 27.16 Favored 'General case' 0 N--CA 1.403 -2.782 0 O-C-N 118.113 -2.867 . . . . 0.0 110.98 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.42 151.51 17.25 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 3.6 m -98.69 -39.94 8.42 Favored 'General case' 0 CA--C 1.484 -1.585 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.233 169.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.52 124.78 25.04 Favored 'General case' 0 N--CA 1.415 -2.211 0 O-C-N 126.02 2.075 . . . . 0.0 109.374 169.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -76.58 -25.77 64.61 Favored Glycine 0 C--N 1.356 1.652 0 O-C-N 120.452 -1.405 . . . . 0.0 116.528 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -66.4 -34.87 78.93 Favored 'General case' 0 C--O 1.2 -1.544 0 N-CA-C 113.007 0.744 . . . . 0.0 113.007 174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -63.26 -44.87 93.9 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 167.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.91 77.93 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 171.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -64.47 -50.79 66.1 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 164.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -57.73 -41.43 81.81 Favored 'General case' 0 N--CA 1.529 3.479 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.99 -44.33 87.11 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.83 -39.82 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.351 -0.94 . . . . 0.0 113.209 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -65.14 -41.84 94.38 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-N 121.552 1.978 . . . . 0.0 110.315 175.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 mmm180 -60.85 -38.19 84.65 Favored 'General case' 0 CA--C 1.584 2.251 1 O-C-N 116.198 -4.064 . . . . 0.0 115.593 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.6 mt -64.79 -44.04 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 119.917 -1.739 . . . . 0.0 110.264 172.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -54.85 -41.12 70.37 Favored 'General case' 0 CA--C 1.557 1.237 0 CA-C-O 115.527 -2.178 . . . . 0.0 114.776 168.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -63.82 -41.47 97.86 Favored 'General case' 0 C--N 1.38 1.903 0 CA-C-N 122.225 2.284 . . . . 0.0 115.287 173.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.7 mt -69.08 -39.8 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 CA-C-N 122.217 2.281 . . . . 0.0 114.681 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 45.3 p -77.59 -11.5 59.87 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 116.913 2.19 . . . . 0.0 116.913 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.69 -31.22 72.11 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 120.937 1.699 . . . . 0.0 114.091 160.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -69.47 160.06 32.12 Favored 'General case' 0 C--N 1.349 0.553 0 CA-C-O 125.572 2.606 . . . . 0.0 116.108 -163.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.8 mm -102.87 130.72 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-O 124.119 1.914 . . . . 0.0 113.759 -155.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -84.01 123.8 30.38 Favored 'General case' 0 C--O 1.188 -2.15 0 CA-C-N 111.209 -2.723 . . . . 0.0 117.87 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 72.2 t -66.73 122.49 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.862 0 C-N-CA 126.311 1.844 . . . . 0.0 106.858 173.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.07 8.03 59.25 Favored Glycine 0 N--CA 1.471 0.972 0 CA-C-N 112.808 -1.997 . . . . 0.0 113.224 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -96.75 164.22 12.67 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 106.36 -1.718 . . . . 0.0 106.36 169.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.2 t -102.97 136.47 35.35 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -114.51 158.75 21.21 Favored 'General case' 0 N--CA 1.433 -1.316 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 m -98.37 124.41 43.02 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.361 1.077 . . . . 0.0 108.447 167.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -132.97 -174.05 13.48 Favored Glycine 0 C--N 1.347 1.139 0 O-C-N 120.241 -1.537 . . . . 0.0 112.188 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -131.39 134.94 46.77 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 -177.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.7 t -69.92 119.77 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 C-N-CA 124.176 0.991 . . . . 0.0 109.072 -175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -84.86 -22.39 29.43 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 119.975 -1.703 . . . . 0.0 114.668 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 174.57 132.79 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.366 -169.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 67.6 mt -108.96 128.31 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.5 m -114.68 173.79 3.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -53.14 -47.88 68.36 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 120.395 -1.44 . . . . 0.0 113.493 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -104.08 17.89 23.17 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 120.045 -1.659 . . . . 0.0 113.618 -173.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 179.78 -176.41 47.5 Favored Glycine 0 N--CA 1.502 3.077 0 C-N-CA 118.27 -1.919 . . . . 0.0 115.485 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.83 117.74 9.38 Favored 'General case' 0 C--N 1.373 1.618 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 171.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -75.58 137.72 40.98 Favored 'General case' 0 C--N 1.372 1.578 0 O-C-N 125.559 1.787 . . . . 0.0 111.46 176.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 61.4 t -134.25 132.57 55.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.586 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 -171.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.42 136.41 37.9 Favored 'General case' 0 C--N 1.363 1.171 0 CA-C-O 122.702 1.239 . . . . 0.0 108.753 -175.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 15.9 pt -139.76 160.01 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.516 0 CA-C-O 117.448 -1.263 . . . . 0.0 111.15 -168.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.17 138.01 0.54 Allowed Glycine 0 CA--C 1.562 2.992 0 N-CA-C 122.391 3.717 . . . . 0.0 122.391 -166.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.92 18.58 62.99 Favored Glycine 0 CA--C 1.483 -1.938 0 CA-C-O 116.189 -2.451 . . . . 0.0 116.827 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.59 33.82 41.69 Favored Glycine 0 CA--C 1.544 1.888 0 CA-C-N 120.371 2.085 . . . . 0.0 117.5 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -114.52 151.62 33.03 Favored 'General case' 0 N--CA 1.515 2.781 0 C-N-CA 124.222 1.009 . . . . 0.0 112.544 174.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -143.79 123.34 13.23 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 113.3 -1.773 . . . . 0.0 106.219 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -120.85 174.66 15.85 Favored Glycine 0 C--N 1.364 2.125 0 O-C-N 126.748 2.53 . . . . 0.0 113.003 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 38.7 tp -128.98 126.46 39.62 Favored 'General case' 0 C--O 1.21 -1.023 0 CA-C-N 112.587 -1.807 . . . . 0.0 111.835 -166.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.3 t -95.59 116.66 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 N-CA-C 102.329 -3.212 . . . . 0.0 102.329 173.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.472 ' CD2' ' H ' ' A' ' 112' ' ' SER . 58.5 t60 -66.63 151.74 46.74 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 120.352 -1.467 . . . . 0.0 111.462 171.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.333 14.2 tt -39.07 -34.43 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.372 1.563 0 N-CA-C 120.634 3.568 . . . . 0.0 120.634 172.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.472 ' H ' ' CD2' ' A' ' 110' ' ' HIS . 66.5 m -69.63 -18.87 63.62 Favored 'General case' 0 N--CA 1.534 3.725 0 O-C-N 125.758 1.911 . . . . 0.0 113.446 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -120.24 6.83 10.71 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.718 0.807 . . . . 0.0 110.817 -160.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.9 mm -74.19 -42.04 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.707 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 170.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -143.05 167.75 21.34 Favored 'General case' 0 CA--C 1.549 0.927 0 O-C-N 119.98 -1.7 . . . . 0.0 112.427 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . 0.316 53.6 p30 -41.6 -67.0 0.29 Allowed 'General case' 0 C--N 1.363 1.161 0 O-C-N 128.584 3.678 . . . . 0.0 118.081 173.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . 0.257 66.6 mttt -99.71 164.96 11.83 Favored 'General case' 0 CA--C 1.582 2.21 0 C-N-CA 129.408 3.083 . . . . 0.0 106.091 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -59.05 140.56 55.65 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 116.758 2.133 . . . . 0.0 116.758 -174.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 52.1 t -102.71 136.57 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 125.057 1.473 . . . . 0.0 110.228 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -92.25 -48.62 6.59 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 114.154 -1.384 . . . . 0.0 109.697 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -143.99 127.97 17.46 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.1 t -72.33 -24.22 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 123.889 1.804 . . . . 0.0 113.129 -164.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 66.8 p -63.62 -26.83 68.86 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 126.691 1.996 . . . . 0.0 112.721 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -63.89 -25.59 68.22 Favored 'General case' 0 C--O 1.261 1.688 0 O-C-N 119.326 -2.109 . . . . 0.0 115.306 168.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -96.35 -46.49 6.38 Favored 'General case' 0 C--N 1.371 1.53 0 O-C-N 126.725 2.515 . . . . 0.0 114.47 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.2 mt -114.67 135.62 53.96 Favored 'General case' 0 N--CA 1.434 -1.256 0 O-C-N 125.687 1.867 . . . . 0.0 108.536 -166.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -105.94 141.62 37.04 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 30.8 ttp -63.95 137.19 57.9 Favored 'General case' 0 C--O 1.203 -1.362 0 O-C-N 126.328 2.267 . . . . 0.0 114.063 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.01 -24.52 7.84 Favored Glycine 0 N--CA 1.428 -1.858 0 CA-C-O 116.898 -2.057 . . . . 0.0 115.731 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 47.6 mm-40 -72.01 163.91 27.05 Favored 'General case' 0 C--O 1.2 -1.507 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -78.45 134.77 37.31 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 112.785 -2.007 . . . . 0.0 111.69 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.6 m -139.85 141.21 26.7 Favored Pre-proline 0 C--N 1.369 1.419 0 O-C-N 118.753 -2.467 . . . . 0.0 112.042 174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.06 127.77 10.9 Favored 'Trans proline' 0 C--N 1.286 -2.739 0 C-N-CA 121.106 1.204 . . . . 0.0 111.707 165.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.1 m -128.33 128.43 68.39 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -91.61 132.68 36.16 Favored 'General case' 0 C--N 1.373 1.602 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.701 165.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.488 ' HA ' HD23 ' A' ' 147' ' ' LEU . 46.4 t -75.7 104.45 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 CA-C-O 119.17 -0.443 . . . . 0.0 111.667 177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 79.0 mt -61.11 -42.65 98.92 Favored 'General case' 0 C--N 1.39 2.327 0 C-N-CA 127.048 2.139 . . . . 0.0 112.894 168.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -165.56 140.69 4.98 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 123.939 0.775 . . . . 0.0 112.298 -175.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.9 t -106.88 116.0 49.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 156.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.251 0.3 OUTLIER -80.55 171.55 14.89 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-O 123.768 1.747 . . . . 0.0 113.698 179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 47.5 mtt180 -64.34 -33.82 76.72 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 119.066 -2.271 . . . . 0.0 112.617 -175.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.5 mm-40 -71.11 -37.74 72.36 Favored 'General case' 0 C--O 1.202 -1.431 0 CA-C-O 116.757 -1.592 . . . . 0.0 110.02 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.77 9.22 1.78 Allowed Glycine 0 C--N 1.359 1.834 0 CA-C-N 122.101 2.228 . . . . 0.0 114.736 177.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 44.2 mtm180 -95.7 134.02 39.11 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -163.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 9.4 mt -105.54 108.88 26.05 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 O-C-N 121.412 -0.805 . . . . 0.0 110.333 -167.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -85.9 136.55 33.24 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 136' ' ' VAL . 92.4 mt -127.68 163.06 25.1 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 126.077 2.111 . . . . 0.0 111.332 -170.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 42.9 t -148.9 134.55 18.73 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 -175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 96.8 mt -105.27 -30.51 2.7 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.45 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 168.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -61.1 -40.97 95.74 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-O 116.675 -1.631 . . . . 0.0 109.765 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.4 -14.8 60.91 Favored 'General case' 0 CA--C 1.562 1.419 0 O-C-N 125.117 1.511 . . . . 0.0 110.232 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -96.61 -14.94 21.82 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 23.3 p -103.19 0.93 32.41 Favored 'General case' 0 CA--C 1.488 -1.406 0 O-C-N 126.978 2.674 . . . . 0.0 111.703 161.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 65.65 38.76 5.21 Favored 'General case' 0 CA--C 1.559 1.324 0 O-C-N 127.107 2.754 . . . . 0.0 113.777 163.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 43.9 mm-40 . . . . . 0 N--CA 1.43 -1.434 0 CA-C-O 117.212 -1.375 . . . . 0.0 112.749 175.576 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 . . . . . 0 CA--C 1.552 1.021 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tp -64.74 122.76 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.737 -1.227 . . . . 0.0 111.743 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -75.96 135.79 40.04 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-O 126.027 2.823 . . . . 0.0 114.663 177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.466 HG22 ' HG2' ' A' ' 56' ' ' LYS . 43.5 p -141.67 154.97 45.69 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 112.45 -2.159 . . . . 0.0 111.915 -176.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 57' ' ' ILE . 6.7 mt -130.3 128.4 64.04 Favored 'Isoleucine or valine' 0 C--N 1.366 1.315 0 O-C-N 126.753 2.533 . . . . 0.0 107.716 172.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.4 tttp -77.69 126.22 30.54 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 36.0 mm -106.18 133.97 49.1 Favored 'Isoleucine or valine' 0 C--N 1.366 1.291 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -63.39 140.07 97.67 Favored Pre-proline 0 N--CA 1.485 1.321 0 CA-C-O 117.165 -1.397 . . . . 0.0 110.178 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -44.89 -45.71 13.59 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.622 2.881 . . . . 0.0 116.472 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -73.98 -21.29 60.06 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 128.04 3.338 . . . . 0.0 106.536 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -101.47 -4.65 26.43 Favored 'General case' 0 C--N 1.387 2.227 0 O-C-N 119.737 -1.852 . . . . 0.0 113.839 -170.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 82.4 mt -59.25 -42.27 86.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 117.23 -1.367 . . . . 0.0 114.577 168.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -58.34 -40.37 81.95 Favored 'General case' 0 C--O 1.267 1.999 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 170.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -65.88 -35.57 81.0 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 117.56 -1.209 . . . . 0.0 112.432 174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.2 t -70.05 -44.9 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 123.867 0.73 . . . . 0.0 111.679 174.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.0 mm -85.85 -38.37 12.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 122.079 2.218 . . . . 0.0 112.487 -172.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.48 154.21 16.97 Favored Glycine 0 CA--C 1.474 -2.521 0 CA-C-N 120.684 1.584 . . . . 0.0 115.817 -177.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -70.53 130.6 42.29 Favored 'General case' 0 N--CA 1.419 -1.987 0 O-C-N 119.699 -2.059 . . . . 0.0 111.026 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.74 10.07 60.29 Favored Glycine 0 N--CA 1.481 1.636 0 CA-C-O 115.373 -2.904 . . . . 0.0 113.507 -173.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 78.14 22.8 67.46 Favored Glycine 0 CA--C 1.563 3.077 0 O-C-N 127.163 2.331 . . . . 0.0 112.048 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.0 p -55.29 -49.31 72.45 Favored 'General case' 0 C--O 1.261 1.681 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.5 t -71.29 -43.3 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 N-CA-C 113.519 0.933 . . . . 0.0 113.519 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.441 HD12 ' HB2' ' A' ' 39' ' ' LEU . 10.4 tp -68.56 -30.69 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 O-C-N 120.002 -1.686 . . . . 0.0 113.417 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 58.8 mtm-85 -63.02 -39.1 93.75 Favored 'General case' 0 C--O 1.217 -0.654 0 CA-C-O 122.375 1.083 . . . . 0.0 110.875 168.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.93 98.25 Favored 'General case' 0 CA--C 1.551 1.014 0 O-C-N 119.874 -1.766 . . . . 0.0 114.324 166.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.441 ' HB2' HD12 ' A' ' 36' ' ' ILE . 36.3 mt -67.22 -38.82 85.91 Favored 'General case' 0 C--O 1.188 -2.134 0 O-C-N 118.338 -2.727 . . . . 0.0 109.714 -176.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.281 15.3 t -59.46 -39.73 84.6 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 114.282 -2.77 . . . . 0.0 114.185 165.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -69.96 -38.92 76.25 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 122.827 2.558 . . . . 0.0 115.669 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -69.36 -43.13 74.24 Favored 'General case' 0 C--N 1.285 -2.218 0 O-C-N 126.787 2.554 . . . . 0.0 111.058 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.7 p -83.7 -25.14 30.89 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.1 30.75 54.76 Favored Glycine 0 C--N 1.318 -0.42 0 CA-C-O 117.192 -1.893 . . . . 0.0 110.201 173.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 t -152.63 162.21 41.54 Favored 'General case' 0 C--N 1.396 2.621 0 C-N-CA 128.68 2.792 . . . . 0.0 106.034 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.4 m -73.83 124.09 25.43 Favored 'General case' 0 C--N 1.371 1.539 0 C-N-CA 126.134 1.774 . . . . 0.0 113.922 172.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.1 mm -112.69 135.01 53.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 112.943 -1.935 . . . . 0.0 108.768 -178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -132.96 158.31 42.98 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.0 mm -109.45 132.36 57.8 Favored 'Isoleucine or valine' 0 C--N 1.368 1.387 0 O-C-N 119.691 -1.88 . . . . 0.0 107.959 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -115.5 169.76 8.93 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -40.06 139.59 0.67 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 124.396 2.046 . . . . 0.0 113.731 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.317 28.2 m-20 67.51 38.34 3.16 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 113.244 -1.798 . . . . 0.0 113.0 173.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.53 41.1 77.55 Favored Glycine 0 N--CA 1.422 -2.276 0 CA-C-O 115.989 -2.561 . . . . 0.0 117.357 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 96.0 m -103.84 108.82 20.31 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 120.189 1.994 . . . . 0.0 111.646 -169.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.0 t -73.43 127.59 35.45 Favored 'Isoleucine or valine' 0 C--N 1.382 2.02 0 O-C-N 123.632 0.582 . . . . 0.0 111.303 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.466 ' HG2' HG22 ' A' ' 17' ' ' THR . 38.5 mtmt -119.41 137.16 53.93 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 124.584 2.135 . . . . 0.0 111.21 173.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.428 HD11 HD11 ' A' ' 18' ' ' ILE . 43.8 mt -104.33 112.48 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-N 113.069 -1.878 . . . . 0.0 109.425 -172.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.63 -47.48 78.42 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 116.911 -1.518 . . . . 0.0 112.969 -173.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.8 138.04 53.86 Favored 'General case' 0 C--N 1.369 1.44 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.0 p -95.54 -0.57 51.91 Favored 'General case' 0 C--N 1.369 1.426 0 O-C-N 120.185 -1.572 . . . . 0.0 114.07 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -55.47 151.94 9.56 Favored 'General case' 0 CA--C 1.552 1.028 0 O-C-N 126.37 2.294 . . . . 0.0 114.827 168.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -82.29 -48.32 5.71 Favored Glycine 0 N--CA 1.478 1.487 0 O-C-N 120.596 -1.315 . . . . 0.0 112.108 -172.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -70.17 -26.44 63.91 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.22 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -65.16 -41.53 94.59 Favored 'General case' 0 C--N 1.386 2.171 0 C-N-CA 123.42 0.688 . . . . 0.0 111.414 174.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -69.1 -46.49 67.58 Favored 'General case' 0 C--O 1.252 1.224 0 O-C-N 124.045 0.841 . . . . 0.0 110.561 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -63.29 -40.71 98.12 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.41 172.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -68.25 -45.81 72.17 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 121.124 1.784 . . . . 0.0 110.564 -177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.33 -46.91 87.32 Favored 'General case' 0 C--O 1.258 1.532 0 O-C-N 124.634 1.209 . . . . 0.0 112.302 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.256 15.0 tt -70.71 -31.56 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-O 117.361 -1.304 . . . . 0.0 111.372 174.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -61.28 -42.95 99.5 Favored 'General case' 0 CA--C 1.574 1.903 0 CA-C-N 121.043 1.747 . . . . 0.0 114.865 171.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -60.53 -47.19 87.26 Favored 'General case' 0 CA--C 1.556 1.187 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.4 mm -56.47 -38.66 57.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 O-C-N 120.457 -1.402 . . . . 0.0 112.722 170.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.17 -53.91 52.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 124.84 1.337 . . . . 0.0 113.113 176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.8 mt-10 -59.58 -37.2 77.87 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.911 1.285 . . . . 0.0 114.154 174.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.9 mt -69.45 -36.07 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.8 m -64.72 -40.03 94.64 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.925 1.391 . . . . 0.0 109.137 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.58 1.73 36.69 Favored 'General case' 0 CA--C 1.589 2.469 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.77 149.66 49.8 Favored 'General case' 0 N--CA 1.516 2.864 0 O-C-N 119.603 -1.936 . . . . 0.0 110.327 175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.0 mm -61.23 131.66 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.349 -1.47 . . . . 0.0 112.698 -171.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -91.64 135.19 34.06 Favored 'General case' 0 C--N 1.374 1.656 0 O-C-N 119.928 -1.733 . . . . 0.0 112.676 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.8 t -73.5 140.31 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.798 0 O-C-N 127.171 2.795 . . . . 0.0 113.589 171.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 81.05 -8.43 57.48 Favored Glycine 0 C--N 1.387 3.374 0 C-N-CA 126.276 1.894 . . . . 0.0 114.806 -171.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 60.9 ttt180 -89.83 149.37 22.7 Favored 'General case' 0 C--N 1.365 1.269 0 O-C-N 121.234 -1.157 . . . . 0.0 109.537 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.46 121.78 58.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.133 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.39 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -111.42 166.46 11.1 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 104.011 -2.588 . . . . 0.0 104.011 178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 53.0 m -112.79 134.53 54.27 Favored 'General case' 0 CA--C 1.476 -1.887 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 169.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -135.09 168.32 23.75 Favored Glycine 0 CA--C 1.475 -2.462 0 C-N-CA 117.547 -2.263 . . . . 0.0 108.648 -177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -118.41 135.37 54.38 Favored 'General case' 0 C--O 1.198 -1.619 0 CA-C-N 113.242 -1.479 . . . . 0.0 113.631 -175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 82.3 t -69.3 135.82 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.233 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.759 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 41.9 p -128.4 -18.05 4.09 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 120.909 -1.119 . . . . 0.0 108.249 -177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.3 mtm-85 -154.42 156.88 37.62 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 119.679 -1.888 . . . . 0.0 108.249 175.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 mm -123.88 135.32 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 CA-C-O 123.653 1.692 . . . . 0.0 111.136 173.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.9 m -126.7 168.43 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-N 113.99 -1.459 . . . . 0.0 110.694 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.61 -46.16 48.91 Favored 'General case' 0 C--O 1.179 -2.618 0 C-N-CA 123.899 0.88 . . . . 0.0 111.976 175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -107.44 17.63 22.53 Favored 'General case' 0 N--CA 1.514 2.73 0 C-N-CA 125.898 1.679 . . . . 0.0 114.622 -169.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.93 -163.32 33.66 Favored Glycine 0 C--N 1.363 2.05 0 O-C-N 118.394 -2.691 . . . . 0.0 108.977 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -147.76 165.5 30.35 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 170.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -107.88 127.27 53.59 Favored 'General case' 0 N--CA 1.509 2.483 0 O-C-N 126.718 2.511 . . . . 0.0 111.867 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.6 t -122.45 126.22 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.527 0 CA-C-N 112.593 -2.094 . . . . 0.0 108.925 -166.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.8 109.9 21.77 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 126.157 2.161 . . . . 0.0 110.316 -171.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 27.7 pt -105.35 161.65 5.02 Favored 'Isoleucine or valine' 0 C--N 1.364 1.203 0 C-N-CA 126.085 1.754 . . . . 0.0 111.916 177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.36 136.75 7.0 Favored Glycine 0 C--N 1.36 1.894 1 N-CA-C 124.032 4.373 . . . . 0.0 124.032 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.66 4.0 39.99 Favored Glycine 0 C--N 1.306 -1.1 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 81.84 23.99 56.53 Favored Glycine 0 N--CA 1.423 -2.17 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -107.28 148.54 28.85 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 118.981 1.391 . . . . 0.0 112.226 -173.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -127.37 127.46 44.25 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 125.698 1.874 . . . . 0.0 110.782 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -119.38 155.93 15.93 Favored Glycine 0 CA--C 1.556 2.645 0 N-CA-C 117.09 1.596 . . . . 0.0 117.09 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.3 tp -90.47 118.36 29.88 Favored 'General case' 0 N--CA 1.518 2.972 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.27 107.67 20.36 Favored 'Isoleucine or valine' 0 C--N 1.396 2.62 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 38.9 m-70 -68.88 162.41 26.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 118.299 -2.751 . . . . 0.0 116.872 172.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.2 tt -61.83 -37.64 78.63 Favored 'Isoleucine or valine' 0 C--O 1.247 0.922 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -59.51 -19.6 49.33 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 126.804 2.565 . . . . 0.0 116.345 167.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -106.15 9.78 32.17 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.499 -1.228 . . . . 0.0 112.588 -177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 47.9 mt -88.38 -49.42 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-N 119.087 0.858 . . . . 0.0 109.856 177.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.12 157.57 43.65 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 116.009 -1.948 . . . . 0.0 107.036 -172.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -71.46 -19.22 62.25 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 173.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -95.06 134.57 37.6 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.816 2.046 . . . . 0.0 105.892 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.19 116.44 1.86 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.66 120.01 35.54 Favored 'Isoleucine or valine' 0 C--O 1.262 1.724 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.34 -40.9 90.17 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 126.343 2.277 . . . . 0.0 111.808 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -157.52 151.69 24.67 Favored 'General case' 0 CA--C 1.486 -1.484 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.2 t -63.12 -36.81 77.45 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.938 0 CA-C-O 116.727 -1.606 . . . . 0.0 113.15 -170.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.59 -25.2 16.33 Favored 'General case' 0 N--CA 1.513 2.692 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -69.04 -19.85 64.11 Favored 'General case' 0 CA--C 1.575 1.918 0 C-N-CA 125.354 1.462 . . . . 0.0 113.872 173.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -123.48 -37.0 2.71 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.201 -1.562 . . . . 0.0 112.485 -175.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 20.3 mt -130.23 150.94 51.24 Favored 'General case' 0 CA--C 1.574 1.903 0 CA-C-O 124.293 1.997 . . . . 0.0 115.328 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -159.34 155.98 27.77 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -172.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -43.95 125.69 4.44 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 122.705 1.241 . . . . 0.0 113.227 165.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.58 -2.72 80.85 Favored Glycine 0 N--CA 1.494 2.556 0 CA-C-N 114.264 -1.335 . . . . 0.0 116.087 -175.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.7 mm100 -73.65 128.48 35.61 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.471 171.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 61.1 mt-10 -106.52 124.92 50.33 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 124.516 1.135 . . . . 0.0 109.666 168.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.97 151.12 61.55 Favored Pre-proline 0 C--N 1.379 1.856 0 C-N-CA 127.72 2.408 . . . . 0.0 110.982 -171.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -90.81 138.89 2.56 Favored 'Trans proline' 0 CA--C 1.493 -1.565 0 N-CA-C 104.814 -2.802 . . . . 0.0 104.814 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.464 HG21 HD13 ' A' ' 147' ' ' LEU . 6.2 m -136.41 126.77 40.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 110.946 -2.843 . . . . 0.0 109.133 -168.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 48.9 tttt -100.26 122.18 42.65 Favored 'General case' 0 C--N 1.368 1.397 0 O-C-N 120.222 -1.549 . . . . 0.0 111.395 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.0 t -63.13 118.73 5.66 Favored 'Isoleucine or valine' 0 C--O 1.264 1.856 0 CA-C-N 113.553 -1.658 . . . . 0.0 110.488 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 148' ' ' SER . 63.5 mt -90.68 -50.26 6.01 Favored 'General case' 0 C--O 1.254 1.295 0 CA-C-N 111.888 -2.414 . . . . 0.0 113.613 178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -159.78 148.58 17.6 Favored 'General case' 0 C--N 1.355 0.819 0 CA-C-O 116.047 -1.93 . . . . 0.0 107.371 -175.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 145' ' ' ILE . 18.0 t -133.93 120.33 35.5 Favored 'Isoleucine or valine' 0 C--N 1.388 2.271 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -67.92 146.78 53.28 Favored 'General case' 0 CA--C 1.556 1.205 0 O-C-N 126.028 2.08 . . . . 0.0 111.676 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 39.6 mmt180 -46.69 -33.76 4.55 Favored 'General case' 0 CA--C 1.577 1.991 0 N-CA-C 118.662 2.838 . . . . 0.0 118.662 167.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -92.73 29.15 1.84 Allowed 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.11 1.364 . . . . 0.0 109.656 173.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.98 59.16 7.8 Favored Glycine 0 C--N 1.348 1.209 0 N-CA-C 120.041 2.776 . . . . 0.0 120.041 166.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -137.19 136.82 38.52 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 171.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.405 HG23 HG22 ' A' ' 139' ' ' VAL . 3.3 mt -121.66 122.68 67.64 Favored 'Isoleucine or valine' 0 C--N 1.343 0.315 0 O-C-N 126.466 2.354 . . . . 0.0 108.892 -158.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.4 mpp_? -94.19 136.23 34.71 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 172.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 134' ' ' VAL . 18.9 mt -124.73 152.35 43.9 Favored 'General case' 0 C--N 1.372 1.557 0 O-C-N 127.408 2.942 . . . . 0.0 111.524 -173.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.54 ' HB2' HD11 ' A' ' 137' ' ' LEU . 38.9 t -140.6 138.9 34.77 Favored 'General case' 0 CA--C 1.484 -1.585 0 O-C-N 120.534 -1.354 . . . . 0.0 109.974 177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 64.6 mt -87.65 -34.71 7.55 Favored 'Isoleucine or valine' 0 C--O 1.258 1.512 0 O-C-N 125.86 1.975 . . . . 0.0 110.432 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -77.12 -33.28 56.81 Favored 'General case' 0 C--O 1.198 -1.654 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -168.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -71.34 -30.97 66.83 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.43 -21.81 35.56 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 119.024 -2.297 . . . . 0.0 109.314 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 11.7 p -93.09 7.27 44.86 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 121.007 1.73 . . . . 0.0 113.655 171.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.258 27.6 mt-10 74.8 51.6 0.08 Allowed 'General case' 0 C--O 1.243 0.755 0 O-C-N 118.042 -2.911 . . . . 0.0 113.295 169.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 57.4 mm-40 . . . . . 0 C--N 1.375 1.709 0 CA-C-O 123.501 1.619 . . . . 0.0 111.896 163.567 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.911 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 tp -110.34 135.68 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.093 0 O-C-N 124.609 1.193 . . . . 0.0 108.328 172.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 17.2 m-70 -116.03 113.88 23.82 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 162.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.7 m -100.62 106.13 17.59 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.5 mt -109.3 158.5 9.2 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.212 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.421 -172.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -108.96 140.09 42.93 Favored 'General case' 0 C--N 1.368 1.401 0 O-C-N 119.111 -2.243 . . . . 0.0 109.021 167.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.89 162.27 36.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -64.53 132.22 95.32 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-O 114.254 -2.784 . . . . 0.0 112.576 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . 0.271 42.6 Cg_exo -48.79 -29.25 14.42 Favored 'Trans proline' 0 N--CA 1.515 2.742 0 N-CA-C 120.204 3.117 . . . . 0.0 120.204 -174.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -81.2 -7.72 59.62 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 127.129 2.171 . . . . 0.0 111.38 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -98.98 7.88 45.57 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 115.59 -2.148 . . . . 0.0 114.321 174.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 74.6 mt -66.35 -36.91 78.51 Favored 'Isoleucine or valine' 0 C--O 1.247 0.945 0 CA-C-N 121.25 1.841 . . . . 0.0 110.101 169.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -58.09 -44.57 87.69 Favored 'General case' 0 N--CA 1.385 -3.7 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 170.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -72.46 -39.19 67.94 Favored 'General case' 0 CA--C 1.484 -1.567 0 O-C-N 126.004 2.065 . . . . 0.0 112.61 -178.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -66.1 -42.34 91.21 Favored 'Isoleucine or valine' 0 C--O 1.253 1.245 0 O-C-N 125.794 1.934 . . . . 0.0 113.802 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.7 mt -72.3 -43.02 65.66 Favored 'Isoleucine or valine' 0 C--N 1.348 0.517 0 O-C-N 119.063 -2.273 . . . . 0.0 113.564 175.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.416 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 78.49 171.86 39.76 Favored Glycine 0 CA--C 1.56 2.897 0 CA-C-O 121.774 0.652 . . . . 0.0 113.915 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 5.6 mmmm -66.87 110.61 3.38 Favored 'General case' 1 N--CA 1.539 4.004 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 177.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.65 31.37 79.78 Favored Glycine 0 CA--C 1.544 1.845 0 O-C-N 125.036 1.46 . . . . 0.0 110.902 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 67.13 25.54 73.42 Favored Glycine 0 N--CA 1.509 3.505 0 C-N-CA 128.035 2.731 . . . . 0.0 114.847 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 t -62.43 -47.68 83.03 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-O 116.849 -1.548 . . . . 0.0 113.662 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 76.6 t -71.45 -50.0 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-N 120.29 1.404 . . . . 0.0 108.836 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.5 tt -55.3 -36.17 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 121.399 1.908 . . . . 0.0 112.755 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -78.84 -36.03 43.11 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 118.931 -1.108 . . . . 0.0 112.029 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.63 -40.65 84.6 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 117.361 -3.337 . . . . 0.0 108.125 175.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.1 tp -62.87 -40.26 96.95 Favored 'General case' 0 C--N 1.361 1.107 0 O-C-N 120.689 -1.257 . . . . 0.0 111.67 -175.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.1 m -67.2 -48.76 66.92 Favored 'General case' 0 C--N 1.373 1.602 0 O-C-N 125.27 1.606 . . . . 0.0 112.256 169.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -63.97 -43.85 94.53 Favored 'General case' 0 C--N 1.381 1.97 0 O-C-N 116.502 -3.874 . . . . 0.0 115.025 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -59.23 -40.73 86.82 Favored 'General case' 0 C--N 1.385 2.121 0 N-CA-C 117.632 2.456 . . . . 0.0 117.632 177.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 77.8 p -108.01 -3.03 19.14 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -162.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.65 25.26 75.14 Favored Glycine 0 CA--C 1.552 2.401 0 N-CA-C 118.86 2.304 . . . . 0.0 118.86 -173.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 21.2 p -124.32 159.26 30.7 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.624 1.17 . . . . 0.0 113.578 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.0 m -110.53 131.57 54.94 Favored 'General case' 0 C--N 1.399 2.744 0 CA-C-N 119.649 1.113 . . . . 0.0 110.289 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.3 mm -115.53 138.8 44.73 Favored 'Isoleucine or valine' 0 C--N 1.37 1.481 0 O-C-N 120.785 -1.197 . . . . 0.0 111.403 -168.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -131.95 157.25 44.54 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 169.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . 0.269 6.2 tt -150.67 125.02 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 O-C-N 116.716 -3.74 . . . . 0.0 109.776 -177.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -86.53 154.05 21.38 Favored 'General case' 0 CA--C 1.565 1.525 0 O-C-N 119.318 -2.114 . . . . 0.0 112.53 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -53.0 -32.33 45.95 Favored 'General case' 0 C--N 1.393 2.458 0 C-N-CA 127.194 2.197 . . . . 0.0 113.095 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.8 p30 -86.57 12.57 10.17 Favored 'General case' 0 C--O 1.201 -1.495 0 CA-C-N 119.804 1.183 . . . . 0.0 110.892 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 75.29 26.51 65.87 Favored Glycine 0 N--CA 1.48 1.597 0 CA-C-O 123.22 1.455 . . . . 0.0 114.11 174.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.9 m -92.09 108.92 20.29 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 104.636 -2.357 . . . . 0.0 104.636 167.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.2 p -101.27 144.58 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 103.043 -2.947 . . . . 0.0 103.043 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -131.61 115.05 15.58 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -174.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.39 108.68 25.95 Favored 'Isoleucine or valine' 0 C--N 1.376 1.726 0 C-N-CA 125.661 1.585 . . . . 0.0 109.896 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -99.14 128.93 45.35 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.38 178.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -151.88 149.05 28.53 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 104.4 -2.445 . . . . 0.0 104.4 173.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 p -78.37 -27.1 46.81 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.425 1.078 . . . . 0.0 110.388 171.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -101.54 136.22 41.74 Favored 'General case' 0 CA--C 1.58 2.1 0 C-N-CA 128.343 2.657 . . . . 0.0 112.167 -173.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.04 -49.49 40.56 Favored Glycine 0 CA--C 1.558 2.769 0 C-N-CA 124.35 0.976 . . . . 0.0 112.576 176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.27 -33.69 73.95 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-N 121.609 2.705 . . . . 0.0 114.201 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 54.7 mttp -68.52 -45.17 72.98 Favored 'General case' 0 C--N 1.314 -0.973 0 O-C-N 126.331 2.269 . . . . 0.0 110.914 -179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.23 -44.58 83.38 Favored 'General case' 0 C--O 1.241 0.612 0 O-C-N 119.326 -2.109 . . . . 0.0 113.053 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . 0.297 91.9 mttt -54.04 -41.58 68.26 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.473 1.109 . . . . 0.0 113.246 169.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -62.81 -38.59 91.32 Favored 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.95 -35.83 74.81 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 119.042 -2.286 . . . . 0.0 116.313 171.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.74 -37.24 79.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.938 0 O-C-N 124.676 1.235 . . . . 0.0 109.882 176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.0 mmp_? -67.58 -40.34 84.86 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.46 1.482 . . . . 0.0 113.097 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -68.13 -40.64 82.41 Favored 'General case' 0 CA--C 1.559 1.309 0 O-C-N 120.144 -1.598 . . . . 0.0 110.814 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.2 mt -59.04 -41.83 84.54 Favored 'Isoleucine or valine' 0 CA--C 1.591 2.526 0 CA-C-O 116.822 -1.561 . . . . 0.0 112.049 172.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -48.47 -52.12 23.83 Favored 'General case' 0 C--N 1.383 2.037 0 CA-C-N 122.676 2.489 . . . . 0.0 115.956 166.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -59.77 -45.86 90.98 Favored 'General case' 0 CA--C 1.569 1.708 0 O-C-N 127.094 2.746 . . . . 0.0 111.141 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.5 mt -62.71 -40.3 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.941 0.896 . . . . 0.0 110.493 178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.7 p -85.06 -10.51 56.83 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 123.963 1.84 . . . . 0.0 111.517 -172.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.43 -37.54 71.43 Favored 'General case' 0 N--CA 1.407 -2.595 0 O-C-N 120.359 -1.463 . . . . 0.0 112.721 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -57.33 132.37 52.86 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 124.831 1.252 . . . . 0.0 110.166 -165.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.7 mm -59.95 127.18 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 N-CA-C 116.239 1.94 . . . . 0.0 116.239 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -73.86 148.99 41.85 Favored 'General case' 0 CA--C 1.579 2.066 0 CA-C-O 122.449 1.118 . . . . 0.0 112.575 165.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.6 137.27 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 89.03 -10.25 73.63 Favored Glycine 0 C--N 1.376 2.776 0 C-N-CA 126.989 2.233 . . . . 0.0 113.783 -174.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -97.93 163.06 12.94 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -172.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.6 t -108.14 139.35 30.65 Favored 'Isoleucine or valine' 0 C--N 1.386 2.196 0 CA-C-O 123.038 1.399 . . . . 0.0 110.612 -175.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -130.87 172.3 12.18 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 113.81 -1.541 . . . . 0.0 108.377 175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 133' ' ' PRO . 86.9 m -133.0 123.36 25.71 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.19 -171.61 12.75 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.8 pttt -120.26 154.94 34.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 125.384 1.285 . . . . 0.0 114.029 -176.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.446 HG21 HD22 ' A' ' 126' ' ' LEU . 45.7 t -85.31 127.75 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.344 0 CA-C-O 123.331 1.538 . . . . 0.0 109.31 -175.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.9 -36.49 6.36 Favored 'General case' 0 N--CA 1.413 -2.291 0 CA-C-N 111.609 -2.541 . . . . 0.0 112.293 -172.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.4 mtt-85 -150.11 145.89 26.6 Favored 'General case' 0 CA--C 1.558 1.279 0 CA-C-O 122.763 1.268 . . . . 0.0 109.894 -170.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 80.3 mt -124.26 134.97 65.21 Favored 'Isoleucine or valine' 0 C--N 1.366 1.316 0 CA-C-O 124.434 2.064 . . . . 0.0 110.453 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.69 165.66 18.42 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.681 0 CA-C-N 111.585 -2.552 . . . . 0.0 107.941 166.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -52.75 -35.44 56.13 Favored 'General case' 0 C--O 1.224 -0.283 0 N-CA-C 119.347 3.092 . . . . 0.0 119.347 -163.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -118.3 19.12 13.55 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 124.733 1.213 . . . . 0.0 112.161 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.83 168.64 41.04 Favored Glycine 0 N--CA 1.48 1.629 0 N-CA-C 116.95 1.54 . . . . 0.0 116.95 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.98 167.3 18.46 Favored 'General case' 0 C--N 1.374 1.656 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -124.02 136.79 54.51 Favored 'General case' 0 C--O 1.201 -1.49 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.455 173.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.17 131.97 72.24 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.397 0 C-N-CA 123.532 0.733 . . . . 0.0 111.21 -178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.96 121.64 40.12 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 123.217 1.484 . . . . 0.0 112.511 -178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.6 pt -115.74 166.97 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 112.043 -2.344 . . . . 0.0 114.484 -175.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -31.51 142.77 0.03 OUTLIER Glycine 0 CA--C 1.57 3.507 0 N-CA-C 122.132 3.613 . . . . 0.0 122.132 172.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 64.19 25.7 69.87 Favored Glycine 0 N--CA 1.484 1.866 0 O-C-N 120.445 -1.621 . . . . 0.0 114.811 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.91 22.74 65.46 Favored Glycine 0 C--O 1.255 1.467 0 N-CA-C 118.529 2.171 . . . . 0.0 118.529 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -94.49 152.22 18.75 Favored 'General case' 0 CA--C 1.555 1.142 0 CA-C-O 122.137 0.97 . . . . 0.0 113.308 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -130.96 151.33 51.49 Favored 'General case' 0 C--O 1.253 1.266 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 168.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -140.8 175.29 22.21 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.375 170.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.56 139.14 35.65 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 125.259 1.424 . . . . 0.0 112.289 -174.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.6 t -125.0 106.55 16.65 Favored 'Isoleucine or valine' 0 C--O 1.261 1.665 0 CA-C-O 124.431 2.062 . . . . 0.0 106.996 175.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -77.59 151.13 34.56 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.328 -1.482 . . . . 0.0 112.85 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.48 -33.11 43.46 Favored 'Isoleucine or valine' 0 C--N 1.391 2.411 0 CA-C-O 115.918 -1.991 . . . . 0.0 114.144 -164.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 95.7 p -56.57 -32.65 65.39 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 124.94 3.518 . . . . 0.0 118.342 164.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -97.91 4.18 49.59 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 121.063 1.756 . . . . 0.0 113.66 -161.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.2 -39.87 85.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 O-C-N 124.651 1.22 . . . . 0.0 107.776 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -162.97 161.58 25.66 Favored 'General case' 0 C--N 1.287 -2.131 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -69.17 -37.74 78.35 Favored 'General case' 0 N--CA 1.521 3.111 0 C-N-CA 127.47 2.308 . . . . 0.0 109.699 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 9.0 mptt -69.79 142.8 53.12 Favored 'General case' 0 CA--C 1.572 1.827 0 CA-C-N 113.316 -1.765 . . . . 0.0 108.194 170.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -82.71 115.12 21.5 Favored 'General case' 0 N--CA 1.513 2.708 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 -170.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 58.5 t -100.28 122.85 52.71 Favored 'Isoleucine or valine' 0 C--N 1.385 2.151 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -164.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -107.45 -13.86 14.99 Favored 'General case' 0 C--N 1.361 1.091 0 CA-C-O 116.565 -1.683 . . . . 0.0 114.625 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . 0.259 18.2 pttp -150.54 140.24 21.7 Favored 'General case' 0 C--O 1.21 -1.023 0 O-C-N 126.973 2.671 . . . . 0.0 106.336 159.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.1 t -71.54 -33.53 49.75 Favored 'Isoleucine or valine' 0 C--N 1.361 1.097 0 O-C-N 127.112 2.758 . . . . 0.0 112.915 -159.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -53.3 -36.54 61.32 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 109.895 -3.32 . . . . 0.0 116.713 175.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -57.02 -37.73 72.13 Favored 'General case' 0 N--CA 1.439 -1.025 0 O-C-N 125.221 1.576 . . . . 0.0 112.74 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -93.54 -42.89 8.98 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 121.68 2.036 . . . . 0.0 114.262 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.446 HD22 HG21 ' A' ' 89' ' ' VAL . 80.8 mt -109.13 123.01 48.51 Favored 'General case' 0 N--CA 1.498 1.962 0 C-N-CA 123.929 0.892 . . . . 0.0 109.867 -163.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -108.63 142.14 39.55 Favored 'General case' 0 C--N 1.363 1.195 0 C-N-CA 126.029 1.731 . . . . 0.0 109.129 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 33.4 mmm -66.66 144.15 56.56 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 114.163 -1.38 . . . . 0.0 113.179 -169.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 46.93 39.07 10.91 Favored Glycine 0 CA--C 1.54 1.638 0 O-C-N 127.273 2.858 . . . . 0.0 117.505 -175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.9 mm-40 -119.75 136.02 54.61 Favored 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 125.549 1.54 . . . . 0.0 111.713 165.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -58.61 128.91 39.55 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 118.616 2.821 . . . . 0.0 118.616 177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.8 m -122.54 131.04 24.43 Favored Pre-proline 0 C--O 1.286 3.013 0 CA-C-N 111.173 -2.739 . . . . 0.0 106.032 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 0.4 OUTLIER -63.24 148.49 92.98 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 121.05 1.167 . . . . 0.0 109.464 159.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 35.9 m -137.6 134.91 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 C-N-CA 124.873 1.269 . . . . 0.0 107.604 -177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.407 ' N ' ' HB2' ' A' ' 152' ' ' ALA . 13.7 tppt? -95.82 132.66 40.83 Favored 'General case' 0 N--CA 1.519 2.983 0 C-N-CA 123.154 0.582 . . . . 0.0 110.757 164.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.2 t -83.71 110.69 18.76 Favored 'Isoleucine or valine' 0 C--N 1.374 1.662 0 O-C-N 120.282 -1.511 . . . . 0.0 109.493 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.4 mt -75.87 -33.43 59.99 Favored 'General case' 0 C--N 1.373 1.615 0 O-C-N 125.719 1.887 . . . . 0.0 113.381 -178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -178.47 144.16 0.29 Allowed 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -168.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.6 t -118.41 126.25 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 O-C-N 125.071 1.482 . . . . 0.0 107.889 161.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.292 0.0 OUTLIER -85.23 173.51 10.33 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 126.118 2.866 . . . . 0.0 113.572 -170.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.64 -38.17 59.82 Favored 'General case' 0 CA--C 1.599 2.859 0 CA-C-N 110.873 -2.876 . . . . 0.0 111.293 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -85.62 -27.47 25.42 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 113.845 -1.525 . . . . 0.0 109.566 -176.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 116.38 24.72 3.7 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.681 1.134 . . . . 0.0 111.518 170.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -80.9 140.87 35.08 Favored 'General case' 0 C--N 1.373 1.591 0 C-N-CA 126.5 1.92 . . . . 0.0 110.262 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.8 mt -105.12 132.38 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 40.2 mtt180 -125.27 119.45 28.46 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -168.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.7 mt -126.18 161.94 26.54 Favored 'General case' 0 C--N 1.36 1.049 0 O-C-N 124.458 1.099 . . . . 0.0 111.403 -163.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.4 t -138.88 135.49 34.54 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 171.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 54.7 mt -83.28 -38.84 14.8 Favored 'Isoleucine or valine' 0 C--N 1.362 1.112 0 CA-C-O 116.177 -1.868 . . . . 0.0 107.032 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -76.28 -19.14 58.58 Favored 'General case' 0 C--N 1.366 1.299 0 O-C-N 125.684 1.865 . . . . 0.0 108.661 -171.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -81.65 -20.88 38.7 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 119.58 -1.95 . . . . 0.0 112.16 166.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.407 ' HB2' ' N ' ' A' ' 135' ' ' LYS . . . -73.58 -36.91 65.61 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 119.411 -2.056 . . . . 0.0 111.025 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 37.0 p -96.38 20.67 10.16 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.218 -175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 35.0 64.37 0.43 Allowed 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 127.027 2.131 . . . . 0.0 115.0 -174.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 . . . . . 0 C--O 1.25 1.102 0 O-C-N 117.699 -3.125 . . . . 0.0 106.03 172.032 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 55.4 ttt180 . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 115.524 -2.179 . . . . 0.0 107.026 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 30.9 mm -119.3 125.45 74.44 Favored 'Isoleucine or valine' 0 C--O 1.263 1.795 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -170.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -119.18 131.53 55.86 Favored 'General case' 0 C--O 1.254 1.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.277 -171.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 m -112.33 129.47 56.28 Favored 'General case' 0 C--N 1.366 1.311 0 O-C-N 124.763 1.289 . . . . 0.0 113.752 -164.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.9 pt -130.2 170.2 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.874 0 O-C-N 125.075 1.485 . . . . 0.0 109.795 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -131.84 141.9 49.56 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.606 -1.237 . . . . 0.0 111.414 178.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 49.7 mm -109.9 133.54 54.91 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.863 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 -59.38 157.98 22.36 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 124.902 1.281 . . . . 0.0 112.645 175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -70.49 -37.45 7.4 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 122.844 2.363 . . . . 0.0 110.45 -166.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -62.13 -46.41 89.13 Favored 'General case' 0 C--N 1.37 1.482 0 C-N-CA 118.307 -1.357 . . . . 0.0 114.366 168.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -78.26 -20.67 51.19 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -170.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.7 tp -59.37 -34.3 53.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 117.717 -1.593 . . . . 0.0 114.702 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -59.95 -34.0 72.67 Favored 'General case' 0 CA--C 1.557 1.242 0 O-C-N 124.724 1.265 . . . . 0.0 113.589 170.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -68.45 -42.98 78.05 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-O 122.62 1.2 . . . . 0.0 114.105 172.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.3 t -64.11 -40.62 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.756 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.5 HG22 ' O ' ' A' ' 29' ' ' ILE . 24.8 mm -98.6 28.0 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.106 0 CA-C-N 119.02 0.827 . . . . 0.0 111.498 -177.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -47.89 125.44 11.93 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 118.613 2.205 . . . . 0.0 118.613 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . 0.45 7.1 mptt 60.88 51.5 4.65 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.35 45.22 96.39 Favored Glycine 0 N--CA 1.49 2.297 0 O-C-N 126.29 2.244 . . . . 0.0 114.986 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.0 0.76 67.97 Favored Glycine 0 C--N 1.358 1.774 0 CA-C-N 118.571 1.185 . . . . 0.0 111.493 174.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -66.47 -34.26 77.53 Favored 'General case' 0 C--O 1.202 -1.436 0 CA-C-N 119.389 1.595 . . . . 0.0 110.865 -169.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.38 -45.59 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.929 0 CA-C-O 116.623 -1.656 . . . . 0.0 109.626 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.7 tp -80.52 -31.76 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 O-C-N 125.823 1.952 . . . . 0.0 111.153 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -57.71 -48.38 79.73 Favored 'General case' 0 N--CA 1.515 2.781 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 166.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.12 -45.17 82.06 Favored 'General case' 0 CA--C 1.581 2.171 0 C-N-CA 124.426 1.09 . . . . 0.0 111.012 175.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tt -59.7 -37.92 80.16 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 171.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . 0.263 33.3 p -64.6 -38.4 90.87 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 118.236 2.68 . . . . 0.0 118.236 171.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -63.58 -47.78 80.07 Favored 'General case' 0 C--O 1.248 0.974 0 O-C-N 125.008 1.443 . . . . 0.0 111.646 169.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -67.45 -47.14 71.03 Favored 'General case' 0 CA--C 1.457 -2.611 0 CA-C-O 117.646 -1.169 . . . . 0.0 111.864 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.6 p -85.56 -8.41 58.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 127.583 3.052 . . . . 0.0 113.962 -173.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.16 21.33 79.26 Favored Glycine 0 C--N 1.365 2.149 0 CA-C-O 121.819 0.677 . . . . 0.0 113.359 173.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 25.6 m -134.89 139.65 45.16 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 122.261 -0.552 . . . . 0.0 109.97 -155.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.0 m -78.23 135.27 37.55 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 119.715 1.143 . . . . 0.0 108.975 166.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.4 mt -133.01 118.2 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 114.034 -1.439 . . . . 0.0 109.244 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -84.52 131.56 34.63 Favored 'General case' 0 CA--C 1.557 1.229 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.6 mm -112.97 112.79 41.94 Favored 'Isoleucine or valine' 0 C--N 1.373 1.627 0 CA-C-N 120.342 1.428 . . . . 0.0 107.945 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -123.06 170.48 10.13 Favored 'General case' 0 C--O 1.201 -1.463 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -36.13 149.31 0.02 OUTLIER 'General case' 0 C--O 1.205 -1.277 1 C-N-CA 131.921 4.088 . . . . 0.0 118.844 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.8 t0 62.39 35.72 14.79 Favored 'General case' 0 N--CA 1.506 2.338 0 C-N-CA 124.418 1.087 . . . . 0.0 110.845 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 47.27 28.98 4.79 Favored Glycine 0 C--O 1.205 -1.67 0 CA-C-N 112.224 -2.262 . . . . 0.0 115.723 -169.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.5 m -64.15 125.48 24.64 Favored 'General case' 0 C--N 1.307 -1.266 0 O-C-N 121.716 -0.873 . . . . 0.0 110.366 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 74.1 t -124.94 138.68 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.4 mtmp? -129.38 122.04 28.64 Favored 'General case' 0 C--N 1.366 1.314 0 O-C-N 127.596 3.06 . . . . 0.0 108.686 -178.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 22.5 mm -95.52 130.15 44.64 Favored 'Isoleucine or valine' 0 C--N 1.373 1.626 0 O-C-N 120.22 -1.55 . . . . 0.0 107.838 -176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.95 117.98 33.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 117.984 -1.486 . . . . 0.0 107.355 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -150.3 148.67 29.13 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 120.671 -1.268 . . . . 0.0 110.871 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.8 m -69.0 -57.35 5.58 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 118.129 -1.428 . . . . 0.0 109.232 164.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -99.03 135.31 40.62 Favored 'General case' 0 CA--C 1.56 1.34 0 O-C-N 120.396 -1.44 . . . . 0.0 113.675 -163.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.12 -28.63 73.81 Favored Glycine 0 CA--C 1.506 -0.49 0 O-C-N 120.351 -1.468 . . . . 0.0 115.863 -167.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -57.87 -39.87 78.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.998 -0.707 . . . . 0.0 112.801 172.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -73.17 -37.9 66.39 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.96 -40.96 95.8 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -61.82 -42.9 99.61 Favored 'General case' 0 C--O 1.205 -1.275 0 CA-C-O 117.727 -1.13 . . . . 0.0 111.844 168.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -62.7 -39.3 93.57 Favored 'General case' 0 N--CA 1.52 3.033 0 CA-C-N 121.995 2.18 . . . . 0.0 115.093 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.65 -46.49 69.03 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 120.365 1.439 . . . . 0.0 110.36 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.88 -44.48 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-O 122.594 1.188 . . . . 0.0 111.451 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -60.97 -42.39 98.22 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 168.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 74' ' ' GLU . 21.8 mmm180 -64.63 -39.67 94.11 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 124.479 1.111 . . . . 0.0 112.231 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.5 mm -58.75 -40.7 80.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.137 168.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.65 -42.27 86.94 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.294 1.406 . . . . 0.0 110.917 168.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HB2' ' HA ' ' A' ' 71' ' ' ARG . 68.9 mt-10 -58.16 -43.12 87.25 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 16.9 mm -60.14 -44.39 95.09 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.817 0 CA-C-O 123.173 1.463 . . . . 0.0 113.808 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.9 p -77.56 -12.0 59.92 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -88.92 1.74 54.93 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 167.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -74.3 159.21 32.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 123.153 1.454 . . . . 0.0 108.775 178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 14.9 mm -88.18 118.52 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 CA-C-O 114.989 -2.434 . . . . 0.0 111.955 -171.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -125.09 134.85 52.33 Favored 'General case' 0 C--N 1.384 2.081 0 CA-C-N 121.288 1.858 . . . . 0.0 109.41 168.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.8 t -58.77 136.76 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.942 1.697 . . . . 0.0 111.372 -174.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.59 -34.76 4.67 Favored Glycine 0 CA--C 1.55 2.28 0 O-C-N 120.809 -1.182 . . . . 0.0 113.789 -168.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 20.2 mmt85 -68.91 147.81 51.12 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-O 124.425 2.06 . . . . 0.0 113.147 -171.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.8 t -89.1 133.3 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.694 0 CA-C-O 124.016 1.865 . . . . 0.0 111.868 169.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -133.13 169.68 16.51 Favored 'General case' 0 CA--C 1.488 -1.425 0 C-N-CA 126.874 2.07 . . . . 0.0 106.483 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 68.6 p -120.09 152.22 37.91 Favored 'General case' 0 C--O 1.202 -1.414 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.065 167.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.49 166.27 37.11 Favored Glycine 0 CA--C 1.465 -3.082 0 CA-C-O 123.776 1.765 . . . . 0.0 116.036 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 130' ' ' GLN . 55.6 mttm -106.31 127.76 53.49 Favored 'General case' 0 N--CA 1.42 -1.939 0 CA-C-N 110.968 -2.616 . . . . 0.0 115.334 -161.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 90.3 t -56.03 111.29 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.032 0 N-CA-C 116.778 2.14 . . . . 0.0 116.778 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.6 t -111.78 -13.44 13.71 Favored 'General case' 0 N--CA 1.525 3.309 0 CA-C-N 114.124 -1.398 . . . . 0.0 114.648 -173.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.46 HH12 ' CD ' ' A' ' 106' ' ' GLU . 78.9 mtm-85 -155.02 153.48 31.04 Favored 'General case' 0 C--O 1.257 1.478 0 N-CA-C 103.902 -2.629 . . . . 0.0 103.902 168.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 79.7 mt -132.21 125.47 54.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.7 m -138.3 166.83 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.585 -156.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -57.15 -35.23 69.28 Favored 'General case' 0 C--N 1.36 1.034 0 O-C-N 126.87 2.606 . . . . 0.0 110.86 -165.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -111.74 10.25 20.92 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -174.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.0 -148.67 18.74 Favored Glycine 0 C--O 1.175 -3.534 0 CA-C-N 120.828 1.649 . . . . 0.0 115.83 -173.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.91 157.13 43.9 Favored 'General case' 0 C--O 1.201 -1.457 0 O-C-N 119.489 -2.183 . . . . 0.0 108.88 -177.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.433 ' CE2' HD13 ' A' ' 108' ' ' LEU . 85.3 m-85 -119.76 143.98 47.52 Favored 'General case' 0 C--O 1.245 0.854 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 40.2 t -130.54 125.59 59.29 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.37 0 CA-C-N 111.608 -2.542 . . . . 0.0 108.816 -166.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.01 123.87 31.05 Favored 'General case' 0 CA--C 1.495 -1.171 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.6 mm -114.28 142.39 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.725 0 CA-C-N 112.205 -2.271 . . . . 0.0 107.405 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -34.84 138.58 0.21 Allowed Glycine 0 C--N 1.389 3.491 0 C-N-CA 128.001 2.715 . . . . 0.0 114.994 175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 71.06 29.82 68.44 Favored Glycine 0 C--O 1.222 -0.599 0 CA-C-O 118.863 -0.965 . . . . 0.0 112.391 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 77.31 30.65 53.95 Favored Glycine 0 CA--C 1.477 -2.33 0 O-C-N 124.983 1.049 . . . . 0.0 115.413 167.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -106.34 162.14 13.95 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 125.862 1.566 . . . . 0.0 109.671 -170.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.46 ' CD ' HH12 ' A' ' 91' ' ' ARG . 32.7 tt0 -149.32 122.17 8.73 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.498 1.499 . . . . 0.0 108.98 -171.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.89 162.13 15.77 Favored Glycine 0 CA--C 1.481 -2.033 0 CA-C-N 114.395 -1.275 . . . . 0.0 114.667 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.433 HD13 ' CE2' ' A' ' 98' ' ' PHE . 36.0 tp -114.56 126.24 54.7 Favored 'General case' 0 CA--C 1.491 -1.298 0 O-C-N 126.629 2.017 . . . . 0.0 111.343 -166.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.1 t -109.39 119.05 58.03 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 N-CA-C 100.693 -3.818 . . . . 0.0 100.693 173.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -82.93 169.68 15.76 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 120.725 -1.234 . . . . 0.0 109.254 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.9 tt -77.7 -25.72 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -157.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 81.7 p -92.26 7.03 44.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 119.416 -2.053 . . . . 0.0 111.259 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -120.33 27.36 8.65 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-O 114.779 -2.534 . . . . 0.0 109.591 -170.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 38.2 mt -105.03 -49.22 9.26 Favored 'Isoleucine or valine' 0 C--N 1.37 1.48 0 O-C-N 127.014 2.696 . . . . 0.0 109.117 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -139.22 173.73 11.24 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.333 -1.48 . . . . 0.0 109.031 -163.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -82.13 -53.39 6.12 Favored 'General case' 0 C--O 1.2 -1.509 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 41.1 mmtm -65.75 138.84 58.21 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 123.695 0.798 . . . . 0.0 110.944 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.4 ttt180 -53.93 134.29 43.08 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-N 114.139 -1.391 . . . . 0.0 114.649 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -119.96 124.6 73.05 Favored 'Isoleucine or valine' 0 C--N 1.368 1.411 0 O-C-N 123.943 0.777 . . . . 0.0 111.851 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -109.18 -18.85 13.52 Favored 'General case' 0 CA--C 1.569 1.686 0 CA-C-O 115.908 -1.996 . . . . 0.0 110.709 173.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -128.58 127.89 43.18 Favored 'General case' 0 C--N 1.381 1.936 0 CA-C-O 123.247 1.498 . . . . 0.0 109.024 174.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.9 t -68.21 -41.09 83.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 O-C-N 121.087 -1.008 . . . . 0.0 113.068 -174.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.3 p -55.88 -7.38 0.31 Allowed 'General case' 0 C--N 1.352 0.69 0 O-C-N 126.528 2.393 . . . . 0.0 112.481 176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -69.5 -35.59 75.67 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 120.317 1.417 . . . . 0.0 113.871 173.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -115.23 -52.33 2.68 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 128.155 3.409 . . . . 0.0 114.251 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.1 mt -93.34 143.97 25.77 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 118.661 -0.685 . . . . 0.0 110.129 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -149.46 154.18 38.43 Favored 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 103.169 -2.9 . . . . 0.0 103.169 -174.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 65.7 mmm -66.69 121.86 16.34 Favored 'General case' 0 C--O 1.192 -1.949 0 C-N-CA 127.399 2.28 . . . . 0.0 113.992 -165.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.17 -0.66 78.8 Favored Glycine 1 N--CA 1.518 4.13 0 N-CA-C 118.498 2.159 . . . . 0.0 118.498 -171.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' A' ' 88' ' ' LYS . 16.7 tt0 -57.75 141.09 49.89 Favored 'General case' 0 CA--C 1.578 2.021 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 167.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -87.13 121.48 29.63 Favored 'General case' 0 C--N 1.37 1.499 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.581 170.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.2 m -113.4 129.33 24.72 Favored Pre-proline 0 C--O 1.215 -0.761 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -77.41 139.19 18.24 Favored 'Trans proline' 0 C--N 1.266 -3.815 0 N-CA-C 108.616 -1.34 . . . . 0.0 108.616 162.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -144.57 148.43 18.21 Favored 'Isoleucine or valine' 0 C--N 1.363 1.194 0 CA-C-O 123.169 1.461 . . . . 0.0 113.501 -178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -104.69 129.08 52.92 Favored 'General case' 0 C--O 1.19 -2.061 0 CA-C-N 111.843 -2.435 . . . . 0.0 111.819 172.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 81.6 t -82.4 122.27 36.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 125.575 1.797 . . . . 0.0 111.541 -170.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.407 HD21 ' HB2' ' A' ' 148' ' ' SER . 3.5 mt -101.09 -33.13 10.26 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-O 117.601 -1.19 . . . . 0.0 112.227 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -145.23 146.52 31.74 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.3 p -134.42 119.8 31.14 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-O 123.157 1.456 . . . . 0.0 108.854 155.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -62.16 156.56 21.42 Favored 'General case' 0 C--O 1.254 1.322 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.335 169.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -51.98 -31.95 31.57 Favored 'General case' 0 C--N 1.401 2.845 0 N-CA-C 117.809 2.522 . . . . 0.0 117.809 173.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.79 13.17 33.28 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 120.427 1.467 . . . . 0.0 114.588 168.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.93 12.76 48.79 Favored Glycine 0 C--N 1.364 2.118 0 N-CA-C 118.068 1.987 . . . . 0.0 118.068 169.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -78.8 137.14 37.58 Favored 'General case' 0 C--O 1.201 -1.498 0 CA-C-N 120.549 2.175 . . . . 0.0 109.29 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.8 mt -126.41 129.62 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 CA-C-O 117.413 -1.28 . . . . 0.0 112.089 -159.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.09 128.67 51.73 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 117.821 -1.085 . . . . 0.0 111.622 171.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 56.6 mt -118.54 162.27 18.65 Favored 'General case' 0 N--CA 1.52 3.05 0 O-C-N 125.068 1.48 . . . . 0.0 114.385 -170.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.407 ' HB2' HD21 ' A' ' 137' ' ' LEU . 35.8 t -129.91 138.78 51.09 Favored 'General case' 0 C--N 1.362 1.139 0 C-N-CA 124.231 1.013 . . . . 0.0 109.414 168.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.9 mt -99.95 -28.62 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 167.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -57.85 -42.22 83.99 Favored 'General case' 0 C--N 1.37 1.469 0 O-C-N 119.442 -2.036 . . . . 0.0 111.6 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -65.33 -42.46 92.9 Favored 'General case' 0 CA--C 1.594 2.655 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.25 . . -61.6 -45.02 95.86 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 120.12 -1.613 . . . . 0.0 111.017 170.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 38.5 p -89.53 11.47 19.42 Favored 'General case' 0 C--O 1.2 -1.539 0 C-N-CA 119.578 -0.849 . . . . 0.0 112.723 -175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 49.0 54.14 11.41 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 129.863 3.265 . . . . 0.0 116.161 178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 . . . . . 0 CA--C 1.504 -0.816 0 O-C-N 119.315 -2.116 . . . . 0.0 108.81 -169.102 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 119.562 -0.256 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.7 mm -62.48 142.57 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.166 0 C-N-CA 117.702 -1.599 . . . . 0.0 112.503 169.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -135.79 129.36 32.38 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.78 163.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 17.3 m -111.62 138.4 48.23 Favored 'General case' 0 C--O 1.251 1.179 0 CA-C-O 122.099 0.952 . . . . 0.0 111.876 -172.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt -134.86 130.82 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-N 113.75 -1.568 . . . . 0.0 107.977 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm -82.11 130.11 35.0 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-O 122.506 1.146 . . . . 0.0 111.607 163.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.2 mm -121.41 128.36 75.88 Favored 'Isoleucine or valine' 0 C--N 1.401 2.827 0 O-C-N 120.506 -1.371 . . . . 0.0 109.542 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.413 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 5.7 m-20 -56.24 156.85 10.03 Favored Pre-proline 0 C--N 1.371 1.539 0 CA-C-N 119.555 1.07 . . . . 0.0 112.726 -171.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 21' ' ' ASN . 54.5 Cg_exo -66.2 -25.47 50.26 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 N-CA-C 116.757 1.791 . . . . 0.0 116.757 -167.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -84.2 -27.49 27.98 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-O 117.04 -1.457 . . . . 0.0 110.777 172.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -86.64 -26.51 24.33 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 121.546 1.976 . . . . 0.0 110.109 -169.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.533 HD11 HD12 ' A' ' 49' ' ' ILE . 10.0 tp -74.85 -19.61 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.407 0 O-C-N 124.61 1.194 . . . . 0.0 108.277 173.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.269 35.5 mmtm -64.93 -39.53 93.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.057 -1.027 . . . . 0.0 113.298 168.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -63.11 -38.6 91.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.865 1.666 . . . . 0.0 113.574 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 t -67.03 -33.31 62.47 Favored 'Isoleucine or valine' 0 C--N 1.375 1.706 0 C-N-CA 125.483 1.513 . . . . 0.0 111.352 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 29' ' ' ILE . 47.6 mm -97.57 11.04 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-O 123.178 1.466 . . . . 0.0 111.581 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.37 167.39 13.29 Favored Glycine 0 C--N 1.296 -1.674 0 CA-C-N 111.792 -2.458 . . . . 0.0 115.944 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm 58.3 43.98 19.29 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 125.208 1.403 . . . . 0.0 113.327 177.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.3 12.72 81.83 Favored Glycine 0 CA--C 1.558 2.757 0 O-C-N 120.807 -1.183 . . . . 0.0 115.818 -177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.03 5.26 77.23 Favored Glycine 0 C--N 1.369 2.402 0 N-CA-C 107.299 -2.32 . . . . 0.0 107.299 -171.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.7 m -63.08 -39.99 96.33 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-O 116.903 -1.522 . . . . 0.0 113.623 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 t -61.44 -47.36 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.309 6.4 tp -62.96 -39.33 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 CA-C-N 119.427 1.012 . . . . 0.0 111.327 179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -64.37 -51.57 62.66 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 119.131 -0.461 . . . . 0.0 111.351 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.05 -43.81 82.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 126.352 2.283 . . . . 0.0 115.286 175.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.91 -50.95 71.32 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 33.7 p -64.83 -35.2 80.33 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 120.673 -1.267 . . . . 0.0 112.564 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.5 tp10 -72.36 -39.51 68.03 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 125.832 1.957 . . . . 0.0 110.338 176.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.0 tt0 -61.76 -38.51 88.27 Favored 'General case' 0 C--O 1.259 1.555 0 CA-C-O 124.166 1.936 . . . . 0.0 113.003 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 67.5 p -91.24 -17.06 26.62 Favored 'General case' 0 C--N 1.367 1.335 0 O-C-N 118.663 -2.523 . . . . 0.0 116.363 -173.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.03 28.6 73.73 Favored Glycine 0 CA--C 1.474 -2.484 1 O-C-N 129.254 4.096 . . . . 0.0 112.352 175.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.4 t -148.31 159.3 44.13 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 124.305 2.002 . . . . 0.0 107.671 -166.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 90.6 m -83.42 118.0 23.44 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 112.407 -2.179 . . . . 0.0 108.581 -171.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.632 HG23 HD13 ' A' ' 57' ' ' ILE . 16.4 mt -124.08 121.32 61.71 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 175.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -113.22 147.42 37.52 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 125.573 2.606 . . . . 0.0 108.092 -177.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.533 HD12 HD11 ' A' ' 25' ' ' ILE . 16.3 mm -112.09 123.4 67.81 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-N 112.014 -2.357 . . . . 0.0 109.227 -178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -123.88 166.83 14.98 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -165.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.281 81.9 m-20 -47.4 142.49 4.11 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.024 -1.672 . . . . 0.0 114.196 -173.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.8 t0 54.27 67.3 1.03 Allowed 'General case' 0 C--N 1.35 0.598 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 171.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 52.53 27.47 26.39 Favored Glycine 0 C--N 1.301 -1.396 0 N-CA-C 118.322 2.089 . . . . 0.0 118.322 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 74.7 m -107.39 114.79 29.03 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 -171.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 49' ' ' ILE . 24.5 t -104.43 141.79 19.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -173.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -129.29 123.39 31.74 Favored 'General case' 0 C--N 1.363 1.19 0 CA-C-O 122.54 1.162 . . . . 0.0 109.498 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.632 HD13 HG23 ' A' ' 47' ' ' ILE . 12.6 mm -86.83 130.03 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.117 167.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -126.67 51.16 1.86 Allowed 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 -179.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.87 153.38 21.37 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 119.048 -2.283 . . . . 0.0 114.729 172.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.7 p -100.04 21.92 12.05 Favored 'General case' 0 C--N 1.381 1.949 0 CA-C-O 115.476 -2.202 . . . . 0.0 111.301 -175.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -151.49 145.58 25.3 Favored 'General case' 0 C--N 1.372 1.585 0 O-C-N 127.244 2.84 . . . . 0.0 110.08 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.1 -33.98 61.87 Favored Glycine 0 N--CA 1.439 -1.128 0 O-C-N 125.248 1.592 . . . . 0.0 114.425 175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -64.31 -45.43 87.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 116.703 -1.618 . . . . 0.0 108.186 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -58.74 -42.07 87.95 Favored 'General case' 0 C--N 1.375 1.681 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 170.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.86 98.13 Favored 'General case' 0 C--O 1.272 2.267 0 N-CA-C 118.196 2.665 . . . . 0.0 118.196 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -68.63 -37.41 79.68 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 125.394 1.684 . . . . 0.0 108.697 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -66.92 -42.86 84.65 Favored 'General case' 0 C--O 1.248 0.993 0 O-C-N 120.074 -1.641 . . . . 0.0 114.521 170.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.15 -54.38 31.35 Favored 'General case' 0 C--O 1.191 -2.008 0 CA-C-N 121.176 1.807 . . . . 0.0 111.556 172.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 36.1 mt -60.87 -45.14 98.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 124.46 1.104 . . . . 0.0 110.168 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 18.5 tpt180 -56.33 -44.29 79.85 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 116.637 2.088 . . . . 0.0 116.637 169.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 -63.16 -41.56 99.27 Favored 'General case' 0 C--O 1.205 -1.252 0 CA-C-N 120.597 1.544 . . . . 0.0 107.827 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 69.6 mt -59.19 -42.09 85.82 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.971 0 CA-C-O 116.805 -1.569 . . . . 0.0 110.234 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.32 -42.18 90.79 Favored 'General case' 0 N--CA 1.537 3.883 0 CA-C-N 121.734 2.061 . . . . 0.0 111.281 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -69.31 -39.16 78.42 Favored 'General case' 0 N--CA 1.507 2.419 0 O-C-N 126.242 2.214 . . . . 0.0 114.688 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.6 mt -71.61 -32.41 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 168.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 76.1 p -99.22 24.68 7.65 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.769 1.622 . . . . 0.0 109.672 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.33 0.9 12.34 Favored 'General case' 0 N--CA 1.44 -0.967 0 CA-C-O 117.547 -1.216 . . . . 0.0 111.712 162.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . 0.358 40.0 mt-10 -60.33 129.27 40.81 Favored 'General case' 0 N--CA 1.515 2.781 0 CA-C-O 124.295 1.998 . . . . 0.0 108.72 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 11.7 mm -83.76 128.67 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-O 125.039 2.352 . . . . 0.0 115.254 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -115.59 134.55 54.94 Favored 'General case' 0 C--N 1.373 1.616 0 CA-C-N 113.028 -1.896 . . . . 0.0 106.379 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.2 t -64.17 139.03 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 O-C-N 128.134 3.396 . . . . 0.0 110.31 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.95 -10.21 48.69 Favored Glycine 0 CA--C 1.551 2.342 0 O-C-N 119.39 -2.069 . . . . 0.0 113.835 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -81.87 159.33 23.73 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-N 119.662 1.731 . . . . 0.0 111.176 167.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.0 p -111.41 140.32 31.36 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.887 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -130.83 161.65 31.32 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 104.407 -2.442 . . . . 0.0 104.407 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.9 m -117.25 125.72 51.58 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.99 -169.76 12.41 Favored Glycine 0 N--CA 1.42 -2.412 0 C-N-CA 120.295 -0.955 . . . . 0.0 114.986 -173.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -128.56 143.22 50.92 Favored 'General case' 0 CA--C 1.57 1.727 0 CA-C-O 122.937 1.351 . . . . 0.0 114.432 174.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 72.3 t -73.76 122.75 27.47 Favored 'Isoleucine or valine' 0 C--N 1.382 2.008 0 O-C-N 118.078 -2.889 . . . . 0.0 115.288 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -116.12 -25.4 7.63 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 115.929 -1.986 . . . . 0.0 113.785 -170.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 -146.22 151.47 37.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 168.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 59.1 mt -123.65 131.44 73.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.04 174.47 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 124.047 1.88 . . . . 0.0 111.324 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -58.62 -37.4 75.8 Favored 'General case' 0 CA--C 1.564 1.505 0 C-N-CA 117.565 -1.654 . . . . 0.0 114.518 177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -98.41 18.91 15.4 Favored 'General case' 0 C--N 1.374 1.664 0 CA-C-N 120.876 1.671 . . . . 0.0 111.737 -176.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 145.56 -135.92 6.19 Favored Glycine 0 C--N 1.383 3.182 0 N-CA-C 115.057 0.783 . . . . 0.0 115.057 177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -145.57 160.81 41.09 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 125.649 1.441 . . . . 0.0 114.831 167.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.29 131.48 54.17 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-O 121.884 0.849 . . . . 0.0 111.122 172.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 72.9 t -110.85 134.3 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.14 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.646 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -98.49 127.71 44.54 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 120.221 -1.549 . . . . 0.0 109.395 176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 81.9 mt -117.92 150.79 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.421 0 CA-C-N 112.883 -1.962 . . . . 0.0 112.188 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.67 154.38 0.62 Allowed Glycine 0 CA--C 1.564 3.128 0 N-CA-C 118.958 2.343 . . . . 0.0 118.958 173.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 63.56 8.09 24.3 Favored Glycine 0 C--N 1.366 2.214 0 C-N-CA 127.663 2.554 . . . . 0.0 117.57 -168.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.79 22.86 16.95 Favored Glycine 0 C--O 1.256 1.494 0 O-C-N 127.585 2.58 . . . . 0.0 117.219 175.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.96 128.14 34.19 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 117.256 0.528 . . . . 0.0 110.491 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.0 146.83 35.98 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 123.343 1.544 . . . . 0.0 108.685 169.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -145.24 163.96 28.04 Favored Glycine 0 CA--C 1.48 -2.141 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.06 178.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.0 tp -110.61 136.4 49.77 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 124.372 0.689 . . . . 0.0 110.462 -178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 41.1 t -109.73 113.73 45.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 CA-C-O 123.824 1.773 . . . . 0.0 108.796 160.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -62.91 150.65 41.47 Favored 'General case' 0 CA--C 1.56 1.329 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 12.9 tt -52.89 -24.83 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 28.3 p -90.32 6.3 43.62 Favored 'General case' 0 N--CA 1.501 2.104 0 C-N-CA 125.825 1.65 . . . . 0.0 112.198 175.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -120.45 5.35 10.66 Favored 'General case' 0 CA--C 1.564 1.484 0 O-C-N 120.16 -1.588 . . . . 0.0 114.072 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 18.5 mm -82.84 -48.56 17.7 Favored 'Isoleucine or valine' 0 C--O 1.283 2.821 0 CA-C-O 123.734 1.73 . . . . 0.0 112.304 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -150.29 173.84 13.52 Favored 'General case' 0 N--CA 1.406 -2.645 0 O-C-N 116.939 -3.601 . . . . 0.0 107.224 -173.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -66.0 -33.7 76.4 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 114.187 -1.369 . . . . 0.0 111.2 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -71.56 161.19 31.4 Favored 'General case' 0 C--N 1.365 1.264 0 C-N-CA 124.733 1.213 . . . . 0.0 114.024 -173.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -70.63 122.22 19.36 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-O 124.679 2.181 . . . . 0.0 108.82 167.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.28 146.01 16.8 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.779 0 CA-C-N 112.38 -2.191 . . . . 0.0 110.157 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -119.84 -35.33 3.53 Favored 'General case' 0 C--N 1.369 1.445 0 CA-C-N 120.359 1.436 . . . . 0.0 113.826 160.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -123.17 129.3 51.22 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 122.7 1.238 . . . . 0.0 109.149 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.4 t -85.3 -20.43 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 CA-C-N 111.814 -2.448 . . . . 0.0 106.646 -166.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 11.4 p -60.43 -23.0 64.05 Favored 'General case' 0 C--N 1.39 2.346 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -66.52 -45.33 79.85 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 125.716 1.606 . . . . 0.0 112.921 170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -95.06 -17.97 21.42 Favored 'General case' 0 N--CA 1.508 2.434 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -169.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.7 mt -126.99 129.45 48.13 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -174.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 72.6 mm-40 -98.72 156.2 16.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.62 -1.3 . . . . 0.0 110.291 168.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 51.5 tpp -67.93 133.86 49.83 Favored 'General case' 0 N--CA 1.427 -1.58 0 O-C-N 118.641 -2.537 . . . . 0.0 109.165 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.09 15.91 79.65 Favored Glycine 0 CA--C 1.548 2.132 0 O-C-N 126.061 2.1 . . . . 0.0 112.059 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -65.24 132.42 49.05 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.294 -1.709 . . . . 0.0 113.151 175.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -85.12 118.55 24.75 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 123.748 1.737 . . . . 0.0 112.957 175.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.4 m -131.86 125.33 20.23 Favored Pre-proline 0 CA--C 1.582 2.174 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -158.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.65 131.43 24.37 Favored 'Trans proline' 0 N--CA 1.518 2.923 0 O-C-N 117.726 -1.776 . . . . 0.0 111.786 165.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 15.6 m -130.15 136.82 57.89 Favored 'Isoleucine or valine' 0 C--N 1.357 0.897 0 CA-C-O 123.061 1.41 . . . . 0.0 110.452 177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.6 tttt -105.01 143.42 33.22 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 120.702 -1.249 . . . . 0.0 109.764 173.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 46.9 t -86.9 137.48 20.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-O 122.17 0.986 . . . . 0.0 109.409 -170.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.65 -43.17 3.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 118.944 -2.348 . . . . 0.0 108.558 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -153.12 146.86 25.19 Favored 'General case' 0 N--CA 1.418 -2.028 0 CA-C-O 124.139 1.923 . . . . 0.0 108.205 -166.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.7 p -145.64 123.21 4.46 Favored 'Isoleucine or valine' 0 C--O 1.245 0.853 0 CA-C-O 124.119 1.914 . . . . 0.0 110.092 171.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.458 ' CG ' HH12 ' A' ' 146' ' ' ARG . 60.2 m-20 -71.74 175.34 5.79 Favored 'General case' 0 CA--C 1.592 2.593 0 O-C-N 119.826 -1.796 . . . . 0.0 115.207 -174.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -68.51 -16.27 63.83 Favored 'General case' 0 CA--C 1.584 2.274 0 N-CA-C 115.143 1.535 . . . . 0.0 115.143 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.74 19.16 21.0 Favored 'General case' 0 N--CA 1.438 -1.042 0 O-C-N 120.055 -1.653 . . . . 0.0 111.476 167.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.85 16.93 79.21 Favored Glycine 0 C--N 1.362 2.015 0 O-C-N 125.961 2.038 . . . . 0.0 114.468 168.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . 0.332 36.0 mtm180 -69.75 129.31 39.24 Favored 'General case' 0 CA--C 1.572 1.796 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 163.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.4 mt -108.68 141.33 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.205 0 O-C-N 119.545 -1.972 . . . . 0.0 110.714 -165.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.458 HH12 ' CG ' ' A' ' 140' ' ' ASP . 0.4 OUTLIER -113.1 150.09 32.6 Favored 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.606 160.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.4 mt -140.33 171.86 13.55 Favored 'General case' 0 C--O 1.258 1.508 0 CA-C-O 124.087 1.898 . . . . 0.0 111.391 -166.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 18.5 t -154.84 134.49 12.76 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 19.0 mt -87.96 -17.86 8.4 Favored 'Isoleucine or valine' 0 C--N 1.377 1.777 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -62.57 -50.18 72.34 Favored 'General case' 0 C--O 1.244 0.797 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 172.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -70.56 -25.58 63.16 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 122.111 0.958 . . . . 0.0 109.714 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.08 -49.26 68.22 Favored 'General case' 0 C--O 1.257 1.478 0 O-C-N 119.797 -1.814 . . . . 0.0 115.01 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 50.9 p -92.2 10.5 29.22 Favored 'General case' 0 C--O 1.268 2.042 0 CA-C-N 112.138 -2.301 . . . . 0.0 111.214 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.337 45.8 mt-10 71.87 53.1 0.2 Allowed 'General case' 0 C--N 1.38 1.927 0 N-CA-C 116.07 1.878 . . . . 0.0 116.07 166.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 69.7 mm-40 . . . . . 0 C--N 1.353 0.733 0 CA-C-O 116.814 -1.565 . . . . 0.0 113.717 177.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.9 ptt180 . . . . . 0 CA--C 1.561 1.383 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.2 mm -71.31 125.77 30.39 Favored 'Isoleucine or valine' 0 C--N 1.365 1.269 0 CA-C-O 126.28 2.943 . . . . 0.0 112.266 161.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 58.5 m-70 -116.17 138.96 50.82 Favored 'General case' 0 CA--C 1.59 2.486 0 CA-C-N 109.829 -3.35 . . . . 0.0 104.877 169.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.1 t -136.66 164.51 28.07 Favored 'General case' 0 N--CA 1.532 3.635 0 CA-C-O 117.627 -1.178 . . . . 0.0 112.252 -177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 tp -172.02 145.7 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.071 0 O-C-N 126.793 2.558 . . . . 0.0 105.228 178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -128.58 130.63 47.64 Favored 'General case' 0 N--CA 1.431 -1.393 0 C-N-CA 124.8 1.24 . . . . 0.0 109.535 -177.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.6 pt -133.33 162.99 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.834 0 O-C-N 126.513 2.383 . . . . 0.0 108.637 -166.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -43.95 141.96 2.2 Favored Pre-proline 0 N--CA 1.524 3.26 0 CA-C-N 120.024 1.284 . . . . 0.0 112.376 174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -59.94 -34.33 95.25 Favored 'Trans proline' 0 CA--C 1.474 -2.475 0 C-N-CA 122.866 2.378 . . . . 0.0 112.567 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -65.2 -28.16 69.19 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-N 121.816 2.098 . . . . 0.0 113.425 -177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -68.2 -22.07 64.83 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.6 mm -60.01 -43.59 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 C-N-CA 124.969 1.307 . . . . 0.0 110.649 171.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -51.87 -43.65 63.35 Favored 'General case' 0 C--N 1.364 1.231 0 N-CA-C 117.813 2.523 . . . . 0.0 117.813 170.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -79.81 -22.13 43.42 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.71 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.8 t -70.61 -54.08 19.7 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 CA-C-O 116.263 -1.827 . . . . 0.0 110.084 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -58.99 -42.49 86.34 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.506 0 CA-C-N 120.098 1.317 . . . . 0.0 109.022 173.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.1 175.97 49.14 Favored Glycine 0 C--N 1.374 2.69 0 O-C-N 119.425 -2.047 . . . . 0.0 113.888 173.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -74.78 119.2 18.64 Favored 'General case' 0 C--N 1.387 2.204 0 CA-C-N 119.704 1.752 . . . . 0.0 106.804 -171.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.49 4.48 87.36 Favored Glycine 0 C--N 1.361 1.919 0 N-CA-C 116.129 1.211 . . . . 0.0 116.129 -177.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.43 17.64 70.73 Favored Glycine 0 N--CA 1.485 1.949 0 C-N-CA 118.628 -1.748 . . . . 0.0 115.962 -175.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 54.1 p -69.3 -37.29 77.72 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 119.972 3.323 . . . . 0.0 119.972 171.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 82.6 t -74.28 -39.11 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.588 0 O-C-N 124.696 1.248 . . . . 0.0 112.5 -171.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.287 17.0 tt -63.54 -41.21 91.87 Favored 'Isoleucine or valine' 0 C--O 1.262 1.738 0 O-C-N 127.16 2.787 . . . . 0.0 112.711 173.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -64.15 -37.5 87.67 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 125.666 1.854 . . . . 0.0 111.609 169.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.58 -41.24 79.92 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.7 mt -61.08 -42.32 98.29 Favored 'General case' 0 C--O 1.196 -1.744 0 O-C-N 118.328 -2.732 . . . . 0.0 108.558 170.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 44.1 m -59.26 -48.81 80.24 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.049 0.94 . . . . 0.0 111.024 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -73.92 -35.81 64.64 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 116.316 -2.153 . . . . 0.0 110.024 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -73.11 -41.55 63.9 Favored 'General case' 0 C--O 1.258 1.542 0 CA-C-N 122.314 2.325 . . . . 0.0 111.54 -175.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 80.7 p -81.85 -24.95 35.5 Favored 'General case' 0 C--N 1.364 1.197 0 O-C-N 118.377 -2.702 . . . . 0.0 113.2 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.6 35.09 59.45 Favored Glycine 0 C--N 1.394 3.77 0 CA-C-N 122.061 2.209 . . . . 0.0 116.495 -169.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 p -129.55 177.37 7.26 Favored 'General case' 0 N--CA 1.51 2.543 0 C-N-CA 126.127 1.771 . . . . 0.0 107.383 -165.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.2 m -121.68 114.77 21.6 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-O 123.121 1.439 . . . . 0.0 107.136 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.6 mt -101.43 128.24 53.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-N 112.622 -2.081 . . . . 0.0 112.56 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -135.44 151.09 50.08 Favored 'General case' 0 C--N 1.371 1.542 0 CA-C-O 123.601 1.667 . . . . 0.0 109.715 174.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 44.0 mm -114.71 126.7 72.34 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.761 0 CA-C-N 112.969 -1.923 . . . . 0.0 110.865 -171.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -118.58 147.14 44.02 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 -178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -47.19 162.95 0.05 OUTLIER 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 116.347 1.98 . . . . 0.0 116.347 -173.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 52.22 36.25 18.87 Favored 'General case' 0 N--CA 1.501 2.097 0 C-N-CA 126.511 1.924 . . . . 0.0 115.485 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.07 8.76 66.45 Favored Glycine 0 CA--C 1.468 -2.903 0 CA-C-O 116.112 -2.493 . . . . 0.0 116.203 172.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 65.8 m -77.0 135.13 38.66 Favored 'General case' 0 C--O 1.256 1.432 0 O-C-N 127.248 2.381 . . . . 0.0 113.748 175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.3 t -114.12 136.18 51.47 Favored 'Isoleucine or valine' 0 C--N 1.367 1.367 0 O-C-N 120.66 -1.275 . . . . 0.0 114.354 165.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -125.85 116.77 22.08 Favored 'General case' 0 C--O 1.196 -1.745 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.111 -177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.2 mt -114.04 119.87 62.32 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.556 0 N-CA-C 107.013 -1.476 . . . . 0.0 107.013 -172.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -98.02 142.11 30.14 Favored 'General case' 0 C--O 1.262 1.754 0 O-C-N 126.883 2.614 . . . . 0.0 110.79 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.75 175.09 14.37 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-O 124.836 2.255 . . . . 0.0 106.131 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.9 t -116.95 -15.81 10.59 Favored 'General case' 0 N--CA 1.532 3.646 0 CA-C-N 112.671 -2.059 . . . . 0.0 112.296 171.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -120.42 114.51 21.92 Favored 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 101.888 -3.375 . . . . 0.0 101.888 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.18 -38.15 95.15 Favored Glycine 0 N--CA 1.505 3.268 0 N-CA-C 118.428 2.131 . . . . 0.0 118.428 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -61.0 -31.88 71.48 Favored 'General case' 0 C--N 1.377 1.804 0 CA-C-N 121.314 2.557 . . . . 0.0 113.772 167.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -67.69 -34.92 77.86 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 121.738 2.063 . . . . 0.0 114.385 170.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.51 -45.55 79.15 Favored 'General case' 0 C--O 1.254 1.341 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 171.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.42 ' HA ' HD12 ' A' ' 69' ' ' ILE . 43.5 mmtt -58.39 -37.08 74.56 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 115.08 -2.391 . . . . 0.0 110.742 167.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -62.93 -36.51 83.64 Favored 'General case' 0 CA--C 1.56 1.339 0 CA-C-N 122.756 2.525 . . . . 0.0 111.361 173.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.36 -38.15 74.72 Favored 'General case' 0 N--CA 1.463 0.19 0 O-C-N 120.31 -1.494 . . . . 0.0 112.88 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 66' ' ' LYS . 19.3 mt -60.32 -43.27 93.3 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.284 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.84 168.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -60.17 -49.27 78.3 Favored 'General case' 0 C--O 1.249 1.029 0 O-C-N 120.495 -1.378 . . . . 0.0 113.787 172.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -67.38 -30.0 69.68 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 120.061 1.301 . . . . 0.0 112.757 -174.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 76.5 mt -56.9 -47.39 83.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.277 0 CA-C-O 115.492 -2.194 . . . . 0.0 110.674 166.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -57.67 -39.55 77.35 Favored 'General case' 0 C--O 1.206 -1.227 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 177.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -64.07 -55.18 23.94 Favored 'General case' 0 C--O 1.196 -1.734 0 CA-C-O 115.927 -1.987 . . . . 0.0 114.029 171.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 36.6 mm -55.25 -43.49 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.368 0 CA-C-N 121.577 1.99 . . . . 0.0 109.285 177.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.3 p -67.44 -19.47 65.37 Favored 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 117.474 2.398 . . . . 0.0 117.474 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.97 -19.76 36.48 Favored 'General case' 0 CA--C 1.503 -0.847 0 O-C-N 120.977 -1.077 . . . . 0.0 113.591 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -68.01 122.85 19.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 124.701 1.251 . . . . 0.0 111.501 -164.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 13.0 mm -69.08 124.85 25.76 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 CA-C-O 117.551 -1.214 . . . . 0.0 114.242 -178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -121.0 139.82 52.77 Favored 'General case' 0 C--N 1.366 1.318 0 CA-C-O 123.613 1.673 . . . . 0.0 107.239 168.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.4 t -61.05 130.12 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 O-C-N 117.16 -3.463 . . . . 0.0 115.287 171.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 106.06 -8.15 41.78 Favored Glycine 0 CA--C 1.485 -1.817 0 CA-C-O 117.014 -1.992 . . . . 0.0 112.498 173.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -57.28 147.98 24.0 Favored 'General case' 0 C--N 1.371 1.511 0 O-C-N 124.981 1.048 . . . . 0.0 112.838 166.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.4 t -106.9 129.56 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 O-C-N 128.167 3.417 . . . . 0.0 106.905 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -135.78 168.5 19.19 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 123.444 1.592 . . . . 0.0 110.014 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.1 m -112.45 121.88 46.09 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 171.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.1 -172.24 13.33 Favored Glycine 0 C--N 1.353 1.494 0 N-CA-C 106.969 -2.452 . . . . 0.0 106.969 176.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 56.9 mttm -139.76 144.33 37.38 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.3 t -61.33 138.2 22.4 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.179 0 N-CA-C 116.497 2.036 . . . . 0.0 116.497 170.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.4 p -115.3 -40.16 3.48 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 120.158 -1.589 . . . . 0.0 109.478 176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 22.4 mtm-85 -146.88 141.96 27.13 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.157 0.983 . . . . 0.0 110.052 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 92' ' ' ILE . 96.9 mt -120.24 143.33 32.4 Favored 'Isoleucine or valine' 0 C--N 1.38 1.931 0 CA-C-O 122.451 1.12 . . . . 0.0 109.927 176.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 m -144.31 168.93 9.98 Favored 'Isoleucine or valine' 0 C--N 1.388 2.278 0 O-C-N 117.955 -2.965 . . . . 0.0 104.251 -170.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -56.66 -37.89 71.42 Favored 'General case' 0 C--O 1.269 2.094 0 CA-C-N 118.493 0.588 . . . . 0.0 111.743 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -96.06 11.33 34.52 Favored 'General case' 0 C--O 1.252 1.209 0 O-C-N 120.914 -1.117 . . . . 0.0 111.7 -168.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.72 -177.94 30.94 Favored Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 118.913 -1.613 . . . . 0.0 110.973 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -119.16 127.09 53.0 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 124.744 0.908 . . . . 0.0 110.276 174.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -76.26 131.86 39.51 Favored 'General case' 0 C--O 1.238 0.447 0 CA-C-O 123.806 1.765 . . . . 0.0 111.948 166.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.4 t -129.61 135.17 62.06 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.711 0 CA-C-N 112.051 -2.341 . . . . 0.0 112.024 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.96 129.97 41.62 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-N 112.21 -2.268 . . . . 0.0 112.632 167.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.5 mm -119.03 135.34 59.77 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.05 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -40.4 145.86 0.37 Allowed Glycine 0 C--N 1.378 2.909 0 N-CA-C 117.141 1.617 . . . . 0.0 117.141 174.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 77.54 38.84 27.28 Favored Glycine 0 N--CA 1.504 3.192 0 CA-C-N 112.78 -1.71 . . . . 0.0 111.051 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 76.48 6.92 84.99 Favored Glycine 0 N--CA 1.495 2.606 0 N-CA-C 120.507 2.963 . . . . 0.0 120.507 176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -87.42 160.06 18.46 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 118.267 2.692 . . . . 0.0 118.267 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.87 131.63 20.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.349 -0.845 . . . . 0.0 109.707 172.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -122.9 163.1 16.43 Favored Glycine 0 C--N 1.349 1.25 0 C-N-CA 123.733 0.683 . . . . 0.0 112.156 177.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.8 tp -98.94 124.91 44.21 Favored 'General case' 0 C--O 1.203 -1.345 0 O-C-N 126.892 2.172 . . . . 0.0 110.491 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.444 HG22 ' HB2' ' A' ' 147' ' ' LEU . 74.1 t -96.93 100.29 10.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 102.605 -3.109 . . . . 0.0 102.605 168.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -67.58 154.87 40.45 Favored 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.312 -173.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.273 6.3 tt -52.69 -38.69 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 117.388 2.366 . . . . 0.0 117.388 -170.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 85.6 p -73.4 -0.96 16.33 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 148' ' ' SER . 91.1 mm-40 -119.01 5.77 11.34 Favored 'General case' 0 CA--C 1.576 1.968 0 O-C-N 123.986 0.804 . . . . 0.0 112.577 -175.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.0 mm -77.68 -33.24 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.183 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -157.65 -176.19 5.8 Favored 'General case' 0 CA--C 1.495 -1.157 0 O-C-N 120.076 -1.64 . . . . 0.0 111.079 -170.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -105.57 -23.43 12.78 Favored 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 165.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.7 mmtm -62.05 158.28 16.92 Favored 'General case' 0 C--N 1.36 1.029 0 O-C-N 120.092 -1.63 . . . . 0.0 112.648 173.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -74.25 131.56 41.32 Favored 'General case' 0 C--O 1.205 -1.273 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.49 HG22 ' CE2' ' A' ' 125' ' ' TYR . 17.8 t -122.21 127.72 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.469 0 C-N-CA 125.793 1.637 . . . . 0.0 114.188 -173.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -110.25 -46.1 3.48 Favored 'General case' 0 C--N 1.386 2.18 0 C-N-CA 124.893 1.277 . . . . 0.0 110.202 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 30.9 mmtt -120.48 150.36 40.94 Favored 'General case' 0 CA--C 1.506 -0.718 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 170.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.11 -23.2 14.71 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 CA-C-N 113.719 -1.582 . . . . 0.0 113.038 173.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.93 -19.39 65.09 Favored 'General case' 0 CA--C 1.581 2.141 0 O-C-N 120.115 -1.616 . . . . 0.0 114.616 174.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -76.59 -29.64 56.65 Favored 'General case' 0 N--CA 1.539 3.977 0 C-N-CA 126.577 1.951 . . . . 0.0 110.484 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.49 ' CE2' HG22 ' A' ' 119' ' ' VAL . 76.7 m-85 -100.79 -15.46 17.64 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 126' ' ' LEU . 30.6 mt -151.99 162.42 41.11 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 124.22 0.95 . . . . 0.0 109.689 -172.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -134.5 160.1 39.08 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 162.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.0 ppp? -72.08 139.98 48.7 Favored 'General case' 0 C--N 1.316 -0.869 0 O-C-N 120.378 -1.451 . . . . 0.0 113.851 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 94.64 -12.35 68.84 Favored Glycine 0 N--CA 1.505 3.253 0 CA-C-O 125.39 2.661 . . . . 0.0 111.608 -175.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -68.66 131.81 45.82 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 123.682 1.706 . . . . 0.0 111.177 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -79.65 129.6 34.62 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.931 177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.0 m -133.57 127.16 19.48 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 120.527 -1.358 . . . . 0.0 109.062 -169.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.42 127.11 24.83 Favored 'Trans proline' 0 CA--C 1.576 2.579 0 CA-C-O 116.769 -1.43 . . . . 0.0 113.278 160.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.0 129.43 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-N 122.669 2.486 . . . . 0.0 110.188 -176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -97.86 140.75 31.76 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 172.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.2 t -86.74 116.21 28.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.034 0 O-C-N 125.742 1.901 . . . . 0.0 106.789 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 50.0 tp -101.87 -48.01 4.41 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 116.323 -1.799 . . . . 0.0 110.658 -174.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -136.12 150.84 49.26 Favored 'General case' 0 C--O 1.204 -1.294 0 O-C-N 125.029 1.456 . . . . 0.0 107.726 174.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.8 t -134.64 120.46 32.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 103.46 -2.793 . . . . 0.0 103.46 173.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -75.89 155.66 35.02 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.616 -1.302 . . . . 0.0 111.238 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . 0.31 29.5 mmt180 -70.85 -27.06 63.57 Favored 'General case' 0 C--O 1.204 -1.335 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -177.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -65.74 -31.99 73.29 Favored 'General case' 0 CA--C 1.553 1.088 0 O-C-N 126.158 2.161 . . . . 0.0 115.833 157.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 138.02 -13.98 3.57 Favored Glycine 0 CA--C 1.549 2.206 0 C-N-CA 125.19 1.376 . . . . 0.0 111.646 162.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -54.37 137.84 41.03 Favored 'General case' 0 CA--C 1.574 1.868 0 N-CA-C 117.041 2.237 . . . . 0.0 117.041 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 10.6 mt -118.06 131.52 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 C-N-CA 125.061 1.344 . . . . 0.0 113.14 -167.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -110.09 144.33 38.85 Favored 'General case' 0 N--CA 1.527 3.418 0 CA-C-O 123.283 1.516 . . . . 0.0 111.227 164.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.444 ' HB2' HG22 ' A' ' 109' ' ' VAL . 67.1 mt -129.12 151.87 49.33 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.079 -2.328 . . . . 0.0 110.29 -169.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 113' ' ' GLN . 33.8 t -125.82 115.82 20.61 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 125.062 1.345 . . . . 0.0 109.148 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 33.6 mt -74.87 -38.24 43.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 O-C-N 119.838 -1.789 . . . . 0.0 112.164 171.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -59.46 -47.24 86.25 Favored 'General case' 0 N--CA 1.479 0.988 0 O-C-N 127.015 2.697 . . . . 0.0 114.634 -178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -66.59 -46.34 76.27 Favored 'General case' 0 C--O 1.258 1.514 0 CA-C-N 118.345 0.52 . . . . 0.0 111.63 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.6 -18.23 64.91 Favored 'General case' 0 N--CA 1.425 -1.719 0 CA-C-O 116.912 -1.518 . . . . 0.0 112.569 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.1 p -98.68 3.25 47.72 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 117.629 -1.176 . . . . 0.0 108.234 172.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.471 8.7 mt-10 80.69 25.27 0.3 Allowed 'General case' 0 C--N 1.364 1.236 0 CA-C-N 120.521 1.509 . . . . 0.0 113.184 162.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 25.9 mm100 . . . . . 0 C--O 1.24 0.577 0 O-C-N 127.344 2.903 . . . . 0.0 108.273 -177.632 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.574 1.874 0 CA-C-O 119.077 -0.487 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 31.0 mm -63.8 135.0 28.34 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 CA-C-O 122.001 0.905 . . . . 0.0 113.395 -171.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -123.04 138.97 54.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 124.395 2.045 . . . . 0.0 113.674 169.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 t -135.13 139.7 44.85 Favored 'General case' 0 CA--C 1.497 -1.077 0 CA-C-N 113.326 -1.761 . . . . 0.0 110.121 -173.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.3 pt -133.37 161.44 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.672 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 162.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.2 mmtm -83.45 146.1 28.6 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 125.02 2.343 . . . . 0.0 109.447 160.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.2 pt -122.58 147.87 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.317 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 157.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . 0.283 1.6 t-20 -63.35 138.53 97.38 Favored Pre-proline 0 N--CA 1.514 2.748 0 C-N-CA 128.472 2.709 . . . . 0.0 108.381 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -80.95 3.76 7.53 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 O-C-N 118.007 -1.628 . . . . 0.0 114.328 -171.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -91.43 -2.33 57.3 Favored 'General case' 0 CA--C 1.562 1.425 0 O-C-N 120.59 -1.319 . . . . 0.0 110.443 164.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.6 mmmt -111.74 3.82 18.04 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.285 -0.884 . . . . 0.0 109.322 -170.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.4 mt -68.45 -41.31 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 119.828 -1.795 . . . . 0.0 112.366 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -52.5 -13.15 0.34 Allowed 'General case' 0 C--N 1.353 0.738 0 C-N-CA 128.34 2.656 . . . . 0.0 117.415 164.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -102.62 -32.71 9.75 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 115.734 -2.079 . . . . 0.0 113.318 171.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.3 t -84.15 -31.34 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 O-C-N 125.099 1.499 . . . . 0.0 109.466 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.3 mm -93.25 -55.21 6.36 Favored 'Isoleucine or valine' 0 C--N 1.361 1.08 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.62 -173.39 30.21 Favored Glycine 0 C--N 1.369 2.37 0 CA-C-O 123.506 1.614 . . . . 0.0 115.432 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -74.88 108.96 7.96 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 116.588 -1.672 . . . . 0.0 110.593 -167.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.53 9.76 59.84 Favored Glycine 0 CA--C 1.468 -2.855 0 O-C-N 127.474 2.984 . . . . 0.0 110.434 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 65.65 30.37 77.21 Favored Glycine 0 CA--C 1.54 1.613 0 O-C-N 125.362 1.272 . . . . 0.0 112.259 -162.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.1 t -53.05 -54.42 35.69 Favored 'General case' 0 N--CA 1.517 2.888 0 C-N-CA 126.213 1.805 . . . . 0.0 111.225 -178.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.0 t -89.82 -35.56 7.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -160.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.1 tp -67.81 -38.64 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -66.12 -44.29 84.7 Favored 'General case' 0 C--N 1.399 2.731 0 C-N-CA 125.147 1.379 . . . . 0.0 110.489 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.68 -54.23 47.78 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 127.814 3.196 . . . . 0.0 110.026 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.2 mt -51.63 -48.74 63.2 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 116.07 -1.919 . . . . 0.0 113.92 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.8 t -60.83 -34.42 74.54 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 120.6 1.545 . . . . 0.0 112.966 -175.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -67.25 -31.23 71.43 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 116.651 2.093 . . . . 0.0 116.651 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -96.46 -28.12 14.57 Favored 'General case' 0 N--CA 1.433 -1.29 0 C-N-CA 126.285 1.834 . . . . 0.0 111.662 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.468 HG21 ' HA ' ' A' ' 68' ' ' ALA . 11.1 p -84.67 -19.64 32.53 Favored 'General case' 0 C--N 1.396 2.62 0 CA-C-N 120.954 1.706 . . . . 0.0 110.754 176.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.18 24.85 74.73 Favored Glycine 0 N--CA 1.472 1.042 0 C-N-CA 127.906 2.669 . . . . 0.0 114.12 171.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.1 t -141.45 161.78 37.08 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 123.871 0.868 . . . . 0.0 108.736 -173.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -81.68 126.09 31.37 Favored 'General case' 0 N--CA 1.504 2.267 0 O-C-N 125.177 1.548 . . . . 0.0 110.74 173.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.6 mt -114.72 121.61 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.414 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -116.83 148.79 40.92 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 124.831 2.253 . . . . 0.0 107.168 177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 7.8 mt -128.06 123.5 60.66 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 CA-C-O 123.236 1.494 . . . . 0.0 111.487 -176.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -87.73 148.99 24.49 Favored 'General case' 0 CA--C 1.556 1.186 0 CA-C-O 117.274 -1.346 . . . . 0.0 112.254 172.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -71.12 -3.16 18.48 Favored 'General case' 0 C--N 1.393 2.485 0 N-CA-C 117.759 2.503 . . . . 0.0 117.759 -157.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 53.1 p30 -89.69 -1.85 58.12 Favored 'General case' 0 N--CA 1.517 2.885 0 O-C-N 125.064 1.477 . . . . 0.0 113.336 171.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.75 9.07 33.55 Favored Glycine 0 CA--C 1.48 -2.131 0 N-CA-C 108.325 -1.91 . . . . 0.0 108.325 172.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 m -79.6 108.58 13.26 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-O 124.395 2.045 . . . . 0.0 111.003 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.63 127.72 39.59 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.877 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 166.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -116.45 123.91 48.65 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-N 113.347 -1.752 . . . . 0.0 107.549 -173.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -123.56 130.23 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 170.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -104.05 -8.73 19.32 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 118.551 2.797 . . . . 0.0 118.551 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -17.55 133.6 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 120.929 3.677 . . . . 0.0 120.929 177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.8 m -67.6 -40.69 84.73 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 116.973 -1.489 . . . . 0.0 112.249 168.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -80.71 126.48 31.34 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 171.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.61 -40.44 95.97 Favored Glycine 0 C--N 1.361 1.954 0 O-C-N 124.493 1.121 . . . . 0.0 113.744 169.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -57.76 -36.25 71.86 Favored 'General case' 0 CA--C 1.586 2.363 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -66.14 -48.28 71.31 Favored 'General case' 0 N--CA 1.505 2.294 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 175.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.17 -44.02 80.75 Favored 'General case' 0 CA--C 1.549 0.917 0 O-C-N 125.159 1.537 . . . . 0.0 113.722 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -68.68 -37.11 79.32 Favored 'General case' 0 N--CA 1.439 -0.98 0 O-C-N 121.48 -0.762 . . . . 0.0 110.06 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -61.53 -47.21 86.61 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 118.293 -0.86 . . . . 0.0 110.111 167.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.468 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -60.59 -45.07 95.35 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 mt -59.42 -43.73 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 124.43 1.092 . . . . 0.0 113.665 172.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -65.88 -40.84 91.98 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 117.219 2.303 . . . . 0.0 117.219 171.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -67.8 -38.52 83.43 Favored 'General case' 0 N--CA 1.52 3.033 0 O-C-N 119.905 -1.747 . . . . 0.0 115.045 171.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 mt -59.34 -41.53 84.54 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 CA-C-N 119.457 1.026 . . . . 0.0 111.564 167.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -55.3 -45.44 76.25 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -62.38 -45.95 90.83 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 126.979 2.112 . . . . 0.0 112.644 171.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.258 1.1 mp -58.88 -33.23 49.07 Favored 'Isoleucine or valine' 0 C--N 1.359 0.983 0 N-CA-C 117.103 2.26 . . . . 0.0 117.103 168.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 37.3 p -101.34 8.46 42.32 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 125.601 1.813 . . . . 0.0 112.941 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.57 23.55 0.51 Allowed 'General case' 0 CA--C 1.601 2.931 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 -176.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -115.74 130.52 56.88 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 125.989 1.716 . . . . 0.0 112.774 -167.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 12.7 pt -100.76 144.51 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -164.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -118.37 139.65 51.05 Favored 'General case' 0 C--O 1.206 -1.2 0 CA-C-N 114.608 -1.178 . . . . 0.0 112.684 -158.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.0 p -60.75 137.77 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.28 0.32 52.24 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.179 -1.486 . . . . 0.0 115.318 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -98.17 150.39 21.53 Favored 'General case' 0 C--O 1.211 -0.97 0 O-C-N 120.017 -1.873 . . . . 0.0 111.679 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 48.1 t -105.59 143.32 16.91 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 O-C-N 125.992 2.058 . . . . 0.0 110.935 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -137.7 157.31 46.74 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 127.119 2.762 . . . . 0.0 107.396 -168.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 47.1 m -94.28 123.24 37.56 Favored 'General case' 0 C--N 1.372 1.55 0 N-CA-C 106.579 -1.638 . . . . 0.0 106.579 164.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -122.52 170.5 15.24 Favored Glycine 0 C--O 1.21 -1.37 0 N-CA-C 108.886 -1.685 . . . . 0.0 108.886 177.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 21.0 ttmt -126.39 135.9 52.01 Favored 'General case' 0 C--O 1.199 -1.599 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.4 t -68.39 120.52 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 122.865 1.317 . . . . 0.0 111.346 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 22.8 p -104.24 -31.68 9.47 Favored 'General case' 0 CA--C 1.551 1.012 0 O-C-N 118.839 -2.413 . . . . 0.0 111.913 -176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -162.92 124.02 2.45 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 124.327 2.013 . . . . 0.0 114.236 175.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.6 mt -82.97 132.76 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-O 124.545 2.117 . . . . 0.0 109.937 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.4 m -121.39 172.11 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.606 3.128 0 C-N-CA 127.632 2.373 . . . . 0.0 108.862 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -63.69 -32.47 73.97 Favored 'General case' 0 N--CA 1.509 2.517 0 O-C-N 119.108 -2.245 . . . . 0.0 113.834 -166.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -118.06 23.08 11.85 Favored 'General case' 0 CA--C 1.576 1.972 0 CA-C-N 113.297 -1.774 . . . . 0.0 111.968 -173.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 164.69 164.28 19.65 Favored Glycine 0 C--O 1.2 -2.005 0 CA-C-O 125.005 2.447 . . . . 0.0 115.186 -171.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -122.15 130.64 53.41 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 112.465 -1.867 . . . . 0.0 113.113 170.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -73.47 137.71 44.68 Favored 'General case' 0 C--N 1.376 1.737 0 CA-C-O 123.926 1.822 . . . . 0.0 108.821 169.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.1 t -131.18 134.78 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.691 0 CA-C-O 124.252 1.977 . . . . 0.0 107.09 178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.22 141.41 35.1 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 113.653 -1.612 . . . . 0.0 114.302 175.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.31 147.75 32.12 Favored 'Isoleucine or valine' 0 C--N 1.36 1.045 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 -174.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -46.8 151.56 1.59 Allowed Glycine 0 C--N 1.362 2.013 0 N-CA-C 119.001 2.36 . . . . 0.0 119.001 178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 87.79 17.27 58.45 Favored Glycine 0 C--N 1.368 2.353 0 CA-C-O 118.129 -1.373 . . . . 0.0 114.734 -175.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 75.25 23.72 73.11 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 116.965 1.546 . . . . 0.0 116.965 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -114.37 130.88 56.71 Favored 'General case' 0 C--O 1.194 -1.841 0 CA-C-O 123.989 1.852 . . . . 0.0 108.926 -175.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -127.13 134.43 50.21 Favored 'General case' 0 CA--C 1.561 1.403 0 O-C-N 120.728 -1.232 . . . . 0.0 111.453 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.48 173.26 17.49 Favored Glycine 0 C--O 1.205 -1.717 0 O-C-N 121.135 -0.978 . . . . 0.0 112.724 -178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.7 tp -104.08 139.37 39.26 Favored 'General case' 0 CA--C 1.557 1.24 0 CA-C-O 125.427 2.537 . . . . 0.0 110.294 172.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.0 t -99.13 96.47 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 CA-C-N 113.694 -1.593 . . . . 0.0 110.633 158.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -53.39 162.59 0.74 Allowed 'General case' 0 CA--C 1.576 1.967 0 CA-C-N 119.6 1.091 . . . . 0.0 113.433 176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.48 ' HA ' HD12 ' A' ' 114' ' ' ILE . 3.9 tt -48.26 -33.81 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 N-CA-C 118.293 2.701 . . . . 0.0 118.293 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 p -90.26 7.09 40.04 Favored 'General case' 0 C--N 1.364 1.234 0 C-N-CA 126.122 1.769 . . . . 0.0 111.569 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -119.48 12.35 12.36 Favored 'General case' 0 CA--C 1.572 1.817 0 O-C-N 119.667 -1.895 . . . . 0.0 111.861 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 111' ' ' ILE . 9.8 mt -100.31 -45.85 11.75 Favored 'Isoleucine or valine' 0 C--O 1.254 1.299 0 O-C-N 117.451 -3.281 . . . . 0.0 109.991 -170.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.94 167.76 24.87 Favored 'General case' 0 C--N 1.402 2.872 0 CA-C-O 124.959 2.314 . . . . 0.0 114.541 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -66.13 -41.5 90.4 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 127.056 2.143 . . . . 0.0 115.547 163.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -42.5 150.96 0.13 Allowed 'General case' 0 CA--C 1.539 0.539 0 O-C-N 128.164 3.415 . . . . 0.0 115.385 169.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.0 mmt180 -65.89 97.4 0.35 Allowed 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 168.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.1 t -94.64 125.35 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-N 118.77 0.714 . . . . 0.0 109.684 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -111.76 -33.41 6.33 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.1 pttm -145.38 148.71 33.66 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 171.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 97.0 t -74.81 -24.97 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 116.389 -1.767 . . . . 0.0 111.358 -163.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.2 p -59.3 -31.56 69.24 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 126.003 1.721 . . . . 0.0 109.014 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -73.58 -16.4 61.25 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 116.692 2.108 . . . . 0.0 116.692 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -128.28 -4.47 5.51 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 115.755 1.761 . . . . 0.0 115.755 -173.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 91.2 mt -144.85 167.13 23.34 Favored 'General case' 0 C--O 1.197 -1.701 0 O-C-N 119.706 -1.871 . . . . 0.0 109.605 165.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -138.52 159.17 42.76 Favored 'General case' 0 CA--C 1.57 1.731 0 C-N-CA 124.948 1.299 . . . . 0.0 110.815 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -71.58 148.55 46.52 Favored 'General case' 0 CA--C 1.582 2.206 0 O-C-N 120.331 -1.48 . . . . 0.0 112.862 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 59.37 28.72 65.04 Favored Glycine 0 C--N 1.369 2.401 0 C-N-CA 129.957 3.646 . . . . 0.0 114.342 -170.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -95.98 145.92 25.03 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 169.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -86.04 142.55 28.65 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 125.115 2.388 . . . . 0.0 106.302 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.15 127.75 11.58 Favored Pre-proline 0 N--CA 1.426 -1.639 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -170.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -54.29 121.79 10.33 Favored 'Trans proline' 0 N--CA 1.51 2.452 0 CA-C-N 121.053 1.412 . . . . 0.0 114.157 154.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . 0.351 5.4 m -123.11 131.75 72.67 Favored 'Isoleucine or valine' 0 C--N 1.383 2.064 0 CA-C-O 124.406 2.05 . . . . 0.0 114.635 176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 43.9 tttt -107.66 129.71 54.98 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 84.6 t -84.57 134.28 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 1 O-C-N 114.009 -5.432 . . . . 0.0 106.004 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 34.7 mt -112.42 -5.27 14.1 Favored 'General case' 0 C--O 1.246 0.888 0 CA-C-N 120.514 1.507 . . . . 0.0 111.758 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -171.7 128.19 0.64 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 124.594 2.14 . . . . 0.0 110.408 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 43.9 t -105.24 104.59 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 155.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -84.64 149.06 26.1 Favored 'General case' 0 N--CA 1.509 2.486 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 174.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -76.79 -5.71 49.32 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 120.791 -1.193 . . . . 0.0 114.161 -171.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -90.48 -2.43 57.93 Favored 'General case' 0 C--O 1.213 -0.823 0 CA-C-O 115.931 -1.985 . . . . 0.0 111.142 171.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 104.17 23.3 8.17 Favored Glycine 0 N--CA 1.477 1.378 0 CA-C-O 123.515 1.619 . . . . 0.0 111.972 172.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 -108.7 115.84 30.85 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 -162.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 69.3 mt -114.11 117.96 57.06 Favored 'Isoleucine or valine' 0 C--N 1.398 2.703 0 CA-C-O 122.522 1.154 . . . . 0.0 108.005 -161.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -109.97 112.7 24.88 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 124.829 2.252 . . . . 0.0 111.742 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 76.1 mt -108.62 158.83 17.22 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 111.083 -2.78 . . . . 0.0 108.481 -171.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 23.1 t -143.38 152.65 41.84 Favored 'General case' 0 N--CA 1.516 2.832 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 57.1 mt -107.38 -45.16 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 171.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -58.08 -37.42 74.44 Favored 'General case' 0 CA--C 1.476 -1.896 0 C-N-CA 124.15 0.98 . . . . 0.0 111.824 -173.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -76.21 -24.57 54.65 Favored 'General case' 0 N--CA 1.397 -3.114 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.25 -28.95 47.88 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 117.926 -1.035 . . . . 0.0 111.002 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 65.8 p -91.56 0.23 57.52 Favored 'General case' 0 CA--C 1.579 2.074 0 O-C-N 127.312 2.882 . . . . 0.0 108.066 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 56.94 44.79 22.42 Favored 'General case' 0 CA--C 1.492 -1.26 0 C-N-CA 130.675 3.59 . . . . 0.0 113.374 174.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 52.6 mm-40 . . . . . 0 CA--C 1.502 -0.876 0 O-C-N 125.883 1.989 . . . . 0.0 115.306 179.849 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 . . . . . 0 C--O 1.215 -0.761 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.6 tp -58.43 140.81 16.24 Favored 'Isoleucine or valine' 0 C--N 1.38 1.927 0 C-N-CA 125.303 1.441 . . . . 0.0 114.162 -176.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -98.31 130.34 44.99 Favored 'General case' 0 C--O 1.27 2.153 0 O-C-N 118.8 -2.437 . . . . 0.0 107.056 171.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 t -148.98 165.7 30.85 Favored 'General case' 0 C--N 1.37 1.488 0 CA-C-O 118.338 -0.839 . . . . 0.0 109.152 -164.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.6 tt -153.16 146.74 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 169.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -110.13 117.39 33.58 Favored 'General case' 0 N--CA 1.423 -1.778 0 O-C-N 116.614 -3.804 . . . . 0.0 104.277 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 pt -108.07 165.13 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.414 2.685 . . . . 0.0 109.712 -174.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -67.23 129.02 93.89 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 112.031 -2.349 . . . . 0.0 110.746 172.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HA ' HG13 ' A' ' 25' ' ' ILE . 100.0 Cg_exo -57.45 -20.44 40.63 Favored 'Trans proline' 0 N--CA 1.515 2.762 0 N-CA-C 117.68 2.146 . . . . 0.0 117.68 177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -74.14 -21.29 59.93 Favored 'General case' 0 N--CA 1.41 -2.448 0 C-N-CA 125.222 1.409 . . . . 0.0 112.524 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -97.53 -1.75 43.34 Favored 'General case' 0 CA--C 1.49 -1.352 0 C-N-CA 126.74 2.016 . . . . 0.0 109.517 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' A' ' 22' ' ' PRO . 96.6 mt -57.72 -46.11 86.82 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 CA-C-O 117.035 -1.459 . . . . 0.0 112.381 164.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.4 pttm -69.7 -29.46 66.88 Favored 'General case' 0 C--O 1.186 -2.277 0 CA-C-N 119.86 1.209 . . . . 0.0 111.73 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -72.73 -45.29 59.48 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.661 0.784 . . . . 0.0 111.819 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.443 ' HA ' HG21 ' A' ' 75' ' ' ILE . 38.6 t -68.5 -39.36 80.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-O 118.766 -0.635 . . . . 0.0 111.602 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.4 mt -63.86 -51.82 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 C-N-CA 124.489 1.116 . . . . 0.0 111.902 171.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.38 179.99 52.48 Favored Glycine 0 C--O 1.208 -1.511 0 CA-C-N 112.759 -2.019 . . . . 0.0 113.872 -176.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -77.74 116.32 18.18 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.404 0.708 . . . . 0.0 110.682 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.41 20.79 79.51 Favored Glycine 0 CA--C 1.551 2.307 0 CA-C-N 112.459 -2.155 . . . . 0.0 116.03 -175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.09 7.23 88.76 Favored Glycine 0 C--N 1.368 2.333 0 CA-C-N 120.353 2.077 . . . . 0.0 115.901 -173.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 t -56.26 -50.67 70.67 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 112.246 -1.977 . . . . 0.0 113.116 -173.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 85.2 t -73.14 -32.24 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.144 0.884 . . . . 0.0 109.275 -175.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.769 HD11 HG22 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -57.03 -48.82 81.12 Favored 'Isoleucine or valine' 0 C--N 1.371 1.5 0 CA-C-O 118.521 -0.752 . . . . 0.0 110.395 172.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -62.72 -44.28 96.63 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 125.684 2.659 . . . . 0.0 112.308 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.2 73.42 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 117.309 -3.37 . . . . 0.0 116.981 -178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . 0.263 46.8 mt -61.05 -45.03 96.42 Favored 'General case' 0 CA--C 1.562 1.416 0 O-C-N 125.137 1.523 . . . . 0.0 108.816 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.1 m -58.61 -56.09 26.67 Favored 'General case' 0 C--N 1.389 2.288 0 O-C-N 118.579 -2.576 . . . . 0.0 115.408 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -56.44 -48.48 76.93 Favored 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 125.615 1.566 . . . . 0.0 112.844 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 67.8 tt0 -62.28 -51.02 69.36 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 68' ' ' ALA . 68.5 p -79.65 -8.27 59.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 124.628 1.205 . . . . 0.0 112.344 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.93 19.88 70.14 Favored Glycine 0 C--O 1.247 0.933 0 O-C-N 125.553 1.783 . . . . 0.0 114.371 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 t -148.13 152.84 37.99 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.2 m -69.04 140.32 54.92 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 124.82 2.248 . . . . 0.0 114.352 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.7 mm -119.15 127.63 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 -175.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -135.25 151.19 50.36 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 119.411 -0.915 . . . . 0.0 112.111 169.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.769 HG22 HD11 ' A' ' 36' ' ' ILE . 8.3 tt -136.4 124.48 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 O-C-N 120.908 -1.12 . . . . 0.0 110.963 -170.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -86.68 168.79 13.26 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-O 123.432 1.587 . . . . 0.0 112.15 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -76.85 -15.67 59.64 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 117.376 2.361 . . . . 0.0 117.376 -169.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -85.96 -4.25 59.12 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 123.164 1.459 . . . . 0.0 112.37 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.45 3.35 27.37 Favored Glycine 0 CA--C 1.544 1.879 0 O-C-N 119.514 -1.992 . . . . 0.0 109.967 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.8 m -89.16 107.15 18.89 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 120.685 2.242 . . . . 0.0 113.943 -176.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.3 t -87.96 136.82 22.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 118.946 -1.102 . . . . 0.0 111.291 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -115.72 120.64 39.99 Favored 'General case' 0 C--N 1.391 2.388 0 N-CA-C 107.097 -1.445 . . . . 0.0 107.097 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.01 120.1 58.76 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.626 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 -173.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.91 90.73 Favored 'General case' 0 C--O 1.192 -1.934 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -38.04 152.97 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 1 N-CA-C 121.89 4.033 . . . . 0.0 121.89 177.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.7 m -121.16 -44.39 2.39 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.61 132.43 53.26 Favored 'General case' 0 C--N 1.389 2.32 0 CA-C-O 124.451 2.072 . . . . 0.0 107.757 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -49.87 -52.73 24.78 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 118.318 2.087 . . . . 0.0 118.318 -167.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 66' ' ' LYS . 70.8 mm-40 -66.05 -37.7 86.5 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.491 2.404 . . . . 0.0 117.491 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -66.32 -42.51 88.15 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.329 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.14 -47.18 80.93 Favored 'General case' 0 C--N 1.284 -2.268 0 CA-C-O 116.31 -1.805 . . . . 0.0 110.092 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HB3' ' HA ' ' A' ' 63' ' ' GLU . 16.9 tttt -61.13 -36.44 79.77 Favored 'General case' 0 C--N 1.366 1.289 0 C-N-CA 125.96 1.704 . . . . 0.0 113.887 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -64.51 -41.01 96.68 Favored 'General case' 0 N--CA 1.511 2.615 0 CA-C-O 124.375 2.036 . . . . 0.0 114.754 172.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.496 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -64.76 -38.02 89.58 Favored 'General case' 0 C--O 1.257 1.456 0 O-C-N 117.976 -2.952 . . . . 0.0 111.635 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.4 mt -64.78 -49.89 77.99 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.098 0 O-C-N 125.542 1.776 . . . . 0.0 109.241 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -58.39 -37.72 75.85 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 177.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.439 ' HE ' ' CD ' ' A' ' 42' ' ' GLU . 11.8 mmm180 -71.38 -41.57 69.51 Favored 'General case' 0 C--N 1.366 1.31 0 O-C-N 126.751 2.532 . . . . 0.0 112.09 174.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.4 mm -56.53 -42.82 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-O 121.941 0.877 . . . . 0.0 109.599 167.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . 0.256 12.5 mt-10 -62.56 -42.72 99.72 Favored 'General case' 0 CA--C 1.572 1.818 0 O-C-N 121.063 -1.023 . . . . 0.0 112.932 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -57.81 -44.18 86.17 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 117.481 -1.247 . . . . 0.0 113.406 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.443 HG21 ' HA ' ' A' ' 28' ' ' VAL . 19.3 mm -78.38 -25.46 13.84 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 CA-C-N 121.481 1.946 . . . . 0.0 109.09 -173.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 17.3 p -79.5 -17.33 54.35 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 123.934 0.771 . . . . 0.0 112.322 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.05 -19.96 58.17 Favored 'General case' 0 C--N 1.37 1.479 1 O-C-N 116.002 -4.187 . . . . 0.0 114.008 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -67.09 119.47 12.08 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -162.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.1 pt -72.39 137.85 22.7 Favored 'Isoleucine or valine' 0 C--O 1.279 2.653 0 CA-C-O 128.356 3.931 . . . . 0.0 114.98 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -122.76 147.43 46.51 Favored 'General case' 0 C--O 1.202 -1.396 0 O-C-N 118.23 -2.794 . . . . 0.0 108.311 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.3 m -64.79 154.94 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-O 123.91 1.814 . . . . 0.0 112.551 171.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.07 -9.6 45.68 Favored Glycine 0 CA--C 1.561 2.911 0 O-C-N 119.644 -1.91 . . . . 0.0 116.664 -177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -96.69 153.78 17.66 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 115.131 -2.366 . . . . 0.0 110.468 -172.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.499 HG13 ' HB1' ' A' ' 152' ' ' ALA . 62.4 t -115.31 117.03 54.32 Favored 'Isoleucine or valine' 0 C--N 1.378 1.835 0 O-C-N 125.067 1.48 . . . . 0.0 110.333 179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -110.51 166.75 10.74 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.806 2.442 . . . . 0.0 105.82 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 83.1 m -101.53 116.87 33.74 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 171.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.67 157.62 15.65 Favored Glycine 0 CA--C 1.469 -2.829 0 O-C-N 119.654 -1.903 . . . . 0.0 109.642 -173.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -115.93 128.82 56.06 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 118.791 -1.163 . . . . 0.0 111.69 174.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 85.5 t -56.06 126.2 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.587 2.391 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.2 p -102.52 -35.54 8.71 Favored 'General case' 0 C--N 1.375 1.7 0 CA-C-N 120.731 1.605 . . . . 0.0 114.249 177.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -165.46 157.43 14.91 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 127.061 2.725 . . . . 0.0 110.892 -173.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.5 mt -140.64 142.8 30.0 Favored 'Isoleucine or valine' 0 C--N 1.383 2.06 0 O-C-N 126.294 2.246 . . . . 0.0 107.008 -167.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.479 HG11 ' CZ ' ' A' ' 95' ' ' PHE . 2.9 p -141.19 -164.43 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.455 ' H ' HG22 ' A' ' 93' ' ' VAL . 37.3 m-20 -67.56 -38.99 84.93 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 128.72 2.808 . . . . 0.0 115.648 176.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CZ ' HG11 ' A' ' 93' ' ' VAL . 21.0 p90 -95.46 0.39 53.22 Favored 'General case' 0 N--CA 1.527 3.409 0 CA-C-O 114.07 -2.872 . . . . 0.0 116.044 174.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.64 -174.99 36.56 Favored Glycine 0 C--N 1.361 1.948 0 CA-C-N 125.245 3.657 . . . . 0.0 115.065 -170.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.61 137.25 51.59 Favored 'General case' 0 C--O 1.244 0.785 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -91.9 144.16 25.75 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 103.237 -2.875 . . . . 0.0 103.237 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.6 t -143.18 136.75 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-N 113.554 -1.657 . . . . 0.0 108.267 -173.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.502 ' HA ' ' HA ' ' A' ' 106' ' ' GLU . . . -107.76 144.67 34.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 125.008 2.337 . . . . 0.0 111.258 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 7.1 pt -140.25 167.73 18.17 Favored 'Isoleucine or valine' 0 C--O 1.259 1.582 0 CA-C-N 112.597 -2.092 . . . . 0.0 108.099 -176.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -27.77 131.2 0.06 OUTLIER Glycine 0 CA--C 1.575 3.793 0 N-CA-C 122.634 3.814 . . . . 0.0 122.634 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 90.95 6.59 66.92 Favored Glycine 0 N--CA 1.478 1.454 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -173.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 73.16 36.92 55.84 Favored Glycine 0 C--O 1.194 -2.366 0 CA-C-O 118.319 -1.267 . . . . 0.0 112.494 -175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -103.17 110.45 22.4 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 119.034 1.417 . . . . 0.0 112.822 -170.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 100' ' ' ALA . 27.1 tt0 -93.59 124.82 37.84 Favored 'General case' 0 N--CA 1.515 2.814 0 O-C-N 119.291 -2.13 . . . . 0.0 110.441 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -124.77 -175.91 14.43 Favored Glycine 0 CA--C 1.541 1.695 0 N-CA-C 109.01 -1.636 . . . . 0.0 109.01 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 29.6 tp -121.43 127.66 51.36 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 122.843 1.306 . . . . 0.0 111.103 -171.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.9 t -99.64 112.37 31.83 Favored 'Isoleucine or valine' 0 C--O 1.256 1.414 0 CA-C-N 113.932 -1.486 . . . . 0.0 107.193 166.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -65.44 152.88 42.86 Favored 'General case' 0 C--N 1.374 1.652 0 CA-C-O 125.217 2.436 . . . . 0.0 116.324 164.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.4 tt -52.98 -37.11 25.34 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 CA-C-N 111.076 -2.784 . . . . 0.0 113.569 -176.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 76.7 p -76.75 -14.33 59.95 Favored 'General case' 0 C--N 1.364 1.232 0 C-N-CA 124.941 1.297 . . . . 0.0 109.488 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 65.4 mm-40 -101.88 7.78 41.44 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 124.675 1.19 . . . . 0.0 109.618 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 43.8 mm -78.1 -33.77 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.585 2.326 0 CA-C-O 123.106 1.431 . . . . 0.0 110.722 -177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -165.38 -178.58 5.06 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 119.067 -2.271 . . . . 0.0 112.509 -169.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.19 -54.65 41.66 Favored 'General case' 0 CA--C 1.578 2.04 0 CA-C-N 112.729 -2.032 . . . . 0.0 111.857 165.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -93.63 160.55 14.73 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -177.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -84.25 127.38 33.92 Favored 'General case' 0 N--CA 1.512 2.643 0 O-C-N 125.698 1.874 . . . . 0.0 113.436 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.37 131.54 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 O-C-N 120.878 -1.139 . . . . 0.0 108.082 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 -63.33 -40.04 96.21 Favored 'General case' 0 CA--C 1.502 -0.878 0 O-C-N 118.468 -2.645 . . . . 0.0 112.987 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -129.27 118.07 21.72 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.93 1.292 . . . . 0.0 110.532 -175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.56 -30.16 49.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.932 0 C-N-CA 124.339 1.056 . . . . 0.0 109.602 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.97 -23.31 63.15 Favored 'General case' 0 C--O 1.261 1.659 0 O-C-N 119.066 -2.271 . . . . 0.0 113.712 -176.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -78.16 -20.92 51.06 Favored 'General case' 0 CA--C 1.49 -1.331 0 O-C-N 118.315 -2.741 . . . . 0.0 113.036 174.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -106.87 -8.79 16.56 Favored 'General case' 0 C--N 1.379 1.865 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 172.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 94.2 mt -146.0 159.01 43.86 Favored 'General case' 0 N--CA 1.402 -2.844 0 CA-C-O 124.018 1.866 . . . . 0.0 108.262 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -144.35 150.53 37.94 Favored 'General case' 0 C--O 1.201 -1.467 0 CA-C-N 111.334 -2.666 . . . . 0.0 106.074 -168.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -70.21 141.1 52.57 Favored 'General case' 0 CA--C 1.594 2.661 0 CA-C-O 123.607 1.67 . . . . 0.0 113.525 -174.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.79 -11.59 68.35 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 108.06 -2.016 . . . . 0.0 108.06 -176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.25 140.42 40.07 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 121.016 2.408 . . . . 0.0 115.472 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -102.13 129.79 48.57 Favored 'General case' 0 C--N 1.381 1.959 0 O-C-N 124.949 1.406 . . . . 0.0 110.573 -163.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.11 143.28 46.52 Favored Pre-proline 0 CA--C 1.577 1.999 0 CA-C-O 117.507 -1.235 . . . . 0.0 112.263 -176.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.15 136.04 70.11 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 CA-C-N 122.794 2.034 . . . . 0.0 110.447 169.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 17.3 m -136.54 148.17 27.21 Favored 'Isoleucine or valine' 0 C--O 1.255 1.371 0 O-C-N 125.732 1.895 . . . . 0.0 109.935 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -116.55 135.33 53.91 Favored 'General case' 0 C--O 1.216 -0.687 0 O-C-N 127.387 2.929 . . . . 0.0 104.736 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 96.8 t -87.05 127.89 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 126.76 2.537 . . . . 0.0 106.246 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 148' ' ' SER . 28.1 mt -101.03 -57.57 2.06 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -169.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -163.31 159.34 22.48 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 122.049 0.928 . . . . 0.0 109.407 -174.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.3 t -114.68 119.86 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 N-CA-C 102.323 -3.214 . . . . 0.0 102.323 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.421 ' CG ' ' HE ' ' A' ' 144' ' ' ARG . 3.5 t70 -71.52 162.18 29.85 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 129.003 2.921 . . . . 0.0 111.741 174.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -58.57 -33.53 70.05 Favored 'General case' 0 C--N 1.381 1.971 0 O-C-N 125.637 1.836 . . . . 0.0 113.111 -168.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -90.58 11.14 22.86 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 119.296 -2.127 . . . . 0.0 109.946 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.04 16.64 69.23 Favored Glycine 0 C--O 1.251 1.193 0 CA-C-O 123.38 1.545 . . . . 0.0 113.973 174.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.421 ' HE ' ' CG ' ' A' ' 140' ' ' ASP . 9.2 mtm180 -71.12 117.28 12.43 Favored 'General case' 0 C--O 1.266 1.964 0 CA-C-N 112.384 -1.908 . . . . 0.0 114.062 177.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.1 mt -88.3 123.71 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.99 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -96.89 131.56 43.53 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-O 122.185 0.993 . . . . 0.0 110.573 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 45.5 mt -129.89 144.57 51.38 Favored 'General case' 0 N--CA 1.513 2.712 0 O-C-N 120.16 -1.588 . . . . 0.0 109.423 -175.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.432 ' HB2' HD11 ' A' ' 137' ' ' LEU . 35.4 t -121.7 133.05 54.94 Favored 'General case' 0 C--N 1.375 1.708 0 CA-C-N 121.376 1.898 . . . . 0.0 110.656 163.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 76.3 mt -79.33 -45.1 23.97 Favored 'Isoleucine or valine' 0 C--N 1.377 1.801 0 N-CA-C 104.783 -2.302 . . . . 0.0 104.783 175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.0 pttt -55.71 -42.98 76.07 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 127.78 3.175 . . . . 0.0 112.418 -164.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -85.15 -19.9 31.08 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-O 115.042 -2.409 . . . . 0.0 109.892 -174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.499 ' HB1' HG13 ' A' ' 84' ' ' VAL . . . -74.31 -36.96 63.75 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 121.754 2.07 . . . . 0.0 113.773 167.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 24.5 p -78.21 -10.96 59.88 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 125.597 1.81 . . . . 0.0 111.629 174.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.259 75.0 mt-10 87.7 40.05 0.01 OUTLIER 'General case' 0 CA--C 1.477 -1.861 0 CA-C-N 119.041 0.837 . . . . 0.0 112.44 157.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 . . . . . 0 N--CA 1.412 -2.361 0 CA-C-O 123.805 1.764 . . . . 0.0 113.818 -175.524 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 . . . . . 0 CA--C 1.568 1.663 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.4 mt -114.41 139.67 39.18 Favored 'Isoleucine or valine' 0 C--O 1.251 1.138 0 CA-C-O 124.251 1.977 . . . . 0.0 108.479 -172.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -118.17 138.25 52.43 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 112.581 -2.099 . . . . 0.0 111.352 169.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -115.46 133.45 56.02 Favored 'General case' 0 C--N 1.38 1.918 0 O-C-N 120.271 -1.518 . . . . 0.0 110.496 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.7 mm -137.87 137.42 44.92 Favored 'Isoleucine or valine' 0 C--N 1.37 1.475 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 -175.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.9 mtpt -98.01 137.38 36.9 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 123.156 1.455 . . . . 0.0 112.58 167.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 pt -116.5 169.4 7.01 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 C-N-CA 125.63 1.572 . . . . 0.0 112.862 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 48.7 t-20 -57.08 124.77 67.59 Favored Pre-proline 0 CA--C 1.586 2.358 0 CA-C-N 113.698 -1.592 . . . . 0.0 113.065 167.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.45 -3.21 13.31 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.67 2.246 . . . . 0.0 115.182 -176.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -72.58 -19.4 61.49 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 126.631 1.973 . . . . 0.0 115.848 161.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -99.58 -3.98 32.09 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 116.604 -1.665 . . . . 0.0 111.082 -166.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 61.0 mt -54.96 -44.41 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 119.204 0.911 . . . . 0.0 110.937 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . 0.31 0.1 OUTLIER -57.8 -38.0 74.75 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 125.121 1.513 . . . . 0.0 111.731 178.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -75.89 -35.6 59.78 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-O 114.673 -2.584 . . . . 0.0 112.925 173.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.76 -52.65 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 116.065 -1.922 . . . . 0.0 114.287 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.7 mt -78.22 -32.39 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 126.024 2.078 . . . . 0.0 113.247 -176.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 54.39 -180.0 0.18 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 120.637 3.015 . . . . 0.0 120.637 -172.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.9 mmtp -56.4 122.05 11.0 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 113.613 -1.294 . . . . 0.0 113.397 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 49.77 22.4 4.23 Favored Glycine 0 C--N 1.36 1.882 0 N-CA-C 116.98 1.552 . . . . 0.0 116.98 -172.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.7 77.87 Favored Glycine 1 C--N 1.402 4.221 0 CA-C-N 122.191 2.995 . . . . 0.0 113.275 -175.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.1 m -58.58 -43.46 89.45 Favored 'General case' 0 C--O 1.207 -1.172 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -172.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.0 t -72.67 -47.02 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 O-C-N 124.263 0.977 . . . . 0.0 111.53 -172.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.251 7.0 tt -62.94 -38.77 82.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-O 113.66 -3.067 . . . . 0.0 114.604 172.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -59.01 -49.42 77.96 Favored 'General case' 0 C--O 1.263 1.783 0 O-C-N 126.193 2.183 . . . . 0.0 111.878 167.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.16 95.89 Favored 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 117.541 2.423 . . . . 0.0 117.541 175.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.77 -39.27 93.85 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 124.112 0.882 . . . . 0.0 111.793 172.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.8 m -52.0 -46.04 64.77 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 117.203 -1.379 . . . . 0.0 110.94 167.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -67.75 -37.08 81.66 Favored 'General case' 0 C--N 1.37 1.495 0 C-N-CA 125.602 1.561 . . . . 0.0 113.323 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -74.12 -37.34 64.12 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 19.0 p -95.09 -34.38 12.32 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 116.35 -1.786 . . . . 0.0 114.363 -176.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.99 37.26 22.7 Favored Glycine 0 C--N 1.386 3.317 0 CA-C-O 124.454 2.141 . . . . 0.0 108.923 -177.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.8 p -119.64 162.05 19.64 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.982 -1.305 . . . . 0.0 109.114 -175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -101.62 127.49 48.33 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 122.443 1.116 . . . . 0.0 109.197 169.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 4.2 mt -114.9 126.54 72.51 Favored 'Isoleucine or valine' 0 C--O 1.247 0.97 0 N-CA-C 103.072 -2.936 . . . . 0.0 103.072 -171.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -124.15 135.4 53.47 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 123.207 1.479 . . . . 0.0 107.714 173.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.9 tt -140.54 141.18 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 119.055 -2.278 . . . . 0.0 109.726 -169.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -125.5 165.79 17.82 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-O 123.242 1.496 . . . . 0.0 107.769 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.32 43.4 p-10 -88.88 8.0 31.46 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 118.346 2.721 . . . . 0.0 118.346 -162.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.0 p30 -96.53 15.23 22.13 Favored 'General case' 0 C--O 1.254 1.293 0 CA-C-N 113.651 -1.613 . . . . 0.0 107.866 167.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 69.94 34.53 71.23 Favored Glycine 0 C--N 1.365 2.184 0 O-C-N 119.706 -1.871 . . . . 0.0 112.458 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.8 m -96.62 113.85 25.45 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-O 116.447 -1.74 . . . . 0.0 108.462 164.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 p -109.34 138.74 35.27 Favored 'Isoleucine or valine' 0 C--N 1.378 1.827 0 CA-C-O 122.886 1.327 . . . . 0.0 107.612 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.17 123.26 48.46 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 112.59 -2.095 . . . . 0.0 111.031 -176.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -125.55 119.18 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 119.348 -2.095 . . . . 0.0 111.733 177.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -109.89 127.18 54.56 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.155 2.582 . . . . 0.0 109.19 -174.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -145.84 162.31 37.99 Favored 'General case' 0 CA--C 1.491 -1.295 0 O-C-N 120.133 -1.604 . . . . 0.0 108.022 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.4 p -84.91 0.69 50.26 Favored 'General case' 0 N--CA 1.415 -2.22 0 C-N-CA 118.492 -1.283 . . . . 0.0 111.196 173.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -142.82 140.66 31.4 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.584 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.68 -15.33 81.35 Favored Glycine 0 C--N 1.365 2.161 0 CA-C-O 116.363 -2.354 . . . . 0.0 113.053 -174.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -66.74 -42.07 86.81 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 121.084 2.442 . . . . 0.0 109.86 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -64.13 -46.42 84.21 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 112.525 -2.125 . . . . 0.0 108.437 177.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.24 -43.13 98.91 Favored 'General case' 0 C--N 1.36 1.047 0 O-C-N 120.292 -1.505 . . . . 0.0 114.422 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -65.62 -35.01 79.56 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 114.984 -2.436 . . . . 0.0 112.2 172.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -65.64 -38.18 88.63 Favored 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 125.82 1.95 . . . . 0.0 109.216 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.04 99.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.82 -1.175 . . . . 0.0 112.958 169.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 41.5 mt -57.19 -45.5 84.6 Favored 'Isoleucine or valine' 0 C--N 1.362 1.146 0 O-C-N 120.014 -1.679 . . . . 0.0 112.925 168.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 16.4 mmp_? -60.69 -35.29 75.91 Favored 'General case' 0 C--O 1.206 -1.193 0 CA-C-N 120.805 1.638 . . . . 0.0 114.052 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -74.63 -27.56 60.5 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 116.474 -1.727 . . . . 0.0 114.6 165.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . 0.349 11.3 mt -76.63 -32.22 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.46 -45.32 88.84 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.68 1.992 . . . . 0.0 115.026 169.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -64.47 -36.96 85.89 Favored 'General case' 0 C--O 1.195 -1.765 0 O-C-N 125.976 2.048 . . . . 0.0 106.743 173.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 40.2 mt -60.8 -44.53 97.71 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.377 0 CA-C-N 125.592 3.815 . . . . 0.0 111.427 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 18.9 p -93.26 -6.56 47.3 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 116.951 2.204 . . . . 0.0 116.951 -162.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.11 -38.49 61.12 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -71.0 132.24 44.87 Favored 'General case' 0 CA--C 1.572 1.822 0 CA-C-O 122.386 1.089 . . . . 0.0 109.666 -169.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.0 mm -68.74 146.52 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-N 111.614 -2.539 . . . . 0.0 116.417 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -112.33 137.27 50.71 Favored 'General case' 0 CA--C 1.578 2.033 0 CA-C-O 124.487 2.089 . . . . 0.0 111.115 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 42.6 t -80.18 130.25 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 O-C-N 120.573 -1.329 . . . . 0.0 109.553 -174.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.52 64.75 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 116.613 1.405 . . . . 0.0 116.613 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.9 mmm180 -119.58 135.28 54.86 Favored 'General case' 0 C--O 1.198 -1.652 0 C-N-CA 123.882 0.873 . . . . 0.0 112.208 -174.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.0 t -72.53 130.18 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 171.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -128.7 154.53 46.23 Favored 'General case' 0 C--O 1.268 2.062 0 CA-C-N 112.452 -2.158 . . . . 0.0 107.425 171.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 50.1 m -105.88 128.24 53.64 Favored 'General case' 0 C--N 1.355 0.821 0 CA-C-N 114.374 -1.285 . . . . 0.0 109.61 167.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 131' ' ' GLU . . . -138.53 -173.0 12.78 Favored Glycine 0 C--O 1.206 -1.606 0 O-C-N 126.791 2.557 . . . . 0.0 108.985 -167.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -144.59 150.58 37.69 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 122.139 -0.624 . . . . 0.0 112.365 166.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 31.6 t -59.61 132.89 25.04 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.491 0 CA-C-N 112.4 -2.182 . . . . 0.0 111.452 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.2 p -110.48 -57.08 2.26 Favored 'General case' 0 C--O 1.214 -0.805 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -134.87 150.47 50.46 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 122.803 1.287 . . . . 0.0 110.586 177.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.71 136.49 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 112.94 -1.937 . . . . 0.0 107.292 171.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.5 m -135.29 -177.15 1.85 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 111.889 -2.414 . . . . 0.0 108.576 -168.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.55 -23.81 67.54 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 119.162 -2.211 . . . . 0.0 115.617 -175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -125.66 -0.52 7.43 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.61 0.764 . . . . 0.0 111.211 -165.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.25 -169.72 41.57 Favored Glycine 0 CA--C 1.48 -2.144 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.414 ' O ' ' N ' ' A' ' 109' ' ' VAL . . . -120.44 146.61 46.05 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 111.663 -2.269 . . . . 0.0 108.22 167.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -100.13 137.34 38.71 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 168.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 73.3 t -129.44 129.55 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.669 0 C-N-CA 126.541 1.936 . . . . 0.0 106.246 -177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.66 125.26 41.0 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.404 HD13 HG21 ' A' ' 101' ' ' ILE . 1.8 pt -116.86 164.59 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 C-N-CA 125.874 1.67 . . . . 0.0 106.984 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -45.03 153.58 0.54 Allowed Glycine 0 CA--C 1.543 1.821 0 N-CA-C 118.659 2.223 . . . . 0.0 118.659 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.48 23.28 65.47 Favored Glycine 0 N--CA 1.487 2.083 0 O-C-N 119.523 -2.163 . . . . 0.0 112.599 175.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 63.75 36.25 93.08 Favored Glycine 0 C--N 1.358 1.79 0 C-N-CA 126.863 2.173 . . . . 0.0 117.356 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 50.0 mmtt -112.97 135.13 54.08 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 123.355 1.55 . . . . 0.0 109.842 -169.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -111.22 138.86 47.15 Favored 'General case' 0 CA--C 1.505 -0.779 0 O-C-N 119.546 -1.971 . . . . 0.0 105.999 176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.0 165.51 24.61 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-O 118.732 -1.038 . . . . 0.0 111.316 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 61.0 tp -101.5 114.18 27.97 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.055 -1.458 . . . . 0.0 109.783 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 97' ' ' ALA . 47.9 t -77.5 98.56 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.933 0 CA-C-O 125.738 2.685 . . . . 0.0 110.317 160.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -65.43 149.64 49.67 Favored 'General case' 0 CA--C 1.558 1.284 1 O-C-N 115.878 -4.264 . . . . 0.0 113.146 172.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 20.5 tt -65.29 -16.07 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 CA-C-N 113.411 -1.722 . . . . 0.0 114.775 -173.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 89.6 p -90.11 -1.51 57.96 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 119.694 -1.879 . . . . 0.0 110.184 175.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -121.39 36.48 4.6 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.3 mt -110.65 -44.02 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 C-N-CA 127.144 2.178 . . . . 0.0 109.37 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -145.04 163.11 35.24 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 111.842 -2.435 . . . . 0.0 112.646 -177.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -70.98 -45.94 63.16 Favored 'General case' 0 CA--C 1.576 1.961 0 O-C-N 119.623 -1.923 . . . . 0.0 115.924 171.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -77.63 149.83 34.7 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 120.616 -1.303 . . . . 0.0 111.336 178.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.259 94.8 mtt180 -47.44 132.06 13.5 Favored 'General case' 0 N--CA 1.506 2.347 0 CA-C-O 125.11 2.386 . . . . 0.0 115.012 174.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 94.3 t -107.2 115.35 48.4 Favored 'Isoleucine or valine' 0 C--N 1.371 1.531 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -66.83 -40.13 87.9 Favored 'General case' 0 C--O 1.197 -1.708 0 C-N-CA 118.066 -1.454 . . . . 0.0 113.45 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.7 pttm -147.44 145.88 29.35 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.73 1.15 . . . . 0.0 108.397 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.7 t -63.76 -34.94 71.15 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.233 -172.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 40.4 p -68.32 -26.45 65.62 Favored 'General case' 0 C--N 1.365 1.275 0 CA-C-O 125.023 2.344 . . . . 0.0 113.285 -167.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -58.49 -34.77 71.28 Favored 'General case' 0 C--O 1.205 -1.258 0 O-C-N 118.5 -2.625 . . . . 0.0 113.896 175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -86.96 -61.91 1.62 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 128.116 2.567 . . . . 0.0 112.586 172.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 66.2 mt -109.45 157.54 18.85 Favored 'General case' 0 CA--C 1.493 -1.242 0 O-C-N 125.729 1.893 . . . . 0.0 111.129 -162.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -142.55 156.54 45.13 Favored 'General case' 0 C--O 1.209 -1.062 0 O-C-N 126.28 2.237 . . . . 0.0 105.835 172.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -66.97 141.76 57.49 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 127.252 2.221 . . . . 0.0 112.83 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.93 -6.59 74.07 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-O 115.889 -2.617 . . . . 0.0 114.006 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -77.96 125.62 29.61 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 126.715 2.068 . . . . 0.0 113.589 -178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 87' ' ' GLY . 35.3 mt-10 -67.8 136.77 54.68 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-O 123.392 1.567 . . . . 0.0 112.717 166.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 p -152.87 142.68 15.0 Favored Pre-proline 0 C--O 1.184 -2.383 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.765 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -66.14 123.49 11.3 Favored 'Trans proline' 0 C--N 1.276 -3.277 0 C-N-CA 123.521 2.814 . . . . 0.0 119.026 160.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.8 m -123.4 137.8 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-O 123.356 1.55 . . . . 0.0 107.325 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -100.0 132.5 45.32 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 113.745 -1.571 . . . . 0.0 110.533 174.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.85 124.58 38.8 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 O-C-N 126.225 2.203 . . . . 0.0 109.526 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 30.4 mt -111.87 -28.29 8.12 Favored 'General case' 0 C--O 1.211 -0.936 0 O-C-N 120.598 -1.313 . . . . 0.0 112.786 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -160.71 144.06 13.34 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.266 1.026 . . . . 0.0 111.749 175.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.8 t -115.93 115.16 48.33 Favored 'Isoleucine or valine' 0 C--N 1.375 1.694 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 167.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . 0.322 0.0 OUTLIER -82.33 161.35 22.61 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 105.391 -2.078 . . . . 0.0 105.391 -174.189 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -89.91 -1.05 57.9 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 119.55 -1.969 . . . . 0.0 112.768 -168.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -85.82 0.74 52.17 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 127.094 3.33 . . . . 0.0 109.635 166.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.04 4.21 61.52 Favored Glycine 0 C--O 1.217 -0.942 0 CA-C-O 115.672 -2.738 . . . . 0.0 116.323 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -76.23 105.93 7.56 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-N 120.578 2.189 . . . . 0.0 111.851 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.5 mt -78.51 130.86 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 173.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 -123.34 131.05 53.53 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.756 -169.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 67.5 mt -127.94 140.58 51.91 Favored 'General case' 0 C--N 1.348 0.503 0 C-N-CA 123.979 0.912 . . . . 0.0 112.734 -163.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.1 t -126.61 120.78 30.39 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 34.4 mt -79.04 -28.62 13.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 167.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -61.69 -51.25 69.19 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 116.753 2.131 . . . . 0.0 116.753 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -74.79 -19.46 60.2 Favored 'General case' 0 C--O 1.258 1.548 0 CA-C-O 121.877 0.846 . . . . 0.0 113.078 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -85.89 -25.91 25.9 Favored 'General case' 0 C--N 1.369 1.415 0 O-C-N 117.088 -3.507 . . . . 0.0 111.286 169.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 21.8 p -86.63 -11.13 52.25 Favored 'General case' 0 C--O 1.251 1.142 0 C-N-CA 118.017 -1.473 . . . . 0.0 111.259 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 77.37 34.52 0.37 Allowed 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.911 -1.118 . . . . 0.0 109.527 170.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 169.743 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 . . . . . 0 CA--C 1.569 1.707 0 N-CA-C 118.01 2.596 . . . . 0.0 118.01 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.3 pt -73.62 134.89 28.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.905 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -89.2 143.09 27.1 Favored 'General case' 0 C--N 1.368 1.402 0 CA-C-N 113.651 -1.613 . . . . 0.0 106.786 168.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.2 t -139.89 150.19 44.3 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-O 128.497 3.999 . . . . 0.0 114.624 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 17.4 tt -137.56 134.15 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.502 0 CA-C-N 110.517 -3.038 . . . . 0.0 106.061 171.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -86.2 118.56 25.73 Favored 'General case' 0 CA--C 1.473 -2.013 0 O-C-N 125.38 1.675 . . . . 0.0 111.45 174.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.9 pt -112.0 152.41 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 119.492 -0.883 . . . . 0.0 108.651 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -47.63 114.46 3.17 Favored Pre-proline 0 C--O 1.212 -0.904 0 CA-C-O 115.371 -2.252 . . . . 0.0 114.323 163.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.17 -0.31 10.57 Favored 'Trans proline' 0 N--CA 1.492 1.386 0 CA-C-N 123.655 2.341 . . . . 0.0 115.894 -167.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -65.47 -29.88 70.59 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 125.761 1.913 . . . . 0.0 115.03 165.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -90.34 8.67 32.27 Favored 'General case' 0 C--N 1.308 -1.212 0 O-C-N 125.276 1.61 . . . . 0.0 113.394 -173.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 53.9 mt -66.07 -38.2 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 120.13 1.332 . . . . 0.0 112.321 -171.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -58.93 -45.3 90.73 Favored 'General case' 0 C--O 1.251 1.171 0 O-C-N 125.76 1.913 . . . . 0.0 115.601 171.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.33 -49.43 77.62 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 125.266 1.604 . . . . 0.0 112.163 172.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 t -55.26 -49.5 71.98 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.114 0 O-C-N 128.66 3.725 . . . . 0.0 116.017 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.1 pt -74.85 -24.35 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 114.287 -2.768 . . . . 0.0 114.484 -178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.19 157.49 20.89 Favored Glycine 0 C--N 1.358 1.805 0 CA-C-N 120.8 1.636 . . . . 0.0 113.404 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.61 138.3 56.31 Favored 'General case' 0 C--N 1.378 1.82 0 CA-C-O 124.827 2.251 . . . . 0.0 107.593 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 43.92 29.05 1.35 Allowed Glycine 0 CA--C 1.557 2.665 0 CA-C-N 112.633 -2.076 . . . . 0.0 116.785 -158.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 63.17 20.84 63.32 Favored Glycine 0 C--O 1.213 -1.2 0 CA-C-N 121.131 2.465 . . . . 0.0 116.686 175.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 91.3 p -62.91 -37.7 88.01 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 127.11 2.164 . . . . 0.0 113.781 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.252 41.3 t -75.55 -35.47 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 O-C-N 123.724 0.64 . . . . 0.0 111.134 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.26 19.8 tt -67.64 -37.02 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 C-N-CA 116.417 -2.113 . . . . 0.0 112.21 173.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 93.0 mtm-85 -60.03 -43.4 95.34 Favored 'General case' 0 CA--C 1.584 2.271 0 CA-C-N 120.85 1.659 . . . . 0.0 114.697 171.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.73 82.89 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 128.149 2.58 . . . . 0.0 113.242 173.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -60.03 -45.1 93.91 Favored 'General case' 0 N--CA 1.511 2.587 0 O-C-N 124.973 1.42 . . . . 0.0 108.421 170.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 31.2 m -56.3 -54.45 45.28 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 120.684 1.584 . . . . 0.0 107.563 175.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -60.42 -43.5 96.7 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 119.568 3.173 . . . . 0.0 119.568 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -83.22 -25.46 31.7 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 28.9 p -78.15 -49.18 14.34 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 119.813 -1.805 . . . . 0.0 108.842 170.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.18 34.13 6.27 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 116.49 -2.283 . . . . 0.0 109.727 -173.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.3 p -131.15 172.77 11.73 Favored 'General case' 0 C--N 1.381 1.949 0 O-C-N 126.046 1.674 . . . . 0.0 110.436 -179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.6 m -109.2 138.42 45.58 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 123.44 1.591 . . . . 0.0 111.587 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.6 mp -135.48 127.68 46.7 Favored 'Isoleucine or valine' 0 C--N 1.387 2.196 0 CA-C-O 123.105 1.431 . . . . 0.0 110.223 -165.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . 0.258 29.2 tt0 -128.43 129.2 45.8 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 117.662 -3.149 . . . . 0.0 106.831 164.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 75.4 mt -100.71 121.31 51.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 O-C-N 125.652 1.845 . . . . 0.0 109.874 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -87.36 150.76 23.61 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.259 174.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -54.09 -30.63 49.14 Favored 'General case' 0 C--O 1.261 1.668 0 N-CA-C 117.336 2.347 . . . . 0.0 117.336 -168.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -82.64 0.46 42.99 Favored 'General case' 0 CA--C 1.56 1.355 0 C-N-CA 126.76 2.024 . . . . 0.0 111.765 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.56 18.23 57.16 Favored Glycine 0 N--CA 1.504 3.232 0 O-C-N 119.327 -2.108 . . . . 0.0 110.745 -175.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.8 m -84.38 101.82 12.27 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.56 133.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 125.467 1.729 . . . . 0.0 112.236 175.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -118.16 112.08 19.69 Favored 'General case' 0 CA--C 1.582 2.194 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 25.5 mm -103.88 127.89 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 126.606 1.963 . . . . 0.0 108.977 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -130.34 130.75 44.83 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -161.8 174.13 13.62 Favored 'General case' 0 C--O 1.204 -1.313 0 O-C-N 120.704 -1.247 . . . . 0.0 109.02 -159.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.9 p -132.53 14.36 4.5 Favored 'General case' 0 CA--C 1.479 -1.753 0 CA-C-O 117.366 -1.302 . . . . 0.0 109.118 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -150.51 150.22 30.99 Favored 'General case' 0 N--CA 1.42 -1.966 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.61 -44.51 6.1 Favored Glycine 0 N--CA 1.507 3.405 0 C-N-CA 127.024 2.25 . . . . 0.0 113.816 -163.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -50.48 -44.12 55.69 Favored 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 163.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -62.56 -45.25 93.79 Favored 'General case' 0 CA--C 1.564 1.494 0 O-C-N 124.883 1.364 . . . . 0.0 110.194 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.05 -38.37 85.72 Favored 'General case' 0 CA--C 1.56 1.349 0 C-N-CA 124.604 1.162 . . . . 0.0 110.91 173.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -58.83 -45.28 90.39 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 169.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -58.56 -41.34 85.43 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 126.38 2.3 . . . . 0.0 113.718 176.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.94 -50.77 65.13 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.5 mm -62.97 -46.2 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.804 0 CA-C-N 111.144 -2.753 . . . . 0.0 108.323 -177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -64.27 -49.97 69.76 Favored 'General case' 0 C--O 1.205 -1.252 0 O-C-N 124.529 1.143 . . . . 0.0 113.746 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -57.78 -39.46 77.53 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.801 1.24 . . . . 0.0 113.398 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.4 mt -62.62 -49.38 84.01 Favored 'Isoleucine or valine' 0 C--O 1.257 1.474 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 168.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -55.68 -41.72 74.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -61.97 -47.69 83.69 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 127.752 2.421 . . . . 0.0 113.374 -178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.1 tt -71.29 -35.47 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.774 0 C-N-CA 124.349 1.06 . . . . 0.0 111.861 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 79.0 m -61.18 -40.37 93.63 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 116.214 -1.851 . . . . 0.0 109.911 168.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -85.68 -11.8 52.86 Favored 'General case' 0 C--N 1.374 1.655 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 177.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -58.95 127.94 34.72 Favored 'General case' 0 C--O 1.204 -1.324 0 CA-C-N 122.791 2.541 . . . . 0.0 116.465 171.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.498 HG21 HD13 ' A' ' 145' ' ' ILE . 6.4 mm -107.95 116.55 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 CA-C-O 126.141 2.877 . . . . 0.0 104.434 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -117.83 140.52 49.58 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.694 1.998 . . . . 0.0 112.105 -173.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 33.3 m -65.43 148.76 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.667 -1.213 . . . . 0.0 113.479 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 85.45 -19.67 22.3 Favored Glycine 0 C--O 1.208 -1.511 0 CA-C-O 113.862 -3.743 . . . . 0.0 117.016 -171.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -96.92 158.82 15.25 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.98 1.89 . . . . 0.0 111.17 -166.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.1 t -119.71 127.8 75.88 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.061 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -175.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -121.35 159.54 25.88 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-O 124.016 1.865 . . . . 0.0 109.109 -172.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 16.8 m -98.35 118.72 35.65 Favored 'General case' 0 C--O 1.202 -1.444 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 167.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -147.03 175.43 26.41 Favored Glycine 0 CA--C 1.569 3.416 0 C-N-CA 124.41 1.005 . . . . 0.0 114.829 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtmm -117.15 133.15 56.35 Favored 'General case' 0 C--O 1.205 -1.269 0 CA-C-O 125.633 2.635 . . . . 0.0 111.45 -169.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 18.3 t -67.8 121.13 16.4 Favored 'Isoleucine or valine' 0 C--N 1.366 1.304 0 O-C-N 119.214 -2.179 . . . . 0.0 106.487 175.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.4 p -103.8 -36.87 7.68 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 114.256 -1.338 . . . . 0.0 110.037 -173.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -146.37 154.8 42.06 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.0 mt -126.22 130.17 72.06 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.533 0 O-C-N 125.796 1.935 . . . . 0.0 110.812 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.1 m -121.83 173.16 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -174.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -64.07 -27.73 69.3 Favored 'General case' 0 CA--C 1.557 1.216 0 CA-C-O 123.262 1.506 . . . . 0.0 113.436 176.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -113.81 21.85 14.56 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -166.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.91 -153.01 24.95 Favored Glycine 0 C--O 1.204 -1.778 0 CA-C-O 116.991 -2.005 . . . . 0.0 111.305 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -149.69 174.33 12.69 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 102.203 -3.258 . . . . 0.0 102.203 167.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -114.86 128.76 56.48 Favored 'General case' 0 C--O 1.201 -1.47 0 O-C-N 127.669 3.106 . . . . 0.0 111.527 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.0 t -124.86 124.66 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 O-C-N 125.363 1.665 . . . . 0.0 107.494 -177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -75.69 117.53 17.55 Favored 'General case' 0 C--O 1.215 -0.732 1 O-C-N 129.434 4.209 . . . . 0.0 114.405 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 101' ' ' ILE . 46.0 pt -138.78 157.62 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 113.894 -1.503 . . . . 0.0 114.868 -167.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 62.25 -111.84 4.34 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-O 117.339 -1.812 . . . . 0.0 110.772 -176.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -81.83 -16.03 73.78 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 120.796 2.298 . . . . 0.0 112.809 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.59 -26.16 1.5 Allowed Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 116.947 -2.549 . . . . 0.0 112.377 -171.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -49.51 132.91 20.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 120.434 3.494 . . . . 0.0 120.434 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -72.48 143.64 48.34 Favored 'General case' 0 C--N 1.385 2.121 0 CA-C-O 123.966 1.841 . . . . 0.0 111.259 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -121.11 157.93 15.97 Favored Glycine 0 CA--C 1.539 1.565 0 N-CA-C 106.99 -2.444 . . . . 0.0 106.99 169.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.423 HD21 ' CE1' ' A' ' 110' ' ' HIS . 4.1 tp -112.46 116.43 30.27 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 118.843 1.322 . . . . 0.0 111.001 -175.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 p -101.56 118.4 48.28 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 171.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.423 ' CE1' HD21 ' A' ' 108' ' ' LEU . 90.8 m-70 -80.0 163.45 24.23 Favored 'General case' 0 C--O 1.192 -1.966 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 21.0 tt -56.29 -39.59 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 C-N-CA 126.327 1.851 . . . . 0.0 114.856 -170.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.8 p -77.87 -5.15 50.01 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 125.087 1.492 . . . . 0.0 114.971 171.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.77 3.49 42.2 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 173.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.6 mm -74.17 -39.76 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 124.225 1.964 . . . . 0.0 113.789 169.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -148.58 151.94 35.92 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.429 -170.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -92.42 -1.03 57.29 Favored 'General case' 0 N--CA 1.427 -1.598 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.872 160.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -87.26 170.58 11.32 Favored 'General case' 0 CA--C 1.577 2.018 0 CA-C-O 124.523 2.106 . . . . 0.0 107.944 158.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.57 147.84 47.88 Favored 'General case' 0 C--O 1.2 -1.503 0 N-CA-C 118.071 2.619 . . . . 0.0 118.071 -173.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 15.5 t -139.31 125.09 22.36 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.47 -46.8 5.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 C-N-CA 125.313 1.445 . . . . 0.0 108.527 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -140.05 146.09 38.53 Favored 'General case' 0 CA--C 1.554 1.118 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 58.2 t -92.69 -3.87 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 120.167 1.349 . . . . 0.0 110.982 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 14.0 p -68.59 -23.28 64.45 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 116.149 -1.881 . . . . 0.0 114.47 165.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -74.93 -8.33 56.18 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 127.391 2.932 . . . . 0.0 111.469 170.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -119.93 -68.93 0.88 Allowed 'General case' 0 C--N 1.356 0.884 0 O-C-N 120.315 -1.491 . . . . 0.0 111.049 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.8 mt -90.74 152.49 20.79 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-O 122.454 1.121 . . . . 0.0 108.047 -173.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 -124.66 135.12 52.8 Favored 'General case' 0 C--N 1.385 2.118 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 24.7 mtm -65.83 142.97 57.76 Favored 'General case' 0 C--O 1.21 -0.987 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -176.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 87.85 1.57 82.42 Favored Glycine 0 C--O 1.197 -2.191 0 CA-C-O 114.255 -3.525 . . . . 0.0 116.16 -177.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -97.65 143.11 28.64 Favored 'General case' 0 C--N 1.358 0.947 0 CA-C-N 120.931 2.366 . . . . 0.0 107.9 -174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -71.07 117.68 12.89 Favored 'General case' 0 C--O 1.2 -1.517 0 O-C-N 126.257 2.223 . . . . 0.0 111.092 -178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 26.7 m -120.97 128.15 25.89 Favored Pre-proline 0 CA--C 1.587 2.379 0 C-N-CA 123.868 0.867 . . . . 0.0 110.408 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.37 128.17 27.48 Favored 'Trans proline' 0 N--CA 1.525 3.341 0 C-N-CA 123.432 2.754 . . . . 0.0 113.588 153.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.8 m -140.99 135.42 33.01 Favored 'Isoleucine or valine' 0 C--N 1.374 1.645 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -101.89 141.44 34.73 Favored 'General case' 0 CA--C 1.566 1.585 0 O-C-N 120.335 -1.478 . . . . 0.0 108.62 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 65.3 t -93.78 126.71 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 123.428 1.585 . . . . 0.0 110.39 -176.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 84.5 mt -97.48 -76.41 0.52 Allowed 'General case' 0 C--N 1.365 1.282 0 CA-C-O 116.56 -1.686 . . . . 0.0 109.975 -172.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.43 148.75 36.62 Favored 'General case' 0 N--CA 1.416 -2.14 0 N-CA-C 104.227 -2.509 . . . . 0.0 104.227 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.6 t -85.99 135.24 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 125.902 2.001 . . . . 0.0 110.34 160.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -84.56 168.75 15.1 Favored 'General case' 0 C--N 1.369 1.414 0 N-CA-C 106.646 -1.612 . . . . 0.0 106.646 -177.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -67.57 -38.45 84.1 Favored 'General case' 0 C--O 1.253 1.288 0 CA-C-O 117.592 -1.194 . . . . 0.0 112.788 -170.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 89.5 mm-40 -76.53 -7.66 55.61 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 118.535 2.791 . . . . 0.0 118.535 173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 131.64 1.99 4.52 Favored Glycine 0 CA--C 1.496 -1.15 0 CA-C-O 117.219 -1.878 . . . . 0.0 116.998 165.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.82 147.73 22.61 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 120.652 2.226 . . . . 0.0 113.965 -171.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.498 HD13 HG21 ' A' ' 79' ' ' ILE . 24.4 mt -100.0 141.39 17.17 Favored 'Isoleucine or valine' 0 C--N 1.376 1.719 0 C-N-CA 117.323 -1.751 . . . . 0.0 110.614 176.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 -113.55 132.17 55.81 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.734 -176.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 72.8 mt -124.55 165.39 17.91 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -165.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 11.0 t -136.69 135.31 38.1 Favored 'General case' 0 N--CA 1.524 3.253 0 CA-C-N 114.529 -1.214 . . . . 0.0 112.624 168.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mm -88.32 -42.29 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 O-C-N 125.971 2.045 . . . . 0.0 109.441 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -64.65 -32.37 74.01 Favored 'General case' 0 CA--C 1.551 0.998 0 O-C-N 119.632 -1.917 . . . . 0.0 116.036 -169.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -87.9 -3.48 58.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.416 -1.428 . . . . 0.0 110.79 -177.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.266 . . -98.92 17.08 20.44 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.9 t -140.17 136.93 33.96 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.775 1.23 . . . . 0.0 110.438 168.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -59.79 163.86 4.16 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 126.683 1.993 . . . . 0.0 112.158 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 . . . . . 0 N--CA 1.477 0.91 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.047 -176.954 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . 0.278 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 117.751 -1.119 . . . . 0.0 108.61 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 36.1 mt -105.03 135.95 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 126.394 2.309 . . . . 0.0 108.186 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -113.99 131.29 56.39 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.72 1.263 . . . . 0.0 107.902 169.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.6 m -110.06 107.85 17.85 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 123.112 1.434 . . . . 0.0 110.507 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 28.4 mm -119.7 126.06 74.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 113.758 -1.565 . . . . 0.0 111.224 -169.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.9 mmtt -95.51 129.27 42.74 Favored 'General case' 0 C--O 1.26 1.627 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.9 pt -127.87 162.81 33.01 Favored 'Isoleucine or valine' 0 C--N 1.381 1.966 0 CA-C-N 113.914 -1.494 . . . . 0.0 111.995 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -45.87 116.48 3.37 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.954 1.701 . . . . 0.0 113.625 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -66.84 8.29 0.35 Allowed 'Trans proline' 0 N--CA 1.51 2.498 0 O-C-N 116.87 -2.226 . . . . 0.0 114.547 178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -88.25 -15.39 35.97 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 120.29 1.405 . . . . 0.0 111.51 169.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -119.42 22.06 11.89 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 125.832 1.958 . . . . 0.0 114.902 -170.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.9 mt -70.81 -40.11 76.29 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.251 0 C-N-CA 124.069 0.948 . . . . 0.0 109.884 171.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -58.2 -39.75 79.79 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 126.771 2.028 . . . . 0.0 115.976 172.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 57.1 m-20 -74.76 -35.19 62.58 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.007 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.0 t -71.04 -41.08 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 123.271 1.51 . . . . 0.0 111.659 170.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.435 HG23 ' HA2' ' A' ' 33' ' ' GLY . 94.2 mt -64.13 -55.82 19.86 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.951 0 CA-C-O 116.389 -1.767 . . . . 0.0 111.181 173.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.721 ' HA3' ' H ' ' A' ' 35' ' ' VAL . . . 88.78 -177.9 45.16 Favored Glycine 0 C--O 1.205 -1.708 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 -172.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -77.79 122.75 25.83 Favored 'General case' 0 CA--C 1.557 1.23 0 O-C-N 119.033 -2.451 . . . . 0.0 110.293 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.94 22.41 64.6 Favored Glycine 1 N--CA 1.521 4.361 0 C-N-CA 118.159 -1.972 . . . . 0.0 112.513 -178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.435 ' HA2' HG23 ' A' ' 29' ' ' ILE . . . 89.97 5.7 70.45 Favored Glycine 0 N--CA 1.467 0.739 0 CA-C-O 116.625 -2.209 . . . . 0.0 114.308 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 69.6 m -55.64 -46.81 77.4 Favored 'General case' 0 N--CA 1.512 2.663 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -174.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.721 ' H ' ' HA3' ' A' ' 30' ' ' GLY . 73.1 t -67.12 -44.22 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 tt -69.61 -34.48 61.61 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.957 0 O-C-N 118.934 -2.354 . . . . 0.0 110.796 -176.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -49.12 -53.87 18.78 Favored 'General case' 0 C--N 1.381 1.973 0 O-C-N 126.07 2.106 . . . . 0.0 113.755 165.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.68 -36.8 85.43 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 124.876 1.36 . . . . 0.0 114.152 178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 19.3 tp -61.2 -47.05 87.9 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.872 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.8 t -71.19 -25.09 62.37 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -72.62 -46.16 55.44 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 117.933 -1.507 . . . . 0.0 113.301 166.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -73.58 -32.32 64.07 Favored 'General case' 0 C--O 1.255 1.354 0 O-C-N 125.145 1.528 . . . . 0.0 108.709 -167.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.64 HG21 ' HA ' ' A' ' 68' ' ' ALA . 75.2 p -82.84 -21.16 34.49 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 120.201 -1.562 . . . . 0.0 112.877 174.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.03 34.58 87.26 Favored Glycine 0 C--N 1.381 3.075 0 C-N-CA 129.222 3.296 . . . . 0.0 112.182 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 t -146.98 157.95 43.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 119.696 -2.061 . . . . 0.0 108.572 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.2 m -74.12 128.76 36.37 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 124.325 1.016 . . . . 0.0 112.611 -172.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 58.5 mt -136.13 137.69 48.16 Favored 'Isoleucine or valine' 0 C--N 1.365 1.254 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -170.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -136.89 150.01 47.99 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 125.987 1.715 . . . . 0.0 109.336 -169.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.2 tt -141.94 155.16 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 118.82 -1.152 . . . . 0.0 112.417 -174.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -127.17 155.27 43.65 Favored 'General case' 0 C--N 1.362 1.137 0 CA-C-N 113.997 -1.456 . . . . 0.0 107.636 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -86.83 20.4 2.61 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -174.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.5 p30 -115.57 13.86 16.44 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.32 5.99 89.11 Favored Glycine 0 C--N 1.36 1.893 0 C-N-CA 119.081 -1.533 . . . . 0.0 110.385 179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.4 m -88.09 114.63 24.9 Favored 'General case' 0 N--CA 1.513 2.68 0 O-C-N 119.963 -1.904 . . . . 0.0 108.964 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 p -115.71 138.33 46.49 Favored 'Isoleucine or valine' 0 C--N 1.365 1.249 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -123.79 131.56 53.62 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 112.731 -2.032 . . . . 0.0 111.58 -169.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.39 106.96 19.7 Favored 'Isoleucine or valine' 0 C--N 1.371 1.513 0 O-C-N 125.408 1.693 . . . . 0.0 109.801 -176.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.39 121.93 33.54 Favored 'General case' 0 C--N 1.36 1.06 0 CA-C-N 112.806 -1.997 . . . . 0.0 105.977 177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -155.04 151.87 28.92 Favored 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.379 2.363 . . . . 0.0 117.379 -165.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 41.2 p -123.94 -10.12 7.71 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-N 113.8 -1.545 . . . . 0.0 112.075 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -120.25 123.7 43.86 Favored 'General case' 0 C--N 1.377 1.762 0 CA-C-N 119.305 0.957 . . . . 0.0 110.42 171.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.28 -36.56 53.06 Favored Glycine 0 C--N 1.361 1.92 0 CA-C-O 122.629 1.127 . . . . 0.0 114.308 177.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -67.31 -40.73 86.01 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 117.243 -1.36 . . . . 0.0 112.686 177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 51.7 mttp -68.09 -42.18 80.75 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 119.523 1.056 . . . . 0.0 112.115 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.7 -47.61 84.94 Favored 'General case' 0 C--N 1.358 0.965 0 O-C-N 125.571 1.795 . . . . 0.0 112.869 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -62.76 -42.67 99.79 Favored 'General case' 0 C--O 1.261 1.678 0 O-C-N 125.179 1.55 . . . . 0.0 113.082 173.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . 0.287 12.1 t-80 -63.29 -37.64 88.05 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 126.61 2.444 . . . . 0.0 115.138 177.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.64 ' HA ' HG21 ' A' ' 43' ' ' THR . . . -67.58 -43.39 80.68 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.865 170.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . 0.318 61.4 mt -60.32 -41.74 88.22 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.312 0 CA-C-N 119.113 0.87 . . . . 0.0 109.683 178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.3 mmp_? -61.2 -46.02 92.17 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 117.522 -1.228 . . . . 0.0 112.825 -179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 -59.58 -43.07 93.78 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 127.836 2.454 . . . . 0.0 110.131 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 63.6 mt -61.06 -44.9 99.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -62.26 -40.05 94.92 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-O 119.079 -0.486 . . . . 0.0 111.06 178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -54.56 -56.02 23.3 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 123.013 1.387 . . . . 0.0 113.698 173.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.257 76.9 mt -63.95 -45.16 97.63 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-N 112.299 -2.228 . . . . 0.0 109.776 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.7 p -79.4 -23.32 43.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.619 1.554 . . . . 0.0 114.752 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.14 -24.66 58.0 Favored 'General case' 0 C--O 1.273 2.295 0 CA-C-N 120.573 1.533 . . . . 0.0 113.336 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -55.04 144.13 24.47 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 124.488 2.09 . . . . 0.0 114.536 -177.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 19.6 mm -72.91 148.26 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 119.636 -1.915 . . . . 0.0 114.834 -157.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -115.03 154.86 28.06 Favored 'General case' 0 C--O 1.249 1.053 0 O-C-N 119.631 -1.918 . . . . 0.0 108.965 172.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.07 143.7 10.97 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.85 0 O-C-N 119.097 -2.252 . . . . 0.0 113.51 171.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.22 9.05 85.6 Favored Glycine 0 N--CA 1.496 2.656 0 O-C-N 120.986 -1.071 . . . . 0.0 113.569 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -111.58 152.37 27.66 Favored 'General case' 0 N--CA 1.509 2.507 0 C-N-CA 123.387 0.675 . . . . 0.0 110.804 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.7 t -97.58 140.09 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 126.554 2.409 . . . . 0.0 109.675 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -129.4 159.94 34.65 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 125.187 2.423 . . . . 0.0 106.657 170.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.5 109.86 21.98 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 118.64 -2.537 . . . . 0.0 109.319 174.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.44 166.08 18.33 Favored Glycine 0 C--N 1.368 2.348 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -169.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -120.28 149.08 42.87 Favored 'General case' 0 N--CA 1.506 2.342 0 CA-C-N 112.231 -1.984 . . . . 0.0 113.544 174.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.18 127.71 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 124.109 1.909 . . . . 0.0 112.024 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.9 p -97.48 -30.2 13.03 Favored 'General case' 0 CA--C 1.48 -1.712 0 CA-C-O 116.268 -1.825 . . . . 0.0 114.218 176.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.8 ptt85 -171.0 151.27 3.24 Favored 'General case' 0 CA--C 1.489 -1.391 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 64.8 mt -123.98 140.28 47.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 O-C-N 121.444 -0.785 . . . . 0.0 109.456 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.4 m -142.51 172.02 9.21 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.242 0 C-N-CA 126.366 1.866 . . . . 0.0 112.797 -173.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -65.16 -35.53 81.38 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 118.356 -2.715 . . . . 0.0 113.811 -165.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -109.81 18.34 20.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 125.385 1.678 . . . . 0.0 113.207 -174.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 159.56 -161.81 32.47 Favored Glycine 0 CA--C 1.549 2.174 0 N-CA-C 117.711 1.845 . . . . 0.0 117.711 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.19 142.86 26.6 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 120.913 -1.345 . . . . 0.0 110.441 -173.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -99.37 134.76 41.76 Favored 'General case' 0 C--N 1.364 1.23 0 CA-C-O 123.827 1.775 . . . . 0.0 109.039 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.2 t -136.03 123.26 33.95 Favored 'Isoleucine or valine' 0 C--O 1.186 -2.245 0 CA-C-N 112.434 -2.166 . . . . 0.0 110.497 -171.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.39 147.78 22.79 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 125.559 1.787 . . . . 0.0 113.236 179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 11.9 pt -145.35 164.95 11.51 Favored 'Isoleucine or valine' 0 C--N 1.362 1.143 0 O-C-N 126.022 2.076 . . . . 0.0 110.125 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -41.88 141.33 1.49 Allowed Glycine 0 CA--C 1.541 1.718 0 N-CA-C 121.521 3.368 . . . . 0.0 121.521 176.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 83.13 24.68 51.31 Favored Glycine 0 CA--C 1.496 -1.138 0 CA-C-O 116.682 -2.177 . . . . 0.0 115.979 -174.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 60.47 42.85 99.19 Favored Glycine 0 CA--C 1.562 2.976 0 N-CA-C 117.329 1.692 . . . . 0.0 117.329 176.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -121.76 148.93 44.01 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 120.148 -1.796 . . . . 0.0 113.325 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -130.34 119.65 23.1 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 124.103 1.906 . . . . 0.0 107.45 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -101.39 171.67 22.41 Favored Glycine 0 N--CA 1.408 -3.177 0 C-N-CA 125.692 1.615 . . . . 0.0 110.125 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 8.2 tp -116.08 136.56 52.91 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 115.29 -2.29 . . . . 0.0 109.709 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.8 t -101.76 115.08 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-N 122.159 2.254 . . . . 0.0 109.14 167.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 13.7 t60 -62.66 149.54 43.25 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.269 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.0 tt -56.46 -38.89 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 118.23 2.678 . . . . 0.0 118.23 -175.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . 0.301 71.4 m -73.81 -10.13 59.36 Favored 'General case' 0 CA--C 1.486 -1.511 0 C-N-CA 124.387 1.075 . . . . 0.0 111.208 177.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -117.2 18.76 14.43 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.663 1.185 . . . . 0.0 113.213 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.407 ' HB ' HG21 ' A' ' 119' ' ' VAL . 37.2 mt -81.9 -53.79 11.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 125.347 1.459 . . . . 0.0 111.521 167.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -149.46 166.95 27.59 Favored 'General case' 0 C--O 1.198 -1.624 0 O-C-N 123.574 0.546 . . . . 0.0 111.617 -171.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.9 p-10 -69.53 -43.66 72.57 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 117.389 -1.291 . . . . 0.0 112.371 163.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 28.0 mmtm -48.14 145.84 2.96 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 162.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -66.58 131.57 46.31 Favored 'General case' 0 N--CA 1.517 2.9 0 CA-C-N 114.371 -1.286 . . . . 0.0 112.956 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.407 HG21 ' HB ' ' A' ' 114' ' ' ILE . 18.6 t -110.29 102.98 14.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.802 0 N-CA-C 104.655 -2.35 . . . . 0.0 104.655 170.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -81.56 -43.08 19.21 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 124.757 1.286 . . . . 0.0 108.876 161.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -133.31 148.06 51.89 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.006 -1.684 . . . . 0.0 108.727 170.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 91.8 t -70.35 -33.06 52.55 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 126.539 1.936 . . . . 0.0 115.152 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.2 p -62.59 -9.03 7.52 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 116.409 -1.758 . . . . 0.0 115.69 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -69.1 -41.99 76.7 Favored 'General case' 0 C--N 1.372 1.578 0 CA-C-N 123.691 2.951 . . . . 0.0 110.648 168.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -109.97 -34.03 6.54 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -164.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 76.7 mt -109.48 142.83 39.95 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -168.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -126.51 150.35 48.82 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 176.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -55.34 136.29 49.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 125.807 1.942 . . . . 0.0 114.236 168.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.49 3.44 88.79 Favored Glycine 0 C--N 1.381 3.07 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.396 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -79.99 122.96 27.37 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 -178.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.46 107.2 1.3 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 128.373 3.545 . . . . 0.0 114.069 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 27.4 m -118.4 148.01 43.05 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 111.382 -2.644 . . . . 0.0 105.582 -176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -90.57 134.1 1.89 Allowed 'Trans proline' 1 C--N 1.255 -4.364 0 N-CA-C 104.648 -2.866 . . . . 0.0 104.648 170.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.74 137.27 39.5 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.939 0 C-N-CA 118.119 -1.432 . . . . 0.0 109.537 -172.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -113.61 135.02 54.37 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-O 122.863 1.316 . . . . 0.0 108.39 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.572 HG22 HD23 ' A' ' 147' ' ' LEU . 65.8 t -80.17 121.55 33.75 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 CA-C-N 113.265 -1.789 . . . . 0.0 108.977 173.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 43.4 mt -104.98 -6.8 19.74 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.483 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -168.48 144.66 3.72 Favored 'General case' 0 N--CA 1.533 3.678 0 O-C-N 119.792 -1.817 . . . . 0.0 114.659 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.282 7.2 t -127.09 103.56 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 126.444 2.34 . . . . 0.0 106.041 174.169 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.46 166.05 24.16 Favored 'General case' 0 CA--C 1.581 2.144 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 -177.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -71.56 -7.61 48.75 Favored 'General case' 0 N--CA 1.505 2.316 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -107.96 14.83 24.94 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 125.727 1.611 . . . . 0.0 108.808 173.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.89 31.34 75.35 Favored Glycine 0 N--CA 1.414 -2.786 0 O-C-N 120.663 -1.273 . . . . 0.0 115.582 -178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . 0.252 58.3 mtm180 -80.74 117.63 21.58 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 124.027 1.87 . . . . 0.0 109.892 168.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 64.6 mt -101.94 121.2 52.64 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.26 0 O-C-N 118.582 -2.574 . . . . 0.0 107.955 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -109.76 106.14 15.65 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 123.832 1.777 . . . . 0.0 114.344 -175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.572 HD23 HG22 ' A' ' 136' ' ' VAL . 20.0 mt -87.3 150.03 24.14 Favored 'General case' 0 C--N 1.389 2.284 0 CA-C-O 127.979 3.752 . . . . 0.0 110.861 176.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.3 t -119.51 129.1 54.54 Favored 'General case' 0 C--O 1.288 3.113 0 CA-C-N 110.158 -3.201 . . . . 0.0 110.734 165.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 63.1 mt -86.41 -30.27 6.08 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 O-C-N 119.189 -2.194 . . . . 0.0 105.631 167.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -62.24 -46.92 86.71 Favored 'General case' 0 CA--C 1.553 1.075 0 O-C-N 120.537 -1.352 . . . . 0.0 114.136 -174.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.0 mm-40 -69.63 -24.39 63.63 Favored 'General case' 0 C--O 1.264 1.837 0 N-CA-C 118.134 2.642 . . . . 0.0 118.134 171.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -77.11 -35.82 56.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 124.927 1.392 . . . . 0.0 111.414 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.4 p -90.01 26.2 1.92 Allowed 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 173.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.261 16.2 mt-10 71.71 17.44 5.48 Favored 'General case' 0 CA--C 1.574 1.892 0 CA-C-O 123.864 1.792 . . . . 0.0 113.92 166.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 . . . . . 0 C--O 1.274 2.393 0 O-C-N 118.029 -2.919 . . . . 0.0 112.725 -178.277 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 . . . . . 0 CA--C 1.567 1.597 0 N-CA-C 118.683 2.846 . . . . 0.0 118.683 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.1 mm -108.86 119.68 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -113.87 151.48 32.1 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 102.959 -2.978 . . . . 0.0 102.959 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.4 p -148.29 151.81 36.04 Favored 'General case' 0 CA--C 1.576 1.976 0 CA-C-O 124.819 2.247 . . . . 0.0 112.67 -179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.1 pt -145.87 155.58 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 O-C-N 118.669 -2.519 . . . . 0.0 105.243 171.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.6 mmtm -107.21 119.75 40.25 Favored 'General case' 0 CA--C 1.555 1.136 0 O-C-N 121.464 -0.772 . . . . 0.0 110.217 -175.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 42.7 mm -115.05 141.66 30.9 Favored 'Isoleucine or valine' 0 C--N 1.353 0.761 0 C-N-CA 126.124 1.77 . . . . 0.0 108.815 -176.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 -73.02 146.01 86.91 Favored Pre-proline 0 C--O 1.213 -0.819 0 CA-C-O 115.33 -2.271 . . . . 0.0 113.555 -176.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -67.2 -19.58 50.48 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 124.25 1.658 . . . . 0.0 113.251 -160.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -57.74 -44.41 86.05 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 119.871 -1.768 . . . . 0.0 111.652 166.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -92.87 -18.28 23.01 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.241 -1.537 . . . . 0.0 109.237 -167.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 7.9 mm -59.74 -34.78 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 O-C-N 124.776 1.298 . . . . 0.0 108.688 165.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -61.8 -43.37 98.99 Favored 'General case' 0 CA--C 1.579 2.082 0 O-C-N 120.94 -1.1 . . . . 0.0 112.21 175.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -68.74 -31.0 69.74 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 114.05 -2.881 . . . . 0.0 112.262 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -70.28 -42.47 78.83 Favored 'Isoleucine or valine' 0 C--N 1.381 1.968 0 O-C-N 127.709 3.131 . . . . 0.0 108.843 177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 94.8 mt -68.8 -48.29 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 124.176 1.941 . . . . 0.0 111.296 175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.99 -176.58 49.26 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 111.4 -2.636 . . . . 0.0 114.71 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -70.11 142.03 52.64 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 116.911 -1.915 . . . . 0.0 110.532 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.01 23.21 45.48 Favored Glycine 0 N--CA 1.511 3.641 0 O-C-N 120.263 -1.523 . . . . 0.0 114.702 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 52.8 43.27 60.33 Favored Glycine 0 CA--C 1.477 -2.305 0 C-N-CA 126.389 1.947 . . . . 0.0 114.689 -168.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.6 p -97.95 -33.84 11.06 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 117.446 -1.702 . . . . 0.0 114.618 -169.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -65.66 -36.19 77.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.64 0 O-C-N 120.499 -1.376 . . . . 0.0 112.528 -177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 tp -64.54 -42.05 94.05 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 O-C-N 119.487 -2.008 . . . . 0.0 114.097 167.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -62.71 -37.27 85.86 Favored 'General case' 0 CA--C 1.583 2.244 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 171.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.8 -48.15 69.88 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 117.056 -1.449 . . . . 0.0 111.186 170.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 22.3 tp -55.62 -42.56 75.1 Favored 'General case' 0 C--N 1.37 1.458 0 C-N-CA 124.52 1.128 . . . . 0.0 108.579 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 14.9 m -61.86 -47.69 83.88 Favored 'General case' 0 CA--C 1.567 1.597 0 CA-C-N 114.607 -1.178 . . . . 0.0 112.163 -176.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -61.28 -45.81 92.95 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 112.772 -2.013 . . . . 0.0 112.283 172.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -65.97 -53.2 42.04 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-O 114.655 -2.593 . . . . 0.0 114.001 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.1 p -69.19 -22.93 63.86 Favored 'General case' 0 CA--C 1.497 -1.071 0 O-C-N 125.857 1.973 . . . . 0.0 113.336 -170.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.03 13.18 53.82 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-O 114.841 -3.199 . . . . 0.0 117.548 -176.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.98 161.66 34.17 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.693 2.247 . . . . 0.0 108.714 -162.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.3 m -66.3 123.71 20.69 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 176.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.8 mm -118.15 134.65 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -140.48 167.54 21.92 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 123.344 1.545 . . . . 0.0 108.421 170.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.6 mm -113.29 130.64 66.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 104.235 -2.505 . . . . 0.0 104.235 177.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -118.77 163.91 16.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -45.37 160.62 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.308 79.3 m-20 69.37 32.14 3.61 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 123.515 1.626 . . . . 0.0 114.841 170.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 50.7 53.75 24.37 Favored Glycine 0 C--O 1.281 3.064 0 N-CA-C 116.044 1.178 . . . . 0.0 116.044 -168.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.1 m -102.63 132.89 48.44 Favored 'General case' 0 C--N 1.318 -0.77 0 O-C-N 125.898 1.587 . . . . 0.0 110.989 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.6 t -94.94 134.44 32.3 Favored 'Isoleucine or valine' 0 C--N 1.37 1.47 0 O-C-N 119.046 -2.284 . . . . 0.0 108.305 158.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -107.78 130.36 54.97 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.7 mp -112.05 124.87 69.18 Favored 'Isoleucine or valine' 0 C--N 1.372 1.555 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 167.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -112.55 114.93 27.83 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 -175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.88 140.91 22.94 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-O 123.298 1.523 . . . . 0.0 113.636 -164.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.4 p -110.47 4.58 20.62 Favored 'General case' 0 CA--C 1.489 -1.379 0 C-N-CA 126.61 1.964 . . . . 0.0 111.953 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -126.2 139.33 53.43 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 103.132 -2.914 . . . . 0.0 103.132 169.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.32 -27.73 24.48 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 125.605 1.574 . . . . 0.0 113.577 -174.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -62.02 -39.64 92.97 Favored 'General case' 0 C--O 1.248 0.976 0 O-C-N 121.316 -1.108 . . . . 0.0 113.423 168.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -65.97 -37.36 85.77 Favored 'General case' 0 N--CA 1.415 -2.182 0 CA-C-N 118.483 0.583 . . . . 0.0 112.308 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.41 89.37 Favored 'General case' 0 CA--C 1.567 1.601 0 CA-C-O 123.469 1.604 . . . . 0.0 114.224 173.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -67.33 -42.91 82.81 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 115.179 -2.343 . . . . 0.0 113.035 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -62.61 -40.79 98.07 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 126.456 2.348 . . . . 0.0 111.577 169.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.64 -48.45 69.38 Favored 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.89 -37.36 71.62 Favored 'Isoleucine or valine' 0 C--N 1.368 1.397 0 O-C-N 125.399 1.687 . . . . 0.0 109.271 173.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.306 27.5 tpt180 -67.82 -41.86 82.42 Favored 'General case' 0 C--N 1.375 1.709 0 O-C-N 124.726 1.266 . . . . 0.0 114.413 172.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -62.41 -39.3 92.85 Favored 'General case' 0 C--O 1.253 1.274 0 C-N-CA 118.935 -1.106 . . . . 0.0 113.132 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.2 mm -55.43 -31.98 28.71 Favored 'Isoleucine or valine' 0 C--N 1.372 1.578 0 CA-C-O 117.331 -1.319 . . . . 0.0 108.668 176.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -72.82 -29.33 63.16 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 116.956 -1.898 . . . . 0.0 109.142 -176.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -68.79 -40.57 79.57 Favored 'General case' 0 C--O 1.26 1.651 0 O-C-N 120.437 -1.415 . . . . 0.0 109.121 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.39 -38.33 32.05 Favored 'Isoleucine or valine' 0 C--O 1.264 1.862 0 O-C-N 127.338 2.899 . . . . 0.0 117.191 165.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.0 p -88.14 -17.11 31.69 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 117.879 -3.013 . . . . 0.0 115.998 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.44 -25.36 23.81 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 177.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -71.97 148.11 46.29 Favored 'General case' 0 C--O 1.246 0.876 0 CA-C-O 126.482 3.039 . . . . 0.0 113.4 171.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 45.0 mm -79.99 135.06 26.21 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.794 0 CA-C-O 126.023 2.82 . . . . 0.0 111.827 -169.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -87.09 134.42 33.51 Favored 'General case' 0 N--CA 1.509 2.484 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.313 -167.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.46 129.07 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 CA-C-O 123.629 1.681 . . . . 0.0 112.568 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.43 16.87 79.92 Favored Glycine 0 N--CA 1.513 3.769 0 C-N-CA 126.698 2.094 . . . . 0.0 117.967 165.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.5 mmt85 -120.16 161.43 21.05 Favored 'General case' 0 N--CA 1.415 -2.211 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 -173.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.8 t -104.42 113.14 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 CA-C-N 112.417 -2.174 . . . . 0.0 109.441 -164.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -94.7 163.01 13.54 Favored 'General case' 0 CA--C 1.572 1.791 0 CA-C-N 113.188 -1.823 . . . . 0.0 113.662 169.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.6 m -104.85 127.48 52.69 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 116.944 -3.598 . . . . 0.0 104.007 163.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -125.66 -164.88 11.93 Favored Glycine 0 CA--C 1.493 -1.318 0 C-N-CA 126.978 2.228 . . . . 0.0 108.149 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -149.38 151.73 34.57 Favored 'General case' 0 C--O 1.211 -0.943 0 CA-C-O 116.854 -1.546 . . . . 0.0 109.915 172.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.2 t -75.88 109.59 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 126.855 2.062 . . . . 0.0 111.864 -177.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -94.19 -55.71 3.1 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.91 -173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 36.7 mtm-85 -131.81 123.46 27.64 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -176.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 93.1 mt -98.65 128.97 49.65 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 CA-C-O 123.481 1.61 . . . . 0.0 107.087 176.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.71 174.49 9.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.86 0 O-C-N 120.476 -1.39 . . . . 0.0 110.059 -169.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -59.68 -25.53 64.82 Favored 'General case' 0 C--N 1.377 1.767 0 O-C-N 117.835 -3.041 . . . . 0.0 116.054 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -125.51 14.32 8.19 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-O 117.571 -1.204 . . . . 0.0 112.637 -172.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 171.42 -159.14 30.72 Favored Glycine 0 C--O 1.193 -2.448 0 CA-C-N 120.647 1.567 . . . . 0.0 110.661 -178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -140.96 155.58 46.21 Favored 'General case' 0 CA--C 1.477 -1.838 0 O-C-N 124.759 0.917 . . . . 0.0 109.282 158.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -87.43 147.01 25.61 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.896 0.855 . . . . 0.0 109.894 169.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 13.4 t -136.97 130.85 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.62 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.269 176.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -102.47 139.47 38.03 Favored 'General case' 0 N--CA 1.407 -2.599 0 CA-C-O 125.14 2.4 . . . . 0.0 106.04 -174.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.3 mt -119.86 137.57 53.28 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-N 111.539 -2.573 . . . . 0.0 111.955 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -37.84 129.26 1.5 Allowed Glycine 0 N--CA 1.503 3.143 0 N-CA-C 120.95 3.14 . . . . 0.0 120.95 172.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 97.08 18.23 29.82 Favored Glycine 0 C--N 1.364 2.112 0 C-N-CA 124.459 1.028 . . . . 0.0 114.343 -163.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 68.1 27.73 73.6 Favored Glycine 0 CA--C 1.54 1.64 0 O-C-N 125.871 1.571 . . . . 0.0 113.971 175.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -100.0 149.57 23.33 Favored 'General case' 0 C--N 1.369 1.448 0 CA-C-N 119.534 1.667 . . . . 0.0 112.178 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -146.48 141.35 26.99 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 123.119 1.438 . . . . 0.0 114.353 178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -125.63 166.46 18.36 Favored Glycine 0 CA--C 1.495 -1.202 0 O-C-N 120.348 -1.47 . . . . 0.0 110.05 -174.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 60.2 tp -103.22 130.71 50.52 Favored 'General case' 0 N--CA 1.518 2.934 0 C-N-CA 118.612 -1.235 . . . . 0.0 108.385 173.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 32.9 t -98.58 109.61 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 163.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -70.03 150.59 46.47 Favored 'General case' 0 C--O 1.2 -1.551 0 CA-C-N 113.815 -1.539 . . . . 0.0 114.409 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.432 8.6 tt -49.47 -21.79 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 118.711 2.856 . . . . 0.0 118.711 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.7 p -106.32 14.45 27.4 Favored 'General case' 0 C--N 1.389 2.287 0 CA-C-O 117.781 -1.104 . . . . 0.0 110.855 177.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 43.6 mm-40 -124.41 22.44 8.45 Favored 'General case' 0 CA--C 1.556 1.204 0 O-C-N 124.867 1.354 . . . . 0.0 111.597 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.7 mt -99.08 -39.35 7.79 Favored 'Isoleucine or valine' 0 C--N 1.377 1.784 0 CA-C-N 123.075 2.67 . . . . 0.0 110.24 175.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -159.39 149.79 19.23 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 117.285 -1.766 . . . . 0.0 113.58 -170.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -74.29 -26.44 60.19 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 118.92 -2.363 . . . . 0.0 108.523 163.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 17.4 mttm -57.42 151.56 16.16 Favored 'General case' 0 N--CA 1.405 -2.691 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 162.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? -66.65 142.2 57.53 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.653 1.216 . . . . 0.0 108.464 -177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 70.6 t -128.34 137.24 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.888 178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -107.7 -75.19 0.64 Allowed 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 102.154 -3.276 . . . . 0.0 102.154 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -114.39 155.37 26.42 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 173.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.25 -26.32 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 122.019 2.19 . . . . 0.0 114.257 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.3 p -65.01 -20.29 66.42 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.931 1.292 . . . . 0.0 112.979 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -102.97 31.91 3.97 Favored 'General case' 0 C--O 1.256 1.404 0 O-C-N 126.492 2.37 . . . . 0.0 107.517 -172.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -153.36 -55.98 0.12 Allowed 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 104.467 -2.42 . . . . 0.0 104.467 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.7 mt -97.7 157.17 16.2 Favored 'General case' 0 C--N 1.375 1.706 0 C-N-CA 125.016 1.326 . . . . 0.0 111.447 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -117.39 148.18 41.99 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 127.137 2.773 . . . . 0.0 105.93 176.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -70.18 143.27 52.3 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 124.047 1.88 . . . . 0.0 110.084 174.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 83.6 -17.9 22.68 Favored Glycine 0 N--CA 1.438 -1.209 0 CA-C-N 112.158 -2.292 . . . . 0.0 115.786 -178.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -58.99 143.76 47.26 Favored 'General case' 0 N--CA 1.424 -1.74 0 C-N-CA 124.999 1.32 . . . . 0.0 111.562 -173.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -111.24 99.4 8.23 Favored 'General case' 0 N--CA 1.513 2.679 0 CA-C-O 123.875 1.798 . . . . 0.0 113.461 -165.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.4 p -109.04 134.33 20.43 Favored Pre-proline 0 N--CA 1.399 -2.994 0 CA-C-N 113.215 -1.811 . . . . 0.0 108.369 -160.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -58.66 140.07 93.34 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 O-C-N 123.127 1.067 . . . . 0.0 112.957 160.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.6 p -149.16 130.27 4.9 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 123.668 1.699 . . . . 0.0 111.667 -173.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.459 ' H ' ' HB2' ' A' ' 152' ' ' ALA . 83.8 tttt -94.39 131.5 39.99 Favored 'General case' 0 C--O 1.205 -1.28 0 CA-C-N 112.746 -2.025 . . . . 0.0 111.118 172.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.45 132.12 33.83 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-O 126.714 3.15 . . . . 0.0 111.382 170.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.412 HD11 ' HB2' ' A' ' 148' ' ' SER . 58.8 mt -100.14 -51.61 3.62 Favored 'General case' 0 C--O 1.253 1.244 0 O-C-N 117.728 -3.108 . . . . 0.0 114.866 173.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.413 ' CD ' HH21 ' A' ' 146' ' ' ARG . 41.3 mt-10 -139.05 142.64 38.2 Favored 'General case' 0 N--CA 1.41 -2.457 0 O-C-N 125.435 1.709 . . . . 0.0 107.416 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.0 t -120.46 126.25 75.04 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 163.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -91.07 156.56 17.82 Favored 'General case' 0 CA--C 1.553 1.058 0 O-C-N 125.428 1.705 . . . . 0.0 108.36 167.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -70.94 -23.49 62.25 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -92.78 26.89 2.55 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-O 123.05 1.405 . . . . 0.0 111.94 168.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.73 8.43 82.79 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 122.723 3.849 . . . . 0.0 122.723 161.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.2 mtm180 -85.09 144.9 27.94 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.265 -0.468 . . . . 0.0 110.951 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.8 mt -127.89 132.25 68.94 Favored 'Isoleucine or valine' 0 C--N 1.36 1.063 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -176.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 138' ' ' GLU . 1.3 mpp_? -103.61 133.94 47.79 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.023 162.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.8 mt -121.96 152.33 39.81 Favored 'General case' 0 CA--C 1.565 1.538 0 CA-C-N 112.269 -2.241 . . . . 0.0 108.607 -169.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.412 ' HB2' HD11 ' A' ' 137' ' ' LEU . 9.8 t -125.34 123.88 40.35 Favored 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 126.044 1.738 . . . . 0.0 110.649 175.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 69.4 mt -86.83 -31.0 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 CA-C-O 117.507 -1.235 . . . . 0.0 109.981 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -60.46 -49.93 75.58 Favored 'General case' 0 C--O 1.276 2.49 0 C-N-CA 129.359 3.064 . . . . 0.0 117.518 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -88.07 -7.11 57.48 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 118.749 -1.18 . . . . 0.0 112.14 -176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.459 ' HB2' ' H ' ' A' ' 135' ' ' LYS . . . -67.63 -37.04 81.92 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 124.153 0.981 . . . . 0.0 112.76 174.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 29.7 p -104.13 9.5 36.25 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.245 1.018 . . . . 0.0 109.209 171.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 62.01 48.49 5.14 Favored 'General case' 0 C--N 1.376 1.757 0 O-C-N 119.04 -2.287 . . . . 0.0 117.116 176.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 . . . . . 0 CA--C 1.563 1.458 0 C-N-CA 125.243 1.417 . . . . 0.0 114.387 -178.28 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 . . . . . 0 C--O 1.216 -0.697 0 CA-C-O 124.057 1.884 . . . . 0.0 108.303 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 22.1 mm -100.51 125.85 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 119.07 -2.269 . . . . 0.0 109.07 173.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.445 ' HB3' HD11 ' A' ' 69' ' ' ILE . 66.1 m80 -80.16 111.04 16.14 Favored 'General case' 0 C--N 1.37 1.46 0 O-C-N 127.17 2.793 . . . . 0.0 114.622 165.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.6 p -109.92 139.98 44.4 Favored 'General case' 0 C--O 1.251 1.161 0 C-N-CA 127.123 2.169 . . . . 0.0 106.996 -170.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.8 tt -132.3 128.57 58.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 N-CA-C 102.462 -3.162 . . . . 0.0 102.462 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -110.84 128.55 55.82 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 pt -128.92 154.25 39.62 Favored 'Isoleucine or valine' 0 C--N 1.365 1.253 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.39 -162.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -58.08 148.75 59.81 Favored Pre-proline 0 C--O 1.211 -0.945 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -65.45 -31.25 51.89 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 N-CA-C 116.232 1.589 . . . . 0.0 116.232 -173.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -64.83 -40.78 95.73 Favored 'General case' 0 CA--C 1.557 1.249 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 169.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -57.46 -28.28 63.21 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 63.6 mt -57.63 -36.89 56.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -65.86 -18.59 65.44 Favored 'General case' 0 C--O 1.245 0.851 0 C-N-CA 127.617 2.367 . . . . 0.0 115.94 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -93.02 -20.34 20.66 Favored 'General case' 0 C--O 1.206 -1.189 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.679 167.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -91.27 -22.89 6.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.231 0 O-C-N 118.243 -2.786 . . . . 0.0 114.05 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 43.3 mt -92.05 -55.33 6.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 119.419 -2.051 . . . . 0.0 109.642 166.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.25 173.5 48.53 Favored Glycine 0 C--N 1.375 2.703 0 O-C-N 127.551 3.032 . . . . 0.0 115.75 175.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -66.05 120.89 13.96 Favored 'General case' 0 CA--C 1.581 2.136 0 CA-C-O 124.239 1.971 . . . . 0.0 110.916 176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.68 9.69 46.29 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 120.28 -1.512 . . . . 0.0 112.751 -172.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 75.43 22.57 75.39 Favored Glycine 0 C--O 1.196 -2.228 0 O-C-N 120.89 -1.359 . . . . 0.0 112.257 175.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.1 t -61.09 -41.81 97.34 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 125.042 1.337 . . . . 0.0 114.502 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.1 t -72.64 -44.79 59.73 Favored 'Isoleucine or valine' 0 C--O 1.258 1.541 0 CA-C-N 120.65 1.568 . . . . 0.0 113.396 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 tt -60.79 -41.14 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 119.804 -1.81 . . . . 0.0 110.437 174.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -59.9 -49.17 78.74 Favored 'General case' 0 C--O 1.221 -0.395 0 CA-C-O 123.556 1.646 . . . . 0.0 112.843 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.56 94.15 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 124.023 1.868 . . . . 0.0 112.57 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.0 tp -56.5 -37.0 69.79 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.504 173.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 46.7 m -57.74 -60.14 4.15 Favored 'General case' 0 CA--C 1.558 1.268 0 CA-C-O 115.556 -2.164 . . . . 0.0 116.239 175.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -60.63 -40.6 92.53 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 126.815 2.572 . . . . 0.0 114.336 174.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.512 ' CD ' ' HE ' ' A' ' 71' ' ' ARG . 28.1 tt0 -60.65 -47.7 85.08 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-O 124.889 2.28 . . . . 0.0 112.223 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 81.3 p -88.24 -24.65 23.19 Favored 'General case' 0 C--O 1.21 -0.991 0 O-C-N 118.98 -2.325 . . . . 0.0 109.436 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.25 38.74 94.03 Favored Glycine 0 N--CA 1.484 1.855 0 C-N-CA 118.915 -1.612 . . . . 0.0 116.95 -166.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 70.6 p -139.85 176.89 8.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 119.94 1.87 . . . . 0.0 108.156 -172.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 89.4 m -118.11 121.44 40.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 119.811 -1.806 . . . . 0.0 107.937 -174.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.5 126.12 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 119.782 1.174 . . . . 0.0 108.818 -170.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -123.58 147.59 47.17 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 102.091 -3.3 . . . . 0.0 102.091 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.0 mt -127.75 115.6 40.07 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.831 0 CA-C-N 115.067 -0.969 . . . . 0.0 111.182 -173.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -77.1 167.55 21.59 Favored 'General case' 0 N--CA 1.525 3.307 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -76.42 -19.38 58.15 Favored 'General case' 0 C--N 1.378 1.835 0 C-N-CA 122.749 0.42 . . . . 0.0 111.018 -170.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -85.31 -12.89 51.25 Favored 'General case' 0 C--N 1.359 0.982 0 CA-C-O 118.827 -0.606 . . . . 0.0 110.297 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.51 17.29 34.14 Favored Glycine 0 N--CA 1.475 1.257 0 CA-C-O 116.496 -2.28 . . . . 0.0 116.917 -167.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 m -78.82 122.22 25.78 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 120.862 2.331 . . . . 0.0 108.815 165.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 87.3 t -94.67 126.81 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 169.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.3 mtmt -108.13 126.07 52.33 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.449 HD11 HD12 ' A' ' 72' ' ' ILE . 5.0 mt -115.67 113.83 44.52 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.933 0 CA-C-N 121.366 1.894 . . . . 0.0 113.978 178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.42 137.42 32.38 Favored 'General case' 0 CA--C 1.5 -0.975 0 O-C-N 119.661 -1.9 . . . . 0.0 108.17 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -135.66 141.6 45.03 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 113.889 -1.505 . . . . 0.0 112.817 -176.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -68.39 -36.92 79.86 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.594 1.088 . . . . 0.0 108.707 170.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -119.76 129.85 54.68 Favored 'General case' 0 CA--C 1.557 1.23 0 CA-C-O 124.401 2.048 . . . . 0.0 107.67 175.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.88 -29.93 71.77 Favored Glycine 0 N--CA 1.475 1.296 0 O-C-N 118.992 -2.317 . . . . 0.0 116.242 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -67.49 -28.54 67.93 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 120.358 2.079 . . . . 0.0 111.371 176.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -67.23 -37.99 84.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 124.456 1.098 . . . . 0.0 110.919 170.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.77 -35.26 79.67 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 120.131 -1.606 . . . . 0.0 112.509 172.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -63.82 -45.24 90.52 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 117.59 -1.195 . . . . 0.0 109.797 174.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -63.58 -38.88 92.82 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 124.938 1.399 . . . . 0.0 112.919 175.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.56 -42.49 82.53 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 174.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 16' ' ' HIS . 46.4 mt -52.72 -43.94 45.78 Favored 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 124.234 1.014 . . . . 0.0 110.474 170.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 -60.23 -46.29 90.29 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.583 2.068 . . . . 0.0 116.583 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.512 ' HE ' ' CD ' ' A' ' 42' ' ' GLU . 4.6 mmm180 -61.34 -37.22 82.51 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.101 1.319 . . . . 0.0 112.111 174.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.449 HD12 HD11 ' A' ' 57' ' ' ILE . 63.1 mt -61.54 -41.69 91.11 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.05 0 O-C-N 121.299 -0.876 . . . . 0.0 112.536 175.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -62.04 -41.97 98.68 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 164.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -67.13 -39.46 86.62 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 175.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.46 -46.69 82.26 Favored 'Isoleucine or valine' 0 C--N 1.371 1.541 0 C-N-CA 125.735 1.614 . . . . 0.0 110.227 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 77.8 p -90.55 -3.47 57.57 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 121.739 2.063 . . . . 0.0 113.073 -168.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -87.63 -39.96 14.6 Favored 'General case' 0 C--O 1.248 0.978 0 O-C-N 120.721 -1.237 . . . . 0.0 112.471 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -57.64 116.74 3.59 Favored 'General case' 0 C--N 1.356 0.871 0 CA-C-O 125.461 2.553 . . . . 0.0 113.697 -165.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 29.0 mm -57.94 141.24 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 CA-C-N 113.349 -1.751 . . . . 0.0 111.344 175.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -104.21 121.98 44.42 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 172.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 92.5 t -60.79 129.3 23.28 Favored 'Isoleucine or valine' 0 C--N 1.369 1.427 0 O-C-N 119.676 -1.89 . . . . 0.0 111.239 158.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.73 1.46 63.63 Favored Glycine 0 CA--C 1.482 -2.009 0 C-N-CA 118.676 -1.726 . . . . 0.0 111.273 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' HB3' ' HE1' ' A' ' 85' ' ' TYR . 21.6 ttm180 -92.54 146.89 23.32 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 122.449 1.119 . . . . 0.0 111.038 167.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 135' ' ' LYS . 40.3 t -100.64 135.5 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.426 ' HE1' ' HB3' ' A' ' 83' ' ' ARG . 27.9 m-85 -125.25 159.3 31.97 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.564 1.946 . . . . 0.0 108.491 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.64 113.68 27.13 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 120.738 -1.226 . . . . 0.0 108.363 169.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -124.75 169.09 16.74 Favored Glycine 0 CA--C 1.47 -2.727 0 C-N-CA 118.447 -1.835 . . . . 0.0 114.099 -174.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -121.1 153.05 37.96 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.932 1.866 . . . . 0.0 107.922 -175.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 81.4 t -63.68 130.79 28.92 Favored 'Isoleucine or valine' 0 C--N 1.365 1.252 0 C-N-CA 123.849 0.86 . . . . 0.0 110.572 177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 68.4 p -100.24 -11.98 19.92 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 116.264 1.95 . . . . 0.0 116.264 169.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.3 ptt-85 165.92 159.85 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 126.591 1.956 . . . . 0.0 107.176 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.467 HD12 HG22 ' A' ' 123' ' ' THR . 55.1 mt -121.55 146.66 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 O-C-N 120.64 -1.288 . . . . 0.0 109.915 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.8 m -141.32 178.3 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.271 0 O-C-N 117.938 -2.976 . . . . 0.0 108.612 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -65.56 -44.45 86.75 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 116.476 2.028 . . . . 0.0 116.476 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -78.52 0.2 27.03 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 115.13 -2.367 . . . . 0.0 112.263 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.4 -155.32 26.06 Favored Glycine 0 CA--C 1.553 2.421 0 O-C-N 124.826 1.329 . . . . 0.0 115.716 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.97 155.9 47.15 Favored 'General case' 0 CA--C 1.587 2.375 0 CA-C-N 121.873 2.837 . . . . 0.0 110.549 169.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -86.29 129.67 34.77 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-O 124.159 1.933 . . . . 0.0 113.257 171.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 24.6 t -127.59 122.64 59.66 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-N 112.711 -2.041 . . . . 0.0 113.881 -177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -90.01 111.82 23.04 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.468 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 29.6 pt -102.91 148.5 8.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-O 125.903 2.763 . . . . 0.0 105.221 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -51.54 138.42 28.74 Favored Glycine 0 N--CA 1.422 -2.295 0 CA-C-N 112.487 -2.142 . . . . 0.0 113.137 -173.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.64 15.41 13.54 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 119.343 1.572 . . . . 0.0 110.546 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 80.21 21.4 65.14 Favored Glycine 0 C--N 1.303 -1.266 0 CA-C-N 120.707 2.253 . . . . 0.0 117.573 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -125.34 120.22 30.53 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -89.57 133.85 34.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 124.004 1.859 . . . . 0.0 109.09 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -114.54 -177.68 18.98 Favored Glycine 0 C--N 1.308 -1.009 0 O-C-N 120.88 -1.137 . . . . 0.0 110.7 178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 59.3 tp -137.39 115.37 11.53 Favored 'General case' 0 C--O 1.249 1.049 0 CA-C-N 110.124 -3.038 . . . . 0.0 108.176 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.7 t -100.1 105.15 17.13 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 O-C-N 125.714 1.884 . . . . 0.0 108.592 172.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . 0.288 34.8 m80 -59.31 157.82 10.26 Favored 'General case' 0 C--O 1.191 -2.013 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 171.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.9 tp -62.23 -30.67 49.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -171.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.1 p -82.44 -18.76 40.66 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 127.831 2.452 . . . . 0.0 111.773 175.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -100.57 -2.62 32.42 Favored 'General case' 0 CA--C 1.556 1.188 0 O-C-N 124.889 1.368 . . . . 0.0 109.836 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 54.0 mt -73.8 -38.85 51.54 Favored 'Isoleucine or valine' 0 CA--C 1.589 2.467 0 O-C-N 119.292 -2.13 . . . . 0.0 114.101 165.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -155.77 148.01 23.6 Favored 'General case' 0 N--CA 1.483 1.202 1 O-C-N 114.243 -5.285 . . . . 0.0 107.14 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -69.39 -51.83 32.84 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 114.383 -1.28 . . . . 0.0 109.442 -173.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 40.0 mmtm -87.99 9.72 21.37 Favored 'General case' 0 N--CA 1.521 3.109 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.358 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . 0.278 10.5 mpt_? 70.51 113.73 0.05 Allowed 'General case' 0 C--O 1.193 -1.885 0 C-N-CA 126.715 2.006 . . . . 0.0 112.831 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.419 ' H ' HG22 ' A' ' 119' ' ' VAL . 14.8 m -72.84 155.73 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 123.697 1.713 . . . . 0.0 114.0 168.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.95 -48.6 81.06 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.712 1.605 . . . . 0.0 113.032 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -159.62 152.26 21.43 Favored 'General case' 0 C--N 1.361 1.1 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 168.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.62 HG12 HD12 ' A' ' 126' ' ' LEU . 20.9 t -58.25 -41.45 81.08 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.577 0 C-N-CA 124.946 1.298 . . . . 0.0 112.52 -171.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.467 HG22 HD12 ' A' ' 92' ' ' ILE . 43.5 p -68.51 -20.56 64.58 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 112.301 -2.227 . . . . 0.0 115.957 178.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -90.02 0.73 56.95 Favored 'General case' 0 CA--C 1.558 1.268 0 O-C-N 119.258 -2.151 . . . . 0.0 114.089 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -120.01 -21.15 7.21 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 169.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.62 HD12 HG12 ' A' ' 122' ' ' VAL . 95.9 mt -105.2 150.15 25.33 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 119.219 -2.176 . . . . 0.0 112.943 -175.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -135.51 145.36 46.99 Favored 'General case' 0 C--N 1.366 1.295 0 O-C-N 125.894 1.996 . . . . 0.0 108.507 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 73.9 mmm -85.62 143.85 28.2 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 125.59 1.806 . . . . 0.0 111.916 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.54 0.64 84.7 Favored Glycine 0 CA--C 1.544 1.855 0 CA-C-N 110.346 -3.115 . . . . 0.0 113.859 -170.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -101.13 143.42 31.25 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.478 -1.601 . . . . 0.0 109.805 -174.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -80.94 123.24 28.15 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 125.88 1.988 . . . . 0.0 113.5 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.61 125.52 51.23 Favored Pre-proline 0 C--N 1.367 1.358 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 170.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -62.72 123.15 11.82 Favored 'Trans proline' 0 C--N 1.29 -2.54 0 O-C-N 117.439 -1.927 . . . . 0.0 112.063 164.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -136.49 130.16 46.69 Favored 'Isoleucine or valine' 0 C--N 1.373 1.614 0 O-C-N 119.294 -2.129 . . . . 0.0 109.582 -173.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.443 ' HB2' HG22 ' A' ' 84' ' ' VAL . 33.3 ttpt -95.16 144.27 25.91 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 117.215 -1.794 . . . . 0.0 110.935 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.7 t -83.97 130.95 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.588 2.417 0 C-N-CA 117.158 -1.817 . . . . 0.0 114.894 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 68.0 mt -101.68 -44.33 5.59 Favored 'General case' 0 C--N 1.37 1.491 0 C-N-CA 126.033 1.733 . . . . 0.0 114.066 -177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -154.11 138.6 16.81 Favored 'General case' 0 C--O 1.202 -1.427 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -174.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 86.3 t -92.72 137.8 21.49 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 CA-C-O 122.725 1.25 . . . . 0.0 108.959 167.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -128.27 142.25 51.21 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -103.04 -5.7 23.08 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.032 -171.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 62.3 mm-40 -122.14 -40.26 2.52 Favored 'General case' 0 CA--C 1.563 1.46 0 O-C-N 124.853 1.345 . . . . 0.0 112.872 169.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.26 -174.02 34.03 Favored Glycine 0 C--N 1.37 2.42 0 C-N-CA 128.677 3.037 . . . . 0.0 109.139 178.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 48.1 mmt-85 -88.72 158.77 18.08 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 112.638 -1.781 . . . . 0.0 108.122 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.7 mm -66.17 138.06 23.72 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 O-C-N 120.856 -1.152 . . . . 0.0 111.501 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.6 mmt-85 -94.13 131.93 39.16 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 117.045 -1.862 . . . . 0.0 107.001 -170.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 18.7 mt -139.99 152.63 46.44 Favored 'General case' 0 C--N 1.381 1.963 0 N-CA-C 117.246 2.313 . . . . 0.0 117.246 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 30.4 t -121.7 120.74 35.57 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 124.412 1.085 . . . . 0.0 108.307 -176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 48.9 mt -80.2 -34.68 15.09 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 O-C-N 119.639 -1.913 . . . . 0.0 107.075 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -70.78 -20.68 62.58 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 -172.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -92.14 4.65 52.73 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.142 -175.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -132.17 -41.03 1.01 Allowed 'General case' 0 N--CA 1.423 -1.775 0 C-N-CA 125.02 1.328 . . . . 0.0 108.376 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.2 t -71.07 136.6 48.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 119.713 -1.867 . . . . 0.0 108.506 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.284 44.3 mt-10 77.7 4.71 2.98 Favored 'General case' 0 C--O 1.248 0.983 0 O-C-N 125.238 1.586 . . . . 0.0 113.246 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 . . . . . 0 C--O 1.253 1.254 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -175.581 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 117.138 2.273 . . . . 0.0 117.138 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.0 mt -103.99 116.73 48.31 Favored 'Isoleucine or valine' 0 C--N 1.383 2.061 0 CA-C-O 122.97 1.366 . . . . 0.0 113.868 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -102.8 149.31 24.61 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 111.217 -2.72 . . . . 0.0 107.761 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.8 p -128.65 145.38 51.17 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 19.1 tt -127.51 142.4 43.7 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.614 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 tptp -110.99 114.58 27.99 Favored 'General case' 0 N--CA 1.514 2.726 0 O-C-N 120.307 -1.496 . . . . 0.0 108.627 -167.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 21' ' ' ASN . 4.5 tp -142.25 151.8 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 O-C-N 120.854 -1.154 . . . . 0.0 111.54 -157.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.56 ' H ' HD12 ' A' ' 20' ' ' ILE . 92.9 m-20 -83.25 148.68 56.64 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-O 114.657 -2.592 . . . . 0.0 108.809 -175.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . 0.275 50.5 Cg_exo -53.44 -48.21 23.16 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 N-CA-C 118.468 2.449 . . . . 0.0 118.468 -169.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.65 -10.34 45.13 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 122.162 2.256 . . . . 0.0 115.472 -171.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -105.79 -1.11 24.71 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 114.868 1.433 . . . . 0.0 114.868 169.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.439 HG12 HG23 ' A' ' 20' ' ' ILE . 37.8 mt -69.18 -43.12 81.76 Favored 'Isoleucine or valine' 0 C--O 1.263 1.812 0 C-N-CA 118.45 -1.3 . . . . 0.0 111.234 162.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -57.53 -42.02 82.07 Favored 'General case' 0 CA--C 1.504 -0.798 0 CA-C-O 115.932 -1.985 . . . . 0.0 113.809 -172.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -50.89 -32.63 21.11 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 128.809 3.818 . . . . 0.0 113.368 170.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 41.8 t -71.49 -44.31 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 123.928 0.767 . . . . 0.0 111.466 174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.4 mt -69.57 -6.75 6.88 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.351 0 O-C-N 120.892 -1.13 . . . . 0.0 110.663 171.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -15.84 132.16 0.01 OUTLIER Glycine 0 CA--C 1.537 1.414 1 N-CA-C 127.468 5.747 . . . . 0.0 127.468 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.3 mttm 59.14 44.77 15.42 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 124.113 1.911 . . . . 0.0 113.411 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.99 30.32 65.74 Favored Glycine 0 CA--C 1.554 2.472 0 O-C-N 117.96 -2.962 . . . . 0.0 112.397 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 88.7 -2.15 84.26 Favored Glycine 0 C--N 1.387 3.387 0 C-N-CA 128.414 2.912 . . . . 0.0 112.941 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.3 t -58.17 -38.51 76.8 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 121.339 -1.094 . . . . 0.0 111.404 -176.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.8 t -66.7 -47.83 81.9 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.653 0 CA-C-O 116.692 -1.623 . . . . 0.0 110.313 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.3 mt -55.4 -51.68 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 C-N-CA 116.741 -1.984 . . . . 0.0 111.719 -177.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -58.82 -43.23 90.57 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 118.174 -0.917 . . . . 0.0 112.18 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.64 88.36 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 120.037 1.29 . . . . 0.0 114.151 176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 26.9 tp -63.46 -44.27 94.96 Favored 'General case' 0 C--O 1.209 -1.06 0 O-C-N 125.238 1.586 . . . . 0.0 109.082 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.1 p -62.25 -43.3 99.14 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 177.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.16 -42.13 99.37 Favored 'General case' 0 N--CA 1.514 2.743 0 CA-C-N 121.581 1.992 . . . . 0.0 113.431 166.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . 0.281 32.2 tt0 -72.19 -48.15 45.33 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.532 0.682 . . . . 0.0 111.321 -170.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 70.0 p -78.55 -22.05 47.8 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 114.474 -2.679 . . . . 0.0 115.531 176.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 80.16 31.54 38.24 Favored Glycine 0 C--N 1.362 1.986 0 CA-C-N 121.199 1.818 . . . . 0.0 111.466 175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.526 HG21 ' HB2' ' A' ' 68' ' ' ALA . 17.6 p -132.57 171.04 14.33 Favored 'General case' 0 C--O 1.213 -0.867 0 C-N-CA 126.529 1.932 . . . . 0.0 111.291 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.7 m -127.94 135.91 50.61 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 101.023 -3.695 . . . . 0.0 101.023 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 72.2 mt -118.96 135.05 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.636 0 CA-C-N 120.379 1.445 . . . . 0.0 112.938 -171.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -129.7 133.57 47.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 118.89 -2.382 . . . . 0.0 109.779 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.67 131.58 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.106 175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -134.38 155.84 49.57 Favored 'General case' 0 C--N 1.363 1.177 0 O-C-N 119.416 -2.052 . . . . 0.0 110.221 175.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -40.14 151.77 0.04 OUTLIER 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 117.397 2.369 . . . . 0.0 117.397 172.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 t0 65.63 19.42 11.45 Favored 'General case' 0 CA--C 1.569 1.685 0 O-C-N 127.251 2.844 . . . . 0.0 117.349 -172.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.4 46.77 11.6 Favored Glycine 0 N--CA 1.444 -0.77 0 O-C-N 117.33 -3.356 . . . . 0.0 107.857 -174.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.7 m -104.47 111.38 24.02 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 117.614 -1.634 . . . . 0.0 106.912 173.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -96.24 118.73 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.144 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 176.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -108.4 126.46 52.9 Favored 'General case' 0 C--N 1.378 1.819 0 CA-C-O 122.87 1.319 . . . . 0.0 111.643 -167.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.424 HG21 ' HB3' ' A' ' 68' ' ' ALA . 32.7 mm -107.35 104.94 17.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.68 0 CA-C-N 112.824 -1.989 . . . . 0.0 110.208 -175.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.18 135.04 38.53 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.517 ' HB2' HG22 ' A' ' 45' ' ' THR . . . -149.61 158.58 44.3 Favored 'General case' 0 CA--C 1.486 -1.502 0 O-C-N 118.752 -2.468 . . . . 0.0 109.598 163.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.6 m -65.29 -37.14 86.24 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 115.218 -2.325 . . . . 0.0 114.748 176.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -102.52 153.95 19.58 Favored 'General case' 0 C--N 1.28 -2.451 1 O-C-N 129.922 4.514 . . . . 0.0 109.986 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -65.84 -48.96 61.96 Favored Glycine 0 C--N 1.374 2.676 0 C-N-CA 124.838 1.209 . . . . 0.0 112.603 171.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -61.57 -42.04 98.26 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 122.384 1.088 . . . . 0.0 112.078 -175.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -57.44 -44.35 84.67 Favored 'General case' 0 C--N 1.282 -2.355 0 CA-C-N 110.783 -2.917 . . . . 0.0 115.888 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.75 95.63 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 173.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -68.66 -33.71 74.47 Favored 'General case' 0 CA--C 1.585 2.291 0 CA-C-O 123.787 1.756 . . . . 0.0 114.05 -177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -66.61 -44.16 82.84 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 127.29 2.236 . . . . 0.0 112.452 167.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' HG21 ' A' ' 45' ' ' THR . . . -62.18 -45.55 92.88 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 119.272 -0.971 . . . . 0.0 112.519 169.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 19.5 mm -50.43 -42.5 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.0 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 167.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -73.53 -40.44 64.0 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-O 118.278 -0.867 . . . . 0.0 112.238 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -58.38 -44.13 88.76 Favored 'General case' 0 CA--C 1.579 2.094 0 CA-C-O 123.466 1.603 . . . . 0.0 114.393 172.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.7 mm -60.45 -48.51 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.083 0 C-N-CA 127.066 2.147 . . . . 0.0 114.679 168.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -57.16 -44.11 83.17 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 119.636 -1.915 . . . . 0.0 107.592 170.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -64.9 -39.52 93.66 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 121.056 1.753 . . . . 0.0 112.396 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.3 mt -62.4 -52.11 64.08 Favored 'Isoleucine or valine' 0 C--N 1.373 1.615 0 CA-C-O 117.014 -1.47 . . . . 0.0 112.999 168.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.9 p -66.85 -23.75 66.06 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 123.367 1.556 . . . . 0.0 113.358 -170.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.15 -39.4 82.34 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 112.983 -1.917 . . . . 0.0 114.354 175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -58.88 143.16 48.54 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 116.091 1.886 . . . . 0.0 116.091 -167.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 mm -83.91 113.97 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 CA-C-N 109.67 -3.423 . . . . 0.0 110.412 176.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -107.1 146.28 31.44 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.371 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.4 t -80.89 150.5 4.67 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.397 0 CA-C-O 124.188 1.946 . . . . 0.0 109.811 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.61 14.81 82.05 Favored Glycine 0 C--N 1.277 -2.702 0 CA-C-N 112.57 -2.104 . . . . 0.0 116.794 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 22.9 mmt85 -105.88 143.27 34.26 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 119.968 -1.901 . . . . 0.0 106.247 179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 36.8 t -90.09 144.04 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.385 0 C-N-CA 119.081 -1.048 . . . . 0.0 110.196 171.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -132.85 166.68 21.74 Favored 'General case' 0 C--N 1.404 2.97 0 O-C-N 125.915 2.009 . . . . 0.0 109.24 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 m -116.89 132.68 56.64 Favored 'General case' 0 CA--C 1.481 -1.678 0 N-CA-C 104.028 -2.582 . . . . 0.0 104.028 173.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -140.2 177.35 20.72 Favored Glycine 0 N--CA 1.419 -2.441 0 O-C-N 124.769 1.293 . . . . 0.0 111.725 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mtmm -118.46 136.29 53.88 Favored 'General case' 0 N--CA 1.51 2.538 0 CA-C-O 123.79 1.757 . . . . 0.0 113.314 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 69.1 t -69.93 137.21 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 N-CA-C 103.965 -2.606 . . . . 0.0 103.965 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.8 t -131.71 -18.34 2.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.871 1.357 . . . . 0.0 110.261 177.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 48.4 mtm-85 -142.18 150.86 41.59 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 172.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.2 mt -137.56 136.98 46.03 Favored 'Isoleucine or valine' 0 C--N 1.395 2.573 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.18 169.29 12.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 113.631 -1.622 . . . . 0.0 106.879 -162.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -54.13 -37.17 64.06 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 178.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -100.29 13.73 33.35 Favored 'General case' 0 N--CA 1.53 3.563 0 O-C-N 118.491 -2.63 . . . . 0.0 108.418 -178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 151.09 -159.34 28.13 Favored Glycine 0 C--O 1.183 -3.068 0 CA-C-N 123.445 2.839 . . . . 0.0 115.6 -177.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -133.36 135.93 45.04 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -90.78 131.48 36.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.659 -1.275 . . . . 0.0 110.004 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.2 t -112.36 137.92 43.37 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.487 0 CA-C-N 113.042 -1.89 . . . . 0.0 112.662 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.3 147.69 24.93 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 127.214 2.821 . . . . 0.0 105.592 172.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.7 pt -142.63 159.13 18.98 Favored 'Isoleucine or valine' 0 C--N 1.372 1.566 0 C-N-CA 125.715 1.606 . . . . 0.0 108.228 174.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -43.06 142.07 1.93 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 120.278 2.871 . . . . 0.0 120.278 -173.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.94 13.75 45.27 Favored Glycine 0 CA--C 1.545 1.911 0 O-C-N 120.095 -1.826 . . . . 0.0 114.535 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.89 21.47 78.45 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 125.205 1.383 . . . . 0.0 110.943 -175.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -89.84 136.76 32.85 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.824 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -131.07 134.86 47.02 Favored 'General case' 0 C--N 1.361 1.1 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -135.31 161.68 24.7 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 125.304 1.43 . . . . 0.0 114.933 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.9 tp -95.4 125.26 39.9 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 114.817 -0.692 . . . . 0.0 111.657 -173.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.4 t -95.1 111.23 25.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 CA-C-O 115.674 -2.108 . . . . 0.0 105.663 164.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -60.73 153.8 23.25 Favored 'General case' 0 C--O 1.171 -3.049 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 171.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.479 HG13 HG22 ' A' ' 122' ' ' VAL . 20.6 tt -52.36 -31.6 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 119.737 -1.852 . . . . 0.0 114.536 175.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 72.0 p -83.38 -15.79 48.46 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -93.51 19.03 8.93 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.582 HD11 HG13 ' A' ' 122' ' ' VAL . 17.8 mt -92.14 -47.2 14.13 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 CA-C-O 119.491 -0.29 . . . . 0.0 111.582 -173.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -147.5 162.63 38.67 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.081 0.952 . . . . 0.0 112.178 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -65.56 -37.78 87.67 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 125.032 2.349 . . . . 0.0 110.52 -177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 49.3 mttp -55.99 153.02 9.38 Favored 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 112.373 -2.194 . . . . 0.0 111.536 175.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 80.8 mmt-85 -68.58 142.07 55.29 Favored 'General case' 0 CA--C 1.566 1.587 0 O-C-N 119.961 -1.712 . . . . 0.0 111.108 173.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.449 HG11 HD12 ' A' ' 114' ' ' ILE . 42.9 t -133.23 143.25 39.76 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.435 -175.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -112.95 -38.13 4.61 Favored 'General case' 0 C--N 1.37 1.493 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -173.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -143.44 146.71 33.67 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 169.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.582 HG13 HD11 ' A' ' 114' ' ' ILE . 24.7 t -74.14 -16.45 16.78 Favored 'Isoleucine or valine' 0 C--N 1.366 1.292 0 CA-C-O 122.856 1.312 . . . . 0.0 111.191 -164.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.3 p -85.44 -4.17 59.08 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -60.7 -40.61 92.87 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.924 1.29 . . . . 0.0 109.56 167.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -108.67 -24.87 11.14 Favored 'General case' 0 CA--C 1.557 1.22 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.9 mt -118.04 126.53 52.46 Favored 'General case' 0 N--CA 1.517 2.912 0 O-C-N 117.821 -3.049 . . . . 0.0 113.696 -167.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . 0.43 ' HA ' HE21 ' A' ' 127' ' ' GLN . 0.3 OUTLIER -117.59 166.85 11.9 Favored 'General case' 0 C--O 1.199 -1.556 0 C-N-CA 117.042 -1.863 . . . . 0.0 109.507 166.134 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -62.13 145.07 54.38 Favored 'General case' 0 CA--C 1.562 1.412 0 CA-C-O 126.102 2.858 . . . . 0.0 114.969 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 74.55 -6.04 26.27 Favored Glycine 0 C--O 1.21 -1.404 0 CA-C-O 115.758 -2.69 . . . . 0.0 110.906 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -68.42 137.85 54.84 Favored 'General case' 0 C--N 1.361 1.079 0 CA-C-N 120.513 2.156 . . . . 0.0 115.747 175.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -88.03 104.48 16.69 Favored 'General case' 0 C--O 1.259 1.555 0 CA-C-O 123.854 1.788 . . . . 0.0 111.608 -164.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 5.0 m -108.57 117.95 53.11 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 114.018 -1.446 . . . . 0.0 110.048 -173.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -58.04 130.46 38.23 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 121.055 1.17 . . . . 0.0 112.285 158.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.37 145.67 34.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -111.69 138.3 48.45 Favored 'General case' 0 N--CA 1.433 -1.277 0 O-C-N 119.564 -1.96 . . . . 0.0 109.338 171.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.3 t -71.34 139.77 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 117.343 -3.348 . . . . 0.0 112.504 178.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.8 mt -106.62 -36.69 6.67 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-O 115.277 -2.297 . . . . 0.0 109.803 173.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -157.81 164.23 37.22 Favored 'General case' 0 CA--C 1.473 -1.996 0 O-C-N 126.41 2.318 . . . . 0.0 107.116 -166.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . 0.313 7.2 p -168.16 97.12 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-O 125.205 2.431 . . . . 0.0 110.154 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -71.65 165.91 22.99 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 119.882 -1.761 . . . . 0.0 112.273 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -61.03 -25.56 67.0 Favored 'General case' 0 C--N 1.37 1.466 0 O-C-N 125.331 1.644 . . . . 0.0 115.094 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.2 mp0 -94.31 3.4 55.26 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.437 1.711 . . . . 0.0 110.723 -169.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 98.96 3.46 56.94 Favored Glycine 0 CA--C 1.552 2.38 0 O-C-N 119.432 -2.043 . . . . 0.0 113.9 -179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.1 mtm180 -84.2 118.4 24.12 Favored 'General case' 0 CA--C 1.569 1.681 0 C-N-CA 124.813 1.245 . . . . 0.0 108.404 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 51.8 mt -125.32 131.39 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 120.268 -1.52 . . . . 0.0 108.965 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -109.16 146.47 34.07 Favored 'General case' 0 N--CA 1.506 2.368 0 CA-C-N 120.635 1.561 . . . . 0.0 107.121 173.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.8 mt -129.64 157.19 42.8 Favored 'General case' 0 C--O 1.269 2.124 0 C-N-CA 126.194 1.798 . . . . 0.0 113.436 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 38.9 t -132.01 111.71 11.74 Favored 'General case' 0 C--N 1.387 2.232 0 O-C-N 126.99 2.681 . . . . 0.0 110.226 166.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 50.8 mt -63.17 -41.63 93.53 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 158.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -66.38 -31.57 72.43 Favored 'General case' 0 C--N 1.379 1.863 0 CA-C-N 121.97 2.168 . . . . 0.0 111.831 -170.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -64.94 -49.0 72.08 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 124.694 1.198 . . . . 0.0 112.307 168.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -57.33 -42.17 81.4 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 126.148 2.155 . . . . 0.0 109.822 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . 0.259 27.5 p -89.3 -1.34 58.03 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.016 0.913 . . . . 0.0 113.211 -176.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 63.12 55.93 1.84 Allowed 'General case' 0 C--O 1.256 1.437 0 C-N-CA 129.275 3.03 . . . . 0.0 113.778 168.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 . . . . . 0 C--O 1.257 1.474 0 CA-C-N 113.216 -1.811 . . . . 0.0 111.16 -176.384 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 . . . . . 0 CA--C 1.569 1.707 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 64.0 mt -116.32 127.95 73.78 Favored 'Isoleucine or valine' 0 C--N 1.376 1.759 0 CA-C-N 119.04 0.836 . . . . 0.0 109.549 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.445 ' CD2' ' HB1' ' A' ' 65' ' ' ALA . 26.3 m-70 -129.28 135.58 48.95 Favored 'General case' 0 CA--C 1.492 -1.275 0 O-C-N 125.134 1.521 . . . . 0.0 109.127 -177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 p -116.17 153.92 30.96 Favored 'General case' 0 C--N 1.377 1.78 0 C-N-CA 118.646 -1.222 . . . . 0.0 113.824 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.3 148.48 31.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 166.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 tptp -116.87 130.33 56.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -174.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.5 tp -150.04 170.5 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 CA-C-N 121.762 2.074 . . . . 0.0 113.838 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -64.13 125.67 88.61 Favored Pre-proline 0 CA--C 1.561 1.4 0 O-C-N 119.156 -2.215 . . . . 0.0 110.308 -172.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.92 -20.04 22.67 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 123.465 2.777 . . . . 0.0 116.865 -165.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.9 -45.14 86.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 127.413 2.946 . . . . 0.0 111.265 167.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -79.89 -4.39 52.1 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.581 1.181 . . . . 0.0 110.553 -175.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.413 ' HA ' ' HB ' ' A' ' 28' ' ' VAL . 17.2 mm -84.33 -22.37 8.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.7 mtpp -77.94 -28.69 49.65 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 122.702 2.501 . . . . 0.0 107.99 173.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -57.85 -41.24 81.97 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 114.35 -1.295 . . . . 0.0 112.66 162.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.413 ' HB ' ' HA ' ' A' ' 25' ' ' ILE 0.275 47.1 t -67.71 -38.75 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.594 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 175.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 45.2 mt -73.06 -45.86 53.01 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 CA-C-O 118.187 -0.911 . . . . 0.0 109.064 176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.57 174.2 24.44 Favored Glycine 0 CA--C 1.556 2.612 0 O-C-N 126.096 2.122 . . . . 0.0 110.144 -171.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -77.79 122.5 25.5 Favored 'General case' 0 CA--C 1.556 1.207 0 O-C-N 118.953 -2.499 . . . . 0.0 107.68 -165.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.94 19.36 75.25 Favored Glycine 0 N--CA 1.498 2.804 0 O-C-N 120.125 -1.609 . . . . 0.0 110.529 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.8 16.91 66.83 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 117.348 1.699 . . . . 0.0 117.348 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.9 t -60.25 -42.95 96.38 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -173.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.9 t -80.78 -32.18 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 CA-C-N 121.031 1.741 . . . . 0.0 108.998 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 tt -75.86 -31.09 21.82 Favored 'Isoleucine or valine' 0 C--N 1.374 1.65 0 CA-C-N 120.713 1.597 . . . . 0.0 110.741 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -59.68 -45.89 90.71 Favored 'General case' 0 CA--C 1.562 1.414 0 O-C-N 120.191 -1.568 . . . . 0.0 114.456 164.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.72 88.34 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 170.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 38.9 tp -61.06 -34.93 75.68 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 113.063 -1.881 . . . . 0.0 114.559 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.6 p -66.45 -42.97 86.84 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 122.641 2.473 . . . . 0.0 114.372 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -62.26 -46.38 89.07 Favored 'General case' 0 N--CA 1.507 2.393 0 O-C-N 127.411 2.944 . . . . 0.0 113.903 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -53.68 -46.2 70.59 Favored 'General case' 0 CA--C 1.483 -1.616 0 CA-C-O 117.207 -1.378 . . . . 0.0 114.27 174.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 14.7 p -88.62 -23.39 23.09 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 125.55 1.781 . . . . 0.0 114.607 -171.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 79.36 27.71 54.49 Favored Glycine 0 CA--C 1.559 2.835 0 C-N-CA 125.41 1.481 . . . . 0.0 110.258 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.5 p -134.8 166.34 23.21 Favored 'General case' 0 C--N 1.373 1.626 0 CA-C-O 124.721 2.2 . . . . 0.0 108.955 -174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.5 m -102.01 126.13 48.86 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 111.613 -2.54 . . . . 0.0 106.565 170.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.4 mt -118.15 142.72 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.121 0 N-CA-C 102.137 -3.283 . . . . 0.0 102.137 -171.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -145.08 139.62 27.5 Favored 'General case' 0 N--CA 1.399 -2.998 0 CA-C-O 123.572 1.653 . . . . 0.0 108.193 -179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 18.0 mm -101.36 139.2 23.18 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.276 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.175 -169.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -138.36 163.02 32.93 Favored 'General case' 0 N--CA 1.484 1.273 0 O-C-N 119.21 -2.181 . . . . 0.0 109.499 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . 0.307 27.1 m-20 -55.44 142.09 34.05 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 112.897 -1.956 . . . . 0.0 114.954 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.277 31.9 t0 90.56 31.75 0.02 OUTLIER 'General case' 0 C--N 1.375 1.712 0 CA-C-N 110.322 -3.126 . . . . 0.0 111.177 172.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.95 46.66 90.92 Favored Glycine 0 N--CA 1.479 1.51 0 C-N-CA 125.754 1.645 . . . . 0.0 111.39 -169.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 41.1 m -103.37 121.32 42.54 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 119.777 1.788 . . . . 0.0 110.597 -171.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.28 122.05 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.703 0 CA-C-O 123.261 1.505 . . . . 0.0 106.998 177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . 0.31 59.7 mtpt -106.95 139.38 41.44 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 103.992 -2.596 . . . . 0.0 103.992 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.266 44.1 mm -125.52 119.94 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.709 -1.244 . . . . 0.0 108.855 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -102.24 136.13 42.61 Favored 'General case' 0 CA--C 1.588 2.417 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -164.81 157.49 16.45 Favored 'General case' 0 C--N 1.398 2.695 0 C-N-CA 125.395 1.478 . . . . 0.0 110.794 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.9 m -92.31 -17.9 24.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 O-C-N 125.626 1.829 . . . . 0.0 112.793 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -123.36 141.41 52.01 Favored 'General case' 0 CA--C 1.505 -0.768 0 O-C-N 120.131 -1.606 . . . . 0.0 110.307 -168.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.41 -48.58 81.17 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 112.637 -2.074 . . . . 0.0 114.012 -178.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.4 -37.23 86.78 Favored 'General case' 0 CA--C 1.589 2.445 0 O-C-N 119.901 -1.94 . . . . 0.0 115.363 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -64.52 -41.64 96.26 Favored 'General case' 0 C--N 1.344 0.333 0 O-C-N 120.522 -1.361 . . . . 0.0 109.174 171.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.445 ' HB1' ' CD2' ' A' ' 16' ' ' HIS . . . -64.24 -35.89 82.3 Favored 'General case' 0 C--N 1.359 1.003 0 CA-C-O 117.574 -1.203 . . . . 0.0 112.955 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -73.98 -33.9 64.01 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -64.95 -45.29 86.34 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 126.398 2.311 . . . . 0.0 114.101 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.91 -45.61 86.22 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 112.974 -1.921 . . . . 0.0 110.629 173.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.9 mm -61.67 -51.21 75.44 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.531 0 CA-C-O 116.648 -1.644 . . . . 0.0 112.606 172.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -61.76 -34.96 76.79 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 116.047 -1.93 . . . . 0.0 112.609 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -65.81 -39.44 90.88 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 124.538 1.149 . . . . 0.0 111.486 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.97 -48.52 88.18 Favored 'Isoleucine or valine' 0 C--N 1.368 1.396 0 CA-C-N 120.482 1.492 . . . . 0.0 108.616 175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -45.37 -57.43 4.05 Favored 'General case' 0 C--N 1.377 1.767 0 C-N-CA 126.547 1.939 . . . . 0.0 114.07 172.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -58.94 -48.06 82.83 Favored 'General case' 0 N--CA 1.513 2.711 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 173.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 69.9 mt -66.42 -35.03 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.7 p -80.89 -7.96 59.61 Favored 'General case' 0 N--CA 1.505 2.323 0 C-N-CA 124.79 1.236 . . . . 0.0 111.955 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -101.6 -16.05 16.86 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.067 -0.395 . . . . 0.0 111.817 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -65.13 139.01 58.65 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 118.988 -1.085 . . . . 0.0 111.954 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.08 120.09 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 113.745 -1.57 . . . . 0.0 110.395 -174.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -101.83 146.74 27.39 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-O 123.054 1.407 . . . . 0.0 112.801 171.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.8 t -67.05 143.24 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 113.424 -1.716 . . . . 0.0 109.829 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.93 26.01 56.74 Favored Glycine 1 N--CA 1.526 4.685 1 O-C-N 115.749 -4.344 . . . . 0.0 116.344 175.524 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -119.1 150.14 40.52 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.61 -1.295 . . . . 0.0 112.536 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.49 126.9 54.0 Favored 'Isoleucine or valine' 0 C--O 1.255 1.367 0 CA-C-O 124.911 2.291 . . . . 0.0 113.102 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -126.95 160.92 29.6 Favored 'General case' 0 C--O 1.213 -0.844 0 CA-C-N 109.908 -3.314 . . . . 0.0 104.989 -176.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.9 m -119.6 139.92 51.4 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 102.654 -3.091 . . . . 0.0 102.654 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -145.06 -173.58 16.47 Favored Glycine 0 CA--C 1.576 3.844 0 CA-C-O 123.241 1.467 . . . . 0.0 112.416 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -128.91 138.48 52.03 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 123.109 1.433 . . . . 0.0 111.332 177.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.8 t -79.28 138.11 20.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 CA-C-N 113.284 -1.78 . . . . 0.0 106.799 -177.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -124.81 -28.97 3.45 Favored 'General case' 0 CA--C 1.478 -1.824 0 CA-C-O 114.951 -2.452 . . . . 0.0 106.842 -173.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.5 mtm-85 -143.91 146.47 33.0 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 122.42 2.373 . . . . 0.0 108.589 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 70.7 mt -113.28 138.98 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 CA-C-O 115.579 -2.153 . . . . 0.0 113.745 168.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 m -128.78 173.6 13.43 Favored 'Isoleucine or valine' 0 C--N 1.401 2.812 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -66.4 -18.21 65.23 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 118.276 2.695 . . . . 0.0 118.276 -178.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.257 24.6 p90 -103.16 0.8 32.29 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.498 0.719 . . . . 0.0 111.751 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 152.37 -172.52 31.57 Favored Glycine 0 C--N 1.357 1.72 0 C-N-CA 117.893 -2.098 . . . . 0.0 112.752 -162.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.55 132.81 35.69 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . 0.281 93.5 m-85 -79.99 133.25 36.15 Favored 'General case' 0 C--N 1.371 1.532 0 O-C-N 126.893 2.621 . . . . 0.0 109.579 178.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.453 HG12 HG13 ' A' ' 101' ' ' ILE . 41.8 t -125.9 130.82 72.33 Favored 'Isoleucine or valine' 0 C--O 1.251 1.181 0 CA-C-N 112.577 -2.102 . . . . 0.0 105.337 -171.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . 0.261 . . -96.05 124.56 40.11 Favored 'General case' 0 CA--C 1.578 2.029 0 CA-C-N 113.54 -1.664 . . . . 0.0 107.227 171.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.453 HG13 HG12 ' A' ' 99' ' ' VAL . 77.6 mt -112.37 144.73 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 126.334 1.854 . . . . 0.0 106.484 -176.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -52.66 135.11 38.48 Favored Glycine 0 C--O 1.213 -1.194 0 CA-C-O 124.623 2.235 . . . . 0.0 116.125 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 99.16 4.73 56.41 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.357 1.932 . . . . 0.0 113.211 -175.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.83 31.27 5.48 Favored Glycine 0 CA--C 1.473 -2.579 0 CA-C-O 117.054 -1.97 . . . . 0.0 112.795 171.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . 0.294 51.4 mmtt -120.52 118.25 29.75 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -165.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -105.04 135.69 45.91 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 125.002 2.334 . . . . 0.0 109.754 -170.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -139.77 166.68 25.56 Favored Glycine 0 C--O 1.215 -1.086 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.699 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . 0.276 14.6 tp -113.03 135.43 53.8 Favored 'General case' 0 N--CA 1.424 -1.725 0 C-N-CA 124.374 1.07 . . . . 0.0 108.217 175.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 53.0 t -102.99 115.98 45.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 104.64 -2.356 . . . . 0.0 104.64 162.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 46.8 m-70 -67.66 165.69 16.62 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-O 124.582 2.134 . . . . 0.0 113.984 173.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . 0.258 11.4 tt -61.29 -32.15 52.27 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.337 0 CA-C-N 111.911 -2.404 . . . . 0.0 116.703 -176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 62.3 p -84.42 -5.66 59.3 Favored 'General case' 0 C--O 1.268 2.067 0 O-C-N 124.365 1.041 . . . . 0.0 112.427 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -106.97 14.74 26.12 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 116.62 2.082 . . . . 0.0 116.62 -168.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.0 mt -85.63 -48.51 16.1 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-O 116.179 -1.867 . . . . 0.0 114.07 175.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -140.2 165.18 28.09 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 126.587 2.43 . . . . 0.0 110.053 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.15 -33.64 76.24 Favored 'General case' 0 C--O 1.251 1.168 0 CA-C-N 114.531 -1.213 . . . . 0.0 114.132 166.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -74.45 148.63 40.9 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 123.242 1.496 . . . . 0.0 113.945 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -70.42 145.2 51.19 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.428 -1.714 . . . . 0.0 111.773 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 37.7 t -112.62 133.86 57.03 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.215 0 CA-C-O 124.169 1.938 . . . . 0.0 110.884 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -92.72 -42.17 9.74 Favored 'General case' 0 C--N 1.38 1.906 0 O-C-N 118.574 -2.579 . . . . 0.0 108.871 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.4 tptt -134.77 145.87 48.82 Favored 'General case' 0 N--CA 1.526 3.342 0 O-C-N 124.473 1.108 . . . . 0.0 110.043 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.23 -29.82 47.19 Favored 'Isoleucine or valine' 0 C--O 1.254 1.292 0 CA-C-O 122.776 1.274 . . . . 0.0 113.916 -173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -86.84 20.54 2.56 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -86.34 -15.33 40.86 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 121.109 1.777 . . . . 0.0 111.561 161.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -125.62 -79.48 0.6 Allowed 'General case' 0 C--O 1.208 -1.088 0 C-N-CA 126.701 2.0 . . . . 0.0 110.731 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.1 mt -70.57 152.37 44.02 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 121.692 2.042 . . . . 0.0 111.752 -172.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -132.23 152.29 51.4 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 118.777 -2.452 . . . . 0.0 106.31 165.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 40.1 mtm -63.19 131.76 49.5 Favored 'General case' 0 N--CA 1.51 2.533 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.572 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.45 0.58 50.17 Favored Glycine 0 C--N 1.363 2.06 0 O-C-N 125.011 1.444 . . . . 0.0 114.211 -171.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -84.04 149.3 26.34 Favored 'General case' 0 C--O 1.2 -1.5 0 CA-C-O 123.729 1.728 . . . . 0.0 112.765 174.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -101.14 126.07 47.81 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.646 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 132' ' ' VAL . 14.2 m -137.11 121.02 12.06 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 113.665 -1.607 . . . . 0.0 110.322 -168.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -73.2 140.46 30.9 Favored 'Trans proline' 0 CA--C 1.492 -1.578 0 N-CA-C 107.512 -1.765 . . . . 0.0 107.512 166.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.16 126.11 29.98 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.154 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -163.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.2 tttt -91.18 135.81 33.53 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 102.243 -3.243 . . . . 0.0 102.243 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 71.2 t -79.67 136.44 23.56 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.475 0 O-C-N 121.125 -0.984 . . . . 0.0 110.947 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 28.8 mt -113.81 -33.81 5.67 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.604 0.716 . . . . 0.0 111.251 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.435 ' CD ' HH21 ' A' ' 146' ' ' ARG 0.297 28.5 mt-10 -145.55 154.99 42.78 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 172.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.8 p -147.64 118.81 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.377 1.795 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -70.02 170.18 11.88 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 125.71 2.671 . . . . 0.0 114.058 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -66.23 -30.33 70.75 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 111.93 -2.395 . . . . 0.0 110.028 169.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -93.4 14.11 19.53 Favored 'General case' 0 C--N 1.364 1.221 0 CA-C-O 117.37 -1.3 . . . . 0.0 111.504 -176.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.65 53.14 25.7 Favored Glycine 0 C--N 1.358 1.777 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 174.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 19.6 mtm180 -133.76 135.11 43.69 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 127.698 2.646 . . . . 0.0 107.838 -178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.4 mt -124.11 134.88 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 O-C-N 124.956 1.41 . . . . 0.0 110.379 -162.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.435 HH21 ' CD ' ' A' ' 138' ' ' GLU . 1.8 mpp_? -102.46 134.05 46.41 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 124.967 2.318 . . . . 0.0 107.931 170.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 37.3 mt -134.65 156.3 48.99 Favored 'General case' 0 C--O 1.216 -0.695 0 O-C-N 120.518 -1.364 . . . . 0.0 110.428 -163.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 26.1 t -135.29 118.91 17.02 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 124.288 1.035 . . . . 0.0 111.581 177.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . 0.262 95.3 mt -81.23 -24.25 10.44 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.845 0 CA-C-O 123.791 1.758 . . . . 0.0 108.092 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.425 ' HZ2' ' CD ' ' A' ' 151' ' ' GLU . 14.6 pttp -86.69 -32.59 20.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.353 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.425 ' CD ' ' HZ2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -69.92 -43.6 71.35 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 170.267 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.56 -19.41 60.9 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.551 -1.259 . . . . 0.0 112.624 -175.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 22.2 p -97.82 7.69 45.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.456 168.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . 0.258 49.8 mt-10 55.31 56.75 6.07 Favored 'General case' 0 N--CA 1.528 3.441 1 N-CA-C 123.778 4.733 . . . . 0.0 123.778 173.481 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 . . . . . 0 N--CA 1.417 -2.101 0 O-C-N 117.805 -3.059 . . . . 0.0 111.593 -176.471 . . . . . . . . 0 0 . 1 stop_ save_